data_2kxh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.613 0.244 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 111' ' ' MET . . . -56.77 -48.66 77.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.973 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.454 HD11 ' HG3' ' A' ' 163' ' ' PRO . 59.0 tp -71.47 -36.62 71.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.93 84.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.369 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.2 pt -78.6 -34.55 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.427 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 107' ' ' ALA . 89.9 mtp -61.52 -26.76 68.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -84.35 -2.19 56.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.6 0.238 . . . . 0.0 111.279 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 27.0 ttp180 -128.74 109.48 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.927 0.394 . . . . 0.0 110.714 -175.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.1 m -92.57 141.28 14.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.484 0.659 . . . . 0.0 111.649 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 53.0 t80 -86.09 130.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.982 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 111.71 37.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.07 0.462 . . . . 0.0 110.085 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.07 155.73 15.95 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.928 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.1 m 68.87 49.97 0.64 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 110.462 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.45 127.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.185 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -45.17 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.867 0.729 . . . . 0.0 112.79 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -178.38 -64.54 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.559 0.219 . . . . 0.0 110.98 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.12 18.98 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.006 0.431 . . . . 0.0 112.087 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 3.6 pp -130.21 141.3 50.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.954 0.407 . . . . 0.0 110.489 176.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.66 -152.43 5.96 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.59 -31.57 69.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.528 0.664 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.22 -43.41 98.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.132 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 2.1 m -84.87 -43.77 13.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.336 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.44 -36.58 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -55.71 -44.13 77.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.95 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -77.82 -34.75 51.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.312 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.27 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.631 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 98.2 m-85 -108.14 12.07 27.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.55 -44.87 46.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.268 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 17.8 Cg_endo -61.19 -17.28 51.61 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.215 1.943 . . . . 0.0 112.553 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -80.05 -70.16 0.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.47 155.06 26.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.524 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 24.5 Cg_exo -64.13 132.5 34.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.621 2.214 . . . . 0.0 111.586 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.68 110.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.164 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.879 ' HD3' ' HG2' ' A' ' 161' ' ' GLU . 39.2 tptt -83.26 -46.96 12.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.063 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -160.15 153.99 22.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.33 123.09 49.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.741 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.638 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 21.2 m-20 -90.44 97.34 11.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 14.0 tpt -105.82 148.67 27.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.002 0.43 . . . . 0.0 111.371 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.0 m -119.09 84.31 2.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.704 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -80.2 116.38 20.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 153' ' ' LYS . 14.9 t70 -95.8 117.2 30.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.655 ' HB3' HG22 ' A' ' 149' ' ' THR . 43.9 t 69.13 162.73 0.22 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.059 0.849 . . . . 0.0 111.733 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.45 -22.32 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 147' ' ' SER . 9.8 t -60.29 -25.12 65.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.102 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.2 mtt 64.32 43.36 4.77 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.827 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HG2' HG21 ' A' ' 149' ' ' THR . 31.4 mmmt -93.23 12.79 23.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.052 0.453 . . . . 0.0 110.813 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.0 p80 41.56 44.69 2.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.489 1.116 . . . . 0.0 113.079 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 28.4 tttm -70.75 96.99 1.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.347 0.594 . . . . 0.0 110.033 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 158.18 -129.27 2.27 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.221 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -148.36 170.46 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.238 0.215 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.19 153.13 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 111.047 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.658 ' HE2' ' HD2' ' A' ' 187' ' ' ARG . 90.6 m-85 -123.14 124.8 43.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.036 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.2 t -106.22 111.04 33.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 31.8 tt0 -99.58 131.04 45.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -105.68 174.15 6.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.085 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.879 ' HG2' ' HD3' ' A' ' 139' ' ' LYS . 32.2 mt-10 -85.4 -16.26 40.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.097 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.81 135.29 21.5 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.4 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.454 ' HG3' HD11 ' A' ' 108' ' ' LEU . 55.4 Cg_endo -69.87 -17.77 36.9 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.987 2.458 . . . . 0.0 112.197 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -62.85 -40.21 96.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.696 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.92 89.16 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.248 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.84 86.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.483 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -62.2 -47.1 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.535 HD22 ' HA3' ' A' ' 283' ' ' GLY . 34.4 mt -66.59 -33.49 75.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.15 0.5 . . . . 0.0 110.561 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -64.77 -34.13 77.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.298 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.17 -55.47 5.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.972 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.93 -47.68 76.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.506 ' HG2' ' HD2' ' A' ' 281' ' ' ARG . 17.1 mp0 -91.0 -49.88 6.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.631 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 12.6 mmt -66.97 -30.81 71.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.76 -21.28 37.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.151 0.5 . . . . 0.0 110.891 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.2 m -90.98 -24.01 20.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.114 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.2 t -116.0 119.51 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.193 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 89.6 mtp -67.19 108.7 2.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 110.882 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 178' ' ' LEU . 2.5 pt? -81.2 7.54 10.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.799 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.53 -167.29 35.53 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.98 25.42 2.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.629 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -158.3 133.69 8.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -91.96 129.47 37.91 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.4 pt -91.61 151.69 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -100.95 116.59 33.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.0 t -103.24 122.46 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.546 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 105.96 172.99 23.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.419 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.658 ' HD2' ' HE2' ' A' ' 157' ' ' PHE . 75.7 mtp180 -130.0 92.22 37.28 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.624 0.25 . . . . 0.0 110.411 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.06 80.54 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.894 2.396 . . . . 0.0 111.661 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -143.9 -54.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.18 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -90.04 5.89 44.68 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.09 0.472 . . . . 0.0 111.212 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 39.9 pt -68.11 153.61 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 88.78 -51.74 3.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.928 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.33 69.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.37 0.605 . . . . 0.0 109.764 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -91.53 1.56 57.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.976 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.548 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.7 tp60 -59.57 -50.04 89.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.103 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 11.2 Cg_endo -55.52 -27.46 59.61 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.353 2.036 . . . . 0.0 112.221 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.9 mm -77.38 -43.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.322 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 80.7 mt -59.52 -50.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.89 -29.92 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.206 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -68.01 -50.08 57.67 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.63 -48.56 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.028 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.03 93.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.224 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -69.39 -33.51 73.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.511 . . . . 0.0 110.659 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.02 -45.12 62.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.369 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.12 -24.79 64.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -60.45 -25.04 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.908 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.54 -16.45 64.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.457 ' C ' HD21 ' A' ' 209' ' ' ASN . 60.3 m-85 -104.96 -4.94 21.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.155 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.457 HD21 ' C ' ' A' ' 208' ' ' PHE . 0.1 OUTLIER 32.32 43.17 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 114.252 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 256' ' ' GLU . 24.8 mtp180 -90.16 141.8 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.657 HD12 ' HE1' ' A' ' 229' ' ' PHE . 12.8 tt -99.14 152.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.532 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -107.67 124.54 50.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 0.0 110.24 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.422 HG22 HD12 ' A' ' 255' ' ' ILE . 17.6 t -108.41 116.88 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.002 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.536 ' O ' ' HG ' ' A' ' 280' ' ' LEU . . . -121.07 173.83 7.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.558 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 35.0 m 64.85 28.33 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.744 0.653 . . . . 0.0 110.778 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 225' ' ' ILE . 57.7 t -72.69 133.87 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.374 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 13.6 t-80 -69.1 135.04 50.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 109.764 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -55.62 -41.74 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.667 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.607 ' HB2' ' HB ' ' B' ' 45' ' ' ILE . 2.6 p30 -80.35 -46.95 15.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.555 HD22 ' CD1' ' A' ' 275' ' ' LEU . 0.1 OUTLIER -50.72 122.69 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.403 0.681 . . . . 0.0 109.954 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 22.1 m -99.74 -178.46 3.88 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -167.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.13 -55.42 31.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.014 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.648 ' O ' ' HB2' ' A' ' 226' ' ' LYS . 2.6 m-20 -62.88 -27.35 69.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 221' ' ' SER . 71.9 m-20 -66.66 -49.17 67.04 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.749 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.555 HD12 HG11 ' A' ' 216' ' ' VAL . 21.8 mm -61.16 -24.74 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.271 0.558 . . . . 0.0 109.971 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 223' ' ' ASP . 11.0 mmmm -59.43 -31.8 69.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 174.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.679 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 71.2 m -47.79 -54.94 10.83 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.506 0.669 . . . . 0.0 111.034 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' B' ' 34' ' ' ALA . 12.5 m -75.24 -49.97 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.665 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.657 ' HE1' HD12 ' A' ' 211' ' ' ILE . 50.0 m-85 -61.21 -46.99 88.19 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.526 ' HB2' ' HE2' ' A' ' 226' ' ' LYS . 27.9 tt0 -77.94 -12.53 59.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.368 . . . . 0.0 111.272 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.62 51.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.357 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.719 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 0.9 OUTLIER -93.82 -52.66 4.34 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -138.74 -164.5 9.93 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.438 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -108.82 139.1 44.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.549 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.623 ' HB ' ' HE3' ' A' ' 226' ' ' LYS . 3.2 mp -120.27 134.37 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -97.73 -29.06 13.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 111.721 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.6 t -143.34 132.44 23.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.545 ' SG ' ' HD3' ' A' ' 226' ' ' LYS . 9.1 p -144.03 113.56 7.05 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.836 0.35 . . . . 0.0 110.599 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 63.4 m -151.37 122.43 7.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.517 . . . . 0.0 111.353 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.669 HD22 ' HA3' ' A' ' 253' ' ' GLY . 43.4 mt -85.1 130.04 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.61 129.63 42.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.691 0.281 . . . . 0.0 110.907 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -78.97 140.47 38.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.54 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.3 t70 -111.55 116.82 50.03 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.42 -27.88 46.74 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 123.138 2.559 . . . . 0.0 113.659 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.1 t -93.32 -27.76 16.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.991 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.3 m -81.14 -36.67 29.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.061 0.458 . . . . 0.0 110.167 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 96.74 -18.45 57.48 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.738 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 249' ' ' HIS . 72.3 mmtt -108.04 -84.67 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 0.0 110.46 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 248' ' ' LYS . 29.6 p80 -164.08 154.02 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 56.0 mttm -71.41 155.38 40.7 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.64 31.52 1.03 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 121.293 -0.479 . . . . 0.0 113.661 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.524 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 27.1 p90 -152.97 164.02 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.109 0.454 . . . . 0.0 110.281 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.669 ' HA3' HD22 ' A' ' 240' ' ' LEU . . . -164.15 168.42 38.58 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.62 114.57 26.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.041 0.448 . . . . 0.0 110.582 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 213' ' ' VAL . 43.8 mt -107.1 139.73 27.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.822 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 210' ' ' ARG . 38.1 tt0 -115.67 115.52 26.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.698 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.31 152.93 21.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.554 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 15.0 pt-20 -88.75 -16.98 30.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.878 0.371 . . . . 0.0 110.494 177.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.489 ' HE3' ' HB3' ' A' ' 259' ' ' LYS . 22.5 mtpp -128.57 135.77 49.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.11 -25.17 61.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.618 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -66.03 -50.33 64.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.211 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.9 m -63.61 -33.87 76.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.439 -176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 267' ' ' VAL . 31.7 t -57.3 -46.91 82.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.178 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.55 -34.67 77.53 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.83 -44.43 96.17 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.243 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.22 80.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 263' ' ' SER . 62.0 t -52.73 -36.35 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.853 0.359 . . . . 0.0 111.508 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 42.8 m -69.08 -24.76 64.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 38.9 m -115.33 -27.15 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.532 ' HE3' HG23 ' A' ' 228' ' ' VAL . 43.4 mmm -66.94 -13.69 62.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.28 -35.86 80.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.11 0.957 . . . . 0.0 109.121 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.5 mm? -77.39 -9.28 58.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.981 -175.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.903 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 6.2 t80 -51.26 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.137 0.494 . . . . 0.0 111.173 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -82.97 121.49 27.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.242 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.555 ' CD1' HD22 ' A' ' 220' ' ' LEU . 65.9 mt -125.66 85.87 2.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.041 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.54 27.09 57.93 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.871 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 110.43 -17.42 28.6 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.46 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -102.21 130.45 48.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.816 0.341 . . . . 0.0 110.721 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -80.18 134.61 36.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.655 HD23 ' HD2' ' A' ' 273' ' ' PHE . 2.4 tp -66.78 -178.51 0.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.968 0.792 . . . . 0.0 110.78 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.506 ' HD2' ' HG2' ' A' ' 172' ' ' GLN . 5.6 tpp180 -148.52 112.68 5.21 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.84 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 270' ' ' MET . 18.6 m -111.48 159.48 11.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.558 . . . . 0.0 111.897 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.535 ' HA3' HD22 ' A' ' 168' ' ' LEU . . . -157.8 -136.03 2.01 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.687 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -142.86 167.75 21.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -87.71 124.92 34.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.03 -29.73 3.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.381 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.7 t -129.94 143.87 50.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 CA--C 1.53 0.3 0 C-N-CA 123.34 2.693 . . . . 0.0 112.15 176.657 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . 0.609 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 7.5 t30 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.91 -46.61 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 -43.53 77.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.679 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 9.8 t80 -78.97 -22.51 45.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.958 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.617 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.8 mtpt -79.06 -35.01 43.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.785 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.525 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 58.1 t0 -57.07 -46.48 82.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.719 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -49.09 -52.9 23.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.169 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.79 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.7 -25.28 35.6 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -168.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.617 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 32.8 mt-30 -63.24 -38.05 89.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.679 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 67.3 mtt180 -71.57 -39.29 70.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.734 172.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.903 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.98 -46.85 85.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.147 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.262 31.9 mtt-85 -80.51 -24.35 39.45 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.898 174.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 56.1 tt0 -53.63 -49.87 66.95 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.248 0.546 . . . . 0.0 109.976 167.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.798 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -65.69 -30.45 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -21.84 42.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.387 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.91 72.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.714 ' HG3' HG12 ' B' ' 45' ' ' ILE . 48.5 pttt -72.66 -43.91 62.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.448 174.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.714 HG12 ' HG3' ' B' ' 44' ' ' LYS . 5.7 pt . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.851 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.919 0.39 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.07 96.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.412 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.64 -36.98 85.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.56 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.55 -28.08 66.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.824 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.36 -43.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.137 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 81.4 mmm -61.24 -40.55 94.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.094 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.465 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 98.8 m -65.22 -19.57 66.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 9.8 ptm85 -116.27 107.18 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.528 0.68 . . . . 0.0 111.264 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.8 m -97.33 135.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.363 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 19.4 t80 -78.35 126.78 31.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.384 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.571 HG12 HG21 ' A' ' 185' ' ' VAL . 15.3 m -123.67 111.64 29.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.419 0.628 . . . . 0.0 110.02 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -133.9 102.76 0.47 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.625 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.61 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.6 t 168.12 77.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.3 mt -110.16 134.56 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.06 -75.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.17 0.294 . . . . 0.0 111.199 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -169.12 -53.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.198 0.523 . . . . 0.0 110.359 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -19.6 19.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.817 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.58 108.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 0.0 110.792 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.417 ' HA2' ' NE2' ' A' ' 152' ' ' HIS . . . -83.09 -178.77 52.41 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.614 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.47 -24.42 65.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.749 0.309 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.47 -43.53 93.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.323 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -62.19 -44.58 96.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.71 -46.75 91.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 110.57 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.497 ' HG3' HG13 ' A' ' 138' ' ' ILE . 70.6 ttt180 -57.47 -45.75 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.006 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -77.25 -19.15 56.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.43 57.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.747 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 74.0 m-85 -101.86 7.45 41.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 110.797 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.463 ' HB2' ' HD3' ' A' ' 134' ' ' PRO . . . -72.14 -42.37 9.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.928 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 133' ' ' ALA . 36.6 Cg_exo -63.59 -4.97 7.74 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.155 1.903 . . . . 0.0 112.716 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CZ ' ' HE3' ' A' ' 173' ' ' MET . 29.8 m-85 -92.7 -75.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.784 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.77 168.86 25.8 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 18.6 Cg_exo -66.14 133.71 34.07 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.54 2.16 . . . . 0.0 111.585 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.497 HG13 ' HG3' ' A' ' 129' ' ' ARG . 47.6 mm -72.02 114.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.358 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -94.71 -46.03 7.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 29.9 t -143.88 135.22 25.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 110.946 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.453 HG22 ' HG3' ' A' ' 143' ' ' MET . 65.9 mt -116.65 106.12 19.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.436 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.2 m-20 -111.33 98.28 7.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.453 ' HG3' HG22 ' A' ' 141' ' ' ILE . 79.7 mtp -109.5 163.68 13.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.466 . . . . 0.0 111.148 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.6 m -145.87 85.67 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.83 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.434 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 13.1 p-90 -144.92 160.13 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.697 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.48 91.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.2 m -85.35 -9.53 57.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.361 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 m -80.15 -52.1 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.623 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -112.9 21.38 15.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.434 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 89.7 mmm 61.69 -157.2 0.34 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.16 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm 73.54 105.42 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -172.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.417 ' NE2' ' HA2' ' A' ' 124' ' ' GLY . 14.8 m-70 -77.6 68.87 3.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.35 31.73 1.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.999 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -139.68 175.25 21.88 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.813 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -114.37 173.51 6.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -139.9 148.51 42.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.461 . . . . 0.0 111.689 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.429 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 86.2 m-85 -116.94 118.67 33.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -110.1 120.03 60.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.302 0.572 . . . . 0.0 110.958 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.8 tt0 -107.63 134.76 50.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.906 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.61 167.15 9.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.889 0.376 . . . . 0.0 111.647 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.3 -45.28 88.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.168 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.59 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 23.9 m -115.73 138.2 23.76 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.113 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.465 ' HG3' ' SG ' ' A' ' 112' ' ' CYS . 16.5 Cg_exo -68.09 -20.48 43.98 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.4 2.734 . . . . 0.0 112.29 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.59 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 4.0 mp0 -56.52 -52.24 65.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.469 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.43 62.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.47 53.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -73.13 -32.62 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.754 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.461 HD21 ' CE2' ' A' ' 212' ' ' TYR . 25.2 tp -57.42 -48.6 78.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.034 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.32 99.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.708 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.541 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 4.9 tt -59.51 -62.48 1.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.039 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.18 -35.21 74.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.383 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.665 ' HG3' ' HD2' ' A' ' 281' ' ' ARG . 14.3 mm100 -83.19 -49.5 9.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.747 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 20.6 mmt -73.7 -31.44 63.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -75.01 -16.92 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.403 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.2 m -91.83 -12.25 34.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 173' ' ' MET . 33.6 m -110.59 140.17 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.345 0.593 . . . . 0.0 111.618 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 27.4 ttt -90.72 105.12 17.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.713 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.83 91.57 0.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.46 . . . . 0.0 110.162 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 63.64 -130.21 39.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.829 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.55 5.24 80.19 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.013 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.73 102.64 6.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.311 0.576 . . . . 0.0 110.498 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.77 128.98 38.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.905 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.61 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 21.0 pt -89.39 144.71 8.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.886 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -102.39 110.84 22.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.432 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.571 HG21 HG12 ' A' ' 116' ' ' VAL . 47.1 t -125.12 136.23 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.454 -174.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.541 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 92.57 46.42 3.48 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.971 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.627 ' HA ' HD12 ' A' ' 191' ' ' ILE . 41.5 ttt85 -139.44 78.69 26.65 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.227 0.514 . . . . 0.0 111.118 175.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 -62.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.587 2.191 . . . . 0.0 111.723 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.4 p -171.63 -52.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.544 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 12.6 m120 -81.51 68.66 7.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.005 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 187' ' ' ARG . 50.0 mm -74.68 108.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.858 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.89 -8.06 57.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.643 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 190' ' ' ASN . 53.5 mt-30 -77.14 -12.63 59.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 111.259 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.59 16.84 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.622 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.568 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.0 tp60 -58.45 -52.24 76.06 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.441 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 51.5 Cg_exo -55.85 -30.05 75.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.768 1.645 . . . . 0.0 112.062 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.421 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 47.8 mm -72.61 -56.11 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.769 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.493 ' HA ' HD11 ' A' ' 201' ' ' LEU . 35.2 pt -66.7 -30.74 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.33 -42.05 96.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.397 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -69.72 -35.81 75.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.709 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' A' ' 198' ' ' ILE . 95.6 mt -62.03 -50.66 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.21 -29.65 70.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.72 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 206' ' ' ARG . 39.2 tt0 -62.42 -52.42 63.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.055 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.94 -29.24 68.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.5 . . . . 0.0 110.502 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.71 68.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.596 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.493 ' CZ ' ' HA ' ' A' ' 203' ' ' GLU . 51.1 mtt180 -64.26 -25.54 68.1 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.43 -18.87 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.587 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.18 -29.3 11.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 0.0 110.914 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 58.66 23.98 11.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.688 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 12.3 ptp180 -89.48 150.56 22.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.995 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.98 168.04 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.337 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.461 ' CE2' HD21 ' A' ' 168' ' ' LEU . 71.7 t80 -112.33 121.66 45.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.382 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.52 123.18 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.286 0.565 . . . . 0.0 110.351 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.37 178.31 5.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.721 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.6 m 68.75 25.94 6.22 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 124.022 0.826 . . . . 0.0 111.481 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.59 HG23 HD12 ' A' ' 240' ' ' LEU . 10.8 m -77.2 164.38 3.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.47 ' HB2' HD21 ' A' ' 275' ' ' LEU . 6.9 t-80 -81.09 147.17 30.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -57.31 -55.86 29.29 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.702 ' HB2' HG13 ' B' ' 45' ' ' ILE . 0.2 OUTLIER -70.08 -48.36 58.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.689 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.993 HD13 HG13 ' B' ' 41' ' ' ILE . 0.4 OUTLIER -61.13 114.99 3.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.024 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.2 t -100.43 -177.06 3.39 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -166.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.465 ' HB3' ' HG ' ' A' ' 240' ' ' LEU . 4.3 p30 -60.31 -37.73 81.5 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.64 -31.31 69.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.623 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 13.4 m-20 -78.2 -53.87 6.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.42 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.608 HG13 HD11 ' A' ' 240' ' ' LEU . 32.4 mm -54.89 -25.59 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.041 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -55.79 -33.34 64.31 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.519 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.487 ' HG ' HG23 ' B' ' 41' ' ' ILE . 69.2 m -49.46 -56.0 11.26 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.693 0.758 . . . . 0.0 111.716 -174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' B' ' 34' ' ' ALA . 4.4 m -74.61 -49.68 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.734 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.608 ' CE1' ' HE1' ' A' ' 270' ' ' MET . 58.3 m-85 -60.89 -41.68 96.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.917 0.389 . . . . 0.0 111.626 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.504 ' HB2' HD13 ' A' ' 235' ' ' ILE . 1.1 tm-20 -76.26 -22.4 55.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.34 -23.49 61.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.901 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.81 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 1.0 OUTLIER -93.92 -33.42 13.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.226 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -163.67 -179.78 38.22 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.3 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -74.66 122.65 23.54 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.653 HG21 ' HB2' ' A' ' 238' ' ' CYS . 55.2 mt -97.57 132.82 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 172.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.693 ' HD2' ' HA ' ' A' ' 258' ' ' GLU . 29.3 mtpp -100.8 -46.01 5.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.198 0.523 . . . . 0.0 110.362 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.5 m -136.28 93.88 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.653 ' HB2' HG21 ' A' ' 235' ' ' ILE . 48.3 t -96.76 113.17 24.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.0 m -151.12 116.85 5.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.619 0.247 . . . . 0.0 110.99 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.756 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 78.7 mt -85.34 130.02 34.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.81 134.69 54.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.806 0.336 . . . . 0.0 110.35 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.805 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 12.3 ptm180 -117.7 157.42 26.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.035 0.445 . . . . 0.0 110.889 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.437 ' OD1' HG21 ' A' ' 245' ' ' THR . 9.6 t70 -88.01 122.71 69.86 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.089 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.96 -19.0 40.54 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.112 2.542 . . . . 0.0 114.546 -172.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.437 HG21 ' OD1' ' A' ' 243' ' ' ASP . 6.4 t -99.17 -30.12 12.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.513 -174.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 36.3 p -94.23 -26.35 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.986 0.422 . . . . 0.0 110.622 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.85 -18.49 53.07 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.278 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.81 150.29 22.31 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.805 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.8 p80 -75.61 152.41 37.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.313 0.578 . . . . 0.0 111.215 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.66 158.71 22.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.188 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.44 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -72.22 43.16 0.83 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 43.3 p90 -165.63 166.07 18.32 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.756 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.63 -174.4 40.57 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.552 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.565 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 94.3 m-85 -122.58 124.88 44.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.986 0.422 . . . . 0.0 110.267 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.2 mt -120.29 126.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.669 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 36.0 tt0 -103.67 136.61 43.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.459 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -109.23 151.54 26.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.757 0.789 . . . . 0.0 112.191 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.693 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 3.1 tp10 -80.24 -21.79 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.628 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 50.2 mtpt -143.17 140.14 30.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.807 -171.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.4 -33.64 76.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.86 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -63.61 -41.02 98.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.411 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.513 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 21.7 m -67.8 -39.85 83.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.479 ' O ' HG21 ' A' ' 267' ' ' VAL . 7.8 p -69.61 -32.8 71.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -66.46 -44.07 83.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.423 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.39 -39.51 92.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.56 76.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.259 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 263' ' ' SER . 90.8 t -62.5 -29.03 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 111.58 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 p -89.89 -10.12 46.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 27.8 t -115.84 -40.24 3.37 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.81 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 30.5 mmm -70.84 -14.67 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.91 0.862 . . . . 0.0 110.36 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.213 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.655 ' HE1' ' HB2' ' B' ' 38' ' ' ALA . 51.6 t80 -56.94 98.82 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.521 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.77 119.86 24.88 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.926 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.852 HD23 HD21 ' A' ' 220' ' ' LEU . 19.7 tp -126.09 86.88 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.45 22.68 39.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.551 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.4 15.29 30.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.614 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -140.67 132.37 27.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.653 0.263 . . . . 0.0 110.395 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.33 133.61 42.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 216' ' ' VAL . 1.0 OUTLIER -71.95 -169.78 0.51 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 0.0 110.972 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.665 ' HD2' ' HG3' ' A' ' 172' ' ' GLN . 21.1 tpp180 -147.79 116.39 6.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.47 139.0 52.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -160.42 -178.81 34.73 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.615 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -72.16 152.2 42.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.43 -20.06 66.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.4 t 71.07 -77.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 122.547 0.339 . . . . 0.0 111.764 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.7 121.9 39.76 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.014 0.435 . . . . 0.0 111.956 -174.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.454 -0.799 0 C-N-CA 122.924 2.416 . . . . 0.0 112.41 177.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.27 -33.02 26.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.116 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.25 71.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.151 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.566 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.9 t80 -74.29 -19.61 60.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.336 0.589 . . . . 0.0 110.49 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 53.3 mttp -76.37 -43.76 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -39.71 77.99 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.403 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.711 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.24 -52.57 43.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.904 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.44 -21.95 38.5 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 41.3 mt-30 -63.15 -38.16 90.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.519 ' O ' HG21 ' B' ' 41' ' ' ILE . 76.5 mtp180 -73.71 -35.38 65.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.226 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.792 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -61.47 -45.89 92.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' B' ' 39' ' ' ARG 0.253 16.5 mtp180 -81.38 -25.96 35.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.474 -1.391 . . . . 0.0 113.095 174.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -53.49 -49.72 66.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.155 168.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.993 HG13 HD13 ' A' ' 220' ' ' LEU . 3.9 pt -61.45 -37.91 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.076 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -71.85 -22.37 61.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.095 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.69 -45.57 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.08 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 20.6 pttp -74.96 -23.76 58.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.702 HG13 ' HB2' ' A' ' 219' ' ' ASP . 8.3 tp . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 122.083 0.944 . . . . 0.0 110.052 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.944 0.402 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.6 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.313 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.6 tp -73.77 -30.78 62.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.284 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.76 -29.49 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.094 0.473 . . . . 0.0 110.716 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.73 -38.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.483 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.77 -26.8 68.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.349 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 160' ' ' TYR . 15.5 p -92.3 -1.16 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.58 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -118.27 118.95 33.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.2 m -112.62 125.54 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 111.207 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 27.4 t80 -73.74 137.15 43.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.125 175.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.12 110.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 123.415 0.447 . . . . 0.0 109.822 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.2 170.54 13.96 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.111 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.627 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 6.4 t 62.68 48.67 4.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.423 0.63 . . . . 0.0 110.376 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -81.85 71.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.454 ' HB3' ' H ' ' A' ' 121' ' ' TYR . 22.3 t80 36.31 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.554 1.159 . . . . 0.0 112.512 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.454 ' H ' ' HB3' ' A' ' 120' ' ' TYR . 38.3 t80 -178.71 -62.03 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -91.63 45.21 1.21 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.072 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.0 125.84 49.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.983 0.42 . . . . 0.0 110.622 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.49 159.08 23.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.26 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.53 -36.74 74.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 111.268 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.69 -32.52 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.413 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 m -76.53 -41.26 47.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.901 0.381 . . . . 0.0 111.154 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 63.7 mt -72.72 -41.05 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.251 0.548 . . . . 0.0 110.104 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -54.4 -41.21 69.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.151 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -76.92 -22.98 52.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.28 74.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 110.594 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.407 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 71.4 m-85 -96.54 4.65 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.586 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -63.01 -44.07 83.89 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.857 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.592 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.2 Cg_endo -69.1 -4.33 13.37 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.012 1.808 . . . . 0.0 113.37 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.613 ' HB3' ' HB2' ' A' ' 165' ' ' ALA . 2.7 m-85 -81.06 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.965 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.87 172.99 39.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.176 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.37 128.73 27.08 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.21 117.91 28.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.859 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.586 ' HD3' ' CG ' ' A' ' 161' ' ' GLU . 51.1 tptt -87.34 -53.75 4.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.227 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.8 m -145.79 151.16 37.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.154 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -135.5 107.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 6.4 m-20 -92.3 96.23 10.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.28 0.562 . . . . 0.0 110.172 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.589 ' HE3' ' HB3' ' A' ' 156' ' ' ALA . 41.2 tpp -123.94 94.01 4.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.287 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 t -83.63 84.1 7.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.379 0.609 . . . . 0.0 109.479 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 0.1 OUTLIER -134.05 160.77 36.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.098 -178.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.33 102.72 15.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 m -66.16 -23.5 66.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.295 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.23 -33.89 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 m -96.69 -13.06 23.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.0 110.563 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 45.5 ttm 58.32 34.35 23.97 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.316 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -126.03 143.58 51.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.287 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.742 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 22.8 p80 -103.93 112.39 25.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.142 0.496 . . . . 0.0 111.165 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -76.38 -15.3 59.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.135 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.89 -152.75 8.37 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.568 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.88 175.2 9.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.589 ' HB3' ' HE3' ' A' ' 143' ' ' MET . . . -99.14 137.32 37.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.066 0.46 . . . . 0.0 111.975 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 95.4 m-85 -117.73 106.45 13.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 169.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.7 p -100.46 122.71 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.813 0.816 . . . . 0.0 110.377 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.1 135.19 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.106 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 41.9 m-85 -115.23 164.98 13.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.586 ' CG ' ' HD3' ' A' ' 139' ' ' LYS . 33.6 mt-10 -95.66 10.02 38.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.338 0.59 . . . . 0.0 109.499 170.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.44 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.0 m -130.25 115.11 17.38 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.213 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 162' ' ' VAL . 20.4 Cg_endo -62.43 -21.73 73.13 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.745 2.296 . . . . 0.0 111.686 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 285' ' ' ALA . 15.9 mp0 -59.47 -63.59 1.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.601 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' A' ' 135' ' ' PHE . . . -57.49 -33.46 68.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.599 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.43 62.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.646 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.49 -33.95 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.494 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.416 HD21 ' HG3' ' A' ' 281' ' ' ARG . 8.9 tt -61.29 -48.32 81.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.03 -39.84 91.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.631 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.4 tt -58.83 -55.03 40.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -75.35 -48.14 24.4 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -91.85 -0.36 57.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -165.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.445 ' HG3' HD11 ' A' ' 183' ' ' ILE . 55.1 tpp -116.42 -32.75 5.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.086 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.517 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 6.7 t30 -68.75 -27.04 65.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.365 0.603 . . . . 0.0 110.351 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -90.83 17.18 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.889 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.12 142.79 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.219 0.533 . . . . 0.0 110.623 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.54 100.91 10.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.085 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.94 -55.65 32.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.554 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.84 69.09 0.31 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.382 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.86 -38.89 2.37 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.566 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.495 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 5.2 mpt_? -97.52 136.67 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.3 118.24 17.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 24.1 pt -84.7 157.03 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.121 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -104.18 110.92 23.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 46.3 t -120.4 128.79 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.765 0.317 . . . . 0.0 110.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.631 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 110.9 -105.47 1.9 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.027 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.433 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 14.3 mmt180 66.56 78.06 0.25 Allowed Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.137 0.575 . . . . 0.0 112.456 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.99 97.36 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.831 2.354 . . . . 0.0 110.654 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.3 t -75.48 -28.31 59.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -84.82 80.03 9.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.347 0.594 . . . . 0.0 110.988 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.33 62.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.56 0.695 . . . . 0.0 110.347 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.63 -80.78 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.459 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -82.12 -34.98 28.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.969 0.414 . . . . 0.0 110.535 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -72.85 -33.49 66.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.603 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.49 10.18 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.213 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.619 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 27.2 Cg_endo -62.04 -37.08 67.05 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.795 1.663 . . . . 0.0 112.231 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.44 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 50.5 mm -66.77 -41.45 87.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 194' ' ' ALA . 90.2 mt -59.75 -42.23 88.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.96 -39.82 90.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.551 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 80.8 mm-40 -62.07 -37.84 86.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 99.1 mt -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.529 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.27 85.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.842 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.79 -33.93 76.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.199 0.524 . . . . 0.0 110.563 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.424 ' O ' ' HD1' ' A' ' 208' ' ' PHE . 7.9 tp10 -66.01 -49.59 67.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.258 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.59 78.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -67.28 -23.35 65.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.635 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.87 -28.88 50.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.121 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.424 ' HD1' ' O ' ' A' ' 204' ' ' GLU . 24.6 m-85 -88.62 -19.57 26.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.37 0.605 . . . . 0.0 110.437 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 65.8 t30 61.1 37.12 17.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.001 168.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.58 136.65 40.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.969 0.414 . . . . 0.0 110.176 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.48 ' CG2' ' HB ' ' A' ' 255' ' ' ILE . 9.8 tt -100.45 144.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -108.28 109.51 20.88 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.457 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.3 p -105.64 120.0 55.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 0.0 110.777 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.63 178.16 4.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.447 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.6 m 67.85 14.29 9.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.508 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.64 ' HA ' HD21 ' A' ' 280' ' ' LEU . 10.6 p -71.21 137.49 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.305 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.516 ' HD2' ' O ' ' A' ' 275' ' ' LEU . 2.3 t-80 -67.25 134.81 52.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 -176.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -58.61 -8.8 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.987 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.0 -37.21 47.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.288 0.566 . . . . 0.0 110.319 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.895 HD11 HD12 ' A' ' 275' ' ' LEU . 0.5 OUTLIER -113.32 128.12 56.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.665 -172.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.4 m -100.61 -175.32 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.791 0.437 . . . . 0.0 111.125 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.801 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 6.6 p-10 -53.6 -40.76 65.96 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.86 -35.66 66.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.45 0.643 . . . . 0.0 110.408 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.729 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.8 m-20 -78.89 -58.01 3.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.163 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.508 HG13 HG23 ' A' ' 216' ' ' VAL . 20.6 mm -63.46 -15.52 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.253 0.549 . . . . 0.0 111.067 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.743 ' HG3' HD13 ' A' ' 235' ' ' ILE . 83.1 tttt -54.42 -32.15 56.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.573 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.717 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.7 m -48.78 -61.37 2.08 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.704 0.764 . . . . 0.0 111.477 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.958 ' HB ' ' HE2' ' A' ' 270' ' ' MET . 3.0 m -73.66 -38.92 52.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.506 -172.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 19.0 m-85 -62.89 -50.79 69.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.694 0.283 . . . . 0.0 111.661 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.522 ' HG3' ' HA ' ' A' ' 234' ' ' LYS . 27.6 tt0 -77.83 -17.99 56.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.47 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.198 -0.314 . . . . 0.0 111.008 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.729 ' HE1' ' HB3' ' B' ' 34' ' ' ALA . 2.4 m-30 -82.88 -42.21 18.02 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.85 -107.19 0.79 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.219 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.522 ' HA ' ' HG3' ' A' ' 230' ' ' GLU . 33.6 ttmt -157.51 159.62 37.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.743 HD13 ' HG3' ' A' ' 226' ' ' LYS . 60.3 mt -122.98 128.62 75.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 111.218 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -92.33 -31.03 15.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.333 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 33.2 t -156.93 119.56 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.771 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.61 ' HB3' HG21 ' A' ' 235' ' ' ILE . 6.3 p -117.74 117.12 28.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 36.3 m -153.31 104.99 2.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 112.063 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.801 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 54.7 mt -86.42 119.24 26.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 166.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.95 106.19 0.67 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.731 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -92.59 153.48 18.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.66 96.31 27.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.4 -19.53 49.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -35.98 57.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.248 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.2 m -86.19 -33.0 20.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.45 35.17 5.3 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.329 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.42 156.83 16.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.731 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 12.0 p80 -84.46 138.33 32.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -67.02 152.57 45.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.69 24.61 1.5 Allowed Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.942 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.34 161.31 42.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.284 0.542 . . . . 0.0 110.583 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.674 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.29 -174.95 40.71 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.868 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -120.07 135.89 54.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.035 0.445 . . . . 0.0 111.178 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.48 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 28.8 mm -118.33 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 33.9 tt0 -104.69 126.27 51.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.52 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -101.47 146.83 27.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.47 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 1.3 pm0 -78.34 -16.96 57.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.573 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.47 ' HG3' ' HG2' ' A' ' 258' ' ' GLU . 31.3 mtmm -137.09 148.48 46.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.67 64.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.78 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.36 -43.24 88.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.698 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.2 m -68.56 -31.99 71.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 33.2 t -65.77 -52.21 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.382 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.48 -36.29 83.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.379 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.3 -31.32 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.579 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.94 63.7 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.95 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 42.8 t -54.4 -42.97 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 50.6 m -70.94 -25.89 62.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.4 p -109.65 -37.7 5.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.958 ' HE2' ' HB ' ' A' ' 228' ' ' VAL . 0.4 OUTLIER -65.77 -27.65 68.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.495 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.6 t30 -57.53 -34.38 69.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.743 0.783 . . . . 0.0 110.275 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.466 ' O ' ' HD2' ' A' ' 279' ' ' TYR . 18.5 mt -76.43 -6.55 52.18 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.86 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.827 ' HB2' ' HE1' ' A' ' 270' ' ' MET . 3.2 t80 -54.43 102.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.6 t70 -89.07 122.99 32.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.725 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.895 HD12 HD11 ' A' ' 220' ' ' LEU . 88.8 mt -120.55 87.97 2.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.233 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.59 36.75 47.93 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.03 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.84 7.83 46.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.476 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.0 pt20 -136.8 132.76 35.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.99 0.424 . . . . 0.0 110.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.466 ' HD2' ' O ' ' A' ' 272' ' ' LEU . 79.6 m-85 -90.26 135.26 33.78 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.64 HD21 ' HA ' ' A' ' 216' ' ' VAL . 15.7 mt -69.1 -169.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.697 0.761 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -149.87 112.36 4.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.95 -176.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 271' ' ' ASN . 30.7 m -111.41 147.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.256 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.75 -159.72 9.21 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.898 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -92.91 159.41 15.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.595 0.236 . . . . 0.0 110.71 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -67.83 -21.67 65.19 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.612 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.446 HG13 HG21 ' A' ' 287' ' ' THR . 92.5 t 72.35 -62.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.472 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.697 ' HB ' ' HD2' ' A' ' 288' ' ' PRO . 63.7 p -114.4 170.27 5.63 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.697 ' HD2' ' HB ' ' A' ' 287' ' ' THR . 30.3 Cg_endo . . . . . 0 C--N 1.347 0.484 0 C-N-CA 122.329 2.019 . . . . 0.0 111.486 173.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 . . . . . 0 CA--C 1.519 -0.246 0 CA-C-O 121.366 0.603 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.68 -62.52 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.89 -22.8 66.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.427 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.48 ' O ' ' HB2' ' B' ' 34' ' ' ALA . 5.1 t80 -70.38 -18.0 63.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.241 0.543 . . . . 0.0 110.125 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 50.0 mtmt -69.9 -46.4 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 53.0 t0 -57.44 -44.68 84.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.984 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.805 ' HB1' HG11 ' A' ' 228' ' ' VAL . . . -47.53 -54.11 12.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.125 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.664 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.24 -20.13 38.28 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -168.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 30.1 mt-30 -61.2 -43.6 98.63 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.717 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 45.9 mtt180 -73.67 -28.61 61.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.697 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.749 ' HB2' ' HE1' ' A' ' 273' ' ' PHE . . . -62.56 -48.56 78.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -80.11 -27.16 39.23 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.075 -1.016 . . . . 0.0 111.941 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.56 -45.83 73.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.932 0.396 . . . . 0.0 110.491 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.729 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 14.1 pt -68.75 -35.29 69.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.766 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.411 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -68.74 -20.04 64.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.134 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.56 -46.72 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.477 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.544 ' O ' HG12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -92.6 -14.52 28.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.509 -176.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.544 HG12 ' O ' ' B' ' 44' ' ' LYS . 12.1 pt . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 125.282 1.433 . . . . 0.0 113.639 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.798 0.332 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.03 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.142 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 163' ' ' PRO . 44.2 tp -71.23 -34.47 70.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.825 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.13 -50.29 74.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.218 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.9 pt -72.22 -34.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.0 mmm -59.66 -26.62 65.69 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -84.56 -15.61 45.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.612 0.244 . . . . 0.0 111.533 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 23.6 ttm-85 -109.8 108.61 19.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 110.716 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 169' ' ' ALA . 29.5 m -91.96 134.12 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.73 0.776 . . . . 0.0 111.146 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 21.6 t80 -90.62 122.08 33.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.17 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.547 HG13 HD13 ' A' ' 119' ' ' ILE . 14.3 t -108.81 109.89 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.89 164.34 12.55 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.984 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 m 72.71 -57.22 0.64 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.483 0.713 . . . . 0.0 110.901 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 123' ' ' LEU . 17.9 mm 66.59 -79.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 123.235 0.614 . . . . 0.0 111.099 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.646 ' HA ' ' HG2' ' A' ' 181' ' ' ARG . 89.6 t80 174.48 -72.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.801 0.84 . . . . 0.0 108.743 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 3.6 t80 170.29 -59.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.648 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.09 -24.13 30.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.631 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 127' ' ' THR . 39.1 mt -67.52 128.74 37.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.363 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -123.74 -153.57 8.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.921 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -60.24 -54.78 41.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 111.461 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.26 -35.24 78.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.537 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.827 HG21 HD21 ' A' ' 123' ' ' LEU . 1.9 m -66.22 -41.2 90.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.791 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.63 -38.9 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.15 -47.14 72.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.438 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -71.06 -27.47 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.702 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.34 -42.41 18.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.888 0.375 . . . . 0.0 111.435 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.417 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 84.6 m-85 -96.57 12.17 32.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -175.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.516 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.25 -46.29 50.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.785 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.923 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.1 Cg_endo -68.43 -4.62 13.28 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.744 1.63 . . . . 0.0 112.702 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -98.08 64.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.059 0.457 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.6 175.29 40.6 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.808 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.93 102.62 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.722 2.281 . . . . 0.0 111.555 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.681 HG12 ' HE1' ' A' ' 160' ' ' TYR . 55.5 mt -56.17 119.8 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.206 0.527 . . . . 0.0 110.375 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -89.79 -45.8 9.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.181 -173.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 t -159.55 141.08 12.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 62.0 mt -121.58 115.91 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.429 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.75 106.75 17.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.376 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 78.9 mtp -106.95 152.88 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.1 p -99.74 97.55 8.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -78.28 113.77 16.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -80.44 112.49 17.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.203 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 93.8 p 53.8 -159.73 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.998 0.919 . . . . 0.0 112.296 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.35 -22.49 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.176 0.512 . . . . 0.0 111.089 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -62.84 -14.2 42.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.1 mtm 64.99 22.88 12.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.22 0.533 . . . . 0.0 110.891 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -73.15 91.74 1.66 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.553 ' CE1' HG13 ' A' ' 119' ' ' ILE . 11.5 t-160 -76.36 67.49 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -96.57 112.56 24.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.86 -115.85 0.71 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.388 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -152.28 175.47 12.61 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.88 138.5 18.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.883 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 98.5 m-85 -106.68 123.75 48.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.558 0.218 . . . . 0.0 110.474 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.06 104.69 17.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.065 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.3 tt0 -95.35 130.14 42.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.681 ' HE1' HG12 ' A' ' 138' ' ' ILE . 31.0 m-85 -104.01 166.4 10.43 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -100.29 5.79 44.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.847 0.832 . . . . 0.0 109.145 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.74 119.64 12.9 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.034 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.51 ' HG3' HD11 ' A' ' 108' ' ' LEU . 24.8 Cg_endo -64.19 -21.86 67.32 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.095 2.53 . . . . 0.0 112.792 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.439 ' OE2' ' HG2' ' A' ' 163' ' ' PRO . 16.7 mp0 -61.9 -52.53 63.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.63 75.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.137 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -38.55 90.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.167 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -65.2 -40.57 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.128 0.489 . . . . 0.0 110.488 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.428 HD13 ' HA3' ' A' ' 283' ' ' GLY . 8.9 mp -66.32 -37.17 84.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.503 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.56 -28.92 69.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.294 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.98 -62.17 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.04 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -71.09 -43.42 67.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -87.31 -21.87 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.565 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 54.2 tpp -98.22 -33.19 11.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.808 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -80.3 -8.95 59.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 110.839 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 p -90.31 0.66 57.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.32 168.37 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.696 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 86.3 mtp -129.46 103.02 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.131 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.58 118.69 14.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.79 -73.1 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.514 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.3 38.94 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.646 ' HG2' ' HA ' ' A' ' 120' ' ' TYR . 23.8 tpt180 -140.61 138.6 34.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -80.85 102.74 10.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.66 133.06 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.128 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -100.5 110.95 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.938 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 45.9 t -112.27 129.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.276 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 176.75 -144.47 6.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.098 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -162.98 79.02 1.74 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.05 49.07 2.69 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.957 2.438 . . . . 0.0 113.165 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.5 m -90.29 -57.1 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.034 0.445 . . . . 0.0 110.066 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -137.25 -64.18 0.57 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.1 mt 70.81 138.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.251 0.548 . . . . 0.0 111.676 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.15 -49.97 4.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.385 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -55.48 -56.01 25.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.852 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -105.07 14.0 29.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.053 0.454 . . . . 0.0 110.942 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.571 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 0.3 OUTLIER -64.6 -55.18 31.14 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.427 -177.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 76.7 Cg_exo -52.72 -27.53 34.2 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 122.707 2.271 . . . . 0.0 113.738 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 48.2 mm -62.2 -34.89 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.443 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 51.5 mm -70.93 -39.1 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.654 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.25 -37.64 83.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.472 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 29.8 mm-40 -65.09 -36.77 85.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.176 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 89.5 mt -71.21 -37.35 72.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.706 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.73 -42.02 97.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -67.66 -34.64 77.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.907 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.37 -46.9 84.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.105 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 285' ' ' ALA . . . -62.53 -23.51 67.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.044 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -63.29 -27.57 69.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.774 0.321 . . . . 0.0 110.62 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.94 -13.23 61.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.406 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -93.26 -15.19 26.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.785 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 60.77 17.25 7.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.38 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.73 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 16.1 ptm180 -111.12 144.75 39.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 283' ' ' GLY . 35.5 pt -119.3 169.64 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.302 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.424 ' HE1' ' HD2' ' A' ' 252' ' ' TYR . 84.1 t80 -116.82 115.25 25.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.182 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.71 122.59 66.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.256 0.551 . . . . 0.0 110.694 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 134' ' ' PRO . . . -122.25 -174.69 2.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.352 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.923 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 14.2 t 61.42 30.5 18.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 0.0 110.354 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.544 HG12 HD12 ' A' ' 280' ' ' LEU . 5.4 m -81.6 151.25 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.464 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.595 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 11.5 t-80 -73.9 137.56 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -166.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.514 ' HB2' HG21 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -78.5 -46.46 19.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.898 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.774 HD22 HD12 ' A' ' 225' ' ' ILE . 0.1 OUTLIER -58.56 100.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.606 178.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.7 m -101.05 -174.77 2.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.53 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.607 ' N ' HD12 ' A' ' 240' ' ' LEU . 3.7 p-10 -48.63 -43.28 36.29 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.77 -30.81 71.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.16 0.505 . . . . 0.0 110.819 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.717 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 11.4 m-20 -78.82 -59.65 2.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.774 HD12 HD22 ' A' ' 220' ' ' LEU . 23.5 mm -56.05 -24.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.216 0.532 . . . . 0.0 111.232 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.426 ' HG3' HD11 ' A' ' 235' ' ' ILE . 59.4 tttm -53.73 -32.46 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.018 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.901 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.8 m -51.89 -62.4 1.65 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.878 0.847 . . . . 0.0 112.204 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.578 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 1.9 m -63.03 -53.46 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.306 -173.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.529 ' HD2' ' OH ' ' A' ' 257' ' ' TYR . 84.2 m-85 -59.0 -34.08 71.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.42 -34.36 47.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -60.53 -26.14 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 111.041 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.64 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 3.9 p90 -129.96 40.22 3.58 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.605 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -177.34 153.8 14.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.115 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -94.31 110.47 22.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 0.0 110.167 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.426 HD11 ' HG3' ' A' ' 226' ' ' LYS . 52.5 mt -83.43 130.28 36.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.41 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -89.53 -37.03 15.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.64 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.1 t -168.47 134.04 1.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.37 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.1 t -114.48 113.42 24.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.4 m -136.81 103.77 5.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.996 0.427 . . . . 0.0 111.42 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.744 HD13 HG13 ' A' ' 225' ' ' ILE . 29.7 mt -83.69 129.8 34.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.04 138.91 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.707 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.638 ' HG2' ' HA ' ' A' ' 249' ' ' HIS . 69.2 mtp180 -137.58 149.57 46.78 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.76 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 245' ' ' THR . 3.7 p-10 -80.85 129.34 68.26 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.996 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.13 -16.35 40.13 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.76 2.307 . . . . 0.0 112.027 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 243' ' ' ASP . 12.1 t -74.9 -33.68 62.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.823 -175.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.9 m -134.34 -41.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.007 0.432 . . . . 0.0 111.235 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.12 21.88 5.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.502 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -79.69 153.36 29.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.638 ' HA ' ' HG2' ' A' ' 242' ' ' ARG . 1.9 t-80 -85.72 125.35 33.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.235 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.26 155.41 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.161 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.452 ' C ' HG21 ' A' ' 216' ' ' VAL . . . -73.53 31.77 0.85 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.403 0.521 . . . . 0.0 114.403 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 34.9 p90 -160.13 163.78 33.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.915 0.358 . . . . 0.0 110.073 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -178.15 -169.75 39.42 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.309 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -126.94 140.01 52.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.03 129.86 71.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.73 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 38.5 mt-10 -103.61 146.75 28.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.122 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.529 ' OH ' ' HD2' ' A' ' 229' ' ' PHE . 85.2 m-85 -117.29 158.2 24.78 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.306 0.574 . . . . 0.0 110.698 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -82.52 -17.26 45.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.704 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -134.73 140.61 46.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.958 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.05 -19.53 63.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.22 0.533 . . . . 0.0 109.919 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.54 -45.74 78.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.92 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -68.15 -27.15 66.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.404 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 m -61.79 -48.55 80.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.605 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.44 ' O ' HG11 ' A' ' 267' ' ' VAL . 57.5 tp60 -73.8 -34.34 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.866 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.67 -46.52 82.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.38 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.378 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 282' ' ' VAL . 4.0 p -60.76 -26.46 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.872 0.367 . . . . 0.0 111.666 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 28.9 m -81.06 -18.38 46.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 9.6 p -116.02 -27.6 6.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.598 ' SD ' ' HZ ' ' A' ' 232' ' ' PHE . 34.5 mmm -69.46 -14.52 62.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -170.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 17.4 p-10 -73.74 -15.3 61.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.008 0.432 . . . . 0.0 111.402 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.53 -9.48 59.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.851 ' HE1' ' HB3' ' B' ' 38' ' ' ALA . 4.8 t80 -62.11 87.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.006 0.432 . . . . 0.0 111.406 -170.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.49 124.93 28.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.625 ' CD1' HD23 ' A' ' 220' ' ' LEU . 53.4 mt -123.45 107.71 11.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.86 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.7 -78.71 1.74 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.351 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -155.91 23.03 0.54 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.14 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -140.64 138.85 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.743 -0.269 . . . . 0.0 110.418 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 77.0 m-85 -75.05 123.86 25.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.544 HD12 HG12 ' A' ' 216' ' ' VAL . 5.9 tt -67.84 138.78 56.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -121.08 123.04 41.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.796 0.332 . . . . 0.0 110.773 -167.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.588 HG12 ' HB2' ' A' ' 270' ' ' MET . 14.9 p -117.25 147.7 20.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.094 0.473 . . . . 0.0 111.455 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 211' ' ' ILE . . . -144.71 -170.71 14.06 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -82.04 179.51 7.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.987 0.393 . . . . 0.0 110.549 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.538 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -67.64 -27.18 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 0.0 110.519 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.4 t 73.53 -65.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.299 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 34.4 p -108.57 158.19 34.62 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.345 0.361 0 C-N-CA 122.208 1.939 . . . . 0.0 111.378 173.564 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.374 0.607 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -154.32 -65.65 0.14 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . 0.508 ' CB ' ' HB3' ' A' ' 232' ' ' PHE . . . -77.17 -31.28 55.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 110.85 176.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.447 ' HD1' ' CE1' ' A' ' 232' ' ' PHE . 16.9 t80 -65.77 -16.32 63.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.227 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -71.65 -50.81 27.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.262 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 15.5 t70 -57.88 -42.68 85.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.64 ' CB ' ' HE1' ' A' ' 232' ' ' PHE . . . -49.01 -44.85 41.68 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.54 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.758 ' HA ' ' HB1' ' B' ' 38' ' ' ALA . 2.6 mm? -82.19 -21.03 36.67 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -64.4 -40.72 96.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.901 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 18.6 mmt180 -73.28 -32.59 64.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.363 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.851 ' HB3' ' HE1' ' A' ' 273' ' ' PHE . . . -62.31 -47.06 85.94 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.099 -175.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 27.5 mtt85 -80.97 -26.27 36.69 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.259 -1.526 . . . . 0.0 112.703 174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -54.38 -41.92 69.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.518 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.804 HG12 ' O ' ' B' ' 38' ' ' ALA . 2.7 pt -69.83 -34.02 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.733 0.301 . . . . 0.0 110.775 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.42 -22.64 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.959 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.08 -27.26 22.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.807 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.755 ' HE2' HG21 ' B' ' 41' ' ' ILE . 45.1 pttt -93.11 -52.71 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.56 ' N ' ' HG3' ' B' ' 44' ' ' LYS . 91.9 mt . . . . . 0 C--O 1.234 0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.138 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.423 ' O ' HG12 ' A' ' 110' ' ' ILE . 73.3 mtt180 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.48 0.181 . . . . 0.0 111.402 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.47 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.3 -29.23 70.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.843 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.442 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.764 HD12 HG12 ' A' ' 191' ' ' ILE . 29.0 pt -82.57 -36.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.0 mtp -60.25 -26.19 66.25 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.5 m -82.44 -0.98 48.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ttm180 -122.2 118.25 28.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.56 166.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.045 0.45 . . . . 0.0 110.779 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -119.35 114.25 22.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.335 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -104.78 110.83 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 110.856 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.98 170.49 14.99 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 24.7 m 59.91 47.91 9.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.268 0.556 . . . . 0.0 110.428 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -76.49 123.04 32.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.817 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.539 ' HB3' HD11 ' A' ' 123' ' ' LEU . 54.9 t80 -62.91 140.98 58.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.314 0.578 . . . . 0.0 109.895 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -52.73 -31.71 39.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.27 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.38 6.7 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 120' ' ' TYR . 10.1 mp -100.65 120.46 40.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.68 -165.79 14.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.639 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.519 ' OE2' ' HD2' ' A' ' 129' ' ' ARG . 3.9 tm-20 -59.36 -51.76 68.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.458 0.303 . . . . 0.0 110.762 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.86 -29.64 69.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.437 HG22 ' HG ' ' A' ' 123' ' ' LEU . 5.2 m -64.63 -50.78 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.968 0.413 . . . . 0.0 110.197 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.3 mt -67.48 -40.2 84.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.288 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.519 ' HD2' ' OE2' ' A' ' 125' ' ' GLU . 23.1 ttt180 -51.58 -51.93 51.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.502 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.2 -24.12 51.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.927 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.86 -37.57 73.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.27 12.86 36.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.466 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -70.88 -41.6 11.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.166 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.769 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 33.7 Cg_exo -63.89 -4.69 7.77 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.222 1.948 . . . . 0.0 112.817 173.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.422 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 23.8 m-85 -93.01 -68.44 0.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.306 . . . . 0.0 110.216 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.87 168.68 33.44 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.618 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 13.3 Cg_exo -69.51 121.86 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.513 2.142 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.54 123.87 37.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.95 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -100.35 -36.85 9.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.459 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -145.76 136.93 24.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.942 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 70.0 mt -127.29 116.4 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -103.68 114.55 28.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.319 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 89.1 mtp -113.64 108.29 16.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.353 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.53 ' O ' ' HA3' ' A' ' 154' ' ' GLY . 12.1 p -94.46 61.09 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.456 0.646 . . . . 0.0 110.796 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -114.13 159.59 19.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.628 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.7 m-20 -73.73 88.0 1.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.476 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.2 m -65.98 -36.02 82.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.585 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.9 m -63.52 -23.84 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.247 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.758 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 1.6 m -120.64 2.04 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.382 0.61 . . . . 0.0 110.132 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.9 mtp 56.91 35.61 26.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.535 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.758 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 30.7 mmmt -97.27 126.57 42.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.054 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.452 ' HE1' ' O ' ' A' ' 123' ' ' LEU . 27.1 m-70 -84.3 48.16 1.45 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.477 0.656 . . . . 0.0 110.098 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.47 -34.22 74.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.708 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 144' ' ' SER . . . -95.73 -155.53 31.14 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.026 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -140.46 174.57 10.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.258 0.223 . . . . 0.0 110.554 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.33 138.42 54.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.805 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 97.1 m-85 -107.27 124.94 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.715 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.1 t -119.45 113.59 41.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 10.3 pt-20 -105.43 137.11 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -105.86 172.36 6.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.132 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.402 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 39.0 tt0 -74.53 -29.82 61.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.563 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.3 m -129.44 139.87 36.95 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.583 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.17 -20.54 43.46 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.187 2.592 . . . . 0.0 112.494 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.549 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 11.1 mp0 -55.56 -55.32 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.76 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -58.77 -32.24 69.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.514 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -51.61 36.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.35 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.38 -34.82 76.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.19 0.519 . . . . 0.0 110.091 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.584 HD11 ' HA3' ' A' ' 283' ' ' GLY . 25.8 tp -61.01 -44.71 97.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.239 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.22 87.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.532 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.34 -39.27 94.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -81.59 -47.35 13.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.029 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -87.83 -44.84 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -169.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.6 tpp -69.68 -26.74 64.52 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.097 0.475 . . . . 0.0 110.703 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -69.29 -24.2 63.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.204 0.526 . . . . 0.0 109.983 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 t -81.52 -27.86 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.83 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.88 110.49 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 111.017 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.574 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 21.3 mmt -61.83 124.13 19.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.913 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.52 105.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.967 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.33 -90.06 0.82 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.9 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.12 42.3 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.446 ' HG2' ' HB2' ' A' ' 120' ' ' TYR . 30.4 tpt180 -134.0 126.09 29.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.703 0.287 . . . . 0.0 110.33 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.574 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 8.6 t30 -72.11 85.08 1.02 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.584 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.422 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.4 pt -83.0 156.64 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.272 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -105.94 109.8 21.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.527 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.93 109.59 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.159 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 135.6 -115.53 1.37 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.708 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 57.15 68.9 1.84 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.265 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.502 ' HB3' ' HB ' ' A' ' 191' ' ' ILE . 5.6 Cg_exo -80.77 61.52 8.25 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.802 3.001 . . . . 0.0 112.353 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 m -50.76 -42.45 57.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.706 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -117.56 13.09 14.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.764 HG12 HD12 ' A' ' 110' ' ' ILE . 53.5 mt -98.46 -25.26 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.044 0.45 . . . . 0.0 110.61 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.82 85.45 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.811 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.42 -4.79 52.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 111.204 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.28 7.65 42.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.593 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 61.8 tp60 -53.6 -44.61 98.1 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.79 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.4 Cg_endo -51.79 -32.25 45.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.267 1.978 . . . . 0.0 112.723 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.15 -43.93 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 110.121 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.9 mt -59.76 -38.97 78.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.537 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 66.2 m-20 -54.76 -50.96 67.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.748 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.38 -32.24 73.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.541 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.4 mt -66.01 -49.75 66.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.047 0.451 . . . . 0.0 110.126 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.62 -40.83 98.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.88 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 31.3 mm-40 -64.14 -30.29 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.287 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.83 -45.68 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.54 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.43 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.453 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtp180 -63.03 -21.85 66.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.657 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.99 -29.14 39.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.877 0.37 . . . . 0.0 111.197 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.56 -19.24 14.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.66 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 56.98 37.97 29.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.235 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.27 140.5 31.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.314 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.535 HD11 ' HE2' ' A' ' 229' ' ' PHE . 19.9 tt -115.86 150.34 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.229 -172.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -109.48 135.38 50.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.265 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.491 HG22 ' CZ ' ' A' ' 229' ' ' PHE . 5.1 t -113.39 120.76 64.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.17 167.98 13.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.769 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 28.6 m 63.77 27.15 14.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.201 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.492 ' HA ' HD21 ' A' ' 280' ' ' LEU . 29.9 m -74.12 143.31 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.03 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.434 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 12.6 t-80 -69.65 134.39 48.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.84 -24.09 67.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.963 ' HB2' HG22 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.87 -46.87 16.04 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.937 -0.477 . . . . 0.0 110.92 173.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.691 HD22 HD11 ' A' ' 225' ' ' ILE . 0.2 OUTLIER -58.11 107.66 0.5 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.96 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.9 p -93.18 -177.95 4.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -53.35 -37.56 62.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.947 0.403 . . . . 0.0 111.1 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.89 -34.35 77.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.379 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.597 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 8.8 m-20 -77.47 -55.36 5.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.688 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.757 HG13 HD13 ' A' ' 240' ' ' LEU . 31.4 mm -55.42 -27.58 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.792 0.437 . . . . 0.0 111.764 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.695 ' HG3' HD12 ' A' ' 235' ' ' ILE . 83.4 tttt -54.25 -31.67 54.1 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.651 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 68.7 m -47.86 -61.22 2.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.638 0.732 . . . . 0.0 112.175 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' B' ' 34' ' ' ALA . 4.7 m -69.42 -51.01 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.167 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.559 ' HB2' HD13 ' A' ' 235' ' ' ILE . 40.2 m-85 -56.44 -43.58 79.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.505 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.73 -12.44 59.8 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.36 -35.79 58.51 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.67 -0.644 . . . . 0.0 110.602 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.562 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 0.2 OUTLIER -107.27 21.15 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.946 173.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.571 ' CA ' ' HB3' ' A' ' 262' ' ' SER . . . -170.64 -153.55 8.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.316 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.09 127.27 12.94 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.733 HG22 ' HB2' ' A' ' 238' ' ' CYS . 66.8 mt -101.87 126.57 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.119 -175.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -95.3 -22.91 17.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.706 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 14.2 t -150.38 108.6 3.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.889 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.733 ' HB2' HG22 ' A' ' 235' ' ' ILE . 41.9 t -115.72 111.79 21.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.8 p -143.08 104.57 4.31 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.757 HD13 HG13 ' A' ' 225' ' ' ILE . 40.2 mt -83.93 117.3 23.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -65.35 127.48 31.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 15.5 ptt180 -110.49 153.88 24.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.964 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.11 130.05 51.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.14 -17.1 40.55 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.725 2.283 . . . . 0.0 112.377 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 48.2 m -74.34 -58.86 3.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.268 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 2.3 m -93.4 -41.22 9.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.928 0.394 . . . . 0.0 111.25 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.92 15.65 19.52 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.837 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.437 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 61.4 pttt -109.08 148.81 30.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.4 p80 -78.39 135.62 37.48 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.213 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 252' ' ' TYR . 89.3 mttt -68.01 156.92 36.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.495 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.451 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.6 30.31 0.6 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 114.496 0.558 . . . . 0.0 114.496 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.618 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 39.5 p90 -153.21 173.71 15.19 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.589 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.23 176.24 46.62 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.409 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 94.0 m-85 -121.24 133.38 55.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.69 0.281 . . . . 0.0 110.415 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.641 HG22 HG23 ' A' ' 235' ' ' ILE . 55.0 mt -129.9 136.59 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.128 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -107.53 125.71 51.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.553 ' HE1' ' HA3' ' A' ' 233' ' ' GLY . 17.1 m-85 -98.73 142.79 29.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.212 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.733 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.4 pt-20 -89.01 -23.09 22.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.537 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.733 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 31.6 mmmt -116.95 129.41 56.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.611 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.68 63.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.347 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -56.29 -52.42 64.59 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.48 0.657 . . . . 0.0 110.026 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.571 ' HB3' ' CA ' ' A' ' 233' ' ' GLY . 4.0 m -68.99 -43.72 74.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.172 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 267' ' ' VAL . 10.8 t -61.41 -43.77 98.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.717 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.15 -41.96 97.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.331 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.51 -39.82 57.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.183 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.77 63.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.045 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 263' ' ' SER . 58.3 t -61.31 -26.64 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.186 0.517 . . . . 0.0 111.267 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.6 t -92.84 -36.64 12.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.167 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 3.3 p -87.83 -37.89 16.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.612 ' HE2' ' HD2' ' A' ' 273' ' ' PHE . 35.6 mmm -60.47 -29.08 68.83 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.493 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 31.8 t30 -58.57 -33.2 69.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.924 0.869 . . . . 0.0 110.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.501 HD11 ' N ' ' A' ' 272' ' ' LEU . 6.3 mp -78.89 -9.55 59.52 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.895 ' HE1' ' HB3' ' B' ' 38' ' ' ALA . 1.6 t80 -56.64 101.09 0.05 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.19 0.519 . . . . 0.0 110.895 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.61 112.4 18.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.189 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.631 HD21 ' CZ ' ' A' ' 273' ' ' PHE . 0.8 OUTLIER -113.3 86.2 2.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.389 171.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.71 34.95 29.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.551 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.89 0.72 74.36 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.802 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 10.9 pt20 -113.75 139.68 48.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 95.2 m-85 -89.94 126.21 35.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.369 0.604 . . . . 0.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.788 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.3 OUTLIER -55.38 165.04 0.84 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.217 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.679 ' H ' HD12 ' A' ' 280' ' ' LEU . 4.0 tpt180 -132.24 119.7 21.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.367 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 211' ' ' ILE . 5.6 p -104.82 148.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.513 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.584 ' HA3' HD11 ' A' ' 168' ' ' LEU . . . -150.25 -149.1 4.93 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -139.61 152.99 47.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.549 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -95.23 129.46 42.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.46 -31.81 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.706 -171.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 14.9 t -115.11 135.53 22.52 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.228 0.537 . . . . 0.0 110.466 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.46 -0.443 0 C-N-CA 122.293 1.995 . . . . 0.0 110.995 173.344 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -103.57 -39.2 6.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.082 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.09 84.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.763 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.426 ' O ' ' HB1' ' B' ' 34' ' ' ALA . 8.7 t80 -74.99 -19.01 60.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.54 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.687 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 30.8 mtpp -74.09 -45.81 46.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.4 -45.08 84.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.583 ' HB3' HG12 ' A' ' 228' ' ' VAL . . . -45.87 -51.87 12.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.917 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.783 ' HA ' ' HB1' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.9 -23.42 36.27 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -171.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 61.8 mt-30 -62.71 -40.79 98.25 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.633 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 63.7 mtt180 -70.81 -36.87 73.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.881 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.895 ' HB3' ' HE1' ' A' ' 273' ' ' PHE . . . -63.25 -43.81 96.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.301 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.29 46.3 mtt-85 -82.45 -25.15 33.85 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.282 -1.511 . . . . 0.0 113.064 172.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -54.08 -43.67 70.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.014 168.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.713 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.5 pt -69.64 -35.21 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.872 0.368 . . . . 0.0 110.429 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.56 -16.34 63.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.45 -36.06 16.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.592 ' HG2' ' HA ' ' B' ' 41' ' ' ILE . 21.6 pttp -84.54 -49.1 8.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.202 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.963 HG22 ' HB2' ' A' ' 219' ' ' ASP . 25.3 mm . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.449 0.643 . . . . 0.0 112.091 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.652 0.263 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.8 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.16 -35.91 81.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.74 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.049 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.7 pt -82.64 -35.84 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.4 mtp -69.5 -34.29 74.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.0 m -79.61 0.02 31.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -122.97 109.2 13.82 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.3 m -103.41 135.72 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.458 0.647 . . . . 0.0 111.53 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.448 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 80.2 t80 -87.41 132.88 33.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.232 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.44 111.41 36.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.073 0.463 . . . . 0.0 110.328 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -114.84 176.92 17.12 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.778 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 13.9 t 64.99 53.65 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.85 0.833 . . . . 0.0 109.434 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.526 HG23 ' HD1' ' A' ' 152' ' ' HIS . 73.9 mt -82.54 132.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.828 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -86.09 154.46 21.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.683 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -54.95 -51.59 65.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.607 0.241 . . . . 0.0 111.029 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.86 17.32 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.972 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.5 tp -107.73 97.56 7.27 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.474 ' HA2' ' HE1' ' A' ' 152' ' ' HIS . . . -113.26 -174.08 18.9 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.5 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.464 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 5.8 pt-20 -63.05 -23.94 67.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.956 0.408 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 7.0 m-20 -78.57 -41.62 31.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -69.48 -46.87 65.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.131 0.491 . . . . 0.0 110.546 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.5 -41.99 94.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.453 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 19.0 ptp180 -63.21 -36.3 83.19 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.691 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -72.03 -29.93 64.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.794 0.33 . . . . 0.0 111.438 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.11 56.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.692 ' HB3' ' HH ' ' A' ' 160' ' ' TYR . 85.8 m-85 -96.31 -0.13 50.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.5 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.532 ' HB1' ' HD3' ' A' ' 134' ' ' PRO . . . -65.64 -46.83 67.87 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.614 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.717 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 25.7 Cg_exo -65.21 -4.66 9.59 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.377 2.051 . . . . 0.0 113.121 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.648 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 3.5 m-85 -84.69 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.849 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.53 38.15 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.879 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.46 103.15 0.64 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.921 2.414 . . . . 0.0 112.231 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.6 mt -79.24 108.68 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -90.66 -23.39 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 0.0 110.302 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.852 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 32.1 t -138.81 124.77 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.191 0.519 . . . . 0.0 111.05 -177.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.9 mt -118.98 107.32 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.176 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -116.71 100.82 8.07 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.579 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.464 ' SD ' ' HA ' ' A' ' 125' ' ' GLU . 61.5 mtp -122.77 123.97 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.579 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 26.2 t -108.93 111.52 23.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.771 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.427 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 6.6 p-90 -150.69 158.65 44.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.263 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.82 114.73 4.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.38 0.425 . . . . 0.0 110.169 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.7 m -79.85 -24.85 40.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.713 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.6 t -82.48 -37.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.54 HG22 ' HE3' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -107.69 -7.84 16.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.18 0.514 . . . . 0.0 110.758 -178.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.7 mtp 60.26 35.31 20.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.845 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.54 ' HE3' HG22 ' A' ' 149' ' ' THR . 98.7 mttt -84.07 148.23 26.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.526 ' HD1' HG23 ' A' ' 119' ' ' ILE . 65.9 m-70 -119.73 73.52 0.97 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.68 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -128.21 11.52 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 110.481 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.64 -116.44 1.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.139 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.448 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 44.8 p90 -154.67 167.0 31.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.818 0.342 . . . . 0.0 111.108 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.434 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -146.57 134.92 21.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.52 122.6 35.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.9 t -101.96 111.02 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.852 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 37.9 mt-10 -107.05 119.56 39.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.42 0.628 . . . . 0.0 110.996 -175.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.692 ' HH ' ' HB3' ' A' ' 132' ' ' PHE . 81.2 m-85 -96.2 156.08 16.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.445 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.9 -4.63 57.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 109.325 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.74 130.99 18.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.783 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.18 -11.07 29.63 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.718 2.279 . . . . 0.0 112.808 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.411 ' OE1' HG21 ' A' ' 287' ' ' THR . 4.6 mm-40 -56.7 -64.89 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 135' ' ' PHE . . . -65.91 -22.77 66.53 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.389 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.14 -50.94 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.863 0.363 . . . . 0.0 110.749 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.419 ' HB3' HG23 ' A' ' 286' ' ' VAL . 1.6 tm0? -74.26 -30.87 62.32 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.9 tp -58.72 -51.47 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.075 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.55 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.724 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.78 -50.28 72.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.996 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.01 -47.18 47.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -74.64 -50.8 16.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 135' ' ' PHE . 16.5 mmt -77.3 -26.37 52.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -170.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -73.29 -20.31 60.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.37 0.605 . . . . 0.0 110.086 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.3 m -92.73 -12.98 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.536 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 84.3 t -118.5 137.39 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.16 0.505 . . . . 0.0 111.517 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.434 ' HE3' ' HB2' ' A' ' 182' ' ' ASN . 21.5 ptp -103.47 144.73 31.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.887 175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.55 32.1 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.82 104.71 1.02 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.814 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.44 -59.53 4.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.034 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.748 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -101.84 125.87 48.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.622 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.434 ' HB2' ' HE3' ' A' ' 177' ' ' MET . 5.1 t30 -90.37 110.69 21.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.416 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.778 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 41.8 pt -69.72 157.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 0.0 111.102 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -113.92 110.3 19.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 66.1 t -112.18 117.85 56.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.409 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 110.23 176.31 20.85 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.794 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.94 151.07 3.94 Favored Pre-proline 0 C--N 1.328 -0.37 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.09 70.45 7.1 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.825 2.35 . . . . 0.0 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.8 m -69.42 -52.95 22.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.319 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.441 ' ND2' ' HB1' ' A' ' 194' ' ' ALA . 65.9 t30 -142.65 56.04 1.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.339 0.59 . . . . 0.0 110.533 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.06 151.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.75 -59.56 4.44 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.401 ' HB2' ' OD1' ' A' ' 190' ' ' ASN . 25.7 mt-30 -67.41 -37.63 83.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 0.0 111.549 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.441 ' HB1' ' ND2' ' A' ' 190' ' ' ASN . . . -95.46 -1.56 50.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.348 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.525 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.0 tp60 -61.36 -50.1 84.77 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 16.6 Cg_endo -57.45 -23.98 58.64 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.126 1.884 . . . . 0.0 112.316 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.453 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 49.8 mm -76.8 -45.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.87 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.48 -47.88 90.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.846 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.39 -37.57 78.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.764 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.47 -53.71 47.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.435 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 202' ' ' ALA . 2.3 pp -71.23 -32.8 69.21 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.652 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.526 ' N ' HD13 ' A' ' 201' ' ' LEU . . . -72.99 -43.88 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 206' ' ' ARG . 8.9 mm-40 -75.05 -29.25 60.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.619 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.36 -31.95 73.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.08 -17.47 64.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.286 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 203' ' ' GLU . 15.9 mmt180 -63.62 -31.08 72.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.818 0.342 . . . . 0.0 110.427 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.57 63.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.53 . . . . 0.0 110.757 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -96.69 -5.27 39.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 p30 35.25 40.86 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.011 1.445 . . . . 0.0 113.444 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.834 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 13.7 ptt180 -109.53 139.39 44.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.23 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.37 161.64 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.51 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -109.42 108.74 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.543 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.22 117.13 52.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.514 0.673 . . . . 0.0 110.78 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 134' ' ' PRO . . . -122.1 -173.58 2.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.312 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.717 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 18.7 t 70.62 17.17 6.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.716 0.635 . . . . 0.0 110.239 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 225' ' ' ILE . 93.4 t -67.32 136.44 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.59 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.491 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 11.1 t-80 -67.74 138.32 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -21.51 66.75 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -167.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.554 ' HB2' HG22 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -82.05 -47.66 12.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.315 0.507 . . . . 0.0 111.602 173.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.811 HD23 ' HG ' ' A' ' 275' ' ' LEU . 0.3 OUTLIER -56.43 116.04 2.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.097 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t -101.03 -176.78 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.473 -0.142 . . . . 0.0 111.196 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.11 -36.56 70.78 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.562 0.22 . . . . 0.0 111.365 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.6 -41.0 96.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.187 0.518 . . . . 0.0 110.294 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.448 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 3.9 m-20 -66.06 -57.53 7.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.113 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.7 HD11 HG11 ' A' ' 216' ' ' VAL . 36.6 mm -57.45 -25.26 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -57.84 -32.26 67.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.506 ' HG ' HG23 ' B' ' 41' ' ' ILE . 74.4 m -49.87 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.792 0.806 . . . . 0.0 111.705 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 34' ' ' ALA . 5.4 m -73.18 -39.58 56.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.735 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.595 ' CE1' ' HE3' ' A' ' 270' ' ' MET . 50.3 m-85 -67.51 -41.03 85.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.73 0.3 . . . . 0.0 111.354 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -76.72 -18.81 58.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.126 0.488 . . . . 0.0 111.222 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.27 -31.13 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.692 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.2 m-30 -86.16 -30.57 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.87 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.61 179.74 34.99 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.989 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -77.53 113.18 15.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.108 0.48 . . . . 0.0 111.11 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.77 146.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.118 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.477 ' HE2' ' HB3' ' A' ' 256' ' ' GLU . 34.2 ttpt -106.35 -49.56 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.1 p -153.26 146.32 24.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 46.5 t -126.71 123.42 37.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.885 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.5 p -136.3 104.01 5.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.67 HD22 HG13 ' A' ' 216' ' ' VAL . 10.8 tp -96.86 114.84 26.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.75 136.47 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.619 174.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.75 124.38 81.78 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.404 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -68.79 -18.43 41.75 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.0 113.418 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 m -92.65 -52.95 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.752 0.311 . . . . 0.0 110.995 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.4 m -74.22 -27.5 60.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.462 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.61 21.45 64.04 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.593 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.31 146.93 49.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.3 OUTLIER -82.51 139.86 33.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.592 178.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -79.52 151.76 30.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.45 32.79 1.37 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.764 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -153.51 157.62 40.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.052 0.426 . . . . 0.0 109.915 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.626 ' HA3' HD11 ' A' ' 240' ' ' LEU . . . -164.77 178.37 39.95 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.52 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -118.94 131.52 56.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.2 129.2 72.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.834 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 54.6 mt-10 -109.07 141.93 40.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.005 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -106.78 161.08 14.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 0.0 112.005 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.58 -17.2 30.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.576 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 45.7 mtpt -133.75 133.33 41.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.759 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.15 68.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.629 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -61.67 -46.78 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.428 174.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 45.7 m -64.93 -36.99 86.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.525 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -61.67 -41.4 97.5 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -73.97 -34.39 64.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.195 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.57 -35.13 46.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.109 0.481 . . . . 0.0 111.084 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.5 61.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.466 HG23 HG13 ' A' ' 282' ' ' VAL . 11.0 p -54.59 -39.45 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.7 p -82.13 -25.31 34.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 4.5 m -96.42 -25.81 15.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.984 0.421 . . . . 0.0 111.632 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.648 ' HB3' HG21 ' A' ' 282' ' ' VAL . 26.9 mmm -73.65 -10.46 59.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -173.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 27.8 t-20 -62.05 -32.29 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.029 0.918 . . . . 0.0 110.616 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.4 mm? -76.73 -8.57 57.54 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.364 -172.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.856 ' CE1' ' HB3' ' B' ' 38' ' ' ALA . 1.2 t80 -65.15 105.9 1.18 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.171 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.2 t70 -94.97 121.51 36.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.826 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.811 ' HG ' HD23 ' A' ' 220' ' ' LEU . 2.8 mm? -116.32 85.91 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.348 173.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.53 29.98 34.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.475 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.1 12.35 27.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.541 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 13.5 pt20 -138.46 130.71 28.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.887 0.375 . . . . 0.0 110.34 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.612 ' HB2' HH21 ' A' ' 281' ' ' ARG . 63.8 m-85 -89.99 131.62 35.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.342 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.502 HD21 HD21 ' A' ' 275' ' ' LEU . 17.4 mt -60.97 177.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.909 0.861 . . . . 0.0 111.57 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.612 HH21 ' HB2' ' A' ' 279' ' ' TYR . 4.2 mmt180 -140.41 111.48 7.07 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.648 HG21 ' HB3' ' A' ' 270' ' ' MET . 48.5 t -120.06 135.02 61.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.965 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.94 -151.2 5.44 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.18 149.9 25.53 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.72 91.99 2.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 167' ' ' GLN . 33.8 t -55.57 -46.76 79.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.704 -171.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.411 HG21 ' OE1' ' A' ' 164' ' ' GLU . 5.9 t -104.98 124.96 34.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.927 0.87 . . . . 0.0 112.371 -174.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.457 -0.648 0 C-N-CA 122.595 2.197 . . . . 0.0 110.778 167.488 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . 0.63 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 62.5 t30 . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -73.93 0.31 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.3 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.935 0.398 . . . . 0.0 111.743 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.554 ' O ' ' HB1' ' B' ' 34' ' ' ALA . 16.7 t80 -67.12 -20.02 65.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.308 0.575 . . . . 0.0 110.644 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 92.4 mttt -77.77 -43.37 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.57 -39.04 75.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.692 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.58 -50.02 60.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.539 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.799 ' HA ' ' HB1' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -81.18 -21.67 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 50.9 mt-30 -61.83 -42.14 98.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.497 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 73.7 mtp180 -72.06 -31.86 66.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.53 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.856 ' HB3' ' CE1' ' A' ' 273' ' ' PHE . . . -68.11 -44.69 75.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.255 6.3 mtm180 -82.94 -26.33 31.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.294 -1.504 . . . . 0.0 113.022 171.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -57.32 -42.55 82.08 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.056 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.686 HD12 ' HZ ' ' A' ' 273' ' ' PHE . 9.8 pt -64.3 -42.72 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.23 -24.67 66.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 111.519 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 -29.38 21.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.832 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.441 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -92.13 -33.8 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.554 HG22 ' HB2' ' A' ' 219' ' ' ASP . 79.9 mt . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.35 -28.87 70.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.88 -34.78 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.912 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.23 75.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.426 . . . . 0.0 111.22 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.39 -36.32 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.366 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 27.8 ttt -65.6 -26.67 67.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.875 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.9 m -82.17 4.34 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.517 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 19.5 ptt180 -135.57 134.61 39.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.975 0.417 . . . . 0.0 110.717 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.1 m -110.8 135.6 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.355 0.598 . . . . 0.0 111.522 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 71.0 t80 -78.83 124.47 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.209 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.53 112.06 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.023 0.439 . . . . 0.0 110.155 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.21 170.28 14.04 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.686 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.654 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 50.6 m 67.63 66.74 0.38 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.615 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.49 -19.84 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.136 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.513 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 66.8 t80 65.67 -73.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.286 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 53.4 t80 167.09 -43.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.291 0.636 . . . . 0.0 109.409 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -83.24 6.08 20.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.212 -173.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.8 mt -110.57 100.06 8.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.31 34.82 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.772 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.49 -41.42 94.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.35 -48.38 71.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.238 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -62.18 -53.85 49.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.09 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.75 -46.21 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.298 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -55.5 -48.95 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.494 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -78.27 -29.69 48.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.14 73.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.772 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.82 ' HB3' ' HH ' ' A' ' 160' ' ' TYR . 84.9 m-85 -97.71 7.08 47.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.444 ' HB2' ' HD3' ' A' ' 134' ' ' PRO . . . -68.07 -43.35 35.3 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.582 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 24.2 Cg_exo -65.16 -3.86 8.07 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.249 1.966 . . . . 0.0 112.915 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.721 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 21.8 m-85 -91.06 -63.96 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.683 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.63 175.2 34.28 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.563 ' HD2' HG23 ' A' ' 162' ' ' VAL . 21.1 Cg_exo -65.09 123.1 11.07 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.429 2.086 . . . . 0.0 111.724 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.74 123.17 22.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.163 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -87.04 -56.4 3.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.004 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.9 m -162.29 149.35 13.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.53 106.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.83 110.6 23.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.544 ' HE1' ' HB2' ' A' ' 152' ' ' HIS . 22.9 ptm -137.26 149.44 47.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.043 0.449 . . . . 0.0 111.136 -176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.3 m -80.25 121.93 26.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.804 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.74 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 42.9 m95 -99.95 114.48 27.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.198 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.817 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 2.5 m-20 -69.79 89.82 0.58 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.266 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t 62.5 -163.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.864 0.728 . . . . 0.0 111.586 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 150' ' ' MET . 14.9 p -84.73 -18.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.482 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.47 ' HB ' ' HE2' ' A' ' 151' ' ' LYS . 21.2 p -66.71 11.45 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.74 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 19.8 mmt 59.09 32.13 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.041 0.537 . . . . 0.0 112.305 172.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.817 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 71.0 mmtt -79.22 -49.7 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.934 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.544 ' HB2' ' HE1' ' A' ' 143' ' ' MET . 25.1 p80 40.91 58.15 2.55 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.889 0.743 . . . . 0.0 112.352 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -104.18 94.28 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.288 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.23 -101.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.972 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -147.51 165.95 28.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.742 0.306 . . . . 0.0 110.714 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.47 146.38 33.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.717 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.04 111.71 24.31 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.5 106.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.046 0.45 . . . . 0.0 110.27 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.517 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 45.8 mt-10 -91.62 131.46 37.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.82 ' HH ' ' HB3' ' A' ' 132' ' ' PHE . 23.3 m-85 -102.01 147.62 26.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.424 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -75.17 -14.55 60.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.723 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.563 HG23 ' HD2' ' A' ' 137' ' ' PRO . 19.6 m -136.89 130.24 17.55 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.083 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.29 -19.93 68.54 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.169 2.579 . . . . 0.0 113.231 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.73 -65.15 0.64 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.48 -27.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.824 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.55 69.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.688 0.28 . . . . 0.0 111.14 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.444 ' HB3' HG21 ' A' ' 286' ' ' VAL . 19.5 tt0 -74.54 -36.91 63.13 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.347 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.626 HD22 ' CD2' ' A' ' 212' ' ' TYR . 12.5 tp -55.75 -49.84 72.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.98 96.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.531 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.7 -54.02 45.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.176 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.54 -45.37 81.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.781 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -77.94 -46.04 22.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 23.1 mmt -73.24 -22.98 60.29 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.591 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.01 -23.55 55.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.312 0.577 . . . . 0.0 109.642 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 55.1 m -84.92 -30.66 24.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.458 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.68 130.65 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.1 0.476 . . . . 0.0 111.412 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 181' ' ' ARG . 25.7 ptt? -78.8 130.97 36.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.873 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 178' ' ' LEU . 3.5 pp -85.84 139.97 30.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.808 0.337 . . . . 0.0 111.138 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.2 -40.07 1.46 Allowed Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.345 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.38 2.62 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.537 ' O ' ' HB2' ' A' ' 177' ' ' MET . 30.6 mmt180 -98.13 126.42 43.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -74.85 67.84 1.68 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.665 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.654 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 38.1 pt -66.29 154.67 7.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -116.14 109.05 16.94 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 55.5 t -112.82 109.77 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.264 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.0 141.35 8.07 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.414 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 15.8 mtp180 -129.95 137.05 30.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 2.7 Cg_exo -76.4 48.12 2.26 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 111.335 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 p -81.25 -45.63 15.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.901 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -92.79 35.78 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.496 0.665 . . . . 0.0 109.781 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt -65.99 136.4 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.858 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 89.61 -35.22 3.79 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.104 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -83.2 -42.74 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.023 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.37 -18.6 41.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.49 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mp0 -57.67 -51.89 78.36 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 14.5 Cg_endo -57.02 -30.41 86.57 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.193 1.929 . . . . 0.0 112.472 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mm -75.15 -50.81 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.401 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.28 -43.79 95.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.801 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.68 -42.72 71.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.712 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -60.4 -52.95 63.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' A' ' 287' ' ' THR . 91.1 mt -64.96 -46.38 81.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.077 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.96 94.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.886 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.16 -35.09 68.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.88 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.24 -38.13 78.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.418 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.32 -27.99 69.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -21.74 66.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.188 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.87 -13.1 51.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.973 0.416 . . . . 0.0 111.321 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.74 -17.78 20.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.402 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 65.82 15.0 9.87 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.618 0.574 . . . . 0.0 111.919 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.448 ' HG2' ' HB2' ' A' ' 256' ' ' GLU . 82.1 mtp180 -105.44 135.67 46.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.048 0.452 . . . . 0.0 110.679 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.462 HD11 ' CE1' ' A' ' 229' ' ' PHE . 30.6 pt -117.67 169.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.103 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.626 ' CD2' HD22 ' A' ' 168' ' ' LEU . 44.1 t80 -118.74 118.61 32.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.572 HG23 HG21 ' A' ' 282' ' ' VAL . 2.3 p -116.3 122.45 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.719 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.721 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.06 -179.84 4.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.98 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.582 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 24.7 m 68.07 29.08 6.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.276 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.785 HG12 HD13 ' A' ' 225' ' ' ILE . 73.6 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.319 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -63.25 123.15 17.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.69 -37.37 18.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -167.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.56 -45.75 43.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.616 0.245 . . . . 0.0 111.092 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.813 HD13 HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -58.5 116.43 3.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.6 m -99.88 -178.31 3.82 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.73 -44.42 77.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.651 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.44 -32.79 69.04 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.402 0.62 . . . . 0.0 110.185 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.52 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 57.1 m-20 -73.33 -55.91 5.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.645 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.785 HD13 HG12 ' A' ' 216' ' ' VAL . 33.8 mm -54.57 -29.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.103 0.478 . . . . 0.0 111.565 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.473 ' HG3' HD13 ' A' ' 235' ' ' ILE . 62.3 tttm -53.93 -32.53 53.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.94 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.62 ' HB3' ' HG2' ' B' ' 37' ' ' ARG . 68.0 m -48.99 -61.37 2.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.737 0.779 . . . . 0.0 112.826 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.781 ' HB ' ' HE2' ' A' ' 270' ' ' MET . 3.0 m -70.67 -46.32 69.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.73 -169.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.689 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 57.6 m-85 -57.96 -43.93 86.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.687 0.279 . . . . 0.0 111.151 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.7 tt0 -70.9 -24.3 62.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.266 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.08 -21.09 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.372 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.726 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 0.6 OUTLIER -93.22 -43.75 8.67 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.59 153.69 25.04 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.07 137.94 51.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.487 0.643 . . . . 0.0 111.669 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 229' ' ' PHE . 60.6 mt -95.68 147.51 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.527 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -80.02 -64.3 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.429 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 35.5 t -150.42 147.67 27.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.495 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.95 129.42 52.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.424 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.2 t -142.48 125.31 16.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.172 0.51 . . . . 0.0 111.019 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.409 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 8.4 mp -110.19 130.2 55.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.587 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.68 145.92 50.79 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.509 0.671 . . . . 0.0 111.012 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -122.75 150.19 43.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.553 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -117.04 106.51 47.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.678 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.67 -25.15 34.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.489 2.126 . . . . 0.0 112.094 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.9 m -63.24 -48.29 78.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.355 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -83.65 -30.14 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.677 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.68 6.12 53.01 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.975 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -137.13 177.43 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -82.78 154.04 24.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 110.416 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.7 155.71 21.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.36 43.05 2.83 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.833 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -156.26 157.51 35.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.97 0.385 . . . . 0.0 110.083 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -168.42 -172.95 35.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.583 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -119.31 132.81 55.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.732 0.301 . . . . 0.0 110.501 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.2 mm -111.81 126.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 210' ' ' ARG . 35.6 tt0 -103.72 120.89 41.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -94.23 142.86 26.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.532 0.682 . . . . 0.0 111.754 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.9 -26.25 66.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.179 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.476 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 34.4 mtpt -124.95 136.31 53.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.77 -18.55 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -68.8 -44.52 73.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.549 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 65.3 m -67.91 -21.02 65.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.696 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 m -59.03 -39.42 81.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.026 0.441 . . . . 0.0 110.262 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -75.33 -35.17 61.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.497 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.17 -34.79 76.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.124 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.53 -47.63 22.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.675 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.53 HG11 HG12 ' A' ' 282' ' ' VAL . 31.1 m -59.44 -35.01 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -169.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.2 p -80.04 -9.47 59.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.2 m -113.81 -35.99 4.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.919 0.39 . . . . 0.0 111.694 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.858 ' HA ' ' HE3' ' A' ' 270' ' ' MET . 0.6 OUTLIER -72.31 -16.02 61.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -170.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.81 -30.14 69.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.749 0.785 . . . . 0.0 110.402 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 272' ' ' LEU . 7.9 mp -76.83 -9.47 58.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.603 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.852 ' HB2' ' HE1' ' A' ' 270' ' ' MET . 1.6 t80 -54.85 109.17 0.48 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.676 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 0.2 OUTLIER -113.82 130.31 56.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 -178.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.662 ' HG ' HD21 ' A' ' 220' ' ' LEU . 3.2 mm? -116.08 87.02 2.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.537 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.85 3.47 73.75 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.064 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 134.43 -31.51 2.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.417 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.676 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 17.3 pt20 -84.06 129.25 34.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.171 0.486 . . . . 0.0 110.772 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -89.41 139.83 30.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.732 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.495 HD23 ' HD2' ' A' ' 273' ' ' PHE . 9.2 mp -76.78 -173.17 2.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 0.0 111.568 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 281' ' ' ARG . 39.2 mmt180 -144.66 112.43 6.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.573 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.572 HG21 HG23 ' A' ' 213' ' ' VAL . 46.7 t -125.83 134.32 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.628 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.2 -153.61 6.33 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.768 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -85.11 165.82 17.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.088 0.444 . . . . 0.0 110.151 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.606 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -76.15 -7.49 54.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.998 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 167' ' ' GLN . 64.3 t 71.22 -64.49 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.119 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 201' ' ' LEU . 8.4 t -111.29 148.97 39.86 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo . . . . . 0 C--N 1.346 0.437 0 C-N-CA 122.835 2.357 . . . . 0.0 111.433 173.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.966 0.412 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.39 -38.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . . . -62.1 -35.6 79.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.625 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.604 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 9.1 t80 -74.51 -19.44 60.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.321 0.582 . . . . 0.0 110.032 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.644 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 94.6 mttt -72.84 -45.48 58.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.676 ' HA ' HE21 ' B' ' 36' ' ' GLN . 22.5 t70 -56.28 -44.38 79.75 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.002 0.906 . . . . 0.0 108.744 174.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.726 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -48.23 -54.03 14.97 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.011 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.705 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -83.11 -23.42 33.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -168.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.676 HE21 ' HA ' ' B' ' 33' ' ' ASP . 30.3 mt-30 -55.24 -44.27 75.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.62 ' HG2' ' HB3' ' A' ' 227' ' ' SER . 25.2 ttm105 -74.39 -31.62 62.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.662 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.845 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.76 -46.2 83.14 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.251 11.7 mtp180 -81.18 -25.03 37.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.638 -1.289 . . . . 0.0 112.387 174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.44 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 19.8 tp60 -51.25 -47.28 62.45 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 165.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.813 HG13 HD13 ' A' ' 220' ' ' LEU . 4.6 pt -72.26 -28.42 29.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.844 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 275' ' ' LEU . . . -65.76 -31.89 73.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.907 0.384 . . . . 0.0 111.076 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.41 -25.22 29.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.269 0.557 . . . . 0.0 110.492 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' B' ' 44' ' ' LYS . 4.8 tmmt? -82.1 -63.77 1.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.089 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.235 0.319 0 CA-C-O 121.104 0.478 . . . . 0.0 111.788 179.571 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.548 0.213 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.16 73.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.392 . . . . 0.0 110.479 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.11 -39.12 86.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.65 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.13 72.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.909 0.385 . . . . 0.0 111.511 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.6 mt -83.9 -48.31 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.7 -35.29 80.08 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 80.4 m -83.18 2.64 34.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.53 0.205 . . . . 0.0 111.398 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.813 ' HB2' ' HG3' ' A' ' 159' ' ' GLU . 8.5 ttp180 -113.82 112.39 23.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.984 0.421 . . . . 0.0 111.237 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.39 150.89 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.337 0.589 . . . . 0.0 111.067 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.8 t80 -102.84 115.05 29.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.098 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.03 111.82 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.19 167.0 12.37 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.085 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.0 m 68.73 47.57 0.83 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.277 0.561 . . . . 0.0 110.991 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.726 HD13 ' HE1' ' A' ' 143' ' ' MET . 79.1 mt -66.19 115.97 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.119 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -61.87 -78.85 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.339 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -175.61 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.27 -23.99 67.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.688 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.01 98.6 5.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.134 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.55 -175.15 37.09 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.684 ' HB2' ' HE1' ' A' ' 145' ' ' TRP . 40.4 tt0 -62.81 -41.32 99.25 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.98 -39.47 87.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.519 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -64.75 -46.08 83.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.96 -48.43 88.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.308 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ppt_? -66.87 -33.93 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.465 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -72.16 -35.7 69.11 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.737 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.84 97.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.878 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 81.5 m-85 -97.07 11.29 36.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.266 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.575 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -65.98 -46.02 63.92 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.291 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 1.004 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 27.7 Cg_endo -63.13 -14.88 44.46 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.056 1.837 . . . . 0.0 112.881 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 132' ' ' PHE . 5.0 m-85 -76.07 -66.42 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.18 156.13 26.51 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.16 131.46 46.47 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.532 2.155 . . . . 0.0 111.665 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -72.32 117.3 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -90.13 -39.51 12.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.544 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.4 t -160.04 139.3 10.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.756 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.64 121.08 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.75 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.27 96.73 5.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.726 ' HE1' HD13 ' A' ' 119' ' ' ILE . 27.9 ttt -107.49 145.13 33.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.515 -175.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -78.12 80.61 4.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 0.0 109.863 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.684 ' HE1' ' HB2' ' A' ' 125' ' ' GLU . 6.6 m95 -92.49 133.13 36.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.094 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -94.29 111.9 23.66 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.4 m -75.45 3.26 9.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.193 0.521 . . . . 0.0 110.548 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.13 -54.57 8.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.067 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.556 ' HB ' ' HG3' ' A' ' 151' ' ' LYS . 1.5 m -119.55 -15.01 9.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.62 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.5 mtp 67.11 32.77 5.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.721 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.556 ' HG3' ' HB ' ' A' ' 149' ' ' THR . 17.8 mtpp -97.16 -14.8 21.24 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.506 ' HB2' ' HE2' ' A' ' 143' ' ' MET . 32.2 p80 44.19 47.04 7.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.74 0.816 . . . . 0.0 112.579 170.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.69 102.56 15.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.093 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 171.39 -112.83 0.47 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.75 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -142.0 172.93 12.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.858 0.361 . . . . 0.0 111.349 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.597 ' HB3' ' HG3' ' A' ' 143' ' ' MET . . . -151.67 150.58 30.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.707 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.22 131.7 56.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 58.6 t -128.32 115.78 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.854 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.813 ' HG3' ' HB2' ' A' ' 113' ' ' ARG . 1.8 mp0 -92.31 132.62 36.56 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.948 173.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -101.92 169.0 9.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.939 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.486 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 42.2 tt0 -60.94 -48.83 80.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.478 0.656 . . . . 0.0 110.3 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.489 ' HB ' ' HG2' ' A' ' 164' ' ' GLU . 16.0 m -119.75 147.19 43.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.99 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.07 -16.52 44.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.754 2.303 . . . . 0.0 111.129 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.489 ' HG2' ' HB ' ' A' ' 162' ' ' VAL . 1.0 OUTLIER -63.21 -47.12 83.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.879 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.455 ' H ' HG23 ' A' ' 162' ' ' VAL . . . -62.05 -39.23 91.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.063 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.37 86.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.844 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -59.67 -45.33 92.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 13.1 mt -73.0 -35.16 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.983 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.64 85.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.555 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 2.9 tt -77.15 -63.09 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.081 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -63.57 -47.31 82.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -171.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.644 ' HB3' ' HD3' ' A' ' 281' ' ' ARG . 80.7 mm-40 -84.74 -0.72 54.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -171.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.62 ' HB3' HG23 ' A' ' 185' ' ' VAL . 42.6 tpp -119.95 -33.79 3.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.32 -24.82 63.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.233 0.54 . . . . 0.0 110.48 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.2 m -84.37 -0.97 54.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.416 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.54 177.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.362 . . . . 0.0 110.758 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.542 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 82.2 mtp -118.01 126.04 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.171 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.52 85.49 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 110.072 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.08 -135.22 12.86 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.908 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.53 77.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.922 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -130.17 154.93 47.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.872 0.368 . . . . 0.0 110.748 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.542 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 24.3 p-10 -100.91 108.76 20.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.506 0.669 . . . . 0.0 110.397 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.3 pt -75.57 148.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 184' ' ' LYS . 24.0 tptp -102.24 109.38 21.04 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.135 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 173' ' ' MET . 15.8 m -104.64 127.03 59.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.991 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.555 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 85.75 135.6 3.77 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.285 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -153.34 91.16 3.37 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 81.11 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.201 2.6 . . . . 0.0 112.568 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.6 m -81.7 -17.45 47.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.48 53.5 2.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.065 0.459 . . . . 0.0 110.802 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.69 124.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.522 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.76 -24.71 4.32 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.558 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 13.5 mm-40 -83.68 -47.64 11.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 111.399 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.35 -20.9 27.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.677 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.452 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 27.2 mm-40 -57.98 -55.21 47.56 Favored Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.486 ' O ' ' HG3' ' A' ' 200' ' ' GLN . 19.3 Cg_endo -58.75 -30.97 94.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.109 1.873 . . . . 0.0 112.539 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.0 mm -70.61 -52.43 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.009 0.433 . . . . 0.0 110.178 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.28 -33.54 64.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.963 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.78 -49.46 77.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.597 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 47.1 mt-30 -65.17 -34.85 79.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.118 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.21 -49.81 68.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.477 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -64.67 -29.74 70.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.31 -52.1 66.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.965 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.41 -28.59 59.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.897 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.09 69.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.923 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 14.4 mtm180 -67.23 -20.35 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 0.0 110.96 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -24.27 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.18 0.514 . . . . 0.0 110.639 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -102.1 -29.13 11.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 52.13 79.14 0.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.839 0.712 . . . . 0.0 111.258 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.656 ' HB2' ' HB1' ' A' ' 285' ' ' ALA . 39.5 mtm180 -125.18 142.35 51.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.047 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.673 HD12 ' HE1' ' A' ' 229' ' ' PHE . 13.5 tt -108.82 142.95 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 282' ' ' VAL . 79.4 t80 -108.44 123.19 48.48 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.799 0.333 . . . . 0.0 110.171 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.526 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.3 p -119.04 122.73 70.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.511 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.05 179.6 4.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.191 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 1.004 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 20.0 m 65.29 26.79 12.16 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.799 0.687 . . . . 0.0 110.948 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.429 HG22 ' C ' ' A' ' 251' ' ' GLY . 8.1 m -72.46 145.21 12.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.157 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.437 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 13.4 t-80 -68.4 130.33 42.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.38 -18.47 64.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -164.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.437 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 0.6 OUTLIER -78.27 -44.08 26.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.169 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.654 HD22 HD12 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -52.8 114.37 1.39 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.818 172.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.2 m -98.79 -177.5 3.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 11.0 p-10 -54.36 -41.29 68.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -70.63 -28.93 65.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.76 0.314 . . . . 0.0 110.684 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.57 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 4.8 m-20 -67.54 -55.79 12.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.654 HD12 HD22 ' A' ' 220' ' ' LEU . 30.8 mm -57.38 -27.28 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.11 0.481 . . . . 0.0 110.816 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.488 ' HG3' HD13 ' A' ' 235' ' ' ILE . 87.7 tttt -56.94 -32.85 66.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.292 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.637 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 57.9 m -48.33 -60.22 2.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.936 0.874 . . . . 0.0 112.092 -176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.717 ' HB ' ' CE ' ' A' ' 270' ' ' MET . 2.8 m -72.14 -36.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.731 -170.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.673 ' HE1' HD12 ' A' ' 211' ' ' ILE . 71.3 m-85 -70.79 -37.13 73.29 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.259 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.463 ' OE1' ' HE2' ' A' ' 226' ' ' LYS . 8.5 tt0 -77.27 -21.09 54.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.737 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.84 -18.7 53.59 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.49 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.71 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 3.8 m-30 -87.77 -38.21 15.95 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.521 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.75 -156.97 8.25 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.569 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -94.54 128.59 41.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.488 HD13 ' HG3' ' A' ' 226' ' ' LYS . 20.6 tt -104.1 135.68 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.286 -171.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 256' ' ' GLU . 23.5 tptp -91.08 -52.42 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.81 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 69.3 m -149.95 124.74 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.846 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 3.8 p -100.54 68.13 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.38 0.61 . . . . 0.0 109.739 174.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.5 p -97.8 104.35 16.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.231 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.4 mp -91.72 128.8 37.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.29 133.76 49.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -133.61 151.05 51.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.408 . . . . 0.0 110.738 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.92 118.19 70.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.258 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.75 -17.1 42.41 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.908 2.406 . . . . 0.0 113.412 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 69.7 p -86.8 -47.1 9.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.712 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.1 m -92.23 -25.67 18.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.968 0.413 . . . . 0.0 111.354 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.71 22.61 42.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.986 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.8 122.29 45.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.589 0.233 . . . . 0.0 111.122 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.5 p80 -72.79 138.2 46.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.486 ' HZ3' ' CD ' ' A' ' 161' ' ' GLU . 96.4 mttt -70.5 156.62 39.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.45 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.429 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.97 33.15 0.63 Allowed Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.476 0.485 . . . . 0.0 113.637 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.457 ' H ' ' C ' ' A' ' 250' ' ' LYS . 5.7 p90 -153.24 163.79 39.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.477 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -155.11 162.63 31.04 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.008 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.74 117.14 29.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 237' ' ' SER . 2.3 mp -102.79 128.5 55.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 51.6 mt-10 -102.76 145.78 29.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -119.31 132.22 55.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.268 0.556 . . . . 0.0 111.022 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -78.18 -27.21 47.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.344 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.475 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 20.3 mtpt -112.5 123.05 49.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.157 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.34 75.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.869 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -61.33 -37.69 84.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.222 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.8 m -73.76 -28.83 61.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.046 0.45 . . . . 0.0 110.446 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.7 t -73.78 -22.4 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.896 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -74.99 -49.66 19.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.648 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.49 -33.73 41.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -171.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.28 54.01 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 111.177 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 37.4 t -71.9 -34.13 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 111.378 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.2 p -89.89 -17.93 27.1 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.777 0.322 . . . . 0.0 111.661 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 36.0 m -112.1 1.03 16.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -171.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.755 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 6.0 tpp -119.19 2.4 11.39 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -172.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -82.85 -16.86 46.0 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.184 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 9.1 mp -79.6 -9.37 59.62 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.893 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -45.93 106.05 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.341 0.4 . . . . 0.0 111.583 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.38 114.47 27.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.535 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' B' ' 42' ' ' ALA . 2.4 mm? -119.93 86.38 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.312 169.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.23 40.25 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.834 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.84 -2.5 69.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.999 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.89 128.83 49.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 273' ' ' PHE . 86.2 m-85 -98.83 122.46 42.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.727 HD22 ' CD2' ' A' ' 273' ' ' PHE . 9.9 mp -70.55 -179.44 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.028 0.442 . . . . 0.0 110.676 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.644 ' HD3' ' HB3' ' A' ' 172' ' ' GLN . 3.6 mmp_? -136.48 128.04 28.7 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -174.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 3.1 m -122.96 151.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.456 0.646 . . . . 0.0 112.042 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -160.83 -136.71 2.06 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.352 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.83 152.43 38.4 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.579 -0.365 . . . . 0.0 110.886 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' A' ' 210' ' ' ARG . . . -96.49 102.9 14.76 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -35.42 8.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.609 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 14.9 t -84.92 136.01 39.19 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.819 2.346 . . . . 0.0 112.013 177.42 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . 0.588 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 15.2 m120 . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.92 -52.8 62.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.453 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.99 -31.33 72.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.027 0.441 . . . . 0.0 111.171 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.641 ' HA ' ' CE1' ' A' ' 232' ' ' PHE . 11.7 t80 -76.65 -21.48 55.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.224 0.535 . . . . 0.0 110.289 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 71.8 mttt -74.43 -41.0 61.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.8 t70 -58.0 -41.93 84.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.71 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -50.49 -49.27 55.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.341 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.764 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.87 -25.15 35.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -169.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 24.9 mt-30 -57.71 -44.93 86.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.637 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 60.6 mtt180 -68.11 -35.99 79.02 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.586 174.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.893 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.06 -49.97 72.44 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.272 13.6 mtp180 -81.44 -25.3 36.25 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.202 -1.561 . . . . 0.0 112.751 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -52.47 -46.7 66.65 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 110.073 168.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.827 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.6 pt -67.22 -35.51 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.498 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.52 ' HB3' HD11 ' A' ' 275' ' ' LEU . . . -65.88 -20.1 66.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.388 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.27 -42.28 12.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.8 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.827 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.1 OUTLIER -92.3 -14.48 28.77 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.424 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.2 pt . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.947 0.403 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.82 -26.74 61.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.987 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 tp -76.43 -45.76 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.056 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.35 -45.72 76.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.886 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.5 pt -64.99 -34.2 68.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.09 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 75.4 mtp -70.05 -26.39 64.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.483 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.37 -33.1 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 14.6 ptp180 -109.26 127.72 54.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 111.337 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.98 140.89 24.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.495 0.664 . . . . 0.0 110.794 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.423 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 65.6 t80 -85.12 130.56 34.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.827 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.86 112.23 38.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.547 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.27 169.71 13.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.332 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 48.2 m 57.86 50.7 10.07 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.323 0.583 . . . . 0.0 110.757 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -90.84 10.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.093 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.2 t80 64.05 11.99 6.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.618 0.723 . . . . 0.0 109.406 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.945 ' HB2' ' H ' ' A' ' 153' ' ' LYS . 55.0 p90 42.18 33.52 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.852 1.261 . . . . 0.0 113.319 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.46 -58.07 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.162 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 mp -48.94 135.98 14.86 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.56 0.537 . . . . 0.0 112.373 -174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.63 170.65 48.39 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.447 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.45 -39.17 77.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.603 0.361 . . . . 0.0 111.62 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.32 -27.96 69.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.315 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 48.8 m -66.66 -45.7 78.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 110.307 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.29 -40.03 81.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.984 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -53.35 -48.86 68.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.08 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 78.1 mt-30 -76.96 -30.23 55.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.636 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.39 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 110.703 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.883 ' HB3' ' HH ' ' A' ' 160' ' ' TYR . 89.5 m-85 -105.62 12.12 31.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.973 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.491 ' HB1' ' HD3' ' A' ' 134' ' ' PRO . . . -70.3 -44.03 18.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.843 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.603 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 14.4 Cg_exo -71.46 -4.0 14.14 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.91 1.74 . . . . 0.0 111.73 173.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.442 ' CE2' ' HG2' ' A' ' 281' ' ' ARG . 54.6 m-85 -106.41 58.57 0.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.52 164.01 38.34 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.701 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.5 ' HD2' HG21 ' A' ' 162' ' ' VAL . 68.0 Cg_endo -79.49 132.47 10.04 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.81 2.34 . . . . 0.0 112.461 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.87 119.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.36 -56.21 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 0.0 110.681 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.6 m -157.53 125.26 5.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.622 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.459 HG21 ' HG3' ' A' ' 143' ' ' MET . 54.9 mt -101.22 107.17 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 173.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.55 120.06 27.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.114 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.459 ' HG3' HG21 ' A' ' 141' ' ' ILE . 82.9 mtp -139.02 131.33 28.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.87 0.366 . . . . 0.0 111.399 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.2 m -106.9 105.76 15.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.937 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 10.6 p-90 -159.49 159.86 33.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -83.74 95.53 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.928 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.4 p -70.64 -23.18 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.528 -172.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.9 m -68.82 -32.71 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.454 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.8 p -109.45 -1.89 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.351 0.596 . . . . 0.0 110.71 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.937 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 74.1 mtp 61.06 36.6 18.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -106.02 137.95 43.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.73 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 11.5 m-70 -95.74 -79.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.945 ' H ' ' HB2' ' A' ' 121' ' ' TYR . 29.5 mtpt 52.22 45.88 27.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.22 -170.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -160.27 -122.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.469 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.423 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 29.7 p90 -149.53 174.03 12.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.795 -170.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.99 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.119 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -116.69 108.64 16.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.447 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.4 110.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.49 0.662 . . . . 0.0 110.542 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.4 tt0 -94.57 134.14 37.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.883 ' HH ' ' HB3' ' A' ' 132' ' ' PHE . 84.8 m-85 -102.91 161.01 14.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.426 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.54 -7.96 53.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.676 ' HB ' ' OE2' ' A' ' 164' ' ' GLU . 34.9 m -129.22 128.07 23.25 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.429 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 3.1 Cg_exo -74.83 -22.26 15.41 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.137 2.558 . . . . 0.0 114.083 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.676 ' OE2' ' HB ' ' A' ' 162' ' ' VAL . 1.2 mp0 -63.26 -57.68 9.66 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.617 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 135' ' ' PHE . . . -56.96 -29.63 63.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.627 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.23 64.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.503 ' HB3' HG21 ' A' ' 286' ' ' VAL . 23.6 tm0? -68.49 -39.93 81.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.69 -55.93 26.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.266 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.89 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.317 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.908 ' HG ' ' HA2' ' A' ' 186' ' ' GLY . 7.5 tt -54.87 -63.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.222 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.58 -36.01 15.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -70.51 -27.48 64.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.504 ' HG3' HD11 ' A' ' 183' ' ' ILE . 60.5 tpp -88.87 -27.21 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.12 -8.72 57.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.786 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.4 m -90.61 -7.94 51.43 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.188 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.16 163.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.037 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 20.0 ptp -108.93 144.03 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.117 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.41 59.83 1.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.053 0.454 . . . . 0.0 110.431 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.8 77.31 1.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.857 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.97 -51.31 4.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.586 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 2.5 mpt_? -88.35 126.79 35.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 0.0 110.818 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.2 109.32 8.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.388 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.504 HD11 ' HG3' ' A' ' 173' ' ' MET . 35.5 pt -76.86 162.04 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -119.64 114.02 21.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.001 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 170' ' ' LEU . 27.6 t -117.45 132.85 66.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.976 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.908 ' HA2' ' HG ' ' A' ' 170' ' ' LEU . . . 156.03 -136.29 4.96 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.285 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -149.03 71.57 10.23 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.375 0.607 . . . . 0.0 110.605 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.63 89.0 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.728 2.285 . . . . 0.0 112.794 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.4 m -143.71 -71.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.686 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.27 117.91 17.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.9 pt -102.04 -175.49 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.25 -55.97 4.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.191 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -67.96 -51.53 46.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.76 0.314 . . . . 0.0 111.769 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.05 6.44 36.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.677 0.275 . . . . 0.0 111.73 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.497 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.1 OUTLIER -64.9 -55.51 27.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 9.6 Cg_endo -53.13 -32.22 58.37 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.683 2.255 . . . . 0.0 112.725 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -58.01 -46.84 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.397 . . . . 0.0 110.337 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.82 -43.86 98.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.457 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.36 -44.86 93.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.46 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 32.0 mm-40 -67.11 -39.63 86.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.081 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 286' ' ' VAL . 85.7 mt -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.16 -38.2 88.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.88 -40.89 83.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.146 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.15 -40.42 96.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.215 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.13 86.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 82.9 mtp180 -68.51 -30.73 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.51 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.7 72.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -89.8 -6.06 56.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.893 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.425 ' N ' HD21 ' A' ' 209' ' ' ASN . 0.9 OUTLIER 65.73 26.67 11.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.121 178.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -105.21 136.96 43.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 111.339 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.68 169.68 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.117 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 285' ' ' ALA . 37.5 t80 -119.79 128.18 53.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.437 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.474 HG23 HD22 ' A' ' 280' ' ' LEU . 1.5 p -119.95 118.63 57.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.14 -178.36 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.169 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.603 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 50.6 m 64.93 26.54 12.79 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.889 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.563 HG13 HD11 ' A' ' 225' ' ' ILE . 58.0 t -72.18 134.89 28.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.519 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -63.22 127.59 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -56.57 -29.64 62.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.856 -171.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.18 -45.96 24.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.516 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.705 HD22 HD11 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -75.08 116.13 15.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.014 -177.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.4 t -106.54 -176.17 3.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -166.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -48.5 -45.1 36.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.33 -34.35 64.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.862 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.6 m-20 -79.7 -56.79 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.451 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.76 HG13 HD11 ' A' ' 240' ' ' LEU . 27.1 mm -54.39 -26.25 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.835 0.454 . . . . 0.0 112.071 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.469 ' HZ2' ' CD ' ' A' ' 230' ' ' GLU . 63.6 tttm -50.91 -32.43 20.63 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.77 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.424 ' HB3' ' HG2' ' B' ' 37' ' ' ARG . 67.2 m -48.93 -62.71 1.38 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.575 0.702 . . . . 0.0 112.698 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.849 HG12 ' HB3' ' B' ' 34' ' ' ALA . 2.3 m -74.72 -46.24 42.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.949 -165.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.644 ' HB2' HD12 ' A' ' 235' ' ' ILE . 71.6 m-85 -61.07 -35.89 78.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.967 0.413 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.469 ' CD ' ' HZ2' ' A' ' 226' ' ' LYS . 45.4 tt0 -77.38 -26.52 51.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.192 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.53 81.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.654 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.764 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.5 OUTLIER -82.67 -14.27 54.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.669 -175.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.44 -111.3 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.82 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -156.07 131.19 9.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 110.132 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.644 HD12 ' HB2' ' A' ' 229' ' ' PHE . 58.7 mt -86.39 127.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.472 0.653 . . . . 0.0 110.763 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -79.48 -46.07 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.736 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 5.4 p -167.0 129.34 1.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.699 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.433 ' HB3' HG22 ' A' ' 255' ' ' ILE . 20.4 p -131.2 137.76 49.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.901 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 52.8 m -154.88 120.68 5.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.898 0.38 . . . . 0.0 110.915 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.76 HD11 HG13 ' A' ' 225' ' ' ILE . 52.6 mt -83.46 130.83 35.04 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.13 121.04 11.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.254 0.55 . . . . 0.0 110.319 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.629 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 44.9 mtt180 -93.59 158.04 15.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.475 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.6 t70 -117.89 107.71 43.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.382 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.28 -24.69 57.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.015 2.477 . . . . 0.0 113.187 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.5 p -78.43 -28.36 46.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.688 0.28 . . . . 0.0 111.612 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -96.55 -33.37 11.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.899 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.3 -10.94 58.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.993 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -108.83 -92.52 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.667 -0.314 . . . . 0.0 111.115 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 25.4 p80 -170.0 162.09 9.0 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.475 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 96.0 mttt -84.17 155.82 22.38 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.61 42.03 1.47 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.559 . . . . 0.0 114.05 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.4 p90 -161.09 168.29 24.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 175.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -174.95 -177.82 44.34 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.189 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.25 137.49 54.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.772 0.32 . . . . 0.0 110.62 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 238' ' ' CYS . 56.4 mt -131.61 126.48 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.03 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.3 136.72 44.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.352 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -104.32 155.81 18.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.851 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -81.74 -19.36 41.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.689 173.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.446 ' HB2' ' OG ' ' A' ' 262' ' ' SER . 28.5 mmmt -127.46 120.98 29.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.407 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.29 -22.46 65.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.875 0.369 . . . . 0.0 111.363 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.511 ' HA ' HE21 ' A' ' 264' ' ' GLN . 99.0 mt-30 -65.42 -44.02 88.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 1.9 p -71.58 -29.89 65.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 267' ' ' VAL . 9.1 m -56.06 -41.44 75.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.035 0.445 . . . . 0.0 110.757 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.511 HE21 ' HA ' ' A' ' 261' ' ' GLN . 47.6 mt-30 -67.2 -35.21 79.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.571 -176.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.65 -43.27 63.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -52.17 -44.63 64.72 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.549 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 263' ' ' SER . 67.0 t -61.82 -27.18 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 111.383 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.0 m -91.12 -36.4 14.01 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.193 -0.317 . . . . 0.0 111.463 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 45.3 m -92.24 -35.07 14.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.734 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 40.2 mmm -70.36 -9.23 55.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -59.99 -43.3 95.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.664 0.745 . . . . 0.0 110.649 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 272' ' ' LEU . 8.8 mp -76.63 -8.61 57.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.699 ' CD2' HD21 ' A' ' 280' ' ' LEU . 49.0 t80 -45.41 102.09 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.523 0.514 . . . . 0.0 110.889 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.4 p-10 -94.68 128.82 41.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.489 0.662 . . . . 0.0 111.016 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.705 HD11 HD22 ' A' ' 220' ' ' LEU . 40.5 mt -124.07 87.24 2.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.759 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.63 -111.08 3.44 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -113.15 34.56 5.01 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.424 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.2 pt20 -141.23 159.86 41.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.681 0.24 . . . . 0.0 110.813 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -102.25 162.85 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.84 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 13.3 tp -91.09 -170.08 2.55 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.84 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 21.0 tpp180 -148.61 112.41 5.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 175.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.02 146.3 17.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.889 0.376 . . . . 0.0 110.811 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.85 -145.06 4.08 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.546 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.423 ' O ' HG22 ' A' ' 286' ' ' VAL . 92.4 mttt -123.08 150.7 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.653 -0.322 . . . . 0.0 110.29 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.06 -31.39 72.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.713 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.503 HG21 ' HB3' ' A' ' 167' ' ' GLN . 62.3 t 68.58 -65.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.409 HG23 HG11 ' A' ' 286' ' ' VAL . 3.1 p -115.58 83.77 11.51 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 CA--C 1.553 1.448 0 C-N-CA 122.643 2.229 . . . . 0.0 115.828 174.922 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.714 0.292 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -154.35 -77.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.318 . . . . 0.0 111.026 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.17 -23.36 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.121 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.609 ' O ' HD23 ' B' ' 35' ' ' LEU . 12.1 t80 -72.19 -23.88 61.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.08 0.467 . . . . 0.0 110.032 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 51.5 mtpt -71.4 -39.84 70.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.28 -31.52 72.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.849 ' HB3' HG12 ' A' ' 228' ' ' VAL . . . -56.93 -55.0 40.22 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.549 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.637 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.7 OUTLIER -82.25 -24.13 34.95 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 4.7 pt20 -60.33 -37.32 80.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.166 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.424 ' HG2' ' HB3' ' A' ' 227' ' ' SER . 32.1 ttm180 -74.01 -31.27 62.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.775 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.721 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -71.61 -42.39 67.74 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 121.549 0.69 . . . . 0.0 112.553 -175.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -79.24 -25.21 42.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.88 -1.137 . . . . 0.0 111.389 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -55.87 -49.8 72.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.35 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.721 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.2 pt -65.41 -34.13 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.847 0.356 . . . . 0.0 110.352 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.544 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -68.33 -25.12 64.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.443 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.53 -45.96 34.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.229 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.696 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -86.56 -29.55 22.57 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.51 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 59.4 mt . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 122.868 0.467 . . . . 0.0 111.406 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.9 -26.1 62.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.01 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.5 tp -68.09 -36.18 79.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.28 68.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.4 mt -80.49 -47.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.535 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 52.2 mtm -66.27 -27.02 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.47 -13.41 62.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 21.9 ptt180 -127.23 119.44 26.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.815 0.341 . . . . 0.0 110.566 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.486 HG22 ' HE1' ' A' ' 160' ' ' TYR . 16.8 m -92.47 138.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.69 0.757 . . . . 0.0 111.394 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -86.36 99.49 11.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.642 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.0 t -96.74 115.6 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.155 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.527 ' CA ' ' HD1' ' A' ' 155' ' ' PHE . . . -127.69 -176.91 14.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.8 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 47.2 m 72.43 -72.26 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.582 0.753 . . . . 0.0 111.149 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.426 HD13 HD12 ' A' ' 128' ' ' ILE . 44.1 mm 68.79 158.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 123.23 0.331 . . . . 0.0 110.743 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.402 ' N ' HG21 ' A' ' 119' ' ' ILE . 69.6 t80 -56.26 -64.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.376 -0.203 . . . . 0.0 110.729 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.2 t80 177.86 -49.77 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.104 0 O-C-N 123.456 0.473 . . . . 0.0 110.687 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.6 45.19 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.487 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.41 134.36 46.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.925 0.393 . . . . 0.0 111.102 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.56 -177.33 50.43 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.256 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -63.79 -41.65 97.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.478 -0.361 . . . . 0.0 111.866 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -64.37 -41.32 96.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.534 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.7 m -57.06 -45.21 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.426 HD12 HD13 ' A' ' 119' ' ' ILE . 65.5 mt -71.08 -45.82 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.689 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 129' ' ' ARG . 20.5 ttp180 -56.59 -47.0 80.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.571 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.55 -11.41 59.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.629 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -29.83 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.407 . . . . 0.0 110.443 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.786 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 61.7 m-85 -99.29 8.1 45.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.34 -44.0 12.91 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.583 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.591 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 29.1 Cg_endo -64.84 -4.78 9.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.843 1.695 . . . . 0.0 113.019 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.514 ' HB3' ' HB2' ' A' ' 165' ' ' ALA . 5.4 m-85 -87.25 -68.35 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.795 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.17 167.65 36.18 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.814 ' HG2' ' HB3' ' A' ' 161' ' ' GLU . 19.3 Cg_endo -60.39 126.86 21.11 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.54 2.16 . . . . 0.0 111.833 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.2 mt -87.8 128.89 39.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.367 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -80.26 -56.19 4.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -158.7 152.21 23.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.16 107.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.89 112.61 24.61 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 43.1 ttm -134.85 118.27 16.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.204 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.4 t -91.09 115.47 28.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.585 ' CE3' ' HB2' ' A' ' 152' ' ' HIS . 1.6 p-90 -165.93 151.63 8.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.196 0.522 . . . . 0.0 111.771 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.24 99.8 1.22 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.5 t -94.2 6.53 48.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.6 p -84.75 -31.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.114 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.2 p -108.37 -17.37 14.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 111.202 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.0 mtt 63.21 41.18 8.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.143 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -84.06 -39.93 18.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.585 ' HB2' ' CE3' ' A' ' 145' ' ' TRP . 1.6 t60 60.43 67.04 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.732 0.777 . . . . 0.0 110.357 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -96.7 64.96 2.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.664 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.25 -155.25 11.36 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.743 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.527 ' HD1' ' CA ' ' A' ' 117' ' ' GLY . 28.7 m-85 -104.99 170.46 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.961 0.41 . . . . 0.0 111.16 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.45 145.4 24.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.76 107.85 18.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.727 0.299 . . . . 0.0 110.277 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.36 111.37 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 30.1 tt0 -100.57 129.32 46.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.963 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.486 ' HE1' HG22 ' A' ' 114' ' ' VAL . 90.3 m-85 -102.01 161.34 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.384 0.611 . . . . 0.0 111.412 -176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.814 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 10.8 tp10 -77.62 -27.07 51.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.585 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.55 119.76 23.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.665 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.91 -19.4 54.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.299 2.666 . . . . 0.0 113.002 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.43 -56.92 15.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 110.519 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 135' ' ' PHE . . . -64.33 -28.96 70.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.99 -51.2 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.01 -36.62 75.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.414 HD23 ' CE2' ' A' ' 212' ' ' TYR . 22.2 tp -57.47 -45.95 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.344 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.05 93.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.185 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.32 -41.48 89.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.701 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -85.13 -32.46 22.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -91.3 -29.42 17.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.786 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 14.9 mmt -95.25 -34.23 12.28 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.111 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 9.9 t30 -70.18 -15.91 63.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 110.454 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.4 p -92.64 5.49 50.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.25 146.1 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 110.594 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.669 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 36.0 mtm -94.23 132.78 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 38.1 tp -83.52 83.77 7.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.142 0.496 . . . . 0.0 110.22 -176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.71 -36.44 3.26 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.191 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.13 -38.18 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.99 128.57 36.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.669 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.0 p-10 -75.48 119.09 19.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.276 0.56 . . . . 0.0 109.995 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 19.9 pt -74.97 150.95 6.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.003 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -101.48 117.58 35.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.048 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 42.9 t -122.64 106.33 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.06 175.23 18.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.049 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 38.9 mtp180 -146.7 128.19 7.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 122.459 0.303 . . . . 0.0 110.424 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.0 Cg_endo -82.19 60.69 7.51 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.059 2.506 . . . . 0.0 111.472 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.5 m -115.76 151.37 35.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.974 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.9 32.48 20.02 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.774 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 195' ' ' GLN . 38.1 mt -79.77 73.12 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.995 0.902 . . . . 0.0 110.222 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 163.08 -36.15 0.32 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.492 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -83.56 -52.64 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.35 . . . . 0.0 110.619 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.87 -21.74 15.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.232 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.574 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 26.7 tp60 -52.74 -47.17 95.48 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.7 Cg_endo -55.15 -30.55 71.5 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.454 2.103 . . . . 0.0 113.072 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.1 -39.05 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.441 . . . . 0.0 110.067 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.9 -38.86 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.082 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.1 -40.07 92.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.75 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -63.64 -34.38 77.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.076 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.87 -45.96 22.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.657 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.79 -43.41 98.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.064 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.465 ' OE1' ' HD2' ' A' ' 206' ' ' ARG . 5.5 tp10 -62.72 -33.53 75.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.455 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.613 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 4.2 tp10 -70.2 -40.79 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.019 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -68.47 -28.08 66.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.466 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 88.7 mtt180 -64.25 -22.99 67.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.23 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.03 -4.01 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -111.45 -18.72 12.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.471 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.503 HD22 ' HA ' ' A' ' 260' ' ' ALA . 50.2 t-20 50.58 68.58 0.75 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.348 0.594 . . . . 0.0 110.43 -176.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -130.28 136.66 49.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.505 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.679 HD11 ' HE2' ' A' ' 229' ' ' PHE . 7.6 tt -106.54 147.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.335 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.414 ' CE2' HD23 ' A' ' 168' ' ' LEU . 86.5 t80 -108.01 122.88 47.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.406 ' CG2' HD22 ' A' ' 280' ' ' LEU . 6.5 p -122.87 124.2 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.297 0.57 . . . . 0.0 110.897 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 134' ' ' PRO . . . -122.39 -178.19 3.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.46 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.591 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.0 m 64.77 33.61 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.768 0.668 . . . . 0.0 111.558 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.757 HG23 HD11 ' A' ' 225' ' ' ILE . 7.1 p -82.78 151.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.281 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -68.89 136.22 52.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -57.48 -35.59 70.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -168.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -45.89 19.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.744 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -52.21 110.25 0.47 Allowed 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.78 0.675 . . . . 0.0 110.156 177.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.2 t -94.8 -178.46 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.619 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 2.3 p30 -62.81 -29.36 70.67 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.7 -41.44 73.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.339 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.517 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 52.0 m-20 -80.23 -52.35 7.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.771 -175.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.757 HD11 HG23 ' A' ' 216' ' ' VAL . 47.2 mm -56.21 -25.25 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.227 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.753 ' HG3' HD13 ' A' ' 235' ' ' ILE . 53.8 tttm -55.57 -31.9 62.58 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.47 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.549 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.0 m -51.02 -61.92 1.93 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.826 0.822 . . . . 0.0 112.019 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' B' ' 34' ' ' ALA . 3.1 m -68.05 -48.84 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.574 -171.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.679 ' HE2' HD11 ' A' ' 211' ' ' ILE . 52.5 m-85 -59.27 -45.22 91.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.787 0.327 . . . . 0.0 111.22 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 40.9 tt0 -73.43 -23.82 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.726 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.52 71.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.754 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 0.3 OUTLIER -83.73 -38.08 21.85 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -165.78 148.47 13.85 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.17 139.34 58.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.486 0.66 . . . . 0.0 111.355 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.753 HD13 ' HG3' ' A' ' 226' ' ' LYS . 31.0 pt -119.78 137.04 54.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.666 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -85.64 -68.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.407 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' A' ' 256' ' ' GLU . 11.6 m -94.7 108.99 20.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.336 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 4.3 p -122.12 102.1 7.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.9 m -142.64 116.25 9.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.762 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.619 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 73.6 mt -90.22 117.8 29.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 168.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 123.11 15.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.2 0.524 . . . . 0.0 110.985 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.784 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 53.5 mtt-85 -80.74 157.4 25.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.335 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.597 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 18.5 t70 -117.34 113.89 38.7 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.161 -175.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.79 -20.35 39.86 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.763 2.309 . . . . 0.0 112.336 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.7 m -64.36 -56.69 12.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.496 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 47.2 p -86.81 -35.39 19.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.509 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 106.58 -10.25 41.86 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.1 -157.93 0.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.784 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 29.6 p80 -108.35 149.42 28.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 94.1 mttt -70.7 154.23 42.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.432 ' C ' HG12 ' A' ' 216' ' ' VAL . . . -73.15 34.45 0.77 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 114.669 0.628 . . . . 0.0 114.669 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.456 ' HE2' ' HD3' ' A' ' 137' ' ' PRO . 35.5 p90 -157.07 164.81 37.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.555 0.678 . . . . 0.0 110.633 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.565 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -173.25 -175.41 41.01 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.312 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -123.41 141.58 51.85 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.2 mp -124.78 135.47 63.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.973 174.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.411 ' HB3' ' H ' ' A' ' 237' ' ' SER . 45.6 tt0 -109.04 126.44 53.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.627 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -98.15 144.23 27.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.182 0.515 . . . . 0.0 112.181 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.846 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 5.0 pt-20 -74.84 -31.47 61.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.846 ' HG3' ' HG3' ' A' ' 258' ' ' GLU . 24.0 mtpp -109.47 157.47 18.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.503 ' HA ' HD22 ' A' ' 209' ' ' ASN . . . -81.86 -40.89 21.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 0.0 111.254 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -64.62 -38.63 91.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 6.3 p -62.74 -34.78 77.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.567 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -39.94 86.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.964 0.411 . . . . 0.0 110.612 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.69 -39.67 70.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.775 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -46.7 86.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -60.55 -52.62 64.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.469 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.22 -25.95 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.172 0.51 . . . . 0.0 111.693 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.9 m -84.3 -17.89 38.15 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.098 -0.376 . . . . 0.0 111.993 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.6 p -116.09 -34.41 4.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.658 ' HE3' ' CD2' ' A' ' 273' ' ' PHE . 39.9 mmm -65.48 -4.5 5.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -69.99 -35.28 74.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 122.167 0.984 . . . . 0.0 109.477 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.92 -8.79 58.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.369 -174.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.805 ' CE1' ' HB2' ' B' ' 38' ' ' ALA . 1.2 t80 -52.78 105.37 0.12 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.877 0.37 . . . . 0.0 110.653 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.3 t70 -97.95 119.2 36.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.744 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.6 mm? -117.52 86.31 2.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.995 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.5 26.1 61.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.664 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 118.21 -18.68 11.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.228 -0.986 . . . . 0.0 113.646 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.4 pt20 -106.75 131.76 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.136 0.468 . . . . 0.0 111.362 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 273' ' ' PHE . 50.1 m-85 -94.31 137.95 32.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.275 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.492 HD23 ' HD2' ' A' ' 273' ' ' PHE . 11.1 mp -73.81 -173.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.304 0.573 . . . . 0.0 111.525 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.428 HH12 ' HB2' ' A' ' 279' ' ' TYR . 77.2 mmt-85 -146.89 118.09 7.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.15 146.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.431 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -154.52 -164.37 12.83 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.735 176.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -88.69 169.94 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.499 0.649 . . . . 0.0 110.186 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.91 -32.44 73.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.8 t 70.73 -70.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.954 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 54.0 p -112.84 138.69 22.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.613 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 65.5 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.341 2.028 . . . . 0.0 112.058 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . 0.676 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 51.7 t30 . . . . . 0 C--O 1.224 -0.26 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.61 -67.76 0.35 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -24.16 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.053 0.454 . . . . 0.0 111.273 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.538 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 5.2 t80 -75.14 -17.84 60.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.126 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 89.6 mttt -70.61 -45.5 65.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.52 -40.3 86.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.754 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -48.51 -53.43 18.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.326 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.811 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.22 -17.51 45.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 57.5 mt-30 -66.07 -43.85 86.23 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.549 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 74.0 mtp180 -69.38 -37.35 77.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.108 173.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.811 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -59.55 -50.65 73.06 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.269 31.1 mtp85 -81.55 -25.38 35.91 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.266 -1.521 . . . . 0.0 112.971 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -55.57 -44.89 77.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.018 169.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.811 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -66.33 -33.54 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.517 ' HB3' HD13 ' A' ' 275' ' ' LEU . . . -69.28 -24.81 64.01 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.813 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.58 -22.91 24.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.202 0.525 . . . . 0.0 110.637 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.516 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 20.1 ttpt -90.91 -41.65 11.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.58 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.411 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.3 pt . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 123.786 0.835 . . . . 0.0 112.9 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.52 -52.79 64.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.758 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.55 HD13 ' HG3' ' A' ' 163' ' ' PRO . 3.8 mm? -66.11 -36.78 84.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.88 74.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.359 . . . . 0.0 111.367 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.9 mt -82.11 -41.29 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.81 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.9 mtp -68.05 -37.01 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.059 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 79.8 m -75.91 -17.78 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.798 ' HG2' ' HB3' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.3 99.92 11.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.979 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.78 140.03 17.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.419 0.628 . . . . 0.0 111.226 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.558 ' HE2' ' HE2' ' A' ' 184' ' ' LYS . 42.6 t80 -88.94 121.34 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.406 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.461 HG21 HG12 ' A' ' 185' ' ' VAL . 52.0 t -116.53 110.98 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -130.42 101.98 0.52 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.652 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.543 ' HB3' HG23 ' A' ' 183' ' ' ILE . 8.9 t 168.45 59.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.416 HG21 ' ND1' ' A' ' 152' ' ' HIS . 12.7 mm -82.06 -17.45 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.8 -170.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 t80 66.51 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.1 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.2 t80 179.17 -53.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.69 36.05 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.52 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.56 113.45 18.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.583 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -83.18 159.85 37.77 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.236 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.43 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.1 OUTLIER -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 109.895 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 25.5 t70 -65.13 -42.12 94.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.085 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -58.75 -42.82 89.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.034 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.38 -42.72 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.511 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 129' ' ' ARG . 10.6 ttp180 -61.0 -39.78 91.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 38.3 mt-30 -76.29 -20.42 57.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.05 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.22 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.883 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -94.88 8.12 43.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.476 ' HB2' ' HD3' ' A' ' 134' ' ' PRO . . . -66.63 -44.22 53.73 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.991 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.544 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 23.9 Cg_exo -65.86 -12.74 36.6 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 112.541 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 214' ' ' ALA . 5.9 m-85 -80.39 -68.16 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.654 0.264 . . . . 0.0 110.964 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -149.07 169.55 29.46 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.465 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.496 ' HD2' HG21 ' A' ' 162' ' ' VAL . 15.2 Cg_exo -67.46 100.52 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.682 2.255 . . . . 0.0 111.565 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.34 107.36 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -76.22 -31.83 58.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 p -173.07 128.95 0.47 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.743 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.0 tt -105.92 132.85 51.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 172.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -114.49 115.63 27.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.865 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.583 ' HE3' ' HD1' ' A' ' 152' ' ' HIS . 23.0 ttt -140.81 128.54 21.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.093 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.8 t -118.99 124.92 48.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.86 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 43.6 p-90 -163.64 159.61 21.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.615 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.87 93.25 1.68 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.872 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.453 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 48.3 t -70.86 -22.04 62.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.546 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.82 -26.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.022 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.8 p -121.36 5.73 10.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.86 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 68.5 mtp 60.8 27.35 17.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -91.08 107.57 19.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 0.0 110.608 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.583 ' HD1' ' HE3' ' A' ' 143' ' ' MET . 40.8 m-70 -83.25 74.55 10.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.92 -51.14 17.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.189 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.33 172.7 54.45 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.629 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.09 170.85 7.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -104.7 129.11 52.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 0.0 110.446 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.27 108.03 17.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.27 124.12 67.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.207 0.527 . . . . 0.0 110.554 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.798 ' HB3' ' HG2' ' A' ' 113' ' ' ARG . 10.3 pt-20 -112.82 131.22 55.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.501 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.67 162.89 13.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.731 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -78.27 -15.18 59.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.654 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 17.3 m -129.44 128.98 23.19 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.55 ' HG3' HD13 ' A' ' 108' ' ' LEU . 56.2 Cg_endo -72.07 -14.61 29.04 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.009 2.473 . . . . 0.0 113.16 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.654 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 31.0 mp0 -60.74 -52.21 66.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 110.574 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -22.98 67.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.503 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.31 -50.71 36.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.794 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -39.67 94.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.421 ' CD2' ' HB1' ' A' ' 214' ' ' ALA . 15.5 tp -60.36 -49.65 76.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.846 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.96 -29.2 70.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.196 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.823 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.9 tt -61.37 -61.15 2.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.092 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.99 -39.49 23.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.706 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 17.3 mm-40 -83.14 0.19 46.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.408 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 58.2 tpp -122.38 -36.54 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.079 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.639 ' OD1' ' HA ' ' A' ' 184' ' ' LYS . 10.4 t30 -67.58 -31.09 70.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.959 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.2 m -85.16 -8.91 58.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.81 90.18 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.108 0.48 . . . . 0.0 110.211 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.6 ptm -72.52 118.12 15.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.255 0.55 . . . . 0.0 110.32 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.2 -34.24 68.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.485 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 152.29 133.41 1.94 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.553 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.98 -62.89 3.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.606 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -124.04 155.37 38.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -90.12 127.92 36.21 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.543 HG23 ' HB3' ' A' ' 118' ' ' SER . 23.4 pt -89.97 132.06 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.068 176.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.639 ' HA ' ' OD1' ' A' ' 174' ' ' ASN . 21.8 ptmt -102.15 116.94 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.368 0.604 . . . . 0.0 110.176 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.461 HG12 HG21 ' A' ' 116' ' ' VAL . 62.1 t -123.51 133.5 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.227 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.823 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 106.48 -126.29 8.45 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.841 174.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 54.84 67.93 2.93 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 124.17 0.57 . . . . 0.0 111.013 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.04 -157.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.909 2.406 . . . . 0.0 111.892 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.1 t 72.55 118.6 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.577 0.703 . . . . 0.0 110.681 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.477 ' OD1' HG13 ' A' ' 191' ' ' ILE . 25.2 t-20 -74.85 -63.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.278 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.477 HG13 ' OD1' ' A' ' 190' ' ' ASN . 55.5 mt -137.55 67.48 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.268 0.556 . . . . 0.0 110.463 175.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.01 2.07 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -58.63 -10.31 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -84.85 -30.74 24.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.044 -0.41 . . . . 0.0 111.269 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.1 tp60 -64.18 -50.16 69.66 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.6 Cg_exo -52.52 -33.57 58.44 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.117 1.878 . . . . 0.0 112.437 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.93 -44.03 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 110.094 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.88 -43.55 97.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.608 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -45.11 93.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 84.2 mm-40 -61.11 -46.22 91.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.678 HD13 HG21 ' A' ' 287' ' ' THR . 96.1 mt -71.21 -28.99 64.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.68 94.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.3 -32.45 71.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.178 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.55 -42.14 87.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.201 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.12 72.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.46 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -68.43 -19.4 64.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.82 -13.49 59.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.486 ' HB3' ' HG3' ' A' ' 210' ' ' ARG . 41.4 m-85 -103.39 -23.07 13.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.144 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 59.09 37.1 24.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.501 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 1.003 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 96.3 mtt180 -97.22 138.25 35.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.503 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.09 158.56 17.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.35 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -109.75 128.54 55.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.833 0.349 . . . . 0.0 110.621 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 4.4 p -120.78 119.23 58.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.129 0.49 . . . . 0.0 110.585 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 135' ' ' PHE . . . -123.33 -177.2 3.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.544 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 8.1 t 68.0 22.49 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.055 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.484 HG13 HD12 ' A' ' 225' ' ' ILE . 84.7 t -73.23 129.68 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.018 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -63.18 130.54 45.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.81 -28.82 66.37 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -78.98 -45.87 19.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 111.398 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.663 HD21 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -61.34 110.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.638 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 62.4 m -87.14 -178.26 6.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.9 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 19.7 p-10 -66.94 -37.65 84.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.706 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.704 0.764 . . . . 0.0 109.832 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 0.9 OUTLIER -67.78 -54.62 17.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.723 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.691 HG13 HD11 ' A' ' 240' ' ' LEU . 29.4 mm -59.58 -21.28 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 111.032 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.447 ' HG3' HD11 ' A' ' 235' ' ' ILE . 88.4 tttt -59.19 -31.39 68.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.936 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.4 m -48.76 -59.79 3.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.87 0.843 . . . . 0.0 111.43 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.71 ' HB ' ' HE2' ' A' ' 270' ' ' MET . 2.8 m -68.91 -52.22 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.603 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -58.38 -34.4 70.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.421 ' HA ' HG13 ' A' ' 235' ' ' ILE . 2.2 tm-20 -76.63 -34.67 58.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.026 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.39 -13.75 61.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.69 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 4.2 m-30 -90.06 -10.94 42.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.763 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 173.72 -112.49 0.42 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.583 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -146.45 120.0 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 110.609 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.447 HD11 ' HG3' ' A' ' 226' ' ' LYS . 49.8 mt -85.6 134.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.094 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -86.46 -47.99 8.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.093 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 3.8 m -148.55 132.14 16.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.897 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 45.1 t -120.25 111.59 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.9 m -141.02 107.81 5.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.296 0.569 . . . . 0.0 112.288 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.9 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 79.4 mt -91.68 130.65 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.9 162.17 22.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.954 0.407 . . . . 0.0 110.967 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 56.3 mtp180 -123.68 158.7 30.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -107.77 95.72 15.24 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.94 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.32 -23.42 32.82 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 113.136 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -29.35 55.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.635 ' HB ' ' HE2' ' A' ' 248' ' ' LYS . 1.2 m -114.32 -19.33 11.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 111.509 178.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.63 43.18 5.55 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.877 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.635 ' HE2' ' HB ' ' A' ' 246' ' ' THR . 47.1 mtmt -125.8 -178.51 4.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.755 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -113.18 131.61 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 170.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.431 ' C ' ' H ' ' A' ' 252' ' ' TYR . 70.1 mmtt -65.58 136.44 56.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.62 29.83 1.04 Allowed Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.359 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.6 p90 -154.15 158.46 40.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.673 ' HA3' HD22 ' A' ' 240' ' ' LEU . . . -174.62 -171.42 38.8 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.114 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 164' ' ' GLU . 98.4 m-85 -127.65 133.32 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.936 0.398 . . . . 0.0 110.95 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.07 132.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 1.003 ' HG2' ' HG2' ' A' ' 210' ' ' ARG . 39.7 mt-10 -104.31 144.52 31.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.048 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -120.11 141.44 49.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.225 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.444 ' C ' ' HE3' ' A' ' 259' ' ' LYS . 6.8 pt-20 -81.92 -33.03 30.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.706 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.444 ' HE3' ' C ' ' A' ' 258' ' ' GLU . 0.1 OUTLIER -97.95 113.22 25.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.094 173.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.32 68.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.047 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.65 -35.68 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.2 m -68.37 -25.85 65.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 267' ' ' VAL . 6.9 m -62.42 -30.8 71.48 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.84 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.04 -43.66 57.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.896 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -52.94 -45.52 67.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.349 0.405 . . . . 0.0 110.551 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.536 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . . . -60.56 -42.22 96.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.648 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 263' ' ' SER . 98.2 t -64.46 -39.39 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.716 -176.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.1 p -86.45 -1.0 57.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -115.63 -45.4 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.819 ' HE1' ' HB2' ' A' ' 273' ' ' PHE . 0.0 OUTLIER -64.45 -20.61 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -60.02 -38.27 82.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.744 0.783 . . . . 0.0 110.4 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -78.06 -9.86 59.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.855 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -46.92 106.96 0.09 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.961 0.41 . . . . 0.0 111.494 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.6 108.89 15.54 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.627 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.663 ' HG ' HD21 ' A' ' 220' ' ' LEU . 1.1 mm? -114.7 86.85 2.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.62 -116.83 4.42 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -110.46 23.59 19.91 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.076 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 9.9 pt20 -125.13 151.55 45.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 0.0 111.222 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -107.27 137.84 44.58 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 4.5 tp -69.05 -176.39 0.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.282 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.706 ' HD2' ' HB3' ' A' ' 172' ' ' GLN . 73.2 mmt-85 -141.51 113.26 7.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.832 0.348 . . . . 0.0 110.388 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 270' ' ' MET . 12.3 p -115.19 146.55 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.985 0.422 . . . . 0.0 110.997 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.91 -159.44 9.37 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -108.31 171.64 7.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 117.18 0.49 . . . . 0.0 110.249 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -62.48 -40.59 97.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.609 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.3 t 70.97 -67.05 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.487 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.678 HG21 HD13 ' A' ' 201' ' ' LEU . 0.5 OUTLIER -108.89 160.97 25.38 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.513 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.452 -0.945 0 C-N-CA 123.152 2.568 . . . . 0.0 111.774 173.544 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . 0.479 ' O ' ' HD3' ' B' ' 32' ' ' LYS . 6.4 t30 . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.02 -51.47 3.84 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.904 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 232' ' ' PHE . . . -58.29 -45.76 87.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.009 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.69 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 23.8 t80 -76.36 -20.47 57.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.125 0.488 . . . . 0.0 110.947 -175.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' B' ' 28' ' ' ASN . 0.2 OUTLIER -82.75 -35.45 26.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.101 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 9.7 t70 -57.97 -46.3 85.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 168.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.702 ' HB3' HG12 ' A' ' 228' ' ' VAL . . . -48.46 -46.74 38.36 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.996 176.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.791 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.2 -21.68 39.41 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.1 -41.67 97.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 54.5 mtt180 -68.83 -36.86 78.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.898 173.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.855 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.0 -42.47 97.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.074 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.461 ' HA ' ' HB3' ' B' ' 42' ' ' ALA 0.253 2.7 mtt180 -81.15 -25.99 36.44 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.706 173.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -54.84 -44.34 73.85 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.34 0.59 . . . . 0.0 110.097 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.775 HD12 ' HZ ' ' A' ' 273' ' ' PHE . 5.5 pt -68.74 -32.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 CA-C-O 121.207 0.527 . . . . 0.0 109.958 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' B' ' 39' ' ' ARG . . . -75.2 -4.59 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.036 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.89 -37.67 15.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.259 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' B' ' 41' ' ' ILE . 11.2 ptpt -72.4 -7.8 51.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.056 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.23 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 121.001 0.429 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 -27.91 69.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.651 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 29.7 tp -65.72 -33.28 75.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.565 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.6 67.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 0.0 110.651 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.0 mt -82.99 -42.31 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.959 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.651 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 26.7 ptm -71.32 -25.47 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.977 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.492 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 83.9 m -86.43 5.52 34.67 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.407 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 12.4 ptp180 -123.87 130.91 53.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 0.0 110.728 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.439 HG23 ' HB ' ' A' ' 158' ' ' VAL . 14.7 m -101.7 145.76 11.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.208 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 73.8 t80 -105.43 127.92 53.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.972 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.5 109.88 30.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.7 152.17 17.48 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.373 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.6 m 61.04 64.09 1.17 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.985 0.421 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.9 mm -54.46 132.09 17.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.376 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 88.5 t80 -44.43 -70.1 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.96 0.787 . . . . 0.0 111.733 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 86.1 t80 171.9 -62.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.752 0.658 . . . . 0.0 109.574 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.81 -25.86 37.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.172 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.52 121.48 13.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -106.41 -175.22 23.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.949 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 32.6 tt0 -65.12 -36.61 84.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.044 0.449 . . . . 0.0 110.07 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.533 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 23.4 m-20 -63.84 -40.9 97.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.319 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.7 m -60.85 -49.74 76.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.45 -51.74 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.057 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.533 ' HE ' ' HA ' ' A' ' 126' ' ' ASP . 23.0 ptt180 -63.62 -35.68 81.31 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.691 -0.404 . . . . 0.0 112.026 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.78 -22.78 49.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.56 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.08 -36.97 58.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.393 . . . . 0.0 110.723 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.463 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 86.9 m-85 -93.31 14.72 17.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.563 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.49 -44.48 18.0 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.273 -178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 34.8 Cg_endo -67.16 -4.67 12.04 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.407 ' CZ ' ' HE2' ' A' ' 173' ' ' MET . 34.6 m-85 -92.47 -75.7 0.48 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.69 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -145.1 -177.57 20.01 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.519 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 2.0 Cg_endo -80.72 135.08 10.03 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.712 2.275 . . . . 0.0 112.069 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.15 109.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -79.08 -56.42 4.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.81 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.3 m -156.88 136.57 12.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.679 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.7 mt -121.13 114.72 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.76 106.1 13.48 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 156' ' ' ALA . 25.2 ptm -116.65 142.4 46.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.7 t -81.79 104.27 12.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.01 117.18 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.452 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 150' ' ' MET . 3.3 t70 -77.25 91.86 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.754 172.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.0 p -94.92 4.49 53.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.988 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.55 -54.35 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 t -120.71 4.83 10.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.364 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.598 ' HA ' ' O ' ' A' ' 146' ' ' ASP . 26.8 ptm 45.51 37.67 3.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.565 1.146 . . . . 0.0 113.198 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -102.95 7.14 39.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 72.16 44.96 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.642 171.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -76.26 81.1 3.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.329 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.8 -161.08 24.96 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.898 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.91 166.93 23.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.478 -0.361 . . . . 0.0 110.08 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -133.03 138.99 46.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.817 0.342 . . . . 0.0 111.571 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.29 119.09 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.78 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.439 ' HB ' HG23 ' A' ' 114' ' ' VAL . 47.4 t -112.57 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 51.5 mt-10 -96.52 141.65 29.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.89 160.25 20.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.754 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.519 ' HG2' ' HG2' ' A' ' 137' ' ' PRO . 10.6 pt-20 -87.59 -2.4 58.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.123 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.459 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 12.9 m -133.57 126.38 19.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.23 177.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.492 ' HG3' ' SG ' ' A' ' 112' ' ' CYS . 17.1 Cg_exo -67.88 -18.02 46.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.468 2.779 . . . . 0.0 111.624 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 14.1 mp0 -62.21 -56.64 16.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.835 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -31.41 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.73 -51.02 66.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.634 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -65.03 -43.64 91.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 110.176 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.49 -48.34 79.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.707 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -58.22 -59.95 4.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.687 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.88 -34.08 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -74.24 -45.03 50.6 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.542 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.657 ' HB3' HD12 ' A' ' 183' ' ' ILE . 26.3 mmt -74.97 -17.85 60.48 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.938 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -76.77 -28.45 55.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.38 0.61 . . . . 0.0 109.644 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.5 m -89.57 -42.92 11.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.042 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 67.4 t -89.52 119.91 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.623 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 88.2 mtp -77.41 112.56 14.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 178' ' ' LEU . 0.6 OUTLIER -79.74 102.98 9.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.234 -176.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.7 -134.41 12.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.856 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -100.21 13.59 60.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.97 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -148.79 161.86 40.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.623 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.1 p-10 -98.29 119.2 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 173' ' ' MET . 28.5 pt -64.4 156.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -100.46 109.73 21.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.6 p -136.52 130.27 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.796 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.69 100.37 1.96 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.952 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.58 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.1 OUTLIER -151.74 87.78 4.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.221 177.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.46 101.38 1.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.678 2.252 . . . . 0.0 111.594 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.8 p -72.45 -21.07 61.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -99.8 29.67 4.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.008 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.7 tt -64.35 139.88 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.679 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.25 -69.27 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -82.62 -26.18 32.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 110.637 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.07 -33.95 72.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.532 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.662 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.0 tp60 -60.56 -53.93 59.71 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 55.9 Cg_exo -54.32 -28.83 54.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.479 2.12 . . . . 0.0 112.689 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.13 -52.61 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 194' ' ' ALA . 35.3 mt -64.33 -42.14 94.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.641 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.3 -37.97 89.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.83 -49.29 78.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.623 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.57 -47.5 84.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.449 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.1 -35.6 79.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.745 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.65 -39.08 64.74 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.747 0.308 . . . . 0.0 110.894 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.77 -31.59 70.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.09 0.471 . . . . 0.0 109.946 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.94 69.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.719 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtt180 -66.2 -25.83 67.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.366 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.78 71.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.901 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -95.16 -26.15 16.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.839 0.828 . . . . 0.0 109.861 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.2 t30 62.26 44.35 7.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 112.124 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -95.92 136.88 35.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.695 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 284' ' ' LYS . 12.2 pt -105.47 161.95 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.104 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.47 118.09 35.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.162 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 51.5 t -105.84 115.67 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.176 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -121.48 178.19 4.91 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.502 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.53 31.97 12.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.558 0.694 . . . . 0.0 110.142 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.572 HG12 HD11 ' A' ' 225' ' ' ILE . 58.6 t -80.71 132.84 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.665 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.47 ' HB2' HD23 ' A' ' 275' ' ' LEU . 4.6 t-80 -65.21 128.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -56.34 -31.98 64.26 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.549 -171.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.66 -26.45 50.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.951 0.405 . . . . 0.0 110.968 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.802 HD22 HD22 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -95.1 117.53 30.36 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -173.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 64.6 m -96.38 -176.53 3.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.6 OUTLIER -61.07 -38.88 87.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -58.24 -37.1 74.23 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.478 0.656 . . . . 0.0 109.83 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.4 m-20 -67.0 -58.57 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.495 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.572 HD11 HG12 ' A' ' 216' ' ' VAL . 43.7 mm -53.48 -28.52 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.574 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -53.15 -32.28 46.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.917 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.616 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 63.9 m -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.332 0.587 . . . . 0.0 112.404 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' B' ' 34' ' ' ALA . 2.9 m -64.58 -44.69 96.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.779 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.606 ' CE2' ' HG3' ' A' ' 270' ' ' MET . 86.0 m-85 -67.65 -36.48 80.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.507 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.4 tt0 -76.32 -28.42 56.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.957 0.408 . . . . 0.0 111.174 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.91 -24.98 67.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.763 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.9 OUTLIER -88.57 -51.22 5.81 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -148.84 160.62 28.46 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.722 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -68.92 131.45 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 229' ' ' PHE . 63.9 mt -96.36 134.39 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.52 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -90.36 -41.68 11.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.1 m -139.15 131.6 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 7.9 p -131.52 91.33 2.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.716 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.9 m -132.15 116.98 17.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.504 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 7.4 mp -90.38 129.89 36.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.06 97.43 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.668 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -80.69 149.71 29.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.699 175.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.5 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 0.0 OUTLIER -78.74 140.16 58.73 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 110.219 -176.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 12.2 Cg_exo -70.73 -20.93 29.65 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.709 2.939 . . . . 0.0 114.767 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 t -101.04 -40.29 7.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.484 -169.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.458 ' HG1' ' CG ' ' A' ' 243' ' ' ASP . 0.7 OUTLIER -106.57 -13.06 15.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.806 -0.559 . . . . 0.0 112.175 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.71 10.87 83.68 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.34 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 248' ' ' LYS . 42.6 mtmt -88.14 137.44 32.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.813 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 2.1 p80 -73.8 126.58 30.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.676 ' HD2' ' HE1' ' A' ' 252' ' ' TYR . 23.7 mttp -69.28 157.8 36.27 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.11 35.08 0.64 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 114.146 0.418 . . . . 0.0 114.146 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.676 ' HE1' ' HD2' ' A' ' 250' ' ' LYS . 38.0 p90 -151.64 154.05 35.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -159.28 179.5 34.84 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.86 121.1 36.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 211' ' ' ILE . 41.9 mm -105.89 124.68 61.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -104.16 118.12 35.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.86 139.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.97 -28.79 39.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.323 0.583 . . . . 0.0 109.656 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 262' ' ' SER . 41.2 tptt -101.34 117.3 34.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.642 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.24 83.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.276 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -68.85 -40.66 79.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.991 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 259' ' ' LYS . 31.6 t -63.37 -30.23 71.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 267' ' ' VAL . 44.2 t -59.87 -42.7 94.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.175 173.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.76 -39.94 88.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.438 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -54.93 -50.66 68.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.134 0.492 . . . . 0.0 110.511 175.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.17 -53.07 59.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.754 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 263' ' ' SER . 96.9 t -58.09 -33.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.666 -176.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.2 m -70.99 -20.22 62.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.2 m -115.08 -29.76 6.56 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.606 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 58.3 mmm -73.51 -2.07 21.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -167.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.443 ' HB3' HD23 ' A' ' 272' ' ' LEU . 51.6 t-20 -69.56 -39.72 77.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.203 1.001 . . . . 0.0 108.993 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -76.72 -8.99 58.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.985 -173.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.878 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 57.0 t80 -52.79 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.27 115.99 19.26 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.688 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.802 HD22 HD22 ' A' ' 220' ' ' LEU . 13.9 tp -122.82 86.1 2.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.53 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.41 33.76 55.73 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.04 1.87 62.77 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.033 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 20.3 pt20 -122.89 131.91 53.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.885 0.342 . . . . 0.0 110.701 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -81.32 133.82 35.49 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.863 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.878 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 12.1 tp -67.39 -178.67 0.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.083 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.775 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -147.8 112.29 5.3 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 270' ' ' MET . 7.9 p -115.34 137.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.184 0.516 . . . . 0.0 111.924 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -143.6 -144.59 4.27 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.919 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 34.3 ttmt -136.41 148.5 47.83 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.454 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -69.67 121.32 16.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.47 -18.22 7.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.136 0.493 . . . . 0.0 110.297 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 2.4 m -108.42 125.2 32.39 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.646 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 122.674 2.249 . . . . 0.0 111.459 174.169 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.788 0.328 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.29 -18.21 37.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.964 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . 0.505 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -66.22 -37.21 85.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.871 0.367 . . . . 0.0 110.377 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.723 ' HA ' ' CE1' ' A' ' 232' ' ' PHE . 17.3 t80 -78.02 -19.38 54.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.679 0.752 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.61 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 73.9 mmtt -73.27 -48.25 36.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.69 175.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 26.3 t70 -58.38 -36.62 73.78 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.763 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.52 -54.47 26.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.792 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.679 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 2.9 mm? -81.06 -20.36 41.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.61 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 44.2 mt-30 -63.74 -42.76 97.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.616 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 66.0 mtt180 -68.52 -37.47 80.05 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.939 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.751 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -62.37 -42.18 99.21 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -172.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' B' ' 39' ' ' ARG . 27.5 mtp85 -82.11 -26.25 33.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.385 -1.447 . . . . 0.0 112.589 173.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.93 -41.21 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.183 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.76 HG13 HD12 ' A' ' 220' ' ' LEU . 4.2 pt -68.44 -36.51 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.429 ' HA ' HD11 ' A' ' 220' ' ' LEU . . . -67.04 -15.69 63.88 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.086 0.469 . . . . 0.0 111.092 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.52 -42.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.161 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -82.25 -36.26 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.253 -177.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.401 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 69.3 mt . . . . . 0 N--CA 1.468 0.452 0 C-N-CA 123.555 0.742 . . . . 0.0 112.657 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.751 0.31 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 111' ' ' MET . . . -59.6 -40.27 86.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.013 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.81 -33.92 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.243 -177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.98 82.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.526 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.57 -36.87 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.106 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 107' ' ' ALA . 76.6 mtp -60.3 -26.48 66.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.873 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 75.8 m -73.35 -19.71 60.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.671 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 12.3 ptp180 -118.35 123.35 45.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 0.0 111.321 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -98.13 130.43 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.42 0.629 . . . . 0.0 111.096 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -75.52 119.25 19.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.023 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 42.7 t -108.21 112.24 39.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.57 178.08 28.58 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.841 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t 72.35 -79.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.437 0.695 . . . . 0.0 110.901 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mm 68.45 115.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.219 0.608 . . . . 0.0 111.613 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.638 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 61.9 t80 -72.27 142.65 48.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.476 ' HE1' ' HG2' ' A' ' 151' ' ' LYS . 92.4 t80 -52.85 -58.41 7.01 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -172.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -93.12 34.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.728 . . . . 0.0 110.233 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.638 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 27.8 tp -108.15 95.96 6.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.29 173.36 54.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.919 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.22 -35.58 80.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 129' ' ' ARG . 25.4 t70 -77.45 -29.43 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.772 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 m -67.33 -47.89 69.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.887 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.4 ' O ' ' HD1' ' A' ' 132' ' ' PHE . 85.3 mt -58.21 -42.55 83.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.76 172.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.493 ' HB3' ' O ' ' A' ' 126' ' ' ASP . 53.3 ttt180 -51.13 -49.82 60.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.202 176.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.585 ' HA ' ' HB3' ' A' ' 133' ' ' ALA . 75.5 mt-30 -75.39 -26.83 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.536 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.43 77.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.113 0.482 . . . . 0.0 110.607 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.487 ' CE2' ' HG3' ' A' ' 173' ' ' MET . 52.3 m-85 -100.95 11.14 40.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.462 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 130' ' ' GLN . . . -71.75 -38.34 6.1 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.945 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.855 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 45.4 Cg_exo -60.15 -15.2 32.79 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.647 1.565 . . . . 0.0 112.78 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -80.45 -72.52 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.942 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.26 -171.9 25.69 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.348 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.87 104.16 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.006 2.47 . . . . 0.0 111.83 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.54 117.87 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.796 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -90.71 -34.89 15.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.789 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t -153.25 142.08 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.917 0.389 . . . . 0.0 110.976 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.8 107.52 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 24.7 t70 -104.6 140.92 37.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.08 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.6 ttm -160.47 143.53 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.582 0.23 . . . . 0.0 110.552 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.2 p -73.95 100.85 3.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.912 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.466 ' CH2' ' HG3' ' A' ' 150' ' ' MET . 2.4 m95 -88.12 158.84 18.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -129.84 89.86 2.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 p 46.68 -145.15 0.24 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.496 170.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -81.64 -21.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.911 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 151' ' ' LYS . 9.2 t -66.03 -26.74 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.303 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.466 ' HG3' ' CH2' ' A' ' 145' ' ' TRP . 52.6 ttm 67.21 13.45 9.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.349 0.595 . . . . 0.0 111.561 175.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.476 ' H ' HG23 ' A' ' 149' ' ' THR . 35.7 mtmm -69.28 121.44 16.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.702 -0.623 . . . . 0.0 109.536 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.41 ' HE1' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -141.19 132.2 26.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.114 0.483 . . . . 0.0 111.045 -174.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 153' ' ' LYS . 34.9 ttpt -166.59 122.79 1.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.239 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.85 -94.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.122 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.92 144.07 47.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 0.0 111.918 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -141.26 161.29 38.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.293 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.498 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 92.3 m-85 -132.7 113.22 12.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.13 112.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 43.5 tt0 -105.42 125.49 51.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.167 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.427 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 96.4 m-85 -103.8 162.22 13.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.517 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.36 -19.46 50.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.964 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.59 134.86 25.25 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.592 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.9 -12.69 33.13 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.526 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 7.1 mp0 -63.87 -50.52 68.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.935 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.68 72.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.54 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.37 91.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.442 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -59.92 -49.45 77.65 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.426 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.702 HD21 ' HA3' ' A' ' 283' ' ' GLY . 37.4 mt -63.44 -41.44 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.58 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -62.17 -46.33 89.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.861 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 tt -67.41 -51.58 50.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.152 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -74.56 -47.74 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -79.81 -49.31 12.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.515 ' HB2' ' O ' ' A' ' 169' ' ' ALA . 16.0 mmt -68.32 -35.18 77.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -173.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.72 -17.68 58.95 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.856 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.2 m -91.05 -8.45 48.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.783 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.69 131.0 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.393 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.802 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 73.8 mtp -81.62 89.83 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.2 tp -38.23 -59.5 0.87 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.834 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.6 91.71 0.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.994 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.48 -57.56 4.45 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.026 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -104.6 149.9 25.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.802 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 6.3 p30 -97.58 118.11 33.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.415 0.626 . . . . 0.0 110.957 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.7 pp -77.24 151.53 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.3 OUTLIER -102.34 118.24 36.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.9 115.34 45.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.03 0.443 . . . . 0.0 110.977 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 104.98 -169.05 16.25 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.985 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 33.4 mtt180 57.45 59.13 7.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.708 0.403 . . . . 0.0 111.883 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 3.9 Cg_exo -77.62 -39.62 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.433 2.089 . . . . 0.0 112.533 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 p -171.22 151.77 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.878 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.726 ' HB3' ' HB3' ' A' ' 193' ' ' GLN . 94.6 m-20 59.29 56.92 3.61 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.483 0.489 . . . . 0.0 110.794 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.47 -21.36 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.54 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.24 -29.0 8.19 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.911 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.726 ' HB3' ' HB3' ' A' ' 190' ' ' ASN . 12.4 tt0 -75.67 -33.42 60.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.877 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -74.12 -27.81 61.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.87 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.401 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 28.1 tp60 -54.69 -55.62 36.12 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.604 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 13.4 Cg_endo -57.1 -37.17 98.92 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 121.869 1.713 . . . . 0.0 111.938 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.6 mm -63.81 -41.46 92.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.391 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 194' ' ' ALA . 51.0 mm -56.13 -50.64 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.826 176.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.45 -44.42 94.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.876 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 25.4 mm-40 -61.87 -41.42 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.59 -44.0 36.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.0 95.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.329 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.595 ' OE2' ' HD3' ' A' ' 206' ' ' ARG . 13.9 tp10 -67.91 -30.27 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.072 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.17 -47.86 47.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.259 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.04 -26.47 67.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.286 0.565 . . . . 0.0 110.552 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.595 ' HD3' ' OE2' ' A' ' 203' ' ' GLU . 75.7 ttt180 -62.68 -23.11 66.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.968 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.65 -23.65 66.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.12 0.486 . . . . 0.0 110.827 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -14.66 36.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.541 0.686 . . . . 0.0 109.994 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.8 t30 57.18 45.4 20.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.679 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -108.58 136.49 48.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.906 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.1 pt -113.21 166.88 6.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.18 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -111.35 122.04 46.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.539 -172.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.444 ' HB ' ' CZ ' ' A' ' 229' ' ' PHE . 3.9 p -112.97 121.11 64.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 0.0 110.793 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.4 175.94 6.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.576 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.855 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 8.1 t 68.97 24.61 6.23 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.458 0.703 . . . . 0.0 110.856 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 240' ' ' LEU . 61.2 t -75.05 135.46 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.139 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -76.73 141.41 40.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.066 0.46 . . . . 0.0 110.501 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -65.15 -13.42 58.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.39 -47.26 23.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -173.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.86 HD21 HD11 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -101.71 159.33 15.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.181 -174.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 16.0 m -113.06 -177.89 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.0 OUTLIER -53.71 -47.55 70.44 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.334 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -55.14 -30.03 58.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 0.0 110.931 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.941 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 52.4 m-20 -78.79 -53.75 6.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.363 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.464 HD11 HD13 ' A' ' 220' ' ' LEU . 46.0 mm -61.48 -16.95 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.242 0.544 . . . . 0.0 110.89 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -54.34 -31.37 54.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.093 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.633 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 69.3 m -52.6 -62.13 1.84 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.934 0.873 . . . . 0.0 111.253 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.615 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 3.9 m -66.28 -34.05 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.605 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.444 ' CZ ' ' HB ' ' A' ' 213' ' ' VAL . 48.3 m-85 -74.68 -35.52 62.78 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.625 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.752 ' HG3' HG23 ' A' ' 235' ' ' ILE . 50.3 tt0 -77.23 -32.29 55.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 111.33 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.05 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.695 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.677 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 4.0 m-30 -85.52 -30.88 23.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 110.209 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -174.02 167.95 40.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.378 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -58.04 106.05 0.33 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 112.254 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.752 HG23 ' HG3' ' A' ' 230' ' ' GLU . 15.9 tt -87.97 142.07 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.047 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.06 -44.35 5.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 24.8 t -147.58 137.39 22.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.333 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.83 119.42 33.51 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.4 m -138.1 103.17 4.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 13.5 tp -88.36 129.74 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.31 114.21 2.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.193 0.52 . . . . 0.0 110.843 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 24.9 mtt180 -91.38 156.4 17.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 -176.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.424 ' HB2' ' HE3' ' A' ' 250' ' ' LYS . 26.5 t70 -128.57 113.31 19.34 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.858 -173.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.43 -19.44 37.72 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.87 2.38 . . . . 0.0 112.613 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -55.52 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 110.429 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.6 p -82.34 -35.47 27.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.21 -0.29 44.03 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.33 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -112.03 -103.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 111.301 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 32.1 p80 -163.26 164.22 25.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.439 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 243' ' ' ASP . 7.6 mptt -90.25 157.58 17.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.76 40.86 1.64 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.133 -0.556 . . . . 0.0 113.291 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -157.86 164.62 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.74 -169.59 36.2 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.252 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -125.48 137.99 53.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.36 . . . . 0.0 110.343 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.28 123.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.922 177.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 42.6 tt0 -106.69 131.98 53.2 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.08 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.417 ' CD1' ' HA ' ' A' ' 235' ' ' ILE . 68.5 m-85 -112.47 153.0 28.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.19 0.519 . . . . 0.0 111.498 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.98 -22.4 23.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.772 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.641 ' HE3' ' HB2' ' A' ' 261' ' ' GLN . 35.5 ttpt -115.4 117.64 30.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.6 -25.04 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.926 0.393 . . . . 0.0 111.779 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.641 ' HB2' ' HE3' ' A' ' 259' ' ' LYS . 24.2 mp0 -66.65 -33.72 76.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.637 ' OG ' ' HE2' ' A' ' 259' ' ' LYS . 14.8 m -62.93 -38.04 89.43 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 267' ' ' VAL . 14.5 m -59.76 -38.59 82.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.55 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.01 -45.56 81.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.68 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.51 -44.33 93.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.583 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -61.42 -53.73 52.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.069 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 263' ' ' SER . 84.2 t -57.6 -27.27 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 0.0 111.336 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.3 m -72.41 -48.14 43.72 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.7 t -116.48 -13.0 10.95 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -168.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.817 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 2.2 tpt -61.78 -32.45 72.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -170.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 20.9 p-10 -66.69 -22.63 66.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.81 -10.93 59.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.887 ' CZ ' ' HB2' ' B' ' 38' ' ' ALA . 2.0 t80 -69.28 104.8 2.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.771 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.46 88.55 3.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.54 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.86 HD11 HD21 ' A' ' 220' ' ' LEU . 62.7 tp -93.33 87.14 5.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.449 -174.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.94 37.36 11.6 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.759 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.19 65.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.941 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -141.17 130.92 24.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 99.6 m-85 -67.78 132.69 47.89 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 55.7 mt -61.93 -177.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.595 0.712 . . . . 0.0 110.751 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.31 121.84 9.14 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 7.4 p -121.8 134.59 64.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.224 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.702 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -141.64 -148.36 5.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.454 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -127.93 178.86 5.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.801 0.334 . . . . 0.0 110.56 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.526 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -104.54 117.72 34.82 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 66.3 t -94.38 -33.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.304 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 11.1 t -107.29 133.66 20.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 C--O 1.235 0.352 0 C-N-CA 122.628 2.219 . . . . 0.0 111.919 178.35 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.671 0.272 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.838 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 5.6 m-20 76.52 -43.12 0.45 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.612 0.765 . . . . 0.0 112.821 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.42 68.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.172 0.51 . . . . 0.0 110.043 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 8.5 t80 -79.06 -17.92 54.37 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 109.473 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.838 ' HD3' ' HA ' ' B' ' 29' ' ' ASP . 52.8 mtpt -75.21 -43.62 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.548 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.61 -44.63 85.6 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.677 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -47.59 -52.31 18.2 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.048 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.757 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -82.06 -22.4 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -65.48 -39.01 91.43 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.633 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 22.7 mmt180 -69.28 -41.85 76.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.339 171.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.887 ' HB2' ' CZ ' ' A' ' 273' ' ' PHE . . . -58.5 -45.16 89.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.843 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -79.9 -25.88 40.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.4 -1.437 . . . . 0.0 112.666 174.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.94 -49.06 66.8 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 169.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.941 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 3.2 pt -64.47 -32.42 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.338 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.752 ' HA ' HD22 ' A' ' 220' ' ' LEU . . . -73.12 -25.68 60.94 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.11 -43.06 14.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 2.8 tmmm? -65.98 -41.44 91.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 N--CA 1.467 0.393 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.05 174.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.587 0.232 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -52.7 35.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.654 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 3.1 mm? -60.61 -37.26 80.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.094 -176.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.54 79.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.45 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.422 HD13 ' HB1' ' A' ' 194' ' ' ALA . 35.4 pt -85.27 -40.88 15.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.497 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 25.5 ptm -71.76 -28.24 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -171.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 81.0 m -92.63 6.51 47.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.639 0.257 . . . . 0.0 110.959 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -119.63 101.06 7.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.216 0.532 . . . . 0.0 111.383 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -109.68 125.53 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -91.09 149.1 21.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.524 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 47.1 t -111.52 111.27 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.062 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.5 -178.27 17.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.04 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.847 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 39.3 m 62.13 29.12 17.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.37 0.605 . . . . 0.0 111.027 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.5 mt -70.02 147.16 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.053 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.3 -73.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.433 ' HE1' ' HB3' ' A' ' 151' ' ' LYS . 48.2 t80 -176.42 -67.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -76.93 -26.92 54.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.336 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.822 HD22 HG22 ' A' ' 127' ' ' THR . 90.2 mt -54.61 125.67 20.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.846 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -107.68 -172.02 22.0 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.006 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.49 ' HB2' HG23 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -68.94 -26.6 65.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.896 0.379 . . . . 0.0 110.097 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.7 -40.79 98.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.697 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.822 HG22 HD22 ' A' ' 123' ' ' LEU . 12.2 m -63.58 -46.11 87.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 110.445 177.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -63.14 -39.45 85.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -54.7 -42.49 71.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.028 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -77.69 -34.0 53.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.684 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.49 89.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.565 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 96.5 m-85 -97.17 12.28 33.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -68.1 -44.99 40.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.782 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.944 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.9 Cg_endo -68.46 -5.0 14.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.857 1.705 . . . . 0.0 112.991 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.452 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 4.6 m-85 -84.97 -75.35 0.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.843 0.354 . . . . 0.0 110.122 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -147.47 167.19 28.6 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.478 ' HD2' HG22 ' A' ' 162' ' ' VAL . 22.8 Cg_exo -64.82 121.62 9.2 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.286 1.991 . . . . 0.0 111.729 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.455 HG23 HG13 ' A' ' 141' ' ' ILE . 2.0 mp -68.16 119.29 13.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.171 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -86.64 -46.1 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.544 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 m -148.38 141.33 24.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.357 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 125' ' ' GLU . 54.5 mt -124.26 107.03 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.64 108.33 19.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.751 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.424 ' SD ' ' HB3' ' A' ' 125' ' ' GLU . 27.2 ttt -132.0 119.8 21.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.911 0.386 . . . . 0.0 111.034 -176.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.0 t -90.34 83.09 5.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.551 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 2.9 p-90 -143.26 152.92 42.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.867 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.44 117.4 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.195 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.7 m -75.72 -9.01 58.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.938 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 50.7 t -81.85 -57.44 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.378 . . . . 0.0 110.751 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.41 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 27.9 p -80.06 -29.84 39.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.551 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 81.4 mtp 71.86 -10.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.799 0.84 . . . . 0.0 112.257 176.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 11.7 ptmm? -84.29 114.46 21.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.176 0.512 . . . . 0.0 109.667 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -142.36 145.25 33.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.016 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -119.59 13.06 12.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.624 0.726 . . . . 0.0 109.788 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.57 153.6 22.18 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.479 172.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -106.68 174.26 5.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.868 0.366 . . . . 0.0 110.934 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.19 148.93 36.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.306 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.15 115.25 29.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.068 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.86 108.37 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.043 0.449 . . . . 0.0 110.075 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -102.02 119.67 39.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.439 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.565 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 41.9 m-85 -93.58 149.63 21.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.295 0.569 . . . . 0.0 112.425 -174.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.437 ' OE1' ' HG2' ' A' ' 137' ' ' PRO . 33.8 tt0 -74.29 -27.65 60.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.463 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 137' ' ' PRO . 26.5 m -121.45 120.9 28.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.942 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 33.5 Cg_exo -61.22 -25.85 81.3 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.389 2.726 . . . . 0.0 113.403 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.495 ' OE2' ' HD2' ' A' ' 163' ' ' PRO . 1.7 mp0 -58.56 -50.51 73.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.945 0.403 . . . . 0.0 110.122 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.43 -23.09 64.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.77 77.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.488 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -70.6 -39.54 73.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.573 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -58.93 -41.46 87.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.666 0.269 . . . . 0.0 110.917 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.49 -43.11 99.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.9 0.381 . . . . 0.0 110.427 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.709 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.2 tt -64.57 -42.26 95.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.646 -178.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -47.29 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -79.97 -50.13 10.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.463 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 56.1 tpp -74.16 -28.15 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.831 0.348 . . . . 0.0 111.378 -172.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.437 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 10.7 t30 -81.36 -16.82 51.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.201 0.524 . . . . 0.0 110.521 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 t -84.15 -29.21 26.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.32 175.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 91.4 mtp -111.85 111.63 22.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.022 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 48.9 tp -68.55 104.64 2.0 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.86 -78.56 1.36 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.09 35.04 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -123.34 145.69 48.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.498 0.189 . . . . 0.0 110.81 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -87.65 71.28 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.847 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.6 pt -69.16 156.31 7.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.399 -171.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 6.5 mmmm -101.94 109.99 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.093 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 63.2 t -122.31 121.51 64.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.956 0.408 . . . . 0.0 110.065 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.709 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 73.76 -126.94 10.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.129 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 52.84 77.24 0.46 Allowed Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 110.205 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.93 119.68 7.0 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.509 2.806 . . . . 0.0 113.748 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 m -71.67 -17.64 62.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.036 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.38 6.38 8.52 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.492 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.6 mm 71.34 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.913 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 173.07 50.68 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.43 -47.84 78.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.009 0.433 . . . . 0.0 111.414 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.548 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -111.61 18.04 19.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.787 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.12 -47.38 79.46 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.583 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.9 -42.35 44.99 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.794 2.329 . . . . 0.0 114.599 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 198' ' ' ILE . 2.6 pp -75.44 -24.25 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.776 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 194' ' ' ALA . 34.5 mt -65.24 -38.5 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.63 0.252 . . . . 0.0 110.542 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.05 -44.63 87.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.332 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.72 -44.63 81.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.573 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.739 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 91.2 mt -61.67 -45.57 93.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.841 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.2 -37.52 87.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.557 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.34 -34.13 77.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -73.93 -41.18 62.44 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.985 0.421 . . . . 0.0 110.198 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.62 72.42 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.779 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -57.4 -38.31 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.956 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.21 -13.01 61.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.564 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.552 ' HE2' ' HB3' ' A' ' 288' ' ' PRO . 17.3 m-85 -93.03 -6.94 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.741 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.29 27.34 16.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.748 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -102.26 137.0 41.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.895 0.379 . . . . 0.0 111.159 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.6 pt -121.21 161.5 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.639 175.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -116.02 135.73 53.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.771 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.45 124.56 60.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.885 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.03 -179.22 4.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.944 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 51.0 m 69.64 19.16 7.44 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.709 0.804 . . . . 0.0 111.473 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.64 HG11 HD11 ' A' ' 225' ' ' ILE . 85.1 t -65.61 140.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.392 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -63.45 132.64 52.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.937 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.634 ' HG3' ' H ' ' A' ' 219' ' ' ASP . 6.2 pt20 -41.42 -55.96 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.634 ' H ' ' HG3' ' A' ' 218' ' ' GLN . 0.5 OUTLIER -79.64 -47.27 15.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.739 HD13 HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -55.89 111.96 1.06 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.042 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.445 ' O ' HG12 ' A' ' 225' ' ' ILE . 56.9 p -97.24 -178.01 4.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -162.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 18.8 p-10 -59.76 -44.04 94.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.434 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.44 -29.29 66.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.546 0.689 . . . . 0.0 109.833 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.665 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 64.5 m-20 -78.73 -54.09 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.513 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.64 HD11 HG11 ' A' ' 216' ' ' VAL . 27.9 mm -53.54 -27.59 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.359 0.599 . . . . 0.0 110.947 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.23 -31.6 44.05 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.84 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -48.94 -58.47 4.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.529 0.68 . . . . 0.0 111.932 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' B' ' 34' ' ' ALA . 6.0 m -74.35 -42.26 50.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.607 -171.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.45 ' CE1' ' HG3' ' A' ' 270' ' ' MET . 35.6 m-85 -59.76 -52.99 63.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 0.0 110.927 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.1 tt0 -66.79 -24.03 66.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 -176.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.07 -33.26 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.827 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.76 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 1.6 m-30 -82.95 -42.25 17.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -151.77 148.37 19.3 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 42.0 mmtm -62.02 122.75 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.684 0.754 . . . . 0.0 110.965 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 238' ' ' CYS . 20.1 tt -87.95 141.16 14.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.109 -169.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -91.96 -42.2 10.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 256' ' ' GLU . 12.8 p -161.59 146.7 13.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.599 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.423 ' HB3' HD13 ' A' ' 235' ' ' ILE . 6.3 p -137.94 129.98 28.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.841 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 48.6 m -150.61 119.73 6.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.047 0.451 . . . . 0.0 110.988 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.3 mp -99.38 130.52 45.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.795 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.33 137.22 58.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.077 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 52.3 mtt85 -94.25 157.76 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.188 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.561 ' OD1' HG22 ' A' ' 245' ' ' THR . 8.1 t70 -100.32 108.48 52.92 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 14.8 Cg_exo -70.04 -17.55 36.25 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.364 2.709 . . . . 0.0 114.172 -175.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.561 HG22 ' OD1' ' A' ' 243' ' ' ASP . 3.5 t -94.6 -6.51 43.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.42 . . . . 0.0 111.125 -172.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.471 ' OG1' ' HE3' ' A' ' 248' ' ' LYS . 24.6 p -133.82 -41.78 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 119.96 -24.64 7.81 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.705 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.471 ' HE3' ' OG1' ' A' ' 246' ' ' THR . 0.0 OUTLIER -82.1 -179.86 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.827 0.314 . . . . 0.0 110.776 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.7 p80 -94.0 151.29 19.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.453 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -78.96 154.88 29.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.64 44.62 2.29 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.783 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.431 ' CE2' ' HD3' ' A' ' 137' ' ' PRO . 41.3 p90 -161.8 160.25 28.03 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.149 0.475 . . . . 0.0 110.382 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -170.81 -173.0 37.64 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.354 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.411 ' C ' HD12 ' A' ' 255' ' ' ILE . 87.8 m-85 -123.62 142.6 50.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.681 0.277 . . . . 0.0 110.652 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 254' ' ' PHE . 3.1 mp -124.45 131.32 72.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.618 174.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.444 ' HB3' ' OG ' ' A' ' 237' ' ' SER . 30.6 tt0 -112.28 141.07 46.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -119.57 147.74 44.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.176 0.512 . . . . 0.0 111.49 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -79.97 -21.52 43.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.924 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 261' ' ' GLN . 34.9 ttpt -122.08 113.41 19.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.054 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.5 47.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.189 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.444 ' HB3' ' HE3' ' A' ' 259' ' ' LYS . 20.7 tt0 -56.99 -48.19 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.276 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.0 m -62.72 -31.5 72.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.3 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.4 m -59.67 -39.89 85.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.625 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -74.26 -42.97 58.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.858 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -63.78 -31.58 72.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.549 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -72.43 -54.16 10.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.458 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.58 -26.29 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -85.25 -18.34 34.29 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -115.05 -32.97 5.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.643 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.3 mmm -62.58 -21.33 65.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -172.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -58.07 -36.07 72.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.835 0.826 . . . . 0.0 110.377 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 272' ' ' LEU . 3.9 mm? -75.76 -8.73 57.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.21 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.872 ' HZ ' HD13 ' B' ' 41' ' ' ILE . 1.6 t80 -56.63 102.09 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -175.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.8 t70 -92.26 124.16 36.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.945 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.678 ' HG ' HD21 ' A' ' 220' ' ' LEU . 2.2 mm? -122.78 87.08 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.712 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.64 22.98 44.53 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.939 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.53 7.25 42.9 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.801 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.0 pt20 -125.85 130.66 51.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.789 0.328 . . . . 0.0 110.573 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -87.43 144.54 26.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.698 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 273' ' ' PHE . 11.0 mt -75.92 -173.72 2.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.549 . . . . 0.0 110.409 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.41 113.47 5.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 270' ' ' MET . 7.0 m -114.84 154.04 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.059 0.457 . . . . 0.0 111.866 -177.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.31 -150.9 6.67 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.763 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 284' ' ' LYS . 28.3 mmtp -96.31 157.9 15.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.28 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.6 t 69.17 -71.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.625 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.474 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 12.3 p -89.59 133.86 33.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.412 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.739 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 16.1 Cg_exo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 122.95 2.434 . . . . 0.0 112.613 -175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' B' ' 32' ' ' LYS . 35.2 m-20 72.25 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.786 0.679 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.74 78.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.966 0.412 . . . . 0.0 111.0 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.643 ' O ' HD21 ' B' ' 35' ' ' LEU . 10.6 t80 -73.99 -19.81 60.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.174 0.512 . . . . 0.0 109.861 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.533 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.9 mttt -73.81 -41.49 62.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.95 -38.91 76.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.436 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.76 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -50.13 -54.13 22.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.339 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.916 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -79.76 -17.46 53.4 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -172.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 43.0 mt-30 -60.08 -47.11 87.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.636 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 70.6 mtp180 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.245 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.916 ' HB2' ' HA ' ' B' ' 35' ' ' LEU . . . -68.01 -46.16 72.04 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.474 ' HA ' ' HB2' ' B' ' 42' ' ' ALA . 5.4 mtm180 -79.78 -24.66 41.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.512 -1.368 . . . . 0.0 112.166 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 51.9 tt0 -52.74 -50.03 64.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 109.816 167.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.894 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.4 pt -68.4 -25.39 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.008 0.432 . . . . 0.0 110.58 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' B' ' 39' ' ' ARG . . . -81.2 -11.92 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.65 -30.7 20.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.827 0.346 . . . . 0.0 110.298 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.894 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 15.7 ptpt -76.39 -4.33 41.74 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.598 178.563 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 106' ' ' ARG . 18.0 ttp180 . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.548 0.214 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.72 -36.51 64.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.32 -42.68 44.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.497 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . . . -62.06 -35.38 78.46 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.188 -176.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.98 -35.85 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.121 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.4 mmm -68.61 -36.53 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.407 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 166' ' ' ALA . 23.4 p -81.13 6.25 14.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 78.0 ttt180 -111.39 96.24 5.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 m -92.76 144.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.554 0.692 . . . . 0.0 111.878 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -96.9 127.3 42.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.53 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 111.19 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.651 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.57 -179.72 16.18 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.697 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.1 m 56.45 34.53 24.42 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.351 0.596 . . . . 0.0 110.898 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.4 HG21 ' N ' ' A' ' 120' ' ' TYR . 9.0 mt -73.86 163.82 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.967 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.457 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 85.9 t80 -57.29 -72.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 31.1 t80 173.35 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.438 0.461 . . . . 0.0 109.762 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.72 -20.5 58.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.43 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.737 HD22 HG22 ' A' ' 127' ' ' THR . 47.5 mt -58.57 110.16 0.93 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.062 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -109.24 -153.69 15.39 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.144 -172.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.8 -51.18 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.633 0.255 . . . . 0.0 111.136 -175.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.35 -26.81 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 -175.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.737 HG22 HD22 ' A' ' 123' ' ' LEU . 3.6 m -67.59 -53.81 25.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.021 0.439 . . . . 0.0 110.053 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.32 -39.38 85.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.274 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -59.52 -38.31 80.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.009 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.29 -44.28 25.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.308 . . . . 0.0 111.66 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.69 81.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.583 ' HB3' ' HH ' ' A' ' 160' ' ' TYR . 84.7 m-85 -106.48 18.98 21.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.839 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.599 ' HA ' HD11 ' A' ' 138' ' ' ILE . . . -65.47 -43.91 64.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.031 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.497 ' HD3' ' HB1' ' A' ' 133' ' ' ALA . 22.6 Cg_exo -68.35 -5.16 14.33 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.03 1.82 . . . . 0.0 112.665 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.519 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 9.0 m-85 -94.64 60.27 2.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.535 ' HA3' HG22 ' A' ' 162' ' ' VAL . . . 78.12 175.32 44.54 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.75 118.57 3.83 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.861 2.374 . . . . 0.0 111.91 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.606 HG13 ' HE1' ' A' ' 160' ' ' TYR . 3.8 mp -60.47 118.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -89.57 -49.56 6.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 109.951 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 p -161.45 147.8 14.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.934 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.98 107.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.14 118.42 34.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.7 ptm -143.33 148.29 36.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.53 108.93 11.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.537 0.684 . . . . 0.0 111.633 -177.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.522 ' CZ3' ' HB2' ' A' ' 152' ' ' HIS . 78.0 m95 -104.14 155.68 18.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.452 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -101.76 86.72 2.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.663 0.744 . . . . 0.0 110.197 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.0 p 33.58 -108.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.355 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.45 -28.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -170.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -33.51 67.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.3 mmt 58.93 44.95 15.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.356 0.598 . . . . 0.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HG3' ' CE2' ' A' ' 121' ' ' TYR . 10.6 tptm -93.45 -29.1 15.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.522 ' HB2' ' CZ3' ' A' ' 145' ' ' TRP . 57.0 t60 60.91 75.84 0.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.492 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -102.84 81.21 1.97 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.79 -155.52 11.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.572 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -125.65 175.03 7.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.35 28.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.76 0.314 . . . . 0.0 111.574 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.21 119.91 39.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -114.81 119.42 61.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 0.0 110.463 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.1 tt0 -104.02 130.4 51.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.164 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.606 ' HE1' HG13 ' A' ' 138' ' ' ILE . 51.6 m-85 -110.71 171.54 7.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.644 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.69 14.95 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.535 HG22 ' HA3' ' A' ' 136' ' ' GLY . 8.7 m -134.42 105.88 11.04 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.609 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.44 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 38.6 Cg_exo -58.97 -26.9 83.22 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.173 2.582 . . . . 0.0 113.299 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.503 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 2.1 mp0 -61.8 -57.94 9.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.27 -26.4 66.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.756 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 112' ' ' CYS . . . -63.02 -51.57 66.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.785 0.326 . . . . 0.0 110.796 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -74.55 -31.82 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 59.2 tp -56.07 -50.08 71.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.65 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.94 97.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.908 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.902 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.4 tt -60.68 -42.68 97.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.633 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.6 -46.1 17.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.48 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 75.8 mm-40 -83.95 -50.93 7.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.404 ' HG3' ' CE2' ' A' ' 132' ' ' PHE . 16.0 mmt -74.46 -30.76 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -172.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.37 -24.35 67.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.292 0.567 . . . . 0.0 110.534 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.1 m -92.24 -2.28 56.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.719 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.6 t -118.28 139.86 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.785 ' HE2' ' HB2' ' A' ' 182' ' ' ASN . 58.7 mtt -99.6 117.28 33.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.83 121.49 27.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 69.98 -88.07 0.3 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -173.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.78 11.75 0.96 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -100.5 132.67 45.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.615 -175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.785 ' HB2' ' HE2' ' A' ' 177' ' ' MET . 6.0 t30 -86.78 89.49 7.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 pt -72.54 142.08 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.83 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -102.73 110.04 21.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.61 110.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.902 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 105.07 110.68 3.53 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.876 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 49.5 ttt180 -109.33 113.82 58.18 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 187' ' ' ARG . 38.1 Cg_endo -66.46 77.06 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.101 2.534 . . . . 0.0 111.549 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.1 m -84.56 -22.7 29.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.525 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -123.31 114.23 19.93 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.8 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.9 mt -129.2 98.41 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 138.48 -47.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -81.27 -57.39 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.034 0.445 . . . . 0.0 110.969 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.516 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -92.19 -14.92 28.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.377 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.652 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 24.2 tp60 -56.22 -51.67 78.98 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.057 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 27.6 Cg_exo -63.53 -34.39 64.66 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.028 1.819 . . . . 0.0 111.976 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.07 -42.19 95.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.4 mt -59.57 -44.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.783 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.36 -42.32 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.493 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -59.86 -51.18 70.81 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.755 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.43 HD13 ' N ' ' A' ' 202' ' ' ALA . 3.3 pp -75.71 -29.02 58.81 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.654 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.43 ' N ' HD13 ' A' ' 201' ' ' LEU . . . -73.36 -40.09 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 0.0 110.365 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.44 -44.11 97.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.564 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.73 -30.38 67.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -64.41 -22.5 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -61.14 -32.99 72.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.37 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 111.031 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -87.26 -26.4 23.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.668 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.5 p30 40.53 46.61 2.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.71 0.804 . . . . 0.0 112.944 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 210' ' ' ARG . 29.4 mtp180 -87.41 136.22 33.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.643 HD12 ' HE2' ' A' ' 229' ' ' PHE . 15.8 tt -104.78 146.69 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 0.0 110.359 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -111.36 139.25 46.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.578 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.439 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 5.9 p -136.13 125.91 40.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.181 0.515 . . . . 0.0 110.721 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.42 179.96 4.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.276 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.8 t 65.05 25.4 12.59 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.789 0.681 . . . . 0.0 109.674 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.727 HG12 HD12 ' A' ' 225' ' ' ILE . 46.3 t -70.37 129.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.898 -176.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.62 131.25 50.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.51 -50.56 31.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.864 ' HB2' HG22 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -75.53 -46.44 32.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.804 HD11 HG13 ' B' ' 41' ' ' ILE . 0.9 OUTLIER -63.53 101.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.015 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 225' ' ' ILE . 50.9 m -91.33 -177.18 4.78 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.043 -169.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.811 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 21.8 p-10 -61.07 -39.26 89.19 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -56.36 -30.59 62.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 110.467 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.64 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 9.4 m-20 -78.69 -53.05 7.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.048 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.727 HD12 HG12 ' A' ' 216' ' ' VAL . 30.8 mm -52.04 -29.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.466 0.706 . . . . 0.0 111.238 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.54 ' HG3' HD11 ' A' ' 235' ' ' ILE . 87.7 tttt -50.32 -31.64 14.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.882 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.682 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 63.8 m -48.39 -61.89 1.77 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.543 0.687 . . . . 0.0 111.723 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.785 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 3.7 m -74.04 -35.74 42.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.481 -170.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.643 ' HE2' HD12 ' A' ' 211' ' ' ILE . 38.9 m-85 -68.33 -48.89 63.67 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.091 -0.243 . . . . 0.0 111.311 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 31.4 tt0 -78.24 -11.9 59.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 111.239 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.27 -28.35 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.654 0.264 . . . . 0.0 111.079 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.77 ' HE1' ' HB3' ' B' ' 34' ' ' ALA . 0.8 OUTLIER -94.82 -62.19 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.628 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -117.98 175.98 15.94 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.766 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -92.3 118.34 30.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.156 0.503 . . . . 0.0 111.304 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.54 HD11 ' HG3' ' A' ' 226' ' ' LYS . 65.3 mt -75.66 138.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.958 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -90.96 -45.4 8.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 4.2 p -156.82 131.7 8.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.33 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 9.6 p -120.5 128.09 52.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.747 0.308 . . . . 0.0 110.223 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.3 p -143.23 111.06 5.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.811 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 9.4 mp -101.59 116.88 33.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -53.05 112.82 0.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.086 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.902 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -97.21 144.77 26.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.156 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.44 ' HB3' ' HG1' ' A' ' 246' ' ' THR . 9.5 t70 -89.56 118.49 69.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.279 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.91 -21.84 37.01 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.952 2.435 . . . . 0.0 113.522 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 37.9 p -89.08 -17.65 28.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 0.0 111.527 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.44 ' HG1' ' HB3' ' A' ' 243' ' ' ASP . 31.0 p -102.15 -37.24 8.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.973 0.416 . . . . 0.0 110.52 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.21 1.03 55.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.285 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -128.44 158.03 39.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.931 0.396 . . . . 0.0 110.282 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.902 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -72.9 148.3 44.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.736 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -79.15 155.4 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.86 44.01 1.23 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 20.4 p90 -163.19 160.58 24.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.793 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -176.35 -172.59 41.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.635 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -126.91 139.99 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 111.323 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.94 128.1 75.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -104.93 114.7 29.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.946 0.403 . . . . 0.0 110.115 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -90.97 153.3 20.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.7 pt-20 -91.8 -18.86 23.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.493 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.491 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 29.3 mmmt -122.48 125.15 45.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.72 -22.83 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.717 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -63.27 -44.24 95.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.628 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 34.8 m -65.93 -34.42 78.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 -176.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.9 m -60.46 -32.01 70.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -74.17 -43.45 57.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.858 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.46 -54.01 28.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.225 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.739 ' HA ' HG22 ' A' ' 282' ' ' VAL . 25.2 m -59.1 -26.19 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.02 0.438 . . . . 0.0 111.52 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.2 m -78.05 -19.81 53.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.741 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -114.96 -33.15 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.858 ' HA ' ' HE3' ' A' ' 270' ' ' MET . 4.1 mmt -75.97 5.18 6.93 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -166.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.479 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.9 t30 -81.92 -38.94 24.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.932 0.873 . . . . 0.0 109.489 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.16 -8.53 57.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.277 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.813 ' HE1' ' HB2' ' B' ' 38' ' ' ALA . 4.5 t80 -52.93 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.776 0.431 . . . . 0.0 110.513 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.5 t70 -90.89 125.67 35.82 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.502 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 220' ' ' LEU . 85.8 mt -128.63 85.53 2.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.13 44.81 7.89 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.8 63.98 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.832 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 9.4 pt20 -140.58 130.65 24.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.778 0.323 . . . . 0.0 110.608 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -89.67 133.71 34.52 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.655 HD23 ' CD2' ' A' ' 273' ' ' PHE . 8.5 mp -72.45 -165.75 0.22 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.39 0.614 . . . . 0.0 111.03 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 172' ' ' GLN . 9.6 tpp180 -147.11 116.65 7.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.042 -172.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 267' ' ' VAL . 14.4 p -105.68 146.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.94 0.4 . . . . 0.0 111.271 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.12 -156.71 7.7 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -126.49 174.52 8.58 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.603 -0.351 . . . . 0.0 110.11 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.422 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -59.13 -43.14 91.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 111.429 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 94.4 t 79.8 -52.92 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.676 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 4.5 m -139.76 122.85 10.42 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-O 120.69 0.281 . . . . 0.0 110.846 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 287' ' ' THR . 1.1 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 123.661 2.907 . . . . 0.0 112.194 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . 0.466 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 52.4 t30 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.25 -60.89 1.85 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.869 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . . . -58.27 -33.59 69.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.626 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 5.9 t80 -72.34 -27.18 62.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 28.9 mtpp -62.58 -47.85 82.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.75 -36.15 71.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.739 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.77 ' HB3' ' HE1' ' A' ' 232' ' ' PHE . . . -53.72 -56.21 19.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.184 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.723 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.8 OUTLIER -79.17 -20.72 47.77 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.339 -171.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 81.2 mm-40 -56.84 -45.96 82.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 170.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.682 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 13.2 mmm180 -74.13 -32.93 63.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.429 175.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.813 ' HB2' ' HE1' ' A' ' 273' ' ' PHE . . . -63.86 -44.28 93.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -81.46 -26.64 35.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.813 -1.179 . . . . 0.0 112.599 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -56.44 -45.53 80.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.323 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.947 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 4.5 pt -65.87 -36.02 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.735 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 220' ' ' LEU . . . -73.52 -10.59 59.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.33 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.9 -49.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.009 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.947 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -83.92 -29.57 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.864 HG22 ' HB2' ' A' ' 219' ' ' ASP . 37.6 mm . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 121.167 0.508 . . . . 0.0 111.978 173.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.954 0.407 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.69 85.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.85 -30.05 63.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.854 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.56 73.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.99 -41.41 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.731 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.685 ' HB3' ' HB3' ' A' ' 163' ' ' PRO . 84.4 mmm -61.86 -25.84 67.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -92.62 6.05 48.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -126.85 126.84 44.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 0.0 111.814 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.549 HG13 ' HB1' ' A' ' 166' ' ' ALA . 16.9 m -118.84 142.55 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 111.425 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -87.24 121.37 29.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.915 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.06 111.09 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.144 0.497 . . . . 0.0 110.374 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.07 177.72 20.43 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.813 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 42.1 m 64.99 48.03 2.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.176 0.513 . . . . 0.0 111.061 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.7 mm -71.51 -20.41 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.5 t80 66.83 -83.66 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.497 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.412 ' CE1' ' HG2' ' A' ' 151' ' ' LYS . 78.1 t80 -174.03 -56.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.966 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.54 8.68 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.66 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.621 HD21 HG21 ' A' ' 127' ' ' THR . 67.9 mt -102.86 124.82 49.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.33 -167.21 11.87 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.842 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.97 -35.17 74.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.907 0.384 . . . . 0.0 109.99 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -58.44 -42.33 87.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.293 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.621 HG21 HD21 ' A' ' 123' ' ' LEU . 3.1 m -72.66 -40.6 66.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.481 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.34 -45.65 92.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.752 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 133' ' ' ALA . 41.1 ttm-85 -61.35 -37.43 83.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.222 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -77.25 -36.0 54.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.44 ' O ' ' HD2' ' A' ' 134' ' ' PRO . . . -78.31 -38.93 41.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.981 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.581 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 96.7 m-85 -95.95 5.46 51.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.464 ' HB2' ' HD3' ' A' ' 134' ' ' PRO . . . -68.65 -42.1 24.59 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.671 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 71.7 Cg_exo -54.81 -2.54 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.211 2.607 . . . . 0.0 114.362 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.581 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 60.2 m-85 -108.65 -71.1 0.77 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.834 -0.541 . . . . 0.0 111.452 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -146.37 -166.5 12.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.623 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -81.86 114.61 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.668 2.245 . . . . 0.0 111.918 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.65 107.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.25 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -136.53 143.9 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.3 mt -133.47 107.02 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.165 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 3.8 m-20 -89.12 96.43 10.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 24.2 ptm -126.82 137.14 53.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 110.758 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.8 t -78.79 115.5 18.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.303 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -110.51 98.12 7.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.279 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.54 89.39 6.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -58.25 -38.92 77.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.381 -171.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.0 m -57.08 -30.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 p -119.2 -10.09 9.83 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.566 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 85.3 mtp 62.23 26.72 16.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.412 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 58.2 mttp -109.87 -173.13 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.947 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -126.97 95.91 4.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.128 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -83.53 -19.06 36.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.6 170.54 13.42 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.726 175.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -107.72 175.69 5.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.567 0.222 . . . . 0.0 110.924 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.01 136.72 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.831 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 72.8 m-85 -108.84 114.63 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.546 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.83 126.62 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.802 0.334 . . . . 0.0 110.311 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -120.34 130.49 54.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.326 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 78.3 m-85 -109.53 179.0 4.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -94.67 -2.63 50.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.338 172.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.99 125.53 17.22 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.246 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.685 ' HB3' ' HB3' ' A' ' 111' ' ' MET . 28.0 Cg_exo -64.33 -37.06 41.97 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.198 2.599 . . . . 0.0 112.169 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -57.75 -45.98 85.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.202 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.419 ' CB ' ' HA3' ' A' ' 136' ' ' GLY . . . -55.67 -42.94 75.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 111.278 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.549 ' HB1' HG13 ' A' ' 114' ' ' VAL . . . -65.85 -41.29 91.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.885 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -63.12 -47.94 80.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.478 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.571 HD22 ' HA3' ' A' ' 283' ' ' GLY . 45.9 mt -63.14 -40.25 97.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.276 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.89 93.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.307 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.843 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.1 tt -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -80.78 -48.01 13.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 168' ' ' LEU . 8.0 mm100 -75.99 -40.53 53.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.743 -170.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.4 mmt -80.7 -6.31 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.341 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.1 -21.36 22.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.5 m -90.98 -27.28 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.603 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.1 t -114.67 110.5 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.485 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 23.5 ptm -89.24 138.32 31.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.186 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.47 144.96 39.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.996 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.79 69.88 0.97 Allowed Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.805 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.96 -45.68 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -157.12 137.93 13.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -73.18 92.77 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.813 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 29.2 pt -71.07 158.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.801 -176.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -115.63 110.07 18.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.538 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.6 t -114.11 112.37 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.856 0.36 . . . . 0.0 111.023 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.843 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 112.07 134.43 6.31 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.51 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -162.57 94.27 1.21 Allowed Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.12 -39.77 89.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.026 2.484 . . . . 0.0 112.961 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 71.35 -52.14 0.69 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.387 0.675 . . . . 0.0 111.773 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -98.01 64.17 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.153 0.501 . . . . 0.0 110.226 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 mt -90.06 56.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.751 0.786 . . . . 0.0 109.418 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.33 -55.01 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.048 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -82.85 -48.73 10.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.52 -33.55 62.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.066 -175.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.626 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.7 tp60 -51.93 -53.36 52.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -174.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 49.4 Cg_exo -56.77 -32.22 90.74 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.13 1.887 . . . . 0.0 112.471 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.7 mm -72.46 -41.62 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.184 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 194' ' ' ALA . 43.7 mt -64.22 -39.23 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.626 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.52 -40.5 78.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.59 -47.88 65.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.367 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 97.5 mt -55.91 -43.35 77.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.837 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.22 77.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 206' ' ' ARG . 39.5 tt0 -73.75 -44.19 56.91 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.931 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.65 -28.3 63.66 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.209 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.23 76.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.779 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 203' ' ' GLU . 27.8 ptt180 -71.49 -19.7 62.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.172 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.42 66.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.0 -16.04 27.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.944 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.16 40.83 17.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.245 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 256' ' ' GLU . 98.8 mtt180 -101.93 136.15 42.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.5 pt -116.34 168.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.687 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -118.76 115.15 23.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.477 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.2 p -108.67 121.21 61.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.366 0.603 . . . . 0.0 110.726 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.77 -179.3 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.929 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 134' ' ' PRO . 8.6 t 71.0 14.67 6.79 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.909 0.756 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.671 HG12 HD23 ' A' ' 240' ' ' LEU . 60.6 t -61.93 122.91 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.518 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 6.9 t-80 -60.66 136.08 57.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -63.74 -22.68 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -165.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.518 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 0.0 OUTLIER -79.03 -48.05 15.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -174.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.666 HD21 HD22 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -82.95 147.82 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.358 0.599 . . . . 0.0 111.786 -174.391 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 49.9 m -108.25 -175.49 2.79 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.965 -166.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -50.31 -51.77 42.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.181 0.592 . . . . 0.0 112.307 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.8 -29.88 60.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.325 0.583 . . . . 0.0 110.769 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.674 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 58.3 m-20 -76.04 -56.46 4.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.465 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.565 HD11 HD11 ' A' ' 220' ' ' LEU . 36.7 mm -61.12 -22.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.306 -178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.492 ' HE2' HG21 ' A' ' 235' ' ' ILE . 53.2 tttm -55.62 -31.66 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.399 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.514 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.2 m -48.54 -61.82 1.82 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.452 0.644 . . . . 0.0 112.201 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.668 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 5.2 m -67.28 -46.99 82.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.623 -171.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.477 ' HZ ' ' HB ' ' A' ' 213' ' ' VAL . 64.5 m-85 -61.66 -42.42 98.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.692 0.282 . . . . 0.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 50.7 tt0 -77.13 -23.9 51.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.243 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.96 68.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.739 -0.209 . . . . 0.0 111.017 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.798 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.3 m-85 -83.6 -53.85 5.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -141.05 155.94 25.29 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.422 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 26.9 mmtp -66.37 140.22 58.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.726 0.774 . . . . 0.0 112.169 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.774 HD11 HG23 ' A' ' 255' ' ' ILE . 10.5 tp -84.86 146.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.795 -173.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -107.72 -51.36 2.92 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.604 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 16.0 m -143.6 143.01 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.57 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 28.3 p -144.71 133.8 22.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.273 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.0 m -150.81 103.75 3.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.212 0.529 . . . . 0.0 109.951 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.705 HD12 ' HA3' ' A' ' 253' ' ' GLY . 18.8 tp -83.43 129.95 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.85 137.74 51.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 111.461 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.515 ' HA ' ' H ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -143.45 157.75 44.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.757 176.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.509 ' OD1' ' HE3' ' A' ' 250' ' ' LYS . 9.6 m-20 -71.13 108.36 3.7 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.575 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.61 -31.47 21.11 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.39 2.06 . . . . 0.0 112.329 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -96.03 -3.58 44.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.428 . . . . 0.0 110.757 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 243' ' ' ASP . 24.6 m -113.79 -40.84 3.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 0.0 111.406 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.9 53.66 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.157 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 242' ' ' ARG . 95.6 mttt -87.49 -178.0 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.419 ' HE1' ' O ' ' A' ' 217' ' ' HIS . 0.0 OUTLIER -125.21 138.55 54.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.022 0.439 . . . . 0.0 111.685 -171.109 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.515 ' H ' ' HA ' ' A' ' 242' ' ' ARG . 31.8 mmtp -80.41 149.11 30.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.69 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.76 40.92 2.3 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.719 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.56 162.7 19.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.048 0.424 . . . . 0.0 110.331 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.705 ' HA3' HD12 ' A' ' 240' ' ' LEU . . . -167.96 177.37 42.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.225 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.89 134.41 55.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 0.0 110.438 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.774 HG23 HD11 ' A' ' 235' ' ' ILE . 52.0 mt -130.75 140.2 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.498 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 237' ' ' SER . 43.4 tt0 -122.85 131.9 53.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -105.33 153.25 21.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.469 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -85.48 -16.24 40.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.259 0.552 . . . . 0.0 110.293 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -124.38 123.93 41.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.277 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -68.16 -23.62 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.024 0.44 . . . . 0.0 110.574 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -62.22 -37.83 86.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.373 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.422 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 12.2 m -73.62 -36.4 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.056 -176.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 m -59.63 -34.41 72.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.474 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -73.07 -37.12 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.422 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 4.7 p-10 -79.11 -26.24 42.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.416 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.11 -52.73 45.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.614 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.72 -25.72 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 p -84.71 -13.52 51.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 p -115.07 -32.24 5.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.838 ' HA ' ' HE3' ' A' ' 270' ' ' MET . 2.3 mmt -69.14 -4.55 17.83 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.41 -32.78 62.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.99 0.9 . . . . 0.0 108.993 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.468 HD21 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -77.31 -10.63 59.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.476 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.733 ' HB2' ' HE3' ' A' ' 270' ' ' MET . 2.6 t80 -50.49 105.21 0.09 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.523 0.514 . . . . 0.0 110.403 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.14 125.26 34.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.388 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.666 HD22 HD21 ' A' ' 220' ' ' LEU . 86.0 mt -130.03 86.83 2.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.681 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.01 14.16 63.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.013 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 102.02 25.02 8.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -140.59 142.17 35.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -81.24 139.45 35.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.125 0.488 . . . . 0.0 110.168 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.1 OUTLIER -79.32 -176.56 5.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.107 176.279 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 281' ' ' ARG . 26.6 mmt180 -142.26 112.7 7.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 270' ' ' MET . 8.7 p -118.48 131.62 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.571 ' HA3' HD22 ' A' ' 168' ' ' LEU . . . -134.96 -161.68 9.51 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.385 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -113.2 168.98 9.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.637 0.255 . . . . 0.0 110.332 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -90.26 113.15 24.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.83 -31.79 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.669 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.499 HG23 ' HG2' ' A' ' 163' ' ' PRO . 9.2 t -133.83 141.03 38.37 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.901 175.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 C--O 1.234 0.315 0 C-N-CA 122.358 2.039 . . . . 0.0 111.937 178.297 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.95 0.405 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.23 -59.73 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.053 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.51 75.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 110.946 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.644 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.6 t80 -70.82 -17.79 62.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 30.2 mmmt -64.29 -50.28 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.74 -37.82 74.25 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.455 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.798 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.16 -58.62 4.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.428 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.764 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.6 OUTLIER -80.78 -17.81 49.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 26.2 mm-40 -56.41 -46.42 80.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.604 ' O ' HG23 ' B' ' 41' ' ' ILE . 30.5 mmm180 -73.65 -36.44 65.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.68 175.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.786 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -59.82 -45.04 93.63 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -80.28 -26.4 38.94 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.556 -1.34 . . . . 0.0 112.462 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -57.19 -45.18 83.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.849 169.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.786 HG12 ' O ' ' B' ' 38' ' ' ALA . 4.9 pt -67.03 -31.37 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.663 ' HA ' HD22 ' A' ' 220' ' ' LEU . . . -67.99 -46.12 72.22 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.192 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.43 68.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.574 ' O ' ' HD2' ' B' ' 44' ' ' LYS . 1.3 tmmm? -70.84 -16.54 62.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.957 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' B' ' 44' ' ' LYS . 75.8 mt . . . . . 0 N--CA 1.465 0.283 0 C-N-CA 123.469 0.708 . . . . 0.0 111.337 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 . . . . . 0 N--CA 1.463 0.183 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.79 -49.45 52.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.581 HD12 ' HG3' ' A' ' 163' ' ' PRO . 4.6 mm? -69.3 -26.01 64.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.552 -176.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.168 0.509 . . . . 0.0 110.74 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.0 mm -82.5 -36.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.095 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.7 mtp -70.72 -28.65 64.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.209 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.408 ' SG ' ' HD3' ' A' ' 163' ' ' PRO . 73.2 m -81.72 2.98 27.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -174.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.621 ' HB3' ' HG3' ' A' ' 159' ' ' GLU . 38.9 ptt180 -138.32 140.93 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.582 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.5 m -107.92 141.11 23.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.352 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 44.9 t80 -83.7 116.56 22.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.046 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.662 ' HB ' ' HB1' ' A' ' 156' ' ' ALA . 42.8 t -101.93 111.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.47 146.04 16.83 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.337 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.7 m 74.37 -53.72 0.68 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.788 0.835 . . . . 0.0 111.776 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.6 mt 68.93 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.43 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 27.3 t80 177.26 -85.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.47 ' CD2' ' HD3' ' A' ' 153' ' ' LYS . 1.5 t80 177.58 -77.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.308 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.19 43.93 1.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.552 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 35.6 mt -100.86 123.81 45.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.693 ' HA2' ' HH2' ' A' ' 145' ' ' TRP . . . -83.6 171.12 49.13 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.77 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -63.83 -48.16 77.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.44 -30.46 71.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.628 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 m -59.79 -49.8 76.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.029 0.442 . . . . 0.0 110.453 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.69 -34.52 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.308 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -55.58 -45.73 77.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.794 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 32.1 mm-40 -74.83 -30.54 61.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.439 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.75 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.633 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.45 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 93.2 m-85 -100.77 11.13 40.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.046 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 130' ' ' GLN . . . -68.86 -44.04 29.07 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.789 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.631 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 13.2 Cg_exo -72.29 -8.61 23.02 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.774 1.649 . . . . 0.0 111.994 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.57 ' O ' ' HB3' ' A' ' 165' ' ' ALA . 65.7 m-85 -102.64 65.53 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 110.464 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . 84.31 177.16 51.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.621 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -91.3 115.45 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.906 2.404 . . . . 0.0 112.273 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.498 HD13 ' HE1' ' A' ' 160' ' ' TYR . 36.8 mm -56.75 115.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.089 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -96.4 -55.03 3.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.761 0.315 . . . . 0.0 110.604 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.747 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 23.3 t -135.28 137.08 42.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.11 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.18 127.25 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.624 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.7 t70 -133.25 126.11 30.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.397 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.427 ' HE3' ' HB3' ' A' ' 143' ' ' MET . 65.4 mtp -147.37 147.83 30.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.961 0.41 . . . . 0.0 111.616 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.5 m -79.63 131.17 35.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 168.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.693 ' HH2' ' HA2' ' A' ' 124' ' ' GLY . 82.7 m95 -133.53 150.44 51.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.255 0.55 . . . . 0.0 112.264 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -124.35 89.06 3.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.694 168.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.9 m 65.8 -174.37 0.18 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.199 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.44 -20.98 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 110.424 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 p -67.73 9.74 0.25 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.516 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 20.9 ptp 47.45 38.31 7.52 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 171.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.419 ' HE3' ' OH ' ' A' ' 121' ' ' TYR . 56.2 mtpt -92.49 137.86 32.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -170.55 -78.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' HD3' ' CD2' ' A' ' 121' ' ' TYR . 22.4 mtmm 54.78 35.67 24.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.655 0.382 . . . . 0.0 111.316 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -102.26 -107.78 3.13 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.526 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.96 165.99 23.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.875 0.369 . . . . 0.0 110.581 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' A' ' 116' ' ' VAL . . . -145.18 135.77 24.35 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.447 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 51.2 m-85 -113.31 107.9 16.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.915 0.388 . . . . 0.0 110.134 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.09 103.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 28.6 tt0 -105.94 126.47 52.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 -172.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.498 ' HE1' HD13 ' A' ' 138' ' ' ILE . 78.0 m-85 -109.25 -177.98 3.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.11 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -109.23 -1.73 18.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.909 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.88 122.53 16.53 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.435 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.581 ' HG3' HD12 ' A' ' 108' ' ' LEU . 34.0 Cg_endo -65.65 -21.62 58.84 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.902 2.401 . . . . 0.0 113.397 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.97 -63.75 1.04 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.164 0.507 . . . . 0.0 110.466 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 135' ' ' PHE . . . -52.56 -43.15 65.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.136 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.88 66.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.445 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.548 ' HB3' HG23 ' A' ' 286' ' ' VAL . 57.8 tp60 -66.88 -35.45 80.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.552 HD23 ' CD2' ' A' ' 212' ' ' TYR . 11.0 tp -64.76 -51.77 60.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.197 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.57 -36.58 81.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.308 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.459 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.6 tt -57.19 -62.37 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.485 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.29 -39.0 85.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -67.62 -49.89 60.82 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 57.8 mtt -82.9 -17.78 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -69.49 -35.36 75.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.233 0.54 . . . . 0.0 109.671 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.9 t -88.2 -43.76 11.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.983 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.85 94.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.783 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 62.3 mtm -65.78 167.99 8.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.439 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.8 tp -80.23 74.41 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.891 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.82 -123.41 9.79 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 12.22 70.17 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.894 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -104.14 119.93 40.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.674 0.273 . . . . 0.0 110.76 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.414 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 21.7 p-10 -78.23 116.02 18.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 110.081 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.48 144.97 17.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -102.05 110.39 22.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.1 m -135.39 106.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.53 . . . . 0.0 110.787 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.459 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 125.52 -165.62 18.6 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.796 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 57.86 89.12 0.11 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.312 0.645 . . . . 0.0 110.93 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.25 -14.25 28.4 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.45 2.767 . . . . 0.0 113.82 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 72.95 -61.54 0.5 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.055 0.542 . . . . 0.0 111.209 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -84.05 70.87 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.8 pt -95.75 -172.79 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.323 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.28 -50.29 0.9 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.105 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.67 -43.01 39.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.15 0.5 . . . . 0.0 110.183 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.426 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.66 6.32 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.779 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.536 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 52.8 tp60 -61.98 -49.33 85.84 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.668 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -55.17 -37.27 94.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.061 1.841 . . . . 0.0 111.722 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.41 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.3 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 194' ' ' ALA . 48.2 mm -56.68 -48.32 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.191 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.02 -50.78 64.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.835 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 98.1 mt-30 -57.04 -44.73 83.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.814 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.15 -56.67 6.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.649 0.261 . . . . 0.0 111.135 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.52 73.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.981 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.409 ' HG2' ' NH1' ' A' ' 206' ' ' ARG . 3.0 tm-20 -74.35 -46.13 42.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.429 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.93 -30.15 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.358 . . . . 0.0 110.928 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.93 -25.06 67.97 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.26 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.409 ' NH1' ' HG2' ' A' ' 203' ' ' GLU . 93.6 mtt180 -66.7 -26.22 66.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.59 -17.7 62.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.258 0.551 . . . . 0.0 111.257 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.9 -10.05 19.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.755 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 257' ' ' TYR . 3.2 m-80 54.23 29.32 10.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.489 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.9 136.41 33.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 111.26 -174.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 255' ' ' ILE . 8.9 tt -112.94 147.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.588 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.552 ' CD2' HD23 ' A' ' 168' ' ' LEU . 66.1 t80 -107.86 123.0 47.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.5 . . . . 0.0 109.657 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.457 ' CG2' HD23 ' A' ' 280' ' ' LEU . 1.6 p -114.53 122.97 69.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.188 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.41 178.22 5.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.631 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 15.6 m 68.55 25.6 6.64 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.776 0.672 . . . . 0.0 110.909 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.508 HG11 HD13 ' A' ' 225' ' ' ILE . 85.1 t -68.08 138.7 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.656 ' HB2' HD21 ' A' ' 275' ' ' LEU . 21.2 t-80 -66.41 131.15 45.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -50.55 -44.22 56.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -167.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.602 ' HB2' HG21 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.62 -46.54 17.03 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 178.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.84 HD23 HD23 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -55.32 114.45 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.262 0.625 . . . . 0.0 110.27 -177.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 6.6 t -95.21 -175.8 3.62 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -166.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.56 -44.0 96.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.838 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.79 -27.91 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 221' ' ' SER . 5.5 m-20 -63.49 -59.64 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.508 HD13 HG11 ' A' ' 216' ' ' VAL . 37.6 mm -55.96 -26.06 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.238 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.47 ' HG3' HD11 ' A' ' 235' ' ' ILE . 88.2 tttt -57.24 -32.29 66.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.653 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.676 ' HG ' HG21 ' B' ' 41' ' ' ILE . 74.5 m -49.03 -56.64 8.36 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.922 0.868 . . . . 0.0 111.748 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' B' ' 34' ' ' ALA . 3.2 m -73.85 -49.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.353 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.606 ' HE2' HD12 ' A' ' 211' ' ' ILE . 43.3 m-85 -59.63 -41.82 91.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.629 0.252 . . . . 0.0 111.627 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 30.9 tt0 -74.2 -25.94 59.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.12 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.89 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.724 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.1 OUTLIER -90.18 -58.55 2.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -127.44 154.82 19.72 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 36.7 mmtm -84.11 140.79 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.58 0.705 . . . . 0.0 112.056 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.47 HD11 ' HG3' ' A' ' 226' ' ' LYS . 56.5 mt -103.69 134.38 45.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.094 -171.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 1.074 ' HE2' ' HB3' ' A' ' 258' ' ' GLU . 62.6 mmtt -84.03 -46.08 12.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.986 176.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 21.9 t -147.24 136.63 22.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.614 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.408 ' HB3' HG23 ' A' ' 235' ' ' ILE . 3.5 p -132.64 135.4 45.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.9 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.8 t -157.66 139.77 14.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.336 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.564 HD22 ' HA3' ' A' ' 253' ' ' GLY . 72.7 mt -111.11 129.91 55.78 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.42 134.98 57.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 110.681 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.0 mtp180 -89.19 157.28 18.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.371 0.605 . . . . 0.0 111.695 -177.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.04 97.99 40.63 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.289 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.86 -23.92 29.8 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.838 2.359 . . . . 0.0 111.624 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 24.3 m -64.43 -47.02 80.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.47 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.464 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 1.7 m -94.69 -33.44 12.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.02 0.438 . . . . 0.0 111.108 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.13 43.3 2.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.529 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.464 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 23.2 pttp -147.51 -166.94 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -175.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.4 p80 -112.98 147.52 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 242' ' ' ARG . 88.2 mttt -74.89 152.25 38.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.799 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.422 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -76.91 42.77 1.87 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.539 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -161.85 160.31 27.94 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.564 ' HA3' HD22 ' A' ' 240' ' ' LEU . . . -172.48 -164.08 27.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.333 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -129.85 137.31 50.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.975 0.417 . . . . 0.0 110.828 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 211' ' ' ILE . 41.4 mm -119.56 128.98 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.336 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.64 113.26 26.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.153 0.502 . . . . 0.0 111.301 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 209' ' ' ASN . 49.6 m-85 -93.33 156.88 16.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.064 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 1.074 ' HB3' ' HE2' ' A' ' 236' ' ' LYS . 8.5 pt-20 -92.01 -17.28 25.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.343 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -127.98 118.54 23.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.473 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.1 66.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.601 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.32 -40.58 93.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.576 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 14.7 m -70.49 -36.03 73.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.552 ' O ' HG22 ' A' ' 267' ' ' VAL . 17.7 m -54.34 -48.63 71.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.209 174.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -64.89 -39.59 93.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -63.04 -46.05 89.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.76 86.49 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.542 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.598 ' HA ' HG21 ' A' ' 282' ' ' VAL . 71.3 t -60.39 -35.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 111.28 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.6 m -89.92 -4.73 57.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.711 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 26.5 p -115.74 -47.01 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.768 ' HB2' HG23 ' A' ' 282' ' ' VAL . 55.3 mmm -65.18 -14.83 61.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 15.0 p-10 -72.76 -26.42 61.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.521 0.677 . . . . 0.0 110.323 176.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.55 -8.72 59.69 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.878 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 69.7 t80 -57.95 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 111.363 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.69 103.48 6.68 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.995 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.84 HD23 HD23 ' A' ' 220' ' ' LEU . 22.1 tp -113.43 86.98 2.5 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.925 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 62.01 41.24 99.66 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.662 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 119.23 -21.48 9.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.749 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.423 ' NE2' ' HD2' ' A' ' 217' ' ' HIS . 0.0 OUTLIER -132.9 137.0 46.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.545 0.672 . . . . 0.0 111.777 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -78.04 128.92 34.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.089 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.878 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 8.0 tp -61.46 169.9 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.177 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.452 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 32.3 mmt180 -142.68 113.34 7.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 121.982 -0.448 . . . . 0.0 110.138 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.768 HG23 ' HB2' ' A' ' 270' ' ' MET . 28.7 m -124.94 168.03 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.991 0.424 . . . . 0.0 112.132 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 211' ' ' ILE . . . 176.94 -164.39 33.81 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.314 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 148.36 43.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.821 0.311 . . . . 0.0 110.343 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.37 -16.33 63.5 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' A' ' 167' ' ' GLN . 49.1 t 72.02 -65.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.673 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 6.2 t -97.33 134.36 22.78 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo . . . . . 0 C--O 1.234 0.282 0 C-N-CA 122.736 2.291 . . . . 0.0 111.636 177.626 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 CA--C 1.523 -0.072 0 CA-C-O 121.368 0.604 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -119.79 -51.33 2.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.006 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.08 -41.0 23.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.875 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.621 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.7 t80 -69.02 -19.86 64.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.6 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' B' ' 32' ' ' LYS . 44.0 mtpt -69.08 -47.0 66.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.666 ' HA ' HE21 ' B' ' 36' ' ' GLN . 0.2 OUTLIER -58.97 -39.5 81.93 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.603 0.716 . . . . 0.0 109.118 175.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.724 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.64 -51.37 49.61 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.648 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.697 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.03 -20.85 40.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.666 HE21 ' HA ' ' B' ' 33' ' ' ASP . 37.2 mt-30 -59.53 -44.0 93.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.606 ' O ' HG22 ' B' ' 41' ' ' ILE . 72.7 mtp180 -73.63 -30.3 62.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.685 175.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.831 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -64.5 -49.81 69.86 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -80.1 -24.52 40.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.495 -1.378 . . . . 0.0 112.36 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.18 -50.43 59.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.074 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.831 HG12 ' O ' ' B' ' 38' ' ' ALA . 1.7 pt -66.4 -31.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.54 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.63 -22.61 65.32 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.97 -27.31 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.203 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' A' ' 224' ' ' ASP . 5.3 tmmt? -74.22 -55.26 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.376 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.602 HG21 ' HB2' ' A' ' 219' ' ' ASP . 87.2 mt . . . . . 0 N--CA 1.467 0.378 0 O-C-N 123.573 0.545 . . . . 0.0 112.198 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.7 0.286 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.24 -34.8 61.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 0.0 111.673 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.19 -32.83 69.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.468 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.53 -49.13 62.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.77 0.319 . . . . 0.0 111.65 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.04 -35.93 16.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.79 0.328 . . . . 0.0 111.533 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 91.4 mmm -71.67 -26.58 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.34 -12.34 60.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.19 133.25 50.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.473 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -94.08 138.0 21.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 0.0 110.915 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 188' ' ' PRO . 72.5 t80 -89.66 106.13 18.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.169 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.6 t -103.53 110.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 118' ' ' SER . . . -134.39 100.24 0.37 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.608 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.985 ' HG ' ' HA ' ' A' ' 183' ' ' ILE . 68.5 p 151.59 51.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.306 1.443 . . . . 0.0 107.549 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.81 69.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.483 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.674 ' HE1' ' HA3' ' A' ' 179' ' ' GLY . 35.1 t80 37.86 -92.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.544 1.152 . . . . 0.0 112.387 169.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.496 ' HD2' ' HG3' ' A' ' 122' ' ' GLU . 33.0 t80 -179.3 -72.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.485 173.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 121' ' ' TYR . 48.2 mt-10 -90.07 44.27 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.754 HD22 HG21 ' A' ' 127' ' ' THR . 48.9 mt -102.2 164.63 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.48 175.82 18.1 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.858 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' OE2' ' HB2' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -60.76 -39.59 89.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.3 m-20 -48.43 -50.96 29.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.684 175.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.754 HG21 HD22 ' A' ' 123' ' ' LEU . 6.9 m -57.56 -47.7 81.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.324 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.405 HG21 ' HE2' ' A' ' 132' ' ' PHE . 79.0 mt -69.42 -41.04 80.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.807 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.431 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 14.8 ttm180 -59.57 -44.64 93.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.79 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 92.9 mt-30 -75.52 -21.46 57.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.45 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.96 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.608 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 97.4 m-85 -96.22 13.39 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.012 0.434 . . . . 0.0 111.141 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.67 -43.6 11.65 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.453 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 38.0 Cg_endo -67.08 -4.47 11.61 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 0.0 112.792 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.466 ' CE2' ' HA ' ' A' ' 169' ' ' ALA . 4.9 m-85 -85.4 -83.06 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.55 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.67 -176.25 14.36 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.898 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 252' ' ' TYR . 60.9 Cg_endo -74.57 117.32 4.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.513 2.142 . . . . 0.0 111.444 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -57.12 107.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.917 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 159' ' ' GLU . 23.1 tptp -87.55 -54.49 4.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.379 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -166.73 144.05 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.8 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 63.5 mt -127.35 107.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.32 118.68 35.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.065 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 42.2 ttm -126.56 136.65 52.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.972 0.415 . . . . 0.0 111.189 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.605 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 3.7 m -98.73 111.21 23.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.853 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 2.1 p-90 -164.87 159.64 18.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.03 0.443 . . . . 0.0 111.369 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.45 ' HB2' ' HD2' ' A' ' 153' ' ' LYS . 21.5 t70 -89.34 132.89 34.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.64 -176.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.1 t -101.76 4.98 41.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 110.952 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 91.5 t -85.14 -43.24 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.363 0.601 . . . . 0.0 110.058 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.5 p -119.72 5.22 11.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.002 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 58.46 30.0 19.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.611 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -89.27 128.17 35.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.853 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 58.9 m-70 -81.98 75.41 8.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.522 0.677 . . . . 0.0 110.991 -175.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 146' ' ' ASP . 58.9 mttm -78.5 63.79 3.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.506 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 144' ' ' SER . . . 158.89 -157.86 28.86 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -124.66 174.18 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.69 137.22 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 85.7 m-85 -113.42 113.9 25.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.032 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.0 t -101.01 111.68 31.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.816 0.341 . . . . 0.0 110.256 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 37.8 tt0 -101.52 141.22 34.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.93 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -122.96 172.94 8.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.31 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.63 -27.72 31.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.066 0.46 . . . . 0.0 110.203 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.511 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 6.2 m -121.48 136.52 25.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.864 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 8.2 Cg_exo -73.99 -13.82 23.79 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.72 2.947 . . . . 0.0 112.088 -177.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -60.23 -47.97 83.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.217 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.1 -26.1 68.67 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.5 -49.85 44.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.091 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -66.89 -36.05 81.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.721 0.296 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.86 -43.37 96.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.111 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.466 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . . . -59.86 -38.61 82.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.766 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.5 tt -60.35 -60.45 3.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -69.35 -47.29 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -71.59 -31.26 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.608 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 24.6 mmt -83.36 -28.79 28.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.76 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -76.97 -16.51 59.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 110.513 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.2 m -78.44 -13.91 59.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.152 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.07 143.18 36.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 110.794 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.1 ttt -99.11 104.25 16.23 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.07 -28.79 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.234 -171.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.674 ' HA3' ' HE1' ' A' ' 120' ' ' TYR . . . -161.08 -150.74 6.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.076 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.03 23.18 1.8 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.931 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.59 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 14.4 ptm180 -157.43 151.66 24.8 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -79.31 141.12 37.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.609 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.985 ' HA ' ' HG ' ' A' ' 118' ' ' SER . 27.3 pt -100.12 131.81 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 0.0 110.388 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 81.2 tttt -103.83 117.74 35.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.613 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 48.1 t -125.29 106.58 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 130.82 159.97 9.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.146 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 67.36 83.69 0.18 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.158 0.504 . . . . 0.0 110.817 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.638 ' HA ' ' HB2' ' A' ' 115' ' ' TYR . 17.3 Cg_exo -66.87 -60.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.961 2.441 . . . . 0.0 112.816 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.8 p -151.83 -61.53 0.17 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.918 0.39 . . . . 0.0 110.971 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.53 132.72 33.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.2 tp -142.98 137.34 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.42 . . . . 0.0 110.562 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 195' ' ' GLN . . . 93.42 -42.33 2.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.386 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -59.18 -31.79 69.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.641 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.48 12.11 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 110.849 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.571 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.4 tp60 -63.72 -49.51 76.2 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.563 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.1 -34.2 67.18 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.342 2.028 . . . . 0.0 112.614 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 46.3 mm -67.91 -42.15 85.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.285 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.12 -47.37 93.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.648 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.47 -32.64 74.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.115 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -71.76 -47.1 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.35 -21.49 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.325 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.96 97.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.13 -35.98 76.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.634 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.31 -35.91 82.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.59 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.15 -20.18 62.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.677 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -64.12 -22.27 66.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.948 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.35 58.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.895 0.379 . . . . 0.0 111.138 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -96.48 -17.37 20.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.99 26.25 11.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.776 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 210' ' ' ARG . 8.3 ptm85 -120.23 144.24 47.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.201 0.524 . . . . 0.0 111.654 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.57 170.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.246 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -112.9 133.4 54.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.589 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 33.3 t -118.16 123.45 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.23 169.77 10.57 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.159 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.0 p 53.19 44.53 30.12 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.352 1.061 . . . . 0.0 111.714 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.579 HG13 HD13 ' A' ' 225' ' ' ILE . 48.5 t -79.14 146.13 8.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.218 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.586 ' HB2' HD21 ' A' ' 275' ' ' LEU . 14.1 t-80 -68.95 129.86 41.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -57.0 -36.95 71.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -167.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.965 ' HB2' HG21 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -80.11 -47.63 14.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.074 0.464 . . . . 0.0 111.479 174.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.777 HD22 HD23 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -59.67 108.66 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.948 -178.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 225' ' ' ILE . 44.2 m -97.11 -176.96 3.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -168.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.585 ' HB3' HD13 ' A' ' 240' ' ' LEU . 4.5 p-10 -57.88 -38.65 76.15 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.46 -34.92 69.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.483 0.658 . . . . 0.0 109.974 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.647 ' OD2' ' HE3' ' B' ' 44' ' ' LYS . 3.2 m-20 -73.88 -54.34 8.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.298 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.579 HD13 HG13 ' A' ' 216' ' ' VAL . 31.3 mm -54.71 -24.84 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 222' ' ' ASP . 50.4 mtpt -52.01 -33.88 40.4 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.026 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -49.23 -58.73 4.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.529 0.68 . . . . 0.0 111.816 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.63 HG11 ' CD1' ' A' ' 273' ' ' PHE . 13.7 m -74.41 -45.18 46.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.808 -171.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.529 ' CE1' ' HE3' ' A' ' 270' ' ' MET . 76.5 m-85 -68.52 -38.37 80.84 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.096 -0.378 . . . . 0.0 111.799 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.52 -25.64 45.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.384 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.36 83.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.553 0.216 . . . . 0.0 111.368 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.723 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.4 m-30 -75.64 -27.84 58.56 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.47 -109.07 0.45 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.919 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -157.43 139.63 14.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 238' ' ' CYS . 54.6 mt -94.22 132.16 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.234 0.54 . . . . 0.0 111.085 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -88.32 -42.97 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.17 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 34.5 t -147.35 143.08 27.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.625 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.503 ' HB2' HG23 ' A' ' 235' ' ' ILE . 41.8 t -146.33 124.03 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 62.8 m -157.18 127.21 6.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.585 HD13 ' HB3' ' A' ' 222' ' ' ASP . 7.6 mp -104.49 123.49 47.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.72 136.6 57.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.215 0.531 . . . . 0.0 111.324 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 49.2 mtp85 -101.01 158.66 15.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.653 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.02 107.95 60.3 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 170.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -62.78 -38.41 49.16 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.035 2.49 . . . . 0.0 111.99 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.7 m -59.87 -42.76 94.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.252 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.4 m -90.74 -22.76 20.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 21.7 62.35 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.899 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -134.81 148.95 50.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 10.8 p80 -76.12 142.64 41.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.671 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -69.81 153.16 43.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.2 40.39 1.71 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.979 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.452 ' CZ ' ' HD3' ' A' ' 137' ' ' PRO . 28.8 p90 -159.28 160.45 35.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -169.03 -171.82 35.16 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -126.75 136.98 53.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.834 0.349 . . . . 0.0 111.055 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.12 118.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 57.4 tt0 -105.03 129.88 53.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.006 0.432 . . . . 0.0 110.259 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -107.2 161.57 14.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.84 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -22.14 20.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 262' ' ' SER . 4.8 tppt? -111.8 115.24 28.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.468 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 264' ' ' GLN . . . -60.55 -33.72 73.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.32 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -69.05 -34.51 75.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.978 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.475 ' HB2' ' HB3' ' A' ' 259' ' ' LYS . 9.5 t -62.07 -38.79 90.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.5 m -59.76 -42.99 94.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 260' ' ' ALA . 59.8 mm-40 -68.15 -34.78 76.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 -174.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.4 -40.14 64.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.23 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.83 -51.92 65.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.442 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.04 -26.1 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 97.2 p -65.37 -34.7 78.93 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.672 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.6 t -116.85 0.67 12.56 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.529 ' HE3' ' CE1' ' A' ' 229' ' ' PHE . 34.9 mmm -79.4 -17.81 53.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.509 HD21 ' HD3' ' A' ' 281' ' ' ARG . 18.9 t-20 -61.37 -31.54 71.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.042 0.925 . . . . 0.0 110.083 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -75.32 -8.37 56.47 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.46 -174.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.707 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 55.9 t80 -57.37 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 110.395 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -77.35 119.81 21.5 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.526 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.777 HD23 HD22 ' A' ' 220' ' ' LEU . 14.5 tp -126.2 85.83 2.44 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.486 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.08 32.33 23.65 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.382 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 87.66 19.56 53.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.754 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -140.9 131.97 26.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.81 0.338 . . . . 0.0 110.382 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -76.35 136.1 39.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.075 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.908 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 14.4 tp -70.71 -174.37 0.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.247 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.908 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 6.4 tpp180 -143.88 118.86 10.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' A' ' 270' ' ' MET . 14.7 p -118.31 144.03 27.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 110.544 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.61 -159.9 9.05 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.489 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -118.59 165.13 14.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.828 0.347 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.86 88.86 5.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -51.94 -52.37 23.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 40.8 p -121.85 161.39 42.45 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.409 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.457 -0.672 0 C-N-CA 122.693 2.262 . . . . 0.0 111.409 174.049 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.2 0.524 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -154.51 -63.61 0.13 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.835 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.24 -31.05 33.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.422 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.604 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 15.5 t80 -69.4 -18.48 63.76 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.336 0.588 . . . . 0.0 110.465 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.2 mtpt -70.64 -45.93 64.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.61 -36.15 81.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.905 172.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.723 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.0 -51.01 33.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.483 177.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.601 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -79.86 -23.38 41.97 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -174.036 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 65.6 mt-30 -58.04 -43.31 86.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 170.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 27.1 mmt180 -73.51 -30.68 63.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.456 176.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.72 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -66.51 -43.08 86.26 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -80.86 -26.86 36.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.489 -1.382 . . . . 0.0 112.136 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.15 -44.11 74.85 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.72 HG12 ' O ' ' B' ' 38' ' ' ALA . 4.0 pt -69.1 -34.41 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.619 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.62 ' HA ' HD13 ' A' ' 220' ' ' LEU . . . -64.63 -27.14 68.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.376 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.63 -42.35 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.277 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.647 ' HE3' ' OD2' ' A' ' 224' ' ' ASP . 17.8 pttt -77.45 -35.36 53.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.424 -177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.965 HG21 ' HB2' ' A' ' 219' ' ' ASP . 91.7 mt . . . . . 0 C--O 1.236 0.352 0 CA-C-O 121.388 0.613 . . . . 0.0 111.016 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.754 0.311 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.19 86.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.072 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.89 -32.98 74.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.425 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.82 90.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.4 . . . . 0.0 111.001 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.71 -37.22 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 25.4 ttt -60.44 -28.12 68.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.2 m -91.34 6.21 46.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 113' ' ' ARG . 9.7 ptp180 -130.94 126.26 35.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.829 0.347 . . . . 0.0 110.565 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.475 HG22 ' HB ' ' A' ' 158' ' ' VAL . 4.3 m -92.3 135.84 26.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.651 0.739 . . . . 0.0 110.834 176.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 81.2 t80 -91.1 111.24 22.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.609 -176.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.476 HG13 HD11 ' A' ' 119' ' ' ILE . 9.4 t -103.01 110.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.389 . . . . 0.0 110.272 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.492 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -102.25 171.2 21.21 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.1 t 72.57 -65.69 0.34 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.97 0.508 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.476 HD11 HG13 ' A' ' 116' ' ' VAL . 10.0 mm 63.14 12.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.88 0.371 . . . . 0.0 110.545 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.826 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 11.6 t80 60.4 -80.02 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 50.5 t80 169.75 -45.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.701 0.8 . . . . 0.0 109.379 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -104.62 39.15 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.022 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 66.5 mt -114.05 99.92 8.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.98 -175.04 48.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.4 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -50.63 -49.91 55.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.165 0.507 . . . . 0.0 110.823 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -59.43 -33.68 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -80.69 -39.15 27.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.01 -48.06 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.54 ' HB3' HD12 ' A' ' 141' ' ' ILE . 4.6 ptm180 -62.13 -35.53 79.01 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.61 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.413 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 48.5 mt-30 -75.07 -26.55 59.45 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.302 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.33 -34.75 63.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.678 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 84.1 m-85 -96.81 10.5 38.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.957 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 130' ' ' GLN . . . -70.67 -39.07 8.63 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.655 ' O ' ' HB1' ' A' ' 214' ' ' ALA . 52.6 Cg_exo -59.15 -18.33 43.55 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.786 1.657 . . . . 0.0 112.479 170.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.678 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 57.3 m-85 -101.89 66.6 1.05 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.79 0.328 . . . . 0.0 111.033 -175.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.63 44.27 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.38 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.41 123.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.036 2.491 . . . . 0.0 112.128 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.702 HD11 ' HE1' ' A' ' 160' ' ' TYR . 31.6 mm -67.36 108.07 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.979 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.438 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 82.0 tttt -76.6 -53.05 8.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.318 0.58 . . . . 0.0 110.144 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 139' ' ' LYS . 15.2 m -155.07 143.79 20.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.466 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 129' ' ' ARG . 66.8 mt -113.11 106.15 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 35.9 t70 -81.71 98.24 8.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.0 tpt -130.3 130.05 44.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.904 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -93.53 106.14 18.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.029 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' HB3' ' HA ' ' A' ' 150' ' ' MET . 56.3 m95 -91.98 134.78 34.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.824 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.1 m-20 -73.75 102.61 4.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.261 174.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.1 t 62.07 -160.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.833 0.708 . . . . 0.0 110.551 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.3 p -74.04 -22.24 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.067 0.46 . . . . 0.0 110.494 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -13.65 61.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -173.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.588 ' HA ' ' HB3' ' A' ' 145' ' ' TRP . 88.2 mtp 60.36 47.11 9.27 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.475 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.824 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 30.4 mmmt -77.79 149.99 34.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.498 . . . . 0.0 111.187 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.86 99.99 11.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.235 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.728 ' HZ1' ' HB3' ' A' ' 153' ' ' LYS . 2.3 ttpm? -149.18 64.44 1.03 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.396 0.617 . . . . 0.0 109.611 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 172.84 -179.04 44.56 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.698 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.492 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 84.1 m-85 -112.36 157.85 20.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.02 130.41 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.041 0.448 . . . . 0.0 110.802 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.61 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 67.0 m-85 -111.23 107.77 17.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.872 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.475 ' HB ' HG22 ' A' ' 114' ' ' VAL . 43.0 t -91.77 110.97 23.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.2 138.02 35.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.294 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.702 ' HE1' HD11 ' A' ' 138' ' ' ILE . 50.7 m-85 -118.92 161.01 20.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.37 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 36.0 mt-10 -99.49 9.96 42.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.654 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 10.9 m -132.56 113.51 14.21 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.389 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.46 -24.32 36.62 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 113.326 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.654 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -66.67 -54.46 22.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 110.193 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 162' ' ' VAL . . . -55.38 -40.13 70.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.212 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.29 91.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.8 -41.57 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.519 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.55 HD22 ' HA3' ' A' ' 283' ' ' GLY . 18.9 mt -62.36 -42.4 99.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.012 0.434 . . . . 0.0 110.648 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.36 83.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.789 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.14 -60.92 2.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.82 -46.87 77.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.475 ' OE1' ' HD3' ' A' ' 281' ' ' ARG . 47.6 mt-30 -79.29 -35.82 40.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 51.7 tpp -77.27 -27.11 53.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.32 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -70.44 -20.3 62.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.185 0.516 . . . . 0.0 110.17 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.9 m -90.78 -2.87 57.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.728 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.01 171.12 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 111.403 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.8 mtp -117.18 97.11 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.246 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 52.9 tp -77.78 89.85 4.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 110.261 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 119.42 -157.03 15.58 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.526 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.23 18.07 50.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.016 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.826 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 8.9 ptm180 -157.41 155.72 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.19 105.6 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.274 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.63 155.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.174 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -101.69 109.91 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.902 0.382 . . . . 0.0 110.102 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.3 t -101.32 106.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.43 159.89 34.91 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.58 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -164.88 144.76 5.89 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 102.27 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.963 2.442 . . . . 0.0 112.183 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.5 m -113.99 -42.4 3.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.341 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -150.62 33.82 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.887 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.3 tt -63.29 115.28 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.513 0.673 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 119.02 -38.43 2.85 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -82.28 -39.51 22.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.09 0.472 . . . . 0.0 109.863 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.83 -9.27 57.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.071 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.492 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 24.4 tp60 -63.43 -52.84 57.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.98 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -54.86 -30.81 70.09 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.519 2.146 . . . . 0.0 112.468 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.0 mm -66.04 -57.69 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.0 mt -64.59 -35.55 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.6 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.5 t70 -57.67 -49.55 76.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.435 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.87 -48.12 80.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.237 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 80.2 mt -58.97 -42.6 90.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.52 71.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.371 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 45.1 mt-10 -64.79 -42.99 94.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 288' ' ' PRO . 31.0 mt-10 -70.82 -49.36 47.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.569 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.415 ' HB2' ' HB1' ' A' ' 285' ' ' ALA . . . -59.28 -31.82 69.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.995 -176.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -62.88 -27.2 69.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.92 -14.97 60.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.954 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.58 -15.12 17.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.168 0.508 . . . . 0.0 111.094 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.81 40.74 30.67 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.891 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.492 ' HD3' ' HB3' ' A' ' 254' ' ' PHE . 46.1 ttm180 -103.83 136.24 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.721 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.95 165.89 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.776 0.322 . . . . 0.0 110.792 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.515 ' HD2' HD12 ' A' ' 168' ' ' LEU . 49.1 t80 -116.65 122.88 45.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.057 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.412 HG23 HD11 ' A' ' 255' ' ' ILE . 39.8 t -109.77 121.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.658 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.23 170.49 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.589 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.3 t 67.55 36.28 3.81 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.631 0.582 . . . . 0.0 111.33 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 225' ' ' ILE . 59.9 t -79.86 138.58 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -51.81 -43.68 63.19 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -167.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' B' ' 45' ' ' ILE . 5.2 m-20 -70.17 -45.81 65.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.812 0.339 . . . . 0.0 111.066 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.689 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -66.7 103.94 1.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.464 ' HA ' ' NE2' ' A' ' 249' ' ' HIS . 46.3 m -89.83 -176.85 5.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -166.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.42 -45.46 80.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.849 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.86 -28.94 69.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.277 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.654 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.0 m-20 -67.47 -59.18 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.001 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.669 HG13 HD11 ' A' ' 240' ' ' LEU . 29.5 mm -52.95 -30.58 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.136 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.44 -32.4 39.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.027 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.569 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 70.0 m -49.79 -60.99 2.39 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.654 0.74 . . . . 0.0 112.035 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' B' ' 34' ' ' ALA . 4.0 m -71.74 -39.82 69.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.624 -171.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.759 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 65.1 m-85 -66.71 -39.71 88.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.726 0.298 . . . . 0.0 111.697 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.9 -24.75 55.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.425 ' O ' ' HB1' ' B' ' 30' ' ' ALA . . . -72.98 -24.28 60.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.256 -174.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.666 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.5 m-30 -87.47 24.71 1.59 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.48 0.657 . . . . 0.0 110.525 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 234' ' ' LYS . . . 149.27 -113.42 0.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 233' ' ' GLY . 28.4 mmmt -136.72 161.67 35.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.546 HG12 ' SG ' ' A' ' 238' ' ' CYS . 6.6 tp -122.17 139.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.528 0.68 . . . . 0.0 110.665 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -88.4 -62.74 1.42 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 15.2 m -140.88 143.79 34.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.366 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' A' ' 235' ' ' ILE . 74.7 m -134.52 106.82 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 21.4 m -141.48 104.71 4.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.167 0.508 . . . . 0.0 111.467 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.777 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 79.8 mt -83.57 130.75 35.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.56 101.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.598 0.561 . . . . 0.0 111.205 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.853 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 6.5 ppt_? -90.46 144.73 25.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.509 . . . . 0.0 110.846 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.03 122.76 76.02 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.504 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.67 -20.28 40.66 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.911 2.407 . . . . 0.0 113.514 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.87 -39.14 14.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 44.9 p -88.03 -35.5 17.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.864 0.364 . . . . 0.0 111.338 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.15 -2.32 68.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.658 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -108.75 157.46 18.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.853 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 16.8 p80 -86.4 145.57 26.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.254 0.55 . . . . 0.0 110.925 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.75 158.61 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.04 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -74.8 43.79 1.44 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 114.183 0.433 . . . . 0.0 114.183 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -166.18 164.64 17.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . 178.04 -169.98 42.02 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.559 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.492 ' HB3' ' HD3' ' A' ' 210' ' ' ARG . 90.6 m-85 -119.86 140.01 51.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.847 0.356 . . . . 0.0 110.538 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 213' ' ' VAL . 48.8 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.91 176.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.99 146.25 29.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.357 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.418 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 34.2 m-85 -120.19 137.01 54.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.442 170.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 259' ' ' LYS . 3.3 pm0 -83.6 -29.5 27.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.4 ' N ' ' HG2' ' A' ' 258' ' ' GLU . 17.2 tptm -95.8 113.56 25.21 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.837 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.29 69.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.798 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -69.41 -34.01 73.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.537 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 43.3 m -78.44 -31.51 48.07 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 267' ' ' VAL . 1.5 p -65.6 -42.92 91.1 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.173 -0.329 . . . . 0.0 111.534 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -60.72 -36.58 79.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.588 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.97 -47.38 37.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.745 -176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.43 74.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.076 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 263' ' ' SER . 94.6 t -58.12 -40.25 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.979 0.419 . . . . 0.0 111.254 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.2 t -71.69 -28.9 64.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 t -89.95 -43.51 10.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.768 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.857 ' HB3' HG23 ' A' ' 282' ' ' VAL . 0.0 OUTLIER -74.25 -6.33 47.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.58 -36.6 76.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.416 1.103 . . . . 0.0 109.0 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -79.77 -7.76 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.646 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.687 ' HE1' ' HB2' ' B' ' 38' ' ' ALA . 2.4 t80 -58.84 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.278 0.561 . . . . 0.0 110.563 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 8.3 t70 -93.75 116.32 28.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.221 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.689 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.8 mm? -114.73 87.05 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.761 175.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.73 -86.62 0.6 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.582 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -146.37 26.75 1.69 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.106 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 20.2 pt20 -141.02 131.75 25.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.887 0.375 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.441 ' CD2' ' HB2' ' A' ' 274' ' ' ASP . 63.7 m-85 -91.66 130.81 37.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.265 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.681 HD22 ' HD2' ' A' ' 273' ' ' PHE . 7.2 mp -63.54 168.65 4.48 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.528 0.68 . . . . 0.0 111.005 175.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.475 ' HD3' ' OE1' ' A' ' 172' ' ' GLN . 2.6 mmp_? -132.45 112.11 11.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.857 HG23 ' HB3' ' A' ' 270' ' ' MET . 94.7 t -116.33 133.27 63.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.084 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.55 ' HA3' HD22 ' A' ' 168' ' ' LEU . . . -137.83 -156.09 7.07 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.174 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -103.45 172.67 6.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' ' 205' ' ' ALA . . . -59.41 -35.83 74.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.571 0.224 . . . . 0.0 111.502 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 61.5 t 70.42 -64.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.82 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 164' ' ' GLU . 12.2 t -98.06 143.09 25.64 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 69.5 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 122.722 2.281 . . . . 0.0 112.113 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 . . . . . 0 CA--C 1.526 0.055 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.19 -30.28 18.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.047 0.451 . . . . 0.0 109.919 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 231' ' ' ALA . . . -63.0 -37.02 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.1 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.58 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 19.1 t80 -75.95 -22.75 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 110.271 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -75.8 -43.83 44.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.968 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -61.34 -37.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.666 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.63 -49.44 56.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.611 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.724 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.81 -21.77 37.46 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -171.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -62.55 -38.18 89.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.569 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 61.3 mtp180 -74.09 -35.43 64.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.629 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.724 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -63.13 -44.24 96.13 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -81.65 -26.99 34.32 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 112.96 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.66 -49.17 65.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 0.0 109.82 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.654 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 6.3 pt -68.05 -30.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.496 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.644 ' HA ' HD13 ' A' ' 220' ' ' LEU . . . -67.89 -27.9 67.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.377 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.35 -31.02 19.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.458 ' HZ2' ' CG ' ' A' ' 224' ' ' ASP . 7.3 ttpt -82.18 -38.5 24.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.377 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 219' ' ' ASP . 30.6 pt . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 125.288 1.435 . . . . 0.0 114.043 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.36 0.124 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.26 72.3 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.3 mt -64.95 -38.83 92.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.236 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.45 -31.64 60.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.77 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.61 -36.19 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.362 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.411 ' HE2' HG13 ' A' ' 286' ' ' VAL . 90.0 mtp -69.24 -34.04 74.2 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.479 ' HG ' ' HG3' ' A' ' 159' ' ' GLU . 28.5 p -73.78 -11.35 60.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.906 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.706 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 91.8 mtt180 -105.71 103.26 12.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -91.51 146.6 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.466 0.651 . . . . 0.0 111.377 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 61.5 t80 -86.33 118.68 25.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.878 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.15 113.47 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 110.192 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.79 174.51 15.25 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.345 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 t 74.73 42.41 0.29 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.541 0.737 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.54 136.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.331 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -108.84 98.51 7.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.439 ' HD1' ' HA ' ' A' ' 151' ' ' LYS . 34.0 t80 37.87 -84.22 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 165.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -71.87 -16.73 62.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.786 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 127' ' ' THR . 88.8 mt -77.96 98.91 5.84 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.79 -167.53 43.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.108 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.95 -29.36 70.29 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.77 -49.58 76.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.482 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.484 HG22 HD21 ' A' ' 123' ' ' LEU . 55.9 m -64.27 -42.2 96.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.052 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.92 -42.3 88.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.425 0.631 . . . . 0.0 110.133 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.456 ' HA ' ' CD1' ' A' ' 138' ' ' ILE . 39.5 ttt180 -56.56 -46.8 80.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.024 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -77.97 -33.34 51.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.187 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.65 77.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.511 . . . . 0.0 111.207 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 1.008 ' HB3' ' HH ' ' A' ' 160' ' ' TYR . 46.2 m-85 -99.59 10.33 41.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.601 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.74 -45.25 16.8 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 23.6 Cg_endo -62.06 -10.44 17.9 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.02 1.813 . . . . 0.0 112.795 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.522 ' CZ ' ' HE2' ' A' ' 173' ' ' MET . 2.3 m-85 -79.25 -67.61 0.74 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 109.803 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.49 165.91 33.09 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.71 112.33 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.31 2.007 . . . . 0.0 111.293 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 129' ' ' ARG . 56.7 mt -68.51 129.16 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 109.981 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -96.83 -50.92 4.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.684 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 t -149.23 161.88 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.5 mt -137.28 109.91 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.635 0.255 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.784 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 47.8 m-20 -84.33 111.17 19.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.271 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.572 ' HG2' ' HB3' ' A' ' 145' ' ' TRP . 24.7 ttp -156.2 101.12 2.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 0.0 110.782 175.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.0 m -77.95 69.24 4.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.914 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 14.3 p-90 -96.32 145.79 25.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.96 111.18 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.424 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 m -90.83 -12.89 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.86 -54.03 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.967 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.5 p -91.7 -19.27 22.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.164 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.645 ' HG3' ' CZ3' ' A' ' 145' ' ' TRP . 15.3 ttp 66.74 25.77 9.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.318 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.439 ' HA ' ' HD1' ' A' ' 121' ' ' TYR . 59.5 pttt -105.32 19.78 20.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.438 . . . . 0.0 110.968 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.914 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 41.1 m-70 60.2 -161.33 0.28 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.626 173.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.501 ' HG2' ' HA ' ' A' ' 145' ' ' TRP . 74.6 mmtt -117.99 -44.14 2.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 157.29 -21.39 0.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.611 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.64 161.61 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.201 0.5 . . . . 0.0 112.173 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.499 ' HB3' ' SD ' ' A' ' 143' ' ' MET . . . -149.36 156.25 41.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.504 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.784 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 80.8 m-85 -114.04 112.39 23.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 57.5 t -99.07 116.86 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.944 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.706 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 42.4 tt0 -94.15 130.51 40.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.91 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 1.008 ' HH ' ' HB3' ' A' ' 132' ' ' PHE . 80.4 m-85 -100.18 155.83 17.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.778 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.99 -33.34 75.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 172.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.62 133.31 25.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.038 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.28 -23.15 73.37 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.323 2.682 . . . . 0.0 113.103 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -54.71 -49.91 69.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 111.211 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.32 70.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.056 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.15 86.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.46 -44.85 93.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.142 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 33.7 mt -63.21 -35.4 80.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 0.0 110.577 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -66.6 -30.6 70.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.633 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.46 -59.34 2.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.27 -39.92 14.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 14.6 mm100 -82.45 -34.69 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.522 ' HE2' ' CZ ' ' A' ' 135' ' ' PHE . 55.9 tpp -72.71 -31.74 65.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.462 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.38 -19.8 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.215 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 41.6 t -78.49 -7.73 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.722 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.56 126.52 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 110.799 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 88.5 mtp -83.96 79.77 9.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 55.7 tp -58.51 118.46 5.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.101 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.07 11.89 83.93 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.406 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.67 5.38 89.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.145 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 181' ' ' ARG . 17.6 mtp180 -112.67 155.3 24.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -91.82 103.84 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.852 0.834 . . . . 0.0 109.106 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.47 146.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.116 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -102.08 110.66 22.68 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 16.1 m -118.64 133.85 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.58 145.72 8.61 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.822 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.595 ' HD3' ' HB2' ' A' ' 115' ' ' TYR . 20.8 ptt180 -151.08 123.9 4.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 1.7 Cg_endo -84.36 72.62 4.99 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.258 2.639 . . . . 0.0 111.011 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 m -64.83 -22.36 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.749 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -155.21 151.11 27.75 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.52 125.0 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.839 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.96 -18.7 8.81 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.986 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -72.78 -57.25 4.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.753 0.311 . . . . 0.0 111.239 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.93 5.64 40.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.058 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.513 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 59.8 tp60 -60.96 -51.71 77.4 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.721 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 15.1 Cg_endo -57.78 -25.04 66.83 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.122 1.881 . . . . 0.0 112.169 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.81 -55.93 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.603 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.6 pt -65.84 -32.0 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -45.95 90.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.887 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -58.09 -48.68 79.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.699 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.64 -50.87 70.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.171 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.536 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -60.96 -41.61 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.046 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.28 -44.26 95.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.435 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.53 -43.06 95.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.539 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.96 66.88 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.874 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 75.8 mtp180 -65.87 -18.51 65.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.094 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.95 55.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 111.167 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -104.05 -19.43 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.273 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 59.43 30.45 20.13 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.57 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.495 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 97.4 mtt180 -88.54 140.56 29.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.229 0.538 . . . . 0.0 111.666 -175.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.68 HD12 ' HE1' ' A' ' 229' ' ' PHE . 8.3 tt -119.95 151.15 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -108.88 126.99 53.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.119 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.515 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.8 p -118.75 122.72 70.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.147 0.499 . . . . 0.0 110.717 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.05 -177.91 3.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.882 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 41.8 m 67.71 16.68 9.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.634 0.774 . . . . 0.0 111.485 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.681 HG12 HD11 ' A' ' 225' ' ' ILE . 66.9 t -62.52 135.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.485 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.78 139.77 47.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.74 -30.97 69.71 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -167.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -79.59 -24.72 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.366 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.781 HD21 ' HG ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -83.63 104.86 14.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 2.4 p -87.39 -177.28 5.89 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.64 -54.39 14.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.989 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.46 -27.9 69.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.936 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.612 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 3.3 m-20 -63.68 -55.58 22.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.332 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.681 HD11 HG12 ' A' ' 216' ' ' VAL . 33.5 mm -60.5 -24.51 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.25 -31.34 68.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.199 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.791 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 69.7 m -48.86 -60.39 2.79 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.985 0.898 . . . . 0.0 111.634 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.649 HG13 ' HB1' ' B' ' 34' ' ' ALA . 3.1 m -71.0 -45.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.676 -170.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.68 ' HE1' HD12 ' A' ' 211' ' ' ILE . 41.4 m-85 -60.96 -40.31 92.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -76.68 -34.4 58.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.674 -175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.98 -25.14 66.96 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.724 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 6.9 m-30 -73.59 -42.79 61.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.85 -100.8 0.21 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.672 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.76 157.66 43.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.08 138.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.484 . . . . 0.0 110.831 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 15.0 mmtp -88.02 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.556 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 27.0 t -145.03 145.05 31.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.811 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.31 129.58 45.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.6 p -145.11 112.52 6.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.29 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.609 HD21 ' HA3' ' A' ' 253' ' ' GLY . 78.0 mt -85.91 129.58 34.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.11 143.29 56.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.647 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -121.41 157.27 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.62 121.93 73.32 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.12 -18.01 60.39 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.139 2.56 . . . . 0.0 113.96 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 p -82.34 -33.99 28.67 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.559 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 45.2 p -112.25 -34.58 5.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 111.847 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.25 59.12 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.597 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.9 141.53 42.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 5.9 p80 -79.0 143.35 35.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 0.0 110.576 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -81.15 156.09 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.147 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.447 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -77.69 46.46 2.6 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.88 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.23 157.27 17.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.966 0.383 . . . . 0.0 110.171 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.609 ' HA3' HD21 ' A' ' 240' ' ' LEU . . . -167.97 -175.28 37.59 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.355 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.08 141.17 52.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.763 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.547 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 24.2 mm -124.12 135.75 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.048 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 37.1 mt-10 -104.98 141.6 36.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.675 0.274 . . . . 0.0 111.238 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -124.25 149.55 46.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.214 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 258' ' ' GLU . 1.1 pm0 -87.22 -17.89 31.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.822 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.724 ' HA ' ' HE3' ' A' ' 259' ' ' LYS . 1.0 OUTLIER -137.28 132.05 33.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.985 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -62.04 -40.75 96.81 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.187 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.429 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 13.3 pt20 -63.76 -32.58 74.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 110.694 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.3 t -65.23 -40.66 94.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.1 m -65.13 -36.27 83.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 91.0 mt-30 -61.88 -33.76 74.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.098 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.91 -48.12 64.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.873 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -56.26 -41.68 76.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.661 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 264' ' ' GLN . 22.9 m -65.47 -27.02 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.3 p -94.02 -29.34 15.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.598 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.6 m -92.72 -38.31 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.724 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.8 mmm -65.83 -23.46 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -171.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.415 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 66.6 t30 -59.06 -35.04 72.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.738 . . . . 0.0 110.54 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.449 HD21 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -77.84 -10.51 59.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.859 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -58.64 112.2 1.53 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.388 -175.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.15 120.99 35.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.926 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.781 ' HG ' HD21 ' A' ' 220' ' ' LEU . 2.0 mm? -120.19 87.57 2.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.202 172.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.63 35.67 18.85 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.949 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.25 62.45 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.937 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -124.43 131.68 53.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 110.394 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -75.68 149.55 38.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.732 HD21 HD21 ' A' ' 275' ' ' LEU . 11.4 mt -79.35 -172.79 3.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.958 0.409 . . . . 0.0 110.056 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.415 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 56.8 mmt-85 -147.08 113.45 5.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.873 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 270' ' ' MET . 21.0 m -122.65 157.66 27.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.14 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -177.17 -171.24 40.51 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.767 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -82.0 140.06 34.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.059 0.457 . . . . 0.0 109.917 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -67.24 -21.33 65.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.795 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 74.6 t 71.12 -65.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.787 0.435 . . . . 0.0 111.008 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.5 t -111.58 140.76 23.49 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 CA--C 1.531 0.347 0 C-N-CA 122.287 1.992 . . . . 0.0 112.135 176.68 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.604 0.716 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.83 -71.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.091 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.68 -38.59 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.894 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' B' ' 34' ' ' ALA . 6.1 t80 -65.4 -17.24 64.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.675 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.615 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.4 mttt -69.68 -49.49 52.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.738 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 14.4 t70 -57.12 -42.27 80.56 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.649 ' HB1' HG13 ' A' ' 228' ' ' VAL . . . -45.47 -54.31 7.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.669 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.871 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.91 -21.49 37.32 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -171.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 79.8 mt-30 -64.94 -39.37 93.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.791 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 17.7 mmt180 -73.79 -32.96 64.02 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.626 172.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.871 ' HB2' ' HA ' ' B' ' 35' ' ' LEU . . . -66.62 -44.66 81.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.253 36.8 mtp85 -82.33 -25.69 33.67 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.209 -1.557 . . . . 0.0 112.773 172.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.78 ' HA ' HE21 ' B' ' 40' ' ' GLN . 0.0 OUTLIER -53.29 -47.0 69.55 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 168.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.722 HD12 ' HZ ' ' A' ' 273' ' ' PHE . 9.2 pt -67.27 -34.27 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.468 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.504 ' O ' HG22 ' B' ' 45' ' ' ILE . . . -66.36 -25.44 66.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.888 0.375 . . . . 0.0 111.287 176.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.55 -15.53 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.748 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.538 ' HZ3' ' CG ' ' A' ' 224' ' ' ASP . 1.5 tmmt? -89.84 -33.74 16.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.504 HG22 ' O ' ' B' ' 42' ' ' ALA . 7.3 pt . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.65 157.54 19.66 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.68 -0.119 . . . . 0.0 110.68 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 48.8 ttm 64.94 78.13 0.29 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.594 0.559 . . . . 0.0 110.055 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.96 90.66 4.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.848 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -95.1 -31.26 13.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.575 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 49.79 74.27 0.21 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.223 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 62.83 95.52 0.04 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.305 -173.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -54.21 -31.38 52.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.536 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 111' ' ' MET . . . -56.77 -48.66 77.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.973 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.454 HD11 ' HG3' ' A' ' 163' ' ' PRO . 59.0 tp -71.47 -36.62 71.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.93 84.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.369 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.2 pt -78.6 -34.55 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.427 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 107' ' ' ALA . 89.9 mtp -61.52 -26.76 68.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -84.35 -2.19 56.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.6 0.238 . . . . 0.0 111.279 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 27.0 ttp180 -128.74 109.48 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.927 0.394 . . . . 0.0 110.714 -175.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.1 m -92.57 141.28 14.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.484 0.659 . . . . 0.0 111.649 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 53.0 t80 -86.09 130.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.982 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 111.71 37.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.07 0.462 . . . . 0.0 110.085 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.07 155.73 15.95 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.928 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.1 m 68.87 49.97 0.64 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 110.462 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.45 127.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.185 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -45.17 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.867 0.729 . . . . 0.0 112.79 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -178.38 -64.54 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.559 0.219 . . . . 0.0 110.98 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.12 18.98 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.006 0.431 . . . . 0.0 112.087 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 3.6 pp -130.21 141.3 50.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.954 0.407 . . . . 0.0 110.489 176.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.66 -152.43 5.96 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.59 -31.57 69.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.528 0.664 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.22 -43.41 98.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.132 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 2.1 m -84.87 -43.77 13.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.336 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.44 -36.58 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -55.71 -44.13 77.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.95 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -77.82 -34.75 51.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.312 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.27 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.631 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 98.2 m-85 -108.14 12.07 27.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.55 -44.87 46.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.268 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 17.8 Cg_endo -61.19 -17.28 51.61 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.215 1.943 . . . . 0.0 112.553 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -80.05 -70.16 0.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.47 155.06 26.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.524 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 24.5 Cg_exo -64.13 132.5 34.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.621 2.214 . . . . 0.0 111.586 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.68 110.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.164 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.879 ' HD3' ' HG2' ' A' ' 161' ' ' GLU . 39.2 tptt -83.26 -46.96 12.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.063 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -160.15 153.99 22.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.33 123.09 49.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.741 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.638 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 21.2 m-20 -90.44 97.34 11.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 14.0 tpt -105.82 148.67 27.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.002 0.43 . . . . 0.0 111.371 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.0 m -119.09 84.31 2.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.704 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -80.2 116.38 20.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 153' ' ' LYS . 14.9 t70 -95.8 117.2 30.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.655 ' HB3' HG22 ' A' ' 149' ' ' THR . 43.9 t 69.13 162.73 0.22 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.059 0.849 . . . . 0.0 111.733 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.45 -22.32 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 147' ' ' SER . 9.8 t -60.29 -25.12 65.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.102 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.2 mtt 64.32 43.36 4.77 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.827 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HG2' HG21 ' A' ' 149' ' ' THR . 31.4 mmmt -93.23 12.79 23.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.052 0.453 . . . . 0.0 110.813 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.0 p80 41.56 44.69 2.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.489 1.116 . . . . 0.0 113.079 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 28.4 tttm -70.75 96.99 1.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.347 0.594 . . . . 0.0 110.033 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 158.18 -129.27 2.27 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.221 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -148.36 170.46 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.238 0.215 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.19 153.13 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 111.047 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.658 ' HE2' ' HD2' ' A' ' 187' ' ' ARG . 90.6 m-85 -123.14 124.8 43.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.036 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.2 t -106.22 111.04 33.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 31.8 tt0 -99.58 131.04 45.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -105.68 174.15 6.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.085 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.879 ' HG2' ' HD3' ' A' ' 139' ' ' LYS . 32.2 mt-10 -85.4 -16.26 40.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.097 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.81 135.29 21.5 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.4 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.454 ' HG3' HD11 ' A' ' 108' ' ' LEU . 55.4 Cg_endo -69.87 -17.77 36.9 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.987 2.458 . . . . 0.0 112.197 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -62.85 -40.21 96.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.696 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.92 89.16 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.248 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.84 86.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.483 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -62.2 -47.1 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.535 HD22 ' HA3' ' A' ' 283' ' ' GLY . 34.4 mt -66.59 -33.49 75.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.15 0.5 . . . . 0.0 110.561 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -64.77 -34.13 77.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.298 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.17 -55.47 5.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.972 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.93 -47.68 76.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.506 ' HG2' ' HD2' ' A' ' 281' ' ' ARG . 17.1 mp0 -91.0 -49.88 6.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.631 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 12.6 mmt -66.97 -30.81 71.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.76 -21.28 37.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.151 0.5 . . . . 0.0 110.891 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.2 m -90.98 -24.01 20.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.114 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.2 t -116.0 119.51 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.193 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 89.6 mtp -67.19 108.7 2.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 110.882 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 178' ' ' LEU . 2.5 pt? -81.2 7.54 10.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.799 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.53 -167.29 35.53 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.98 25.42 2.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.629 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -158.3 133.69 8.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -91.96 129.47 37.91 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.4 pt -91.61 151.69 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -100.95 116.59 33.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.0 t -103.24 122.46 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.546 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 105.96 172.99 23.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.419 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.658 ' HD2' ' HE2' ' A' ' 157' ' ' PHE . 75.7 mtp180 -130.0 92.22 37.28 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.624 0.25 . . . . 0.0 110.411 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.06 80.54 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.894 2.396 . . . . 0.0 111.661 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -143.9 -54.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.18 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -90.04 5.89 44.68 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.09 0.472 . . . . 0.0 111.212 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 39.9 pt -68.11 153.61 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 88.78 -51.74 3.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.928 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.33 69.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.37 0.605 . . . . 0.0 109.764 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -91.53 1.56 57.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.976 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.548 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.7 tp60 -59.57 -50.04 89.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.103 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 11.2 Cg_endo -55.52 -27.46 59.61 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.353 2.036 . . . . 0.0 112.221 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.9 mm -77.38 -43.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.322 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 80.7 mt -59.52 -50.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.89 -29.92 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.206 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -68.01 -50.08 57.67 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.63 -48.56 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.028 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.03 93.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.224 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -69.39 -33.51 73.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.511 . . . . 0.0 110.659 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.02 -45.12 62.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.369 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.12 -24.79 64.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -60.45 -25.04 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.908 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.54 -16.45 64.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.457 ' C ' HD21 ' A' ' 209' ' ' ASN . 60.3 m-85 -104.96 -4.94 21.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.155 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.457 HD21 ' C ' ' A' ' 208' ' ' PHE . 0.1 OUTLIER 32.32 43.17 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 114.252 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 256' ' ' GLU . 24.8 mtp180 -90.16 141.8 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.657 HD12 ' HE1' ' A' ' 229' ' ' PHE . 12.8 tt -99.14 152.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.532 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -107.67 124.54 50.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 0.0 110.24 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.422 HG22 HD12 ' A' ' 255' ' ' ILE . 17.6 t -108.41 116.88 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.002 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.536 ' O ' ' HG ' ' A' ' 280' ' ' LEU . . . -121.07 173.83 7.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.558 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 35.0 m 64.85 28.33 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.744 0.653 . . . . 0.0 110.778 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 225' ' ' ILE . 57.7 t -72.69 133.87 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.374 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 13.6 t-80 -69.1 135.04 50.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 109.764 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -55.62 -41.74 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.667 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.607 ' HB2' ' HB ' ' B' ' 45' ' ' ILE . 2.6 p30 -80.35 -46.95 15.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.555 HD22 ' CD1' ' A' ' 275' ' ' LEU . 0.1 OUTLIER -50.72 122.69 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.403 0.681 . . . . 0.0 109.954 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 22.1 m -99.74 -178.46 3.88 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -167.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.13 -55.42 31.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.014 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.648 ' O ' ' HB2' ' A' ' 226' ' ' LYS . 2.6 m-20 -62.88 -27.35 69.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 221' ' ' SER . 71.9 m-20 -66.66 -49.17 67.04 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.749 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.555 HD12 HG11 ' A' ' 216' ' ' VAL . 21.8 mm -61.16 -24.74 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.271 0.558 . . . . 0.0 109.971 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 223' ' ' ASP . 11.0 mmmm -59.43 -31.8 69.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 174.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.679 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 71.2 m -47.79 -54.94 10.83 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.506 0.669 . . . . 0.0 111.034 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' B' ' 34' ' ' ALA . 12.5 m -75.24 -49.97 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.665 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.657 ' HE1' HD12 ' A' ' 211' ' ' ILE . 50.0 m-85 -61.21 -46.99 88.19 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.526 ' HB2' ' HE2' ' A' ' 226' ' ' LYS . 27.9 tt0 -77.94 -12.53 59.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.368 . . . . 0.0 111.272 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.62 51.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.357 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.719 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 0.9 OUTLIER -93.82 -52.66 4.34 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -138.74 -164.5 9.93 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.438 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -108.82 139.1 44.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.549 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.623 ' HB ' ' HE3' ' A' ' 226' ' ' LYS . 3.2 mp -120.27 134.37 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -97.73 -29.06 13.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 111.721 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.6 t -143.34 132.44 23.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.545 ' SG ' ' HD3' ' A' ' 226' ' ' LYS . 9.1 p -144.03 113.56 7.05 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.836 0.35 . . . . 0.0 110.599 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 63.4 m -151.37 122.43 7.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.517 . . . . 0.0 111.353 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.669 HD22 ' HA3' ' A' ' 253' ' ' GLY . 43.4 mt -85.1 130.04 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.61 129.63 42.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.691 0.281 . . . . 0.0 110.907 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -78.97 140.47 38.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.54 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.3 t70 -111.55 116.82 50.03 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.42 -27.88 46.74 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 123.138 2.559 . . . . 0.0 113.659 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.1 t -93.32 -27.76 16.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.991 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.3 m -81.14 -36.67 29.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.061 0.458 . . . . 0.0 110.167 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 96.74 -18.45 57.48 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.738 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 249' ' ' HIS . 72.3 mmtt -108.04 -84.67 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 0.0 110.46 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 248' ' ' LYS . 29.6 p80 -164.08 154.02 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 56.0 mttm -71.41 155.38 40.7 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.64 31.52 1.03 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 121.293 -0.479 . . . . 0.0 113.661 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.524 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 27.1 p90 -152.97 164.02 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.109 0.454 . . . . 0.0 110.281 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.669 ' HA3' HD22 ' A' ' 240' ' ' LEU . . . -164.15 168.42 38.58 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.62 114.57 26.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.041 0.448 . . . . 0.0 110.582 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 213' ' ' VAL . 43.8 mt -107.1 139.73 27.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.822 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 210' ' ' ARG . 38.1 tt0 -115.67 115.52 26.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.698 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.31 152.93 21.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.554 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 15.0 pt-20 -88.75 -16.98 30.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.878 0.371 . . . . 0.0 110.494 177.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.489 ' HE3' ' HB3' ' A' ' 259' ' ' LYS . 22.5 mtpp -128.57 135.77 49.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.11 -25.17 61.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.618 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -66.03 -50.33 64.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.211 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.9 m -63.61 -33.87 76.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.439 -176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 267' ' ' VAL . 31.7 t -57.3 -46.91 82.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.178 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.55 -34.67 77.53 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.83 -44.43 96.17 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.243 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.22 80.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 263' ' ' SER . 62.0 t -52.73 -36.35 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.853 0.359 . . . . 0.0 111.508 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 42.8 m -69.08 -24.76 64.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 38.9 m -115.33 -27.15 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.532 ' HE3' HG23 ' A' ' 228' ' ' VAL . 43.4 mmm -66.94 -13.69 62.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.28 -35.86 80.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.11 0.957 . . . . 0.0 109.121 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.5 mm? -77.39 -9.28 58.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.981 -175.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.903 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 6.2 t80 -51.26 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.137 0.494 . . . . 0.0 111.173 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -82.97 121.49 27.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.242 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.555 ' CD1' HD22 ' A' ' 220' ' ' LEU . 65.9 mt -125.66 85.87 2.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.041 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.54 27.09 57.93 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.871 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 110.43 -17.42 28.6 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.46 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -102.21 130.45 48.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.816 0.341 . . . . 0.0 110.721 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -80.18 134.61 36.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.655 HD23 ' HD2' ' A' ' 273' ' ' PHE . 2.4 tp -66.78 -178.51 0.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.968 0.792 . . . . 0.0 110.78 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.506 ' HD2' ' HG2' ' A' ' 172' ' ' GLN . 5.6 tpp180 -148.52 112.68 5.21 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.84 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 270' ' ' MET . 18.6 m -111.48 159.48 11.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.558 . . . . 0.0 111.897 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.535 ' HA3' HD22 ' A' ' 168' ' ' LEU . . . -157.8 -136.03 2.01 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.687 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -142.86 167.75 21.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -87.71 124.92 34.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.03 -29.73 3.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.381 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.7 t -129.94 143.87 50.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -51.04 104.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.34 2.693 . . . . 0.0 112.15 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.04 40.11 0.91 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.974 2.45 . . . . 0.0 112.399 -173.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 82.2 mtp -133.73 136.95 27.6 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.652 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.54 69.28 2.75 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 122.847 2.365 . . . . 0.0 112.196 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.37 40.71 1.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 110.246 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.54 96.89 6.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.259 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.76 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 25.6 m -61.48 -54.69 50.01 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.479 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.76 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 62.8 Cg_endo -91.27 123.11 0.78 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.15 1.9 . . . . 0.0 112.618 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -84.57 67.35 9.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.111 0.481 . . . . 0.0 110.585 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.605 -0.712 . . . . 0.0 110.715 -177.843 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 112.186 -0.366 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.64 132.56 34.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.92 0.391 . . . . 0.0 111.053 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -83.15 166.05 18.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.966 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.97 -53.82 4.4 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -100.65 53.18 0.87 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' B' ' 31' ' ' PHE . 25.7 m -62.13 133.08 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.691 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.609 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 7.5 t30 -94.52 -46.07 7.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.549 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.91 -46.61 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 -43.53 77.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.679 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 9.8 t80 -78.97 -22.51 45.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.958 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.617 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.8 mtpt -79.06 -35.01 43.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.785 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.525 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 58.1 t0 -57.07 -46.48 82.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.719 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -49.09 -52.9 23.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.169 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.79 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.7 -25.28 35.6 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -168.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.617 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 32.8 mt-30 -63.24 -38.05 89.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.679 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 67.3 mtt180 -71.57 -39.29 70.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.734 172.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.903 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.98 -46.85 85.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.147 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.262 31.9 mtt-85 -80.51 -24.35 39.45 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.898 174.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 56.1 tt0 -53.63 -49.87 66.95 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.248 0.546 . . . . 0.0 109.976 167.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.798 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -65.69 -30.45 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -21.84 42.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.387 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.91 72.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.714 ' HG3' HG12 ' B' ' 45' ' ' ILE . 48.5 pttt -72.66 -43.91 62.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.448 174.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.714 HG12 ' HG3' ' B' ' 44' ' ' LYS . 5.7 pt -139.37 116.64 10.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.851 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.09 -51.36 0.84 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.855 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.69 104.92 0.23 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.878 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.21 123.48 24.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.834 0.349 . . . . 0.0 110.488 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.57 13.49 28.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.206 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.42 -97.07 1.84 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.163 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.5 m -89.41 -67.61 0.83 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.129 0.49 . . . . 0.0 110.098 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 46.9 p . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.895 179.388 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.59 84.59 0.14 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 122.968 0.507 . . . . 0.0 111.625 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.2 ttt -69.52 -31.67 70.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.604 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.23 64.88 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.198 0.523 . . . . 0.0 111.413 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -81.9 67.98 8.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.942 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.556 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.0 ptt180 -74.06 -7.6 53.09 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.421 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.41 -50.76 58.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.361 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -70.32 -29.37 66.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.169 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.07 96.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.412 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 79.9 mt -63.64 -36.98 85.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.56 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.55 -28.08 66.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.824 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.36 -43.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.137 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 81.4 mmm -61.24 -40.55 94.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.094 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.465 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 98.8 m -65.22 -19.57 66.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 9.8 ptm85 -116.27 107.18 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.528 0.68 . . . . 0.0 111.264 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.8 m -97.33 135.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.363 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 19.4 t80 -78.35 126.78 31.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.384 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.571 HG12 HG21 ' A' ' 185' ' ' VAL . 15.3 m -123.67 111.64 29.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.419 0.628 . . . . 0.0 110.02 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -133.9 102.76 0.47 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.625 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.61 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.6 t 168.12 77.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.3 mt -110.16 134.56 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.06 -75.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.17 0.294 . . . . 0.0 111.199 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -169.12 -53.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.198 0.523 . . . . 0.0 110.359 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -19.6 19.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.817 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.58 108.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 0.0 110.792 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.417 ' HA2' ' NE2' ' A' ' 152' ' ' HIS . . . -83.09 -178.77 52.41 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.614 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.47 -24.42 65.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.749 0.309 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.47 -43.53 93.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.323 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -62.19 -44.58 96.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.71 -46.75 91.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 110.57 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.497 ' HG3' HG13 ' A' ' 138' ' ' ILE . 70.6 ttt180 -57.47 -45.75 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.006 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -77.25 -19.15 56.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.43 57.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.747 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 74.0 m-85 -101.86 7.45 41.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 110.797 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.463 ' HB2' ' HD3' ' A' ' 134' ' ' PRO . . . -72.14 -42.37 9.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.928 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 133' ' ' ALA . 36.6 Cg_exo -63.59 -4.97 7.74 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.155 1.903 . . . . 0.0 112.716 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CZ ' ' HE3' ' A' ' 173' ' ' MET . 29.8 m-85 -92.7 -75.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.784 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.77 168.86 25.8 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.454 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 18.6 Cg_exo -66.14 133.71 34.07 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.54 2.16 . . . . 0.0 111.585 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.497 HG13 ' HG3' ' A' ' 129' ' ' ARG . 47.6 mm -72.02 114.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.358 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -94.71 -46.03 7.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 29.9 t -143.88 135.22 25.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 110.946 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.453 HG22 ' HG3' ' A' ' 143' ' ' MET . 65.9 mt -116.65 106.12 19.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.436 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.2 m-20 -111.33 98.28 7.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.453 ' HG3' HG22 ' A' ' 141' ' ' ILE . 79.7 mtp -109.5 163.68 13.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.466 . . . . 0.0 111.148 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.6 m -145.87 85.67 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.83 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.434 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 13.1 p-90 -144.92 160.13 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.697 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.48 91.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.2 m -85.35 -9.53 57.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.361 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 m -80.15 -52.1 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.623 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -112.9 21.38 15.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.434 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 89.7 mmm 61.69 -157.2 0.34 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.16 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm 73.54 105.42 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -172.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.417 ' NE2' ' HA2' ' A' ' 124' ' ' GLY . 14.8 m-70 -77.6 68.87 3.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.35 31.73 1.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.999 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -139.68 175.25 21.88 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.813 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -114.37 173.51 6.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -139.9 148.51 42.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.461 . . . . 0.0 111.689 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.429 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 86.2 m-85 -116.94 118.67 33.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -110.1 120.03 60.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.302 0.572 . . . . 0.0 110.958 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.8 tt0 -107.63 134.76 50.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.906 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.61 167.15 9.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.889 0.376 . . . . 0.0 111.647 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.3 -45.28 88.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.168 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.59 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 23.9 m -115.73 138.2 23.76 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.113 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.465 ' HG3' ' SG ' ' A' ' 112' ' ' CYS . 16.5 Cg_exo -68.09 -20.48 43.98 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.4 2.734 . . . . 0.0 112.29 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.59 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 4.0 mp0 -56.52 -52.24 65.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.469 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.43 62.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.47 53.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -73.13 -32.62 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.754 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.461 HD21 ' CE2' ' A' ' 212' ' ' TYR . 25.2 tp -57.42 -48.6 78.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.034 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.32 99.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.708 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.541 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 4.9 tt -59.51 -62.48 1.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.039 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.18 -35.21 74.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.383 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.665 ' HG3' ' HD2' ' A' ' 281' ' ' ARG . 14.3 mm100 -83.19 -49.5 9.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.747 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 20.6 mmt -73.7 -31.44 63.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -75.01 -16.92 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.403 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.2 m -91.83 -12.25 34.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 173' ' ' MET . 33.6 m -110.59 140.17 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.345 0.593 . . . . 0.0 111.618 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 27.4 ttt -90.72 105.12 17.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.713 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.83 91.57 0.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.46 . . . . 0.0 110.162 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 63.64 -130.21 39.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.829 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.55 5.24 80.19 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.013 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.73 102.64 6.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.311 0.576 . . . . 0.0 110.498 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.77 128.98 38.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.905 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.61 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 21.0 pt -89.39 144.71 8.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.886 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -102.39 110.84 22.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.432 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.571 HG21 HG12 ' A' ' 116' ' ' VAL . 47.1 t -125.12 136.23 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.454 -174.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.541 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 92.57 46.42 3.48 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.971 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.627 ' HA ' HD12 ' A' ' 191' ' ' ILE . 41.5 ttt85 -139.44 78.69 26.65 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.227 0.514 . . . . 0.0 111.118 175.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 -62.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.587 2.191 . . . . 0.0 111.723 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.4 p -171.63 -52.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.544 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 12.6 m120 -81.51 68.66 7.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.005 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 187' ' ' ARG . 50.0 mm -74.68 108.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.858 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.89 -8.06 57.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.643 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 190' ' ' ASN . 53.5 mt-30 -77.14 -12.63 59.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 111.259 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.59 16.84 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.622 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.568 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.0 tp60 -58.45 -52.24 76.06 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.441 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 51.5 Cg_exo -55.85 -30.05 75.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.768 1.645 . . . . 0.0 112.062 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.421 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 47.8 mm -72.61 -56.11 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.769 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.493 ' HA ' HD11 ' A' ' 201' ' ' LEU . 35.2 pt -66.7 -30.74 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.33 -42.05 96.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.397 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -69.72 -35.81 75.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.709 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.518 HD22 ' HD2' ' A' ' 104' ' ' ARG . 95.6 mt -62.03 -50.66 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.21 -29.65 70.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.72 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 206' ' ' ARG . 39.2 tt0 -62.42 -52.42 63.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.055 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.94 -29.24 68.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.5 . . . . 0.0 110.502 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.71 68.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.596 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.493 ' CZ ' ' HA ' ' A' ' 203' ' ' GLU . 51.1 mtt180 -64.26 -25.54 68.1 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.43 -18.87 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.587 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.18 -29.3 11.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 0.0 110.914 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 58.66 23.98 11.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.688 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 12.3 ptp180 -89.48 150.56 22.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.995 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.98 168.04 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.337 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.461 ' CE2' HD21 ' A' ' 168' ' ' LEU . 71.7 t80 -112.33 121.66 45.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.382 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.52 123.18 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.286 0.565 . . . . 0.0 110.351 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.37 178.31 5.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.721 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.6 m 68.75 25.94 6.22 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 124.022 0.826 . . . . 0.0 111.481 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.59 HG23 HD12 ' A' ' 240' ' ' LEU . 10.8 m -77.2 164.38 3.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.47 ' HB2' HD21 ' A' ' 275' ' ' LEU . 6.9 t-80 -81.09 147.17 30.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -57.31 -55.86 29.29 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.702 ' HB2' HG13 ' B' ' 45' ' ' ILE . 0.2 OUTLIER -70.08 -48.36 58.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.689 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.993 HD13 HG13 ' B' ' 41' ' ' ILE . 0.4 OUTLIER -61.13 114.99 3.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.024 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.2 t -100.43 -177.06 3.39 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -166.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.465 ' HB3' ' HG ' ' A' ' 240' ' ' LEU . 4.3 p30 -60.31 -37.73 81.5 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.64 -31.31 69.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.623 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 13.4 m-20 -78.2 -53.87 6.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.42 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.608 HG13 HD11 ' A' ' 240' ' ' LEU . 32.4 mm -54.89 -25.59 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.041 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -55.79 -33.34 64.31 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.519 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.487 ' HG ' HG23 ' B' ' 41' ' ' ILE . 69.2 m -49.46 -56.0 11.26 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.693 0.758 . . . . 0.0 111.716 -174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' B' ' 34' ' ' ALA . 4.4 m -74.61 -49.68 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.734 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.608 ' CE1' ' HE1' ' A' ' 270' ' ' MET . 58.3 m-85 -60.89 -41.68 96.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.917 0.389 . . . . 0.0 111.626 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.504 ' HB2' HD13 ' A' ' 235' ' ' ILE . 1.1 tm-20 -76.26 -22.4 55.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.34 -23.49 61.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.901 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.81 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 1.0 OUTLIER -93.92 -33.42 13.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.226 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -163.67 -179.78 38.22 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.3 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -74.66 122.65 23.54 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.653 HG21 ' HB2' ' A' ' 238' ' ' CYS . 55.2 mt -97.57 132.82 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 172.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.693 ' HD2' ' HA ' ' A' ' 258' ' ' GLU . 29.3 mtpp -100.8 -46.01 5.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.198 0.523 . . . . 0.0 110.362 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.5 m -136.28 93.88 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.653 ' HB2' HG21 ' A' ' 235' ' ' ILE . 48.3 t -96.76 113.17 24.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.0 m -151.12 116.85 5.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.619 0.247 . . . . 0.0 110.99 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.756 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 78.7 mt -85.34 130.02 34.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.81 134.69 54.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.806 0.336 . . . . 0.0 110.35 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.805 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 12.3 ptm180 -117.7 157.42 26.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.035 0.445 . . . . 0.0 110.889 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.437 ' OD1' HG21 ' A' ' 245' ' ' THR . 9.6 t70 -88.01 122.71 69.86 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.089 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.96 -19.0 40.54 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.112 2.542 . . . . 0.0 114.546 -172.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.437 HG21 ' OD1' ' A' ' 243' ' ' ASP . 6.4 t -99.17 -30.12 12.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.513 -174.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 36.3 p -94.23 -26.35 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.986 0.422 . . . . 0.0 110.622 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.85 -18.49 53.07 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.278 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.81 150.29 22.31 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.805 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.8 p80 -75.61 152.41 37.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.313 0.578 . . . . 0.0 111.215 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.66 158.71 22.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.188 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.44 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -72.22 43.16 0.83 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 43.3 p90 -165.63 166.07 18.32 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.756 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.63 -174.4 40.57 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.552 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.565 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 94.3 m-85 -122.58 124.88 44.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.986 0.422 . . . . 0.0 110.267 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.2 mt -120.29 126.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.669 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 36.0 tt0 -103.67 136.61 43.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.459 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -109.23 151.54 26.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.757 0.789 . . . . 0.0 112.191 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.693 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 3.1 tp10 -80.24 -21.79 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.628 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 50.2 mtpt -143.17 140.14 30.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.807 -171.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.4 -33.64 76.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.86 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -63.61 -41.02 98.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.411 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.513 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 21.7 m -67.8 -39.85 83.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.479 ' O ' HG21 ' A' ' 267' ' ' VAL . 7.8 p -69.61 -32.8 71.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -66.46 -44.07 83.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.423 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.455 ' CG ' HG23 ' B' ' 27' ' ' VAL . 1.7 m-20 -65.39 -39.51 92.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.56 76.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.259 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 263' ' ' SER . 90.8 t -62.5 -29.03 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 111.58 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 p -89.89 -10.12 46.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 27.8 t -115.84 -40.24 3.37 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.81 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 30.5 mmm -70.84 -14.67 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.91 0.862 . . . . 0.0 110.36 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.213 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.655 ' HE1' ' HB2' ' B' ' 38' ' ' ALA . 51.6 t80 -56.94 98.82 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.521 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.77 119.86 24.88 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.926 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.852 HD23 HD21 ' A' ' 220' ' ' LEU . 19.7 tp -126.09 86.88 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.45 22.68 39.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.551 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.4 15.29 30.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.614 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -140.67 132.37 27.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.653 0.263 . . . . 0.0 110.395 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.33 133.61 42.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 216' ' ' VAL . 1.0 OUTLIER -71.95 -169.78 0.51 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 0.0 110.972 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.665 ' HD2' ' HG3' ' A' ' 172' ' ' GLN . 21.1 tpp180 -147.79 116.39 6.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.47 139.0 52.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -160.42 -178.81 34.73 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.615 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -72.16 152.2 42.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.43 -20.06 66.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.4 t 71.07 -77.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 122.547 0.339 . . . . 0.0 111.764 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.7 121.9 39.76 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.014 0.435 . . . . 0.0 111.956 -174.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -90.29 110.04 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.924 2.416 . . . . 0.0 112.41 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.18 110.99 2.97 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.481 2.121 . . . . 0.0 111.877 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.449 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 83.7 mtp -88.6 119.74 70.12 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.798 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 3.6 Cg_exo -80.65 88.79 1.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.059 2.506 . . . . 0.0 111.285 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 49.4 tp -131.84 90.81 2.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.024 0.44 . . . . 0.0 110.928 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 52.2 tp -108.22 90.75 3.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.703 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 2.6 p -117.52 102.55 51.84 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.571 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.56 58.92 6.04 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.257 2.638 . . . . 0.0 111.865 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -90.06 75.41 7.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.328 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 29.1 m . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.13 177.166 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.184 -0.367 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.43 71.07 8.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.198 0.523 . . . . 0.0 111.223 -175.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.406 ' O ' ' HD1' ' B' ' 26' ' ' TYR . 70.6 mtm -128.97 146.48 50.96 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.32 126.83 7.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.871 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.406 ' HD1' ' O ' ' B' ' 24' ' ' MET . 41.1 p90 -150.12 23.24 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -176.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.455 HG23 ' CG ' ' A' ' 265' ' ' ASP . 23.8 t -59.85 121.42 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.121 0.486 . . . . 0.0 110.727 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -137.8 -52.41 0.63 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.372 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.27 -33.02 26.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.116 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.405 ' HB1' HG12 ' B' ' 27' ' ' VAL . . . -66.35 -31.25 71.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.151 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.566 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.9 t80 -74.29 -19.61 60.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.336 0.589 . . . . 0.0 110.49 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 53.3 mttp -76.37 -43.76 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -39.71 77.99 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.403 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.711 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.24 -52.57 43.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.904 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.44 -21.95 38.5 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 41.3 mt-30 -63.15 -38.16 90.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.519 ' O ' HG21 ' B' ' 41' ' ' ILE . 76.5 mtp180 -73.71 -35.38 65.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.226 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.792 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -61.47 -45.89 92.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' B' ' 39' ' ' ARG 0.253 16.5 mtp180 -81.38 -25.96 35.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.474 -1.391 . . . . 0.0 113.095 174.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -53.49 -49.72 66.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.155 168.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.993 HG13 HD13 ' A' ' 220' ' ' LEU . 3.9 pt -61.45 -37.91 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.076 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -71.85 -22.37 61.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.095 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.69 -45.57 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.08 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 20.6 pttp -74.96 -23.76 58.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.702 HG13 ' HB2' ' A' ' 219' ' ' ASP . 8.3 tp -147.19 102.79 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 122.083 0.944 . . . . 0.0 110.052 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' OD1' ' A' ' 219' ' ' ASP . . . -161.01 -144.86 4.11 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.03 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.01 35.11 4.99 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.453 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -163.37 160.45 23.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.65 -6.34 58.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.373 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.99 41.2 4.12 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.378 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.71 52.79 1.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.344 0.593 . . . . 0.0 111.289 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.83 176.416 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.41 114.07 16.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.763 0.316 . . . . 0.0 110.506 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.485 ' HB3' HD21 ' A' ' 108' ' ' LEU . 10.0 tpt 58.73 43.49 18.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.226 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.47 -17.98 61.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.187 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -82.98 -4.48 58.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.021 0.438 . . . . 0.0 110.864 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -96.39 -55.8 2.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -147.73 116.23 6.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.011 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -58.83 -33.54 70.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.75 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.6 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.313 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 101' ' ' MET . 61.6 tp -73.77 -30.78 62.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.284 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.76 -29.49 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.094 0.473 . . . . 0.0 110.716 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.73 -38.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.483 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.77 -26.8 68.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.349 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 160' ' ' TYR . 15.5 p -92.3 -1.16 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.58 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -118.27 118.95 33.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.2 m -112.62 125.54 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 111.207 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 27.4 t80 -73.74 137.15 43.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.125 175.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.12 110.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 123.415 0.447 . . . . 0.0 109.822 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.2 170.54 13.96 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.111 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.627 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 6.4 t 62.68 48.67 4.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.423 0.63 . . . . 0.0 110.376 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -81.85 71.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.454 ' HB3' ' H ' ' A' ' 121' ' ' TYR . 22.3 t80 36.31 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.554 1.159 . . . . 0.0 112.512 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.454 ' H ' ' HB3' ' A' ' 120' ' ' TYR . 38.3 t80 -178.71 -62.03 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -91.63 45.21 1.21 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.072 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.0 125.84 49.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.983 0.42 . . . . 0.0 110.622 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.49 159.08 23.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.26 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.53 -36.74 74.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 111.268 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.69 -32.52 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.413 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 m -76.53 -41.26 47.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.901 0.381 . . . . 0.0 111.154 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 63.7 mt -72.72 -41.05 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.251 0.548 . . . . 0.0 110.104 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -54.4 -41.21 69.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.151 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -76.92 -22.98 52.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.28 74.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 110.594 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.407 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 71.4 m-85 -96.54 4.65 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.586 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -63.01 -44.07 83.89 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.857 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.592 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.2 Cg_endo -69.1 -4.33 13.37 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.012 1.808 . . . . 0.0 113.37 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.613 ' HB3' ' HB2' ' A' ' 165' ' ' ALA . 2.7 m-85 -81.06 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.965 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.87 172.99 39.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.176 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.37 128.73 27.08 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.21 117.91 28.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.859 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.586 ' HD3' ' CG ' ' A' ' 161' ' ' GLU . 51.1 tptt -87.34 -53.75 4.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.227 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.8 m -145.79 151.16 37.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.154 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -135.5 107.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 6.4 m-20 -92.3 96.23 10.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.28 0.562 . . . . 0.0 110.172 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.589 ' HE3' ' HB3' ' A' ' 156' ' ' ALA . 41.2 tpp -123.94 94.01 4.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.287 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 t -83.63 84.1 7.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.379 0.609 . . . . 0.0 109.479 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 0.1 OUTLIER -134.05 160.77 36.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.098 -178.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.33 102.72 15.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 m -66.16 -23.5 66.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.295 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.23 -33.89 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 m -96.69 -13.06 23.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.0 110.563 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 45.5 ttm 58.32 34.35 23.97 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.316 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -126.03 143.58 51.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.287 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.742 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 22.8 p80 -103.93 112.39 25.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.142 0.496 . . . . 0.0 111.165 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -76.38 -15.3 59.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.135 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.89 -152.75 8.37 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.568 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.88 175.2 9.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.589 ' HB3' ' HE3' ' A' ' 143' ' ' MET . . . -99.14 137.32 37.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.066 0.46 . . . . 0.0 111.975 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 95.4 m-85 -117.73 106.45 13.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 169.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.7 p -100.46 122.71 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.813 0.816 . . . . 0.0 110.377 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.1 135.19 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.106 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 41.9 m-85 -115.23 164.98 13.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.586 ' CG ' ' HD3' ' A' ' 139' ' ' LYS . 33.6 mt-10 -95.66 10.02 38.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.338 0.59 . . . . 0.0 109.499 170.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.44 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.0 m -130.25 115.11 17.38 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.213 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 162' ' ' VAL . 20.4 Cg_endo -62.43 -21.73 73.13 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.745 2.296 . . . . 0.0 111.686 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 285' ' ' ALA . 15.9 mp0 -59.47 -63.59 1.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.601 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' A' ' 135' ' ' PHE . . . -57.49 -33.46 68.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.599 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.43 62.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.646 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.49 -33.95 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.494 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.416 HD21 ' HG3' ' A' ' 281' ' ' ARG . 8.9 tt -61.29 -48.32 81.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.03 -39.84 91.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.631 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.4 tt -58.83 -55.03 40.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -75.35 -48.14 24.4 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -91.85 -0.36 57.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -165.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.445 ' HG3' HD11 ' A' ' 183' ' ' ILE . 55.1 tpp -116.42 -32.75 5.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.086 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.517 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 6.7 t30 -68.75 -27.04 65.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.365 0.603 . . . . 0.0 110.351 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -90.83 17.18 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.889 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.12 142.79 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.219 0.533 . . . . 0.0 110.623 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.54 100.91 10.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.085 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.94 -55.65 32.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.554 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.84 69.09 0.31 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.382 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.86 -38.89 2.37 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.566 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.495 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 5.2 mpt_? -97.52 136.67 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.3 118.24 17.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 24.1 pt -84.7 157.03 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.121 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -104.18 110.92 23.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 46.3 t -120.4 128.79 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.765 0.317 . . . . 0.0 110.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.631 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 110.9 -105.47 1.9 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.027 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.433 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 14.3 mmt180 66.56 78.06 0.25 Allowed Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.137 0.575 . . . . 0.0 112.456 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.99 97.36 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.831 2.354 . . . . 0.0 110.654 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.3 t -75.48 -28.31 59.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -84.82 80.03 9.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.347 0.594 . . . . 0.0 110.988 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.33 62.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.56 0.695 . . . . 0.0 110.347 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.63 -80.78 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.459 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -82.12 -34.98 28.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.969 0.414 . . . . 0.0 110.535 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -72.85 -33.49 66.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.603 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.49 10.18 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.213 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.619 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 27.2 Cg_endo -62.04 -37.08 67.05 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.795 1.663 . . . . 0.0 112.231 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.44 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 50.5 mm -66.77 -41.45 87.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 194' ' ' ALA . 90.2 mt -59.75 -42.23 88.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.96 -39.82 90.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.551 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 80.8 mm-40 -62.07 -37.84 86.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 99.1 mt -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.529 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.27 85.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.842 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.79 -33.93 76.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.199 0.524 . . . . 0.0 110.563 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.424 ' O ' ' HD1' ' A' ' 208' ' ' PHE . 7.9 tp10 -66.01 -49.59 67.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.258 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.59 78.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -67.28 -23.35 65.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.635 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.87 -28.88 50.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.121 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.424 ' HD1' ' O ' ' A' ' 204' ' ' GLU . 24.6 m-85 -88.62 -19.57 26.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.37 0.605 . . . . 0.0 110.437 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 65.8 t30 61.1 37.12 17.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.001 168.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.511 ' HD2' ' HG2' ' A' ' 289' ' ' PRO . 98.9 mtt180 -100.58 136.65 40.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.969 0.414 . . . . 0.0 110.176 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.48 ' CG2' ' HB ' ' A' ' 255' ' ' ILE . 9.8 tt -100.45 144.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -108.28 109.51 20.88 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.457 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.3 p -105.64 120.0 55.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 0.0 110.777 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.63 178.16 4.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.447 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.6 m 67.85 14.29 9.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.508 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.64 ' HA ' HD21 ' A' ' 280' ' ' LEU . 10.6 p -71.21 137.49 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.305 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.516 ' HD2' ' O ' ' A' ' 275' ' ' LEU . 2.3 t-80 -67.25 134.81 52.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 -176.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -58.61 -8.8 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.987 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.0 -37.21 47.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.288 0.566 . . . . 0.0 110.319 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.895 HD11 HD12 ' A' ' 275' ' ' LEU . 0.5 OUTLIER -113.32 128.12 56.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.665 -172.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.4 m -100.61 -175.32 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.791 0.437 . . . . 0.0 111.125 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.801 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 6.6 p-10 -53.6 -40.76 65.96 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.86 -35.66 66.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.45 0.643 . . . . 0.0 110.408 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.729 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.8 m-20 -78.89 -58.01 3.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.163 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.508 HG13 HG23 ' A' ' 216' ' ' VAL . 20.6 mm -63.46 -15.52 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.253 0.549 . . . . 0.0 111.067 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.743 ' HG3' HD13 ' A' ' 235' ' ' ILE . 83.1 tttt -54.42 -32.15 56.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.573 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.717 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.7 m -48.78 -61.37 2.08 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.704 0.764 . . . . 0.0 111.477 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.958 ' HB ' ' HE2' ' A' ' 270' ' ' MET . 3.0 m -73.66 -38.92 52.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.506 -172.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 19.0 m-85 -62.89 -50.79 69.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.694 0.283 . . . . 0.0 111.661 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.522 ' HG3' ' HA ' ' A' ' 234' ' ' LYS . 27.6 tt0 -77.83 -17.99 56.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.47 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.198 -0.314 . . . . 0.0 111.008 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.729 ' HE1' ' HB3' ' B' ' 34' ' ' ALA . 2.4 m-30 -82.88 -42.21 18.02 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.85 -107.19 0.79 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.219 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.522 ' HA ' ' HG3' ' A' ' 230' ' ' GLU . 33.6 ttmt -157.51 159.62 37.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.743 HD13 ' HG3' ' A' ' 226' ' ' LYS . 60.3 mt -122.98 128.62 75.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 111.218 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -92.33 -31.03 15.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.333 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 33.2 t -156.93 119.56 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.771 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.61 ' HB3' HG21 ' A' ' 235' ' ' ILE . 6.3 p -117.74 117.12 28.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 36.3 m -153.31 104.99 2.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 112.063 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.801 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 54.7 mt -86.42 119.24 26.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 166.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.95 106.19 0.67 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.731 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -92.59 153.48 18.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.66 96.31 27.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.4 -19.53 49.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -35.98 57.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.248 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.2 m -86.19 -33.0 20.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.45 35.17 5.3 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.329 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.42 156.83 16.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.731 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 12.0 p80 -84.46 138.33 32.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -67.02 152.57 45.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.69 24.61 1.5 Allowed Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.942 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.34 161.31 42.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.284 0.542 . . . . 0.0 110.583 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.674 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.29 -174.95 40.71 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.868 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -120.07 135.89 54.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.035 0.445 . . . . 0.0 111.178 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.48 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 28.8 mm -118.33 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 33.9 tt0 -104.69 126.27 51.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.52 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -101.47 146.83 27.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.47 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 1.3 pm0 -78.34 -16.96 57.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.573 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.47 ' HG3' ' HG2' ' A' ' 258' ' ' GLU . 31.3 mtmm -137.09 148.48 46.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.67 64.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.78 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.36 -43.24 88.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.698 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.2 m -68.56 -31.99 71.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 33.2 t -65.77 -52.21 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.382 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.48 -36.29 83.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.379 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.3 -31.32 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.579 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.94 63.7 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.95 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 42.8 t -54.4 -42.97 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 50.6 m -70.94 -25.89 62.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.4 p -109.65 -37.7 5.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.958 ' HE2' ' HB ' ' A' ' 228' ' ' VAL . 0.4 OUTLIER -65.77 -27.65 68.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.495 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.6 t30 -57.53 -34.38 69.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.743 0.783 . . . . 0.0 110.275 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.466 ' O ' ' HD2' ' A' ' 279' ' ' TYR . 18.5 mt -76.43 -6.55 52.18 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.86 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.827 ' HB2' ' HE1' ' A' ' 270' ' ' MET . 3.2 t80 -54.43 102.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.6 t70 -89.07 122.99 32.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.725 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.895 HD12 HD11 ' A' ' 220' ' ' LEU . 88.8 mt -120.55 87.97 2.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.233 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.59 36.75 47.93 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.03 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.84 7.83 46.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.476 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.0 pt20 -136.8 132.76 35.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.99 0.424 . . . . 0.0 110.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.466 ' HD2' ' O ' ' A' ' 272' ' ' LEU . 79.6 m-85 -90.26 135.26 33.78 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.64 HD21 ' HA ' ' A' ' 216' ' ' VAL . 15.7 mt -69.1 -169.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.697 0.761 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -149.87 112.36 4.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.95 -176.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 271' ' ' ASN . 30.7 m -111.41 147.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.256 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.75 -159.72 9.21 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.898 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -92.91 159.41 15.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.595 0.236 . . . . 0.0 110.71 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -67.83 -21.67 65.19 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.612 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.446 HG13 HG21 ' A' ' 287' ' ' THR . 92.5 t 72.35 -62.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.472 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.697 ' HB ' ' HD2' ' A' ' 288' ' ' PRO . 63.7 p -114.4 170.27 5.63 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.697 ' HD2' ' HB ' ' A' ' 287' ' ' THR . 30.3 Cg_endo -64.83 108.11 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.329 2.019 . . . . 0.0 111.486 173.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.511 ' HG2' ' HD2' ' A' ' 210' ' ' ARG . 24.3 Cg_exo -64.57 -31.01 60.83 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.033 2.488 . . . . 0.0 112.669 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 27.7 ttt -154.54 80.32 4.66 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.274 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -79.72 -9.57 14.53 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.38 2.054 . . . . 0.0 111.907 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 41.2 tp -84.53 62.04 7.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.429 0.633 . . . . 0.0 110.445 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.79 92.22 4.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.185 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 295' ' ' PRO . 2.5 p -60.77 -39.73 68.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.464 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.531 ' HD3' ' OG1' ' A' ' 294' ' ' THR . 17.1 Cg_exo -69.67 74.5 1.24 Allowed 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.709 1.606 . . . . 0.0 110.961 170.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.97 143.46 56.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.238 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 C--O 1.251 1.155 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.86 178.253 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -159.44 102.09 1.55 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 24.5 mmt 63.82 86.66 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.785 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.82 57.18 3.89 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.318 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -101.9 153.49 19.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.927 0.394 . . . . 0.0 110.444 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' B' ' 31' ' ' PHE . 11.5 t -72.48 80.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.947 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -106.32 -7.73 17.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.366 0.603 . . . . 0.0 109.39 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.68 -62.52 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.415 ' HB2' HG13 ' B' ' 27' ' ' VAL . . . -65.89 -22.8 66.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.427 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.6 ' HB2' HG11 ' B' ' 27' ' ' VAL . 5.1 t80 -70.38 -18.0 63.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.241 0.543 . . . . 0.0 110.125 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 50.0 mtmt -69.9 -46.4 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 53.0 t0 -57.44 -44.68 84.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.984 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.805 ' HB1' HG11 ' A' ' 228' ' ' VAL . . . -47.53 -54.11 12.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.125 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.664 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.24 -20.13 38.28 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -168.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 30.1 mt-30 -61.2 -43.6 98.63 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.717 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 45.9 mtt180 -73.67 -28.61 61.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.697 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.749 ' HB2' ' HE1' ' A' ' 273' ' ' PHE . . . -62.56 -48.56 78.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -80.11 -27.16 39.23 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.075 -1.016 . . . . 0.0 111.941 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.56 -45.83 73.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.932 0.396 . . . . 0.0 110.491 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.729 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 14.1 pt -68.75 -35.29 69.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.766 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.411 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -68.74 -20.04 64.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.134 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.56 -46.72 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.477 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.544 ' O ' HG12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -92.6 -14.52 28.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.509 -176.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.544 HG12 ' O ' ' B' ' 44' ' ' LYS . 12.1 pt 52.92 -179.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.282 1.433 . . . . 0.0 113.639 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.09 146.25 13.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.215 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.88 -166.37 11.31 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.943 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -87.04 131.22 34.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.825 0.345 . . . . 0.0 110.587 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.81 31.34 2.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.134 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.4 43.05 2.25 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.229 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 m -68.59 -50.37 52.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.606 0.241 . . . . 0.0 110.441 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.249 1.073 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.839 178.803 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 70.73 -61.98 0.46 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.599 0.759 . . . . 0.0 112.778 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.8 ptp -102.83 35.61 2.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.06 0.457 . . . . 0.0 111.789 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.1 122.12 22.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.222 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.413 ' O ' ' HB3' ' A' ' 104' ' ' ARG . 45.5 tt0 -155.75 78.12 0.98 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.948 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' A' ' 106' ' ' ARG . 54.5 ttt180 68.45 147.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.792 0.682 . . . . 0.0 110.538 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.562 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 11.5 tp60 -76.91 46.67 0.48 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.465 0.65 . . . . 0.0 109.832 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 104' ' ' ARG . 72.9 ttt180 -61.31 -37.27 82.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.734 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.03 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.142 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HB3' ' HG3' ' A' ' 105' ' ' GLN . 44.2 tp -71.23 -34.47 70.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.825 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.13 -50.29 74.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.218 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.9 pt -72.22 -34.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.0 mmm -59.66 -26.62 65.69 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -84.56 -15.61 45.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.612 0.244 . . . . 0.0 111.533 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 23.6 ttm-85 -109.8 108.61 19.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 110.716 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 169' ' ' ALA . 29.5 m -91.96 134.12 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.73 0.776 . . . . 0.0 111.146 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 21.6 t80 -90.62 122.08 33.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.17 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.547 HG13 HD13 ' A' ' 119' ' ' ILE . 14.3 t -108.81 109.89 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.89 164.34 12.55 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.984 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 m 72.71 -57.22 0.64 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.483 0.713 . . . . 0.0 110.901 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 123' ' ' LEU . 17.9 mm 66.59 -79.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 123.235 0.614 . . . . 0.0 111.099 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.646 ' HA ' ' HG2' ' A' ' 181' ' ' ARG . 89.6 t80 174.48 -72.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.801 0.84 . . . . 0.0 108.743 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 3.6 t80 170.29 -59.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.648 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.09 -24.13 30.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.631 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 127' ' ' THR . 39.1 mt -67.52 128.74 37.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.363 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -123.74 -153.57 8.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.921 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -60.24 -54.78 41.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 111.461 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.26 -35.24 78.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.537 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.827 HG21 HD21 ' A' ' 123' ' ' LEU . 1.9 m -66.22 -41.2 90.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.791 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.63 -38.9 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.15 -47.14 72.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.438 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -71.06 -27.47 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.702 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.34 -42.41 18.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.888 0.375 . . . . 0.0 111.435 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.417 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 84.6 m-85 -96.57 12.17 32.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -175.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.516 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.25 -46.29 50.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.785 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.923 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.1 Cg_endo -68.43 -4.62 13.28 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.744 1.63 . . . . 0.0 112.702 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -98.08 64.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.059 0.457 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.6 175.29 40.6 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.808 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.93 102.62 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.722 2.281 . . . . 0.0 111.555 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.681 HG12 ' HE1' ' A' ' 160' ' ' TYR . 55.5 mt -56.17 119.8 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.206 0.527 . . . . 0.0 110.375 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -89.79 -45.8 9.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.181 -173.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 t -159.55 141.08 12.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 62.0 mt -121.58 115.91 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.429 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.75 106.75 17.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.376 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 78.9 mtp -106.95 152.88 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.1 p -99.74 97.55 8.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -78.28 113.77 16.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -80.44 112.49 17.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.203 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 93.8 p 53.8 -159.73 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.998 0.919 . . . . 0.0 112.296 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.35 -22.49 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.176 0.512 . . . . 0.0 111.089 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -62.84 -14.2 42.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.1 mtm 64.99 22.88 12.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.22 0.533 . . . . 0.0 110.891 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -73.15 91.74 1.66 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.553 ' CE1' HG13 ' A' ' 119' ' ' ILE . 11.5 t-160 -76.36 67.49 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -96.57 112.56 24.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.86 -115.85 0.71 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.388 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -152.28 175.47 12.61 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.88 138.5 18.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.883 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 98.5 m-85 -106.68 123.75 48.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.558 0.218 . . . . 0.0 110.474 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.06 104.69 17.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.065 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.3 tt0 -95.35 130.14 42.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.681 ' HE1' HG12 ' A' ' 138' ' ' ILE . 31.0 m-85 -104.01 166.4 10.43 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -100.29 5.79 44.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.847 0.832 . . . . 0.0 109.145 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.74 119.64 12.9 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.034 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.51 ' HG3' HD11 ' A' ' 108' ' ' LEU . 24.8 Cg_endo -64.19 -21.86 67.32 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.095 2.53 . . . . 0.0 112.792 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.439 ' OE2' ' HG2' ' A' ' 163' ' ' PRO . 16.7 mp0 -61.9 -52.53 63.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.63 75.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.137 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -38.55 90.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.167 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -65.2 -40.57 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.128 0.489 . . . . 0.0 110.488 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.428 HD13 ' HA3' ' A' ' 283' ' ' GLY . 8.9 mp -66.32 -37.17 84.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.503 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.56 -28.92 69.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.294 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.98 -62.17 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.04 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -71.09 -43.42 67.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -87.31 -21.87 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.565 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 54.2 tpp -98.22 -33.19 11.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.808 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -80.3 -8.95 59.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 110.839 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 p -90.31 0.66 57.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.32 168.37 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.696 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 86.3 mtp -129.46 103.02 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.131 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.58 118.69 14.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.79 -73.1 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.514 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.3 38.94 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.646 ' HG2' ' HA ' ' A' ' 120' ' ' TYR . 23.8 tpt180 -140.61 138.6 34.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -80.85 102.74 10.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.66 133.06 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.128 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -100.5 110.95 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.938 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 45.9 t -112.27 129.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.276 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 176.75 -144.47 6.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.098 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -162.98 79.02 1.74 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.05 49.07 2.69 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.957 2.438 . . . . 0.0 113.165 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.5 m -90.29 -57.1 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.034 0.445 . . . . 0.0 110.066 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -137.25 -64.18 0.57 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.1 mt 70.81 138.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.251 0.548 . . . . 0.0 111.676 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.15 -49.97 4.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.385 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -55.48 -56.01 25.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.852 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -105.07 14.0 29.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.053 0.454 . . . . 0.0 110.942 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.571 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 0.3 OUTLIER -64.6 -55.18 31.14 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.427 -177.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 76.7 Cg_exo -52.72 -27.53 34.2 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 122.707 2.271 . . . . 0.0 113.738 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 48.2 mm -62.2 -34.89 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.443 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 51.5 mm -70.93 -39.1 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.654 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.25 -37.64 83.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.472 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 29.8 mm-40 -65.09 -36.77 85.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.176 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 89.5 mt -71.21 -37.35 72.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.706 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.73 -42.02 97.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -67.66 -34.64 77.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.907 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.37 -46.9 84.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.105 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 285' ' ' ALA . . . -62.53 -23.51 67.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.044 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -63.29 -27.57 69.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.774 0.321 . . . . 0.0 110.62 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.94 -13.23 61.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.406 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -93.26 -15.19 26.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.785 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 60.77 17.25 7.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.38 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.73 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 16.1 ptm180 -111.12 144.75 39.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 283' ' ' GLY . 35.5 pt -119.3 169.64 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.302 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.424 ' HE1' ' HD2' ' A' ' 252' ' ' TYR . 84.1 t80 -116.82 115.25 25.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.182 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.71 122.59 66.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.256 0.551 . . . . 0.0 110.694 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 134' ' ' PRO . . . -122.25 -174.69 2.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.352 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.923 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 14.2 t 61.42 30.5 18.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 0.0 110.354 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.544 HG12 HD12 ' A' ' 280' ' ' LEU . 5.4 m -81.6 151.25 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.464 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.595 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 11.5 t-80 -73.9 137.56 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -166.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.514 ' HB2' HG21 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -78.5 -46.46 19.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.898 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.774 HD22 HD12 ' A' ' 225' ' ' ILE . 0.1 OUTLIER -58.56 100.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.606 178.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.7 m -101.05 -174.77 2.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.53 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.607 ' N ' HD12 ' A' ' 240' ' ' LEU . 3.7 p-10 -48.63 -43.28 36.29 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.77 -30.81 71.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.16 0.505 . . . . 0.0 110.819 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.717 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 11.4 m-20 -78.82 -59.65 2.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.774 HD12 HD22 ' A' ' 220' ' ' LEU . 23.5 mm -56.05 -24.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.216 0.532 . . . . 0.0 111.232 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.426 ' HG3' HD11 ' A' ' 235' ' ' ILE . 59.4 tttm -53.73 -32.46 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.018 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.901 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.8 m -51.89 -62.4 1.65 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.878 0.847 . . . . 0.0 112.204 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.578 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 1.9 m -63.03 -53.46 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.306 -173.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.529 ' HD2' ' OH ' ' A' ' 257' ' ' TYR . 84.2 m-85 -59.0 -34.08 71.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.42 -34.36 47.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -60.53 -26.14 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 111.041 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.64 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 3.9 p90 -129.96 40.22 3.58 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.605 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -177.34 153.8 14.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.115 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -94.31 110.47 22.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 0.0 110.167 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.426 HD11 ' HG3' ' A' ' 226' ' ' LYS . 52.5 mt -83.43 130.28 36.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.41 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -89.53 -37.03 15.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.64 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.1 t -168.47 134.04 1.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.37 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.1 t -114.48 113.42 24.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.4 m -136.81 103.77 5.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.996 0.427 . . . . 0.0 111.42 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.744 HD13 HG13 ' A' ' 225' ' ' ILE . 29.7 mt -83.69 129.8 34.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.04 138.91 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.707 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.638 ' HG2' ' HA ' ' A' ' 249' ' ' HIS . 69.2 mtp180 -137.58 149.57 46.78 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.76 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 245' ' ' THR . 3.7 p-10 -80.85 129.34 68.26 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.996 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.13 -16.35 40.13 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.76 2.307 . . . . 0.0 112.027 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 243' ' ' ASP . 12.1 t -74.9 -33.68 62.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.823 -175.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.9 m -134.34 -41.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.007 0.432 . . . . 0.0 111.235 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.12 21.88 5.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.502 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -79.69 153.36 29.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.638 ' HA ' ' HG2' ' A' ' 242' ' ' ARG . 1.9 t-80 -85.72 125.35 33.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.235 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.26 155.41 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.161 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.452 ' C ' HG21 ' A' ' 216' ' ' VAL . . . -73.53 31.77 0.85 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.403 0.521 . . . . 0.0 114.403 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 34.9 p90 -160.13 163.78 33.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.915 0.358 . . . . 0.0 110.073 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -178.15 -169.75 39.42 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.309 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -126.94 140.01 52.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.03 129.86 71.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.73 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 38.5 mt-10 -103.61 146.75 28.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.122 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.529 ' OH ' ' HD2' ' A' ' 229' ' ' PHE . 85.2 m-85 -117.29 158.2 24.78 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.306 0.574 . . . . 0.0 110.698 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -82.52 -17.26 45.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.704 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -134.73 140.61 46.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.958 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.05 -19.53 63.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.22 0.533 . . . . 0.0 109.919 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.54 -45.74 78.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.92 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -68.15 -27.15 66.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.404 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 m -61.79 -48.55 80.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.605 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.44 ' O ' HG11 ' A' ' 267' ' ' VAL . 57.5 tp60 -73.8 -34.34 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.866 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.67 -46.52 82.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.38 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.378 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 282' ' ' VAL . 4.0 p -60.76 -26.46 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.872 0.367 . . . . 0.0 111.666 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 28.9 m -81.06 -18.38 46.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 9.6 p -116.02 -27.6 6.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.598 ' SD ' ' HZ ' ' A' ' 232' ' ' PHE . 34.5 mmm -69.46 -14.52 62.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -170.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 17.4 p-10 -73.74 -15.3 61.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.008 0.432 . . . . 0.0 111.402 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.53 -9.48 59.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.851 ' HE1' ' HB3' ' B' ' 38' ' ' ALA . 4.8 t80 -62.11 87.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.006 0.432 . . . . 0.0 111.406 -170.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.49 124.93 28.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.625 ' CD1' HD23 ' A' ' 220' ' ' LEU . 53.4 mt -123.45 107.71 11.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.86 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.7 -78.71 1.74 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.351 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -155.91 23.03 0.54 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.14 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -140.64 138.85 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.743 -0.269 . . . . 0.0 110.418 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 77.0 m-85 -75.05 123.86 25.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.544 HD12 HG12 ' A' ' 216' ' ' VAL . 5.9 tt -67.84 138.78 56.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -121.08 123.04 41.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.796 0.332 . . . . 0.0 110.773 -167.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.588 HG12 ' HB2' ' A' ' 270' ' ' MET . 14.9 p -117.25 147.7 20.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.094 0.473 . . . . 0.0 111.455 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 211' ' ' ILE . . . -144.71 -170.71 14.06 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -82.04 179.51 7.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.987 0.393 . . . . 0.0 110.549 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.538 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -67.64 -27.18 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 0.0 110.519 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.4 t 73.53 -65.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.299 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 34.4 p -108.57 158.19 34.62 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.46 105.22 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.208 1.939 . . . . 0.0 111.378 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.666 ' HG2' ' HD3' ' A' ' 210' ' ' ARG . 3.3 Cg_exo -75.37 65.44 6.38 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.384 2.722 . . . . 0.0 113.088 -172.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -141.87 70.69 24.38 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.026 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.65 123.92 9.83 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.777 2.318 . . . . 0.0 112.209 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.12 68.57 4.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.203 0.525 . . . . 0.0 110.242 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 30.3 tp -81.11 67.78 7.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.184 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.5 m 61.79 77.63 0.34 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.844 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.95 31.26 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.196 2.598 . . . . 0.0 112.153 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -147.63 102.43 3.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.265 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.746 -0.645 . . . . 0.0 109.865 179.795 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.8 121.27 31.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 92.8 mmm -98.85 -55.53 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.118 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.38 84.5 1.17 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.328 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 69.39 103.59 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.164 0.586 . . . . 0.0 111.231 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.88 72.81 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.958 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -82.46 63.9 6.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.374 0.607 . . . . 0.0 109.841 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -154.32 -65.65 0.14 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.508 ' CB ' ' HB3' ' A' ' 232' ' ' PHE . . . -77.17 -31.28 55.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 110.85 176.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.447 ' HD1' ' CE1' ' A' ' 232' ' ' PHE . 16.9 t80 -65.77 -16.32 63.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.227 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -71.65 -50.81 27.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.262 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 15.5 t70 -57.88 -42.68 85.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.64 ' CB ' ' HE1' ' A' ' 232' ' ' PHE . . . -49.01 -44.85 41.68 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.54 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.758 ' HA ' ' HB1' ' B' ' 38' ' ' ALA . 2.6 mm? -82.19 -21.03 36.67 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -64.4 -40.72 96.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.901 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 18.6 mmt180 -73.28 -32.59 64.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.363 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.851 ' HB3' ' HE1' ' A' ' 273' ' ' PHE . . . -62.31 -47.06 85.94 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.099 -175.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 27.5 mtt85 -80.97 -26.27 36.69 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.259 -1.526 . . . . 0.0 112.703 174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -54.38 -41.92 69.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.518 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.804 HG12 ' O ' ' B' ' 38' ' ' ALA . 2.7 pt -69.83 -34.02 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.733 0.301 . . . . 0.0 110.775 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.42 -22.64 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.959 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.08 -27.26 22.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.807 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.755 ' HE2' HG21 ' B' ' 41' ' ' ILE . 45.1 pttt -93.11 -52.71 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.56 ' N ' ' HG3' ' B' ' 44' ' ' LYS . 91.9 mt 65.47 90.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.138 -173.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.86 24.53 23.77 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.695 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.66 -59.68 6.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.038 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -163.52 -63.92 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.55 133.24 33.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.788 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.22 153.31 30.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.213 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.5 m -50.22 112.42 0.68 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 111.842 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.639 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.875 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.73 123.61 32.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.642 0.258 . . . . 0.0 110.345 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 49.3 tpp -82.16 77.37 8.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.542 0.687 . . . . 0.0 110.891 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -124.65 47.88 2.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.148 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.07 -47.02 69.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.082 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -160.85 132.76 5.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.153 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -99.41 127.32 45.44 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' O ' HG12 ' A' ' 110' ' ' ILE . 73.3 mtt180 -61.53 -30.7 70.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.402 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.47 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.3 -29.23 70.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.843 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.442 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.764 HD12 HG12 ' A' ' 191' ' ' ILE . 29.0 pt -82.57 -36.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.0 mtp -60.25 -26.19 66.25 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.5 m -82.44 -0.98 48.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ttm180 -122.2 118.25 28.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.56 166.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.045 0.45 . . . . 0.0 110.779 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -119.35 114.25 22.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.335 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -104.78 110.83 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 110.856 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.98 170.49 14.99 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 24.7 m 59.91 47.91 9.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.268 0.556 . . . . 0.0 110.428 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -76.49 123.04 32.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.817 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.539 ' HB3' HD11 ' A' ' 123' ' ' LEU . 54.9 t80 -62.91 140.98 58.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.314 0.578 . . . . 0.0 109.895 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -52.73 -31.71 39.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.27 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.38 6.7 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 120' ' ' TYR . 10.1 mp -100.65 120.46 40.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.68 -165.79 14.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.639 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.519 ' OE2' ' HD2' ' A' ' 129' ' ' ARG . 3.9 tm-20 -59.36 -51.76 68.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.458 0.303 . . . . 0.0 110.762 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.86 -29.64 69.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.437 HG22 ' HG ' ' A' ' 123' ' ' LEU . 5.2 m -64.63 -50.78 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.968 0.413 . . . . 0.0 110.197 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.3 mt -67.48 -40.2 84.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.288 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.519 ' HD2' ' OE2' ' A' ' 125' ' ' GLU . 23.1 ttt180 -51.58 -51.93 51.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.502 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.2 -24.12 51.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.927 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.86 -37.57 73.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.27 12.86 36.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.466 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -70.88 -41.6 11.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.166 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.769 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 33.7 Cg_exo -63.89 -4.69 7.77 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.222 1.948 . . . . 0.0 112.817 173.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.422 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 23.8 m-85 -93.01 -68.44 0.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.306 . . . . 0.0 110.216 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.87 168.68 33.44 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.618 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 13.3 Cg_exo -69.51 121.86 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.513 2.142 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.54 123.87 37.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.95 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -100.35 -36.85 9.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.459 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -145.76 136.93 24.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.942 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 70.0 mt -127.29 116.4 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -103.68 114.55 28.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.319 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 89.1 mtp -113.64 108.29 16.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.353 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.53 ' O ' ' HA3' ' A' ' 154' ' ' GLY . 12.1 p -94.46 61.09 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.456 0.646 . . . . 0.0 110.796 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -114.13 159.59 19.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.628 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.7 m-20 -73.73 88.0 1.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.476 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.2 m -65.98 -36.02 82.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.585 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.9 m -63.52 -23.84 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.247 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.758 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 1.6 m -120.64 2.04 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.382 0.61 . . . . 0.0 110.132 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.9 mtp 56.91 35.61 26.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.535 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.758 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 30.7 mmmt -97.27 126.57 42.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.054 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.452 ' HE1' ' O ' ' A' ' 123' ' ' LEU . 27.1 m-70 -84.3 48.16 1.45 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.477 0.656 . . . . 0.0 110.098 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.47 -34.22 74.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.708 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 144' ' ' SER . . . -95.73 -155.53 31.14 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.026 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -140.46 174.57 10.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.258 0.223 . . . . 0.0 110.554 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -124.33 138.42 54.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.805 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 97.1 m-85 -107.27 124.94 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.715 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.1 t -119.45 113.59 41.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 10.3 pt-20 -105.43 137.11 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -105.86 172.36 6.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.132 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.402 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 39.0 tt0 -74.53 -29.82 61.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.563 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.3 m -129.44 139.87 36.95 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.583 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.17 -20.54 43.46 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.187 2.592 . . . . 0.0 112.494 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.549 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 11.1 mp0 -55.56 -55.32 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.76 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -58.77 -32.24 69.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.514 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -51.61 36.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.35 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.38 -34.82 76.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.19 0.519 . . . . 0.0 110.091 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.584 HD11 ' HA3' ' A' ' 283' ' ' GLY . 25.8 tp -61.01 -44.71 97.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.239 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.22 87.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.532 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.34 -39.27 94.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -81.59 -47.35 13.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.029 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -87.83 -44.84 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -169.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.6 tpp -69.68 -26.74 64.52 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.097 0.475 . . . . 0.0 110.703 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -69.29 -24.2 63.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.204 0.526 . . . . 0.0 109.983 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 t -81.52 -27.86 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.83 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.88 110.49 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 111.017 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.574 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 21.3 mmt -61.83 124.13 19.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.913 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.52 105.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.967 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.33 -90.06 0.82 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.9 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.12 42.3 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.446 ' HG2' ' HB2' ' A' ' 120' ' ' TYR . 30.4 tpt180 -134.0 126.09 29.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.703 0.287 . . . . 0.0 110.33 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.574 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 8.6 t30 -72.11 85.08 1.02 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.584 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.422 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.4 pt -83.0 156.64 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.272 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -105.94 109.8 21.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.527 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.93 109.59 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.159 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 135.6 -115.53 1.37 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.708 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 57.15 68.9 1.84 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.265 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.502 ' HB3' ' HB ' ' A' ' 191' ' ' ILE . 5.6 Cg_exo -80.77 61.52 8.25 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.802 3.001 . . . . 0.0 112.353 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 m -50.76 -42.45 57.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.706 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -117.56 13.09 14.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.764 HG12 HD12 ' A' ' 110' ' ' ILE . 53.5 mt -98.46 -25.26 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.044 0.45 . . . . 0.0 110.61 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.82 85.45 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.811 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.42 -4.79 52.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 111.204 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.28 7.65 42.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.593 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 61.8 tp60 -53.6 -44.61 98.1 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.79 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.4 Cg_endo -51.79 -32.25 45.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.267 1.978 . . . . 0.0 112.723 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.15 -43.93 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 110.121 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.9 mt -59.76 -38.97 78.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.537 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 66.2 m-20 -54.76 -50.96 67.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.748 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.38 -32.24 73.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.541 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.4 mt -66.01 -49.75 66.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.047 0.451 . . . . 0.0 110.126 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.62 -40.83 98.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.88 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 31.3 mm-40 -64.14 -30.29 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.287 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.83 -45.68 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.54 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.43 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.453 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtp180 -63.03 -21.85 66.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.657 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.99 -29.14 39.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.877 0.37 . . . . 0.0 111.197 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.56 -19.24 14.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.66 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 56.98 37.97 29.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.235 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.27 140.5 31.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.314 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.535 HD11 ' HE2' ' A' ' 229' ' ' PHE . 19.9 tt -115.86 150.34 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.229 -172.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -109.48 135.38 50.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.265 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.491 HG22 ' CZ ' ' A' ' 229' ' ' PHE . 5.1 t -113.39 120.76 64.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.17 167.98 13.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.769 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 28.6 m 63.77 27.15 14.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.201 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.492 ' HA ' HD21 ' A' ' 280' ' ' LEU . 29.9 m -74.12 143.31 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.03 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.434 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 12.6 t-80 -69.65 134.39 48.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.84 -24.09 67.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.963 ' HB2' HG22 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.87 -46.87 16.04 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.937 -0.477 . . . . 0.0 110.92 173.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.691 HD22 HD11 ' A' ' 225' ' ' ILE . 0.2 OUTLIER -58.11 107.66 0.5 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.96 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.9 p -93.18 -177.95 4.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -53.35 -37.56 62.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.947 0.403 . . . . 0.0 111.1 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.89 -34.35 77.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.379 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.597 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 8.8 m-20 -77.47 -55.36 5.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.688 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.757 HG13 HD13 ' A' ' 240' ' ' LEU . 31.4 mm -55.42 -27.58 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.792 0.437 . . . . 0.0 111.764 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.695 ' HG3' HD12 ' A' ' 235' ' ' ILE . 83.4 tttt -54.25 -31.67 54.1 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.651 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 68.7 m -47.86 -61.22 2.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.638 0.732 . . . . 0.0 112.175 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' B' ' 34' ' ' ALA . 4.7 m -69.42 -51.01 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.167 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.559 ' HB2' HD13 ' A' ' 235' ' ' ILE . 40.2 m-85 -56.44 -43.58 79.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.505 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.73 -12.44 59.8 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.36 -35.79 58.51 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.67 -0.644 . . . . 0.0 110.602 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.562 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 0.2 OUTLIER -107.27 21.15 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.946 173.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.571 ' CA ' ' HB3' ' A' ' 262' ' ' SER . . . -170.64 -153.55 8.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.316 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.09 127.27 12.94 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.733 HG22 ' HB2' ' A' ' 238' ' ' CYS . 66.8 mt -101.87 126.57 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.119 -175.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -95.3 -22.91 17.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.706 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 14.2 t -150.38 108.6 3.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.889 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.733 ' HB2' HG22 ' A' ' 235' ' ' ILE . 41.9 t -115.72 111.79 21.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.8 p -143.08 104.57 4.31 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.757 HD13 HG13 ' A' ' 225' ' ' ILE . 40.2 mt -83.93 117.3 23.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -65.35 127.48 31.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 15.5 ptt180 -110.49 153.88 24.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.964 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.11 130.05 51.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.14 -17.1 40.55 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.725 2.283 . . . . 0.0 112.377 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 48.2 m -74.34 -58.86 3.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.268 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 2.3 m -93.4 -41.22 9.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.928 0.394 . . . . 0.0 111.25 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.92 15.65 19.52 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.837 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.437 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 61.4 pttt -109.08 148.81 30.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.4 p80 -78.39 135.62 37.48 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.213 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 252' ' ' TYR . 89.3 mttt -68.01 156.92 36.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.495 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.451 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.6 30.31 0.6 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 114.496 0.558 . . . . 0.0 114.496 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.618 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 39.5 p90 -153.21 173.71 15.19 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.589 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.23 176.24 46.62 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.409 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 94.0 m-85 -121.24 133.38 55.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.69 0.281 . . . . 0.0 110.415 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.641 HG22 HG23 ' A' ' 235' ' ' ILE . 55.0 mt -129.9 136.59 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.128 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -107.53 125.71 51.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.553 ' HE1' ' HA3' ' A' ' 233' ' ' GLY . 17.1 m-85 -98.73 142.79 29.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.212 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.733 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.4 pt-20 -89.01 -23.09 22.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.537 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.733 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 31.6 mmmt -116.95 129.41 56.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.611 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.68 63.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.347 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -56.29 -52.42 64.59 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.48 0.657 . . . . 0.0 110.026 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.571 ' HB3' ' CA ' ' A' ' 233' ' ' GLY . 4.0 m -68.99 -43.72 74.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.172 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 267' ' ' VAL . 10.8 t -61.41 -43.77 98.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.717 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.15 -41.96 97.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.331 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.51 -39.82 57.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.183 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.77 63.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.045 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 263' ' ' SER . 58.3 t -61.31 -26.64 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.186 0.517 . . . . 0.0 111.267 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.6 t -92.84 -36.64 12.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.167 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' SER . . . . . 0.462 ' HB3' HG23 ' B' ' 27' ' ' VAL . 3.3 p -87.83 -37.89 16.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.612 ' HE2' ' HD2' ' A' ' 273' ' ' PHE . 35.6 mmm -60.47 -29.08 68.83 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.493 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 31.8 t30 -58.57 -33.2 69.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.924 0.869 . . . . 0.0 110.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.501 HD11 ' N ' ' A' ' 272' ' ' LEU . 6.3 mp -78.89 -9.55 59.52 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.895 ' HE1' ' HB3' ' B' ' 38' ' ' ALA . 1.6 t80 -56.64 101.09 0.05 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.19 0.519 . . . . 0.0 110.895 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.61 112.4 18.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.189 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.631 HD21 ' CZ ' ' A' ' 273' ' ' PHE . 0.8 OUTLIER -113.3 86.2 2.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.389 171.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.71 34.95 29.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.551 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.89 0.72 74.36 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.802 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 10.9 pt20 -113.75 139.68 48.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 95.2 m-85 -89.94 126.21 35.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.369 0.604 . . . . 0.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.788 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.3 OUTLIER -55.38 165.04 0.84 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.217 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.679 ' H ' HD12 ' A' ' 280' ' ' LEU . 4.0 tpt180 -132.24 119.7 21.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.367 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 211' ' ' ILE . 5.6 p -104.82 148.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.513 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.584 ' HA3' HD11 ' A' ' 168' ' ' LEU . . . -150.25 -149.1 4.93 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -139.61 152.99 47.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.549 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -95.23 129.46 42.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.46 -31.81 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.706 -171.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 14.9 t -115.11 135.53 22.52 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.228 0.537 . . . . 0.0 110.466 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.67 119.06 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.293 1.995 . . . . 0.0 110.995 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.25 -24.85 69.47 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.983 2.455 . . . . 0.0 112.855 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.08 88.41 51.0 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.09 135.04 24.36 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.1 2.533 . . . . 0.0 112.028 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.74 126.31 32.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.371 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 293' ' ' LEU . 3.9 mm? -78.74 87.38 4.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.968 0.414 . . . . 0.0 110.072 177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.502 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 5.3 m -61.09 -50.3 85.02 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.304 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.502 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 86.3 Cg_endo -79.19 55.54 5.66 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.041 1.828 . . . . 0.0 112.036 174.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -78.83 70.2 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.275 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.784 178.168 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -145.01 -67.32 0.31 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 23.6 ptm -175.24 148.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.397 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.93 131.94 4.02 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.942 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -77.68 -25.35 49.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 0.0 110.389 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 269' ' ' SER . 17.3 t -77.18 73.92 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.396 0.617 . . . . 0.0 110.879 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -138.5 -60.43 0.61 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.28 174.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -103.57 -39.2 6.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.082 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.09 84.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.763 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.426 ' O ' ' HB1' ' B' ' 34' ' ' ALA . 8.7 t80 -74.99 -19.01 60.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.54 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.687 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 30.8 mtpp -74.09 -45.81 46.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.4 -45.08 84.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.583 ' HB3' HG12 ' A' ' 228' ' ' VAL . . . -45.87 -51.87 12.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.917 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.783 ' HA ' ' HB1' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.9 -23.42 36.27 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -171.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 61.8 mt-30 -62.71 -40.79 98.25 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.633 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 63.7 mtt180 -70.81 -36.87 73.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.881 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.895 ' HB3' ' HE1' ' A' ' 273' ' ' PHE . . . -63.25 -43.81 96.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.301 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.29 46.3 mtt-85 -82.45 -25.15 33.85 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.282 -1.511 . . . . 0.0 113.064 172.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -54.08 -43.67 70.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.014 168.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.713 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.5 pt -69.64 -35.21 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.872 0.368 . . . . 0.0 110.429 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.56 -16.34 63.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.45 -36.06 16.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.592 ' HG2' ' HA ' ' B' ' 41' ' ' ILE . 21.6 pttp -84.54 -49.1 8.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.202 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.963 HG22 ' HB2' ' A' ' 219' ' ' ASP . 25.3 mm 65.08 91.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.449 0.643 . . . . 0.0 112.091 173.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.64 -157.62 21.31 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.081 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.09 144.72 15.3 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.77 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -118.16 85.38 2.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.978 0.418 . . . . 0.0 110.225 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.23 -21.34 19.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.07 0.462 . . . . 0.0 110.651 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.54 114.68 3.78 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.34 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.0 m -82.93 -34.91 26.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.375 0.607 . . . . 0.0 109.546 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.466 177.394 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.53 -31.47 69.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.371 . . . . 0.0 111.025 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.2 mmt -119.94 39.08 3.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.055 0.455 . . . . 0.0 110.223 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.62 79.24 9.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.516 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -86.95 91.13 8.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.227 0.537 . . . . 0.0 110.348 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -114.26 108.66 17.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.239 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -95.67 37.48 1.2 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.128 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -56.17 -41.35 75.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.378 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.8 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.16 -35.91 81.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.74 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.049 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.7 pt -82.64 -35.84 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.4 mtp -69.5 -34.29 74.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.0 m -79.61 0.02 31.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -122.97 109.2 13.82 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.3 m -103.41 135.72 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.458 0.647 . . . . 0.0 111.53 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.448 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 80.2 t80 -87.41 132.88 33.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.232 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.44 111.41 36.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.073 0.463 . . . . 0.0 110.328 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -114.84 176.92 17.12 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.778 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 13.9 t 64.99 53.65 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.85 0.833 . . . . 0.0 109.434 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.526 HG23 ' HD1' ' A' ' 152' ' ' HIS . 73.9 mt -82.54 132.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.828 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -86.09 154.46 21.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.683 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -54.95 -51.59 65.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.607 0.241 . . . . 0.0 111.029 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.86 17.32 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.972 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.5 tp -107.73 97.56 7.27 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.474 ' HA2' ' HE1' ' A' ' 152' ' ' HIS . . . -113.26 -174.08 18.9 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.5 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.464 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 5.8 pt-20 -63.05 -23.94 67.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.956 0.408 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 7.0 m-20 -78.57 -41.62 31.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -69.48 -46.87 65.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.131 0.491 . . . . 0.0 110.546 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.5 -41.99 94.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.453 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 19.0 ptp180 -63.21 -36.3 83.19 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.691 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -72.03 -29.93 64.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.794 0.33 . . . . 0.0 111.438 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.11 56.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.692 ' HB3' ' HH ' ' A' ' 160' ' ' TYR . 85.8 m-85 -96.31 -0.13 50.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.5 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.532 ' HB1' ' HD3' ' A' ' 134' ' ' PRO . . . -65.64 -46.83 67.87 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.614 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.717 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 25.7 Cg_exo -65.21 -4.66 9.59 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.377 2.051 . . . . 0.0 113.121 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.648 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 3.5 m-85 -84.69 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.849 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.53 38.15 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.879 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.46 103.15 0.64 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.921 2.414 . . . . 0.0 112.231 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.6 mt -79.24 108.68 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -90.66 -23.39 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 0.0 110.302 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.852 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 32.1 t -138.81 124.77 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.191 0.519 . . . . 0.0 111.05 -177.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.9 mt -118.98 107.32 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.176 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -116.71 100.82 8.07 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.579 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.464 ' SD ' ' HA ' ' A' ' 125' ' ' GLU . 61.5 mtp -122.77 123.97 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.579 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 26.2 t -108.93 111.52 23.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.771 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.427 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 6.6 p-90 -150.69 158.65 44.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.263 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.82 114.73 4.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.38 0.425 . . . . 0.0 110.169 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.7 m -79.85 -24.85 40.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.713 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.6 t -82.48 -37.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.54 HG22 ' HE3' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -107.69 -7.84 16.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.18 0.514 . . . . 0.0 110.758 -178.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.7 mtp 60.26 35.31 20.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.845 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.54 ' HE3' HG22 ' A' ' 149' ' ' THR . 98.7 mttt -84.07 148.23 26.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.526 ' HD1' HG23 ' A' ' 119' ' ' ILE . 65.9 m-70 -119.73 73.52 0.97 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.68 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -128.21 11.52 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 110.481 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.64 -116.44 1.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.139 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.448 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 44.8 p90 -154.67 167.0 31.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.818 0.342 . . . . 0.0 111.108 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.434 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -146.57 134.92 21.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.52 122.6 35.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.9 t -101.96 111.02 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.852 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 37.9 mt-10 -107.05 119.56 39.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.42 0.628 . . . . 0.0 110.996 -175.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.692 ' HH ' ' HB3' ' A' ' 132' ' ' PHE . 81.2 m-85 -96.2 156.08 16.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.445 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.9 -4.63 57.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 109.325 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.74 130.99 18.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.783 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.18 -11.07 29.63 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.718 2.279 . . . . 0.0 112.808 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.411 ' OE1' HG21 ' A' ' 287' ' ' THR . 4.6 mm-40 -56.7 -64.89 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 135' ' ' PHE . . . -65.91 -22.77 66.53 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.389 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.14 -50.94 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.863 0.363 . . . . 0.0 110.749 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.419 ' HB3' HG23 ' A' ' 286' ' ' VAL . 1.6 tm0? -74.26 -30.87 62.32 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.9 tp -58.72 -51.47 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.075 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.55 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.724 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.78 -50.28 72.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.996 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.01 -47.18 47.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -74.64 -50.8 16.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 135' ' ' PHE . 16.5 mmt -77.3 -26.37 52.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -170.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -73.29 -20.31 60.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.37 0.605 . . . . 0.0 110.086 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.3 m -92.73 -12.98 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.536 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 84.3 t -118.5 137.39 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.16 0.505 . . . . 0.0 111.517 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.434 ' HE3' ' HB2' ' A' ' 182' ' ' ASN . 21.5 ptp -103.47 144.73 31.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.887 175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.55 32.1 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.82 104.71 1.02 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.814 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.44 -59.53 4.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.034 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.748 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -101.84 125.87 48.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.622 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.434 ' HB2' ' HE3' ' A' ' 177' ' ' MET . 5.1 t30 -90.37 110.69 21.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.416 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.778 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 41.8 pt -69.72 157.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 0.0 111.102 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -113.92 110.3 19.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 66.1 t -112.18 117.85 56.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.409 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 110.23 176.31 20.85 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.794 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.94 151.07 3.94 Favored Pre-proline 0 C--N 1.328 -0.37 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.09 70.45 7.1 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.825 2.35 . . . . 0.0 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.8 m -69.42 -52.95 22.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.319 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.441 ' ND2' ' HB1' ' A' ' 194' ' ' ALA . 65.9 t30 -142.65 56.04 1.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.339 0.59 . . . . 0.0 110.533 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.06 151.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.75 -59.56 4.44 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.401 ' HB2' ' OD1' ' A' ' 190' ' ' ASN . 25.7 mt-30 -67.41 -37.63 83.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 0.0 111.549 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.441 ' HB1' ' ND2' ' A' ' 190' ' ' ASN . . . -95.46 -1.56 50.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.348 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.525 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.0 tp60 -61.36 -50.1 84.77 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 16.6 Cg_endo -57.45 -23.98 58.64 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.126 1.884 . . . . 0.0 112.316 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.453 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 49.8 mm -76.8 -45.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.87 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.48 -47.88 90.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.846 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.39 -37.57 78.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.764 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.47 -53.71 47.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.435 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 202' ' ' ALA . 2.3 pp -71.23 -32.8 69.21 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.652 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.526 ' N ' HD13 ' A' ' 201' ' ' LEU . . . -72.99 -43.88 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 206' ' ' ARG . 8.9 mm-40 -75.05 -29.25 60.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.619 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.36 -31.95 73.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.08 -17.47 64.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.286 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 203' ' ' GLU . 15.9 mmt180 -63.62 -31.08 72.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.818 0.342 . . . . 0.0 110.427 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.57 63.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.53 . . . . 0.0 110.757 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -96.69 -5.27 39.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 p30 35.25 40.86 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.011 1.445 . . . . 0.0 113.444 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.834 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 13.7 ptt180 -109.53 139.39 44.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.23 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.37 161.64 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.51 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -109.42 108.74 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.543 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.22 117.13 52.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.514 0.673 . . . . 0.0 110.78 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 134' ' ' PRO . . . -122.1 -173.58 2.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.312 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.717 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 18.7 t 70.62 17.17 6.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.716 0.635 . . . . 0.0 110.239 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 225' ' ' ILE . 93.4 t -67.32 136.44 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.59 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.491 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 11.1 t-80 -67.74 138.32 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -21.51 66.75 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -167.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.554 ' HB2' HG22 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -82.05 -47.66 12.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.315 0.507 . . . . 0.0 111.602 173.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.811 HD23 ' HG ' ' A' ' 275' ' ' LEU . 0.3 OUTLIER -56.43 116.04 2.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.097 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t -101.03 -176.78 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.473 -0.142 . . . . 0.0 111.196 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.11 -36.56 70.78 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.562 0.22 . . . . 0.0 111.365 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.6 -41.0 96.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.187 0.518 . . . . 0.0 110.294 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.448 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 3.9 m-20 -66.06 -57.53 7.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.113 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.7 HD11 HG11 ' A' ' 216' ' ' VAL . 36.6 mm -57.45 -25.26 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -57.84 -32.26 67.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.506 ' HG ' HG23 ' B' ' 41' ' ' ILE . 74.4 m -49.87 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.792 0.806 . . . . 0.0 111.705 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 34' ' ' ALA . 5.4 m -73.18 -39.58 56.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.735 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.595 ' CE1' ' HE3' ' A' ' 270' ' ' MET . 50.3 m-85 -67.51 -41.03 85.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.73 0.3 . . . . 0.0 111.354 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -76.72 -18.81 58.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.126 0.488 . . . . 0.0 111.222 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.27 -31.13 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.692 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.2 m-30 -86.16 -30.57 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.87 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.61 179.74 34.99 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.989 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -77.53 113.18 15.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.108 0.48 . . . . 0.0 111.11 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.77 146.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.118 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.477 ' HE2' ' HB3' ' A' ' 256' ' ' GLU . 34.2 ttpt -106.35 -49.56 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.1 p -153.26 146.32 24.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 46.5 t -126.71 123.42 37.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.885 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.5 p -136.3 104.01 5.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.67 HD22 HG13 ' A' ' 216' ' ' VAL . 10.8 tp -96.86 114.84 26.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.75 136.47 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.619 174.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.75 124.38 81.78 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.404 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -68.79 -18.43 41.75 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.0 113.418 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 m -92.65 -52.95 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.752 0.311 . . . . 0.0 110.995 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.4 m -74.22 -27.5 60.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.462 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.61 21.45 64.04 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.593 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.31 146.93 49.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.3 OUTLIER -82.51 139.86 33.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.592 178.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -79.52 151.76 30.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.45 32.79 1.37 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.764 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -153.51 157.62 40.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.052 0.426 . . . . 0.0 109.915 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.626 ' HA3' HD11 ' A' ' 240' ' ' LEU . . . -164.77 178.37 39.95 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.52 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -118.94 131.52 56.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.2 129.2 72.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.834 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 54.6 mt-10 -109.07 141.93 40.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.005 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -106.78 161.08 14.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 0.0 112.005 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.58 -17.2 30.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.576 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 45.7 mtpt -133.75 133.33 41.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.759 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.15 68.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.629 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -61.67 -46.78 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.428 174.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 45.7 m -64.93 -36.99 86.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.525 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -61.67 -41.4 97.5 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -73.97 -34.39 64.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.195 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.57 -35.13 46.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.109 0.481 . . . . 0.0 111.084 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.5 61.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.466 HG23 HG13 ' A' ' 282' ' ' VAL . 11.0 p -54.59 -39.45 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.7 p -82.13 -25.31 34.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 4.5 m -96.42 -25.81 15.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.984 0.421 . . . . 0.0 111.632 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.648 ' HB3' HG21 ' A' ' 282' ' ' VAL . 26.9 mmm -73.65 -10.46 59.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -173.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 27.8 t-20 -62.05 -32.29 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.029 0.918 . . . . 0.0 110.616 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.4 mm? -76.73 -8.57 57.54 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.364 -172.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.856 ' CE1' ' HB3' ' B' ' 38' ' ' ALA . 1.2 t80 -65.15 105.9 1.18 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.171 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.2 t70 -94.97 121.51 36.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.826 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.811 ' HG ' HD23 ' A' ' 220' ' ' LEU . 2.8 mm? -116.32 85.91 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.348 173.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.53 29.98 34.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.475 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.1 12.35 27.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.541 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 13.5 pt20 -138.46 130.71 28.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.887 0.375 . . . . 0.0 110.34 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.612 ' HB2' HH21 ' A' ' 281' ' ' ARG . 63.8 m-85 -89.99 131.62 35.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.342 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.502 HD21 HD21 ' A' ' 275' ' ' LEU . 17.4 mt -60.97 177.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.909 0.861 . . . . 0.0 111.57 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.612 HH21 ' HB2' ' A' ' 279' ' ' TYR . 4.2 mmt180 -140.41 111.48 7.07 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.648 HG21 ' HB3' ' A' ' 270' ' ' MET . 48.5 t -120.06 135.02 61.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.965 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.94 -151.2 5.44 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.18 149.9 25.53 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.72 91.99 2.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 167' ' ' GLN . 33.8 t -55.57 -46.76 79.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.704 -171.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.411 HG21 ' OE1' ' A' ' 164' ' ' GLU . 5.9 t -104.98 124.96 34.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.927 0.87 . . . . 0.0 112.371 -174.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 55.7 Cg_endo -73.9 121.96 7.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.595 2.197 . . . . 0.0 110.778 167.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 288' ' ' PRO . 13.2 Cg_exo -69.97 83.21 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.155 2.57 . . . . 0.0 112.59 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 81.7 mmm -97.63 119.56 62.37 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.614 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 24.1 Cg_exo -64.27 112.62 1.95 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.058 2.505 . . . . 0.0 112.664 -177.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.0 105.89 2.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.405 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.86 171.58 17.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.643 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 11.0 p -107.43 125.1 33.16 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.106 0.479 . . . . 0.0 110.843 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.02 -49.94 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.777 2.318 . . . . 0.0 112.8 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -154.69 72.93 0.87 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.075 0.464 . . . . 0.0 110.589 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.196 -178.78 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.27 145.62 37.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.661 0.267 . . . . 0.0 110.367 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -119.31 6.69 11.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.019 0.437 . . . . 0.0 110.178 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.42 67.14 3.14 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.8 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -122.63 24.62 9.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 93.5 t 70.35 -55.68 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 123.576 0.548 . . . . 0.0 110.421 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.63 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 62.5 t30 73.76 -52.89 0.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.097 0.959 . . . . 0.0 112.256 174.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -73.93 0.31 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.3 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.935 0.398 . . . . 0.0 111.743 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 16.7 t80 -67.12 -20.02 65.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.308 0.575 . . . . 0.0 110.644 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 92.4 mttt -77.77 -43.37 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.57 -39.04 75.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.692 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.58 -50.02 60.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.539 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.799 ' HA ' ' HB1' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -81.18 -21.67 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 50.9 mt-30 -61.83 -42.14 98.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.497 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 73.7 mtp180 -72.06 -31.86 66.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.53 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.856 ' HB3' ' CE1' ' A' ' 273' ' ' PHE . . . -68.11 -44.69 75.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.255 6.3 mtm180 -82.94 -26.33 31.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.294 -1.504 . . . . 0.0 113.022 171.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -57.32 -42.55 82.08 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.056 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.686 HD12 ' HZ ' ' A' ' 273' ' ' PHE . 9.8 pt -64.3 -42.72 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.23 -24.67 66.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 111.519 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 -29.38 21.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.832 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.441 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -92.13 -33.8 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.554 HG22 ' HB2' ' A' ' 219' ' ' ASP . 79.9 mt 63.88 106.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.25 66.35 1.9 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.641 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.92 45.97 3.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.063 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.56 117.6 7.0 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.552 0.341 . . . . 0.0 110.318 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . 63.98 29.11 14.44 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.668 0.605 . . . . 0.0 110.649 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.44 -58.38 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.607 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 52.4 p 54.06 -174.54 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.892 0.877 . . . . 0.0 112.83 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.247 178.088 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.78 96.9 7.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.409 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.9 mmm -85.93 -22.18 27.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.485 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.75 20.49 0.74 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.161 0.505 . . . . 0.0 110.97 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -85.53 -23.7 27.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.998 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -100.17 127.75 46.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 60.2 81.72 0.17 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.485 0.66 . . . . 0.0 111.125 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -56.88 -29.16 62.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.078 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.35 -28.87 70.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.88 -34.78 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.912 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.23 75.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.426 . . . . 0.0 111.22 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.39 -36.32 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.366 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 27.8 ttt -65.6 -26.67 67.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.875 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.9 m -82.17 4.34 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.517 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 19.5 ptt180 -135.57 134.61 39.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.975 0.417 . . . . 0.0 110.717 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.1 m -110.8 135.6 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.355 0.598 . . . . 0.0 111.522 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 71.0 t80 -78.83 124.47 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.209 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.53 112.06 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.023 0.439 . . . . 0.0 110.155 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.21 170.28 14.04 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.686 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.654 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 50.6 m 67.63 66.74 0.38 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.615 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.49 -19.84 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.136 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.513 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 66.8 t80 65.67 -73.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.286 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 53.4 t80 167.09 -43.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.291 0.636 . . . . 0.0 109.409 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -83.24 6.08 20.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.212 -173.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.8 mt -110.57 100.06 8.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.31 34.82 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.772 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.49 -41.42 94.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.35 -48.38 71.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.238 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -62.18 -53.85 49.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.09 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.75 -46.21 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.298 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -55.5 -48.95 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.494 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -78.27 -29.69 48.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.14 73.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.772 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.82 ' HB3' ' HH ' ' A' ' 160' ' ' TYR . 84.9 m-85 -97.71 7.08 47.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.444 ' HB2' ' HD3' ' A' ' 134' ' ' PRO . . . -68.07 -43.35 35.3 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.582 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 24.2 Cg_exo -65.16 -3.86 8.07 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.249 1.966 . . . . 0.0 112.915 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.721 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 21.8 m-85 -91.06 -63.96 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.683 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.63 175.2 34.28 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.563 ' HD2' HG23 ' A' ' 162' ' ' VAL . 21.1 Cg_exo -65.09 123.1 11.07 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.429 2.086 . . . . 0.0 111.724 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.74 123.17 22.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.163 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -87.04 -56.4 3.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.004 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.9 m -162.29 149.35 13.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.53 106.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.83 110.6 23.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.544 ' HE1' ' HB2' ' A' ' 152' ' ' HIS . 22.9 ptm -137.26 149.44 47.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.043 0.449 . . . . 0.0 111.136 -176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.3 m -80.25 121.93 26.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.804 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.74 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 42.9 m95 -99.95 114.48 27.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.198 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.817 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 2.5 m-20 -69.79 89.82 0.58 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.266 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t 62.5 -163.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.864 0.728 . . . . 0.0 111.586 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 150' ' ' MET . 14.9 p -84.73 -18.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.482 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.47 ' HB ' ' HE2' ' A' ' 151' ' ' LYS . 21.2 p -66.71 11.45 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.74 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 19.8 mmt 59.09 32.13 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.041 0.537 . . . . 0.0 112.305 172.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.817 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 71.0 mmtt -79.22 -49.7 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.934 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.544 ' HB2' ' HE1' ' A' ' 143' ' ' MET . 25.1 p80 40.91 58.15 2.55 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.889 0.743 . . . . 0.0 112.352 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -104.18 94.28 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.288 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.23 -101.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.972 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -147.51 165.95 28.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.742 0.306 . . . . 0.0 110.714 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.47 146.38 33.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.717 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.04 111.71 24.31 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.5 106.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.046 0.45 . . . . 0.0 110.27 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.517 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 45.8 mt-10 -91.62 131.46 37.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.82 ' HH ' ' HB3' ' A' ' 132' ' ' PHE . 23.3 m-85 -102.01 147.62 26.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.424 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -75.17 -14.55 60.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.723 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.563 HG23 ' HD2' ' A' ' 137' ' ' PRO . 19.6 m -136.89 130.24 17.55 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.083 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.29 -19.93 68.54 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.169 2.579 . . . . 0.0 113.231 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.73 -65.15 0.64 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.48 -27.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.824 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.55 69.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.688 0.28 . . . . 0.0 111.14 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.444 ' HB3' HG21 ' A' ' 286' ' ' VAL . 19.5 tt0 -74.54 -36.91 63.13 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.347 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.626 HD22 ' CD2' ' A' ' 212' ' ' TYR . 12.5 tp -55.75 -49.84 72.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.98 96.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.531 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.7 -54.02 45.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.176 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.54 -45.37 81.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.781 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -77.94 -46.04 22.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 23.1 mmt -73.24 -22.98 60.29 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.591 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.01 -23.55 55.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.312 0.577 . . . . 0.0 109.642 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 55.1 m -84.92 -30.66 24.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.458 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.68 130.65 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.1 0.476 . . . . 0.0 111.412 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 181' ' ' ARG . 25.7 ptt? -78.8 130.97 36.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.873 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 178' ' ' LEU . 3.5 pp -85.84 139.97 30.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.808 0.337 . . . . 0.0 111.138 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.2 -40.07 1.46 Allowed Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.345 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.38 2.62 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.537 ' O ' ' HB2' ' A' ' 177' ' ' MET . 30.6 mmt180 -98.13 126.42 43.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -74.85 67.84 1.68 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.665 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.654 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 38.1 pt -66.29 154.67 7.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -116.14 109.05 16.94 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 55.5 t -112.82 109.77 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.264 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.0 141.35 8.07 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.414 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 15.8 mtp180 -129.95 137.05 30.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 2.7 Cg_exo -76.4 48.12 2.26 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 111.335 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 p -81.25 -45.63 15.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.901 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -92.79 35.78 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.496 0.665 . . . . 0.0 109.781 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt -65.99 136.4 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.858 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 89.61 -35.22 3.79 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.104 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -83.2 -42.74 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.023 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.37 -18.6 41.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.49 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mp0 -57.67 -51.89 78.36 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 14.5 Cg_endo -57.02 -30.41 86.57 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.193 1.929 . . . . 0.0 112.472 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mm -75.15 -50.81 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.401 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.28 -43.79 95.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.801 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.68 -42.72 71.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.712 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -60.4 -52.95 63.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' A' ' 287' ' ' THR . 91.1 mt -64.96 -46.38 81.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.077 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.96 94.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.886 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.16 -35.09 68.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.88 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.24 -38.13 78.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.418 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.32 -27.99 69.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -21.74 66.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.188 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.87 -13.1 51.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.973 0.416 . . . . 0.0 111.321 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.74 -17.78 20.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.402 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 65.82 15.0 9.87 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.618 0.574 . . . . 0.0 111.919 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.493 ' NH1' ' HB2' ' A' ' 289' ' ' PRO . 82.1 mtp180 -105.44 135.67 46.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.048 0.452 . . . . 0.0 110.679 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.462 HD11 ' CE1' ' A' ' 229' ' ' PHE . 30.6 pt -117.67 169.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.103 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.626 ' CD2' HD22 ' A' ' 168' ' ' LEU . 44.1 t80 -118.74 118.61 32.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.572 HG23 HG21 ' A' ' 282' ' ' VAL . 2.3 p -116.3 122.45 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.719 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.721 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.06 -179.84 4.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.98 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.582 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 24.7 m 68.07 29.08 6.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.276 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.785 HG12 HD13 ' A' ' 225' ' ' ILE . 73.6 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.319 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -63.25 123.15 17.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.69 -37.37 18.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -167.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.56 -45.75 43.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.616 0.245 . . . . 0.0 111.092 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.813 HD13 HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -58.5 116.43 3.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.6 m -99.88 -178.31 3.82 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.73 -44.42 77.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.651 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.44 -32.79 69.04 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.402 0.62 . . . . 0.0 110.185 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.52 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 57.1 m-20 -73.33 -55.91 5.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.645 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.785 HD13 HG12 ' A' ' 216' ' ' VAL . 33.8 mm -54.57 -29.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.103 0.478 . . . . 0.0 111.565 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.473 ' HG3' HD13 ' A' ' 235' ' ' ILE . 62.3 tttm -53.93 -32.53 53.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.94 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.62 ' HB3' ' HG2' ' B' ' 37' ' ' ARG . 68.0 m -48.99 -61.37 2.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.737 0.779 . . . . 0.0 112.826 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.781 ' HB ' ' HE2' ' A' ' 270' ' ' MET . 3.0 m -70.67 -46.32 69.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.73 -169.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.689 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 57.6 m-85 -57.96 -43.93 86.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.687 0.279 . . . . 0.0 111.151 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.7 tt0 -70.9 -24.3 62.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.266 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.08 -21.09 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.372 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.726 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 0.6 OUTLIER -93.22 -43.75 8.67 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.59 153.69 25.04 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.07 137.94 51.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.487 0.643 . . . . 0.0 111.669 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 229' ' ' PHE . 60.6 mt -95.68 147.51 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.527 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -80.02 -64.3 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.429 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 35.5 t -150.42 147.67 27.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.495 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.95 129.42 52.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.424 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.2 t -142.48 125.31 16.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.172 0.51 . . . . 0.0 111.019 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.409 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 8.4 mp -110.19 130.2 55.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.587 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.68 145.92 50.79 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.509 0.671 . . . . 0.0 111.012 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -122.75 150.19 43.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.553 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -117.04 106.51 47.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.678 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.67 -25.15 34.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.489 2.126 . . . . 0.0 112.094 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.9 m -63.24 -48.29 78.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.355 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -83.65 -30.14 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.677 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.68 6.12 53.01 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.975 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -137.13 177.43 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -82.78 154.04 24.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 110.416 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.7 155.71 21.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.36 43.05 2.83 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.833 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -156.26 157.51 35.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.97 0.385 . . . . 0.0 110.083 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -168.42 -172.95 35.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.583 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -119.31 132.81 55.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.732 0.301 . . . . 0.0 110.501 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.2 mm -111.81 126.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 210' ' ' ARG . 35.6 tt0 -103.72 120.89 41.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -94.23 142.86 26.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.532 0.682 . . . . 0.0 111.754 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.9 -26.25 66.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.179 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.476 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 34.4 mtpt -124.95 136.31 53.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.77 -18.55 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -68.8 -44.52 73.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.549 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 65.3 m -67.91 -21.02 65.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.696 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 m -59.03 -39.42 81.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.026 0.441 . . . . 0.0 110.262 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -75.33 -35.17 61.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.497 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 1.0 ' HA ' ' HA2' ' B' ' 25' ' ' GLY . 34.6 t70 -68.17 -34.79 76.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.124 -175.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.53 -47.63 22.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.675 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.53 HG11 HG12 ' A' ' 282' ' ' VAL . 31.1 m -59.44 -35.01 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -169.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.2 p -80.04 -9.47 59.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.2 m -113.81 -35.99 4.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.919 0.39 . . . . 0.0 111.694 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.858 ' HA ' ' HE3' ' A' ' 270' ' ' MET . 0.6 OUTLIER -72.31 -16.02 61.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -170.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.81 -30.14 69.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.749 0.785 . . . . 0.0 110.402 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 272' ' ' LEU . 7.9 mp -76.83 -9.47 58.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.603 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.852 ' HB2' ' HE1' ' A' ' 270' ' ' MET . 1.6 t80 -54.85 109.17 0.48 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.676 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 0.2 OUTLIER -113.82 130.31 56.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 -178.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.662 ' HG ' HD21 ' A' ' 220' ' ' LEU . 3.2 mm? -116.08 87.02 2.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.537 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.85 3.47 73.75 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.064 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 134.43 -31.51 2.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.417 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.676 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 17.3 pt20 -84.06 129.25 34.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.171 0.486 . . . . 0.0 110.772 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -89.41 139.83 30.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.732 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.495 HD23 ' HD2' ' A' ' 273' ' ' PHE . 9.2 mp -76.78 -173.17 2.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 0.0 111.568 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 281' ' ' ARG . 39.2 mmt180 -144.66 112.43 6.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.573 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.572 HG21 HG23 ' A' ' 213' ' ' VAL . 46.7 t -125.83 134.32 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.628 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.2 -153.61 6.33 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.768 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -85.11 165.82 17.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.088 0.444 . . . . 0.0 110.151 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.606 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -76.15 -7.49 54.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.998 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 167' ' ' GLN . 64.3 t 71.22 -64.49 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.119 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 201' ' ' LEU . 8.4 t -111.29 148.97 39.86 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 3.6 Cg_endo -47.42 114.65 1.09 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.835 2.357 . . . . 0.0 111.433 173.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.493 ' HB2' ' NH1' ' A' ' 210' ' ' ARG . 2.9 Cg_exo -74.17 50.95 2.35 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.595 2.863 . . . . 0.0 113.141 -171.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.604 ' N ' ' HD2' ' A' ' 291' ' ' PRO . 70.4 mtm -73.44 -37.44 3.63 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.213 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 290' ' ' MET . 36.4 Cg_endo -66.32 68.97 0.45 Allowed 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 121.937 1.758 . . . . 0.0 112.876 174.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 53.8 tp -80.23 70.13 6.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 74.7 mt -73.56 116.13 13.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.007 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 28.6 m -97.48 106.96 36.27 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.918 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.73 103.09 1.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.928 2.419 . . . . 0.0 111.972 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 63.09 -175.73 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.129 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.916 -179.099 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.57 105.12 17.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.147 0.499 . . . . 0.0 111.226 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 22.8 ptp -134.59 144.42 47.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 1.0 ' HA2' ' HA ' ' A' ' 265' ' ' ASP . . . 89.42 11.2 64.69 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.877 -172.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -132.6 88.2 2.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.086 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.587 ' CG2' ' HB2' ' B' ' 31' ' ' PHE . 29.1 m -86.69 134.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.112 0.482 . . . . 0.0 110.858 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -125.63 4.64 7.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.472 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.39 -38.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . . . -62.1 -35.6 79.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.625 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.604 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 9.1 t80 -74.51 -19.44 60.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.321 0.582 . . . . 0.0 110.032 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.644 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 94.6 mttt -72.84 -45.48 58.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.676 ' HA ' HE21 ' B' ' 36' ' ' GLN . 22.5 t70 -56.28 -44.38 79.75 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.002 0.906 . . . . 0.0 108.744 174.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.726 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -48.23 -54.03 14.97 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.011 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.705 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -83.11 -23.42 33.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -168.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.676 HE21 ' HA ' ' B' ' 33' ' ' ASP . 30.3 mt-30 -55.24 -44.27 75.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.62 ' HG2' ' HB3' ' A' ' 227' ' ' SER . 25.2 ttm105 -74.39 -31.62 62.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.662 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.845 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.76 -46.2 83.14 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.251 11.7 mtp180 -81.18 -25.03 37.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.638 -1.289 . . . . 0.0 112.387 174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.44 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 19.8 tp60 -51.25 -47.28 62.45 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 165.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.813 HG13 HD13 ' A' ' 220' ' ' LEU . 4.6 pt -72.26 -28.42 29.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.844 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 275' ' ' LEU . . . -65.76 -31.89 73.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.907 0.384 . . . . 0.0 111.076 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.41 -25.22 29.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.269 0.557 . . . . 0.0 110.492 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' B' ' 44' ' ' LYS . 4.8 tmmt? -82.1 -63.77 1.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.089 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 85.0 mt 66.49 102.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.104 0.478 . . . . 0.0 111.788 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.48 -168.12 13.46 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.545 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.6 -112.8 0.52 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.699 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -59.26 99.4 0.05 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.131 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.45 89.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.01 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.67 139.43 6.5 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.628 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 14.0 t -92.47 -175.34 3.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.664 -179.879 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.25 157.24 21.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 24.7 mmt 56.27 53.79 8.46 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.518 0.511 . . . . 0.0 110.839 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.61 91.51 1.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.568 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.93 45.75 2.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.436 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -90.35 67.76 6.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.8 52.88 4.09 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.43 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -61.0 -34.54 74.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.238 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.16 73.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.392 . . . . 0.0 110.479 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.11 -39.12 86.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.65 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.13 72.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.909 0.385 . . . . 0.0 111.511 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.6 mt -83.9 -48.31 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.7 -35.29 80.08 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 80.4 m -83.18 2.64 34.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.53 0.205 . . . . 0.0 111.398 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.813 ' HB2' ' HG3' ' A' ' 159' ' ' GLU . 8.5 ttp180 -113.82 112.39 23.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.984 0.421 . . . . 0.0 111.237 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.39 150.89 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.337 0.589 . . . . 0.0 111.067 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.8 t80 -102.84 115.05 29.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.098 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.03 111.82 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.19 167.0 12.37 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.085 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.0 m 68.73 47.57 0.83 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.277 0.561 . . . . 0.0 110.991 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.726 HD13 ' HE1' ' A' ' 143' ' ' MET . 79.1 mt -66.19 115.97 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.119 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -61.87 -78.85 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.339 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -175.61 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.27 -23.99 67.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.688 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.01 98.6 5.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.134 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.55 -175.15 37.09 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.684 ' HB2' ' HE1' ' A' ' 145' ' ' TRP . 40.4 tt0 -62.81 -41.32 99.25 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.98 -39.47 87.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.519 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -64.75 -46.08 83.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.96 -48.43 88.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.308 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ppt_? -66.87 -33.93 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.465 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -72.16 -35.7 69.11 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.737 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.84 97.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.878 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 81.5 m-85 -97.07 11.29 36.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.266 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.575 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -65.98 -46.02 63.92 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.291 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 1.004 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 27.7 Cg_endo -63.13 -14.88 44.46 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.056 1.837 . . . . 0.0 112.881 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 132' ' ' PHE . 5.0 m-85 -76.07 -66.42 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.18 156.13 26.51 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.16 131.46 46.47 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.532 2.155 . . . . 0.0 111.665 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -72.32 117.3 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -90.13 -39.51 12.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.544 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.4 t -160.04 139.3 10.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.756 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.64 121.08 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.75 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.27 96.73 5.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.726 ' HE1' HD13 ' A' ' 119' ' ' ILE . 27.9 ttt -107.49 145.13 33.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.515 -175.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -78.12 80.61 4.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 0.0 109.863 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.684 ' HE1' ' HB2' ' A' ' 125' ' ' GLU . 6.6 m95 -92.49 133.13 36.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.094 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -94.29 111.9 23.66 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.4 m -75.45 3.26 9.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.193 0.521 . . . . 0.0 110.548 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.13 -54.57 8.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.067 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.556 ' HB ' ' HG3' ' A' ' 151' ' ' LYS . 1.5 m -119.55 -15.01 9.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.62 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.5 mtp 67.11 32.77 5.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.721 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.556 ' HG3' ' HB ' ' A' ' 149' ' ' THR . 17.8 mtpp -97.16 -14.8 21.24 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.506 ' HB2' ' HE2' ' A' ' 143' ' ' MET . 32.2 p80 44.19 47.04 7.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.74 0.816 . . . . 0.0 112.579 170.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.69 102.56 15.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.093 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 171.39 -112.83 0.47 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.75 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -142.0 172.93 12.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.858 0.361 . . . . 0.0 111.349 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.597 ' HB3' ' HG3' ' A' ' 143' ' ' MET . . . -151.67 150.58 30.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.707 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.22 131.7 56.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 58.6 t -128.32 115.78 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.854 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.813 ' HG3' ' HB2' ' A' ' 113' ' ' ARG . 1.8 mp0 -92.31 132.62 36.56 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.948 173.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -101.92 169.0 9.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.939 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.486 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 42.2 tt0 -60.94 -48.83 80.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.478 0.656 . . . . 0.0 110.3 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.489 ' HB ' ' HG2' ' A' ' 164' ' ' GLU . 16.0 m -119.75 147.19 43.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.99 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.07 -16.52 44.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.754 2.303 . . . . 0.0 111.129 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.489 ' HG2' ' HB ' ' A' ' 162' ' ' VAL . 1.0 OUTLIER -63.21 -47.12 83.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.879 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.455 ' H ' HG23 ' A' ' 162' ' ' VAL . . . -62.05 -39.23 91.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.063 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.37 86.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.844 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -59.67 -45.33 92.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 13.1 mt -73.0 -35.16 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.983 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.64 85.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.555 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 2.9 tt -77.15 -63.09 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.081 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -63.57 -47.31 82.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -171.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.644 ' HB3' ' HD3' ' A' ' 281' ' ' ARG . 80.7 mm-40 -84.74 -0.72 54.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -171.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.62 ' HB3' HG23 ' A' ' 185' ' ' VAL . 42.6 tpp -119.95 -33.79 3.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.32 -24.82 63.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.233 0.54 . . . . 0.0 110.48 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.2 m -84.37 -0.97 54.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.416 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.54 177.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.362 . . . . 0.0 110.758 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.542 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 82.2 mtp -118.01 126.04 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.171 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.52 85.49 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 110.072 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.08 -135.22 12.86 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.908 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.53 77.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.922 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -130.17 154.93 47.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.872 0.368 . . . . 0.0 110.748 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.542 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 24.3 p-10 -100.91 108.76 20.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.506 0.669 . . . . 0.0 110.397 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.3 pt -75.57 148.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 184' ' ' LYS . 24.0 tptp -102.24 109.38 21.04 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.135 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 173' ' ' MET . 15.8 m -104.64 127.03 59.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.991 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.555 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 85.75 135.6 3.77 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.285 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -153.34 91.16 3.37 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 81.11 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.201 2.6 . . . . 0.0 112.568 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.6 m -81.7 -17.45 47.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.48 53.5 2.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.065 0.459 . . . . 0.0 110.802 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.69 124.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.522 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.76 -24.71 4.32 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.558 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 13.5 mm-40 -83.68 -47.64 11.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 111.399 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.35 -20.9 27.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.677 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.452 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 27.2 mm-40 -57.98 -55.21 47.56 Favored Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.486 ' O ' ' HG3' ' A' ' 200' ' ' GLN . 19.3 Cg_endo -58.75 -30.97 94.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.109 1.873 . . . . 0.0 112.539 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.0 mm -70.61 -52.43 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.009 0.433 . . . . 0.0 110.178 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.28 -33.54 64.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.963 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.78 -49.46 77.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.597 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 47.1 mt-30 -65.17 -34.85 79.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.118 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.21 -49.81 68.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.477 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -64.67 -29.74 70.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.31 -52.1 66.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.965 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.41 -28.59 59.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.897 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.09 69.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.923 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 14.4 mtm180 -67.23 -20.35 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 0.0 110.96 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -24.27 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.18 0.514 . . . . 0.0 110.639 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -102.1 -29.13 11.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 52.13 79.14 0.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.839 0.712 . . . . 0.0 111.258 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.656 ' HB2' ' HB1' ' A' ' 285' ' ' ALA . 39.5 mtm180 -125.18 142.35 51.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.047 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.673 HD12 ' HE1' ' A' ' 229' ' ' PHE . 13.5 tt -108.82 142.95 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 282' ' ' VAL . 79.4 t80 -108.44 123.19 48.48 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.799 0.333 . . . . 0.0 110.171 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.526 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.3 p -119.04 122.73 70.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.511 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.05 179.6 4.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.191 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 1.004 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 20.0 m 65.29 26.79 12.16 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.799 0.687 . . . . 0.0 110.948 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.429 HG22 ' C ' ' A' ' 251' ' ' GLY . 8.1 m -72.46 145.21 12.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.157 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.437 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 13.4 t-80 -68.4 130.33 42.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.38 -18.47 64.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -164.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.437 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 0.6 OUTLIER -78.27 -44.08 26.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.169 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.654 HD22 HD12 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -52.8 114.37 1.39 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.818 172.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.2 m -98.79 -177.5 3.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 11.0 p-10 -54.36 -41.29 68.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -70.63 -28.93 65.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.76 0.314 . . . . 0.0 110.684 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.57 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 4.8 m-20 -67.54 -55.79 12.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.654 HD12 HD22 ' A' ' 220' ' ' LEU . 30.8 mm -57.38 -27.28 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.11 0.481 . . . . 0.0 110.816 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.488 ' HG3' HD13 ' A' ' 235' ' ' ILE . 87.7 tttt -56.94 -32.85 66.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.292 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.637 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 57.9 m -48.33 -60.22 2.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.936 0.874 . . . . 0.0 112.092 -176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.717 ' HB ' ' CE ' ' A' ' 270' ' ' MET . 2.8 m -72.14 -36.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.731 -170.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.673 ' HE1' HD12 ' A' ' 211' ' ' ILE . 71.3 m-85 -70.79 -37.13 73.29 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.259 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.463 ' OE1' ' HE2' ' A' ' 226' ' ' LYS . 8.5 tt0 -77.27 -21.09 54.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.737 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.84 -18.7 53.59 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.49 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.71 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 3.8 m-30 -87.77 -38.21 15.95 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.521 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.75 -156.97 8.25 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.569 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -94.54 128.59 41.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.488 HD13 ' HG3' ' A' ' 226' ' ' LYS . 20.6 tt -104.1 135.68 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.286 -171.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 256' ' ' GLU . 23.5 tptp -91.08 -52.42 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.81 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 69.3 m -149.95 124.74 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.846 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 3.8 p -100.54 68.13 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.38 0.61 . . . . 0.0 109.739 174.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.5 p -97.8 104.35 16.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.231 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.4 mp -91.72 128.8 37.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.29 133.76 49.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -133.61 151.05 51.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.408 . . . . 0.0 110.738 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.92 118.19 70.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.258 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.75 -17.1 42.41 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.908 2.406 . . . . 0.0 113.412 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 69.7 p -86.8 -47.1 9.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.712 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.1 m -92.23 -25.67 18.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.968 0.413 . . . . 0.0 111.354 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.71 22.61 42.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.986 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.8 122.29 45.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.589 0.233 . . . . 0.0 111.122 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.5 p80 -72.79 138.2 46.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.486 ' HZ3' ' CD ' ' A' ' 161' ' ' GLU . 96.4 mttt -70.5 156.62 39.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.45 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.429 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.97 33.15 0.63 Allowed Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.476 0.485 . . . . 0.0 113.637 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.457 ' H ' ' C ' ' A' ' 250' ' ' LYS . 5.7 p90 -153.24 163.79 39.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.477 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -155.11 162.63 31.04 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.008 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.74 117.14 29.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 237' ' ' SER . 2.3 mp -102.79 128.5 55.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 51.6 mt-10 -102.76 145.78 29.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -119.31 132.22 55.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.268 0.556 . . . . 0.0 111.022 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -78.18 -27.21 47.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.344 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.475 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 20.3 mtpt -112.5 123.05 49.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.157 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.34 75.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.869 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -61.33 -37.69 84.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.222 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.8 m -73.76 -28.83 61.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.046 0.45 . . . . 0.0 110.446 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.7 t -73.78 -22.4 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.896 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -74.99 -49.66 19.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.648 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.49 -33.73 41.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -171.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.28 54.01 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 111.177 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 37.4 t -71.9 -34.13 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 111.378 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.2 p -89.89 -17.93 27.1 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.777 0.322 . . . . 0.0 111.661 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 36.0 m -112.1 1.03 16.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -171.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.755 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 6.0 tpp -119.19 2.4 11.39 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -172.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -82.85 -16.86 46.0 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.184 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 9.1 mp -79.6 -9.37 59.62 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.893 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -45.93 106.05 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.341 0.4 . . . . 0.0 111.583 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.38 114.47 27.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.535 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' B' ' 42' ' ' ALA . 2.4 mm? -119.93 86.38 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.312 169.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.23 40.25 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.834 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.84 -2.5 69.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.999 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.89 128.83 49.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 273' ' ' PHE . 86.2 m-85 -98.83 122.46 42.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.727 HD22 ' CD2' ' A' ' 273' ' ' PHE . 9.9 mp -70.55 -179.44 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.028 0.442 . . . . 0.0 110.676 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.644 ' HD3' ' HB3' ' A' ' 172' ' ' GLN . 3.6 mmp_? -136.48 128.04 28.7 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -174.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 3.1 m -122.96 151.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.456 0.646 . . . . 0.0 112.042 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -160.83 -136.71 2.06 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.352 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.83 152.43 38.4 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.579 -0.365 . . . . 0.0 110.886 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' A' ' 210' ' ' ARG . . . -96.49 102.9 14.76 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -35.42 8.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.609 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 14.9 t -84.92 136.01 39.19 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.5 123.34 11.3 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.819 2.346 . . . . 0.0 112.013 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -75.6 81.75 2.26 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.818 2.345 . . . . 0.0 112.918 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 26.1 ptt? -76.79 127.89 82.98 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.754 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.588 ' HB2' ' HG ' ' A' ' 293' ' ' LEU . 6.0 Cg_exo -74.12 146.46 36.64 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.948 2.432 . . . . 0.0 112.441 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 35.0 tp -81.85 66.92 7.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.399 0.618 . . . . 0.0 109.816 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 291' ' ' PRO . 86.6 mt -83.79 -22.5 31.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.258 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 2.1 p -96.5 146.26 31.0 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.726 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 6.3 Cg_exo -73.7 61.89 4.58 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.153 2.568 . . . . 0.0 112.642 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -83.11 85.44 7.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.296 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 72.1 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.022 -179.451 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.21 69.09 0.78 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.822 0.344 . . . . 0.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.98 129.62 40.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.912 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.41 -26.59 23.99 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -173.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -111.43 34.59 4.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' B' ' 30' ' ' ALA . 47.7 t -77.47 104.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.642 0.734 . . . . 0.0 112.053 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.588 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 15.2 m120 -122.68 -45.78 2.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.184 167.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.92 -52.8 62.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.453 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.55 ' HB2' HG12 ' B' ' 27' ' ' VAL . . . -63.99 -31.33 72.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.027 0.441 . . . . 0.0 111.171 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.641 ' HA ' ' CE1' ' A' ' 232' ' ' PHE . 11.7 t80 -76.65 -21.48 55.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.224 0.535 . . . . 0.0 110.289 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 71.8 mttt -74.43 -41.0 61.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.8 t70 -58.0 -41.93 84.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.71 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -50.49 -49.27 55.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.341 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.764 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.87 -25.15 35.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -169.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 24.9 mt-30 -57.71 -44.93 86.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.637 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 60.6 mtt180 -68.11 -35.99 79.02 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.586 174.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.893 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.06 -49.97 72.44 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.272 13.6 mtp180 -81.44 -25.3 36.25 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.202 -1.561 . . . . 0.0 112.751 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -52.47 -46.7 66.65 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 110.073 168.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.827 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.6 pt -67.22 -35.51 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.498 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.52 ' HB3' HD11 ' A' ' 275' ' ' LEU . . . -65.88 -20.1 66.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.388 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.27 -42.28 12.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.8 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.827 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.1 OUTLIER -92.3 -14.48 28.77 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.424 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.2 pt 42.32 76.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.16 -143.11 16.39 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.576 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.0 -140.72 11.54 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.119 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.3 128.55 34.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.845 0.355 . . . . 0.0 110.591 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.08 18.06 0.12 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.959 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.72 68.87 0.52 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.457 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 58.1 m -73.16 97.72 2.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.003 0.43 . . . . 0.0 110.324 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.431 -0.795 . . . . 0.0 108.964 -179.195 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.62 82.47 5.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.865 0.365 . . . . 0.0 110.094 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.63 -42.4 4.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.632 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.37 78.84 3.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.498 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -89.43 9.74 25.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.626 -175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -81.76 -0.34 42.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.422 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 12.3 pt20 -92.91 29.0 1.92 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.114 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 -58.12 -45.25 87.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 111.099 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.82 -26.74 61.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.987 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 59.4 tp -76.43 -45.76 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.056 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.35 -45.72 76.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.886 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.5 pt -64.99 -34.2 68.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.09 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 75.4 mtp -70.05 -26.39 64.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.483 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.37 -33.1 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 14.6 ptp180 -109.26 127.72 54.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 111.337 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.98 140.89 24.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.495 0.664 . . . . 0.0 110.794 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.423 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 65.6 t80 -85.12 130.56 34.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.827 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.86 112.23 38.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.547 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.27 169.71 13.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.332 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 48.2 m 57.86 50.7 10.07 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.323 0.583 . . . . 0.0 110.757 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -90.84 10.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.093 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.2 t80 64.05 11.99 6.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.618 0.723 . . . . 0.0 109.406 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.945 ' HB2' ' H ' ' A' ' 153' ' ' LYS . 55.0 p90 42.18 33.52 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.852 1.261 . . . . 0.0 113.319 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.46 -58.07 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.162 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 mp -48.94 135.98 14.86 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.56 0.537 . . . . 0.0 112.373 -174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.63 170.65 48.39 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.447 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.45 -39.17 77.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.603 0.361 . . . . 0.0 111.62 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.32 -27.96 69.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.315 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 48.8 m -66.66 -45.7 78.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 110.307 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.29 -40.03 81.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.984 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -53.35 -48.86 68.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.08 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 78.1 mt-30 -76.96 -30.23 55.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.636 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.39 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 110.703 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.883 ' HB3' ' HH ' ' A' ' 160' ' ' TYR . 89.5 m-85 -105.62 12.12 31.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.973 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.491 ' HB1' ' HD3' ' A' ' 134' ' ' PRO . . . -70.3 -44.03 18.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.843 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.603 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 14.4 Cg_exo -71.46 -4.0 14.14 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.91 1.74 . . . . 0.0 111.73 173.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.442 ' CE2' ' HG2' ' A' ' 281' ' ' ARG . 54.6 m-85 -106.41 58.57 0.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.52 164.01 38.34 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.701 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.5 ' HD2' HG21 ' A' ' 162' ' ' VAL . 68.0 Cg_endo -79.49 132.47 10.04 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.81 2.34 . . . . 0.0 112.461 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.87 119.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.36 -56.21 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 0.0 110.681 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.6 m -157.53 125.26 5.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.622 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.459 HG21 ' HG3' ' A' ' 143' ' ' MET . 54.9 mt -101.22 107.17 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 173.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.55 120.06 27.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.114 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.459 ' HG3' HG21 ' A' ' 141' ' ' ILE . 82.9 mtp -139.02 131.33 28.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.87 0.366 . . . . 0.0 111.399 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.2 m -106.9 105.76 15.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.937 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 10.6 p-90 -159.49 159.86 33.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -83.74 95.53 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.928 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.4 p -70.64 -23.18 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.528 -172.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.9 m -68.82 -32.71 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.454 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.8 p -109.45 -1.89 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.351 0.596 . . . . 0.0 110.71 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.937 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 74.1 mtp 61.06 36.6 18.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -106.02 137.95 43.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.73 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 11.5 m-70 -95.74 -79.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.945 ' H ' ' HB2' ' A' ' 121' ' ' TYR . 29.5 mtpt 52.22 45.88 27.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.22 -170.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -160.27 -122.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.469 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.423 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 29.7 p90 -149.53 174.03 12.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.795 -170.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.99 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.119 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -116.69 108.64 16.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.447 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.4 110.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.49 0.662 . . . . 0.0 110.542 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.4 tt0 -94.57 134.14 37.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.883 ' HH ' ' HB3' ' A' ' 132' ' ' PHE . 84.8 m-85 -102.91 161.01 14.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.426 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.54 -7.96 53.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.676 ' HB ' ' OE2' ' A' ' 164' ' ' GLU . 34.9 m -129.22 128.07 23.25 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.429 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 3.1 Cg_exo -74.83 -22.26 15.41 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.137 2.558 . . . . 0.0 114.083 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.676 ' OE2' ' HB ' ' A' ' 162' ' ' VAL . 1.2 mp0 -63.26 -57.68 9.66 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.617 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 135' ' ' PHE . . . -56.96 -29.63 63.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.627 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.23 64.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.503 ' HB3' HG21 ' A' ' 286' ' ' VAL . 23.6 tm0? -68.49 -39.93 81.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.69 -55.93 26.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.266 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.89 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.317 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.908 ' HG ' ' HA2' ' A' ' 186' ' ' GLY . 7.5 tt -54.87 -63.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.222 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.58 -36.01 15.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -70.51 -27.48 64.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.504 ' HG3' HD11 ' A' ' 183' ' ' ILE . 60.5 tpp -88.87 -27.21 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.12 -8.72 57.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.786 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.4 m -90.61 -7.94 51.43 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.188 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.16 163.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.037 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 20.0 ptp -108.93 144.03 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.117 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.41 59.83 1.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.053 0.454 . . . . 0.0 110.431 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.8 77.31 1.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.857 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.97 -51.31 4.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.586 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 2.5 mpt_? -88.35 126.79 35.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 0.0 110.818 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.2 109.32 8.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.388 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.504 HD11 ' HG3' ' A' ' 173' ' ' MET . 35.5 pt -76.86 162.04 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -119.64 114.02 21.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.001 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 170' ' ' LEU . 27.6 t -117.45 132.85 66.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.976 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.908 ' HA2' ' HG ' ' A' ' 170' ' ' LEU . . . 156.03 -136.29 4.96 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.285 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -149.03 71.57 10.23 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.375 0.607 . . . . 0.0 110.605 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.63 89.0 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.728 2.285 . . . . 0.0 112.794 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.4 m -143.71 -71.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.686 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.27 117.91 17.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.9 pt -102.04 -175.49 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.25 -55.97 4.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.191 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -67.96 -51.53 46.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.76 0.314 . . . . 0.0 111.769 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.05 6.44 36.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.677 0.275 . . . . 0.0 111.73 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.497 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.1 OUTLIER -64.9 -55.51 27.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 9.6 Cg_endo -53.13 -32.22 58.37 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.683 2.255 . . . . 0.0 112.725 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -58.01 -46.84 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.397 . . . . 0.0 110.337 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.82 -43.86 98.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.457 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.36 -44.86 93.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.46 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 32.0 mm-40 -67.11 -39.63 86.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.081 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 286' ' ' VAL . 85.7 mt -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.16 -38.2 88.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.88 -40.89 83.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.146 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.15 -40.42 96.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.215 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.13 86.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 82.9 mtp180 -68.51 -30.73 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.51 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.7 72.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -89.8 -6.06 56.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.893 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.425 ' N ' HD21 ' A' ' 209' ' ' ASN . 0.9 OUTLIER 65.73 26.67 11.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.121 178.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -105.21 136.96 43.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 111.339 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.68 169.68 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.117 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.466 ' HB2' ' HA ' ' A' ' 285' ' ' ALA . 37.5 t80 -119.79 128.18 53.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.437 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.474 HG23 HD22 ' A' ' 280' ' ' LEU . 1.5 p -119.95 118.63 57.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.14 -178.36 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.169 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.603 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 50.6 m 64.93 26.54 12.79 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.889 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.563 HG13 HD11 ' A' ' 225' ' ' ILE . 58.0 t -72.18 134.89 28.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.519 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -63.22 127.59 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -56.57 -29.64 62.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.856 -171.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.18 -45.96 24.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.516 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.705 HD22 HD11 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -75.08 116.13 15.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.014 -177.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.4 t -106.54 -176.17 3.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -166.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -48.5 -45.1 36.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.33 -34.35 64.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.862 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.6 m-20 -79.7 -56.79 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.451 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.76 HG13 HD11 ' A' ' 240' ' ' LEU . 27.1 mm -54.39 -26.25 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.835 0.454 . . . . 0.0 112.071 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.469 ' HZ2' ' CD ' ' A' ' 230' ' ' GLU . 63.6 tttm -50.91 -32.43 20.63 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.77 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.424 ' HB3' ' HG2' ' B' ' 37' ' ' ARG . 67.2 m -48.93 -62.71 1.38 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.575 0.702 . . . . 0.0 112.698 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.849 HG12 ' HB3' ' B' ' 34' ' ' ALA . 2.3 m -74.72 -46.24 42.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.949 -165.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.644 ' HB2' HD12 ' A' ' 235' ' ' ILE . 71.6 m-85 -61.07 -35.89 78.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.967 0.413 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.469 ' CD ' ' HZ2' ' A' ' 226' ' ' LYS . 45.4 tt0 -77.38 -26.52 51.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.192 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.53 81.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.654 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.764 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.5 OUTLIER -82.67 -14.27 54.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.669 -175.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.44 -111.3 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.82 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -156.07 131.19 9.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 110.132 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.644 HD12 ' HB2' ' A' ' 229' ' ' PHE . 58.7 mt -86.39 127.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.472 0.653 . . . . 0.0 110.763 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -79.48 -46.07 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.736 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 5.4 p -167.0 129.34 1.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.699 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.433 ' HB3' HG22 ' A' ' 255' ' ' ILE . 20.4 p -131.2 137.76 49.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.901 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 52.8 m -154.88 120.68 5.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.898 0.38 . . . . 0.0 110.915 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.76 HD11 HG13 ' A' ' 225' ' ' ILE . 52.6 mt -83.46 130.83 35.04 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.13 121.04 11.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.254 0.55 . . . . 0.0 110.319 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.629 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 44.9 mtt180 -93.59 158.04 15.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.475 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.6 t70 -117.89 107.71 43.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.382 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.28 -24.69 57.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.015 2.477 . . . . 0.0 113.187 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.5 p -78.43 -28.36 46.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.688 0.28 . . . . 0.0 111.612 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -96.55 -33.37 11.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.899 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.3 -10.94 58.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.993 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -108.83 -92.52 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.667 -0.314 . . . . 0.0 111.115 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 25.4 p80 -170.0 162.09 9.0 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.475 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 96.0 mttt -84.17 155.82 22.38 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.61 42.03 1.47 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.559 . . . . 0.0 114.05 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.4 p90 -161.09 168.29 24.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 175.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -174.95 -177.82 44.34 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.189 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.25 137.49 54.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.772 0.32 . . . . 0.0 110.62 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 238' ' ' CYS . 56.4 mt -131.61 126.48 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.03 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.3 136.72 44.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.352 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -104.32 155.81 18.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.851 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -81.74 -19.36 41.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.689 173.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.446 ' HB2' ' OG ' ' A' ' 262' ' ' SER . 28.5 mmmt -127.46 120.98 29.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.407 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.29 -22.46 65.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.875 0.369 . . . . 0.0 111.363 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.511 ' HA ' HE21 ' A' ' 264' ' ' GLN . 99.0 mt-30 -65.42 -44.02 88.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 1.9 p -71.58 -29.89 65.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 267' ' ' VAL . 9.1 m -56.06 -41.44 75.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.035 0.445 . . . . 0.0 110.757 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.511 HE21 ' HA ' ' A' ' 261' ' ' GLN . 47.6 mt-30 -67.2 -35.21 79.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.571 -176.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.65 -43.27 63.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -52.17 -44.63 64.72 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.549 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 263' ' ' SER . 67.0 t -61.82 -27.18 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 111.383 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.0 m -91.12 -36.4 14.01 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.193 -0.317 . . . . 0.0 111.463 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 45.3 m -92.24 -35.07 14.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.734 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 40.2 mmm -70.36 -9.23 55.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -59.99 -43.3 95.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.664 0.745 . . . . 0.0 110.649 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 272' ' ' LEU . 8.8 mp -76.63 -8.61 57.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.699 ' CD2' HD21 ' A' ' 280' ' ' LEU . 49.0 t80 -45.41 102.09 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.523 0.514 . . . . 0.0 110.889 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.4 p-10 -94.68 128.82 41.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.489 0.662 . . . . 0.0 111.016 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.705 HD11 HD22 ' A' ' 220' ' ' LEU . 40.5 mt -124.07 87.24 2.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.759 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.63 -111.08 3.44 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -113.15 34.56 5.01 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.424 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.2 pt20 -141.23 159.86 41.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.681 0.24 . . . . 0.0 110.813 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -102.25 162.85 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.84 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 13.3 tp -91.09 -170.08 2.55 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.84 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 21.0 tpp180 -148.61 112.41 5.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 175.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.02 146.3 17.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.889 0.376 . . . . 0.0 110.811 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.85 -145.06 4.08 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.546 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.423 ' O ' HG22 ' A' ' 286' ' ' VAL . 92.4 mttt -123.08 150.7 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.653 -0.322 . . . . 0.0 110.29 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.06 -31.39 72.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.713 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.503 HG21 ' HB3' ' A' ' 167' ' ' GLN . 62.3 t 68.58 -65.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.409 HG23 HG11 ' A' ' 286' ' ' VAL . 3.1 p -115.58 83.77 11.51 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 289' ' ' PRO . 19.0 Cg_endo -63.99 -33.82 61.47 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 122.643 2.229 . . . . 0.0 115.828 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.467 ' HD3' ' HG2' ' A' ' 288' ' ' PRO . 96.1 Cg_endo -77.43 48.12 2.47 Favored 'Trans proline' 0 C--N 1.367 1.539 0 CA-C-N 121.437 1.549 . . . . 0.0 113.555 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.497 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 50.5 ttp -102.09 124.42 40.03 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 6.2 Cg_exo -74.16 68.56 4.99 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.27 2.647 . . . . 0.0 112.286 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 292' ' ' LEU . 2.0 pp -74.18 142.89 45.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.4 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.8 mt -119.28 72.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.165 0.507 . . . . 0.0 110.532 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.523 ' N ' ' HD2' ' A' ' 295' ' ' PRO . 9.2 m -63.03 -45.58 86.57 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.884 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 294' ' ' THR . 24.1 Cg_endo -64.02 93.28 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.617 1.544 . . . . 0.0 111.647 171.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -79.17 69.61 5.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.597 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.484 -178.82 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.489 ' HB2' HG23 ' B' ' 27' ' ' VAL . . . -122.37 176.1 6.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.603 0.24 . . . . 0.0 110.705 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 66.7 mtt -131.24 46.88 2.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.095 0.474 . . . . 0.0 109.894 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.37 124.49 5.45 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 65.07 70.49 0.47 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.837 0.455 . . . . 0.0 110.378 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 17.8 t -60.08 103.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.195 0.521 . . . . 0.0 111.138 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -87.05 34.17 0.68 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -154.35 -77.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.318 . . . . 0.0 111.026 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.498 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -64.17 -23.36 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.121 -176.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.671 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 12.1 t80 -72.19 -23.88 61.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.08 0.467 . . . . 0.0 110.032 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 51.5 mtpt -71.4 -39.84 70.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.28 -31.52 72.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.849 ' HB3' HG12 ' A' ' 228' ' ' VAL . . . -56.93 -55.0 40.22 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.549 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.637 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.7 OUTLIER -82.25 -24.13 34.95 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 4.7 pt20 -60.33 -37.32 80.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.166 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.424 ' HG2' ' HB3' ' A' ' 227' ' ' SER . 32.1 ttm180 -74.01 -31.27 62.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.775 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.721 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -71.61 -42.39 67.74 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 121.549 0.69 . . . . 0.0 112.553 -175.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -79.24 -25.21 42.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.88 -1.137 . . . . 0.0 111.389 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -55.87 -49.8 72.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.35 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.721 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.2 pt -65.41 -34.13 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.847 0.356 . . . . 0.0 110.352 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.544 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -68.33 -25.12 64.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.443 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.53 -45.96 34.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.229 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.696 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -86.56 -29.55 22.57 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.51 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 59.4 mt 60.22 -87.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 122.868 0.467 . . . . 0.0 111.406 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.65 91.93 0.98 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.54 -119.62 4.44 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.685 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -90.56 31.78 1.01 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.348 0.594 . . . . 0.0 111.093 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.39 56.43 3.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.438 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.65 -122.84 6.94 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.098 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 59.0 m 69.03 -86.95 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.845 0.458 . . . . 0.0 110.573 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.242 -0.885 . . . . 0.0 109.74 176.814 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 103' ' ' GLN . . . -66.57 163.03 19.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.3 ttt -47.37 -58.05 4.58 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.517 0.51 . . . . 0.0 111.934 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.62 16.99 16.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.294 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.497 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 56.8 tp60 65.38 108.9 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.581 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -71.89 87.55 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.331 0.586 . . . . 0.0 110.315 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 103' ' ' GLN . 66.3 mt-30 -88.53 40.94 0.99 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.315 -172.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -66.17 -29.16 69.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.459 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.9 -26.1 62.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.01 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.5 tp -68.09 -36.18 79.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.28 68.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.4 mt -80.49 -47.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.535 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 52.2 mtm -66.27 -27.02 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.47 -13.41 62.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 21.9 ptt180 -127.23 119.44 26.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.815 0.341 . . . . 0.0 110.566 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.486 HG22 ' HE1' ' A' ' 160' ' ' TYR . 16.8 m -92.47 138.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.69 0.757 . . . . 0.0 111.394 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -86.36 99.49 11.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.642 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.0 t -96.74 115.6 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.155 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.527 ' CA ' ' HD1' ' A' ' 155' ' ' PHE . . . -127.69 -176.91 14.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.8 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 47.2 m 72.43 -72.26 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.582 0.753 . . . . 0.0 111.149 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.426 HD13 HD12 ' A' ' 128' ' ' ILE . 44.1 mm 68.79 158.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 123.23 0.331 . . . . 0.0 110.743 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.402 ' N ' HG21 ' A' ' 119' ' ' ILE . 69.6 t80 -56.26 -64.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.376 -0.203 . . . . 0.0 110.729 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.2 t80 177.86 -49.77 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.104 0 O-C-N 123.456 0.473 . . . . 0.0 110.687 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.6 45.19 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.487 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.41 134.36 46.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.925 0.393 . . . . 0.0 111.102 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.56 -177.33 50.43 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.256 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -63.79 -41.65 97.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.478 -0.361 . . . . 0.0 111.866 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -64.37 -41.32 96.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.534 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.7 m -57.06 -45.21 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.426 HD12 HD13 ' A' ' 119' ' ' ILE . 65.5 mt -71.08 -45.82 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.689 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 129' ' ' ARG . 20.5 ttp180 -56.59 -47.0 80.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.571 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.55 -11.41 59.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.629 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -29.83 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.407 . . . . 0.0 110.443 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.786 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 61.7 m-85 -99.29 8.1 45.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.34 -44.0 12.91 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.583 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.591 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 29.1 Cg_endo -64.84 -4.78 9.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.843 1.695 . . . . 0.0 113.019 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.514 ' HB3' ' HB2' ' A' ' 165' ' ' ALA . 5.4 m-85 -87.25 -68.35 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.795 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.17 167.65 36.18 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.814 ' HG2' ' HB3' ' A' ' 161' ' ' GLU . 19.3 Cg_endo -60.39 126.86 21.11 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.54 2.16 . . . . 0.0 111.833 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.2 mt -87.8 128.89 39.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.367 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -80.26 -56.19 4.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -158.7 152.21 23.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.16 107.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.89 112.61 24.61 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 43.1 ttm -134.85 118.27 16.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.204 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.4 t -91.09 115.47 28.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.585 ' CE3' ' HB2' ' A' ' 152' ' ' HIS . 1.6 p-90 -165.93 151.63 8.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.196 0.522 . . . . 0.0 111.771 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.24 99.8 1.22 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.5 t -94.2 6.53 48.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.6 p -84.75 -31.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.114 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.2 p -108.37 -17.37 14.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 111.202 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.0 mtt 63.21 41.18 8.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.143 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -84.06 -39.93 18.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.585 ' HB2' ' CE3' ' A' ' 145' ' ' TRP . 1.6 t60 60.43 67.04 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.732 0.777 . . . . 0.0 110.357 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -96.7 64.96 2.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.664 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.25 -155.25 11.36 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.743 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.527 ' HD1' ' CA ' ' A' ' 117' ' ' GLY . 28.7 m-85 -104.99 170.46 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.961 0.41 . . . . 0.0 111.16 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.45 145.4 24.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.76 107.85 18.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.727 0.299 . . . . 0.0 110.277 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.36 111.37 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 30.1 tt0 -100.57 129.32 46.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.963 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.486 ' HE1' HG22 ' A' ' 114' ' ' VAL . 90.3 m-85 -102.01 161.34 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.384 0.611 . . . . 0.0 111.412 -176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.814 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 10.8 tp10 -77.62 -27.07 51.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.585 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.55 119.76 23.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.665 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.91 -19.4 54.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.299 2.666 . . . . 0.0 113.002 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.43 -56.92 15.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 110.519 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 135' ' ' PHE . . . -64.33 -28.96 70.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.99 -51.2 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.01 -36.62 75.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.414 HD23 ' CE2' ' A' ' 212' ' ' TYR . 22.2 tp -57.47 -45.95 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.344 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.05 93.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.185 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.32 -41.48 89.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.701 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -85.13 -32.46 22.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -91.3 -29.42 17.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.786 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 14.9 mmt -95.25 -34.23 12.28 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.111 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 9.9 t30 -70.18 -15.91 63.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 110.454 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.4 p -92.64 5.49 50.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.25 146.1 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 110.594 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.669 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 36.0 mtm -94.23 132.78 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 38.1 tp -83.52 83.77 7.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.142 0.496 . . . . 0.0 110.22 -176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.71 -36.44 3.26 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.191 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.13 -38.18 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.99 128.57 36.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.669 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.0 p-10 -75.48 119.09 19.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.276 0.56 . . . . 0.0 109.995 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 19.9 pt -74.97 150.95 6.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.003 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -101.48 117.58 35.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.048 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 42.9 t -122.64 106.33 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.06 175.23 18.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.049 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 38.9 mtp180 -146.7 128.19 7.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 122.459 0.303 . . . . 0.0 110.424 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.0 Cg_endo -82.19 60.69 7.51 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.059 2.506 . . . . 0.0 111.472 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.5 m -115.76 151.37 35.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.974 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.9 32.48 20.02 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.774 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 195' ' ' GLN . 38.1 mt -79.77 73.12 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.995 0.902 . . . . 0.0 110.222 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 163.08 -36.15 0.32 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.492 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -83.56 -52.64 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.35 . . . . 0.0 110.619 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.87 -21.74 15.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.232 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.574 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 26.7 tp60 -52.74 -47.17 95.48 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.7 Cg_endo -55.15 -30.55 71.5 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.454 2.103 . . . . 0.0 113.072 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.1 -39.05 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.441 . . . . 0.0 110.067 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.9 -38.86 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.082 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.1 -40.07 92.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.75 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -63.64 -34.38 77.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.076 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.87 -45.96 22.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.657 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.79 -43.41 98.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.064 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.465 ' OE1' ' HD2' ' A' ' 206' ' ' ARG . 5.5 tp10 -62.72 -33.53 75.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.455 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.613 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 4.2 tp10 -70.2 -40.79 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.019 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -68.47 -28.08 66.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.466 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 88.7 mtt180 -64.25 -22.99 67.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.23 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.03 -4.01 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 291' ' ' PRO . 94.6 m-85 -111.45 -18.72 12.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.471 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.503 HD22 ' HA ' ' A' ' 260' ' ' ALA . 50.2 t-20 50.58 68.58 0.75 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.348 0.594 . . . . 0.0 110.43 -176.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -130.28 136.66 49.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.505 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.679 HD11 ' HE2' ' A' ' 229' ' ' PHE . 7.6 tt -106.54 147.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.335 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.414 ' CE2' HD23 ' A' ' 168' ' ' LEU . 86.5 t80 -108.01 122.88 47.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.406 ' CG2' HD22 ' A' ' 280' ' ' LEU . 6.5 p -122.87 124.2 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.297 0.57 . . . . 0.0 110.897 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 134' ' ' PRO . . . -122.39 -178.19 3.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.46 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.591 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.0 m 64.77 33.61 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.768 0.668 . . . . 0.0 111.558 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.757 HG23 HD11 ' A' ' 225' ' ' ILE . 7.1 p -82.78 151.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.281 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -68.89 136.22 52.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -57.48 -35.59 70.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -168.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -45.89 19.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.744 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -52.21 110.25 0.47 Allowed 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.78 0.675 . . . . 0.0 110.156 177.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.2 t -94.8 -178.46 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.619 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 2.3 p30 -62.81 -29.36 70.67 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.7 -41.44 73.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.339 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.517 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 52.0 m-20 -80.23 -52.35 7.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.771 -175.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.757 HD11 HG23 ' A' ' 216' ' ' VAL . 47.2 mm -56.21 -25.25 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.227 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.753 ' HG3' HD13 ' A' ' 235' ' ' ILE . 53.8 tttm -55.57 -31.9 62.58 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.47 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.549 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.0 m -51.02 -61.92 1.93 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.826 0.822 . . . . 0.0 112.019 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' B' ' 34' ' ' ALA . 3.1 m -68.05 -48.84 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.574 -171.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.679 ' HE2' HD11 ' A' ' 211' ' ' ILE . 52.5 m-85 -59.27 -45.22 91.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.787 0.327 . . . . 0.0 111.22 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 40.9 tt0 -73.43 -23.82 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.726 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.52 71.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.754 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 0.3 OUTLIER -83.73 -38.08 21.85 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -165.78 148.47 13.85 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.17 139.34 58.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.486 0.66 . . . . 0.0 111.355 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.753 HD13 ' HG3' ' A' ' 226' ' ' LYS . 31.0 pt -119.78 137.04 54.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.666 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -85.64 -68.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.407 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' A' ' 256' ' ' GLU . 11.6 m -94.7 108.99 20.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.336 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 4.3 p -122.12 102.1 7.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.9 m -142.64 116.25 9.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.762 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.619 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 73.6 mt -90.22 117.8 29.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 168.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 123.11 15.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.2 0.524 . . . . 0.0 110.985 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.784 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 53.5 mtt-85 -80.74 157.4 25.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.335 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.597 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 18.5 t70 -117.34 113.89 38.7 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.161 -175.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.79 -20.35 39.86 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.763 2.309 . . . . 0.0 112.336 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.7 m -64.36 -56.69 12.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.496 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 47.2 p -86.81 -35.39 19.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.509 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 106.58 -10.25 41.86 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.1 -157.93 0.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.784 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 29.6 p80 -108.35 149.42 28.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 94.1 mttt -70.7 154.23 42.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.432 ' C ' HG12 ' A' ' 216' ' ' VAL . . . -73.15 34.45 0.77 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 114.669 0.628 . . . . 0.0 114.669 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.456 ' HE2' ' HD3' ' A' ' 137' ' ' PRO . 35.5 p90 -157.07 164.81 37.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.555 0.678 . . . . 0.0 110.633 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.565 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -173.25 -175.41 41.01 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.312 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -123.41 141.58 51.85 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.2 mp -124.78 135.47 63.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.973 174.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.411 ' HB3' ' H ' ' A' ' 237' ' ' SER . 45.6 tt0 -109.04 126.44 53.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.627 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -98.15 144.23 27.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.182 0.515 . . . . 0.0 112.181 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.846 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 5.0 pt-20 -74.84 -31.47 61.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.846 ' HG3' ' HG3' ' A' ' 258' ' ' GLU . 24.0 mtpp -109.47 157.47 18.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.503 ' HA ' HD22 ' A' ' 209' ' ' ASN . . . -81.86 -40.89 21.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 0.0 111.254 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -64.62 -38.63 91.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 6.3 p -62.74 -34.78 77.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.567 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -39.94 86.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.964 0.411 . . . . 0.0 110.612 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.69 -39.67 70.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.775 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -46.7 86.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -60.55 -52.62 64.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.469 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.22 -25.95 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.172 0.51 . . . . 0.0 111.693 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.9 m -84.3 -17.89 38.15 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.098 -0.376 . . . . 0.0 111.993 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.6 p -116.09 -34.41 4.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.658 ' HE3' ' CD2' ' A' ' 273' ' ' PHE . 39.9 mmm -65.48 -4.5 5.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -69.99 -35.28 74.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 122.167 0.984 . . . . 0.0 109.477 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.92 -8.79 58.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.369 -174.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.805 ' CE1' ' HB2' ' B' ' 38' ' ' ALA . 1.2 t80 -52.78 105.37 0.12 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.877 0.37 . . . . 0.0 110.653 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.3 t70 -97.95 119.2 36.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.744 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.6 mm? -117.52 86.31 2.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.995 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.5 26.1 61.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.664 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 118.21 -18.68 11.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.228 -0.986 . . . . 0.0 113.646 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.4 pt20 -106.75 131.76 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.136 0.468 . . . . 0.0 111.362 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 273' ' ' PHE . 50.1 m-85 -94.31 137.95 32.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.275 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.492 HD23 ' HD2' ' A' ' 273' ' ' PHE . 11.1 mp -73.81 -173.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.304 0.573 . . . . 0.0 111.525 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.428 HH12 ' HB2' ' A' ' 279' ' ' TYR . 77.2 mmt-85 -146.89 118.09 7.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.15 146.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.431 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -154.52 -164.37 12.83 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.735 176.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -88.69 169.94 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.499 0.649 . . . . 0.0 110.186 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.91 -32.44 73.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.8 t 70.73 -70.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.954 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.505 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 54.0 p -112.84 138.69 22.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.613 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 65.5 Cg_endo -76.39 104.5 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.341 2.028 . . . . 0.0 112.058 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 287' ' ' THR . 5.4 Cg_exo -77.96 -18.12 13.27 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.688 2.259 . . . . 0.0 111.852 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 86.1 mtp -136.65 67.98 59.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.844 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 208' ' ' PHE . 91.9 Cg_endo -83.49 169.14 12.54 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.602 2.202 . . . . 0.0 111.208 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.702 HD11 ' H ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -108.39 130.79 55.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.39 0.614 . . . . 0.0 110.598 178.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.11 87.77 2.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.271 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 12.1 t -120.72 140.57 30.81 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.031 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.05 108.25 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.632 2.222 . . . . 0.0 111.579 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -82.32 69.43 9.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.178 0.513 . . . . 0.0 110.664 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.877 179.351 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.99 124.9 53.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.028 0.442 . . . . 0.0 110.725 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 71.8 mtm -137.92 105.92 5.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.652 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.06 94.15 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.458 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -52.8 -45.54 67.25 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.766 0.427 . . . . 0.0 111.698 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 58.8 t -70.34 -44.52 77.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.006 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.676 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 51.7 t30 66.46 -79.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.498 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.61 -67.76 0.35 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -24.16 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.053 0.454 . . . . 0.0 111.273 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.552 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 5.2 t80 -75.14 -17.84 60.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.126 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 89.6 mttt -70.61 -45.5 65.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.52 -40.3 86.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.754 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -48.51 -53.43 18.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.326 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.811 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.22 -17.51 45.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 57.5 mt-30 -66.07 -43.85 86.23 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.549 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 74.0 mtp180 -69.38 -37.35 77.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.108 173.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.811 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -59.55 -50.65 73.06 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.269 31.1 mtp85 -81.55 -25.38 35.91 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.266 -1.521 . . . . 0.0 112.971 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -55.57 -44.89 77.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.018 169.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.811 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -66.33 -33.54 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.517 ' HB3' HD13 ' A' ' 275' ' ' LEU . . . -69.28 -24.81 64.01 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.813 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.58 -22.91 24.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.202 0.525 . . . . 0.0 110.637 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.516 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 20.1 ttpt -90.91 -41.65 11.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.58 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.411 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.3 pt 41.6 52.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.786 0.835 . . . . 0.0 112.9 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -155.15 122.74 1.25 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.835 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.3 175.19 43.27 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.122 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -123.25 132.43 54.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.035 0.445 . . . . 0.0 110.946 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.75 63.17 4.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.701 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.19 -154.91 25.33 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.935 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -91.3 126.56 36.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.91 0.385 . . . . 0.0 110.978 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.252 1.228 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.313 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.68 47.43 1.19 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.212 0.529 . . . . 0.0 110.97 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 24.0 mmt -80.62 3.46 21.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.041 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.31 -12.98 41.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.982 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -97.67 28.48 3.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.747 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.84 92.05 6.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . 32.1 mm-40 -69.65 116.96 10.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.087 -174.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -60.45 -37.95 82.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.773 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.52 -52.79 64.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.758 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.55 HD13 ' HG3' ' A' ' 163' ' ' PRO . 3.8 mm? -66.11 -36.78 84.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.88 74.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.359 . . . . 0.0 111.367 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.9 mt -82.11 -41.29 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.81 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.9 mtp -68.05 -37.01 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.059 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 79.8 m -75.91 -17.78 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.798 ' HG2' ' HB3' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.3 99.92 11.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.979 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.78 140.03 17.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.419 0.628 . . . . 0.0 111.226 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.558 ' HE2' ' HE2' ' A' ' 184' ' ' LYS . 42.6 t80 -88.94 121.34 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.406 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.461 HG21 HG12 ' A' ' 185' ' ' VAL . 52.0 t -116.53 110.98 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -130.42 101.98 0.52 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.652 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.543 ' HB3' HG23 ' A' ' 183' ' ' ILE . 8.9 t 168.45 59.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.416 HG21 ' ND1' ' A' ' 152' ' ' HIS . 12.7 mm -82.06 -17.45 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.8 -170.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 t80 66.51 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.1 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.2 t80 179.17 -53.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.69 36.05 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.52 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.56 113.45 18.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.583 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -83.18 159.85 37.77 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.236 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.43 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.1 OUTLIER -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 109.895 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 25.5 t70 -65.13 -42.12 94.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.085 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -58.75 -42.82 89.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.034 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.38 -42.72 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.511 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 129' ' ' ARG . 10.6 ttp180 -61.0 -39.78 91.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 38.3 mt-30 -76.29 -20.42 57.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.05 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.22 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.883 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -94.88 8.12 43.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.476 ' HB2' ' HD3' ' A' ' 134' ' ' PRO . . . -66.63 -44.22 53.73 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.991 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.544 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 23.9 Cg_exo -65.86 -12.74 36.6 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 112.541 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 214' ' ' ALA . 5.9 m-85 -80.39 -68.16 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.654 0.264 . . . . 0.0 110.964 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -149.07 169.55 29.46 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.465 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.496 ' HD2' HG21 ' A' ' 162' ' ' VAL . 15.2 Cg_exo -67.46 100.52 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.682 2.255 . . . . 0.0 111.565 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.34 107.36 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -76.22 -31.83 58.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 p -173.07 128.95 0.47 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.743 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.0 tt -105.92 132.85 51.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 172.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -114.49 115.63 27.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.865 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.583 ' HE3' ' HD1' ' A' ' 152' ' ' HIS . 23.0 ttt -140.81 128.54 21.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.093 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.8 t -118.99 124.92 48.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.86 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 43.6 p-90 -163.64 159.61 21.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.615 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.87 93.25 1.68 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.872 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.453 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 48.3 t -70.86 -22.04 62.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.546 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.82 -26.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.022 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.8 p -121.36 5.73 10.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.86 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 68.5 mtp 60.8 27.35 17.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -91.08 107.57 19.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 0.0 110.608 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.583 ' HD1' ' HE3' ' A' ' 143' ' ' MET . 40.8 m-70 -83.25 74.55 10.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.92 -51.14 17.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.189 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.33 172.7 54.45 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.629 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.09 170.85 7.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -104.7 129.11 52.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 0.0 110.446 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.27 108.03 17.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.27 124.12 67.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.207 0.527 . . . . 0.0 110.554 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.798 ' HB3' ' HG2' ' A' ' 113' ' ' ARG . 10.3 pt-20 -112.82 131.22 55.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.501 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.67 162.89 13.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.731 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -78.27 -15.18 59.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.654 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 17.3 m -129.44 128.98 23.19 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.55 ' HG3' HD13 ' A' ' 108' ' ' LEU . 56.2 Cg_endo -72.07 -14.61 29.04 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.009 2.473 . . . . 0.0 113.16 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.654 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 31.0 mp0 -60.74 -52.21 66.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 110.574 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -22.98 67.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.503 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.31 -50.71 36.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.794 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -39.67 94.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.421 ' CD2' ' HB1' ' A' ' 214' ' ' ALA . 15.5 tp -60.36 -49.65 76.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.846 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.96 -29.2 70.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.196 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.823 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.9 tt -61.37 -61.15 2.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.092 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.99 -39.49 23.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.706 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 17.3 mm-40 -83.14 0.19 46.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.408 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 58.2 tpp -122.38 -36.54 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.079 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.639 ' OD1' ' HA ' ' A' ' 184' ' ' LYS . 10.4 t30 -67.58 -31.09 70.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.959 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.2 m -85.16 -8.91 58.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.81 90.18 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.108 0.48 . . . . 0.0 110.211 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.6 ptm -72.52 118.12 15.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.255 0.55 . . . . 0.0 110.32 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.2 -34.24 68.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.485 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 152.29 133.41 1.94 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.553 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.98 -62.89 3.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.606 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -124.04 155.37 38.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -90.12 127.92 36.21 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.543 HG23 ' HB3' ' A' ' 118' ' ' SER . 23.4 pt -89.97 132.06 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.068 176.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.639 ' HA ' ' OD1' ' A' ' 174' ' ' ASN . 21.8 ptmt -102.15 116.94 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.368 0.604 . . . . 0.0 110.176 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.461 HG12 HG21 ' A' ' 116' ' ' VAL . 62.1 t -123.51 133.5 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.227 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.823 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 106.48 -126.29 8.45 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.841 174.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 54.84 67.93 2.93 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 124.17 0.57 . . . . 0.0 111.013 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.04 -157.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.909 2.406 . . . . 0.0 111.892 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.1 t 72.55 118.6 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.577 0.703 . . . . 0.0 110.681 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.477 ' OD1' HG13 ' A' ' 191' ' ' ILE . 25.2 t-20 -74.85 -63.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.278 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.477 HG13 ' OD1' ' A' ' 190' ' ' ASN . 55.5 mt -137.55 67.48 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.268 0.556 . . . . 0.0 110.463 175.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.01 2.07 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -58.63 -10.31 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -84.85 -30.74 24.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.044 -0.41 . . . . 0.0 111.269 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.1 tp60 -64.18 -50.16 69.66 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.6 Cg_exo -52.52 -33.57 58.44 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.117 1.878 . . . . 0.0 112.437 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.93 -44.03 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 110.094 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.88 -43.55 97.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.608 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -45.11 93.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 84.2 mm-40 -61.11 -46.22 91.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.678 HD13 HG21 ' A' ' 287' ' ' THR . 96.1 mt -71.21 -28.99 64.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.68 94.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.3 -32.45 71.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.178 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.55 -42.14 87.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.201 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.12 72.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.46 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -68.43 -19.4 64.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.82 -13.49 59.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.486 ' HB3' ' HG3' ' A' ' 210' ' ' ARG . 41.4 m-85 -103.39 -23.07 13.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.144 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 59.09 37.1 24.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.501 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 1.003 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 96.3 mtt180 -97.22 138.25 35.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.503 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.09 158.56 17.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.35 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -109.75 128.54 55.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.833 0.349 . . . . 0.0 110.621 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 4.4 p -120.78 119.23 58.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.129 0.49 . . . . 0.0 110.585 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 135' ' ' PHE . . . -123.33 -177.2 3.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.544 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 8.1 t 68.0 22.49 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.055 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.484 HG13 HD12 ' A' ' 225' ' ' ILE . 84.7 t -73.23 129.68 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.018 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -63.18 130.54 45.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.81 -28.82 66.37 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -78.98 -45.87 19.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 111.398 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.663 HD21 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -61.34 110.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.638 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 62.4 m -87.14 -178.26 6.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.9 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 19.7 p-10 -66.94 -37.65 84.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.706 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.704 0.764 . . . . 0.0 109.832 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 0.9 OUTLIER -67.78 -54.62 17.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.723 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.691 HG13 HD11 ' A' ' 240' ' ' LEU . 29.4 mm -59.58 -21.28 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 111.032 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.447 ' HG3' HD11 ' A' ' 235' ' ' ILE . 88.4 tttt -59.19 -31.39 68.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.936 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.4 m -48.76 -59.79 3.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.87 0.843 . . . . 0.0 111.43 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.71 ' HB ' ' HE2' ' A' ' 270' ' ' MET . 2.8 m -68.91 -52.22 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.603 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -58.38 -34.4 70.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.421 ' HA ' HG13 ' A' ' 235' ' ' ILE . 2.2 tm-20 -76.63 -34.67 58.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.026 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.39 -13.75 61.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.69 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 4.2 m-30 -90.06 -10.94 42.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.763 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 173.72 -112.49 0.42 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.583 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -146.45 120.0 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 110.609 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.447 HD11 ' HG3' ' A' ' 226' ' ' LYS . 49.8 mt -85.6 134.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.094 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -86.46 -47.99 8.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.093 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 3.8 m -148.55 132.14 16.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.897 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 45.1 t -120.25 111.59 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.9 m -141.02 107.81 5.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.296 0.569 . . . . 0.0 112.288 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.9 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 79.4 mt -91.68 130.65 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.9 162.17 22.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.954 0.407 . . . . 0.0 110.967 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 56.3 mtp180 -123.68 158.7 30.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -107.77 95.72 15.24 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.94 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.32 -23.42 32.82 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 113.136 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -29.35 55.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.635 ' HB ' ' HE2' ' A' ' 248' ' ' LYS . 1.2 m -114.32 -19.33 11.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 111.509 178.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.63 43.18 5.55 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.877 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.635 ' HE2' ' HB ' ' A' ' 246' ' ' THR . 47.1 mtmt -125.8 -178.51 4.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.755 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -113.18 131.61 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 170.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.431 ' C ' ' H ' ' A' ' 252' ' ' TYR . 70.1 mmtt -65.58 136.44 56.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.62 29.83 1.04 Allowed Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.359 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.6 p90 -154.15 158.46 40.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.673 ' HA3' HD22 ' A' ' 240' ' ' LEU . . . -174.62 -171.42 38.8 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.114 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 164' ' ' GLU . 98.4 m-85 -127.65 133.32 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.936 0.398 . . . . 0.0 110.95 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.07 132.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 1.003 ' HG2' ' HG2' ' A' ' 210' ' ' ARG . 39.7 mt-10 -104.31 144.52 31.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.048 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -120.11 141.44 49.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.225 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.444 ' C ' ' HE3' ' A' ' 259' ' ' LYS . 6.8 pt-20 -81.92 -33.03 30.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.706 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.444 ' HE3' ' C ' ' A' ' 258' ' ' GLU . 0.1 OUTLIER -97.95 113.22 25.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.094 173.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.32 68.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.047 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.65 -35.68 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.2 m -68.37 -25.85 65.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 267' ' ' VAL . 6.9 m -62.42 -30.8 71.48 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.84 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.04 -43.66 57.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.896 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -52.94 -45.52 67.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.349 0.405 . . . . 0.0 110.551 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.536 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . . . -60.56 -42.22 96.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.648 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 263' ' ' SER . 98.2 t -64.46 -39.39 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.716 -176.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.1 p -86.45 -1.0 57.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -115.63 -45.4 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.819 ' HE1' ' HB2' ' A' ' 273' ' ' PHE . 0.0 OUTLIER -64.45 -20.61 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -60.02 -38.27 82.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.744 0.783 . . . . 0.0 110.4 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -78.06 -9.86 59.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.855 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -46.92 106.96 0.09 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.961 0.41 . . . . 0.0 111.494 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.6 108.89 15.54 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.627 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.663 ' HG ' HD21 ' A' ' 220' ' ' LEU . 1.1 mm? -114.7 86.85 2.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.62 -116.83 4.42 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -110.46 23.59 19.91 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.076 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 9.9 pt20 -125.13 151.55 45.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 0.0 111.222 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -107.27 137.84 44.58 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 4.5 tp -69.05 -176.39 0.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.282 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.706 ' HD2' ' HB3' ' A' ' 172' ' ' GLN . 73.2 mmt-85 -141.51 113.26 7.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.832 0.348 . . . . 0.0 110.388 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 270' ' ' MET . 12.3 p -115.19 146.55 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.985 0.422 . . . . 0.0 110.997 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.91 -159.44 9.37 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -108.31 171.64 7.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 117.18 0.49 . . . . 0.0 110.249 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -62.48 -40.59 97.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.609 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.3 t 70.97 -67.05 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.487 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.678 HG21 HD13 ' A' ' 201' ' ' LEU . 0.5 OUTLIER -108.89 160.97 25.38 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.513 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -93.8 95.89 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.152 2.568 . . . . 0.0 111.774 173.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.89 137.93 36.23 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.643 2.229 . . . . 0.0 112.316 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 71.3 mtm -110.99 117.82 49.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.427 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.22 64.47 4.34 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.082 2.521 . . . . 0.0 112.432 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 59.3 tp -101.76 118.05 36.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.439 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.39 95.56 9.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.119 0.485 . . . . 0.0 110.649 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.525 ' N ' ' HD2' ' A' ' 295' ' ' PRO . 27.9 m -63.02 -50.26 77.43 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.661 175.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 294' ' ' THR . 30.2 Cg_endo -63.63 148.78 92.09 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.276 1.984 . . . . 0.0 112.854 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 71.65 125.7 0.03 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.931 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.797 179.328 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.665 -0.174 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.15 34.76 2.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.056 0.455 . . . . 0.0 110.52 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 52.9 tpp -166.09 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.73 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -169.16 -85.9 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.336 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.469 ' C ' ' H ' ' B' ' 28' ' ' ASN . 15.8 m-85 -127.78 171.75 11.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' B' ' 26' ' ' TYR . 90.3 t 73.57 -32.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.479 ' O ' ' HD3' ' B' ' 32' ' ' LYS . 6.4 t30 -46.91 -41.92 16.75 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.673 0.789 . . . . 0.0 112.868 -175.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.02 -51.47 3.84 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.904 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 232' ' ' PHE . . . -58.29 -45.76 87.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.009 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.69 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 23.8 t80 -76.36 -20.47 57.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.125 0.488 . . . . 0.0 110.947 -175.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' B' ' 28' ' ' ASN . 0.2 OUTLIER -82.75 -35.45 26.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.101 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 9.7 t70 -57.97 -46.3 85.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 168.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.702 ' HB3' HG12 ' A' ' 228' ' ' VAL . . . -48.46 -46.74 38.36 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.996 176.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.791 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.2 -21.68 39.41 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.1 -41.67 97.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 54.5 mtt180 -68.83 -36.86 78.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.898 173.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.855 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.0 -42.47 97.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.074 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.461 ' HA ' ' HB3' ' B' ' 42' ' ' ALA 0.253 2.7 mtt180 -81.15 -25.99 36.44 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.706 173.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -54.84 -44.34 73.85 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.34 0.59 . . . . 0.0 110.097 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.775 HD12 ' HZ ' ' A' ' 273' ' ' PHE . 5.5 pt -68.74 -32.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 CA-C-O 121.207 0.527 . . . . 0.0 109.958 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' B' ' 39' ' ' ARG . . . -75.2 -4.59 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.036 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.89 -37.67 15.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.259 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' B' ' 41' ' ' ILE . 11.2 ptpt -72.4 -7.8 51.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.056 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 51.1 mt -28.48 116.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.09 -89.01 0.11 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.745 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.0 -142.73 40.27 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.81 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.8 -34.22 19.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.986 0.422 . . . . 0.0 111.255 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.54 91.48 3.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.77 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.14 77.2 0.38 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.442 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 9.9 p -72.85 -68.63 0.47 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.855 0.359 . . . . 0.0 110.061 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.569 177.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 101' ' ' MET . . . -88.02 78.44 8.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.763 0.281 . . . . 0.0 110.706 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.537 ' HG2' ' O ' ' A' ' 100' ' ' ALA . 6.6 ptp 64.99 149.57 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.758 1.223 . . . . 0.0 112.477 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -142.61 18.08 2.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.537 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -113.34 123.87 51.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.796 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -161.09 166.51 27.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.586 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 43.05 34.22 0.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.331 1.02 . . . . 0.0 112.863 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -70.08 -29.31 66.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.001 0.429 . . . . 0.0 110.545 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 -27.91 69.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.651 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 29.7 tp -65.72 -33.28 75.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.565 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.6 67.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 0.0 110.651 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.0 mt -82.99 -42.31 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.959 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.651 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 26.7 ptm -71.32 -25.47 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.977 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.492 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 83.9 m -86.43 5.52 34.67 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.407 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 12.4 ptp180 -123.87 130.91 53.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 0.0 110.728 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.439 HG23 ' HB ' ' A' ' 158' ' ' VAL . 14.7 m -101.7 145.76 11.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.208 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 73.8 t80 -105.43 127.92 53.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.972 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.5 109.88 30.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.7 152.17 17.48 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.373 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.6 m 61.04 64.09 1.17 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.985 0.421 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.9 mm -54.46 132.09 17.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.376 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 88.5 t80 -44.43 -70.1 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.96 0.787 . . . . 0.0 111.733 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 86.1 t80 171.9 -62.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.752 0.658 . . . . 0.0 109.574 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.81 -25.86 37.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.172 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.52 121.48 13.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -106.41 -175.22 23.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.949 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 32.6 tt0 -65.12 -36.61 84.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.044 0.449 . . . . 0.0 110.07 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.533 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 23.4 m-20 -63.84 -40.9 97.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.319 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.7 m -60.85 -49.74 76.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.45 -51.74 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.057 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.533 ' HE ' ' HA ' ' A' ' 126' ' ' ASP . 23.0 ptt180 -63.62 -35.68 81.31 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.691 -0.404 . . . . 0.0 112.026 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.78 -22.78 49.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.56 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.08 -36.97 58.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.393 . . . . 0.0 110.723 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.463 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 86.9 m-85 -93.31 14.72 17.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.563 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.49 -44.48 18.0 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.273 -178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 34.8 Cg_endo -67.16 -4.67 12.04 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.407 ' CZ ' ' HE2' ' A' ' 173' ' ' MET . 34.6 m-85 -92.47 -75.7 0.48 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.69 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -145.1 -177.57 20.01 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.519 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 2.0 Cg_endo -80.72 135.08 10.03 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.712 2.275 . . . . 0.0 112.069 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.15 109.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -79.08 -56.42 4.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.81 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.3 m -156.88 136.57 12.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.679 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.7 mt -121.13 114.72 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.76 106.1 13.48 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 156' ' ' ALA . 25.2 ptm -116.65 142.4 46.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.7 t -81.79 104.27 12.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.01 117.18 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.452 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 150' ' ' MET . 3.3 t70 -77.25 91.86 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.754 172.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.0 p -94.92 4.49 53.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.988 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.55 -54.35 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 t -120.71 4.83 10.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.364 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.598 ' HA ' ' O ' ' A' ' 146' ' ' ASP . 26.8 ptm 45.51 37.67 3.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.565 1.146 . . . . 0.0 113.198 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -102.95 7.14 39.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 72.16 44.96 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.642 171.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -76.26 81.1 3.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.329 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.8 -161.08 24.96 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.898 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.91 166.93 23.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.478 -0.361 . . . . 0.0 110.08 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -133.03 138.99 46.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.817 0.342 . . . . 0.0 111.571 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.29 119.09 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.78 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.439 ' HB ' HG23 ' A' ' 114' ' ' VAL . 47.4 t -112.57 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 51.5 mt-10 -96.52 141.65 29.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.89 160.25 20.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.754 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.519 ' HG2' ' HG2' ' A' ' 137' ' ' PRO . 10.6 pt-20 -87.59 -2.4 58.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.123 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.459 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 12.9 m -133.57 126.38 19.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.23 177.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.492 ' HG3' ' SG ' ' A' ' 112' ' ' CYS . 17.1 Cg_exo -67.88 -18.02 46.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.468 2.779 . . . . 0.0 111.624 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 14.1 mp0 -62.21 -56.64 16.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.835 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -31.41 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.73 -51.02 66.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.634 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -65.03 -43.64 91.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 110.176 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.49 -48.34 79.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.707 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -58.22 -59.95 4.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.687 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.88 -34.08 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -74.24 -45.03 50.6 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.542 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.657 ' HB3' HD12 ' A' ' 183' ' ' ILE . 26.3 mmt -74.97 -17.85 60.48 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.938 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -76.77 -28.45 55.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.38 0.61 . . . . 0.0 109.644 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.5 m -89.57 -42.92 11.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.042 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 67.4 t -89.52 119.91 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.623 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 88.2 mtp -77.41 112.56 14.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 178' ' ' LEU . 0.6 OUTLIER -79.74 102.98 9.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.234 -176.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.7 -134.41 12.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.856 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -100.21 13.59 60.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.97 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -148.79 161.86 40.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.623 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.1 p-10 -98.29 119.2 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 173' ' ' MET . 28.5 pt -64.4 156.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -100.46 109.73 21.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.6 p -136.52 130.27 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.796 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.69 100.37 1.96 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.952 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.58 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.1 OUTLIER -151.74 87.78 4.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.221 177.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.46 101.38 1.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.678 2.252 . . . . 0.0 111.594 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.8 p -72.45 -21.07 61.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -99.8 29.67 4.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.008 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.7 tt -64.35 139.88 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.679 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.25 -69.27 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -82.62 -26.18 32.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 110.637 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.07 -33.95 72.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.532 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.662 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.0 tp60 -60.56 -53.93 59.71 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 55.9 Cg_exo -54.32 -28.83 54.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.479 2.12 . . . . 0.0 112.689 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.13 -52.61 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 194' ' ' ALA . 35.3 mt -64.33 -42.14 94.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.641 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.3 -37.97 89.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.83 -49.29 78.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.623 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.57 -47.5 84.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.449 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.1 -35.6 79.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.745 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.65 -39.08 64.74 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.747 0.308 . . . . 0.0 110.894 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.77 -31.59 70.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.09 0.471 . . . . 0.0 109.946 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.94 69.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.719 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtt180 -66.2 -25.83 67.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.366 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.78 71.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.901 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -95.16 -26.15 16.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.839 0.828 . . . . 0.0 109.861 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.2 t30 62.26 44.35 7.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 112.124 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -95.92 136.88 35.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.695 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 284' ' ' LYS . 12.2 pt -105.47 161.95 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.104 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.47 118.09 35.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.162 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 51.5 t -105.84 115.67 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.176 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -121.48 178.19 4.91 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.502 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.53 31.97 12.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.558 0.694 . . . . 0.0 110.142 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.572 HG12 HD11 ' A' ' 225' ' ' ILE . 58.6 t -80.71 132.84 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.665 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.47 ' HB2' HD23 ' A' ' 275' ' ' LEU . 4.6 t-80 -65.21 128.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -56.34 -31.98 64.26 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.549 -171.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.66 -26.45 50.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.951 0.405 . . . . 0.0 110.968 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.802 HD22 HD22 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -95.1 117.53 30.36 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -173.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 64.6 m -96.38 -176.53 3.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.6 OUTLIER -61.07 -38.88 87.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -58.24 -37.1 74.23 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.478 0.656 . . . . 0.0 109.83 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.4 m-20 -67.0 -58.57 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.495 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.572 HD11 HG12 ' A' ' 216' ' ' VAL . 43.7 mm -53.48 -28.52 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.574 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -53.15 -32.28 46.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.917 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.616 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 63.9 m -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.332 0.587 . . . . 0.0 112.404 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' B' ' 34' ' ' ALA . 2.9 m -64.58 -44.69 96.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.779 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.606 ' CE2' ' HG3' ' A' ' 270' ' ' MET . 86.0 m-85 -67.65 -36.48 80.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.507 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.4 tt0 -76.32 -28.42 56.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.957 0.408 . . . . 0.0 111.174 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.91 -24.98 67.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.763 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.9 OUTLIER -88.57 -51.22 5.81 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -148.84 160.62 28.46 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.722 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -68.92 131.45 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 229' ' ' PHE . 63.9 mt -96.36 134.39 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.52 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -90.36 -41.68 11.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.1 m -139.15 131.6 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 7.9 p -131.52 91.33 2.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.716 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.9 m -132.15 116.98 17.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.504 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 7.4 mp -90.38 129.89 36.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.06 97.43 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.668 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -80.69 149.71 29.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.699 175.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.5 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 0.0 OUTLIER -78.74 140.16 58.73 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 110.219 -176.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 12.2 Cg_exo -70.73 -20.93 29.65 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.709 2.939 . . . . 0.0 114.767 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 t -101.04 -40.29 7.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.484 -169.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.458 ' HG1' ' CG ' ' A' ' 243' ' ' ASP . 0.7 OUTLIER -106.57 -13.06 15.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.806 -0.559 . . . . 0.0 112.175 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.71 10.87 83.68 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.34 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 248' ' ' LYS . 42.6 mtmt -88.14 137.44 32.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.813 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 2.1 p80 -73.8 126.58 30.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.676 ' HD2' ' HE1' ' A' ' 252' ' ' TYR . 23.7 mttp -69.28 157.8 36.27 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.11 35.08 0.64 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 114.146 0.418 . . . . 0.0 114.146 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.676 ' HE1' ' HD2' ' A' ' 250' ' ' LYS . 38.0 p90 -151.64 154.05 35.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -159.28 179.5 34.84 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.86 121.1 36.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 211' ' ' ILE . 41.9 mm -105.89 124.68 61.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -104.16 118.12 35.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.86 139.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.97 -28.79 39.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.323 0.583 . . . . 0.0 109.656 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 262' ' ' SER . 41.2 tptt -101.34 117.3 34.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.642 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.24 83.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.276 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -68.85 -40.66 79.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.991 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 259' ' ' LYS . 31.6 t -63.37 -30.23 71.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 267' ' ' VAL . 44.2 t -59.87 -42.7 94.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.175 173.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.76 -39.94 88.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.438 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -54.93 -50.66 68.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.134 0.492 . . . . 0.0 110.511 175.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.17 -53.07 59.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.754 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 263' ' ' SER . 96.9 t -58.09 -33.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.666 -176.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.2 m -70.99 -20.22 62.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.2 m -115.08 -29.76 6.56 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.606 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 58.3 mmm -73.51 -2.07 21.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -167.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.443 ' HB3' HD23 ' A' ' 272' ' ' LEU . 51.6 t-20 -69.56 -39.72 77.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.203 1.001 . . . . 0.0 108.993 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -76.72 -8.99 58.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.985 -173.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.878 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 57.0 t80 -52.79 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.27 115.99 19.26 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.688 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.802 HD22 HD22 ' A' ' 220' ' ' LEU . 13.9 tp -122.82 86.1 2.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.53 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.41 33.76 55.73 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.04 1.87 62.77 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.033 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 20.3 pt20 -122.89 131.91 53.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.885 0.342 . . . . 0.0 110.701 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -81.32 133.82 35.49 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.863 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.878 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 12.1 tp -67.39 -178.67 0.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.083 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.775 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -147.8 112.29 5.3 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 270' ' ' MET . 7.9 p -115.34 137.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.184 0.516 . . . . 0.0 111.924 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -143.6 -144.59 4.27 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.919 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 34.3 ttmt -136.41 148.5 47.83 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.454 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -69.67 121.32 16.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.47 -18.22 7.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.136 0.493 . . . . 0.0 110.297 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 2.4 m -108.42 125.2 32.39 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.646 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.37 118.69 5.32 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.674 2.249 . . . . 0.0 111.459 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.09 119.47 6.15 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.58 2.854 . . . . 0.0 113.408 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.711 ' HB2' ' HD3' ' A' ' 291' ' ' PRO . 65.2 mtm -102.47 -54.2 0.13 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.206 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.711 ' HD3' ' HB2' ' A' ' 290' ' ' MET . 1.8 Cg_endo -83.87 151.09 12.73 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.47 2.114 . . . . 0.0 112.385 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.64 140.09 35.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.972 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.07 3.43 38.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.009 0.433 . . . . 0.0 110.733 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.3 p -98.09 152.28 37.95 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.386 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.17 72.37 4.11 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.792 2.328 . . . . 0.0 112.882 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 70.8 -1.37 2.65 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.508 0.723 . . . . 0.0 111.795 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 20.9 m . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.289 178.906 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.56 69.35 10.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.673 0.273 . . . . 0.0 111.679 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 22.4 mmt 62.43 89.52 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.07 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.82 -11.95 53.1 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.646 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' B' ' 28' ' ' ASN . 88.3 t80 -101.92 119.4 38.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.0 110.663 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.755 HG12 ' HB2' ' B' ' 30' ' ' ALA . 58.5 t -119.41 118.45 57.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.095 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.424 ' HB2' ' CE2' ' B' ' 26' ' ' TYR . 23.3 t-20 -107.01 -79.94 0.57 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.788 0.328 . . . . 0.0 110.787 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.29 -18.21 37.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.964 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.755 ' HB2' HG12 ' B' ' 27' ' ' VAL . . . -66.22 -37.21 85.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.871 0.367 . . . . 0.0 110.377 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.723 ' HA ' ' CE1' ' A' ' 232' ' ' PHE . 17.3 t80 -78.02 -19.38 54.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.679 0.752 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.61 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 73.9 mmtt -73.27 -48.25 36.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.69 175.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 26.3 t70 -58.38 -36.62 73.78 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.763 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.52 -54.47 26.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.792 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.679 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 2.9 mm? -81.06 -20.36 41.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.61 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 44.2 mt-30 -63.74 -42.76 97.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.616 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 66.0 mtt180 -68.52 -37.47 80.05 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.939 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.751 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -62.37 -42.18 99.21 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -172.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' B' ' 39' ' ' ARG . 27.5 mtp85 -82.11 -26.25 33.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.385 -1.447 . . . . 0.0 112.589 173.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.93 -41.21 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.183 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.76 HG13 HD12 ' A' ' 220' ' ' LEU . 4.2 pt -68.44 -36.51 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.429 ' HA ' HD11 ' A' ' 220' ' ' LEU . . . -67.04 -15.69 63.88 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.086 0.469 . . . . 0.0 111.092 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.52 -42.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.161 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -82.25 -36.26 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.253 -177.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.401 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 69.3 mt 62.93 -71.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.555 0.742 . . . . 0.0 112.657 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.73 76.86 1.83 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.508 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.41 44.68 3.33 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.428 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.88 -67.84 0.66 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.037 0.446 . . . . 0.0 110.019 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.22 145.16 17.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.075 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.93 -87.75 0.8 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.785 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 39.0 m 71.67 97.21 0.07 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.904 0.414 . . . . 0.0 110.197 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.812 -178.165 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 112.719 -0.152 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 56.8 85.42 0.08 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.239 0.616 . . . . 0.0 112.541 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.6 ptm -81.39 -27.17 34.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.229 0.538 . . . . 0.0 109.828 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.63 101.51 8.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.988 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -79.18 -10.19 59.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.595 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 65.39 34.88 7.83 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.325 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 67.05 101.38 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.19 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -58.86 -29.79 67.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.452 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 111' ' ' MET . . . -59.6 -40.27 86.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.013 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.81 -33.92 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.243 -177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.98 82.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.526 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.57 -36.87 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.106 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 107' ' ' ALA . 76.6 mtp -60.3 -26.48 66.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.873 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 75.8 m -73.35 -19.71 60.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.671 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 12.3 ptp180 -118.35 123.35 45.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 0.0 111.321 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -98.13 130.43 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.42 0.629 . . . . 0.0 111.096 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -75.52 119.25 19.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.023 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 42.7 t -108.21 112.24 39.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.57 178.08 28.58 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.841 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t 72.35 -79.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.437 0.695 . . . . 0.0 110.901 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mm 68.45 115.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.219 0.608 . . . . 0.0 111.613 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.638 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 61.9 t80 -72.27 142.65 48.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.476 ' HE1' ' HG2' ' A' ' 151' ' ' LYS . 92.4 t80 -52.85 -58.41 7.01 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -172.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -93.12 34.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.728 . . . . 0.0 110.233 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.638 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 27.8 tp -108.15 95.96 6.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.29 173.36 54.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.919 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.22 -35.58 80.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 129' ' ' ARG . 25.4 t70 -77.45 -29.43 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.772 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 m -67.33 -47.89 69.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.887 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.4 ' O ' ' HD1' ' A' ' 132' ' ' PHE . 85.3 mt -58.21 -42.55 83.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.76 172.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.493 ' HB3' ' O ' ' A' ' 126' ' ' ASP . 53.3 ttt180 -51.13 -49.82 60.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.202 176.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.585 ' HA ' ' HB3' ' A' ' 133' ' ' ALA . 75.5 mt-30 -75.39 -26.83 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.536 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.43 77.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.113 0.482 . . . . 0.0 110.607 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.487 ' CE2' ' HG3' ' A' ' 173' ' ' MET . 52.3 m-85 -100.95 11.14 40.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.462 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 130' ' ' GLN . . . -71.75 -38.34 6.1 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.945 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.855 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 45.4 Cg_exo -60.15 -15.2 32.79 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.647 1.565 . . . . 0.0 112.78 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -80.45 -72.52 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.942 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.26 -171.9 25.69 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.348 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.87 104.16 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.006 2.47 . . . . 0.0 111.83 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.54 117.87 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.796 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -90.71 -34.89 15.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.789 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t -153.25 142.08 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.917 0.389 . . . . 0.0 110.976 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.8 107.52 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 24.7 t70 -104.6 140.92 37.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.08 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.6 ttm -160.47 143.53 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.582 0.23 . . . . 0.0 110.552 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.2 p -73.95 100.85 3.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.912 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.466 ' CH2' ' HG3' ' A' ' 150' ' ' MET . 2.4 m95 -88.12 158.84 18.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -129.84 89.86 2.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 p 46.68 -145.15 0.24 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.496 170.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -81.64 -21.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.911 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 151' ' ' LYS . 9.2 t -66.03 -26.74 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.303 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.466 ' HG3' ' CH2' ' A' ' 145' ' ' TRP . 52.6 ttm 67.21 13.45 9.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.349 0.595 . . . . 0.0 111.561 175.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.476 ' H ' HG23 ' A' ' 149' ' ' THR . 35.7 mtmm -69.28 121.44 16.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.702 -0.623 . . . . 0.0 109.536 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.41 ' HE1' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -141.19 132.2 26.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.114 0.483 . . . . 0.0 111.045 -174.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 153' ' ' LYS . 34.9 ttpt -166.59 122.79 1.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.239 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.85 -94.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.122 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.92 144.07 47.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 0.0 111.918 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -141.26 161.29 38.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.293 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.498 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 92.3 m-85 -132.7 113.22 12.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.13 112.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 43.5 tt0 -105.42 125.49 51.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.167 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.427 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 96.4 m-85 -103.8 162.22 13.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.517 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.36 -19.46 50.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.964 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.59 134.86 25.25 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.592 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.9 -12.69 33.13 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.526 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 7.1 mp0 -63.87 -50.52 68.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.935 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.68 72.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.54 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.37 91.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.442 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -59.92 -49.45 77.65 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.426 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.702 HD21 ' HA3' ' A' ' 283' ' ' GLY . 37.4 mt -63.44 -41.44 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.58 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -62.17 -46.33 89.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.861 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 tt -67.41 -51.58 50.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.152 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -74.56 -47.74 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -79.81 -49.31 12.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.515 ' HB2' ' O ' ' A' ' 169' ' ' ALA . 16.0 mmt -68.32 -35.18 77.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -173.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.72 -17.68 58.95 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.856 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.2 m -91.05 -8.45 48.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.783 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.69 131.0 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.393 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.802 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 73.8 mtp -81.62 89.83 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.2 tp -38.23 -59.5 0.87 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.834 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.6 91.71 0.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.994 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.48 -57.56 4.45 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.026 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -104.6 149.9 25.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.802 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 6.3 p30 -97.58 118.11 33.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.415 0.626 . . . . 0.0 110.957 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.7 pp -77.24 151.53 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.3 OUTLIER -102.34 118.24 36.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.9 115.34 45.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.03 0.443 . . . . 0.0 110.977 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 104.98 -169.05 16.25 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.985 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 33.4 mtt180 57.45 59.13 7.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.708 0.403 . . . . 0.0 111.883 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 3.9 Cg_exo -77.62 -39.62 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.433 2.089 . . . . 0.0 112.533 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 p -171.22 151.77 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.878 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.726 ' HB3' ' HB3' ' A' ' 193' ' ' GLN . 94.6 m-20 59.29 56.92 3.61 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.483 0.489 . . . . 0.0 110.794 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.47 -21.36 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.54 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.24 -29.0 8.19 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.911 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.726 ' HB3' ' HB3' ' A' ' 190' ' ' ASN . 12.4 tt0 -75.67 -33.42 60.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.877 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -74.12 -27.81 61.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.87 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.401 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 28.1 tp60 -54.69 -55.62 36.12 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.604 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 13.4 Cg_endo -57.1 -37.17 98.92 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 121.869 1.713 . . . . 0.0 111.938 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.6 mm -63.81 -41.46 92.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.391 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 194' ' ' ALA . 51.0 mm -56.13 -50.64 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.826 176.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.45 -44.42 94.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.876 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 25.4 mm-40 -61.87 -41.42 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.59 -44.0 36.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.0 95.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.329 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.595 ' OE2' ' HD3' ' A' ' 206' ' ' ARG . 13.9 tp10 -67.91 -30.27 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.072 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.17 -47.86 47.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.259 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.04 -26.47 67.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.286 0.565 . . . . 0.0 110.552 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.595 ' HD3' ' OE2' ' A' ' 203' ' ' GLU . 75.7 ttt180 -62.68 -23.11 66.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.968 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.65 -23.65 66.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.12 0.486 . . . . 0.0 110.827 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -14.66 36.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.541 0.686 . . . . 0.0 109.994 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.8 t30 57.18 45.4 20.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.679 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.505 ' HD2' ' HG2' ' A' ' 289' ' ' PRO . 94.2 mtt180 -108.58 136.49 48.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.906 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.1 pt -113.21 166.88 6.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.18 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -111.35 122.04 46.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.539 -172.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.444 ' HB ' ' CZ ' ' A' ' 229' ' ' PHE . 3.9 p -112.97 121.11 64.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 0.0 110.793 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.4 175.94 6.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.576 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.855 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 8.1 t 68.97 24.61 6.23 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.458 0.703 . . . . 0.0 110.856 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 240' ' ' LEU . 61.2 t -75.05 135.46 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.139 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -76.73 141.41 40.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.066 0.46 . . . . 0.0 110.501 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -65.15 -13.42 58.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.39 -47.26 23.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -173.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.86 HD21 HD11 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -101.71 159.33 15.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.181 -174.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 16.0 m -113.06 -177.89 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.0 OUTLIER -53.71 -47.55 70.44 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.334 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -55.14 -30.03 58.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 0.0 110.931 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.941 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 52.4 m-20 -78.79 -53.75 6.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.363 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.464 HD11 HD13 ' A' ' 220' ' ' LEU . 46.0 mm -61.48 -16.95 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.242 0.544 . . . . 0.0 110.89 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -54.34 -31.37 54.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.093 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.633 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 69.3 m -52.6 -62.13 1.84 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.934 0.873 . . . . 0.0 111.253 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.615 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 3.9 m -66.28 -34.05 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.605 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.444 ' CZ ' ' HB ' ' A' ' 213' ' ' VAL . 48.3 m-85 -74.68 -35.52 62.78 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.625 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.752 ' HG3' HG23 ' A' ' 235' ' ' ILE . 50.3 tt0 -77.23 -32.29 55.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 111.33 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.05 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.695 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.677 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 4.0 m-30 -85.52 -30.88 23.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 110.209 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -174.02 167.95 40.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.378 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -58.04 106.05 0.33 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 112.254 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.752 HG23 ' HG3' ' A' ' 230' ' ' GLU . 15.9 tt -87.97 142.07 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.047 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.06 -44.35 5.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 24.8 t -147.58 137.39 22.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.333 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.83 119.42 33.51 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.4 m -138.1 103.17 4.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 13.5 tp -88.36 129.74 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.31 114.21 2.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.193 0.52 . . . . 0.0 110.843 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 24.9 mtt180 -91.38 156.4 17.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 -176.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.424 ' HB2' ' HE3' ' A' ' 250' ' ' LYS . 26.5 t70 -128.57 113.31 19.34 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.858 -173.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.43 -19.44 37.72 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.87 2.38 . . . . 0.0 112.613 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -55.52 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 110.429 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.6 p -82.34 -35.47 27.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.21 -0.29 44.03 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.33 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -112.03 -103.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 111.301 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 32.1 p80 -163.26 164.22 25.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.439 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 243' ' ' ASP . 7.6 mptt -90.25 157.58 17.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.76 40.86 1.64 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.133 -0.556 . . . . 0.0 113.291 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -157.86 164.62 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.74 -169.59 36.2 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.252 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -125.48 137.99 53.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.36 . . . . 0.0 110.343 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.28 123.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.922 177.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 42.6 tt0 -106.69 131.98 53.2 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.08 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.417 ' CD1' ' HA ' ' A' ' 235' ' ' ILE . 68.5 m-85 -112.47 153.0 28.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.19 0.519 . . . . 0.0 111.498 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.98 -22.4 23.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.772 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.641 ' HE3' ' HB2' ' A' ' 261' ' ' GLN . 35.5 ttpt -115.4 117.64 30.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.6 -25.04 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.926 0.393 . . . . 0.0 111.779 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.641 ' HB2' ' HE3' ' A' ' 259' ' ' LYS . 24.2 mp0 -66.65 -33.72 76.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.637 ' OG ' ' HE2' ' A' ' 259' ' ' LYS . 14.8 m -62.93 -38.04 89.43 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 267' ' ' VAL . 14.5 m -59.76 -38.59 82.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.55 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.01 -45.56 81.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.68 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.51 -44.33 93.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.583 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -61.42 -53.73 52.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.069 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 263' ' ' SER . 84.2 t -57.6 -27.27 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 0.0 111.336 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.3 m -72.41 -48.14 43.72 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.7 t -116.48 -13.0 10.95 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -168.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.817 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 2.2 tpt -61.78 -32.45 72.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -170.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 20.9 p-10 -66.69 -22.63 66.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.81 -10.93 59.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.887 ' CZ ' ' HB2' ' B' ' 38' ' ' ALA . 2.0 t80 -69.28 104.8 2.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.771 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.46 88.55 3.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.54 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.86 HD11 HD21 ' A' ' 220' ' ' LEU . 62.7 tp -93.33 87.14 5.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.449 -174.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.94 37.36 11.6 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.759 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.19 65.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.941 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -141.17 130.92 24.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 99.6 m-85 -67.78 132.69 47.89 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 55.7 mt -61.93 -177.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.595 0.712 . . . . 0.0 110.751 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.31 121.84 9.14 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 7.4 p -121.8 134.59 64.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.224 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.702 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -141.64 -148.36 5.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.454 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -127.93 178.86 5.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.801 0.334 . . . . 0.0 110.56 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.526 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -104.54 117.72 34.82 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 66.3 t -94.38 -33.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.304 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 11.1 t -107.29 133.66 20.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.93 121.78 10.68 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.628 2.219 . . . . 0.0 111.919 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.505 ' HG2' ' HD2' ' A' ' 210' ' ' ARG . 27.9 Cg_exo -62.16 96.29 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.993 2.462 . . . . 0.0 111.941 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 18.2 ptp -82.89 139.6 43.15 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.253 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.52 47.32 1.84 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.496 2.798 . . . . 0.0 113.134 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 55.7 tp -84.87 93.42 8.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 48.7 tp -99.06 94.56 6.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.759 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 13.9 t -71.28 146.31 91.95 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.671 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.83 86.41 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.662 2.241 . . . . 0.0 111.814 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -94.27 59.56 2.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.572 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.5 177.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.44 96.99 10.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.863 0.364 . . . . 0.0 110.171 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mmm -78.1 71.95 4.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.12 73.55 0.17 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -166.62 151.66 7.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.764 0.316 . . . . 0.0 110.524 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' B' ' 30' ' ' ALA . 51.9 t -112.34 139.87 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.523 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -110.3 125.12 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.559 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.838 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 5.6 m-20 76.52 -43.12 0.45 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.612 0.765 . . . . 0.0 112.821 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.462 ' HB2' ' CG1' ' B' ' 27' ' ' VAL . . . -68.24 -29.42 68.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.172 0.51 . . . . 0.0 110.043 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 8.5 t80 -79.06 -17.92 54.37 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 109.473 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.838 ' HD3' ' HA ' ' B' ' 29' ' ' ASP . 52.8 mtpt -75.21 -43.62 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.548 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.61 -44.63 85.6 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.677 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -47.59 -52.31 18.2 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.048 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.757 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -82.06 -22.4 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -65.48 -39.01 91.43 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.633 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 22.7 mmt180 -69.28 -41.85 76.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.339 171.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.887 ' HB2' ' CZ ' ' A' ' 273' ' ' PHE . . . -58.5 -45.16 89.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.843 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -79.9 -25.88 40.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.4 -1.437 . . . . 0.0 112.666 174.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.94 -49.06 66.8 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 169.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.941 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 3.2 pt -64.47 -32.42 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.338 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.752 ' HA ' HD22 ' A' ' 220' ' ' LEU . . . -73.12 -25.68 60.94 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.11 -43.06 14.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 2.8 tmmm? -65.98 -41.44 91.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt 70.78 -80.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.05 174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.96 166.49 21.4 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.847 -173.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.96 114.74 2.29 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.722 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.87 139.13 58.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.675 0.274 . . . . 0.0 110.488 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.91 26.35 9.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.949 0.404 . . . . 0.0 111.002 -176.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.01 99.05 2.19 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.085 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 p -83.63 126.95 33.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.701 0.286 . . . . 0.0 110.744 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.914 179.85 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 112.024 -0.431 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.38 117.3 22.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.802 0.334 . . . . 0.0 110.85 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -134.29 -175.72 3.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.078 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -86.32 -69.11 0.69 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.868 0.366 . . . . 0.0 110.701 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 178.52 -68.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.484 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.686 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 46.9 ttp180 -166.86 100.8 0.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.45 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -103.6 56.44 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.765 0.317 . . . . 0.0 111.101 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.686 ' HG2' ' HG2' ' A' ' 104' ' ' ARG . 24.1 mmm180 -71.8 -32.5 67.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.047 -177.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -52.7 35.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.654 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 3.1 mm? -60.61 -37.26 80.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.094 -176.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.54 79.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.45 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.422 HD13 ' HB1' ' A' ' 194' ' ' ALA . 35.4 pt -85.27 -40.88 15.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.497 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 25.5 ptm -71.76 -28.24 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -171.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 81.0 m -92.63 6.51 47.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.639 0.257 . . . . 0.0 110.959 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -119.63 101.06 7.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.216 0.532 . . . . 0.0 111.383 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -109.68 125.53 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -91.09 149.1 21.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.524 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 47.1 t -111.52 111.27 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.062 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.5 -178.27 17.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.04 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.847 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 39.3 m 62.13 29.12 17.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.37 0.605 . . . . 0.0 111.027 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.5 mt -70.02 147.16 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.053 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.3 -73.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.433 ' HE1' ' HB3' ' A' ' 151' ' ' LYS . 48.2 t80 -176.42 -67.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -76.93 -26.92 54.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.336 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.822 HD22 HG22 ' A' ' 127' ' ' THR . 90.2 mt -54.61 125.67 20.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.846 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -107.68 -172.02 22.0 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.006 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.49 ' HB2' HG23 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -68.94 -26.6 65.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.896 0.379 . . . . 0.0 110.097 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.7 -40.79 98.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.697 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.822 HG22 HD22 ' A' ' 123' ' ' LEU . 12.2 m -63.58 -46.11 87.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 110.445 177.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -63.14 -39.45 85.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -54.7 -42.49 71.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.028 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -77.69 -34.0 53.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.684 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.49 89.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.565 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 96.5 m-85 -97.17 12.28 33.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -68.1 -44.99 40.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.782 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.944 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.9 Cg_endo -68.46 -5.0 14.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.857 1.705 . . . . 0.0 112.991 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.452 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 4.6 m-85 -84.97 -75.35 0.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.843 0.354 . . . . 0.0 110.122 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -147.47 167.19 28.6 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.478 ' HD2' HG22 ' A' ' 162' ' ' VAL . 22.8 Cg_exo -64.82 121.62 9.2 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.286 1.991 . . . . 0.0 111.729 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.455 HG23 HG13 ' A' ' 141' ' ' ILE . 2.0 mp -68.16 119.29 13.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.171 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -86.64 -46.1 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.544 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 m -148.38 141.33 24.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.357 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 125' ' ' GLU . 54.5 mt -124.26 107.03 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.64 108.33 19.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.751 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.424 ' SD ' ' HB3' ' A' ' 125' ' ' GLU . 27.2 ttt -132.0 119.8 21.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.911 0.386 . . . . 0.0 111.034 -176.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.0 t -90.34 83.09 5.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.551 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 2.9 p-90 -143.26 152.92 42.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.867 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.44 117.4 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.195 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.7 m -75.72 -9.01 58.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.938 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 50.7 t -81.85 -57.44 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.378 . . . . 0.0 110.751 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.41 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 27.9 p -80.06 -29.84 39.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.551 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 81.4 mtp 71.86 -10.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.799 0.84 . . . . 0.0 112.257 176.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 11.7 ptmm? -84.29 114.46 21.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.176 0.512 . . . . 0.0 109.667 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -142.36 145.25 33.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.016 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -119.59 13.06 12.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.624 0.726 . . . . 0.0 109.788 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.57 153.6 22.18 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.479 172.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -106.68 174.26 5.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.868 0.366 . . . . 0.0 110.934 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.19 148.93 36.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.306 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.15 115.25 29.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.068 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.86 108.37 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.043 0.449 . . . . 0.0 110.075 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -102.02 119.67 39.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.439 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.565 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 41.9 m-85 -93.58 149.63 21.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.295 0.569 . . . . 0.0 112.425 -174.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.437 ' OE1' ' HG2' ' A' ' 137' ' ' PRO . 33.8 tt0 -74.29 -27.65 60.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.463 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 137' ' ' PRO . 26.5 m -121.45 120.9 28.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.942 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 33.5 Cg_exo -61.22 -25.85 81.3 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.389 2.726 . . . . 0.0 113.403 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.495 ' OE2' ' HD2' ' A' ' 163' ' ' PRO . 1.7 mp0 -58.56 -50.51 73.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.945 0.403 . . . . 0.0 110.122 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.43 -23.09 64.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.77 77.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.488 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -70.6 -39.54 73.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.573 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -58.93 -41.46 87.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.666 0.269 . . . . 0.0 110.917 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.49 -43.11 99.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.9 0.381 . . . . 0.0 110.427 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.709 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.2 tt -64.57 -42.26 95.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.646 -178.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -47.29 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -79.97 -50.13 10.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.463 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 56.1 tpp -74.16 -28.15 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.831 0.348 . . . . 0.0 111.378 -172.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.437 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 10.7 t30 -81.36 -16.82 51.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.201 0.524 . . . . 0.0 110.521 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 t -84.15 -29.21 26.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.32 175.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 91.4 mtp -111.85 111.63 22.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.022 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 48.9 tp -68.55 104.64 2.0 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.86 -78.56 1.36 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.09 35.04 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -123.34 145.69 48.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.498 0.189 . . . . 0.0 110.81 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -87.65 71.28 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.847 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.6 pt -69.16 156.31 7.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.399 -171.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 6.5 mmmm -101.94 109.99 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.093 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 63.2 t -122.31 121.51 64.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.956 0.408 . . . . 0.0 110.065 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.709 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 73.76 -126.94 10.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.129 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 52.84 77.24 0.46 Allowed Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 110.205 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.93 119.68 7.0 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.509 2.806 . . . . 0.0 113.748 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 m -71.67 -17.64 62.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.036 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.38 6.38 8.52 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.492 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.6 mm 71.34 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.913 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 173.07 50.68 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.43 -47.84 78.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.009 0.433 . . . . 0.0 111.414 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.548 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -111.61 18.04 19.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.787 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.12 -47.38 79.46 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.583 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.9 -42.35 44.99 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.794 2.329 . . . . 0.0 114.599 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 198' ' ' ILE . 2.6 pp -75.44 -24.25 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.776 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 194' ' ' ALA . 34.5 mt -65.24 -38.5 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.63 0.252 . . . . 0.0 110.542 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.05 -44.63 87.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.332 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.72 -44.63 81.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.573 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.739 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 91.2 mt -61.67 -45.57 93.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.841 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.2 -37.52 87.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.557 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.34 -34.13 77.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -73.93 -41.18 62.44 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.985 0.421 . . . . 0.0 110.198 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.62 72.42 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.779 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -57.4 -38.31 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.956 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.21 -13.01 61.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.564 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.552 ' HE2' ' HB3' ' A' ' 288' ' ' PRO . 17.3 m-85 -93.03 -6.94 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.741 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.29 27.34 16.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.748 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.749 ' HD2' ' HG2' ' A' ' 289' ' ' PRO . 92.2 mtt180 -102.26 137.0 41.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.895 0.379 . . . . 0.0 111.159 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.6 pt -121.21 161.5 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.639 175.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -116.02 135.73 53.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.771 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.45 124.56 60.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.885 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.03 -179.22 4.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.944 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 51.0 m 69.64 19.16 7.44 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.709 0.804 . . . . 0.0 111.473 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.64 HG11 HD11 ' A' ' 225' ' ' ILE . 85.1 t -65.61 140.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.392 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -63.45 132.64 52.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.937 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.634 ' HG3' ' H ' ' A' ' 219' ' ' ASP . 6.2 pt20 -41.42 -55.96 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.634 ' H ' ' HG3' ' A' ' 218' ' ' GLN . 0.5 OUTLIER -79.64 -47.27 15.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.739 HD13 HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -55.89 111.96 1.06 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.042 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.445 ' O ' HG12 ' A' ' 225' ' ' ILE . 56.9 p -97.24 -178.01 4.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -162.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 18.8 p-10 -59.76 -44.04 94.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.434 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.44 -29.29 66.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.546 0.689 . . . . 0.0 109.833 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.665 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 64.5 m-20 -78.73 -54.09 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.513 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.64 HD11 HG11 ' A' ' 216' ' ' VAL . 27.9 mm -53.54 -27.59 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.359 0.599 . . . . 0.0 110.947 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.23 -31.6 44.05 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.84 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -48.94 -58.47 4.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.529 0.68 . . . . 0.0 111.932 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' B' ' 34' ' ' ALA . 6.0 m -74.35 -42.26 50.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.607 -171.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.45 ' CE1' ' HG3' ' A' ' 270' ' ' MET . 35.6 m-85 -59.76 -52.99 63.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 0.0 110.927 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.1 tt0 -66.79 -24.03 66.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 -176.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.07 -33.26 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.827 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.76 ' HE1' ' HB1' ' B' ' 34' ' ' ALA . 1.6 m-30 -82.95 -42.25 17.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -151.77 148.37 19.3 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 42.0 mmtm -62.02 122.75 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.684 0.754 . . . . 0.0 110.965 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 238' ' ' CYS . 20.1 tt -87.95 141.16 14.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.109 -169.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -91.96 -42.2 10.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 256' ' ' GLU . 12.8 p -161.59 146.7 13.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.599 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.423 ' HB3' HD13 ' A' ' 235' ' ' ILE . 6.3 p -137.94 129.98 28.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.841 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 48.6 m -150.61 119.73 6.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.047 0.451 . . . . 0.0 110.988 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.3 mp -99.38 130.52 45.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.795 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.33 137.22 58.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.077 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 52.3 mtt85 -94.25 157.76 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.188 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.561 ' OD1' HG22 ' A' ' 245' ' ' THR . 8.1 t70 -100.32 108.48 52.92 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 14.8 Cg_exo -70.04 -17.55 36.25 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.364 2.709 . . . . 0.0 114.172 -175.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.561 HG22 ' OD1' ' A' ' 243' ' ' ASP . 3.5 t -94.6 -6.51 43.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.42 . . . . 0.0 111.125 -172.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.471 ' OG1' ' HE3' ' A' ' 248' ' ' LYS . 24.6 p -133.82 -41.78 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 119.96 -24.64 7.81 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.705 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.471 ' HE3' ' OG1' ' A' ' 246' ' ' THR . 0.0 OUTLIER -82.1 -179.86 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.827 0.314 . . . . 0.0 110.776 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.7 p80 -94.0 151.29 19.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.453 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -78.96 154.88 29.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.64 44.62 2.29 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.783 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.431 ' CE2' ' HD3' ' A' ' 137' ' ' PRO . 41.3 p90 -161.8 160.25 28.03 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.149 0.475 . . . . 0.0 110.382 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -170.81 -173.0 37.64 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.354 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.411 ' C ' HD12 ' A' ' 255' ' ' ILE . 87.8 m-85 -123.62 142.6 50.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.681 0.277 . . . . 0.0 110.652 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 254' ' ' PHE . 3.1 mp -124.45 131.32 72.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.618 174.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.444 ' HB3' ' OG ' ' A' ' 237' ' ' SER . 30.6 tt0 -112.28 141.07 46.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -119.57 147.74 44.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.176 0.512 . . . . 0.0 111.49 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -79.97 -21.52 43.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.924 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 261' ' ' GLN . 34.9 ttpt -122.08 113.41 19.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.054 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.5 47.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.189 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.444 ' HB3' ' HE3' ' A' ' 259' ' ' LYS . 20.7 tt0 -56.99 -48.19 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.276 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.0 m -62.72 -31.5 72.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.3 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.4 m -59.67 -39.89 85.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.625 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -74.26 -42.97 58.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.858 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -63.78 -31.58 72.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.549 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -72.43 -54.16 10.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.458 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.58 -26.29 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -85.25 -18.34 34.29 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -115.05 -32.97 5.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.643 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.3 mmm -62.58 -21.33 65.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -172.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -58.07 -36.07 72.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.835 0.826 . . . . 0.0 110.377 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 272' ' ' LEU . 3.9 mm? -75.76 -8.73 57.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.21 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.872 ' HZ ' HD13 ' B' ' 41' ' ' ILE . 1.6 t80 -56.63 102.09 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -175.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.8 t70 -92.26 124.16 36.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.945 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.678 ' HG ' HD21 ' A' ' 220' ' ' LEU . 2.2 mm? -122.78 87.08 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.712 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.64 22.98 44.53 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.939 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.53 7.25 42.9 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.801 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.0 pt20 -125.85 130.66 51.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.789 0.328 . . . . 0.0 110.573 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -87.43 144.54 26.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.698 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 273' ' ' PHE . 11.0 mt -75.92 -173.72 2.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.549 . . . . 0.0 110.409 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.41 113.47 5.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 270' ' ' MET . 7.0 m -114.84 154.04 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.059 0.457 . . . . 0.0 111.866 -177.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.31 -150.9 6.67 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.763 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 284' ' ' LYS . 28.3 mmtp -96.31 157.9 15.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.28 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.6 t 69.17 -71.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.625 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.474 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 12.3 p -89.59 133.86 33.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.412 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.739 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 16.1 Cg_exo -67.29 122.29 9.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.95 2.434 . . . . 0.0 112.613 -175.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.749 ' HG2' ' HD2' ' A' ' 210' ' ' ARG . 12.8 Cg_exo -70.92 75.57 1.68 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.065 2.51 . . . . 0.0 111.581 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 51.5 ttm -72.91 122.59 88.02 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 6.5 Cg_exo -74.7 59.26 4.91 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.192 2.594 . . . . 0.0 112.024 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 292' ' ' LEU . 0.2 OUTLIER -82.08 66.47 7.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.382 0.611 . . . . 0.0 110.18 -177.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 98.8 mt -101.92 19.25 18.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.349 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.459 ' N ' ' CD ' ' A' ' 295' ' ' PRO . 4.7 p -76.33 -31.3 0.95 Allowed Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 294' ' ' THR . 80.1 Cg_exo -47.23 106.65 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.373 2.049 . . . . 0.0 113.083 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -107.99 84.17 1.91 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.278 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 60.9 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.325 -179.692 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.68 102.22 1.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.001 0.429 . . . . 0.0 111.372 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mmm -102.11 153.02 20.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.658 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.23 -171.33 40.78 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.723 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -112.95 29.92 7.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.044 0.449 . . . . 0.0 110.424 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.438 HG11 ' HB3' ' B' ' 30' ' ' ALA . 98.2 t -99.07 115.49 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.197 0.522 . . . . 0.0 111.774 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -136.02 143.82 44.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' B' ' 32' ' ' LYS . 35.2 m-20 72.25 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.786 0.679 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.438 ' HB3' HG11 ' B' ' 27' ' ' VAL . . . -60.38 -36.74 78.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.966 0.412 . . . . 0.0 111.0 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.643 ' O ' HD21 ' B' ' 35' ' ' LEU . 10.6 t80 -73.99 -19.81 60.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.174 0.512 . . . . 0.0 109.861 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.533 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.9 mttt -73.81 -41.49 62.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.95 -38.91 76.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.436 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.76 ' HB1' ' HE1' ' A' ' 232' ' ' PHE . . . -50.13 -54.13 22.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.339 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.916 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -79.76 -17.46 53.4 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -172.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 43.0 mt-30 -60.08 -47.11 87.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.636 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 70.6 mtp180 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.245 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.916 ' HB2' ' HA ' ' B' ' 35' ' ' LEU . . . -68.01 -46.16 72.04 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.474 ' HA ' ' HB2' ' B' ' 42' ' ' ALA . 5.4 mtm180 -79.78 -24.66 41.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.512 -1.368 . . . . 0.0 112.166 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 51.9 tt0 -52.74 -50.03 64.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 109.816 167.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.894 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.4 pt -68.4 -25.39 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.008 0.432 . . . . 0.0 110.58 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' B' ' 39' ' ' ARG . . . -81.2 -11.92 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.65 -30.7 20.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.827 0.346 . . . . 0.0 110.298 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.894 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 15.7 ptpt -76.39 -4.33 41.74 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.72 117.92 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.598 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.94 -9.55 37.07 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.65 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.92 -64.94 4.2 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 t70 56.14 41.8 29.02 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.846 0.458 . . . . 0.0 110.45 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . 73.7 -38.97 0.42 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.785 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.19 -54.48 4.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.339 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -134.23 138.49 45.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.247 0.929 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.37 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.69 146.04 27.96 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -116.69 -177.29 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.453 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 66.16 49.6 1.5 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 123.837 0.711 . . . . 0.0 110.175 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 54.1 mt-30 -63.57 -84.04 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.54 ' HG2' HG21 ' A' ' 297' ' ' THR . 23.4 mtp180 52.45 32.82 11.95 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 173.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 59.69 31.55 20.93 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.016 0.436 . . . . 0.0 110.97 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 103' ' ' GLN . 18.0 ttp180 -65.03 -28.15 69.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.915 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.72 -36.51 64.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.32 -42.68 44.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.497 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . . . -62.06 -35.38 78.46 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.188 -176.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.98 -35.85 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.121 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.4 mmm -68.61 -36.53 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.407 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 166' ' ' ALA . 23.4 p -81.13 6.25 14.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 78.0 ttt180 -111.39 96.24 5.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 m -92.76 144.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.554 0.692 . . . . 0.0 111.878 -175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -96.9 127.3 42.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.53 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 111.19 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.651 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.57 -179.72 16.18 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.697 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.1 m 56.45 34.53 24.42 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.351 0.596 . . . . 0.0 110.898 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.4 HG21 ' N ' ' A' ' 120' ' ' TYR . 9.0 mt -73.86 163.82 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.967 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.457 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 85.9 t80 -57.29 -72.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 31.1 t80 173.35 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.438 0.461 . . . . 0.0 109.762 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.72 -20.5 58.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.43 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.737 HD22 HG22 ' A' ' 127' ' ' THR . 47.5 mt -58.57 110.16 0.93 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.062 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -109.24 -153.69 15.39 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.144 -172.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.8 -51.18 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.633 0.255 . . . . 0.0 111.136 -175.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.35 -26.81 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 -175.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.737 HG22 HD22 ' A' ' 123' ' ' LEU . 3.6 m -67.59 -53.81 25.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.021 0.439 . . . . 0.0 110.053 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.32 -39.38 85.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.274 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -59.52 -38.31 80.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.009 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.29 -44.28 25.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.308 . . . . 0.0 111.66 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.69 81.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.583 ' HB3' ' HH ' ' A' ' 160' ' ' TYR . 84.7 m-85 -106.48 18.98 21.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.839 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.599 ' HA ' HD11 ' A' ' 138' ' ' ILE . . . -65.47 -43.91 64.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.031 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.497 ' HD3' ' HB1' ' A' ' 133' ' ' ALA . 22.6 Cg_exo -68.35 -5.16 14.33 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.03 1.82 . . . . 0.0 112.665 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.519 ' HB3' ' HB3' ' A' ' 165' ' ' ALA . 9.0 m-85 -94.64 60.27 2.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.535 ' HA3' HG22 ' A' ' 162' ' ' VAL . . . 78.12 175.32 44.54 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.75 118.57 3.83 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.861 2.374 . . . . 0.0 111.91 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.606 HG13 ' HE1' ' A' ' 160' ' ' TYR . 3.8 mp -60.47 118.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -89.57 -49.56 6.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 109.951 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 p -161.45 147.8 14.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.934 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.98 107.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.14 118.42 34.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.7 ptm -143.33 148.29 36.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.53 108.93 11.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.537 0.684 . . . . 0.0 111.633 -177.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.522 ' CZ3' ' HB2' ' A' ' 152' ' ' HIS . 78.0 m95 -104.14 155.68 18.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.452 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -101.76 86.72 2.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.663 0.744 . . . . 0.0 110.197 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.0 p 33.58 -108.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.355 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.45 -28.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -170.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -33.51 67.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.3 mmt 58.93 44.95 15.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.356 0.598 . . . . 0.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HG3' ' CE2' ' A' ' 121' ' ' TYR . 10.6 tptm -93.45 -29.1 15.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.522 ' HB2' ' CZ3' ' A' ' 145' ' ' TRP . 57.0 t60 60.91 75.84 0.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.492 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -102.84 81.21 1.97 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.79 -155.52 11.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.572 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -125.65 175.03 7.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.35 28.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.76 0.314 . . . . 0.0 111.574 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.21 119.91 39.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -114.81 119.42 61.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 0.0 110.463 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.1 tt0 -104.02 130.4 51.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.164 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.606 ' HE1' HG13 ' A' ' 138' ' ' ILE . 51.6 m-85 -110.71 171.54 7.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.644 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.69 14.95 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.535 HG22 ' HA3' ' A' ' 136' ' ' GLY . 8.7 m -134.42 105.88 11.04 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.609 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.44 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 38.6 Cg_exo -58.97 -26.9 83.22 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.173 2.582 . . . . 0.0 113.299 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.503 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 2.1 mp0 -61.8 -57.94 9.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.27 -26.4 66.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.756 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 112' ' ' CYS . . . -63.02 -51.57 66.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.785 0.326 . . . . 0.0 110.796 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -74.55 -31.82 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 59.2 tp -56.07 -50.08 71.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.65 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.94 97.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.908 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.902 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.4 tt -60.68 -42.68 97.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.633 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.6 -46.1 17.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.48 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 75.8 mm-40 -83.95 -50.93 7.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.404 ' HG3' ' CE2' ' A' ' 132' ' ' PHE . 16.0 mmt -74.46 -30.76 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -172.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.37 -24.35 67.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.292 0.567 . . . . 0.0 110.534 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.1 m -92.24 -2.28 56.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.719 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.6 t -118.28 139.86 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.785 ' HE2' ' HB2' ' A' ' 182' ' ' ASN . 58.7 mtt -99.6 117.28 33.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.83 121.49 27.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 69.98 -88.07 0.3 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -173.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.78 11.75 0.96 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -100.5 132.67 45.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.615 -175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.785 ' HB2' ' HE2' ' A' ' 177' ' ' MET . 6.0 t30 -86.78 89.49 7.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 pt -72.54 142.08 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.83 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -102.73 110.04 21.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.61 110.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.902 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 105.07 110.68 3.53 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.876 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 49.5 ttt180 -109.33 113.82 58.18 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 187' ' ' ARG . 38.1 Cg_endo -66.46 77.06 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.101 2.534 . . . . 0.0 111.549 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.1 m -84.56 -22.7 29.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.525 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -123.31 114.23 19.93 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.8 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.9 mt -129.2 98.41 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 138.48 -47.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -81.27 -57.39 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.034 0.445 . . . . 0.0 110.969 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.516 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -92.19 -14.92 28.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.377 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.652 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 24.2 tp60 -56.22 -51.67 78.98 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.057 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 27.6 Cg_exo -63.53 -34.39 64.66 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.028 1.819 . . . . 0.0 111.976 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.07 -42.19 95.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.4 mt -59.57 -44.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.783 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.36 -42.32 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.493 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -59.86 -51.18 70.81 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.755 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.43 HD13 ' N ' ' A' ' 202' ' ' ALA . 3.3 pp -75.71 -29.02 58.81 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.654 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.43 ' N ' HD13 ' A' ' 201' ' ' LEU . . . -73.36 -40.09 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 0.0 110.365 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.44 -44.11 97.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.564 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.73 -30.38 67.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -64.41 -22.5 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -61.14 -32.99 72.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.37 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 111.031 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -87.26 -26.4 23.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.668 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.5 p30 40.53 46.61 2.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.71 0.804 . . . . 0.0 112.944 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 210' ' ' ARG . 29.4 mtp180 -87.41 136.22 33.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.643 HD12 ' HE2' ' A' ' 229' ' ' PHE . 15.8 tt -104.78 146.69 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 0.0 110.359 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -111.36 139.25 46.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.578 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.439 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 5.9 p -136.13 125.91 40.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.181 0.515 . . . . 0.0 110.721 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.42 179.96 4.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.276 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.8 t 65.05 25.4 12.59 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.789 0.681 . . . . 0.0 109.674 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.727 HG12 HD12 ' A' ' 225' ' ' ILE . 46.3 t -70.37 129.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.898 -176.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.62 131.25 50.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.51 -50.56 31.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.864 ' HB2' HG22 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -75.53 -46.44 32.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.804 HD11 HG13 ' B' ' 41' ' ' ILE . 0.9 OUTLIER -63.53 101.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.015 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 225' ' ' ILE . 50.9 m -91.33 -177.18 4.78 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.043 -169.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.811 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 21.8 p-10 -61.07 -39.26 89.19 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -56.36 -30.59 62.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 110.467 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.64 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 9.4 m-20 -78.69 -53.05 7.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.048 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.727 HD12 HG12 ' A' ' 216' ' ' VAL . 30.8 mm -52.04 -29.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.466 0.706 . . . . 0.0 111.238 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.54 ' HG3' HD11 ' A' ' 235' ' ' ILE . 87.7 tttt -50.32 -31.64 14.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.882 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.682 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 63.8 m -48.39 -61.89 1.77 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.543 0.687 . . . . 0.0 111.723 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.785 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 3.7 m -74.04 -35.74 42.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.481 -170.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.643 ' HE2' HD12 ' A' ' 211' ' ' ILE . 38.9 m-85 -68.33 -48.89 63.67 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.091 -0.243 . . . . 0.0 111.311 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 31.4 tt0 -78.24 -11.9 59.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 111.239 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.27 -28.35 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.654 0.264 . . . . 0.0 111.079 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.77 ' HE1' ' HB3' ' B' ' 34' ' ' ALA . 0.8 OUTLIER -94.82 -62.19 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.628 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -117.98 175.98 15.94 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.766 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -92.3 118.34 30.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.156 0.503 . . . . 0.0 111.304 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.54 HD11 ' HG3' ' A' ' 226' ' ' LYS . 65.3 mt -75.66 138.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.958 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -90.96 -45.4 8.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 4.2 p -156.82 131.7 8.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.33 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 9.6 p -120.5 128.09 52.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.747 0.308 . . . . 0.0 110.223 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.3 p -143.23 111.06 5.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.811 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 9.4 mp -101.59 116.88 33.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -53.05 112.82 0.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.086 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.902 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -97.21 144.77 26.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.156 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.44 ' HB3' ' HG1' ' A' ' 246' ' ' THR . 9.5 t70 -89.56 118.49 69.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.279 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.91 -21.84 37.01 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.952 2.435 . . . . 0.0 113.522 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 37.9 p -89.08 -17.65 28.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 0.0 111.527 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.44 ' HG1' ' HB3' ' A' ' 243' ' ' ASP . 31.0 p -102.15 -37.24 8.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.973 0.416 . . . . 0.0 110.52 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.21 1.03 55.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.285 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -128.44 158.03 39.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.931 0.396 . . . . 0.0 110.282 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.902 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -72.9 148.3 44.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.736 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -79.15 155.4 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.86 44.01 1.23 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 20.4 p90 -163.19 160.58 24.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.793 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -176.35 -172.59 41.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.635 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -126.91 139.99 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 111.323 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.94 128.1 75.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -104.93 114.7 29.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.946 0.403 . . . . 0.0 110.115 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -90.97 153.3 20.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.7 pt-20 -91.8 -18.86 23.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.493 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.491 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 29.3 mmmt -122.48 125.15 45.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.72 -22.83 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.717 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -63.27 -44.24 95.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.628 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 34.8 m -65.93 -34.42 78.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 -176.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.9 m -60.46 -32.01 70.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -74.17 -43.45 57.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.858 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.46 -54.01 28.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.225 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.739 ' HA ' HG22 ' A' ' 282' ' ' VAL . 25.2 m -59.1 -26.19 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.02 0.438 . . . . 0.0 111.52 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.2 m -78.05 -19.81 53.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.741 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -114.96 -33.15 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.858 ' HA ' ' HE3' ' A' ' 270' ' ' MET . 4.1 mmt -75.97 5.18 6.93 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -166.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.479 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.9 t30 -81.92 -38.94 24.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.932 0.873 . . . . 0.0 109.489 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.16 -8.53 57.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.277 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.813 ' HE1' ' HB2' ' B' ' 38' ' ' ALA . 4.5 t80 -52.93 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.776 0.431 . . . . 0.0 110.513 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.5 t70 -90.89 125.67 35.82 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.502 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 220' ' ' LEU . 85.8 mt -128.63 85.53 2.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.13 44.81 7.89 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.8 63.98 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.832 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 9.4 pt20 -140.58 130.65 24.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.778 0.323 . . . . 0.0 110.608 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -89.67 133.71 34.52 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.655 HD23 ' CD2' ' A' ' 273' ' ' PHE . 8.5 mp -72.45 -165.75 0.22 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.39 0.614 . . . . 0.0 111.03 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 172' ' ' GLN . 9.6 tpp180 -147.11 116.65 7.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.042 -172.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 267' ' ' VAL . 14.4 p -105.68 146.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.94 0.4 . . . . 0.0 111.271 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.12 -156.71 7.7 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -126.49 174.52 8.58 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.603 -0.351 . . . . 0.0 110.11 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.422 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -59.13 -43.14 91.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 111.429 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 94.4 t 79.8 -52.92 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.676 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 4.5 m -139.76 122.85 10.42 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-O 120.69 0.281 . . . . 0.0 110.846 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 287' ' ' THR . 1.1 Cg_endo -88.27 113.45 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.661 2.907 . . . . 0.0 112.194 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.01 122.9 10.82 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.682 2.255 . . . . 0.0 111.5 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 63.2 mtm -92.78 112.29 55.12 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.016 -177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.62 -22.71 2.41 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.654 2.236 . . . . 0.0 112.473 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.18 95.69 5.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.981 0.419 . . . . 0.0 110.438 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -166.55 170.66 12.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 6.6 t -101.83 109.51 59.78 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 121.172 0.51 . . . . 0.0 109.838 174.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 13.3 Cg_exo -70.26 115.42 4.15 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.022 2.481 . . . . 0.0 112.226 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -100.81 53.83 0.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.523 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.54 HG21 ' HG2' ' A' ' 104' ' ' ARG . 85.3 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.818 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.42 166.08 13.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 22.1 ptp -157.71 178.03 10.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.98 0.419 . . . . 0.0 111.214 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.49 -114.88 4.04 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.827 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -111.38 -4.9 14.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.254 0.55 . . . . 0.0 109.758 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.47 97.93 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.23 0.538 . . . . 0.0 110.708 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.466 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 52.4 t30 -167.73 -66.48 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.109 173.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.25 -60.89 1.85 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.869 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . . . -58.27 -33.59 69.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.626 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 5.9 t80 -72.34 -27.18 62.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 28.9 mtpp -62.58 -47.85 82.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.75 -36.15 71.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.739 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.77 ' HB3' ' HE1' ' A' ' 232' ' ' PHE . . . -53.72 -56.21 19.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.184 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.723 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.8 OUTLIER -79.17 -20.72 47.77 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.339 -171.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 81.2 mm-40 -56.84 -45.96 82.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 170.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.682 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 13.2 mmm180 -74.13 -32.93 63.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.429 175.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.813 ' HB2' ' HE1' ' A' ' 273' ' ' PHE . . . -63.86 -44.28 93.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -81.46 -26.64 35.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.813 -1.179 . . . . 0.0 112.599 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -56.44 -45.53 80.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.323 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.947 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 4.5 pt -65.87 -36.02 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.735 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 220' ' ' LEU . . . -73.52 -10.59 59.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.33 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.9 -49.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.009 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.947 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -83.92 -29.57 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.864 HG22 ' HB2' ' A' ' 219' ' ' ASP . 37.6 mm 69.37 106.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.167 0.508 . . . . 0.0 111.978 173.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.6 22.63 19.89 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.559 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.56 -99.74 2.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.845 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -112.71 129.71 56.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.083 0.468 . . . . 0.0 110.228 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -113.93 84.6 2.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.234 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.87 -72.35 0.98 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.577 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.9 m -98.98 98.01 9.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.688 0.28 . . . . 0.0 110.437 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 179.825 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.77 48.72 1.41 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.971 0.415 . . . . 0.0 110.995 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.9 mtt -109.65 2.03 19.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.977 0.417 . . . . 0.0 111.031 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.95 72.37 10.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.683 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -160.16 155.51 25.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -101.0 43.4 1.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.705 0.288 . . . . 0.0 110.716 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 55.22 31.54 16.71 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.346 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -62.3 -29.42 70.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.45 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.69 85.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.85 -30.05 63.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.854 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.56 73.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.99 -41.41 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.731 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.685 ' HB3' ' HB3' ' A' ' 163' ' ' PRO . 84.4 mmm -61.86 -25.84 67.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -92.62 6.05 48.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -126.85 126.84 44.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 0.0 111.814 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.549 HG13 ' HB1' ' A' ' 166' ' ' ALA . 16.9 m -118.84 142.55 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 111.425 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -87.24 121.37 29.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.915 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.06 111.09 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.144 0.497 . . . . 0.0 110.374 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.07 177.72 20.43 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.813 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 42.1 m 64.99 48.03 2.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.176 0.513 . . . . 0.0 111.061 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.7 mm -71.51 -20.41 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.5 t80 66.83 -83.66 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.497 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.412 ' CE1' ' HG2' ' A' ' 151' ' ' LYS . 78.1 t80 -174.03 -56.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.966 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.54 8.68 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.66 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.621 HD21 HG21 ' A' ' 127' ' ' THR . 67.9 mt -102.86 124.82 49.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.33 -167.21 11.87 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.842 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.97 -35.17 74.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.907 0.384 . . . . 0.0 109.99 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -58.44 -42.33 87.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.293 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.621 HG21 HD21 ' A' ' 123' ' ' LEU . 3.1 m -72.66 -40.6 66.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.481 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.34 -45.65 92.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.752 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 133' ' ' ALA . 41.1 ttm-85 -61.35 -37.43 83.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.222 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -77.25 -36.0 54.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.44 ' O ' ' HD2' ' A' ' 134' ' ' PRO . . . -78.31 -38.93 41.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.981 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.581 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 96.7 m-85 -95.95 5.46 51.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.464 ' HB2' ' HD3' ' A' ' 134' ' ' PRO . . . -68.65 -42.1 24.59 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.671 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 71.7 Cg_exo -54.81 -2.54 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.211 2.607 . . . . 0.0 114.362 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.581 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 60.2 m-85 -108.65 -71.1 0.77 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.834 -0.541 . . . . 0.0 111.452 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -146.37 -166.5 12.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.623 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -81.86 114.61 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.668 2.245 . . . . 0.0 111.918 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.65 107.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.25 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -136.53 143.9 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.3 mt -133.47 107.02 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.165 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 3.8 m-20 -89.12 96.43 10.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 24.2 ptm -126.82 137.14 53.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 110.758 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.8 t -78.79 115.5 18.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.303 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -110.51 98.12 7.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.279 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.54 89.39 6.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -58.25 -38.92 77.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.381 -171.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.0 m -57.08 -30.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 p -119.2 -10.09 9.83 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.566 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 85.3 mtp 62.23 26.72 16.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.412 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 58.2 mttp -109.87 -173.13 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.947 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -126.97 95.91 4.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.128 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -83.53 -19.06 36.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.6 170.54 13.42 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.726 175.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -107.72 175.69 5.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.567 0.222 . . . . 0.0 110.924 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.01 136.72 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.831 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 72.8 m-85 -108.84 114.63 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.546 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.83 126.62 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.802 0.334 . . . . 0.0 110.311 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -120.34 130.49 54.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.326 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 78.3 m-85 -109.53 179.0 4.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -94.67 -2.63 50.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.338 172.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.99 125.53 17.22 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.246 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.685 ' HB3' ' HB3' ' A' ' 111' ' ' MET . 28.0 Cg_exo -64.33 -37.06 41.97 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.198 2.599 . . . . 0.0 112.169 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -57.75 -45.98 85.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.202 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.419 ' CB ' ' HA3' ' A' ' 136' ' ' GLY . . . -55.67 -42.94 75.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 111.278 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.549 ' HB1' HG13 ' A' ' 114' ' ' VAL . . . -65.85 -41.29 91.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.885 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -63.12 -47.94 80.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.478 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.571 HD22 ' HA3' ' A' ' 283' ' ' GLY . 45.9 mt -63.14 -40.25 97.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.276 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.89 93.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.307 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.843 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.1 tt -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -80.78 -48.01 13.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 168' ' ' LEU . 8.0 mm100 -75.99 -40.53 53.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.743 -170.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.4 mmt -80.7 -6.31 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.341 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.1 -21.36 22.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.5 m -90.98 -27.28 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.603 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.1 t -114.67 110.5 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.485 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 23.5 ptm -89.24 138.32 31.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.186 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.47 144.96 39.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.996 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.79 69.88 0.97 Allowed Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.805 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.96 -45.68 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -157.12 137.93 13.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -73.18 92.77 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.813 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 29.2 pt -71.07 158.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.801 -176.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -115.63 110.07 18.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.538 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.6 t -114.11 112.37 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.856 0.36 . . . . 0.0 111.023 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.843 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 112.07 134.43 6.31 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.51 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -162.57 94.27 1.21 Allowed Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.12 -39.77 89.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.026 2.484 . . . . 0.0 112.961 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 71.35 -52.14 0.69 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.387 0.675 . . . . 0.0 111.773 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -98.01 64.17 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.153 0.501 . . . . 0.0 110.226 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 mt -90.06 56.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.751 0.786 . . . . 0.0 109.418 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.33 -55.01 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.048 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -82.85 -48.73 10.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.52 -33.55 62.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.066 -175.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.626 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.7 tp60 -51.93 -53.36 52.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -174.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 49.4 Cg_exo -56.77 -32.22 90.74 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.13 1.887 . . . . 0.0 112.471 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.7 mm -72.46 -41.62 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.184 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 194' ' ' ALA . 43.7 mt -64.22 -39.23 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.626 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.52 -40.5 78.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.59 -47.88 65.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.367 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 97.5 mt -55.91 -43.35 77.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.837 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.22 77.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 206' ' ' ARG . 39.5 tt0 -73.75 -44.19 56.91 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.931 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.65 -28.3 63.66 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.209 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.23 76.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.779 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 203' ' ' GLU . 27.8 ptt180 -71.49 -19.7 62.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.172 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.42 66.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.0 -16.04 27.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.944 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.16 40.83 17.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.245 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 256' ' ' GLU . 98.8 mtt180 -101.93 136.15 42.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.5 pt -116.34 168.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.687 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -118.76 115.15 23.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.477 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.2 p -108.67 121.21 61.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.366 0.603 . . . . 0.0 110.726 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.77 -179.3 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.929 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 134' ' ' PRO . 8.6 t 71.0 14.67 6.79 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.909 0.756 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.671 HG12 HD23 ' A' ' 240' ' ' LEU . 60.6 t -61.93 122.91 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.518 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 6.9 t-80 -60.66 136.08 57.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -63.74 -22.68 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -165.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.518 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 0.0 OUTLIER -79.03 -48.05 15.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -174.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.666 HD21 HD22 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -82.95 147.82 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.358 0.599 . . . . 0.0 111.786 -174.391 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 49.9 m -108.25 -175.49 2.79 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.965 -166.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -50.31 -51.77 42.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.181 0.592 . . . . 0.0 112.307 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.8 -29.88 60.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.325 0.583 . . . . 0.0 110.769 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.674 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 58.3 m-20 -76.04 -56.46 4.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.465 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.565 HD11 HD11 ' A' ' 220' ' ' LEU . 36.7 mm -61.12 -22.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.306 -178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.492 ' HE2' HG21 ' A' ' 235' ' ' ILE . 53.2 tttm -55.62 -31.66 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.399 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.514 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.2 m -48.54 -61.82 1.82 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.452 0.644 . . . . 0.0 112.201 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.668 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 5.2 m -67.28 -46.99 82.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.623 -171.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.477 ' HZ ' ' HB ' ' A' ' 213' ' ' VAL . 64.5 m-85 -61.66 -42.42 98.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.692 0.282 . . . . 0.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 50.7 tt0 -77.13 -23.9 51.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.243 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.96 68.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.739 -0.209 . . . . 0.0 111.017 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.798 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.3 m-85 -83.6 -53.85 5.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -141.05 155.94 25.29 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.422 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 26.9 mmtp -66.37 140.22 58.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.726 0.774 . . . . 0.0 112.169 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.774 HD11 HG23 ' A' ' 255' ' ' ILE . 10.5 tp -84.86 146.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.795 -173.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -107.72 -51.36 2.92 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.604 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 16.0 m -143.6 143.01 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.57 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 28.3 p -144.71 133.8 22.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.273 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.0 m -150.81 103.75 3.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.212 0.529 . . . . 0.0 109.951 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.705 HD12 ' HA3' ' A' ' 253' ' ' GLY . 18.8 tp -83.43 129.95 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.85 137.74 51.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 111.461 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.515 ' HA ' ' H ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -143.45 157.75 44.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.757 176.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.509 ' OD1' ' HE3' ' A' ' 250' ' ' LYS . 9.6 m-20 -71.13 108.36 3.7 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.575 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.61 -31.47 21.11 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.39 2.06 . . . . 0.0 112.329 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -96.03 -3.58 44.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.428 . . . . 0.0 110.757 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 243' ' ' ASP . 24.6 m -113.79 -40.84 3.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 0.0 111.406 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.9 53.66 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.157 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 242' ' ' ARG . 95.6 mttt -87.49 -178.0 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.419 ' HE1' ' O ' ' A' ' 217' ' ' HIS . 0.0 OUTLIER -125.21 138.55 54.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.022 0.439 . . . . 0.0 111.685 -171.109 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.515 ' H ' ' HA ' ' A' ' 242' ' ' ARG . 31.8 mmtp -80.41 149.11 30.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.69 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.76 40.92 2.3 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.719 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.56 162.7 19.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.048 0.424 . . . . 0.0 110.331 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.705 ' HA3' HD12 ' A' ' 240' ' ' LEU . . . -167.96 177.37 42.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.225 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.89 134.41 55.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 0.0 110.438 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.774 HG23 HD11 ' A' ' 235' ' ' ILE . 52.0 mt -130.75 140.2 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.498 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 237' ' ' SER . 43.4 tt0 -122.85 131.9 53.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -105.33 153.25 21.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.469 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -85.48 -16.24 40.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.259 0.552 . . . . 0.0 110.293 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -124.38 123.93 41.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.277 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -68.16 -23.62 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.024 0.44 . . . . 0.0 110.574 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -62.22 -37.83 86.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.373 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.422 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 12.2 m -73.62 -36.4 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.056 -176.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 m -59.63 -34.41 72.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.474 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -73.07 -37.12 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.422 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 4.7 p-10 -79.11 -26.24 42.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.416 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.11 -52.73 45.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.614 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.72 -25.72 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 p -84.71 -13.52 51.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 p -115.07 -32.24 5.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.838 ' HA ' ' HE3' ' A' ' 270' ' ' MET . 2.3 mmt -69.14 -4.55 17.83 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.41 -32.78 62.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.99 0.9 . . . . 0.0 108.993 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.468 HD21 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -77.31 -10.63 59.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.476 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.733 ' HB2' ' HE3' ' A' ' 270' ' ' MET . 2.6 t80 -50.49 105.21 0.09 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.523 0.514 . . . . 0.0 110.403 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.14 125.26 34.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.388 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.666 HD22 HD21 ' A' ' 220' ' ' LEU . 86.0 mt -130.03 86.83 2.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.681 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.01 14.16 63.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.013 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 102.02 25.02 8.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -140.59 142.17 35.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -81.24 139.45 35.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.125 0.488 . . . . 0.0 110.168 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.1 OUTLIER -79.32 -176.56 5.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.107 176.279 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 281' ' ' ARG . 26.6 mmt180 -142.26 112.7 7.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 270' ' ' MET . 8.7 p -118.48 131.62 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.571 ' HA3' HD22 ' A' ' 168' ' ' LEU . . . -134.96 -161.68 9.51 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.385 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -113.2 168.98 9.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.637 0.255 . . . . 0.0 110.332 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -90.26 113.15 24.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.83 -31.79 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.669 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.499 HG23 ' HG2' ' A' ' 163' ' ' PRO . 9.2 t -133.83 141.03 38.37 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.901 175.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.59 108.75 0.65 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.358 2.039 . . . . 0.0 111.937 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.85 70.03 6.69 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.596 2.197 . . . . 0.0 112.216 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 46.0 ttm -96.11 109.72 48.43 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.95 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.61 136.14 65.11 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.94 2.426 . . . . 0.0 112.479 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.02 114.8 27.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 43.9 tp -92.85 -12.31 31.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.445 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 18.5 p -105.62 116.75 59.5 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.905 0.384 . . . . 0.0 111.647 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 1.4 Cg_endo -83.23 117.01 2.44 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.193 2.595 . . . . 0.0 111.808 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -83.6 51.17 1.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.059 0.457 . . . . 0.0 111.591 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.57 177.347 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.51 87.16 7.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.043 0.449 . . . . 0.0 111.071 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 67.5 mtt -137.61 173.6 11.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.843 177.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.76 -56.58 4.93 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.56 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -81.71 112.57 19.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.966 0.412 . . . . 0.0 111.707 -176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.418 HG12 ' H ' ' B' ' 31' ' ' PHE . 9.4 t 56.05 46.36 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.377 175.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -85.4 26.67 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.553 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.23 -59.73 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.053 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.51 75.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 110.946 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.644 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.6 t80 -70.82 -17.79 62.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 30.2 mmmt -64.29 -50.28 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.74 -37.82 74.25 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.455 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.798 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.16 -58.62 4.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.428 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.764 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.6 OUTLIER -80.78 -17.81 49.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 26.2 mm-40 -56.41 -46.42 80.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.604 ' O ' HG23 ' B' ' 41' ' ' ILE . 30.5 mmm180 -73.65 -36.44 65.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.68 175.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.786 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -59.82 -45.04 93.63 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -80.28 -26.4 38.94 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.556 -1.34 . . . . 0.0 112.462 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -57.19 -45.18 83.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.849 169.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.786 HG12 ' O ' ' B' ' 38' ' ' ALA . 4.9 pt -67.03 -31.37 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.663 ' HA ' HD22 ' A' ' 220' ' ' LEU . . . -67.99 -46.12 72.22 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.192 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.43 68.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.671 ' HE3' ' HA2' ' B' ' 46' ' ' GLY . 1.3 tmmm? -70.84 -16.54 62.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.957 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' B' ' 44' ' ' LYS . 75.8 mt 78.88 -63.27 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.469 0.708 . . . . 0.0 111.337 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.671 ' HA2' ' HE3' ' B' ' 44' ' ' LYS . . . 141.21 -106.58 0.48 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.48 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.61 16.73 59.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.306 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -126.44 87.77 2.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.53 53.1 0.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.96 -174.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.68 83.07 0.07 OUTLIER Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.78 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -74.12 77.53 1.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.217 0.532 . . . . 0.0 110.112 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.179 -0.915 . . . . 0.0 108.649 -179.525 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.92 70.14 0.6 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.1 0.476 . . . . 0.0 111.635 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.5 mmt -98.18 17.52 18.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.985 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.61 92.25 5.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.755 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -61.94 -60.25 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.047 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 13.9 ptm180 -164.06 22.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -89.13 -61.03 1.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.49 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -52.15 -45.24 64.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.83 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.79 -49.45 52.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.581 HD12 ' HG3' ' A' ' 163' ' ' PRO . 4.6 mm? -69.3 -26.01 64.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.552 -176.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.168 0.509 . . . . 0.0 110.74 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.0 mm -82.5 -36.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.095 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.7 mtp -70.72 -28.65 64.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.209 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.408 ' SG ' ' HD3' ' A' ' 163' ' ' PRO . 73.2 m -81.72 2.98 27.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -174.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.621 ' HB3' ' HG3' ' A' ' 159' ' ' GLU . 38.9 ptt180 -138.32 140.93 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.582 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.5 m -107.92 141.11 23.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.352 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 44.9 t80 -83.7 116.56 22.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.046 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.662 ' HB ' ' HB1' ' A' ' 156' ' ' ALA . 42.8 t -101.93 111.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.47 146.04 16.83 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.337 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.7 m 74.37 -53.72 0.68 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.788 0.835 . . . . 0.0 111.776 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.6 mt 68.93 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.43 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 27.3 t80 177.26 -85.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.47 ' CD2' ' HD3' ' A' ' 153' ' ' LYS . 1.5 t80 177.58 -77.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.308 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.19 43.93 1.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.552 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 35.6 mt -100.86 123.81 45.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.693 ' HA2' ' HH2' ' A' ' 145' ' ' TRP . . . -83.6 171.12 49.13 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.77 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -63.83 -48.16 77.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.44 -30.46 71.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.628 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 m -59.79 -49.8 76.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.029 0.442 . . . . 0.0 110.453 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.69 -34.52 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.308 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -55.58 -45.73 77.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.794 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 32.1 mm-40 -74.83 -30.54 61.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.439 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.75 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.633 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.45 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 93.2 m-85 -100.77 11.13 40.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.046 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 130' ' ' GLN . . . -68.86 -44.04 29.07 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.789 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.631 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 13.2 Cg_exo -72.29 -8.61 23.02 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.774 1.649 . . . . 0.0 111.994 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.57 ' O ' ' HB3' ' A' ' 165' ' ' ALA . 65.7 m-85 -102.64 65.53 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 110.464 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . 84.31 177.16 51.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.621 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -91.3 115.45 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.906 2.404 . . . . 0.0 112.273 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.498 HD13 ' HE1' ' A' ' 160' ' ' TYR . 36.8 mm -56.75 115.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.089 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -96.4 -55.03 3.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.761 0.315 . . . . 0.0 110.604 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.747 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 23.3 t -135.28 137.08 42.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.11 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.18 127.25 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.624 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.7 t70 -133.25 126.11 30.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.397 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.427 ' HE3' ' HB3' ' A' ' 143' ' ' MET . 65.4 mtp -147.37 147.83 30.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.961 0.41 . . . . 0.0 111.616 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.5 m -79.63 131.17 35.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 168.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.693 ' HH2' ' HA2' ' A' ' 124' ' ' GLY . 82.7 m95 -133.53 150.44 51.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.255 0.55 . . . . 0.0 112.264 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -124.35 89.06 3.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.694 168.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.9 m 65.8 -174.37 0.18 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.199 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.44 -20.98 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 110.424 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 p -67.73 9.74 0.25 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.516 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 20.9 ptp 47.45 38.31 7.52 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 171.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.419 ' HE3' ' OH ' ' A' ' 121' ' ' TYR . 56.2 mtpt -92.49 137.86 32.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -170.55 -78.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' HD3' ' CD2' ' A' ' 121' ' ' TYR . 22.4 mtmm 54.78 35.67 24.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.655 0.382 . . . . 0.0 111.316 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -102.26 -107.78 3.13 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.526 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.96 165.99 23.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.875 0.369 . . . . 0.0 110.581 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' A' ' 116' ' ' VAL . . . -145.18 135.77 24.35 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.447 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 51.2 m-85 -113.31 107.9 16.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.915 0.388 . . . . 0.0 110.134 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.09 103.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 28.6 tt0 -105.94 126.47 52.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 -172.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.498 ' HE1' HD13 ' A' ' 138' ' ' ILE . 78.0 m-85 -109.25 -177.98 3.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.11 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -109.23 -1.73 18.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.909 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.88 122.53 16.53 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.435 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.581 ' HG3' HD12 ' A' ' 108' ' ' LEU . 34.0 Cg_endo -65.65 -21.62 58.84 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.902 2.401 . . . . 0.0 113.397 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.97 -63.75 1.04 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.164 0.507 . . . . 0.0 110.466 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 135' ' ' PHE . . . -52.56 -43.15 65.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.136 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.88 66.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.445 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.548 ' HB3' HG23 ' A' ' 286' ' ' VAL . 57.8 tp60 -66.88 -35.45 80.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.552 HD23 ' CD2' ' A' ' 212' ' ' TYR . 11.0 tp -64.76 -51.77 60.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.197 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.57 -36.58 81.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.308 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.459 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.6 tt -57.19 -62.37 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.485 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.29 -39.0 85.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -67.62 -49.89 60.82 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 57.8 mtt -82.9 -17.78 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -69.49 -35.36 75.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.233 0.54 . . . . 0.0 109.671 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.9 t -88.2 -43.76 11.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.983 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.85 94.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.783 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 62.3 mtm -65.78 167.99 8.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.439 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.8 tp -80.23 74.41 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.891 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.82 -123.41 9.79 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 12.22 70.17 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.894 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -104.14 119.93 40.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.674 0.273 . . . . 0.0 110.76 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.414 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 21.7 p-10 -78.23 116.02 18.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 110.081 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.48 144.97 17.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -102.05 110.39 22.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.1 m -135.39 106.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.53 . . . . 0.0 110.787 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.459 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 125.52 -165.62 18.6 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.796 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 57.86 89.12 0.11 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.312 0.645 . . . . 0.0 110.93 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.25 -14.25 28.4 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.45 2.767 . . . . 0.0 113.82 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 72.95 -61.54 0.5 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.055 0.542 . . . . 0.0 111.209 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -84.05 70.87 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.8 pt -95.75 -172.79 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.323 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.28 -50.29 0.9 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.105 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.67 -43.01 39.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.15 0.5 . . . . 0.0 110.183 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.426 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.66 6.32 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.779 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.536 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 52.8 tp60 -61.98 -49.33 85.84 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.668 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -55.17 -37.27 94.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.061 1.841 . . . . 0.0 111.722 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.41 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.3 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 194' ' ' ALA . 48.2 mm -56.68 -48.32 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.191 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.02 -50.78 64.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.835 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 98.1 mt-30 -57.04 -44.73 83.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.814 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.15 -56.67 6.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.649 0.261 . . . . 0.0 111.135 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.52 73.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.981 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.409 ' HG2' ' NH1' ' A' ' 206' ' ' ARG . 3.0 tm-20 -74.35 -46.13 42.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.429 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.93 -30.15 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.358 . . . . 0.0 110.928 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.93 -25.06 67.97 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.26 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.409 ' NH1' ' HG2' ' A' ' 203' ' ' GLU . 93.6 mtt180 -66.7 -26.22 66.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.59 -17.7 62.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.258 0.551 . . . . 0.0 111.257 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.9 -10.05 19.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.755 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 257' ' ' TYR . 3.2 m-80 54.23 29.32 10.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.489 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.9 136.41 33.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 111.26 -174.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 255' ' ' ILE . 8.9 tt -112.94 147.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.588 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.552 ' CD2' HD23 ' A' ' 168' ' ' LEU . 66.1 t80 -107.86 123.0 47.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.5 . . . . 0.0 109.657 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.457 ' CG2' HD23 ' A' ' 280' ' ' LEU . 1.6 p -114.53 122.97 69.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.188 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.41 178.22 5.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.631 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 15.6 m 68.55 25.6 6.64 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.776 0.672 . . . . 0.0 110.909 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.508 HG11 HD13 ' A' ' 225' ' ' ILE . 85.1 t -68.08 138.7 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.656 ' HB2' HD21 ' A' ' 275' ' ' LEU . 21.2 t-80 -66.41 131.15 45.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -50.55 -44.22 56.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -167.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.602 ' HB2' HG21 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.62 -46.54 17.03 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 178.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.84 HD23 HD23 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -55.32 114.45 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.262 0.625 . . . . 0.0 110.27 -177.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 6.6 t -95.21 -175.8 3.62 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -166.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.56 -44.0 96.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.838 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.79 -27.91 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 221' ' ' SER . 5.5 m-20 -63.49 -59.64 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.508 HD13 HG11 ' A' ' 216' ' ' VAL . 37.6 mm -55.96 -26.06 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.238 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.47 ' HG3' HD11 ' A' ' 235' ' ' ILE . 88.2 tttt -57.24 -32.29 66.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.653 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.676 ' HG ' HG21 ' B' ' 41' ' ' ILE . 74.5 m -49.03 -56.64 8.36 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.922 0.868 . . . . 0.0 111.748 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' B' ' 34' ' ' ALA . 3.2 m -73.85 -49.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.353 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.606 ' HE2' HD12 ' A' ' 211' ' ' ILE . 43.3 m-85 -59.63 -41.82 91.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.629 0.252 . . . . 0.0 111.627 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 30.9 tt0 -74.2 -25.94 59.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.12 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.89 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.724 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.1 OUTLIER -90.18 -58.55 2.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -127.44 154.82 19.72 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 36.7 mmtm -84.11 140.79 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.58 0.705 . . . . 0.0 112.056 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.47 HD11 ' HG3' ' A' ' 226' ' ' LYS . 56.5 mt -103.69 134.38 45.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.094 -171.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 1.074 ' HE2' ' HB3' ' A' ' 258' ' ' GLU . 62.6 mmtt -84.03 -46.08 12.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.986 176.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 21.9 t -147.24 136.63 22.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.614 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.408 ' HB3' HG23 ' A' ' 235' ' ' ILE . 3.5 p -132.64 135.4 45.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.9 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.8 t -157.66 139.77 14.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.336 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.564 HD22 ' HA3' ' A' ' 253' ' ' GLY . 72.7 mt -111.11 129.91 55.78 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.42 134.98 57.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 110.681 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.0 mtp180 -89.19 157.28 18.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.371 0.605 . . . . 0.0 111.695 -177.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.04 97.99 40.63 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.289 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.86 -23.92 29.8 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.838 2.359 . . . . 0.0 111.624 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 24.3 m -64.43 -47.02 80.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.47 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.464 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 1.7 m -94.69 -33.44 12.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.02 0.438 . . . . 0.0 111.108 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.13 43.3 2.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.529 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.464 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 23.2 pttp -147.51 -166.94 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -175.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.4 p80 -112.98 147.52 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 242' ' ' ARG . 88.2 mttt -74.89 152.25 38.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.799 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.422 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -76.91 42.77 1.87 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.539 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -161.85 160.31 27.94 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.564 ' HA3' HD22 ' A' ' 240' ' ' LEU . . . -172.48 -164.08 27.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.333 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -129.85 137.31 50.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.975 0.417 . . . . 0.0 110.828 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 211' ' ' ILE . 41.4 mm -119.56 128.98 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.336 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.64 113.26 26.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.153 0.502 . . . . 0.0 111.301 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 209' ' ' ASN . 49.6 m-85 -93.33 156.88 16.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.064 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 1.074 ' HB3' ' HE2' ' A' ' 236' ' ' LYS . 8.5 pt-20 -92.01 -17.28 25.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.343 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -127.98 118.54 23.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.473 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.1 66.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.601 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.32 -40.58 93.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.576 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 14.7 m -70.49 -36.03 73.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.552 ' O ' HG22 ' A' ' 267' ' ' VAL . 17.7 m -54.34 -48.63 71.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.209 174.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -64.89 -39.59 93.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -63.04 -46.05 89.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.76 86.49 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.542 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.598 ' HA ' HG21 ' A' ' 282' ' ' VAL . 71.3 t -60.39 -35.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 111.28 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.6 m -89.92 -4.73 57.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.711 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' SER . . . . . 0.475 ' HB3' ' CG2' ' B' ' 27' ' ' VAL . 26.5 p -115.74 -47.01 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.768 ' HB2' HG23 ' A' ' 282' ' ' VAL . 55.3 mmm -65.18 -14.83 61.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 15.0 p-10 -72.76 -26.42 61.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.521 0.677 . . . . 0.0 110.323 176.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.55 -8.72 59.69 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.878 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 69.7 t80 -57.95 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 111.363 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.69 103.48 6.68 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.995 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.84 HD23 HD23 ' A' ' 220' ' ' LEU . 22.1 tp -113.43 86.98 2.5 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.925 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 62.01 41.24 99.66 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.662 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 119.23 -21.48 9.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.749 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.423 ' NE2' ' HD2' ' A' ' 217' ' ' HIS . 0.0 OUTLIER -132.9 137.0 46.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.545 0.672 . . . . 0.0 111.777 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -78.04 128.92 34.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.089 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.878 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 8.0 tp -61.46 169.9 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.177 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.452 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 32.3 mmt180 -142.68 113.34 7.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 121.982 -0.448 . . . . 0.0 110.138 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.768 HG23 ' HB2' ' A' ' 270' ' ' MET . 28.7 m -124.94 168.03 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.991 0.424 . . . . 0.0 112.132 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 211' ' ' ILE . . . 176.94 -164.39 33.81 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.314 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 148.36 43.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.821 0.311 . . . . 0.0 110.343 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.37 -16.33 63.5 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' A' ' 167' ' ' GLN . 49.1 t 72.02 -65.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.673 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 6.2 t -97.33 134.36 22.78 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.27 110.42 1.37 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.736 2.291 . . . . 0.0 111.636 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.14 110.15 1.69 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.809 2.34 . . . . 0.0 112.241 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 290' ' ' MET . 24.8 ptt? 42.21 76.85 0.48 Allowed Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.139 0.976 . . . . 0.0 113.215 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.48 -28.26 53.91 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.165 1.91 . . . . 0.0 110.246 170.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 96.5 mt -123.82 -158.65 0.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.493 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.419 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 90.2 mt 62.98 32.96 15.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.991 0.424 . . . . 0.0 111.007 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 27.4 m -96.01 106.17 26.43 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.019 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 293' ' ' LEU . 4.0 Cg_exo -77.46 60.23 7.0 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.256 2.638 . . . . 0.0 112.163 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -93.49 103.05 15.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.324 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.17 179.937 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.941 -0.463 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.52 40.96 0.92 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 80.9 mtp -59.42 -50.95 71.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.405 0.622 . . . . 0.0 110.437 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.92 123.12 0.68 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.884 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.06 89.82 7.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.73 0.776 . . . . 0.0 109.19 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 269' ' ' SER . 8.8 p -66.36 -33.58 64.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.888 -170.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -80.39 15.49 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.368 0.604 . . . . 0.0 110.677 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -119.79 -51.33 2.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.006 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.08 -41.0 23.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.875 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.621 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.7 t80 -69.02 -19.86 64.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.6 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' B' ' 32' ' ' LYS . 44.0 mtpt -69.08 -47.0 66.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.666 ' HA ' HE21 ' B' ' 36' ' ' GLN . 0.2 OUTLIER -58.97 -39.5 81.93 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.603 0.716 . . . . 0.0 109.118 175.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.724 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.64 -51.37 49.61 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.648 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.697 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.03 -20.85 40.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.666 HE21 ' HA ' ' B' ' 33' ' ' ASP . 37.2 mt-30 -59.53 -44.0 93.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.606 ' O ' HG22 ' B' ' 41' ' ' ILE . 72.7 mtp180 -73.63 -30.3 62.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.685 175.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.831 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -64.5 -49.81 69.86 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -80.1 -24.52 40.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.495 -1.378 . . . . 0.0 112.36 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.18 -50.43 59.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.074 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.831 HG12 ' O ' ' B' ' 38' ' ' ALA . 1.7 pt -66.4 -31.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.54 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.63 -22.61 65.32 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.97 -27.31 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.203 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' A' ' 224' ' ' ASP . 5.3 tmmt? -74.22 -55.26 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.376 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.602 HG21 ' HB2' ' A' ' 219' ' ' ASP . 87.2 mt 66.77 104.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 O-C-N 123.573 0.545 . . . . 0.0 112.198 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.84 165.42 28.05 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.549 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.22 -179.81 50.8 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.193 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.94 96.97 5.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.072 0.463 . . . . 0.0 110.43 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' B' ' 52' ' ' SER . . . -78.45 -21.77 48.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.843 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.22 -116.87 6.94 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.811 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.3 p -93.53 47.27 1.23 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.266 0.555 . . . . 0.0 111.007 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' B' ' 49' ' ' ALA . 5.1 t . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.309 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 112.422 -0.271 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.77 79.03 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.699 0.285 . . . . 0.0 111.225 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 39.4 ttm 62.02 16.76 8.44 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.147 172.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.54 -46.16 60.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.082 0.467 . . . . 0.0 110.51 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -94.6 153.87 17.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.139 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -80.63 50.57 1.34 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.216 0.532 . . . . 0.0 110.49 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.49 20.57 12.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.575 -177.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -53.85 -51.03 64.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.553 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.24 -34.8 61.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 0.0 111.673 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.19 -32.83 69.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.468 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.53 -49.13 62.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.77 0.319 . . . . 0.0 111.65 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.04 -35.93 16.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.79 0.328 . . . . 0.0 111.533 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 91.4 mmm -71.67 -26.58 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.34 -12.34 60.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.19 133.25 50.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.473 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -94.08 138.0 21.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 0.0 110.915 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 188' ' ' PRO . 72.5 t80 -89.66 106.13 18.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.169 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.6 t -103.53 110.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 118' ' ' SER . . . -134.39 100.24 0.37 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.608 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.985 ' HG ' ' HA ' ' A' ' 183' ' ' ILE . 68.5 p 151.59 51.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.306 1.443 . . . . 0.0 107.549 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.81 69.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.483 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.674 ' HE1' ' HA3' ' A' ' 179' ' ' GLY . 35.1 t80 37.86 -92.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.544 1.152 . . . . 0.0 112.387 169.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.496 ' HD2' ' HG3' ' A' ' 122' ' ' GLU . 33.0 t80 -179.3 -72.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.485 173.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 121' ' ' TYR . 48.2 mt-10 -90.07 44.27 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.754 HD22 HG21 ' A' ' 127' ' ' THR . 48.9 mt -102.2 164.63 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.48 175.82 18.1 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.858 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' OE2' ' HB2' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -60.76 -39.59 89.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.3 m-20 -48.43 -50.96 29.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.684 175.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.754 HG21 HD22 ' A' ' 123' ' ' LEU . 6.9 m -57.56 -47.7 81.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.324 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.405 HG21 ' HE2' ' A' ' 132' ' ' PHE . 79.0 mt -69.42 -41.04 80.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.807 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.431 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 14.8 ttm180 -59.57 -44.64 93.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.79 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 92.9 mt-30 -75.52 -21.46 57.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.45 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.96 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.608 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 97.4 m-85 -96.22 13.39 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.012 0.434 . . . . 0.0 111.141 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.67 -43.6 11.65 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.453 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 38.0 Cg_endo -67.08 -4.47 11.61 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 0.0 112.792 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.466 ' CE2' ' HA ' ' A' ' 169' ' ' ALA . 4.9 m-85 -85.4 -83.06 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.55 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.67 -176.25 14.36 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.898 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 252' ' ' TYR . 60.9 Cg_endo -74.57 117.32 4.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.513 2.142 . . . . 0.0 111.444 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -57.12 107.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.917 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 159' ' ' GLU . 23.1 tptp -87.55 -54.49 4.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.379 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -166.73 144.05 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.8 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 63.5 mt -127.35 107.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.32 118.68 35.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.065 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 42.2 ttm -126.56 136.65 52.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.972 0.415 . . . . 0.0 111.189 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.605 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 3.7 m -98.73 111.21 23.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.853 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 2.1 p-90 -164.87 159.64 18.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.03 0.443 . . . . 0.0 111.369 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.45 ' HB2' ' HD2' ' A' ' 153' ' ' LYS . 21.5 t70 -89.34 132.89 34.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.64 -176.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.1 t -101.76 4.98 41.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 110.952 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 91.5 t -85.14 -43.24 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.363 0.601 . . . . 0.0 110.058 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.5 p -119.72 5.22 11.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.002 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 58.46 30.0 19.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.611 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -89.27 128.17 35.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.853 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 58.9 m-70 -81.98 75.41 8.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.522 0.677 . . . . 0.0 110.991 -175.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 146' ' ' ASP . 58.9 mttm -78.5 63.79 3.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.506 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 144' ' ' SER . . . 158.89 -157.86 28.86 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -124.66 174.18 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.69 137.22 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 85.7 m-85 -113.42 113.9 25.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.032 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.0 t -101.01 111.68 31.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.816 0.341 . . . . 0.0 110.256 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 37.8 tt0 -101.52 141.22 34.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.93 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -122.96 172.94 8.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.31 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.63 -27.72 31.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.066 0.46 . . . . 0.0 110.203 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.511 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 6.2 m -121.48 136.52 25.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.864 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 8.2 Cg_exo -73.99 -13.82 23.79 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.72 2.947 . . . . 0.0 112.088 -177.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -60.23 -47.97 83.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.217 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.1 -26.1 68.67 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.5 -49.85 44.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.091 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -66.89 -36.05 81.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.721 0.296 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.86 -43.37 96.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.111 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.466 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . . . -59.86 -38.61 82.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.766 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.5 tt -60.35 -60.45 3.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -69.35 -47.29 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -71.59 -31.26 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.608 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 24.6 mmt -83.36 -28.79 28.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.76 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -76.97 -16.51 59.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 110.513 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.2 m -78.44 -13.91 59.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.152 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.07 143.18 36.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 110.794 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.1 ttt -99.11 104.25 16.23 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.07 -28.79 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.234 -171.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.674 ' HA3' ' HE1' ' A' ' 120' ' ' TYR . . . -161.08 -150.74 6.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.076 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.03 23.18 1.8 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.931 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.59 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 14.4 ptm180 -157.43 151.66 24.8 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -79.31 141.12 37.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.609 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.985 ' HA ' ' HG ' ' A' ' 118' ' ' SER . 27.3 pt -100.12 131.81 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 0.0 110.388 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 81.2 tttt -103.83 117.74 35.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.613 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 48.1 t -125.29 106.58 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 130.82 159.97 9.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.146 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 67.36 83.69 0.18 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.158 0.504 . . . . 0.0 110.817 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.638 ' HA ' ' HB2' ' A' ' 115' ' ' TYR . 17.3 Cg_exo -66.87 -60.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.961 2.441 . . . . 0.0 112.816 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.8 p -151.83 -61.53 0.17 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.918 0.39 . . . . 0.0 110.971 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.53 132.72 33.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.2 tp -142.98 137.34 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.42 . . . . 0.0 110.562 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 195' ' ' GLN . . . 93.42 -42.33 2.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.386 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -59.18 -31.79 69.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.641 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.48 12.11 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 110.849 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.571 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.4 tp60 -63.72 -49.51 76.2 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.563 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.1 -34.2 67.18 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.342 2.028 . . . . 0.0 112.614 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 46.3 mm -67.91 -42.15 85.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.285 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.12 -47.37 93.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.648 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.47 -32.64 74.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.115 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -71.76 -47.1 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.35 -21.49 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.325 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.96 97.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.13 -35.98 76.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.634 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.31 -35.91 82.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.59 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.15 -20.18 62.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.677 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -64.12 -22.27 66.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.948 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.35 58.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.895 0.379 . . . . 0.0 111.138 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -96.48 -17.37 20.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.99 26.25 11.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.776 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 210' ' ' ARG . 8.3 ptm85 -120.23 144.24 47.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.201 0.524 . . . . 0.0 111.654 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.57 170.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.246 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -112.9 133.4 54.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.589 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 33.3 t -118.16 123.45 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.23 169.77 10.57 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.159 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.0 p 53.19 44.53 30.12 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.352 1.061 . . . . 0.0 111.714 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.579 HG13 HD13 ' A' ' 225' ' ' ILE . 48.5 t -79.14 146.13 8.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.218 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.586 ' HB2' HD21 ' A' ' 275' ' ' LEU . 14.1 t-80 -68.95 129.86 41.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -57.0 -36.95 71.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -167.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.965 ' HB2' HG21 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -80.11 -47.63 14.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.074 0.464 . . . . 0.0 111.479 174.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.777 HD22 HD23 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -59.67 108.66 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.948 -178.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 225' ' ' ILE . 44.2 m -97.11 -176.96 3.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -168.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.585 ' HB3' HD13 ' A' ' 240' ' ' LEU . 4.5 p-10 -57.88 -38.65 76.15 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.46 -34.92 69.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.483 0.658 . . . . 0.0 109.974 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.647 ' OD2' ' HE3' ' B' ' 44' ' ' LYS . 3.2 m-20 -73.88 -54.34 8.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.298 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.579 HD13 HG13 ' A' ' 216' ' ' VAL . 31.3 mm -54.71 -24.84 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 222' ' ' ASP . 50.4 mtpt -52.01 -33.88 40.4 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.026 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -49.23 -58.73 4.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.529 0.68 . . . . 0.0 111.816 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.63 HG11 ' CD1' ' A' ' 273' ' ' PHE . 13.7 m -74.41 -45.18 46.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.808 -171.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.529 ' CE1' ' HE3' ' A' ' 270' ' ' MET . 76.5 m-85 -68.52 -38.37 80.84 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.096 -0.378 . . . . 0.0 111.799 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.52 -25.64 45.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.384 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.36 83.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.553 0.216 . . . . 0.0 111.368 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.723 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.4 m-30 -75.64 -27.84 58.56 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.47 -109.07 0.45 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.919 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -157.43 139.63 14.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 238' ' ' CYS . 54.6 mt -94.22 132.16 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.234 0.54 . . . . 0.0 111.085 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -88.32 -42.97 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.17 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 34.5 t -147.35 143.08 27.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.625 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.503 ' HB2' HG23 ' A' ' 235' ' ' ILE . 41.8 t -146.33 124.03 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 62.8 m -157.18 127.21 6.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.585 HD13 ' HB3' ' A' ' 222' ' ' ASP . 7.6 mp -104.49 123.49 47.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.72 136.6 57.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.215 0.531 . . . . 0.0 111.324 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 49.2 mtp85 -101.01 158.66 15.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.653 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.02 107.95 60.3 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 170.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -62.78 -38.41 49.16 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.035 2.49 . . . . 0.0 111.99 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.7 m -59.87 -42.76 94.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.252 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.4 m -90.74 -22.76 20.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 21.7 62.35 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.899 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -134.81 148.95 50.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 10.8 p80 -76.12 142.64 41.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.671 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -69.81 153.16 43.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.2 40.39 1.71 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.979 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.452 ' CZ ' ' HD3' ' A' ' 137' ' ' PRO . 28.8 p90 -159.28 160.45 35.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -169.03 -171.82 35.16 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -126.75 136.98 53.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.834 0.349 . . . . 0.0 111.055 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.12 118.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 57.4 tt0 -105.03 129.88 53.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.006 0.432 . . . . 0.0 110.259 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -107.2 161.57 14.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.84 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -22.14 20.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 262' ' ' SER . 4.8 tppt? -111.8 115.24 28.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.468 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 264' ' ' GLN . . . -60.55 -33.72 73.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.32 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -69.05 -34.51 75.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.978 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.475 ' HB2' ' HB3' ' A' ' 259' ' ' LYS . 9.5 t -62.07 -38.79 90.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.5 m -59.76 -42.99 94.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 260' ' ' ALA . 59.8 mm-40 -68.15 -34.78 76.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 -174.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.4 -40.14 64.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.23 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.83 -51.92 65.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.442 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.04 -26.1 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 97.2 p -65.37 -34.7 78.93 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.672 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.6 t -116.85 0.67 12.56 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.529 ' HE3' ' CE1' ' A' ' 229' ' ' PHE . 34.9 mmm -79.4 -17.81 53.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.509 HD21 ' HD3' ' A' ' 281' ' ' ARG . 18.9 t-20 -61.37 -31.54 71.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.042 0.925 . . . . 0.0 110.083 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' B' ' 24' ' ' MET . 3.3 mm? -75.32 -8.37 56.47 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.46 -174.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.707 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 55.9 t80 -57.37 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 110.395 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -77.35 119.81 21.5 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.526 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.777 HD23 HD22 ' A' ' 220' ' ' LEU . 14.5 tp -126.2 85.83 2.44 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.486 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.08 32.33 23.65 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.382 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 87.66 19.56 53.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.754 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -140.9 131.97 26.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.81 0.338 . . . . 0.0 110.382 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -76.35 136.1 39.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.075 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.908 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 14.4 tp -70.71 -174.37 0.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.247 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.908 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 6.4 tpp180 -143.88 118.86 10.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' A' ' 270' ' ' MET . 14.7 p -118.31 144.03 27.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 110.544 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.61 -159.9 9.05 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.489 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -118.59 165.13 14.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.828 0.347 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.86 88.86 5.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -51.94 -52.37 23.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.616 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 40.8 p -121.85 161.39 42.45 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.409 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.71 101.4 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.693 2.262 . . . . 0.0 111.409 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 287' ' ' THR . 85.7 Cg_endo -79.4 -5.85 14.4 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.692 2.261 . . . . 0.0 111.874 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 61.2 mtt -133.66 66.79 74.25 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.952 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -93.35 153.65 2.5 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.829 2.352 . . . . 0.0 112.814 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 92.5 mt -82.16 99.57 9.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.472 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 91.8 mt -67.29 126.42 29.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.033 -176.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 7.2 p -100.8 100.78 13.47 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.506 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 293' ' ' LEU . 5.0 Cg_endo -86.33 41.18 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.561 2.841 . . . . 0.0 112.306 -177.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.41 ' C ' ' HG1' ' A' ' 297' ' ' THR . . . -78.22 -27.16 47.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.12 0.486 . . . . 0.0 110.532 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 296' ' ' ALA . 91.2 m . . . . . 0 C--O 1.25 1.079 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.285 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.59 -49.84 3.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.781 0.291 . . . . 0.0 111.032 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.607 ' O ' ' HG ' ' A' ' 272' ' ' LEU . 43.9 ttm 68.74 -60.02 0.45 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.045 0.84 . . . . 0.0 111.229 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.64 169.26 42.19 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -118.91 11.65 12.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.07 0.462 . . . . 0.0 110.847 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 12.3 t -131.72 50.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -75.38 53.63 0.68 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.2 0.524 . . . . 0.0 111.656 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -154.51 -63.61 0.13 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.835 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.24 -31.05 33.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.422 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.604 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 15.5 t80 -69.4 -18.48 63.76 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.336 0.588 . . . . 0.0 110.465 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.2 mtpt -70.64 -45.93 64.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.61 -36.15 81.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.905 172.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.723 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.0 -51.01 33.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.483 177.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.601 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -79.86 -23.38 41.97 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -174.036 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 65.6 mt-30 -58.04 -43.31 86.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 170.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 27.1 mmt180 -73.51 -30.68 63.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.456 176.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.72 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -66.51 -43.08 86.26 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -80.86 -26.86 36.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.489 -1.382 . . . . 0.0 112.136 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.15 -44.11 74.85 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.72 HG12 ' O ' ' B' ' 38' ' ' ALA . 4.0 pt -69.1 -34.41 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.619 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.62 ' HA ' HD13 ' A' ' 220' ' ' LEU . . . -64.63 -27.14 68.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.376 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.63 -42.35 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.277 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.647 ' HE3' ' OD2' ' A' ' 224' ' ' ASP . 17.8 pttt -77.45 -35.36 53.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.424 -177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.965 HG21 ' HB2' ' A' ' 219' ' ' ASP . 91.7 mt 63.59 86.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 121.388 0.613 . . . . 0.0 111.016 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.42 -82.48 1.67 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.627 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.85 -82.26 0.85 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.284 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 25.9 t0 52.03 84.27 0.05 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.026 0.531 . . . . 0.0 110.651 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.59 119.37 4.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.328 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.91 29.07 1.07 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.54 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 21.8 m -71.03 127.3 32.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.965 0.412 . . . . 0.0 110.959 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.688 -0.672 . . . . 0.0 109.905 178.025 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.32 -27.73 13.01 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 47.4 ttp 56.51 77.93 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.546 0.529 . . . . 0.0 110.946 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.57 -64.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.676 -0.409 . . . . 0.0 112.051 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -87.5 -40.55 14.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.443 ' HB3' ' HG2' ' A' ' 106' ' ' ARG . 75.1 mtt85 -69.75 -69.39 0.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -175.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.496 ' HB3' HD13 ' A' ' 108' ' ' LEU . 95.9 mt-30 55.8 49.22 16.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.28 0.562 . . . . 0.0 110.398 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.443 ' HG2' ' HB3' ' A' ' 104' ' ' ARG . 26.2 mmm180 -66.25 -36.21 82.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.377 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.19 86.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.072 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 105' ' ' GLN . 94.4 mt -66.89 -32.98 74.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.425 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.82 90.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.4 . . . . 0.0 111.001 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.71 -37.22 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 25.4 ttt -60.44 -28.12 68.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.2 m -91.34 6.21 46.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 113' ' ' ARG . 9.7 ptp180 -130.94 126.26 35.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.829 0.347 . . . . 0.0 110.565 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG22 ' HB ' ' A' ' 158' ' ' VAL . 4.3 m -92.3 135.84 26.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.651 0.739 . . . . 0.0 110.834 176.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 81.2 t80 -91.1 111.24 22.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.609 -176.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.476 HG13 HD11 ' A' ' 119' ' ' ILE . 9.4 t -103.01 110.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.389 . . . . 0.0 110.272 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.492 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -102.25 171.2 21.21 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.1 t 72.57 -65.69 0.34 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.97 0.508 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.476 HD11 HG13 ' A' ' 116' ' ' VAL . 10.0 mm 63.14 12.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.88 0.371 . . . . 0.0 110.545 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.826 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 11.6 t80 60.4 -80.02 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 50.5 t80 169.75 -45.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.701 0.8 . . . . 0.0 109.379 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -104.62 39.15 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.022 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 66.5 mt -114.05 99.92 8.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.98 -175.04 48.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.4 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -50.63 -49.91 55.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.165 0.507 . . . . 0.0 110.823 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -59.43 -33.68 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -80.69 -39.15 27.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.01 -48.06 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.54 ' HB3' HD12 ' A' ' 141' ' ' ILE . 4.6 ptm180 -62.13 -35.53 79.01 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.61 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.413 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 48.5 mt-30 -75.07 -26.55 59.45 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.302 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.33 -34.75 63.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.678 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 84.1 m-85 -96.81 10.5 38.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.957 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 130' ' ' GLN . . . -70.67 -39.07 8.63 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.655 ' O ' ' HB1' ' A' ' 214' ' ' ALA . 52.6 Cg_exo -59.15 -18.33 43.55 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.786 1.657 . . . . 0.0 112.479 170.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.678 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 57.3 m-85 -101.89 66.6 1.05 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.79 0.328 . . . . 0.0 111.033 -175.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.63 44.27 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.38 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.41 123.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.036 2.491 . . . . 0.0 112.128 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.702 HD11 ' HE1' ' A' ' 160' ' ' TYR . 31.6 mm -67.36 108.07 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.979 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.438 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 82.0 tttt -76.6 -53.05 8.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.318 0.58 . . . . 0.0 110.144 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 139' ' ' LYS . 15.2 m -155.07 143.79 20.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.466 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 129' ' ' ARG . 66.8 mt -113.11 106.15 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 35.9 t70 -81.71 98.24 8.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.0 tpt -130.3 130.05 44.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.904 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -93.53 106.14 18.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.029 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' HB3' ' HA ' ' A' ' 150' ' ' MET . 56.3 m95 -91.98 134.78 34.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.824 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.1 m-20 -73.75 102.61 4.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.261 174.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.1 t 62.07 -160.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.833 0.708 . . . . 0.0 110.551 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.3 p -74.04 -22.24 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.067 0.46 . . . . 0.0 110.494 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -13.65 61.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -173.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.588 ' HA ' ' HB3' ' A' ' 145' ' ' TRP . 88.2 mtp 60.36 47.11 9.27 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.475 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.824 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 30.4 mmmt -77.79 149.99 34.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.498 . . . . 0.0 111.187 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.86 99.99 11.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.235 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.728 ' HZ1' ' HB3' ' A' ' 153' ' ' LYS . 2.3 ttpm? -149.18 64.44 1.03 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.396 0.617 . . . . 0.0 109.611 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 172.84 -179.04 44.56 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.698 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.492 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 84.1 m-85 -112.36 157.85 20.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.02 130.41 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.041 0.448 . . . . 0.0 110.802 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.61 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 67.0 m-85 -111.23 107.77 17.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.872 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.475 ' HB ' HG22 ' A' ' 114' ' ' VAL . 43.0 t -91.77 110.97 23.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.2 138.02 35.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.294 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.702 ' HE1' HD11 ' A' ' 138' ' ' ILE . 50.7 m-85 -118.92 161.01 20.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.37 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 36.0 mt-10 -99.49 9.96 42.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.654 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 10.9 m -132.56 113.51 14.21 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.389 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.46 -24.32 36.62 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 113.326 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.654 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -66.67 -54.46 22.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 110.193 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 162' ' ' VAL . . . -55.38 -40.13 70.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.212 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.29 91.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.8 -41.57 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.519 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.55 HD22 ' HA3' ' A' ' 283' ' ' GLY . 18.9 mt -62.36 -42.4 99.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.012 0.434 . . . . 0.0 110.648 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.36 83.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.789 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.14 -60.92 2.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.82 -46.87 77.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.475 ' OE1' ' HD3' ' A' ' 281' ' ' ARG . 47.6 mt-30 -79.29 -35.82 40.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 51.7 tpp -77.27 -27.11 53.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.32 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -70.44 -20.3 62.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.185 0.516 . . . . 0.0 110.17 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.9 m -90.78 -2.87 57.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.728 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.01 171.12 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 111.403 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.8 mtp -117.18 97.11 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.246 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 52.9 tp -77.78 89.85 4.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 110.261 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 119.42 -157.03 15.58 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.526 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.23 18.07 50.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.016 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.826 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 8.9 ptm180 -157.41 155.72 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.19 105.6 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.274 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.63 155.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.174 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -101.69 109.91 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.902 0.382 . . . . 0.0 110.102 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.3 t -101.32 106.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.43 159.89 34.91 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.58 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -164.88 144.76 5.89 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 102.27 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.963 2.442 . . . . 0.0 112.183 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.5 m -113.99 -42.4 3.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.341 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -150.62 33.82 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.887 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.3 tt -63.29 115.28 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.513 0.673 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 119.02 -38.43 2.85 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -82.28 -39.51 22.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.09 0.472 . . . . 0.0 109.863 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.83 -9.27 57.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.071 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.492 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 24.4 tp60 -63.43 -52.84 57.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.98 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -54.86 -30.81 70.09 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.519 2.146 . . . . 0.0 112.468 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.0 mm -66.04 -57.69 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.0 mt -64.59 -35.55 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.6 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.5 t70 -57.67 -49.55 76.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.435 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.87 -48.12 80.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.237 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 80.2 mt -58.97 -42.6 90.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.52 71.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.371 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 45.1 mt-10 -64.79 -42.99 94.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 288' ' ' PRO . 31.0 mt-10 -70.82 -49.36 47.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.569 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.415 ' HB2' ' HB1' ' A' ' 285' ' ' ALA . . . -59.28 -31.82 69.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.995 -176.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -62.88 -27.2 69.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.92 -14.97 60.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.954 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.58 -15.12 17.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.168 0.508 . . . . 0.0 111.094 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.81 40.74 30.67 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.891 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.56 HH11 ' HG2' ' A' ' 289' ' ' PRO . 46.1 ttm180 -103.83 136.24 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.721 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.95 165.89 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.776 0.322 . . . . 0.0 110.792 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.515 ' HD2' HD12 ' A' ' 168' ' ' LEU . 49.1 t80 -116.65 122.88 45.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.057 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.412 HG23 HD11 ' A' ' 255' ' ' ILE . 39.8 t -109.77 121.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.658 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.23 170.49 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.589 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.3 t 67.55 36.28 3.81 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.631 0.582 . . . . 0.0 111.33 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 225' ' ' ILE . 59.9 t -79.86 138.58 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -51.81 -43.68 63.19 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -167.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' B' ' 45' ' ' ILE . 5.2 m-20 -70.17 -45.81 65.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.812 0.339 . . . . 0.0 111.066 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.689 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -66.7 103.94 1.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.464 ' HA ' ' NE2' ' A' ' 249' ' ' HIS . 46.3 m -89.83 -176.85 5.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -166.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.42 -45.46 80.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.849 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.86 -28.94 69.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.277 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.654 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.0 m-20 -67.47 -59.18 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.001 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.669 HG13 HD11 ' A' ' 240' ' ' LEU . 29.5 mm -52.95 -30.58 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.136 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.44 -32.4 39.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.027 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.569 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 70.0 m -49.79 -60.99 2.39 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.654 0.74 . . . . 0.0 112.035 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' B' ' 34' ' ' ALA . 4.0 m -71.74 -39.82 69.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.624 -171.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.759 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 65.1 m-85 -66.71 -39.71 88.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.726 0.298 . . . . 0.0 111.697 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.9 -24.75 55.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.425 ' O ' ' HB1' ' B' ' 30' ' ' ALA . . . -72.98 -24.28 60.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.256 -174.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.666 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.5 m-30 -87.47 24.71 1.59 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.48 0.657 . . . . 0.0 110.525 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 234' ' ' LYS . . . 149.27 -113.42 0.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 233' ' ' GLY . 28.4 mmmt -136.72 161.67 35.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.546 HG12 ' SG ' ' A' ' 238' ' ' CYS . 6.6 tp -122.17 139.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.528 0.68 . . . . 0.0 110.665 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -88.4 -62.74 1.42 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 15.2 m -140.88 143.79 34.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.366 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' A' ' 235' ' ' ILE . 74.7 m -134.52 106.82 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 21.4 m -141.48 104.71 4.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.167 0.508 . . . . 0.0 111.467 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.777 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 79.8 mt -83.57 130.75 35.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.56 101.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.598 0.561 . . . . 0.0 111.205 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.853 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 6.5 ppt_? -90.46 144.73 25.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.509 . . . . 0.0 110.846 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.03 122.76 76.02 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.504 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.67 -20.28 40.66 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.911 2.407 . . . . 0.0 113.514 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.87 -39.14 14.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 44.9 p -88.03 -35.5 17.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.864 0.364 . . . . 0.0 111.338 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.15 -2.32 68.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.658 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -108.75 157.46 18.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.853 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 16.8 p80 -86.4 145.57 26.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.254 0.55 . . . . 0.0 110.925 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.75 158.61 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.04 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -74.8 43.79 1.44 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 114.183 0.433 . . . . 0.0 114.183 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -166.18 164.64 17.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . 178.04 -169.98 42.02 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.559 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.492 ' HB3' ' HD3' ' A' ' 210' ' ' ARG . 90.6 m-85 -119.86 140.01 51.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.847 0.356 . . . . 0.0 110.538 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 213' ' ' VAL . 48.8 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.91 176.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.99 146.25 29.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.357 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.418 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 34.2 m-85 -120.19 137.01 54.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.442 170.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 259' ' ' LYS . 3.3 pm0 -83.6 -29.5 27.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.4 ' N ' ' HG2' ' A' ' 258' ' ' GLU . 17.2 tptm -95.8 113.56 25.21 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.837 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.29 69.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.798 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -69.41 -34.01 73.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.537 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 43.3 m -78.44 -31.51 48.07 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 267' ' ' VAL . 1.5 p -65.6 -42.92 91.1 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.173 -0.329 . . . . 0.0 111.534 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -60.72 -36.58 79.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.588 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.97 -47.38 37.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.745 -176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.43 74.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.076 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 263' ' ' SER . 94.6 t -58.12 -40.25 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.979 0.419 . . . . 0.0 111.254 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.2 t -71.69 -28.9 64.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 t -89.95 -43.51 10.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.768 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.857 ' HB3' HG23 ' A' ' 282' ' ' VAL . 0.0 OUTLIER -74.25 -6.33 47.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.58 -36.6 76.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.416 1.103 . . . . 0.0 109.0 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -79.77 -7.76 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.646 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.687 ' HE1' ' HB2' ' B' ' 38' ' ' ALA . 2.4 t80 -58.84 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.278 0.561 . . . . 0.0 110.563 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 8.3 t70 -93.75 116.32 28.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.221 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.689 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.8 mm? -114.73 87.05 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.761 175.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.73 -86.62 0.6 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.582 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -146.37 26.75 1.69 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.106 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 20.2 pt20 -141.02 131.75 25.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.887 0.375 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.441 ' CD2' ' HB2' ' A' ' 274' ' ' ASP . 63.7 m-85 -91.66 130.81 37.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.265 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.681 HD22 ' HD2' ' A' ' 273' ' ' PHE . 7.2 mp -63.54 168.65 4.48 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.528 0.68 . . . . 0.0 111.005 175.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.475 ' HD3' ' OE1' ' A' ' 172' ' ' GLN . 2.6 mmp_? -132.45 112.11 11.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.857 HG23 ' HB3' ' A' ' 270' ' ' MET . 94.7 t -116.33 133.27 63.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.084 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.55 ' HA3' HD22 ' A' ' 168' ' ' LEU . . . -137.83 -156.09 7.07 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.174 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -103.45 172.67 6.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' ' 205' ' ' ALA . . . -59.41 -35.83 74.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.571 0.224 . . . . 0.0 111.502 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 61.5 t 70.42 -64.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.82 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.456 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 12.2 t -98.06 143.09 25.64 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 69.5 Cg_endo -79.69 106.25 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.722 2.281 . . . . 0.0 112.113 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.56 ' HG2' HH11 ' A' ' 210' ' ' ARG . 3.0 Cg_exo -76.62 70.77 6.26 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.133 2.555 . . . . 0.0 111.854 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.546 ' N ' ' HD2' ' A' ' 291' ' ' PRO . 15.2 tpt -65.3 -47.8 69.71 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.288 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 290' ' ' MET . 12.9 Cg_endo -57.34 143.84 92.81 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.988 1.792 . . . . 0.0 111.888 173.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 295' ' ' PRO . 8.9 mp -79.81 53.54 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.097 0.475 . . . . 0.0 111.21 -175.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 76.5 mt -92.29 -17.1 25.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.837 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.667 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 31.4 m -117.16 -52.85 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.924 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 9.0 Cg_exo -73.0 65.73 4.13 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.302 2.002 . . . . 0.0 112.659 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -66.32 107.64 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.147 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.052 -175.286 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.66 -39.11 58.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.878 0.339 . . . . 0.0 111.13 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 55.8 mtm 70.52 -54.21 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.906 0.883 . . . . 0.0 111.291 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -135.46 130.91 5.57 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -84.99 -12.42 53.29 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.71 99.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.067 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -155.12 -85.1 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.19 -30.28 18.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.047 0.451 . . . . 0.0 109.919 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 231' ' ' ALA . . . -63.0 -37.02 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.1 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.58 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 19.1 t80 -75.95 -22.75 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 110.271 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -75.8 -43.83 44.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.968 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -61.34 -37.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.666 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.63 -49.44 56.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.611 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.724 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.81 -21.77 37.46 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -171.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -62.55 -38.18 89.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.569 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 61.3 mtp180 -74.09 -35.43 64.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.629 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.724 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -63.13 -44.24 96.13 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -81.65 -26.99 34.32 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 112.96 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.66 -49.17 65.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 0.0 109.82 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.654 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 6.3 pt -68.05 -30.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.496 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.644 ' HA ' HD13 ' A' ' 220' ' ' LEU . . . -67.89 -27.9 67.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.377 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.35 -31.02 19.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.458 ' HZ2' ' CG ' ' A' ' 224' ' ' ASP . 7.3 ttpt -82.18 -38.5 24.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.377 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.724 HG13 ' H ' ' B' ' 46' ' ' GLY . 30.6 pt 49.66 -76.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.288 1.435 . . . . 0.0 114.043 -178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.724 ' H ' HG13 ' B' ' 45' ' ' ILE . . . -146.2 124.63 2.08 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.166 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.3 -179.91 17.03 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.012 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -124.74 9.63 8.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.083 0.468 . . . . 0.0 110.822 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.89 110.57 15.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.81 -95.72 0.2 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 176.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -150.96 24.52 0.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.803 0.811 . . . . 0.0 109.527 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.252 1.223 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.646 -178.256 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.67 116.37 15.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.59 0.234 . . . . 0.0 111.017 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 63.9 mtt 63.19 39.94 9.3 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.898 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.25 102.17 4.24 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 67.02 161.88 0.17 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.823 0.702 . . . . 0.0 110.704 -174.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -134.73 148.46 50.29 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.269 -0.269 . . . . 0.0 111.133 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 58.47 64.45 1.47 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.72 0.638 . . . . 0.0 111.255 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -62.0 -29.51 70.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.128 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.26 72.3 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.3 mt -64.95 -38.83 92.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.236 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.45 -31.64 60.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.77 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.61 -36.19 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.362 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.411 ' HE2' HG13 ' A' ' 286' ' ' VAL . 90.0 mtp -69.24 -34.04 74.2 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.479 ' HG ' ' HG3' ' A' ' 159' ' ' GLU . 28.5 p -73.78 -11.35 60.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.906 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.706 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 91.8 mtt180 -105.71 103.26 12.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -91.51 146.6 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.466 0.651 . . . . 0.0 111.377 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 61.5 t80 -86.33 118.68 25.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.878 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.15 113.47 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 110.192 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.79 174.51 15.25 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.345 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 t 74.73 42.41 0.29 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.541 0.737 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.54 136.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.331 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -108.84 98.51 7.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.439 ' HD1' ' HA ' ' A' ' 151' ' ' LYS . 34.0 t80 37.87 -84.22 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 165.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -71.87 -16.73 62.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.786 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 127' ' ' THR . 88.8 mt -77.96 98.91 5.84 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.79 -167.53 43.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.108 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.95 -29.36 70.29 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.77 -49.58 76.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.482 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.484 HG22 HD21 ' A' ' 123' ' ' LEU . 55.9 m -64.27 -42.2 96.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.052 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.92 -42.3 88.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.425 0.631 . . . . 0.0 110.133 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.456 ' HA ' ' CD1' ' A' ' 138' ' ' ILE . 39.5 ttt180 -56.56 -46.8 80.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.024 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -77.97 -33.34 51.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.187 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.65 77.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.511 . . . . 0.0 111.207 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 1.008 ' HB3' ' HH ' ' A' ' 160' ' ' TYR . 46.2 m-85 -99.59 10.33 41.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.601 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.74 -45.25 16.8 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 23.6 Cg_endo -62.06 -10.44 17.9 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.02 1.813 . . . . 0.0 112.795 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.522 ' CZ ' ' HE2' ' A' ' 173' ' ' MET . 2.3 m-85 -79.25 -67.61 0.74 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 109.803 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.49 165.91 33.09 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.71 112.33 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.31 2.007 . . . . 0.0 111.293 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 129' ' ' ARG . 56.7 mt -68.51 129.16 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 109.981 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -96.83 -50.92 4.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.684 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 t -149.23 161.88 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.5 mt -137.28 109.91 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.635 0.255 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.784 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 47.8 m-20 -84.33 111.17 19.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.271 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.572 ' HG2' ' HB3' ' A' ' 145' ' ' TRP . 24.7 ttp -156.2 101.12 2.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 0.0 110.782 175.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.0 m -77.95 69.24 4.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.914 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 14.3 p-90 -96.32 145.79 25.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.96 111.18 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.424 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 m -90.83 -12.89 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.86 -54.03 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.967 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.5 p -91.7 -19.27 22.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.164 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.645 ' HG3' ' CZ3' ' A' ' 145' ' ' TRP . 15.3 ttp 66.74 25.77 9.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.318 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.439 ' HA ' ' HD1' ' A' ' 121' ' ' TYR . 59.5 pttt -105.32 19.78 20.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.438 . . . . 0.0 110.968 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.914 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 41.1 m-70 60.2 -161.33 0.28 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.626 173.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.501 ' HG2' ' HA ' ' A' ' 145' ' ' TRP . 74.6 mmtt -117.99 -44.14 2.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 157.29 -21.39 0.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.611 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.64 161.61 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.201 0.5 . . . . 0.0 112.173 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.499 ' HB3' ' SD ' ' A' ' 143' ' ' MET . . . -149.36 156.25 41.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.504 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.784 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 80.8 m-85 -114.04 112.39 23.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 57.5 t -99.07 116.86 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.944 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.706 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 42.4 tt0 -94.15 130.51 40.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.91 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 1.008 ' HH ' ' HB3' ' A' ' 132' ' ' PHE . 80.4 m-85 -100.18 155.83 17.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.778 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.99 -33.34 75.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 172.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.62 133.31 25.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.038 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.28 -23.15 73.37 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.323 2.682 . . . . 0.0 113.103 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -54.71 -49.91 69.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 111.211 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.32 70.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.056 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.15 86.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.46 -44.85 93.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.142 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 33.7 mt -63.21 -35.4 80.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 0.0 110.577 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -66.6 -30.6 70.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.633 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.46 -59.34 2.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.27 -39.92 14.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 14.6 mm100 -82.45 -34.69 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.522 ' HE2' ' CZ ' ' A' ' 135' ' ' PHE . 55.9 tpp -72.71 -31.74 65.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.462 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.38 -19.8 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.215 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 41.6 t -78.49 -7.73 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.722 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.56 126.52 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 110.799 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 88.5 mtp -83.96 79.77 9.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 55.7 tp -58.51 118.46 5.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.101 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.07 11.89 83.93 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.406 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.67 5.38 89.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.145 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 181' ' ' ARG . 17.6 mtp180 -112.67 155.3 24.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -91.82 103.84 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.852 0.834 . . . . 0.0 109.106 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.47 146.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.116 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -102.08 110.66 22.68 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 16.1 m -118.64 133.85 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.58 145.72 8.61 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.822 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.595 ' HD3' ' HB2' ' A' ' 115' ' ' TYR . 20.8 ptt180 -151.08 123.9 4.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 1.7 Cg_endo -84.36 72.62 4.99 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.258 2.639 . . . . 0.0 111.011 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 m -64.83 -22.36 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.749 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -155.21 151.11 27.75 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.52 125.0 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.839 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.96 -18.7 8.81 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.986 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -72.78 -57.25 4.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.753 0.311 . . . . 0.0 111.239 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.93 5.64 40.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.058 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.513 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 59.8 tp60 -60.96 -51.71 77.4 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.721 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 15.1 Cg_endo -57.78 -25.04 66.83 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.122 1.881 . . . . 0.0 112.169 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.81 -55.93 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.603 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.6 pt -65.84 -32.0 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -45.95 90.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.887 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -58.09 -48.68 79.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.699 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.64 -50.87 70.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.171 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.536 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -60.96 -41.61 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.046 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.28 -44.26 95.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.435 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.53 -43.06 95.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.539 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.96 66.88 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.874 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 75.8 mtp180 -65.87 -18.51 65.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.094 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.95 55.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 111.167 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -104.05 -19.43 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.273 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 59.43 30.45 20.13 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.57 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.495 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 97.4 mtt180 -88.54 140.56 29.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.229 0.538 . . . . 0.0 111.666 -175.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.68 HD12 ' HE1' ' A' ' 229' ' ' PHE . 8.3 tt -119.95 151.15 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -108.88 126.99 53.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.119 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.515 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.8 p -118.75 122.72 70.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.147 0.499 . . . . 0.0 110.717 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.05 -177.91 3.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.882 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 41.8 m 67.71 16.68 9.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.634 0.774 . . . . 0.0 111.485 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.681 HG12 HD11 ' A' ' 225' ' ' ILE . 66.9 t -62.52 135.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.485 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.78 139.77 47.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.74 -30.97 69.71 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -167.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -79.59 -24.72 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.366 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.781 HD21 ' HG ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -83.63 104.86 14.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 2.4 p -87.39 -177.28 5.89 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.64 -54.39 14.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.989 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.46 -27.9 69.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.936 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.612 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 3.3 m-20 -63.68 -55.58 22.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.332 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.681 HD11 HG12 ' A' ' 216' ' ' VAL . 33.5 mm -60.5 -24.51 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.25 -31.34 68.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.199 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.791 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 69.7 m -48.86 -60.39 2.79 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.985 0.898 . . . . 0.0 111.634 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.649 HG13 ' HB1' ' B' ' 34' ' ' ALA . 3.1 m -71.0 -45.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.676 -170.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.68 ' HE1' HD12 ' A' ' 211' ' ' ILE . 41.4 m-85 -60.96 -40.31 92.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -76.68 -34.4 58.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.674 -175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.98 -25.14 66.96 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.724 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 6.9 m-30 -73.59 -42.79 61.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.85 -100.8 0.21 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.672 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.76 157.66 43.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.08 138.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.484 . . . . 0.0 110.831 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 15.0 mmtp -88.02 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.556 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 27.0 t -145.03 145.05 31.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.811 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.31 129.58 45.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.6 p -145.11 112.52 6.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.29 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.609 HD21 ' HA3' ' A' ' 253' ' ' GLY . 78.0 mt -85.91 129.58 34.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.11 143.29 56.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.647 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -121.41 157.27 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.62 121.93 73.32 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.12 -18.01 60.39 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.139 2.56 . . . . 0.0 113.96 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 p -82.34 -33.99 28.67 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.559 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 45.2 p -112.25 -34.58 5.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 111.847 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.25 59.12 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.597 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.9 141.53 42.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 5.9 p80 -79.0 143.35 35.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 0.0 110.576 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -81.15 156.09 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.147 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.447 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -77.69 46.46 2.6 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.88 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.23 157.27 17.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.966 0.383 . . . . 0.0 110.171 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.609 ' HA3' HD21 ' A' ' 240' ' ' LEU . . . -167.97 -175.28 37.59 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.355 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.08 141.17 52.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.763 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.547 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 24.2 mm -124.12 135.75 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.048 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 37.1 mt-10 -104.98 141.6 36.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.675 0.274 . . . . 0.0 111.238 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -124.25 149.55 46.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.214 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 258' ' ' GLU . 1.1 pm0 -87.22 -17.89 31.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.822 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.724 ' HA ' ' HE3' ' A' ' 259' ' ' LYS . 1.0 OUTLIER -137.28 132.05 33.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.985 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -62.04 -40.75 96.81 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.187 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.429 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 13.3 pt20 -63.76 -32.58 74.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 110.694 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.3 t -65.23 -40.66 94.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.1 m -65.13 -36.27 83.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 91.0 mt-30 -61.88 -33.76 74.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.098 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.91 -48.12 64.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.873 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -56.26 -41.68 76.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.661 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 264' ' ' GLN . 22.9 m -65.47 -27.02 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.3 p -94.02 -29.34 15.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.598 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.6 m -92.72 -38.31 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.724 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.8 mmm -65.83 -23.46 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -171.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.415 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 66.6 t30 -59.06 -35.04 72.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.738 . . . . 0.0 110.54 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.449 HD21 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -77.84 -10.51 59.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.859 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -58.64 112.2 1.53 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.388 -175.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.15 120.99 35.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.926 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.781 ' HG ' HD21 ' A' ' 220' ' ' LEU . 2.0 mm? -120.19 87.57 2.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.202 172.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.63 35.67 18.85 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.949 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.25 62.45 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.937 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -124.43 131.68 53.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 110.394 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -75.68 149.55 38.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.732 HD21 HD21 ' A' ' 275' ' ' LEU . 11.4 mt -79.35 -172.79 3.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.958 0.409 . . . . 0.0 110.056 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.415 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 56.8 mmt-85 -147.08 113.45 5.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.873 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 270' ' ' MET . 21.0 m -122.65 157.66 27.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.14 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -177.17 -171.24 40.51 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.767 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -82.0 140.06 34.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.059 0.457 . . . . 0.0 109.917 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -67.24 -21.33 65.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.795 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 74.6 t 71.12 -65.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.787 0.435 . . . . 0.0 111.008 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.464 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 7.5 t -111.58 140.76 23.49 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.85 108.68 2.63 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.287 1.992 . . . . 0.0 112.135 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 287' ' ' THR . 23.7 Cg_exo -64.88 -32.97 54.29 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.729 2.286 . . . . 0.0 111.85 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.51 83.49 5.38 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.72 10.99 3.45 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.776 2.318 . . . . 0.0 112.839 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 36.0 tp 61.53 61.13 1.53 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.837 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 54.9 tp -55.8 110.39 0.72 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.018 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 24.1 m -106.46 110.0 63.53 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.978 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.09 168.85 21.31 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.753 2.302 . . . . 0.0 111.836 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 59.27 33.06 22.41 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.286 0.565 . . . . 0.0 110.749 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.856 -179.088 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.13 46.71 2.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.132 0.491 . . . . 0.0 110.77 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 67.9 mtt -89.92 85.85 6.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.926 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.27 114.92 2.83 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.659 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -77.35 -47.96 18.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.105 0.479 . . . . 0.0 110.849 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' B' ' 31' ' ' PHE . 1.7 m -126.16 -119.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.667 -170.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 64.4 t30 67.53 19.22 9.97 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.604 0.716 . . . . 0.0 109.785 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.83 -71.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.091 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.68 -38.59 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.894 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' B' ' 34' ' ' ALA . 6.1 t80 -65.4 -17.24 64.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.675 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.615 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.4 mttt -69.68 -49.49 52.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.738 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 14.4 t70 -57.12 -42.27 80.56 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.649 ' HB1' HG13 ' A' ' 228' ' ' VAL . . . -45.47 -54.31 7.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.669 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.871 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.91 -21.49 37.32 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -171.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 79.8 mt-30 -64.94 -39.37 93.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.791 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 17.7 mmt180 -73.79 -32.96 64.02 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.626 172.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.871 ' HB2' ' HA ' ' B' ' 35' ' ' LEU . . . -66.62 -44.66 81.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.253 36.8 mtp85 -82.33 -25.69 33.67 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.209 -1.557 . . . . 0.0 112.773 172.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.78 ' HA ' HE21 ' B' ' 40' ' ' GLN . 0.0 OUTLIER -53.29 -47.0 69.55 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 168.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.722 HD12 ' HZ ' ' A' ' 273' ' ' PHE . 9.2 pt -67.27 -34.27 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.468 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.504 ' O ' HG22 ' B' ' 45' ' ' ILE . . . -66.36 -25.44 66.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.888 0.375 . . . . 0.0 111.287 176.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.55 -15.53 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.748 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.538 ' HZ3' ' CG ' ' A' ' 224' ' ' ASP . 1.5 tmmt? -89.84 -33.74 16.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.504 HG22 ' O ' ' B' ' 42' ' ' ALA . 7.3 pt 36.89 84.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 171.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.96 153.03 8.43 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.463 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.4 110.52 3.29 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.986 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.65 71.59 9.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.256 0.55 . . . . 0.0 110.307 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.97 137.34 44.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.179 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.25 173.37 39.1 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.984 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.9 p -59.55 -43.19 93.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.244 0.777 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.946 175.96 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.613 0.244 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 111' ' ' MET . . . -56.77 -48.66 77.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.973 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.48 HD11 ' HG3' ' A' ' 163' ' ' PRO . 59.0 tp -71.47 -36.62 71.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.93 84.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.369 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.2 pt -78.6 -34.55 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.427 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 107' ' ' ALA . 89.9 mtp -61.52 -26.76 68.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -84.35 -2.19 56.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.6 0.238 . . . . 0.0 111.279 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 27.0 ttp180 -128.74 109.48 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.927 0.394 . . . . 0.0 110.714 -175.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.1 m -92.57 141.28 14.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.484 0.659 . . . . 0.0 111.649 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 53.0 t80 -86.09 130.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.982 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 111.71 37.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.07 0.462 . . . . 0.0 110.085 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.07 155.73 15.95 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.928 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.1 m 68.87 49.97 0.64 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 110.462 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.45 127.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.185 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -45.17 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.867 0.729 . . . . 0.0 112.79 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -178.38 -64.54 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.559 0.219 . . . . 0.0 110.98 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.12 18.98 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.006 0.431 . . . . 0.0 112.087 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 3.6 pp -130.21 141.3 50.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.954 0.407 . . . . 0.0 110.489 176.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.66 -152.43 5.96 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.59 -31.57 69.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.528 0.664 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.22 -43.41 98.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.132 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 2.1 m -84.87 -43.77 13.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.336 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.44 -36.58 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -55.71 -44.13 77.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.95 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -77.82 -34.75 51.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.312 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.27 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.636 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 98.2 m-85 -108.14 12.07 27.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.609 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.55 -44.87 46.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.268 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 17.8 Cg_endo -61.19 -17.28 51.61 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.215 1.943 . . . . 0.0 112.553 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -80.05 -70.16 0.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.47 155.06 26.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.544 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 24.5 Cg_exo -64.13 132.5 34.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.621 2.214 . . . . 0.0 111.586 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.68 110.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.164 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.899 ' HD3' ' HG2' ' A' ' 161' ' ' GLU . 39.2 tptt -83.26 -46.96 12.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.063 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -160.15 153.99 22.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.33 123.09 49.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.741 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 21.2 m-20 -90.44 97.34 11.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 14.0 tpt -105.82 148.67 27.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.002 0.43 . . . . 0.0 111.371 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.0 m -119.09 84.31 2.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.704 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -80.2 116.38 20.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 153' ' ' LYS . 14.9 t70 -95.8 117.2 30.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.649 ' HB3' HG22 ' A' ' 149' ' ' THR . 43.9 t 69.13 162.73 0.22 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.059 0.849 . . . . 0.0 111.733 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.45 -22.32 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.649 HG22 ' HB3' ' A' ' 147' ' ' SER . 9.8 t -60.29 -25.12 65.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.102 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.2 mtt 64.32 43.36 4.77 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.827 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.513 ' HG2' HG23 ' A' ' 149' ' ' THR . 31.4 mmmt -93.23 12.79 23.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.052 0.453 . . . . 0.0 110.813 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.0 p80 41.56 44.69 2.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.489 1.116 . . . . 0.0 113.079 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 28.4 tttm -70.75 96.99 1.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.347 0.594 . . . . 0.0 110.033 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 158.18 -129.27 2.27 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.221 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -148.36 170.46 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.238 0.215 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.19 153.13 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 111.047 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HE2' ' HD2' ' A' ' 187' ' ' ARG . 90.6 m-85 -123.14 124.8 43.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.036 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.2 t -106.22 111.04 33.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 31.8 tt0 -99.58 131.04 45.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -105.68 174.15 6.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.085 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.899 ' HG2' ' HD3' ' A' ' 139' ' ' LYS . 32.2 mt-10 -85.4 -16.26 40.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.097 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.81 135.29 21.5 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.4 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.48 ' HG3' HD11 ' A' ' 108' ' ' LEU . 55.4 Cg_endo -69.87 -17.77 36.9 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.987 2.458 . . . . 0.0 112.197 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -62.85 -40.21 96.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.696 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.92 89.16 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.248 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.84 86.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.483 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -62.2 -47.1 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 283' ' ' GLY . 34.4 mt -66.59 -33.49 75.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.15 0.5 . . . . 0.0 110.561 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.614 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -64.77 -34.13 77.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.298 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.17 -55.47 5.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.972 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.93 -47.68 76.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.511 ' HG2' ' HD2' ' A' ' 281' ' ' ARG . 17.1 mp0 -91.0 -49.88 6.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.636 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 12.6 mmt -66.97 -30.81 71.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.76 -21.28 37.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.151 0.5 . . . . 0.0 110.891 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.2 m -90.98 -24.01 20.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.114 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.2 t -116.0 119.51 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.193 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 89.6 mtp -67.19 108.7 2.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 110.882 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 178' ' ' LEU . 2.5 pt? -81.2 7.54 10.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.799 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.53 -167.29 35.53 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.98 25.42 2.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.629 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -158.3 133.69 8.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -91.96 129.47 37.91 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.4 pt -91.61 151.69 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 184' ' ' LYS . 20.6 ptmt -100.95 116.59 33.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.0 t -103.24 122.46 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.546 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 105.96 172.99 23.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.419 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.669 ' HD2' ' HE2' ' A' ' 157' ' ' PHE . 75.7 mtp180 -130.0 92.22 37.28 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.624 0.25 . . . . 0.0 110.411 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.06 80.54 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.894 2.396 . . . . 0.0 111.661 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -143.9 -54.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.18 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -90.04 5.89 44.68 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.09 0.472 . . . . 0.0 111.212 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 39.9 pt -68.11 153.61 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 88.78 -51.74 3.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.928 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.33 69.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.37 0.605 . . . . 0.0 109.764 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -91.53 1.56 57.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.976 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.554 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.7 tp60 -59.57 -50.04 89.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.103 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 11.2 Cg_endo -55.52 -27.46 59.61 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.353 2.036 . . . . 0.0 112.221 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.9 mm -77.38 -43.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.322 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 80.7 mt -59.52 -50.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.89 -29.92 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.206 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -68.01 -50.08 57.67 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.63 -48.56 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.028 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.03 93.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.224 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 206' ' ' ARG . 3.3 tp10 -69.39 -33.51 73.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.511 . . . . 0.0 110.659 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.02 -45.12 62.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.369 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.12 -24.79 64.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 203' ' ' GLU . 68.3 ttt180 -60.45 -25.04 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.908 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.54 -16.45 64.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -104.96 -4.94 21.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.155 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 32.32 43.17 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 114.252 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 256' ' ' GLU . 24.8 mtp180 -90.16 141.8 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.697 HD13 ' HE1' ' A' ' 229' ' ' PHE . 12.8 tt -99.14 152.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.532 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -107.67 124.54 50.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 0.0 110.24 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 255' ' ' ILE . 17.6 t -108.41 116.88 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.002 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.539 ' O ' ' HG ' ' A' ' 280' ' ' LEU . . . -121.07 173.83 7.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.56 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 35.0 m 64.85 28.33 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.744 0.653 . . . . 0.0 110.778 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.548 HG13 HD11 ' A' ' 225' ' ' ILE . 57.7 t -72.69 133.87 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.374 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 13.6 t-80 -69.1 135.04 50.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 109.764 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -55.62 -41.74 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.667 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.604 ' HB2' ' HB ' ' B' ' 45' ' ' ILE . 2.6 p30 -80.35 -46.95 15.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.625 HD13 HD22 ' A' ' 275' ' ' LEU . 0.1 OUTLIER -50.72 122.69 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.403 0.681 . . . . 0.0 109.954 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 225' ' ' ILE . 22.1 m -99.74 -178.46 3.88 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -167.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.13 -55.42 31.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.014 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 226' ' ' LYS . 2.6 m-20 -62.88 -27.35 69.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.411 ' HB3' HD12 ' B' ' 41' ' ' ILE . 71.9 m-20 -66.66 -49.17 67.04 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.749 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.548 HD11 HG13 ' A' ' 216' ' ' VAL . 21.8 mm -61.16 -24.74 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.271 0.558 . . . . 0.0 109.971 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 223' ' ' ASP . 11.0 mmmm -59.43 -31.8 69.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 174.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 71.2 m -47.79 -54.94 10.83 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.506 0.669 . . . . 0.0 111.034 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.611 HG12 ' HB1' ' B' ' 34' ' ' ALA . 12.5 m -75.24 -49.97 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.665 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.697 ' HE1' HD13 ' A' ' 211' ' ' ILE . 50.0 m-85 -61.21 -46.99 88.19 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.55 ' HB2' ' HE2' ' A' ' 226' ' ' LYS . 27.9 tt0 -77.94 -12.53 59.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.368 . . . . 0.0 111.272 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.62 51.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.357 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.694 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 0.9 OUTLIER -93.82 -52.66 4.34 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.104 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -138.74 -164.5 9.93 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.438 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -108.82 139.1 44.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.549 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.635 ' HB ' ' HE3' ' A' ' 226' ' ' LYS . 3.2 mp -120.27 134.37 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -97.73 -29.06 13.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 111.721 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.6 t -143.34 132.44 23.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.545 ' SG ' ' HD3' ' A' ' 226' ' ' LYS . 9.1 p -144.03 113.56 7.05 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.836 0.35 . . . . 0.0 110.599 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 63.4 m -151.37 122.43 7.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.517 . . . . 0.0 111.353 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.683 HD23 ' HA3' ' A' ' 253' ' ' GLY . 43.4 mt -85.1 130.04 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.61 129.63 42.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.691 0.281 . . . . 0.0 110.907 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -78.97 140.47 38.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.558 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.3 t70 -111.55 116.82 50.03 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.42 -27.88 46.74 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 123.138 2.559 . . . . 0.0 113.659 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.42 HG22 ' OD1' ' A' ' 243' ' ' ASP . 5.1 t -93.32 -27.76 16.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.991 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.3 m -81.14 -36.67 29.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.061 0.458 . . . . 0.0 110.167 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 96.74 -18.45 57.48 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.738 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -108.04 -84.67 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 0.0 110.46 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -164.08 154.02 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.558 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 56.0 mttm -71.41 155.38 40.7 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.64 31.52 1.03 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 121.293 -0.479 . . . . 0.0 113.661 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 27.1 p90 -152.97 164.02 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.109 0.454 . . . . 0.0 110.281 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.683 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -164.15 168.42 38.58 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.62 114.57 26.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.041 0.448 . . . . 0.0 110.582 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.425 HD12 HG21 ' A' ' 213' ' ' VAL . 43.8 mt -107.1 139.73 27.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.822 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 210' ' ' ARG . 38.1 tt0 -115.67 115.52 26.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.698 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.31 152.93 21.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.554 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.518 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 15.0 pt-20 -88.75 -16.98 30.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.878 0.371 . . . . 0.0 110.494 177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.518 ' HG3' ' HG3' ' A' ' 258' ' ' GLU . 22.5 mtpp -128.57 135.77 49.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.11 -25.17 61.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.618 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -66.03 -50.33 64.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.211 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.9 m -63.61 -33.87 76.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.439 -176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 267' ' ' VAL . 31.7 t -57.3 -46.91 82.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.178 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.55 -34.67 77.53 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.83 -44.43 96.17 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.243 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.22 80.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 263' ' ' SER . 62.0 t -52.73 -36.35 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.853 0.359 . . . . 0.0 111.508 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 42.8 m -69.08 -24.76 64.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 38.9 m -115.33 -27.15 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.587 ' HE1' HG21 ' A' ' 228' ' ' VAL . 43.4 mmm -66.94 -13.69 62.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.28 -35.86 80.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.11 0.957 . . . . 0.0 109.121 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.5 mm? -77.39 -9.28 58.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.981 -175.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.922 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 6.2 t80 -51.26 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.137 0.494 . . . . 0.0 111.173 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -82.97 121.49 27.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.242 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.625 HD22 HD13 ' A' ' 220' ' ' LEU . 65.9 mt -125.66 85.87 2.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.041 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.54 27.09 57.93 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.871 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 110.43 -17.42 28.6 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.46 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 18.0 pt20 -102.21 130.45 48.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.816 0.341 . . . . 0.0 110.721 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -80.18 134.61 36.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.654 HD22 ' HD2' ' A' ' 273' ' ' PHE . 2.4 tp -66.78 -178.51 0.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.968 0.792 . . . . 0.0 110.78 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.511 ' HD2' ' HG2' ' A' ' 172' ' ' GLN . 5.6 tpp180 -148.52 112.68 5.21 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.84 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 270' ' ' MET . 18.6 m -111.48 159.48 11.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.558 . . . . 0.0 111.897 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -157.8 -136.03 2.01 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.687 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -142.86 167.75 21.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -87.71 124.92 34.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.03 -29.73 3.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.381 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.7 t -129.94 143.87 50.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 CA--C 1.53 0.3 0 C-N-CA 123.34 2.693 . . . . 0.0 112.15 176.657 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 7.5 t30 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.91 -46.61 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 -43.53 77.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.694 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 9.8 t80 -78.97 -22.51 45.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.958 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.8 mtpt -79.06 -35.01 43.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.785 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.527 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 58.1 t0 -57.07 -46.48 82.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.689 ' HB2' ' CE1' ' A' ' 232' ' ' PHE . . . -49.09 -52.9 23.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.169 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.803 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.7 -25.28 35.6 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -168.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 32.8 mt-30 -63.24 -38.05 89.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.703 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 67.3 mtt180 -71.57 -39.29 70.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.734 172.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.922 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.98 -46.85 85.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.147 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.262 31.9 mtt-85 -80.51 -24.35 39.45 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.898 174.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 56.1 tt0 -53.63 -49.87 66.95 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.248 0.546 . . . . 0.0 109.976 167.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.809 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -65.69 -30.45 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -21.84 42.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.387 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.91 72.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.732 ' HG3' HG12 ' B' ' 45' ' ' ILE . 48.5 pttt -72.66 -43.91 62.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.448 174.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.732 HG12 ' HG3' ' B' ' 44' ' ' LYS . 5.7 pt . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.851 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.919 0.39 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.07 96.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.412 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.64 -36.98 85.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.56 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.55 -28.08 66.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.824 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.36 -43.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.137 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 81.4 mmm -61.24 -40.55 94.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.094 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.452 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 98.8 m -65.22 -19.57 66.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 9.8 ptm85 -116.27 107.18 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.528 0.68 . . . . 0.0 111.264 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.8 m -97.33 135.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.363 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 19.4 t80 -78.35 126.78 31.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.384 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 185' ' ' VAL . 15.3 m -123.67 111.64 29.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.419 0.628 . . . . 0.0 110.02 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -133.9 102.76 0.47 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.625 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.622 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.6 t 168.12 77.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.3 mt -110.16 134.56 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.06 -75.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.17 0.294 . . . . 0.0 111.199 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -169.12 -53.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.198 0.523 . . . . 0.0 110.359 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -19.6 19.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.817 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.58 108.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 0.0 110.792 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 152' ' ' HIS . . . -83.09 -178.77 52.41 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.614 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.47 -24.42 65.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.749 0.309 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.47 -43.53 93.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.323 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -62.19 -44.58 96.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.71 -46.75 91.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 110.57 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.528 ' HG3' HG13 ' A' ' 138' ' ' ILE . 70.6 ttt180 -57.47 -45.75 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.006 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -77.25 -19.15 56.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.43 57.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.762 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 74.0 m-85 -101.86 7.45 41.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 110.797 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -72.14 -42.37 9.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.928 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 133' ' ' ALA . 36.6 Cg_exo -63.59 -4.97 7.74 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.155 1.903 . . . . 0.0 112.716 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -92.7 -75.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.784 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.77 168.86 25.8 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 18.6 Cg_exo -66.14 133.71 34.07 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.54 2.16 . . . . 0.0 111.585 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.528 HG13 ' HG3' ' A' ' 129' ' ' ARG . 47.6 mm -72.02 114.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.358 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -94.71 -46.03 7.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 29.9 t -143.88 135.22 25.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 110.946 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.467 HG22 ' HG3' ' A' ' 143' ' ' MET . 65.9 mt -116.65 106.12 19.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.436 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.2 m-20 -111.33 98.28 7.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.467 ' HG3' HG22 ' A' ' 141' ' ' ILE . 79.7 mtp -109.5 163.68 13.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.466 . . . . 0.0 111.148 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.41 ' O ' ' HA3' ' A' ' 154' ' ' GLY . 66.6 m -145.87 85.67 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.83 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.443 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 13.1 p-90 -144.92 160.13 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.697 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.48 91.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.2 m -85.35 -9.53 57.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.361 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 m -80.15 -52.1 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.623 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -112.9 21.38 15.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.443 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 89.7 mmm 61.69 -157.2 0.34 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.16 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm 73.54 105.42 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -172.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.423 ' NE2' ' HA2' ' A' ' 124' ' ' GLY . 14.8 m-70 -77.6 68.87 3.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.35 31.73 1.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.999 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 144' ' ' SER . . . -139.68 175.25 21.88 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.813 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -114.37 173.51 6.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.425 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -139.9 148.51 42.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.461 . . . . 0.0 111.689 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.449 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 86.2 m-85 -116.94 118.67 33.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -110.1 120.03 60.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.302 0.572 . . . . 0.0 110.958 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.8 tt0 -107.63 134.76 50.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.906 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.61 167.15 9.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.889 0.376 . . . . 0.0 111.647 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.3 -45.28 88.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.168 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.593 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 23.9 m -115.73 138.2 23.76 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.113 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.452 ' HG3' ' SG ' ' A' ' 112' ' ' CYS . 16.5 Cg_exo -68.09 -20.48 43.98 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.4 2.734 . . . . 0.0 112.29 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.593 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 4.0 mp0 -56.52 -52.24 65.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.469 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.43 62.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.47 53.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -73.13 -32.62 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.754 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.464 HD22 ' CE2' ' A' ' 212' ' ' TYR . 25.2 tp -57.42 -48.6 78.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.034 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.32 99.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.708 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.531 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 4.9 tt -59.51 -62.48 1.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.039 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.18 -35.21 74.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.383 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.656 ' HG3' ' HD2' ' A' ' 281' ' ' ARG . 84.9 mm-40 -83.19 -49.5 9.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.762 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 20.6 mmt -73.7 -31.44 63.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -75.01 -16.92 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.403 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.2 m -91.83 -12.25 34.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 173' ' ' MET . 33.6 m -110.59 140.17 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.345 0.593 . . . . 0.0 111.618 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 27.4 ttt -90.72 105.12 17.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.713 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.83 91.57 0.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.46 . . . . 0.0 110.162 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 63.64 -130.21 39.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.829 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.55 5.24 80.19 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.013 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.73 102.64 6.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.311 0.576 . . . . 0.0 110.498 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.77 128.98 38.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.905 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.622 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 21.0 pt -89.39 144.71 8.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.886 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -102.39 110.84 22.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.432 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 116' ' ' VAL . 47.1 t -125.12 136.23 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.454 -174.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.531 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 92.57 46.42 3.48 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.971 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.65 ' HA ' HD11 ' A' ' 191' ' ' ILE . 41.5 ttt85 -139.44 78.69 26.65 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.227 0.514 . . . . 0.0 111.118 175.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 -62.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.587 2.191 . . . . 0.0 111.723 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.4 p -171.63 -52.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.557 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 12.6 m120 -81.51 68.66 7.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.005 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.65 HD11 ' HA ' ' A' ' 187' ' ' ARG . 50.0 mm -74.68 108.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.858 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.89 -8.06 57.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.643 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.557 ' OE1' ' HA ' ' A' ' 190' ' ' ASN . 53.5 mt-30 -77.14 -12.63 59.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 111.259 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.59 16.84 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.622 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.574 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.0 tp60 -58.45 -52.24 76.06 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.441 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 51.5 Cg_exo -55.85 -30.05 75.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.768 1.645 . . . . 0.0 112.062 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 47.8 mm -72.61 -56.11 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.769 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 201' ' ' LEU . 35.2 pt -66.7 -30.74 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.33 -42.05 96.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.397 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 203' ' ' GLU . 88.9 mt-30 -69.72 -35.81 75.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.709 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 198' ' ' ILE . 95.6 mt -62.03 -50.66 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.21 -29.65 70.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.72 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 206' ' ' ARG . 39.2 tt0 -62.42 -52.42 63.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.055 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.94 -29.24 68.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.5 . . . . 0.0 110.502 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.71 68.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.596 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 203' ' ' GLU . 51.1 mtt180 -64.26 -25.54 68.1 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.43 -18.87 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.587 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.18 -29.3 11.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 0.0 110.914 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 58.66 23.98 11.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.688 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 12.3 ptp180 -89.48 150.56 22.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.995 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.98 168.04 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.337 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' A' ' 285' ' ' ALA . 71.7 t80 -112.33 121.66 45.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.382 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.52 123.18 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.286 0.565 . . . . 0.0 110.351 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.37 178.31 5.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.721 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.6 m 68.75 25.94 6.22 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 124.022 0.826 . . . . 0.0 111.481 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.586 HG21 HD13 ' A' ' 240' ' ' LEU . 10.8 m -77.2 164.38 3.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.53 ' HB2' HD23 ' A' ' 275' ' ' LEU . 6.9 t-80 -81.09 147.17 30.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -57.31 -55.86 29.29 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.718 ' HB2' HG13 ' B' ' 45' ' ' ILE . 0.2 OUTLIER -70.08 -48.36 58.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.689 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 1.011 HD11 HG13 ' B' ' 41' ' ' ILE . 0.4 OUTLIER -61.13 114.99 3.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.024 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.2 t -100.43 -177.06 3.39 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -166.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 240' ' ' LEU . 4.3 p30 -60.31 -37.73 81.5 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.64 -31.31 69.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.617 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 13.4 m-20 -78.2 -53.87 6.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.42 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.643 HG13 HD11 ' A' ' 240' ' ' LEU . 32.4 mm -54.89 -25.59 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.041 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -55.79 -33.34 64.31 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.519 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.47 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 69.2 m -49.46 -56.0 11.26 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.693 0.758 . . . . 0.0 111.716 -174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.663 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.4 m -74.61 -49.68 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.734 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' A' ' 235' ' ' ILE . 58.3 m-85 -60.89 -41.68 96.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.917 0.389 . . . . 0.0 111.626 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.541 ' HB2' HD12 ' A' ' 235' ' ' ILE . 1.1 tm-20 -76.26 -22.4 55.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.34 -23.49 61.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.901 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.808 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 1.0 OUTLIER -93.92 -33.42 13.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.226 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -163.67 -179.78 38.22 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.3 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 258' ' ' GLU . 9.1 mmmm -74.66 122.65 23.54 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.676 HG21 ' HB2' ' A' ' 238' ' ' CYS . 55.2 mt -97.57 132.82 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 172.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.71 ' HD2' ' HA ' ' A' ' 258' ' ' GLU . 29.3 mtpp -100.8 -46.01 5.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.198 0.523 . . . . 0.0 110.362 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.5 m -136.28 93.88 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.676 ' HB2' HG21 ' A' ' 235' ' ' ILE . 48.3 t -96.76 113.17 24.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.0 m -151.12 116.85 5.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.619 0.247 . . . . 0.0 110.99 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.798 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 78.7 mt -85.34 130.02 34.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.81 134.69 54.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.806 0.336 . . . . 0.0 110.35 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.828 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 12.3 ptm180 -117.7 157.42 26.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.035 0.445 . . . . 0.0 110.889 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.452 ' OD1' HG22 ' A' ' 245' ' ' THR . 9.6 t70 -88.01 122.71 69.86 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.089 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.96 -19.0 40.54 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.112 2.542 . . . . 0.0 114.546 -172.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.452 HG22 ' OD1' ' A' ' 243' ' ' ASP . 6.4 t -99.17 -30.12 12.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.513 -174.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 36.3 p -94.23 -26.35 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.986 0.422 . . . . 0.0 110.622 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.85 -18.49 53.07 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.278 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.81 150.29 22.31 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.828 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.8 p80 -75.61 152.41 37.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.313 0.578 . . . . 0.0 111.215 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.66 158.71 22.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.188 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.455 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -72.22 43.16 0.83 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.445 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 43.3 p90 -165.63 166.07 18.32 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.798 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.63 -174.4 40.57 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.552 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.577 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 94.3 m-85 -122.58 124.88 44.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.986 0.422 . . . . 0.0 110.267 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.2 mt -120.29 126.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 36.0 tt0 -103.67 136.61 43.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.459 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -109.23 151.54 26.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.757 0.789 . . . . 0.0 112.191 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.71 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 3.1 tp10 -80.24 -21.79 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.628 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 50.2 mtpt -143.17 140.14 30.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.807 -171.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.4 -33.64 76.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.86 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -63.61 -41.02 98.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.411 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.504 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 21.7 m -67.8 -39.85 83.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 267' ' ' VAL . 7.8 p -69.61 -32.8 71.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -66.46 -44.07 83.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.423 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.39 -39.51 92.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.56 76.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.259 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 263' ' ' SER . 90.8 t -62.5 -29.03 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 111.58 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 p -89.89 -10.12 46.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 27.8 t -115.84 -40.24 3.37 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.808 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 30.5 mmm -70.84 -14.67 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.91 0.862 . . . . 0.0 110.36 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.213 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.653 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 51.6 t80 -56.94 98.82 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.521 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 13.5 t70 -82.77 119.86 24.88 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.926 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.875 HD21 HD22 ' A' ' 220' ' ' LEU . 19.7 tp -126.09 86.88 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.45 22.68 39.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.551 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.4 15.29 30.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.614 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 26.9 pt20 -140.67 132.37 27.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.653 0.263 . . . . 0.0 110.395 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.33 133.61 42.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 216' ' ' VAL . 1.0 OUTLIER -71.95 -169.78 0.51 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 0.0 110.972 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.656 ' HD2' ' HG3' ' A' ' 172' ' ' GLN . 21.1 tpp180 -147.79 116.39 6.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.47 139.0 52.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -160.42 -178.81 34.73 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.615 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -72.16 152.2 42.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.43 -20.06 66.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.4 t 71.07 -77.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 122.547 0.339 . . . . 0.0 111.764 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 0.1 OUTLIER -110.7 121.9 39.76 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.014 0.435 . . . . 0.0 111.956 -174.079 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 287' ' ' THR . 74.2 Cg_endo . . . . . 0 N--CA 1.454 -0.799 0 C-N-CA 122.924 2.416 . . . . 0.0 112.41 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.27 -33.02 26.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.116 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.25 71.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.151 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.58 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.9 t80 -74.29 -19.61 60.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.336 0.589 . . . . 0.0 110.49 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 53.3 mttp -76.37 -43.76 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -39.71 77.99 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.403 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.679 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.24 -52.57 43.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.904 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.683 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.44 -21.95 38.5 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 41.3 mt-30 -63.15 -38.16 90.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.542 ' O ' HG23 ' B' ' 41' ' ' ILE . 76.5 mtp180 -73.71 -35.38 65.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.226 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.802 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -61.47 -45.89 92.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' B' ' 39' ' ' ARG 0.253 16.5 mtp180 -81.38 -25.96 35.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.474 -1.391 . . . . 0.0 113.095 174.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -53.49 -49.72 66.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.155 168.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 1.011 HG13 HD11 ' A' ' 220' ' ' LEU . 3.9 pt -61.45 -37.91 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.076 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.61 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -71.85 -22.37 61.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.095 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.69 -45.57 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.08 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 20.6 pttp -74.96 -23.76 58.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.718 HG13 ' HB2' ' A' ' 219' ' ' ASP . 8.3 tp . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 122.083 0.944 . . . . 0.0 110.052 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.944 0.402 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.6 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.313 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.6 tp -73.77 -30.78 62.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.284 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.76 -29.49 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.094 0.473 . . . . 0.0 110.716 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.73 -38.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.483 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.77 -26.8 68.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.349 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 160' ' ' TYR . 15.5 p -92.3 -1.16 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.58 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -118.27 118.95 33.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.4 HG23 HG13 ' A' ' 158' ' ' VAL . 13.2 m -112.62 125.54 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 111.207 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 27.4 t80 -73.74 137.15 43.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.125 175.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.12 110.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 123.415 0.447 . . . . 0.0 109.822 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.2 170.54 13.96 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.111 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 6.4 t 62.68 48.67 4.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.423 0.63 . . . . 0.0 110.376 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -81.85 71.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.437 ' HB3' ' H ' ' A' ' 121' ' ' TYR . 22.3 t80 36.31 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.554 1.159 . . . . 0.0 112.512 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.437 ' H ' ' HB3' ' A' ' 120' ' ' TYR . 38.3 t80 -178.71 -62.03 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -91.63 45.21 1.21 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.072 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.0 125.84 49.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.983 0.42 . . . . 0.0 110.622 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.49 159.08 23.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.26 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.53 -36.74 74.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 111.268 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.69 -32.52 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.413 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 m -76.53 -41.26 47.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.901 0.381 . . . . 0.0 111.154 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 63.7 mt -72.72 -41.05 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.251 0.548 . . . . 0.0 110.104 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -54.4 -41.21 69.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.151 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -76.92 -22.98 52.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.28 74.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 110.594 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.42 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 71.4 m-85 -96.54 4.65 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.586 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -63.01 -44.07 83.89 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.857 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.624 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.2 Cg_endo -69.1 -4.33 13.37 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.012 1.808 . . . . 0.0 113.37 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.622 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 2.7 m-85 -81.06 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.965 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.87 172.99 39.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.176 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.37 128.73 27.08 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.21 117.91 28.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.859 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.591 ' HD3' ' CG ' ' A' ' 161' ' ' GLU . 51.1 tptt -87.34 -53.75 4.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.227 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.8 m -145.79 151.16 37.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.154 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -135.5 107.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 6.4 m-20 -92.3 96.23 10.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.28 0.562 . . . . 0.0 110.172 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.446 ' CE ' ' HB2' ' A' ' 156' ' ' ALA . 41.2 tpp -123.94 94.01 4.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.287 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 t -83.63 84.1 7.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.379 0.609 . . . . 0.0 109.479 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.774 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 0.1 OUTLIER -134.05 160.77 36.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.098 -178.213 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.33 102.72 15.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 m -66.16 -23.5 66.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.295 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.23 -33.89 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 m -96.69 -13.06 23.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.0 110.563 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 45.5 ttm 58.32 34.35 23.97 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.316 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -126.03 143.58 51.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.287 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.774 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 22.8 p80 -103.93 112.39 25.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.142 0.496 . . . . 0.0 111.165 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -76.38 -15.3 59.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.135 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.89 -152.75 8.37 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.568 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.88 175.2 9.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.446 ' HB2' ' CE ' ' A' ' 143' ' ' MET . . . -99.14 137.32 37.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.066 0.46 . . . . 0.0 111.975 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.643 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 95.4 m-85 -117.73 106.45 13.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 169.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 114' ' ' VAL . 2.7 p -100.46 122.71 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.813 0.816 . . . . 0.0 110.377 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.1 135.19 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.106 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 41.9 m-85 -115.23 164.98 13.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.591 ' CG ' ' HD3' ' A' ' 139' ' ' LYS . 33.6 mt-10 -95.66 10.02 38.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.338 0.59 . . . . 0.0 109.499 170.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.45 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.0 m -130.25 115.11 17.38 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.213 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 162' ' ' VAL . 20.4 Cg_endo -62.43 -21.73 73.13 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.745 2.296 . . . . 0.0 111.686 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 285' ' ' ALA . 15.9 mp0 -59.47 -63.59 1.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.601 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -57.49 -33.46 68.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.599 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.43 62.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.646 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.49 -33.95 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.494 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.441 HD21 ' HG3' ' A' ' 281' ' ' ARG . 8.9 tt -61.29 -48.32 81.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.03 -39.84 91.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.623 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.4 tt -58.83 -55.03 40.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -75.35 -48.14 24.4 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -91.85 -0.36 57.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -165.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.475 ' HG3' HD11 ' A' ' 183' ' ' ILE . 55.1 tpp -116.42 -32.75 5.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.086 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 6.7 t30 -68.75 -27.04 65.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.365 0.603 . . . . 0.0 110.351 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -90.83 17.18 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.889 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.12 142.79 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.219 0.533 . . . . 0.0 110.623 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.54 100.91 10.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.085 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.94 -55.65 32.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.554 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.84 69.09 0.31 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.382 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.86 -38.89 2.37 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.566 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.497 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 5.2 mpt_? -97.52 136.67 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.3 118.24 17.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 24.1 pt -84.7 157.03 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.121 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -104.18 110.92 23.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 46.3 t -120.4 128.79 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.765 0.317 . . . . 0.0 110.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.623 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 110.9 -105.47 1.9 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.027 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 14.3 mmt180 66.56 78.06 0.25 Allowed Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.137 0.575 . . . . 0.0 112.456 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.99 97.36 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.831 2.354 . . . . 0.0 110.654 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.3 t -75.48 -28.31 59.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -84.82 80.03 9.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.347 0.594 . . . . 0.0 110.988 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.33 62.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.56 0.695 . . . . 0.0 110.347 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.63 -80.78 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.459 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -82.12 -34.98 28.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.969 0.414 . . . . 0.0 110.535 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -72.85 -33.49 66.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.603 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.49 10.18 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.213 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.628 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 27.2 Cg_endo -62.04 -37.08 67.05 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.795 1.663 . . . . 0.0 112.231 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.45 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 50.5 mm -66.77 -41.45 87.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 194' ' ' ALA . 90.2 mt -59.75 -42.23 88.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.96 -39.82 90.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.551 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 80.8 mm-40 -62.07 -37.84 86.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 99.1 mt -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.529 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.27 85.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.842 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.79 -33.93 76.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.199 0.524 . . . . 0.0 110.563 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.426 ' O ' ' HD1' ' A' ' 208' ' ' PHE . 7.9 tp10 -66.01 -49.59 67.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.258 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.59 78.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -67.28 -23.35 65.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.635 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.87 -28.88 50.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.121 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.426 ' HD1' ' O ' ' A' ' 204' ' ' GLU . 24.6 m-85 -88.62 -19.57 26.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.37 0.605 . . . . 0.0 110.437 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 65.8 t30 61.1 37.12 17.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.001 168.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.58 136.65 40.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.969 0.414 . . . . 0.0 110.176 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.487 ' CG2' ' HB ' ' A' ' 255' ' ' ILE . 9.8 tt -100.45 144.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -108.28 109.51 20.88 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.454 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.3 p -105.64 120.0 55.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 0.0 110.777 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.63 178.16 4.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.447 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.6 m 67.85 14.29 9.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.508 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.655 ' HA ' HD22 ' A' ' 280' ' ' LEU . 10.6 p -71.21 137.49 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.305 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -67.25 134.81 52.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -58.61 -8.8 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.987 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.0 -37.21 47.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.288 0.566 . . . . 0.0 110.319 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.897 HD13 HD13 ' A' ' 275' ' ' LEU . 0.5 OUTLIER -113.32 128.12 56.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.665 -172.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.4 m -100.61 -175.32 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.791 0.437 . . . . 0.0 111.125 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.871 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 6.6 p-10 -53.6 -40.76 65.96 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.86 -35.66 66.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.45 0.643 . . . . 0.0 110.408 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.72 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.8 m-20 -78.89 -58.01 3.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.163 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.508 HG13 HG21 ' A' ' 216' ' ' VAL . 20.6 mm -63.46 -15.52 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.253 0.549 . . . . 0.0 111.067 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.773 ' HG3' HD12 ' A' ' 235' ' ' ILE . 83.1 tttt -54.42 -32.15 56.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.573 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.743 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.7 m -48.78 -61.37 2.08 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.704 0.764 . . . . 0.0 111.477 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.841 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.0 m -73.66 -38.92 52.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.506 -172.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.492 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 19.0 m-85 -62.89 -50.79 69.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.694 0.283 . . . . 0.0 111.661 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.558 ' HG3' ' HA ' ' A' ' 234' ' ' LYS . 27.6 tt0 -77.83 -17.99 56.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.47 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.198 -0.314 . . . . 0.0 111.008 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.7 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.4 m-30 -82.88 -42.21 18.02 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.85 -107.19 0.79 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.219 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.558 ' HA ' ' HG3' ' A' ' 230' ' ' GLU . 33.6 ttmt -157.51 159.62 37.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.773 HD12 ' HG3' ' A' ' 226' ' ' LYS . 60.3 mt -122.98 128.62 75.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 111.218 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -92.33 -31.03 15.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.333 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 33.2 t -156.93 119.56 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.771 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.621 ' HB3' HG21 ' A' ' 235' ' ' ILE . 6.3 p -117.74 117.12 28.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 36.3 m -153.31 104.99 2.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 112.063 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.871 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 54.7 mt -86.42 119.24 26.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 166.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.95 106.19 0.67 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -92.59 153.48 18.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.342 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.66 96.31 27.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.4 -19.53 49.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -35.98 57.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.248 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.2 m -86.19 -33.0 20.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.45 35.17 5.3 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.329 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.42 156.83 16.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.774 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 12.0 p80 -84.46 138.33 32.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -67.02 152.57 45.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.69 24.61 1.5 Allowed Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.942 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.34 161.31 42.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.284 0.542 . . . . 0.0 110.583 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.29 -174.95 40.71 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.868 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -120.07 135.89 54.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.035 0.445 . . . . 0.0 111.178 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.487 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 28.8 mm -118.33 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 33.9 tt0 -104.69 126.27 51.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.52 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -101.47 146.83 27.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 1.3 pm0 -78.34 -16.96 57.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.573 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 258' ' ' GLU . 31.3 mtmm -137.09 148.48 46.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.67 64.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.78 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.36 -43.24 88.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.698 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.2 m -68.56 -31.99 71.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 267' ' ' VAL . 33.2 t -65.77 -52.21 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.382 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.48 -36.29 83.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.379 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.3 -31.32 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.579 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.94 63.7 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.95 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 263' ' ' SER . 42.8 t -54.4 -42.97 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 50.6 m -70.94 -25.89 62.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.4 p -109.65 -37.7 5.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.751 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 0.4 OUTLIER -65.77 -27.65 68.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.496 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.6 t30 -57.53 -34.38 69.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.743 0.783 . . . . 0.0 110.275 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.468 ' O ' ' HD2' ' A' ' 279' ' ' TYR . 18.5 mt -76.43 -6.55 52.18 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.86 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.821 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 3.2 t80 -54.43 102.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.6 t70 -89.07 122.99 32.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.725 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.897 HD13 HD13 ' A' ' 220' ' ' LEU . 88.8 mt -120.55 87.97 2.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.233 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.59 36.75 47.93 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.03 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.84 7.83 46.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.476 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.0 pt20 -136.8 132.76 35.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.99 0.424 . . . . 0.0 110.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.468 ' HD2' ' O ' ' A' ' 272' ' ' LEU . 79.6 m-85 -90.26 135.26 33.78 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.655 HD22 ' HA ' ' A' ' 216' ' ' VAL . 15.7 mt -69.1 -169.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.697 0.761 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -149.87 112.36 4.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.95 -176.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' ' 271' ' ' ASN . 30.7 m -111.41 147.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.256 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.75 -159.72 9.21 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.898 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -92.91 159.41 15.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.595 0.236 . . . . 0.0 110.71 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -67.83 -21.67 65.19 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.612 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.461 HG12 HG23 ' A' ' 287' ' ' THR . 92.5 t 72.35 -62.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.472 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.711 ' HB ' ' HD2' ' A' ' 288' ' ' PRO . 63.7 p -114.4 170.27 5.63 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.711 ' HD2' ' HB ' ' A' ' 287' ' ' THR . 30.3 Cg_endo . . . . . 0 C--N 1.347 0.484 0 C-N-CA 122.329 2.019 . . . . 0.0 111.486 173.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 . . . . . 0 CA--C 1.519 -0.246 0 CA-C-O 121.366 0.603 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.68 -62.52 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.89 -22.8 66.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.427 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.512 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 5.1 t80 -70.38 -18.0 63.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.241 0.543 . . . . 0.0 110.125 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.602 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 50.0 mtmt -69.9 -46.4 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 53.0 t0 -57.44 -44.68 84.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.984 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.841 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -47.53 -54.11 12.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.125 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.685 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.24 -20.13 38.28 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -168.725 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 30.1 mt-30 -61.2 -43.6 98.63 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.743 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 45.9 mtt180 -73.67 -28.61 61.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.697 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.821 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.56 -48.56 78.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -80.11 -27.16 39.23 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.075 -1.016 . . . . 0.0 111.941 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.56 -45.83 73.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.932 0.396 . . . . 0.0 110.491 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 14.1 pt -68.75 -35.29 69.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.766 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' A' ' 220' ' ' LEU . . . -68.74 -20.04 64.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.134 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.56 -46.72 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.477 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.564 ' O ' HG12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -92.6 -14.52 28.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.509 -176.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.564 HG12 ' O ' ' B' ' 44' ' ' LYS . 12.1 pt . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 125.282 1.433 . . . . 0.0 113.639 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.798 0.332 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.431 ' HB2' ' HB1' ' A' ' 194' ' ' ALA . . . -60.03 -46.03 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.142 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.506 HD11 ' HG3' ' A' ' 163' ' ' PRO . 44.2 tp -71.23 -34.47 70.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.825 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.13 -50.29 74.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.218 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.426 ' HB ' ' HG2' ' A' ' 187' ' ' ARG . 33.9 pt -72.22 -34.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.0 mmm -59.66 -26.62 65.69 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -84.56 -15.61 45.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.612 0.244 . . . . 0.0 111.533 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 23.6 ttm-85 -109.8 108.61 19.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 110.716 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -91.96 134.12 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.73 0.776 . . . . 0.0 111.146 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 21.6 t80 -90.62 122.08 33.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.17 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.559 HG12 HD13 ' A' ' 119' ' ' ILE . 14.3 t -108.81 109.89 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.89 164.34 12.55 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.984 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 m 72.71 -57.22 0.64 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.483 0.713 . . . . 0.0 110.901 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' A' ' 123' ' ' LEU . 17.9 mm 66.59 -79.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 123.235 0.614 . . . . 0.0 111.099 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HA ' ' HG2' ' A' ' 181' ' ' ARG . 89.6 t80 174.48 -72.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.801 0.84 . . . . 0.0 108.743 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 3.6 t80 170.29 -59.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.648 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.09 -24.13 30.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.631 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 127' ' ' THR . 39.1 mt -67.52 128.74 37.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.363 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -123.74 -153.57 8.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.921 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -60.24 -54.78 41.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 111.461 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.26 -35.24 78.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.537 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.849 HG21 HD22 ' A' ' 123' ' ' LEU . 1.9 m -66.22 -41.2 90.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.791 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.63 -38.9 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.15 -47.14 72.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.438 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -71.06 -27.47 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.702 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.34 -42.41 18.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.888 0.375 . . . . 0.0 111.435 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.421 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 84.6 m-85 -96.57 12.17 32.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -175.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.25 -46.29 50.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.785 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.939 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.1 Cg_endo -68.43 -4.62 13.28 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.744 1.63 . . . . 0.0 112.702 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -98.08 64.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.059 0.457 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.6 175.29 40.6 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.808 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.93 102.62 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.722 2.281 . . . . 0.0 111.555 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.701 HG12 ' HE1' ' A' ' 160' ' ' TYR . 55.5 mt -56.17 119.8 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.206 0.527 . . . . 0.0 110.375 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -89.79 -45.8 9.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.181 -173.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 t -159.55 141.08 12.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 62.0 mt -121.58 115.91 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.429 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.75 106.75 17.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.376 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.424 ' HB3' ' HE2' ' A' ' 143' ' ' MET . 78.9 mtp -106.95 152.88 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.1 p -99.74 97.55 8.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -78.28 113.77 16.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 151' ' ' LYS . 12.7 t70 -80.44 112.49 17.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.203 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 93.8 p 53.8 -159.73 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.998 0.919 . . . . 0.0 112.296 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.35 -22.49 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.176 0.512 . . . . 0.0 111.089 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -62.84 -14.2 42.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.1 mtm 64.99 22.88 12.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.22 0.533 . . . . 0.0 110.891 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 146' ' ' ASP . 23.6 ttmm -73.15 91.74 1.66 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.552 ' CE1' HG13 ' A' ' 119' ' ' ILE . 11.5 t-160 -76.36 67.49 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -96.57 112.56 24.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.86 -115.85 0.71 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.388 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -152.28 175.47 12.61 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.88 138.5 18.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.883 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 98.5 m-85 -106.68 123.75 48.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.558 0.218 . . . . 0.0 110.474 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.06 104.69 17.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.065 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.3 tt0 -95.35 130.14 42.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.701 ' HE1' HG12 ' A' ' 138' ' ' ILE . 31.0 m-85 -104.01 166.4 10.43 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -100.29 5.79 44.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.847 0.832 . . . . 0.0 109.145 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.74 119.64 12.9 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.034 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.506 ' HG3' HD11 ' A' ' 108' ' ' LEU . 24.8 Cg_endo -64.19 -21.86 67.32 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.095 2.53 . . . . 0.0 112.792 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.447 ' OE2' ' HG2' ' A' ' 163' ' ' PRO . 16.7 mp0 -61.9 -52.53 63.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.63 75.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.137 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -38.55 90.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.167 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.449 ' HG2' HG22 ' A' ' 286' ' ' VAL . 56.8 tp60 -65.2 -40.57 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.128 0.489 . . . . 0.0 110.488 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.42 HD11 ' HA3' ' A' ' 283' ' ' GLY . 8.9 mp -66.32 -37.17 84.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.503 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.56 -28.92 69.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.294 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.98 -62.17 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.04 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -71.09 -43.42 67.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -87.31 -21.87 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.583 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 54.2 tpp -98.22 -33.19 11.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.808 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -80.3 -8.95 59.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 110.839 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 p -90.31 0.66 57.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.32 168.37 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.696 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 86.3 mtp -129.46 103.02 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.131 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.58 118.69 14.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.79 -73.1 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.514 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.3 38.94 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.653 ' HG2' ' HA ' ' A' ' 120' ' ' TYR . 23.8 tpt180 -140.61 138.6 34.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -80.85 102.74 10.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.66 133.06 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.128 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -100.5 110.95 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.938 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 45.9 t -112.27 129.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.276 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 176.75 -144.47 6.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.098 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.426 ' HG2' ' HB ' ' A' ' 110' ' ' ILE . 23.3 tpt180 -162.98 79.02 1.74 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.05 49.07 2.69 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.957 2.438 . . . . 0.0 113.165 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.5 m -90.29 -57.1 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.034 0.445 . . . . 0.0 110.066 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -137.25 -64.18 0.57 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.1 mt 70.81 138.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.251 0.548 . . . . 0.0 111.676 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.15 -49.97 4.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.385 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -55.48 -56.01 25.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.852 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 107' ' ' ALA . . . -105.07 14.0 29.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.053 0.454 . . . . 0.0 110.942 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 0.3 OUTLIER -64.6 -55.18 31.14 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.427 -177.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 76.7 Cg_exo -52.72 -27.53 34.2 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 122.707 2.271 . . . . 0.0 113.738 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 48.2 mm -62.2 -34.89 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.443 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 51.5 mm -70.93 -39.1 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.654 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.25 -37.64 83.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.472 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 29.8 mm-40 -65.09 -36.77 85.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.176 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 89.5 mt -71.21 -37.35 72.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.706 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.73 -42.02 97.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -67.66 -34.64 77.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.907 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.37 -46.9 84.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.105 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 285' ' ' ALA . . . -62.53 -23.51 67.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.044 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -63.29 -27.57 69.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.774 0.321 . . . . 0.0 110.62 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.94 -13.23 61.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.406 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -93.26 -15.19 26.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.785 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 60.77 17.25 7.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.38 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.74 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 16.1 ptm180 -111.12 144.75 39.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 283' ' ' GLY . 35.5 pt -119.3 169.64 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.302 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.429 ' HE1' ' HD2' ' A' ' 252' ' ' TYR . 84.1 t80 -116.82 115.25 25.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.182 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.71 122.59 66.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.256 0.551 . . . . 0.0 110.694 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.25 -174.69 2.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.352 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.939 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 14.2 t 61.42 30.5 18.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 0.0 110.354 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.538 HG12 HD11 ' A' ' 280' ' ' LEU . 5.4 m -81.6 151.25 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.464 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 11.5 t-80 -73.9 137.56 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -166.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.539 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -78.5 -46.46 19.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.898 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.766 HD23 HD13 ' A' ' 225' ' ' ILE . 0.1 OUTLIER -58.56 100.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.606 178.067 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.7 m -101.05 -174.77 2.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.53 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.611 ' N ' HD12 ' A' ' 240' ' ' LEU . 3.7 p-10 -48.63 -43.28 36.29 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.77 -30.81 71.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.16 0.505 . . . . 0.0 110.819 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.719 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 11.4 m-20 -78.82 -59.65 2.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.772 HG13 HD11 ' A' ' 240' ' ' LEU . 23.5 mm -56.05 -24.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.216 0.532 . . . . 0.0 111.232 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.463 ' HG3' HD12 ' A' ' 235' ' ' ILE . 59.4 tttm -53.73 -32.46 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.018 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.923 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.8 m -51.89 -62.4 1.65 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.878 0.847 . . . . 0.0 112.204 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.65 HG21 ' HE1' ' A' ' 270' ' ' MET . 1.9 m -63.03 -53.46 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.306 -173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.568 ' HD2' ' HH ' ' A' ' 257' ' ' TYR . 84.2 m-85 -59.0 -34.08 71.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.42 -34.36 47.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -60.53 -26.14 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 111.041 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.623 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 3.9 p90 -129.96 40.22 3.58 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.605 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -177.34 153.8 14.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.115 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -94.31 110.47 22.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 0.0 110.167 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.463 HD12 ' HG3' ' A' ' 226' ' ' LYS . 52.5 mt -83.43 130.28 36.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.41 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -89.53 -37.03 15.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.64 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.1 t -168.47 134.04 1.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.37 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.1 t -114.48 113.42 24.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.4 m -136.81 103.77 5.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.996 0.427 . . . . 0.0 111.42 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.772 HD11 HG13 ' A' ' 225' ' ' ILE . 29.7 mt -83.69 129.8 34.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.04 138.91 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.707 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.658 ' HG2' ' HA ' ' A' ' 249' ' ' HIS . 69.2 mtp180 -137.58 149.57 46.78 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.76 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.627 ' HB2' HG22 ' A' ' 245' ' ' THR . 3.7 p-10 -80.85 129.34 68.26 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.996 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.13 -16.35 40.13 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.76 2.307 . . . . 0.0 112.027 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 243' ' ' ASP . 12.1 t -74.9 -33.68 62.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.823 -175.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.9 m -134.34 -41.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.007 0.432 . . . . 0.0 111.235 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.12 21.88 5.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.502 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -79.69 153.36 29.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 242' ' ' ARG . 1.9 t-80 -85.72 125.35 33.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.235 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.26 155.41 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.161 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.456 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -73.53 31.77 0.85 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.403 0.521 . . . . 0.0 114.403 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 34.9 p90 -160.13 163.78 33.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.915 0.358 . . . . 0.0 110.073 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -178.15 -169.75 39.42 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.309 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.418 ' CB ' HH21 ' A' ' 210' ' ' ARG . 95.5 m-85 -126.94 140.01 52.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.03 129.86 71.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.74 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 38.5 mt-10 -103.61 146.75 28.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.122 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.568 ' HH ' ' HD2' ' A' ' 229' ' ' PHE . 85.2 m-85 -117.29 158.2 24.78 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.306 0.574 . . . . 0.0 110.698 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -82.52 -17.26 45.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.704 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -134.73 140.61 46.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.958 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.05 -19.53 63.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.22 0.533 . . . . 0.0 109.919 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.54 -45.74 78.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.92 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -68.15 -27.15 66.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.404 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 m -61.79 -48.55 80.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.605 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.452 ' O ' HG12 ' A' ' 267' ' ' VAL . 57.5 tp60 -73.8 -34.34 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.866 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.67 -46.52 82.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.38 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.378 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 282' ' ' VAL . 4.0 p -60.76 -26.46 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.872 0.367 . . . . 0.0 111.666 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 28.9 m -81.06 -18.38 46.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 9.6 p -116.02 -27.6 6.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.65 ' HE1' HG21 ' A' ' 228' ' ' VAL . 34.5 mmm -69.46 -14.52 62.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -170.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 17.4 p-10 -73.74 -15.3 61.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.008 0.432 . . . . 0.0 111.402 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.53 -9.48 59.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.884 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 4.8 t80 -62.11 87.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.006 0.432 . . . . 0.0 111.406 -170.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.49 124.93 28.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' A' ' 220' ' ' LEU . 53.4 mt -123.45 107.71 11.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.86 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.7 -78.71 1.74 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.351 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -155.91 23.03 0.54 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.14 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -140.64 138.85 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.743 -0.269 . . . . 0.0 110.418 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 77.0 m-85 -75.05 123.86 25.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.538 HD11 HG12 ' A' ' 216' ' ' VAL . 5.9 tt -67.84 138.78 56.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.478 ' H ' ' HB3' ' A' ' 215' ' ' SER . 34.4 mmt180 -121.08 123.04 41.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.796 0.332 . . . . 0.0 110.773 -167.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' A' ' 270' ' ' MET . 14.9 p -117.25 147.7 20.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.094 0.473 . . . . 0.0 111.455 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 211' ' ' ILE . . . -144.71 -170.71 14.06 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -82.04 179.51 7.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.987 0.393 . . . . 0.0 110.549 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.562 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -67.64 -27.18 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 0.0 110.519 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 167' ' ' GLN . 44.4 t 73.53 -65.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.299 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 34.4 p -108.57 158.19 34.62 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.345 0.361 0 C-N-CA 122.208 1.939 . . . . 0.0 111.378 173.564 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.374 0.607 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -154.32 -65.65 0.14 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 232' ' ' PHE . . . -77.17 -31.28 55.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 110.85 176.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.449 ' HD1' ' CE1' ' A' ' 232' ' ' PHE . 16.9 t80 -65.77 -16.32 63.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.227 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -71.65 -50.81 27.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.262 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.599 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 15.5 t70 -57.88 -42.68 85.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.623 ' CB ' ' HE1' ' A' ' 232' ' ' PHE . . . -49.01 -44.85 41.68 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.54 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.711 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 2.6 mm? -82.19 -21.03 36.67 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -64.4 -40.72 96.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.923 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 18.6 mmt180 -73.28 -32.59 64.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.363 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.884 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.31 -47.06 85.94 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.099 -175.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 27.5 mtt85 -80.97 -26.27 36.69 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.259 -1.526 . . . . 0.0 112.703 174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -54.38 -41.92 69.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.518 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.815 HG12 ' O ' ' B' ' 38' ' ' ALA . 2.7 pt -69.83 -34.02 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.733 0.301 . . . . 0.0 110.775 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.42 -22.64 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.959 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.08 -27.26 22.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.807 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.793 ' HE2' HG22 ' B' ' 41' ' ' ILE . 45.1 pttt -93.11 -52.71 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.562 ' N ' ' HG3' ' B' ' 44' ' ' LYS . 91.9 mt . . . . . 0 C--O 1.234 0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.138 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.426 ' O ' HG12 ' A' ' 110' ' ' ILE . 73.3 mtt180 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.48 0.181 . . . . 0.0 111.402 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.47 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.3 -29.23 70.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.843 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.442 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.787 HD12 HG12 ' A' ' 191' ' ' ILE . 29.0 pt -82.57 -36.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.0 mtp -60.25 -26.19 66.25 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.5 m -82.44 -0.98 48.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ttm180 -122.2 118.25 28.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.56 166.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.045 0.45 . . . . 0.0 110.779 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -119.35 114.25 22.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.335 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -104.78 110.83 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 110.856 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.98 170.49 14.99 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 24.7 m 59.91 47.91 9.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.268 0.556 . . . . 0.0 110.428 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -76.49 123.04 32.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.817 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.553 ' HB3' HD13 ' A' ' 123' ' ' LEU . 54.9 t80 -62.91 140.98 58.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.314 0.578 . . . . 0.0 109.895 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -52.73 -31.71 39.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.27 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.38 6.7 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.553 HD13 ' HB3' ' A' ' 120' ' ' TYR . 10.1 mp -100.65 120.46 40.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.68 -165.79 14.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.639 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.521 ' OE2' ' HD2' ' A' ' 129' ' ' ARG . 3.9 tm-20 -59.36 -51.76 68.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.458 0.303 . . . . 0.0 110.762 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.86 -29.64 69.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.49 HG21 ' HG ' ' A' ' 123' ' ' LEU . 5.2 m -64.63 -50.78 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.968 0.413 . . . . 0.0 110.197 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.3 mt -67.48 -40.2 84.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.288 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.521 ' HD2' ' OE2' ' A' ' 125' ' ' GLU . 23.1 ttt180 -51.58 -51.93 51.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.502 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.2 -24.12 51.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.927 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.86 -37.57 73.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.27 12.86 36.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -70.88 -41.6 11.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.166 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.79 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 33.7 Cg_exo -63.89 -4.69 7.77 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.222 1.948 . . . . 0.0 112.817 173.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.432 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 23.8 m-85 -93.01 -68.44 0.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.306 . . . . 0.0 110.216 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.87 168.68 33.44 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.62 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 13.3 Cg_exo -69.51 121.86 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.513 2.142 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.54 123.87 37.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.95 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -100.35 -36.85 9.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.459 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -145.76 136.93 24.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.942 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 70.0 mt -127.29 116.4 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -103.68 114.55 28.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.319 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' A' ' 156' ' ' ALA . 89.1 mtp -113.64 108.29 16.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.353 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.541 ' O ' ' HA3' ' A' ' 154' ' ' GLY . 12.1 p -94.46 61.09 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.456 0.646 . . . . 0.0 110.796 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -114.13 159.59 19.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.628 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.652 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.7 m-20 -73.73 88.0 1.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.476 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.2 m -65.98 -36.02 82.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.585 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.9 m -63.52 -23.84 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.247 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.799 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 1.6 m -120.64 2.04 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.382 0.61 . . . . 0.0 110.132 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.9 mtp 56.91 35.61 26.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.535 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.799 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 30.7 mmmt -97.27 126.57 42.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.054 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -84.3 48.16 1.45 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.477 0.656 . . . . 0.0 110.098 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.47 -34.22 74.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.708 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 144' ' ' SER . . . -95.73 -155.53 31.14 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.026 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -140.46 174.57 10.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.258 0.223 . . . . 0.0 110.554 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.432 ' HB2' ' HG2' ' A' ' 143' ' ' MET . . . -124.33 138.42 54.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.805 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 97.1 m-85 -107.27 124.94 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.715 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.1 t -119.45 113.59 41.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 10.3 pt-20 -105.43 137.11 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -105.86 172.36 6.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.132 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 39.0 tt0 -74.53 -29.82 61.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.563 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.3 m -129.44 139.87 36.95 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.583 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.17 -20.54 43.46 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.187 2.592 . . . . 0.0 112.494 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 11.1 mp0 -55.56 -55.32 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.76 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -58.77 -32.24 69.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.514 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -51.61 36.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.35 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.38 -34.82 76.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.19 0.519 . . . . 0.0 110.091 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.612 HD13 ' HA3' ' A' ' 283' ' ' GLY . 25.8 tp -61.01 -44.71 97.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.239 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.22 87.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.532 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.34 -39.27 94.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -81.59 -47.35 13.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.029 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.418 ' CD ' ' HE ' ' A' ' 281' ' ' ARG . 20.3 mm-40 -87.83 -44.84 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -169.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.6 tpp -69.68 -26.74 64.52 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.097 0.475 . . . . 0.0 110.703 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -69.29 -24.2 63.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.204 0.526 . . . . 0.0 109.983 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 t -81.52 -27.86 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.83 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.88 110.49 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 111.017 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.589 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 21.3 mmt -61.83 124.13 19.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.913 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.52 105.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.967 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.33 -90.06 0.82 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.9 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.12 42.3 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 120' ' ' TYR . 30.4 tpt180 -134.0 126.09 29.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.703 0.287 . . . . 0.0 110.33 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.589 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 8.6 t30 -72.11 85.08 1.02 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.584 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.4 pt -83.0 156.64 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.272 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -105.94 109.8 21.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.527 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.93 109.59 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.159 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 135.6 -115.53 1.37 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.708 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 57.15 68.9 1.84 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.265 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.527 ' HB3' ' HB ' ' A' ' 191' ' ' ILE . 5.6 Cg_exo -80.77 61.52 8.25 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.802 3.001 . . . . 0.0 112.353 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 m -50.76 -42.45 57.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.706 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -117.56 13.09 14.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.787 HG12 HD12 ' A' ' 110' ' ' ILE . 53.5 mt -98.46 -25.26 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.044 0.45 . . . . 0.0 110.61 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.82 85.45 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.811 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -79.42 -4.79 52.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 111.204 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.28 7.65 42.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.601 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 61.8 tp60 -53.6 -44.61 98.1 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.79 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.4 Cg_endo -51.79 -32.25 45.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.267 1.978 . . . . 0.0 112.723 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.15 -43.93 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 110.121 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.9 mt -59.76 -38.97 78.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.537 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 66.2 m-20 -54.76 -50.96 67.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.748 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.38 -32.24 73.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.541 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.4 mt -66.01 -49.75 66.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.047 0.451 . . . . 0.0 110.126 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.62 -40.83 98.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.88 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 31.3 mm-40 -64.14 -30.29 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.287 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.83 -45.68 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.54 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.43 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.453 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtp180 -63.03 -21.85 66.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.657 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.99 -29.14 39.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.877 0.37 . . . . 0.0 111.197 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.56 -19.24 14.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.66 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 56.98 37.97 29.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.235 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.27 140.5 31.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.314 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 282' ' ' VAL . 19.9 tt -115.86 150.34 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.229 -172.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -109.48 135.38 50.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.265 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 229' ' ' PHE . 5.1 t -113.39 120.76 64.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.17 167.98 13.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.79 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 28.6 m 63.77 27.15 14.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.201 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.523 ' HA ' HD21 ' A' ' 280' ' ' LEU . 29.9 m -74.12 143.31 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.03 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.434 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 12.6 t-80 -69.65 134.39 48.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.84 -24.09 67.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.995 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.87 -46.87 16.04 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.937 -0.477 . . . . 0.0 110.92 173.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.686 HD23 HD13 ' A' ' 225' ' ' ILE . 0.2 OUTLIER -58.11 107.66 0.5 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.96 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.9 p -93.18 -177.95 4.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 4.7 p-10 -53.35 -37.56 62.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.947 0.403 . . . . 0.0 111.1 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.89 -34.35 77.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.379 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 8.8 m-20 -77.47 -55.36 5.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.688 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.789 HG13 HD11 ' A' ' 240' ' ' LEU . 31.4 mm -55.42 -27.58 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.792 0.437 . . . . 0.0 111.764 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.704 ' HG3' HD12 ' A' ' 235' ' ' ILE . 83.4 tttt -54.25 -31.67 54.1 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.651 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.655 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 68.7 m -47.86 -61.22 2.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.638 0.732 . . . . 0.0 112.175 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.623 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.7 m -69.42 -51.01 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.167 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.61 ' HB2' HD11 ' A' ' 235' ' ' ILE . 40.2 m-85 -56.44 -43.58 79.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.505 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.73 -12.44 59.8 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.36 -35.79 58.51 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.67 -0.644 . . . . 0.0 110.602 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.546 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 0.2 OUTLIER -107.27 21.15 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.946 173.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.575 ' CA ' ' HB3' ' A' ' 262' ' ' SER . . . -170.64 -153.55 8.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.316 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.09 127.27 12.94 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 238' ' ' CYS . 66.8 mt -101.87 126.57 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.119 -175.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -95.3 -22.91 17.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.706 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 14.2 t -150.38 108.6 3.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.889 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.746 ' HB2' HG21 ' A' ' 235' ' ' ILE . 41.9 t -115.72 111.79 21.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.8 p -143.08 104.57 4.31 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.789 HD11 HG13 ' A' ' 225' ' ' ILE . 40.2 mt -83.93 117.3 23.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -65.35 127.48 31.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.781 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 15.5 ptt180 -110.49 153.88 24.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.964 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.11 130.05 51.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.14 -17.1 40.55 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.725 2.283 . . . . 0.0 112.377 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 48.2 m -74.34 -58.86 3.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.268 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 2.3 m -93.4 -41.22 9.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.928 0.394 . . . . 0.0 111.25 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.92 15.65 19.52 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.837 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.453 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 61.4 pttt -109.08 148.81 30.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.4 p80 -78.39 135.62 37.48 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.213 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.01 156.92 36.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.495 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.6 30.31 0.6 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 114.496 0.558 . . . . 0.0 114.496 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.62 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 39.5 p90 -153.21 173.71 15.19 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.624 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.23 176.24 46.62 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.412 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 94.0 m-85 -121.24 133.38 55.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.69 0.281 . . . . 0.0 110.415 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.657 HG23 HG23 ' A' ' 235' ' ' ILE . 55.0 mt -129.9 136.59 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.128 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -107.53 125.71 51.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.567 ' HE1' ' HA3' ' A' ' 233' ' ' GLY . 17.1 m-85 -98.73 142.79 29.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.212 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.749 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.4 pt-20 -89.01 -23.09 22.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.537 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.749 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 31.6 mmmt -116.95 129.41 56.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.611 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.68 63.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.347 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -56.29 -52.42 64.59 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.48 0.657 . . . . 0.0 110.026 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.575 ' HB3' ' CA ' ' A' ' 233' ' ' GLY . 4.0 m -68.99 -43.72 74.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.172 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 267' ' ' VAL . 10.8 t -61.41 -43.77 98.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.717 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.15 -41.96 97.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.331 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.51 -39.82 57.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.183 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.77 63.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.045 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 263' ' ' SER . 58.3 t -61.31 -26.64 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.186 0.517 . . . . 0.0 111.267 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.6 t -92.84 -36.64 12.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.167 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 3.3 p -87.83 -37.89 16.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 35.6 mmm -60.47 -29.08 68.83 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 31.8 t30 -58.57 -33.2 69.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.924 0.869 . . . . 0.0 110.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 272' ' ' LEU . 6.3 mp -78.89 -9.55 59.52 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.901 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -56.64 101.09 0.05 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.19 0.519 . . . . 0.0 110.895 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.61 112.4 18.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.189 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.61 HD21 ' CZ ' ' A' ' 273' ' ' PHE . 0.8 OUTLIER -113.3 86.2 2.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.389 171.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.71 34.95 29.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.551 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.89 0.72 74.36 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.802 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 10.9 pt20 -113.75 139.68 48.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.509 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 95.2 m-85 -89.94 126.21 35.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.369 0.604 . . . . 0.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.802 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.3 OUTLIER -55.38 165.04 0.84 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.217 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.678 ' H ' HD13 ' A' ' 280' ' ' LEU . 4.0 tpt180 -132.24 119.7 21.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.367 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.54 ' CG2' HD11 ' A' ' 211' ' ' ILE . 5.6 p -104.82 148.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.513 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.612 ' HA3' HD13 ' A' ' 168' ' ' LEU . . . -150.25 -149.1 4.93 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -139.61 152.99 47.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.576 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -95.23 129.46 42.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.46 -31.81 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.706 -171.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.409 HG22 ' OE2' ' A' ' 164' ' ' GLU . 14.9 t -115.11 135.53 22.52 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.228 0.537 . . . . 0.0 110.466 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.46 -0.443 0 C-N-CA 122.293 1.995 . . . . 0.0 110.995 173.344 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -103.57 -39.2 6.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.082 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.09 84.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.763 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 8.7 t80 -74.99 -19.01 60.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.54 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.701 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 30.8 mtpp -74.09 -45.81 46.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.4 -45.08 84.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.623 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -45.87 -51.87 12.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.917 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.807 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.9 -23.42 36.27 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -171.196 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.701 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 61.8 mt-30 -62.71 -40.79 98.25 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.655 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 63.7 mtt180 -70.81 -36.87 73.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.881 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.901 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.25 -43.81 96.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.301 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.29 46.3 mtt-85 -82.45 -25.15 33.85 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.282 -1.511 . . . . 0.0 113.064 172.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -54.08 -43.67 70.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.014 168.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.726 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.5 pt -69.64 -35.21 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.872 0.368 . . . . 0.0 110.429 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.56 -16.34 63.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.45 -36.06 16.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.591 ' HG2' ' HA ' ' B' ' 41' ' ' ILE . 21.6 pttp -84.54 -49.1 8.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.202 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.995 HG23 ' HB2' ' A' ' 219' ' ' ASP . 25.3 mm . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.449 0.643 . . . . 0.0 112.091 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.652 0.263 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.8 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.16 -35.91 81.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.74 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.049 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.7 pt -82.64 -35.84 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.4 mtp -69.5 -34.29 74.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.0 m -79.61 0.02 31.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -122.97 109.2 13.82 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.3 m -103.41 135.72 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.458 0.647 . . . . 0.0 111.53 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.469 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 80.2 t80 -87.41 132.88 33.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.232 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.44 111.41 36.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.073 0.463 . . . . 0.0 110.328 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -114.84 176.92 17.12 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.793 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 13.9 t 64.99 53.65 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.85 0.833 . . . . 0.0 109.434 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.9 mt -82.54 132.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.828 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 62.3 t80 -86.09 154.46 21.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.683 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -54.95 -51.59 65.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.607 0.241 . . . . 0.0 111.029 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.86 17.32 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.972 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 33.5 tp -107.73 97.56 7.27 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.486 ' HA2' ' HE1' ' A' ' 152' ' ' HIS . . . -113.26 -174.08 18.9 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.5 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.458 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 5.8 pt-20 -63.05 -23.94 67.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.956 0.408 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 7.0 m-20 -78.57 -41.62 31.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -69.48 -46.87 65.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.131 0.491 . . . . 0.0 110.546 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.5 -41.99 94.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.453 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 19.0 ptp180 -63.21 -36.3 83.19 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.691 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.03 -29.93 64.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.794 0.33 . . . . 0.0 111.438 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.11 56.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.431 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 85.8 m-85 -96.31 -0.13 50.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.5 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.532 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -65.64 -46.83 67.87 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.614 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.745 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 25.7 Cg_exo -65.21 -4.66 9.59 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.377 2.051 . . . . 0.0 113.121 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.675 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 3.5 m-85 -84.69 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.849 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.53 38.15 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.879 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.46 103.15 0.64 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.921 2.414 . . . . 0.0 112.231 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.6 mt -79.24 108.68 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -90.66 -23.39 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 0.0 110.302 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.866 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 32.1 t -138.81 124.77 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.191 0.519 . . . . 0.0 111.05 -177.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.9 mt -118.98 107.32 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.176 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -116.71 100.82 8.07 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.579 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 125' ' ' GLU . 61.5 mtp -122.77 123.97 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.579 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 26.2 t -108.93 111.52 23.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.771 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.443 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 6.6 p-90 -150.69 158.65 44.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.263 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.82 114.73 4.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.38 0.425 . . . . 0.0 110.169 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.7 m -79.85 -24.85 40.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.713 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.6 t -82.48 -37.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.544 HG21 ' HE3' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -107.69 -7.84 16.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.18 0.514 . . . . 0.0 110.758 -178.332 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.7 mtp 60.26 35.31 20.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.845 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 149' ' ' THR . 98.7 mttt -84.07 148.23 26.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.486 ' HE1' ' HA2' ' A' ' 124' ' ' GLY . 65.9 m-70 -119.73 73.52 0.97 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.68 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -128.21 11.52 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 110.481 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.64 -116.44 1.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.139 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.469 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 44.8 p90 -154.67 167.0 31.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.818 0.342 . . . . 0.0 111.108 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.439 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -146.57 134.92 21.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.52 122.6 35.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.9 t -101.96 111.02 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 37.9 mt-10 -107.05 119.56 39.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.42 0.628 . . . . 0.0 110.996 -175.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 81.2 m-85 -96.2 156.08 16.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.445 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.9 -4.63 57.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 109.325 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.74 130.99 18.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.783 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.18 -11.07 29.63 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.718 2.279 . . . . 0.0 112.808 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.42 ' OE1' HG22 ' A' ' 287' ' ' THR . 4.6 mm-40 -56.7 -64.89 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -65.91 -22.77 66.53 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.389 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.14 -50.94 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.863 0.363 . . . . 0.0 110.749 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HB3' HG21 ' A' ' 286' ' ' VAL . 1.6 tm0? -74.26 -30.87 62.32 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.9 tp -58.72 -51.47 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.075 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.55 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.724 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.78 -50.28 72.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.996 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.01 -47.18 47.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -74.64 -50.8 16.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.415 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 16.5 mmt -77.3 -26.37 52.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -170.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -73.29 -20.31 60.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.37 0.605 . . . . 0.0 110.086 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.3 m -92.73 -12.98 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.536 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 84.3 t -118.5 137.39 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.16 0.505 . . . . 0.0 111.517 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 21.5 ptp -103.47 144.73 31.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.887 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.55 32.1 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.82 104.71 1.02 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.814 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.44 -59.53 4.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.034 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.821 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -101.84 125.87 48.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.622 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -90.37 110.69 21.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.416 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.793 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 41.8 pt -69.72 157.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 0.0 111.102 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -113.92 110.3 19.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 66.1 t -112.18 117.85 56.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.409 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 110.23 176.31 20.85 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.794 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.94 151.07 3.94 Favored Pre-proline 0 C--N 1.328 -0.37 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.09 70.45 7.1 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.825 2.35 . . . . 0.0 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.8 m -69.42 -52.95 22.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.319 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 194' ' ' ALA . 65.9 t30 -142.65 56.04 1.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.339 0.59 . . . . 0.0 110.533 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.06 151.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.75 -59.56 4.44 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 190' ' ' ASN . 25.7 mt-30 -67.41 -37.63 83.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 0.0 111.549 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.428 ' HB2' ' ND2' ' A' ' 190' ' ' ASN . . . -95.46 -1.56 50.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.348 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.533 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.0 tp60 -61.36 -50.1 84.77 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 16.6 Cg_endo -57.45 -23.98 58.64 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.126 1.884 . . . . 0.0 112.316 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 49.8 mm -76.8 -45.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.87 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.48 -47.88 90.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.846 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.39 -37.57 78.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.764 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.47 -53.71 47.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.435 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 202' ' ' ALA . 2.3 pp -71.23 -32.8 69.21 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.652 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.543 ' N ' HD12 ' A' ' 201' ' ' LEU . . . -72.99 -43.88 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 206' ' ' ARG . 8.9 mm-40 -75.05 -29.25 60.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.619 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.36 -31.95 73.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.08 -17.47 64.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.286 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 203' ' ' GLU . 15.9 mmt180 -63.62 -31.08 72.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.818 0.342 . . . . 0.0 110.427 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.57 63.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.53 . . . . 0.0 110.757 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -96.69 -5.27 39.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 p30 35.25 40.86 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.011 1.445 . . . . 0.0 113.444 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.86 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 13.7 ptt180 -109.53 139.39 44.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.23 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.37 161.64 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.51 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -109.42 108.74 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.543 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.22 117.13 52.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.514 0.673 . . . . 0.0 110.78 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.1 -173.58 2.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.312 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.745 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 18.7 t 70.62 17.17 6.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.716 0.635 . . . . 0.0 110.239 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.676 HG11 HD21 ' A' ' 240' ' ' LEU . 93.4 t -67.32 136.44 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.59 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.506 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 11.1 t-80 -67.74 138.32 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -64.68 -21.51 66.75 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -167.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.581 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -82.05 -47.66 12.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.315 0.507 . . . . 0.0 111.602 173.113 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.803 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.3 OUTLIER -56.43 116.04 2.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.097 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t -101.03 -176.78 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.473 -0.142 . . . . 0.0 111.196 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.11 -36.56 70.78 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.562 0.22 . . . . 0.0 111.365 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.6 -41.0 96.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.187 0.518 . . . . 0.0 110.294 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.452 ' HB3' ' HG ' ' A' ' 220' ' ' LEU . 3.9 m-20 -66.06 -57.53 7.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.113 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.68 HD13 HD23 ' A' ' 220' ' ' LEU . 36.6 mm -57.45 -25.26 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -57.84 -32.26 67.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.495 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 74.4 m -49.87 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.792 0.806 . . . . 0.0 111.705 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.697 HG12 ' HB1' ' B' ' 34' ' ' ALA . 5.4 m -73.18 -39.58 56.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.735 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -67.51 -41.03 85.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.73 0.3 . . . . 0.0 111.354 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -76.72 -18.81 58.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.126 0.488 . . . . 0.0 111.222 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.27 -31.13 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.654 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.2 m-30 -86.16 -30.57 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.87 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.61 179.74 34.99 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.989 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -77.53 113.18 15.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.108 0.48 . . . . 0.0 111.11 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.77 146.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.118 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.507 ' HE2' ' HB3' ' A' ' 256' ' ' GLU . 34.2 ttpt -106.35 -49.56 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.1 p -153.26 146.32 24.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 46.5 t -126.71 123.42 37.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.885 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.5 p -136.3 104.01 5.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.676 HD21 HG11 ' A' ' 216' ' ' VAL . 10.8 tp -96.86 114.84 26.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.75 136.47 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.619 174.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.75 124.38 81.78 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.404 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -68.79 -18.43 41.75 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.0 113.418 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 m -92.65 -52.95 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.752 0.311 . . . . 0.0 110.995 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.4 m -74.22 -27.5 60.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.462 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.61 21.45 64.04 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.593 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.31 146.93 49.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.3 OUTLIER -82.51 139.86 33.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.592 178.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -79.52 151.76 30.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.45 32.79 1.37 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.764 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -153.51 157.62 40.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.052 0.426 . . . . 0.0 109.915 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.635 ' HA3' HD12 ' A' ' 240' ' ' LEU . . . -164.77 178.37 39.95 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.52 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -118.94 131.52 56.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.2 129.2 72.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.86 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 54.6 mt-10 -109.07 141.93 40.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.005 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -106.78 161.08 14.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 0.0 112.005 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.58 -17.2 30.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.576 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 45.7 mtpt -133.75 133.33 41.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.759 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.15 68.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.629 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -61.67 -46.78 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.428 174.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 45.7 m -64.93 -36.99 86.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.525 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -61.67 -41.4 97.5 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -73.97 -34.39 64.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.195 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.57 -35.13 46.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.109 0.481 . . . . 0.0 111.084 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.5 61.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 282' ' ' VAL . 11.0 p -54.59 -39.45 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.7 p -82.13 -25.31 34.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 4.5 m -96.42 -25.81 15.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.984 0.421 . . . . 0.0 111.632 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.693 ' HB3' HG21 ' A' ' 282' ' ' VAL . 26.9 mmm -73.65 -10.46 59.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -173.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 6.8 t30 -62.05 -32.29 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.029 0.918 . . . . 0.0 110.616 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.4 mm? -76.73 -8.57 57.54 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.364 -172.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.878 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.2 t80 -65.15 105.9 1.18 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.171 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.2 t70 -94.97 121.51 36.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.826 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.803 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.8 mm? -116.32 85.91 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.348 173.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.53 29.98 34.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.475 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.1 12.35 27.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 13.5 pt20 -138.46 130.71 28.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.887 0.375 . . . . 0.0 110.34 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.638 ' HB2' HH21 ' A' ' 281' ' ' ARG . 63.8 m-85 -89.99 131.62 35.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.342 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 275' ' ' LEU . 17.4 mt -60.97 177.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.909 0.861 . . . . 0.0 111.57 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.638 HH21 ' HB2' ' A' ' 279' ' ' TYR . 4.2 mmt180 -140.41 111.48 7.07 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' A' ' 270' ' ' MET . 48.5 t -120.06 135.02 61.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.965 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.94 -151.2 5.44 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.18 149.9 25.53 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.72 91.99 2.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 167' ' ' GLN . 33.8 t -55.57 -46.76 79.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.704 -171.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.42 HG22 ' OE1' ' A' ' 164' ' ' GLU . 5.9 t -104.98 124.96 34.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.927 0.87 . . . . 0.0 112.371 -174.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.457 -0.648 0 C-N-CA 122.595 2.197 . . . . 0.0 110.778 167.488 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.638 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 62.5 t30 . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -73.93 0.31 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.3 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.935 0.398 . . . . 0.0 111.743 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 16.7 t80 -67.12 -20.02 65.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.308 0.575 . . . . 0.0 110.644 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.638 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 92.4 mttt -77.77 -43.37 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.57 -39.04 75.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.697 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -51.58 -50.02 60.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.539 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.802 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -81.18 -21.67 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.638 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 50.9 mt-30 -61.83 -42.14 98.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.495 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 73.7 mtp180 -72.06 -31.86 66.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.53 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.878 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -68.11 -44.69 75.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.255 6.3 mtm180 -82.94 -26.33 31.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.294 -1.504 . . . . 0.0 113.022 171.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -57.32 -42.55 82.08 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.056 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.695 HD11 ' HZ ' ' A' ' 273' ' ' PHE . 9.8 pt -64.3 -42.72 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.23 -24.67 66.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 111.519 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 -29.38 21.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.832 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -92.13 -33.8 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.581 HG23 ' HB2' ' A' ' 219' ' ' ASP . 79.9 mt . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.35 -28.87 70.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.88 -34.78 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.912 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.23 75.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.426 . . . . 0.0 111.22 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.39 -36.32 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.366 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 27.8 ttt -65.6 -26.67 67.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.875 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.9 m -82.17 4.34 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.541 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 19.5 ptt180 -135.57 134.61 39.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.975 0.417 . . . . 0.0 110.717 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.1 m -110.8 135.6 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.355 0.598 . . . . 0.0 111.522 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 71.0 t80 -78.83 124.47 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.209 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.53 112.06 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.023 0.439 . . . . 0.0 110.155 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.21 170.28 14.04 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.686 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.675 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 50.6 m 67.63 66.74 0.38 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.615 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.49 -19.84 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.136 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 66.8 t80 65.67 -73.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.286 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 53.4 t80 167.09 -43.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.291 0.636 . . . . 0.0 109.409 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.442 ' H ' ' HD2' ' A' ' 120' ' ' TYR . 28.1 tt0 -83.24 6.08 20.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.212 -173.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.8 mt -110.57 100.06 8.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.31 34.82 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.772 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.49 -41.42 94.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.35 -48.38 71.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.238 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -62.18 -53.85 49.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.09 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.75 -46.21 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.298 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -55.5 -48.95 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.494 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -78.27 -29.69 48.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.14 73.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.772 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.541 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 84.9 m-85 -97.71 7.08 47.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.464 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.07 -43.35 35.3 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.607 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 24.2 Cg_exo -65.16 -3.86 8.07 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.249 1.966 . . . . 0.0 112.915 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.705 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 21.8 m-85 -91.06 -63.96 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.683 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.63 175.2 34.28 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 162' ' ' VAL . 21.1 Cg_exo -65.09 123.1 11.07 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.429 2.086 . . . . 0.0 111.724 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.74 123.17 22.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.163 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -87.04 -56.4 3.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.004 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.9 m -162.29 149.35 13.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.53 106.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.83 110.6 23.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 22.9 ptm -137.26 149.44 47.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.043 0.449 . . . . 0.0 111.136 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.3 m -80.25 121.93 26.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.804 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 42.9 m95 -99.95 114.48 27.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.198 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.843 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 2.5 m-20 -69.79 89.82 0.58 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.266 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t 62.5 -163.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.864 0.728 . . . . 0.0 111.586 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.73 -18.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.482 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.491 ' HB ' ' HE2' ' A' ' 151' ' ' LYS . 21.2 p -66.71 11.45 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.731 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 19.8 mmt 59.09 32.13 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.041 0.537 . . . . 0.0 112.305 172.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.843 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 71.0 mmtt -79.22 -49.7 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.934 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p80 40.91 58.15 2.55 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.889 0.743 . . . . 0.0 112.352 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -104.18 94.28 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.288 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.23 -101.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.972 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -147.51 165.95 28.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.742 0.306 . . . . 0.0 110.714 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.47 146.38 33.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.717 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.04 111.71 24.31 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.5 106.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.046 0.45 . . . . 0.0 110.27 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.541 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 45.8 mt-10 -91.62 131.46 37.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.541 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 23.3 m-85 -102.01 147.62 26.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.424 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -75.17 -14.55 60.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.723 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.591 HG22 ' HD2' ' A' ' 137' ' ' PRO . 19.6 m -136.89 130.24 17.55 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.083 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.29 -19.93 68.54 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.169 2.579 . . . . 0.0 113.231 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.73 -65.15 0.64 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.48 -27.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.824 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.55 69.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.688 0.28 . . . . 0.0 111.14 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HB3' HG21 ' A' ' 286' ' ' VAL . 19.5 tt0 -74.54 -36.91 63.13 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.347 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.637 HD22 ' CD2' ' A' ' 212' ' ' TYR . 12.5 tp -55.75 -49.84 72.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.98 96.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.531 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.7 -54.02 45.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.176 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.54 -45.37 81.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.781 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -77.94 -46.04 22.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 23.1 mmt -73.24 -22.98 60.29 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.591 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.01 -23.55 55.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.312 0.577 . . . . 0.0 109.642 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 55.1 m -84.92 -30.66 24.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.458 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.68 130.65 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.1 0.476 . . . . 0.0 111.412 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.55 ' HB2' ' O ' ' A' ' 181' ' ' ARG . 25.7 ptt? -78.8 130.97 36.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.873 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 178' ' ' LEU . 3.5 pp -85.84 139.97 30.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.808 0.337 . . . . 0.0 111.138 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.2 -40.07 1.46 Allowed Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.345 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.38 2.62 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 177' ' ' MET . 30.6 mmt180 -98.13 126.42 43.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -74.85 67.84 1.68 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.665 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.675 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 38.1 pt -66.29 154.67 7.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -116.14 109.05 16.94 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 55.5 t -112.82 109.77 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.264 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.0 141.35 8.07 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.414 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 15.8 mtp180 -129.95 137.05 30.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 2.7 Cg_exo -76.4 48.12 2.26 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 111.335 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 p -81.25 -45.63 15.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.901 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -92.79 35.78 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.496 0.665 . . . . 0.0 109.781 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt -65.99 136.4 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.858 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 89.61 -35.22 3.79 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.104 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -83.2 -42.74 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.023 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.37 -18.6 41.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mp0 -57.67 -51.89 78.36 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 14.5 Cg_endo -57.02 -30.41 86.57 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.193 1.929 . . . . 0.0 112.472 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mm -75.15 -50.81 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.401 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.28 -43.79 95.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.801 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.68 -42.72 71.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.712 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -60.4 -52.95 63.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 287' ' ' THR . 91.1 mt -64.96 -46.38 81.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.077 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.96 94.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.886 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.16 -35.09 68.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.88 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.24 -38.13 78.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.418 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.32 -27.99 69.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -21.74 66.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.188 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.87 -13.1 51.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.973 0.416 . . . . 0.0 111.321 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.74 -17.78 20.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.402 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 65.82 15.0 9.87 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.618 0.574 . . . . 0.0 111.919 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 256' ' ' GLU . 82.1 mtp180 -105.44 135.67 46.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.048 0.452 . . . . 0.0 110.679 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.462 HD11 ' CE1' ' A' ' 229' ' ' PHE . 30.6 pt -117.67 169.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.103 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.637 ' CD2' HD22 ' A' ' 168' ' ' LEU . 44.1 t80 -118.74 118.61 32.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.584 HG23 HG22 ' A' ' 282' ' ' VAL . 2.3 p -116.3 122.45 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.719 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.705 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.06 -179.84 4.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.98 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.607 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 24.7 m 68.07 29.08 6.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.276 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.814 HG13 HD11 ' A' ' 225' ' ' ILE . 73.6 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.319 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -63.25 123.15 17.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.69 -37.37 18.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -167.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.56 -45.75 43.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.616 0.245 . . . . 0.0 111.092 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.834 HD11 HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -58.5 116.43 3.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.6 m -99.88 -178.31 3.82 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.73 -44.42 77.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.651 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.44 -32.79 69.04 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.402 0.62 . . . . 0.0 110.185 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.518 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 57.1 m-20 -73.33 -55.91 5.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.645 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.814 HD11 HG13 ' A' ' 216' ' ' VAL . 33.8 mm -54.57 -29.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.103 0.478 . . . . 0.0 111.565 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.489 ' HG3' HD12 ' A' ' 235' ' ' ILE . 62.3 tttm -53.93 -32.53 53.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.94 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.573 ' HB3' ' HG2' ' B' ' 37' ' ' ARG . 68.0 m -48.99 -61.37 2.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.737 0.779 . . . . 0.0 112.826 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.695 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.0 m -70.67 -46.32 69.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.73 -169.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 57.6 m-85 -57.96 -43.93 86.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.687 0.279 . . . . 0.0 111.151 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.7 tt0 -70.9 -24.3 62.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.266 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.08 -21.09 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.372 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.692 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.6 OUTLIER -93.22 -43.75 8.67 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.59 153.69 25.04 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.07 137.94 51.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.487 0.643 . . . . 0.0 111.669 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 229' ' ' PHE . 60.6 mt -95.68 147.51 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.527 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 236' ' ' LYS . 9.7 mmmm -80.02 -64.3 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.429 171.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 35.5 t -150.42 147.67 27.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.495 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.95 129.42 52.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.424 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.2 t -142.48 125.31 16.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.172 0.51 . . . . 0.0 111.019 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.447 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 8.4 mp -110.19 130.2 55.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.587 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.68 145.92 50.79 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.509 0.671 . . . . 0.0 111.012 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.749 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -122.75 150.19 43.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.553 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -117.04 106.51 47.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.678 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.67 -25.15 34.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.489 2.126 . . . . 0.0 112.094 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.9 m -63.24 -48.29 78.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.355 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -83.65 -30.14 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.677 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.68 6.12 53.01 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.975 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -137.13 177.43 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -82.78 154.04 24.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 110.416 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.7 155.71 21.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.36 43.05 2.83 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.833 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -156.26 157.51 35.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.97 0.385 . . . . 0.0 110.083 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -168.42 -172.95 35.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.583 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -119.31 132.81 55.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.732 0.301 . . . . 0.0 110.501 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.2 mm -111.81 126.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 210' ' ' ARG . 35.6 tt0 -103.72 120.89 41.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -94.23 142.86 26.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.532 0.682 . . . . 0.0 111.754 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.9 -26.25 66.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.179 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.474 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 34.4 mtpt -124.95 136.31 53.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.77 -18.55 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -68.8 -44.52 73.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.549 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 65.3 m -67.91 -21.02 65.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.696 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 m -59.03 -39.42 81.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.026 0.441 . . . . 0.0 110.262 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -75.33 -35.17 61.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.497 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.17 -34.79 76.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.124 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.53 -47.63 22.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.675 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.551 HG12 HG12 ' A' ' 282' ' ' VAL . 31.1 m -59.44 -35.01 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -169.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.2 p -80.04 -9.47 59.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.2 m -113.81 -35.99 4.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.919 0.39 . . . . 0.0 111.694 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.695 ' HE2' ' HB2' ' A' ' 273' ' ' PHE . 0.6 OUTLIER -72.31 -16.02 61.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -170.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.4 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 8.4 t30 -60.81 -30.14 69.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.749 0.785 . . . . 0.0 110.402 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 272' ' ' LEU . 7.9 mp -76.83 -9.47 58.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.603 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.849 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -54.85 109.17 0.48 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 0.2 OUTLIER -113.82 130.31 56.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 -178.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.676 ' HG ' HD22 ' A' ' 220' ' ' LEU . 3.2 mm? -116.08 87.02 2.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.537 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.85 3.47 73.75 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.064 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 134.43 -31.51 2.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.417 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 17.3 pt20 -84.06 129.25 34.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.171 0.486 . . . . 0.0 110.772 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -89.41 139.83 30.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.732 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 273' ' ' PHE . 9.2 mp -76.78 -173.17 2.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 0.0 111.568 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 281' ' ' ARG . 39.2 mmt180 -144.66 112.43 6.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.573 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.584 HG22 HG23 ' A' ' 213' ' ' VAL . 46.7 t -125.83 134.32 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.628 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.2 -153.61 6.33 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.768 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -85.11 165.82 17.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.088 0.444 . . . . 0.0 110.151 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -76.15 -7.49 54.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.998 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 167' ' ' GLN . 64.3 t 71.22 -64.49 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.119 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 201' ' ' LEU . 8.4 t -111.29 148.97 39.86 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo . . . . . 0 C--N 1.346 0.437 0 C-N-CA 122.835 2.357 . . . . 0.0 111.433 173.909 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.51 ' N ' HD21 ' B' ' 28' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.966 0.412 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.39 -38.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -62.1 -35.6 79.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.625 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.623 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 9.1 t80 -74.51 -19.44 60.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.321 0.582 . . . . 0.0 110.032 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.665 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 94.6 mttt -72.84 -45.48 58.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -56.28 -44.38 79.75 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.002 0.906 . . . . 0.0 108.744 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.695 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -48.23 -54.03 14.97 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.011 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -83.11 -23.42 33.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -168.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.665 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 29.5 mt-30 -55.24 -44.27 75.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.573 ' HG2' ' HB3' ' A' ' 227' ' ' SER . 25.2 ttm105 -74.39 -31.62 62.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.662 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.849 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.76 -46.2 83.14 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.251 11.7 mtp180 -81.18 -25.03 37.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.638 -1.289 . . . . 0.0 112.387 174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 19.8 tp60 -51.25 -47.28 62.45 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 165.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.834 HG13 HD11 ' A' ' 220' ' ' LEU . 4.6 pt -72.26 -28.42 29.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.844 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.507 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -65.76 -31.89 73.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.907 0.384 . . . . 0.0 111.076 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.41 -25.22 29.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.269 0.557 . . . . 0.0 110.492 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' B' ' 44' ' ' LYS . 4.8 tmmt? -82.1 -63.77 1.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.089 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.235 0.319 0 CA-C-O 121.104 0.478 . . . . 0.0 111.788 179.571 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.548 0.213 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.16 73.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.392 . . . . 0.0 110.479 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.11 -39.12 86.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.65 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.13 72.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.909 0.385 . . . . 0.0 111.511 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.6 mt -83.9 -48.31 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.7 -35.29 80.08 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 80.4 m -83.18 2.64 34.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.53 0.205 . . . . 0.0 111.398 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.825 ' HB2' ' HG3' ' A' ' 159' ' ' GLU . 8.5 ttp180 -113.82 112.39 23.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.984 0.421 . . . . 0.0 111.237 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.39 150.89 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.337 0.589 . . . . 0.0 111.067 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.8 t80 -102.84 115.05 29.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.098 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.03 111.82 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.19 167.0 12.37 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.085 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 45.0 m 68.73 47.57 0.83 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.277 0.561 . . . . 0.0 110.991 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 79.1 mt -66.19 115.97 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.119 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -61.87 -78.85 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.339 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -175.61 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.27 -23.99 67.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.688 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.01 98.6 5.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.134 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.55 -175.15 37.09 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.731 ' HB2' ' HE1' ' A' ' 145' ' ' TRP . 40.4 tt0 -62.81 -41.32 99.25 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.98 -39.47 87.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.519 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -64.75 -46.08 83.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.96 -48.43 88.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.308 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ppt_? -66.87 -33.93 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.465 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -72.16 -35.7 69.11 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.737 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.84 97.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.878 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.422 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 81.5 m-85 -97.07 11.29 36.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.266 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.583 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -65.98 -46.02 63.92 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.291 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 1.021 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 27.7 Cg_endo -63.13 -14.88 44.46 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.056 1.837 . . . . 0.0 112.881 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.431 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 5.0 m-85 -76.07 -66.42 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.18 156.13 26.51 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.16 131.46 46.47 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.532 2.155 . . . . 0.0 111.665 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -72.32 117.3 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -90.13 -39.51 12.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.544 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.4 t -160.04 139.3 10.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.756 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.64 121.08 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.75 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.27 96.73 5.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.647 ' HG3' ' HB2' ' A' ' 156' ' ' ALA . 27.9 ttt -107.49 145.13 33.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.515 -175.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -78.12 80.61 4.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 0.0 109.863 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HE1' ' HB2' ' A' ' 125' ' ' GLU . 6.6 m95 -92.49 133.13 36.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.094 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -94.29 111.9 23.66 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.4 m -75.45 3.26 9.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.193 0.521 . . . . 0.0 110.548 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.13 -54.57 8.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.067 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.581 ' HB ' ' HG3' ' A' ' 151' ' ' LYS . 1.5 m -119.55 -15.01 9.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.62 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.5 mtp 67.11 32.77 5.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.721 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.581 ' HG3' ' HB ' ' A' ' 149' ' ' THR . 17.8 mtpp -97.16 -14.8 21.24 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.2 p80 44.19 47.04 7.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.74 0.816 . . . . 0.0 112.579 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.69 102.56 15.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.093 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 171.39 -112.83 0.47 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.75 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -142.0 172.93 12.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.858 0.361 . . . . 0.0 111.349 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.647 ' HB2' ' HG3' ' A' ' 143' ' ' MET . . . -151.67 150.58 30.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.707 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.22 131.7 56.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 58.6 t -128.32 115.78 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.854 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.825 ' HG3' ' HB2' ' A' ' 113' ' ' ARG . 1.8 mp0 -92.31 132.62 36.56 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.948 173.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -101.92 169.0 9.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.939 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.94 -48.83 80.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.478 0.656 . . . . 0.0 110.3 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.516 ' HB ' ' HG2' ' A' ' 164' ' ' GLU . 16.0 m -119.75 147.19 43.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.99 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.07 -16.52 44.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.754 2.303 . . . . 0.0 111.129 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.516 ' HG2' ' HB ' ' A' ' 162' ' ' VAL . 1.0 OUTLIER -63.21 -47.12 83.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.879 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.503 ' H ' HG23 ' A' ' 162' ' ' VAL . . . -62.05 -39.23 91.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.063 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.37 86.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.844 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -59.67 -45.33 92.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 13.1 mt -73.0 -35.16 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.983 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.64 85.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.552 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 2.9 tt -77.15 -63.09 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.081 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -63.57 -47.31 82.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -171.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.672 ' HB3' ' HD3' ' A' ' 281' ' ' ARG . 80.7 mm-40 -84.74 -0.72 54.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -171.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.63 ' HB3' HG21 ' A' ' 185' ' ' VAL . 42.6 tpp -119.95 -33.79 3.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.32 -24.82 63.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.233 0.54 . . . . 0.0 110.48 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.2 m -84.37 -0.97 54.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.416 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.54 177.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.362 . . . . 0.0 110.758 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 82.2 mtp -118.01 126.04 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.171 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.52 85.49 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 110.072 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.08 -135.22 12.86 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.908 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.53 77.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.922 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -130.17 154.93 47.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.872 0.368 . . . . 0.0 110.748 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.555 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 24.3 p-10 -100.91 108.76 20.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.506 0.669 . . . . 0.0 110.397 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 45.3 pt -75.57 148.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 184' ' ' LYS . 24.0 tptp -102.24 109.38 21.04 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.135 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 173' ' ' MET . 15.8 m -104.64 127.03 59.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.991 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.552 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 85.75 135.6 3.77 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.285 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -153.34 91.16 3.37 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 81.11 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.201 2.6 . . . . 0.0 112.568 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.6 m -81.7 -17.45 47.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.48 53.5 2.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.065 0.459 . . . . 0.0 110.802 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.69 124.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.522 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.76 -24.71 4.32 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.558 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 13.5 mm-40 -83.68 -47.64 11.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 111.399 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.35 -20.9 27.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.677 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 27.2 mm-40 -57.98 -55.21 47.56 Favored Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 200' ' ' GLN . 19.3 Cg_endo -58.75 -30.97 94.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.109 1.873 . . . . 0.0 112.539 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.0 mm -70.61 -52.43 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.009 0.433 . . . . 0.0 110.178 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.28 -33.54 64.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.963 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.78 -49.46 77.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.597 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 47.1 mt-30 -65.17 -34.85 79.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.118 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.21 -49.81 68.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.477 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -64.67 -29.74 70.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.31 -52.1 66.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.965 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.41 -28.59 59.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.897 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.09 69.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.923 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 14.4 mtm180 -67.23 -20.35 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 0.0 110.96 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -24.27 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.18 0.514 . . . . 0.0 110.639 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -102.1 -29.13 11.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 52.13 79.14 0.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.839 0.712 . . . . 0.0 111.258 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.682 ' HB2' ' HB3' ' A' ' 285' ' ' ALA . 39.5 mtm180 -125.18 142.35 51.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.047 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.717 HD13 ' HE1' ' A' ' 229' ' ' PHE . 13.5 tt -108.82 142.95 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 282' ' ' VAL . 79.4 t80 -108.44 123.19 48.48 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.799 0.333 . . . . 0.0 110.171 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.527 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.3 p -119.04 122.73 70.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.511 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -123.05 179.6 4.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.191 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . 1.021 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 20.0 m 65.29 26.79 12.16 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.799 0.687 . . . . 0.0 110.948 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.43 HG22 ' C ' ' A' ' 251' ' ' GLY . 8.1 m -72.46 145.21 12.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.157 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.442 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 13.4 t-80 -68.4 130.33 42.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.38 -18.47 64.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -164.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.442 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 0.6 OUTLIER -78.27 -44.08 26.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.169 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.693 HD23 HD13 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -52.8 114.37 1.39 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.818 172.034 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.2 m -98.79 -177.5 3.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 11.0 p-10 -54.36 -41.29 68.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -70.63 -28.93 65.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.76 0.314 . . . . 0.0 110.684 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.572 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 4.8 m-20 -67.54 -55.79 12.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.693 HD13 HD23 ' A' ' 220' ' ' LEU . 30.8 mm -57.38 -27.28 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.11 0.481 . . . . 0.0 110.816 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.514 ' HG3' HD13 ' A' ' 235' ' ' ILE . 87.7 tttt -56.94 -32.85 66.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.292 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.664 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 57.9 m -48.33 -60.22 2.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.936 0.874 . . . . 0.0 112.092 -176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.721 ' HB ' ' CE ' ' A' ' 270' ' ' MET . 2.8 m -72.14 -36.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.731 -170.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.717 ' HE1' HD13 ' A' ' 211' ' ' ILE . 71.3 m-85 -70.79 -37.13 73.29 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.259 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.472 ' OE1' ' HE2' ' A' ' 226' ' ' LYS . 8.5 tt0 -77.27 -21.09 54.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.737 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.84 -18.7 53.59 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.49 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.676 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 3.8 m-30 -87.77 -38.21 15.95 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.521 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.75 -156.97 8.25 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.569 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 234' ' ' LYS . 32.3 mmtp -94.54 128.59 41.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.514 HD13 ' HG3' ' A' ' 226' ' ' LYS . 20.6 tt -104.1 135.68 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.286 -171.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 256' ' ' GLU . 23.5 tptp -91.08 -52.42 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.81 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 69.3 m -149.95 124.74 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.846 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 3.8 p -100.54 68.13 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.38 0.61 . . . . 0.0 109.739 174.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.5 p -97.8 104.35 16.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.231 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.4 mp -91.72 128.8 37.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.29 133.76 49.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.627 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -133.61 151.05 51.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.408 . . . . 0.0 110.738 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.92 118.19 70.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.258 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.75 -17.1 42.41 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.908 2.406 . . . . 0.0 113.412 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 69.7 p -86.8 -47.1 9.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.712 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.1 m -92.23 -25.67 18.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.968 0.413 . . . . 0.0 111.354 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.71 22.61 42.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.986 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.8 122.29 45.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.589 0.233 . . . . 0.0 111.122 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.5 p80 -72.79 138.2 46.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 252' ' ' TYR . 96.4 mttt -70.5 156.62 39.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.45 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.43 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.97 33.15 0.63 Allowed Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.476 0.485 . . . . 0.0 113.637 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 250' ' ' LYS . 5.7 p90 -153.24 163.79 39.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.503 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -155.11 162.63 31.04 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.008 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.74 117.14 29.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 237' ' ' SER . 2.3 mp -102.79 128.5 55.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 51.6 mt-10 -102.76 145.78 29.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -119.31 132.22 55.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.268 0.556 . . . . 0.0 111.022 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -78.18 -27.21 47.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.344 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 20.3 mtpt -112.5 123.05 49.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.157 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -61.85 -34.34 75.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.869 -176.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -61.33 -37.69 84.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.222 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.8 m -73.76 -28.83 61.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.046 0.45 . . . . 0.0 110.446 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.7 t -73.78 -22.4 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.896 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 55.3 mt-30 -74.99 -49.66 19.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.648 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.49 -33.73 41.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -171.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.28 54.01 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 111.177 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 37.4 t -71.9 -34.13 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 111.378 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.2 p -89.89 -17.93 27.1 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.777 0.322 . . . . 0.0 111.661 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 36.0 m -112.1 1.03 16.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -171.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.743 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 6.0 tpp -119.19 2.4 11.39 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -172.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -82.85 -16.86 46.0 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.184 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 9.1 mp -79.6 -9.37 59.62 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.943 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -45.93 106.05 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.341 0.4 . . . . 0.0 111.583 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.404 ' O ' HD13 ' A' ' 275' ' ' LEU . 0.7 OUTLIER -91.38 114.47 27.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.535 -178.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' B' ' 42' ' ' ALA . 2.4 mm? -119.93 86.38 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.312 169.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.23 40.25 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.834 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.84 -2.5 69.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.999 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.89 128.83 49.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 273' ' ' PHE . 86.2 m-85 -98.83 122.46 42.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.742 HD22 ' CD2' ' A' ' 273' ' ' PHE . 9.9 mp -70.55 -179.44 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.028 0.442 . . . . 0.0 110.676 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.672 ' HD3' ' HB3' ' A' ' 172' ' ' GLN . 3.6 mmp_? -136.48 128.04 28.7 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -174.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 3.1 m -122.96 151.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.456 0.646 . . . . 0.0 112.042 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.562 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -160.83 -136.71 2.06 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.352 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.83 152.43 38.4 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.579 -0.365 . . . . 0.0 110.886 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 210' ' ' ARG . . . -96.49 102.9 14.76 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -35.42 8.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.609 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 14.9 t -84.92 136.01 39.19 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.819 2.346 . . . . 0.0 112.013 177.42 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.611 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 15.2 m120 . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.92 -52.8 62.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.453 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.99 -31.33 72.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.027 0.441 . . . . 0.0 111.171 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.652 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 11.7 t80 -76.65 -21.48 55.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.224 0.535 . . . . 0.0 110.289 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 71.8 mttt -74.43 -41.0 61.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.8 t70 -58.0 -41.93 84.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.676 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.49 -49.27 55.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.341 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.87 -25.15 35.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -169.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 24.9 mt-30 -57.71 -44.93 86.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.664 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 60.6 mtt180 -68.11 -35.99 79.02 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.586 174.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.943 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.06 -49.97 72.44 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 39' ' ' ARG 0.272 13.6 mtp180 -81.44 -25.3 36.25 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.202 -1.561 . . . . 0.0 112.751 174.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -52.47 -46.7 66.65 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 110.073 168.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.847 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.6 pt -67.22 -35.51 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.498 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.554 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -65.88 -20.1 66.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.388 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.27 -42.28 12.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.8 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.847 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.1 OUTLIER -92.3 -14.48 28.77 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.436 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.2 pt . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.947 0.403 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.82 -26.74 61.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.987 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 tp -76.43 -45.76 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.056 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.35 -45.72 76.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.886 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.5 pt -64.99 -34.2 68.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.09 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 75.4 mtp -70.05 -26.39 64.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.483 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.37 -33.1 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 14.6 ptp180 -109.26 127.72 54.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 111.337 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.98 140.89 24.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.495 0.664 . . . . 0.0 110.794 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.446 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 65.6 t80 -85.12 130.56 34.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.827 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.86 112.23 38.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.547 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.27 169.71 13.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.332 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.444 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 48.2 m 57.86 50.7 10.07 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.323 0.583 . . . . 0.0 110.757 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -90.84 10.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.093 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.2 t80 64.05 11.99 6.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.618 0.723 . . . . 0.0 109.406 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.995 ' HB2' ' H ' ' A' ' 153' ' ' LYS . 55.0 p90 42.18 33.52 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.852 1.261 . . . . 0.0 113.319 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.46 -58.07 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.162 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.478 ' H ' HD12 ' A' ' 123' ' ' LEU . 7.5 mp -48.94 135.98 14.86 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.56 0.537 . . . . 0.0 112.373 -174.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.63 170.65 48.39 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.447 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.45 -39.17 77.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.603 0.361 . . . . 0.0 111.62 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.32 -27.96 69.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.315 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 48.8 m -66.66 -45.7 78.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 110.307 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.29 -40.03 81.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.984 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -53.35 -48.86 68.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.08 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 78.1 mt-30 -76.96 -30.23 55.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.636 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.39 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 110.703 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.512 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 89.5 m-85 -105.62 12.12 31.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.973 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -70.3 -44.03 18.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.843 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.612 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 14.4 Cg_exo -71.46 -4.0 14.14 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.91 1.74 . . . . 0.0 111.73 173.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.454 ' O ' ' HB1' ' A' ' 165' ' ' ALA . 54.6 m-85 -106.41 58.57 0.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.52 164.01 38.34 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.701 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.525 ' HD2' HG22 ' A' ' 162' ' ' VAL . 68.0 Cg_endo -79.49 132.47 10.04 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.81 2.34 . . . . 0.0 112.461 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.87 119.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.36 -56.21 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 0.0 110.681 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.6 m -157.53 125.26 5.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.622 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.478 HG22 ' HG3' ' A' ' 143' ' ' MET . 54.9 mt -101.22 107.17 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 173.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.55 120.06 27.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.114 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.478 ' HG3' HG22 ' A' ' 141' ' ' ILE . 82.9 mtp -139.02 131.33 28.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.87 0.366 . . . . 0.0 111.399 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.2 m -106.9 105.76 15.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.934 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 10.6 p-90 -159.49 159.86 33.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -83.74 95.53 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.928 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.404 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 10.4 p -70.64 -23.18 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.528 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.9 m -68.82 -32.71 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.454 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.8 p -109.45 -1.89 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.351 0.596 . . . . 0.0 110.71 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.934 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 74.1 mtp 61.06 36.6 18.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -106.02 137.95 43.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.73 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 11.5 m-70 -95.74 -79.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.995 ' H ' ' HB2' ' A' ' 121' ' ' TYR . 29.5 mtpt 52.22 45.88 27.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.22 -170.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -160.27 -122.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.469 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.446 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 29.7 p90 -149.53 174.03 12.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.795 -170.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.99 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.119 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -116.69 108.64 16.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.447 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.4 110.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.49 0.662 . . . . 0.0 110.542 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.4 tt0 -94.57 134.14 37.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.512 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 84.8 m-85 -102.91 161.01 14.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.426 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.54 -7.96 53.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.687 ' HB ' ' OE2' ' A' ' 164' ' ' GLU . 34.9 m -129.22 128.07 23.25 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.429 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 3.1 Cg_exo -74.83 -22.26 15.41 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.137 2.558 . . . . 0.0 114.083 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.687 ' OE2' ' HB ' ' A' ' 162' ' ' VAL . 1.2 mp0 -63.26 -57.68 9.66 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.617 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 135' ' ' PHE . . . -56.96 -29.63 63.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.627 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.23 64.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.522 ' HB3' HG21 ' A' ' 286' ' ' VAL . 23.6 tm0? -68.49 -39.93 81.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.69 -55.93 26.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.266 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.89 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.317 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.933 ' HG ' ' HA2' ' A' ' 186' ' ' GLY . 7.5 tt -54.87 -63.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.222 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.58 -36.01 15.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -70.51 -27.48 64.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.519 ' HG3' HD11 ' A' ' 183' ' ' ILE . 60.5 tpp -88.87 -27.21 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.12 -8.72 57.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.786 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.4 m -90.61 -7.94 51.43 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.188 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.16 163.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.037 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 20.0 ptp -108.93 144.03 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.117 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.41 59.83 1.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.053 0.454 . . . . 0.0 110.431 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.8 77.31 1.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.857 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.97 -51.31 4.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.586 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 2.5 mpt_? -88.35 126.79 35.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 0.0 110.818 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.2 109.32 8.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.388 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.519 HD11 ' HG3' ' A' ' 173' ' ' MET . 35.5 pt -76.86 162.04 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -119.64 114.02 21.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.001 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 170' ' ' LEU . 27.6 t -117.45 132.85 66.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.976 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.933 ' HA2' ' HG ' ' A' ' 170' ' ' LEU . . . 156.03 -136.29 4.96 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.285 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -149.03 71.57 10.23 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.375 0.607 . . . . 0.0 110.605 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.63 89.0 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.728 2.285 . . . . 0.0 112.794 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.4 m -143.71 -71.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.686 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.27 117.91 17.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.9 pt -102.04 -175.49 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.25 -55.97 4.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.191 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -67.96 -51.53 46.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.76 0.314 . . . . 0.0 111.769 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.05 6.44 36.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.677 0.275 . . . . 0.0 111.73 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.503 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.1 OUTLIER -64.9 -55.51 27.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 9.6 Cg_endo -53.13 -32.22 58.37 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.683 2.255 . . . . 0.0 112.725 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -58.01 -46.84 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.397 . . . . 0.0 110.337 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.82 -43.86 98.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.457 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.36 -44.86 93.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.46 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 32.0 mm-40 -67.11 -39.63 86.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.081 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 286' ' ' VAL . 85.7 mt -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.16 -38.2 88.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.88 -40.89 83.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.146 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.15 -40.42 96.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.215 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.13 86.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 82.9 mtp180 -68.51 -30.73 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.51 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.7 72.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -89.8 -6.06 56.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.893 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 65.73 26.67 11.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.121 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -105.21 136.96 43.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 111.339 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.68 169.68 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.117 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.474 ' HB2' ' HA ' ' A' ' 285' ' ' ALA . 37.5 t80 -119.79 128.18 53.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.437 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.468 HG23 HD21 ' A' ' 280' ' ' LEU . 1.5 p -119.95 118.63 57.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.14 -178.36 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.169 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.612 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 50.6 m 64.93 26.54 12.79 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.889 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.575 HG13 HD11 ' A' ' 225' ' ' ILE . 58.0 t -72.18 134.89 28.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.519 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -63.22 127.59 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -56.57 -29.64 62.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.856 -171.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.18 -45.96 24.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.516 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.644 HD22 HD11 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -75.08 116.13 15.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.014 -177.245 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.4 t -106.54 -176.17 3.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -166.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -48.5 -45.1 36.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.33 -34.35 64.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.862 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.44 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.6 m-20 -79.7 -56.79 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.451 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.802 HG13 HD11 ' A' ' 240' ' ' LEU . 27.1 mm -54.39 -26.25 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.835 0.454 . . . . 0.0 112.071 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -50.91 -32.43 20.63 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.77 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 67.2 m -48.93 -62.71 1.38 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.575 0.702 . . . . 0.0 112.698 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.864 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.3 m -74.72 -46.24 42.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.949 -165.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.675 ' HB2' HD11 ' A' ' 235' ' ' ILE . 71.6 m-85 -61.07 -35.89 78.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.967 0.413 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -77.38 -26.52 51.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.192 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.53 81.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.654 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.753 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.5 OUTLIER -82.67 -14.27 54.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.669 -175.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.44 -111.3 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.82 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -156.07 131.19 9.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 110.132 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' A' ' 229' ' ' PHE . 58.7 mt -86.39 127.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.472 0.653 . . . . 0.0 110.763 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -79.48 -46.07 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.736 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 5.4 p -167.0 129.34 1.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.699 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.445 ' HB3' HG23 ' A' ' 255' ' ' ILE . 20.4 p -131.2 137.76 49.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.901 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 52.8 m -154.88 120.68 5.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.898 0.38 . . . . 0.0 110.915 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.802 HD11 HG13 ' A' ' 225' ' ' ILE . 52.6 mt -83.46 130.83 35.04 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.13 121.04 11.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.254 0.55 . . . . 0.0 110.319 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 44.9 mtt180 -93.59 158.04 15.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.507 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.6 t70 -117.89 107.71 43.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.382 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.28 -24.69 57.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.015 2.477 . . . . 0.0 113.187 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.5 p -78.43 -28.36 46.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.688 0.28 . . . . 0.0 111.612 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -96.55 -33.37 11.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.899 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.3 -10.94 58.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.993 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -108.83 -92.52 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.667 -0.314 . . . . 0.0 111.115 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 25.4 p80 -170.0 162.09 9.0 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.507 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 96.0 mttt -84.17 155.82 22.38 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.61 42.03 1.47 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.559 . . . . 0.0 114.05 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.4 p90 -161.09 168.29 24.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 175.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.729 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -174.95 -177.82 44.34 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.189 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.25 137.49 54.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.772 0.32 . . . . 0.0 110.62 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 238' ' ' CYS . 56.4 mt -131.61 126.48 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.03 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.3 136.72 44.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.352 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -104.32 155.81 18.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.851 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -81.74 -19.36 41.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.689 173.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 262' ' ' SER . 28.5 mmmt -127.46 120.98 29.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.407 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.29 -22.46 65.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.875 0.369 . . . . 0.0 111.363 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -65.42 -44.02 88.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 1.9 p -71.58 -29.89 65.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.497 ' O ' HG23 ' A' ' 267' ' ' VAL . 9.1 m -56.06 -41.44 75.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.035 0.445 . . . . 0.0 110.757 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -67.2 -35.21 79.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.571 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.65 -43.27 63.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -52.17 -44.63 64.72 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.549 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 263' ' ' SER . 67.0 t -61.82 -27.18 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 111.383 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.0 m -91.12 -36.4 14.01 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.193 -0.317 . . . . 0.0 111.463 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 45.3 m -92.24 -35.07 14.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.731 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 40.2 mmm -70.36 -9.23 55.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -59.99 -43.3 95.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.664 0.745 . . . . 0.0 110.649 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 8.8 mp -76.63 -8.61 57.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.709 ' CD2' HD22 ' A' ' 280' ' ' LEU . 49.0 t80 -45.41 102.09 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.523 0.514 . . . . 0.0 110.889 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.4 p-10 -94.68 128.82 41.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.489 0.662 . . . . 0.0 111.016 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.644 HD11 HD22 ' A' ' 220' ' ' LEU . 40.5 mt -124.07 87.24 2.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.759 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.63 -111.08 3.44 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -113.15 34.56 5.01 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.424 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.2 pt20 -141.23 159.86 41.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.681 0.24 . . . . 0.0 110.813 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -102.25 162.85 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.826 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 13.3 tp -91.09 -170.08 2.55 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.826 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 21.0 tpp180 -148.61 112.41 5.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 175.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 270' ' ' MET . 7.5 p -112.02 146.3 17.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.889 0.376 . . . . 0.0 110.811 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.85 -145.06 4.08 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.546 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 286' ' ' VAL . 92.4 mttt -123.08 150.7 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.653 -0.322 . . . . 0.0 110.29 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.06 -31.39 72.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.713 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 167' ' ' GLN . 62.3 t 68.58 -65.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.431 HG23 HG12 ' A' ' 286' ' ' VAL . 3.1 p -115.58 83.77 11.51 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 CA--C 1.553 1.448 0 C-N-CA 122.643 2.229 . . . . 0.0 115.828 174.922 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.675 ' N ' HD21 ' B' ' 28' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.714 0.292 . . . . 0.0 110.905 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -154.35 -77.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.318 . . . . 0.0 111.026 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.17 -23.36 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.121 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.616 ' O ' HD22 ' B' ' 35' ' ' LEU . 12.1 t80 -72.19 -23.88 61.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.08 0.467 . . . . 0.0 110.032 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 51.5 mtpt -71.4 -39.84 70.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.28 -31.52 72.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.864 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -56.93 -55.0 40.22 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.549 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.669 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.7 OUTLIER -82.25 -24.13 34.95 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 4.7 pt20 -60.33 -37.32 80.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.166 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.426 ' O ' HG23 ' B' ' 41' ' ' ILE . 32.1 ttm180 -74.01 -31.27 62.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.775 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.738 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -71.61 -42.39 67.74 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 121.549 0.69 . . . . 0.0 112.553 -175.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 58.4 mtp180 -79.24 -25.21 42.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.88 -1.137 . . . . 0.0 111.389 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -55.87 -49.8 72.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.35 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.738 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.2 pt -65.41 -34.13 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.847 0.356 . . . . 0.0 110.352 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -68.33 -25.12 64.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.443 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.53 -45.96 34.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.229 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.717 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -86.56 -29.55 22.57 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 59.4 mt . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 122.868 0.467 . . . . 0.0 111.406 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.9 -26.1 62.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.01 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.5 tp -68.09 -36.18 79.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.28 68.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.4 mt -80.49 -47.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.535 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 52.2 mtm -66.27 -27.02 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.47 -13.41 62.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 21.9 ptt180 -127.23 119.44 26.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.815 0.341 . . . . 0.0 110.566 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.466 HG22 ' HE1' ' A' ' 160' ' ' TYR . 16.8 m -92.47 138.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.69 0.757 . . . . 0.0 111.394 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -86.36 99.49 11.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.642 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.0 t -96.74 115.6 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.155 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.527 ' CA ' ' HD1' ' A' ' 155' ' ' PHE . . . -127.69 -176.91 14.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.8 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 47.2 m 72.43 -72.26 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.582 0.753 . . . . 0.0 111.149 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.42 HD12 HD11 ' A' ' 128' ' ' ILE . 44.1 mm 68.79 158.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 123.23 0.331 . . . . 0.0 110.743 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 69.6 t80 -56.26 -64.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.376 -0.203 . . . . 0.0 110.729 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 42.2 t80 177.86 -49.77 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.104 0 O-C-N 123.456 0.473 . . . . 0.0 110.687 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' LYS . 6.0 pt-20 -136.6 45.19 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.487 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.41 134.36 46.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.925 0.393 . . . . 0.0 111.102 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.56 -177.33 50.43 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.256 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -63.79 -41.65 97.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.478 -0.361 . . . . 0.0 111.866 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -64.37 -41.32 96.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.534 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.7 m -57.06 -45.21 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 119' ' ' ILE . 65.5 mt -71.08 -45.82 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.689 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 129' ' ' ARG . 20.5 ttp180 -56.59 -47.0 80.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.571 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.55 -11.41 59.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.629 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -29.83 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.407 . . . . 0.0 110.443 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.796 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 61.7 m-85 -99.29 8.1 45.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.583 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.34 -44.0 12.91 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.583 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.596 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 29.1 Cg_endo -64.84 -4.78 9.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.843 1.695 . . . . 0.0 113.019 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 5.4 m-85 -87.25 -68.35 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.795 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.17 167.65 36.18 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.827 ' HG2' ' HB3' ' A' ' 161' ' ' GLU . 19.3 Cg_endo -60.39 126.86 21.11 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.54 2.16 . . . . 0.0 111.833 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.2 mt -87.8 128.89 39.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.367 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -80.26 -56.19 4.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -158.7 152.21 23.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.402 HG12 HG13 ' A' ' 158' ' ' VAL . 68.4 mt -124.16 107.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.89 112.61 24.61 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 43.1 ttm -134.85 118.27 16.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.204 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.4 t -91.09 115.47 28.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' CE3' ' HB2' ' A' ' 152' ' ' HIS . 1.6 p-90 -165.93 151.63 8.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.196 0.522 . . . . 0.0 111.771 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.24 99.8 1.22 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.5 t -94.2 6.53 48.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.6 p -84.75 -31.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.114 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.2 p -108.37 -17.37 14.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 111.202 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.0 mtt 63.21 41.18 8.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.143 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 33.8 mmtp -84.06 -39.93 18.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.588 ' HB2' ' CE3' ' A' ' 145' ' ' TRP . 1.6 t60 60.43 67.04 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.732 0.777 . . . . 0.0 110.357 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -96.7 64.96 2.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.664 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.25 -155.25 11.36 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.743 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.527 ' HD1' ' CA ' ' A' ' 117' ' ' GLY . 28.7 m-85 -104.99 170.46 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.961 0.41 . . . . 0.0 111.16 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.45 145.4 24.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.76 107.85 18.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.727 0.299 . . . . 0.0 110.277 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.402 HG13 HG12 ' A' ' 141' ' ' ILE . 23.3 t -98.36 111.37 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 30.1 tt0 -100.57 129.32 46.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.963 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.466 ' HE1' HG22 ' A' ' 114' ' ' VAL . 90.3 m-85 -102.01 161.34 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.384 0.611 . . . . 0.0 111.412 -176.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.827 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 10.8 tp10 -77.62 -27.07 51.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.585 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 16.1 m -126.55 119.76 23.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.665 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 162' ' ' VAL . 19.7 Cg_endo -59.91 -19.4 54.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.299 2.666 . . . . 0.0 113.002 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.43 -56.92 15.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 110.519 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -64.33 -28.96 70.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.99 -51.2 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.01 -36.62 75.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.422 HD22 ' CE2' ' A' ' 212' ' ' TYR . 22.2 tp -57.47 -45.95 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.344 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.05 93.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.185 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.32 -41.48 89.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.701 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -85.13 -32.46 22.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -91.3 -29.42 17.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.796 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 14.9 mmt -95.25 -34.23 12.28 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.111 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 9.9 t30 -70.18 -15.91 63.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 110.454 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.4 p -92.64 5.49 50.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.25 146.1 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 110.594 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.682 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 36.0 mtm -94.23 132.78 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 38.1 tp -83.52 83.77 7.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.142 0.496 . . . . 0.0 110.22 -176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.71 -36.44 3.26 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.191 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.13 -38.18 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -90.99 128.57 36.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.682 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.0 p-10 -75.48 119.09 19.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.276 0.56 . . . . 0.0 109.995 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.434 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 19.9 pt -74.97 150.95 6.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.003 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -101.48 117.58 35.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.048 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 42.9 t -122.64 106.33 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.06 175.23 18.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.049 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 38.9 mtp180 -146.7 128.19 7.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 122.459 0.303 . . . . 0.0 110.424 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.0 Cg_endo -82.19 60.69 7.51 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.059 2.506 . . . . 0.0 111.472 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.5 m -115.76 151.37 35.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.974 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.9 32.48 20.02 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.774 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.479 ' HA ' ' HB2' ' A' ' 195' ' ' GLN . 38.1 mt -79.77 73.12 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.995 0.902 . . . . 0.0 110.222 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 163.08 -36.15 0.32 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.492 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -83.56 -52.64 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.35 . . . . 0.0 110.619 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.87 -21.74 15.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.232 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.58 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 26.7 tp60 -52.74 -47.17 95.48 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.7 Cg_endo -55.15 -30.55 71.5 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.454 2.103 . . . . 0.0 113.072 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.1 -39.05 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.441 . . . . 0.0 110.067 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.9 -38.86 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.082 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.1 -40.07 92.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.75 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -63.64 -34.38 77.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.076 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.87 -45.96 22.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.657 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.79 -43.41 98.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.064 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' ' 206' ' ' ARG . 5.5 tp10 -62.72 -33.53 75.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.455 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 4.2 tp10 -70.2 -40.79 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.019 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -68.47 -28.08 66.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.466 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 88.7 mtt180 -64.25 -22.99 67.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.23 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.03 -4.01 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -111.45 -18.72 12.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.471 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.544 HD21 ' HA ' ' A' ' 260' ' ' ALA . 50.2 t-20 50.58 68.58 0.75 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.348 0.594 . . . . 0.0 110.43 -176.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -130.28 136.66 49.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.505 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.663 HD13 ' HE2' ' A' ' 229' ' ' PHE . 7.6 tt -106.54 147.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.335 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.422 ' CE2' HD22 ' A' ' 168' ' ' LEU . 86.5 t80 -108.01 122.88 47.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.42 ' CG2' HD23 ' A' ' 280' ' ' LEU . 6.5 p -122.87 124.2 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.297 0.57 . . . . 0.0 110.897 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.39 -178.19 3.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.46 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.0 m 64.77 33.61 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.768 0.668 . . . . 0.0 111.558 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.758 HG23 HD11 ' A' ' 225' ' ' ILE . 7.1 p -82.78 151.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.281 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 14.7 t-80 -68.89 136.22 52.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -57.48 -35.59 70.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -168.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.42 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 1.0 OUTLIER -79.01 -45.89 19.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 177.502 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.748 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -52.21 110.25 0.47 Allowed 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.78 0.675 . . . . 0.0 110.156 177.305 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.2 t -94.8 -178.46 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.674 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 2.3 p30 -62.81 -29.36 70.67 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.7 -41.44 73.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.339 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.518 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 52.0 m-20 -80.23 -52.35 7.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.771 -175.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.758 HD11 HG23 ' A' ' 216' ' ' VAL . 47.2 mm -56.21 -25.25 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.227 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.764 ' HG3' HD11 ' A' ' 235' ' ' ILE . 53.8 tttm -55.57 -31.9 62.58 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.47 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.55 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.0 m -51.02 -61.92 1.93 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.826 0.822 . . . . 0.0 112.019 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.561 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.1 m -68.05 -48.84 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.574 -171.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.663 ' HE2' HD13 ' A' ' 211' ' ' ILE . 52.5 m-85 -59.27 -45.22 91.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.787 0.327 . . . . 0.0 111.22 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 40.9 tt0 -73.43 -23.82 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.726 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.52 71.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.73 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.3 OUTLIER -83.73 -38.08 21.85 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -165.78 148.47 13.85 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.17 139.34 58.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.486 0.66 . . . . 0.0 111.355 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.764 HD11 ' HG3' ' A' ' 226' ' ' LYS . 31.0 pt -119.78 137.04 54.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.666 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -85.64 -68.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.407 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' ' 256' ' ' GLU . 11.6 m -94.7 108.99 20.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.336 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 4.3 p -122.12 102.1 7.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.9 m -142.64 116.25 9.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.762 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.674 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 73.6 mt -90.22 117.8 29.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 168.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 123.11 15.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.2 0.524 . . . . 0.0 110.985 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.831 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 53.5 mtt-85 -80.74 157.4 25.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.335 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.637 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 18.5 t70 -117.34 113.89 38.7 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.161 -175.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.79 -20.35 39.86 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.763 2.309 . . . . 0.0 112.336 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.7 m -64.36 -56.69 12.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.496 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 47.2 p -86.81 -35.39 19.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.509 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 106.58 -10.25 41.86 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.1 -157.93 0.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.831 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 29.6 p80 -108.35 149.42 28.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.637 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 94.1 mttt -70.7 154.23 42.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.443 ' C ' HG12 ' A' ' 216' ' ' VAL . . . -73.15 34.45 0.77 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 114.669 0.628 . . . . 0.0 114.669 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.478 ' HE2' ' HD3' ' A' ' 137' ' ' PRO . 35.5 p90 -157.07 164.81 37.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.555 0.678 . . . . 0.0 110.633 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.25 -175.41 41.01 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.312 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.4 ' C ' HD12 ' A' ' 255' ' ' ILE . 86.5 m-85 -123.41 141.58 51.85 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.4 HD12 ' C ' ' A' ' 254' ' ' PHE . 2.2 mp -124.78 135.47 63.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.973 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.496 ' HB3' ' H ' ' A' ' 237' ' ' SER . 45.6 tt0 -109.04 126.44 53.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.627 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.404 ' OH ' ' HB2' ' A' ' 266' ' ' ALA . 7.9 m-85 -98.15 144.23 27.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.182 0.515 . . . . 0.0 112.181 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.88 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 5.0 pt-20 -74.84 -31.47 61.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.88 ' HG3' ' HG3' ' A' ' 258' ' ' GLU . 24.0 mtpp -109.47 157.47 18.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.544 ' HA ' HD21 ' A' ' 209' ' ' ASN . . . -81.86 -40.89 21.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 0.0 111.254 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -64.62 -38.63 91.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.588 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 6.3 p -62.74 -34.78 77.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.567 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -39.94 86.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.964 0.411 . . . . 0.0 110.612 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.69 -39.67 70.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.775 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -46.7 86.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.404 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . . . -60.55 -52.62 64.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.469 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.22 -25.95 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.172 0.51 . . . . 0.0 111.693 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.9 m -84.3 -17.89 38.15 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.098 -0.376 . . . . 0.0 111.993 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.6 p -116.09 -34.41 4.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.51 ' HE3' ' HB2' ' A' ' 273' ' ' PHE . 39.9 mmm -65.48 -4.5 5.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -69.99 -35.28 74.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 122.167 0.984 . . . . 0.0 109.477 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.92 -8.79 58.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.369 -174.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.825 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.2 t80 -52.78 105.37 0.12 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.877 0.37 . . . . 0.0 110.653 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.3 t70 -97.95 119.2 36.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.748 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.6 mm? -117.52 86.31 2.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.995 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.5 26.1 61.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.664 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 118.21 -18.68 11.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.228 -0.986 . . . . 0.0 113.646 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.4 pt20 -106.75 131.76 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.136 0.468 . . . . 0.0 111.362 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.462 ' HB2' HH12 ' A' ' 281' ' ' ARG . 50.1 m-85 -94.31 137.95 32.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.275 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.515 HD22 ' HD2' ' A' ' 273' ' ' PHE . 11.1 mp -73.81 -173.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.304 0.573 . . . . 0.0 111.525 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.462 HH12 ' HB2' ' A' ' 279' ' ' TYR . 77.2 mmt-85 -146.89 118.09 7.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.15 146.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -154.52 -164.37 12.83 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.735 176.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -88.69 169.94 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.499 0.649 . . . . 0.0 110.186 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.91 -32.44 73.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 287' ' ' THR . 54.8 t 70.73 -70.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.954 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 286' ' ' VAL . 54.0 p -112.84 138.69 22.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 65.5 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.341 2.028 . . . . 0.0 112.058 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.691 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 51.7 t30 . . . . . 0 C--O 1.224 -0.26 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.61 -67.76 0.35 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -24.16 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.053 0.454 . . . . 0.0 111.273 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.554 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 5.2 t80 -75.14 -17.84 60.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.126 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 89.6 mttt -70.61 -45.5 65.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.52 -40.3 86.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.73 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -48.51 -53.43 18.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.326 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.823 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.22 -17.51 45.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 57.5 mt-30 -66.07 -43.85 86.23 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.55 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 74.0 mtp180 -69.38 -37.35 77.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.108 173.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -59.55 -50.65 73.06 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.269 31.1 mtp85 -81.55 -25.38 35.91 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.266 -1.521 . . . . 0.0 112.971 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -55.57 -44.89 77.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.018 169.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.821 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -66.33 -33.54 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.625 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -69.28 -24.81 64.01 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.813 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.58 -22.91 24.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.202 0.525 . . . . 0.0 110.637 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 20.1 ttpt -90.91 -41.65 11.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.58 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.419 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.3 pt . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 123.786 0.835 . . . . 0.0 112.9 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.52 -52.79 64.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.758 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.545 HD12 ' HG3' ' A' ' 163' ' ' PRO . 3.8 mm? -66.11 -36.78 84.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.88 74.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.359 . . . . 0.0 111.367 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.9 mt -82.11 -41.29 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.81 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.9 mtp -68.05 -37.01 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.059 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 79.8 m -75.91 -17.78 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.832 ' HG2' ' HB3' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.3 99.92 11.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.979 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.78 140.03 17.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.419 0.628 . . . . 0.0 111.226 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.55 ' HE2' ' HE2' ' A' ' 184' ' ' LYS . 42.6 t80 -88.94 121.34 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.406 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.472 HG22 HG13 ' A' ' 185' ' ' VAL . 52.0 t -116.53 110.98 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -130.42 101.98 0.52 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.652 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.544 ' HB3' HG22 ' A' ' 183' ' ' ILE . 8.9 t 168.45 59.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.411 HG21 ' ND1' ' A' ' 152' ' ' HIS . 12.7 mm -82.06 -17.45 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.8 -170.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 t80 66.51 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.1 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.2 t80 179.17 -53.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.69 36.05 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.52 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.56 113.45 18.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.583 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -83.18 159.85 37.77 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.236 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.1 OUTLIER -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 109.895 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 25.5 t70 -65.13 -42.12 94.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.085 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -58.75 -42.82 89.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.034 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.38 -42.72 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.511 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 129' ' ' ARG . 10.6 ttp180 -61.0 -39.78 91.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 38.3 mt-30 -76.29 -20.42 57.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.05 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.22 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.883 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.43 ' HB2' HD11 ' A' ' 138' ' ' ILE . 78.9 m-85 -94.88 8.12 43.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -66.63 -44.22 53.73 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.991 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 23.9 Cg_exo -65.86 -12.74 36.6 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 112.541 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.584 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 5.9 m-85 -80.39 -68.16 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.654 0.264 . . . . 0.0 110.964 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -149.07 169.55 29.46 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.465 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.55 ' HD2' HG22 ' A' ' 162' ' ' VAL . 15.2 Cg_exo -67.46 100.52 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.682 2.255 . . . . 0.0 111.565 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.43 HD11 ' HB2' ' A' ' 132' ' ' PHE . 64.6 mt -69.34 107.36 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -76.22 -31.83 58.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 p -173.07 128.95 0.47 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.743 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.0 tt -105.92 132.85 51.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 172.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -114.49 115.63 27.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.865 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' A' ' 125' ' ' GLU . 23.0 ttt -140.81 128.54 21.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.093 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.8 t -118.99 124.92 48.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.851 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 43.6 p-90 -163.64 159.61 21.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.615 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.87 93.25 1.68 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.872 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.454 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 48.3 t -70.86 -22.04 62.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.546 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.82 -26.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.022 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.8 p -121.36 5.73 10.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.851 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 68.5 mtp 60.8 27.35 17.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -91.08 107.57 19.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 0.0 110.608 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.411 ' ND1' HG21 ' A' ' 119' ' ' ILE . 40.8 m-70 -83.25 74.55 10.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.92 -51.14 17.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.189 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.33 172.7 54.45 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.629 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.09 170.85 7.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -104.7 129.11 52.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 0.0 110.446 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.27 108.03 17.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.27 124.12 67.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.207 0.527 . . . . 0.0 110.554 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.832 ' HB3' ' HG2' ' A' ' 113' ' ' ARG . 10.3 pt-20 -112.82 131.22 55.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.501 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.67 162.89 13.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.731 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -78.27 -15.18 59.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.664 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 17.3 m -129.44 128.98 23.19 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.545 ' HG3' HD12 ' A' ' 108' ' ' LEU . 56.2 Cg_endo -72.07 -14.61 29.04 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.009 2.473 . . . . 0.0 113.16 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.664 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 31.0 mp0 -60.74 -52.21 66.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 110.574 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -22.98 67.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.503 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.31 -50.71 36.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.794 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -39.67 94.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.447 ' CD2' ' HB3' ' A' ' 214' ' ' ALA . 15.5 tp -60.36 -49.65 76.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.846 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.96 -29.2 70.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.196 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.84 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.9 tt -61.37 -61.15 2.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.092 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.99 -39.49 23.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.704 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 17.3 mm-40 -83.14 0.19 46.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.426 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 58.2 tpp -122.38 -36.54 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.079 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.658 ' OD1' ' HA ' ' A' ' 184' ' ' LYS . 10.4 t30 -67.58 -31.09 70.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.959 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.2 m -85.16 -8.91 58.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.81 90.18 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.108 0.48 . . . . 0.0 110.211 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.6 ptm -72.52 118.12 15.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.255 0.55 . . . . 0.0 110.32 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.2 -34.24 68.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.485 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 152.29 133.41 1.94 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.553 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.98 -62.89 3.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.606 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -124.04 155.37 38.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -90.12 127.92 36.21 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.544 HG22 ' HB3' ' A' ' 118' ' ' SER . 23.4 pt -89.97 132.06 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.068 176.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.658 ' HA ' ' OD1' ' A' ' 174' ' ' ASN . 21.8 ptmt -102.15 116.94 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.368 0.604 . . . . 0.0 110.176 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 116' ' ' VAL . 62.1 t -123.51 133.5 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.227 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.84 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 106.48 -126.29 8.45 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.841 174.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 54.84 67.93 2.93 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 124.17 0.57 . . . . 0.0 111.013 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.04 -157.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.909 2.406 . . . . 0.0 111.892 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 194' ' ' ALA . 34.1 t 72.55 118.6 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.577 0.703 . . . . 0.0 110.681 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.481 ' OD1' HG13 ' A' ' 191' ' ' ILE . 25.2 t-20 -74.85 -63.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.278 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.481 HG13 ' OD1' ' A' ' 190' ' ' ASN . 55.5 mt -137.55 67.48 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.268 0.556 . . . . 0.0 110.463 175.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.01 2.07 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -58.63 -10.31 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 189' ' ' SER . . . -84.85 -30.74 24.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.044 -0.41 . . . . 0.0 111.269 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.514 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.1 tp60 -64.18 -50.16 69.66 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.6 Cg_exo -52.52 -33.57 58.44 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.117 1.878 . . . . 0.0 112.437 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.93 -44.03 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 110.094 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.88 -43.55 97.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.608 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -45.11 93.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 84.2 mm-40 -61.11 -46.22 91.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.704 HD13 HG22 ' A' ' 287' ' ' THR . 96.1 mt -71.21 -28.99 64.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.68 94.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.3 -32.45 71.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.178 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.55 -42.14 87.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.201 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.12 72.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.46 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -68.43 -19.4 64.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.82 -13.49 59.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.512 ' HB3' ' HG3' ' A' ' 210' ' ' ARG . 41.4 m-85 -103.39 -23.07 13.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.144 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 59.09 37.1 24.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.501 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 1.015 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 96.3 mtt180 -97.22 138.25 35.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.503 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.09 158.56 17.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.35 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -109.75 128.54 55.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.833 0.349 . . . . 0.0 110.621 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 4.4 p -120.78 119.23 58.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.129 0.49 . . . . 0.0 110.585 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -123.33 -177.2 3.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.558 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 8.1 t 68.0 22.49 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.055 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.504 HG13 HD11 ' A' ' 225' ' ' ILE . 84.7 t -73.23 129.68 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.018 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -63.18 130.54 45.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.81 -28.82 66.37 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -78.98 -45.87 19.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 111.398 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.662 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -61.34 110.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.638 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 62.4 m -87.14 -178.26 6.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.908 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 19.7 p-10 -66.94 -37.65 84.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.706 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.704 0.764 . . . . 0.0 109.832 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 0.9 OUTLIER -67.78 -54.62 17.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.723 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.726 HG13 HD11 ' A' ' 240' ' ' LEU . 29.4 mm -59.58 -21.28 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 111.032 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.47 ' HG3' HD12 ' A' ' 235' ' ' ILE . 88.4 tttt -59.19 -31.39 68.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.936 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.4 m -48.76 -59.79 3.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.87 0.843 . . . . 0.0 111.43 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.707 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.8 m -68.91 -52.22 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.603 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -58.38 -34.4 70.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.423 ' HA ' HG13 ' A' ' 235' ' ' ILE . 2.2 tm-20 -76.63 -34.67 58.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.026 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.39 -13.75 61.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.709 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 4.2 m-30 -90.06 -10.94 42.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.763 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 173.72 -112.49 0.42 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.583 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -146.45 120.0 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 110.609 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 226' ' ' LYS . 49.8 mt -85.6 134.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.094 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -86.46 -47.99 8.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.093 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 3.8 m -148.55 132.14 16.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.897 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 45.1 t -120.25 111.59 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.9 m -141.02 107.81 5.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.296 0.569 . . . . 0.0 112.288 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 79.4 mt -91.68 130.65 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.9 162.17 22.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.954 0.407 . . . . 0.0 110.967 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 56.3 mtp180 -123.68 158.7 30.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -107.77 95.72 15.24 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.94 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.32 -23.42 32.82 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 113.136 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -29.35 55.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.634 ' HB ' ' HE2' ' A' ' 248' ' ' LYS . 1.2 m -114.32 -19.33 11.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 111.509 178.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.63 43.18 5.55 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.877 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.634 ' HE2' ' HB ' ' A' ' 246' ' ' THR . 47.1 mtmt -125.8 -178.51 4.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.755 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -113.18 131.61 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 170.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -65.58 136.44 56.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.62 29.83 1.04 Allowed Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.359 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.6 p90 -154.15 158.46 40.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.681 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.62 -171.42 38.8 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.114 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.488 ' CZ ' ' HG2' ' A' ' 164' ' ' GLU . 98.4 m-85 -127.65 133.32 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.936 0.398 . . . . 0.0 110.95 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.07 132.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 1.015 ' HG2' ' HG2' ' A' ' 210' ' ' ARG . 39.7 mt-10 -104.31 144.52 31.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.048 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -120.11 141.44 49.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.225 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.451 ' C ' ' HE3' ' A' ' 259' ' ' LYS . 6.8 pt-20 -81.92 -33.03 30.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.706 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.451 ' HE3' ' C ' ' A' ' 258' ' ' GLU . 0.1 OUTLIER -97.95 113.22 25.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.094 173.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.32 68.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.047 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.65 -35.68 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.2 m -68.37 -25.85 65.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 267' ' ' VAL . 6.9 m -62.42 -30.8 71.48 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.84 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.04 -43.66 57.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.896 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -52.94 -45.52 67.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.349 0.405 . . . . 0.0 110.551 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.524 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . . . -60.56 -42.22 96.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.648 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 263' ' ' SER . 98.2 t -64.46 -39.39 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.716 -176.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.1 p -86.45 -1.0 57.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -115.63 -45.4 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.89 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 0.0 OUTLIER -64.45 -20.61 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.088 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -60.02 -38.27 82.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.744 0.783 . . . . 0.0 110.4 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -78.06 -9.86 59.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.871 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -46.92 106.96 0.09 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.961 0.41 . . . . 0.0 111.494 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.6 108.89 15.54 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.627 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.662 ' HG ' HD22 ' A' ' 220' ' ' LEU . 1.1 mm? -114.7 86.85 2.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.62 -116.83 4.42 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -110.46 23.59 19.91 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.076 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 9.9 pt20 -125.13 151.55 45.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 0.0 111.222 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -107.27 137.84 44.58 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.79 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 4.5 tp -69.05 -176.39 0.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.282 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.704 ' HD2' ' HB3' ' A' ' 172' ' ' GLN . 73.2 mmt-85 -141.51 113.26 7.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.832 0.348 . . . . 0.0 110.388 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 270' ' ' MET . 12.3 p -115.19 146.55 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.985 0.422 . . . . 0.0 110.997 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.91 -159.44 9.37 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -108.31 171.64 7.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 117.18 0.49 . . . . 0.0 110.249 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -62.48 -40.59 97.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.609 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.3 t 70.97 -67.05 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.487 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.704 HG22 HD13 ' A' ' 201' ' ' LEU . 0.5 OUTLIER -108.89 160.97 25.38 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.513 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.452 -0.945 0 C-N-CA 123.152 2.568 . . . . 0.0 111.774 173.544 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.476 ' O ' ' HD3' ' B' ' 32' ' ' LYS . 6.4 t30 . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.02 -51.47 3.84 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.904 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.587 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -58.29 -45.76 87.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.009 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.709 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 23.8 t80 -76.36 -20.47 57.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.125 0.488 . . . . 0.0 110.947 -175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' B' ' 28' ' ' ASN . 0.2 OUTLIER -82.75 -35.45 26.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.101 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 9.7 t70 -57.97 -46.3 85.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 168.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.707 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -48.46 -46.74 38.36 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.996 176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.799 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.2 -21.68 39.41 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.235 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.1 -41.67 97.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.693 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 54.5 mtt180 -68.83 -36.86 78.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.898 173.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.871 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.0 -42.47 97.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.074 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' B' ' 42' ' ' ALA 0.253 2.7 mtt180 -81.15 -25.99 36.44 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.706 173.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -54.84 -44.34 73.85 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.34 0.59 . . . . 0.0 110.097 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.742 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.5 pt -68.74 -32.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 CA-C-O 121.207 0.527 . . . . 0.0 109.958 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' B' ' 39' ' ' ARG . . . -75.2 -4.59 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.036 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.89 -37.67 15.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.259 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' B' ' 41' ' ' ILE . 11.2 ptpt -72.4 -7.8 51.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.056 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.23 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 121.001 0.429 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 -27.91 69.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.658 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 29.7 tp -65.72 -33.28 75.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.565 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.6 67.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 0.0 110.651 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.411 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 56.0 mt -82.99 -42.31 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.959 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.658 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 26.7 ptm -71.32 -25.47 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.977 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.486 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 83.9 m -86.43 5.52 34.67 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 12.4 ptp180 -123.87 130.91 53.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 0.0 110.728 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 158' ' ' VAL . 14.7 m -101.7 145.76 11.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.208 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 73.8 t80 -105.43 127.92 53.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.972 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.5 109.88 30.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.7 152.17 17.48 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.373 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.6 m 61.04 64.09 1.17 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.985 0.421 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.9 mm -54.46 132.09 17.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.376 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 88.5 t80 -44.43 -70.1 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.96 0.787 . . . . 0.0 111.733 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 86.1 t80 171.9 -62.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.752 0.658 . . . . 0.0 109.574 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.81 -25.86 37.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.172 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.52 121.48 13.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -106.41 -175.22 23.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.949 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 32.6 tt0 -65.12 -36.61 84.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.044 0.449 . . . . 0.0 110.07 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.566 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 23.4 m-20 -63.84 -40.9 97.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.319 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.7 m -60.85 -49.74 76.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.45 -51.74 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.057 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 126' ' ' ASP . 23.0 ptt180 -63.62 -35.68 81.31 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.691 -0.404 . . . . 0.0 112.026 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.78 -22.78 49.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.56 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.08 -36.97 58.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.393 . . . . 0.0 110.723 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.482 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 86.9 m-85 -93.31 14.72 17.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.49 -44.48 18.0 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.273 -178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 34.8 Cg_endo -67.16 -4.67 12.04 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -92.47 -75.7 0.48 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.69 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -145.1 -177.57 20.01 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 2.0 Cg_endo -80.72 135.08 10.03 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.712 2.275 . . . . 0.0 112.069 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.15 109.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -79.08 -56.42 4.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.81 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.3 m -156.88 136.57 12.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.679 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.7 mt -121.13 114.72 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.76 106.1 13.48 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 156' ' ' ALA . 25.2 ptm -116.65 142.4 46.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.7 t -81.79 104.27 12.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.01 117.18 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.452 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' MET . 3.3 t70 -77.25 91.86 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.754 172.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.0 p -94.92 4.49 53.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.988 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.55 -54.35 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 t -120.71 4.83 10.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.364 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 146' ' ' ASP . 26.8 ptm 45.51 37.67 3.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.565 1.146 . . . . 0.0 113.198 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -102.95 7.14 39.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 72.16 44.96 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.642 171.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -76.26 81.1 3.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.329 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.8 -161.08 24.96 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.898 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.91 166.93 23.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.478 -0.361 . . . . 0.0 110.08 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -133.03 138.99 46.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.817 0.342 . . . . 0.0 111.571 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.29 119.09 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.78 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.435 ' HB ' HG23 ' A' ' 114' ' ' VAL . 47.4 t -112.57 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.443 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 51.5 mt-10 -96.52 141.65 29.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.89 160.25 20.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.754 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 137' ' ' PRO . 10.6 pt-20 -87.59 -2.4 58.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.123 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.493 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 12.9 m -133.57 126.38 19.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.23 177.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 17.1 Cg_exo -67.88 -18.02 46.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.468 2.779 . . . . 0.0 111.624 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.487 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 14.1 mp0 -62.21 -56.64 16.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.835 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -31.41 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.73 -51.02 66.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.634 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -65.03 -43.64 91.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 110.176 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.49 -48.34 79.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.707 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -58.22 -59.95 4.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.687 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.88 -34.08 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -74.24 -45.03 50.6 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.542 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.677 ' HB3' HD11 ' A' ' 183' ' ' ILE . 26.3 mmt -74.97 -17.85 60.48 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.938 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -76.77 -28.45 55.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.38 0.61 . . . . 0.0 109.644 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.5 m -89.57 -42.92 11.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.042 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 67.4 t -89.52 119.91 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.633 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 88.2 mtp -77.41 112.56 14.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 178' ' ' LEU . 0.6 OUTLIER -79.74 102.98 9.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.234 -176.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.7 -134.41 12.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.856 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -100.21 13.59 60.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.97 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -148.79 161.86 40.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.633 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.1 p-10 -98.29 119.2 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 173' ' ' MET . 28.5 pt -64.4 156.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -100.46 109.73 21.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.6 p -136.52 130.27 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.796 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.69 100.37 1.96 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.952 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.1 OUTLIER -151.74 87.78 4.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.221 177.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.46 101.38 1.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.678 2.252 . . . . 0.0 111.594 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.8 p -72.45 -21.07 61.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -99.8 29.67 4.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.008 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.7 tt -64.35 139.88 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.679 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.25 -69.27 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -82.62 -26.18 32.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 110.637 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.432 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.07 -33.95 72.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.532 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.0 tp60 -60.56 -53.93 59.71 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 55.9 Cg_exo -54.32 -28.83 54.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.479 2.12 . . . . 0.0 112.689 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.13 -52.61 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 194' ' ' ALA . 35.3 mt -64.33 -42.14 94.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.641 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.3 -37.97 89.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.83 -49.29 78.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.623 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.57 -47.5 84.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.449 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.1 -35.6 79.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.745 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.65 -39.08 64.74 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.747 0.308 . . . . 0.0 110.894 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.77 -31.59 70.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.09 0.471 . . . . 0.0 109.946 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.94 69.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.719 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtt180 -66.2 -25.83 67.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.366 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.78 71.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.901 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -95.16 -26.15 16.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.839 0.828 . . . . 0.0 109.861 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 260' ' ' ALA . 5.1 t-20 62.26 44.35 7.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 112.124 168.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -95.92 136.88 35.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.695 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 284' ' ' LYS . 12.2 pt -105.47 161.95 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.104 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.47 118.09 35.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.162 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 51.5 t -105.84 115.67 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.176 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -121.48 178.19 4.91 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.502 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.53 31.97 12.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.558 0.694 . . . . 0.0 110.142 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.589 HG13 HD11 ' A' ' 225' ' ' ILE . 58.6 t -80.71 132.84 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.665 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.484 ' HB2' HD23 ' A' ' 275' ' ' LEU . 1.9 t60 -65.21 128.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' A' ' 218' ' ' GLN . 7.8 mt-30 -56.34 -31.98 64.26 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.549 -171.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.66 -26.45 50.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.951 0.405 . . . . 0.0 110.968 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.801 HD11 HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -95.1 117.53 30.36 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -173.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 64.6 m -96.38 -176.53 3.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.6 OUTLIER -61.07 -38.88 87.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -58.24 -37.1 74.23 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.478 0.656 . . . . 0.0 109.83 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.4 m-20 -67.0 -58.57 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.495 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.589 HD11 HG13 ' A' ' 216' ' ' VAL . 43.7 mm -53.48 -28.52 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.574 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -53.15 -32.28 46.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.917 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.63 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 63.9 m -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.332 0.587 . . . . 0.0 112.404 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.665 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.9 m -64.58 -44.69 96.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.779 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.612 ' CE2' ' HG3' ' A' ' 270' ' ' MET . 86.0 m-85 -67.65 -36.48 80.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.507 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.4 tt0 -76.32 -28.42 56.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.957 0.408 . . . . 0.0 111.174 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.91 -24.98 67.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.75 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 0.9 OUTLIER -88.57 -51.22 5.81 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -148.84 160.62 28.46 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.722 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -68.92 131.45 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 229' ' ' PHE . 63.9 mt -96.36 134.39 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.52 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -90.36 -41.68 11.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.1 m -139.15 131.6 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 7.9 p -131.52 91.33 2.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.716 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.9 m -132.15 116.98 17.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.504 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 7.4 mp -90.38 129.89 36.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.06 97.43 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.668 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -80.69 149.71 29.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.699 175.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.511 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 0.0 OUTLIER -78.74 140.16 58.73 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 110.219 -176.378 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 12.2 Cg_exo -70.73 -20.93 29.65 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.709 2.939 . . . . 0.0 114.767 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 t -101.04 -40.29 7.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.484 -169.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.403 ' OG1' ' HE2' ' A' ' 248' ' ' LYS . 0.7 OUTLIER -106.57 -13.06 15.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.806 -0.559 . . . . 0.0 112.175 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.71 10.87 83.68 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.34 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 248' ' ' LYS . 42.6 mtmt -88.14 137.44 32.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.812 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 2.1 p80 -73.8 126.58 30.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.694 ' HD2' ' HE1' ' A' ' 252' ' ' TYR . 23.7 mttp -69.28 157.8 36.27 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.11 35.08 0.64 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 114.146 0.418 . . . . 0.0 114.146 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.694 ' HE1' ' HD2' ' A' ' 250' ' ' LYS . 38.0 p90 -151.64 154.05 35.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -159.28 179.5 34.84 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.86 121.1 36.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.422 ' O ' HG12 ' A' ' 211' ' ' ILE . 41.9 mm -105.89 124.68 61.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -104.16 118.12 35.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.86 139.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.97 -28.79 39.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.323 0.583 . . . . 0.0 109.656 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 262' ' ' SER . 41.2 tptt -101.34 117.3 34.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.642 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' A' ' 209' ' ' ASN . . . -61.76 -37.24 83.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.276 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -68.85 -40.66 79.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.991 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 259' ' ' LYS . 31.6 t -63.37 -30.23 71.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 267' ' ' VAL . 44.2 t -59.87 -42.7 94.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.175 173.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.76 -39.94 88.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.438 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -54.93 -50.66 68.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.134 0.492 . . . . 0.0 110.511 175.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.17 -53.07 59.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.754 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 263' ' ' SER . 96.9 t -58.09 -33.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.666 -176.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.2 m -70.99 -20.22 62.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.2 m -115.08 -29.76 6.56 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.612 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 58.3 mmm -73.51 -2.07 21.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -167.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.451 ' HB3' HD22 ' A' ' 272' ' ' LEU . 51.6 t-20 -69.56 -39.72 77.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.203 1.001 . . . . 0.0 108.993 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -76.72 -8.99 58.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.985 -173.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.879 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 57.0 t80 -52.79 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.27 115.99 19.26 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.688 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.798 HD21 HD22 ' A' ' 220' ' ' LEU . 13.9 tp -122.82 86.1 2.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.53 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.41 33.76 55.73 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.04 1.87 62.77 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.033 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 20.3 pt20 -122.89 131.91 53.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.885 0.342 . . . . 0.0 110.701 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -81.32 133.82 35.49 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.863 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.879 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 12.1 tp -67.39 -178.67 0.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.083 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.75 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -147.8 112.29 5.3 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.62 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 270' ' ' MET . 7.9 p -115.34 137.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.184 0.516 . . . . 0.0 111.924 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -143.6 -144.59 4.27 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.919 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 34.3 ttmt -136.41 148.5 47.83 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.487 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -69.67 121.32 16.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.47 -18.22 7.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.136 0.493 . . . . 0.0 110.297 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 2.4 m -108.42 125.2 32.39 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.646 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 122.674 2.249 . . . . 0.0 111.459 174.169 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.788 0.328 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.29 -18.21 37.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.964 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.541 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -66.22 -37.21 85.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.871 0.367 . . . . 0.0 110.377 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.75 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 17.3 t80 -78.02 -19.38 54.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.679 0.752 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.631 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 73.9 mmtt -73.27 -48.25 36.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.69 175.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 26.3 t70 -58.38 -36.62 73.78 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.73 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.52 -54.47 26.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.792 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.704 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 2.9 mm? -81.06 -20.36 41.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 44.2 mt-30 -63.74 -42.76 97.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.63 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 66.0 mtt180 -68.52 -37.47 80.05 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.939 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.762 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -62.37 -42.18 99.21 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -172.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 39' ' ' ARG . 27.5 mtp85 -82.11 -26.25 33.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.385 -1.447 . . . . 0.0 112.589 173.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.93 -41.21 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.183 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.801 HG13 HD11 ' A' ' 220' ' ' LEU . 4.2 pt -68.44 -36.51 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.404 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.04 -15.69 63.88 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.086 0.469 . . . . 0.0 111.092 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.52 -42.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.161 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -82.25 -36.26 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.253 -177.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.405 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 69.3 mt . . . . . 0 N--CA 1.468 0.452 0 C-N-CA 123.555 0.742 . . . . 0.0 112.657 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.751 0.31 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.27 86.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.013 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.81 -33.92 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.243 -177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.98 82.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.526 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.57 -36.87 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.106 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 76.6 mtp -60.3 -26.48 66.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.873 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 75.8 m -73.35 -19.71 60.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.671 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 12.3 ptp180 -118.35 123.35 45.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 0.0 111.321 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -98.13 130.43 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.42 0.629 . . . . 0.0 111.096 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -75.52 119.25 19.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.023 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 42.7 t -108.21 112.24 39.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.57 178.08 28.58 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.841 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t 72.35 -79.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.437 0.695 . . . . 0.0 110.901 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mm 68.45 115.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.219 0.608 . . . . 0.0 111.613 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.657 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 61.9 t80 -72.27 142.65 48.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.471 ' HE1' ' HG2' ' A' ' 151' ' ' LYS . 92.4 t80 -52.85 -58.41 7.01 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -172.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -93.12 34.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.728 . . . . 0.0 110.233 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 27.8 tp -108.15 95.96 6.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.29 173.36 54.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.919 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.22 -35.58 80.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 129' ' ' ARG . 25.4 t70 -77.45 -29.43 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.772 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 m -67.33 -47.89 69.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.887 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.3 mt -58.21 -42.55 83.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.76 172.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 126' ' ' ASP . 53.3 ttt180 -51.13 -49.82 60.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.202 176.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 75.5 mt-30 -75.39 -26.83 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.536 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.43 77.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.113 0.482 . . . . 0.0 110.607 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.495 ' CE2' ' HG3' ' A' ' 173' ' ' MET . 52.3 m-85 -100.95 11.14 40.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.462 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 130' ' ' GLN . . . -71.75 -38.34 6.1 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.945 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.865 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 45.4 Cg_exo -60.15 -15.2 32.79 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.647 1.565 . . . . 0.0 112.78 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -80.45 -72.52 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.942 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.26 -171.9 25.69 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.348 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.87 104.16 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.006 2.47 . . . . 0.0 111.83 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.54 117.87 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.796 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -90.71 -34.89 15.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.789 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t -153.25 142.08 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.917 0.389 . . . . 0.0 110.976 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.8 107.52 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 24.7 t70 -104.6 140.92 37.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.08 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.6 ttm -160.47 143.53 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.582 0.23 . . . . 0.0 110.552 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.2 p -73.95 100.85 3.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.912 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.482 ' CH2' ' HG3' ' A' ' 150' ' ' MET . 2.4 m95 -88.12 158.84 18.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -129.84 89.86 2.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 p 46.68 -145.15 0.24 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.496 170.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -81.64 -21.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.911 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 151' ' ' LYS . 9.2 t -66.03 -26.74 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.303 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.482 ' HG3' ' CH2' ' A' ' 145' ' ' TRP . 52.6 ttm 67.21 13.45 9.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.349 0.595 . . . . 0.0 111.561 175.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.535 ' H ' HG23 ' A' ' 149' ' ' THR . 35.7 mtmm -69.28 121.44 16.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.702 -0.623 . . . . 0.0 109.536 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.406 ' HE1' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -141.19 132.2 26.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.114 0.483 . . . . 0.0 111.045 -174.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.445 ' HB3' ' HE2' ' A' ' 153' ' ' LYS . 34.9 ttpt -166.59 122.79 1.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.239 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.85 -94.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.122 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.92 144.07 47.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 0.0 111.918 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -141.26 161.29 38.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.293 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 92.3 m-85 -132.7 113.22 12.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.13 112.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 43.5 tt0 -105.42 125.49 51.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.167 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 96.4 m-85 -103.8 162.22 13.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.517 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.36 -19.46 50.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.964 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.59 134.86 25.25 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.592 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.9 -12.69 33.13 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 7.1 mp0 -63.87 -50.52 68.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.935 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.68 72.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.54 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.37 91.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.442 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -59.92 -49.45 77.65 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.426 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.724 HD21 ' HA3' ' A' ' 283' ' ' GLY . 37.4 mt -63.44 -41.44 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.58 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -62.17 -46.33 89.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.861 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 tt -67.41 -51.58 50.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.152 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -74.56 -47.74 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -79.81 -49.31 12.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.517 ' HB2' ' O ' ' A' ' 169' ' ' ALA . 16.0 mmt -68.32 -35.18 77.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -173.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -76.72 -17.68 58.95 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.856 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.2 m -91.05 -8.45 48.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.783 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.69 131.0 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.393 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.808 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 73.8 mtp -81.62 89.83 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.2 tp -38.23 -59.5 0.87 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.834 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.6 91.71 0.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.994 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.48 -57.56 4.45 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.026 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.406 ' HD3' ' HD2' ' A' ' 120' ' ' TYR . 10.9 ptm180 -104.6 149.9 25.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.808 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 6.3 p30 -97.58 118.11 33.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.415 0.626 . . . . 0.0 110.957 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 183' ' ' ILE . 1.7 pp -77.24 151.53 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.3 OUTLIER -102.34 118.24 36.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.9 115.34 45.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.03 0.443 . . . . 0.0 110.977 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 104.98 -169.05 16.25 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.985 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.471 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 33.4 mtt180 57.45 59.13 7.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.708 0.403 . . . . 0.0 111.883 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 3.9 Cg_exo -77.62 -39.62 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.433 2.089 . . . . 0.0 112.533 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 p -171.22 151.77 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.878 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 193' ' ' GLN . 94.6 m-20 59.29 56.92 3.61 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.483 0.489 . . . . 0.0 110.794 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.47 -21.36 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.54 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.24 -29.0 8.19 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.911 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 190' ' ' ASN . 12.4 tt0 -75.67 -33.42 60.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.877 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -74.12 -27.81 61.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.87 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.41 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 28.1 tp60 -54.69 -55.62 36.12 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.606 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 13.4 Cg_endo -57.1 -37.17 98.92 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 121.869 1.713 . . . . 0.0 111.938 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.6 mm -63.81 -41.46 92.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.391 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 194' ' ' ALA . 51.0 mm -56.13 -50.64 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.826 176.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.45 -44.42 94.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.876 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 25.4 mm-40 -61.87 -41.42 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.59 -44.0 36.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.0 95.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.329 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.609 ' OE2' ' HD3' ' A' ' 206' ' ' ARG . 13.9 tp10 -67.91 -30.27 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.072 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.17 -47.86 47.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.259 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.04 -26.47 67.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.286 0.565 . . . . 0.0 110.552 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.609 ' HD3' ' OE2' ' A' ' 203' ' ' GLU . 75.7 ttt180 -62.68 -23.11 66.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.968 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.65 -23.65 66.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.12 0.486 . . . . 0.0 110.827 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -14.66 36.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.541 0.686 . . . . 0.0 109.994 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.8 t30 57.18 45.4 20.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.679 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -108.58 136.49 48.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.906 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.1 pt -113.21 166.88 6.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.18 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.427 ' HD2' HD11 ' A' ' 168' ' ' LEU . 18.7 t80 -111.35 122.04 46.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.539 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 229' ' ' PHE . 3.9 p -112.97 121.11 64.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 0.0 110.793 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.4 175.94 6.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.576 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.865 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 8.1 t 68.97 24.61 6.23 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.458 0.703 . . . . 0.0 110.856 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.566 HG21 HD11 ' A' ' 240' ' ' LEU . 61.2 t -75.05 135.46 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.139 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -76.73 141.41 40.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.066 0.46 . . . . 0.0 110.501 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -65.15 -13.42 58.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.39 -47.26 23.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -173.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.898 HD21 HD11 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -101.71 159.33 15.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.181 -174.719 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 16.0 m -113.06 -177.89 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.0 OUTLIER -53.71 -47.55 70.44 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.334 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -55.14 -30.03 58.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 0.0 110.931 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.935 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 52.4 m-20 -78.79 -53.75 6.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.363 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.483 HD11 HD13 ' A' ' 220' ' ' LEU . 46.0 mm -61.48 -16.95 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.242 0.544 . . . . 0.0 110.89 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -54.34 -31.37 54.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.093 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 69.3 m -52.6 -62.13 1.84 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.934 0.873 . . . . 0.0 111.253 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.609 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.9 m -66.28 -34.05 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.605 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 213' ' ' VAL . 48.3 m-85 -74.68 -35.52 62.78 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.625 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.756 ' HG3' HG22 ' A' ' 235' ' ' ILE . 50.3 tt0 -77.23 -32.29 55.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 111.33 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.05 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.695 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.656 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 4.0 m-30 -85.52 -30.88 23.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 110.209 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -174.02 167.95 40.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.378 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -58.04 106.05 0.33 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 112.254 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.756 HG22 ' HG3' ' A' ' 230' ' ' GLU . 15.9 tt -87.97 142.07 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.047 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.06 -44.35 5.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 24.8 t -147.58 137.39 22.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.333 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.83 119.42 33.51 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.4 m -138.1 103.17 4.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 13.5 tp -88.36 129.74 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.31 114.21 2.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.193 0.52 . . . . 0.0 110.843 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 24.9 mtt180 -91.38 156.4 17.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 -176.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -128.57 113.31 19.34 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.858 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.43 -19.44 37.72 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.87 2.38 . . . . 0.0 112.613 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -55.52 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 110.429 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.6 p -82.34 -35.47 27.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.21 -0.29 44.03 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.33 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -112.03 -103.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 111.301 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 32.1 p80 -163.26 164.22 25.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.439 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -90.25 157.58 17.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.76 40.86 1.64 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.133 -0.556 . . . . 0.0 113.291 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -157.86 164.62 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.74 -169.59 36.2 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.252 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -125.48 137.99 53.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.36 . . . . 0.0 110.343 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.28 123.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.922 177.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 42.6 tt0 -106.69 131.98 53.2 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.08 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.427 ' CD1' ' HA ' ' A' ' 235' ' ' ILE . 68.5 m-85 -112.47 153.0 28.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.19 0.519 . . . . 0.0 111.498 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.98 -22.4 23.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.772 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 261' ' ' GLN . 35.5 ttpt -115.4 117.64 30.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.6 -25.04 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.926 0.393 . . . . 0.0 111.779 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.664 ' HB2' ' HE3' ' A' ' 259' ' ' LYS . 24.2 mp0 -66.65 -33.72 76.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.655 ' OG ' ' HE2' ' A' ' 259' ' ' LYS . 14.8 m -62.93 -38.04 89.43 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 267' ' ' VAL . 14.5 m -59.76 -38.59 82.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.55 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.01 -45.56 81.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.68 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.51 -44.33 93.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.582 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -61.42 -53.73 52.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.069 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 263' ' ' SER . 84.2 t -57.6 -27.27 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 0.0 111.336 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.3 m -72.41 -48.14 43.72 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.7 t -116.48 -13.0 10.95 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -168.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.48 ' HA ' ' CE ' ' A' ' 270' ' ' MET . 2.2 tpt -61.78 -32.45 72.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -170.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 20.9 p-10 -66.69 -22.63 66.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.81 -10.93 59.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.901 ' CZ ' ' HB1' ' B' ' 38' ' ' ALA . 2.0 t80 -69.28 104.8 2.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.771 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.46 88.55 3.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.54 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.898 HD11 HD21 ' A' ' 220' ' ' LEU . 62.7 tp -93.33 87.14 5.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.449 -174.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.94 37.36 11.6 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.759 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.19 65.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.941 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -141.17 130.92 24.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 99.6 m-85 -67.78 132.69 47.89 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 55.7 mt -61.93 -177.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.595 0.712 . . . . 0.0 110.751 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.31 121.84 9.14 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 7.4 p -121.8 134.59 64.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.224 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.724 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -141.64 -148.36 5.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.454 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -127.93 178.86 5.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.801 0.334 . . . . 0.0 110.56 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -104.54 117.72 34.82 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 66.3 t -94.38 -33.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.304 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 11.1 t -107.29 133.66 20.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 C--O 1.235 0.352 0 C-N-CA 122.628 2.219 . . . . 0.0 111.919 178.35 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.671 0.272 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.852 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 5.6 m-20 76.52 -43.12 0.45 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.612 0.765 . . . . 0.0 112.821 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.42 68.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.172 0.51 . . . . 0.0 110.043 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 8.5 t80 -79.06 -17.92 54.37 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 109.473 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.852 ' HD3' ' HA ' ' B' ' 29' ' ' ASP . 52.8 mtpt -75.21 -43.62 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.548 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.61 -44.63 85.6 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.656 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -47.59 -52.31 18.2 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.048 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.811 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -82.06 -22.4 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -65.48 -39.01 91.43 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.634 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 22.7 mmt180 -69.28 -41.85 76.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.339 171.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.901 ' HB1' ' CZ ' ' A' ' 273' ' ' PHE . . . -58.5 -45.16 89.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.843 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -79.9 -25.88 40.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.4 -1.437 . . . . 0.0 112.666 174.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.94 -49.06 66.8 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 169.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.935 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 3.2 pt -64.47 -32.42 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.338 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.774 ' HA ' HD23 ' A' ' 220' ' ' LEU . . . -73.12 -25.68 60.94 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.11 -43.06 14.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 2.8 tmmm? -65.98 -41.44 91.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 N--CA 1.467 0.393 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.05 174.999 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.587 0.232 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -52.7 35.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.654 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 3.1 mm? -60.61 -37.26 80.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.094 -176.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.54 79.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.45 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 194' ' ' ALA . 35.4 pt -85.27 -40.88 15.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.518 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 25.5 ptm -71.76 -28.24 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -171.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 81.0 m -92.63 6.51 47.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.639 0.257 . . . . 0.0 110.959 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -119.63 101.06 7.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.216 0.532 . . . . 0.0 111.383 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -109.68 125.53 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -91.09 149.1 21.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.524 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 47.1 t -111.52 111.27 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.062 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.5 -178.27 17.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.04 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.879 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 39.3 m 62.13 29.12 17.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.37 0.605 . . . . 0.0 111.027 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 119' ' ' ILE . 8.5 mt -70.02 147.16 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.053 -178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.3 -73.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 151' ' ' LYS . 48.2 t80 -176.42 -67.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -76.93 -26.92 54.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.336 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.847 HD22 HG21 ' A' ' 127' ' ' THR . 90.2 mt -54.61 125.67 20.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.846 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -107.68 -172.02 22.0 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.006 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.505 ' HB2' HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -68.94 -26.6 65.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.896 0.379 . . . . 0.0 110.097 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.7 -40.79 98.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.697 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.847 HG21 HD22 ' A' ' 123' ' ' LEU . 12.2 m -63.58 -46.11 87.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 110.445 177.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -63.14 -39.45 85.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -54.7 -42.49 71.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.028 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -77.69 -34.0 53.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.684 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.49 89.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.563 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 96.5 m-85 -97.17 12.28 33.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.555 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -68.1 -44.99 40.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.782 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.97 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.9 Cg_endo -68.46 -5.0 14.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.857 1.705 . . . . 0.0 112.991 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.469 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 4.6 m-85 -84.97 -75.35 0.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.843 0.354 . . . . 0.0 110.122 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -147.47 167.19 28.6 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 162' ' ' VAL . 22.8 Cg_exo -64.82 121.62 9.2 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.286 1.991 . . . . 0.0 111.729 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.456 HG21 HG13 ' A' ' 141' ' ' ILE . 2.0 mp -68.16 119.29 13.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.171 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -86.64 -46.1 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.544 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 m -148.38 141.33 24.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.357 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.505 HG21 ' HB2' ' A' ' 125' ' ' GLU . 54.5 mt -124.26 107.03 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.64 108.33 19.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.751 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 125' ' ' GLU . 27.2 ttt -132.0 119.8 21.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.911 0.386 . . . . 0.0 111.034 -176.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.0 t -90.34 83.09 5.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.553 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 2.9 p-90 -143.26 152.92 42.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.867 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.44 117.4 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.195 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.7 m -75.72 -9.01 58.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.938 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 50.7 t -81.85 -57.44 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.378 . . . . 0.0 110.751 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.419 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 27.9 p -80.06 -29.84 39.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.553 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 81.4 mtp 71.86 -10.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.799 0.84 . . . . 0.0 112.257 176.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.447 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 11.7 ptmm? -84.29 114.46 21.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.176 0.512 . . . . 0.0 109.667 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -142.36 145.25 33.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.016 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -119.59 13.06 12.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.624 0.726 . . . . 0.0 109.788 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.57 153.6 22.18 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.479 172.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -106.68 174.26 5.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.868 0.366 . . . . 0.0 110.934 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.19 148.93 36.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.306 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.15 115.25 29.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.068 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.86 108.37 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.043 0.449 . . . . 0.0 110.075 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -102.02 119.67 39.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.439 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.563 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 41.9 m-85 -93.58 149.63 21.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.295 0.569 . . . . 0.0 112.425 -174.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.439 ' OE1' ' HG2' ' A' ' 137' ' ' PRO . 33.8 tt0 -74.29 -27.65 60.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.463 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.507 HG22 ' HD2' ' A' ' 137' ' ' PRO . 26.5 m -121.45 120.9 28.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.942 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.497 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 33.5 Cg_exo -61.22 -25.85 81.3 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.389 2.726 . . . . 0.0 113.403 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.497 ' OE2' ' HD2' ' A' ' 163' ' ' PRO . 1.7 mp0 -58.56 -50.51 73.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.945 0.403 . . . . 0.0 110.122 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.43 -23.09 64.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.77 77.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.488 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -70.6 -39.54 73.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.573 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -58.93 -41.46 87.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.666 0.269 . . . . 0.0 110.917 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.49 -43.11 99.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.9 0.381 . . . . 0.0 110.427 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.712 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.2 tt -64.57 -42.26 95.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.646 -178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -47.29 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -79.97 -50.13 10.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 56.1 tpp -74.16 -28.15 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.831 0.348 . . . . 0.0 111.378 -172.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 10.7 t30 -81.36 -16.82 51.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.201 0.524 . . . . 0.0 110.521 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 t -84.15 -29.21 26.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.32 175.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 91.4 mtp -111.85 111.63 22.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.022 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 48.9 tp -68.55 104.64 2.0 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.86 -78.56 1.36 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.09 35.04 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.407 ' HB2' HG23 ' A' ' 183' ' ' ILE . 18.7 mmm180 -123.34 145.69 48.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.498 0.189 . . . . 0.0 110.81 -176.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -87.65 71.28 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.879 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.6 pt -69.16 156.31 7.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.399 -171.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 6.5 mmmm -101.94 109.99 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.093 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 63.2 t -122.31 121.51 64.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.956 0.408 . . . . 0.0 110.065 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.712 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 73.76 -126.94 10.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.129 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 52.84 77.24 0.46 Allowed Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 110.205 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.93 119.68 7.0 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.509 2.806 . . . . 0.0 113.748 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 m -71.67 -17.64 62.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.036 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.38 6.38 8.52 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.492 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.6 mm 71.34 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.913 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 173.07 50.68 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.43 -47.84 78.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.009 0.433 . . . . 0.0 111.414 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.555 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -111.61 18.04 19.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.787 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.4 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 21.5 tm0? -64.12 -47.38 79.46 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.583 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 74.1 Cg_exo -49.9 -42.35 44.99 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.794 2.329 . . . . 0.0 114.599 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 198' ' ' ILE . 2.6 pp -75.44 -24.25 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.776 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 194' ' ' ALA . 34.5 mt -65.24 -38.5 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.63 0.252 . . . . 0.0 110.542 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.05 -44.63 87.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.332 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.72 -44.63 81.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.573 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.761 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 91.2 mt -61.67 -45.57 93.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.841 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.2 -37.52 87.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.557 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.34 -34.13 77.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -73.93 -41.18 62.44 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.985 0.421 . . . . 0.0 110.198 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.62 72.42 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.779 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -57.4 -38.31 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.956 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.21 -13.01 61.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.564 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' A' ' 288' ' ' PRO . 17.3 m-85 -93.03 -6.94 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.741 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.29 27.34 16.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.748 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -102.26 137.0 41.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.895 0.379 . . . . 0.0 111.159 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.6 pt -121.21 161.5 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.639 175.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -116.02 135.73 53.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.771 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.45 124.56 60.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.885 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.03 -179.22 4.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.97 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 51.0 m 69.64 19.16 7.44 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.709 0.804 . . . . 0.0 111.473 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 225' ' ' ILE . 85.1 t -65.61 140.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.392 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -63.45 132.64 52.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.937 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.614 ' HG3' ' H ' ' A' ' 219' ' ' ASP . 6.2 pt20 -41.42 -55.96 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.614 ' H ' ' HG3' ' A' ' 218' ' ' GLN . 0.5 OUTLIER -79.64 -47.27 15.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.776 HD11 HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -55.89 111.96 1.06 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.042 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 225' ' ' ILE . 56.9 p -97.24 -178.01 4.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -162.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 18.8 p-10 -59.76 -44.04 94.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.434 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.44 -29.29 66.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.546 0.689 . . . . 0.0 109.833 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.674 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 64.5 m-20 -78.73 -54.09 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.513 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.65 HD11 HG13 ' A' ' 216' ' ' VAL . 27.9 mm -53.54 -27.59 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.359 0.599 . . . . 0.0 110.947 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.23 -31.6 44.05 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.84 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -48.94 -58.47 4.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.529 0.68 . . . . 0.0 111.932 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.738 HG12 ' HB1' ' B' ' 34' ' ' ALA . 6.0 m -74.35 -42.26 50.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.607 -171.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 270' ' ' MET . 35.6 m-85 -59.76 -52.99 63.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 0.0 110.927 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.1 tt0 -66.79 -24.03 66.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 -176.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.07 -33.26 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.827 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.753 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.6 m-30 -82.95 -42.25 17.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -151.77 148.37 19.3 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 42.0 mmtm -62.02 122.75 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.684 0.754 . . . . 0.0 110.965 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 238' ' ' CYS . 20.1 tt -87.95 141.16 14.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.109 -169.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 256' ' ' GLU . 82.2 tttt -91.96 -42.2 10.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 256' ' ' GLU . 12.8 p -161.59 146.7 13.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.599 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.44 ' HB3' HD11 ' A' ' 235' ' ' ILE . 6.3 p -137.94 129.98 28.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.841 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 48.6 m -150.61 119.73 6.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.047 0.451 . . . . 0.0 110.988 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.3 mp -99.38 130.52 45.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.795 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.33 137.22 58.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.077 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 52.3 mtt85 -94.25 157.76 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.188 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.551 ' OD1' HG22 ' A' ' 245' ' ' THR . 8.1 t70 -100.32 108.48 52.92 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 14.8 Cg_exo -70.04 -17.55 36.25 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.364 2.709 . . . . 0.0 114.172 -175.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 243' ' ' ASP . 3.5 t -94.6 -6.51 43.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.42 . . . . 0.0 111.125 -172.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 245' ' ' THR . 24.6 p -133.82 -41.78 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 119.96 -24.64 7.81 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.705 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.46 ' HE3' ' OG1' ' A' ' 246' ' ' THR . 0.0 OUTLIER -82.1 -179.86 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.827 0.314 . . . . 0.0 110.776 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.7 p80 -94.0 151.29 19.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.453 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -78.96 154.88 29.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.64 44.62 2.29 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.783 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.432 ' CE2' ' HD3' ' A' ' 137' ' ' PRO . 41.3 p90 -161.8 160.25 28.03 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.149 0.475 . . . . 0.0 110.382 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -170.81 -173.0 37.64 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.354 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.418 ' C ' HD12 ' A' ' 255' ' ' ILE . 87.8 m-85 -123.62 142.6 50.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.681 0.277 . . . . 0.0 110.652 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 254' ' ' PHE . 3.1 mp -124.45 131.32 72.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.618 174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.461 ' HB3' ' OG ' ' A' ' 237' ' ' SER . 30.6 tt0 -112.28 141.07 46.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -119.57 147.74 44.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.176 0.512 . . . . 0.0 111.49 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -79.97 -21.52 43.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.924 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 261' ' ' GLN . 34.9 ttpt -122.08 113.41 19.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.054 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.5 47.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.189 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.444 ' HB3' ' HE3' ' A' ' 259' ' ' LYS . 20.7 tt0 -56.99 -48.19 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.276 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.0 m -62.72 -31.5 72.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.3 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.4 m -59.67 -39.89 85.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.625 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -74.26 -42.97 58.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.858 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -63.78 -31.58 72.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.549 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -72.43 -54.16 10.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.458 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.58 -26.29 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -85.25 -18.34 34.29 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -115.05 -32.97 5.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.633 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.3 mmm -62.58 -21.33 65.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -172.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -58.07 -36.07 72.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.835 0.826 . . . . 0.0 110.377 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.76 -8.73 57.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.21 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.84 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -56.63 102.09 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -175.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.8 t70 -92.26 124.16 36.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.945 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.693 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.2 mm? -122.78 87.08 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.712 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.64 22.98 44.53 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.939 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.53 7.25 42.9 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.801 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.0 pt20 -125.85 130.66 51.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.789 0.328 . . . . 0.0 110.573 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -87.43 144.54 26.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.698 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 273' ' ' PHE . 11.0 mt -75.92 -173.72 2.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.549 . . . . 0.0 110.409 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.41 113.47 5.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 270' ' ' MET . 7.0 m -114.84 154.04 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.059 0.457 . . . . 0.0 111.866 -177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.31 -150.9 6.67 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.763 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 284' ' ' LYS . 28.3 mmtp -96.31 157.9 15.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.28 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.6 t 69.17 -71.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.625 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.487 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 12.3 p -89.59 133.86 33.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.412 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.761 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 16.1 Cg_exo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 122.95 2.434 . . . . 0.0 112.613 -175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ASP . . . . . 0.433 ' HA ' ' CD ' ' B' ' 32' ' ' LYS . 35.2 m-20 72.25 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.786 0.679 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.74 78.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.966 0.412 . . . . 0.0 111.0 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.646 ' O ' HD22 ' B' ' 35' ' ' LEU . 10.6 t80 -73.99 -19.81 60.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.174 0.512 . . . . 0.0 109.861 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.9 mttt -73.81 -41.49 62.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.95 -38.91 76.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.436 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.753 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.13 -54.13 22.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.339 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.887 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -79.76 -17.46 53.4 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -172.054 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 43.0 mt-30 -60.08 -47.11 87.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 70.6 mtp180 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.245 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -68.01 -46.16 72.04 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.559 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 5.4 mtm180 -79.78 -24.66 41.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.512 -1.368 . . . . 0.0 112.166 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 51.9 tt0 -52.74 -50.03 64.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 109.816 167.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.902 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.4 pt -68.4 -25.39 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.008 0.432 . . . . 0.0 110.58 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' B' ' 39' ' ' ARG . . . -81.2 -11.92 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.65 -30.7 20.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.827 0.346 . . . . 0.0 110.298 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.902 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 15.7 ptpt -76.39 -4.33 41.74 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.598 178.563 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 106' ' ' ARG . 18.0 ttp180 . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.548 0.214 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.72 -36.51 64.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.32 -42.68 44.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.527 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . . . -62.06 -35.38 78.46 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.188 -176.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.98 -35.85 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.121 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.4 mmm -68.61 -36.53 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.407 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.573 ' HA ' ' HB2' ' A' ' 166' ' ' ALA . 23.4 p -81.13 6.25 14.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 78.0 ttt180 -111.39 96.24 5.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.4 HG23 HG13 ' A' ' 158' ' ' VAL . 11.6 m -92.76 144.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.554 0.692 . . . . 0.0 111.878 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 187' ' ' ARG . 44.1 t80 -96.9 127.3 42.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.53 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 111.19 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.651 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.57 -179.72 16.18 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.697 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.1 m 56.45 34.53 24.42 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.351 0.596 . . . . 0.0 110.898 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.0 mt -73.86 163.82 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.967 -176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 85.9 t80 -57.29 -72.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 31.1 t80 173.35 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.438 0.461 . . . . 0.0 109.762 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.72 -20.5 58.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.43 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.78 HD22 HG21 ' A' ' 127' ' ' THR . 47.5 mt -58.57 110.16 0.93 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.062 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -109.24 -153.69 15.39 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.144 -172.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.8 -51.18 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.633 0.255 . . . . 0.0 111.136 -175.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.35 -26.81 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 -175.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.78 HG21 HD22 ' A' ' 123' ' ' LEU . 3.6 m -67.59 -53.81 25.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.021 0.439 . . . . 0.0 110.053 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.32 -39.38 85.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.274 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -59.52 -38.31 80.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.009 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.29 -44.28 25.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.308 . . . . 0.0 111.66 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.69 81.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 173' ' ' MET . 84.7 m-85 -106.48 18.98 21.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.839 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.62 ' HA ' HD11 ' A' ' 138' ' ' ILE . . . -65.47 -43.91 64.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.031 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 133' ' ' ALA . 22.6 Cg_exo -68.35 -5.16 14.33 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.03 1.82 . . . . 0.0 112.665 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 9.0 m-85 -94.64 60.27 2.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.563 ' HA3' HG21 ' A' ' 162' ' ' VAL . . . 78.12 175.32 44.54 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.75 118.57 3.83 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.861 2.374 . . . . 0.0 111.91 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 133' ' ' ALA . 3.8 mp -60.47 118.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -89.57 -49.56 6.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 109.951 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 p -161.45 147.8 14.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.934 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.98 107.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.14 118.42 34.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.7 ptm -143.33 148.29 36.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.53 108.93 11.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.537 0.684 . . . . 0.0 111.633 -177.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 152' ' ' HIS . 78.0 m95 -104.14 155.68 18.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.452 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -101.76 86.72 2.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.663 0.744 . . . . 0.0 110.197 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.0 p 33.58 -108.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.355 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.45 -28.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -170.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -33.51 67.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.3 mmt 58.93 44.95 15.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.356 0.598 . . . . 0.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 121' ' ' TYR . 10.6 tptm -93.45 -29.1 15.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 145' ' ' TRP . 57.0 t60 60.91 75.84 0.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.492 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -102.84 81.21 1.97 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.79 -155.52 11.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.572 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -125.65 175.03 7.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.35 28.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.76 0.314 . . . . 0.0 111.574 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.21 119.91 39.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 114' ' ' VAL . 2.5 p -114.81 119.42 61.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 0.0 110.463 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.1 tt0 -104.02 130.4 51.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.164 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.603 ' HE1' HG13 ' A' ' 138' ' ' ILE . 51.6 m-85 -110.71 171.54 7.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.644 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.69 14.95 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.563 HG21 ' HA3' ' A' ' 136' ' ' GLY . 8.7 m -134.42 105.88 11.04 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.609 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 38.6 Cg_exo -58.97 -26.9 83.22 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.173 2.582 . . . . 0.0 113.299 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 164' ' ' GLU . 2.1 mp0 -61.8 -57.94 9.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.575 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.27 -26.4 66.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.756 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 112' ' ' CYS . . . -63.02 -51.57 66.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.785 0.326 . . . . 0.0 110.796 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -74.55 -31.82 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 59.2 tp -56.07 -50.08 71.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.65 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.94 97.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.908 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.911 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.4 tt -60.68 -42.68 97.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.633 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.6 -46.1 17.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 75.8 mm-40 -83.95 -50.93 7.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.41 ' HG3' ' CE2' ' A' ' 132' ' ' PHE . 16.0 mmt -74.46 -30.76 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -172.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.37 -24.35 67.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.292 0.567 . . . . 0.0 110.534 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.1 m -92.24 -2.28 56.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.719 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 172' ' ' GLN . 91.6 t -118.28 139.86 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 182' ' ' ASN . 58.7 mtt -99.6 117.28 33.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.83 121.49 27.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 69.98 -88.07 0.3 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -173.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.78 11.75 0.96 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -100.5 132.67 45.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.615 -175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 177' ' ' MET . 6.0 t30 -86.78 89.49 7.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 pt -72.54 142.08 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.83 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -102.73 110.04 21.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.61 110.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.911 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 105.07 110.68 3.53 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.876 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 49.5 ttt180 -109.33 113.82 58.18 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 187' ' ' ARG . 38.1 Cg_endo -66.46 77.06 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.101 2.534 . . . . 0.0 111.549 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.1 m -84.56 -22.7 29.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.525 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -123.31 114.23 19.93 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.8 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.9 mt -129.2 98.41 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 138.48 -47.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -81.27 -57.39 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.034 0.445 . . . . 0.0 110.969 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -92.19 -14.92 28.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.377 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.657 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 24.2 tp60 -56.22 -51.67 78.98 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.057 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 27.6 Cg_exo -63.53 -34.39 64.66 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.028 1.819 . . . . 0.0 111.976 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.07 -42.19 95.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.4 mt -59.57 -44.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.783 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.36 -42.32 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.493 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -59.86 -51.18 70.81 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.755 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 202' ' ' ALA . 3.3 pp -75.71 -29.02 58.81 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.654 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.444 ' N ' HD12 ' A' ' 201' ' ' LEU . . . -73.36 -40.09 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 0.0 110.365 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.44 -44.11 97.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.564 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.73 -30.38 67.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 288' ' ' PRO . . . -64.41 -22.5 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -61.14 -32.99 72.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.37 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 111.031 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -87.26 -26.4 23.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.668 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.5 p30 40.53 46.61 2.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.71 0.804 . . . . 0.0 112.944 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -87.41 136.22 33.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 229' ' ' PHE . 15.8 tt -104.78 146.69 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 0.0 110.359 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -111.36 139.25 46.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.578 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.438 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 5.9 p -136.13 125.91 40.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.181 0.515 . . . . 0.0 110.721 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.42 179.96 4.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.276 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.476 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.8 t 65.05 25.4 12.59 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.789 0.681 . . . . 0.0 109.674 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 225' ' ' ILE . 46.3 t -70.37 129.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.898 -176.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.62 131.25 50.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.51 -50.56 31.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.898 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -75.53 -46.44 32.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.822 HD11 HG13 ' B' ' 41' ' ' ILE . 0.9 OUTLIER -63.53 101.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.015 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.483 ' O ' HG12 ' A' ' 225' ' ' ILE . 50.9 m -91.33 -177.18 4.78 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.043 -169.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.806 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 21.8 p-10 -61.07 -39.26 89.19 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -56.36 -30.59 62.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 110.467 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.644 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 9.4 m-20 -78.69 -53.05 7.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.048 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 216' ' ' VAL . 30.8 mm -52.04 -29.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.466 0.706 . . . . 0.0 111.238 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.573 ' HG3' HD12 ' A' ' 235' ' ' ILE . 87.7 tttt -50.32 -31.64 14.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.882 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 63.8 m -48.39 -61.89 1.77 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.543 0.687 . . . . 0.0 111.723 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.807 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 3.7 m -74.04 -35.74 42.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.481 -170.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.63 ' HE2' HD13 ' A' ' 211' ' ' ILE . 38.9 m-85 -68.33 -48.89 63.67 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.091 -0.243 . . . . 0.0 111.311 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 31.4 tt0 -78.24 -11.9 59.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 111.239 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.27 -28.35 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.654 0.264 . . . . 0.0 111.079 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.751 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.8 OUTLIER -94.82 -62.19 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.62 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -117.98 175.98 15.94 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.766 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -92.3 118.34 30.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.156 0.503 . . . . 0.0 111.304 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.573 HD12 ' HG3' ' A' ' 226' ' ' LYS . 65.3 mt -75.66 138.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.958 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -90.96 -45.4 8.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 4.2 p -156.82 131.7 8.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.33 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 9.6 p -120.5 128.09 52.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.747 0.308 . . . . 0.0 110.223 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.3 p -143.23 111.06 5.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.815 ' HG ' ' HA3' ' A' ' 253' ' ' GLY . 9.4 mp -101.59 116.88 33.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -53.05 112.82 0.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.086 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.942 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -97.21 144.77 26.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.156 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -89.56 118.49 69.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.279 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.91 -21.84 37.01 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.952 2.435 . . . . 0.0 113.522 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 37.9 p -89.08 -17.65 28.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 0.0 111.527 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 31.0 p -102.15 -37.24 8.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.973 0.416 . . . . 0.0 110.52 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.21 1.03 55.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.285 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -128.44 158.03 39.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.931 0.396 . . . . 0.0 110.282 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.942 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -72.9 148.3 44.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.736 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -79.15 155.4 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.86 44.01 1.23 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 20.4 p90 -163.19 160.58 24.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.815 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -176.35 -172.59 41.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.635 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.402 ' CE2' ' HG2' ' A' ' 164' ' ' GLU . 91.3 m-85 -126.91 139.99 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 111.323 -176.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 211' ' ' ILE . 2.7 mp -117.94 128.1 75.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -104.93 114.7 29.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.946 0.403 . . . . 0.0 110.115 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -90.97 153.3 20.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.7 pt-20 -91.8 -18.86 23.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.493 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 29.3 mmmt -122.48 125.15 45.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.72 -22.83 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.717 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -63.27 -44.24 95.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.62 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 34.8 m -65.93 -34.42 78.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 -176.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.9 m -60.46 -32.01 70.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -74.17 -43.45 57.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.858 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.46 -54.01 28.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.225 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.723 ' HA ' HG21 ' A' ' 282' ' ' VAL . 25.2 m -59.1 -26.19 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.02 0.438 . . . . 0.0 111.52 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.2 m -78.05 -19.81 53.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.741 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -114.96 -33.15 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.807 ' HE1' ' HB ' ' A' ' 228' ' ' VAL . 4.1 mmt -75.97 5.18 6.93 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -166.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.495 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.9 t30 -81.92 -38.94 24.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.932 0.873 . . . . 0.0 109.489 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.16 -8.53 57.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.277 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.787 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 4.5 t80 -52.93 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.776 0.431 . . . . 0.0 110.513 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.5 t70 -90.89 125.67 35.82 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.502 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.586 HD22 HD13 ' A' ' 220' ' ' LEU . 85.8 mt -128.63 85.53 2.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.13 44.81 7.89 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.8 63.98 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.832 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 9.4 pt20 -140.58 130.65 24.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.778 0.323 . . . . 0.0 110.608 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -89.67 133.71 34.52 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.658 HD22 ' CD2' ' A' ' 273' ' ' PHE . 8.5 mp -72.45 -165.75 0.22 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.39 0.614 . . . . 0.0 111.03 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 9.6 tpp180 -147.11 116.65 7.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.042 -172.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.723 HG21 ' HA ' ' A' ' 267' ' ' VAL . 14.4 p -105.68 146.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.94 0.4 . . . . 0.0 111.271 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.12 -156.71 7.7 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 286' ' ' VAL . 93.9 mttt -126.49 174.52 8.58 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.603 -0.351 . . . . 0.0 110.11 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -59.13 -43.14 91.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 111.429 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 94.4 t 79.8 -52.92 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.676 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 4.5 m -139.76 122.85 10.42 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-O 120.69 0.281 . . . . 0.0 110.846 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 287' ' ' THR . 1.1 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 123.661 2.907 . . . . 0.0 112.194 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.463 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 52.4 t30 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.25 -60.89 1.85 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.869 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -58.27 -33.59 69.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.635 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 5.9 t80 -72.34 -27.18 62.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 28.9 mtpp -62.58 -47.85 82.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.75 -36.15 71.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.739 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.763 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -53.72 -56.21 19.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.184 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.8 OUTLIER -79.17 -20.72 47.77 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.339 -171.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 81.2 mm-40 -56.84 -45.96 82.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 170.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.703 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 13.2 mmm180 -74.13 -32.93 63.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.429 175.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.787 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.86 -44.28 93.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -81.46 -26.64 35.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.813 -1.179 . . . . 0.0 112.599 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -56.44 -45.53 80.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.323 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.956 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 4.5 pt -65.87 -36.02 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.735 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.52 -10.59 59.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.33 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.9 -49.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.009 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.956 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -83.92 -29.57 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.898 HG23 ' HB2' ' A' ' 219' ' ' ASP . 37.6 mm . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 121.167 0.508 . . . . 0.0 111.978 173.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.954 0.407 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.69 85.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.85 -30.05 63.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.854 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.56 73.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.99 -41.41 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.731 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.708 ' HB3' ' HB3' ' A' ' 163' ' ' PRO . 84.4 mmm -61.86 -25.84 67.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -92.62 6.05 48.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -126.85 126.84 44.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 0.0 111.814 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.513 HG13 ' HB1' ' A' ' 166' ' ' ALA . 16.9 m -118.84 142.55 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 111.425 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -87.24 121.37 29.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.915 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.06 111.09 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.144 0.497 . . . . 0.0 110.374 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.07 177.72 20.43 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.825 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 42.1 m 64.99 48.03 2.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.176 0.513 . . . . 0.0 111.061 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.7 mm -71.51 -20.41 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.5 t80 66.83 -83.66 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.497 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 151' ' ' LYS . 78.1 t80 -174.03 -56.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.966 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.54 8.68 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.66 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.609 HD22 HG21 ' A' ' 127' ' ' THR . 67.9 mt -102.86 124.82 49.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.33 -167.21 11.87 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.842 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.97 -35.17 74.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.907 0.384 . . . . 0.0 109.99 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -58.44 -42.33 87.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.293 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.609 HG21 HD22 ' A' ' 123' ' ' LEU . 3.1 m -72.66 -40.6 66.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.481 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.34 -45.65 92.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.752 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.1 ttm-85 -61.35 -37.43 83.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.222 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -77.25 -36.0 54.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.448 ' O ' ' HD2' ' A' ' 134' ' ' PRO . . . -78.31 -38.93 41.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.981 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.603 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 96.7 m-85 -95.95 5.46 51.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.478 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.65 -42.1 24.59 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.68 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 71.7 Cg_exo -54.81 -2.54 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.211 2.607 . . . . 0.0 114.362 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.603 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 60.2 m-85 -108.65 -71.1 0.77 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.834 -0.541 . . . . 0.0 111.452 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -146.37 -166.5 12.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.623 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -81.86 114.61 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.668 2.245 . . . . 0.0 111.918 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.65 107.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.25 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -136.53 143.9 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.3 mt -133.47 107.02 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.165 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 3.8 m-20 -89.12 96.43 10.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 24.2 ptm -126.82 137.14 53.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 110.758 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.8 t -78.79 115.5 18.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.303 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -110.51 98.12 7.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.279 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.54 89.39 6.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -58.25 -38.92 77.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.381 -171.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.0 m -57.08 -30.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 p -119.2 -10.09 9.83 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.566 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 85.3 mtp 62.23 26.72 16.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 58.2 mttp -109.87 -173.13 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.947 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -126.97 95.91 4.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.128 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -83.53 -19.06 36.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.6 170.54 13.42 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.726 175.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -107.72 175.69 5.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.567 0.222 . . . . 0.0 110.924 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.01 136.72 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.831 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 72.8 m-85 -108.84 114.63 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.546 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.83 126.62 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.802 0.334 . . . . 0.0 110.311 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -120.34 130.49 54.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.326 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 78.3 m-85 -109.53 179.0 4.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -94.67 -2.63 50.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.338 172.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.99 125.53 17.22 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.246 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.708 ' HB3' ' HB3' ' A' ' 111' ' ' MET . 28.0 Cg_exo -64.33 -37.06 41.97 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.198 2.599 . . . . 0.0 112.169 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -57.75 -45.98 85.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.202 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 136' ' ' GLY . . . -55.67 -42.94 75.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 111.278 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.513 ' HB1' HG13 ' A' ' 114' ' ' VAL . . . -65.85 -41.29 91.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.885 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -63.12 -47.94 80.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.478 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.581 HD21 ' HA3' ' A' ' 283' ' ' GLY . 45.9 mt -63.14 -40.25 97.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.276 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.89 93.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.307 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.849 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.1 tt -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -80.78 -48.01 13.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 168' ' ' LEU . 8.0 mm100 -75.99 -40.53 53.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.743 -170.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.4 mmt -80.7 -6.31 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.341 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.1 -21.36 22.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.5 m -90.98 -27.28 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.603 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.1 t -114.67 110.5 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.485 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 23.5 ptm -89.24 138.32 31.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.186 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.47 144.96 39.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.996 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.79 69.88 0.97 Allowed Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.805 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.96 -45.68 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -157.12 137.93 13.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -73.18 92.77 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.825 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 29.2 pt -71.07 158.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.801 -176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -115.63 110.07 18.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.538 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.6 t -114.11 112.37 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.856 0.36 . . . . 0.0 111.023 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.849 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 112.07 134.43 6.31 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.51 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -162.57 94.27 1.21 Allowed Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.12 -39.77 89.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.026 2.484 . . . . 0.0 112.961 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 71.35 -52.14 0.69 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.387 0.675 . . . . 0.0 111.773 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -98.01 64.17 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.153 0.501 . . . . 0.0 110.226 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 mt -90.06 56.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.751 0.786 . . . . 0.0 109.418 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.33 -55.01 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.048 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -82.85 -48.73 10.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.575 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.52 -33.55 62.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.066 -175.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.637 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.7 tp60 -51.93 -53.36 52.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -174.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 49.4 Cg_exo -56.77 -32.22 90.74 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.13 1.887 . . . . 0.0 112.471 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 48.7 mm -72.46 -41.62 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.184 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 194' ' ' ALA . 43.7 mt -64.22 -39.23 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.626 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.52 -40.5 78.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.59 -47.88 65.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.367 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 97.5 mt -55.91 -43.35 77.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.837 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.22 77.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 206' ' ' ARG . 39.5 tt0 -73.75 -44.19 56.91 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.931 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.65 -28.3 63.66 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.209 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.23 76.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.779 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 203' ' ' GLU . 27.8 ptt180 -71.49 -19.7 62.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.172 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.42 66.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.0 -16.04 27.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.944 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.16 40.83 17.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.245 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HG2' ' HB2' ' A' ' 256' ' ' GLU . 98.8 mtt180 -101.93 136.15 42.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.5 pt -116.34 168.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.687 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -118.76 115.15 23.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.475 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.2 p -108.67 121.21 61.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.366 0.603 . . . . 0.0 110.726 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.77 -179.3 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.929 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 134' ' ' PRO . 8.6 t 71.0 14.67 6.79 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.909 0.756 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.702 HG11 HD21 ' A' ' 240' ' ' LEU . 60.6 t -61.93 122.91 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.429 ' HB3' HD11 ' A' ' 220' ' ' LEU . 6.9 t-80 -60.66 136.08 57.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -63.74 -22.68 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -165.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -48.05 15.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -174.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -82.95 147.82 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.358 0.599 . . . . 0.0 111.786 -174.391 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 49.9 m -108.25 -175.49 2.79 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.965 -166.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -50.31 -51.77 42.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.181 0.592 . . . . 0.0 112.307 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 226' ' ' LYS . 26.1 t70 -55.8 -29.88 60.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.325 0.583 . . . . 0.0 110.769 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.665 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 58.3 m-20 -76.04 -56.46 4.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.465 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.591 HD11 HD13 ' A' ' 220' ' ' LEU . 36.7 mm -61.12 -22.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.306 -178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.537 ' HE2' HG21 ' A' ' 235' ' ' ILE . 53.2 tttm -55.62 -31.66 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.399 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.2 m -48.54 -61.82 1.82 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.452 0.644 . . . . 0.0 112.201 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.725 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 5.2 m -67.28 -46.99 82.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.623 -171.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.475 ' HZ ' ' HB ' ' A' ' 213' ' ' VAL . 64.5 m-85 -61.66 -42.42 98.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.692 0.282 . . . . 0.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 50.7 tt0 -77.13 -23.9 51.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.243 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.96 68.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.739 -0.209 . . . . 0.0 111.017 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.77 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.3 m-85 -83.6 -53.85 5.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -141.05 155.94 25.29 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.422 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.491 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 26.9 mmtp -66.37 140.22 58.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.726 0.774 . . . . 0.0 112.169 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.786 HD11 HG23 ' A' ' 255' ' ' ILE . 10.5 tp -84.86 146.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.795 -173.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -107.72 -51.36 2.92 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 16.0 m -143.6 143.01 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.57 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 28.3 p -144.71 133.8 22.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.273 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.0 m -150.81 103.75 3.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.212 0.529 . . . . 0.0 109.951 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.719 HD12 ' HA3' ' A' ' 253' ' ' GLY . 18.8 tp -83.43 129.95 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.85 137.74 51.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 111.461 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.533 ' HA ' ' H ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -143.45 157.75 44.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.757 176.435 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.527 ' OD1' ' HE3' ' A' ' 250' ' ' LYS . 9.6 m-20 -71.13 108.36 3.7 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.575 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.61 -31.47 21.11 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.39 2.06 . . . . 0.0 112.329 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -96.03 -3.58 44.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.428 . . . . 0.0 110.757 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 243' ' ' ASP . 24.6 m -113.79 -40.84 3.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 0.0 111.406 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.9 53.66 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.157 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 242' ' ' ARG . 95.6 mttt -87.49 -178.0 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -125.21 138.55 54.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.022 0.439 . . . . 0.0 111.685 -171.109 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.533 ' H ' ' HA ' ' A' ' 242' ' ' ARG . 31.8 mmtp -80.41 149.11 30.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.69 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.76 40.92 2.3 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.719 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.56 162.7 19.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.048 0.424 . . . . 0.0 110.331 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.719 ' HA3' HD12 ' A' ' 240' ' ' LEU . . . -167.96 177.37 42.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.225 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.89 134.41 55.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 0.0 110.438 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.786 HG23 HD11 ' A' ' 235' ' ' ILE . 52.0 mt -130.75 140.2 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.498 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 237' ' ' SER . 43.4 tt0 -122.85 131.9 53.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -105.33 153.25 21.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.469 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -85.48 -16.24 40.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.259 0.552 . . . . 0.0 110.293 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -124.38 123.93 41.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.277 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -68.16 -23.62 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.024 0.44 . . . . 0.0 110.574 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -62.22 -37.83 86.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.373 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.442 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 12.2 m -73.62 -36.4 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.056 -176.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 m -59.63 -34.41 72.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.474 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -73.07 -37.12 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 4.7 p-10 -79.11 -26.24 42.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.416 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.11 -52.73 45.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.614 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.72 -25.72 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 p -84.71 -13.52 51.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 p -115.07 -32.24 5.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.839 ' HE2' ' HB2' ' A' ' 273' ' ' PHE . 2.3 mmt -69.14 -4.55 17.83 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.41 -32.78 62.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.99 0.9 . . . . 0.0 108.993 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -77.31 -10.63 59.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.476 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.839 ' HB2' ' HE2' ' A' ' 270' ' ' MET . 2.6 t80 -50.49 105.21 0.09 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.523 0.514 . . . . 0.0 110.403 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.14 125.26 34.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.388 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 220' ' ' LEU . 86.0 mt -130.03 86.83 2.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.681 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.01 14.16 63.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.013 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 102.02 25.02 8.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -140.59 142.17 35.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -81.24 139.45 35.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.125 0.488 . . . . 0.0 110.168 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.1 OUTLIER -79.32 -176.56 5.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.107 176.279 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 281' ' ' ARG . 26.6 mmt180 -142.26 112.7 7.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.687 HG11 ' HB2' ' A' ' 270' ' ' MET . 8.7 p -118.48 131.62 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.581 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -134.96 -161.68 9.51 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.385 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -113.2 168.98 9.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.637 0.255 . . . . 0.0 110.332 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -90.26 113.15 24.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.83 -31.79 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.669 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.51 HG21 ' HG2' ' A' ' 163' ' ' PRO . 9.2 t -133.83 141.03 38.37 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.901 175.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 C--O 1.234 0.315 0 C-N-CA 122.358 2.039 . . . . 0.0 111.937 178.297 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.95 0.405 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.23 -59.73 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.053 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.51 75.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 110.946 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.657 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.6 t80 -70.82 -17.79 62.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 30.2 mmmt -64.29 -50.28 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.74 -37.82 74.25 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.455 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.77 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.16 -58.62 4.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.428 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.758 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.6 OUTLIER -80.78 -17.81 49.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.631 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 26.2 mm-40 -56.41 -46.42 80.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.615 ' O ' HG23 ' B' ' 41' ' ' ILE . 30.5 mmm180 -73.65 -36.44 65.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.68 175.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.799 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -59.82 -45.04 93.63 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -80.28 -26.4 38.94 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.556 -1.34 . . . . 0.0 112.462 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -57.19 -45.18 83.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.849 169.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.799 HG12 ' O ' ' B' ' 38' ' ' ALA . 4.9 pt -67.03 -31.37 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.675 ' HA ' HD23 ' A' ' 220' ' ' LEU . . . -67.99 -46.12 72.22 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.192 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.43 68.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.572 ' O ' ' HD2' ' B' ' 44' ' ' LYS . 1.3 tmmm? -70.84 -16.54 62.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.957 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' B' ' 44' ' ' LYS . 75.8 mt . . . . . 0 N--CA 1.465 0.283 0 C-N-CA 123.469 0.708 . . . . 0.0 111.337 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 . . . . . 0 N--CA 1.463 0.183 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.79 -49.45 52.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.562 HD12 ' HG3' ' A' ' 163' ' ' PRO . 4.6 mm? -69.3 -26.01 64.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.552 -176.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.168 0.509 . . . . 0.0 110.74 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.0 mm -82.5 -36.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.095 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.7 mtp -70.72 -28.65 64.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.209 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.2 m -81.72 2.98 27.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.641 ' HB3' ' HG3' ' A' ' 159' ' ' GLU . 38.9 ptt180 -138.32 140.93 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.582 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.5 m -107.92 141.11 23.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.352 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 44.9 t80 -83.7 116.56 22.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.046 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' A' ' 156' ' ' ALA . 42.8 t -101.93 111.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.47 146.04 16.83 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.337 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.7 m 74.37 -53.72 0.68 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.788 0.835 . . . . 0.0 111.776 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 123' ' ' LEU . 63.6 mt 68.93 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.437 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 27.3 t80 177.26 -85.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.483 ' CD2' ' HD3' ' A' ' 153' ' ' LYS . 1.5 t80 177.58 -77.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.308 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.19 43.93 1.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.552 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 35.6 mt -100.86 123.81 45.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.697 ' HA2' ' HH2' ' A' ' 145' ' ' TRP . . . -83.6 171.12 49.13 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.77 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -63.83 -48.16 77.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 129' ' ' ARG . 34.5 t70 -62.44 -30.46 71.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.628 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 m -59.79 -49.8 76.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.029 0.442 . . . . 0.0 110.453 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.69 -34.52 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.308 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.411 ' HB3' ' HA ' ' A' ' 126' ' ' ASP . 26.6 ttm180 -55.58 -45.73 77.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.794 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 32.1 mm-40 -74.83 -30.54 61.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.439 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.75 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.633 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.454 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 93.2 m-85 -100.77 11.13 40.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.046 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.86 -44.04 29.07 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.789 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.633 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 13.2 Cg_exo -72.29 -8.61 23.02 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.774 1.649 . . . . 0.0 111.994 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.567 ' O ' ' HB1' ' A' ' 165' ' ' ALA . 65.7 m-85 -102.64 65.53 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 110.464 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . 84.31 177.16 51.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.621 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -91.3 115.45 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.906 2.404 . . . . 0.0 112.273 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.521 HD13 ' HE1' ' A' ' 160' ' ' TYR . 36.8 mm -56.75 115.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.089 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -96.4 -55.03 3.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.761 0.315 . . . . 0.0 110.604 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.751 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 23.3 t -135.28 137.08 42.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.11 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.18 127.25 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.624 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.7 t70 -133.25 126.11 30.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.397 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.4 mtp -147.37 147.83 30.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.961 0.41 . . . . 0.0 111.616 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.5 m -79.63 131.17 35.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 168.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.697 ' HH2' ' HA2' ' A' ' 124' ' ' GLY . 82.7 m95 -133.53 150.44 51.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.255 0.55 . . . . 0.0 112.264 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -124.35 89.06 3.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.694 168.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.9 m 65.8 -174.37 0.18 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.199 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.44 -20.98 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 110.424 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 p -67.73 9.74 0.25 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.503 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 20.9 ptp 47.45 38.31 7.52 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 171.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.421 ' HE3' ' OH ' ' A' ' 121' ' ' TYR . 56.2 mtpt -92.49 137.86 32.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -170.55 -78.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.483 ' HD3' ' CD2' ' A' ' 121' ' ' TYR . 22.4 mtmm 54.78 35.67 24.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.655 0.382 . . . . 0.0 111.316 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -102.26 -107.78 3.13 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.526 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.96 165.99 23.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.875 0.369 . . . . 0.0 110.581 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.672 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . . . -145.18 135.77 24.35 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.447 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 51.2 m-85 -113.31 107.9 16.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.915 0.388 . . . . 0.0 110.134 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.09 103.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 28.6 tt0 -105.94 126.47 52.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 -172.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.521 ' HE1' HD13 ' A' ' 138' ' ' ILE . 78.0 m-85 -109.25 -177.98 3.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.11 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -109.23 -1.73 18.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.909 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.88 122.53 16.53 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.435 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.562 ' HG3' HD12 ' A' ' 108' ' ' LEU . 34.0 Cg_endo -65.65 -21.62 58.84 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.902 2.401 . . . . 0.0 113.397 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.97 -63.75 1.04 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.164 0.507 . . . . 0.0 110.466 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 135' ' ' PHE . . . -52.56 -43.15 65.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.136 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.88 66.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.445 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.564 ' HB3' HG21 ' A' ' 286' ' ' VAL . 57.8 tp60 -66.88 -35.45 80.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 212' ' ' TYR . 11.0 tp -64.76 -51.77 60.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.197 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.57 -36.58 81.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.308 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.473 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.6 tt -57.19 -62.37 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.485 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.29 -39.0 85.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -67.62 -49.89 60.82 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 57.8 mtt -82.9 -17.78 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -69.49 -35.36 75.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.233 0.54 . . . . 0.0 109.671 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.9 t -88.2 -43.76 11.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.983 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.85 94.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.783 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.437 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 62.3 mtm -65.78 167.99 8.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.439 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.8 tp -80.23 74.41 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.891 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.82 -123.41 9.79 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 12.22 70.17 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.894 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 177' ' ' MET . 30.1 tpt180 -104.14 119.93 40.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.674 0.273 . . . . 0.0 110.76 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.437 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 21.7 p-10 -78.23 116.02 18.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 110.081 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.48 144.97 17.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -102.05 110.39 22.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.1 m -135.39 106.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.53 . . . . 0.0 110.787 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.473 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 125.52 -165.62 18.6 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.796 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 57.86 89.12 0.11 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.312 0.645 . . . . 0.0 110.93 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.25 -14.25 28.4 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.45 2.767 . . . . 0.0 113.82 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 72.95 -61.54 0.5 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.055 0.542 . . . . 0.0 111.209 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -84.05 70.87 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.8 pt -95.75 -172.79 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.323 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.475 ' H ' ' HB2' ' A' ' 195' ' ' GLN . . . 103.28 -50.29 0.9 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.105 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.67 -43.01 39.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.15 0.5 . . . . 0.0 110.183 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.66 6.32 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.779 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.54 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 52.8 tp60 -61.98 -49.33 85.84 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.668 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -55.17 -37.27 94.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.061 1.841 . . . . 0.0 111.722 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.41 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.3 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 194' ' ' ALA . 48.2 mm -56.68 -48.32 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.191 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.02 -50.78 64.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.835 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 98.1 mt-30 -57.04 -44.73 83.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.814 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.15 -56.67 6.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.649 0.261 . . . . 0.0 111.135 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.52 73.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.981 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HG2' ' NH1' ' A' ' 206' ' ' ARG . 3.0 tm-20 -74.35 -46.13 42.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.429 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.93 -30.15 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.358 . . . . 0.0 110.928 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.93 -25.06 67.97 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.26 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.425 ' NH1' ' HG2' ' A' ' 203' ' ' GLU . 93.6 mtt180 -66.7 -26.22 66.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.59 -17.7 62.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.258 0.551 . . . . 0.0 111.257 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.9 -10.05 19.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.755 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 257' ' ' TYR . 3.2 m-80 54.23 29.32 10.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.489 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.9 136.41 33.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 111.26 -174.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 255' ' ' ILE . 8.9 tt -112.94 147.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.588 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.561 ' CD2' HD22 ' A' ' 168' ' ' LEU . 66.1 t80 -107.86 123.0 47.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.5 . . . . 0.0 109.657 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 280' ' ' LEU . 1.6 p -114.53 122.97 69.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.188 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.41 178.22 5.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.633 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 15.6 m 68.55 25.6 6.64 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.776 0.672 . . . . 0.0 110.909 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 225' ' ' ILE . 85.1 t -68.08 138.7 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.683 ' HB2' HD23 ' A' ' 275' ' ' LEU . 21.2 t-80 -66.41 131.15 45.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -50.55 -44.22 56.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -167.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.61 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.62 -46.54 17.03 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 178.327 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.854 HD22 HD21 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -55.32 114.45 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.262 0.625 . . . . 0.0 110.27 -177.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 6.6 t -95.21 -175.8 3.62 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -166.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.56 -44.0 96.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.838 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.79 -27.91 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 221' ' ' SER . 5.5 m-20 -63.49 -59.64 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.525 HD11 HG13 ' A' ' 216' ' ' VAL . 37.6 mm -55.96 -26.06 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.238 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.493 ' HG3' HD12 ' A' ' 235' ' ' ILE . 88.2 tttt -57.24 -32.29 66.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.653 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.526 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 74.5 m -49.03 -56.64 8.36 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.922 0.868 . . . . 0.0 111.748 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.632 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.2 m -73.85 -49.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.353 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.599 ' HE2' HD13 ' A' ' 211' ' ' ILE . 43.3 m-85 -59.63 -41.82 91.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.629 0.252 . . . . 0.0 111.627 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 30.9 tt0 -74.2 -25.94 59.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.12 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.89 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.693 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.1 OUTLIER -90.18 -58.55 2.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -127.44 154.82 19.72 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 36.7 mmtm -84.11 140.79 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.58 0.705 . . . . 0.0 112.056 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.493 HD12 ' HG3' ' A' ' 226' ' ' LYS . 56.5 mt -103.69 134.38 45.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.094 -171.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 1.092 ' HE2' ' HB3' ' A' ' 258' ' ' GLU . 62.6 mmtt -84.03 -46.08 12.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.986 176.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 21.9 t -147.24 136.63 22.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.614 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.415 ' HB3' HG21 ' A' ' 235' ' ' ILE . 3.5 p -132.64 135.4 45.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.9 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.8 t -157.66 139.77 14.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.336 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.576 HD23 ' HA3' ' A' ' 253' ' ' GLY . 72.7 mt -111.11 129.91 55.78 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.42 134.98 57.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 110.681 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.653 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.0 mtp180 -89.19 157.28 18.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.371 0.605 . . . . 0.0 111.695 -177.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.04 97.99 40.63 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.289 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.86 -23.92 29.8 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.838 2.359 . . . . 0.0 111.624 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 24.3 m -64.43 -47.02 80.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.47 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.469 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 1.7 m -94.69 -33.44 12.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.02 0.438 . . . . 0.0 111.108 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.13 43.3 2.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.529 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.469 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 23.2 pttp -147.51 -166.94 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -175.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.4 p80 -112.98 147.52 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' A' ' 242' ' ' ARG . 88.2 mttt -74.89 152.25 38.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.799 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -76.91 42.77 1.87 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.539 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -161.85 160.31 27.94 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.576 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -172.48 -164.08 27.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.333 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -129.85 137.31 50.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.975 0.417 . . . . 0.0 110.828 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.66 ' HB ' HG23 ' A' ' 211' ' ' ILE . 41.4 mm -119.56 128.98 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.336 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.64 113.26 26.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.153 0.502 . . . . 0.0 111.301 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.511 ' O ' ' HB2' ' A' ' 209' ' ' ASN . 49.6 m-85 -93.33 156.88 16.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.064 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 1.092 ' HB3' ' HE2' ' A' ' 236' ' ' LYS . 8.5 pt-20 -92.01 -17.28 25.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.343 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -127.98 118.54 23.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.473 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.1 66.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.601 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.32 -40.58 93.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.597 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 14.7 m -70.49 -36.03 73.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 267' ' ' VAL . 17.7 m -54.34 -48.63 71.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.209 174.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -64.89 -39.59 93.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -63.04 -46.05 89.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.76 86.49 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.542 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.562 ' HA ' HG23 ' A' ' 282' ' ' VAL . 71.3 t -60.39 -35.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 111.28 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.6 m -89.92 -4.73 57.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.711 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 26.5 p -115.74 -47.01 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.771 ' HB2' HG21 ' A' ' 282' ' ' VAL . 55.3 mmm -65.18 -14.83 61.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 15.0 p-10 -72.76 -26.42 61.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.521 0.677 . . . . 0.0 110.323 176.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.55 -8.72 59.69 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.886 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 69.7 t80 -57.95 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 111.363 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.69 103.48 6.68 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.995 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.854 HD21 HD22 ' A' ' 220' ' ' LEU . 22.1 tp -113.43 86.98 2.5 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.925 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 62.01 41.24 99.66 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.662 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 119.23 -21.48 9.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.749 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.9 137.0 46.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.545 0.672 . . . . 0.0 111.777 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -78.04 128.92 34.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.089 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.886 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 8.0 tp -61.46 169.9 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.177 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.42 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 32.3 mmt180 -142.68 113.34 7.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 121.982 -0.448 . . . . 0.0 110.138 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.771 HG21 ' HB2' ' A' ' 270' ' ' MET . 28.7 m -124.94 168.03 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.991 0.424 . . . . 0.0 112.132 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.544 ' O ' HG13 ' A' ' 211' ' ' ILE . . . 176.94 -164.39 33.81 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.314 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 148.36 43.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.821 0.311 . . . . 0.0 110.343 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -69.37 -16.33 63.5 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 167' ' ' GLN . 49.1 t 72.02 -65.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.673 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 6.2 t -97.33 134.36 22.78 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo . . . . . 0 C--O 1.234 0.282 0 C-N-CA 122.736 2.291 . . . . 0.0 111.636 177.626 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 CA--C 1.523 -0.072 0 CA-C-O 121.368 0.604 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -119.79 -51.33 2.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.006 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.08 -41.0 23.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.875 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.631 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.7 t80 -69.02 -19.86 64.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.6 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' B' ' 32' ' ' LYS . 44.0 mtpt -69.08 -47.0 66.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -39.5 81.93 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.603 0.716 . . . . 0.0 109.118 175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.693 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.64 -51.37 49.61 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.648 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.03 -20.85 40.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.055 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 35.7 mt-30 -59.53 -44.0 93.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.615 ' O ' HG23 ' B' ' 41' ' ' ILE . 72.7 mtp180 -73.63 -30.3 62.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.685 175.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.843 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -64.5 -49.81 69.86 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -80.1 -24.52 40.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.495 -1.378 . . . . 0.0 112.36 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.18 -50.43 59.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.074 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.843 HG12 ' O ' ' B' ' 38' ' ' ALA . 1.7 pt -66.4 -31.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.63 -22.61 65.32 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.97 -27.31 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.203 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 tmmt? -74.22 -55.26 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.376 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.61 HG23 ' HB2' ' A' ' 219' ' ' ASP . 87.2 mt . . . . . 0 N--CA 1.467 0.378 0 O-C-N 123.573 0.545 . . . . 0.0 112.198 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.7 0.286 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.24 -34.8 61.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 0.0 111.673 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.19 -32.83 69.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.468 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.53 -49.13 62.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.77 0.319 . . . . 0.0 111.65 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.04 -35.93 16.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.79 0.328 . . . . 0.0 111.533 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 91.4 mmm -71.67 -26.58 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.34 -12.34 60.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.19 133.25 50.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.473 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -94.08 138.0 21.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 0.0 110.915 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.567 ' HB2' ' HA ' ' A' ' 188' ' ' PRO . 72.5 t80 -89.66 106.13 18.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.169 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.6 t -103.53 110.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 118' ' ' SER . . . -134.39 100.24 0.37 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.608 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.607 ' OG ' ' HA ' ' A' ' 183' ' ' ILE . 68.5 p 151.59 51.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.306 1.443 . . . . 0.0 107.549 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.81 69.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.483 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.687 ' HE1' ' HA3' ' A' ' 179' ' ' GLY . 35.1 t80 37.86 -92.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.544 1.152 . . . . 0.0 112.387 169.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' HD2' ' HG3' ' A' ' 122' ' ' GLU . 33.0 t80 -179.3 -72.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.485 173.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.522 ' HG3' ' HD2' ' A' ' 121' ' ' TYR . 48.2 mt-10 -90.07 44.27 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 127' ' ' THR . 48.9 mt -102.2 164.63 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.48 175.82 18.1 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.858 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -60.76 -39.59 89.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.3 m-20 -48.43 -50.96 29.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.684 175.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.774 HG21 HD22 ' A' ' 123' ' ' LEU . 6.9 m -57.56 -47.7 81.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.324 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.411 HG23 ' HE2' ' A' ' 132' ' ' PHE . 79.0 mt -69.42 -41.04 80.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.807 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.446 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 14.8 ttm180 -59.57 -44.64 93.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.79 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 92.9 mt-30 -75.52 -21.46 57.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.45 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.96 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.623 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 97.4 m-85 -96.22 13.39 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.012 0.434 . . . . 0.0 111.141 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.584 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.67 -43.6 11.65 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.453 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 38.0 Cg_endo -67.08 -4.47 11.61 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 0.0 112.792 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 169' ' ' ALA . 4.9 m-85 -85.4 -83.06 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.55 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.67 -176.25 14.36 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.898 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.457 ' HD3' ' CZ ' ' A' ' 252' ' ' TYR . 60.9 Cg_endo -74.57 117.32 4.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.513 2.142 . . . . 0.0 111.444 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -57.12 107.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.917 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 159' ' ' GLU . 23.1 tptp -87.55 -54.49 4.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.379 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -166.73 144.05 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.8 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 63.5 mt -127.35 107.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.32 118.68 35.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.065 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 42.2 ttm -126.56 136.65 52.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.972 0.415 . . . . 0.0 111.189 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.628 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 3.7 m -98.73 111.21 23.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.886 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 2.1 p-90 -164.87 159.64 18.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.03 0.443 . . . . 0.0 111.369 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 153' ' ' LYS . 21.5 t70 -89.34 132.89 34.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.64 -176.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.1 t -101.76 4.98 41.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 110.952 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 91.5 t -85.14 -43.24 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.363 0.601 . . . . 0.0 110.058 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.5 p -119.72 5.22 11.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.002 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 58.46 30.0 19.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.611 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -89.27 128.17 35.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.886 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 58.9 m-70 -81.98 75.41 8.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.522 0.677 . . . . 0.0 110.991 -175.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 146' ' ' ASP . 58.9 mttm -78.5 63.79 3.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.506 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 144' ' ' SER . . . 158.89 -157.86 28.86 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -124.66 174.18 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.69 137.22 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 85.7 m-85 -113.42 113.9 25.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.032 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.0 t -101.01 111.68 31.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.816 0.341 . . . . 0.0 110.256 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 37.8 tt0 -101.52 141.22 34.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.93 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -122.96 172.94 8.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.31 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.63 -27.72 31.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.066 0.46 . . . . 0.0 110.203 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.508 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 6.2 m -121.48 136.52 25.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.864 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 8.2 Cg_exo -73.99 -13.82 23.79 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.72 2.947 . . . . 0.0 112.088 -177.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -60.23 -47.97 83.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.217 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.1 -26.1 68.67 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.5 -49.85 44.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.091 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -66.89 -36.05 81.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.721 0.296 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.86 -43.37 96.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.111 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . . . -59.86 -38.61 82.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.766 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.5 tt -60.35 -60.45 3.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -69.35 -47.29 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -71.59 -31.26 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.623 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 24.6 mmt -83.36 -28.79 28.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.76 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -76.97 -16.51 59.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 110.513 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.2 m -78.44 -13.91 59.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.152 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.07 143.18 36.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 110.794 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.1 ttt -99.11 104.25 16.23 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.07 -28.79 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.234 -171.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.687 ' HA3' ' HE1' ' A' ' 120' ' ' TYR . . . -161.08 -150.74 6.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.076 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.03 23.18 1.8 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.931 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.628 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 14.4 ptm180 -157.43 151.66 24.8 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -79.31 141.12 37.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.609 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.607 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 27.3 pt -100.12 131.81 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 0.0 110.388 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 81.2 tttt -103.83 117.74 35.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 48.1 t -125.29 106.58 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 130.82 159.97 9.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.146 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 67.36 83.69 0.18 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.158 0.504 . . . . 0.0 110.817 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 115' ' ' TYR . 17.3 Cg_exo -66.87 -60.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.961 2.441 . . . . 0.0 112.816 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.8 p -151.83 -61.53 0.17 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.918 0.39 . . . . 0.0 110.971 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.53 132.72 33.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.2 tp -142.98 137.34 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.42 . . . . 0.0 110.562 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 195' ' ' GLN . . . 93.42 -42.33 2.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.386 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -59.18 -31.79 69.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.641 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.48 12.11 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 110.849 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.574 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.4 tp60 -63.72 -49.51 76.2 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.563 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.1 -34.2 67.18 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.342 2.028 . . . . 0.0 112.614 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 46.3 mm -67.91 -42.15 85.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.285 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.12 -47.37 93.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.648 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.47 -32.64 74.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.115 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -71.76 -47.1 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.35 -21.49 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.325 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.96 97.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.13 -35.98 76.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.634 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.31 -35.91 82.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.59 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.15 -20.18 62.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.677 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -64.12 -22.27 66.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.948 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.35 58.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.895 0.379 . . . . 0.0 111.138 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -96.48 -17.37 20.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.99 26.25 11.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.776 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 210' ' ' ARG . 8.3 ptm85 -120.23 144.24 47.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.201 0.524 . . . . 0.0 111.654 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.57 170.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.246 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -112.9 133.4 54.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.589 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 33.3 t -118.16 123.45 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.23 169.77 10.57 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.159 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.0 p 53.19 44.53 30.12 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.352 1.061 . . . . 0.0 111.714 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.593 HG13 HD11 ' A' ' 225' ' ' ILE . 48.5 t -79.14 146.13 8.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.218 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.626 ' HB2' HD23 ' A' ' 275' ' ' LEU . 14.1 t-80 -68.95 129.86 41.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -57.0 -36.95 71.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -167.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.978 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -80.11 -47.63 14.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.074 0.464 . . . . 0.0 111.479 174.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -59.67 108.66 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.948 -178.135 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 225' ' ' ILE . 44.2 m -97.11 -176.96 3.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -168.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.617 ' HB3' HD13 ' A' ' 240' ' ' LEU . 4.5 p-10 -57.88 -38.65 76.15 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.46 -34.92 69.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.483 0.658 . . . . 0.0 109.974 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.649 ' OD2' ' HE3' ' B' ' 44' ' ' LYS . 3.2 m-20 -73.88 -54.34 8.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.298 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.593 HD11 HG13 ' A' ' 216' ' ' VAL . 31.3 mm -54.71 -24.84 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 222' ' ' ASP . 50.4 mtpt -52.01 -33.88 40.4 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.026 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -49.23 -58.73 4.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.529 0.68 . . . . 0.0 111.816 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.661 HG11 ' CD1' ' A' ' 273' ' ' PHE . 13.7 m -74.41 -45.18 46.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.808 -171.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.496 ' CE1' ' HE2' ' A' ' 270' ' ' MET . 76.5 m-85 -68.52 -38.37 80.84 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.096 -0.378 . . . . 0.0 111.799 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.52 -25.64 45.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.384 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.36 83.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.553 0.216 . . . . 0.0 111.368 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.711 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.4 m-30 -75.64 -27.84 58.56 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.47 -109.07 0.45 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.919 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -157.43 139.63 14.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.528 HG21 ' HB2' ' A' ' 238' ' ' CYS . 54.6 mt -94.22 132.16 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.234 0.54 . . . . 0.0 111.085 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -88.32 -42.97 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.17 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.8 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 34.5 t -147.35 143.08 27.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.625 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.528 ' HB2' HG21 ' A' ' 235' ' ' ILE . 41.8 t -146.33 124.03 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 62.8 m -157.18 127.21 6.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 222' ' ' ASP . 7.6 mp -104.49 123.49 47.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.72 136.6 57.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.215 0.531 . . . . 0.0 111.324 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.783 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 49.2 mtp85 -101.01 158.66 15.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.653 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.02 107.95 60.3 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 170.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -62.78 -38.41 49.16 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.035 2.49 . . . . 0.0 111.99 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.7 m -59.87 -42.76 94.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.252 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.4 m -90.74 -22.76 20.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 21.7 62.35 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.899 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -134.81 148.95 50.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.783 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 10.8 p80 -76.12 142.64 41.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.671 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -69.81 153.16 43.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.2 40.39 1.71 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.979 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.457 ' CZ ' ' HD3' ' A' ' 137' ' ' PRO . 28.8 p90 -159.28 160.45 35.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -169.03 -171.82 35.16 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -126.75 136.98 53.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.834 0.349 . . . . 0.0 111.055 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.12 118.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.8 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 57.4 tt0 -105.03 129.88 53.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.006 0.432 . . . . 0.0 110.259 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -107.2 161.57 14.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.84 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -22.14 20.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 262' ' ' SER . 4.8 tppt? -111.8 115.24 28.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.468 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 264' ' ' GLN . . . -60.55 -33.72 73.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.32 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -69.05 -34.51 75.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.978 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 259' ' ' LYS . 9.5 t -62.07 -38.79 90.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.5 m -59.76 -42.99 94.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 260' ' ' ALA . 59.8 mm-40 -68.15 -34.78 76.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 -174.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.4 -40.14 64.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.23 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.83 -51.92 65.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.442 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.04 -26.1 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 97.2 p -65.37 -34.7 78.93 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.672 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.6 t -116.85 0.67 12.56 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.524 ' HB2' HG11 ' A' ' 282' ' ' VAL . 34.9 mmm -79.4 -17.81 53.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.37 -31.54 71.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.042 0.925 . . . . 0.0 110.083 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -75.32 -8.37 56.47 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.46 -174.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.713 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 55.9 t80 -57.37 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 110.395 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -77.35 119.81 21.5 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.526 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.79 HD21 HD22 ' A' ' 220' ' ' LEU . 14.5 tp -126.2 85.83 2.44 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.486 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.08 32.33 23.65 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.382 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 87.66 19.56 53.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.754 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -140.9 131.97 26.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.81 0.338 . . . . 0.0 110.382 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -76.35 136.1 39.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.075 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.91 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 14.4 tp -70.71 -174.37 0.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.247 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.91 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 6.4 tpp180 -143.88 118.86 10.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.524 HG11 ' HB2' ' A' ' 270' ' ' MET . 14.7 p -118.31 144.03 27.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 110.544 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.61 -159.9 9.05 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.489 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -118.59 165.13 14.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.828 0.347 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.86 88.86 5.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -51.94 -52.37 23.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 40.8 p -121.85 161.39 42.45 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.409 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.457 -0.672 0 C-N-CA 122.693 2.262 . . . . 0.0 111.409 174.049 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.2 0.524 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -154.51 -63.61 0.13 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.835 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.24 -31.05 33.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.422 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.615 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 15.5 t80 -69.4 -18.48 63.76 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.336 0.588 . . . . 0.0 110.465 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.2 mtpt -70.64 -45.93 64.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.61 -36.15 81.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.905 172.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.711 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.0 -51.01 33.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.483 177.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.593 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -79.86 -23.38 41.97 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -174.036 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 65.6 mt-30 -58.04 -43.31 86.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 170.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 27.1 mmt180 -73.51 -30.68 63.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.456 176.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.731 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -66.51 -43.08 86.26 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -80.86 -26.86 36.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.489 -1.382 . . . . 0.0 112.136 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.15 -44.11 74.85 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.767 HG13 HD11 ' A' ' 220' ' ' LEU . 4.0 pt -69.1 -34.41 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.619 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -64.63 -27.14 68.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.376 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.63 -42.35 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.277 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.649 ' HE3' ' OD2' ' A' ' 224' ' ' ASP . 17.8 pttt -77.45 -35.36 53.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.424 -177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.978 HG23 ' HB2' ' A' ' 219' ' ' ASP . 91.7 mt . . . . . 0 C--O 1.236 0.352 0 CA-C-O 121.388 0.613 . . . . 0.0 111.016 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.754 0.311 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.19 86.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.072 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.89 -32.98 74.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.425 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.82 90.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.4 . . . . 0.0 111.001 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.71 -37.22 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 25.4 ttt -60.44 -28.12 68.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.2 m -91.34 6.21 46.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 113' ' ' ARG . 9.7 ptp180 -130.94 126.26 35.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.829 0.347 . . . . 0.0 110.565 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 158' ' ' VAL . 4.3 m -92.3 135.84 26.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.651 0.739 . . . . 0.0 110.834 176.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 81.2 t80 -91.1 111.24 22.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.609 -176.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 119' ' ' ILE . 9.4 t -103.01 110.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.389 . . . . 0.0 110.272 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.509 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -102.25 171.2 21.21 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.1 t 72.57 -65.69 0.34 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.97 0.508 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.512 HD13 HG12 ' A' ' 116' ' ' VAL . 10.0 mm 63.14 12.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.88 0.371 . . . . 0.0 110.545 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.835 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 11.6 t80 60.4 -80.02 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 50.5 t80 169.75 -45.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.701 0.8 . . . . 0.0 109.379 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -104.62 39.15 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.022 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 66.5 mt -114.05 99.92 8.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.98 -175.04 48.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.4 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -50.63 -49.91 55.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.165 0.507 . . . . 0.0 110.823 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -59.43 -33.68 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -80.69 -39.15 27.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.01 -48.06 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 141' ' ' ILE . 4.6 ptm180 -62.13 -35.53 79.01 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.61 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -75.07 -26.55 59.45 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.302 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.33 -34.75 63.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.695 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 84.1 m-85 -96.81 10.5 38.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.957 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 134' ' ' PRO . . . -70.67 -39.07 8.63 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.639 ' O ' ' HB1' ' A' ' 214' ' ' ALA . 52.6 Cg_exo -59.15 -18.33 43.55 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.786 1.657 . . . . 0.0 112.479 170.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.695 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 57.3 m-85 -101.89 66.6 1.05 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.79 0.328 . . . . 0.0 111.033 -175.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.63 44.27 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.38 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.41 123.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.036 2.491 . . . . 0.0 112.128 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.713 HD13 ' HE1' ' A' ' 160' ' ' TYR . 31.6 mm -67.36 108.07 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.979 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.469 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 82.0 tttt -76.6 -53.05 8.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.318 0.58 . . . . 0.0 110.144 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.2 m -155.07 143.79 20.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.466 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 129' ' ' ARG . 66.8 mt -113.11 106.15 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 35.9 t70 -81.71 98.24 8.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.0 tpt -130.3 130.05 44.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.904 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -93.53 106.14 18.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.029 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.593 ' HB3' ' HA ' ' A' ' 150' ' ' MET . 56.3 m95 -91.98 134.78 34.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.1 m-20 -73.75 102.61 4.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.261 174.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.1 t 62.07 -160.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.833 0.708 . . . . 0.0 110.551 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.3 p -74.04 -22.24 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.067 0.46 . . . . 0.0 110.494 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -13.65 61.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -173.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 145' ' ' TRP . 88.2 mtp 60.36 47.11 9.27 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.475 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.834 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 30.4 mmmt -77.79 149.99 34.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.498 . . . . 0.0 111.187 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.86 99.99 11.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.235 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.584 ' NZ ' ' HB3' ' A' ' 153' ' ' LYS . 2.3 ttpm? -149.18 64.44 1.03 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.396 0.617 . . . . 0.0 109.611 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 172.84 -179.04 44.56 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.698 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.509 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 84.1 m-85 -112.36 157.85 20.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.02 130.41 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.041 0.448 . . . . 0.0 110.802 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 67.0 m-85 -111.23 107.77 17.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.872 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.475 ' HB ' HG23 ' A' ' 114' ' ' VAL . 43.0 t -91.77 110.97 23.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.2 138.02 35.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.294 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.713 ' HE1' HD13 ' A' ' 138' ' ' ILE . 50.7 m-85 -118.92 161.01 20.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.37 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 36.0 mt-10 -99.49 9.96 42.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.661 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 10.9 m -132.56 113.51 14.21 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.389 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.46 -24.32 36.62 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 113.326 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.661 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -66.67 -54.46 22.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 110.193 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.515 ' HB3' HG23 ' A' ' 162' ' ' VAL . . . -55.38 -40.13 70.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.212 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.29 91.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.8 -41.57 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.519 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.551 HD21 ' HA3' ' A' ' 283' ' ' GLY . 18.9 mt -62.36 -42.4 99.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.012 0.434 . . . . 0.0 110.648 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.36 83.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.789 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.14 -60.92 2.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.82 -46.87 77.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.473 ' OE1' ' HD3' ' A' ' 281' ' ' ARG . 47.6 mt-30 -79.29 -35.82 40.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.431 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 51.7 tpp -77.27 -27.11 53.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.32 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -70.44 -20.3 62.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.185 0.516 . . . . 0.0 110.17 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.9 m -90.78 -2.87 57.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.728 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.01 171.12 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 111.403 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.8 mtp -117.18 97.11 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.246 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 52.9 tp -77.78 89.85 4.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 110.261 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 119.42 -157.03 15.58 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.526 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.23 18.07 50.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.016 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.835 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 8.9 ptm180 -157.41 155.72 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.19 105.6 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.274 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.63 155.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.174 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -101.69 109.91 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.902 0.382 . . . . 0.0 110.102 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.3 t -101.32 106.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.43 159.89 34.91 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.58 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -164.88 144.76 5.89 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 102.27 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.963 2.442 . . . . 0.0 112.183 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.5 m -113.99 -42.4 3.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.341 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 193' ' ' GLN . 28.5 p30 -150.62 33.82 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.887 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.3 tt -63.29 115.28 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.513 0.673 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 119.02 -38.43 2.85 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 190' ' ' ASN . 14.4 mm100 -82.28 -39.51 22.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.09 0.472 . . . . 0.0 109.863 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.83 -9.27 57.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.071 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 24.4 tp60 -63.43 -52.84 57.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.98 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -54.86 -30.81 70.09 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.519 2.146 . . . . 0.0 112.468 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.0 mm -66.04 -57.69 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.0 mt -64.59 -35.55 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.609 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.5 t70 -57.67 -49.55 76.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.435 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.87 -48.12 80.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.237 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.608 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 80.2 mt -58.97 -42.6 90.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.52 71.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.371 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 45.1 mt-10 -64.79 -42.99 94.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 288' ' ' PRO . 31.0 mt-10 -70.82 -49.36 47.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.569 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 285' ' ' ALA . . . -59.28 -31.82 69.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.995 -176.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -62.88 -27.2 69.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.92 -14.97 60.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.954 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.58 -15.12 17.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.168 0.508 . . . . 0.0 111.094 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.81 40.74 30.67 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.891 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.503 ' HD3' ' HB3' ' A' ' 254' ' ' PHE . 46.1 ttm180 -103.83 136.24 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.721 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.95 165.89 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.776 0.322 . . . . 0.0 110.792 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.526 ' HD2' HD11 ' A' ' 168' ' ' LEU . 49.1 t80 -116.65 122.88 45.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.057 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 255' ' ' ILE . 39.8 t -109.77 121.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.658 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.23 170.49 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.591 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.3 t 67.55 36.28 3.81 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.631 0.582 . . . . 0.0 111.33 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.537 HG13 HD11 ' A' ' 225' ' ' ILE . 59.9 t -79.86 138.58 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -51.81 -43.68 63.19 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -167.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.638 ' HB3' ' HB ' ' B' ' 45' ' ' ILE . 5.2 m-20 -70.17 -45.81 65.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.812 0.339 . . . . 0.0 111.066 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.687 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -66.7 103.94 1.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.466 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 225' ' ' ILE . 46.3 m -89.83 -176.85 5.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -166.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.42 -45.46 80.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.849 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.86 -28.94 69.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.277 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.655 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.0 m-20 -67.47 -59.18 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.001 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.701 HG13 HD11 ' A' ' 240' ' ' LEU . 29.5 mm -52.95 -30.58 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.136 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.44 -32.4 39.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.027 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.568 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 70.0 m -49.79 -60.99 2.39 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.654 0.74 . . . . 0.0 112.035 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.589 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.0 m -71.74 -39.82 69.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.624 -171.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.762 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 65.1 m-85 -66.71 -39.71 88.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.726 0.298 . . . . 0.0 111.697 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.9 -24.75 55.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.421 ' O ' ' HB1' ' B' ' 30' ' ' ALA . . . -72.98 -24.28 60.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.256 -174.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.626 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.5 m-30 -87.47 24.71 1.59 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.48 0.657 . . . . 0.0 110.525 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 234' ' ' LYS . . . 149.27 -113.42 0.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 233' ' ' GLY . 28.4 mmmt -136.72 161.67 35.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.567 HG12 ' SG ' ' A' ' 238' ' ' CYS . 6.6 tp -122.17 139.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.528 0.68 . . . . 0.0 110.665 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -88.4 -62.74 1.42 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 15.2 m -140.88 143.79 34.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.366 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.567 ' SG ' HG12 ' A' ' 235' ' ' ILE . 74.7 m -134.52 106.82 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 21.4 m -141.48 104.71 4.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.167 0.508 . . . . 0.0 111.467 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.806 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 79.8 mt -83.57 130.75 35.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.56 101.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.598 0.561 . . . . 0.0 111.205 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 6.5 ppt_? -90.46 144.73 25.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.509 . . . . 0.0 110.846 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.03 122.76 76.02 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.504 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.67 -20.28 40.66 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.911 2.407 . . . . 0.0 113.514 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.87 -39.14 14.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 44.9 p -88.03 -35.5 17.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.864 0.364 . . . . 0.0 111.338 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.15 -2.32 68.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.658 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -108.75 157.46 18.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.887 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 16.8 p80 -86.4 145.57 26.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.254 0.55 . . . . 0.0 110.925 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.75 158.61 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.04 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -74.8 43.79 1.44 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 114.183 0.433 . . . . 0.0 114.183 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -166.18 164.64 17.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.806 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . 178.04 -169.98 42.02 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.559 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.503 ' HB3' ' HD3' ' A' ' 210' ' ' ARG . 90.6 m-85 -119.86 140.01 51.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.847 0.356 . . . . 0.0 110.538 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.433 HD12 HG21 ' A' ' 213' ' ' VAL . 48.8 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.91 176.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.99 146.25 29.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.357 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.415 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 34.2 m-85 -120.19 137.01 54.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.442 170.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -83.6 -29.5 27.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -95.8 113.56 25.21 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.837 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.29 69.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.798 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -69.41 -34.01 73.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.537 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 43.3 m -78.44 -31.51 48.07 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 267' ' ' VAL . 1.5 p -65.6 -42.92 91.1 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.173 -0.329 . . . . 0.0 111.534 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -60.72 -36.58 79.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.588 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.97 -47.38 37.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.745 -176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.43 74.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.076 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 263' ' ' SER . 94.6 t -58.12 -40.25 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.979 0.419 . . . . 0.0 111.254 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.2 t -71.69 -28.9 64.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 t -89.95 -43.51 10.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.768 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.881 ' HB3' HG21 ' A' ' 282' ' ' VAL . 0.0 OUTLIER -74.25 -6.33 47.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.639 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.58 -36.6 76.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.416 1.103 . . . . 0.0 109.0 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -79.77 -7.76 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.646 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.715 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 2.4 t80 -58.84 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.278 0.561 . . . . 0.0 110.563 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 8.3 t70 -93.75 116.32 28.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.221 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.687 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.8 mm? -114.73 87.05 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.761 175.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.73 -86.62 0.6 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.582 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -146.37 26.75 1.69 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.106 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 20.2 pt20 -141.02 131.75 25.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.887 0.375 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.454 ' CD2' ' HB2' ' A' ' 274' ' ' ASP . 63.7 m-85 -91.66 130.81 37.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.265 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.693 HD22 ' HD2' ' A' ' 273' ' ' PHE . 7.2 mp -63.54 168.65 4.48 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.528 0.68 . . . . 0.0 111.005 175.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.473 ' HD3' ' OE1' ' A' ' 172' ' ' GLN . 2.6 mmp_? -132.45 112.11 11.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' A' ' 270' ' ' MET . 94.7 t -116.33 133.27 63.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.084 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.551 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -137.83 -156.09 7.07 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.174 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -103.45 172.67 6.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.412 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -59.41 -35.83 74.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.571 0.224 . . . . 0.0 111.502 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 61.5 t 70.42 -64.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.82 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.458 HG22 ' HG3' ' A' ' 164' ' ' GLU . 12.2 t -98.06 143.09 25.64 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 69.5 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 122.722 2.281 . . . . 0.0 112.113 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 . . . . . 0 CA--C 1.526 0.055 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.19 -30.28 18.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.047 0.451 . . . . 0.0 109.919 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 231' ' ' ALA . . . -63.0 -37.02 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.1 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.594 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 19.1 t80 -75.95 -22.75 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 110.271 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -75.8 -43.83 44.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.968 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -61.34 -37.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.626 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.63 -49.44 56.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.611 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.718 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.81 -21.77 37.46 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -171.091 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -62.55 -38.18 89.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.568 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 61.3 mtp180 -74.09 -35.43 64.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.629 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.718 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -63.13 -44.24 96.13 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 34.3 mtt180 -81.65 -26.99 34.32 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 112.96 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.66 -49.17 65.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 0.0 109.82 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 6.3 pt -68.05 -30.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.496 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.89 -27.9 67.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.377 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.35 -31.02 19.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 7.3 ttpt -82.18 -38.5 24.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.377 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.638 ' HB ' ' HB3' ' A' ' 219' ' ' ASP . 30.6 pt . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 125.288 1.435 . . . . 0.0 114.043 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.36 0.124 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.26 72.3 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.3 mt -64.95 -38.83 92.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.236 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.45 -31.64 60.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.77 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.61 -36.19 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.362 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.0 mtp -69.24 -34.04 74.2 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 28.5 p -73.78 -11.35 60.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.906 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.695 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 91.8 mtt180 -105.71 103.26 12.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -91.51 146.6 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.466 0.651 . . . . 0.0 111.377 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 61.5 t80 -86.33 118.68 25.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.878 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.15 113.47 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 110.192 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.79 174.51 15.25 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.345 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 t 74.73 42.41 0.29 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.541 0.737 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.54 136.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.331 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -108.84 98.51 7.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.451 ' HD1' ' HA ' ' A' ' 151' ' ' LYS . 34.0 t80 37.87 -84.22 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 165.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -71.87 -16.73 62.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.786 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 127' ' ' THR . 88.8 mt -77.96 98.91 5.84 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.79 -167.53 43.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.108 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.95 -29.36 70.29 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.77 -49.58 76.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.482 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.502 HG21 HD22 ' A' ' 123' ' ' LEU . 55.9 m -64.27 -42.2 96.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.052 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.92 -42.3 88.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.425 0.631 . . . . 0.0 110.133 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.481 ' HA ' ' CD1' ' A' ' 138' ' ' ILE . 39.5 ttt180 -56.56 -46.8 80.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.024 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -77.97 -33.34 51.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.187 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.65 77.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.511 . . . . 0.0 111.207 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.496 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 46.2 m-85 -99.59 10.33 41.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.74 -45.25 16.8 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 23.6 Cg_endo -62.06 -10.44 17.9 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.02 1.813 . . . . 0.0 112.795 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -79.25 -67.61 0.74 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 109.803 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.49 165.91 33.09 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.71 112.33 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.31 2.007 . . . . 0.0 111.293 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 129' ' ' ARG . 56.7 mt -68.51 129.16 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 109.981 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -96.83 -50.92 4.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.684 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 t -149.23 161.88 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.5 mt -137.28 109.91 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.635 0.255 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.797 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 47.8 m-20 -84.33 111.17 19.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.271 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.582 ' HG2' ' HB3' ' A' ' 145' ' ' TRP . 24.7 ttp -156.2 101.12 2.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 0.0 110.782 175.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.0 m -77.95 69.24 4.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.91 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 14.3 p-90 -96.32 145.79 25.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.96 111.18 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.424 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 m -90.83 -12.89 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.86 -54.03 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.967 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.5 p -91.7 -19.27 22.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.164 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.652 ' HG3' ' CZ3' ' A' ' 145' ' ' TRP . 15.3 ttp 66.74 25.77 9.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.318 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.451 ' HA ' ' HD1' ' A' ' 121' ' ' TYR . 59.5 pttt -105.32 19.78 20.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.438 . . . . 0.0 110.968 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.91 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 41.1 m-70 60.2 -161.33 0.28 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.626 173.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 145' ' ' TRP . 74.6 mmtt -117.99 -44.14 2.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 157.29 -21.39 0.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.611 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.64 161.61 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.201 0.5 . . . . 0.0 112.173 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.509 ' HB2' ' SD ' ' A' ' 143' ' ' MET . . . -149.36 156.25 41.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.504 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.797 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 80.8 m-85 -114.04 112.39 23.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 57.5 t -99.07 116.86 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.944 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.695 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 42.4 tt0 -94.15 130.51 40.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.91 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 80.4 m-85 -100.18 155.83 17.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.778 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.99 -33.34 75.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 172.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 17.3 m -128.62 133.31 25.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.038 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 37.6 Cg_exo -60.28 -23.15 73.37 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.323 2.682 . . . . 0.0 113.103 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -54.71 -49.91 69.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 111.211 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.32 70.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.056 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.15 86.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.46 -44.85 93.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.142 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 33.7 mt -63.21 -35.4 80.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 0.0 110.577 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -66.6 -30.6 70.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.633 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.46 -59.34 2.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.27 -39.92 14.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 14.6 mm100 -82.45 -34.69 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 55.9 tpp -72.71 -31.74 65.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.462 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.38 -19.8 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.215 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 41.6 t -78.49 -7.73 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.722 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.56 126.52 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 110.799 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 88.5 mtp -83.96 79.77 9.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 55.7 tp -58.51 118.46 5.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.101 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.07 11.89 83.93 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.406 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.67 5.38 89.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.145 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 181' ' ' ARG . 17.6 mtp180 -112.67 155.3 24.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -91.82 103.84 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.852 0.834 . . . . 0.0 109.106 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.47 146.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.116 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -102.08 110.66 22.68 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 16.1 m -118.64 133.85 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.58 145.72 8.61 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.822 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.589 ' HD3' ' HB2' ' A' ' 115' ' ' TYR . 20.8 ptt180 -151.08 123.9 4.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 1.7 Cg_endo -84.36 72.62 4.99 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.258 2.639 . . . . 0.0 111.011 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 m -64.83 -22.36 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.749 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -155.21 151.11 27.75 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.52 125.0 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.839 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.96 -18.7 8.81 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.986 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -72.78 -57.25 4.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.753 0.311 . . . . 0.0 111.239 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.93 5.64 40.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.058 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.517 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 59.8 tp60 -60.96 -51.71 77.4 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.721 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 15.1 Cg_endo -57.78 -25.04 66.83 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.122 1.881 . . . . 0.0 112.169 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.81 -55.93 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.603 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.6 pt -65.84 -32.0 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -45.95 90.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.887 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.09 -48.68 79.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.699 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.64 -50.87 70.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.171 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -60.96 -41.61 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.046 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.28 -44.26 95.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.435 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.53 -43.06 95.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.539 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.96 66.88 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.874 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 75.8 mtp180 -65.87 -18.51 65.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.094 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.95 55.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 111.167 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -104.05 -19.43 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.273 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 257' ' ' TYR . 88.6 m-20 59.43 30.45 20.13 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.57 177.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.505 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 97.4 mtt180 -88.54 140.56 29.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.229 0.538 . . . . 0.0 111.666 -175.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.723 HD13 ' HE1' ' A' ' 229' ' ' PHE . 8.3 tt -119.95 151.15 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -108.88 126.99 53.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.119 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.518 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.8 p -118.75 122.72 70.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.147 0.499 . . . . 0.0 110.717 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.05 -177.91 3.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.882 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 41.8 m 67.71 16.68 9.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.634 0.774 . . . . 0.0 111.485 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.675 HG13 HD11 ' A' ' 225' ' ' ILE . 66.9 t -62.52 135.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.485 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.78 139.77 47.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.74 -30.97 69.71 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -167.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -79.59 -24.72 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.366 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.801 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -83.63 104.86 14.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 2.4 p -87.39 -177.28 5.89 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.64 -54.39 14.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.989 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.46 -27.9 69.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.936 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.613 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 3.3 m-20 -63.68 -55.58 22.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.332 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.675 HD11 HG13 ' A' ' 216' ' ' VAL . 33.5 mm -60.5 -24.51 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.25 -31.34 68.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.199 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 69.7 m -48.86 -60.39 2.79 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.985 0.898 . . . . 0.0 111.634 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.676 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.1 m -71.0 -45.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.676 -170.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.723 ' HE1' HD13 ' A' ' 211' ' ' ILE . 41.4 m-85 -60.96 -40.31 92.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -76.68 -34.4 58.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.674 -175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.98 -25.14 66.96 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.724 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 6.9 m-30 -73.59 -42.79 61.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.85 -100.8 0.21 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.672 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.76 157.66 43.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.08 138.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.484 . . . . 0.0 110.831 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 15.0 mmtp -88.02 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.556 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 27.0 t -145.03 145.05 31.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.811 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.31 129.58 45.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.6 p -145.11 112.52 6.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.29 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.623 HD23 ' HA3' ' A' ' 253' ' ' GLY . 78.0 mt -85.91 129.58 34.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.11 143.29 56.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -121.41 157.27 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.62 121.93 73.32 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.12 -18.01 60.39 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.139 2.56 . . . . 0.0 113.96 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 p -82.34 -33.99 28.67 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.559 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 45.2 p -112.25 -34.58 5.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 111.847 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.25 59.12 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.597 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.9 141.53 42.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 5.9 p80 -79.0 143.35 35.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 0.0 110.576 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -81.15 156.09 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.147 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -77.69 46.46 2.6 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.88 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.23 157.27 17.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.966 0.383 . . . . 0.0 110.171 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.623 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -167.97 -175.28 37.59 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.355 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.08 141.17 52.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.763 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.555 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 24.2 mm -124.12 135.75 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.048 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 37.1 mt-10 -104.98 141.6 36.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.675 0.274 . . . . 0.0 111.238 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 209' ' ' ASN . 36.3 m-85 -124.25 149.55 46.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.214 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 258' ' ' GLU . 1.1 pm0 -87.22 -17.89 31.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.822 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.755 ' HA ' ' HE3' ' A' ' 259' ' ' LYS . 1.0 OUTLIER -137.28 132.05 33.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.985 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -62.04 -40.75 96.81 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.187 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 13.3 pt20 -63.76 -32.58 74.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 110.694 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.3 t -65.23 -40.66 94.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.1 m -65.13 -36.27 83.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 91.0 mt-30 -61.88 -33.76 74.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.098 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.91 -48.12 64.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.873 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -56.26 -41.68 76.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.661 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 264' ' ' GLN . 22.9 m -65.47 -27.02 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.3 p -94.02 -29.34 15.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.598 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.6 m -92.72 -38.31 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.724 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.8 mmm -65.83 -23.46 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -171.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.432 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 66.6 t30 -59.06 -35.04 72.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.738 . . . . 0.0 110.54 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.411 ' N ' HD22 ' A' ' 272' ' ' LEU . 3.8 mm? -77.84 -10.51 59.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.879 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -58.64 112.2 1.53 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.388 -175.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.15 120.99 35.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.926 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.801 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.0 mm? -120.19 87.57 2.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.202 172.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.63 35.67 18.85 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.949 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.25 62.45 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.937 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -124.43 131.68 53.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 110.394 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -75.68 149.55 38.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.744 HD21 HD23 ' A' ' 275' ' ' LEU . 11.4 mt -79.35 -172.79 3.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.958 0.409 . . . . 0.0 110.056 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.432 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 56.8 mmt-85 -147.08 113.45 5.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.873 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 270' ' ' MET . 21.0 m -122.65 157.66 27.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.14 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -177.17 -171.24 40.51 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.767 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -82.0 140.06 34.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.059 0.457 . . . . 0.0 109.917 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -67.24 -21.33 65.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.795 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 74.6 t 71.12 -65.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.787 0.435 . . . . 0.0 111.008 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.5 t -111.58 140.76 23.49 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 CA--C 1.531 0.347 0 C-N-CA 122.287 1.992 . . . . 0.0 112.135 176.68 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.604 0.716 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.83 -71.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.091 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.68 -38.59 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.894 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.571 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 6.1 t80 -65.4 -17.24 64.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.675 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.622 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.4 mttt -69.68 -49.49 52.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.751 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 14.4 t70 -57.12 -42.27 80.56 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.676 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -45.47 -54.31 7.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.669 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.865 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.91 -21.49 37.32 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -171.453 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 79.8 mt-30 -64.94 -39.37 93.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.821 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 17.7 mmt180 -73.79 -32.96 64.02 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.626 172.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.879 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -66.62 -44.66 81.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.253 36.8 mtp85 -82.33 -25.69 33.67 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.209 -1.557 . . . . 0.0 112.773 172.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -53.29 -47.0 69.55 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.749 HD11 ' HZ ' ' A' ' 273' ' ' PHE . 9.2 pt -67.27 -34.27 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.468 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.521 ' O ' HG23 ' B' ' 45' ' ' ILE . . . -66.36 -25.44 66.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.888 0.375 . . . . 0.0 111.287 176.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.55 -15.53 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.748 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.487 ' HE3' ' HB3' ' B' ' 44' ' ' LYS . 1.5 tmmt? -89.84 -33.74 16.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.521 HG23 ' O ' ' B' ' 42' ' ' ALA . 7.3 pt . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.65 157.54 19.66 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.68 -0.119 . . . . 0.0 110.68 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 48.8 ttm 64.94 78.13 0.29 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.594 0.559 . . . . 0.0 110.055 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.96 90.66 4.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.848 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -95.1 -31.26 13.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.575 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 49.79 74.27 0.21 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.223 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 62.83 95.52 0.04 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.305 -173.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -54.21 -31.38 52.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.536 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 111' ' ' MET . . . -56.77 -48.66 77.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.973 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.48 HD11 ' HG3' ' A' ' 163' ' ' PRO . 59.0 tp -71.47 -36.62 71.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.93 84.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.369 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.2 pt -78.6 -34.55 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.427 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 107' ' ' ALA . 89.9 mtp -61.52 -26.76 68.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -84.35 -2.19 56.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.6 0.238 . . . . 0.0 111.279 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 27.0 ttp180 -128.74 109.48 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.927 0.394 . . . . 0.0 110.714 -175.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.1 m -92.57 141.28 14.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.484 0.659 . . . . 0.0 111.649 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 53.0 t80 -86.09 130.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.982 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 111.71 37.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.07 0.462 . . . . 0.0 110.085 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.07 155.73 15.95 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.928 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.1 m 68.87 49.97 0.64 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 110.462 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.45 127.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.185 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -45.17 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.867 0.729 . . . . 0.0 112.79 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -178.38 -64.54 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.559 0.219 . . . . 0.0 110.98 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.12 18.98 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.006 0.431 . . . . 0.0 112.087 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 3.6 pp -130.21 141.3 50.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.954 0.407 . . . . 0.0 110.489 176.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.66 -152.43 5.96 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.59 -31.57 69.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.528 0.664 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.22 -43.41 98.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.132 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 2.1 m -84.87 -43.77 13.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.336 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.44 -36.58 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -55.71 -44.13 77.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.95 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -77.82 -34.75 51.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.312 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.27 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.636 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 98.2 m-85 -108.14 12.07 27.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.609 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.55 -44.87 46.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.268 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 17.8 Cg_endo -61.19 -17.28 51.61 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.215 1.943 . . . . 0.0 112.553 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -80.05 -70.16 0.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.47 155.06 26.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.544 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 24.5 Cg_exo -64.13 132.5 34.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.621 2.214 . . . . 0.0 111.586 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.68 110.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.164 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.899 ' HD3' ' HG2' ' A' ' 161' ' ' GLU . 39.2 tptt -83.26 -46.96 12.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.063 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -160.15 153.99 22.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.33 123.09 49.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.741 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 21.2 m-20 -90.44 97.34 11.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 14.0 tpt -105.82 148.67 27.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.002 0.43 . . . . 0.0 111.371 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.0 m -119.09 84.31 2.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.704 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -80.2 116.38 20.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 153' ' ' LYS . 14.9 t70 -95.8 117.2 30.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.649 ' HB3' HG22 ' A' ' 149' ' ' THR . 43.9 t 69.13 162.73 0.22 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.059 0.849 . . . . 0.0 111.733 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.45 -22.32 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.649 HG22 ' HB3' ' A' ' 147' ' ' SER . 9.8 t -60.29 -25.12 65.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.102 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.2 mtt 64.32 43.36 4.77 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.827 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.513 ' HG2' HG23 ' A' ' 149' ' ' THR . 31.4 mmmt -93.23 12.79 23.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.052 0.453 . . . . 0.0 110.813 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.0 p80 41.56 44.69 2.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.489 1.116 . . . . 0.0 113.079 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 28.4 tttm -70.75 96.99 1.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.347 0.594 . . . . 0.0 110.033 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 158.18 -129.27 2.27 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.221 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -148.36 170.46 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.238 0.215 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.19 153.13 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 111.047 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HE2' ' HD2' ' A' ' 187' ' ' ARG . 90.6 m-85 -123.14 124.8 43.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.036 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.2 t -106.22 111.04 33.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 31.8 tt0 -99.58 131.04 45.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -105.68 174.15 6.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.085 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.899 ' HG2' ' HD3' ' A' ' 139' ' ' LYS . 32.2 mt-10 -85.4 -16.26 40.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.097 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.81 135.29 21.5 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.4 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.48 ' HG3' HD11 ' A' ' 108' ' ' LEU . 55.4 Cg_endo -69.87 -17.77 36.9 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.987 2.458 . . . . 0.0 112.197 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -62.85 -40.21 96.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.696 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.92 89.16 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.248 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.84 86.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.483 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -62.2 -47.1 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 283' ' ' GLY . 34.4 mt -66.59 -33.49 75.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.15 0.5 . . . . 0.0 110.561 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.614 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -64.77 -34.13 77.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.298 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.17 -55.47 5.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.972 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.93 -47.68 76.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.511 ' HG2' ' HD2' ' A' ' 281' ' ' ARG . 17.1 mp0 -91.0 -49.88 6.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.636 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 12.6 mmt -66.97 -30.81 71.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.76 -21.28 37.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.151 0.5 . . . . 0.0 110.891 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.2 m -90.98 -24.01 20.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.114 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.2 t -116.0 119.51 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.193 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 89.6 mtp -67.19 108.7 2.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 110.882 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 178' ' ' LEU . 2.5 pt? -81.2 7.54 10.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.799 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.53 -167.29 35.53 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.98 25.42 2.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.629 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -158.3 133.69 8.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -91.96 129.47 37.91 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.4 pt -91.61 151.69 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 184' ' ' LYS . 20.6 ptmt -100.95 116.59 33.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.0 t -103.24 122.46 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.546 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 105.96 172.99 23.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.419 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.669 ' HD2' ' HE2' ' A' ' 157' ' ' PHE . 75.7 mtp180 -130.0 92.22 37.28 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.624 0.25 . . . . 0.0 110.411 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.06 80.54 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.894 2.396 . . . . 0.0 111.661 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -143.9 -54.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.18 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -90.04 5.89 44.68 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.09 0.472 . . . . 0.0 111.212 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 39.9 pt -68.11 153.61 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 88.78 -51.74 3.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.928 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.33 69.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.37 0.605 . . . . 0.0 109.764 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -91.53 1.56 57.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.976 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.554 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.7 tp60 -59.57 -50.04 89.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.103 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 11.2 Cg_endo -55.52 -27.46 59.61 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.353 2.036 . . . . 0.0 112.221 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.9 mm -77.38 -43.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.322 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 80.7 mt -59.52 -50.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.89 -29.92 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.206 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -68.01 -50.08 57.67 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.63 -48.56 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.028 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.03 93.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.224 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 206' ' ' ARG . 3.3 tp10 -69.39 -33.51 73.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.511 . . . . 0.0 110.659 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.02 -45.12 62.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.369 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.12 -24.79 64.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 203' ' ' GLU . 68.3 ttt180 -60.45 -25.04 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.908 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.54 -16.45 64.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -104.96 -4.94 21.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.155 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 32.32 43.17 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 114.252 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 256' ' ' GLU . 24.8 mtp180 -90.16 141.8 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.697 HD13 ' HE1' ' A' ' 229' ' ' PHE . 12.8 tt -99.14 152.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.532 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -107.67 124.54 50.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 0.0 110.24 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 255' ' ' ILE . 17.6 t -108.41 116.88 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.002 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.539 ' O ' ' HG ' ' A' ' 280' ' ' LEU . . . -121.07 173.83 7.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.56 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 35.0 m 64.85 28.33 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.744 0.653 . . . . 0.0 110.778 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.548 HG13 HD11 ' A' ' 225' ' ' ILE . 57.7 t -72.69 133.87 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.374 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 13.6 t-80 -69.1 135.04 50.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 109.764 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -55.62 -41.74 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.667 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.604 ' HB2' ' HB ' ' B' ' 45' ' ' ILE . 2.6 p30 -80.35 -46.95 15.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.625 HD13 HD22 ' A' ' 275' ' ' LEU . 0.1 OUTLIER -50.72 122.69 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.403 0.681 . . . . 0.0 109.954 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 225' ' ' ILE . 22.1 m -99.74 -178.46 3.88 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -167.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.13 -55.42 31.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.014 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 226' ' ' LYS . 2.6 m-20 -62.88 -27.35 69.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.411 ' HB3' HD12 ' B' ' 41' ' ' ILE . 71.9 m-20 -66.66 -49.17 67.04 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.749 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.548 HD11 HG13 ' A' ' 216' ' ' VAL . 21.8 mm -61.16 -24.74 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.271 0.558 . . . . 0.0 109.971 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 223' ' ' ASP . 11.0 mmmm -59.43 -31.8 69.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 174.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 71.2 m -47.79 -54.94 10.83 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.506 0.669 . . . . 0.0 111.034 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.611 HG12 ' HB1' ' B' ' 34' ' ' ALA . 12.5 m -75.24 -49.97 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.665 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.697 ' HE1' HD13 ' A' ' 211' ' ' ILE . 50.0 m-85 -61.21 -46.99 88.19 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.55 ' HB2' ' HE2' ' A' ' 226' ' ' LYS . 27.9 tt0 -77.94 -12.53 59.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.368 . . . . 0.0 111.272 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.62 51.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.357 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.694 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 0.9 OUTLIER -93.82 -52.66 4.34 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -138.74 -164.5 9.93 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.438 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -108.82 139.1 44.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.549 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.635 ' HB ' ' HE3' ' A' ' 226' ' ' LYS . 3.2 mp -120.27 134.37 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -97.73 -29.06 13.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 111.721 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.6 t -143.34 132.44 23.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.545 ' SG ' ' HD3' ' A' ' 226' ' ' LYS . 9.1 p -144.03 113.56 7.05 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.836 0.35 . . . . 0.0 110.599 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 63.4 m -151.37 122.43 7.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.517 . . . . 0.0 111.353 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.683 HD23 ' HA3' ' A' ' 253' ' ' GLY . 43.4 mt -85.1 130.04 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.61 129.63 42.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.691 0.281 . . . . 0.0 110.907 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -78.97 140.47 38.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.558 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.3 t70 -111.55 116.82 50.03 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.42 -27.88 46.74 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 123.138 2.559 . . . . 0.0 113.659 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.42 HG22 ' OD1' ' A' ' 243' ' ' ASP . 5.1 t -93.32 -27.76 16.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.991 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.3 m -81.14 -36.67 29.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.061 0.458 . . . . 0.0 110.167 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 96.74 -18.45 57.48 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.738 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -108.04 -84.67 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 0.0 110.46 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -164.08 154.02 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.558 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 56.0 mttm -71.41 155.38 40.7 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.64 31.52 1.03 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 121.293 -0.479 . . . . 0.0 113.661 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 27.1 p90 -152.97 164.02 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.109 0.454 . . . . 0.0 110.281 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.683 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -164.15 168.42 38.58 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.62 114.57 26.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.041 0.448 . . . . 0.0 110.582 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.425 HD12 HG21 ' A' ' 213' ' ' VAL . 43.8 mt -107.1 139.73 27.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.822 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 210' ' ' ARG . 38.1 tt0 -115.67 115.52 26.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.698 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.31 152.93 21.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.554 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.518 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 15.0 pt-20 -88.75 -16.98 30.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.878 0.371 . . . . 0.0 110.494 177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.518 ' HG3' ' HG3' ' A' ' 258' ' ' GLU . 22.5 mtpp -128.57 135.77 49.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.11 -25.17 61.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.618 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -66.03 -50.33 64.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.211 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.9 m -63.61 -33.87 76.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.439 -176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 267' ' ' VAL . 31.7 t -57.3 -46.91 82.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.178 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.55 -34.67 77.53 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.83 -44.43 96.17 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.243 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.22 80.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 263' ' ' SER . 62.0 t -52.73 -36.35 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.853 0.359 . . . . 0.0 111.508 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 42.8 m -69.08 -24.76 64.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 38.9 m -115.33 -27.15 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.587 ' HE1' HG21 ' A' ' 228' ' ' VAL . 43.4 mmm -66.94 -13.69 62.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.28 -35.86 80.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.11 0.957 . . . . 0.0 109.121 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.5 mm? -77.39 -9.28 58.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.981 -175.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.922 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 6.2 t80 -51.26 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.137 0.494 . . . . 0.0 111.173 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -82.97 121.49 27.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.242 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.625 HD22 HD13 ' A' ' 220' ' ' LEU . 65.9 mt -125.66 85.87 2.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.041 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.54 27.09 57.93 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.871 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 110.43 -17.42 28.6 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.46 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 18.0 pt20 -102.21 130.45 48.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.816 0.341 . . . . 0.0 110.721 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -80.18 134.61 36.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.654 HD22 ' HD2' ' A' ' 273' ' ' PHE . 2.4 tp -66.78 -178.51 0.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.968 0.792 . . . . 0.0 110.78 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.511 ' HD2' ' HG2' ' A' ' 172' ' ' GLN . 5.6 tpp180 -148.52 112.68 5.21 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.84 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 270' ' ' MET . 18.6 m -111.48 159.48 11.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.558 . . . . 0.0 111.897 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -157.8 -136.03 2.01 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.687 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -142.86 167.75 21.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -87.71 124.92 34.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.03 -29.73 3.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.381 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.7 t -129.94 143.87 50.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -51.04 104.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.34 2.693 . . . . 0.0 112.15 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.04 40.11 0.91 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.974 2.45 . . . . 0.0 112.399 -173.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 82.2 mtp -133.73 136.95 27.6 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.652 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.54 69.28 2.75 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 122.847 2.365 . . . . 0.0 112.196 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.37 40.71 1.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 110.246 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.54 96.89 6.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.259 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.767 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 25.6 m -61.48 -54.69 50.01 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.479 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.767 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 62.8 Cg_endo -91.27 123.11 0.78 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.15 1.9 . . . . 0.0 112.618 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -84.57 67.35 9.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.111 0.481 . . . . 0.0 110.585 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.605 -0.712 . . . . 0.0 110.715 -177.843 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 112.186 -0.366 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.64 132.56 34.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.92 0.391 . . . . 0.0 111.053 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -83.15 166.05 18.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.966 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.97 -53.82 4.4 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -100.65 53.18 0.87 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.558 HG23 ' HB2' ' B' ' 31' ' ' PHE . 25.7 m -62.13 133.08 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.691 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 7.5 t30 -94.52 -46.07 7.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.549 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.91 -46.61 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 -43.53 77.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.694 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 9.8 t80 -78.97 -22.51 45.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.958 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.8 mtpt -79.06 -35.01 43.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.785 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.527 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 58.1 t0 -57.07 -46.48 82.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.689 ' HB2' ' CE1' ' A' ' 232' ' ' PHE . . . -49.09 -52.9 23.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.169 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.803 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.7 -25.28 35.6 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -168.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 32.8 mt-30 -63.24 -38.05 89.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.703 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 67.3 mtt180 -71.57 -39.29 70.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.734 172.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.922 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.98 -46.85 85.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.147 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.262 31.9 mtt-85 -80.51 -24.35 39.45 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.898 174.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 56.1 tt0 -53.63 -49.87 66.95 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.248 0.546 . . . . 0.0 109.976 167.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.809 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -65.69 -30.45 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -21.84 42.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.387 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.91 72.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.732 ' HG3' HG12 ' B' ' 45' ' ' ILE . 48.5 pttt -72.66 -43.91 62.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.448 174.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.732 HG12 ' HG3' ' B' ' 44' ' ' LYS . 5.7 pt -139.37 116.64 10.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.851 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.09 -51.36 0.84 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.855 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.69 104.92 0.23 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.878 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.21 123.48 24.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.834 0.349 . . . . 0.0 110.488 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.57 13.49 28.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.206 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.42 -97.07 1.84 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.163 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.5 m -89.41 -67.61 0.83 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.129 0.49 . . . . 0.0 110.098 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 46.9 p . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.895 179.388 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.59 84.59 0.14 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 122.968 0.507 . . . . 0.0 111.625 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.2 ttt -69.52 -31.67 70.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.604 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.23 64.88 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.198 0.523 . . . . 0.0 111.413 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -81.9 67.98 8.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.942 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.567 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.0 ptt180 -74.06 -7.6 53.09 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.421 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.41 -50.76 58.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.361 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -70.32 -29.37 66.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.169 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.07 96.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.412 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 79.9 mt -63.64 -36.98 85.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.56 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.55 -28.08 66.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.824 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.36 -43.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.137 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 81.4 mmm -61.24 -40.55 94.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.094 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.452 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 98.8 m -65.22 -19.57 66.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 9.8 ptm85 -116.27 107.18 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.528 0.68 . . . . 0.0 111.264 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.8 m -97.33 135.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.363 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 19.4 t80 -78.35 126.78 31.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.384 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 185' ' ' VAL . 15.3 m -123.67 111.64 29.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.419 0.628 . . . . 0.0 110.02 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -133.9 102.76 0.47 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.625 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.622 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.6 t 168.12 77.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.3 mt -110.16 134.56 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.06 -75.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.17 0.294 . . . . 0.0 111.199 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -169.12 -53.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.198 0.523 . . . . 0.0 110.359 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -19.6 19.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.817 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.58 108.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 0.0 110.792 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 152' ' ' HIS . . . -83.09 -178.77 52.41 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.614 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.47 -24.42 65.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.749 0.309 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.47 -43.53 93.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.323 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -62.19 -44.58 96.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.71 -46.75 91.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 110.57 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.528 ' HG3' HG13 ' A' ' 138' ' ' ILE . 70.6 ttt180 -57.47 -45.75 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.006 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -77.25 -19.15 56.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.43 57.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.762 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 74.0 m-85 -101.86 7.45 41.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 110.797 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -72.14 -42.37 9.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.928 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 133' ' ' ALA . 36.6 Cg_exo -63.59 -4.97 7.74 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.155 1.903 . . . . 0.0 112.716 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -92.7 -75.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.784 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.77 168.86 25.8 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 18.6 Cg_exo -66.14 133.71 34.07 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.54 2.16 . . . . 0.0 111.585 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.528 HG13 ' HG3' ' A' ' 129' ' ' ARG . 47.6 mm -72.02 114.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.358 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -94.71 -46.03 7.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 29.9 t -143.88 135.22 25.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 110.946 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.467 HG22 ' HG3' ' A' ' 143' ' ' MET . 65.9 mt -116.65 106.12 19.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.436 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.2 m-20 -111.33 98.28 7.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.467 ' HG3' HG22 ' A' ' 141' ' ' ILE . 79.7 mtp -109.5 163.68 13.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.466 . . . . 0.0 111.148 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.41 ' O ' ' HA3' ' A' ' 154' ' ' GLY . 66.6 m -145.87 85.67 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.83 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.443 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 13.1 p-90 -144.92 160.13 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.697 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.48 91.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.2 m -85.35 -9.53 57.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.361 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 m -80.15 -52.1 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.623 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -112.9 21.38 15.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.443 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 89.7 mmm 61.69 -157.2 0.34 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.16 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm 73.54 105.42 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -172.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.423 ' NE2' ' HA2' ' A' ' 124' ' ' GLY . 14.8 m-70 -77.6 68.87 3.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.35 31.73 1.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.999 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 144' ' ' SER . . . -139.68 175.25 21.88 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.813 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -114.37 173.51 6.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.425 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -139.9 148.51 42.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.461 . . . . 0.0 111.689 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.449 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 86.2 m-85 -116.94 118.67 33.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -110.1 120.03 60.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.302 0.572 . . . . 0.0 110.958 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.8 tt0 -107.63 134.76 50.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.906 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.61 167.15 9.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.889 0.376 . . . . 0.0 111.647 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.3 -45.28 88.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.168 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.593 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 23.9 m -115.73 138.2 23.76 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.113 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.452 ' HG3' ' SG ' ' A' ' 112' ' ' CYS . 16.5 Cg_exo -68.09 -20.48 43.98 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.4 2.734 . . . . 0.0 112.29 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.593 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 4.0 mp0 -56.52 -52.24 65.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.469 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.43 62.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.47 53.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -73.13 -32.62 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.754 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.464 HD22 ' CE2' ' A' ' 212' ' ' TYR . 25.2 tp -57.42 -48.6 78.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.034 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.32 99.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.708 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.531 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 4.9 tt -59.51 -62.48 1.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.039 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.18 -35.21 74.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.383 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.656 ' HG3' ' HD2' ' A' ' 281' ' ' ARG . 84.9 mm-40 -83.19 -49.5 9.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.762 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 20.6 mmt -73.7 -31.44 63.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -75.01 -16.92 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.403 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.2 m -91.83 -12.25 34.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 173' ' ' MET . 33.6 m -110.59 140.17 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.345 0.593 . . . . 0.0 111.618 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 27.4 ttt -90.72 105.12 17.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.713 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.83 91.57 0.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.46 . . . . 0.0 110.162 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 63.64 -130.21 39.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.829 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.55 5.24 80.19 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.013 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.73 102.64 6.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.311 0.576 . . . . 0.0 110.498 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.77 128.98 38.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.905 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.622 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 21.0 pt -89.39 144.71 8.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.886 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -102.39 110.84 22.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.432 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 116' ' ' VAL . 47.1 t -125.12 136.23 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.454 -174.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.531 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 92.57 46.42 3.48 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.971 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.65 ' HA ' HD11 ' A' ' 191' ' ' ILE . 41.5 ttt85 -139.44 78.69 26.65 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.227 0.514 . . . . 0.0 111.118 175.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 -62.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.587 2.191 . . . . 0.0 111.723 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.4 p -171.63 -52.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.557 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 12.6 m120 -81.51 68.66 7.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.005 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.65 HD11 ' HA ' ' A' ' 187' ' ' ARG . 50.0 mm -74.68 108.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.858 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.89 -8.06 57.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.643 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.557 ' OE1' ' HA ' ' A' ' 190' ' ' ASN . 53.5 mt-30 -77.14 -12.63 59.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 111.259 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.59 16.84 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.622 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.574 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.0 tp60 -58.45 -52.24 76.06 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.441 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 51.5 Cg_exo -55.85 -30.05 75.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.768 1.645 . . . . 0.0 112.062 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 47.8 mm -72.61 -56.11 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.769 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 201' ' ' LEU . 35.2 pt -66.7 -30.74 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.33 -42.05 96.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.397 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 203' ' ' GLU . 88.9 mt-30 -69.72 -35.81 75.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.709 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.546 HD21 ' HD2' ' A' ' 104' ' ' ARG . 95.6 mt -62.03 -50.66 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.21 -29.65 70.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.72 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 206' ' ' ARG . 39.2 tt0 -62.42 -52.42 63.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.055 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.94 -29.24 68.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.5 . . . . 0.0 110.502 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.71 68.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.596 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 203' ' ' GLU . 51.1 mtt180 -64.26 -25.54 68.1 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.43 -18.87 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.587 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.18 -29.3 11.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 0.0 110.914 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 58.66 23.98 11.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.688 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 12.3 ptp180 -89.48 150.56 22.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.995 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.98 168.04 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.337 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' A' ' 285' ' ' ALA . 71.7 t80 -112.33 121.66 45.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.382 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.52 123.18 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.286 0.565 . . . . 0.0 110.351 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.37 178.31 5.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.721 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.6 m 68.75 25.94 6.22 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 124.022 0.826 . . . . 0.0 111.481 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.586 HG21 HD13 ' A' ' 240' ' ' LEU . 10.8 m -77.2 164.38 3.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.53 ' HB2' HD23 ' A' ' 275' ' ' LEU . 6.9 t-80 -81.09 147.17 30.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -57.31 -55.86 29.29 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.718 ' HB2' HG13 ' B' ' 45' ' ' ILE . 0.2 OUTLIER -70.08 -48.36 58.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.689 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 1.011 HD11 HG13 ' B' ' 41' ' ' ILE . 0.4 OUTLIER -61.13 114.99 3.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.024 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.2 t -100.43 -177.06 3.39 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -166.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 240' ' ' LEU . 4.3 p30 -60.31 -37.73 81.5 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.64 -31.31 69.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.617 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 13.4 m-20 -78.2 -53.87 6.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.42 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.643 HG13 HD11 ' A' ' 240' ' ' LEU . 32.4 mm -54.89 -25.59 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.041 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -55.79 -33.34 64.31 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.519 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.47 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 69.2 m -49.46 -56.0 11.26 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.693 0.758 . . . . 0.0 111.716 -174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.663 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.4 m -74.61 -49.68 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.734 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' A' ' 235' ' ' ILE . 58.3 m-85 -60.89 -41.68 96.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.917 0.389 . . . . 0.0 111.626 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.541 ' HB2' HD12 ' A' ' 235' ' ' ILE . 1.1 tm-20 -76.26 -22.4 55.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.34 -23.49 61.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.901 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.808 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 1.0 OUTLIER -93.92 -33.42 13.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.226 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -163.67 -179.78 38.22 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.3 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 258' ' ' GLU . 9.1 mmmm -74.66 122.65 23.54 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.676 HG21 ' HB2' ' A' ' 238' ' ' CYS . 55.2 mt -97.57 132.82 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 172.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.71 ' HD2' ' HA ' ' A' ' 258' ' ' GLU . 29.3 mtpp -100.8 -46.01 5.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.198 0.523 . . . . 0.0 110.362 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.5 m -136.28 93.88 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.676 ' HB2' HG21 ' A' ' 235' ' ' ILE . 48.3 t -96.76 113.17 24.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.0 m -151.12 116.85 5.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.619 0.247 . . . . 0.0 110.99 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.798 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 78.7 mt -85.34 130.02 34.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.81 134.69 54.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.806 0.336 . . . . 0.0 110.35 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.828 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 12.3 ptm180 -117.7 157.42 26.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.035 0.445 . . . . 0.0 110.889 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.452 ' OD1' HG22 ' A' ' 245' ' ' THR . 9.6 t70 -88.01 122.71 69.86 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.089 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.96 -19.0 40.54 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.112 2.542 . . . . 0.0 114.546 -172.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.452 HG22 ' OD1' ' A' ' 243' ' ' ASP . 6.4 t -99.17 -30.12 12.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.513 -174.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 36.3 p -94.23 -26.35 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.986 0.422 . . . . 0.0 110.622 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.85 -18.49 53.07 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.278 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.81 150.29 22.31 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.828 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.8 p80 -75.61 152.41 37.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.313 0.578 . . . . 0.0 111.215 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.66 158.71 22.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.188 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.455 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -72.22 43.16 0.83 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.445 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 43.3 p90 -165.63 166.07 18.32 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.798 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.63 -174.4 40.57 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.552 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.577 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 94.3 m-85 -122.58 124.88 44.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.986 0.422 . . . . 0.0 110.267 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.2 mt -120.29 126.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 36.0 tt0 -103.67 136.61 43.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.459 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -109.23 151.54 26.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.757 0.789 . . . . 0.0 112.191 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.71 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 3.1 tp10 -80.24 -21.79 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.628 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 50.2 mtpt -143.17 140.14 30.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.807 -171.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.4 -33.64 76.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.86 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -63.61 -41.02 98.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.411 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.504 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 21.7 m -67.8 -39.85 83.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 267' ' ' VAL . 7.8 p -69.61 -32.8 71.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -66.46 -44.07 83.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.423 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.458 ' CG ' HG23 ' B' ' 27' ' ' VAL . 1.7 m-20 -65.39 -39.51 92.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.56 76.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.259 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 263' ' ' SER . 90.8 t -62.5 -29.03 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 111.58 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 p -89.89 -10.12 46.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 27.8 t -115.84 -40.24 3.37 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.808 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 30.5 mmm -70.84 -14.67 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.91 0.862 . . . . 0.0 110.36 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.213 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.653 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 51.6 t80 -56.94 98.82 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.521 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 13.5 t70 -82.77 119.86 24.88 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.926 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.875 HD21 HD22 ' A' ' 220' ' ' LEU . 19.7 tp -126.09 86.88 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.45 22.68 39.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.551 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.4 15.29 30.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.614 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 26.9 pt20 -140.67 132.37 27.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.653 0.263 . . . . 0.0 110.395 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.33 133.61 42.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 216' ' ' VAL . 1.0 OUTLIER -71.95 -169.78 0.51 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 0.0 110.972 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.656 ' HD2' ' HG3' ' A' ' 172' ' ' GLN . 21.1 tpp180 -147.79 116.39 6.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.47 139.0 52.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -160.42 -178.81 34.73 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.615 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -72.16 152.2 42.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.43 -20.06 66.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.4 t 71.07 -77.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 122.547 0.339 . . . . 0.0 111.764 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 0.1 OUTLIER -110.7 121.9 39.76 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.014 0.435 . . . . 0.0 111.956 -174.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 287' ' ' THR . 74.2 Cg_endo -90.29 110.04 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.924 2.416 . . . . 0.0 112.41 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 288' ' ' PRO . 47.4 Cg_endo -71.18 110.99 2.97 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.481 2.121 . . . . 0.0 111.877 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.458 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 83.7 mtp -88.6 119.74 70.12 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.798 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 3.6 Cg_exo -80.65 88.79 1.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.059 2.506 . . . . 0.0 111.285 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 49.4 tp -131.84 90.81 2.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.024 0.44 . . . . 0.0 110.928 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 52.2 tp -108.22 90.75 3.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.703 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 2.6 p -117.52 102.55 51.84 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.571 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.56 58.92 6.04 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.257 2.638 . . . . 0.0 111.865 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -90.06 75.41 7.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.328 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 29.1 m . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.13 177.166 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.184 -0.367 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.43 71.07 8.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.198 0.523 . . . . 0.0 111.223 -175.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.41 ' O ' ' HD1' ' B' ' 26' ' ' TYR . 70.6 mtm -128.97 146.48 50.96 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.32 126.83 7.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.871 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.41 ' HD1' ' O ' ' B' ' 24' ' ' MET . 41.1 p90 -150.12 23.24 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -176.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.458 HG23 ' CG ' ' A' ' 265' ' ' ASP . 23.8 t -59.85 121.42 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.121 0.486 . . . . 0.0 110.727 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -137.8 -52.41 0.63 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.372 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.27 -33.02 26.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.116 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.42 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -66.35 -31.25 71.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.151 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.58 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.9 t80 -74.29 -19.61 60.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.336 0.589 . . . . 0.0 110.49 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 53.3 mttp -76.37 -43.76 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -39.71 77.99 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.403 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.679 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.24 -52.57 43.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.904 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.683 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.44 -21.95 38.5 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 41.3 mt-30 -63.15 -38.16 90.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.542 ' O ' HG23 ' B' ' 41' ' ' ILE . 76.5 mtp180 -73.71 -35.38 65.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.226 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.802 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -61.47 -45.89 92.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' B' ' 39' ' ' ARG 0.253 16.5 mtp180 -81.38 -25.96 35.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.474 -1.391 . . . . 0.0 113.095 174.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -53.49 -49.72 66.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.155 168.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 1.011 HG13 HD11 ' A' ' 220' ' ' LEU . 3.9 pt -61.45 -37.91 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.076 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.61 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -71.85 -22.37 61.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.095 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.69 -45.57 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.08 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 20.6 pttp -74.96 -23.76 58.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.718 HG13 ' HB2' ' A' ' 219' ' ' ASP . 8.3 tp -147.19 102.79 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 122.083 0.944 . . . . 0.0 110.052 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' A' ' 219' ' ' ASP . . . -161.01 -144.86 4.11 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.03 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.01 35.11 4.99 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.453 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -163.37 160.45 23.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.65 -6.34 58.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.373 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.99 41.2 4.12 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.378 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.71 52.79 1.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.344 0.593 . . . . 0.0 111.289 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.83 176.416 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.41 114.07 16.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.763 0.316 . . . . 0.0 110.506 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.465 ' HB3' HD23 ' A' ' 108' ' ' LEU . 10.0 tpt 58.73 43.49 18.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.226 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.47 -17.98 61.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.187 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -82.98 -4.48 58.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.021 0.438 . . . . 0.0 110.864 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -96.39 -55.8 2.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -147.73 116.23 6.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.011 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -58.83 -33.54 70.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.75 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.6 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.313 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 101' ' ' MET . 61.6 tp -73.77 -30.78 62.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.284 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.76 -29.49 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.094 0.473 . . . . 0.0 110.716 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.73 -38.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.483 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.77 -26.8 68.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.349 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 160' ' ' TYR . 15.5 p -92.3 -1.16 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.58 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -118.27 118.95 33.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.4 HG23 HG13 ' A' ' 158' ' ' VAL . 13.2 m -112.62 125.54 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 111.207 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 27.4 t80 -73.74 137.15 43.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.125 175.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.12 110.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 123.415 0.447 . . . . 0.0 109.822 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.2 170.54 13.96 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.111 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 6.4 t 62.68 48.67 4.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.423 0.63 . . . . 0.0 110.376 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -81.85 71.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.437 ' HB3' ' H ' ' A' ' 121' ' ' TYR . 22.3 t80 36.31 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.554 1.159 . . . . 0.0 112.512 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.437 ' H ' ' HB3' ' A' ' 120' ' ' TYR . 38.3 t80 -178.71 -62.03 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -91.63 45.21 1.21 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.072 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.0 125.84 49.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.983 0.42 . . . . 0.0 110.622 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.49 159.08 23.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.26 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.53 -36.74 74.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 111.268 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.69 -32.52 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.413 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 m -76.53 -41.26 47.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.901 0.381 . . . . 0.0 111.154 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 63.7 mt -72.72 -41.05 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.251 0.548 . . . . 0.0 110.104 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -54.4 -41.21 69.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.151 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -76.92 -22.98 52.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.28 74.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 110.594 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.42 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 71.4 m-85 -96.54 4.65 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.586 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -63.01 -44.07 83.89 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.857 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.624 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.2 Cg_endo -69.1 -4.33 13.37 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.012 1.808 . . . . 0.0 113.37 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.622 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 2.7 m-85 -81.06 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.965 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.87 172.99 39.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.176 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.37 128.73 27.08 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.21 117.91 28.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.859 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.591 ' HD3' ' CG ' ' A' ' 161' ' ' GLU . 51.1 tptt -87.34 -53.75 4.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.227 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.8 m -145.79 151.16 37.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.154 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -135.5 107.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 6.4 m-20 -92.3 96.23 10.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.28 0.562 . . . . 0.0 110.172 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.446 ' CE ' ' HB2' ' A' ' 156' ' ' ALA . 41.2 tpp -123.94 94.01 4.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.287 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 t -83.63 84.1 7.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.379 0.609 . . . . 0.0 109.479 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.774 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 0.1 OUTLIER -134.05 160.77 36.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.098 -178.213 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.33 102.72 15.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 m -66.16 -23.5 66.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.295 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.23 -33.89 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 m -96.69 -13.06 23.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.0 110.563 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 45.5 ttm 58.32 34.35 23.97 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.316 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -126.03 143.58 51.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.287 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.774 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 22.8 p80 -103.93 112.39 25.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.142 0.496 . . . . 0.0 111.165 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -76.38 -15.3 59.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.135 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.89 -152.75 8.37 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.568 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.88 175.2 9.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.446 ' HB2' ' CE ' ' A' ' 143' ' ' MET . . . -99.14 137.32 37.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.066 0.46 . . . . 0.0 111.975 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.643 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 95.4 m-85 -117.73 106.45 13.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 169.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 114' ' ' VAL . 2.7 p -100.46 122.71 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.813 0.816 . . . . 0.0 110.377 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.1 135.19 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.106 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 41.9 m-85 -115.23 164.98 13.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.591 ' CG ' ' HD3' ' A' ' 139' ' ' LYS . 33.6 mt-10 -95.66 10.02 38.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.338 0.59 . . . . 0.0 109.499 170.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.45 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.0 m -130.25 115.11 17.38 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.213 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 162' ' ' VAL . 20.4 Cg_endo -62.43 -21.73 73.13 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.745 2.296 . . . . 0.0 111.686 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 285' ' ' ALA . 15.9 mp0 -59.47 -63.59 1.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.601 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -57.49 -33.46 68.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.599 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.43 62.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.646 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.49 -33.95 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.494 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.441 HD21 ' HG3' ' A' ' 281' ' ' ARG . 8.9 tt -61.29 -48.32 81.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.03 -39.84 91.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.623 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.4 tt -58.83 -55.03 40.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -75.35 -48.14 24.4 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -91.85 -0.36 57.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -165.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.475 ' HG3' HD11 ' A' ' 183' ' ' ILE . 55.1 tpp -116.42 -32.75 5.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.086 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 6.7 t30 -68.75 -27.04 65.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.365 0.603 . . . . 0.0 110.351 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -90.83 17.18 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.889 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.12 142.79 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.219 0.533 . . . . 0.0 110.623 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.54 100.91 10.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.085 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.94 -55.65 32.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.554 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.84 69.09 0.31 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.382 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.86 -38.89 2.37 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.566 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.497 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 5.2 mpt_? -97.52 136.67 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.3 118.24 17.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 24.1 pt -84.7 157.03 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.121 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -104.18 110.92 23.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 46.3 t -120.4 128.79 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.765 0.317 . . . . 0.0 110.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.623 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 110.9 -105.47 1.9 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.027 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 14.3 mmt180 66.56 78.06 0.25 Allowed Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.137 0.575 . . . . 0.0 112.456 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.99 97.36 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.831 2.354 . . . . 0.0 110.654 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.3 t -75.48 -28.31 59.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -84.82 80.03 9.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.347 0.594 . . . . 0.0 110.988 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.33 62.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.56 0.695 . . . . 0.0 110.347 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.63 -80.78 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.459 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -82.12 -34.98 28.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.969 0.414 . . . . 0.0 110.535 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -72.85 -33.49 66.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.603 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.49 10.18 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.213 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.628 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 27.2 Cg_endo -62.04 -37.08 67.05 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.795 1.663 . . . . 0.0 112.231 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.45 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 50.5 mm -66.77 -41.45 87.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 194' ' ' ALA . 90.2 mt -59.75 -42.23 88.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.96 -39.82 90.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.551 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 80.8 mm-40 -62.07 -37.84 86.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 99.1 mt -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.529 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.27 85.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.842 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.79 -33.93 76.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.199 0.524 . . . . 0.0 110.563 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.426 ' O ' ' HD1' ' A' ' 208' ' ' PHE . 7.9 tp10 -66.01 -49.59 67.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.258 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.59 78.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -67.28 -23.35 65.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.635 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.87 -28.88 50.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.121 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.426 ' HD1' ' O ' ' A' ' 204' ' ' GLU . 24.6 m-85 -88.62 -19.57 26.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.37 0.605 . . . . 0.0 110.437 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 65.8 t30 61.1 37.12 17.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.001 168.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.519 ' HD2' ' HG2' ' A' ' 289' ' ' PRO . 98.9 mtt180 -100.58 136.65 40.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.969 0.414 . . . . 0.0 110.176 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.487 ' CG2' ' HB ' ' A' ' 255' ' ' ILE . 9.8 tt -100.45 144.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -108.28 109.51 20.88 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.454 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.3 p -105.64 120.0 55.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 0.0 110.777 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.63 178.16 4.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.447 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.6 m 67.85 14.29 9.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.508 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.655 ' HA ' HD22 ' A' ' 280' ' ' LEU . 10.6 p -71.21 137.49 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.305 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -67.25 134.81 52.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -58.61 -8.8 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.987 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.0 -37.21 47.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.288 0.566 . . . . 0.0 110.319 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.897 HD13 HD13 ' A' ' 275' ' ' LEU . 0.5 OUTLIER -113.32 128.12 56.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.665 -172.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.4 m -100.61 -175.32 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.791 0.437 . . . . 0.0 111.125 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.871 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 6.6 p-10 -53.6 -40.76 65.96 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.86 -35.66 66.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.45 0.643 . . . . 0.0 110.408 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.72 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.8 m-20 -78.89 -58.01 3.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.163 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.508 HG13 HG21 ' A' ' 216' ' ' VAL . 20.6 mm -63.46 -15.52 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.253 0.549 . . . . 0.0 111.067 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.773 ' HG3' HD12 ' A' ' 235' ' ' ILE . 83.1 tttt -54.42 -32.15 56.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.573 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.743 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.7 m -48.78 -61.37 2.08 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.704 0.764 . . . . 0.0 111.477 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.841 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.0 m -73.66 -38.92 52.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.506 -172.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.492 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 19.0 m-85 -62.89 -50.79 69.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.694 0.283 . . . . 0.0 111.661 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.558 ' HG3' ' HA ' ' A' ' 234' ' ' LYS . 27.6 tt0 -77.83 -17.99 56.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.47 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.198 -0.314 . . . . 0.0 111.008 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.7 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.4 m-30 -82.88 -42.21 18.02 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.85 -107.19 0.79 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.219 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.558 ' HA ' ' HG3' ' A' ' 230' ' ' GLU . 33.6 ttmt -157.51 159.62 37.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.773 HD12 ' HG3' ' A' ' 226' ' ' LYS . 60.3 mt -122.98 128.62 75.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 111.218 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -92.33 -31.03 15.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.333 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 33.2 t -156.93 119.56 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.771 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.621 ' HB3' HG21 ' A' ' 235' ' ' ILE . 6.3 p -117.74 117.12 28.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 36.3 m -153.31 104.99 2.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 112.063 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.871 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 54.7 mt -86.42 119.24 26.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 166.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.95 106.19 0.67 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -92.59 153.48 18.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.66 96.31 27.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.4 -19.53 49.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -35.98 57.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.248 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.2 m -86.19 -33.0 20.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.45 35.17 5.3 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.329 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.42 156.83 16.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.774 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 12.0 p80 -84.46 138.33 32.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -67.02 152.57 45.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.69 24.61 1.5 Allowed Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.942 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.34 161.31 42.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.284 0.542 . . . . 0.0 110.583 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.29 -174.95 40.71 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.868 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -120.07 135.89 54.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.035 0.445 . . . . 0.0 111.178 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.487 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 28.8 mm -118.33 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 33.9 tt0 -104.69 126.27 51.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.52 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -101.47 146.83 27.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 1.3 pm0 -78.34 -16.96 57.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.573 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 258' ' ' GLU . 31.3 mtmm -137.09 148.48 46.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.67 64.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.78 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.36 -43.24 88.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.698 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.2 m -68.56 -31.99 71.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 267' ' ' VAL . 33.2 t -65.77 -52.21 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.382 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.48 -36.29 83.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.379 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.3 -31.32 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.579 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.94 63.7 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.95 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 263' ' ' SER . 42.8 t -54.4 -42.97 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 50.6 m -70.94 -25.89 62.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.4 p -109.65 -37.7 5.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.751 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 0.4 OUTLIER -65.77 -27.65 68.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.496 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.6 t30 -57.53 -34.38 69.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.743 0.783 . . . . 0.0 110.275 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.468 ' O ' ' HD2' ' A' ' 279' ' ' TYR . 18.5 mt -76.43 -6.55 52.18 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.86 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.821 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 3.2 t80 -54.43 102.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.6 t70 -89.07 122.99 32.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.725 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.897 HD13 HD13 ' A' ' 220' ' ' LEU . 88.8 mt -120.55 87.97 2.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.233 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.59 36.75 47.93 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.03 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.84 7.83 46.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.476 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.0 pt20 -136.8 132.76 35.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.99 0.424 . . . . 0.0 110.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.468 ' HD2' ' O ' ' A' ' 272' ' ' LEU . 79.6 m-85 -90.26 135.26 33.78 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.655 HD22 ' HA ' ' A' ' 216' ' ' VAL . 15.7 mt -69.1 -169.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.697 0.761 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -149.87 112.36 4.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.95 -176.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' ' 271' ' ' ASN . 30.7 m -111.41 147.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.256 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.75 -159.72 9.21 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.898 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -92.91 159.41 15.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.595 0.236 . . . . 0.0 110.71 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -67.83 -21.67 65.19 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.612 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.461 HG12 HG23 ' A' ' 287' ' ' THR . 92.5 t 72.35 -62.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.472 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.711 ' HB ' ' HD2' ' A' ' 288' ' ' PRO . 63.7 p -114.4 170.27 5.63 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.711 ' HD2' ' HB ' ' A' ' 287' ' ' THR . 30.3 Cg_endo -64.83 108.11 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.329 2.019 . . . . 0.0 111.486 173.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.519 ' HG2' ' HD2' ' A' ' 210' ' ' ARG . 24.3 Cg_exo -64.57 -31.01 60.83 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.033 2.488 . . . . 0.0 112.669 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 27.7 ttt -154.54 80.32 4.66 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.274 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -79.72 -9.57 14.53 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.38 2.054 . . . . 0.0 111.907 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 41.2 tp -84.53 62.04 7.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.429 0.633 . . . . 0.0 110.445 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.79 92.22 4.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.185 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.543 ' OG1' ' HD3' ' A' ' 295' ' ' PRO . 2.5 p -60.77 -39.73 68.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.464 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.543 ' HD3' ' OG1' ' A' ' 294' ' ' THR . 17.1 Cg_exo -69.67 74.5 1.24 Allowed 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.709 1.606 . . . . 0.0 110.961 170.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.97 143.46 56.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.238 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 C--O 1.251 1.155 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.86 178.253 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -159.44 102.09 1.55 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 24.5 mmt 63.82 86.66 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.785 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.82 57.18 3.89 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.318 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -101.9 153.49 19.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.927 0.394 . . . . 0.0 110.444 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.656 HG12 ' HB2' ' B' ' 31' ' ' PHE . 11.5 t -72.48 80.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.947 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -106.32 -7.73 17.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.366 0.603 . . . . 0.0 109.39 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.68 -62.52 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.433 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -65.89 -22.8 66.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.427 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.656 ' HB2' HG12 ' B' ' 27' ' ' VAL . 5.1 t80 -70.38 -18.0 63.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.241 0.543 . . . . 0.0 110.125 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.602 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 50.0 mtmt -69.9 -46.4 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 53.0 t0 -57.44 -44.68 84.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.984 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.841 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -47.53 -54.11 12.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.125 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.685 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.24 -20.13 38.28 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -168.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 30.1 mt-30 -61.2 -43.6 98.63 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.743 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 45.9 mtt180 -73.67 -28.61 61.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.697 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.821 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.56 -48.56 78.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -80.11 -27.16 39.23 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.075 -1.016 . . . . 0.0 111.941 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.56 -45.83 73.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.932 0.396 . . . . 0.0 110.491 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 14.1 pt -68.75 -35.29 69.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.766 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' A' ' 220' ' ' LEU . . . -68.74 -20.04 64.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.134 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.56 -46.72 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.477 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.564 ' O ' HG12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -92.6 -14.52 28.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.509 -176.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.564 HG12 ' O ' ' B' ' 44' ' ' LYS . 12.1 pt 52.92 -179.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.282 1.433 . . . . 0.0 113.639 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.09 146.25 13.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.215 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.88 -166.37 11.31 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.943 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -87.04 131.22 34.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.825 0.345 . . . . 0.0 110.587 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.81 31.34 2.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.134 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.4 43.05 2.25 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.229 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 m -68.59 -50.37 52.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.606 0.241 . . . . 0.0 110.441 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.249 1.073 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.839 178.803 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 70.73 -61.98 0.46 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.599 0.759 . . . . 0.0 112.778 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.8 ptp -102.83 35.61 2.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.06 0.457 . . . . 0.0 111.789 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.1 122.12 22.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.222 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 104' ' ' ARG . 45.5 tt0 -155.75 78.12 0.98 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.948 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 103' ' ' GLN . 54.5 ttt180 68.45 147.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.792 0.682 . . . . 0.0 110.538 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.6 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 11.5 tp60 -76.91 46.67 0.48 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.465 0.65 . . . . 0.0 109.832 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -61.31 -37.27 82.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.734 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.431 ' HB2' ' HB1' ' A' ' 194' ' ' ALA . . . -60.03 -46.03 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.142 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.6 ' HB3' ' HG3' ' A' ' 105' ' ' GLN . 44.2 tp -71.23 -34.47 70.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.825 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.13 -50.29 74.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.218 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.426 ' HB ' ' HG2' ' A' ' 187' ' ' ARG . 33.9 pt -72.22 -34.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.0 mmm -59.66 -26.62 65.69 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -84.56 -15.61 45.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.612 0.244 . . . . 0.0 111.533 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 23.6 ttm-85 -109.8 108.61 19.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 110.716 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -91.96 134.12 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.73 0.776 . . . . 0.0 111.146 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 21.6 t80 -90.62 122.08 33.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.17 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.559 HG12 HD13 ' A' ' 119' ' ' ILE . 14.3 t -108.81 109.89 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.89 164.34 12.55 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.984 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 m 72.71 -57.22 0.64 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.483 0.713 . . . . 0.0 110.901 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' A' ' 123' ' ' LEU . 17.9 mm 66.59 -79.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 123.235 0.614 . . . . 0.0 111.099 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HA ' ' HG2' ' A' ' 181' ' ' ARG . 89.6 t80 174.48 -72.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.801 0.84 . . . . 0.0 108.743 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 3.6 t80 170.29 -59.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.648 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.09 -24.13 30.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.631 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 127' ' ' THR . 39.1 mt -67.52 128.74 37.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.363 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -123.74 -153.57 8.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.921 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -60.24 -54.78 41.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 111.461 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.26 -35.24 78.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.537 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.849 HG21 HD22 ' A' ' 123' ' ' LEU . 1.9 m -66.22 -41.2 90.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.791 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.63 -38.9 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.15 -47.14 72.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.438 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -71.06 -27.47 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.702 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.34 -42.41 18.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.888 0.375 . . . . 0.0 111.435 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.421 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 84.6 m-85 -96.57 12.17 32.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -175.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.25 -46.29 50.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.785 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.939 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.1 Cg_endo -68.43 -4.62 13.28 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.744 1.63 . . . . 0.0 112.702 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -98.08 64.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.059 0.457 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.6 175.29 40.6 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.808 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.93 102.62 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.722 2.281 . . . . 0.0 111.555 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.701 HG12 ' HE1' ' A' ' 160' ' ' TYR . 55.5 mt -56.17 119.8 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.206 0.527 . . . . 0.0 110.375 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -89.79 -45.8 9.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.181 -173.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 t -159.55 141.08 12.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 62.0 mt -121.58 115.91 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.429 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.75 106.75 17.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.376 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.424 ' HB3' ' HE2' ' A' ' 143' ' ' MET . 78.9 mtp -106.95 152.88 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.1 p -99.74 97.55 8.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -78.28 113.77 16.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 151' ' ' LYS . 12.7 t70 -80.44 112.49 17.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.203 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 93.8 p 53.8 -159.73 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.998 0.919 . . . . 0.0 112.296 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.35 -22.49 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.176 0.512 . . . . 0.0 111.089 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -62.84 -14.2 42.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.1 mtm 64.99 22.88 12.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.22 0.533 . . . . 0.0 110.891 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 146' ' ' ASP . 23.6 ttmm -73.15 91.74 1.66 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.552 ' CE1' HG13 ' A' ' 119' ' ' ILE . 11.5 t-160 -76.36 67.49 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -96.57 112.56 24.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.86 -115.85 0.71 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.388 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -152.28 175.47 12.61 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.88 138.5 18.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.883 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 98.5 m-85 -106.68 123.75 48.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.558 0.218 . . . . 0.0 110.474 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.06 104.69 17.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.065 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.3 tt0 -95.35 130.14 42.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.701 ' HE1' HG12 ' A' ' 138' ' ' ILE . 31.0 m-85 -104.01 166.4 10.43 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -100.29 5.79 44.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.847 0.832 . . . . 0.0 109.145 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.74 119.64 12.9 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.034 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.506 ' HG3' HD11 ' A' ' 108' ' ' LEU . 24.8 Cg_endo -64.19 -21.86 67.32 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.095 2.53 . . . . 0.0 112.792 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.447 ' OE2' ' HG2' ' A' ' 163' ' ' PRO . 16.7 mp0 -61.9 -52.53 63.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.63 75.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.137 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -38.55 90.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.167 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.449 ' HG2' HG22 ' A' ' 286' ' ' VAL . 56.8 tp60 -65.2 -40.57 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.128 0.489 . . . . 0.0 110.488 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.42 HD11 ' HA3' ' A' ' 283' ' ' GLY . 8.9 mp -66.32 -37.17 84.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.503 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.56 -28.92 69.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.294 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.98 -62.17 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.04 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -71.09 -43.42 67.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -87.31 -21.87 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.583 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 54.2 tpp -98.22 -33.19 11.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.808 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -80.3 -8.95 59.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 110.839 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 p -90.31 0.66 57.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.32 168.37 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.696 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 86.3 mtp -129.46 103.02 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.131 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.58 118.69 14.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.79 -73.1 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.514 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.3 38.94 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.653 ' HG2' ' HA ' ' A' ' 120' ' ' TYR . 23.8 tpt180 -140.61 138.6 34.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -80.85 102.74 10.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.66 133.06 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.128 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -100.5 110.95 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.938 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 45.9 t -112.27 129.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.276 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 176.75 -144.47 6.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.098 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.426 ' HG2' ' HB ' ' A' ' 110' ' ' ILE . 23.3 tpt180 -162.98 79.02 1.74 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.05 49.07 2.69 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.957 2.438 . . . . 0.0 113.165 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.5 m -90.29 -57.1 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.034 0.445 . . . . 0.0 110.066 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -137.25 -64.18 0.57 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.1 mt 70.81 138.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.251 0.548 . . . . 0.0 111.676 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.15 -49.97 4.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.385 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -55.48 -56.01 25.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.852 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 107' ' ' ALA . . . -105.07 14.0 29.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.053 0.454 . . . . 0.0 110.942 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 0.3 OUTLIER -64.6 -55.18 31.14 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.427 -177.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 76.7 Cg_exo -52.72 -27.53 34.2 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 122.707 2.271 . . . . 0.0 113.738 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 48.2 mm -62.2 -34.89 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.443 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 51.5 mm -70.93 -39.1 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.654 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.25 -37.64 83.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.472 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 29.8 mm-40 -65.09 -36.77 85.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.176 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 89.5 mt -71.21 -37.35 72.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.706 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.73 -42.02 97.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -67.66 -34.64 77.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.907 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.37 -46.9 84.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.105 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 285' ' ' ALA . . . -62.53 -23.51 67.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.044 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -63.29 -27.57 69.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.774 0.321 . . . . 0.0 110.62 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.94 -13.23 61.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.406 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -93.26 -15.19 26.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.785 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 60.77 17.25 7.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.38 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.74 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 16.1 ptm180 -111.12 144.75 39.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 283' ' ' GLY . 35.5 pt -119.3 169.64 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.302 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.429 ' HE1' ' HD2' ' A' ' 252' ' ' TYR . 84.1 t80 -116.82 115.25 25.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.182 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.71 122.59 66.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.256 0.551 . . . . 0.0 110.694 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.25 -174.69 2.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.352 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.939 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 14.2 t 61.42 30.5 18.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 0.0 110.354 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.538 HG12 HD11 ' A' ' 280' ' ' LEU . 5.4 m -81.6 151.25 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.464 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 11.5 t-80 -73.9 137.56 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -166.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.539 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -78.5 -46.46 19.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.898 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.766 HD23 HD13 ' A' ' 225' ' ' ILE . 0.1 OUTLIER -58.56 100.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.606 178.067 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.7 m -101.05 -174.77 2.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.53 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.611 ' N ' HD12 ' A' ' 240' ' ' LEU . 3.7 p-10 -48.63 -43.28 36.29 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.77 -30.81 71.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.16 0.505 . . . . 0.0 110.819 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.719 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 11.4 m-20 -78.82 -59.65 2.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.772 HG13 HD11 ' A' ' 240' ' ' LEU . 23.5 mm -56.05 -24.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.216 0.532 . . . . 0.0 111.232 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.463 ' HG3' HD12 ' A' ' 235' ' ' ILE . 59.4 tttm -53.73 -32.46 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.018 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.923 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.8 m -51.89 -62.4 1.65 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.878 0.847 . . . . 0.0 112.204 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.65 HG21 ' HE1' ' A' ' 270' ' ' MET . 1.9 m -63.03 -53.46 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.306 -173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.568 ' HD2' ' HH ' ' A' ' 257' ' ' TYR . 84.2 m-85 -59.0 -34.08 71.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.42 -34.36 47.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -60.53 -26.14 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 111.041 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.623 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 3.9 p90 -129.96 40.22 3.58 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.605 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -177.34 153.8 14.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.115 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -94.31 110.47 22.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 0.0 110.167 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.463 HD12 ' HG3' ' A' ' 226' ' ' LYS . 52.5 mt -83.43 130.28 36.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.41 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -89.53 -37.03 15.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.64 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.1 t -168.47 134.04 1.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.37 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.1 t -114.48 113.42 24.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.4 m -136.81 103.77 5.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.996 0.427 . . . . 0.0 111.42 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.772 HD11 HG13 ' A' ' 225' ' ' ILE . 29.7 mt -83.69 129.8 34.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.04 138.91 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.707 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.658 ' HG2' ' HA ' ' A' ' 249' ' ' HIS . 69.2 mtp180 -137.58 149.57 46.78 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.76 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.627 ' HB2' HG22 ' A' ' 245' ' ' THR . 3.7 p-10 -80.85 129.34 68.26 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.996 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.13 -16.35 40.13 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.76 2.307 . . . . 0.0 112.027 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 243' ' ' ASP . 12.1 t -74.9 -33.68 62.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.823 -175.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.9 m -134.34 -41.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.007 0.432 . . . . 0.0 111.235 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.12 21.88 5.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.502 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -79.69 153.36 29.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 242' ' ' ARG . 1.9 t-80 -85.72 125.35 33.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.235 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.26 155.41 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.161 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.456 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -73.53 31.77 0.85 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.403 0.521 . . . . 0.0 114.403 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 34.9 p90 -160.13 163.78 33.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.915 0.358 . . . . 0.0 110.073 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -178.15 -169.75 39.42 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.309 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.418 ' CB ' HH21 ' A' ' 210' ' ' ARG . 95.5 m-85 -126.94 140.01 52.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.03 129.86 71.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.74 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 38.5 mt-10 -103.61 146.75 28.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.122 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.568 ' HH ' ' HD2' ' A' ' 229' ' ' PHE . 85.2 m-85 -117.29 158.2 24.78 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.306 0.574 . . . . 0.0 110.698 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -82.52 -17.26 45.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.704 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -134.73 140.61 46.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.958 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.05 -19.53 63.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.22 0.533 . . . . 0.0 109.919 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.54 -45.74 78.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.92 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -68.15 -27.15 66.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.404 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 m -61.79 -48.55 80.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.605 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.452 ' O ' HG12 ' A' ' 267' ' ' VAL . 57.5 tp60 -73.8 -34.34 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.866 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.67 -46.52 82.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.38 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.378 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 282' ' ' VAL . 4.0 p -60.76 -26.46 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.872 0.367 . . . . 0.0 111.666 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 28.9 m -81.06 -18.38 46.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 9.6 p -116.02 -27.6 6.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.65 ' HE1' HG21 ' A' ' 228' ' ' VAL . 34.5 mmm -69.46 -14.52 62.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -170.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 17.4 p-10 -73.74 -15.3 61.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.008 0.432 . . . . 0.0 111.402 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.53 -9.48 59.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.884 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 4.8 t80 -62.11 87.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.006 0.432 . . . . 0.0 111.406 -170.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.49 124.93 28.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' A' ' 220' ' ' LEU . 53.4 mt -123.45 107.71 11.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.86 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.7 -78.71 1.74 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.351 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -155.91 23.03 0.54 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.14 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -140.64 138.85 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.743 -0.269 . . . . 0.0 110.418 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 77.0 m-85 -75.05 123.86 25.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.538 HD11 HG12 ' A' ' 216' ' ' VAL . 5.9 tt -67.84 138.78 56.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.478 ' H ' ' HB3' ' A' ' 215' ' ' SER . 34.4 mmt180 -121.08 123.04 41.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.796 0.332 . . . . 0.0 110.773 -167.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' A' ' 270' ' ' MET . 14.9 p -117.25 147.7 20.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.094 0.473 . . . . 0.0 111.455 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 211' ' ' ILE . . . -144.71 -170.71 14.06 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -82.04 179.51 7.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.987 0.393 . . . . 0.0 110.549 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.562 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -67.64 -27.18 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 0.0 110.519 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 167' ' ' GLN . 44.4 t 73.53 -65.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.299 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 34.4 p -108.57 158.19 34.62 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.46 105.22 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.208 1.939 . . . . 0.0 111.378 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.656 ' HG2' ' HD3' ' A' ' 210' ' ' ARG . 3.3 Cg_exo -75.37 65.44 6.38 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.384 2.722 . . . . 0.0 113.088 -172.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -141.87 70.69 24.38 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.026 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.65 123.92 9.83 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.777 2.318 . . . . 0.0 112.209 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.12 68.57 4.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.203 0.525 . . . . 0.0 110.242 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 30.3 tp -81.11 67.78 7.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.184 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.5 m 61.79 77.63 0.34 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.844 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.95 31.26 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.196 2.598 . . . . 0.0 112.153 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -147.63 102.43 3.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.265 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.746 -0.645 . . . . 0.0 109.865 179.795 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.8 121.27 31.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 92.8 mmm -98.85 -55.53 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.118 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.38 84.5 1.17 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.328 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 69.39 103.59 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.164 0.586 . . . . 0.0 111.231 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.88 72.81 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.958 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -82.46 63.9 6.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.374 0.607 . . . . 0.0 109.841 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -154.32 -65.65 0.14 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 232' ' ' PHE . . . -77.17 -31.28 55.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 110.85 176.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.449 ' HD1' ' CE1' ' A' ' 232' ' ' PHE . 16.9 t80 -65.77 -16.32 63.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.227 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -71.65 -50.81 27.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.262 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.599 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 15.5 t70 -57.88 -42.68 85.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.623 ' CB ' ' HE1' ' A' ' 232' ' ' PHE . . . -49.01 -44.85 41.68 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.54 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.711 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 2.6 mm? -82.19 -21.03 36.67 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -64.4 -40.72 96.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.923 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 18.6 mmt180 -73.28 -32.59 64.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.363 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.884 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.31 -47.06 85.94 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.099 -175.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 27.5 mtt85 -80.97 -26.27 36.69 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.259 -1.526 . . . . 0.0 112.703 174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -54.38 -41.92 69.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.518 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.815 HG12 ' O ' ' B' ' 38' ' ' ALA . 2.7 pt -69.83 -34.02 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.733 0.301 . . . . 0.0 110.775 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.42 -22.64 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.959 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.08 -27.26 22.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.807 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.793 ' HE2' HG22 ' B' ' 41' ' ' ILE . 45.1 pttt -93.11 -52.71 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.562 ' N ' ' HG3' ' B' ' 44' ' ' LYS . 91.9 mt 65.47 90.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.138 -173.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.86 24.53 23.77 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.695 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.66 -59.68 6.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.038 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -163.52 -63.92 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.55 133.24 33.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.788 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.22 153.31 30.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.213 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.5 m -50.22 112.42 0.68 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 111.842 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.639 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.875 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.73 123.61 32.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.642 0.258 . . . . 0.0 110.345 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 49.3 tpp -82.16 77.37 8.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.542 0.687 . . . . 0.0 110.891 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -124.65 47.88 2.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.148 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.07 -47.02 69.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.082 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -160.85 132.76 5.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.153 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -99.41 127.32 45.44 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.426 ' O ' HG12 ' A' ' 110' ' ' ILE . 73.3 mtt180 -61.53 -30.7 70.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.402 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.47 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.3 -29.23 70.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.843 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.442 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.787 HD12 HG12 ' A' ' 191' ' ' ILE . 29.0 pt -82.57 -36.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.0 mtp -60.25 -26.19 66.25 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.5 m -82.44 -0.98 48.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ttm180 -122.2 118.25 28.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.56 166.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.045 0.45 . . . . 0.0 110.779 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -119.35 114.25 22.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.335 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -104.78 110.83 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 110.856 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.98 170.49 14.99 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 24.7 m 59.91 47.91 9.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.268 0.556 . . . . 0.0 110.428 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -76.49 123.04 32.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.817 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.553 ' HB3' HD13 ' A' ' 123' ' ' LEU . 54.9 t80 -62.91 140.98 58.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.314 0.578 . . . . 0.0 109.895 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -52.73 -31.71 39.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.27 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.38 6.7 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.553 HD13 ' HB3' ' A' ' 120' ' ' TYR . 10.1 mp -100.65 120.46 40.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.68 -165.79 14.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.639 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.521 ' OE2' ' HD2' ' A' ' 129' ' ' ARG . 3.9 tm-20 -59.36 -51.76 68.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.458 0.303 . . . . 0.0 110.762 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.86 -29.64 69.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.49 HG21 ' HG ' ' A' ' 123' ' ' LEU . 5.2 m -64.63 -50.78 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.968 0.413 . . . . 0.0 110.197 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.3 mt -67.48 -40.2 84.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.288 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.521 ' HD2' ' OE2' ' A' ' 125' ' ' GLU . 23.1 ttt180 -51.58 -51.93 51.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.502 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.2 -24.12 51.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.927 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.86 -37.57 73.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.27 12.86 36.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -70.88 -41.6 11.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.166 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.79 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 33.7 Cg_exo -63.89 -4.69 7.77 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.222 1.948 . . . . 0.0 112.817 173.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.432 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 23.8 m-85 -93.01 -68.44 0.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.306 . . . . 0.0 110.216 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.87 168.68 33.44 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.62 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 13.3 Cg_exo -69.51 121.86 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.513 2.142 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.54 123.87 37.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.95 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -100.35 -36.85 9.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.459 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -145.76 136.93 24.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.942 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 70.0 mt -127.29 116.4 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -103.68 114.55 28.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.319 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' A' ' 156' ' ' ALA . 89.1 mtp -113.64 108.29 16.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.353 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.541 ' O ' ' HA3' ' A' ' 154' ' ' GLY . 12.1 p -94.46 61.09 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.456 0.646 . . . . 0.0 110.796 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -114.13 159.59 19.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.628 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.652 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.7 m-20 -73.73 88.0 1.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.476 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.2 m -65.98 -36.02 82.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.585 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.9 m -63.52 -23.84 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.247 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.799 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 1.6 m -120.64 2.04 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.382 0.61 . . . . 0.0 110.132 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.9 mtp 56.91 35.61 26.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.535 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.799 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 30.7 mmmt -97.27 126.57 42.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.054 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -84.3 48.16 1.45 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.477 0.656 . . . . 0.0 110.098 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.47 -34.22 74.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.708 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 144' ' ' SER . . . -95.73 -155.53 31.14 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.026 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -140.46 174.57 10.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.258 0.223 . . . . 0.0 110.554 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.432 ' HB2' ' HG2' ' A' ' 143' ' ' MET . . . -124.33 138.42 54.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.805 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 97.1 m-85 -107.27 124.94 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.715 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.1 t -119.45 113.59 41.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 10.3 pt-20 -105.43 137.11 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -105.86 172.36 6.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.132 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 39.0 tt0 -74.53 -29.82 61.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.563 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.3 m -129.44 139.87 36.95 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.583 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.17 -20.54 43.46 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.187 2.592 . . . . 0.0 112.494 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 11.1 mp0 -55.56 -55.32 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.76 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -58.77 -32.24 69.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.514 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -51.61 36.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.35 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.38 -34.82 76.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.19 0.519 . . . . 0.0 110.091 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.612 HD13 ' HA3' ' A' ' 283' ' ' GLY . 25.8 tp -61.01 -44.71 97.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.239 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.22 87.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.532 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.34 -39.27 94.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -81.59 -47.35 13.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.029 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.418 ' CD ' ' HE ' ' A' ' 281' ' ' ARG . 20.3 mm-40 -87.83 -44.84 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -169.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.6 tpp -69.68 -26.74 64.52 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.097 0.475 . . . . 0.0 110.703 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -69.29 -24.2 63.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.204 0.526 . . . . 0.0 109.983 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 t -81.52 -27.86 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.83 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.88 110.49 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 111.017 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.589 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 21.3 mmt -61.83 124.13 19.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.913 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.52 105.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.967 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.33 -90.06 0.82 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.9 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.12 42.3 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 120' ' ' TYR . 30.4 tpt180 -134.0 126.09 29.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.703 0.287 . . . . 0.0 110.33 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.589 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 8.6 t30 -72.11 85.08 1.02 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.584 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.4 pt -83.0 156.64 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.272 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -105.94 109.8 21.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.527 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.93 109.59 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.159 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 135.6 -115.53 1.37 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.708 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 57.15 68.9 1.84 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.265 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.527 ' HB3' ' HB ' ' A' ' 191' ' ' ILE . 5.6 Cg_exo -80.77 61.52 8.25 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.802 3.001 . . . . 0.0 112.353 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 m -50.76 -42.45 57.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.706 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -117.56 13.09 14.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.787 HG12 HD12 ' A' ' 110' ' ' ILE . 53.5 mt -98.46 -25.26 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.044 0.45 . . . . 0.0 110.61 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.82 85.45 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.811 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -79.42 -4.79 52.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 111.204 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.28 7.65 42.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.601 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 61.8 tp60 -53.6 -44.61 98.1 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.79 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.4 Cg_endo -51.79 -32.25 45.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.267 1.978 . . . . 0.0 112.723 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.15 -43.93 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 110.121 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.9 mt -59.76 -38.97 78.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.537 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 66.2 m-20 -54.76 -50.96 67.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.748 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.38 -32.24 73.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.541 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.4 mt -66.01 -49.75 66.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.047 0.451 . . . . 0.0 110.126 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.62 -40.83 98.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.88 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 31.3 mm-40 -64.14 -30.29 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.287 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.83 -45.68 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.54 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.43 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.453 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtp180 -63.03 -21.85 66.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.657 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.99 -29.14 39.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.877 0.37 . . . . 0.0 111.197 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.56 -19.24 14.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.66 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 56.98 37.97 29.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.235 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.27 140.5 31.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.314 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 282' ' ' VAL . 19.9 tt -115.86 150.34 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.229 -172.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -109.48 135.38 50.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.265 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 229' ' ' PHE . 5.1 t -113.39 120.76 64.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.17 167.98 13.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.79 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 28.6 m 63.77 27.15 14.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.201 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.523 ' HA ' HD21 ' A' ' 280' ' ' LEU . 29.9 m -74.12 143.31 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.03 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.434 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 12.6 t-80 -69.65 134.39 48.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.84 -24.09 67.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.995 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.87 -46.87 16.04 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.937 -0.477 . . . . 0.0 110.92 173.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.686 HD23 HD13 ' A' ' 225' ' ' ILE . 0.2 OUTLIER -58.11 107.66 0.5 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.96 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.9 p -93.18 -177.95 4.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 4.7 p-10 -53.35 -37.56 62.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.947 0.403 . . . . 0.0 111.1 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.89 -34.35 77.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.379 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 8.8 m-20 -77.47 -55.36 5.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.688 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.789 HG13 HD11 ' A' ' 240' ' ' LEU . 31.4 mm -55.42 -27.58 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.792 0.437 . . . . 0.0 111.764 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.704 ' HG3' HD12 ' A' ' 235' ' ' ILE . 83.4 tttt -54.25 -31.67 54.1 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.651 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.655 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 68.7 m -47.86 -61.22 2.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.638 0.732 . . . . 0.0 112.175 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.623 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.7 m -69.42 -51.01 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.167 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.61 ' HB2' HD11 ' A' ' 235' ' ' ILE . 40.2 m-85 -56.44 -43.58 79.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.505 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.73 -12.44 59.8 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.36 -35.79 58.51 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.67 -0.644 . . . . 0.0 110.602 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.546 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 0.2 OUTLIER -107.27 21.15 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.946 173.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.575 ' CA ' ' HB3' ' A' ' 262' ' ' SER . . . -170.64 -153.55 8.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.316 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.09 127.27 12.94 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 238' ' ' CYS . 66.8 mt -101.87 126.57 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.119 -175.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -95.3 -22.91 17.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.706 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 14.2 t -150.38 108.6 3.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.889 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.746 ' HB2' HG21 ' A' ' 235' ' ' ILE . 41.9 t -115.72 111.79 21.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.8 p -143.08 104.57 4.31 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.789 HD11 HG13 ' A' ' 225' ' ' ILE . 40.2 mt -83.93 117.3 23.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -65.35 127.48 31.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.781 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 15.5 ptt180 -110.49 153.88 24.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.964 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.11 130.05 51.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.14 -17.1 40.55 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.725 2.283 . . . . 0.0 112.377 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 48.2 m -74.34 -58.86 3.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.268 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 2.3 m -93.4 -41.22 9.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.928 0.394 . . . . 0.0 111.25 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.92 15.65 19.52 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.837 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.453 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 61.4 pttt -109.08 148.81 30.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.4 p80 -78.39 135.62 37.48 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.213 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.01 156.92 36.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.495 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.6 30.31 0.6 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 114.496 0.558 . . . . 0.0 114.496 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.62 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 39.5 p90 -153.21 173.71 15.19 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.624 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.23 176.24 46.62 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.412 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 94.0 m-85 -121.24 133.38 55.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.69 0.281 . . . . 0.0 110.415 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.657 HG23 HG23 ' A' ' 235' ' ' ILE . 55.0 mt -129.9 136.59 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.128 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -107.53 125.71 51.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.567 ' HE1' ' HA3' ' A' ' 233' ' ' GLY . 17.1 m-85 -98.73 142.79 29.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.212 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.749 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.4 pt-20 -89.01 -23.09 22.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.537 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.749 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 31.6 mmmt -116.95 129.41 56.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.611 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.68 63.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.347 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -56.29 -52.42 64.59 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.48 0.657 . . . . 0.0 110.026 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.575 ' HB3' ' CA ' ' A' ' 233' ' ' GLY . 4.0 m -68.99 -43.72 74.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.172 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 267' ' ' VAL . 10.8 t -61.41 -43.77 98.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.717 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.15 -41.96 97.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.331 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.51 -39.82 57.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.183 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.77 63.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.045 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 263' ' ' SER . 58.3 t -61.31 -26.64 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.186 0.517 . . . . 0.0 111.267 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.6 t -92.84 -36.64 12.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.167 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' SER . . . . . 0.552 ' HB3' HG22 ' B' ' 27' ' ' VAL . 3.3 p -87.83 -37.89 16.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 35.6 mmm -60.47 -29.08 68.83 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 31.8 t30 -58.57 -33.2 69.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.924 0.869 . . . . 0.0 110.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 272' ' ' LEU . 6.3 mp -78.89 -9.55 59.52 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.901 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -56.64 101.09 0.05 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.19 0.519 . . . . 0.0 110.895 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.61 112.4 18.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.189 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.61 HD21 ' CZ ' ' A' ' 273' ' ' PHE . 0.8 OUTLIER -113.3 86.2 2.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.389 171.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.71 34.95 29.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.551 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.89 0.72 74.36 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.802 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 10.9 pt20 -113.75 139.68 48.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.509 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 95.2 m-85 -89.94 126.21 35.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.369 0.604 . . . . 0.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.802 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.3 OUTLIER -55.38 165.04 0.84 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.217 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.678 ' H ' HD13 ' A' ' 280' ' ' LEU . 4.0 tpt180 -132.24 119.7 21.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.367 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.54 ' CG2' HD11 ' A' ' 211' ' ' ILE . 5.6 p -104.82 148.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.513 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.612 ' HA3' HD13 ' A' ' 168' ' ' LEU . . . -150.25 -149.1 4.93 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -139.61 152.99 47.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.576 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -95.23 129.46 42.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.46 -31.81 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.706 -171.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.409 HG22 ' OE2' ' A' ' 164' ' ' GLU . 14.9 t -115.11 135.53 22.52 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.228 0.537 . . . . 0.0 110.466 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 37.2 Cg_endo -68.67 119.06 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.293 1.995 . . . . 0.0 110.995 173.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 288' ' ' PRO . 34.3 Cg_exo -58.25 -24.85 69.47 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.983 2.455 . . . . 0.0 112.855 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.08 88.41 51.0 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.09 135.04 24.36 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.1 2.533 . . . . 0.0 112.028 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.74 126.31 32.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.371 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 293' ' ' LEU . 3.9 mm? -78.74 87.38 4.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.968 0.414 . . . . 0.0 110.072 177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.532 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 5.3 m -61.09 -50.3 85.02 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.304 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.532 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 86.3 Cg_endo -79.19 55.54 5.66 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.041 1.828 . . . . 0.0 112.036 174.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -78.83 70.2 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.275 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.784 178.168 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -145.01 -67.32 0.31 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 23.6 ptm -175.24 148.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.397 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.93 131.94 4.02 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.942 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -77.68 -25.35 49.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 0.0 110.389 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 269' ' ' SER . 17.3 t -77.18 73.92 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.396 0.617 . . . . 0.0 110.879 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -138.5 -60.43 0.61 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.28 174.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -103.57 -39.2 6.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.082 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.09 84.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.763 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 8.7 t80 -74.99 -19.01 60.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.54 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.701 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 30.8 mtpp -74.09 -45.81 46.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.4 -45.08 84.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.623 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -45.87 -51.87 12.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.917 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.807 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.9 -23.42 36.27 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -171.196 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.701 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 61.8 mt-30 -62.71 -40.79 98.25 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.655 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 63.7 mtt180 -70.81 -36.87 73.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.881 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.901 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.25 -43.81 96.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.301 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.29 46.3 mtt-85 -82.45 -25.15 33.85 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.282 -1.511 . . . . 0.0 113.064 172.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -54.08 -43.67 70.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.014 168.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.726 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.5 pt -69.64 -35.21 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.872 0.368 . . . . 0.0 110.429 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.56 -16.34 63.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.45 -36.06 16.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.591 ' HG2' ' HA ' ' B' ' 41' ' ' ILE . 21.6 pttp -84.54 -49.1 8.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.202 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.995 HG23 ' HB2' ' A' ' 219' ' ' ASP . 25.3 mm 65.08 91.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.449 0.643 . . . . 0.0 112.091 173.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.64 -157.62 21.31 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.081 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.09 144.72 15.3 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.77 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -118.16 85.38 2.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.978 0.418 . . . . 0.0 110.225 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.23 -21.34 19.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.07 0.462 . . . . 0.0 110.651 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.54 114.68 3.78 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.34 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.0 m -82.93 -34.91 26.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.375 0.607 . . . . 0.0 109.546 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.466 177.394 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.53 -31.47 69.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.371 . . . . 0.0 111.025 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.2 mmt -119.94 39.08 3.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.055 0.455 . . . . 0.0 110.223 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.62 79.24 9.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.516 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -86.95 91.13 8.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.227 0.537 . . . . 0.0 110.348 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -114.26 108.66 17.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.239 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -95.67 37.48 1.2 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.128 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -56.17 -41.35 75.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.378 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.8 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.16 -35.91 81.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.74 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.049 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.7 pt -82.64 -35.84 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.4 mtp -69.5 -34.29 74.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.0 m -79.61 0.02 31.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -122.97 109.2 13.82 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.3 m -103.41 135.72 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.458 0.647 . . . . 0.0 111.53 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.469 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 80.2 t80 -87.41 132.88 33.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.232 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.44 111.41 36.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.073 0.463 . . . . 0.0 110.328 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -114.84 176.92 17.12 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.793 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 13.9 t 64.99 53.65 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.85 0.833 . . . . 0.0 109.434 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.9 mt -82.54 132.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.828 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 62.3 t80 -86.09 154.46 21.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.683 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -54.95 -51.59 65.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.607 0.241 . . . . 0.0 111.029 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.86 17.32 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.972 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 33.5 tp -107.73 97.56 7.27 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.486 ' HA2' ' HE1' ' A' ' 152' ' ' HIS . . . -113.26 -174.08 18.9 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.5 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.458 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 5.8 pt-20 -63.05 -23.94 67.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.956 0.408 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 7.0 m-20 -78.57 -41.62 31.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -69.48 -46.87 65.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.131 0.491 . . . . 0.0 110.546 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.5 -41.99 94.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.453 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 19.0 ptp180 -63.21 -36.3 83.19 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.691 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.03 -29.93 64.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.794 0.33 . . . . 0.0 111.438 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.11 56.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.431 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 85.8 m-85 -96.31 -0.13 50.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.5 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.532 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -65.64 -46.83 67.87 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.614 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.745 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 25.7 Cg_exo -65.21 -4.66 9.59 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.377 2.051 . . . . 0.0 113.121 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.675 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 3.5 m-85 -84.69 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.849 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.53 38.15 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.879 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.46 103.15 0.64 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.921 2.414 . . . . 0.0 112.231 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.6 mt -79.24 108.68 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -90.66 -23.39 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 0.0 110.302 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.866 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 32.1 t -138.81 124.77 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.191 0.519 . . . . 0.0 111.05 -177.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.9 mt -118.98 107.32 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.176 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -116.71 100.82 8.07 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.579 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 125' ' ' GLU . 61.5 mtp -122.77 123.97 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.579 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 26.2 t -108.93 111.52 23.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.771 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.443 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 6.6 p-90 -150.69 158.65 44.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.263 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.82 114.73 4.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.38 0.425 . . . . 0.0 110.169 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.7 m -79.85 -24.85 40.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.713 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.6 t -82.48 -37.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.544 HG21 ' HE3' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -107.69 -7.84 16.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.18 0.514 . . . . 0.0 110.758 -178.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.7 mtp 60.26 35.31 20.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.845 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 149' ' ' THR . 98.7 mttt -84.07 148.23 26.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.486 ' HE1' ' HA2' ' A' ' 124' ' ' GLY . 65.9 m-70 -119.73 73.52 0.97 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.68 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -128.21 11.52 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 110.481 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.64 -116.44 1.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.139 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.469 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 44.8 p90 -154.67 167.0 31.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.818 0.342 . . . . 0.0 111.108 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.439 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -146.57 134.92 21.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.52 122.6 35.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.9 t -101.96 111.02 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 37.9 mt-10 -107.05 119.56 39.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.42 0.628 . . . . 0.0 110.996 -175.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 81.2 m-85 -96.2 156.08 16.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.445 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.9 -4.63 57.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 109.325 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.74 130.99 18.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.783 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.18 -11.07 29.63 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.718 2.279 . . . . 0.0 112.808 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.42 ' OE1' HG22 ' A' ' 287' ' ' THR . 4.6 mm-40 -56.7 -64.89 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -65.91 -22.77 66.53 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.389 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.14 -50.94 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.863 0.363 . . . . 0.0 110.749 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HB3' HG21 ' A' ' 286' ' ' VAL . 1.6 tm0? -74.26 -30.87 62.32 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.9 tp -58.72 -51.47 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.075 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.55 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.724 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.78 -50.28 72.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.996 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.01 -47.18 47.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -74.64 -50.8 16.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.415 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 16.5 mmt -77.3 -26.37 52.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -170.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -73.29 -20.31 60.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.37 0.605 . . . . 0.0 110.086 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.3 m -92.73 -12.98 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.536 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 84.3 t -118.5 137.39 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.16 0.505 . . . . 0.0 111.517 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 21.5 ptp -103.47 144.73 31.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.887 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.55 32.1 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.82 104.71 1.02 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.814 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.44 -59.53 4.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.034 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.821 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -101.84 125.87 48.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.622 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -90.37 110.69 21.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.416 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.793 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 41.8 pt -69.72 157.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 0.0 111.102 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -113.92 110.3 19.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 66.1 t -112.18 117.85 56.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.409 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 110.23 176.31 20.85 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.794 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.94 151.07 3.94 Favored Pre-proline 0 C--N 1.328 -0.37 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.09 70.45 7.1 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.825 2.35 . . . . 0.0 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.8 m -69.42 -52.95 22.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.319 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 194' ' ' ALA . 65.9 t30 -142.65 56.04 1.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.339 0.59 . . . . 0.0 110.533 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.06 151.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.75 -59.56 4.44 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 190' ' ' ASN . 25.7 mt-30 -67.41 -37.63 83.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 0.0 111.549 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.428 ' HB2' ' ND2' ' A' ' 190' ' ' ASN . . . -95.46 -1.56 50.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.348 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.533 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.0 tp60 -61.36 -50.1 84.77 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 16.6 Cg_endo -57.45 -23.98 58.64 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.126 1.884 . . . . 0.0 112.316 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 49.8 mm -76.8 -45.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.87 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.48 -47.88 90.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.846 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.39 -37.57 78.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.764 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.47 -53.71 47.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.435 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 202' ' ' ALA . 2.3 pp -71.23 -32.8 69.21 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.652 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.543 ' N ' HD12 ' A' ' 201' ' ' LEU . . . -72.99 -43.88 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 206' ' ' ARG . 8.9 mm-40 -75.05 -29.25 60.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.619 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.36 -31.95 73.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.08 -17.47 64.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.286 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 203' ' ' GLU . 15.9 mmt180 -63.62 -31.08 72.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.818 0.342 . . . . 0.0 110.427 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.57 63.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.53 . . . . 0.0 110.757 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -96.69 -5.27 39.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 p30 35.25 40.86 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.011 1.445 . . . . 0.0 113.444 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.86 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 13.7 ptt180 -109.53 139.39 44.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.23 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.37 161.64 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.51 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -109.42 108.74 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.543 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.22 117.13 52.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.514 0.673 . . . . 0.0 110.78 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.1 -173.58 2.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.312 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.745 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 18.7 t 70.62 17.17 6.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.716 0.635 . . . . 0.0 110.239 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.676 HG11 HD21 ' A' ' 240' ' ' LEU . 93.4 t -67.32 136.44 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.59 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.506 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 11.1 t-80 -67.74 138.32 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -64.68 -21.51 66.75 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -167.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.581 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -82.05 -47.66 12.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.315 0.507 . . . . 0.0 111.602 173.113 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.803 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.3 OUTLIER -56.43 116.04 2.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.097 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t -101.03 -176.78 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.473 -0.142 . . . . 0.0 111.196 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.11 -36.56 70.78 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.562 0.22 . . . . 0.0 111.365 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.6 -41.0 96.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.187 0.518 . . . . 0.0 110.294 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.452 ' HB3' ' HG ' ' A' ' 220' ' ' LEU . 3.9 m-20 -66.06 -57.53 7.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.113 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.68 HD13 HD23 ' A' ' 220' ' ' LEU . 36.6 mm -57.45 -25.26 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -57.84 -32.26 67.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.495 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 74.4 m -49.87 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.792 0.806 . . . . 0.0 111.705 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.697 HG12 ' HB1' ' B' ' 34' ' ' ALA . 5.4 m -73.18 -39.58 56.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.735 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -67.51 -41.03 85.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.73 0.3 . . . . 0.0 111.354 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -76.72 -18.81 58.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.126 0.488 . . . . 0.0 111.222 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.27 -31.13 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.654 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.2 m-30 -86.16 -30.57 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.87 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.61 179.74 34.99 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.989 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -77.53 113.18 15.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.108 0.48 . . . . 0.0 111.11 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.77 146.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.118 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.507 ' HE2' ' HB3' ' A' ' 256' ' ' GLU . 34.2 ttpt -106.35 -49.56 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.1 p -153.26 146.32 24.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 46.5 t -126.71 123.42 37.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.885 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.5 p -136.3 104.01 5.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.676 HD21 HG11 ' A' ' 216' ' ' VAL . 10.8 tp -96.86 114.84 26.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.75 136.47 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.619 174.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.75 124.38 81.78 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.404 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -68.79 -18.43 41.75 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.0 113.418 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 m -92.65 -52.95 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.752 0.311 . . . . 0.0 110.995 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.4 m -74.22 -27.5 60.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.462 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.61 21.45 64.04 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.593 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.31 146.93 49.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.3 OUTLIER -82.51 139.86 33.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.592 178.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -79.52 151.76 30.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.45 32.79 1.37 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.764 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -153.51 157.62 40.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.052 0.426 . . . . 0.0 109.915 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.635 ' HA3' HD12 ' A' ' 240' ' ' LEU . . . -164.77 178.37 39.95 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.52 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -118.94 131.52 56.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.2 129.2 72.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.86 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 54.6 mt-10 -109.07 141.93 40.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.005 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -106.78 161.08 14.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 0.0 112.005 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.58 -17.2 30.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.576 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 45.7 mtpt -133.75 133.33 41.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.759 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.15 68.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.629 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -61.67 -46.78 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.428 174.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 45.7 m -64.93 -36.99 86.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.525 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -61.67 -41.4 97.5 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -73.97 -34.39 64.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.195 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.57 -35.13 46.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.109 0.481 . . . . 0.0 111.084 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.5 61.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 282' ' ' VAL . 11.0 p -54.59 -39.45 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.7 p -82.13 -25.31 34.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 4.5 m -96.42 -25.81 15.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.984 0.421 . . . . 0.0 111.632 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.693 ' HB3' HG21 ' A' ' 282' ' ' VAL . 26.9 mmm -73.65 -10.46 59.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -173.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 6.8 t30 -62.05 -32.29 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.029 0.918 . . . . 0.0 110.616 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.4 mm? -76.73 -8.57 57.54 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.364 -172.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.878 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.2 t80 -65.15 105.9 1.18 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.171 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.2 t70 -94.97 121.51 36.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.826 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.803 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.8 mm? -116.32 85.91 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.348 173.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.53 29.98 34.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.475 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.1 12.35 27.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 13.5 pt20 -138.46 130.71 28.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.887 0.375 . . . . 0.0 110.34 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.638 ' HB2' HH21 ' A' ' 281' ' ' ARG . 63.8 m-85 -89.99 131.62 35.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.342 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 275' ' ' LEU . 17.4 mt -60.97 177.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.909 0.861 . . . . 0.0 111.57 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.638 HH21 ' HB2' ' A' ' 279' ' ' TYR . 4.2 mmt180 -140.41 111.48 7.07 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' A' ' 270' ' ' MET . 48.5 t -120.06 135.02 61.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.965 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.94 -151.2 5.44 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.18 149.9 25.53 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.72 91.99 2.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 167' ' ' GLN . 33.8 t -55.57 -46.76 79.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.704 -171.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.42 HG22 ' OE1' ' A' ' 164' ' ' GLU . 5.9 t -104.98 124.96 34.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.927 0.87 . . . . 0.0 112.371 -174.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.468 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 55.7 Cg_endo -73.9 121.96 7.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.595 2.197 . . . . 0.0 110.778 167.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 288' ' ' PRO . 13.2 Cg_exo -69.97 83.21 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.155 2.57 . . . . 0.0 112.59 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 81.7 mmm -97.63 119.56 62.37 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.614 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 24.1 Cg_exo -64.27 112.62 1.95 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.058 2.505 . . . . 0.0 112.664 -177.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 292' ' ' LEU . 1.0 OUTLIER -154.0 105.89 2.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.405 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.86 171.58 17.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.643 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 11.0 p -107.43 125.1 33.16 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.106 0.479 . . . . 0.0 110.843 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.02 -49.94 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.777 2.318 . . . . 0.0 112.8 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -154.69 72.93 0.87 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.075 0.464 . . . . 0.0 110.589 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.196 -178.78 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.27 145.62 37.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.661 0.267 . . . . 0.0 110.367 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -119.31 6.69 11.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.019 0.437 . . . . 0.0 110.178 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.42 67.14 3.14 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.8 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.411 ' O ' ' HB ' ' B' ' 27' ' ' VAL . 59.4 m-85 -122.63 24.62 9.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 93.5 t 70.35 -55.68 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 123.576 0.548 . . . . 0.0 110.421 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.638 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 62.5 t30 73.76 -52.89 0.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.097 0.959 . . . . 0.0 112.256 174.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -73.93 0.31 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.3 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.935 0.398 . . . . 0.0 111.743 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 16.7 t80 -67.12 -20.02 65.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.308 0.575 . . . . 0.0 110.644 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.638 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 92.4 mttt -77.77 -43.37 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.57 -39.04 75.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.697 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -51.58 -50.02 60.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.539 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.802 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -81.18 -21.67 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.638 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 50.9 mt-30 -61.83 -42.14 98.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.495 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 73.7 mtp180 -72.06 -31.86 66.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.53 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.878 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -68.11 -44.69 75.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.255 6.3 mtm180 -82.94 -26.33 31.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.294 -1.504 . . . . 0.0 113.022 171.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -57.32 -42.55 82.08 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.056 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.695 HD11 ' HZ ' ' A' ' 273' ' ' PHE . 9.8 pt -64.3 -42.72 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.23 -24.67 66.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 111.519 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 -29.38 21.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.832 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -92.13 -33.8 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.581 HG23 ' HB2' ' A' ' 219' ' ' ASP . 79.9 mt 63.88 106.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.25 66.35 1.9 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.641 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.92 45.97 3.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.063 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.56 117.6 7.0 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.552 0.341 . . . . 0.0 110.318 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . 63.98 29.11 14.44 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.668 0.605 . . . . 0.0 110.649 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.44 -58.38 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.607 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 52.4 p 54.06 -174.54 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.892 0.877 . . . . 0.0 112.83 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.247 178.088 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.78 96.9 7.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.409 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.9 mmm -85.93 -22.18 27.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.485 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.75 20.49 0.74 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.161 0.505 . . . . 0.0 110.97 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -85.53 -23.7 27.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.998 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.4 ' HG3' ' HG3' ' A' ' 105' ' ' GLN . 30.0 tpt180 -100.17 127.75 46.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.4 ' HG3' ' HG3' ' A' ' 104' ' ' ARG . 90.0 mt-30 60.2 81.72 0.17 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.485 0.66 . . . . 0.0 111.125 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -56.88 -29.16 62.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.078 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.35 -28.87 70.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.88 -34.78 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.912 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.23 75.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.426 . . . . 0.0 111.22 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.39 -36.32 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.366 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 27.8 ttt -65.6 -26.67 67.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.875 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.9 m -82.17 4.34 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.541 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 19.5 ptt180 -135.57 134.61 39.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.975 0.417 . . . . 0.0 110.717 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.1 m -110.8 135.6 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.355 0.598 . . . . 0.0 111.522 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 71.0 t80 -78.83 124.47 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.209 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.53 112.06 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.023 0.439 . . . . 0.0 110.155 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.21 170.28 14.04 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.686 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.675 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 50.6 m 67.63 66.74 0.38 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.615 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.49 -19.84 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.136 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 66.8 t80 65.67 -73.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.286 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 53.4 t80 167.09 -43.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.291 0.636 . . . . 0.0 109.409 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.442 ' H ' ' HD2' ' A' ' 120' ' ' TYR . 28.1 tt0 -83.24 6.08 20.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.212 -173.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.8 mt -110.57 100.06 8.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.31 34.82 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.772 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.49 -41.42 94.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.35 -48.38 71.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.238 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -62.18 -53.85 49.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.09 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.75 -46.21 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.298 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -55.5 -48.95 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.494 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -78.27 -29.69 48.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.14 73.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.772 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.541 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 84.9 m-85 -97.71 7.08 47.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.464 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.07 -43.35 35.3 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.607 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 24.2 Cg_exo -65.16 -3.86 8.07 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.249 1.966 . . . . 0.0 112.915 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.705 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 21.8 m-85 -91.06 -63.96 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.683 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.63 175.2 34.28 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 162' ' ' VAL . 21.1 Cg_exo -65.09 123.1 11.07 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.429 2.086 . . . . 0.0 111.724 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.74 123.17 22.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.163 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -87.04 -56.4 3.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.004 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.9 m -162.29 149.35 13.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.53 106.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.83 110.6 23.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 22.9 ptm -137.26 149.44 47.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.043 0.449 . . . . 0.0 111.136 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.3 m -80.25 121.93 26.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.804 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 42.9 m95 -99.95 114.48 27.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.198 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.843 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 2.5 m-20 -69.79 89.82 0.58 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.266 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t 62.5 -163.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.864 0.728 . . . . 0.0 111.586 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.73 -18.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.482 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.491 ' HB ' ' HE2' ' A' ' 151' ' ' LYS . 21.2 p -66.71 11.45 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.731 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 19.8 mmt 59.09 32.13 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.041 0.537 . . . . 0.0 112.305 172.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.843 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 71.0 mmtt -79.22 -49.7 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.934 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p80 40.91 58.15 2.55 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.889 0.743 . . . . 0.0 112.352 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -104.18 94.28 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.288 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.23 -101.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.972 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -147.51 165.95 28.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.742 0.306 . . . . 0.0 110.714 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.47 146.38 33.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.717 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.04 111.71 24.31 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.5 106.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.046 0.45 . . . . 0.0 110.27 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.541 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 45.8 mt-10 -91.62 131.46 37.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.541 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 23.3 m-85 -102.01 147.62 26.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.424 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -75.17 -14.55 60.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.723 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.591 HG22 ' HD2' ' A' ' 137' ' ' PRO . 19.6 m -136.89 130.24 17.55 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.083 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.29 -19.93 68.54 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.169 2.579 . . . . 0.0 113.231 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.73 -65.15 0.64 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.48 -27.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.824 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.55 69.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.688 0.28 . . . . 0.0 111.14 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HB3' HG21 ' A' ' 286' ' ' VAL . 19.5 tt0 -74.54 -36.91 63.13 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.347 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.637 HD22 ' CD2' ' A' ' 212' ' ' TYR . 12.5 tp -55.75 -49.84 72.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.98 96.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.531 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.7 -54.02 45.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.176 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.54 -45.37 81.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.781 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -77.94 -46.04 22.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 23.1 mmt -73.24 -22.98 60.29 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.591 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.01 -23.55 55.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.312 0.577 . . . . 0.0 109.642 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 55.1 m -84.92 -30.66 24.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.458 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.68 130.65 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.1 0.476 . . . . 0.0 111.412 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.55 ' HB2' ' O ' ' A' ' 181' ' ' ARG . 25.7 ptt? -78.8 130.97 36.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.873 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 178' ' ' LEU . 3.5 pp -85.84 139.97 30.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.808 0.337 . . . . 0.0 111.138 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.2 -40.07 1.46 Allowed Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.345 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.38 2.62 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 177' ' ' MET . 30.6 mmt180 -98.13 126.42 43.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -74.85 67.84 1.68 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.665 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.675 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 38.1 pt -66.29 154.67 7.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -116.14 109.05 16.94 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 55.5 t -112.82 109.77 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.264 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.0 141.35 8.07 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.414 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 15.8 mtp180 -129.95 137.05 30.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 2.7 Cg_exo -76.4 48.12 2.26 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 111.335 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 p -81.25 -45.63 15.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.901 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -92.79 35.78 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.496 0.665 . . . . 0.0 109.781 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt -65.99 136.4 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.858 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 89.61 -35.22 3.79 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.104 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -83.2 -42.74 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.023 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.37 -18.6 41.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mp0 -57.67 -51.89 78.36 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 14.5 Cg_endo -57.02 -30.41 86.57 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.193 1.929 . . . . 0.0 112.472 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mm -75.15 -50.81 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.401 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.28 -43.79 95.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.801 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.68 -42.72 71.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.712 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -60.4 -52.95 63.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 287' ' ' THR . 91.1 mt -64.96 -46.38 81.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.077 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.96 94.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.886 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.16 -35.09 68.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.88 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.24 -38.13 78.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.418 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.32 -27.99 69.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -21.74 66.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.188 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.87 -13.1 51.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.973 0.416 . . . . 0.0 111.321 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.74 -17.78 20.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.402 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 65.82 15.0 9.87 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.618 0.574 . . . . 0.0 111.919 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.495 ' NH1' ' HB2' ' A' ' 289' ' ' PRO . 82.1 mtp180 -105.44 135.67 46.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.048 0.452 . . . . 0.0 110.679 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.462 HD11 ' CE1' ' A' ' 229' ' ' PHE . 30.6 pt -117.67 169.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.103 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.637 ' CD2' HD22 ' A' ' 168' ' ' LEU . 44.1 t80 -118.74 118.61 32.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.584 HG23 HG22 ' A' ' 282' ' ' VAL . 2.3 p -116.3 122.45 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.719 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.705 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.06 -179.84 4.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.98 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.607 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 24.7 m 68.07 29.08 6.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.276 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.814 HG13 HD11 ' A' ' 225' ' ' ILE . 73.6 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.319 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -63.25 123.15 17.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.69 -37.37 18.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -167.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.56 -45.75 43.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.616 0.245 . . . . 0.0 111.092 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.834 HD11 HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -58.5 116.43 3.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.6 m -99.88 -178.31 3.82 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.73 -44.42 77.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.651 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.44 -32.79 69.04 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.402 0.62 . . . . 0.0 110.185 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.518 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 57.1 m-20 -73.33 -55.91 5.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.645 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.814 HD11 HG13 ' A' ' 216' ' ' VAL . 33.8 mm -54.57 -29.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.103 0.478 . . . . 0.0 111.565 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.489 ' HG3' HD12 ' A' ' 235' ' ' ILE . 62.3 tttm -53.93 -32.53 53.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.94 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.573 ' HB3' ' HG2' ' B' ' 37' ' ' ARG . 68.0 m -48.99 -61.37 2.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.737 0.779 . . . . 0.0 112.826 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.695 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.0 m -70.67 -46.32 69.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.73 -169.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 57.6 m-85 -57.96 -43.93 86.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.687 0.279 . . . . 0.0 111.151 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.7 tt0 -70.9 -24.3 62.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.266 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.08 -21.09 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.372 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.692 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.6 OUTLIER -93.22 -43.75 8.67 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.59 153.69 25.04 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.07 137.94 51.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.487 0.643 . . . . 0.0 111.669 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 229' ' ' PHE . 60.6 mt -95.68 147.51 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.527 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 236' ' ' LYS . 9.7 mmmm -80.02 -64.3 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.429 171.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 35.5 t -150.42 147.67 27.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.495 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.95 129.42 52.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.424 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.2 t -142.48 125.31 16.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.172 0.51 . . . . 0.0 111.019 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.447 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 8.4 mp -110.19 130.2 55.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.587 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.68 145.92 50.79 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.509 0.671 . . . . 0.0 111.012 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.749 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -122.75 150.19 43.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.553 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -117.04 106.51 47.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.678 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.67 -25.15 34.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.489 2.126 . . . . 0.0 112.094 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.9 m -63.24 -48.29 78.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.355 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -83.65 -30.14 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.677 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.68 6.12 53.01 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.975 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -137.13 177.43 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -82.78 154.04 24.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 110.416 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.7 155.71 21.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.36 43.05 2.83 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.833 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -156.26 157.51 35.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.97 0.385 . . . . 0.0 110.083 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -168.42 -172.95 35.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.583 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -119.31 132.81 55.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.732 0.301 . . . . 0.0 110.501 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.2 mm -111.81 126.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 210' ' ' ARG . 35.6 tt0 -103.72 120.89 41.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -94.23 142.86 26.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.532 0.682 . . . . 0.0 111.754 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.9 -26.25 66.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.179 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.474 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 34.4 mtpt -124.95 136.31 53.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.77 -18.55 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -68.8 -44.52 73.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.549 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 65.3 m -67.91 -21.02 65.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.696 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 m -59.03 -39.42 81.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.026 0.441 . . . . 0.0 110.262 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -75.33 -35.17 61.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.497 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 1.004 ' HA ' ' HA2' ' B' ' 25' ' ' GLY . 34.6 t70 -68.17 -34.79 76.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.124 -175.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.53 -47.63 22.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.675 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.551 HG12 HG12 ' A' ' 282' ' ' VAL . 31.1 m -59.44 -35.01 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -169.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.2 p -80.04 -9.47 59.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.2 m -113.81 -35.99 4.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.919 0.39 . . . . 0.0 111.694 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.695 ' HE2' ' HB2' ' A' ' 273' ' ' PHE . 0.6 OUTLIER -72.31 -16.02 61.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -170.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.4 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 8.4 t30 -60.81 -30.14 69.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.749 0.785 . . . . 0.0 110.402 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 272' ' ' LEU . 7.9 mp -76.83 -9.47 58.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.603 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.849 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -54.85 109.17 0.48 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 0.2 OUTLIER -113.82 130.31 56.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 -178.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.676 ' HG ' HD22 ' A' ' 220' ' ' LEU . 3.2 mm? -116.08 87.02 2.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.537 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.85 3.47 73.75 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.064 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 134.43 -31.51 2.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.417 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 17.3 pt20 -84.06 129.25 34.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.171 0.486 . . . . 0.0 110.772 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -89.41 139.83 30.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.732 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 273' ' ' PHE . 9.2 mp -76.78 -173.17 2.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 0.0 111.568 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 281' ' ' ARG . 39.2 mmt180 -144.66 112.43 6.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.573 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.584 HG22 HG23 ' A' ' 213' ' ' VAL . 46.7 t -125.83 134.32 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.628 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.2 -153.61 6.33 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.768 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -85.11 165.82 17.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.088 0.444 . . . . 0.0 110.151 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -76.15 -7.49 54.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.998 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 167' ' ' GLN . 64.3 t 71.22 -64.49 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.119 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 201' ' ' LEU . 8.4 t -111.29 148.97 39.86 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 3.6 Cg_endo -47.42 114.65 1.09 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.835 2.357 . . . . 0.0 111.433 173.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.495 ' HB2' ' NH1' ' A' ' 210' ' ' ARG . 2.9 Cg_exo -74.17 50.95 2.35 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.595 2.863 . . . . 0.0 113.141 -171.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.609 ' N ' ' HD2' ' A' ' 291' ' ' PRO . 70.4 mtm -73.44 -37.44 3.63 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.213 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 290' ' ' MET . 36.4 Cg_endo -66.32 68.97 0.45 Allowed 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 121.937 1.758 . . . . 0.0 112.876 174.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 53.8 tp -80.23 70.13 6.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 74.7 mt -73.56 116.13 13.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.007 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 28.6 m -97.48 106.96 36.27 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.918 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.73 103.09 1.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.928 2.419 . . . . 0.0 111.972 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 63.09 -175.73 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.129 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.916 -179.099 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.57 105.12 17.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.147 0.499 . . . . 0.0 111.226 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 22.8 ptp -134.59 144.42 47.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 1.004 ' HA2' ' HA ' ' A' ' 265' ' ' ASP . . . 89.42 11.2 64.69 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.877 -172.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -132.6 88.2 2.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.086 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.627 HG21 ' HB2' ' B' ' 31' ' ' PHE . 29.1 m -86.69 134.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.112 0.482 . . . . 0.0 110.858 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -125.63 4.64 7.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.472 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.39 -38.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -62.1 -35.6 79.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.625 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.627 ' HB2' HG21 ' B' ' 27' ' ' VAL . 9.1 t80 -74.51 -19.44 60.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.321 0.582 . . . . 0.0 110.032 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.665 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 94.6 mttt -72.84 -45.48 58.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -56.28 -44.38 79.75 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.002 0.906 . . . . 0.0 108.744 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.695 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -48.23 -54.03 14.97 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.011 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -83.11 -23.42 33.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -168.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.665 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 29.5 mt-30 -55.24 -44.27 75.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.573 ' HG2' ' HB3' ' A' ' 227' ' ' SER . 25.2 ttm105 -74.39 -31.62 62.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.662 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.849 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.76 -46.2 83.14 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.251 11.7 mtp180 -81.18 -25.03 37.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.638 -1.289 . . . . 0.0 112.387 174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 19.8 tp60 -51.25 -47.28 62.45 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 165.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.834 HG13 HD11 ' A' ' 220' ' ' LEU . 4.6 pt -72.26 -28.42 29.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.844 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.507 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -65.76 -31.89 73.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.907 0.384 . . . . 0.0 111.076 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.41 -25.22 29.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.269 0.557 . . . . 0.0 110.492 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' B' ' 44' ' ' LYS . 4.8 tmmt? -82.1 -63.77 1.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.089 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 85.0 mt 66.49 102.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.104 0.478 . . . . 0.0 111.788 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.48 -168.12 13.46 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.545 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.6 -112.8 0.52 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.699 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -59.26 99.4 0.05 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.131 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.45 89.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.01 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.67 139.43 6.5 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.628 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 14.0 t -92.47 -175.34 3.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.664 -179.879 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.25 157.24 21.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 24.7 mmt 56.27 53.79 8.46 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.518 0.511 . . . . 0.0 110.839 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.61 91.51 1.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.568 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.93 45.75 2.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.436 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -90.35 67.76 6.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.8 52.88 4.09 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.43 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -61.0 -34.54 74.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.238 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.16 73.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.392 . . . . 0.0 110.479 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.11 -39.12 86.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.65 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.13 72.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.909 0.385 . . . . 0.0 111.511 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.6 mt -83.9 -48.31 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.7 -35.29 80.08 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 80.4 m -83.18 2.64 34.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.53 0.205 . . . . 0.0 111.398 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.825 ' HB2' ' HG3' ' A' ' 159' ' ' GLU . 8.5 ttp180 -113.82 112.39 23.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.984 0.421 . . . . 0.0 111.237 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.39 150.89 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.337 0.589 . . . . 0.0 111.067 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.8 t80 -102.84 115.05 29.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.098 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.03 111.82 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.19 167.0 12.37 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.085 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 45.0 m 68.73 47.57 0.83 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.277 0.561 . . . . 0.0 110.991 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 79.1 mt -66.19 115.97 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.119 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -61.87 -78.85 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.339 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -175.61 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.27 -23.99 67.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.688 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.01 98.6 5.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.134 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.55 -175.15 37.09 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.731 ' HB2' ' HE1' ' A' ' 145' ' ' TRP . 40.4 tt0 -62.81 -41.32 99.25 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.98 -39.47 87.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.519 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -64.75 -46.08 83.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.96 -48.43 88.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.308 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ppt_? -66.87 -33.93 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.465 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -72.16 -35.7 69.11 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.737 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.84 97.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.878 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.422 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 81.5 m-85 -97.07 11.29 36.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.266 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.583 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -65.98 -46.02 63.92 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.291 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 1.021 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 27.7 Cg_endo -63.13 -14.88 44.46 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.056 1.837 . . . . 0.0 112.881 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.431 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 5.0 m-85 -76.07 -66.42 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.18 156.13 26.51 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.16 131.46 46.47 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.532 2.155 . . . . 0.0 111.665 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -72.32 117.3 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -90.13 -39.51 12.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.544 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.4 t -160.04 139.3 10.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.756 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.64 121.08 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.75 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.27 96.73 5.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.647 ' HG3' ' HB2' ' A' ' 156' ' ' ALA . 27.9 ttt -107.49 145.13 33.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.515 -175.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -78.12 80.61 4.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 0.0 109.863 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HE1' ' HB2' ' A' ' 125' ' ' GLU . 6.6 m95 -92.49 133.13 36.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.094 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -94.29 111.9 23.66 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.4 m -75.45 3.26 9.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.193 0.521 . . . . 0.0 110.548 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.13 -54.57 8.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.067 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.581 ' HB ' ' HG3' ' A' ' 151' ' ' LYS . 1.5 m -119.55 -15.01 9.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.62 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.5 mtp 67.11 32.77 5.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.721 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.581 ' HG3' ' HB ' ' A' ' 149' ' ' THR . 17.8 mtpp -97.16 -14.8 21.24 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.2 p80 44.19 47.04 7.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.74 0.816 . . . . 0.0 112.579 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.69 102.56 15.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.093 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 171.39 -112.83 0.47 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.75 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -142.0 172.93 12.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.858 0.361 . . . . 0.0 111.349 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.647 ' HB2' ' HG3' ' A' ' 143' ' ' MET . . . -151.67 150.58 30.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.707 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.22 131.7 56.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 58.6 t -128.32 115.78 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.854 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.825 ' HG3' ' HB2' ' A' ' 113' ' ' ARG . 1.8 mp0 -92.31 132.62 36.56 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.948 173.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -101.92 169.0 9.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.939 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.94 -48.83 80.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.478 0.656 . . . . 0.0 110.3 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.516 ' HB ' ' HG2' ' A' ' 164' ' ' GLU . 16.0 m -119.75 147.19 43.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.99 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.07 -16.52 44.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.754 2.303 . . . . 0.0 111.129 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.516 ' HG2' ' HB ' ' A' ' 162' ' ' VAL . 1.0 OUTLIER -63.21 -47.12 83.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.879 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.503 ' H ' HG23 ' A' ' 162' ' ' VAL . . . -62.05 -39.23 91.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.063 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.37 86.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.844 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -59.67 -45.33 92.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 13.1 mt -73.0 -35.16 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.983 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.64 85.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.552 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 2.9 tt -77.15 -63.09 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.081 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -63.57 -47.31 82.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -171.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.672 ' HB3' ' HD3' ' A' ' 281' ' ' ARG . 80.7 mm-40 -84.74 -0.72 54.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -171.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.63 ' HB3' HG21 ' A' ' 185' ' ' VAL . 42.6 tpp -119.95 -33.79 3.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.32 -24.82 63.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.233 0.54 . . . . 0.0 110.48 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.2 m -84.37 -0.97 54.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.416 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.54 177.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.362 . . . . 0.0 110.758 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 82.2 mtp -118.01 126.04 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.171 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.52 85.49 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 110.072 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.08 -135.22 12.86 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.908 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.53 77.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.922 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -130.17 154.93 47.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.872 0.368 . . . . 0.0 110.748 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.555 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 24.3 p-10 -100.91 108.76 20.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.506 0.669 . . . . 0.0 110.397 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 45.3 pt -75.57 148.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 184' ' ' LYS . 24.0 tptp -102.24 109.38 21.04 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.135 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 173' ' ' MET . 15.8 m -104.64 127.03 59.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.991 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.552 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 85.75 135.6 3.77 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.285 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -153.34 91.16 3.37 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 81.11 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.201 2.6 . . . . 0.0 112.568 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.6 m -81.7 -17.45 47.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.48 53.5 2.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.065 0.459 . . . . 0.0 110.802 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.69 124.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.522 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.76 -24.71 4.32 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.558 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 13.5 mm-40 -83.68 -47.64 11.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 111.399 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.35 -20.9 27.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.677 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 27.2 mm-40 -57.98 -55.21 47.56 Favored Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 200' ' ' GLN . 19.3 Cg_endo -58.75 -30.97 94.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.109 1.873 . . . . 0.0 112.539 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.0 mm -70.61 -52.43 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.009 0.433 . . . . 0.0 110.178 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.28 -33.54 64.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.963 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.78 -49.46 77.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.597 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 47.1 mt-30 -65.17 -34.85 79.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.118 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.21 -49.81 68.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.477 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -64.67 -29.74 70.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.31 -52.1 66.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.965 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.41 -28.59 59.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.897 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.09 69.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.923 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 14.4 mtm180 -67.23 -20.35 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 0.0 110.96 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -24.27 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.18 0.514 . . . . 0.0 110.639 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -102.1 -29.13 11.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 52.13 79.14 0.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.839 0.712 . . . . 0.0 111.258 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.682 ' HB2' ' HB3' ' A' ' 285' ' ' ALA . 39.5 mtm180 -125.18 142.35 51.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.047 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.717 HD13 ' HE1' ' A' ' 229' ' ' PHE . 13.5 tt -108.82 142.95 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 282' ' ' VAL . 79.4 t80 -108.44 123.19 48.48 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.799 0.333 . . . . 0.0 110.171 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.527 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.3 p -119.04 122.73 70.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.511 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -123.05 179.6 4.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.191 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . 1.021 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 20.0 m 65.29 26.79 12.16 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.799 0.687 . . . . 0.0 110.948 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.43 HG22 ' C ' ' A' ' 251' ' ' GLY . 8.1 m -72.46 145.21 12.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.157 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.442 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 13.4 t-80 -68.4 130.33 42.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.38 -18.47 64.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -164.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.442 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 0.6 OUTLIER -78.27 -44.08 26.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.169 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.693 HD23 HD13 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -52.8 114.37 1.39 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.818 172.034 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.2 m -98.79 -177.5 3.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 11.0 p-10 -54.36 -41.29 68.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -70.63 -28.93 65.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.76 0.314 . . . . 0.0 110.684 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.572 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 4.8 m-20 -67.54 -55.79 12.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.693 HD13 HD23 ' A' ' 220' ' ' LEU . 30.8 mm -57.38 -27.28 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.11 0.481 . . . . 0.0 110.816 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.514 ' HG3' HD13 ' A' ' 235' ' ' ILE . 87.7 tttt -56.94 -32.85 66.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.292 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.664 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 57.9 m -48.33 -60.22 2.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.936 0.874 . . . . 0.0 112.092 -176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.721 ' HB ' ' CE ' ' A' ' 270' ' ' MET . 2.8 m -72.14 -36.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.731 -170.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.717 ' HE1' HD13 ' A' ' 211' ' ' ILE . 71.3 m-85 -70.79 -37.13 73.29 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.259 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.472 ' OE1' ' HE2' ' A' ' 226' ' ' LYS . 8.5 tt0 -77.27 -21.09 54.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.737 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.84 -18.7 53.59 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.49 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.676 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 3.8 m-30 -87.77 -38.21 15.95 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.521 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.75 -156.97 8.25 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.569 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 234' ' ' LYS . 32.3 mmtp -94.54 128.59 41.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.514 HD13 ' HG3' ' A' ' 226' ' ' LYS . 20.6 tt -104.1 135.68 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.286 -171.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 256' ' ' GLU . 23.5 tptp -91.08 -52.42 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.81 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 69.3 m -149.95 124.74 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.846 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 3.8 p -100.54 68.13 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.38 0.61 . . . . 0.0 109.739 174.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.5 p -97.8 104.35 16.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.231 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.4 mp -91.72 128.8 37.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.29 133.76 49.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.627 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -133.61 151.05 51.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.408 . . . . 0.0 110.738 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.92 118.19 70.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.258 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.75 -17.1 42.41 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.908 2.406 . . . . 0.0 113.412 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 69.7 p -86.8 -47.1 9.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.712 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.1 m -92.23 -25.67 18.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.968 0.413 . . . . 0.0 111.354 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.71 22.61 42.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.986 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.8 122.29 45.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.589 0.233 . . . . 0.0 111.122 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.5 p80 -72.79 138.2 46.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 252' ' ' TYR . 96.4 mttt -70.5 156.62 39.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.45 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.43 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.97 33.15 0.63 Allowed Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.476 0.485 . . . . 0.0 113.637 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 250' ' ' LYS . 5.7 p90 -153.24 163.79 39.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.503 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -155.11 162.63 31.04 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.008 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.74 117.14 29.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 237' ' ' SER . 2.3 mp -102.79 128.5 55.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 51.6 mt-10 -102.76 145.78 29.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -119.31 132.22 55.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.268 0.556 . . . . 0.0 111.022 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -78.18 -27.21 47.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.344 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 20.3 mtpt -112.5 123.05 49.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.157 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -61.85 -34.34 75.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.869 -176.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -61.33 -37.69 84.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.222 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.8 m -73.76 -28.83 61.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.046 0.45 . . . . 0.0 110.446 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.7 t -73.78 -22.4 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.896 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 55.3 mt-30 -74.99 -49.66 19.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.648 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.49 -33.73 41.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -171.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.28 54.01 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 111.177 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 37.4 t -71.9 -34.13 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 111.378 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.2 p -89.89 -17.93 27.1 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.777 0.322 . . . . 0.0 111.661 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 36.0 m -112.1 1.03 16.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -171.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.743 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 6.0 tpp -119.19 2.4 11.39 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -172.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -82.85 -16.86 46.0 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.184 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 9.1 mp -79.6 -9.37 59.62 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.943 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -45.93 106.05 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.341 0.4 . . . . 0.0 111.583 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.404 ' O ' HD13 ' A' ' 275' ' ' LEU . 0.7 OUTLIER -91.38 114.47 27.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.535 -178.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' B' ' 42' ' ' ALA . 2.4 mm? -119.93 86.38 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.312 169.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.23 40.25 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.834 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.84 -2.5 69.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.999 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.89 128.83 49.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 273' ' ' PHE . 86.2 m-85 -98.83 122.46 42.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.742 HD22 ' CD2' ' A' ' 273' ' ' PHE . 9.9 mp -70.55 -179.44 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.028 0.442 . . . . 0.0 110.676 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.672 ' HD3' ' HB3' ' A' ' 172' ' ' GLN . 3.6 mmp_? -136.48 128.04 28.7 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -174.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 3.1 m -122.96 151.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.456 0.646 . . . . 0.0 112.042 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.562 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -160.83 -136.71 2.06 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.352 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.83 152.43 38.4 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.579 -0.365 . . . . 0.0 110.886 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 210' ' ' ARG . . . -96.49 102.9 14.76 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -35.42 8.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.609 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 14.9 t -84.92 136.01 39.19 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.5 123.34 11.3 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.819 2.346 . . . . 0.0 112.013 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.416 ' HG3' ' HD3' ' A' ' 210' ' ' ARG . 66.1 Cg_endo -75.6 81.75 2.26 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.818 2.345 . . . . 0.0 112.918 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.455 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 26.1 ptt? -76.79 127.89 82.98 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.754 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.601 ' HB2' ' HG ' ' A' ' 293' ' ' LEU . 6.0 Cg_exo -74.12 146.46 36.64 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.948 2.432 . . . . 0.0 112.441 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 35.0 tp -81.85 66.92 7.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.399 0.618 . . . . 0.0 109.816 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 291' ' ' PRO . 86.6 mt -83.79 -22.5 31.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.258 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 2.1 p -96.5 146.26 31.0 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.726 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 6.3 Cg_exo -73.7 61.89 4.58 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.153 2.568 . . . . 0.0 112.642 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -83.11 85.44 7.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.296 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 72.1 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.022 -179.451 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.21 69.09 0.78 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.822 0.344 . . . . 0.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.98 129.62 40.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.912 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.41 -26.59 23.99 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -173.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -111.43 34.59 4.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' B' ' 30' ' ' ALA . 47.7 t -77.47 104.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.642 0.734 . . . . 0.0 112.053 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.611 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 15.2 m120 -122.68 -45.78 2.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.184 167.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.92 -52.8 62.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.453 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.586 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -63.99 -31.33 72.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.027 0.441 . . . . 0.0 111.171 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.652 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 11.7 t80 -76.65 -21.48 55.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.224 0.535 . . . . 0.0 110.289 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 71.8 mttt -74.43 -41.0 61.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.8 t70 -58.0 -41.93 84.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.676 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.49 -49.27 55.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.341 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.87 -25.15 35.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -169.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 24.9 mt-30 -57.71 -44.93 86.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.664 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 60.6 mtt180 -68.11 -35.99 79.02 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.586 174.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.943 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.06 -49.97 72.44 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 39' ' ' ARG 0.272 13.6 mtp180 -81.44 -25.3 36.25 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.202 -1.561 . . . . 0.0 112.751 174.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -52.47 -46.7 66.65 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 110.073 168.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.847 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.6 pt -67.22 -35.51 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.498 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.554 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -65.88 -20.1 66.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.388 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.27 -42.28 12.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.8 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.847 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.1 OUTLIER -92.3 -14.48 28.77 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.436 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.2 pt 42.32 76.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.16 -143.11 16.39 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.576 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.0 -140.72 11.54 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.119 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.3 128.55 34.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.845 0.355 . . . . 0.0 110.591 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.08 18.06 0.12 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.959 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.72 68.87 0.52 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.457 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 58.1 m -73.16 97.72 2.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.003 0.43 . . . . 0.0 110.324 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.431 -0.795 . . . . 0.0 108.964 -179.195 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.62 82.47 5.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.865 0.365 . . . . 0.0 110.094 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.63 -42.4 4.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.632 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.37 78.84 3.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.498 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -89.43 9.74 25.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.626 -175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -81.76 -0.34 42.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.422 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 12.3 pt20 -92.91 29.0 1.92 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.114 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 -58.12 -45.25 87.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 111.099 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.82 -26.74 61.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.987 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 59.4 tp -76.43 -45.76 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.056 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.35 -45.72 76.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.886 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.5 pt -64.99 -34.2 68.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.09 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 75.4 mtp -70.05 -26.39 64.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.483 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.37 -33.1 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 14.6 ptp180 -109.26 127.72 54.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 111.337 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.98 140.89 24.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.495 0.664 . . . . 0.0 110.794 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.446 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 65.6 t80 -85.12 130.56 34.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.827 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.86 112.23 38.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.547 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.27 169.71 13.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.332 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.444 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 48.2 m 57.86 50.7 10.07 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.323 0.583 . . . . 0.0 110.757 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -90.84 10.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.093 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.2 t80 64.05 11.99 6.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.618 0.723 . . . . 0.0 109.406 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.995 ' HB2' ' H ' ' A' ' 153' ' ' LYS . 55.0 p90 42.18 33.52 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.852 1.261 . . . . 0.0 113.319 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.46 -58.07 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.162 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.478 ' H ' HD12 ' A' ' 123' ' ' LEU . 7.5 mp -48.94 135.98 14.86 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.56 0.537 . . . . 0.0 112.373 -174.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.63 170.65 48.39 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.447 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.45 -39.17 77.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.603 0.361 . . . . 0.0 111.62 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.32 -27.96 69.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.315 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 48.8 m -66.66 -45.7 78.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 110.307 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.29 -40.03 81.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.984 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -53.35 -48.86 68.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.08 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 78.1 mt-30 -76.96 -30.23 55.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.636 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.39 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 110.703 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.512 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 89.5 m-85 -105.62 12.12 31.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.973 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -70.3 -44.03 18.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.843 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.612 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 14.4 Cg_exo -71.46 -4.0 14.14 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.91 1.74 . . . . 0.0 111.73 173.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.454 ' O ' ' HB1' ' A' ' 165' ' ' ALA . 54.6 m-85 -106.41 58.57 0.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.52 164.01 38.34 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.701 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.525 ' HD2' HG22 ' A' ' 162' ' ' VAL . 68.0 Cg_endo -79.49 132.47 10.04 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.81 2.34 . . . . 0.0 112.461 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.87 119.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.36 -56.21 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 0.0 110.681 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.6 m -157.53 125.26 5.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.622 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.478 HG22 ' HG3' ' A' ' 143' ' ' MET . 54.9 mt -101.22 107.17 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 173.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.55 120.06 27.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.114 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.478 ' HG3' HG22 ' A' ' 141' ' ' ILE . 82.9 mtp -139.02 131.33 28.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.87 0.366 . . . . 0.0 111.399 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.2 m -106.9 105.76 15.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.934 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 10.6 p-90 -159.49 159.86 33.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -83.74 95.53 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.928 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.404 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 10.4 p -70.64 -23.18 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.528 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.9 m -68.82 -32.71 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.454 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.8 p -109.45 -1.89 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.351 0.596 . . . . 0.0 110.71 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.934 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 74.1 mtp 61.06 36.6 18.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -106.02 137.95 43.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.73 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 11.5 m-70 -95.74 -79.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.995 ' H ' ' HB2' ' A' ' 121' ' ' TYR . 29.5 mtpt 52.22 45.88 27.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.22 -170.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -160.27 -122.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.469 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.446 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 29.7 p90 -149.53 174.03 12.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.795 -170.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.99 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.119 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -116.69 108.64 16.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.447 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.4 110.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.49 0.662 . . . . 0.0 110.542 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.4 tt0 -94.57 134.14 37.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.512 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 84.8 m-85 -102.91 161.01 14.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.426 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.54 -7.96 53.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.687 ' HB ' ' OE2' ' A' ' 164' ' ' GLU . 34.9 m -129.22 128.07 23.25 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.429 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 3.1 Cg_exo -74.83 -22.26 15.41 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.137 2.558 . . . . 0.0 114.083 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.687 ' OE2' ' HB ' ' A' ' 162' ' ' VAL . 1.2 mp0 -63.26 -57.68 9.66 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.617 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 135' ' ' PHE . . . -56.96 -29.63 63.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.627 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.23 64.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.522 ' HB3' HG21 ' A' ' 286' ' ' VAL . 23.6 tm0? -68.49 -39.93 81.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.69 -55.93 26.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.266 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.89 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.317 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.933 ' HG ' ' HA2' ' A' ' 186' ' ' GLY . 7.5 tt -54.87 -63.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.222 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.58 -36.01 15.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -70.51 -27.48 64.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.519 ' HG3' HD11 ' A' ' 183' ' ' ILE . 60.5 tpp -88.87 -27.21 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.12 -8.72 57.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.786 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.4 m -90.61 -7.94 51.43 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.188 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.16 163.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.037 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 20.0 ptp -108.93 144.03 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.117 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.41 59.83 1.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.053 0.454 . . . . 0.0 110.431 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.8 77.31 1.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.857 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.97 -51.31 4.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.586 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 2.5 mpt_? -88.35 126.79 35.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 0.0 110.818 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.2 109.32 8.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.388 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.519 HD11 ' HG3' ' A' ' 173' ' ' MET . 35.5 pt -76.86 162.04 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -119.64 114.02 21.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.001 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 170' ' ' LEU . 27.6 t -117.45 132.85 66.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.976 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.933 ' HA2' ' HG ' ' A' ' 170' ' ' LEU . . . 156.03 -136.29 4.96 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.285 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -149.03 71.57 10.23 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.375 0.607 . . . . 0.0 110.605 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.63 89.0 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.728 2.285 . . . . 0.0 112.794 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.4 m -143.71 -71.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.686 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.27 117.91 17.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.9 pt -102.04 -175.49 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.25 -55.97 4.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.191 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -67.96 -51.53 46.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.76 0.314 . . . . 0.0 111.769 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.05 6.44 36.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.677 0.275 . . . . 0.0 111.73 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.503 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.1 OUTLIER -64.9 -55.51 27.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 9.6 Cg_endo -53.13 -32.22 58.37 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.683 2.255 . . . . 0.0 112.725 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -58.01 -46.84 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.397 . . . . 0.0 110.337 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.82 -43.86 98.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.457 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.36 -44.86 93.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.46 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 32.0 mm-40 -67.11 -39.63 86.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.081 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 286' ' ' VAL . 85.7 mt -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.16 -38.2 88.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.88 -40.89 83.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.146 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.15 -40.42 96.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.215 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.13 86.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 82.9 mtp180 -68.51 -30.73 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.51 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.7 72.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -89.8 -6.06 56.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.893 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 65.73 26.67 11.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.121 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -105.21 136.96 43.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 111.339 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.68 169.68 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.117 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.474 ' HB2' ' HA ' ' A' ' 285' ' ' ALA . 37.5 t80 -119.79 128.18 53.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.437 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.468 HG23 HD21 ' A' ' 280' ' ' LEU . 1.5 p -119.95 118.63 57.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.14 -178.36 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.169 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.612 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 50.6 m 64.93 26.54 12.79 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.889 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.575 HG13 HD11 ' A' ' 225' ' ' ILE . 58.0 t -72.18 134.89 28.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.519 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -63.22 127.59 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -56.57 -29.64 62.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.856 -171.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.18 -45.96 24.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.516 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.644 HD22 HD11 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -75.08 116.13 15.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.014 -177.245 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.4 t -106.54 -176.17 3.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -166.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -48.5 -45.1 36.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.33 -34.35 64.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.862 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.44 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.6 m-20 -79.7 -56.79 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.451 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.802 HG13 HD11 ' A' ' 240' ' ' LEU . 27.1 mm -54.39 -26.25 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.835 0.454 . . . . 0.0 112.071 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -50.91 -32.43 20.63 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.77 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 67.2 m -48.93 -62.71 1.38 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.575 0.702 . . . . 0.0 112.698 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.864 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.3 m -74.72 -46.24 42.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.949 -165.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.675 ' HB2' HD11 ' A' ' 235' ' ' ILE . 71.6 m-85 -61.07 -35.89 78.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.967 0.413 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -77.38 -26.52 51.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.192 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.53 81.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.654 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.753 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.5 OUTLIER -82.67 -14.27 54.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.669 -175.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.44 -111.3 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.82 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -156.07 131.19 9.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 110.132 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' A' ' 229' ' ' PHE . 58.7 mt -86.39 127.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.472 0.653 . . . . 0.0 110.763 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -79.48 -46.07 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.736 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 5.4 p -167.0 129.34 1.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.699 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.445 ' HB3' HG23 ' A' ' 255' ' ' ILE . 20.4 p -131.2 137.76 49.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.901 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 52.8 m -154.88 120.68 5.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.898 0.38 . . . . 0.0 110.915 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.802 HD11 HG13 ' A' ' 225' ' ' ILE . 52.6 mt -83.46 130.83 35.04 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.13 121.04 11.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.254 0.55 . . . . 0.0 110.319 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 44.9 mtt180 -93.59 158.04 15.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.507 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.6 t70 -117.89 107.71 43.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.382 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.28 -24.69 57.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.015 2.477 . . . . 0.0 113.187 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.5 p -78.43 -28.36 46.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.688 0.28 . . . . 0.0 111.612 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -96.55 -33.37 11.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.899 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.3 -10.94 58.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.993 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -108.83 -92.52 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.667 -0.314 . . . . 0.0 111.115 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 25.4 p80 -170.0 162.09 9.0 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.507 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 96.0 mttt -84.17 155.82 22.38 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.61 42.03 1.47 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.559 . . . . 0.0 114.05 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.4 p90 -161.09 168.29 24.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 175.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.729 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -174.95 -177.82 44.34 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.189 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.25 137.49 54.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.772 0.32 . . . . 0.0 110.62 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 238' ' ' CYS . 56.4 mt -131.61 126.48 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.03 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.3 136.72 44.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.352 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -104.32 155.81 18.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.851 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -81.74 -19.36 41.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.689 173.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 262' ' ' SER . 28.5 mmmt -127.46 120.98 29.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.407 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.29 -22.46 65.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.875 0.369 . . . . 0.0 111.363 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -65.42 -44.02 88.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 1.9 p -71.58 -29.89 65.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.497 ' O ' HG23 ' A' ' 267' ' ' VAL . 9.1 m -56.06 -41.44 75.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.035 0.445 . . . . 0.0 110.757 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -67.2 -35.21 79.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.571 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.65 -43.27 63.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -52.17 -44.63 64.72 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.549 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 263' ' ' SER . 67.0 t -61.82 -27.18 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 111.383 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.0 m -91.12 -36.4 14.01 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.193 -0.317 . . . . 0.0 111.463 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 45.3 m -92.24 -35.07 14.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.731 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 40.2 mmm -70.36 -9.23 55.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -59.99 -43.3 95.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.664 0.745 . . . . 0.0 110.649 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 8.8 mp -76.63 -8.61 57.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.709 ' CD2' HD22 ' A' ' 280' ' ' LEU . 49.0 t80 -45.41 102.09 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.523 0.514 . . . . 0.0 110.889 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.4 p-10 -94.68 128.82 41.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.489 0.662 . . . . 0.0 111.016 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.644 HD11 HD22 ' A' ' 220' ' ' LEU . 40.5 mt -124.07 87.24 2.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.759 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.63 -111.08 3.44 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -113.15 34.56 5.01 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.424 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.2 pt20 -141.23 159.86 41.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.681 0.24 . . . . 0.0 110.813 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -102.25 162.85 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.826 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 13.3 tp -91.09 -170.08 2.55 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.826 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 21.0 tpp180 -148.61 112.41 5.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 175.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 270' ' ' MET . 7.5 p -112.02 146.3 17.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.889 0.376 . . . . 0.0 110.811 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.85 -145.06 4.08 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.546 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 286' ' ' VAL . 92.4 mttt -123.08 150.7 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.653 -0.322 . . . . 0.0 110.29 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.06 -31.39 72.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.713 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 167' ' ' GLN . 62.3 t 68.58 -65.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.431 HG23 HG12 ' A' ' 286' ' ' VAL . 3.1 p -115.58 83.77 11.51 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.473 ' HG2' ' HD3' ' A' ' 289' ' ' PRO . 19.0 Cg_endo -63.99 -33.82 61.47 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 122.643 2.229 . . . . 0.0 115.828 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.473 ' HD3' ' HG2' ' A' ' 288' ' ' PRO . 96.1 Cg_endo -77.43 48.12 2.47 Favored 'Trans proline' 0 C--N 1.367 1.539 0 CA-C-N 121.437 1.549 . . . . 0.0 113.555 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.505 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 50.5 ttp -102.09 124.42 40.03 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 6.2 Cg_exo -74.16 68.56 4.99 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.27 2.647 . . . . 0.0 112.286 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 292' ' ' LEU . 2.0 pp -74.18 142.89 45.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.4 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.8 mt -119.28 72.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.165 0.507 . . . . 0.0 110.532 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' A' ' 295' ' ' PRO . 9.2 m -63.03 -45.58 86.57 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.884 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 294' ' ' THR . 24.1 Cg_endo -64.02 93.28 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.617 1.544 . . . . 0.0 111.647 171.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -79.17 69.61 5.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.597 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.484 -178.82 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.51 ' HB3' HG22 ' B' ' 27' ' ' VAL . . . -122.37 176.1 6.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.603 0.24 . . . . 0.0 110.705 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 66.7 mtt -131.24 46.88 2.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.095 0.474 . . . . 0.0 109.894 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.37 124.49 5.45 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 65.07 70.49 0.47 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.837 0.455 . . . . 0.0 110.378 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 17.8 t -60.08 103.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.195 0.521 . . . . 0.0 111.138 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -87.05 34.17 0.68 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -154.35 -77.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.318 . . . . 0.0 111.026 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.535 ' HB3' HG11 ' B' ' 27' ' ' VAL . . . -64.17 -23.36 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.121 -176.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.7 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 12.1 t80 -72.19 -23.88 61.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.08 0.467 . . . . 0.0 110.032 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 51.5 mtpt -71.4 -39.84 70.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.28 -31.52 72.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.864 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -56.93 -55.0 40.22 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.549 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.669 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.7 OUTLIER -82.25 -24.13 34.95 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 4.7 pt20 -60.33 -37.32 80.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.166 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.426 ' O ' HG23 ' B' ' 41' ' ' ILE . 32.1 ttm180 -74.01 -31.27 62.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.775 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.738 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -71.61 -42.39 67.74 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 121.549 0.69 . . . . 0.0 112.553 -175.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 58.4 mtp180 -79.24 -25.21 42.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.88 -1.137 . . . . 0.0 111.389 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -55.87 -49.8 72.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.35 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.738 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.2 pt -65.41 -34.13 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.847 0.356 . . . . 0.0 110.352 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -68.33 -25.12 64.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.443 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.53 -45.96 34.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.229 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.717 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -86.56 -29.55 22.57 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 59.4 mt 60.22 -87.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 122.868 0.467 . . . . 0.0 111.406 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.65 91.93 0.98 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.54 -119.62 4.44 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.685 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -90.56 31.78 1.01 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.348 0.594 . . . . 0.0 111.093 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.39 56.43 3.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.438 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.65 -122.84 6.94 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.098 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 59.0 m 69.03 -86.95 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.845 0.458 . . . . 0.0 110.573 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.242 -0.885 . . . . 0.0 109.74 176.814 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . . . -66.57 163.03 19.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.3 ttt -47.37 -58.05 4.58 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.517 0.51 . . . . 0.0 111.934 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.62 16.99 16.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.294 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 56.8 tp60 65.38 108.9 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.581 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 104' ' ' ARG . 51.5 mtm180 -71.89 87.55 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.331 0.586 . . . . 0.0 110.315 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 103' ' ' GLN . 66.3 mt-30 -88.53 40.94 0.99 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.315 -172.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -66.17 -29.16 69.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.459 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.9 -26.1 62.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.01 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.5 tp -68.09 -36.18 79.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.28 68.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.4 mt -80.49 -47.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.535 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 52.2 mtm -66.27 -27.02 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.47 -13.41 62.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 21.9 ptt180 -127.23 119.44 26.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.815 0.341 . . . . 0.0 110.566 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.466 HG22 ' HE1' ' A' ' 160' ' ' TYR . 16.8 m -92.47 138.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.69 0.757 . . . . 0.0 111.394 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -86.36 99.49 11.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.642 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.0 t -96.74 115.6 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.155 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.527 ' CA ' ' HD1' ' A' ' 155' ' ' PHE . . . -127.69 -176.91 14.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.8 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 47.2 m 72.43 -72.26 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.582 0.753 . . . . 0.0 111.149 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.42 HD12 HD11 ' A' ' 128' ' ' ILE . 44.1 mm 68.79 158.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 123.23 0.331 . . . . 0.0 110.743 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 69.6 t80 -56.26 -64.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.376 -0.203 . . . . 0.0 110.729 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 42.2 t80 177.86 -49.77 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.104 0 O-C-N 123.456 0.473 . . . . 0.0 110.687 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' LYS . 6.0 pt-20 -136.6 45.19 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.487 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.41 134.36 46.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.925 0.393 . . . . 0.0 111.102 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.56 -177.33 50.43 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.256 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -63.79 -41.65 97.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.478 -0.361 . . . . 0.0 111.866 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -64.37 -41.32 96.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.534 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.7 m -57.06 -45.21 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 119' ' ' ILE . 65.5 mt -71.08 -45.82 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.689 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 129' ' ' ARG . 20.5 ttp180 -56.59 -47.0 80.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.571 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.55 -11.41 59.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.629 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -29.83 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.407 . . . . 0.0 110.443 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.796 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 61.7 m-85 -99.29 8.1 45.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.583 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.34 -44.0 12.91 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.583 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.596 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 29.1 Cg_endo -64.84 -4.78 9.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.843 1.695 . . . . 0.0 113.019 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 5.4 m-85 -87.25 -68.35 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.795 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.17 167.65 36.18 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.827 ' HG2' ' HB3' ' A' ' 161' ' ' GLU . 19.3 Cg_endo -60.39 126.86 21.11 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.54 2.16 . . . . 0.0 111.833 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.2 mt -87.8 128.89 39.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.367 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -80.26 -56.19 4.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -158.7 152.21 23.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.402 HG12 HG13 ' A' ' 158' ' ' VAL . 68.4 mt -124.16 107.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.89 112.61 24.61 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 43.1 ttm -134.85 118.27 16.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.204 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.4 t -91.09 115.47 28.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' CE3' ' HB2' ' A' ' 152' ' ' HIS . 1.6 p-90 -165.93 151.63 8.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.196 0.522 . . . . 0.0 111.771 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.24 99.8 1.22 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.5 t -94.2 6.53 48.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.6 p -84.75 -31.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.114 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.2 p -108.37 -17.37 14.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 111.202 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.0 mtt 63.21 41.18 8.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.143 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 33.8 mmtp -84.06 -39.93 18.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.588 ' HB2' ' CE3' ' A' ' 145' ' ' TRP . 1.6 t60 60.43 67.04 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.732 0.777 . . . . 0.0 110.357 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -96.7 64.96 2.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.664 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.25 -155.25 11.36 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.743 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.527 ' HD1' ' CA ' ' A' ' 117' ' ' GLY . 28.7 m-85 -104.99 170.46 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.961 0.41 . . . . 0.0 111.16 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.45 145.4 24.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.76 107.85 18.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.727 0.299 . . . . 0.0 110.277 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.402 HG13 HG12 ' A' ' 141' ' ' ILE . 23.3 t -98.36 111.37 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 30.1 tt0 -100.57 129.32 46.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.963 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.466 ' HE1' HG22 ' A' ' 114' ' ' VAL . 90.3 m-85 -102.01 161.34 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.384 0.611 . . . . 0.0 111.412 -176.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.827 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 10.8 tp10 -77.62 -27.07 51.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.585 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 16.1 m -126.55 119.76 23.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.665 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 162' ' ' VAL . 19.7 Cg_endo -59.91 -19.4 54.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.299 2.666 . . . . 0.0 113.002 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.43 -56.92 15.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 110.519 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -64.33 -28.96 70.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.99 -51.2 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.01 -36.62 75.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.422 HD22 ' CE2' ' A' ' 212' ' ' TYR . 22.2 tp -57.47 -45.95 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.344 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.05 93.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.185 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.32 -41.48 89.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.701 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -85.13 -32.46 22.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -91.3 -29.42 17.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.796 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 14.9 mmt -95.25 -34.23 12.28 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.111 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 9.9 t30 -70.18 -15.91 63.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 110.454 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.4 p -92.64 5.49 50.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.25 146.1 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 110.594 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.682 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 36.0 mtm -94.23 132.78 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 38.1 tp -83.52 83.77 7.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.142 0.496 . . . . 0.0 110.22 -176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.71 -36.44 3.26 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.191 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.13 -38.18 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -90.99 128.57 36.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.682 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.0 p-10 -75.48 119.09 19.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.276 0.56 . . . . 0.0 109.995 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.434 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 19.9 pt -74.97 150.95 6.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.003 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -101.48 117.58 35.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.048 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 42.9 t -122.64 106.33 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.06 175.23 18.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.049 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 38.9 mtp180 -146.7 128.19 7.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 122.459 0.303 . . . . 0.0 110.424 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.0 Cg_endo -82.19 60.69 7.51 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.059 2.506 . . . . 0.0 111.472 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.5 m -115.76 151.37 35.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.974 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.9 32.48 20.02 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.774 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.479 ' HA ' ' HB2' ' A' ' 195' ' ' GLN . 38.1 mt -79.77 73.12 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.995 0.902 . . . . 0.0 110.222 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 163.08 -36.15 0.32 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.492 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -83.56 -52.64 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.35 . . . . 0.0 110.619 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.87 -21.74 15.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.232 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.58 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 26.7 tp60 -52.74 -47.17 95.48 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.7 Cg_endo -55.15 -30.55 71.5 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.454 2.103 . . . . 0.0 113.072 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.1 -39.05 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.441 . . . . 0.0 110.067 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.9 -38.86 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.082 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.1 -40.07 92.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.75 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -63.64 -34.38 77.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.076 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.87 -45.96 22.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.657 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.79 -43.41 98.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.064 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' ' 206' ' ' ARG . 5.5 tp10 -62.72 -33.53 75.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.455 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 4.2 tp10 -70.2 -40.79 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.019 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -68.47 -28.08 66.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.466 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 88.7 mtt180 -64.25 -22.99 67.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.23 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.03 -4.01 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 291' ' ' PRO . 94.6 m-85 -111.45 -18.72 12.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.471 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.544 HD21 ' HA ' ' A' ' 260' ' ' ALA . 50.2 t-20 50.58 68.58 0.75 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.348 0.594 . . . . 0.0 110.43 -176.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -130.28 136.66 49.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.505 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.663 HD13 ' HE2' ' A' ' 229' ' ' PHE . 7.6 tt -106.54 147.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.335 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.422 ' CE2' HD22 ' A' ' 168' ' ' LEU . 86.5 t80 -108.01 122.88 47.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.42 ' CG2' HD23 ' A' ' 280' ' ' LEU . 6.5 p -122.87 124.2 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.297 0.57 . . . . 0.0 110.897 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.39 -178.19 3.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.46 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.0 m 64.77 33.61 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.768 0.668 . . . . 0.0 111.558 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.758 HG23 HD11 ' A' ' 225' ' ' ILE . 7.1 p -82.78 151.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.281 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 14.7 t-80 -68.89 136.22 52.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -57.48 -35.59 70.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -168.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.42 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 1.0 OUTLIER -79.01 -45.89 19.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 177.502 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.748 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -52.21 110.25 0.47 Allowed 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.78 0.675 . . . . 0.0 110.156 177.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.2 t -94.8 -178.46 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.674 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 2.3 p30 -62.81 -29.36 70.67 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.7 -41.44 73.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.339 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.518 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 52.0 m-20 -80.23 -52.35 7.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.771 -175.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.758 HD11 HG23 ' A' ' 216' ' ' VAL . 47.2 mm -56.21 -25.25 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.227 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.764 ' HG3' HD11 ' A' ' 235' ' ' ILE . 53.8 tttm -55.57 -31.9 62.58 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.47 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.55 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.0 m -51.02 -61.92 1.93 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.826 0.822 . . . . 0.0 112.019 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.561 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.1 m -68.05 -48.84 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.574 -171.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.663 ' HE2' HD13 ' A' ' 211' ' ' ILE . 52.5 m-85 -59.27 -45.22 91.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.787 0.327 . . . . 0.0 111.22 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 40.9 tt0 -73.43 -23.82 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.726 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.52 71.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.73 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.3 OUTLIER -83.73 -38.08 21.85 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -165.78 148.47 13.85 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.17 139.34 58.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.486 0.66 . . . . 0.0 111.355 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.764 HD11 ' HG3' ' A' ' 226' ' ' LYS . 31.0 pt -119.78 137.04 54.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.666 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -85.64 -68.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.407 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' ' 256' ' ' GLU . 11.6 m -94.7 108.99 20.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.336 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 4.3 p -122.12 102.1 7.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.9 m -142.64 116.25 9.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.762 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.674 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 73.6 mt -90.22 117.8 29.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 168.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 123.11 15.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.2 0.524 . . . . 0.0 110.985 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.831 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 53.5 mtt-85 -80.74 157.4 25.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.335 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.637 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 18.5 t70 -117.34 113.89 38.7 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.161 -175.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.79 -20.35 39.86 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.763 2.309 . . . . 0.0 112.336 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.7 m -64.36 -56.69 12.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.496 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 47.2 p -86.81 -35.39 19.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.509 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 106.58 -10.25 41.86 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.1 -157.93 0.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.831 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 29.6 p80 -108.35 149.42 28.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.637 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 94.1 mttt -70.7 154.23 42.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.443 ' C ' HG12 ' A' ' 216' ' ' VAL . . . -73.15 34.45 0.77 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 114.669 0.628 . . . . 0.0 114.669 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.478 ' HE2' ' HD3' ' A' ' 137' ' ' PRO . 35.5 p90 -157.07 164.81 37.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.555 0.678 . . . . 0.0 110.633 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.25 -175.41 41.01 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.312 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.4 ' C ' HD12 ' A' ' 255' ' ' ILE . 86.5 m-85 -123.41 141.58 51.85 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.4 HD12 ' C ' ' A' ' 254' ' ' PHE . 2.2 mp -124.78 135.47 63.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.973 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.496 ' HB3' ' H ' ' A' ' 237' ' ' SER . 45.6 tt0 -109.04 126.44 53.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.627 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.404 ' OH ' ' HB2' ' A' ' 266' ' ' ALA . 7.9 m-85 -98.15 144.23 27.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.182 0.515 . . . . 0.0 112.181 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.88 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 5.0 pt-20 -74.84 -31.47 61.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.88 ' HG3' ' HG3' ' A' ' 258' ' ' GLU . 24.0 mtpp -109.47 157.47 18.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.544 ' HA ' HD21 ' A' ' 209' ' ' ASN . . . -81.86 -40.89 21.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 0.0 111.254 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -64.62 -38.63 91.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.588 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 6.3 p -62.74 -34.78 77.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.567 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -39.94 86.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.964 0.411 . . . . 0.0 110.612 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.69 -39.67 70.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.775 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -46.7 86.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.404 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . . . -60.55 -52.62 64.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.469 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.22 -25.95 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.172 0.51 . . . . 0.0 111.693 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.9 m -84.3 -17.89 38.15 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.098 -0.376 . . . . 0.0 111.993 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.6 p -116.09 -34.41 4.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.51 ' HE3' ' HB2' ' A' ' 273' ' ' PHE . 39.9 mmm -65.48 -4.5 5.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -69.99 -35.28 74.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 122.167 0.984 . . . . 0.0 109.477 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.92 -8.79 58.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.369 -174.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.825 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.2 t80 -52.78 105.37 0.12 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.877 0.37 . . . . 0.0 110.653 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.3 t70 -97.95 119.2 36.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.748 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.6 mm? -117.52 86.31 2.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.995 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.5 26.1 61.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.664 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 118.21 -18.68 11.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.228 -0.986 . . . . 0.0 113.646 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.4 pt20 -106.75 131.76 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.136 0.468 . . . . 0.0 111.362 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.462 ' HB2' HH12 ' A' ' 281' ' ' ARG . 50.1 m-85 -94.31 137.95 32.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.275 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.515 HD22 ' HD2' ' A' ' 273' ' ' PHE . 11.1 mp -73.81 -173.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.304 0.573 . . . . 0.0 111.525 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.462 HH12 ' HB2' ' A' ' 279' ' ' TYR . 77.2 mmt-85 -146.89 118.09 7.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.15 146.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -154.52 -164.37 12.83 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.735 176.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -88.69 169.94 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.499 0.649 . . . . 0.0 110.186 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.91 -32.44 73.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 287' ' ' THR . 54.8 t 70.73 -70.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.954 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.489 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 54.0 p -112.84 138.69 22.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 65.5 Cg_endo -76.39 104.5 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.341 2.028 . . . . 0.0 112.058 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 287' ' ' THR . 5.4 Cg_exo -77.96 -18.12 13.27 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.688 2.259 . . . . 0.0 111.852 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 86.1 mtp -136.65 67.98 59.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.844 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 208' ' ' PHE . 91.9 Cg_endo -83.49 169.14 12.54 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.602 2.202 . . . . 0.0 111.208 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.763 HD13 ' H ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -108.39 130.79 55.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.39 0.614 . . . . 0.0 110.598 178.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.11 87.77 2.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.271 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 12.1 t -120.72 140.57 30.81 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.031 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.05 108.25 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.632 2.222 . . . . 0.0 111.579 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -82.32 69.43 9.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.178 0.513 . . . . 0.0 110.664 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.877 179.351 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.99 124.9 53.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.028 0.442 . . . . 0.0 110.725 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 71.8 mtm -137.92 105.92 5.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.652 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.06 94.15 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.458 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -52.8 -45.54 67.25 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.766 0.427 . . . . 0.0 111.698 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 58.8 t -70.34 -44.52 77.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.006 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.691 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 51.7 t30 66.46 -79.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.498 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.61 -67.76 0.35 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -24.16 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.053 0.454 . . . . 0.0 111.273 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.576 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 5.2 t80 -75.14 -17.84 60.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.126 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 89.6 mttt -70.61 -45.5 65.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.52 -40.3 86.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.73 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -48.51 -53.43 18.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.326 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.823 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.22 -17.51 45.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 57.5 mt-30 -66.07 -43.85 86.23 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.55 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 74.0 mtp180 -69.38 -37.35 77.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.108 173.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -59.55 -50.65 73.06 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.269 31.1 mtp85 -81.55 -25.38 35.91 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.266 -1.521 . . . . 0.0 112.971 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -55.57 -44.89 77.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.018 169.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.821 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -66.33 -33.54 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.625 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -69.28 -24.81 64.01 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.813 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.58 -22.91 24.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.202 0.525 . . . . 0.0 110.637 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 20.1 ttpt -90.91 -41.65 11.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.58 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.419 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.3 pt 41.6 52.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.786 0.835 . . . . 0.0 112.9 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -155.15 122.74 1.25 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.835 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.3 175.19 43.27 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.122 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -123.25 132.43 54.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.035 0.445 . . . . 0.0 110.946 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.75 63.17 4.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.701 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.19 -154.91 25.33 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.935 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -91.3 126.56 36.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.91 0.385 . . . . 0.0 110.978 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.252 1.228 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.313 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.68 47.43 1.19 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.212 0.529 . . . . 0.0 110.97 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 24.0 mmt -80.62 3.46 21.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.041 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.31 -12.98 41.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.982 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -97.67 28.48 3.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.747 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.84 92.05 6.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.436 ' CB ' HD23 ' A' ' 108' ' ' LEU . 32.1 mm-40 -69.65 116.96 10.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.087 -174.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -60.45 -37.95 82.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.773 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.52 -52.79 64.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.758 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.545 HD12 ' HG3' ' A' ' 163' ' ' PRO . 3.8 mm? -66.11 -36.78 84.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.88 74.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.359 . . . . 0.0 111.367 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.9 mt -82.11 -41.29 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.81 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.9 mtp -68.05 -37.01 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.059 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 79.8 m -75.91 -17.78 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.832 ' HG2' ' HB3' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.3 99.92 11.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.979 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.78 140.03 17.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.419 0.628 . . . . 0.0 111.226 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.55 ' HE2' ' HE2' ' A' ' 184' ' ' LYS . 42.6 t80 -88.94 121.34 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.406 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.472 HG22 HG13 ' A' ' 185' ' ' VAL . 52.0 t -116.53 110.98 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -130.42 101.98 0.52 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.652 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.544 ' HB3' HG22 ' A' ' 183' ' ' ILE . 8.9 t 168.45 59.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.411 HG21 ' ND1' ' A' ' 152' ' ' HIS . 12.7 mm -82.06 -17.45 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.8 -170.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 t80 66.51 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.1 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.2 t80 179.17 -53.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.69 36.05 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.52 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.56 113.45 18.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.583 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -83.18 159.85 37.77 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.236 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.1 OUTLIER -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 109.895 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 25.5 t70 -65.13 -42.12 94.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.085 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -58.75 -42.82 89.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.034 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.38 -42.72 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.511 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 129' ' ' ARG . 10.6 ttp180 -61.0 -39.78 91.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 38.3 mt-30 -76.29 -20.42 57.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.05 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.22 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.883 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.43 ' HB2' HD11 ' A' ' 138' ' ' ILE . 78.9 m-85 -94.88 8.12 43.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -66.63 -44.22 53.73 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.991 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 23.9 Cg_exo -65.86 -12.74 36.6 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 112.541 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.584 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 5.9 m-85 -80.39 -68.16 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.654 0.264 . . . . 0.0 110.964 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -149.07 169.55 29.46 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.465 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.55 ' HD2' HG22 ' A' ' 162' ' ' VAL . 15.2 Cg_exo -67.46 100.52 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.682 2.255 . . . . 0.0 111.565 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.43 HD11 ' HB2' ' A' ' 132' ' ' PHE . 64.6 mt -69.34 107.36 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -76.22 -31.83 58.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 p -173.07 128.95 0.47 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.743 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.0 tt -105.92 132.85 51.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 172.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -114.49 115.63 27.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.865 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' A' ' 125' ' ' GLU . 23.0 ttt -140.81 128.54 21.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.093 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.8 t -118.99 124.92 48.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.851 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 43.6 p-90 -163.64 159.61 21.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.615 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.87 93.25 1.68 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.872 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.454 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 48.3 t -70.86 -22.04 62.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.546 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.82 -26.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.022 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.8 p -121.36 5.73 10.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.851 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 68.5 mtp 60.8 27.35 17.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -91.08 107.57 19.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 0.0 110.608 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.411 ' ND1' HG21 ' A' ' 119' ' ' ILE . 40.8 m-70 -83.25 74.55 10.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.92 -51.14 17.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.189 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.33 172.7 54.45 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.629 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.09 170.85 7.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -104.7 129.11 52.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 0.0 110.446 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.27 108.03 17.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.27 124.12 67.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.207 0.527 . . . . 0.0 110.554 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.832 ' HB3' ' HG2' ' A' ' 113' ' ' ARG . 10.3 pt-20 -112.82 131.22 55.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.501 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.67 162.89 13.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.731 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -78.27 -15.18 59.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.664 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 17.3 m -129.44 128.98 23.19 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.545 ' HG3' HD12 ' A' ' 108' ' ' LEU . 56.2 Cg_endo -72.07 -14.61 29.04 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.009 2.473 . . . . 0.0 113.16 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.664 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 31.0 mp0 -60.74 -52.21 66.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 110.574 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -22.98 67.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.503 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.31 -50.71 36.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.794 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -39.67 94.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.447 ' CD2' ' HB3' ' A' ' 214' ' ' ALA . 15.5 tp -60.36 -49.65 76.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.846 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.96 -29.2 70.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.196 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.84 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.9 tt -61.37 -61.15 2.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.092 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.99 -39.49 23.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.704 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 17.3 mm-40 -83.14 0.19 46.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.426 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 58.2 tpp -122.38 -36.54 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.079 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.658 ' OD1' ' HA ' ' A' ' 184' ' ' LYS . 10.4 t30 -67.58 -31.09 70.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.959 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.2 m -85.16 -8.91 58.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.81 90.18 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.108 0.48 . . . . 0.0 110.211 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.6 ptm -72.52 118.12 15.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.255 0.55 . . . . 0.0 110.32 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.2 -34.24 68.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.485 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 152.29 133.41 1.94 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.553 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.98 -62.89 3.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.606 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -124.04 155.37 38.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -90.12 127.92 36.21 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.544 HG22 ' HB3' ' A' ' 118' ' ' SER . 23.4 pt -89.97 132.06 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.068 176.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.658 ' HA ' ' OD1' ' A' ' 174' ' ' ASN . 21.8 ptmt -102.15 116.94 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.368 0.604 . . . . 0.0 110.176 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 116' ' ' VAL . 62.1 t -123.51 133.5 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.227 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.84 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 106.48 -126.29 8.45 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.841 174.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 54.84 67.93 2.93 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 124.17 0.57 . . . . 0.0 111.013 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.04 -157.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.909 2.406 . . . . 0.0 111.892 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 194' ' ' ALA . 34.1 t 72.55 118.6 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.577 0.703 . . . . 0.0 110.681 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.481 ' OD1' HG13 ' A' ' 191' ' ' ILE . 25.2 t-20 -74.85 -63.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.278 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.481 HG13 ' OD1' ' A' ' 190' ' ' ASN . 55.5 mt -137.55 67.48 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.268 0.556 . . . . 0.0 110.463 175.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.01 2.07 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -58.63 -10.31 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 189' ' ' SER . . . -84.85 -30.74 24.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.044 -0.41 . . . . 0.0 111.269 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.514 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.1 tp60 -64.18 -50.16 69.66 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.6 Cg_exo -52.52 -33.57 58.44 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.117 1.878 . . . . 0.0 112.437 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.93 -44.03 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 110.094 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.88 -43.55 97.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.608 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -45.11 93.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 84.2 mm-40 -61.11 -46.22 91.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.704 HD13 HG22 ' A' ' 287' ' ' THR . 96.1 mt -71.21 -28.99 64.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.68 94.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.3 -32.45 71.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.178 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.55 -42.14 87.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.201 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.12 72.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.46 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -68.43 -19.4 64.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.82 -13.49 59.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.512 ' HB3' ' HG3' ' A' ' 210' ' ' ARG . 41.4 m-85 -103.39 -23.07 13.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.144 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 59.09 37.1 24.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.501 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 1.015 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 96.3 mtt180 -97.22 138.25 35.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.503 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.09 158.56 17.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.35 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -109.75 128.54 55.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.833 0.349 . . . . 0.0 110.621 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 4.4 p -120.78 119.23 58.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.129 0.49 . . . . 0.0 110.585 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -123.33 -177.2 3.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.558 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 8.1 t 68.0 22.49 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.055 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.504 HG13 HD11 ' A' ' 225' ' ' ILE . 84.7 t -73.23 129.68 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.018 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -63.18 130.54 45.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.81 -28.82 66.37 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -78.98 -45.87 19.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 111.398 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.662 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -61.34 110.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.638 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 62.4 m -87.14 -178.26 6.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.908 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 19.7 p-10 -66.94 -37.65 84.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.706 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.704 0.764 . . . . 0.0 109.832 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 0.9 OUTLIER -67.78 -54.62 17.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.723 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.726 HG13 HD11 ' A' ' 240' ' ' LEU . 29.4 mm -59.58 -21.28 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 111.032 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.47 ' HG3' HD12 ' A' ' 235' ' ' ILE . 88.4 tttt -59.19 -31.39 68.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.936 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.4 m -48.76 -59.79 3.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.87 0.843 . . . . 0.0 111.43 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.707 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.8 m -68.91 -52.22 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.603 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -58.38 -34.4 70.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.423 ' HA ' HG13 ' A' ' 235' ' ' ILE . 2.2 tm-20 -76.63 -34.67 58.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.026 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.39 -13.75 61.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.709 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 4.2 m-30 -90.06 -10.94 42.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.763 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 173.72 -112.49 0.42 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.583 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -146.45 120.0 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 110.609 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 226' ' ' LYS . 49.8 mt -85.6 134.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.094 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -86.46 -47.99 8.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.093 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 3.8 m -148.55 132.14 16.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.897 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 45.1 t -120.25 111.59 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.9 m -141.02 107.81 5.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.296 0.569 . . . . 0.0 112.288 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 79.4 mt -91.68 130.65 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.9 162.17 22.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.954 0.407 . . . . 0.0 110.967 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 56.3 mtp180 -123.68 158.7 30.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -107.77 95.72 15.24 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.94 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.32 -23.42 32.82 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 113.136 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -29.35 55.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.634 ' HB ' ' HE2' ' A' ' 248' ' ' LYS . 1.2 m -114.32 -19.33 11.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 111.509 178.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.63 43.18 5.55 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.877 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.634 ' HE2' ' HB ' ' A' ' 246' ' ' THR . 47.1 mtmt -125.8 -178.51 4.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.755 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -113.18 131.61 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 170.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -65.58 136.44 56.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.62 29.83 1.04 Allowed Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.359 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.6 p90 -154.15 158.46 40.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.681 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.62 -171.42 38.8 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.114 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.488 ' CZ ' ' HG2' ' A' ' 164' ' ' GLU . 98.4 m-85 -127.65 133.32 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.936 0.398 . . . . 0.0 110.95 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.07 132.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 1.015 ' HG2' ' HG2' ' A' ' 210' ' ' ARG . 39.7 mt-10 -104.31 144.52 31.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.048 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -120.11 141.44 49.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.225 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.451 ' C ' ' HE3' ' A' ' 259' ' ' LYS . 6.8 pt-20 -81.92 -33.03 30.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.706 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.451 ' HE3' ' C ' ' A' ' 258' ' ' GLU . 0.1 OUTLIER -97.95 113.22 25.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.094 173.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.32 68.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.047 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.65 -35.68 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.2 m -68.37 -25.85 65.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 267' ' ' VAL . 6.9 m -62.42 -30.8 71.48 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.84 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.04 -43.66 57.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.896 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -52.94 -45.52 67.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.349 0.405 . . . . 0.0 110.551 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.524 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . . . -60.56 -42.22 96.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.648 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 263' ' ' SER . 98.2 t -64.46 -39.39 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.716 -176.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.1 p -86.45 -1.0 57.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -115.63 -45.4 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.89 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 0.0 OUTLIER -64.45 -20.61 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.088 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -60.02 -38.27 82.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.744 0.783 . . . . 0.0 110.4 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -78.06 -9.86 59.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.871 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -46.92 106.96 0.09 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.961 0.41 . . . . 0.0 111.494 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.6 108.89 15.54 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.627 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.662 ' HG ' HD22 ' A' ' 220' ' ' LEU . 1.1 mm? -114.7 86.85 2.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.62 -116.83 4.42 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -110.46 23.59 19.91 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.076 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 9.9 pt20 -125.13 151.55 45.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 0.0 111.222 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -107.27 137.84 44.58 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.79 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 4.5 tp -69.05 -176.39 0.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.282 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.704 ' HD2' ' HB3' ' A' ' 172' ' ' GLN . 73.2 mmt-85 -141.51 113.26 7.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.832 0.348 . . . . 0.0 110.388 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 270' ' ' MET . 12.3 p -115.19 146.55 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.985 0.422 . . . . 0.0 110.997 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.91 -159.44 9.37 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -108.31 171.64 7.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 117.18 0.49 . . . . 0.0 110.249 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -62.48 -40.59 97.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.609 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.3 t 70.97 -67.05 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.487 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.704 HG22 HD13 ' A' ' 201' ' ' LEU . 0.5 OUTLIER -108.89 160.97 25.38 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.513 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -93.8 95.89 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.152 2.568 . . . . 0.0 111.774 173.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 287' ' ' THR . 54.1 Cg_endo -69.89 137.93 36.23 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.643 2.229 . . . . 0.0 112.316 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 71.3 mtm -110.99 117.82 49.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.427 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.22 64.47 4.34 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.082 2.521 . . . . 0.0 112.432 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 59.3 tp -101.76 118.05 36.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.439 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.39 95.56 9.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.119 0.485 . . . . 0.0 110.649 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.535 ' N ' ' HD2' ' A' ' 295' ' ' PRO . 27.9 m -63.02 -50.26 77.43 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.661 175.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 294' ' ' THR . 30.2 Cg_endo -63.63 148.78 92.09 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.276 1.984 . . . . 0.0 112.854 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 71.65 125.7 0.03 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.931 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.797 179.328 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.665 -0.174 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.15 34.76 2.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.056 0.455 . . . . 0.0 110.52 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 52.9 tpp -166.09 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.73 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -169.16 -85.9 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.336 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.46 ' O ' ' HB ' ' B' ' 27' ' ' VAL . 15.8 m-85 -127.78 171.75 11.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' B' ' 26' ' ' TYR . 90.3 t 73.57 -32.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.476 ' O ' ' HD3' ' B' ' 32' ' ' LYS . 6.4 t30 -46.91 -41.92 16.75 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.673 0.789 . . . . 0.0 112.868 -175.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.02 -51.47 3.84 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.904 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.587 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -58.29 -45.76 87.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.009 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.709 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 23.8 t80 -76.36 -20.47 57.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.125 0.488 . . . . 0.0 110.947 -175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' B' ' 28' ' ' ASN . 0.2 OUTLIER -82.75 -35.45 26.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.101 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 9.7 t70 -57.97 -46.3 85.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 168.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.707 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -48.46 -46.74 38.36 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.996 176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.799 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.2 -21.68 39.41 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.235 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.1 -41.67 97.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.693 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 54.5 mtt180 -68.83 -36.86 78.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.898 173.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.871 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.0 -42.47 97.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.074 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' B' ' 42' ' ' ALA 0.253 2.7 mtt180 -81.15 -25.99 36.44 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.706 173.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -54.84 -44.34 73.85 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.34 0.59 . . . . 0.0 110.097 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.742 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.5 pt -68.74 -32.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 CA-C-O 121.207 0.527 . . . . 0.0 109.958 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' B' ' 39' ' ' ARG . . . -75.2 -4.59 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.036 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.89 -37.67 15.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.259 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' B' ' 41' ' ' ILE . 11.2 ptpt -72.4 -7.8 51.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.056 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 51.1 mt -28.48 116.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.09 -89.01 0.11 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.745 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.0 -142.73 40.27 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.81 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.8 -34.22 19.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.986 0.422 . . . . 0.0 111.255 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.54 91.48 3.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.77 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.14 77.2 0.38 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.442 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 9.9 p -72.85 -68.63 0.47 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.855 0.359 . . . . 0.0 110.061 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.569 177.914 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.547 ' O ' ' HG2' ' A' ' 101' ' ' MET . . . -88.02 78.44 8.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.763 0.281 . . . . 0.0 110.706 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 100' ' ' ALA . 6.6 ptp 64.99 149.57 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.758 1.223 . . . . 0.0 112.477 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -142.61 18.08 2.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.537 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -113.34 123.87 51.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.796 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -161.09 166.51 27.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.586 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 43.05 34.22 0.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.331 1.02 . . . . 0.0 112.863 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -70.08 -29.31 66.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.001 0.429 . . . . 0.0 110.545 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 -27.91 69.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.658 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 29.7 tp -65.72 -33.28 75.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.565 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.6 67.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 0.0 110.651 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.411 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 56.0 mt -82.99 -42.31 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.959 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.658 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 26.7 ptm -71.32 -25.47 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.977 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.486 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 83.9 m -86.43 5.52 34.67 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 12.4 ptp180 -123.87 130.91 53.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 0.0 110.728 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 158' ' ' VAL . 14.7 m -101.7 145.76 11.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.208 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 73.8 t80 -105.43 127.92 53.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.972 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.5 109.88 30.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.7 152.17 17.48 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.373 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.6 m 61.04 64.09 1.17 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.985 0.421 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.9 mm -54.46 132.09 17.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.376 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 88.5 t80 -44.43 -70.1 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.96 0.787 . . . . 0.0 111.733 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 86.1 t80 171.9 -62.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.752 0.658 . . . . 0.0 109.574 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.81 -25.86 37.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.172 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.52 121.48 13.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -106.41 -175.22 23.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.949 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 32.6 tt0 -65.12 -36.61 84.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.044 0.449 . . . . 0.0 110.07 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.566 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 23.4 m-20 -63.84 -40.9 97.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.319 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.7 m -60.85 -49.74 76.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.45 -51.74 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.057 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 126' ' ' ASP . 23.0 ptt180 -63.62 -35.68 81.31 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.691 -0.404 . . . . 0.0 112.026 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.78 -22.78 49.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.56 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.08 -36.97 58.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.393 . . . . 0.0 110.723 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.482 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 86.9 m-85 -93.31 14.72 17.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.49 -44.48 18.0 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.273 -178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 34.8 Cg_endo -67.16 -4.67 12.04 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -92.47 -75.7 0.48 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.69 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -145.1 -177.57 20.01 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 2.0 Cg_endo -80.72 135.08 10.03 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.712 2.275 . . . . 0.0 112.069 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.15 109.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -79.08 -56.42 4.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.81 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.3 m -156.88 136.57 12.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.679 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.7 mt -121.13 114.72 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.76 106.1 13.48 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 156' ' ' ALA . 25.2 ptm -116.65 142.4 46.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.7 t -81.79 104.27 12.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.01 117.18 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.452 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' MET . 3.3 t70 -77.25 91.86 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.754 172.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.0 p -94.92 4.49 53.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.988 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.55 -54.35 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 t -120.71 4.83 10.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.364 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 146' ' ' ASP . 26.8 ptm 45.51 37.67 3.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.565 1.146 . . . . 0.0 113.198 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -102.95 7.14 39.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 72.16 44.96 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.642 171.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -76.26 81.1 3.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.329 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.8 -161.08 24.96 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.898 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.91 166.93 23.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.478 -0.361 . . . . 0.0 110.08 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -133.03 138.99 46.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.817 0.342 . . . . 0.0 111.571 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.29 119.09 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.78 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.435 ' HB ' HG23 ' A' ' 114' ' ' VAL . 47.4 t -112.57 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.443 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 51.5 mt-10 -96.52 141.65 29.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.89 160.25 20.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.754 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 137' ' ' PRO . 10.6 pt-20 -87.59 -2.4 58.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.123 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.493 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 12.9 m -133.57 126.38 19.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.23 177.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 17.1 Cg_exo -67.88 -18.02 46.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.468 2.779 . . . . 0.0 111.624 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.487 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 14.1 mp0 -62.21 -56.64 16.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.835 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -31.41 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.73 -51.02 66.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.634 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -65.03 -43.64 91.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 110.176 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.49 -48.34 79.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.707 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -58.22 -59.95 4.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.687 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.88 -34.08 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -74.24 -45.03 50.6 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.542 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.677 ' HB3' HD11 ' A' ' 183' ' ' ILE . 26.3 mmt -74.97 -17.85 60.48 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.938 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -76.77 -28.45 55.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.38 0.61 . . . . 0.0 109.644 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.5 m -89.57 -42.92 11.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.042 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 67.4 t -89.52 119.91 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.633 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 88.2 mtp -77.41 112.56 14.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 178' ' ' LEU . 0.6 OUTLIER -79.74 102.98 9.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.234 -176.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.7 -134.41 12.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.856 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -100.21 13.59 60.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.97 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -148.79 161.86 40.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.633 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.1 p-10 -98.29 119.2 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 173' ' ' MET . 28.5 pt -64.4 156.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -100.46 109.73 21.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.6 p -136.52 130.27 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.796 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.69 100.37 1.96 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.952 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.1 OUTLIER -151.74 87.78 4.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.221 177.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.46 101.38 1.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.678 2.252 . . . . 0.0 111.594 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.8 p -72.45 -21.07 61.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -99.8 29.67 4.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.008 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.7 tt -64.35 139.88 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.679 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.25 -69.27 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -82.62 -26.18 32.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 110.637 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.432 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.07 -33.95 72.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.532 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.0 tp60 -60.56 -53.93 59.71 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 55.9 Cg_exo -54.32 -28.83 54.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.479 2.12 . . . . 0.0 112.689 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.13 -52.61 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 194' ' ' ALA . 35.3 mt -64.33 -42.14 94.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.641 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.3 -37.97 89.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.83 -49.29 78.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.623 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.57 -47.5 84.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.449 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.1 -35.6 79.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.745 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.65 -39.08 64.74 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.747 0.308 . . . . 0.0 110.894 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.77 -31.59 70.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.09 0.471 . . . . 0.0 109.946 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.94 69.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.719 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtt180 -66.2 -25.83 67.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.366 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.78 71.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.901 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -95.16 -26.15 16.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.839 0.828 . . . . 0.0 109.861 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 260' ' ' ALA . 5.1 t-20 62.26 44.35 7.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 112.124 168.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -95.92 136.88 35.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.695 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 284' ' ' LYS . 12.2 pt -105.47 161.95 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.104 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.47 118.09 35.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.162 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 51.5 t -105.84 115.67 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.176 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -121.48 178.19 4.91 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.502 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.53 31.97 12.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.558 0.694 . . . . 0.0 110.142 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.589 HG13 HD11 ' A' ' 225' ' ' ILE . 58.6 t -80.71 132.84 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.665 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.484 ' HB2' HD23 ' A' ' 275' ' ' LEU . 1.9 t60 -65.21 128.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' A' ' 218' ' ' GLN . 7.8 mt-30 -56.34 -31.98 64.26 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.549 -171.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.66 -26.45 50.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.951 0.405 . . . . 0.0 110.968 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.801 HD11 HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -95.1 117.53 30.36 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -173.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 64.6 m -96.38 -176.53 3.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.6 OUTLIER -61.07 -38.88 87.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -58.24 -37.1 74.23 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.478 0.656 . . . . 0.0 109.83 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.4 m-20 -67.0 -58.57 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.495 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.589 HD11 HG13 ' A' ' 216' ' ' VAL . 43.7 mm -53.48 -28.52 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.574 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -53.15 -32.28 46.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.917 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.63 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 63.9 m -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.332 0.587 . . . . 0.0 112.404 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.665 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.9 m -64.58 -44.69 96.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.779 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.612 ' CE2' ' HG3' ' A' ' 270' ' ' MET . 86.0 m-85 -67.65 -36.48 80.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.507 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.4 tt0 -76.32 -28.42 56.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.957 0.408 . . . . 0.0 111.174 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.91 -24.98 67.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.75 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 0.9 OUTLIER -88.57 -51.22 5.81 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -148.84 160.62 28.46 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.722 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -68.92 131.45 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 229' ' ' PHE . 63.9 mt -96.36 134.39 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.52 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -90.36 -41.68 11.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.1 m -139.15 131.6 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 7.9 p -131.52 91.33 2.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.716 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.9 m -132.15 116.98 17.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.504 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 7.4 mp -90.38 129.89 36.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.06 97.43 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.668 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -80.69 149.71 29.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.699 175.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.511 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 0.0 OUTLIER -78.74 140.16 58.73 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 110.219 -176.378 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 12.2 Cg_exo -70.73 -20.93 29.65 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.709 2.939 . . . . 0.0 114.767 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 t -101.04 -40.29 7.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.484 -169.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.403 ' OG1' ' HE2' ' A' ' 248' ' ' LYS . 0.7 OUTLIER -106.57 -13.06 15.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.806 -0.559 . . . . 0.0 112.175 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.71 10.87 83.68 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.34 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 248' ' ' LYS . 42.6 mtmt -88.14 137.44 32.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.812 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 2.1 p80 -73.8 126.58 30.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.694 ' HD2' ' HE1' ' A' ' 252' ' ' TYR . 23.7 mttp -69.28 157.8 36.27 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.11 35.08 0.64 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 114.146 0.418 . . . . 0.0 114.146 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.694 ' HE1' ' HD2' ' A' ' 250' ' ' LYS . 38.0 p90 -151.64 154.05 35.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -159.28 179.5 34.84 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.86 121.1 36.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.422 ' O ' HG12 ' A' ' 211' ' ' ILE . 41.9 mm -105.89 124.68 61.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -104.16 118.12 35.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.86 139.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.97 -28.79 39.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.323 0.583 . . . . 0.0 109.656 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 262' ' ' SER . 41.2 tptt -101.34 117.3 34.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.642 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' A' ' 209' ' ' ASN . . . -61.76 -37.24 83.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.276 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -68.85 -40.66 79.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.991 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 259' ' ' LYS . 31.6 t -63.37 -30.23 71.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 267' ' ' VAL . 44.2 t -59.87 -42.7 94.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.175 173.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.76 -39.94 88.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.438 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -54.93 -50.66 68.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.134 0.492 . . . . 0.0 110.511 175.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.17 -53.07 59.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.754 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 263' ' ' SER . 96.9 t -58.09 -33.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.666 -176.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.2 m -70.99 -20.22 62.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.2 m -115.08 -29.76 6.56 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.612 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 58.3 mmm -73.51 -2.07 21.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -167.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.451 ' HB3' HD22 ' A' ' 272' ' ' LEU . 51.6 t-20 -69.56 -39.72 77.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.203 1.001 . . . . 0.0 108.993 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -76.72 -8.99 58.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.985 -173.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.879 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 57.0 t80 -52.79 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.27 115.99 19.26 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.688 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.798 HD21 HD22 ' A' ' 220' ' ' LEU . 13.9 tp -122.82 86.1 2.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.53 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.41 33.76 55.73 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.04 1.87 62.77 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.033 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 20.3 pt20 -122.89 131.91 53.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.885 0.342 . . . . 0.0 110.701 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -81.32 133.82 35.49 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.863 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.879 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 12.1 tp -67.39 -178.67 0.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.083 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.75 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -147.8 112.29 5.3 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 270' ' ' MET . 7.9 p -115.34 137.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.184 0.516 . . . . 0.0 111.924 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -143.6 -144.59 4.27 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.919 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 34.3 ttmt -136.41 148.5 47.83 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.487 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -69.67 121.32 16.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.47 -18.22 7.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.136 0.493 . . . . 0.0 110.297 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 2.4 m -108.42 125.2 32.39 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.646 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.37 118.69 5.32 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.674 2.249 . . . . 0.0 111.459 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.09 119.47 6.15 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.58 2.854 . . . . 0.0 113.408 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.714 ' HB2' ' HD3' ' A' ' 291' ' ' PRO . 65.2 mtm -102.47 -54.2 0.13 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.206 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.714 ' HD3' ' HB2' ' A' ' 290' ' ' MET . 1.8 Cg_endo -83.87 151.09 12.73 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.47 2.114 . . . . 0.0 112.385 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.64 140.09 35.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.972 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.07 3.43 38.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.009 0.433 . . . . 0.0 110.733 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.3 p -98.09 152.28 37.95 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.386 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.17 72.37 4.11 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.792 2.328 . . . . 0.0 112.882 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 70.8 -1.37 2.65 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.508 0.723 . . . . 0.0 111.795 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 20.9 m . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.289 178.906 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.56 69.35 10.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.673 0.273 . . . . 0.0 111.679 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 22.4 mmt 62.43 89.52 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.07 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.82 -11.95 53.1 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.646 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' B' ' 28' ' ' ASN . 88.3 t80 -101.92 119.4 38.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.0 110.663 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.767 HG13 ' HB3' ' B' ' 30' ' ' ALA . 58.5 t -119.41 118.45 57.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.095 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.433 ' HB2' ' CE2' ' B' ' 26' ' ' TYR . 23.3 t-20 -107.01 -79.94 0.57 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.788 0.328 . . . . 0.0 110.787 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.29 -18.21 37.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.964 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.767 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -66.22 -37.21 85.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.871 0.367 . . . . 0.0 110.377 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.75 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 17.3 t80 -78.02 -19.38 54.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.679 0.752 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.631 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 73.9 mmtt -73.27 -48.25 36.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.69 175.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 26.3 t70 -58.38 -36.62 73.78 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.73 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.52 -54.47 26.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.792 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.704 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 2.9 mm? -81.06 -20.36 41.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 44.2 mt-30 -63.74 -42.76 97.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.63 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 66.0 mtt180 -68.52 -37.47 80.05 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.939 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.762 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -62.37 -42.18 99.21 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -172.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 39' ' ' ARG . 27.5 mtp85 -82.11 -26.25 33.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.385 -1.447 . . . . 0.0 112.589 173.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.93 -41.21 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.183 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.801 HG13 HD11 ' A' ' 220' ' ' LEU . 4.2 pt -68.44 -36.51 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.404 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.04 -15.69 63.88 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.086 0.469 . . . . 0.0 111.092 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.52 -42.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.161 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -82.25 -36.26 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.253 -177.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.405 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 69.3 mt 62.93 -71.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.555 0.742 . . . . 0.0 112.657 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.73 76.86 1.83 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.508 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.41 44.68 3.33 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.428 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.88 -67.84 0.66 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.037 0.446 . . . . 0.0 110.019 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.22 145.16 17.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.075 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.93 -87.75 0.8 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.785 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 39.0 m 71.67 97.21 0.07 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.904 0.414 . . . . 0.0 110.197 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.812 -178.165 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 112.719 -0.152 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 56.8 85.42 0.08 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.239 0.616 . . . . 0.0 112.541 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.6 ptm -81.39 -27.17 34.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.229 0.538 . . . . 0.0 109.828 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.63 101.51 8.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.988 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -79.18 -10.19 59.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.595 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 65.39 34.88 7.83 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.325 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 67.05 101.38 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.19 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -58.86 -29.79 67.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.452 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.27 86.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.013 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.81 -33.92 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.243 -177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.98 82.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.526 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.57 -36.87 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.106 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 76.6 mtp -60.3 -26.48 66.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.873 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 75.8 m -73.35 -19.71 60.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.671 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 12.3 ptp180 -118.35 123.35 45.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 0.0 111.321 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -98.13 130.43 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.42 0.629 . . . . 0.0 111.096 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -75.52 119.25 19.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.023 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 42.7 t -108.21 112.24 39.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.57 178.08 28.58 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.841 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t 72.35 -79.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.437 0.695 . . . . 0.0 110.901 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mm 68.45 115.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.219 0.608 . . . . 0.0 111.613 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.657 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 61.9 t80 -72.27 142.65 48.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.471 ' HE1' ' HG2' ' A' ' 151' ' ' LYS . 92.4 t80 -52.85 -58.41 7.01 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -172.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -93.12 34.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.728 . . . . 0.0 110.233 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 27.8 tp -108.15 95.96 6.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.29 173.36 54.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.919 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.22 -35.58 80.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 129' ' ' ARG . 25.4 t70 -77.45 -29.43 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.772 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 m -67.33 -47.89 69.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.887 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.3 mt -58.21 -42.55 83.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.76 172.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 126' ' ' ASP . 53.3 ttt180 -51.13 -49.82 60.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.202 176.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 75.5 mt-30 -75.39 -26.83 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.536 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.43 77.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.113 0.482 . . . . 0.0 110.607 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.495 ' CE2' ' HG3' ' A' ' 173' ' ' MET . 52.3 m-85 -100.95 11.14 40.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.462 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 130' ' ' GLN . . . -71.75 -38.34 6.1 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.945 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.865 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 45.4 Cg_exo -60.15 -15.2 32.79 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.647 1.565 . . . . 0.0 112.78 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -80.45 -72.52 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.942 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.26 -171.9 25.69 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.348 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.87 104.16 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.006 2.47 . . . . 0.0 111.83 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.54 117.87 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.796 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -90.71 -34.89 15.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.789 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t -153.25 142.08 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.917 0.389 . . . . 0.0 110.976 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.8 107.52 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 24.7 t70 -104.6 140.92 37.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.08 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.6 ttm -160.47 143.53 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.582 0.23 . . . . 0.0 110.552 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.2 p -73.95 100.85 3.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.912 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.482 ' CH2' ' HG3' ' A' ' 150' ' ' MET . 2.4 m95 -88.12 158.84 18.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -129.84 89.86 2.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 p 46.68 -145.15 0.24 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.496 170.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -81.64 -21.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.911 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 151' ' ' LYS . 9.2 t -66.03 -26.74 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.303 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.482 ' HG3' ' CH2' ' A' ' 145' ' ' TRP . 52.6 ttm 67.21 13.45 9.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.349 0.595 . . . . 0.0 111.561 175.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.535 ' H ' HG23 ' A' ' 149' ' ' THR . 35.7 mtmm -69.28 121.44 16.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.702 -0.623 . . . . 0.0 109.536 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.406 ' HE1' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -141.19 132.2 26.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.114 0.483 . . . . 0.0 111.045 -174.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.445 ' HB3' ' HE2' ' A' ' 153' ' ' LYS . 34.9 ttpt -166.59 122.79 1.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.239 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.85 -94.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.122 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.92 144.07 47.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 0.0 111.918 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -141.26 161.29 38.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.293 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 92.3 m-85 -132.7 113.22 12.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.13 112.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 43.5 tt0 -105.42 125.49 51.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.167 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 96.4 m-85 -103.8 162.22 13.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.517 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.36 -19.46 50.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.964 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.59 134.86 25.25 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.592 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.9 -12.69 33.13 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 7.1 mp0 -63.87 -50.52 68.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.935 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.68 72.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.54 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.37 91.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.442 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -59.92 -49.45 77.65 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.426 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.724 HD21 ' HA3' ' A' ' 283' ' ' GLY . 37.4 mt -63.44 -41.44 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.58 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -62.17 -46.33 89.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.861 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 tt -67.41 -51.58 50.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.152 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -74.56 -47.74 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -79.81 -49.31 12.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.517 ' HB2' ' O ' ' A' ' 169' ' ' ALA . 16.0 mmt -68.32 -35.18 77.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -173.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -76.72 -17.68 58.95 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.856 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.2 m -91.05 -8.45 48.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.783 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.69 131.0 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.393 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.808 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 73.8 mtp -81.62 89.83 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.2 tp -38.23 -59.5 0.87 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.834 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.6 91.71 0.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.994 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.48 -57.56 4.45 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.026 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.406 ' HD3' ' HD2' ' A' ' 120' ' ' TYR . 10.9 ptm180 -104.6 149.9 25.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.808 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 6.3 p30 -97.58 118.11 33.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.415 0.626 . . . . 0.0 110.957 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 183' ' ' ILE . 1.7 pp -77.24 151.53 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.3 OUTLIER -102.34 118.24 36.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.9 115.34 45.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.03 0.443 . . . . 0.0 110.977 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 104.98 -169.05 16.25 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.985 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.471 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 33.4 mtt180 57.45 59.13 7.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.708 0.403 . . . . 0.0 111.883 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 3.9 Cg_exo -77.62 -39.62 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.433 2.089 . . . . 0.0 112.533 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 p -171.22 151.77 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.878 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 193' ' ' GLN . 94.6 m-20 59.29 56.92 3.61 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.483 0.489 . . . . 0.0 110.794 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.47 -21.36 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.54 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.24 -29.0 8.19 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.911 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 190' ' ' ASN . 12.4 tt0 -75.67 -33.42 60.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.877 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -74.12 -27.81 61.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.87 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.41 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 28.1 tp60 -54.69 -55.62 36.12 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.606 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 13.4 Cg_endo -57.1 -37.17 98.92 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 121.869 1.713 . . . . 0.0 111.938 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.6 mm -63.81 -41.46 92.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.391 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 194' ' ' ALA . 51.0 mm -56.13 -50.64 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.826 176.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.45 -44.42 94.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.876 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 25.4 mm-40 -61.87 -41.42 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.59 -44.0 36.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.0 95.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.329 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.609 ' OE2' ' HD3' ' A' ' 206' ' ' ARG . 13.9 tp10 -67.91 -30.27 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.072 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.17 -47.86 47.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.259 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.04 -26.47 67.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.286 0.565 . . . . 0.0 110.552 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.609 ' HD3' ' OE2' ' A' ' 203' ' ' GLU . 75.7 ttt180 -62.68 -23.11 66.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.968 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.65 -23.65 66.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.12 0.486 . . . . 0.0 110.827 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -14.66 36.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.541 0.686 . . . . 0.0 109.994 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.8 t30 57.18 45.4 20.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.679 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.523 ' HD2' ' HG2' ' A' ' 289' ' ' PRO . 94.2 mtt180 -108.58 136.49 48.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.906 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.1 pt -113.21 166.88 6.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.18 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.427 ' HD2' HD11 ' A' ' 168' ' ' LEU . 18.7 t80 -111.35 122.04 46.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.539 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 229' ' ' PHE . 3.9 p -112.97 121.11 64.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 0.0 110.793 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.4 175.94 6.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.576 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.865 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 8.1 t 68.97 24.61 6.23 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.458 0.703 . . . . 0.0 110.856 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.566 HG21 HD11 ' A' ' 240' ' ' LEU . 61.2 t -75.05 135.46 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.139 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -76.73 141.41 40.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.066 0.46 . . . . 0.0 110.501 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -65.15 -13.42 58.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.39 -47.26 23.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -173.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.898 HD21 HD11 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -101.71 159.33 15.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.181 -174.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 16.0 m -113.06 -177.89 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.0 OUTLIER -53.71 -47.55 70.44 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.334 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -55.14 -30.03 58.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 0.0 110.931 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.935 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 52.4 m-20 -78.79 -53.75 6.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.363 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.483 HD11 HD13 ' A' ' 220' ' ' LEU . 46.0 mm -61.48 -16.95 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.242 0.544 . . . . 0.0 110.89 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -54.34 -31.37 54.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.093 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 69.3 m -52.6 -62.13 1.84 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.934 0.873 . . . . 0.0 111.253 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.609 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.9 m -66.28 -34.05 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.605 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 213' ' ' VAL . 48.3 m-85 -74.68 -35.52 62.78 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.625 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.756 ' HG3' HG22 ' A' ' 235' ' ' ILE . 50.3 tt0 -77.23 -32.29 55.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 111.33 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.05 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.695 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.656 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 4.0 m-30 -85.52 -30.88 23.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 110.209 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -174.02 167.95 40.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.378 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -58.04 106.05 0.33 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 112.254 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.756 HG22 ' HG3' ' A' ' 230' ' ' GLU . 15.9 tt -87.97 142.07 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.047 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.06 -44.35 5.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 24.8 t -147.58 137.39 22.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.333 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.83 119.42 33.51 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.4 m -138.1 103.17 4.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 13.5 tp -88.36 129.74 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.31 114.21 2.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.193 0.52 . . . . 0.0 110.843 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 24.9 mtt180 -91.38 156.4 17.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 -176.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -128.57 113.31 19.34 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.858 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.445 ' HG3' ' HB1' ' A' ' 296' ' ' ALA . 49.2 Cg_endo -69.43 -19.44 37.72 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.87 2.38 . . . . 0.0 112.613 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -55.52 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 110.429 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.6 p -82.34 -35.47 27.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.21 -0.29 44.03 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.33 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -112.03 -103.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 111.301 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 32.1 p80 -163.26 164.22 25.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.439 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -90.25 157.58 17.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.76 40.86 1.64 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.133 -0.556 . . . . 0.0 113.291 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -157.86 164.62 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.74 -169.59 36.2 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.252 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -125.48 137.99 53.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.36 . . . . 0.0 110.343 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.28 123.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.922 177.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 42.6 tt0 -106.69 131.98 53.2 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.08 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.427 ' CD1' ' HA ' ' A' ' 235' ' ' ILE . 68.5 m-85 -112.47 153.0 28.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.19 0.519 . . . . 0.0 111.498 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.98 -22.4 23.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.772 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 261' ' ' GLN . 35.5 ttpt -115.4 117.64 30.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.6 -25.04 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.926 0.393 . . . . 0.0 111.779 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.664 ' HB2' ' HE3' ' A' ' 259' ' ' LYS . 24.2 mp0 -66.65 -33.72 76.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.655 ' OG ' ' HE2' ' A' ' 259' ' ' LYS . 14.8 m -62.93 -38.04 89.43 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 267' ' ' VAL . 14.5 m -59.76 -38.59 82.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.55 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.01 -45.56 81.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.68 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.51 -44.33 93.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.582 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -61.42 -53.73 52.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.069 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 263' ' ' SER . 84.2 t -57.6 -27.27 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 0.0 111.336 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.3 m -72.41 -48.14 43.72 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.7 t -116.48 -13.0 10.95 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -168.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.48 ' HA ' ' CE ' ' A' ' 270' ' ' MET . 2.2 tpt -61.78 -32.45 72.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -170.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 20.9 p-10 -66.69 -22.63 66.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.81 -10.93 59.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.901 ' CZ ' ' HB1' ' B' ' 38' ' ' ALA . 2.0 t80 -69.28 104.8 2.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.771 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.46 88.55 3.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.54 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.898 HD11 HD21 ' A' ' 220' ' ' LEU . 62.7 tp -93.33 87.14 5.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.449 -174.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.94 37.36 11.6 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.759 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.19 65.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.941 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -141.17 130.92 24.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 99.6 m-85 -67.78 132.69 47.89 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 55.7 mt -61.93 -177.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.595 0.712 . . . . 0.0 110.751 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.31 121.84 9.14 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 7.4 p -121.8 134.59 64.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.224 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.724 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -141.64 -148.36 5.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.454 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -127.93 178.86 5.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.801 0.334 . . . . 0.0 110.56 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -104.54 117.72 34.82 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 66.3 t -94.38 -33.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.304 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 11.1 t -107.29 133.66 20.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 12.0 Cg_endo -56.93 121.78 10.68 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.628 2.219 . . . . 0.0 111.919 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.523 ' HG2' ' HD2' ' A' ' 210' ' ' ARG . 27.9 Cg_exo -62.16 96.29 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.993 2.462 . . . . 0.0 111.941 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 18.2 ptp -82.89 139.6 43.15 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.253 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 4.2 Cg_exo -75.52 47.32 1.84 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.496 2.798 . . . . 0.0 113.134 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 55.7 tp -84.87 93.42 8.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 48.7 tp -99.06 94.56 6.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.759 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 13.9 t -71.28 146.31 91.95 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.671 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.83 86.41 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.662 2.241 . . . . 0.0 111.814 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.445 ' HB1' ' HG3' ' A' ' 244' ' ' PRO . . . -94.27 59.56 2.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.572 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.5 177.988 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.44 96.99 10.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.863 0.364 . . . . 0.0 110.171 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mmm -78.1 71.95 4.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.12 73.55 0.17 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -166.62 151.66 7.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.764 0.316 . . . . 0.0 110.524 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' B' ' 30' ' ' ALA . 51.9 t -112.34 139.87 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.523 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -110.3 125.12 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.559 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.852 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 5.6 m-20 76.52 -43.12 0.45 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.612 0.765 . . . . 0.0 112.821 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.474 ' HB3' ' CG1' ' B' ' 27' ' ' VAL . . . -68.24 -29.42 68.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.172 0.51 . . . . 0.0 110.043 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 8.5 t80 -79.06 -17.92 54.37 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 109.473 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.852 ' HD3' ' HA ' ' B' ' 29' ' ' ASP . 52.8 mtpt -75.21 -43.62 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.548 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.61 -44.63 85.6 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.656 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -47.59 -52.31 18.2 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.048 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.811 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -82.06 -22.4 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -65.48 -39.01 91.43 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.634 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 22.7 mmt180 -69.28 -41.85 76.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.339 171.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.901 ' HB1' ' CZ ' ' A' ' 273' ' ' PHE . . . -58.5 -45.16 89.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.843 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -79.9 -25.88 40.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.4 -1.437 . . . . 0.0 112.666 174.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.94 -49.06 66.8 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 169.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.935 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 3.2 pt -64.47 -32.42 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.338 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.774 ' HA ' HD23 ' A' ' 220' ' ' LEU . . . -73.12 -25.68 60.94 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.11 -43.06 14.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 2.8 tmmm? -65.98 -41.44 91.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt 70.78 -80.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.05 174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.96 166.49 21.4 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.847 -173.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.96 114.74 2.29 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.722 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.87 139.13 58.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.675 0.274 . . . . 0.0 110.488 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.91 26.35 9.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.949 0.404 . . . . 0.0 111.002 -176.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.01 99.05 2.19 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.085 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 p -83.63 126.95 33.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.701 0.286 . . . . 0.0 110.744 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.914 179.85 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 112.024 -0.431 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.38 117.3 22.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.802 0.334 . . . . 0.0 110.85 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -134.29 -175.72 3.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.078 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -86.32 -69.11 0.69 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.868 0.366 . . . . 0.0 110.701 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 178.52 -68.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.484 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.706 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 46.9 ttp180 -166.86 100.8 0.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.45 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -103.6 56.44 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.765 0.317 . . . . 0.0 111.101 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.706 ' HG2' ' HG2' ' A' ' 104' ' ' ARG . 24.1 mmm180 -71.8 -32.5 67.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.047 -177.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -52.7 35.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.654 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 3.1 mm? -60.61 -37.26 80.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.094 -176.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.54 79.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.45 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 194' ' ' ALA . 35.4 pt -85.27 -40.88 15.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.518 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 25.5 ptm -71.76 -28.24 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -171.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 81.0 m -92.63 6.51 47.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.639 0.257 . . . . 0.0 110.959 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -119.63 101.06 7.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.216 0.532 . . . . 0.0 111.383 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -109.68 125.53 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -91.09 149.1 21.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.524 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 47.1 t -111.52 111.27 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.062 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.5 -178.27 17.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.04 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.879 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 39.3 m 62.13 29.12 17.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.37 0.605 . . . . 0.0 111.027 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 119' ' ' ILE . 8.5 mt -70.02 147.16 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.053 -178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.3 -73.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 151' ' ' LYS . 48.2 t80 -176.42 -67.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -76.93 -26.92 54.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.336 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.847 HD22 HG21 ' A' ' 127' ' ' THR . 90.2 mt -54.61 125.67 20.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.846 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -107.68 -172.02 22.0 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.006 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.505 ' HB2' HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -68.94 -26.6 65.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.896 0.379 . . . . 0.0 110.097 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.7 -40.79 98.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.697 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.847 HG21 HD22 ' A' ' 123' ' ' LEU . 12.2 m -63.58 -46.11 87.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 110.445 177.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -63.14 -39.45 85.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -54.7 -42.49 71.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.028 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -77.69 -34.0 53.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.684 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.49 89.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.563 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 96.5 m-85 -97.17 12.28 33.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.555 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -68.1 -44.99 40.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.782 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.97 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.9 Cg_endo -68.46 -5.0 14.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.857 1.705 . . . . 0.0 112.991 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.469 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 4.6 m-85 -84.97 -75.35 0.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.843 0.354 . . . . 0.0 110.122 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -147.47 167.19 28.6 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 162' ' ' VAL . 22.8 Cg_exo -64.82 121.62 9.2 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.286 1.991 . . . . 0.0 111.729 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.456 HG21 HG13 ' A' ' 141' ' ' ILE . 2.0 mp -68.16 119.29 13.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.171 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -86.64 -46.1 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.544 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 m -148.38 141.33 24.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.357 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.505 HG21 ' HB2' ' A' ' 125' ' ' GLU . 54.5 mt -124.26 107.03 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.64 108.33 19.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.751 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 125' ' ' GLU . 27.2 ttt -132.0 119.8 21.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.911 0.386 . . . . 0.0 111.034 -176.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.0 t -90.34 83.09 5.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.553 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 2.9 p-90 -143.26 152.92 42.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.867 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.44 117.4 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.195 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.7 m -75.72 -9.01 58.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.938 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 50.7 t -81.85 -57.44 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.378 . . . . 0.0 110.751 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.419 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 27.9 p -80.06 -29.84 39.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.553 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 81.4 mtp 71.86 -10.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.799 0.84 . . . . 0.0 112.257 176.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.447 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 11.7 ptmm? -84.29 114.46 21.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.176 0.512 . . . . 0.0 109.667 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -142.36 145.25 33.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.016 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -119.59 13.06 12.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.624 0.726 . . . . 0.0 109.788 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.57 153.6 22.18 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.479 172.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -106.68 174.26 5.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.868 0.366 . . . . 0.0 110.934 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.19 148.93 36.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.306 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.15 115.25 29.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.068 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.86 108.37 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.043 0.449 . . . . 0.0 110.075 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -102.02 119.67 39.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.439 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.563 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 41.9 m-85 -93.58 149.63 21.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.295 0.569 . . . . 0.0 112.425 -174.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.439 ' OE1' ' HG2' ' A' ' 137' ' ' PRO . 33.8 tt0 -74.29 -27.65 60.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.463 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.507 HG22 ' HD2' ' A' ' 137' ' ' PRO . 26.5 m -121.45 120.9 28.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.942 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.497 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 33.5 Cg_exo -61.22 -25.85 81.3 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.389 2.726 . . . . 0.0 113.403 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.497 ' OE2' ' HD2' ' A' ' 163' ' ' PRO . 1.7 mp0 -58.56 -50.51 73.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.945 0.403 . . . . 0.0 110.122 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.43 -23.09 64.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.77 77.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.488 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -70.6 -39.54 73.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.573 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -58.93 -41.46 87.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.666 0.269 . . . . 0.0 110.917 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.49 -43.11 99.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.9 0.381 . . . . 0.0 110.427 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.712 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.2 tt -64.57 -42.26 95.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.646 -178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -47.29 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -79.97 -50.13 10.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 56.1 tpp -74.16 -28.15 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.831 0.348 . . . . 0.0 111.378 -172.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 10.7 t30 -81.36 -16.82 51.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.201 0.524 . . . . 0.0 110.521 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 t -84.15 -29.21 26.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.32 175.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 91.4 mtp -111.85 111.63 22.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.022 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 48.9 tp -68.55 104.64 2.0 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.86 -78.56 1.36 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.09 35.04 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.407 ' HB2' HG23 ' A' ' 183' ' ' ILE . 18.7 mmm180 -123.34 145.69 48.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.498 0.189 . . . . 0.0 110.81 -176.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -87.65 71.28 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.879 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.6 pt -69.16 156.31 7.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.399 -171.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 6.5 mmmm -101.94 109.99 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.093 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 63.2 t -122.31 121.51 64.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.956 0.408 . . . . 0.0 110.065 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.712 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 73.76 -126.94 10.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.129 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 52.84 77.24 0.46 Allowed Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 110.205 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.93 119.68 7.0 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.509 2.806 . . . . 0.0 113.748 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 m -71.67 -17.64 62.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.036 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.38 6.38 8.52 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.492 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.6 mm 71.34 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.913 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 173.07 50.68 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.43 -47.84 78.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.009 0.433 . . . . 0.0 111.414 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.555 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -111.61 18.04 19.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.787 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.4 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 21.5 tm0? -64.12 -47.38 79.46 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.583 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 74.1 Cg_exo -49.9 -42.35 44.99 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.794 2.329 . . . . 0.0 114.599 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 198' ' ' ILE . 2.6 pp -75.44 -24.25 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.776 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 194' ' ' ALA . 34.5 mt -65.24 -38.5 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.63 0.252 . . . . 0.0 110.542 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.05 -44.63 87.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.332 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.72 -44.63 81.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.573 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.761 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 91.2 mt -61.67 -45.57 93.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.841 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.2 -37.52 87.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.557 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.34 -34.13 77.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -73.93 -41.18 62.44 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.985 0.421 . . . . 0.0 110.198 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.62 72.42 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.779 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -57.4 -38.31 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.956 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.21 -13.01 61.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.564 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' A' ' 288' ' ' PRO . 17.3 m-85 -93.03 -6.94 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.741 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.29 27.34 16.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.748 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.776 ' HD2' ' HG2' ' A' ' 289' ' ' PRO . 92.2 mtt180 -102.26 137.0 41.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.895 0.379 . . . . 0.0 111.159 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.6 pt -121.21 161.5 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.639 175.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -116.02 135.73 53.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.771 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.45 124.56 60.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.885 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.03 -179.22 4.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.97 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 51.0 m 69.64 19.16 7.44 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.709 0.804 . . . . 0.0 111.473 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 225' ' ' ILE . 85.1 t -65.61 140.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.392 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -63.45 132.64 52.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.937 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.614 ' HG3' ' H ' ' A' ' 219' ' ' ASP . 6.2 pt20 -41.42 -55.96 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.614 ' H ' ' HG3' ' A' ' 218' ' ' GLN . 0.5 OUTLIER -79.64 -47.27 15.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.776 HD11 HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -55.89 111.96 1.06 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.042 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 225' ' ' ILE . 56.9 p -97.24 -178.01 4.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -162.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 18.8 p-10 -59.76 -44.04 94.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.434 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.44 -29.29 66.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.546 0.689 . . . . 0.0 109.833 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.674 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 64.5 m-20 -78.73 -54.09 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.513 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.65 HD11 HG13 ' A' ' 216' ' ' VAL . 27.9 mm -53.54 -27.59 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.359 0.599 . . . . 0.0 110.947 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.23 -31.6 44.05 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.84 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -48.94 -58.47 4.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.529 0.68 . . . . 0.0 111.932 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.738 HG12 ' HB1' ' B' ' 34' ' ' ALA . 6.0 m -74.35 -42.26 50.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.607 -171.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 270' ' ' MET . 35.6 m-85 -59.76 -52.99 63.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 0.0 110.927 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.1 tt0 -66.79 -24.03 66.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 -176.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.07 -33.26 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.827 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.753 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.6 m-30 -82.95 -42.25 17.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -151.77 148.37 19.3 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 42.0 mmtm -62.02 122.75 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.684 0.754 . . . . 0.0 110.965 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 238' ' ' CYS . 20.1 tt -87.95 141.16 14.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.109 -169.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 256' ' ' GLU . 82.2 tttt -91.96 -42.2 10.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 256' ' ' GLU . 12.8 p -161.59 146.7 13.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.599 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.44 ' HB3' HD11 ' A' ' 235' ' ' ILE . 6.3 p -137.94 129.98 28.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.841 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 48.6 m -150.61 119.73 6.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.047 0.451 . . . . 0.0 110.988 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.3 mp -99.38 130.52 45.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.795 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.33 137.22 58.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.077 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 52.3 mtt85 -94.25 157.76 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.188 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.551 ' OD1' HG22 ' A' ' 245' ' ' THR . 8.1 t70 -100.32 108.48 52.92 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 14.8 Cg_exo -70.04 -17.55 36.25 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.364 2.709 . . . . 0.0 114.172 -175.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 243' ' ' ASP . 3.5 t -94.6 -6.51 43.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.42 . . . . 0.0 111.125 -172.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 245' ' ' THR . 24.6 p -133.82 -41.78 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 119.96 -24.64 7.81 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.705 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.46 ' HE3' ' OG1' ' A' ' 246' ' ' THR . 0.0 OUTLIER -82.1 -179.86 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.827 0.314 . . . . 0.0 110.776 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.7 p80 -94.0 151.29 19.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.453 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -78.96 154.88 29.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.64 44.62 2.29 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.783 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.432 ' CE2' ' HD3' ' A' ' 137' ' ' PRO . 41.3 p90 -161.8 160.25 28.03 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.149 0.475 . . . . 0.0 110.382 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -170.81 -173.0 37.64 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.354 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.418 ' C ' HD12 ' A' ' 255' ' ' ILE . 87.8 m-85 -123.62 142.6 50.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.681 0.277 . . . . 0.0 110.652 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 254' ' ' PHE . 3.1 mp -124.45 131.32 72.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.618 174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.461 ' HB3' ' OG ' ' A' ' 237' ' ' SER . 30.6 tt0 -112.28 141.07 46.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -119.57 147.74 44.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.176 0.512 . . . . 0.0 111.49 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -79.97 -21.52 43.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.924 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 261' ' ' GLN . 34.9 ttpt -122.08 113.41 19.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.054 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.5 47.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.189 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.444 ' HB3' ' HE3' ' A' ' 259' ' ' LYS . 20.7 tt0 -56.99 -48.19 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.276 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.0 m -62.72 -31.5 72.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.3 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.4 m -59.67 -39.89 85.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.625 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -74.26 -42.97 58.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.858 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -63.78 -31.58 72.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.549 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -72.43 -54.16 10.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.458 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.58 -26.29 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -85.25 -18.34 34.29 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -115.05 -32.97 5.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.633 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.3 mmm -62.58 -21.33 65.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -172.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -58.07 -36.07 72.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.835 0.826 . . . . 0.0 110.377 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.76 -8.73 57.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.21 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.84 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -56.63 102.09 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -175.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.8 t70 -92.26 124.16 36.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.945 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.693 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.2 mm? -122.78 87.08 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.712 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.64 22.98 44.53 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.939 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.53 7.25 42.9 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.801 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.0 pt20 -125.85 130.66 51.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.789 0.328 . . . . 0.0 110.573 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -87.43 144.54 26.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.698 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 273' ' ' PHE . 11.0 mt -75.92 -173.72 2.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.549 . . . . 0.0 110.409 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.41 113.47 5.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 270' ' ' MET . 7.0 m -114.84 154.04 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.059 0.457 . . . . 0.0 111.866 -177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.31 -150.9 6.67 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.763 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 284' ' ' LYS . 28.3 mmtp -96.31 157.9 15.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.28 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.6 t 69.17 -71.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.625 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.487 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 12.3 p -89.59 133.86 33.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.412 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.761 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 16.1 Cg_exo -67.29 122.29 9.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.95 2.434 . . . . 0.0 112.613 -175.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.776 ' HG2' ' HD2' ' A' ' 210' ' ' ARG . 12.8 Cg_exo -70.92 75.57 1.68 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.065 2.51 . . . . 0.0 111.581 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.463 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 51.5 ttm -72.91 122.59 88.02 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 6.5 Cg_exo -74.7 59.26 4.91 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.192 2.594 . . . . 0.0 112.024 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 292' ' ' LEU . 0.2 OUTLIER -82.08 66.47 7.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.382 0.611 . . . . 0.0 110.18 -177.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 98.8 mt -101.92 19.25 18.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.349 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.459 ' N ' ' CD ' ' A' ' 295' ' ' PRO . 4.7 p -76.33 -31.3 0.95 Allowed Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 294' ' ' THR . 80.1 Cg_exo -47.23 106.65 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.373 2.049 . . . . 0.0 113.083 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -107.99 84.17 1.91 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.278 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 60.9 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.325 -179.692 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.68 102.22 1.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.001 0.429 . . . . 0.0 111.372 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mmm -102.11 153.02 20.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.658 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.23 -171.33 40.78 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.723 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -112.95 29.92 7.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.044 0.449 . . . . 0.0 110.424 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' B' ' 30' ' ' ALA . 98.2 t -99.07 115.49 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.197 0.522 . . . . 0.0 111.774 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -136.02 143.82 44.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ASP . . . . . 0.433 ' HA ' ' CD ' ' B' ' 32' ' ' LYS . 35.2 m-20 72.25 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.786 0.679 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.454 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -60.38 -36.74 78.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.966 0.412 . . . . 0.0 111.0 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.646 ' O ' HD22 ' B' ' 35' ' ' LEU . 10.6 t80 -73.99 -19.81 60.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.174 0.512 . . . . 0.0 109.861 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.9 mttt -73.81 -41.49 62.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.95 -38.91 76.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.436 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.753 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.13 -54.13 22.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.339 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.887 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -79.76 -17.46 53.4 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -172.054 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 43.0 mt-30 -60.08 -47.11 87.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 70.6 mtp180 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.245 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -68.01 -46.16 72.04 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.559 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 5.4 mtm180 -79.78 -24.66 41.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.512 -1.368 . . . . 0.0 112.166 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 51.9 tt0 -52.74 -50.03 64.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 109.816 167.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.902 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.4 pt -68.4 -25.39 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.008 0.432 . . . . 0.0 110.58 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' B' ' 39' ' ' ARG . . . -81.2 -11.92 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.65 -30.7 20.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.827 0.346 . . . . 0.0 110.298 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.902 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 15.7 ptpt -76.39 -4.33 41.74 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.72 117.92 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.598 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.94 -9.55 37.07 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.65 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.92 -64.94 4.2 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 t70 56.14 41.8 29.02 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.846 0.458 . . . . 0.0 110.45 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . 73.7 -38.97 0.42 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.785 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.19 -54.48 4.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.339 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -134.23 138.49 45.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.247 0.929 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.37 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.69 146.04 27.96 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -116.69 -177.29 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.453 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 66.16 49.6 1.5 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 123.837 0.711 . . . . 0.0 110.175 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 54.1 mt-30 -63.57 -84.04 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.562 ' HG2' HG21 ' A' ' 297' ' ' THR . 23.4 mtp180 52.45 32.82 11.95 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 173.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 59.69 31.55 20.93 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.016 0.436 . . . . 0.0 110.97 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 103' ' ' GLN . 18.0 ttp180 -65.03 -28.15 69.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.915 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.72 -36.51 64.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.32 -42.68 44.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . . . -62.06 -35.38 78.46 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.188 -176.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.98 -35.85 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.121 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.4 mmm -68.61 -36.53 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.407 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.573 ' HA ' ' HB2' ' A' ' 166' ' ' ALA . 23.4 p -81.13 6.25 14.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 78.0 ttt180 -111.39 96.24 5.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.4 HG23 HG13 ' A' ' 158' ' ' VAL . 11.6 m -92.76 144.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.554 0.692 . . . . 0.0 111.878 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 187' ' ' ARG . 44.1 t80 -96.9 127.3 42.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.53 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 111.19 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.651 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.57 -179.72 16.18 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.697 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.1 m 56.45 34.53 24.42 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.351 0.596 . . . . 0.0 110.898 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.0 mt -73.86 163.82 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.967 -176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 85.9 t80 -57.29 -72.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 31.1 t80 173.35 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.438 0.461 . . . . 0.0 109.762 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.72 -20.5 58.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.43 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.78 HD22 HG21 ' A' ' 127' ' ' THR . 47.5 mt -58.57 110.16 0.93 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.062 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -109.24 -153.69 15.39 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.144 -172.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.8 -51.18 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.633 0.255 . . . . 0.0 111.136 -175.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.35 -26.81 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 -175.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.78 HG21 HD22 ' A' ' 123' ' ' LEU . 3.6 m -67.59 -53.81 25.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.021 0.439 . . . . 0.0 110.053 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.32 -39.38 85.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.274 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -59.52 -38.31 80.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.009 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.29 -44.28 25.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.308 . . . . 0.0 111.66 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.69 81.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 173' ' ' MET . 84.7 m-85 -106.48 18.98 21.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.839 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.62 ' HA ' HD11 ' A' ' 138' ' ' ILE . . . -65.47 -43.91 64.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.031 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 133' ' ' ALA . 22.6 Cg_exo -68.35 -5.16 14.33 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.03 1.82 . . . . 0.0 112.665 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 9.0 m-85 -94.64 60.27 2.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.563 ' HA3' HG21 ' A' ' 162' ' ' VAL . . . 78.12 175.32 44.54 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.75 118.57 3.83 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.861 2.374 . . . . 0.0 111.91 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 133' ' ' ALA . 3.8 mp -60.47 118.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -89.57 -49.56 6.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 109.951 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 p -161.45 147.8 14.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.934 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.98 107.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.14 118.42 34.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.7 ptm -143.33 148.29 36.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.53 108.93 11.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.537 0.684 . . . . 0.0 111.633 -177.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 152' ' ' HIS . 78.0 m95 -104.14 155.68 18.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.452 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -101.76 86.72 2.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.663 0.744 . . . . 0.0 110.197 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.0 p 33.58 -108.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.355 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.45 -28.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -170.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -33.51 67.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.3 mmt 58.93 44.95 15.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.356 0.598 . . . . 0.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 121' ' ' TYR . 10.6 tptm -93.45 -29.1 15.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 145' ' ' TRP . 57.0 t60 60.91 75.84 0.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.492 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -102.84 81.21 1.97 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.79 -155.52 11.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.572 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -125.65 175.03 7.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.35 28.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.76 0.314 . . . . 0.0 111.574 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.21 119.91 39.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 114' ' ' VAL . 2.5 p -114.81 119.42 61.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 0.0 110.463 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.1 tt0 -104.02 130.4 51.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.164 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.603 ' HE1' HG13 ' A' ' 138' ' ' ILE . 51.6 m-85 -110.71 171.54 7.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.644 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.69 14.95 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.563 HG21 ' HA3' ' A' ' 136' ' ' GLY . 8.7 m -134.42 105.88 11.04 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.609 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 38.6 Cg_exo -58.97 -26.9 83.22 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.173 2.582 . . . . 0.0 113.299 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 164' ' ' GLU . 2.1 mp0 -61.8 -57.94 9.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.575 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.27 -26.4 66.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.756 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 112' ' ' CYS . . . -63.02 -51.57 66.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.785 0.326 . . . . 0.0 110.796 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -74.55 -31.82 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 59.2 tp -56.07 -50.08 71.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.65 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.94 97.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.908 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.911 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.4 tt -60.68 -42.68 97.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.633 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.6 -46.1 17.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 75.8 mm-40 -83.95 -50.93 7.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.41 ' HG3' ' CE2' ' A' ' 132' ' ' PHE . 16.0 mmt -74.46 -30.76 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -172.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.37 -24.35 67.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.292 0.567 . . . . 0.0 110.534 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.1 m -92.24 -2.28 56.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.719 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 172' ' ' GLN . 91.6 t -118.28 139.86 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 182' ' ' ASN . 58.7 mtt -99.6 117.28 33.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.83 121.49 27.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 69.98 -88.07 0.3 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -173.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.78 11.75 0.96 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -100.5 132.67 45.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.615 -175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 177' ' ' MET . 6.0 t30 -86.78 89.49 7.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 pt -72.54 142.08 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.83 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -102.73 110.04 21.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.61 110.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.911 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 105.07 110.68 3.53 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.876 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 49.5 ttt180 -109.33 113.82 58.18 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 187' ' ' ARG . 38.1 Cg_endo -66.46 77.06 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.101 2.534 . . . . 0.0 111.549 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.1 m -84.56 -22.7 29.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.525 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -123.31 114.23 19.93 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.8 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.9 mt -129.2 98.41 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 138.48 -47.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -81.27 -57.39 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.034 0.445 . . . . 0.0 110.969 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -92.19 -14.92 28.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.377 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.657 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 24.2 tp60 -56.22 -51.67 78.98 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.057 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 27.6 Cg_exo -63.53 -34.39 64.66 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.028 1.819 . . . . 0.0 111.976 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.07 -42.19 95.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.4 mt -59.57 -44.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.783 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.36 -42.32 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.493 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -59.86 -51.18 70.81 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.755 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 202' ' ' ALA . 3.3 pp -75.71 -29.02 58.81 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.654 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.444 ' N ' HD12 ' A' ' 201' ' ' LEU . . . -73.36 -40.09 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 0.0 110.365 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.44 -44.11 97.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.564 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.73 -30.38 67.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 288' ' ' PRO . . . -64.41 -22.5 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -61.14 -32.99 72.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.37 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 111.031 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -87.26 -26.4 23.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.668 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.5 p30 40.53 46.61 2.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.71 0.804 . . . . 0.0 112.944 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -87.41 136.22 33.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 229' ' ' PHE . 15.8 tt -104.78 146.69 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 0.0 110.359 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -111.36 139.25 46.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.578 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.438 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 5.9 p -136.13 125.91 40.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.181 0.515 . . . . 0.0 110.721 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.42 179.96 4.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.276 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.476 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.8 t 65.05 25.4 12.59 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.789 0.681 . . . . 0.0 109.674 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 225' ' ' ILE . 46.3 t -70.37 129.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.898 -176.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.62 131.25 50.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.51 -50.56 31.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.898 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -75.53 -46.44 32.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.822 HD11 HG13 ' B' ' 41' ' ' ILE . 0.9 OUTLIER -63.53 101.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.015 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.483 ' O ' HG12 ' A' ' 225' ' ' ILE . 50.9 m -91.33 -177.18 4.78 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.043 -169.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.806 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 21.8 p-10 -61.07 -39.26 89.19 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -56.36 -30.59 62.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 110.467 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.644 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 9.4 m-20 -78.69 -53.05 7.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.048 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 216' ' ' VAL . 30.8 mm -52.04 -29.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.466 0.706 . . . . 0.0 111.238 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.573 ' HG3' HD12 ' A' ' 235' ' ' ILE . 87.7 tttt -50.32 -31.64 14.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.882 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 63.8 m -48.39 -61.89 1.77 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.543 0.687 . . . . 0.0 111.723 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.807 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 3.7 m -74.04 -35.74 42.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.481 -170.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.63 ' HE2' HD13 ' A' ' 211' ' ' ILE . 38.9 m-85 -68.33 -48.89 63.67 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.091 -0.243 . . . . 0.0 111.311 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 31.4 tt0 -78.24 -11.9 59.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 111.239 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.27 -28.35 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.654 0.264 . . . . 0.0 111.079 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.751 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.8 OUTLIER -94.82 -62.19 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.62 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -117.98 175.98 15.94 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.766 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -92.3 118.34 30.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.156 0.503 . . . . 0.0 111.304 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.573 HD12 ' HG3' ' A' ' 226' ' ' LYS . 65.3 mt -75.66 138.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.958 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -90.96 -45.4 8.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 4.2 p -156.82 131.7 8.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.33 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 9.6 p -120.5 128.09 52.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.747 0.308 . . . . 0.0 110.223 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.3 p -143.23 111.06 5.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.815 ' HG ' ' HA3' ' A' ' 253' ' ' GLY . 9.4 mp -101.59 116.88 33.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -53.05 112.82 0.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.086 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.942 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -97.21 144.77 26.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.156 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -89.56 118.49 69.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.279 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.91 -21.84 37.01 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.952 2.435 . . . . 0.0 113.522 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 37.9 p -89.08 -17.65 28.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 0.0 111.527 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 31.0 p -102.15 -37.24 8.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.973 0.416 . . . . 0.0 110.52 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.21 1.03 55.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.285 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -128.44 158.03 39.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.931 0.396 . . . . 0.0 110.282 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.942 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -72.9 148.3 44.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.736 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -79.15 155.4 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.86 44.01 1.23 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 20.4 p90 -163.19 160.58 24.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.815 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -176.35 -172.59 41.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.635 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.402 ' CE2' ' HG2' ' A' ' 164' ' ' GLU . 91.3 m-85 -126.91 139.99 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 111.323 -176.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 211' ' ' ILE . 2.7 mp -117.94 128.1 75.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -104.93 114.7 29.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.946 0.403 . . . . 0.0 110.115 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -90.97 153.3 20.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.7 pt-20 -91.8 -18.86 23.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.493 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 29.3 mmmt -122.48 125.15 45.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.72 -22.83 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.717 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -63.27 -44.24 95.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.62 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 34.8 m -65.93 -34.42 78.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 -176.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.9 m -60.46 -32.01 70.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -74.17 -43.45 57.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.858 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.46 -54.01 28.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.225 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.723 ' HA ' HG21 ' A' ' 282' ' ' VAL . 25.2 m -59.1 -26.19 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.02 0.438 . . . . 0.0 111.52 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.2 m -78.05 -19.81 53.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.741 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -114.96 -33.15 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.807 ' HE1' ' HB ' ' A' ' 228' ' ' VAL . 4.1 mmt -75.97 5.18 6.93 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -166.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.495 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.9 t30 -81.92 -38.94 24.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.932 0.873 . . . . 0.0 109.489 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.16 -8.53 57.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.277 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.787 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 4.5 t80 -52.93 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.776 0.431 . . . . 0.0 110.513 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.5 t70 -90.89 125.67 35.82 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.502 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.586 HD22 HD13 ' A' ' 220' ' ' LEU . 85.8 mt -128.63 85.53 2.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.13 44.81 7.89 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.8 63.98 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.832 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 9.4 pt20 -140.58 130.65 24.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.778 0.323 . . . . 0.0 110.608 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -89.67 133.71 34.52 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.658 HD22 ' CD2' ' A' ' 273' ' ' PHE . 8.5 mp -72.45 -165.75 0.22 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.39 0.614 . . . . 0.0 111.03 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 9.6 tpp180 -147.11 116.65 7.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.042 -172.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.723 HG21 ' HA ' ' A' ' 267' ' ' VAL . 14.4 p -105.68 146.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.94 0.4 . . . . 0.0 111.271 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.12 -156.71 7.7 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 286' ' ' VAL . 93.9 mttt -126.49 174.52 8.58 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.603 -0.351 . . . . 0.0 110.11 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -59.13 -43.14 91.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 111.429 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 94.4 t 79.8 -52.92 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.676 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 4.5 m -139.76 122.85 10.42 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-O 120.69 0.281 . . . . 0.0 110.846 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 287' ' ' THR . 1.1 Cg_endo -88.27 113.45 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.661 2.907 . . . . 0.0 112.194 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.01 122.9 10.82 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.682 2.255 . . . . 0.0 111.5 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 63.2 mtm -92.78 112.29 55.12 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.016 -177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.62 -22.71 2.41 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.654 2.236 . . . . 0.0 112.473 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.18 95.69 5.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.981 0.419 . . . . 0.0 110.438 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -166.55 170.66 12.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 6.6 t -101.83 109.51 59.78 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 121.172 0.51 . . . . 0.0 109.838 174.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 13.3 Cg_exo -70.26 115.42 4.15 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.022 2.481 . . . . 0.0 112.226 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -100.81 53.83 0.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.523 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.562 HG21 ' HG2' ' A' ' 104' ' ' ARG . 85.3 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.818 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.42 166.08 13.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 22.1 ptp -157.71 178.03 10.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.98 0.419 . . . . 0.0 111.214 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.49 -114.88 4.04 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.827 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -111.38 -4.9 14.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.254 0.55 . . . . 0.0 109.758 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.47 97.93 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.23 0.538 . . . . 0.0 110.708 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.463 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 52.4 t30 -167.73 -66.48 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.109 173.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.25 -60.89 1.85 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.869 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -58.27 -33.59 69.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.635 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 5.9 t80 -72.34 -27.18 62.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 28.9 mtpp -62.58 -47.85 82.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.75 -36.15 71.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.739 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.763 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -53.72 -56.21 19.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.184 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.8 OUTLIER -79.17 -20.72 47.77 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.339 -171.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 81.2 mm-40 -56.84 -45.96 82.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 170.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.703 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 13.2 mmm180 -74.13 -32.93 63.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.429 175.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.787 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.86 -44.28 93.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -81.46 -26.64 35.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.813 -1.179 . . . . 0.0 112.599 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -56.44 -45.53 80.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.323 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.956 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 4.5 pt -65.87 -36.02 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.735 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.52 -10.59 59.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.33 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.9 -49.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.009 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.956 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -83.92 -29.57 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.898 HG23 ' HB2' ' A' ' 219' ' ' ASP . 37.6 mm 69.37 106.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.167 0.508 . . . . 0.0 111.978 173.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.6 22.63 19.89 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.559 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.46 ' H ' HG22 ' B' ' 45' ' ' ILE . . . -116.56 -99.74 2.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.845 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -112.71 129.71 56.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.083 0.468 . . . . 0.0 110.228 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -113.93 84.6 2.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.234 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.87 -72.35 0.98 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.577 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.9 m -98.98 98.01 9.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.688 0.28 . . . . 0.0 110.437 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 179.825 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.77 48.72 1.41 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.971 0.415 . . . . 0.0 110.995 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.9 mtt -109.65 2.03 19.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.977 0.417 . . . . 0.0 111.031 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.95 72.37 10.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.683 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -160.16 155.51 25.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -101.0 43.4 1.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.705 0.288 . . . . 0.0 110.716 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 55.22 31.54 16.71 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.346 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -62.3 -29.42 70.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.45 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.69 85.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.85 -30.05 63.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.854 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.56 73.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.99 -41.41 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.731 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.708 ' HB3' ' HB3' ' A' ' 163' ' ' PRO . 84.4 mmm -61.86 -25.84 67.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -92.62 6.05 48.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -126.85 126.84 44.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 0.0 111.814 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.513 HG13 ' HB1' ' A' ' 166' ' ' ALA . 16.9 m -118.84 142.55 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 111.425 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -87.24 121.37 29.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.915 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.06 111.09 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.144 0.497 . . . . 0.0 110.374 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.07 177.72 20.43 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.825 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 42.1 m 64.99 48.03 2.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.176 0.513 . . . . 0.0 111.061 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.7 mm -71.51 -20.41 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.5 t80 66.83 -83.66 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.497 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 151' ' ' LYS . 78.1 t80 -174.03 -56.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.966 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.54 8.68 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.66 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.609 HD22 HG21 ' A' ' 127' ' ' THR . 67.9 mt -102.86 124.82 49.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.33 -167.21 11.87 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.842 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.97 -35.17 74.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.907 0.384 . . . . 0.0 109.99 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -58.44 -42.33 87.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.293 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.609 HG21 HD22 ' A' ' 123' ' ' LEU . 3.1 m -72.66 -40.6 66.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.481 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.34 -45.65 92.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.752 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.1 ttm-85 -61.35 -37.43 83.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.222 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -77.25 -36.0 54.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.448 ' O ' ' HD2' ' A' ' 134' ' ' PRO . . . -78.31 -38.93 41.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.981 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.603 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 96.7 m-85 -95.95 5.46 51.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.478 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.65 -42.1 24.59 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.68 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 71.7 Cg_exo -54.81 -2.54 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.211 2.607 . . . . 0.0 114.362 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.603 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 60.2 m-85 -108.65 -71.1 0.77 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.834 -0.541 . . . . 0.0 111.452 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -146.37 -166.5 12.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.623 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -81.86 114.61 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.668 2.245 . . . . 0.0 111.918 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.65 107.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.25 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -136.53 143.9 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.3 mt -133.47 107.02 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.165 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 3.8 m-20 -89.12 96.43 10.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 24.2 ptm -126.82 137.14 53.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 110.758 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.8 t -78.79 115.5 18.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.303 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -110.51 98.12 7.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.279 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.54 89.39 6.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -58.25 -38.92 77.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.381 -171.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.0 m -57.08 -30.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 p -119.2 -10.09 9.83 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.566 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 85.3 mtp 62.23 26.72 16.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 58.2 mttp -109.87 -173.13 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.947 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -126.97 95.91 4.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.128 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -83.53 -19.06 36.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.6 170.54 13.42 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.726 175.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -107.72 175.69 5.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.567 0.222 . . . . 0.0 110.924 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.01 136.72 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.831 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 72.8 m-85 -108.84 114.63 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.546 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.83 126.62 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.802 0.334 . . . . 0.0 110.311 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -120.34 130.49 54.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.326 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 78.3 m-85 -109.53 179.0 4.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -94.67 -2.63 50.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.338 172.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.99 125.53 17.22 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.246 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.708 ' HB3' ' HB3' ' A' ' 111' ' ' MET . 28.0 Cg_exo -64.33 -37.06 41.97 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.198 2.599 . . . . 0.0 112.169 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -57.75 -45.98 85.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.202 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 136' ' ' GLY . . . -55.67 -42.94 75.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 111.278 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.513 ' HB1' HG13 ' A' ' 114' ' ' VAL . . . -65.85 -41.29 91.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.885 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -63.12 -47.94 80.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.478 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.581 HD21 ' HA3' ' A' ' 283' ' ' GLY . 45.9 mt -63.14 -40.25 97.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.276 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.89 93.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.307 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.849 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.1 tt -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -80.78 -48.01 13.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 168' ' ' LEU . 8.0 mm100 -75.99 -40.53 53.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.743 -170.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.4 mmt -80.7 -6.31 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.341 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.1 -21.36 22.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.5 m -90.98 -27.28 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.603 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.1 t -114.67 110.5 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.485 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 23.5 ptm -89.24 138.32 31.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.186 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.47 144.96 39.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.996 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.79 69.88 0.97 Allowed Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.805 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.96 -45.68 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -157.12 137.93 13.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -73.18 92.77 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.825 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 29.2 pt -71.07 158.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.801 -176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -115.63 110.07 18.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.538 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.6 t -114.11 112.37 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.856 0.36 . . . . 0.0 111.023 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.849 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 112.07 134.43 6.31 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.51 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -162.57 94.27 1.21 Allowed Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.12 -39.77 89.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.026 2.484 . . . . 0.0 112.961 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 71.35 -52.14 0.69 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.387 0.675 . . . . 0.0 111.773 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -98.01 64.17 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.153 0.501 . . . . 0.0 110.226 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 mt -90.06 56.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.751 0.786 . . . . 0.0 109.418 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.33 -55.01 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.048 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -82.85 -48.73 10.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.575 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.52 -33.55 62.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.066 -175.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.637 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.7 tp60 -51.93 -53.36 52.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -174.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 49.4 Cg_exo -56.77 -32.22 90.74 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.13 1.887 . . . . 0.0 112.471 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 48.7 mm -72.46 -41.62 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.184 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 194' ' ' ALA . 43.7 mt -64.22 -39.23 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.626 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.52 -40.5 78.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.59 -47.88 65.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.367 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 97.5 mt -55.91 -43.35 77.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.837 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.22 77.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 206' ' ' ARG . 39.5 tt0 -73.75 -44.19 56.91 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.931 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.65 -28.3 63.66 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.209 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.23 76.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.779 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 203' ' ' GLU . 27.8 ptt180 -71.49 -19.7 62.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.172 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.42 66.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.0 -16.04 27.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.944 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.16 40.83 17.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.245 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HG2' ' HB2' ' A' ' 256' ' ' GLU . 98.8 mtt180 -101.93 136.15 42.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.5 pt -116.34 168.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.687 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -118.76 115.15 23.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.475 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.2 p -108.67 121.21 61.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.366 0.603 . . . . 0.0 110.726 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.77 -179.3 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.929 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 134' ' ' PRO . 8.6 t 71.0 14.67 6.79 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.909 0.756 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.702 HG11 HD21 ' A' ' 240' ' ' LEU . 60.6 t -61.93 122.91 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.429 ' HB3' HD11 ' A' ' 220' ' ' LEU . 6.9 t-80 -60.66 136.08 57.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -63.74 -22.68 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -165.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -48.05 15.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -174.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -82.95 147.82 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.358 0.599 . . . . 0.0 111.786 -174.391 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 49.9 m -108.25 -175.49 2.79 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.965 -166.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -50.31 -51.77 42.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.181 0.592 . . . . 0.0 112.307 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 226' ' ' LYS . 26.1 t70 -55.8 -29.88 60.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.325 0.583 . . . . 0.0 110.769 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.665 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 58.3 m-20 -76.04 -56.46 4.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.465 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.591 HD11 HD13 ' A' ' 220' ' ' LEU . 36.7 mm -61.12 -22.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.306 -178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.537 ' HE2' HG21 ' A' ' 235' ' ' ILE . 53.2 tttm -55.62 -31.66 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.399 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.2 m -48.54 -61.82 1.82 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.452 0.644 . . . . 0.0 112.201 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.725 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 5.2 m -67.28 -46.99 82.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.623 -171.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.475 ' HZ ' ' HB ' ' A' ' 213' ' ' VAL . 64.5 m-85 -61.66 -42.42 98.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.692 0.282 . . . . 0.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 50.7 tt0 -77.13 -23.9 51.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.243 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.96 68.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.739 -0.209 . . . . 0.0 111.017 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.77 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.3 m-85 -83.6 -53.85 5.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -141.05 155.94 25.29 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.422 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.491 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 26.9 mmtp -66.37 140.22 58.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.726 0.774 . . . . 0.0 112.169 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.786 HD11 HG23 ' A' ' 255' ' ' ILE . 10.5 tp -84.86 146.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.795 -173.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -107.72 -51.36 2.92 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 16.0 m -143.6 143.01 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.57 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 28.3 p -144.71 133.8 22.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.273 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.0 m -150.81 103.75 3.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.212 0.529 . . . . 0.0 109.951 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.719 HD12 ' HA3' ' A' ' 253' ' ' GLY . 18.8 tp -83.43 129.95 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.85 137.74 51.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 111.461 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.533 ' HA ' ' H ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -143.45 157.75 44.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.757 176.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.527 ' OD1' ' HE3' ' A' ' 250' ' ' LYS . 9.6 m-20 -71.13 108.36 3.7 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.575 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.61 -31.47 21.11 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.39 2.06 . . . . 0.0 112.329 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -96.03 -3.58 44.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.428 . . . . 0.0 110.757 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 243' ' ' ASP . 24.6 m -113.79 -40.84 3.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 0.0 111.406 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.9 53.66 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.157 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 242' ' ' ARG . 95.6 mttt -87.49 -178.0 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -125.21 138.55 54.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.022 0.439 . . . . 0.0 111.685 -171.109 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.533 ' H ' ' HA ' ' A' ' 242' ' ' ARG . 31.8 mmtp -80.41 149.11 30.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.69 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.76 40.92 2.3 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.719 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.56 162.7 19.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.048 0.424 . . . . 0.0 110.331 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.719 ' HA3' HD12 ' A' ' 240' ' ' LEU . . . -167.96 177.37 42.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.225 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.89 134.41 55.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 0.0 110.438 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.786 HG23 HD11 ' A' ' 235' ' ' ILE . 52.0 mt -130.75 140.2 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.498 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 237' ' ' SER . 43.4 tt0 -122.85 131.9 53.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -105.33 153.25 21.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.469 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -85.48 -16.24 40.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.259 0.552 . . . . 0.0 110.293 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -124.38 123.93 41.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.277 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -68.16 -23.62 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.024 0.44 . . . . 0.0 110.574 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -62.22 -37.83 86.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.373 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.442 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 12.2 m -73.62 -36.4 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.056 -176.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 m -59.63 -34.41 72.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.474 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -73.07 -37.12 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 4.7 p-10 -79.11 -26.24 42.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.416 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.11 -52.73 45.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.614 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.72 -25.72 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 p -84.71 -13.52 51.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 p -115.07 -32.24 5.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.839 ' HE2' ' HB2' ' A' ' 273' ' ' PHE . 2.3 mmt -69.14 -4.55 17.83 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.41 -32.78 62.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.99 0.9 . . . . 0.0 108.993 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -77.31 -10.63 59.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.476 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.839 ' HB2' ' HE2' ' A' ' 270' ' ' MET . 2.6 t80 -50.49 105.21 0.09 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.523 0.514 . . . . 0.0 110.403 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.14 125.26 34.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.388 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 220' ' ' LEU . 86.0 mt -130.03 86.83 2.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.681 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.01 14.16 63.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.013 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 102.02 25.02 8.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -140.59 142.17 35.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -81.24 139.45 35.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.125 0.488 . . . . 0.0 110.168 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.1 OUTLIER -79.32 -176.56 5.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.107 176.279 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 281' ' ' ARG . 26.6 mmt180 -142.26 112.7 7.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.687 HG11 ' HB2' ' A' ' 270' ' ' MET . 8.7 p -118.48 131.62 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.581 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -134.96 -161.68 9.51 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.385 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -113.2 168.98 9.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.637 0.255 . . . . 0.0 110.332 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -90.26 113.15 24.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.83 -31.79 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.669 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.51 HG21 ' HG2' ' A' ' 163' ' ' PRO . 9.2 t -133.83 141.03 38.37 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.901 175.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.59 108.75 0.65 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.358 2.039 . . . . 0.0 111.937 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.85 70.03 6.69 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.596 2.197 . . . . 0.0 112.216 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 46.0 ttm -96.11 109.72 48.43 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.95 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.61 136.14 65.11 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.94 2.426 . . . . 0.0 112.479 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.02 114.8 27.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 43.9 tp -92.85 -12.31 31.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.445 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 18.5 p -105.62 116.75 59.5 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.905 0.384 . . . . 0.0 111.647 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 1.4 Cg_endo -83.23 117.01 2.44 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.193 2.595 . . . . 0.0 111.808 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -83.6 51.17 1.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.059 0.457 . . . . 0.0 111.591 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.57 177.347 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.51 87.16 7.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.043 0.449 . . . . 0.0 111.071 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 67.5 mtt -137.61 173.6 11.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.843 177.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.76 -56.58 4.93 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.56 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -81.71 112.57 19.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.966 0.412 . . . . 0.0 111.707 -176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.467 HG12 ' H ' ' B' ' 31' ' ' PHE . 9.4 t 56.05 46.36 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.377 175.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -85.4 26.67 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.553 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.23 -59.73 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.053 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.51 75.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 110.946 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.657 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.6 t80 -70.82 -17.79 62.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 30.2 mmmt -64.29 -50.28 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.74 -37.82 74.25 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.455 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.77 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.16 -58.62 4.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.428 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.758 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.6 OUTLIER -80.78 -17.81 49.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.631 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 26.2 mm-40 -56.41 -46.42 80.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.615 ' O ' HG23 ' B' ' 41' ' ' ILE . 30.5 mmm180 -73.65 -36.44 65.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.68 175.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.799 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -59.82 -45.04 93.63 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -80.28 -26.4 38.94 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.556 -1.34 . . . . 0.0 112.462 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -57.19 -45.18 83.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.849 169.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.799 HG12 ' O ' ' B' ' 38' ' ' ALA . 4.9 pt -67.03 -31.37 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.675 ' HA ' HD23 ' A' ' 220' ' ' LEU . . . -67.99 -46.12 72.22 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.192 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.43 68.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.679 ' HE3' ' HA2' ' B' ' 46' ' ' GLY . 1.3 tmmm? -70.84 -16.54 62.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.957 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' B' ' 44' ' ' LYS . 75.8 mt 78.88 -63.27 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.469 0.708 . . . . 0.0 111.337 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.679 ' HA2' ' HE3' ' B' ' 44' ' ' LYS . . . 141.21 -106.58 0.48 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.48 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.61 16.73 59.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.306 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -126.44 87.77 2.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.53 53.1 0.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.96 -174.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.68 83.07 0.07 OUTLIER Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.78 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -74.12 77.53 1.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.217 0.532 . . . . 0.0 110.112 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.179 -0.915 . . . . 0.0 108.649 -179.525 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.92 70.14 0.6 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.1 0.476 . . . . 0.0 111.635 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.5 mmt -98.18 17.52 18.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.985 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.61 92.25 5.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.755 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -61.94 -60.25 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.047 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 13.9 ptm180 -164.06 22.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -89.13 -61.03 1.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.49 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -52.15 -45.24 64.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.83 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.79 -49.45 52.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.562 HD12 ' HG3' ' A' ' 163' ' ' PRO . 4.6 mm? -69.3 -26.01 64.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.552 -176.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.168 0.509 . . . . 0.0 110.74 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.0 mm -82.5 -36.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.095 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.7 mtp -70.72 -28.65 64.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.209 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.2 m -81.72 2.98 27.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.641 ' HB3' ' HG3' ' A' ' 159' ' ' GLU . 38.9 ptt180 -138.32 140.93 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.582 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.5 m -107.92 141.11 23.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.352 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 44.9 t80 -83.7 116.56 22.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.046 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' A' ' 156' ' ' ALA . 42.8 t -101.93 111.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.47 146.04 16.83 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.337 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.7 m 74.37 -53.72 0.68 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.788 0.835 . . . . 0.0 111.776 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 123' ' ' LEU . 63.6 mt 68.93 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.437 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 27.3 t80 177.26 -85.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.483 ' CD2' ' HD3' ' A' ' 153' ' ' LYS . 1.5 t80 177.58 -77.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.308 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.19 43.93 1.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.552 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 35.6 mt -100.86 123.81 45.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.697 ' HA2' ' HH2' ' A' ' 145' ' ' TRP . . . -83.6 171.12 49.13 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.77 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -63.83 -48.16 77.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 129' ' ' ARG . 34.5 t70 -62.44 -30.46 71.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.628 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 m -59.79 -49.8 76.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.029 0.442 . . . . 0.0 110.453 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.69 -34.52 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.308 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.411 ' HB3' ' HA ' ' A' ' 126' ' ' ASP . 26.6 ttm180 -55.58 -45.73 77.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.794 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 32.1 mm-40 -74.83 -30.54 61.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.439 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.75 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.633 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.454 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 93.2 m-85 -100.77 11.13 40.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.046 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.86 -44.04 29.07 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.789 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.633 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 13.2 Cg_exo -72.29 -8.61 23.02 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.774 1.649 . . . . 0.0 111.994 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.567 ' O ' ' HB1' ' A' ' 165' ' ' ALA . 65.7 m-85 -102.64 65.53 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 110.464 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . 84.31 177.16 51.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.621 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -91.3 115.45 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.906 2.404 . . . . 0.0 112.273 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.521 HD13 ' HE1' ' A' ' 160' ' ' TYR . 36.8 mm -56.75 115.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.089 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -96.4 -55.03 3.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.761 0.315 . . . . 0.0 110.604 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.751 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 23.3 t -135.28 137.08 42.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.11 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.18 127.25 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.624 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.7 t70 -133.25 126.11 30.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.397 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.4 mtp -147.37 147.83 30.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.961 0.41 . . . . 0.0 111.616 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.5 m -79.63 131.17 35.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 168.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.697 ' HH2' ' HA2' ' A' ' 124' ' ' GLY . 82.7 m95 -133.53 150.44 51.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.255 0.55 . . . . 0.0 112.264 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -124.35 89.06 3.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.694 168.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.9 m 65.8 -174.37 0.18 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.199 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.44 -20.98 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 110.424 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 p -67.73 9.74 0.25 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.503 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 20.9 ptp 47.45 38.31 7.52 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 171.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.421 ' HE3' ' OH ' ' A' ' 121' ' ' TYR . 56.2 mtpt -92.49 137.86 32.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -170.55 -78.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.483 ' HD3' ' CD2' ' A' ' 121' ' ' TYR . 22.4 mtmm 54.78 35.67 24.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.655 0.382 . . . . 0.0 111.316 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -102.26 -107.78 3.13 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.526 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.96 165.99 23.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.875 0.369 . . . . 0.0 110.581 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.672 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . . . -145.18 135.77 24.35 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.447 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 51.2 m-85 -113.31 107.9 16.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.915 0.388 . . . . 0.0 110.134 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.09 103.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 28.6 tt0 -105.94 126.47 52.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 -172.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.521 ' HE1' HD13 ' A' ' 138' ' ' ILE . 78.0 m-85 -109.25 -177.98 3.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.11 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -109.23 -1.73 18.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.909 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.88 122.53 16.53 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.435 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.562 ' HG3' HD12 ' A' ' 108' ' ' LEU . 34.0 Cg_endo -65.65 -21.62 58.84 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.902 2.401 . . . . 0.0 113.397 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.97 -63.75 1.04 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.164 0.507 . . . . 0.0 110.466 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 135' ' ' PHE . . . -52.56 -43.15 65.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.136 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.88 66.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.445 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.564 ' HB3' HG21 ' A' ' 286' ' ' VAL . 57.8 tp60 -66.88 -35.45 80.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 212' ' ' TYR . 11.0 tp -64.76 -51.77 60.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.197 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.57 -36.58 81.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.308 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.473 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.6 tt -57.19 -62.37 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.485 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.29 -39.0 85.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -67.62 -49.89 60.82 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 57.8 mtt -82.9 -17.78 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -69.49 -35.36 75.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.233 0.54 . . . . 0.0 109.671 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.9 t -88.2 -43.76 11.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.983 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.85 94.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.783 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.437 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 62.3 mtm -65.78 167.99 8.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.439 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.8 tp -80.23 74.41 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.891 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.82 -123.41 9.79 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 12.22 70.17 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.894 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 177' ' ' MET . 30.1 tpt180 -104.14 119.93 40.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.674 0.273 . . . . 0.0 110.76 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.437 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 21.7 p-10 -78.23 116.02 18.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 110.081 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.48 144.97 17.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -102.05 110.39 22.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.1 m -135.39 106.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.53 . . . . 0.0 110.787 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.473 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 125.52 -165.62 18.6 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.796 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 57.86 89.12 0.11 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.312 0.645 . . . . 0.0 110.93 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.25 -14.25 28.4 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.45 2.767 . . . . 0.0 113.82 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 72.95 -61.54 0.5 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.055 0.542 . . . . 0.0 111.209 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -84.05 70.87 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.8 pt -95.75 -172.79 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.323 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.475 ' H ' ' HB2' ' A' ' 195' ' ' GLN . . . 103.28 -50.29 0.9 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.105 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.67 -43.01 39.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.15 0.5 . . . . 0.0 110.183 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.66 6.32 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.779 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.54 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 52.8 tp60 -61.98 -49.33 85.84 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.668 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -55.17 -37.27 94.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.061 1.841 . . . . 0.0 111.722 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.41 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.3 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 194' ' ' ALA . 48.2 mm -56.68 -48.32 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.191 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.02 -50.78 64.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.835 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 98.1 mt-30 -57.04 -44.73 83.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.814 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.15 -56.67 6.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.649 0.261 . . . . 0.0 111.135 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.52 73.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.981 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HG2' ' NH1' ' A' ' 206' ' ' ARG . 3.0 tm-20 -74.35 -46.13 42.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.429 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.93 -30.15 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.358 . . . . 0.0 110.928 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.93 -25.06 67.97 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.26 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.425 ' NH1' ' HG2' ' A' ' 203' ' ' GLU . 93.6 mtt180 -66.7 -26.22 66.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.59 -17.7 62.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.258 0.551 . . . . 0.0 111.257 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.9 -10.05 19.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.755 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 257' ' ' TYR . 3.2 m-80 54.23 29.32 10.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.489 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.9 136.41 33.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 111.26 -174.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 255' ' ' ILE . 8.9 tt -112.94 147.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.588 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.561 ' CD2' HD22 ' A' ' 168' ' ' LEU . 66.1 t80 -107.86 123.0 47.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.5 . . . . 0.0 109.657 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 280' ' ' LEU . 1.6 p -114.53 122.97 69.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.188 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.41 178.22 5.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.633 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 15.6 m 68.55 25.6 6.64 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.776 0.672 . . . . 0.0 110.909 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 225' ' ' ILE . 85.1 t -68.08 138.7 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.683 ' HB2' HD23 ' A' ' 275' ' ' LEU . 21.2 t-80 -66.41 131.15 45.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -50.55 -44.22 56.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -167.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.61 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.62 -46.54 17.03 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 178.327 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.854 HD22 HD21 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -55.32 114.45 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.262 0.625 . . . . 0.0 110.27 -177.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 6.6 t -95.21 -175.8 3.62 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -166.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.56 -44.0 96.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.838 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.79 -27.91 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 221' ' ' SER . 5.5 m-20 -63.49 -59.64 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.525 HD11 HG13 ' A' ' 216' ' ' VAL . 37.6 mm -55.96 -26.06 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.238 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.493 ' HG3' HD12 ' A' ' 235' ' ' ILE . 88.2 tttt -57.24 -32.29 66.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.653 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.526 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 74.5 m -49.03 -56.64 8.36 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.922 0.868 . . . . 0.0 111.748 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.632 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.2 m -73.85 -49.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.353 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.599 ' HE2' HD13 ' A' ' 211' ' ' ILE . 43.3 m-85 -59.63 -41.82 91.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.629 0.252 . . . . 0.0 111.627 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 30.9 tt0 -74.2 -25.94 59.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.12 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.89 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.693 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.1 OUTLIER -90.18 -58.55 2.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -127.44 154.82 19.72 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 36.7 mmtm -84.11 140.79 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.58 0.705 . . . . 0.0 112.056 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.493 HD12 ' HG3' ' A' ' 226' ' ' LYS . 56.5 mt -103.69 134.38 45.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.094 -171.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 1.092 ' HE2' ' HB3' ' A' ' 258' ' ' GLU . 62.6 mmtt -84.03 -46.08 12.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.986 176.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 21.9 t -147.24 136.63 22.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.614 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.415 ' HB3' HG21 ' A' ' 235' ' ' ILE . 3.5 p -132.64 135.4 45.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.9 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.8 t -157.66 139.77 14.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.336 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.576 HD23 ' HA3' ' A' ' 253' ' ' GLY . 72.7 mt -111.11 129.91 55.78 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.42 134.98 57.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 110.681 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.653 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.0 mtp180 -89.19 157.28 18.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.371 0.605 . . . . 0.0 111.695 -177.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.04 97.99 40.63 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.289 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.86 -23.92 29.8 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.838 2.359 . . . . 0.0 111.624 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 24.3 m -64.43 -47.02 80.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.47 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.469 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 1.7 m -94.69 -33.44 12.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.02 0.438 . . . . 0.0 111.108 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.13 43.3 2.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.529 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.469 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 23.2 pttp -147.51 -166.94 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -175.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.4 p80 -112.98 147.52 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' A' ' 242' ' ' ARG . 88.2 mttt -74.89 152.25 38.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.799 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -76.91 42.77 1.87 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.539 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -161.85 160.31 27.94 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.576 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -172.48 -164.08 27.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.333 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -129.85 137.31 50.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.975 0.417 . . . . 0.0 110.828 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.66 ' HB ' HG23 ' A' ' 211' ' ' ILE . 41.4 mm -119.56 128.98 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.336 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.64 113.26 26.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.153 0.502 . . . . 0.0 111.301 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.511 ' O ' ' HB2' ' A' ' 209' ' ' ASN . 49.6 m-85 -93.33 156.88 16.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.064 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 1.092 ' HB3' ' HE2' ' A' ' 236' ' ' LYS . 8.5 pt-20 -92.01 -17.28 25.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.343 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -127.98 118.54 23.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.473 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.1 66.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.601 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.32 -40.58 93.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.597 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 14.7 m -70.49 -36.03 73.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 267' ' ' VAL . 17.7 m -54.34 -48.63 71.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.209 174.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -64.89 -39.59 93.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -63.04 -46.05 89.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.76 86.49 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.542 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.562 ' HA ' HG23 ' A' ' 282' ' ' VAL . 71.3 t -60.39 -35.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 111.28 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.6 m -89.92 -4.73 57.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.711 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' SER . . . . . 0.496 ' HB3' ' CG2' ' B' ' 27' ' ' VAL . 26.5 p -115.74 -47.01 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.771 ' HB2' HG21 ' A' ' 282' ' ' VAL . 55.3 mmm -65.18 -14.83 61.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 15.0 p-10 -72.76 -26.42 61.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.521 0.677 . . . . 0.0 110.323 176.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.55 -8.72 59.69 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.886 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 69.7 t80 -57.95 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 111.363 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.69 103.48 6.68 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.995 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.854 HD21 HD22 ' A' ' 220' ' ' LEU . 22.1 tp -113.43 86.98 2.5 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.925 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 62.01 41.24 99.66 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.662 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 119.23 -21.48 9.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.749 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.9 137.0 46.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.545 0.672 . . . . 0.0 111.777 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -78.04 128.92 34.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.089 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.886 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 8.0 tp -61.46 169.9 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.177 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.42 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 32.3 mmt180 -142.68 113.34 7.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 121.982 -0.448 . . . . 0.0 110.138 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.771 HG21 ' HB2' ' A' ' 270' ' ' MET . 28.7 m -124.94 168.03 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.991 0.424 . . . . 0.0 112.132 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.544 ' O ' HG13 ' A' ' 211' ' ' ILE . . . 176.94 -164.39 33.81 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.314 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 148.36 43.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.821 0.311 . . . . 0.0 110.343 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -69.37 -16.33 63.5 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 167' ' ' GLN . 49.1 t 72.02 -65.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.673 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 6.2 t -97.33 134.36 22.78 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.416 ' HB2' ' HG3' ' A' ' 291' ' ' PRO . 27.2 Cg_endo -64.27 110.42 1.37 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.736 2.291 . . . . 0.0 111.636 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.14 110.15 1.69 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.809 2.34 . . . . 0.0 112.241 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 290' ' ' MET . 24.8 ptt? 42.21 76.85 0.48 Allowed Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.139 0.976 . . . . 0.0 113.215 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.416 ' HG3' ' HB2' ' A' ' 288' ' ' PRO . 23.4 Cg_exo -65.48 -28.26 53.91 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.165 1.91 . . . . 0.0 110.246 170.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 96.5 mt -123.82 -158.65 0.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.493 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 90.2 mt 62.98 32.96 15.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.991 0.424 . . . . 0.0 111.007 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 27.4 m -96.01 106.17 26.43 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.019 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 4.0 Cg_exo -77.46 60.23 7.0 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.256 2.638 . . . . 0.0 112.163 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -93.49 103.05 15.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.324 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.17 179.937 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.941 -0.463 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.52 40.96 0.92 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 80.9 mtp -59.42 -50.95 71.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.405 0.622 . . . . 0.0 110.437 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.92 123.12 0.68 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.884 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.06 89.82 7.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.73 0.776 . . . . 0.0 109.19 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' A' ' 269' ' ' SER . 8.8 p -66.36 -33.58 64.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.888 -170.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -80.39 15.49 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.368 0.604 . . . . 0.0 110.677 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -119.79 -51.33 2.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.006 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.08 -41.0 23.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.875 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.631 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.7 t80 -69.02 -19.86 64.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.6 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' B' ' 32' ' ' LYS . 44.0 mtpt -69.08 -47.0 66.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -39.5 81.93 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.603 0.716 . . . . 0.0 109.118 175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.693 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.64 -51.37 49.61 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.648 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.03 -20.85 40.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.055 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 35.7 mt-30 -59.53 -44.0 93.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.615 ' O ' HG23 ' B' ' 41' ' ' ILE . 72.7 mtp180 -73.63 -30.3 62.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.685 175.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.843 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -64.5 -49.81 69.86 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -80.1 -24.52 40.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.495 -1.378 . . . . 0.0 112.36 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.18 -50.43 59.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.074 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.843 HG12 ' O ' ' B' ' 38' ' ' ALA . 1.7 pt -66.4 -31.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.63 -22.61 65.32 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.97 -27.31 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.203 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 tmmt? -74.22 -55.26 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.376 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.61 HG23 ' HB2' ' A' ' 219' ' ' ASP . 87.2 mt 66.77 104.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 O-C-N 123.573 0.545 . . . . 0.0 112.198 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.84 165.42 28.05 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.549 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.22 -179.81 50.8 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.193 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.94 96.97 5.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.072 0.463 . . . . 0.0 110.43 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' B' ' 52' ' ' SER . . . -78.45 -21.77 48.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.843 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.22 -116.87 6.94 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.811 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.3 p -93.53 47.27 1.23 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.266 0.555 . . . . 0.0 111.007 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.626 ' HB3' ' HB1' ' B' ' 49' ' ' ALA . 5.1 t . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.309 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 112.422 -0.271 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.77 79.03 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.699 0.285 . . . . 0.0 111.225 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 39.4 ttm 62.02 16.76 8.44 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.147 172.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.54 -46.16 60.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.082 0.467 . . . . 0.0 110.51 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -94.6 153.87 17.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.139 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -80.63 50.57 1.34 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.216 0.532 . . . . 0.0 110.49 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.49 20.57 12.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.575 -177.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -53.85 -51.03 64.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.553 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.24 -34.8 61.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 0.0 111.673 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.19 -32.83 69.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.468 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.53 -49.13 62.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.77 0.319 . . . . 0.0 111.65 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.04 -35.93 16.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.79 0.328 . . . . 0.0 111.533 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 91.4 mmm -71.67 -26.58 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.34 -12.34 60.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.19 133.25 50.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.473 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -94.08 138.0 21.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 0.0 110.915 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.567 ' HB2' ' HA ' ' A' ' 188' ' ' PRO . 72.5 t80 -89.66 106.13 18.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.169 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.6 t -103.53 110.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 118' ' ' SER . . . -134.39 100.24 0.37 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.608 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.607 ' OG ' ' HA ' ' A' ' 183' ' ' ILE . 68.5 p 151.59 51.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.306 1.443 . . . . 0.0 107.549 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.81 69.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.483 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.687 ' HE1' ' HA3' ' A' ' 179' ' ' GLY . 35.1 t80 37.86 -92.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.544 1.152 . . . . 0.0 112.387 169.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' HD2' ' HG3' ' A' ' 122' ' ' GLU . 33.0 t80 -179.3 -72.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.485 173.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.522 ' HG3' ' HD2' ' A' ' 121' ' ' TYR . 48.2 mt-10 -90.07 44.27 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 127' ' ' THR . 48.9 mt -102.2 164.63 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.48 175.82 18.1 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.858 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -60.76 -39.59 89.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.3 m-20 -48.43 -50.96 29.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.684 175.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.774 HG21 HD22 ' A' ' 123' ' ' LEU . 6.9 m -57.56 -47.7 81.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.324 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.411 HG23 ' HE2' ' A' ' 132' ' ' PHE . 79.0 mt -69.42 -41.04 80.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.807 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.446 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 14.8 ttm180 -59.57 -44.64 93.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.79 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 92.9 mt-30 -75.52 -21.46 57.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.45 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.96 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.623 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 97.4 m-85 -96.22 13.39 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.012 0.434 . . . . 0.0 111.141 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.584 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.67 -43.6 11.65 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.453 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 38.0 Cg_endo -67.08 -4.47 11.61 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 0.0 112.792 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 169' ' ' ALA . 4.9 m-85 -85.4 -83.06 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.55 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.67 -176.25 14.36 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.898 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.457 ' HD3' ' CZ ' ' A' ' 252' ' ' TYR . 60.9 Cg_endo -74.57 117.32 4.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.513 2.142 . . . . 0.0 111.444 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -57.12 107.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.917 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 159' ' ' GLU . 23.1 tptp -87.55 -54.49 4.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.379 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -166.73 144.05 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.8 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 63.5 mt -127.35 107.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.32 118.68 35.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.065 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 42.2 ttm -126.56 136.65 52.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.972 0.415 . . . . 0.0 111.189 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.628 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 3.7 m -98.73 111.21 23.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.886 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 2.1 p-90 -164.87 159.64 18.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.03 0.443 . . . . 0.0 111.369 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 153' ' ' LYS . 21.5 t70 -89.34 132.89 34.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.64 -176.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.1 t -101.76 4.98 41.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 110.952 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 91.5 t -85.14 -43.24 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.363 0.601 . . . . 0.0 110.058 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.5 p -119.72 5.22 11.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.002 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 58.46 30.0 19.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.611 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -89.27 128.17 35.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.886 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 58.9 m-70 -81.98 75.41 8.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.522 0.677 . . . . 0.0 110.991 -175.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 146' ' ' ASP . 58.9 mttm -78.5 63.79 3.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.506 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 144' ' ' SER . . . 158.89 -157.86 28.86 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -124.66 174.18 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.69 137.22 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 85.7 m-85 -113.42 113.9 25.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.032 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.0 t -101.01 111.68 31.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.816 0.341 . . . . 0.0 110.256 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 37.8 tt0 -101.52 141.22 34.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.93 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -122.96 172.94 8.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.31 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.63 -27.72 31.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.066 0.46 . . . . 0.0 110.203 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.508 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 6.2 m -121.48 136.52 25.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.864 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 8.2 Cg_exo -73.99 -13.82 23.79 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.72 2.947 . . . . 0.0 112.088 -177.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -60.23 -47.97 83.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.217 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.1 -26.1 68.67 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.5 -49.85 44.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.091 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -66.89 -36.05 81.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.721 0.296 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.86 -43.37 96.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.111 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . . . -59.86 -38.61 82.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.766 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.5 tt -60.35 -60.45 3.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -69.35 -47.29 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -71.59 -31.26 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.623 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 24.6 mmt -83.36 -28.79 28.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.76 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -76.97 -16.51 59.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 110.513 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.2 m -78.44 -13.91 59.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.152 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.07 143.18 36.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 110.794 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.1 ttt -99.11 104.25 16.23 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.07 -28.79 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.234 -171.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.687 ' HA3' ' HE1' ' A' ' 120' ' ' TYR . . . -161.08 -150.74 6.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.076 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.03 23.18 1.8 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.931 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.628 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 14.4 ptm180 -157.43 151.66 24.8 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -79.31 141.12 37.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.609 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.607 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 27.3 pt -100.12 131.81 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 0.0 110.388 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 81.2 tttt -103.83 117.74 35.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 48.1 t -125.29 106.58 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 130.82 159.97 9.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.146 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 67.36 83.69 0.18 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.158 0.504 . . . . 0.0 110.817 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 115' ' ' TYR . 17.3 Cg_exo -66.87 -60.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.961 2.441 . . . . 0.0 112.816 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.8 p -151.83 -61.53 0.17 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.918 0.39 . . . . 0.0 110.971 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.53 132.72 33.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.2 tp -142.98 137.34 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.42 . . . . 0.0 110.562 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 195' ' ' GLN . . . 93.42 -42.33 2.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.386 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -59.18 -31.79 69.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.641 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.48 12.11 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 110.849 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.574 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.4 tp60 -63.72 -49.51 76.2 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.563 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.1 -34.2 67.18 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.342 2.028 . . . . 0.0 112.614 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 46.3 mm -67.91 -42.15 85.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.285 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.12 -47.37 93.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.648 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.47 -32.64 74.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.115 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -71.76 -47.1 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.35 -21.49 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.325 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.96 97.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.13 -35.98 76.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.634 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.31 -35.91 82.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.59 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.15 -20.18 62.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.677 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -64.12 -22.27 66.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.948 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.35 58.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.895 0.379 . . . . 0.0 111.138 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -96.48 -17.37 20.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.99 26.25 11.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.776 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 210' ' ' ARG . 8.3 ptm85 -120.23 144.24 47.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.201 0.524 . . . . 0.0 111.654 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.57 170.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.246 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -112.9 133.4 54.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.589 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 33.3 t -118.16 123.45 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.23 169.77 10.57 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.159 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.0 p 53.19 44.53 30.12 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.352 1.061 . . . . 0.0 111.714 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.593 HG13 HD11 ' A' ' 225' ' ' ILE . 48.5 t -79.14 146.13 8.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.218 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.626 ' HB2' HD23 ' A' ' 275' ' ' LEU . 14.1 t-80 -68.95 129.86 41.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -57.0 -36.95 71.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -167.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.978 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -80.11 -47.63 14.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.074 0.464 . . . . 0.0 111.479 174.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -59.67 108.66 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.948 -178.135 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 225' ' ' ILE . 44.2 m -97.11 -176.96 3.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -168.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.617 ' HB3' HD13 ' A' ' 240' ' ' LEU . 4.5 p-10 -57.88 -38.65 76.15 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.46 -34.92 69.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.483 0.658 . . . . 0.0 109.974 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.649 ' OD2' ' HE3' ' B' ' 44' ' ' LYS . 3.2 m-20 -73.88 -54.34 8.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.298 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.593 HD11 HG13 ' A' ' 216' ' ' VAL . 31.3 mm -54.71 -24.84 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 222' ' ' ASP . 50.4 mtpt -52.01 -33.88 40.4 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.026 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -49.23 -58.73 4.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.529 0.68 . . . . 0.0 111.816 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.661 HG11 ' CD1' ' A' ' 273' ' ' PHE . 13.7 m -74.41 -45.18 46.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.808 -171.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.496 ' CE1' ' HE2' ' A' ' 270' ' ' MET . 76.5 m-85 -68.52 -38.37 80.84 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.096 -0.378 . . . . 0.0 111.799 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.52 -25.64 45.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.384 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.36 83.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.553 0.216 . . . . 0.0 111.368 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.711 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.4 m-30 -75.64 -27.84 58.56 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.47 -109.07 0.45 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.919 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -157.43 139.63 14.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.528 HG21 ' HB2' ' A' ' 238' ' ' CYS . 54.6 mt -94.22 132.16 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.234 0.54 . . . . 0.0 111.085 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -88.32 -42.97 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.17 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.8 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 34.5 t -147.35 143.08 27.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.625 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.528 ' HB2' HG21 ' A' ' 235' ' ' ILE . 41.8 t -146.33 124.03 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 62.8 m -157.18 127.21 6.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 222' ' ' ASP . 7.6 mp -104.49 123.49 47.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.72 136.6 57.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.215 0.531 . . . . 0.0 111.324 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.783 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 49.2 mtp85 -101.01 158.66 15.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.653 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.02 107.95 60.3 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 170.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -62.78 -38.41 49.16 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.035 2.49 . . . . 0.0 111.99 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.7 m -59.87 -42.76 94.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.252 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.4 m -90.74 -22.76 20.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 21.7 62.35 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.899 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -134.81 148.95 50.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.783 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 10.8 p80 -76.12 142.64 41.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.671 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -69.81 153.16 43.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.2 40.39 1.71 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.979 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.457 ' CZ ' ' HD3' ' A' ' 137' ' ' PRO . 28.8 p90 -159.28 160.45 35.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -169.03 -171.82 35.16 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -126.75 136.98 53.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.834 0.349 . . . . 0.0 111.055 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.12 118.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.8 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 57.4 tt0 -105.03 129.88 53.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.006 0.432 . . . . 0.0 110.259 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -107.2 161.57 14.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.84 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -22.14 20.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 262' ' ' SER . 4.8 tppt? -111.8 115.24 28.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.468 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 264' ' ' GLN . . . -60.55 -33.72 73.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.32 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -69.05 -34.51 75.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.978 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 259' ' ' LYS . 9.5 t -62.07 -38.79 90.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.5 m -59.76 -42.99 94.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 260' ' ' ALA . 59.8 mm-40 -68.15 -34.78 76.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 -174.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.4 -40.14 64.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.23 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.83 -51.92 65.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.442 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.04 -26.1 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 97.2 p -65.37 -34.7 78.93 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.672 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.6 t -116.85 0.67 12.56 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.524 ' HB2' HG11 ' A' ' 282' ' ' VAL . 34.9 mmm -79.4 -17.81 53.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.37 -31.54 71.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.042 0.925 . . . . 0.0 110.083 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' B' ' 24' ' ' MET . 3.3 mm? -75.32 -8.37 56.47 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.46 -174.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.713 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 55.9 t80 -57.37 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 110.395 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -77.35 119.81 21.5 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.526 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.79 HD21 HD22 ' A' ' 220' ' ' LEU . 14.5 tp -126.2 85.83 2.44 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.486 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.08 32.33 23.65 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.382 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 87.66 19.56 53.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.754 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -140.9 131.97 26.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.81 0.338 . . . . 0.0 110.382 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -76.35 136.1 39.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.075 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.91 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 14.4 tp -70.71 -174.37 0.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.247 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.91 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 6.4 tpp180 -143.88 118.86 10.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.524 HG11 ' HB2' ' A' ' 270' ' ' MET . 14.7 p -118.31 144.03 27.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 110.544 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.61 -159.9 9.05 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.489 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -118.59 165.13 14.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.828 0.347 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.86 88.86 5.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -51.94 -52.37 23.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.634 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 40.8 p -121.85 161.39 42.45 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.409 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.71 101.4 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.693 2.262 . . . . 0.0 111.409 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 287' ' ' THR . 85.7 Cg_endo -79.4 -5.85 14.4 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.692 2.261 . . . . 0.0 111.874 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 61.2 mtt -133.66 66.79 74.25 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.952 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -93.35 153.65 2.5 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.829 2.352 . . . . 0.0 112.814 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 92.5 mt -82.16 99.57 9.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.467 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 91.8 mt -67.29 126.42 29.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.033 -176.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 7.2 p -100.8 100.78 13.47 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.506 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 293' ' ' LEU . 5.0 Cg_endo -86.33 41.18 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.561 2.841 . . . . 0.0 112.306 -177.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -78.22 -27.16 47.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.12 0.486 . . . . 0.0 110.532 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 C--O 1.25 1.079 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.285 178.292 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.59 -49.84 3.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.781 0.291 . . . . 0.0 111.032 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.615 ' O ' ' HG ' ' A' ' 272' ' ' LEU . 43.9 ttm 68.74 -60.02 0.45 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.045 0.84 . . . . 0.0 111.229 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.64 169.26 42.19 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -118.91 11.65 12.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.07 0.462 . . . . 0.0 110.847 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 12.3 t -131.72 50.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -75.38 53.63 0.68 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.2 0.524 . . . . 0.0 111.656 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -154.51 -63.61 0.13 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.835 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.24 -31.05 33.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.422 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.615 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 15.5 t80 -69.4 -18.48 63.76 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.336 0.588 . . . . 0.0 110.465 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.2 mtpt -70.64 -45.93 64.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.61 -36.15 81.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.905 172.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.711 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.0 -51.01 33.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.483 177.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.593 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -79.86 -23.38 41.97 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -174.036 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 65.6 mt-30 -58.04 -43.31 86.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 170.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 27.1 mmt180 -73.51 -30.68 63.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.456 176.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.731 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -66.51 -43.08 86.26 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -80.86 -26.86 36.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.489 -1.382 . . . . 0.0 112.136 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.15 -44.11 74.85 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.767 HG13 HD11 ' A' ' 220' ' ' LEU . 4.0 pt -69.1 -34.41 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.619 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -64.63 -27.14 68.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.376 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.63 -42.35 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.277 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.649 ' HE3' ' OD2' ' A' ' 224' ' ' ASP . 17.8 pttt -77.45 -35.36 53.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.424 -177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.978 HG23 ' HB2' ' A' ' 219' ' ' ASP . 91.7 mt 63.59 86.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 121.388 0.613 . . . . 0.0 111.016 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.42 -82.48 1.67 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.627 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.85 -82.26 0.85 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.284 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 25.9 t0 52.03 84.27 0.05 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.026 0.531 . . . . 0.0 110.651 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.59 119.37 4.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.328 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.91 29.07 1.07 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.54 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 21.8 m -71.03 127.3 32.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.965 0.412 . . . . 0.0 110.959 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.688 -0.672 . . . . 0.0 109.905 178.025 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.32 -27.73 13.01 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 47.4 ttp 56.51 77.93 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.546 0.529 . . . . 0.0 110.946 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.57 -64.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.676 -0.409 . . . . 0.0 112.051 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -87.5 -40.55 14.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HB3' ' HG2' ' A' ' 106' ' ' ARG . 75.1 mtt85 -69.75 -69.39 0.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -175.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.507 ' HB3' HD12 ' A' ' 108' ' ' LEU . 95.9 mt-30 55.8 49.22 16.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.28 0.562 . . . . 0.0 110.398 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.464 ' HG2' ' HB3' ' A' ' 104' ' ' ARG . 26.2 mmm180 -66.25 -36.21 82.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.377 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.19 86.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.072 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 105' ' ' GLN . 94.4 mt -66.89 -32.98 74.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.425 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.82 90.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.4 . . . . 0.0 111.001 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.71 -37.22 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 25.4 ttt -60.44 -28.12 68.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.2 m -91.34 6.21 46.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 113' ' ' ARG . 9.7 ptp180 -130.94 126.26 35.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.829 0.347 . . . . 0.0 110.565 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 158' ' ' VAL . 4.3 m -92.3 135.84 26.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.651 0.739 . . . . 0.0 110.834 176.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 81.2 t80 -91.1 111.24 22.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.609 -176.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 119' ' ' ILE . 9.4 t -103.01 110.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.389 . . . . 0.0 110.272 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.509 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -102.25 171.2 21.21 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.1 t 72.57 -65.69 0.34 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.97 0.508 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.512 HD13 HG12 ' A' ' 116' ' ' VAL . 10.0 mm 63.14 12.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.88 0.371 . . . . 0.0 110.545 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.835 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 11.6 t80 60.4 -80.02 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 50.5 t80 169.75 -45.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.701 0.8 . . . . 0.0 109.379 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -104.62 39.15 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.022 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 66.5 mt -114.05 99.92 8.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.98 -175.04 48.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.4 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -50.63 -49.91 55.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.165 0.507 . . . . 0.0 110.823 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -59.43 -33.68 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -80.69 -39.15 27.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.01 -48.06 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 141' ' ' ILE . 4.6 ptm180 -62.13 -35.53 79.01 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.61 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -75.07 -26.55 59.45 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.302 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.33 -34.75 63.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.695 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 84.1 m-85 -96.81 10.5 38.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.957 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 134' ' ' PRO . . . -70.67 -39.07 8.63 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.639 ' O ' ' HB1' ' A' ' 214' ' ' ALA . 52.6 Cg_exo -59.15 -18.33 43.55 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.786 1.657 . . . . 0.0 112.479 170.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.695 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 57.3 m-85 -101.89 66.6 1.05 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.79 0.328 . . . . 0.0 111.033 -175.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.63 44.27 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.38 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.41 123.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.036 2.491 . . . . 0.0 112.128 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.713 HD13 ' HE1' ' A' ' 160' ' ' TYR . 31.6 mm -67.36 108.07 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.979 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.469 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 82.0 tttt -76.6 -53.05 8.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.318 0.58 . . . . 0.0 110.144 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.2 m -155.07 143.79 20.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.466 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 129' ' ' ARG . 66.8 mt -113.11 106.15 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 35.9 t70 -81.71 98.24 8.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.0 tpt -130.3 130.05 44.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.904 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -93.53 106.14 18.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.029 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.593 ' HB3' ' HA ' ' A' ' 150' ' ' MET . 56.3 m95 -91.98 134.78 34.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.1 m-20 -73.75 102.61 4.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.261 174.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.1 t 62.07 -160.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.833 0.708 . . . . 0.0 110.551 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.3 p -74.04 -22.24 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.067 0.46 . . . . 0.0 110.494 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -13.65 61.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -173.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 145' ' ' TRP . 88.2 mtp 60.36 47.11 9.27 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.475 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.834 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 30.4 mmmt -77.79 149.99 34.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.498 . . . . 0.0 111.187 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.86 99.99 11.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.235 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.584 ' NZ ' ' HB3' ' A' ' 153' ' ' LYS . 2.3 ttpm? -149.18 64.44 1.03 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.396 0.617 . . . . 0.0 109.611 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 172.84 -179.04 44.56 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.698 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.509 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 84.1 m-85 -112.36 157.85 20.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.02 130.41 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.041 0.448 . . . . 0.0 110.802 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 67.0 m-85 -111.23 107.77 17.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.872 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.475 ' HB ' HG23 ' A' ' 114' ' ' VAL . 43.0 t -91.77 110.97 23.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.2 138.02 35.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.294 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.713 ' HE1' HD13 ' A' ' 138' ' ' ILE . 50.7 m-85 -118.92 161.01 20.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.37 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 36.0 mt-10 -99.49 9.96 42.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.661 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 10.9 m -132.56 113.51 14.21 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.389 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.46 -24.32 36.62 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 113.326 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.661 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -66.67 -54.46 22.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 110.193 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.515 ' HB3' HG23 ' A' ' 162' ' ' VAL . . . -55.38 -40.13 70.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.212 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.29 91.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.8 -41.57 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.519 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.551 HD21 ' HA3' ' A' ' 283' ' ' GLY . 18.9 mt -62.36 -42.4 99.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.012 0.434 . . . . 0.0 110.648 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.36 83.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.789 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.14 -60.92 2.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.82 -46.87 77.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.473 ' OE1' ' HD3' ' A' ' 281' ' ' ARG . 47.6 mt-30 -79.29 -35.82 40.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.431 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 51.7 tpp -77.27 -27.11 53.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.32 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -70.44 -20.3 62.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.185 0.516 . . . . 0.0 110.17 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.9 m -90.78 -2.87 57.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.728 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.01 171.12 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 111.403 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.8 mtp -117.18 97.11 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.246 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 52.9 tp -77.78 89.85 4.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 110.261 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 119.42 -157.03 15.58 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.526 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.23 18.07 50.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.016 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.835 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 8.9 ptm180 -157.41 155.72 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.19 105.6 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.274 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.63 155.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.174 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -101.69 109.91 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.902 0.382 . . . . 0.0 110.102 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.3 t -101.32 106.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.43 159.89 34.91 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.58 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -164.88 144.76 5.89 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 102.27 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.963 2.442 . . . . 0.0 112.183 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.5 m -113.99 -42.4 3.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.341 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 193' ' ' GLN . 28.5 p30 -150.62 33.82 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.887 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.3 tt -63.29 115.28 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.513 0.673 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 119.02 -38.43 2.85 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 190' ' ' ASN . 14.4 mm100 -82.28 -39.51 22.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.09 0.472 . . . . 0.0 109.863 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.83 -9.27 57.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.071 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 24.4 tp60 -63.43 -52.84 57.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.98 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -54.86 -30.81 70.09 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.519 2.146 . . . . 0.0 112.468 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.0 mm -66.04 -57.69 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.0 mt -64.59 -35.55 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.609 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.5 t70 -57.67 -49.55 76.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.435 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.87 -48.12 80.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.237 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.608 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 80.2 mt -58.97 -42.6 90.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.52 71.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.371 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 45.1 mt-10 -64.79 -42.99 94.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 288' ' ' PRO . 31.0 mt-10 -70.82 -49.36 47.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.569 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 285' ' ' ALA . . . -59.28 -31.82 69.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.995 -176.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -62.88 -27.2 69.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.92 -14.97 60.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.954 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.58 -15.12 17.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.168 0.508 . . . . 0.0 111.094 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.81 40.74 30.67 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.891 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.569 HH11 ' HG2' ' A' ' 289' ' ' PRO . 46.1 ttm180 -103.83 136.24 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.721 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.95 165.89 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.776 0.322 . . . . 0.0 110.792 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.526 ' HD2' HD11 ' A' ' 168' ' ' LEU . 49.1 t80 -116.65 122.88 45.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.057 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 255' ' ' ILE . 39.8 t -109.77 121.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.658 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.23 170.49 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.591 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.3 t 67.55 36.28 3.81 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.631 0.582 . . . . 0.0 111.33 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.537 HG13 HD11 ' A' ' 225' ' ' ILE . 59.9 t -79.86 138.58 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -51.81 -43.68 63.19 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -167.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.638 ' HB3' ' HB ' ' B' ' 45' ' ' ILE . 5.2 m-20 -70.17 -45.81 65.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.812 0.339 . . . . 0.0 111.066 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.687 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -66.7 103.94 1.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.466 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 225' ' ' ILE . 46.3 m -89.83 -176.85 5.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -166.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.42 -45.46 80.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.849 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.86 -28.94 69.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.277 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.655 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.0 m-20 -67.47 -59.18 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.001 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.701 HG13 HD11 ' A' ' 240' ' ' LEU . 29.5 mm -52.95 -30.58 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.136 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.44 -32.4 39.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.027 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.568 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 70.0 m -49.79 -60.99 2.39 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.654 0.74 . . . . 0.0 112.035 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.589 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.0 m -71.74 -39.82 69.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.624 -171.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.762 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 65.1 m-85 -66.71 -39.71 88.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.726 0.298 . . . . 0.0 111.697 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.9 -24.75 55.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.421 ' O ' ' HB1' ' B' ' 30' ' ' ALA . . . -72.98 -24.28 60.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.256 -174.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.626 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.5 m-30 -87.47 24.71 1.59 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.48 0.657 . . . . 0.0 110.525 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 234' ' ' LYS . . . 149.27 -113.42 0.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 233' ' ' GLY . 28.4 mmmt -136.72 161.67 35.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.567 HG12 ' SG ' ' A' ' 238' ' ' CYS . 6.6 tp -122.17 139.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.528 0.68 . . . . 0.0 110.665 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -88.4 -62.74 1.42 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 15.2 m -140.88 143.79 34.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.366 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.567 ' SG ' HG12 ' A' ' 235' ' ' ILE . 74.7 m -134.52 106.82 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 21.4 m -141.48 104.71 4.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.167 0.508 . . . . 0.0 111.467 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.806 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 79.8 mt -83.57 130.75 35.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.56 101.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.598 0.561 . . . . 0.0 111.205 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 6.5 ppt_? -90.46 144.73 25.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.509 . . . . 0.0 110.846 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.03 122.76 76.02 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.504 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.67 -20.28 40.66 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.911 2.407 . . . . 0.0 113.514 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.87 -39.14 14.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 44.9 p -88.03 -35.5 17.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.864 0.364 . . . . 0.0 111.338 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.15 -2.32 68.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.658 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -108.75 157.46 18.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.887 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 16.8 p80 -86.4 145.57 26.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.254 0.55 . . . . 0.0 110.925 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.75 158.61 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.04 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -74.8 43.79 1.44 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 114.183 0.433 . . . . 0.0 114.183 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -166.18 164.64 17.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.806 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . 178.04 -169.98 42.02 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.559 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.503 ' HB3' ' HD3' ' A' ' 210' ' ' ARG . 90.6 m-85 -119.86 140.01 51.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.847 0.356 . . . . 0.0 110.538 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.433 HD12 HG21 ' A' ' 213' ' ' VAL . 48.8 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.91 176.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.99 146.25 29.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.357 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.415 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 34.2 m-85 -120.19 137.01 54.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.442 170.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -83.6 -29.5 27.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -95.8 113.56 25.21 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.837 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.29 69.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.798 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -69.41 -34.01 73.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.537 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 43.3 m -78.44 -31.51 48.07 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 267' ' ' VAL . 1.5 p -65.6 -42.92 91.1 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.173 -0.329 . . . . 0.0 111.534 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -60.72 -36.58 79.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.588 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.97 -47.38 37.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.745 -176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.43 74.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.076 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 263' ' ' SER . 94.6 t -58.12 -40.25 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.979 0.419 . . . . 0.0 111.254 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.2 t -71.69 -28.9 64.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 t -89.95 -43.51 10.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.768 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.881 ' HB3' HG21 ' A' ' 282' ' ' VAL . 0.0 OUTLIER -74.25 -6.33 47.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.639 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.58 -36.6 76.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.416 1.103 . . . . 0.0 109.0 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -79.77 -7.76 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.646 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.715 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 2.4 t80 -58.84 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.278 0.561 . . . . 0.0 110.563 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 8.3 t70 -93.75 116.32 28.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.221 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.687 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.8 mm? -114.73 87.05 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.761 175.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.73 -86.62 0.6 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.582 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -146.37 26.75 1.69 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.106 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 20.2 pt20 -141.02 131.75 25.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.887 0.375 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.454 ' CD2' ' HB2' ' A' ' 274' ' ' ASP . 63.7 m-85 -91.66 130.81 37.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.265 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.693 HD22 ' HD2' ' A' ' 273' ' ' PHE . 7.2 mp -63.54 168.65 4.48 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.528 0.68 . . . . 0.0 111.005 175.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.473 ' HD3' ' OE1' ' A' ' 172' ' ' GLN . 2.6 mmp_? -132.45 112.11 11.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' A' ' 270' ' ' MET . 94.7 t -116.33 133.27 63.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.084 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.551 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -137.83 -156.09 7.07 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.174 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -103.45 172.67 6.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.412 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -59.41 -35.83 74.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.571 0.224 . . . . 0.0 111.502 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 61.5 t 70.42 -64.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.82 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.458 HG22 ' HG3' ' A' ' 164' ' ' GLU . 12.2 t -98.06 143.09 25.64 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 69.5 Cg_endo -79.69 106.25 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.722 2.281 . . . . 0.0 112.113 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.569 ' HG2' HH11 ' A' ' 210' ' ' ARG . 3.0 Cg_exo -76.62 70.77 6.26 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.133 2.555 . . . . 0.0 111.854 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.55 ' N ' ' HD2' ' A' ' 291' ' ' PRO . 15.2 tpt -65.3 -47.8 69.71 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.288 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 290' ' ' MET . 12.9 Cg_endo -57.34 143.84 92.81 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.988 1.792 . . . . 0.0 111.888 173.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.449 ' HA ' ' HD2' ' A' ' 295' ' ' PRO . 8.9 mp -79.81 53.54 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.097 0.475 . . . . 0.0 111.21 -175.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 76.5 mt -92.29 -17.1 25.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.837 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.667 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 31.4 m -117.16 -52.85 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.924 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 9.0 Cg_exo -73.0 65.73 4.13 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.302 2.002 . . . . 0.0 112.659 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -66.32 107.64 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.147 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.052 -175.286 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.66 -39.11 58.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.878 0.339 . . . . 0.0 111.13 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 55.8 mtm 70.52 -54.21 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.906 0.883 . . . . 0.0 111.291 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -135.46 130.91 5.57 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -84.99 -12.42 53.29 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.71 99.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.067 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -155.12 -85.1 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.19 -30.28 18.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.047 0.451 . . . . 0.0 109.919 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 231' ' ' ALA . . . -63.0 -37.02 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.1 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.594 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 19.1 t80 -75.95 -22.75 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 110.271 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -75.8 -43.83 44.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.968 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -61.34 -37.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.626 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.63 -49.44 56.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.611 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.718 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.81 -21.77 37.46 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -171.091 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -62.55 -38.18 89.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.568 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 61.3 mtp180 -74.09 -35.43 64.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.629 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.718 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -63.13 -44.24 96.13 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 34.3 mtt180 -81.65 -26.99 34.32 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 112.96 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.66 -49.17 65.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 0.0 109.82 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 6.3 pt -68.05 -30.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.496 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.89 -27.9 67.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.377 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.35 -31.02 19.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 7.3 ttpt -82.18 -38.5 24.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.377 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.762 HG13 ' H ' ' B' ' 46' ' ' GLY . 30.6 pt 49.66 -76.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.288 1.435 . . . . 0.0 114.043 -178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.762 ' H ' HG13 ' B' ' 45' ' ' ILE . . . -146.2 124.63 2.08 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.166 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.3 -179.91 17.03 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.012 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -124.74 9.63 8.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.083 0.468 . . . . 0.0 110.822 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.89 110.57 15.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.81 -95.72 0.2 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 176.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -150.96 24.52 0.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.803 0.811 . . . . 0.0 109.527 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.252 1.223 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.646 -178.256 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.67 116.37 15.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.59 0.234 . . . . 0.0 111.017 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 63.9 mtt 63.19 39.94 9.3 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.898 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.25 102.17 4.24 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 67.02 161.88 0.17 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.823 0.702 . . . . 0.0 110.704 -174.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -134.73 148.46 50.29 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.269 -0.269 . . . . 0.0 111.133 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 58.47 64.45 1.47 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.72 0.638 . . . . 0.0 111.255 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -62.0 -29.51 70.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.128 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.26 72.3 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.3 mt -64.95 -38.83 92.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.236 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.45 -31.64 60.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.77 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.61 -36.19 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.362 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.0 mtp -69.24 -34.04 74.2 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 28.5 p -73.78 -11.35 60.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.906 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.695 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 91.8 mtt180 -105.71 103.26 12.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -91.51 146.6 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.466 0.651 . . . . 0.0 111.377 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 61.5 t80 -86.33 118.68 25.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.878 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.15 113.47 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 110.192 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.79 174.51 15.25 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.345 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 t 74.73 42.41 0.29 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.541 0.737 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.54 136.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.331 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -108.84 98.51 7.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.451 ' HD1' ' HA ' ' A' ' 151' ' ' LYS . 34.0 t80 37.87 -84.22 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 165.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -71.87 -16.73 62.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.786 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 127' ' ' THR . 88.8 mt -77.96 98.91 5.84 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.79 -167.53 43.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.108 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.95 -29.36 70.29 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.77 -49.58 76.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.482 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.502 HG21 HD22 ' A' ' 123' ' ' LEU . 55.9 m -64.27 -42.2 96.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.052 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.92 -42.3 88.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.425 0.631 . . . . 0.0 110.133 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.481 ' HA ' ' CD1' ' A' ' 138' ' ' ILE . 39.5 ttt180 -56.56 -46.8 80.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.024 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -77.97 -33.34 51.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.187 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.65 77.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.511 . . . . 0.0 111.207 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.496 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 46.2 m-85 -99.59 10.33 41.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.74 -45.25 16.8 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 23.6 Cg_endo -62.06 -10.44 17.9 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.02 1.813 . . . . 0.0 112.795 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -79.25 -67.61 0.74 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 109.803 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.49 165.91 33.09 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.71 112.33 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.31 2.007 . . . . 0.0 111.293 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 129' ' ' ARG . 56.7 mt -68.51 129.16 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 109.981 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -96.83 -50.92 4.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.684 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 t -149.23 161.88 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.5 mt -137.28 109.91 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.635 0.255 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.797 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 47.8 m-20 -84.33 111.17 19.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.271 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.582 ' HG2' ' HB3' ' A' ' 145' ' ' TRP . 24.7 ttp -156.2 101.12 2.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 0.0 110.782 175.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.0 m -77.95 69.24 4.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.91 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 14.3 p-90 -96.32 145.79 25.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.96 111.18 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.424 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 m -90.83 -12.89 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.86 -54.03 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.967 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.5 p -91.7 -19.27 22.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.164 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.652 ' HG3' ' CZ3' ' A' ' 145' ' ' TRP . 15.3 ttp 66.74 25.77 9.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.318 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.451 ' HA ' ' HD1' ' A' ' 121' ' ' TYR . 59.5 pttt -105.32 19.78 20.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.438 . . . . 0.0 110.968 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.91 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 41.1 m-70 60.2 -161.33 0.28 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.626 173.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 145' ' ' TRP . 74.6 mmtt -117.99 -44.14 2.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 157.29 -21.39 0.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.611 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.64 161.61 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.201 0.5 . . . . 0.0 112.173 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.509 ' HB2' ' SD ' ' A' ' 143' ' ' MET . . . -149.36 156.25 41.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.504 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.797 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 80.8 m-85 -114.04 112.39 23.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 57.5 t -99.07 116.86 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.944 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.695 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 42.4 tt0 -94.15 130.51 40.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.91 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 80.4 m-85 -100.18 155.83 17.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.778 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.99 -33.34 75.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 172.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 17.3 m -128.62 133.31 25.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.038 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 37.6 Cg_exo -60.28 -23.15 73.37 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.323 2.682 . . . . 0.0 113.103 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -54.71 -49.91 69.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 111.211 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.32 70.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.056 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.15 86.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.46 -44.85 93.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.142 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 33.7 mt -63.21 -35.4 80.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 0.0 110.577 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -66.6 -30.6 70.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.633 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.46 -59.34 2.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.27 -39.92 14.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 14.6 mm100 -82.45 -34.69 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 55.9 tpp -72.71 -31.74 65.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.462 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.38 -19.8 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.215 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 41.6 t -78.49 -7.73 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.722 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.56 126.52 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 110.799 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 88.5 mtp -83.96 79.77 9.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 55.7 tp -58.51 118.46 5.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.101 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.07 11.89 83.93 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.406 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.67 5.38 89.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.145 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 181' ' ' ARG . 17.6 mtp180 -112.67 155.3 24.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -91.82 103.84 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.852 0.834 . . . . 0.0 109.106 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.47 146.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.116 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -102.08 110.66 22.68 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 16.1 m -118.64 133.85 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.58 145.72 8.61 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.822 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.589 ' HD3' ' HB2' ' A' ' 115' ' ' TYR . 20.8 ptt180 -151.08 123.9 4.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 1.7 Cg_endo -84.36 72.62 4.99 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.258 2.639 . . . . 0.0 111.011 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 m -64.83 -22.36 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.749 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -155.21 151.11 27.75 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.52 125.0 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.839 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.96 -18.7 8.81 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.986 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -72.78 -57.25 4.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.753 0.311 . . . . 0.0 111.239 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.93 5.64 40.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.058 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.517 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 59.8 tp60 -60.96 -51.71 77.4 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.721 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 15.1 Cg_endo -57.78 -25.04 66.83 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.122 1.881 . . . . 0.0 112.169 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.81 -55.93 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.603 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.6 pt -65.84 -32.0 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -45.95 90.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.887 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.09 -48.68 79.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.699 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.64 -50.87 70.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.171 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -60.96 -41.61 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.046 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.28 -44.26 95.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.435 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.53 -43.06 95.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.539 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.96 66.88 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.874 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 75.8 mtp180 -65.87 -18.51 65.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.094 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.95 55.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 111.167 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -104.05 -19.43 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.273 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 257' ' ' TYR . 88.6 m-20 59.43 30.45 20.13 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.57 177.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.505 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 97.4 mtt180 -88.54 140.56 29.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.229 0.538 . . . . 0.0 111.666 -175.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.723 HD13 ' HE1' ' A' ' 229' ' ' PHE . 8.3 tt -119.95 151.15 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -108.88 126.99 53.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.119 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.518 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.8 p -118.75 122.72 70.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.147 0.499 . . . . 0.0 110.717 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.05 -177.91 3.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.882 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 41.8 m 67.71 16.68 9.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.634 0.774 . . . . 0.0 111.485 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.675 HG13 HD11 ' A' ' 225' ' ' ILE . 66.9 t -62.52 135.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.485 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.78 139.77 47.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.74 -30.97 69.71 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -167.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -79.59 -24.72 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.366 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.801 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -83.63 104.86 14.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 2.4 p -87.39 -177.28 5.89 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.64 -54.39 14.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.989 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.46 -27.9 69.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.936 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.613 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 3.3 m-20 -63.68 -55.58 22.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.332 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.675 HD11 HG13 ' A' ' 216' ' ' VAL . 33.5 mm -60.5 -24.51 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.25 -31.34 68.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.199 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 69.7 m -48.86 -60.39 2.79 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.985 0.898 . . . . 0.0 111.634 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.676 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.1 m -71.0 -45.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.676 -170.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.723 ' HE1' HD13 ' A' ' 211' ' ' ILE . 41.4 m-85 -60.96 -40.31 92.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -76.68 -34.4 58.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.674 -175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.98 -25.14 66.96 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.724 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 6.9 m-30 -73.59 -42.79 61.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.85 -100.8 0.21 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.672 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.76 157.66 43.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.08 138.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.484 . . . . 0.0 110.831 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 15.0 mmtp -88.02 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.556 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 27.0 t -145.03 145.05 31.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.811 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.31 129.58 45.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.6 p -145.11 112.52 6.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.29 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.623 HD23 ' HA3' ' A' ' 253' ' ' GLY . 78.0 mt -85.91 129.58 34.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.11 143.29 56.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -121.41 157.27 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.62 121.93 73.32 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.12 -18.01 60.39 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.139 2.56 . . . . 0.0 113.96 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 p -82.34 -33.99 28.67 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.559 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 45.2 p -112.25 -34.58 5.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 111.847 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.25 59.12 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.597 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.9 141.53 42.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 5.9 p80 -79.0 143.35 35.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 0.0 110.576 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -81.15 156.09 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.147 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -77.69 46.46 2.6 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.88 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.23 157.27 17.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.966 0.383 . . . . 0.0 110.171 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.623 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -167.97 -175.28 37.59 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.355 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.08 141.17 52.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.763 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.555 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 24.2 mm -124.12 135.75 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.048 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 37.1 mt-10 -104.98 141.6 36.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.675 0.274 . . . . 0.0 111.238 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 209' ' ' ASN . 36.3 m-85 -124.25 149.55 46.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.214 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 258' ' ' GLU . 1.1 pm0 -87.22 -17.89 31.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.822 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.755 ' HA ' ' HE3' ' A' ' 259' ' ' LYS . 1.0 OUTLIER -137.28 132.05 33.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.985 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -62.04 -40.75 96.81 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.187 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 13.3 pt20 -63.76 -32.58 74.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 110.694 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.3 t -65.23 -40.66 94.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.1 m -65.13 -36.27 83.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 91.0 mt-30 -61.88 -33.76 74.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.098 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.91 -48.12 64.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.873 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -56.26 -41.68 76.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.661 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 264' ' ' GLN . 22.9 m -65.47 -27.02 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.3 p -94.02 -29.34 15.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.598 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.6 m -92.72 -38.31 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.724 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.8 mmm -65.83 -23.46 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -171.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.432 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 66.6 t30 -59.06 -35.04 72.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.738 . . . . 0.0 110.54 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.411 ' N ' HD22 ' A' ' 272' ' ' LEU . 3.8 mm? -77.84 -10.51 59.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.879 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -58.64 112.2 1.53 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.388 -175.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.15 120.99 35.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.926 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.801 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.0 mm? -120.19 87.57 2.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.202 172.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.63 35.67 18.85 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.949 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.25 62.45 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.937 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -124.43 131.68 53.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 110.394 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -75.68 149.55 38.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.744 HD21 HD23 ' A' ' 275' ' ' LEU . 11.4 mt -79.35 -172.79 3.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.958 0.409 . . . . 0.0 110.056 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.432 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 56.8 mmt-85 -147.08 113.45 5.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.873 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 270' ' ' MET . 21.0 m -122.65 157.66 27.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.14 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -177.17 -171.24 40.51 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.767 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -82.0 140.06 34.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.059 0.457 . . . . 0.0 109.917 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -67.24 -21.33 65.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.795 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 74.6 t 71.12 -65.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.787 0.435 . . . . 0.0 111.008 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.453 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 7.5 t -111.58 140.76 23.49 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.425 ' HB2' ' HB3' ' A' ' 291' ' ' PRO . 56.0 Cg_endo -72.85 108.68 2.63 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.287 1.992 . . . . 0.0 112.135 176.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 287' ' ' THR . 23.7 Cg_exo -64.88 -32.97 54.29 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.729 2.286 . . . . 0.0 111.85 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.51 83.49 5.38 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.425 ' HB3' ' HB2' ' A' ' 288' ' ' PRO . 83.2 Cg_endo -83.72 10.99 3.45 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.776 2.318 . . . . 0.0 112.839 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 36.0 tp 61.53 61.13 1.53 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.837 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 54.9 tp -55.8 110.39 0.72 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.018 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 24.1 m -106.46 110.0 63.53 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.978 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.09 168.85 21.31 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.753 2.302 . . . . 0.0 111.836 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 59.27 33.06 22.41 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.286 0.565 . . . . 0.0 110.749 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.856 -179.088 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.13 46.71 2.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.132 0.491 . . . . 0.0 110.77 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 67.9 mtt -89.92 85.85 6.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.926 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.27 114.92 2.83 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.659 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -77.35 -47.96 18.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.105 0.479 . . . . 0.0 110.849 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' B' ' 31' ' ' PHE . 1.7 m -126.16 -119.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.667 -170.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 64.4 t30 67.53 19.22 9.97 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.604 0.716 . . . . 0.0 109.785 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.83 -71.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.091 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.68 -38.59 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.894 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.571 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 6.1 t80 -65.4 -17.24 64.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.675 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.622 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.4 mttt -69.68 -49.49 52.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.751 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 14.4 t70 -57.12 -42.27 80.56 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.676 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -45.47 -54.31 7.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.669 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.865 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.91 -21.49 37.32 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -171.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 79.8 mt-30 -64.94 -39.37 93.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.821 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 17.7 mmt180 -73.79 -32.96 64.02 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.626 172.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.879 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -66.62 -44.66 81.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.253 36.8 mtp85 -82.33 -25.69 33.67 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.209 -1.557 . . . . 0.0 112.773 172.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -53.29 -47.0 69.55 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.749 HD11 ' HZ ' ' A' ' 273' ' ' PHE . 9.2 pt -67.27 -34.27 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.468 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.521 ' O ' HG23 ' B' ' 45' ' ' ILE . . . -66.36 -25.44 66.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.888 0.375 . . . . 0.0 111.287 176.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.55 -15.53 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.748 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.487 ' HE3' ' HB3' ' B' ' 44' ' ' LYS . 1.5 tmmt? -89.84 -33.74 16.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.521 HG23 ' O ' ' B' ' 42' ' ' ALA . 7.3 pt 36.89 84.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 171.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.96 153.03 8.43 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.463 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.4 110.52 3.29 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.986 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.65 71.59 9.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.256 0.55 . . . . 0.0 110.307 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.97 137.34 44.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.179 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.25 173.37 39.1 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.984 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.9 p -59.55 -43.19 93.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.244 0.777 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.946 175.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.613 0.244 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 111' ' ' MET . . . -56.77 -48.66 77.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.973 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.48 HD11 ' HG3' ' A' ' 163' ' ' PRO . 59.0 tp -71.47 -36.62 71.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.93 84.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.369 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.2 pt -78.6 -34.55 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.427 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 107' ' ' ALA . 89.9 mtp -61.52 -26.76 68.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -84.35 -2.19 56.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.6 0.238 . . . . 0.0 111.279 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 27.0 ttp180 -128.74 109.48 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.927 0.394 . . . . 0.0 110.714 -175.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.1 m -92.57 141.28 14.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.484 0.659 . . . . 0.0 111.649 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 53.0 t80 -86.09 130.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.982 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 111.71 37.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.07 0.462 . . . . 0.0 110.085 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.07 155.73 15.95 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.928 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.1 m 68.87 49.97 0.64 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 110.462 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.45 127.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.185 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -45.17 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.867 0.729 . . . . 0.0 112.79 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -178.38 -64.54 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.559 0.219 . . . . 0.0 110.98 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.12 18.98 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.006 0.431 . . . . 0.0 112.087 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 3.6 pp -130.21 141.3 50.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.954 0.407 . . . . 0.0 110.489 176.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.66 -152.43 5.96 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.59 -31.57 69.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.528 0.664 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.22 -43.41 98.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.132 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 2.1 m -84.87 -43.77 13.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.336 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.44 -36.58 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -55.71 -44.13 77.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.95 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -77.82 -34.75 51.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.312 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.27 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.636 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 98.2 m-85 -108.14 12.07 27.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.609 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.55 -44.87 46.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.268 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 17.8 Cg_endo -61.19 -17.28 51.61 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.215 1.943 . . . . 0.0 112.553 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -80.05 -70.16 0.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.47 155.06 26.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.544 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 24.5 Cg_exo -64.13 132.5 34.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.621 2.214 . . . . 0.0 111.586 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.68 110.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.164 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.899 ' HD3' ' HG2' ' A' ' 161' ' ' GLU . 39.2 tptt -83.26 -46.96 12.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.063 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -160.15 153.99 22.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.33 123.09 49.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.741 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 21.2 m-20 -90.44 97.34 11.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 14.0 tpt -105.82 148.67 27.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.002 0.43 . . . . 0.0 111.371 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.0 m -119.09 84.31 2.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.704 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -80.2 116.38 20.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 153' ' ' LYS . 14.9 t70 -95.8 117.2 30.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.649 ' HB3' HG22 ' A' ' 149' ' ' THR . 43.9 t 69.13 162.73 0.22 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.059 0.849 . . . . 0.0 111.733 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.45 -22.32 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.649 HG22 ' HB3' ' A' ' 147' ' ' SER . 9.8 t -60.29 -25.12 65.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.102 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.2 mtt 64.32 43.36 4.77 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.827 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.513 ' HG2' HG23 ' A' ' 149' ' ' THR . 31.4 mmmt -93.23 12.79 23.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.052 0.453 . . . . 0.0 110.813 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.0 p80 41.56 44.69 2.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.489 1.116 . . . . 0.0 113.079 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 28.4 tttm -70.75 96.99 1.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.347 0.594 . . . . 0.0 110.033 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 158.18 -129.27 2.27 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.221 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -148.36 170.46 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.238 0.215 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.19 153.13 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 111.047 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HE2' ' HD2' ' A' ' 187' ' ' ARG . 90.6 m-85 -123.14 124.8 43.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.036 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.2 t -106.22 111.04 33.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 31.8 tt0 -99.58 131.04 45.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -105.68 174.15 6.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.085 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.899 ' HG2' ' HD3' ' A' ' 139' ' ' LYS . 32.2 mt-10 -85.4 -16.26 40.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.097 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.81 135.29 21.5 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.4 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.48 ' HG3' HD11 ' A' ' 108' ' ' LEU . 55.4 Cg_endo -69.87 -17.77 36.9 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.987 2.458 . . . . 0.0 112.197 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -62.85 -40.21 96.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.696 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.92 89.16 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.248 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.84 86.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.483 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -62.2 -47.1 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 283' ' ' GLY . 34.4 mt -66.59 -33.49 75.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.15 0.5 . . . . 0.0 110.561 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.614 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -64.77 -34.13 77.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.298 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.17 -55.47 5.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.972 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.93 -47.68 76.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.511 ' HG2' ' HD2' ' A' ' 281' ' ' ARG . 17.1 mp0 -91.0 -49.88 6.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.636 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 12.6 mmt -66.97 -30.81 71.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.76 -21.28 37.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.151 0.5 . . . . 0.0 110.891 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.2 m -90.98 -24.01 20.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.114 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.2 t -116.0 119.51 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.193 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 89.6 mtp -67.19 108.7 2.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 110.882 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 178' ' ' LEU . 2.5 pt? -81.2 7.54 10.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.799 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.53 -167.29 35.53 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.98 25.42 2.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.629 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -158.3 133.69 8.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -91.96 129.47 37.91 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.4 pt -91.61 151.69 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 184' ' ' LYS . 20.6 ptmt -100.95 116.59 33.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.0 t -103.24 122.46 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.546 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 105.96 172.99 23.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.419 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.669 ' HD2' ' HE2' ' A' ' 157' ' ' PHE . 75.7 mtp180 -130.0 92.22 37.28 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.624 0.25 . . . . 0.0 110.411 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.06 80.54 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.894 2.396 . . . . 0.0 111.661 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -143.9 -54.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.18 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -90.04 5.89 44.68 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.09 0.472 . . . . 0.0 111.212 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 39.9 pt -68.11 153.61 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 88.78 -51.74 3.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.928 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.33 69.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.37 0.605 . . . . 0.0 109.764 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -91.53 1.56 57.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.976 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.554 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.7 tp60 -59.57 -50.04 89.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.103 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 11.2 Cg_endo -55.52 -27.46 59.61 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.353 2.036 . . . . 0.0 112.221 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.9 mm -77.38 -43.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.322 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 80.7 mt -59.52 -50.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.89 -29.92 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.206 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -68.01 -50.08 57.67 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.63 -48.56 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.028 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.03 93.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.224 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 206' ' ' ARG . 3.3 tp10 -69.39 -33.51 73.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.511 . . . . 0.0 110.659 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.02 -45.12 62.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.369 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.12 -24.79 64.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 203' ' ' GLU . 68.3 ttt180 -60.45 -25.04 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.908 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.54 -16.45 64.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.481 ' C ' HD22 ' A' ' 209' ' ' ASN . 60.3 m-85 -104.96 -4.94 21.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.155 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.481 HD22 ' C ' ' A' ' 208' ' ' PHE . 0.1 OUTLIER 32.32 43.17 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 114.252 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 256' ' ' GLU . 24.8 mtp180 -90.16 141.8 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.697 HD13 ' HE1' ' A' ' 229' ' ' PHE . 12.8 tt -99.14 152.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.532 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -107.67 124.54 50.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 0.0 110.24 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 255' ' ' ILE . 17.6 t -108.41 116.88 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.002 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.539 ' O ' ' HG ' ' A' ' 280' ' ' LEU . . . -121.07 173.83 7.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.56 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 35.0 m 64.85 28.33 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.744 0.653 . . . . 0.0 110.778 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.548 HG13 HD11 ' A' ' 225' ' ' ILE . 57.7 t -72.69 133.87 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.374 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 13.6 t-80 -69.1 135.04 50.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 109.764 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -55.62 -41.74 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.667 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.604 ' HB2' ' HB ' ' B' ' 45' ' ' ILE . 2.6 p30 -80.35 -46.95 15.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.625 HD13 HD22 ' A' ' 275' ' ' LEU . 0.1 OUTLIER -50.72 122.69 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.403 0.681 . . . . 0.0 109.954 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 225' ' ' ILE . 22.1 m -99.74 -178.46 3.88 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -167.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.13 -55.42 31.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.014 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 226' ' ' LYS . 2.6 m-20 -62.88 -27.35 69.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.411 ' HB3' HD12 ' B' ' 41' ' ' ILE . 71.9 m-20 -66.66 -49.17 67.04 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.749 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.548 HD11 HG13 ' A' ' 216' ' ' VAL . 21.8 mm -61.16 -24.74 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.271 0.558 . . . . 0.0 109.971 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 223' ' ' ASP . 11.0 mmmm -59.43 -31.8 69.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 174.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 71.2 m -47.79 -54.94 10.83 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.506 0.669 . . . . 0.0 111.034 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.611 HG12 ' HB1' ' B' ' 34' ' ' ALA . 12.5 m -75.24 -49.97 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.665 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.697 ' HE1' HD13 ' A' ' 211' ' ' ILE . 50.0 m-85 -61.21 -46.99 88.19 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.55 ' HB2' ' HE2' ' A' ' 226' ' ' LYS . 27.9 tt0 -77.94 -12.53 59.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.368 . . . . 0.0 111.272 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.62 51.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.357 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.694 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 0.9 OUTLIER -93.82 -52.66 4.34 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -138.74 -164.5 9.93 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.438 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -108.82 139.1 44.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.549 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.635 ' HB ' ' HE3' ' A' ' 226' ' ' LYS . 3.2 mp -120.27 134.37 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -97.73 -29.06 13.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 111.721 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.6 t -143.34 132.44 23.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.545 ' SG ' ' HD3' ' A' ' 226' ' ' LYS . 9.1 p -144.03 113.56 7.05 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.836 0.35 . . . . 0.0 110.599 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 63.4 m -151.37 122.43 7.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.517 . . . . 0.0 111.353 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.683 HD23 ' HA3' ' A' ' 253' ' ' GLY . 43.4 mt -85.1 130.04 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.61 129.63 42.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.691 0.281 . . . . 0.0 110.907 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -78.97 140.47 38.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.558 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.3 t70 -111.55 116.82 50.03 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.42 -27.88 46.74 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 123.138 2.559 . . . . 0.0 113.659 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.42 HG22 ' OD1' ' A' ' 243' ' ' ASP . 5.1 t -93.32 -27.76 16.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.991 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.3 m -81.14 -36.67 29.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.061 0.458 . . . . 0.0 110.167 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 96.74 -18.45 57.48 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.738 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -108.04 -84.67 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 0.0 110.46 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -164.08 154.02 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.558 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 56.0 mttm -71.41 155.38 40.7 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.64 31.52 1.03 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 121.293 -0.479 . . . . 0.0 113.661 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 27.1 p90 -152.97 164.02 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.109 0.454 . . . . 0.0 110.281 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.683 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -164.15 168.42 38.58 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.62 114.57 26.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.041 0.448 . . . . 0.0 110.582 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.425 HD12 HG21 ' A' ' 213' ' ' VAL . 43.8 mt -107.1 139.73 27.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.822 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 210' ' ' ARG . 38.1 tt0 -115.67 115.52 26.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.698 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.31 152.93 21.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.554 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.518 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 15.0 pt-20 -88.75 -16.98 30.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.878 0.371 . . . . 0.0 110.494 177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.518 ' HG3' ' HG3' ' A' ' 258' ' ' GLU . 22.5 mtpp -128.57 135.77 49.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.11 -25.17 61.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.618 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -66.03 -50.33 64.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.211 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.9 m -63.61 -33.87 76.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.439 -176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 267' ' ' VAL . 31.7 t -57.3 -46.91 82.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.178 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.55 -34.67 77.53 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.83 -44.43 96.17 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.243 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.22 80.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 263' ' ' SER . 62.0 t -52.73 -36.35 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.853 0.359 . . . . 0.0 111.508 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 42.8 m -69.08 -24.76 64.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 38.9 m -115.33 -27.15 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.587 ' HE1' HG21 ' A' ' 228' ' ' VAL . 43.4 mmm -66.94 -13.69 62.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.28 -35.86 80.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.11 0.957 . . . . 0.0 109.121 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.5 mm? -77.39 -9.28 58.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.981 -175.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.922 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 6.2 t80 -51.26 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.137 0.494 . . . . 0.0 111.173 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -82.97 121.49 27.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.242 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.625 HD22 HD13 ' A' ' 220' ' ' LEU . 65.9 mt -125.66 85.87 2.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.041 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.54 27.09 57.93 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.871 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 110.43 -17.42 28.6 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.46 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 18.0 pt20 -102.21 130.45 48.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.816 0.341 . . . . 0.0 110.721 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -80.18 134.61 36.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.654 HD22 ' HD2' ' A' ' 273' ' ' PHE . 2.4 tp -66.78 -178.51 0.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.968 0.792 . . . . 0.0 110.78 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.511 ' HD2' ' HG2' ' A' ' 172' ' ' GLN . 5.6 tpp180 -148.52 112.68 5.21 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.84 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 270' ' ' MET . 18.6 m -111.48 159.48 11.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.558 . . . . 0.0 111.897 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -157.8 -136.03 2.01 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.687 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -142.86 167.75 21.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -87.71 124.92 34.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.03 -29.73 3.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.381 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.7 t -129.94 143.87 50.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 CA--C 1.53 0.3 0 C-N-CA 123.34 2.693 . . . . 0.0 112.15 176.657 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 7.5 t30 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.91 -46.61 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 -43.53 77.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.694 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 9.8 t80 -78.97 -22.51 45.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.958 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.8 mtpt -79.06 -35.01 43.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.785 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.527 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 58.1 t0 -57.07 -46.48 82.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.689 ' HB2' ' CE1' ' A' ' 232' ' ' PHE . . . -49.09 -52.9 23.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.169 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.803 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.7 -25.28 35.6 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -168.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 32.8 mt-30 -63.24 -38.05 89.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.703 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 67.3 mtt180 -71.57 -39.29 70.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.734 172.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.922 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.98 -46.85 85.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.147 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.262 31.9 mtt-85 -80.51 -24.35 39.45 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.898 174.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 56.1 tt0 -53.63 -49.87 66.95 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.248 0.546 . . . . 0.0 109.976 167.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.809 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -65.69 -30.45 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -21.84 42.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.387 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.91 72.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.732 ' HG3' HG12 ' B' ' 45' ' ' ILE . 48.5 pttt -72.66 -43.91 62.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.448 174.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.732 HG12 ' HG3' ' B' ' 44' ' ' LYS . 5.7 pt . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.851 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.919 0.39 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.07 96.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.412 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.64 -36.98 85.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.56 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.55 -28.08 66.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.824 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.36 -43.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.137 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 81.4 mmm -61.24 -40.55 94.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.094 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.452 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 98.8 m -65.22 -19.57 66.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 9.8 ptm85 -116.27 107.18 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.528 0.68 . . . . 0.0 111.264 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.8 m -97.33 135.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.363 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 19.4 t80 -78.35 126.78 31.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.384 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 185' ' ' VAL . 15.3 m -123.67 111.64 29.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.419 0.628 . . . . 0.0 110.02 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -133.9 102.76 0.47 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.625 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.622 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.6 t 168.12 77.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.3 mt -110.16 134.56 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.06 -75.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.17 0.294 . . . . 0.0 111.199 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -169.12 -53.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.198 0.523 . . . . 0.0 110.359 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -19.6 19.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.817 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.58 108.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 0.0 110.792 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 152' ' ' HIS . . . -83.09 -178.77 52.41 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.614 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.47 -24.42 65.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.749 0.309 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.47 -43.53 93.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.323 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -62.19 -44.58 96.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.71 -46.75 91.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 110.57 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.528 ' HG3' HG13 ' A' ' 138' ' ' ILE . 70.6 ttt180 -57.47 -45.75 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.006 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -77.25 -19.15 56.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.43 57.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.762 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 74.0 m-85 -101.86 7.45 41.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 110.797 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -72.14 -42.37 9.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.928 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 133' ' ' ALA . 36.6 Cg_exo -63.59 -4.97 7.74 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.155 1.903 . . . . 0.0 112.716 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -92.7 -75.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.784 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.77 168.86 25.8 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 18.6 Cg_exo -66.14 133.71 34.07 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.54 2.16 . . . . 0.0 111.585 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.528 HG13 ' HG3' ' A' ' 129' ' ' ARG . 47.6 mm -72.02 114.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.358 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -94.71 -46.03 7.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 29.9 t -143.88 135.22 25.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 110.946 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.467 HG22 ' HG3' ' A' ' 143' ' ' MET . 65.9 mt -116.65 106.12 19.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.436 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.2 m-20 -111.33 98.28 7.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.467 ' HG3' HG22 ' A' ' 141' ' ' ILE . 79.7 mtp -109.5 163.68 13.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.466 . . . . 0.0 111.148 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.41 ' O ' ' HA3' ' A' ' 154' ' ' GLY . 66.6 m -145.87 85.67 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.83 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.443 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 13.1 p-90 -144.92 160.13 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.697 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.48 91.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.2 m -85.35 -9.53 57.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.361 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 m -80.15 -52.1 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.623 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -112.9 21.38 15.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.443 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 89.7 mmm 61.69 -157.2 0.34 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.16 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm 73.54 105.42 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -172.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.423 ' NE2' ' HA2' ' A' ' 124' ' ' GLY . 14.8 m-70 -77.6 68.87 3.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.35 31.73 1.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.999 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 144' ' ' SER . . . -139.68 175.25 21.88 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.813 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -114.37 173.51 6.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.425 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -139.9 148.51 42.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.461 . . . . 0.0 111.689 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.449 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 86.2 m-85 -116.94 118.67 33.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -110.1 120.03 60.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.302 0.572 . . . . 0.0 110.958 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.8 tt0 -107.63 134.76 50.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.906 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.61 167.15 9.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.889 0.376 . . . . 0.0 111.647 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.3 -45.28 88.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.168 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.593 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 23.9 m -115.73 138.2 23.76 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.113 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.452 ' HG3' ' SG ' ' A' ' 112' ' ' CYS . 16.5 Cg_exo -68.09 -20.48 43.98 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.4 2.734 . . . . 0.0 112.29 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.593 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 4.0 mp0 -56.52 -52.24 65.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.469 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.43 62.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.47 53.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -73.13 -32.62 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.754 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.464 HD22 ' CE2' ' A' ' 212' ' ' TYR . 25.2 tp -57.42 -48.6 78.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.034 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.32 99.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.708 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.531 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 4.9 tt -59.51 -62.48 1.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.039 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.18 -35.21 74.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.383 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.656 ' HG3' ' HD2' ' A' ' 281' ' ' ARG . 14.3 mm100 -83.19 -49.5 9.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.762 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 20.6 mmt -73.7 -31.44 63.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -75.01 -16.92 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.403 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.2 m -91.83 -12.25 34.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 173' ' ' MET . 33.6 m -110.59 140.17 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.345 0.593 . . . . 0.0 111.618 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 27.4 ttt -90.72 105.12 17.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.713 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.83 91.57 0.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.46 . . . . 0.0 110.162 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 63.64 -130.21 39.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.829 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.55 5.24 80.19 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.013 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.73 102.64 6.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.311 0.576 . . . . 0.0 110.498 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.77 128.98 38.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.905 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.622 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 21.0 pt -89.39 144.71 8.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.886 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -102.39 110.84 22.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.432 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 116' ' ' VAL . 47.1 t -125.12 136.23 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.454 -174.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.531 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 92.57 46.42 3.48 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.971 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.65 ' HA ' HD11 ' A' ' 191' ' ' ILE . 41.5 ttt85 -139.44 78.69 26.65 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.227 0.514 . . . . 0.0 111.118 175.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 -62.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.587 2.191 . . . . 0.0 111.723 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.4 p -171.63 -52.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.557 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 12.6 m120 -81.51 68.66 7.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.005 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.65 HD11 ' HA ' ' A' ' 187' ' ' ARG . 50.0 mm -74.68 108.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.858 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.89 -8.06 57.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.643 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.557 ' OE1' ' HA ' ' A' ' 190' ' ' ASN . 53.5 mt-30 -77.14 -12.63 59.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 111.259 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.59 16.84 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.622 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.574 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.0 tp60 -58.45 -52.24 76.06 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.441 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 51.5 Cg_exo -55.85 -30.05 75.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.768 1.645 . . . . 0.0 112.062 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 47.8 mm -72.61 -56.11 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.769 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 201' ' ' LEU . 35.2 pt -66.7 -30.74 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.33 -42.05 96.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.397 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 203' ' ' GLU . 88.9 mt-30 -69.72 -35.81 75.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.709 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 198' ' ' ILE . 95.6 mt -62.03 -50.66 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.21 -29.65 70.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.72 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 206' ' ' ARG . 39.2 tt0 -62.42 -52.42 63.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.055 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.94 -29.24 68.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.5 . . . . 0.0 110.502 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.71 68.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.596 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 203' ' ' GLU . 51.1 mtt180 -64.26 -25.54 68.1 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.43 -18.87 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.587 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.18 -29.3 11.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 0.0 110.914 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 58.66 23.98 11.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.688 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 12.3 ptp180 -89.48 150.56 22.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.995 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.98 168.04 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.337 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' A' ' 285' ' ' ALA . 71.7 t80 -112.33 121.66 45.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.382 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.52 123.18 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.286 0.565 . . . . 0.0 110.351 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.37 178.31 5.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.721 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.6 m 68.75 25.94 6.22 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 124.022 0.826 . . . . 0.0 111.481 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.586 HG21 HD13 ' A' ' 240' ' ' LEU . 10.8 m -77.2 164.38 3.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.53 ' HB2' HD23 ' A' ' 275' ' ' LEU . 6.9 t-80 -81.09 147.17 30.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -57.31 -55.86 29.29 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.718 ' HB2' HG13 ' B' ' 45' ' ' ILE . 0.2 OUTLIER -70.08 -48.36 58.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.689 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 1.011 HD11 HG13 ' B' ' 41' ' ' ILE . 0.4 OUTLIER -61.13 114.99 3.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.024 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.2 t -100.43 -177.06 3.39 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -166.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 240' ' ' LEU . 4.3 p30 -60.31 -37.73 81.5 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.64 -31.31 69.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.617 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 13.4 m-20 -78.2 -53.87 6.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.42 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.643 HG13 HD11 ' A' ' 240' ' ' LEU . 32.4 mm -54.89 -25.59 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.041 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -55.79 -33.34 64.31 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.519 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.47 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 69.2 m -49.46 -56.0 11.26 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.693 0.758 . . . . 0.0 111.716 -174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.663 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.4 m -74.61 -49.68 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.734 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' A' ' 235' ' ' ILE . 58.3 m-85 -60.89 -41.68 96.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.917 0.389 . . . . 0.0 111.626 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.541 ' HB2' HD12 ' A' ' 235' ' ' ILE . 1.1 tm-20 -76.26 -22.4 55.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.34 -23.49 61.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.901 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.808 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 1.0 OUTLIER -93.92 -33.42 13.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.226 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -163.67 -179.78 38.22 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.3 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 258' ' ' GLU . 9.1 mmmm -74.66 122.65 23.54 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.676 HG21 ' HB2' ' A' ' 238' ' ' CYS . 55.2 mt -97.57 132.82 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 172.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.71 ' HD2' ' HA ' ' A' ' 258' ' ' GLU . 29.3 mtpp -100.8 -46.01 5.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.198 0.523 . . . . 0.0 110.362 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.5 m -136.28 93.88 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.676 ' HB2' HG21 ' A' ' 235' ' ' ILE . 48.3 t -96.76 113.17 24.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.0 m -151.12 116.85 5.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.619 0.247 . . . . 0.0 110.99 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.798 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 78.7 mt -85.34 130.02 34.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.81 134.69 54.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.806 0.336 . . . . 0.0 110.35 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.828 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 12.3 ptm180 -117.7 157.42 26.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.035 0.445 . . . . 0.0 110.889 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.452 ' OD1' HG22 ' A' ' 245' ' ' THR . 9.6 t70 -88.01 122.71 69.86 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.089 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.96 -19.0 40.54 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.112 2.542 . . . . 0.0 114.546 -172.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.452 HG22 ' OD1' ' A' ' 243' ' ' ASP . 6.4 t -99.17 -30.12 12.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.513 -174.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 36.3 p -94.23 -26.35 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.986 0.422 . . . . 0.0 110.622 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.85 -18.49 53.07 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.278 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.81 150.29 22.31 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.828 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.8 p80 -75.61 152.41 37.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.313 0.578 . . . . 0.0 111.215 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.66 158.71 22.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.188 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.455 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -72.22 43.16 0.83 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.445 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 43.3 p90 -165.63 166.07 18.32 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.798 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.63 -174.4 40.57 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.552 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.577 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 94.3 m-85 -122.58 124.88 44.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.986 0.422 . . . . 0.0 110.267 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.2 mt -120.29 126.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 36.0 tt0 -103.67 136.61 43.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.459 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -109.23 151.54 26.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.757 0.789 . . . . 0.0 112.191 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.71 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 3.1 tp10 -80.24 -21.79 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.628 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 50.2 mtpt -143.17 140.14 30.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.807 -171.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.4 -33.64 76.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.86 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -63.61 -41.02 98.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.411 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.504 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 21.7 m -67.8 -39.85 83.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 267' ' ' VAL . 7.8 p -69.61 -32.8 71.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -66.46 -44.07 83.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.423 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.39 -39.51 92.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.56 76.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.259 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 263' ' ' SER . 90.8 t -62.5 -29.03 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 111.58 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 p -89.89 -10.12 46.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 27.8 t -115.84 -40.24 3.37 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.808 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 30.5 mmm -70.84 -14.67 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.91 0.862 . . . . 0.0 110.36 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.213 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.653 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 51.6 t80 -56.94 98.82 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.521 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 13.5 t70 -82.77 119.86 24.88 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.926 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.875 HD21 HD22 ' A' ' 220' ' ' LEU . 19.7 tp -126.09 86.88 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.45 22.68 39.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.551 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.4 15.29 30.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.614 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 26.9 pt20 -140.67 132.37 27.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.653 0.263 . . . . 0.0 110.395 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.33 133.61 42.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 216' ' ' VAL . 1.0 OUTLIER -71.95 -169.78 0.51 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 0.0 110.972 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.656 ' HD2' ' HG3' ' A' ' 172' ' ' GLN . 21.1 tpp180 -147.79 116.39 6.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.47 139.0 52.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -160.42 -178.81 34.73 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.615 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -72.16 152.2 42.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.43 -20.06 66.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.4 t 71.07 -77.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 122.547 0.339 . . . . 0.0 111.764 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 0.1 OUTLIER -110.7 121.9 39.76 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.014 0.435 . . . . 0.0 111.956 -174.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 287' ' ' THR . 74.2 Cg_endo . . . . . 0 N--CA 1.454 -0.799 0 C-N-CA 122.924 2.416 . . . . 0.0 112.41 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.27 -33.02 26.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.116 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.25 71.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.151 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.58 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.9 t80 -74.29 -19.61 60.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.336 0.589 . . . . 0.0 110.49 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 53.3 mttp -76.37 -43.76 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -39.71 77.99 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.403 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.679 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.24 -52.57 43.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.904 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.683 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.44 -21.95 38.5 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 41.3 mt-30 -63.15 -38.16 90.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.542 ' O ' HG23 ' B' ' 41' ' ' ILE . 76.5 mtp180 -73.71 -35.38 65.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.226 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.802 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -61.47 -45.89 92.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' B' ' 39' ' ' ARG 0.253 16.5 mtp180 -81.38 -25.96 35.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.474 -1.391 . . . . 0.0 113.095 174.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -53.49 -49.72 66.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.155 168.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 1.011 HG13 HD11 ' A' ' 220' ' ' LEU . 3.9 pt -61.45 -37.91 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.076 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.61 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -71.85 -22.37 61.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.095 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.69 -45.57 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.08 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 20.6 pttp -74.96 -23.76 58.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.718 HG13 ' HB2' ' A' ' 219' ' ' ASP . 8.3 tp . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 122.083 0.944 . . . . 0.0 110.052 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.944 0.402 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.6 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.313 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.6 tp -73.77 -30.78 62.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.284 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.76 -29.49 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.094 0.473 . . . . 0.0 110.716 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.73 -38.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.483 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.77 -26.8 68.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.349 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 160' ' ' TYR . 15.5 p -92.3 -1.16 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.58 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -118.27 118.95 33.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.4 HG23 HG13 ' A' ' 158' ' ' VAL . 13.2 m -112.62 125.54 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 111.207 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 27.4 t80 -73.74 137.15 43.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.125 175.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.12 110.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 123.415 0.447 . . . . 0.0 109.822 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.2 170.54 13.96 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.111 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 6.4 t 62.68 48.67 4.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.423 0.63 . . . . 0.0 110.376 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -81.85 71.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.437 ' HB3' ' H ' ' A' ' 121' ' ' TYR . 22.3 t80 36.31 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.554 1.159 . . . . 0.0 112.512 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.437 ' H ' ' HB3' ' A' ' 120' ' ' TYR . 38.3 t80 -178.71 -62.03 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -91.63 45.21 1.21 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.072 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.0 125.84 49.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.983 0.42 . . . . 0.0 110.622 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.49 159.08 23.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.26 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.53 -36.74 74.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 111.268 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.69 -32.52 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.413 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 m -76.53 -41.26 47.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.901 0.381 . . . . 0.0 111.154 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 63.7 mt -72.72 -41.05 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.251 0.548 . . . . 0.0 110.104 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -54.4 -41.21 69.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.151 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -76.92 -22.98 52.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.28 74.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 110.594 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.42 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 71.4 m-85 -96.54 4.65 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.586 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -63.01 -44.07 83.89 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.857 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.624 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.2 Cg_endo -69.1 -4.33 13.37 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.012 1.808 . . . . 0.0 113.37 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.622 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 2.7 m-85 -81.06 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.965 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.87 172.99 39.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.176 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.37 128.73 27.08 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.21 117.91 28.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.859 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.591 ' HD3' ' CG ' ' A' ' 161' ' ' GLU . 51.1 tptt -87.34 -53.75 4.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.227 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.8 m -145.79 151.16 37.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.154 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -135.5 107.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 6.4 m-20 -92.3 96.23 10.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.28 0.562 . . . . 0.0 110.172 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.446 ' CE ' ' HB2' ' A' ' 156' ' ' ALA . 41.2 tpp -123.94 94.01 4.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.287 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 t -83.63 84.1 7.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.379 0.609 . . . . 0.0 109.479 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.774 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 0.1 OUTLIER -134.05 160.77 36.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.098 -178.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.33 102.72 15.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 m -66.16 -23.5 66.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.295 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.23 -33.89 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 m -96.69 -13.06 23.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.0 110.563 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 45.5 ttm 58.32 34.35 23.97 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.316 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -126.03 143.58 51.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.287 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.774 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 22.8 p80 -103.93 112.39 25.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.142 0.496 . . . . 0.0 111.165 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -76.38 -15.3 59.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.135 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.89 -152.75 8.37 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.568 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.88 175.2 9.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.446 ' HB2' ' CE ' ' A' ' 143' ' ' MET . . . -99.14 137.32 37.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.066 0.46 . . . . 0.0 111.975 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.643 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 95.4 m-85 -117.73 106.45 13.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 169.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 114' ' ' VAL . 2.7 p -100.46 122.71 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.813 0.816 . . . . 0.0 110.377 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.1 135.19 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.106 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 41.9 m-85 -115.23 164.98 13.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.591 ' CG ' ' HD3' ' A' ' 139' ' ' LYS . 33.6 mt-10 -95.66 10.02 38.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.338 0.59 . . . . 0.0 109.499 170.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.45 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.0 m -130.25 115.11 17.38 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.213 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 162' ' ' VAL . 20.4 Cg_endo -62.43 -21.73 73.13 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.745 2.296 . . . . 0.0 111.686 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 285' ' ' ALA . 15.9 mp0 -59.47 -63.59 1.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.601 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -57.49 -33.46 68.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.599 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.43 62.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.646 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.49 -33.95 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.494 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.441 HD21 ' HG3' ' A' ' 281' ' ' ARG . 8.9 tt -61.29 -48.32 81.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.03 -39.84 91.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.623 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.4 tt -58.83 -55.03 40.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -75.35 -48.14 24.4 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -91.85 -0.36 57.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -165.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.475 ' HG3' HD11 ' A' ' 183' ' ' ILE . 55.1 tpp -116.42 -32.75 5.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.086 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 6.7 t30 -68.75 -27.04 65.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.365 0.603 . . . . 0.0 110.351 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -90.83 17.18 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.889 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.12 142.79 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.219 0.533 . . . . 0.0 110.623 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.54 100.91 10.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.085 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.94 -55.65 32.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.554 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.84 69.09 0.31 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.382 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.86 -38.89 2.37 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.566 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.497 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 5.2 mpt_? -97.52 136.67 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.3 118.24 17.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 24.1 pt -84.7 157.03 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.121 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -104.18 110.92 23.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 46.3 t -120.4 128.79 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.765 0.317 . . . . 0.0 110.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.623 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 110.9 -105.47 1.9 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.027 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 14.3 mmt180 66.56 78.06 0.25 Allowed Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.137 0.575 . . . . 0.0 112.456 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.99 97.36 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.831 2.354 . . . . 0.0 110.654 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.3 t -75.48 -28.31 59.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -84.82 80.03 9.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.347 0.594 . . . . 0.0 110.988 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.33 62.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.56 0.695 . . . . 0.0 110.347 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.63 -80.78 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.459 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -82.12 -34.98 28.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.969 0.414 . . . . 0.0 110.535 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -72.85 -33.49 66.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.603 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.49 10.18 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.213 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.628 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 27.2 Cg_endo -62.04 -37.08 67.05 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.795 1.663 . . . . 0.0 112.231 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.45 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 50.5 mm -66.77 -41.45 87.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 194' ' ' ALA . 90.2 mt -59.75 -42.23 88.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.96 -39.82 90.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.551 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 80.8 mm-40 -62.07 -37.84 86.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 99.1 mt -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.529 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.27 85.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.842 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.79 -33.93 76.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.199 0.524 . . . . 0.0 110.563 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.426 ' O ' ' HD1' ' A' ' 208' ' ' PHE . 7.9 tp10 -66.01 -49.59 67.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.258 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.59 78.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -67.28 -23.35 65.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.635 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.87 -28.88 50.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.121 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.426 ' HD1' ' O ' ' A' ' 204' ' ' GLU . 24.6 m-85 -88.62 -19.57 26.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.37 0.605 . . . . 0.0 110.437 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 65.8 t30 61.1 37.12 17.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.001 168.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.58 136.65 40.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.969 0.414 . . . . 0.0 110.176 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.487 ' CG2' ' HB ' ' A' ' 255' ' ' ILE . 9.8 tt -100.45 144.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -108.28 109.51 20.88 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.454 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.3 p -105.64 120.0 55.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 0.0 110.777 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.63 178.16 4.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.447 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.6 m 67.85 14.29 9.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.508 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.655 ' HA ' HD22 ' A' ' 280' ' ' LEU . 10.6 p -71.21 137.49 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.305 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.507 ' HD2' ' O ' ' A' ' 275' ' ' LEU . 2.3 t-80 -67.25 134.81 52.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 -176.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -58.61 -8.8 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.987 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.0 -37.21 47.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.288 0.566 . . . . 0.0 110.319 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.897 HD13 HD13 ' A' ' 275' ' ' LEU . 0.5 OUTLIER -113.32 128.12 56.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.665 -172.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.4 m -100.61 -175.32 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.791 0.437 . . . . 0.0 111.125 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.871 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 6.6 p-10 -53.6 -40.76 65.96 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.86 -35.66 66.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.45 0.643 . . . . 0.0 110.408 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.72 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.8 m-20 -78.89 -58.01 3.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.163 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.508 HG13 HG21 ' A' ' 216' ' ' VAL . 20.6 mm -63.46 -15.52 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.253 0.549 . . . . 0.0 111.067 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.773 ' HG3' HD12 ' A' ' 235' ' ' ILE . 83.1 tttt -54.42 -32.15 56.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.573 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.743 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.7 m -48.78 -61.37 2.08 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.704 0.764 . . . . 0.0 111.477 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.841 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.0 m -73.66 -38.92 52.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.506 -172.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.492 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 19.0 m-85 -62.89 -50.79 69.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.694 0.283 . . . . 0.0 111.661 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.558 ' HG3' ' HA ' ' A' ' 234' ' ' LYS . 27.6 tt0 -77.83 -17.99 56.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.47 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.198 -0.314 . . . . 0.0 111.008 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.7 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.4 m-30 -82.88 -42.21 18.02 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.85 -107.19 0.79 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.219 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.558 ' HA ' ' HG3' ' A' ' 230' ' ' GLU . 33.6 ttmt -157.51 159.62 37.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.773 HD12 ' HG3' ' A' ' 226' ' ' LYS . 60.3 mt -122.98 128.62 75.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 111.218 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -92.33 -31.03 15.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.333 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 33.2 t -156.93 119.56 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.771 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.621 ' HB3' HG21 ' A' ' 235' ' ' ILE . 6.3 p -117.74 117.12 28.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 36.3 m -153.31 104.99 2.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 112.063 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.871 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 54.7 mt -86.42 119.24 26.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 166.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.95 106.19 0.67 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -92.59 153.48 18.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.66 96.31 27.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.4 -19.53 49.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -35.98 57.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.248 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.2 m -86.19 -33.0 20.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.45 35.17 5.3 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.329 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.42 156.83 16.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.774 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 12.0 p80 -84.46 138.33 32.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -67.02 152.57 45.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.69 24.61 1.5 Allowed Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.942 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.34 161.31 42.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.284 0.542 . . . . 0.0 110.583 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.29 -174.95 40.71 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.868 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -120.07 135.89 54.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.035 0.445 . . . . 0.0 111.178 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.487 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 28.8 mm -118.33 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 33.9 tt0 -104.69 126.27 51.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.52 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -101.47 146.83 27.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 1.3 pm0 -78.34 -16.96 57.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.573 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 258' ' ' GLU . 31.3 mtmm -137.09 148.48 46.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.67 64.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.78 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.36 -43.24 88.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.698 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.2 m -68.56 -31.99 71.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 267' ' ' VAL . 33.2 t -65.77 -52.21 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.382 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.48 -36.29 83.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.379 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.3 -31.32 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.579 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.94 63.7 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.95 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 263' ' ' SER . 42.8 t -54.4 -42.97 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 50.6 m -70.94 -25.89 62.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.4 p -109.65 -37.7 5.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.751 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 0.4 OUTLIER -65.77 -27.65 68.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.496 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.6 t30 -57.53 -34.38 69.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.743 0.783 . . . . 0.0 110.275 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.468 ' O ' ' HD2' ' A' ' 279' ' ' TYR . 18.5 mt -76.43 -6.55 52.18 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.86 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.821 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 3.2 t80 -54.43 102.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.6 t70 -89.07 122.99 32.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.725 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.897 HD13 HD13 ' A' ' 220' ' ' LEU . 88.8 mt -120.55 87.97 2.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.233 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.59 36.75 47.93 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.03 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.84 7.83 46.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.476 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.0 pt20 -136.8 132.76 35.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.99 0.424 . . . . 0.0 110.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.468 ' HD2' ' O ' ' A' ' 272' ' ' LEU . 79.6 m-85 -90.26 135.26 33.78 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.655 HD22 ' HA ' ' A' ' 216' ' ' VAL . 15.7 mt -69.1 -169.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.697 0.761 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -149.87 112.36 4.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.95 -176.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' ' 271' ' ' ASN . 30.7 m -111.41 147.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.256 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.75 -159.72 9.21 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.898 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -92.91 159.41 15.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.595 0.236 . . . . 0.0 110.71 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -67.83 -21.67 65.19 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.612 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.461 HG12 HG23 ' A' ' 287' ' ' THR . 92.5 t 72.35 -62.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.472 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.711 ' HB ' ' HD2' ' A' ' 288' ' ' PRO . 63.7 p -114.4 170.27 5.63 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.711 ' HD2' ' HB ' ' A' ' 287' ' ' THR . 30.3 Cg_endo . . . . . 0 C--N 1.347 0.484 0 C-N-CA 122.329 2.019 . . . . 0.0 111.486 173.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 . . . . . 0 CA--C 1.519 -0.246 0 CA-C-O 121.366 0.603 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.68 -62.52 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.89 -22.8 66.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.427 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.512 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 5.1 t80 -70.38 -18.0 63.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.241 0.543 . . . . 0.0 110.125 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.602 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 50.0 mtmt -69.9 -46.4 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 53.0 t0 -57.44 -44.68 84.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.984 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.841 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -47.53 -54.11 12.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.125 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.685 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.24 -20.13 38.28 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -168.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 30.1 mt-30 -61.2 -43.6 98.63 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.743 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 45.9 mtt180 -73.67 -28.61 61.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.697 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.821 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.56 -48.56 78.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -80.11 -27.16 39.23 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.075 -1.016 . . . . 0.0 111.941 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.56 -45.83 73.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.932 0.396 . . . . 0.0 110.491 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 14.1 pt -68.75 -35.29 69.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.766 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' A' ' 220' ' ' LEU . . . -68.74 -20.04 64.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.134 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.56 -46.72 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.477 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.564 ' O ' HG12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -92.6 -14.52 28.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.509 -176.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.564 HG12 ' O ' ' B' ' 44' ' ' LYS . 12.1 pt . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 125.282 1.433 . . . . 0.0 113.639 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.798 0.332 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.431 ' HB2' ' HB1' ' A' ' 194' ' ' ALA . . . -60.03 -46.03 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.142 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.506 HD11 ' HG3' ' A' ' 163' ' ' PRO . 44.2 tp -71.23 -34.47 70.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.825 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.13 -50.29 74.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.218 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.426 ' HB ' ' HG2' ' A' ' 187' ' ' ARG . 33.9 pt -72.22 -34.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.0 mmm -59.66 -26.62 65.69 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -84.56 -15.61 45.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.612 0.244 . . . . 0.0 111.533 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 23.6 ttm-85 -109.8 108.61 19.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 110.716 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -91.96 134.12 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.73 0.776 . . . . 0.0 111.146 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 21.6 t80 -90.62 122.08 33.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.17 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.559 HG12 HD13 ' A' ' 119' ' ' ILE . 14.3 t -108.81 109.89 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.89 164.34 12.55 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.984 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 m 72.71 -57.22 0.64 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.483 0.713 . . . . 0.0 110.901 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' A' ' 123' ' ' LEU . 17.9 mm 66.59 -79.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 123.235 0.614 . . . . 0.0 111.099 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HA ' ' HG2' ' A' ' 181' ' ' ARG . 89.6 t80 174.48 -72.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.801 0.84 . . . . 0.0 108.743 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 3.6 t80 170.29 -59.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.648 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.09 -24.13 30.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.631 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 127' ' ' THR . 39.1 mt -67.52 128.74 37.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.363 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -123.74 -153.57 8.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.921 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -60.24 -54.78 41.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 111.461 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.26 -35.24 78.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.537 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.849 HG21 HD22 ' A' ' 123' ' ' LEU . 1.9 m -66.22 -41.2 90.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.791 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.63 -38.9 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.15 -47.14 72.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.438 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -71.06 -27.47 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.702 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.34 -42.41 18.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.888 0.375 . . . . 0.0 111.435 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.421 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 84.6 m-85 -96.57 12.17 32.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -175.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.25 -46.29 50.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.785 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.939 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.1 Cg_endo -68.43 -4.62 13.28 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.744 1.63 . . . . 0.0 112.702 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -98.08 64.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.059 0.457 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.6 175.29 40.6 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.808 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.93 102.62 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.722 2.281 . . . . 0.0 111.555 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.701 HG12 ' HE1' ' A' ' 160' ' ' TYR . 55.5 mt -56.17 119.8 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.206 0.527 . . . . 0.0 110.375 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -89.79 -45.8 9.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.181 -173.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 t -159.55 141.08 12.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 62.0 mt -121.58 115.91 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.429 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.75 106.75 17.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.376 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.424 ' HB3' ' HE2' ' A' ' 143' ' ' MET . 78.9 mtp -106.95 152.88 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.1 p -99.74 97.55 8.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -78.28 113.77 16.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 151' ' ' LYS . 12.7 t70 -80.44 112.49 17.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.203 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 93.8 p 53.8 -159.73 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.998 0.919 . . . . 0.0 112.296 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.35 -22.49 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.176 0.512 . . . . 0.0 111.089 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -62.84 -14.2 42.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.1 mtm 64.99 22.88 12.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.22 0.533 . . . . 0.0 110.891 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 146' ' ' ASP . 23.6 ttmm -73.15 91.74 1.66 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.552 ' CE1' HG13 ' A' ' 119' ' ' ILE . 11.5 t-160 -76.36 67.49 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -96.57 112.56 24.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.86 -115.85 0.71 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.388 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -152.28 175.47 12.61 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.88 138.5 18.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.883 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 98.5 m-85 -106.68 123.75 48.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.558 0.218 . . . . 0.0 110.474 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.06 104.69 17.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.065 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.3 tt0 -95.35 130.14 42.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.701 ' HE1' HG12 ' A' ' 138' ' ' ILE . 31.0 m-85 -104.01 166.4 10.43 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -100.29 5.79 44.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.847 0.832 . . . . 0.0 109.145 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.74 119.64 12.9 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.034 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.506 ' HG3' HD11 ' A' ' 108' ' ' LEU . 24.8 Cg_endo -64.19 -21.86 67.32 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.095 2.53 . . . . 0.0 112.792 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.447 ' OE2' ' HG2' ' A' ' 163' ' ' PRO . 16.7 mp0 -61.9 -52.53 63.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.63 75.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.137 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -38.55 90.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.167 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.449 ' HG2' HG22 ' A' ' 286' ' ' VAL . 56.8 tp60 -65.2 -40.57 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.128 0.489 . . . . 0.0 110.488 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.42 HD11 ' HA3' ' A' ' 283' ' ' GLY . 8.9 mp -66.32 -37.17 84.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.503 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.56 -28.92 69.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.294 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.98 -62.17 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.04 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -71.09 -43.42 67.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -87.31 -21.87 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.583 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 54.2 tpp -98.22 -33.19 11.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.808 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -80.3 -8.95 59.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 110.839 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 p -90.31 0.66 57.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.32 168.37 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.696 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 86.3 mtp -129.46 103.02 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.131 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.58 118.69 14.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.79 -73.1 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.514 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.3 38.94 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.653 ' HG2' ' HA ' ' A' ' 120' ' ' TYR . 23.8 tpt180 -140.61 138.6 34.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -80.85 102.74 10.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.66 133.06 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.128 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -100.5 110.95 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.938 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 45.9 t -112.27 129.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.276 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 176.75 -144.47 6.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.098 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.426 ' HG2' ' HB ' ' A' ' 110' ' ' ILE . 23.3 tpt180 -162.98 79.02 1.74 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.05 49.07 2.69 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.957 2.438 . . . . 0.0 113.165 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.5 m -90.29 -57.1 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.034 0.445 . . . . 0.0 110.066 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -137.25 -64.18 0.57 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.1 mt 70.81 138.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.251 0.548 . . . . 0.0 111.676 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.15 -49.97 4.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.385 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -55.48 -56.01 25.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.852 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 107' ' ' ALA . . . -105.07 14.0 29.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.053 0.454 . . . . 0.0 110.942 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 0.3 OUTLIER -64.6 -55.18 31.14 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.427 -177.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 76.7 Cg_exo -52.72 -27.53 34.2 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 122.707 2.271 . . . . 0.0 113.738 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 48.2 mm -62.2 -34.89 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.443 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 51.5 mm -70.93 -39.1 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.654 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.25 -37.64 83.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.472 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 29.8 mm-40 -65.09 -36.77 85.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.176 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 89.5 mt -71.21 -37.35 72.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.706 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.73 -42.02 97.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -67.66 -34.64 77.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.907 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.37 -46.9 84.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.105 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 285' ' ' ALA . . . -62.53 -23.51 67.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.044 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -63.29 -27.57 69.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.774 0.321 . . . . 0.0 110.62 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.94 -13.23 61.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.406 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -93.26 -15.19 26.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.785 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 60.77 17.25 7.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.38 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.74 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 16.1 ptm180 -111.12 144.75 39.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 283' ' ' GLY . 35.5 pt -119.3 169.64 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.302 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.429 ' HE1' ' HD2' ' A' ' 252' ' ' TYR . 84.1 t80 -116.82 115.25 25.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.182 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.71 122.59 66.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.256 0.551 . . . . 0.0 110.694 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.25 -174.69 2.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.352 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.939 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 14.2 t 61.42 30.5 18.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 0.0 110.354 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.538 HG12 HD11 ' A' ' 280' ' ' LEU . 5.4 m -81.6 151.25 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.464 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 11.5 t-80 -73.9 137.56 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -166.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.539 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -78.5 -46.46 19.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.898 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.766 HD23 HD13 ' A' ' 225' ' ' ILE . 0.1 OUTLIER -58.56 100.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.606 178.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.7 m -101.05 -174.77 2.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.53 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.611 ' N ' HD12 ' A' ' 240' ' ' LEU . 3.7 p-10 -48.63 -43.28 36.29 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.77 -30.81 71.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.16 0.505 . . . . 0.0 110.819 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.719 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 11.4 m-20 -78.82 -59.65 2.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.772 HG13 HD11 ' A' ' 240' ' ' LEU . 23.5 mm -56.05 -24.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.216 0.532 . . . . 0.0 111.232 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.463 ' HG3' HD12 ' A' ' 235' ' ' ILE . 59.4 tttm -53.73 -32.46 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.018 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.923 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.8 m -51.89 -62.4 1.65 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.878 0.847 . . . . 0.0 112.204 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.65 HG21 ' HE1' ' A' ' 270' ' ' MET . 1.9 m -63.03 -53.46 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.306 -173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.568 ' HD2' ' HH ' ' A' ' 257' ' ' TYR . 84.2 m-85 -59.0 -34.08 71.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.42 -34.36 47.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -60.53 -26.14 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 111.041 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.623 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 3.9 p90 -129.96 40.22 3.58 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.605 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -177.34 153.8 14.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.115 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -94.31 110.47 22.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 0.0 110.167 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.463 HD12 ' HG3' ' A' ' 226' ' ' LYS . 52.5 mt -83.43 130.28 36.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.41 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -89.53 -37.03 15.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.64 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.1 t -168.47 134.04 1.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.37 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.1 t -114.48 113.42 24.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.4 m -136.81 103.77 5.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.996 0.427 . . . . 0.0 111.42 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.772 HD11 HG13 ' A' ' 225' ' ' ILE . 29.7 mt -83.69 129.8 34.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.04 138.91 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.707 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.658 ' HG2' ' HA ' ' A' ' 249' ' ' HIS . 69.2 mtp180 -137.58 149.57 46.78 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.76 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.627 ' HB2' HG22 ' A' ' 245' ' ' THR . 3.7 p-10 -80.85 129.34 68.26 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.996 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.13 -16.35 40.13 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.76 2.307 . . . . 0.0 112.027 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 243' ' ' ASP . 12.1 t -74.9 -33.68 62.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.823 -175.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.9 m -134.34 -41.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.007 0.432 . . . . 0.0 111.235 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.12 21.88 5.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.502 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -79.69 153.36 29.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 242' ' ' ARG . 1.9 t-80 -85.72 125.35 33.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.235 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.26 155.41 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.161 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.456 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -73.53 31.77 0.85 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.403 0.521 . . . . 0.0 114.403 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 34.9 p90 -160.13 163.78 33.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.915 0.358 . . . . 0.0 110.073 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -178.15 -169.75 39.42 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.309 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.418 ' CB ' HH21 ' A' ' 210' ' ' ARG . 95.5 m-85 -126.94 140.01 52.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.03 129.86 71.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.74 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 38.5 mt-10 -103.61 146.75 28.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.122 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.568 ' HH ' ' HD2' ' A' ' 229' ' ' PHE . 85.2 m-85 -117.29 158.2 24.78 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.306 0.574 . . . . 0.0 110.698 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -82.52 -17.26 45.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.704 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -134.73 140.61 46.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.958 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.05 -19.53 63.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.22 0.533 . . . . 0.0 109.919 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.54 -45.74 78.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.92 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -68.15 -27.15 66.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.404 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 m -61.79 -48.55 80.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.605 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.452 ' O ' HG12 ' A' ' 267' ' ' VAL . 57.5 tp60 -73.8 -34.34 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.866 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.67 -46.52 82.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.38 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.378 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 282' ' ' VAL . 4.0 p -60.76 -26.46 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.872 0.367 . . . . 0.0 111.666 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 28.9 m -81.06 -18.38 46.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 9.6 p -116.02 -27.6 6.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.65 ' HE1' HG21 ' A' ' 228' ' ' VAL . 34.5 mmm -69.46 -14.52 62.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -170.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 17.4 p-10 -73.74 -15.3 61.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.008 0.432 . . . . 0.0 111.402 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.53 -9.48 59.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.884 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 4.8 t80 -62.11 87.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.006 0.432 . . . . 0.0 111.406 -170.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.49 124.93 28.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' A' ' 220' ' ' LEU . 53.4 mt -123.45 107.71 11.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.86 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.7 -78.71 1.74 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.351 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -155.91 23.03 0.54 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.14 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -140.64 138.85 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.743 -0.269 . . . . 0.0 110.418 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 77.0 m-85 -75.05 123.86 25.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.538 HD11 HG12 ' A' ' 216' ' ' VAL . 5.9 tt -67.84 138.78 56.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.478 ' H ' ' HB3' ' A' ' 215' ' ' SER . 34.4 mmt180 -121.08 123.04 41.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.796 0.332 . . . . 0.0 110.773 -167.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' A' ' 270' ' ' MET . 14.9 p -117.25 147.7 20.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.094 0.473 . . . . 0.0 111.455 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 211' ' ' ILE . . . -144.71 -170.71 14.06 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -82.04 179.51 7.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.987 0.393 . . . . 0.0 110.549 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.562 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -67.64 -27.18 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 0.0 110.519 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 167' ' ' GLN . 44.4 t 73.53 -65.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.299 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 34.4 p -108.57 158.19 34.62 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.345 0.361 0 C-N-CA 122.208 1.939 . . . . 0.0 111.378 173.564 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.374 0.607 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -154.32 -65.65 0.14 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 232' ' ' PHE . . . -77.17 -31.28 55.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 110.85 176.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.449 ' HD1' ' CE1' ' A' ' 232' ' ' PHE . 16.9 t80 -65.77 -16.32 63.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.227 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -71.65 -50.81 27.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.262 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.599 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 15.5 t70 -57.88 -42.68 85.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.623 ' CB ' ' HE1' ' A' ' 232' ' ' PHE . . . -49.01 -44.85 41.68 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.54 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.711 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 2.6 mm? -82.19 -21.03 36.67 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -64.4 -40.72 96.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.923 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 18.6 mmt180 -73.28 -32.59 64.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.363 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.884 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.31 -47.06 85.94 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.099 -175.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 27.5 mtt85 -80.97 -26.27 36.69 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.259 -1.526 . . . . 0.0 112.703 174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -54.38 -41.92 69.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.518 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.815 HG12 ' O ' ' B' ' 38' ' ' ALA . 2.7 pt -69.83 -34.02 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.733 0.301 . . . . 0.0 110.775 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.42 -22.64 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.959 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.08 -27.26 22.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.807 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.793 ' HE2' HG22 ' B' ' 41' ' ' ILE . 45.1 pttt -93.11 -52.71 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.562 ' N ' ' HG3' ' B' ' 44' ' ' LYS . 91.9 mt . . . . . 0 C--O 1.234 0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.138 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.426 ' O ' HG12 ' A' ' 110' ' ' ILE . 73.3 mtt180 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.48 0.181 . . . . 0.0 111.402 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.47 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.3 -29.23 70.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.843 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.442 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.787 HD12 HG12 ' A' ' 191' ' ' ILE . 29.0 pt -82.57 -36.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.0 mtp -60.25 -26.19 66.25 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.5 m -82.44 -0.98 48.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ttm180 -122.2 118.25 28.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.56 166.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.045 0.45 . . . . 0.0 110.779 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -119.35 114.25 22.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.335 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -104.78 110.83 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 110.856 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.98 170.49 14.99 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 24.7 m 59.91 47.91 9.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.268 0.556 . . . . 0.0 110.428 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -76.49 123.04 32.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.817 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.553 ' HB3' HD13 ' A' ' 123' ' ' LEU . 54.9 t80 -62.91 140.98 58.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.314 0.578 . . . . 0.0 109.895 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -52.73 -31.71 39.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.27 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.38 6.7 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.553 HD13 ' HB3' ' A' ' 120' ' ' TYR . 10.1 mp -100.65 120.46 40.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.68 -165.79 14.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.639 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.521 ' OE2' ' HD2' ' A' ' 129' ' ' ARG . 3.9 tm-20 -59.36 -51.76 68.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.458 0.303 . . . . 0.0 110.762 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.86 -29.64 69.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.49 HG21 ' HG ' ' A' ' 123' ' ' LEU . 5.2 m -64.63 -50.78 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.968 0.413 . . . . 0.0 110.197 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.3 mt -67.48 -40.2 84.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.288 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.521 ' HD2' ' OE2' ' A' ' 125' ' ' GLU . 23.1 ttt180 -51.58 -51.93 51.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.502 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.2 -24.12 51.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.927 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.86 -37.57 73.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.27 12.86 36.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -70.88 -41.6 11.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.166 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.79 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 33.7 Cg_exo -63.89 -4.69 7.77 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.222 1.948 . . . . 0.0 112.817 173.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.432 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 23.8 m-85 -93.01 -68.44 0.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.306 . . . . 0.0 110.216 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.87 168.68 33.44 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.62 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 13.3 Cg_exo -69.51 121.86 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.513 2.142 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.54 123.87 37.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.95 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -100.35 -36.85 9.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.459 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -145.76 136.93 24.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.942 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 70.0 mt -127.29 116.4 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -103.68 114.55 28.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.319 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' A' ' 156' ' ' ALA . 89.1 mtp -113.64 108.29 16.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.353 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.541 ' O ' ' HA3' ' A' ' 154' ' ' GLY . 12.1 p -94.46 61.09 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.456 0.646 . . . . 0.0 110.796 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -114.13 159.59 19.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.628 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.652 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.7 m-20 -73.73 88.0 1.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.476 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.2 m -65.98 -36.02 82.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.585 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.9 m -63.52 -23.84 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.247 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.799 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 1.6 m -120.64 2.04 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.382 0.61 . . . . 0.0 110.132 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.9 mtp 56.91 35.61 26.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.535 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.799 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 30.7 mmmt -97.27 126.57 42.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.054 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.453 ' HE1' ' O ' ' A' ' 123' ' ' LEU . 27.1 m-70 -84.3 48.16 1.45 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.477 0.656 . . . . 0.0 110.098 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.47 -34.22 74.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.708 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 144' ' ' SER . . . -95.73 -155.53 31.14 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.026 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -140.46 174.57 10.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.258 0.223 . . . . 0.0 110.554 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.432 ' HB2' ' HG2' ' A' ' 143' ' ' MET . . . -124.33 138.42 54.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.805 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 97.1 m-85 -107.27 124.94 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.715 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.1 t -119.45 113.59 41.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 10.3 pt-20 -105.43 137.11 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -105.86 172.36 6.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.132 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 39.0 tt0 -74.53 -29.82 61.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.563 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.3 m -129.44 139.87 36.95 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.583 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.17 -20.54 43.46 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.187 2.592 . . . . 0.0 112.494 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 11.1 mp0 -55.56 -55.32 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.76 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -58.77 -32.24 69.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.514 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -51.61 36.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.35 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.38 -34.82 76.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.19 0.519 . . . . 0.0 110.091 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.612 HD13 ' HA3' ' A' ' 283' ' ' GLY . 25.8 tp -61.01 -44.71 97.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.239 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.22 87.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.532 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.34 -39.27 94.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -81.59 -47.35 13.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.029 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.418 ' CD ' ' HE ' ' A' ' 281' ' ' ARG . 20.3 mm-40 -87.83 -44.84 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -169.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.6 tpp -69.68 -26.74 64.52 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.097 0.475 . . . . 0.0 110.703 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -69.29 -24.2 63.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.204 0.526 . . . . 0.0 109.983 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 t -81.52 -27.86 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.83 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.88 110.49 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 111.017 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.589 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 21.3 mmt -61.83 124.13 19.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.913 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.52 105.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.967 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.33 -90.06 0.82 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.9 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.12 42.3 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 120' ' ' TYR . 30.4 tpt180 -134.0 126.09 29.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.703 0.287 . . . . 0.0 110.33 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.589 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 8.6 t30 -72.11 85.08 1.02 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.584 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.4 pt -83.0 156.64 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.272 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -105.94 109.8 21.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.527 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.93 109.59 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.159 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 135.6 -115.53 1.37 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.708 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 57.15 68.9 1.84 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.265 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.527 ' HB3' ' HB ' ' A' ' 191' ' ' ILE . 5.6 Cg_exo -80.77 61.52 8.25 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.802 3.001 . . . . 0.0 112.353 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 m -50.76 -42.45 57.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.706 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -117.56 13.09 14.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.787 HG12 HD12 ' A' ' 110' ' ' ILE . 53.5 mt -98.46 -25.26 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.044 0.45 . . . . 0.0 110.61 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.82 85.45 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.811 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.42 -4.79 52.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 111.204 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.28 7.65 42.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.601 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 61.8 tp60 -53.6 -44.61 98.1 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.79 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.4 Cg_endo -51.79 -32.25 45.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.267 1.978 . . . . 0.0 112.723 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.15 -43.93 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 110.121 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.9 mt -59.76 -38.97 78.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.537 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 66.2 m-20 -54.76 -50.96 67.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.748 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.38 -32.24 73.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.541 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.4 mt -66.01 -49.75 66.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.047 0.451 . . . . 0.0 110.126 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.62 -40.83 98.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.88 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 31.3 mm-40 -64.14 -30.29 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.287 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.83 -45.68 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.54 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.43 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.453 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtp180 -63.03 -21.85 66.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.657 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.99 -29.14 39.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.877 0.37 . . . . 0.0 111.197 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.56 -19.24 14.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.66 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 56.98 37.97 29.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.235 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.27 140.5 31.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.314 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 282' ' ' VAL . 19.9 tt -115.86 150.34 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.229 -172.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -109.48 135.38 50.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.265 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 229' ' ' PHE . 5.1 t -113.39 120.76 64.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.17 167.98 13.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.79 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 28.6 m 63.77 27.15 14.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.201 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.523 ' HA ' HD21 ' A' ' 280' ' ' LEU . 29.9 m -74.12 143.31 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.03 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.434 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 12.6 t-80 -69.65 134.39 48.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.84 -24.09 67.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.995 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.87 -46.87 16.04 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.937 -0.477 . . . . 0.0 110.92 173.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.686 HD23 HD13 ' A' ' 225' ' ' ILE . 0.2 OUTLIER -58.11 107.66 0.5 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.96 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.9 p -93.18 -177.95 4.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 4.7 p-10 -53.35 -37.56 62.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.947 0.403 . . . . 0.0 111.1 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.89 -34.35 77.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.379 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 8.8 m-20 -77.47 -55.36 5.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.688 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.789 HG13 HD11 ' A' ' 240' ' ' LEU . 31.4 mm -55.42 -27.58 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.792 0.437 . . . . 0.0 111.764 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.704 ' HG3' HD12 ' A' ' 235' ' ' ILE . 83.4 tttt -54.25 -31.67 54.1 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.651 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.655 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 68.7 m -47.86 -61.22 2.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.638 0.732 . . . . 0.0 112.175 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.623 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.7 m -69.42 -51.01 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.167 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.61 ' HB2' HD11 ' A' ' 235' ' ' ILE . 40.2 m-85 -56.44 -43.58 79.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.505 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.73 -12.44 59.8 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.36 -35.79 58.51 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.67 -0.644 . . . . 0.0 110.602 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.546 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 0.2 OUTLIER -107.27 21.15 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.946 173.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.575 ' CA ' ' HB3' ' A' ' 262' ' ' SER . . . -170.64 -153.55 8.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.316 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.09 127.27 12.94 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 238' ' ' CYS . 66.8 mt -101.87 126.57 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.119 -175.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -95.3 -22.91 17.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.706 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 14.2 t -150.38 108.6 3.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.889 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.746 ' HB2' HG21 ' A' ' 235' ' ' ILE . 41.9 t -115.72 111.79 21.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.8 p -143.08 104.57 4.31 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.789 HD11 HG13 ' A' ' 225' ' ' ILE . 40.2 mt -83.93 117.3 23.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -65.35 127.48 31.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.781 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 15.5 ptt180 -110.49 153.88 24.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.964 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.11 130.05 51.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.14 -17.1 40.55 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.725 2.283 . . . . 0.0 112.377 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 48.2 m -74.34 -58.86 3.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.268 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 2.3 m -93.4 -41.22 9.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.928 0.394 . . . . 0.0 111.25 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.92 15.65 19.52 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.837 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.453 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 61.4 pttt -109.08 148.81 30.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.4 p80 -78.39 135.62 37.48 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.213 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.01 156.92 36.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.495 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.6 30.31 0.6 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 114.496 0.558 . . . . 0.0 114.496 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.62 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 39.5 p90 -153.21 173.71 15.19 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.624 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.23 176.24 46.62 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.412 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 94.0 m-85 -121.24 133.38 55.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.69 0.281 . . . . 0.0 110.415 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.657 HG23 HG23 ' A' ' 235' ' ' ILE . 55.0 mt -129.9 136.59 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.128 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -107.53 125.71 51.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.567 ' HE1' ' HA3' ' A' ' 233' ' ' GLY . 17.1 m-85 -98.73 142.79 29.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.212 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.749 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.4 pt-20 -89.01 -23.09 22.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.537 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.749 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 31.6 mmmt -116.95 129.41 56.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.611 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.68 63.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.347 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -56.29 -52.42 64.59 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.48 0.657 . . . . 0.0 110.026 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.575 ' HB3' ' CA ' ' A' ' 233' ' ' GLY . 4.0 m -68.99 -43.72 74.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.172 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 267' ' ' VAL . 10.8 t -61.41 -43.77 98.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.717 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.15 -41.96 97.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.331 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.51 -39.82 57.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.183 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.77 63.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.045 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 263' ' ' SER . 58.3 t -61.31 -26.64 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.186 0.517 . . . . 0.0 111.267 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.6 t -92.84 -36.64 12.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.167 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 3.3 p -87.83 -37.89 16.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 35.6 mmm -60.47 -29.08 68.83 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 31.8 t30 -58.57 -33.2 69.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.924 0.869 . . . . 0.0 110.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 272' ' ' LEU . 6.3 mp -78.89 -9.55 59.52 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.901 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -56.64 101.09 0.05 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.19 0.519 . . . . 0.0 110.895 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.61 112.4 18.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.189 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.61 HD21 ' CZ ' ' A' ' 273' ' ' PHE . 0.8 OUTLIER -113.3 86.2 2.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.389 171.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.71 34.95 29.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.551 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.89 0.72 74.36 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.802 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 10.9 pt20 -113.75 139.68 48.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.509 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 95.2 m-85 -89.94 126.21 35.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.369 0.604 . . . . 0.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.802 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.3 OUTLIER -55.38 165.04 0.84 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.217 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.678 ' H ' HD13 ' A' ' 280' ' ' LEU . 4.0 tpt180 -132.24 119.7 21.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.367 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.54 ' CG2' HD11 ' A' ' 211' ' ' ILE . 5.6 p -104.82 148.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.513 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.612 ' HA3' HD13 ' A' ' 168' ' ' LEU . . . -150.25 -149.1 4.93 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -139.61 152.99 47.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.576 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -95.23 129.46 42.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.46 -31.81 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.706 -171.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.409 HG22 ' OE2' ' A' ' 164' ' ' GLU . 14.9 t -115.11 135.53 22.52 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.228 0.537 . . . . 0.0 110.466 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.46 -0.443 0 C-N-CA 122.293 1.995 . . . . 0.0 110.995 173.344 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -103.57 -39.2 6.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.082 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.09 84.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.763 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 8.7 t80 -74.99 -19.01 60.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.54 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.701 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 30.8 mtpp -74.09 -45.81 46.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.4 -45.08 84.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.623 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -45.87 -51.87 12.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.917 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.807 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.9 -23.42 36.27 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -171.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.701 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 61.8 mt-30 -62.71 -40.79 98.25 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.655 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 63.7 mtt180 -70.81 -36.87 73.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.881 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.901 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.25 -43.81 96.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.301 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.29 46.3 mtt-85 -82.45 -25.15 33.85 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.282 -1.511 . . . . 0.0 113.064 172.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -54.08 -43.67 70.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.014 168.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.726 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.5 pt -69.64 -35.21 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.872 0.368 . . . . 0.0 110.429 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.56 -16.34 63.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.45 -36.06 16.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.591 ' HG2' ' HA ' ' B' ' 41' ' ' ILE . 21.6 pttp -84.54 -49.1 8.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.202 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.995 HG23 ' HB2' ' A' ' 219' ' ' ASP . 25.3 mm . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.449 0.643 . . . . 0.0 112.091 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.652 0.263 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.8 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.16 -35.91 81.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.74 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.049 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.7 pt -82.64 -35.84 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.4 mtp -69.5 -34.29 74.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.0 m -79.61 0.02 31.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -122.97 109.2 13.82 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.3 m -103.41 135.72 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.458 0.647 . . . . 0.0 111.53 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.469 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 80.2 t80 -87.41 132.88 33.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.232 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.44 111.41 36.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.073 0.463 . . . . 0.0 110.328 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -114.84 176.92 17.12 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.793 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 13.9 t 64.99 53.65 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.85 0.833 . . . . 0.0 109.434 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.9 mt -82.54 132.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.828 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 62.3 t80 -86.09 154.46 21.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.683 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -54.95 -51.59 65.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.607 0.241 . . . . 0.0 111.029 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.86 17.32 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.972 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 33.5 tp -107.73 97.56 7.27 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.486 ' HA2' ' HE1' ' A' ' 152' ' ' HIS . . . -113.26 -174.08 18.9 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.5 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.458 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 5.8 pt-20 -63.05 -23.94 67.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.956 0.408 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 7.0 m-20 -78.57 -41.62 31.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -69.48 -46.87 65.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.131 0.491 . . . . 0.0 110.546 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.5 -41.99 94.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.453 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 19.0 ptp180 -63.21 -36.3 83.19 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.691 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -72.03 -29.93 64.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.794 0.33 . . . . 0.0 111.438 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.11 56.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.431 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 85.8 m-85 -96.31 -0.13 50.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.5 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.532 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -65.64 -46.83 67.87 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.614 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.745 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 25.7 Cg_exo -65.21 -4.66 9.59 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.377 2.051 . . . . 0.0 113.121 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.675 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 3.5 m-85 -84.69 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.849 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.53 38.15 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.879 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.46 103.15 0.64 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.921 2.414 . . . . 0.0 112.231 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.6 mt -79.24 108.68 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -90.66 -23.39 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 0.0 110.302 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.866 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 32.1 t -138.81 124.77 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.191 0.519 . . . . 0.0 111.05 -177.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.9 mt -118.98 107.32 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.176 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -116.71 100.82 8.07 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.579 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 125' ' ' GLU . 61.5 mtp -122.77 123.97 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.579 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 26.2 t -108.93 111.52 23.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.771 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.443 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 6.6 p-90 -150.69 158.65 44.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.263 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.82 114.73 4.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.38 0.425 . . . . 0.0 110.169 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.7 m -79.85 -24.85 40.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.713 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.6 t -82.48 -37.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.544 HG21 ' HE3' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -107.69 -7.84 16.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.18 0.514 . . . . 0.0 110.758 -178.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.7 mtp 60.26 35.31 20.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.845 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 149' ' ' THR . 98.7 mttt -84.07 148.23 26.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.486 ' HE1' ' HA2' ' A' ' 124' ' ' GLY . 65.9 m-70 -119.73 73.52 0.97 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.68 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -128.21 11.52 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 110.481 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.64 -116.44 1.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.139 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.469 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 44.8 p90 -154.67 167.0 31.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.818 0.342 . . . . 0.0 111.108 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.439 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -146.57 134.92 21.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.52 122.6 35.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.9 t -101.96 111.02 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 37.9 mt-10 -107.05 119.56 39.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.42 0.628 . . . . 0.0 110.996 -175.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 81.2 m-85 -96.2 156.08 16.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.445 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.9 -4.63 57.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 109.325 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.74 130.99 18.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.783 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.18 -11.07 29.63 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.718 2.279 . . . . 0.0 112.808 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.42 ' OE1' HG22 ' A' ' 287' ' ' THR . 4.6 mm-40 -56.7 -64.89 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -65.91 -22.77 66.53 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.389 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.14 -50.94 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.863 0.363 . . . . 0.0 110.749 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HB3' HG21 ' A' ' 286' ' ' VAL . 1.6 tm0? -74.26 -30.87 62.32 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.9 tp -58.72 -51.47 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.075 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.55 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.724 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.78 -50.28 72.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.996 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.01 -47.18 47.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -74.64 -50.8 16.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.415 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 16.5 mmt -77.3 -26.37 52.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -170.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -73.29 -20.31 60.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.37 0.605 . . . . 0.0 110.086 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.3 m -92.73 -12.98 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.536 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 84.3 t -118.5 137.39 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.16 0.505 . . . . 0.0 111.517 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 21.5 ptp -103.47 144.73 31.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.887 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.55 32.1 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.82 104.71 1.02 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.814 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.44 -59.53 4.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.034 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.821 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -101.84 125.87 48.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.622 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -90.37 110.69 21.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.416 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.793 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 41.8 pt -69.72 157.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 0.0 111.102 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -113.92 110.3 19.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 66.1 t -112.18 117.85 56.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.409 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 110.23 176.31 20.85 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.794 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.94 151.07 3.94 Favored Pre-proline 0 C--N 1.328 -0.37 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.09 70.45 7.1 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.825 2.35 . . . . 0.0 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.8 m -69.42 -52.95 22.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.319 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 194' ' ' ALA . 65.9 t30 -142.65 56.04 1.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.339 0.59 . . . . 0.0 110.533 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.06 151.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.75 -59.56 4.44 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 190' ' ' ASN . 25.7 mt-30 -67.41 -37.63 83.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 0.0 111.549 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.428 ' HB2' ' ND2' ' A' ' 190' ' ' ASN . . . -95.46 -1.56 50.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.348 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.533 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.0 tp60 -61.36 -50.1 84.77 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 16.6 Cg_endo -57.45 -23.98 58.64 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.126 1.884 . . . . 0.0 112.316 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 49.8 mm -76.8 -45.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.87 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.48 -47.88 90.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.846 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.39 -37.57 78.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.764 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.47 -53.71 47.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.435 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 202' ' ' ALA . 2.3 pp -71.23 -32.8 69.21 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.652 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.543 ' N ' HD12 ' A' ' 201' ' ' LEU . . . -72.99 -43.88 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 206' ' ' ARG . 8.9 mm-40 -75.05 -29.25 60.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.619 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.36 -31.95 73.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.08 -17.47 64.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.286 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 203' ' ' GLU . 15.9 mmt180 -63.62 -31.08 72.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.818 0.342 . . . . 0.0 110.427 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.57 63.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.53 . . . . 0.0 110.757 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -96.69 -5.27 39.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 p30 35.25 40.86 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.011 1.445 . . . . 0.0 113.444 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.86 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 13.7 ptt180 -109.53 139.39 44.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.23 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.37 161.64 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.51 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -109.42 108.74 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.543 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.22 117.13 52.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.514 0.673 . . . . 0.0 110.78 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.1 -173.58 2.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.312 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.745 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 18.7 t 70.62 17.17 6.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.716 0.635 . . . . 0.0 110.239 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.676 HG11 HD21 ' A' ' 240' ' ' LEU . 93.4 t -67.32 136.44 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.59 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.506 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 11.1 t-80 -67.74 138.32 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -21.51 66.75 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -167.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.581 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -82.05 -47.66 12.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.315 0.507 . . . . 0.0 111.602 173.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.803 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.3 OUTLIER -56.43 116.04 2.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.097 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t -101.03 -176.78 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.473 -0.142 . . . . 0.0 111.196 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.11 -36.56 70.78 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.562 0.22 . . . . 0.0 111.365 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.6 -41.0 96.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.187 0.518 . . . . 0.0 110.294 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.452 ' HB3' ' HG ' ' A' ' 220' ' ' LEU . 3.9 m-20 -66.06 -57.53 7.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.113 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.68 HD13 HD23 ' A' ' 220' ' ' LEU . 36.6 mm -57.45 -25.26 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -57.84 -32.26 67.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.495 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 74.4 m -49.87 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.792 0.806 . . . . 0.0 111.705 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.697 HG12 ' HB1' ' B' ' 34' ' ' ALA . 5.4 m -73.18 -39.58 56.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.735 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -67.51 -41.03 85.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.73 0.3 . . . . 0.0 111.354 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -76.72 -18.81 58.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.126 0.488 . . . . 0.0 111.222 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.27 -31.13 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.654 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.2 m-30 -86.16 -30.57 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.87 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.61 179.74 34.99 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.989 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -77.53 113.18 15.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.108 0.48 . . . . 0.0 111.11 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.77 146.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.118 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.507 ' HE2' ' HB3' ' A' ' 256' ' ' GLU . 34.2 ttpt -106.35 -49.56 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.1 p -153.26 146.32 24.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 46.5 t -126.71 123.42 37.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.885 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.5 p -136.3 104.01 5.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.676 HD21 HG11 ' A' ' 216' ' ' VAL . 10.8 tp -96.86 114.84 26.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.75 136.47 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.619 174.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.75 124.38 81.78 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.404 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -68.79 -18.43 41.75 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.0 113.418 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 m -92.65 -52.95 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.752 0.311 . . . . 0.0 110.995 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.4 m -74.22 -27.5 60.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.462 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.61 21.45 64.04 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.593 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.31 146.93 49.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.3 OUTLIER -82.51 139.86 33.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.592 178.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -79.52 151.76 30.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.45 32.79 1.37 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.764 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -153.51 157.62 40.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.052 0.426 . . . . 0.0 109.915 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.635 ' HA3' HD12 ' A' ' 240' ' ' LEU . . . -164.77 178.37 39.95 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.52 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -118.94 131.52 56.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.2 129.2 72.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.86 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 54.6 mt-10 -109.07 141.93 40.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.005 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -106.78 161.08 14.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 0.0 112.005 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.58 -17.2 30.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.576 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 45.7 mtpt -133.75 133.33 41.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.759 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.15 68.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.629 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -61.67 -46.78 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.428 174.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 45.7 m -64.93 -36.99 86.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.525 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -61.67 -41.4 97.5 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -73.97 -34.39 64.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.195 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.57 -35.13 46.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.109 0.481 . . . . 0.0 111.084 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.5 61.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 282' ' ' VAL . 11.0 p -54.59 -39.45 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.7 p -82.13 -25.31 34.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 4.5 m -96.42 -25.81 15.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.984 0.421 . . . . 0.0 111.632 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.693 ' HB3' HG21 ' A' ' 282' ' ' VAL . 26.9 mmm -73.65 -10.46 59.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -173.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 27.8 t-20 -62.05 -32.29 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.029 0.918 . . . . 0.0 110.616 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.4 mm? -76.73 -8.57 57.54 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.364 -172.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.878 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.2 t80 -65.15 105.9 1.18 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.171 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.2 t70 -94.97 121.51 36.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.826 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.803 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.8 mm? -116.32 85.91 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.348 173.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.53 29.98 34.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.475 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.1 12.35 27.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 13.5 pt20 -138.46 130.71 28.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.887 0.375 . . . . 0.0 110.34 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.638 ' HB2' HH21 ' A' ' 281' ' ' ARG . 63.8 m-85 -89.99 131.62 35.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.342 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 275' ' ' LEU . 17.4 mt -60.97 177.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.909 0.861 . . . . 0.0 111.57 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.638 HH21 ' HB2' ' A' ' 279' ' ' TYR . 4.2 mmt180 -140.41 111.48 7.07 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' A' ' 270' ' ' MET . 48.5 t -120.06 135.02 61.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.965 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.94 -151.2 5.44 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.18 149.9 25.53 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.72 91.99 2.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 167' ' ' GLN . 33.8 t -55.57 -46.76 79.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.704 -171.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.42 HG22 ' OE1' ' A' ' 164' ' ' GLU . 5.9 t -104.98 124.96 34.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.927 0.87 . . . . 0.0 112.371 -174.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.457 -0.648 0 C-N-CA 122.595 2.197 . . . . 0.0 110.778 167.488 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.638 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 62.5 t30 . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -73.93 0.31 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.3 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.935 0.398 . . . . 0.0 111.743 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 16.7 t80 -67.12 -20.02 65.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.308 0.575 . . . . 0.0 110.644 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.638 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 92.4 mttt -77.77 -43.37 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.57 -39.04 75.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.697 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -51.58 -50.02 60.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.539 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.802 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -81.18 -21.67 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.638 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 50.9 mt-30 -61.83 -42.14 98.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.495 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 73.7 mtp180 -72.06 -31.86 66.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.53 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.878 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -68.11 -44.69 75.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.255 6.3 mtm180 -82.94 -26.33 31.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.294 -1.504 . . . . 0.0 113.022 171.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -57.32 -42.55 82.08 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.056 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.695 HD11 ' HZ ' ' A' ' 273' ' ' PHE . 9.8 pt -64.3 -42.72 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.23 -24.67 66.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 111.519 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 -29.38 21.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.832 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -92.13 -33.8 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.581 HG23 ' HB2' ' A' ' 219' ' ' ASP . 79.9 mt . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.35 -28.87 70.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.88 -34.78 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.912 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.23 75.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.426 . . . . 0.0 111.22 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.39 -36.32 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.366 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 27.8 ttt -65.6 -26.67 67.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.875 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.9 m -82.17 4.34 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.541 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 19.5 ptt180 -135.57 134.61 39.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.975 0.417 . . . . 0.0 110.717 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.1 m -110.8 135.6 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.355 0.598 . . . . 0.0 111.522 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 71.0 t80 -78.83 124.47 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.209 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.53 112.06 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.023 0.439 . . . . 0.0 110.155 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.21 170.28 14.04 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.686 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.675 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 50.6 m 67.63 66.74 0.38 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.615 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.49 -19.84 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.136 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 66.8 t80 65.67 -73.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.286 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 53.4 t80 167.09 -43.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.291 0.636 . . . . 0.0 109.409 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.442 ' H ' ' HD2' ' A' ' 120' ' ' TYR . 28.1 tt0 -83.24 6.08 20.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.212 -173.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.8 mt -110.57 100.06 8.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.31 34.82 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.772 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.49 -41.42 94.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.35 -48.38 71.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.238 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -62.18 -53.85 49.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.09 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.75 -46.21 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.298 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -55.5 -48.95 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.494 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -78.27 -29.69 48.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.14 73.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.772 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.541 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 84.9 m-85 -97.71 7.08 47.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.464 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.07 -43.35 35.3 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.607 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 24.2 Cg_exo -65.16 -3.86 8.07 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.249 1.966 . . . . 0.0 112.915 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.705 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 21.8 m-85 -91.06 -63.96 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.683 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.63 175.2 34.28 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 162' ' ' VAL . 21.1 Cg_exo -65.09 123.1 11.07 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.429 2.086 . . . . 0.0 111.724 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.74 123.17 22.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.163 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -87.04 -56.4 3.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.004 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.9 m -162.29 149.35 13.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.53 106.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.83 110.6 23.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 22.9 ptm -137.26 149.44 47.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.043 0.449 . . . . 0.0 111.136 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.3 m -80.25 121.93 26.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.804 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 42.9 m95 -99.95 114.48 27.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.198 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.843 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 2.5 m-20 -69.79 89.82 0.58 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.266 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t 62.5 -163.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.864 0.728 . . . . 0.0 111.586 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.73 -18.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.482 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.491 ' HB ' ' HE2' ' A' ' 151' ' ' LYS . 21.2 p -66.71 11.45 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.731 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 19.8 mmt 59.09 32.13 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.041 0.537 . . . . 0.0 112.305 172.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.843 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 71.0 mmtt -79.22 -49.7 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.934 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p80 40.91 58.15 2.55 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.889 0.743 . . . . 0.0 112.352 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -104.18 94.28 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.288 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.23 -101.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.972 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -147.51 165.95 28.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.742 0.306 . . . . 0.0 110.714 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.47 146.38 33.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.717 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.04 111.71 24.31 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.5 106.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.046 0.45 . . . . 0.0 110.27 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.541 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 45.8 mt-10 -91.62 131.46 37.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.541 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 23.3 m-85 -102.01 147.62 26.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.424 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -75.17 -14.55 60.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.723 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.591 HG22 ' HD2' ' A' ' 137' ' ' PRO . 19.6 m -136.89 130.24 17.55 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.083 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.29 -19.93 68.54 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.169 2.579 . . . . 0.0 113.231 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.73 -65.15 0.64 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.48 -27.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.824 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.55 69.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.688 0.28 . . . . 0.0 111.14 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HB3' HG21 ' A' ' 286' ' ' VAL . 19.5 tt0 -74.54 -36.91 63.13 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.347 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.637 HD22 ' CD2' ' A' ' 212' ' ' TYR . 12.5 tp -55.75 -49.84 72.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.98 96.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.531 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.7 -54.02 45.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.176 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.54 -45.37 81.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.781 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -77.94 -46.04 22.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 23.1 mmt -73.24 -22.98 60.29 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.591 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.01 -23.55 55.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.312 0.577 . . . . 0.0 109.642 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 55.1 m -84.92 -30.66 24.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.458 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.68 130.65 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.1 0.476 . . . . 0.0 111.412 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.55 ' HB2' ' O ' ' A' ' 181' ' ' ARG . 25.7 ptt? -78.8 130.97 36.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.873 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 178' ' ' LEU . 3.5 pp -85.84 139.97 30.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.808 0.337 . . . . 0.0 111.138 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.2 -40.07 1.46 Allowed Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.345 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.38 2.62 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 177' ' ' MET . 30.6 mmt180 -98.13 126.42 43.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -74.85 67.84 1.68 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.665 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.675 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 38.1 pt -66.29 154.67 7.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -116.14 109.05 16.94 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 55.5 t -112.82 109.77 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.264 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.0 141.35 8.07 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.414 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 15.8 mtp180 -129.95 137.05 30.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 2.7 Cg_exo -76.4 48.12 2.26 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 111.335 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 p -81.25 -45.63 15.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.901 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -92.79 35.78 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.496 0.665 . . . . 0.0 109.781 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt -65.99 136.4 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.858 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 89.61 -35.22 3.79 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.104 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -83.2 -42.74 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.023 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.37 -18.6 41.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mp0 -57.67 -51.89 78.36 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 14.5 Cg_endo -57.02 -30.41 86.57 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.193 1.929 . . . . 0.0 112.472 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mm -75.15 -50.81 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.401 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.28 -43.79 95.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.801 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.68 -42.72 71.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.712 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -60.4 -52.95 63.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 287' ' ' THR . 91.1 mt -64.96 -46.38 81.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.077 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.96 94.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.886 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.16 -35.09 68.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.88 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.24 -38.13 78.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.418 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.32 -27.99 69.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -21.74 66.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.188 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.87 -13.1 51.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.973 0.416 . . . . 0.0 111.321 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.74 -17.78 20.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.402 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 65.82 15.0 9.87 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.618 0.574 . . . . 0.0 111.919 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 256' ' ' GLU . 82.1 mtp180 -105.44 135.67 46.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.048 0.452 . . . . 0.0 110.679 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.462 HD11 ' CE1' ' A' ' 229' ' ' PHE . 30.6 pt -117.67 169.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.103 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.637 ' CD2' HD22 ' A' ' 168' ' ' LEU . 44.1 t80 -118.74 118.61 32.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.584 HG23 HG22 ' A' ' 282' ' ' VAL . 2.3 p -116.3 122.45 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.719 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.705 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.06 -179.84 4.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.98 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.607 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 24.7 m 68.07 29.08 6.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.276 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.814 HG13 HD11 ' A' ' 225' ' ' ILE . 73.6 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.319 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -63.25 123.15 17.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.69 -37.37 18.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -167.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.56 -45.75 43.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.616 0.245 . . . . 0.0 111.092 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.834 HD11 HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -58.5 116.43 3.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.6 m -99.88 -178.31 3.82 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.73 -44.42 77.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.651 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.44 -32.79 69.04 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.402 0.62 . . . . 0.0 110.185 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.518 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 57.1 m-20 -73.33 -55.91 5.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.645 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.814 HD11 HG13 ' A' ' 216' ' ' VAL . 33.8 mm -54.57 -29.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.103 0.478 . . . . 0.0 111.565 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.489 ' HG3' HD12 ' A' ' 235' ' ' ILE . 62.3 tttm -53.93 -32.53 53.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.94 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.573 ' HB3' ' HG2' ' B' ' 37' ' ' ARG . 68.0 m -48.99 -61.37 2.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.737 0.779 . . . . 0.0 112.826 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.695 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.0 m -70.67 -46.32 69.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.73 -169.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 57.6 m-85 -57.96 -43.93 86.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.687 0.279 . . . . 0.0 111.151 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.7 tt0 -70.9 -24.3 62.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.266 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.08 -21.09 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.372 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.692 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.6 OUTLIER -93.22 -43.75 8.67 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.59 153.69 25.04 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.07 137.94 51.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.487 0.643 . . . . 0.0 111.669 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 229' ' ' PHE . 60.6 mt -95.68 147.51 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.527 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 236' ' ' LYS . 9.7 mmmm -80.02 -64.3 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.429 171.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 35.5 t -150.42 147.67 27.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.495 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.95 129.42 52.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.424 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.2 t -142.48 125.31 16.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.172 0.51 . . . . 0.0 111.019 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.447 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 8.4 mp -110.19 130.2 55.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.587 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.68 145.92 50.79 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.509 0.671 . . . . 0.0 111.012 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.749 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -122.75 150.19 43.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.553 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -117.04 106.51 47.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.678 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.67 -25.15 34.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.489 2.126 . . . . 0.0 112.094 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.9 m -63.24 -48.29 78.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.355 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -83.65 -30.14 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.677 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.68 6.12 53.01 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.975 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -137.13 177.43 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -82.78 154.04 24.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 110.416 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.7 155.71 21.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.36 43.05 2.83 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.833 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -156.26 157.51 35.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.97 0.385 . . . . 0.0 110.083 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -168.42 -172.95 35.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.583 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -119.31 132.81 55.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.732 0.301 . . . . 0.0 110.501 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.2 mm -111.81 126.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 210' ' ' ARG . 35.6 tt0 -103.72 120.89 41.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -94.23 142.86 26.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.532 0.682 . . . . 0.0 111.754 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.9 -26.25 66.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.179 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.474 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 34.4 mtpt -124.95 136.31 53.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.77 -18.55 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -68.8 -44.52 73.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.549 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 65.3 m -67.91 -21.02 65.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.696 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 m -59.03 -39.42 81.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.026 0.441 . . . . 0.0 110.262 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -75.33 -35.17 61.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.497 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.17 -34.79 76.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.124 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.53 -47.63 22.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.675 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.551 HG12 HG12 ' A' ' 282' ' ' VAL . 31.1 m -59.44 -35.01 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -169.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.2 p -80.04 -9.47 59.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.2 m -113.81 -35.99 4.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.919 0.39 . . . . 0.0 111.694 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.695 ' HE2' ' HB2' ' A' ' 273' ' ' PHE . 0.6 OUTLIER -72.31 -16.02 61.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -170.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.4 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 8.4 t30 -60.81 -30.14 69.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.749 0.785 . . . . 0.0 110.402 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 272' ' ' LEU . 7.9 mp -76.83 -9.47 58.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.603 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.849 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -54.85 109.17 0.48 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 0.2 OUTLIER -113.82 130.31 56.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 -178.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.676 ' HG ' HD22 ' A' ' 220' ' ' LEU . 3.2 mm? -116.08 87.02 2.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.537 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.85 3.47 73.75 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.064 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 134.43 -31.51 2.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.417 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 17.3 pt20 -84.06 129.25 34.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.171 0.486 . . . . 0.0 110.772 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -89.41 139.83 30.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.732 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 273' ' ' PHE . 9.2 mp -76.78 -173.17 2.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 0.0 111.568 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 281' ' ' ARG . 39.2 mmt180 -144.66 112.43 6.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.573 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.584 HG22 HG23 ' A' ' 213' ' ' VAL . 46.7 t -125.83 134.32 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.628 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.2 -153.61 6.33 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.768 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -85.11 165.82 17.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.088 0.444 . . . . 0.0 110.151 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -76.15 -7.49 54.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.998 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 167' ' ' GLN . 64.3 t 71.22 -64.49 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.119 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 201' ' ' LEU . 8.4 t -111.29 148.97 39.86 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo . . . . . 0 C--N 1.346 0.437 0 C-N-CA 122.835 2.357 . . . . 0.0 111.433 173.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.966 0.412 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.39 -38.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -62.1 -35.6 79.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.625 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.623 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 9.1 t80 -74.51 -19.44 60.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.321 0.582 . . . . 0.0 110.032 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.665 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 94.6 mttt -72.84 -45.48 58.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.731 ' HA ' HE21 ' B' ' 36' ' ' GLN . 22.5 t70 -56.28 -44.38 79.75 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.002 0.906 . . . . 0.0 108.744 174.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.695 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -48.23 -54.03 14.97 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.011 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -83.11 -23.42 33.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -168.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.731 HE21 ' HA ' ' B' ' 33' ' ' ASP . 30.3 mt-30 -55.24 -44.27 75.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.573 ' HG2' ' HB3' ' A' ' 227' ' ' SER . 25.2 ttm105 -74.39 -31.62 62.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.662 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.849 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.76 -46.2 83.14 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.251 11.7 mtp180 -81.18 -25.03 37.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.638 -1.289 . . . . 0.0 112.387 174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 19.8 tp60 -51.25 -47.28 62.45 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 165.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.834 HG13 HD11 ' A' ' 220' ' ' LEU . 4.6 pt -72.26 -28.42 29.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.844 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.507 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -65.76 -31.89 73.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.907 0.384 . . . . 0.0 111.076 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.41 -25.22 29.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.269 0.557 . . . . 0.0 110.492 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' B' ' 44' ' ' LYS . 4.8 tmmt? -82.1 -63.77 1.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.089 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.235 0.319 0 CA-C-O 121.104 0.478 . . . . 0.0 111.788 179.571 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.548 0.213 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.16 73.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.392 . . . . 0.0 110.479 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.11 -39.12 86.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.65 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.13 72.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.909 0.385 . . . . 0.0 111.511 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.6 mt -83.9 -48.31 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.7 -35.29 80.08 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 80.4 m -83.18 2.64 34.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.53 0.205 . . . . 0.0 111.398 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.825 ' HB2' ' HG3' ' A' ' 159' ' ' GLU . 8.5 ttp180 -113.82 112.39 23.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.984 0.421 . . . . 0.0 111.237 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.39 150.89 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.337 0.589 . . . . 0.0 111.067 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.8 t80 -102.84 115.05 29.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.098 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.03 111.82 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.19 167.0 12.37 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.085 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 45.0 m 68.73 47.57 0.83 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.277 0.561 . . . . 0.0 110.991 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 79.1 mt -66.19 115.97 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.119 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -61.87 -78.85 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.339 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -175.61 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.27 -23.99 67.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.688 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.01 98.6 5.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.134 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.55 -175.15 37.09 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.731 ' HB2' ' HE1' ' A' ' 145' ' ' TRP . 40.4 tt0 -62.81 -41.32 99.25 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.98 -39.47 87.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.519 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -64.75 -46.08 83.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.96 -48.43 88.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.308 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ppt_? -66.87 -33.93 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.465 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -72.16 -35.7 69.11 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.737 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.84 97.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.878 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.422 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 81.5 m-85 -97.07 11.29 36.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.266 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.583 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -65.98 -46.02 63.92 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.291 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 1.021 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 27.7 Cg_endo -63.13 -14.88 44.46 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.056 1.837 . . . . 0.0 112.881 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.431 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 5.0 m-85 -76.07 -66.42 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.18 156.13 26.51 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.16 131.46 46.47 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.532 2.155 . . . . 0.0 111.665 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -72.32 117.3 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -90.13 -39.51 12.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.544 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.4 t -160.04 139.3 10.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.756 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.64 121.08 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.75 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.27 96.73 5.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.647 ' HG3' ' HB2' ' A' ' 156' ' ' ALA . 27.9 ttt -107.49 145.13 33.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.515 -175.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -78.12 80.61 4.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 0.0 109.863 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HE1' ' HB2' ' A' ' 125' ' ' GLU . 6.6 m95 -92.49 133.13 36.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.094 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -94.29 111.9 23.66 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.4 m -75.45 3.26 9.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.193 0.521 . . . . 0.0 110.548 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.13 -54.57 8.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.067 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.581 ' HB ' ' HG3' ' A' ' 151' ' ' LYS . 1.5 m -119.55 -15.01 9.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.62 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.5 mtp 67.11 32.77 5.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.721 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.581 ' HG3' ' HB ' ' A' ' 149' ' ' THR . 17.8 mtpp -97.16 -14.8 21.24 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.2 p80 44.19 47.04 7.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.74 0.816 . . . . 0.0 112.579 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.69 102.56 15.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.093 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 171.39 -112.83 0.47 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.75 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -142.0 172.93 12.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.858 0.361 . . . . 0.0 111.349 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.647 ' HB2' ' HG3' ' A' ' 143' ' ' MET . . . -151.67 150.58 30.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.707 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.22 131.7 56.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 58.6 t -128.32 115.78 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.854 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.825 ' HG3' ' HB2' ' A' ' 113' ' ' ARG . 1.8 mp0 -92.31 132.62 36.56 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.948 173.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -101.92 169.0 9.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.939 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.94 -48.83 80.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.478 0.656 . . . . 0.0 110.3 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.516 ' HB ' ' HG2' ' A' ' 164' ' ' GLU . 16.0 m -119.75 147.19 43.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.99 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.07 -16.52 44.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.754 2.303 . . . . 0.0 111.129 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.516 ' HG2' ' HB ' ' A' ' 162' ' ' VAL . 1.0 OUTLIER -63.21 -47.12 83.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.879 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.503 ' H ' HG23 ' A' ' 162' ' ' VAL . . . -62.05 -39.23 91.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.063 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.37 86.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.844 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -59.67 -45.33 92.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 13.1 mt -73.0 -35.16 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.983 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.64 85.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.552 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 2.9 tt -77.15 -63.09 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.081 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -63.57 -47.31 82.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -171.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.672 ' HB3' ' HD3' ' A' ' 281' ' ' ARG . 80.7 mm-40 -84.74 -0.72 54.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -171.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.63 ' HB3' HG21 ' A' ' 185' ' ' VAL . 42.6 tpp -119.95 -33.79 3.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.32 -24.82 63.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.233 0.54 . . . . 0.0 110.48 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.2 m -84.37 -0.97 54.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.416 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.54 177.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.362 . . . . 0.0 110.758 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 82.2 mtp -118.01 126.04 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.171 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.52 85.49 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 110.072 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.08 -135.22 12.86 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.908 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.53 77.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.922 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -130.17 154.93 47.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.872 0.368 . . . . 0.0 110.748 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.555 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 24.3 p-10 -100.91 108.76 20.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.506 0.669 . . . . 0.0 110.397 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 45.3 pt -75.57 148.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 184' ' ' LYS . 24.0 tptp -102.24 109.38 21.04 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.135 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 173' ' ' MET . 15.8 m -104.64 127.03 59.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.991 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.552 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 85.75 135.6 3.77 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.285 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -153.34 91.16 3.37 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 81.11 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.201 2.6 . . . . 0.0 112.568 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.6 m -81.7 -17.45 47.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.48 53.5 2.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.065 0.459 . . . . 0.0 110.802 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.69 124.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.522 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.76 -24.71 4.32 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.558 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 13.5 mm-40 -83.68 -47.64 11.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 111.399 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.35 -20.9 27.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.677 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 27.2 mm-40 -57.98 -55.21 47.56 Favored Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 200' ' ' GLN . 19.3 Cg_endo -58.75 -30.97 94.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.109 1.873 . . . . 0.0 112.539 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.0 mm -70.61 -52.43 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.009 0.433 . . . . 0.0 110.178 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.28 -33.54 64.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.963 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.78 -49.46 77.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.597 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 47.1 mt-30 -65.17 -34.85 79.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.118 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.21 -49.81 68.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.477 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -64.67 -29.74 70.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.31 -52.1 66.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.965 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.41 -28.59 59.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.897 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.09 69.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.923 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 14.4 mtm180 -67.23 -20.35 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 0.0 110.96 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -24.27 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.18 0.514 . . . . 0.0 110.639 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -102.1 -29.13 11.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 52.13 79.14 0.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.839 0.712 . . . . 0.0 111.258 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.682 ' HB2' ' HB3' ' A' ' 285' ' ' ALA . 39.5 mtm180 -125.18 142.35 51.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.047 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.717 HD13 ' HE1' ' A' ' 229' ' ' PHE . 13.5 tt -108.82 142.95 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 282' ' ' VAL . 79.4 t80 -108.44 123.19 48.48 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.799 0.333 . . . . 0.0 110.171 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.527 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.3 p -119.04 122.73 70.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.511 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -123.05 179.6 4.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.191 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 1.021 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 20.0 m 65.29 26.79 12.16 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.799 0.687 . . . . 0.0 110.948 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.43 HG22 ' C ' ' A' ' 251' ' ' GLY . 8.1 m -72.46 145.21 12.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.157 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.442 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 13.4 t-80 -68.4 130.33 42.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.38 -18.47 64.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -164.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.442 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 0.6 OUTLIER -78.27 -44.08 26.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.169 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.693 HD23 HD13 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -52.8 114.37 1.39 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.818 172.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.2 m -98.79 -177.5 3.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 11.0 p-10 -54.36 -41.29 68.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -70.63 -28.93 65.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.76 0.314 . . . . 0.0 110.684 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.572 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 4.8 m-20 -67.54 -55.79 12.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.693 HD13 HD23 ' A' ' 220' ' ' LEU . 30.8 mm -57.38 -27.28 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.11 0.481 . . . . 0.0 110.816 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.514 ' HG3' HD13 ' A' ' 235' ' ' ILE . 87.7 tttt -56.94 -32.85 66.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.292 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.664 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 57.9 m -48.33 -60.22 2.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.936 0.874 . . . . 0.0 112.092 -176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.721 ' HB ' ' CE ' ' A' ' 270' ' ' MET . 2.8 m -72.14 -36.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.731 -170.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.717 ' HE1' HD13 ' A' ' 211' ' ' ILE . 71.3 m-85 -70.79 -37.13 73.29 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.259 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.472 ' OE1' ' HE2' ' A' ' 226' ' ' LYS . 8.5 tt0 -77.27 -21.09 54.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.737 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.84 -18.7 53.59 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.49 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.676 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 3.8 m-30 -87.77 -38.21 15.95 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.521 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.75 -156.97 8.25 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.569 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 234' ' ' LYS . 32.3 mmtp -94.54 128.59 41.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.514 HD13 ' HG3' ' A' ' 226' ' ' LYS . 20.6 tt -104.1 135.68 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.286 -171.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 256' ' ' GLU . 23.5 tptp -91.08 -52.42 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.81 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 69.3 m -149.95 124.74 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.846 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 3.8 p -100.54 68.13 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.38 0.61 . . . . 0.0 109.739 174.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.5 p -97.8 104.35 16.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.231 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.4 mp -91.72 128.8 37.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.29 133.76 49.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.627 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -133.61 151.05 51.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.408 . . . . 0.0 110.738 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.92 118.19 70.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.258 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.75 -17.1 42.41 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.908 2.406 . . . . 0.0 113.412 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 69.7 p -86.8 -47.1 9.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.712 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.1 m -92.23 -25.67 18.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.968 0.413 . . . . 0.0 111.354 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.71 22.61 42.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.986 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.8 122.29 45.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.589 0.233 . . . . 0.0 111.122 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.5 p80 -72.79 138.2 46.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 252' ' ' TYR . 96.4 mttt -70.5 156.62 39.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.45 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.43 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.97 33.15 0.63 Allowed Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.476 0.485 . . . . 0.0 113.637 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 250' ' ' LYS . 5.7 p90 -153.24 163.79 39.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.503 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -155.11 162.63 31.04 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.008 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.74 117.14 29.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 237' ' ' SER . 2.3 mp -102.79 128.5 55.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 51.6 mt-10 -102.76 145.78 29.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -119.31 132.22 55.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.268 0.556 . . . . 0.0 111.022 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -78.18 -27.21 47.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.344 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 20.3 mtpt -112.5 123.05 49.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.157 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -61.85 -34.34 75.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.869 -176.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -61.33 -37.69 84.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.222 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.8 m -73.76 -28.83 61.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.046 0.45 . . . . 0.0 110.446 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.7 t -73.78 -22.4 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.896 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 55.3 mt-30 -74.99 -49.66 19.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.648 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.49 -33.73 41.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -171.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.28 54.01 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 111.177 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 37.4 t -71.9 -34.13 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 111.378 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.2 p -89.89 -17.93 27.1 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.777 0.322 . . . . 0.0 111.661 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 36.0 m -112.1 1.03 16.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -171.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.743 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 6.0 tpp -119.19 2.4 11.39 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -172.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -82.85 -16.86 46.0 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.184 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 9.1 mp -79.6 -9.37 59.62 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.943 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -45.93 106.05 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.341 0.4 . . . . 0.0 111.583 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.404 ' O ' HD13 ' A' ' 275' ' ' LEU . 0.7 OUTLIER -91.38 114.47 27.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.535 -178.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' B' ' 42' ' ' ALA . 2.4 mm? -119.93 86.38 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.312 169.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.23 40.25 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.834 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.84 -2.5 69.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.999 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.89 128.83 49.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 273' ' ' PHE . 86.2 m-85 -98.83 122.46 42.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.742 HD22 ' CD2' ' A' ' 273' ' ' PHE . 9.9 mp -70.55 -179.44 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.028 0.442 . . . . 0.0 110.676 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.672 ' HD3' ' HB3' ' A' ' 172' ' ' GLN . 3.6 mmp_? -136.48 128.04 28.7 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -174.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 3.1 m -122.96 151.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.456 0.646 . . . . 0.0 112.042 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.562 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -160.83 -136.71 2.06 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.352 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.83 152.43 38.4 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.579 -0.365 . . . . 0.0 110.886 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 210' ' ' ARG . . . -96.49 102.9 14.76 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -35.42 8.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.609 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 14.9 t -84.92 136.01 39.19 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.819 2.346 . . . . 0.0 112.013 177.42 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.611 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 15.2 m120 . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.92 -52.8 62.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.453 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.99 -31.33 72.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.027 0.441 . . . . 0.0 111.171 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.652 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 11.7 t80 -76.65 -21.48 55.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.224 0.535 . . . . 0.0 110.289 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 71.8 mttt -74.43 -41.0 61.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.8 t70 -58.0 -41.93 84.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.676 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.49 -49.27 55.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.341 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.87 -25.15 35.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -169.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 24.9 mt-30 -57.71 -44.93 86.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.664 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 60.6 mtt180 -68.11 -35.99 79.02 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.586 174.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.943 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.06 -49.97 72.44 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 39' ' ' ARG 0.272 13.6 mtp180 -81.44 -25.3 36.25 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.202 -1.561 . . . . 0.0 112.751 174.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -52.47 -46.7 66.65 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 110.073 168.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.847 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.6 pt -67.22 -35.51 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.498 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.554 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -65.88 -20.1 66.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.388 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.27 -42.28 12.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.8 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.847 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.1 OUTLIER -92.3 -14.48 28.77 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.436 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.2 pt . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.947 0.403 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.82 -26.74 61.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.987 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 tp -76.43 -45.76 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.056 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.35 -45.72 76.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.886 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.5 pt -64.99 -34.2 68.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.09 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 75.4 mtp -70.05 -26.39 64.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.483 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.37 -33.1 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 14.6 ptp180 -109.26 127.72 54.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 111.337 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.98 140.89 24.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.495 0.664 . . . . 0.0 110.794 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.446 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 65.6 t80 -85.12 130.56 34.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.827 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.86 112.23 38.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.547 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.27 169.71 13.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.332 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.444 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 48.2 m 57.86 50.7 10.07 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.323 0.583 . . . . 0.0 110.757 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -90.84 10.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.093 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.2 t80 64.05 11.99 6.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.618 0.723 . . . . 0.0 109.406 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.995 ' HB2' ' H ' ' A' ' 153' ' ' LYS . 55.0 p90 42.18 33.52 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.852 1.261 . . . . 0.0 113.319 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.46 -58.07 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.162 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.478 ' H ' HD12 ' A' ' 123' ' ' LEU . 7.5 mp -48.94 135.98 14.86 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.56 0.537 . . . . 0.0 112.373 -174.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.63 170.65 48.39 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.447 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.45 -39.17 77.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.603 0.361 . . . . 0.0 111.62 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.32 -27.96 69.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.315 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 48.8 m -66.66 -45.7 78.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 110.307 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.29 -40.03 81.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.984 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -53.35 -48.86 68.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.08 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 78.1 mt-30 -76.96 -30.23 55.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.636 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.39 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 110.703 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.512 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 89.5 m-85 -105.62 12.12 31.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.973 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -70.3 -44.03 18.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.843 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.612 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 14.4 Cg_exo -71.46 -4.0 14.14 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.91 1.74 . . . . 0.0 111.73 173.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.454 ' O ' ' HB1' ' A' ' 165' ' ' ALA . 54.6 m-85 -106.41 58.57 0.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.52 164.01 38.34 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.701 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.525 ' HD2' HG22 ' A' ' 162' ' ' VAL . 68.0 Cg_endo -79.49 132.47 10.04 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.81 2.34 . . . . 0.0 112.461 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.87 119.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.36 -56.21 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 0.0 110.681 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.6 m -157.53 125.26 5.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.622 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.478 HG22 ' HG3' ' A' ' 143' ' ' MET . 54.9 mt -101.22 107.17 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 173.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.55 120.06 27.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.114 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.478 ' HG3' HG22 ' A' ' 141' ' ' ILE . 82.9 mtp -139.02 131.33 28.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.87 0.366 . . . . 0.0 111.399 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.2 m -106.9 105.76 15.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.934 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 10.6 p-90 -159.49 159.86 33.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -83.74 95.53 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.928 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.404 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 10.4 p -70.64 -23.18 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.528 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.9 m -68.82 -32.71 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.454 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.8 p -109.45 -1.89 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.351 0.596 . . . . 0.0 110.71 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.934 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 74.1 mtp 61.06 36.6 18.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -106.02 137.95 43.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.73 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 11.5 m-70 -95.74 -79.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.995 ' H ' ' HB2' ' A' ' 121' ' ' TYR . 29.5 mtpt 52.22 45.88 27.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.22 -170.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -160.27 -122.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.469 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.446 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 29.7 p90 -149.53 174.03 12.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.795 -170.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.99 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.119 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -116.69 108.64 16.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.447 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.4 110.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.49 0.662 . . . . 0.0 110.542 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.4 tt0 -94.57 134.14 37.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.512 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 84.8 m-85 -102.91 161.01 14.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.426 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.54 -7.96 53.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.687 ' HB ' ' OE2' ' A' ' 164' ' ' GLU . 34.9 m -129.22 128.07 23.25 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.429 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 3.1 Cg_exo -74.83 -22.26 15.41 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.137 2.558 . . . . 0.0 114.083 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.687 ' OE2' ' HB ' ' A' ' 162' ' ' VAL . 1.2 mp0 -63.26 -57.68 9.66 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.617 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 135' ' ' PHE . . . -56.96 -29.63 63.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.627 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.23 64.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.522 ' HB3' HG21 ' A' ' 286' ' ' VAL . 23.6 tm0? -68.49 -39.93 81.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.69 -55.93 26.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.266 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.89 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.317 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.933 ' HG ' ' HA2' ' A' ' 186' ' ' GLY . 7.5 tt -54.87 -63.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.222 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.58 -36.01 15.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -70.51 -27.48 64.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.519 ' HG3' HD11 ' A' ' 183' ' ' ILE . 60.5 tpp -88.87 -27.21 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.12 -8.72 57.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.786 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.4 m -90.61 -7.94 51.43 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.188 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.16 163.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.037 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 20.0 ptp -108.93 144.03 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.117 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.41 59.83 1.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.053 0.454 . . . . 0.0 110.431 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.8 77.31 1.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.857 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.97 -51.31 4.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.586 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 2.5 mpt_? -88.35 126.79 35.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 0.0 110.818 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.2 109.32 8.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.388 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.519 HD11 ' HG3' ' A' ' 173' ' ' MET . 35.5 pt -76.86 162.04 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -119.64 114.02 21.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.001 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 170' ' ' LEU . 27.6 t -117.45 132.85 66.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.976 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.933 ' HA2' ' HG ' ' A' ' 170' ' ' LEU . . . 156.03 -136.29 4.96 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.285 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -149.03 71.57 10.23 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.375 0.607 . . . . 0.0 110.605 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.63 89.0 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.728 2.285 . . . . 0.0 112.794 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.4 m -143.71 -71.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.686 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.27 117.91 17.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.9 pt -102.04 -175.49 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.25 -55.97 4.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.191 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -67.96 -51.53 46.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.76 0.314 . . . . 0.0 111.769 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.05 6.44 36.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.677 0.275 . . . . 0.0 111.73 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.503 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.1 OUTLIER -64.9 -55.51 27.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 9.6 Cg_endo -53.13 -32.22 58.37 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.683 2.255 . . . . 0.0 112.725 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -58.01 -46.84 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.397 . . . . 0.0 110.337 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.82 -43.86 98.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.457 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.36 -44.86 93.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.46 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 32.0 mm-40 -67.11 -39.63 86.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.081 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 286' ' ' VAL . 85.7 mt -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.16 -38.2 88.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.88 -40.89 83.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.146 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.15 -40.42 96.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.215 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.13 86.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 82.9 mtp180 -68.51 -30.73 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.51 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.7 72.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -89.8 -6.06 56.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.893 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.433 HD22 ' N ' ' A' ' 209' ' ' ASN . 0.9 OUTLIER 65.73 26.67 11.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.121 178.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -105.21 136.96 43.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 111.339 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.68 169.68 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.117 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.474 ' HB2' ' HA ' ' A' ' 285' ' ' ALA . 37.5 t80 -119.79 128.18 53.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.437 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.468 HG23 HD21 ' A' ' 280' ' ' LEU . 1.5 p -119.95 118.63 57.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.14 -178.36 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.169 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.612 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 50.6 m 64.93 26.54 12.79 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.889 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.575 HG13 HD11 ' A' ' 225' ' ' ILE . 58.0 t -72.18 134.89 28.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.519 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -63.22 127.59 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -56.57 -29.64 62.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.856 -171.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.18 -45.96 24.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.516 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.644 HD22 HD11 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -75.08 116.13 15.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.014 -177.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.4 t -106.54 -176.17 3.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -166.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -48.5 -45.1 36.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.33 -34.35 64.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.862 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.44 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.6 m-20 -79.7 -56.79 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.451 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.802 HG13 HD11 ' A' ' 240' ' ' LEU . 27.1 mm -54.39 -26.25 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.835 0.454 . . . . 0.0 112.071 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -50.91 -32.43 20.63 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.77 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 67.2 m -48.93 -62.71 1.38 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.575 0.702 . . . . 0.0 112.698 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.864 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.3 m -74.72 -46.24 42.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.949 -165.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.675 ' HB2' HD11 ' A' ' 235' ' ' ILE . 71.6 m-85 -61.07 -35.89 78.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.967 0.413 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -77.38 -26.52 51.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.192 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.53 81.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.654 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.753 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.5 OUTLIER -82.67 -14.27 54.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.669 -175.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.44 -111.3 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.82 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -156.07 131.19 9.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 110.132 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' A' ' 229' ' ' PHE . 58.7 mt -86.39 127.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.472 0.653 . . . . 0.0 110.763 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -79.48 -46.07 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.736 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 5.4 p -167.0 129.34 1.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.699 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.445 ' HB3' HG23 ' A' ' 255' ' ' ILE . 20.4 p -131.2 137.76 49.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.901 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 52.8 m -154.88 120.68 5.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.898 0.38 . . . . 0.0 110.915 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.802 HD11 HG13 ' A' ' 225' ' ' ILE . 52.6 mt -83.46 130.83 35.04 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.13 121.04 11.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.254 0.55 . . . . 0.0 110.319 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 44.9 mtt180 -93.59 158.04 15.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.507 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.6 t70 -117.89 107.71 43.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.382 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.28 -24.69 57.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.015 2.477 . . . . 0.0 113.187 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.5 p -78.43 -28.36 46.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.688 0.28 . . . . 0.0 111.612 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -96.55 -33.37 11.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.899 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.3 -10.94 58.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.993 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -108.83 -92.52 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.667 -0.314 . . . . 0.0 111.115 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 25.4 p80 -170.0 162.09 9.0 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.507 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 96.0 mttt -84.17 155.82 22.38 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.61 42.03 1.47 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.559 . . . . 0.0 114.05 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.4 p90 -161.09 168.29 24.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 175.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.729 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -174.95 -177.82 44.34 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.189 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.25 137.49 54.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.772 0.32 . . . . 0.0 110.62 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 238' ' ' CYS . 56.4 mt -131.61 126.48 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.03 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.3 136.72 44.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.352 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -104.32 155.81 18.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.851 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -81.74 -19.36 41.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.689 173.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 262' ' ' SER . 28.5 mmmt -127.46 120.98 29.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.407 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.29 -22.46 65.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.875 0.369 . . . . 0.0 111.363 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.565 ' HA ' HE21 ' A' ' 264' ' ' GLN . 99.0 mt-30 -65.42 -44.02 88.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 1.9 p -71.58 -29.89 65.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.497 ' O ' HG23 ' A' ' 267' ' ' VAL . 9.1 m -56.06 -41.44 75.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.035 0.445 . . . . 0.0 110.757 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.565 HE21 ' HA ' ' A' ' 261' ' ' GLN . 47.6 mt-30 -67.2 -35.21 79.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.571 -176.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.65 -43.27 63.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -52.17 -44.63 64.72 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.549 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 263' ' ' SER . 67.0 t -61.82 -27.18 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 111.383 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.0 m -91.12 -36.4 14.01 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.193 -0.317 . . . . 0.0 111.463 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 45.3 m -92.24 -35.07 14.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.731 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 40.2 mmm -70.36 -9.23 55.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -59.99 -43.3 95.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.664 0.745 . . . . 0.0 110.649 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 8.8 mp -76.63 -8.61 57.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.709 ' CD2' HD22 ' A' ' 280' ' ' LEU . 49.0 t80 -45.41 102.09 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.523 0.514 . . . . 0.0 110.889 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.4 p-10 -94.68 128.82 41.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.489 0.662 . . . . 0.0 111.016 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.644 HD11 HD22 ' A' ' 220' ' ' LEU . 40.5 mt -124.07 87.24 2.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.759 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.63 -111.08 3.44 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -113.15 34.56 5.01 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.424 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.2 pt20 -141.23 159.86 41.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.681 0.24 . . . . 0.0 110.813 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -102.25 162.85 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.826 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 13.3 tp -91.09 -170.08 2.55 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.826 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 21.0 tpp180 -148.61 112.41 5.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 175.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 270' ' ' MET . 7.5 p -112.02 146.3 17.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.889 0.376 . . . . 0.0 110.811 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.85 -145.06 4.08 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.546 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 286' ' ' VAL . 92.4 mttt -123.08 150.7 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.653 -0.322 . . . . 0.0 110.29 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.06 -31.39 72.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.713 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 167' ' ' GLN . 62.3 t 68.58 -65.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.431 HG23 HG12 ' A' ' 286' ' ' VAL . 3.1 p -115.58 83.77 11.51 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 CA--C 1.553 1.448 0 C-N-CA 122.643 2.229 . . . . 0.0 115.828 174.922 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.714 0.292 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -154.35 -77.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.318 . . . . 0.0 111.026 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.17 -23.36 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.121 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.616 ' O ' HD22 ' B' ' 35' ' ' LEU . 12.1 t80 -72.19 -23.88 61.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.08 0.467 . . . . 0.0 110.032 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 51.5 mtpt -71.4 -39.84 70.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.28 -31.52 72.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.864 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -56.93 -55.0 40.22 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.549 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.669 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.7 OUTLIER -82.25 -24.13 34.95 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 4.7 pt20 -60.33 -37.32 80.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.166 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.426 ' O ' HG23 ' B' ' 41' ' ' ILE . 32.1 ttm180 -74.01 -31.27 62.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.775 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.738 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -71.61 -42.39 67.74 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 121.549 0.69 . . . . 0.0 112.553 -175.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 58.4 mtp180 -79.24 -25.21 42.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.88 -1.137 . . . . 0.0 111.389 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -55.87 -49.8 72.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.35 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.738 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.2 pt -65.41 -34.13 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.847 0.356 . . . . 0.0 110.352 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -68.33 -25.12 64.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.443 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.53 -45.96 34.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.229 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.717 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -86.56 -29.55 22.57 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 59.4 mt . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 122.868 0.467 . . . . 0.0 111.406 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.9 -26.1 62.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.01 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.5 tp -68.09 -36.18 79.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.28 68.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.4 mt -80.49 -47.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.535 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 52.2 mtm -66.27 -27.02 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.47 -13.41 62.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 21.9 ptt180 -127.23 119.44 26.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.815 0.341 . . . . 0.0 110.566 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.466 HG22 ' HE1' ' A' ' 160' ' ' TYR . 16.8 m -92.47 138.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.69 0.757 . . . . 0.0 111.394 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -86.36 99.49 11.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.642 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.0 t -96.74 115.6 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.155 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.527 ' CA ' ' HD1' ' A' ' 155' ' ' PHE . . . -127.69 -176.91 14.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.8 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 47.2 m 72.43 -72.26 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.582 0.753 . . . . 0.0 111.149 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.42 HD12 HD11 ' A' ' 128' ' ' ILE . 44.1 mm 68.79 158.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 123.23 0.331 . . . . 0.0 110.743 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 69.6 t80 -56.26 -64.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.376 -0.203 . . . . 0.0 110.729 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 42.2 t80 177.86 -49.77 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.104 0 O-C-N 123.456 0.473 . . . . 0.0 110.687 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' LYS . 6.0 pt-20 -136.6 45.19 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.487 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.41 134.36 46.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.925 0.393 . . . . 0.0 111.102 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.56 -177.33 50.43 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.256 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -63.79 -41.65 97.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.478 -0.361 . . . . 0.0 111.866 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -64.37 -41.32 96.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.534 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.7 m -57.06 -45.21 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 119' ' ' ILE . 65.5 mt -71.08 -45.82 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.689 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 129' ' ' ARG . 20.5 ttp180 -56.59 -47.0 80.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.571 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.55 -11.41 59.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.629 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -29.83 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.407 . . . . 0.0 110.443 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.796 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 61.7 m-85 -99.29 8.1 45.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.583 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.34 -44.0 12.91 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.583 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.596 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 29.1 Cg_endo -64.84 -4.78 9.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.843 1.695 . . . . 0.0 113.019 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 5.4 m-85 -87.25 -68.35 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.795 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.17 167.65 36.18 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.827 ' HG2' ' HB3' ' A' ' 161' ' ' GLU . 19.3 Cg_endo -60.39 126.86 21.11 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.54 2.16 . . . . 0.0 111.833 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.2 mt -87.8 128.89 39.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.367 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -80.26 -56.19 4.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -158.7 152.21 23.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.402 HG12 HG13 ' A' ' 158' ' ' VAL . 68.4 mt -124.16 107.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.89 112.61 24.61 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 43.1 ttm -134.85 118.27 16.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.204 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.4 t -91.09 115.47 28.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' CE3' ' HB2' ' A' ' 152' ' ' HIS . 1.6 p-90 -165.93 151.63 8.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.196 0.522 . . . . 0.0 111.771 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.24 99.8 1.22 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.5 t -94.2 6.53 48.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.6 p -84.75 -31.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.114 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.2 p -108.37 -17.37 14.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 111.202 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.0 mtt 63.21 41.18 8.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.143 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 33.8 mmtp -84.06 -39.93 18.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.588 ' HB2' ' CE3' ' A' ' 145' ' ' TRP . 1.6 t60 60.43 67.04 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.732 0.777 . . . . 0.0 110.357 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -96.7 64.96 2.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.664 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.25 -155.25 11.36 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.743 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.527 ' HD1' ' CA ' ' A' ' 117' ' ' GLY . 28.7 m-85 -104.99 170.46 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.961 0.41 . . . . 0.0 111.16 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.45 145.4 24.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.76 107.85 18.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.727 0.299 . . . . 0.0 110.277 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.402 HG13 HG12 ' A' ' 141' ' ' ILE . 23.3 t -98.36 111.37 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 30.1 tt0 -100.57 129.32 46.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.963 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.466 ' HE1' HG22 ' A' ' 114' ' ' VAL . 90.3 m-85 -102.01 161.34 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.384 0.611 . . . . 0.0 111.412 -176.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.827 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 10.8 tp10 -77.62 -27.07 51.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.585 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 16.1 m -126.55 119.76 23.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.665 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 162' ' ' VAL . 19.7 Cg_endo -59.91 -19.4 54.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.299 2.666 . . . . 0.0 113.002 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.43 -56.92 15.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 110.519 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -64.33 -28.96 70.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.99 -51.2 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.01 -36.62 75.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.422 HD22 ' CE2' ' A' ' 212' ' ' TYR . 22.2 tp -57.47 -45.95 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.344 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.05 93.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.185 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.32 -41.48 89.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.701 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -85.13 -32.46 22.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -91.3 -29.42 17.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.796 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 14.9 mmt -95.25 -34.23 12.28 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.111 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 9.9 t30 -70.18 -15.91 63.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 110.454 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.4 p -92.64 5.49 50.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.25 146.1 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 110.594 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.682 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 36.0 mtm -94.23 132.78 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 38.1 tp -83.52 83.77 7.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.142 0.496 . . . . 0.0 110.22 -176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.71 -36.44 3.26 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.191 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.13 -38.18 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -90.99 128.57 36.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.682 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.0 p-10 -75.48 119.09 19.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.276 0.56 . . . . 0.0 109.995 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.434 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 19.9 pt -74.97 150.95 6.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.003 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -101.48 117.58 35.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.048 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 42.9 t -122.64 106.33 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.06 175.23 18.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.049 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 38.9 mtp180 -146.7 128.19 7.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 122.459 0.303 . . . . 0.0 110.424 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.0 Cg_endo -82.19 60.69 7.51 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.059 2.506 . . . . 0.0 111.472 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.5 m -115.76 151.37 35.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.974 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.9 32.48 20.02 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.774 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.479 ' HA ' ' HB2' ' A' ' 195' ' ' GLN . 38.1 mt -79.77 73.12 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.995 0.902 . . . . 0.0 110.222 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 163.08 -36.15 0.32 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.492 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -83.56 -52.64 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.35 . . . . 0.0 110.619 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.87 -21.74 15.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.232 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.58 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 26.7 tp60 -52.74 -47.17 95.48 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.7 Cg_endo -55.15 -30.55 71.5 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.454 2.103 . . . . 0.0 113.072 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.1 -39.05 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.441 . . . . 0.0 110.067 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.9 -38.86 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.082 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.1 -40.07 92.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.75 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -63.64 -34.38 77.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.076 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.87 -45.96 22.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.657 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.79 -43.41 98.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.064 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' ' 206' ' ' ARG . 5.5 tp10 -62.72 -33.53 75.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.455 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 4.2 tp10 -70.2 -40.79 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.019 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -68.47 -28.08 66.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.466 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 88.7 mtt180 -64.25 -22.99 67.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.23 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.03 -4.01 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -111.45 -18.72 12.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.471 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.544 HD21 ' HA ' ' A' ' 260' ' ' ALA . 50.2 t-20 50.58 68.58 0.75 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.348 0.594 . . . . 0.0 110.43 -176.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -130.28 136.66 49.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.505 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.663 HD13 ' HE2' ' A' ' 229' ' ' PHE . 7.6 tt -106.54 147.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.335 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.422 ' CE2' HD22 ' A' ' 168' ' ' LEU . 86.5 t80 -108.01 122.88 47.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.42 ' CG2' HD23 ' A' ' 280' ' ' LEU . 6.5 p -122.87 124.2 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.297 0.57 . . . . 0.0 110.897 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.39 -178.19 3.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.46 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.0 m 64.77 33.61 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.768 0.668 . . . . 0.0 111.558 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.758 HG23 HD11 ' A' ' 225' ' ' ILE . 7.1 p -82.78 151.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.281 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 14.7 t-80 -68.89 136.22 52.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -57.48 -35.59 70.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -168.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.42 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 1.0 OUTLIER -79.01 -45.89 19.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 177.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.748 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -52.21 110.25 0.47 Allowed 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.78 0.675 . . . . 0.0 110.156 177.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.2 t -94.8 -178.46 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.674 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 2.3 p30 -62.81 -29.36 70.67 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.7 -41.44 73.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.339 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.518 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 52.0 m-20 -80.23 -52.35 7.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.771 -175.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.758 HD11 HG23 ' A' ' 216' ' ' VAL . 47.2 mm -56.21 -25.25 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.227 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.764 ' HG3' HD11 ' A' ' 235' ' ' ILE . 53.8 tttm -55.57 -31.9 62.58 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.47 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.55 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.0 m -51.02 -61.92 1.93 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.826 0.822 . . . . 0.0 112.019 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.561 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.1 m -68.05 -48.84 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.574 -171.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.663 ' HE2' HD13 ' A' ' 211' ' ' ILE . 52.5 m-85 -59.27 -45.22 91.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.787 0.327 . . . . 0.0 111.22 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 40.9 tt0 -73.43 -23.82 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.726 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.52 71.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.73 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.3 OUTLIER -83.73 -38.08 21.85 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -165.78 148.47 13.85 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.17 139.34 58.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.486 0.66 . . . . 0.0 111.355 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.764 HD11 ' HG3' ' A' ' 226' ' ' LYS . 31.0 pt -119.78 137.04 54.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.666 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -85.64 -68.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.407 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' ' 256' ' ' GLU . 11.6 m -94.7 108.99 20.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.336 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 4.3 p -122.12 102.1 7.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.9 m -142.64 116.25 9.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.762 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.674 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 73.6 mt -90.22 117.8 29.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 168.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 123.11 15.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.2 0.524 . . . . 0.0 110.985 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.831 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 53.5 mtt-85 -80.74 157.4 25.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.335 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.637 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 18.5 t70 -117.34 113.89 38.7 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.161 -175.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.79 -20.35 39.86 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.763 2.309 . . . . 0.0 112.336 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.7 m -64.36 -56.69 12.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.496 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 47.2 p -86.81 -35.39 19.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.509 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 106.58 -10.25 41.86 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.1 -157.93 0.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.831 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 29.6 p80 -108.35 149.42 28.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.637 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 94.1 mttt -70.7 154.23 42.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.443 ' C ' HG12 ' A' ' 216' ' ' VAL . . . -73.15 34.45 0.77 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 114.669 0.628 . . . . 0.0 114.669 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.478 ' HE2' ' HD3' ' A' ' 137' ' ' PRO . 35.5 p90 -157.07 164.81 37.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.555 0.678 . . . . 0.0 110.633 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.25 -175.41 41.01 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.312 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.4 ' C ' HD12 ' A' ' 255' ' ' ILE . 86.5 m-85 -123.41 141.58 51.85 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.4 HD12 ' C ' ' A' ' 254' ' ' PHE . 2.2 mp -124.78 135.47 63.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.973 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.496 ' HB3' ' H ' ' A' ' 237' ' ' SER . 45.6 tt0 -109.04 126.44 53.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.627 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.404 ' OH ' ' HB2' ' A' ' 266' ' ' ALA . 7.9 m-85 -98.15 144.23 27.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.182 0.515 . . . . 0.0 112.181 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.88 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 5.0 pt-20 -74.84 -31.47 61.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.88 ' HG3' ' HG3' ' A' ' 258' ' ' GLU . 24.0 mtpp -109.47 157.47 18.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.544 ' HA ' HD21 ' A' ' 209' ' ' ASN . . . -81.86 -40.89 21.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 0.0 111.254 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -64.62 -38.63 91.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.588 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 6.3 p -62.74 -34.78 77.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.567 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -39.94 86.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.964 0.411 . . . . 0.0 110.612 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.69 -39.67 70.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.775 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -46.7 86.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.404 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . . . -60.55 -52.62 64.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.469 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.22 -25.95 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.172 0.51 . . . . 0.0 111.693 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.9 m -84.3 -17.89 38.15 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.098 -0.376 . . . . 0.0 111.993 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.6 p -116.09 -34.41 4.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.51 ' HE3' ' HB2' ' A' ' 273' ' ' PHE . 39.9 mmm -65.48 -4.5 5.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -69.99 -35.28 74.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 122.167 0.984 . . . . 0.0 109.477 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.92 -8.79 58.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.369 -174.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.825 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.2 t80 -52.78 105.37 0.12 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.877 0.37 . . . . 0.0 110.653 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.3 t70 -97.95 119.2 36.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.748 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.6 mm? -117.52 86.31 2.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.995 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.5 26.1 61.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.664 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 118.21 -18.68 11.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.228 -0.986 . . . . 0.0 113.646 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.4 pt20 -106.75 131.76 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.136 0.468 . . . . 0.0 111.362 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.462 ' HB2' HH12 ' A' ' 281' ' ' ARG . 50.1 m-85 -94.31 137.95 32.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.275 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.515 HD22 ' HD2' ' A' ' 273' ' ' PHE . 11.1 mp -73.81 -173.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.304 0.573 . . . . 0.0 111.525 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.462 HH12 ' HB2' ' A' ' 279' ' ' TYR . 77.2 mmt-85 -146.89 118.09 7.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.15 146.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -154.52 -164.37 12.83 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.735 176.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -88.69 169.94 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.499 0.649 . . . . 0.0 110.186 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.91 -32.44 73.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 287' ' ' THR . 54.8 t 70.73 -70.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.954 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 286' ' ' VAL . 54.0 p -112.84 138.69 22.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 65.5 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.341 2.028 . . . . 0.0 112.058 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.691 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 51.7 t30 . . . . . 0 C--O 1.224 -0.26 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.61 -67.76 0.35 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -24.16 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.053 0.454 . . . . 0.0 111.273 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.554 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 5.2 t80 -75.14 -17.84 60.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.126 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 89.6 mttt -70.61 -45.5 65.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.52 -40.3 86.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.73 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -48.51 -53.43 18.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.326 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.823 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.22 -17.51 45.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 57.5 mt-30 -66.07 -43.85 86.23 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.55 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 74.0 mtp180 -69.38 -37.35 77.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.108 173.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -59.55 -50.65 73.06 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.269 31.1 mtp85 -81.55 -25.38 35.91 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.266 -1.521 . . . . 0.0 112.971 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -55.57 -44.89 77.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.018 169.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.821 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -66.33 -33.54 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.625 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -69.28 -24.81 64.01 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.813 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.58 -22.91 24.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.202 0.525 . . . . 0.0 110.637 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 20.1 ttpt -90.91 -41.65 11.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.58 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.419 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.3 pt . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 123.786 0.835 . . . . 0.0 112.9 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.52 -52.79 64.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.758 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.545 HD12 ' HG3' ' A' ' 163' ' ' PRO . 3.8 mm? -66.11 -36.78 84.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.88 74.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.359 . . . . 0.0 111.367 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.9 mt -82.11 -41.29 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.81 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.9 mtp -68.05 -37.01 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.059 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 79.8 m -75.91 -17.78 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.832 ' HG2' ' HB3' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.3 99.92 11.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.979 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.78 140.03 17.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.419 0.628 . . . . 0.0 111.226 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.55 ' HE2' ' HE2' ' A' ' 184' ' ' LYS . 42.6 t80 -88.94 121.34 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.406 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.472 HG22 HG13 ' A' ' 185' ' ' VAL . 52.0 t -116.53 110.98 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -130.42 101.98 0.52 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.652 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.544 ' HB3' HG22 ' A' ' 183' ' ' ILE . 8.9 t 168.45 59.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.411 HG21 ' ND1' ' A' ' 152' ' ' HIS . 12.7 mm -82.06 -17.45 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.8 -170.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 t80 66.51 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.1 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.2 t80 179.17 -53.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.69 36.05 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.52 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.56 113.45 18.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.583 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -83.18 159.85 37.77 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.236 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.1 OUTLIER -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 109.895 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 25.5 t70 -65.13 -42.12 94.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.085 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -58.75 -42.82 89.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.034 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.38 -42.72 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.511 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 129' ' ' ARG . 10.6 ttp180 -61.0 -39.78 91.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 38.3 mt-30 -76.29 -20.42 57.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.05 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.22 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.883 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.43 ' HB2' HD11 ' A' ' 138' ' ' ILE . 78.9 m-85 -94.88 8.12 43.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -66.63 -44.22 53.73 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.991 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 23.9 Cg_exo -65.86 -12.74 36.6 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 112.541 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.584 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 5.9 m-85 -80.39 -68.16 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.654 0.264 . . . . 0.0 110.964 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -149.07 169.55 29.46 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.465 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.55 ' HD2' HG22 ' A' ' 162' ' ' VAL . 15.2 Cg_exo -67.46 100.52 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.682 2.255 . . . . 0.0 111.565 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.43 HD11 ' HB2' ' A' ' 132' ' ' PHE . 64.6 mt -69.34 107.36 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -76.22 -31.83 58.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 p -173.07 128.95 0.47 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.743 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.0 tt -105.92 132.85 51.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 172.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -114.49 115.63 27.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.865 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' A' ' 125' ' ' GLU . 23.0 ttt -140.81 128.54 21.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.093 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.8 t -118.99 124.92 48.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.851 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 43.6 p-90 -163.64 159.61 21.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.615 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.87 93.25 1.68 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.872 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.454 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 48.3 t -70.86 -22.04 62.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.546 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.82 -26.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.022 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.8 p -121.36 5.73 10.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.851 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 68.5 mtp 60.8 27.35 17.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -91.08 107.57 19.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 0.0 110.608 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.411 ' ND1' HG21 ' A' ' 119' ' ' ILE . 40.8 m-70 -83.25 74.55 10.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.92 -51.14 17.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.189 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.33 172.7 54.45 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.629 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.09 170.85 7.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -104.7 129.11 52.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 0.0 110.446 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.27 108.03 17.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.27 124.12 67.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.207 0.527 . . . . 0.0 110.554 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.832 ' HB3' ' HG2' ' A' ' 113' ' ' ARG . 10.3 pt-20 -112.82 131.22 55.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.501 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.67 162.89 13.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.731 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -78.27 -15.18 59.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.664 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 17.3 m -129.44 128.98 23.19 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.545 ' HG3' HD12 ' A' ' 108' ' ' LEU . 56.2 Cg_endo -72.07 -14.61 29.04 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.009 2.473 . . . . 0.0 113.16 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.664 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 31.0 mp0 -60.74 -52.21 66.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 110.574 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -22.98 67.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.503 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.31 -50.71 36.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.794 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -39.67 94.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.447 ' CD2' ' HB3' ' A' ' 214' ' ' ALA . 15.5 tp -60.36 -49.65 76.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.846 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.96 -29.2 70.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.196 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.84 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.9 tt -61.37 -61.15 2.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.092 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.99 -39.49 23.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.704 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 17.3 mm-40 -83.14 0.19 46.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.426 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 58.2 tpp -122.38 -36.54 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.079 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.658 ' OD1' ' HA ' ' A' ' 184' ' ' LYS . 10.4 t30 -67.58 -31.09 70.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.959 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.2 m -85.16 -8.91 58.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.81 90.18 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.108 0.48 . . . . 0.0 110.211 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.6 ptm -72.52 118.12 15.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.255 0.55 . . . . 0.0 110.32 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.2 -34.24 68.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.485 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 152.29 133.41 1.94 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.553 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.98 -62.89 3.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.606 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -124.04 155.37 38.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -90.12 127.92 36.21 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.544 HG22 ' HB3' ' A' ' 118' ' ' SER . 23.4 pt -89.97 132.06 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.068 176.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.658 ' HA ' ' OD1' ' A' ' 174' ' ' ASN . 21.8 ptmt -102.15 116.94 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.368 0.604 . . . . 0.0 110.176 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 116' ' ' VAL . 62.1 t -123.51 133.5 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.227 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.84 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 106.48 -126.29 8.45 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.841 174.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 54.84 67.93 2.93 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 124.17 0.57 . . . . 0.0 111.013 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.04 -157.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.909 2.406 . . . . 0.0 111.892 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 194' ' ' ALA . 34.1 t 72.55 118.6 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.577 0.703 . . . . 0.0 110.681 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.481 ' OD1' HG13 ' A' ' 191' ' ' ILE . 25.2 t-20 -74.85 -63.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.278 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.481 HG13 ' OD1' ' A' ' 190' ' ' ASN . 55.5 mt -137.55 67.48 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.268 0.556 . . . . 0.0 110.463 175.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.01 2.07 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -58.63 -10.31 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 189' ' ' SER . . . -84.85 -30.74 24.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.044 -0.41 . . . . 0.0 111.269 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.514 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.1 tp60 -64.18 -50.16 69.66 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.6 Cg_exo -52.52 -33.57 58.44 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.117 1.878 . . . . 0.0 112.437 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.93 -44.03 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 110.094 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.88 -43.55 97.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.608 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -45.11 93.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 84.2 mm-40 -61.11 -46.22 91.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.704 HD13 HG22 ' A' ' 287' ' ' THR . 96.1 mt -71.21 -28.99 64.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.68 94.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.3 -32.45 71.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.178 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.55 -42.14 87.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.201 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.12 72.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.46 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -68.43 -19.4 64.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.82 -13.49 59.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.512 ' HB3' ' HG3' ' A' ' 210' ' ' ARG . 41.4 m-85 -103.39 -23.07 13.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.144 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 59.09 37.1 24.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.501 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 1.015 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 96.3 mtt180 -97.22 138.25 35.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.503 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.09 158.56 17.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.35 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -109.75 128.54 55.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.833 0.349 . . . . 0.0 110.621 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 4.4 p -120.78 119.23 58.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.129 0.49 . . . . 0.0 110.585 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -123.33 -177.2 3.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.558 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 8.1 t 68.0 22.49 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.055 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.504 HG13 HD11 ' A' ' 225' ' ' ILE . 84.7 t -73.23 129.68 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.018 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -63.18 130.54 45.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.81 -28.82 66.37 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -78.98 -45.87 19.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 111.398 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.662 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -61.34 110.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.638 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 62.4 m -87.14 -178.26 6.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.908 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 19.7 p-10 -66.94 -37.65 84.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.706 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.704 0.764 . . . . 0.0 109.832 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 0.9 OUTLIER -67.78 -54.62 17.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.723 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.726 HG13 HD11 ' A' ' 240' ' ' LEU . 29.4 mm -59.58 -21.28 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 111.032 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.47 ' HG3' HD12 ' A' ' 235' ' ' ILE . 88.4 tttt -59.19 -31.39 68.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.936 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.4 m -48.76 -59.79 3.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.87 0.843 . . . . 0.0 111.43 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.707 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.8 m -68.91 -52.22 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.603 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -58.38 -34.4 70.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.423 ' HA ' HG13 ' A' ' 235' ' ' ILE . 2.2 tm-20 -76.63 -34.67 58.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.026 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.39 -13.75 61.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.709 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 4.2 m-30 -90.06 -10.94 42.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.763 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 173.72 -112.49 0.42 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.583 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -146.45 120.0 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 110.609 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 226' ' ' LYS . 49.8 mt -85.6 134.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.094 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -86.46 -47.99 8.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.093 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 3.8 m -148.55 132.14 16.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.897 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 45.1 t -120.25 111.59 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.9 m -141.02 107.81 5.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.296 0.569 . . . . 0.0 112.288 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 79.4 mt -91.68 130.65 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.9 162.17 22.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.954 0.407 . . . . 0.0 110.967 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 56.3 mtp180 -123.68 158.7 30.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -107.77 95.72 15.24 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.94 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.32 -23.42 32.82 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 113.136 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -29.35 55.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.634 ' HB ' ' HE2' ' A' ' 248' ' ' LYS . 1.2 m -114.32 -19.33 11.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 111.509 178.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.63 43.18 5.55 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.877 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.634 ' HE2' ' HB ' ' A' ' 246' ' ' THR . 47.1 mtmt -125.8 -178.51 4.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.755 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -113.18 131.61 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 170.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -65.58 136.44 56.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.62 29.83 1.04 Allowed Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.359 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.6 p90 -154.15 158.46 40.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.681 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.62 -171.42 38.8 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.114 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.488 ' CZ ' ' HG2' ' A' ' 164' ' ' GLU . 98.4 m-85 -127.65 133.32 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.936 0.398 . . . . 0.0 110.95 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.07 132.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 1.015 ' HG2' ' HG2' ' A' ' 210' ' ' ARG . 39.7 mt-10 -104.31 144.52 31.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.048 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -120.11 141.44 49.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.225 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.451 ' C ' ' HE3' ' A' ' 259' ' ' LYS . 6.8 pt-20 -81.92 -33.03 30.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.706 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.451 ' HE3' ' C ' ' A' ' 258' ' ' GLU . 0.1 OUTLIER -97.95 113.22 25.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.094 173.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.32 68.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.047 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.65 -35.68 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.2 m -68.37 -25.85 65.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 267' ' ' VAL . 6.9 m -62.42 -30.8 71.48 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.84 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.04 -43.66 57.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.896 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -52.94 -45.52 67.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.349 0.405 . . . . 0.0 110.551 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.524 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . . . -60.56 -42.22 96.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.648 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 263' ' ' SER . 98.2 t -64.46 -39.39 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.716 -176.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.1 p -86.45 -1.0 57.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -115.63 -45.4 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.89 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 0.0 OUTLIER -64.45 -20.61 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -60.02 -38.27 82.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.744 0.783 . . . . 0.0 110.4 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -78.06 -9.86 59.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.871 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -46.92 106.96 0.09 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.961 0.41 . . . . 0.0 111.494 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.6 108.89 15.54 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.627 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.662 ' HG ' HD22 ' A' ' 220' ' ' LEU . 1.1 mm? -114.7 86.85 2.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.62 -116.83 4.42 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -110.46 23.59 19.91 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.076 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 9.9 pt20 -125.13 151.55 45.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 0.0 111.222 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -107.27 137.84 44.58 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.79 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 4.5 tp -69.05 -176.39 0.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.282 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.704 ' HD2' ' HB3' ' A' ' 172' ' ' GLN . 73.2 mmt-85 -141.51 113.26 7.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.832 0.348 . . . . 0.0 110.388 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 270' ' ' MET . 12.3 p -115.19 146.55 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.985 0.422 . . . . 0.0 110.997 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.91 -159.44 9.37 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -108.31 171.64 7.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 117.18 0.49 . . . . 0.0 110.249 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -62.48 -40.59 97.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.609 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.3 t 70.97 -67.05 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.487 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.704 HG22 HD13 ' A' ' 201' ' ' LEU . 0.5 OUTLIER -108.89 160.97 25.38 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.513 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.452 -0.945 0 C-N-CA 123.152 2.568 . . . . 0.0 111.774 173.544 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.476 ' O ' ' HD3' ' B' ' 32' ' ' LYS . 6.4 t30 . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.02 -51.47 3.84 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.904 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.587 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -58.29 -45.76 87.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.009 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.709 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 23.8 t80 -76.36 -20.47 57.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.125 0.488 . . . . 0.0 110.947 -175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' B' ' 28' ' ' ASN . 0.2 OUTLIER -82.75 -35.45 26.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.101 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 9.7 t70 -57.97 -46.3 85.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 168.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.707 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -48.46 -46.74 38.36 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.996 176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.799 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.2 -21.68 39.41 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.1 -41.67 97.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.693 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 54.5 mtt180 -68.83 -36.86 78.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.898 173.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.871 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.0 -42.47 97.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.074 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' B' ' 42' ' ' ALA 0.253 2.7 mtt180 -81.15 -25.99 36.44 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.706 173.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -54.84 -44.34 73.85 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.34 0.59 . . . . 0.0 110.097 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.742 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.5 pt -68.74 -32.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 CA-C-O 121.207 0.527 . . . . 0.0 109.958 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' B' ' 39' ' ' ARG . . . -75.2 -4.59 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.036 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.89 -37.67 15.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.259 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' B' ' 41' ' ' ILE . 11.2 ptpt -72.4 -7.8 51.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.056 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.23 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 121.001 0.429 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 -27.91 69.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.658 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 29.7 tp -65.72 -33.28 75.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.565 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.6 67.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 0.0 110.651 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.411 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 56.0 mt -82.99 -42.31 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.959 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.658 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 26.7 ptm -71.32 -25.47 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.977 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.486 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 83.9 m -86.43 5.52 34.67 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 12.4 ptp180 -123.87 130.91 53.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 0.0 110.728 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 158' ' ' VAL . 14.7 m -101.7 145.76 11.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.208 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 73.8 t80 -105.43 127.92 53.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.972 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.5 109.88 30.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.7 152.17 17.48 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.373 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.6 m 61.04 64.09 1.17 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.985 0.421 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.9 mm -54.46 132.09 17.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.376 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 88.5 t80 -44.43 -70.1 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.96 0.787 . . . . 0.0 111.733 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 86.1 t80 171.9 -62.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.752 0.658 . . . . 0.0 109.574 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.81 -25.86 37.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.172 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.52 121.48 13.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -106.41 -175.22 23.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.949 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 32.6 tt0 -65.12 -36.61 84.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.044 0.449 . . . . 0.0 110.07 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.566 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 23.4 m-20 -63.84 -40.9 97.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.319 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.7 m -60.85 -49.74 76.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.45 -51.74 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.057 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 126' ' ' ASP . 23.0 ptt180 -63.62 -35.68 81.31 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.691 -0.404 . . . . 0.0 112.026 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.78 -22.78 49.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.56 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.08 -36.97 58.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.393 . . . . 0.0 110.723 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.482 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 86.9 m-85 -93.31 14.72 17.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.49 -44.48 18.0 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.273 -178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 34.8 Cg_endo -67.16 -4.67 12.04 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -92.47 -75.7 0.48 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.69 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -145.1 -177.57 20.01 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 2.0 Cg_endo -80.72 135.08 10.03 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.712 2.275 . . . . 0.0 112.069 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.15 109.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -79.08 -56.42 4.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.81 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.3 m -156.88 136.57 12.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.679 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.7 mt -121.13 114.72 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.76 106.1 13.48 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 156' ' ' ALA . 25.2 ptm -116.65 142.4 46.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.7 t -81.79 104.27 12.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.01 117.18 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.452 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' MET . 3.3 t70 -77.25 91.86 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.754 172.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.0 p -94.92 4.49 53.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.988 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.55 -54.35 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 t -120.71 4.83 10.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.364 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 146' ' ' ASP . 26.8 ptm 45.51 37.67 3.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.565 1.146 . . . . 0.0 113.198 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -102.95 7.14 39.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 72.16 44.96 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.642 171.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -76.26 81.1 3.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.329 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.8 -161.08 24.96 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.898 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.91 166.93 23.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.478 -0.361 . . . . 0.0 110.08 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -133.03 138.99 46.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.817 0.342 . . . . 0.0 111.571 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.29 119.09 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.78 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.435 ' HB ' HG23 ' A' ' 114' ' ' VAL . 47.4 t -112.57 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.443 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 51.5 mt-10 -96.52 141.65 29.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.89 160.25 20.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.754 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 137' ' ' PRO . 10.6 pt-20 -87.59 -2.4 58.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.123 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.493 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 12.9 m -133.57 126.38 19.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.23 177.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 17.1 Cg_exo -67.88 -18.02 46.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.468 2.779 . . . . 0.0 111.624 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.487 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 14.1 mp0 -62.21 -56.64 16.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.835 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -31.41 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.73 -51.02 66.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.634 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -65.03 -43.64 91.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 110.176 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.49 -48.34 79.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.707 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -58.22 -59.95 4.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.687 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.88 -34.08 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -74.24 -45.03 50.6 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.542 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.677 ' HB3' HD11 ' A' ' 183' ' ' ILE . 26.3 mmt -74.97 -17.85 60.48 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.938 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -76.77 -28.45 55.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.38 0.61 . . . . 0.0 109.644 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.5 m -89.57 -42.92 11.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.042 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 67.4 t -89.52 119.91 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.633 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 88.2 mtp -77.41 112.56 14.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 178' ' ' LEU . 0.6 OUTLIER -79.74 102.98 9.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.234 -176.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.7 -134.41 12.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.856 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -100.21 13.59 60.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.97 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -148.79 161.86 40.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.633 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.1 p-10 -98.29 119.2 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 173' ' ' MET . 28.5 pt -64.4 156.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -100.46 109.73 21.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.6 p -136.52 130.27 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.796 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.69 100.37 1.96 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.952 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.1 OUTLIER -151.74 87.78 4.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.221 177.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.46 101.38 1.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.678 2.252 . . . . 0.0 111.594 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.8 p -72.45 -21.07 61.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -99.8 29.67 4.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.008 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.7 tt -64.35 139.88 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.679 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.25 -69.27 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -82.62 -26.18 32.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 110.637 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.432 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.07 -33.95 72.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.532 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.0 tp60 -60.56 -53.93 59.71 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 55.9 Cg_exo -54.32 -28.83 54.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.479 2.12 . . . . 0.0 112.689 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.13 -52.61 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 194' ' ' ALA . 35.3 mt -64.33 -42.14 94.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.641 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.3 -37.97 89.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.83 -49.29 78.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.623 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.57 -47.5 84.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.449 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.1 -35.6 79.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.745 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.65 -39.08 64.74 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.747 0.308 . . . . 0.0 110.894 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.77 -31.59 70.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.09 0.471 . . . . 0.0 109.946 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.94 69.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.719 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtt180 -66.2 -25.83 67.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.366 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.78 71.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.901 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -95.16 -26.15 16.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.839 0.828 . . . . 0.0 109.861 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.4 HD21 ' HB2' ' A' ' 263' ' ' SER . 6.2 t30 62.26 44.35 7.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 112.124 168.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -95.92 136.88 35.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.695 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 284' ' ' LYS . 12.2 pt -105.47 161.95 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.104 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.47 118.09 35.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.162 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 51.5 t -105.84 115.67 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.176 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -121.48 178.19 4.91 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.502 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.53 31.97 12.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.558 0.694 . . . . 0.0 110.142 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.589 HG13 HD11 ' A' ' 225' ' ' ILE . 58.6 t -80.71 132.84 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.665 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.484 ' HB2' HD23 ' A' ' 275' ' ' LEU . 4.6 t-80 -65.21 128.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' A' ' 218' ' ' GLN . 7.8 mt-30 -56.34 -31.98 64.26 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.549 -171.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.66 -26.45 50.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.951 0.405 . . . . 0.0 110.968 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.801 HD11 HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -95.1 117.53 30.36 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -173.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 64.6 m -96.38 -176.53 3.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.6 OUTLIER -61.07 -38.88 87.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -58.24 -37.1 74.23 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.478 0.656 . . . . 0.0 109.83 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.4 m-20 -67.0 -58.57 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.495 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.589 HD11 HG13 ' A' ' 216' ' ' VAL . 43.7 mm -53.48 -28.52 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.574 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -53.15 -32.28 46.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.917 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.63 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 63.9 m -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.332 0.587 . . . . 0.0 112.404 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.665 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.9 m -64.58 -44.69 96.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.779 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.612 ' CE2' ' HG3' ' A' ' 270' ' ' MET . 86.0 m-85 -67.65 -36.48 80.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.507 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.4 tt0 -76.32 -28.42 56.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.957 0.408 . . . . 0.0 111.174 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.91 -24.98 67.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.75 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 0.9 OUTLIER -88.57 -51.22 5.81 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -148.84 160.62 28.46 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.722 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -68.92 131.45 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 229' ' ' PHE . 63.9 mt -96.36 134.39 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.52 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -90.36 -41.68 11.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.1 m -139.15 131.6 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 7.9 p -131.52 91.33 2.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.716 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.9 m -132.15 116.98 17.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.504 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 7.4 mp -90.38 129.89 36.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.06 97.43 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.668 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -80.69 149.71 29.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.699 175.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.511 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 0.0 OUTLIER -78.74 140.16 58.73 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 110.219 -176.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 12.2 Cg_exo -70.73 -20.93 29.65 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.709 2.939 . . . . 0.0 114.767 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 t -101.04 -40.29 7.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.484 -169.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.403 ' OG1' ' HE2' ' A' ' 248' ' ' LYS . 0.7 OUTLIER -106.57 -13.06 15.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.806 -0.559 . . . . 0.0 112.175 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.71 10.87 83.68 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.34 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 248' ' ' LYS . 42.6 mtmt -88.14 137.44 32.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.812 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 2.1 p80 -73.8 126.58 30.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.694 ' HD2' ' HE1' ' A' ' 252' ' ' TYR . 23.7 mttp -69.28 157.8 36.27 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.11 35.08 0.64 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 114.146 0.418 . . . . 0.0 114.146 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.694 ' HE1' ' HD2' ' A' ' 250' ' ' LYS . 38.0 p90 -151.64 154.05 35.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -159.28 179.5 34.84 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.86 121.1 36.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.422 ' O ' HG12 ' A' ' 211' ' ' ILE . 41.9 mm -105.89 124.68 61.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -104.16 118.12 35.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.86 139.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.97 -28.79 39.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.323 0.583 . . . . 0.0 109.656 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 262' ' ' SER . 41.2 tptt -101.34 117.3 34.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.642 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.24 83.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.276 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -68.85 -40.66 79.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.991 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 259' ' ' LYS . 31.6 t -63.37 -30.23 71.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 267' ' ' VAL . 44.2 t -59.87 -42.7 94.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.175 173.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.76 -39.94 88.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.438 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -54.93 -50.66 68.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.134 0.492 . . . . 0.0 110.511 175.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.17 -53.07 59.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.754 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 263' ' ' SER . 96.9 t -58.09 -33.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.666 -176.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.2 m -70.99 -20.22 62.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.2 m -115.08 -29.76 6.56 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.612 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 58.3 mmm -73.51 -2.07 21.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -167.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.451 ' HB3' HD22 ' A' ' 272' ' ' LEU . 51.6 t-20 -69.56 -39.72 77.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.203 1.001 . . . . 0.0 108.993 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -76.72 -8.99 58.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.985 -173.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.879 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 57.0 t80 -52.79 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.27 115.99 19.26 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.688 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.798 HD21 HD22 ' A' ' 220' ' ' LEU . 13.9 tp -122.82 86.1 2.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.53 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.41 33.76 55.73 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.04 1.87 62.77 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.033 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 20.3 pt20 -122.89 131.91 53.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.885 0.342 . . . . 0.0 110.701 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -81.32 133.82 35.49 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.863 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.879 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 12.1 tp -67.39 -178.67 0.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.083 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.75 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -147.8 112.29 5.3 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 270' ' ' MET . 7.9 p -115.34 137.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.184 0.516 . . . . 0.0 111.924 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -143.6 -144.59 4.27 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.919 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 34.3 ttmt -136.41 148.5 47.83 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.487 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -69.67 121.32 16.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.47 -18.22 7.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.136 0.493 . . . . 0.0 110.297 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 2.4 m -108.42 125.2 32.39 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.646 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 122.674 2.249 . . . . 0.0 111.459 174.169 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.788 0.328 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.29 -18.21 37.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.964 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.541 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -66.22 -37.21 85.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.871 0.367 . . . . 0.0 110.377 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.75 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 17.3 t80 -78.02 -19.38 54.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.679 0.752 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.631 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 73.9 mmtt -73.27 -48.25 36.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.69 175.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 26.3 t70 -58.38 -36.62 73.78 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.73 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.52 -54.47 26.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.792 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.704 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 2.9 mm? -81.06 -20.36 41.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 44.2 mt-30 -63.74 -42.76 97.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.63 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 66.0 mtt180 -68.52 -37.47 80.05 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.939 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.762 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -62.37 -42.18 99.21 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -172.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 39' ' ' ARG . 27.5 mtp85 -82.11 -26.25 33.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.385 -1.447 . . . . 0.0 112.589 173.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.93 -41.21 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.183 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.801 HG13 HD11 ' A' ' 220' ' ' LEU . 4.2 pt -68.44 -36.51 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.404 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.04 -15.69 63.88 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.086 0.469 . . . . 0.0 111.092 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.52 -42.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.161 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -82.25 -36.26 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.253 -177.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.405 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 69.3 mt . . . . . 0 N--CA 1.468 0.452 0 C-N-CA 123.555 0.742 . . . . 0.0 112.657 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.751 0.31 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.27 86.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.013 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.81 -33.92 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.243 -177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.98 82.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.526 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.57 -36.87 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.106 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 76.6 mtp -60.3 -26.48 66.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.873 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 75.8 m -73.35 -19.71 60.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.671 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 12.3 ptp180 -118.35 123.35 45.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 0.0 111.321 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -98.13 130.43 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.42 0.629 . . . . 0.0 111.096 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -75.52 119.25 19.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.023 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 42.7 t -108.21 112.24 39.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.57 178.08 28.58 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.841 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t 72.35 -79.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.437 0.695 . . . . 0.0 110.901 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mm 68.45 115.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.219 0.608 . . . . 0.0 111.613 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.657 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 61.9 t80 -72.27 142.65 48.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.471 ' HE1' ' HG2' ' A' ' 151' ' ' LYS . 92.4 t80 -52.85 -58.41 7.01 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -172.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -93.12 34.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.728 . . . . 0.0 110.233 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 27.8 tp -108.15 95.96 6.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.29 173.36 54.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.919 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.22 -35.58 80.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 129' ' ' ARG . 25.4 t70 -77.45 -29.43 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.772 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 m -67.33 -47.89 69.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.887 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.3 mt -58.21 -42.55 83.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.76 172.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 126' ' ' ASP . 53.3 ttt180 -51.13 -49.82 60.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.202 176.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 75.5 mt-30 -75.39 -26.83 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.536 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.43 77.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.113 0.482 . . . . 0.0 110.607 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.495 ' CE2' ' HG3' ' A' ' 173' ' ' MET . 52.3 m-85 -100.95 11.14 40.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.462 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 130' ' ' GLN . . . -71.75 -38.34 6.1 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.945 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.865 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 45.4 Cg_exo -60.15 -15.2 32.79 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.647 1.565 . . . . 0.0 112.78 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -80.45 -72.52 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.942 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.26 -171.9 25.69 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.348 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.87 104.16 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.006 2.47 . . . . 0.0 111.83 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.54 117.87 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.796 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -90.71 -34.89 15.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.789 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t -153.25 142.08 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.917 0.389 . . . . 0.0 110.976 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.8 107.52 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 24.7 t70 -104.6 140.92 37.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.08 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.6 ttm -160.47 143.53 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.582 0.23 . . . . 0.0 110.552 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.2 p -73.95 100.85 3.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.912 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.482 ' CH2' ' HG3' ' A' ' 150' ' ' MET . 2.4 m95 -88.12 158.84 18.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -129.84 89.86 2.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 p 46.68 -145.15 0.24 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.496 170.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -81.64 -21.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.911 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 151' ' ' LYS . 9.2 t -66.03 -26.74 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.303 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.482 ' HG3' ' CH2' ' A' ' 145' ' ' TRP . 52.6 ttm 67.21 13.45 9.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.349 0.595 . . . . 0.0 111.561 175.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.535 ' H ' HG23 ' A' ' 149' ' ' THR . 35.7 mtmm -69.28 121.44 16.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.702 -0.623 . . . . 0.0 109.536 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.406 ' HE1' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -141.19 132.2 26.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.114 0.483 . . . . 0.0 111.045 -174.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.445 ' HB3' ' HE2' ' A' ' 153' ' ' LYS . 34.9 ttpt -166.59 122.79 1.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.239 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.85 -94.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.122 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.92 144.07 47.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 0.0 111.918 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -141.26 161.29 38.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.293 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 92.3 m-85 -132.7 113.22 12.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.13 112.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 43.5 tt0 -105.42 125.49 51.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.167 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 96.4 m-85 -103.8 162.22 13.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.517 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.36 -19.46 50.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.964 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.59 134.86 25.25 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.592 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.9 -12.69 33.13 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 7.1 mp0 -63.87 -50.52 68.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.935 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.68 72.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.54 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.37 91.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.442 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -59.92 -49.45 77.65 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.426 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.724 HD21 ' HA3' ' A' ' 283' ' ' GLY . 37.4 mt -63.44 -41.44 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.58 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -62.17 -46.33 89.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.861 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 tt -67.41 -51.58 50.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.152 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -74.56 -47.74 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -79.81 -49.31 12.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.517 ' HB2' ' O ' ' A' ' 169' ' ' ALA . 16.0 mmt -68.32 -35.18 77.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -173.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.72 -17.68 58.95 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.856 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.2 m -91.05 -8.45 48.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.783 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.69 131.0 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.393 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.808 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 73.8 mtp -81.62 89.83 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.2 tp -38.23 -59.5 0.87 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.834 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.6 91.71 0.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.994 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.48 -57.56 4.45 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.026 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.406 ' HD3' ' HD2' ' A' ' 120' ' ' TYR . 10.9 ptm180 -104.6 149.9 25.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.808 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 6.3 p30 -97.58 118.11 33.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.415 0.626 . . . . 0.0 110.957 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 183' ' ' ILE . 1.7 pp -77.24 151.53 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.3 OUTLIER -102.34 118.24 36.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.9 115.34 45.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.03 0.443 . . . . 0.0 110.977 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 104.98 -169.05 16.25 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.985 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.471 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 33.4 mtt180 57.45 59.13 7.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.708 0.403 . . . . 0.0 111.883 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 3.9 Cg_exo -77.62 -39.62 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.433 2.089 . . . . 0.0 112.533 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 p -171.22 151.77 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.878 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 193' ' ' GLN . 94.6 m-20 59.29 56.92 3.61 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.483 0.489 . . . . 0.0 110.794 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.47 -21.36 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.54 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.24 -29.0 8.19 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.911 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 190' ' ' ASN . 12.4 tt0 -75.67 -33.42 60.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.877 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -74.12 -27.81 61.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.87 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.41 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 28.1 tp60 -54.69 -55.62 36.12 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.606 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 13.4 Cg_endo -57.1 -37.17 98.92 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 121.869 1.713 . . . . 0.0 111.938 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.6 mm -63.81 -41.46 92.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.391 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 194' ' ' ALA . 51.0 mm -56.13 -50.64 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.826 176.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.45 -44.42 94.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.876 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 25.4 mm-40 -61.87 -41.42 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.59 -44.0 36.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.0 95.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.329 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.609 ' OE2' ' HD3' ' A' ' 206' ' ' ARG . 13.9 tp10 -67.91 -30.27 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.072 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.17 -47.86 47.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.259 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.04 -26.47 67.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.286 0.565 . . . . 0.0 110.552 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.609 ' HD3' ' OE2' ' A' ' 203' ' ' GLU . 75.7 ttt180 -62.68 -23.11 66.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.968 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.65 -23.65 66.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.12 0.486 . . . . 0.0 110.827 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -14.66 36.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.541 0.686 . . . . 0.0 109.994 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.8 t30 57.18 45.4 20.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.679 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -108.58 136.49 48.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.906 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.1 pt -113.21 166.88 6.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.18 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.427 ' HD2' HD11 ' A' ' 168' ' ' LEU . 18.7 t80 -111.35 122.04 46.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.539 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 229' ' ' PHE . 3.9 p -112.97 121.11 64.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 0.0 110.793 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.4 175.94 6.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.576 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.865 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 8.1 t 68.97 24.61 6.23 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.458 0.703 . . . . 0.0 110.856 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.566 HG21 HD11 ' A' ' 240' ' ' LEU . 61.2 t -75.05 135.46 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.139 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -76.73 141.41 40.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.066 0.46 . . . . 0.0 110.501 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -65.15 -13.42 58.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.39 -47.26 23.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -173.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.898 HD21 HD11 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -101.71 159.33 15.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.181 -174.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 16.0 m -113.06 -177.89 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.0 OUTLIER -53.71 -47.55 70.44 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.334 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -55.14 -30.03 58.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 0.0 110.931 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.935 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 52.4 m-20 -78.79 -53.75 6.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.363 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.483 HD11 HD13 ' A' ' 220' ' ' LEU . 46.0 mm -61.48 -16.95 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.242 0.544 . . . . 0.0 110.89 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -54.34 -31.37 54.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.093 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 69.3 m -52.6 -62.13 1.84 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.934 0.873 . . . . 0.0 111.253 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.609 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.9 m -66.28 -34.05 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.605 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 213' ' ' VAL . 48.3 m-85 -74.68 -35.52 62.78 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.625 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.756 ' HG3' HG22 ' A' ' 235' ' ' ILE . 50.3 tt0 -77.23 -32.29 55.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 111.33 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.05 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.695 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.656 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 4.0 m-30 -85.52 -30.88 23.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 110.209 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -174.02 167.95 40.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.378 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -58.04 106.05 0.33 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 112.254 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.756 HG22 ' HG3' ' A' ' 230' ' ' GLU . 15.9 tt -87.97 142.07 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.047 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.06 -44.35 5.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 24.8 t -147.58 137.39 22.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.333 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.83 119.42 33.51 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.4 m -138.1 103.17 4.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 13.5 tp -88.36 129.74 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.31 114.21 2.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.193 0.52 . . . . 0.0 110.843 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 24.9 mtt180 -91.38 156.4 17.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 -176.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -128.57 113.31 19.34 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.858 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.43 -19.44 37.72 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.87 2.38 . . . . 0.0 112.613 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -55.52 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 110.429 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.6 p -82.34 -35.47 27.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.21 -0.29 44.03 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.33 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -112.03 -103.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 111.301 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 32.1 p80 -163.26 164.22 25.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.439 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -90.25 157.58 17.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.76 40.86 1.64 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.133 -0.556 . . . . 0.0 113.291 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -157.86 164.62 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.74 -169.59 36.2 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.252 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -125.48 137.99 53.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.36 . . . . 0.0 110.343 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.28 123.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.922 177.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 42.6 tt0 -106.69 131.98 53.2 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.08 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.427 ' CD1' ' HA ' ' A' ' 235' ' ' ILE . 68.5 m-85 -112.47 153.0 28.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.19 0.519 . . . . 0.0 111.498 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.98 -22.4 23.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.772 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 261' ' ' GLN . 35.5 ttpt -115.4 117.64 30.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.6 -25.04 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.926 0.393 . . . . 0.0 111.779 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.664 ' HB2' ' HE3' ' A' ' 259' ' ' LYS . 24.2 mp0 -66.65 -33.72 76.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.655 ' OG ' ' HE2' ' A' ' 259' ' ' LYS . 14.8 m -62.93 -38.04 89.43 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 267' ' ' VAL . 14.5 m -59.76 -38.59 82.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.55 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.01 -45.56 81.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.68 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.51 -44.33 93.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.582 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -61.42 -53.73 52.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.069 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 263' ' ' SER . 84.2 t -57.6 -27.27 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 0.0 111.336 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.3 m -72.41 -48.14 43.72 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.7 t -116.48 -13.0 10.95 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -168.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.48 ' HA ' ' CE ' ' A' ' 270' ' ' MET . 2.2 tpt -61.78 -32.45 72.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -170.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 20.9 p-10 -66.69 -22.63 66.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.81 -10.93 59.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.901 ' CZ ' ' HB1' ' B' ' 38' ' ' ALA . 2.0 t80 -69.28 104.8 2.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.771 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.46 88.55 3.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.54 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.898 HD11 HD21 ' A' ' 220' ' ' LEU . 62.7 tp -93.33 87.14 5.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.449 -174.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.94 37.36 11.6 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.759 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.19 65.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.941 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -141.17 130.92 24.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 99.6 m-85 -67.78 132.69 47.89 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 55.7 mt -61.93 -177.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.595 0.712 . . . . 0.0 110.751 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.31 121.84 9.14 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 7.4 p -121.8 134.59 64.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.224 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.724 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -141.64 -148.36 5.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.454 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -127.93 178.86 5.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.801 0.334 . . . . 0.0 110.56 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -104.54 117.72 34.82 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 66.3 t -94.38 -33.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.304 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 11.1 t -107.29 133.66 20.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 C--O 1.235 0.352 0 C-N-CA 122.628 2.219 . . . . 0.0 111.919 178.35 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.671 0.272 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.852 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 5.6 m-20 76.52 -43.12 0.45 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.612 0.765 . . . . 0.0 112.821 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.42 68.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.172 0.51 . . . . 0.0 110.043 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 8.5 t80 -79.06 -17.92 54.37 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 109.473 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.852 ' HD3' ' HA ' ' B' ' 29' ' ' ASP . 52.8 mtpt -75.21 -43.62 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.548 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.61 -44.63 85.6 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.656 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -47.59 -52.31 18.2 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.048 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.811 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -82.06 -22.4 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -65.48 -39.01 91.43 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.634 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 22.7 mmt180 -69.28 -41.85 76.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.339 171.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.901 ' HB1' ' CZ ' ' A' ' 273' ' ' PHE . . . -58.5 -45.16 89.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.843 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -79.9 -25.88 40.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.4 -1.437 . . . . 0.0 112.666 174.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.94 -49.06 66.8 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 169.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.935 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 3.2 pt -64.47 -32.42 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.338 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.774 ' HA ' HD23 ' A' ' 220' ' ' LEU . . . -73.12 -25.68 60.94 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.11 -43.06 14.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 2.8 tmmm? -65.98 -41.44 91.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 N--CA 1.467 0.393 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.05 174.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.587 0.232 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -52.7 35.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.654 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 3.1 mm? -60.61 -37.26 80.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.094 -176.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.54 79.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.45 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 194' ' ' ALA . 35.4 pt -85.27 -40.88 15.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.518 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 25.5 ptm -71.76 -28.24 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -171.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 81.0 m -92.63 6.51 47.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.639 0.257 . . . . 0.0 110.959 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -119.63 101.06 7.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.216 0.532 . . . . 0.0 111.383 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -109.68 125.53 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -91.09 149.1 21.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.524 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 47.1 t -111.52 111.27 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.062 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.5 -178.27 17.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.04 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.879 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 39.3 m 62.13 29.12 17.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.37 0.605 . . . . 0.0 111.027 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 119' ' ' ILE . 8.5 mt -70.02 147.16 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.053 -178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.3 -73.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 151' ' ' LYS . 48.2 t80 -176.42 -67.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -76.93 -26.92 54.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.336 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.847 HD22 HG21 ' A' ' 127' ' ' THR . 90.2 mt -54.61 125.67 20.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.846 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -107.68 -172.02 22.0 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.006 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.505 ' HB2' HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -68.94 -26.6 65.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.896 0.379 . . . . 0.0 110.097 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.7 -40.79 98.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.697 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.847 HG21 HD22 ' A' ' 123' ' ' LEU . 12.2 m -63.58 -46.11 87.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 110.445 177.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -63.14 -39.45 85.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -54.7 -42.49 71.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.028 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -77.69 -34.0 53.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.684 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.49 89.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.563 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 96.5 m-85 -97.17 12.28 33.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.555 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -68.1 -44.99 40.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.782 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.97 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.9 Cg_endo -68.46 -5.0 14.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.857 1.705 . . . . 0.0 112.991 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.469 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 4.6 m-85 -84.97 -75.35 0.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.843 0.354 . . . . 0.0 110.122 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -147.47 167.19 28.6 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 162' ' ' VAL . 22.8 Cg_exo -64.82 121.62 9.2 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.286 1.991 . . . . 0.0 111.729 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.456 HG21 HG13 ' A' ' 141' ' ' ILE . 2.0 mp -68.16 119.29 13.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.171 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -86.64 -46.1 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.544 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 m -148.38 141.33 24.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.357 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.505 HG21 ' HB2' ' A' ' 125' ' ' GLU . 54.5 mt -124.26 107.03 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.64 108.33 19.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.751 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 125' ' ' GLU . 27.2 ttt -132.0 119.8 21.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.911 0.386 . . . . 0.0 111.034 -176.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.0 t -90.34 83.09 5.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.553 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 2.9 p-90 -143.26 152.92 42.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.867 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.44 117.4 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.195 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.7 m -75.72 -9.01 58.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.938 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 50.7 t -81.85 -57.44 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.378 . . . . 0.0 110.751 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.419 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 27.9 p -80.06 -29.84 39.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.553 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 81.4 mtp 71.86 -10.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.799 0.84 . . . . 0.0 112.257 176.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.447 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 11.7 ptmm? -84.29 114.46 21.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.176 0.512 . . . . 0.0 109.667 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -142.36 145.25 33.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.016 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -119.59 13.06 12.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.624 0.726 . . . . 0.0 109.788 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.57 153.6 22.18 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.479 172.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -106.68 174.26 5.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.868 0.366 . . . . 0.0 110.934 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.19 148.93 36.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.306 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.15 115.25 29.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.068 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.86 108.37 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.043 0.449 . . . . 0.0 110.075 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -102.02 119.67 39.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.439 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.563 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 41.9 m-85 -93.58 149.63 21.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.295 0.569 . . . . 0.0 112.425 -174.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.439 ' OE1' ' HG2' ' A' ' 137' ' ' PRO . 33.8 tt0 -74.29 -27.65 60.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.463 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.507 HG22 ' HD2' ' A' ' 137' ' ' PRO . 26.5 m -121.45 120.9 28.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.942 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.497 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 33.5 Cg_exo -61.22 -25.85 81.3 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.389 2.726 . . . . 0.0 113.403 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.497 ' OE2' ' HD2' ' A' ' 163' ' ' PRO . 1.7 mp0 -58.56 -50.51 73.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.945 0.403 . . . . 0.0 110.122 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.43 -23.09 64.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.77 77.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.488 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -70.6 -39.54 73.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.573 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -58.93 -41.46 87.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.666 0.269 . . . . 0.0 110.917 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.49 -43.11 99.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.9 0.381 . . . . 0.0 110.427 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.712 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.2 tt -64.57 -42.26 95.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.646 -178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -47.29 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -79.97 -50.13 10.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 56.1 tpp -74.16 -28.15 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.831 0.348 . . . . 0.0 111.378 -172.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 10.7 t30 -81.36 -16.82 51.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.201 0.524 . . . . 0.0 110.521 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 t -84.15 -29.21 26.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.32 175.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 91.4 mtp -111.85 111.63 22.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.022 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 48.9 tp -68.55 104.64 2.0 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.86 -78.56 1.36 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.09 35.04 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.407 ' HB2' HG23 ' A' ' 183' ' ' ILE . 18.7 mmm180 -123.34 145.69 48.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.498 0.189 . . . . 0.0 110.81 -176.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -87.65 71.28 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.879 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.6 pt -69.16 156.31 7.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.399 -171.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 6.5 mmmm -101.94 109.99 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.093 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 63.2 t -122.31 121.51 64.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.956 0.408 . . . . 0.0 110.065 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.712 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 73.76 -126.94 10.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.129 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 52.84 77.24 0.46 Allowed Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 110.205 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.93 119.68 7.0 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.509 2.806 . . . . 0.0 113.748 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 m -71.67 -17.64 62.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.036 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.38 6.38 8.52 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.492 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.6 mm 71.34 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.913 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 173.07 50.68 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.43 -47.84 78.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.009 0.433 . . . . 0.0 111.414 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.555 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -111.61 18.04 19.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.787 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.4 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 21.5 tm0? -64.12 -47.38 79.46 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.583 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 74.1 Cg_exo -49.9 -42.35 44.99 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.794 2.329 . . . . 0.0 114.599 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 198' ' ' ILE . 2.6 pp -75.44 -24.25 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.776 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 194' ' ' ALA . 34.5 mt -65.24 -38.5 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.63 0.252 . . . . 0.0 110.542 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.05 -44.63 87.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.332 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.72 -44.63 81.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.573 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.761 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 91.2 mt -61.67 -45.57 93.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.841 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.2 -37.52 87.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.557 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.34 -34.13 77.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -73.93 -41.18 62.44 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.985 0.421 . . . . 0.0 110.198 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.62 72.42 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.779 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -57.4 -38.31 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.956 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.21 -13.01 61.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.564 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' A' ' 288' ' ' PRO . 17.3 m-85 -93.03 -6.94 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.741 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.29 27.34 16.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.748 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -102.26 137.0 41.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.895 0.379 . . . . 0.0 111.159 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.6 pt -121.21 161.5 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.639 175.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -116.02 135.73 53.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.771 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.45 124.56 60.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.885 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.03 -179.22 4.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.97 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 51.0 m 69.64 19.16 7.44 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.709 0.804 . . . . 0.0 111.473 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 225' ' ' ILE . 85.1 t -65.61 140.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.392 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -63.45 132.64 52.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.937 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.614 ' HG3' ' H ' ' A' ' 219' ' ' ASP . 6.2 pt20 -41.42 -55.96 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.614 ' H ' ' HG3' ' A' ' 218' ' ' GLN . 0.5 OUTLIER -79.64 -47.27 15.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.776 HD11 HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -55.89 111.96 1.06 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.042 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 225' ' ' ILE . 56.9 p -97.24 -178.01 4.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -162.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 18.8 p-10 -59.76 -44.04 94.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.434 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.44 -29.29 66.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.546 0.689 . . . . 0.0 109.833 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.674 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 64.5 m-20 -78.73 -54.09 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.513 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.65 HD11 HG13 ' A' ' 216' ' ' VAL . 27.9 mm -53.54 -27.59 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.359 0.599 . . . . 0.0 110.947 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.23 -31.6 44.05 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.84 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -48.94 -58.47 4.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.529 0.68 . . . . 0.0 111.932 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.738 HG12 ' HB1' ' B' ' 34' ' ' ALA . 6.0 m -74.35 -42.26 50.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.607 -171.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 270' ' ' MET . 35.6 m-85 -59.76 -52.99 63.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 0.0 110.927 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.1 tt0 -66.79 -24.03 66.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 -176.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.07 -33.26 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.827 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.753 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.6 m-30 -82.95 -42.25 17.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -151.77 148.37 19.3 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 42.0 mmtm -62.02 122.75 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.684 0.754 . . . . 0.0 110.965 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 238' ' ' CYS . 20.1 tt -87.95 141.16 14.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.109 -169.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 256' ' ' GLU . 82.2 tttt -91.96 -42.2 10.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 256' ' ' GLU . 12.8 p -161.59 146.7 13.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.599 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.44 ' HB3' HD11 ' A' ' 235' ' ' ILE . 6.3 p -137.94 129.98 28.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.841 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 48.6 m -150.61 119.73 6.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.047 0.451 . . . . 0.0 110.988 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.3 mp -99.38 130.52 45.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.795 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.33 137.22 58.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.077 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 52.3 mtt85 -94.25 157.76 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.188 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.551 ' OD1' HG22 ' A' ' 245' ' ' THR . 8.1 t70 -100.32 108.48 52.92 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 14.8 Cg_exo -70.04 -17.55 36.25 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.364 2.709 . . . . 0.0 114.172 -175.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 243' ' ' ASP . 3.5 t -94.6 -6.51 43.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.42 . . . . 0.0 111.125 -172.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 245' ' ' THR . 24.6 p -133.82 -41.78 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 119.96 -24.64 7.81 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.705 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.46 ' HE3' ' OG1' ' A' ' 246' ' ' THR . 0.0 OUTLIER -82.1 -179.86 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.827 0.314 . . . . 0.0 110.776 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.7 p80 -94.0 151.29 19.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.453 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -78.96 154.88 29.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.64 44.62 2.29 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.783 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.432 ' CE2' ' HD3' ' A' ' 137' ' ' PRO . 41.3 p90 -161.8 160.25 28.03 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.149 0.475 . . . . 0.0 110.382 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -170.81 -173.0 37.64 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.354 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.418 ' C ' HD12 ' A' ' 255' ' ' ILE . 87.8 m-85 -123.62 142.6 50.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.681 0.277 . . . . 0.0 110.652 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 254' ' ' PHE . 3.1 mp -124.45 131.32 72.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.618 174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.461 ' HB3' ' OG ' ' A' ' 237' ' ' SER . 30.6 tt0 -112.28 141.07 46.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -119.57 147.74 44.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.176 0.512 . . . . 0.0 111.49 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -79.97 -21.52 43.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.924 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 261' ' ' GLN . 34.9 ttpt -122.08 113.41 19.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.054 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.5 47.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.189 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.444 ' HB3' ' HE3' ' A' ' 259' ' ' LYS . 20.7 tt0 -56.99 -48.19 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.276 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.0 m -62.72 -31.5 72.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.3 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.4 m -59.67 -39.89 85.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.625 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -74.26 -42.97 58.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.858 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -63.78 -31.58 72.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.549 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -72.43 -54.16 10.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.458 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.58 -26.29 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -85.25 -18.34 34.29 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -115.05 -32.97 5.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.633 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.3 mmm -62.58 -21.33 65.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -172.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -58.07 -36.07 72.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.835 0.826 . . . . 0.0 110.377 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.76 -8.73 57.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.21 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.84 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -56.63 102.09 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -175.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.8 t70 -92.26 124.16 36.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.945 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.693 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.2 mm? -122.78 87.08 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.712 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.64 22.98 44.53 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.939 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.53 7.25 42.9 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.801 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.0 pt20 -125.85 130.66 51.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.789 0.328 . . . . 0.0 110.573 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -87.43 144.54 26.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.698 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 273' ' ' PHE . 11.0 mt -75.92 -173.72 2.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.549 . . . . 0.0 110.409 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.41 113.47 5.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 270' ' ' MET . 7.0 m -114.84 154.04 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.059 0.457 . . . . 0.0 111.866 -177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.31 -150.9 6.67 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.763 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 284' ' ' LYS . 28.3 mmtp -96.31 157.9 15.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.28 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.6 t 69.17 -71.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.625 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.487 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 12.3 p -89.59 133.86 33.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.412 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.761 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 16.1 Cg_exo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 122.95 2.434 . . . . 0.0 112.613 -175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . 0.433 ' HA ' ' CD ' ' B' ' 32' ' ' LYS . 35.2 m-20 72.25 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.786 0.679 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.74 78.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.966 0.412 . . . . 0.0 111.0 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.646 ' O ' HD22 ' B' ' 35' ' ' LEU . 10.6 t80 -73.99 -19.81 60.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.174 0.512 . . . . 0.0 109.861 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.9 mttt -73.81 -41.49 62.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.95 -38.91 76.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.436 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.753 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.13 -54.13 22.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.339 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.887 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -79.76 -17.46 53.4 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -172.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 43.0 mt-30 -60.08 -47.11 87.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 70.6 mtp180 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.245 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -68.01 -46.16 72.04 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.559 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 5.4 mtm180 -79.78 -24.66 41.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.512 -1.368 . . . . 0.0 112.166 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 51.9 tt0 -52.74 -50.03 64.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 109.816 167.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.902 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.4 pt -68.4 -25.39 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.008 0.432 . . . . 0.0 110.58 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' B' ' 39' ' ' ARG . . . -81.2 -11.92 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.65 -30.7 20.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.827 0.346 . . . . 0.0 110.298 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.902 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 15.7 ptpt -76.39 -4.33 41.74 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.598 178.563 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 106' ' ' ARG . 18.0 ttp180 . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.548 0.214 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.72 -36.51 64.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.32 -42.68 44.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.527 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . . . -62.06 -35.38 78.46 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.188 -176.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.98 -35.85 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.121 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.4 mmm -68.61 -36.53 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.407 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.573 ' HA ' ' HB2' ' A' ' 166' ' ' ALA . 23.4 p -81.13 6.25 14.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 78.0 ttt180 -111.39 96.24 5.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.4 HG23 HG13 ' A' ' 158' ' ' VAL . 11.6 m -92.76 144.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.554 0.692 . . . . 0.0 111.878 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 187' ' ' ARG . 44.1 t80 -96.9 127.3 42.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.53 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 111.19 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.651 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.57 -179.72 16.18 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.697 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.1 m 56.45 34.53 24.42 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.351 0.596 . . . . 0.0 110.898 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.0 mt -73.86 163.82 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.967 -176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 85.9 t80 -57.29 -72.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 31.1 t80 173.35 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.438 0.461 . . . . 0.0 109.762 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.72 -20.5 58.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.43 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.78 HD22 HG21 ' A' ' 127' ' ' THR . 47.5 mt -58.57 110.16 0.93 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.062 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -109.24 -153.69 15.39 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.144 -172.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.8 -51.18 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.633 0.255 . . . . 0.0 111.136 -175.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.35 -26.81 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 -175.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.78 HG21 HD22 ' A' ' 123' ' ' LEU . 3.6 m -67.59 -53.81 25.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.021 0.439 . . . . 0.0 110.053 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.32 -39.38 85.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.274 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -59.52 -38.31 80.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.009 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.29 -44.28 25.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.308 . . . . 0.0 111.66 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.69 81.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 173' ' ' MET . 84.7 m-85 -106.48 18.98 21.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.839 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.62 ' HA ' HD11 ' A' ' 138' ' ' ILE . . . -65.47 -43.91 64.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.031 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 133' ' ' ALA . 22.6 Cg_exo -68.35 -5.16 14.33 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.03 1.82 . . . . 0.0 112.665 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 9.0 m-85 -94.64 60.27 2.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.563 ' HA3' HG21 ' A' ' 162' ' ' VAL . . . 78.12 175.32 44.54 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.75 118.57 3.83 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.861 2.374 . . . . 0.0 111.91 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 133' ' ' ALA . 3.8 mp -60.47 118.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -89.57 -49.56 6.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 109.951 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 p -161.45 147.8 14.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.934 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.98 107.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.14 118.42 34.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.7 ptm -143.33 148.29 36.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.53 108.93 11.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.537 0.684 . . . . 0.0 111.633 -177.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 152' ' ' HIS . 78.0 m95 -104.14 155.68 18.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.452 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -101.76 86.72 2.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.663 0.744 . . . . 0.0 110.197 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.0 p 33.58 -108.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.355 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.45 -28.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -170.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -33.51 67.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.3 mmt 58.93 44.95 15.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.356 0.598 . . . . 0.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 121' ' ' TYR . 10.6 tptm -93.45 -29.1 15.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 145' ' ' TRP . 57.0 t60 60.91 75.84 0.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.492 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -102.84 81.21 1.97 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.79 -155.52 11.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.572 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -125.65 175.03 7.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.35 28.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.76 0.314 . . . . 0.0 111.574 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.21 119.91 39.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 114' ' ' VAL . 2.5 p -114.81 119.42 61.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 0.0 110.463 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.1 tt0 -104.02 130.4 51.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.164 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.603 ' HE1' HG13 ' A' ' 138' ' ' ILE . 51.6 m-85 -110.71 171.54 7.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.644 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.69 14.95 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.563 HG21 ' HA3' ' A' ' 136' ' ' GLY . 8.7 m -134.42 105.88 11.04 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.609 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 38.6 Cg_exo -58.97 -26.9 83.22 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.173 2.582 . . . . 0.0 113.299 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 164' ' ' GLU . 2.1 mp0 -61.8 -57.94 9.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.575 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.27 -26.4 66.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.756 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 112' ' ' CYS . . . -63.02 -51.57 66.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.785 0.326 . . . . 0.0 110.796 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -74.55 -31.82 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 59.2 tp -56.07 -50.08 71.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.65 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.94 97.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.908 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.911 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.4 tt -60.68 -42.68 97.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.633 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.6 -46.1 17.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 75.8 mm-40 -83.95 -50.93 7.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.41 ' HG3' ' CE2' ' A' ' 132' ' ' PHE . 16.0 mmt -74.46 -30.76 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -172.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.37 -24.35 67.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.292 0.567 . . . . 0.0 110.534 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.1 m -92.24 -2.28 56.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.719 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 172' ' ' GLN . 91.6 t -118.28 139.86 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 182' ' ' ASN . 58.7 mtt -99.6 117.28 33.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.83 121.49 27.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 69.98 -88.07 0.3 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -173.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.78 11.75 0.96 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -100.5 132.67 45.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.615 -175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 177' ' ' MET . 6.0 t30 -86.78 89.49 7.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 pt -72.54 142.08 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.83 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -102.73 110.04 21.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.61 110.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.911 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 105.07 110.68 3.53 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.876 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 49.5 ttt180 -109.33 113.82 58.18 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 187' ' ' ARG . 38.1 Cg_endo -66.46 77.06 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.101 2.534 . . . . 0.0 111.549 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.1 m -84.56 -22.7 29.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.525 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -123.31 114.23 19.93 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.8 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.9 mt -129.2 98.41 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 138.48 -47.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -81.27 -57.39 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.034 0.445 . . . . 0.0 110.969 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -92.19 -14.92 28.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.377 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.657 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 24.2 tp60 -56.22 -51.67 78.98 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.057 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 27.6 Cg_exo -63.53 -34.39 64.66 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.028 1.819 . . . . 0.0 111.976 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.07 -42.19 95.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.4 mt -59.57 -44.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.783 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.36 -42.32 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.493 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -59.86 -51.18 70.81 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.755 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 202' ' ' ALA . 3.3 pp -75.71 -29.02 58.81 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.654 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.444 ' N ' HD12 ' A' ' 201' ' ' LEU . . . -73.36 -40.09 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 0.0 110.365 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.44 -44.11 97.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.564 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.73 -30.38 67.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 288' ' ' PRO . . . -64.41 -22.5 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -61.14 -32.99 72.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.37 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 111.031 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -87.26 -26.4 23.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.668 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.5 p30 40.53 46.61 2.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.71 0.804 . . . . 0.0 112.944 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -87.41 136.22 33.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 229' ' ' PHE . 15.8 tt -104.78 146.69 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 0.0 110.359 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -111.36 139.25 46.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.578 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.438 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 5.9 p -136.13 125.91 40.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.181 0.515 . . . . 0.0 110.721 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.42 179.96 4.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.276 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.476 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.8 t 65.05 25.4 12.59 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.789 0.681 . . . . 0.0 109.674 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 225' ' ' ILE . 46.3 t -70.37 129.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.898 -176.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.62 131.25 50.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.51 -50.56 31.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.898 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -75.53 -46.44 32.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.822 HD11 HG13 ' B' ' 41' ' ' ILE . 0.9 OUTLIER -63.53 101.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.015 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.483 ' O ' HG12 ' A' ' 225' ' ' ILE . 50.9 m -91.33 -177.18 4.78 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.043 -169.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.806 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 21.8 p-10 -61.07 -39.26 89.19 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -56.36 -30.59 62.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 110.467 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.644 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 9.4 m-20 -78.69 -53.05 7.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.048 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 216' ' ' VAL . 30.8 mm -52.04 -29.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.466 0.706 . . . . 0.0 111.238 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.573 ' HG3' HD12 ' A' ' 235' ' ' ILE . 87.7 tttt -50.32 -31.64 14.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.882 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 63.8 m -48.39 -61.89 1.77 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.543 0.687 . . . . 0.0 111.723 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.807 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 3.7 m -74.04 -35.74 42.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.481 -170.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.63 ' HE2' HD13 ' A' ' 211' ' ' ILE . 38.9 m-85 -68.33 -48.89 63.67 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.091 -0.243 . . . . 0.0 111.311 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 31.4 tt0 -78.24 -11.9 59.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 111.239 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.27 -28.35 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.654 0.264 . . . . 0.0 111.079 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.751 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.8 OUTLIER -94.82 -62.19 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.62 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -117.98 175.98 15.94 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.766 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -92.3 118.34 30.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.156 0.503 . . . . 0.0 111.304 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.573 HD12 ' HG3' ' A' ' 226' ' ' LYS . 65.3 mt -75.66 138.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.958 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -90.96 -45.4 8.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 4.2 p -156.82 131.7 8.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.33 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 9.6 p -120.5 128.09 52.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.747 0.308 . . . . 0.0 110.223 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.3 p -143.23 111.06 5.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.815 ' HG ' ' HA3' ' A' ' 253' ' ' GLY . 9.4 mp -101.59 116.88 33.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -53.05 112.82 0.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.086 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.942 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -97.21 144.77 26.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.156 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -89.56 118.49 69.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.279 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.91 -21.84 37.01 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.952 2.435 . . . . 0.0 113.522 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 37.9 p -89.08 -17.65 28.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 0.0 111.527 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 31.0 p -102.15 -37.24 8.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.973 0.416 . . . . 0.0 110.52 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.21 1.03 55.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.285 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -128.44 158.03 39.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.931 0.396 . . . . 0.0 110.282 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.942 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -72.9 148.3 44.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.736 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -79.15 155.4 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.86 44.01 1.23 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 20.4 p90 -163.19 160.58 24.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.815 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -176.35 -172.59 41.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.635 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.402 ' CE2' ' HG2' ' A' ' 164' ' ' GLU . 91.3 m-85 -126.91 139.99 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 111.323 -176.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 211' ' ' ILE . 2.7 mp -117.94 128.1 75.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -104.93 114.7 29.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.946 0.403 . . . . 0.0 110.115 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -90.97 153.3 20.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.7 pt-20 -91.8 -18.86 23.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.493 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 29.3 mmmt -122.48 125.15 45.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.72 -22.83 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.717 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -63.27 -44.24 95.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.62 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 34.8 m -65.93 -34.42 78.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 -176.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.9 m -60.46 -32.01 70.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -74.17 -43.45 57.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.858 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.46 -54.01 28.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.225 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.723 ' HA ' HG21 ' A' ' 282' ' ' VAL . 25.2 m -59.1 -26.19 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.02 0.438 . . . . 0.0 111.52 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.2 m -78.05 -19.81 53.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.741 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -114.96 -33.15 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.807 ' HE1' ' HB ' ' A' ' 228' ' ' VAL . 4.1 mmt -75.97 5.18 6.93 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -166.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.495 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.9 t30 -81.92 -38.94 24.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.932 0.873 . . . . 0.0 109.489 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.16 -8.53 57.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.277 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.787 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 4.5 t80 -52.93 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.776 0.431 . . . . 0.0 110.513 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.5 t70 -90.89 125.67 35.82 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.502 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.586 HD22 HD13 ' A' ' 220' ' ' LEU . 85.8 mt -128.63 85.53 2.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.13 44.81 7.89 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.8 63.98 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.832 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 9.4 pt20 -140.58 130.65 24.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.778 0.323 . . . . 0.0 110.608 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -89.67 133.71 34.52 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.658 HD22 ' CD2' ' A' ' 273' ' ' PHE . 8.5 mp -72.45 -165.75 0.22 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.39 0.614 . . . . 0.0 111.03 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 9.6 tpp180 -147.11 116.65 7.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.042 -172.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.723 HG21 ' HA ' ' A' ' 267' ' ' VAL . 14.4 p -105.68 146.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.94 0.4 . . . . 0.0 111.271 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.12 -156.71 7.7 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 286' ' ' VAL . 93.9 mttt -126.49 174.52 8.58 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.603 -0.351 . . . . 0.0 110.11 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -59.13 -43.14 91.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 111.429 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 94.4 t 79.8 -52.92 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.676 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 4.5 m -139.76 122.85 10.42 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-O 120.69 0.281 . . . . 0.0 110.846 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 287' ' ' THR . 1.1 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 123.661 2.907 . . . . 0.0 112.194 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.463 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 52.4 t30 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.25 -60.89 1.85 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.869 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -58.27 -33.59 69.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.635 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 5.9 t80 -72.34 -27.18 62.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 28.9 mtpp -62.58 -47.85 82.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.75 -36.15 71.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.739 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.763 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -53.72 -56.21 19.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.184 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.8 OUTLIER -79.17 -20.72 47.77 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.339 -171.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 81.2 mm-40 -56.84 -45.96 82.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 170.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.703 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 13.2 mmm180 -74.13 -32.93 63.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.429 175.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.787 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.86 -44.28 93.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -81.46 -26.64 35.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.813 -1.179 . . . . 0.0 112.599 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -56.44 -45.53 80.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.323 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.956 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 4.5 pt -65.87 -36.02 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.735 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.52 -10.59 59.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.33 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.9 -49.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.009 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.956 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -83.92 -29.57 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.898 HG23 ' HB2' ' A' ' 219' ' ' ASP . 37.6 mm . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 121.167 0.508 . . . . 0.0 111.978 173.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.954 0.407 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.69 85.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.85 -30.05 63.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.854 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.56 73.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.99 -41.41 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.731 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.708 ' HB3' ' HB3' ' A' ' 163' ' ' PRO . 84.4 mmm -61.86 -25.84 67.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -92.62 6.05 48.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -126.85 126.84 44.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 0.0 111.814 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.513 HG13 ' HB1' ' A' ' 166' ' ' ALA . 16.9 m -118.84 142.55 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 111.425 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -87.24 121.37 29.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.915 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.06 111.09 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.144 0.497 . . . . 0.0 110.374 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.07 177.72 20.43 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.825 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 42.1 m 64.99 48.03 2.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.176 0.513 . . . . 0.0 111.061 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.7 mm -71.51 -20.41 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.5 t80 66.83 -83.66 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.497 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 151' ' ' LYS . 78.1 t80 -174.03 -56.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.966 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.54 8.68 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.66 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.609 HD22 HG21 ' A' ' 127' ' ' THR . 67.9 mt -102.86 124.82 49.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.33 -167.21 11.87 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.842 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.97 -35.17 74.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.907 0.384 . . . . 0.0 109.99 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -58.44 -42.33 87.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.293 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.609 HG21 HD22 ' A' ' 123' ' ' LEU . 3.1 m -72.66 -40.6 66.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.481 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.34 -45.65 92.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.752 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.1 ttm-85 -61.35 -37.43 83.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.222 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -77.25 -36.0 54.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.448 ' O ' ' HD2' ' A' ' 134' ' ' PRO . . . -78.31 -38.93 41.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.981 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.603 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 96.7 m-85 -95.95 5.46 51.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.478 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.65 -42.1 24.59 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.68 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 71.7 Cg_exo -54.81 -2.54 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.211 2.607 . . . . 0.0 114.362 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.603 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 60.2 m-85 -108.65 -71.1 0.77 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.834 -0.541 . . . . 0.0 111.452 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -146.37 -166.5 12.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.623 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -81.86 114.61 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.668 2.245 . . . . 0.0 111.918 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.65 107.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.25 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -136.53 143.9 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.3 mt -133.47 107.02 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.165 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 3.8 m-20 -89.12 96.43 10.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 24.2 ptm -126.82 137.14 53.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 110.758 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.8 t -78.79 115.5 18.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.303 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -110.51 98.12 7.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.279 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.54 89.39 6.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -58.25 -38.92 77.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.381 -171.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.0 m -57.08 -30.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 p -119.2 -10.09 9.83 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.566 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 85.3 mtp 62.23 26.72 16.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 58.2 mttp -109.87 -173.13 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.947 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -126.97 95.91 4.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.128 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -83.53 -19.06 36.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.6 170.54 13.42 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.726 175.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -107.72 175.69 5.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.567 0.222 . . . . 0.0 110.924 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.01 136.72 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.831 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 72.8 m-85 -108.84 114.63 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.546 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.83 126.62 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.802 0.334 . . . . 0.0 110.311 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -120.34 130.49 54.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.326 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 78.3 m-85 -109.53 179.0 4.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -94.67 -2.63 50.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.338 172.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.99 125.53 17.22 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.246 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.708 ' HB3' ' HB3' ' A' ' 111' ' ' MET . 28.0 Cg_exo -64.33 -37.06 41.97 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.198 2.599 . . . . 0.0 112.169 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -57.75 -45.98 85.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.202 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 136' ' ' GLY . . . -55.67 -42.94 75.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 111.278 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.513 ' HB1' HG13 ' A' ' 114' ' ' VAL . . . -65.85 -41.29 91.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.885 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -63.12 -47.94 80.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.478 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.581 HD21 ' HA3' ' A' ' 283' ' ' GLY . 45.9 mt -63.14 -40.25 97.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.276 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.89 93.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.307 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.849 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.1 tt -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -80.78 -48.01 13.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 168' ' ' LEU . 8.0 mm100 -75.99 -40.53 53.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.743 -170.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.4 mmt -80.7 -6.31 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.341 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.1 -21.36 22.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.5 m -90.98 -27.28 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.603 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.1 t -114.67 110.5 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.485 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 23.5 ptm -89.24 138.32 31.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.186 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.47 144.96 39.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.996 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.79 69.88 0.97 Allowed Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.805 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.96 -45.68 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -157.12 137.93 13.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -73.18 92.77 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.825 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 29.2 pt -71.07 158.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.801 -176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -115.63 110.07 18.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.538 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.6 t -114.11 112.37 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.856 0.36 . . . . 0.0 111.023 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.849 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 112.07 134.43 6.31 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.51 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -162.57 94.27 1.21 Allowed Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.12 -39.77 89.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.026 2.484 . . . . 0.0 112.961 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 71.35 -52.14 0.69 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.387 0.675 . . . . 0.0 111.773 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -98.01 64.17 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.153 0.501 . . . . 0.0 110.226 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 mt -90.06 56.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.751 0.786 . . . . 0.0 109.418 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.33 -55.01 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.048 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -82.85 -48.73 10.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.575 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.52 -33.55 62.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.066 -175.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.637 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.7 tp60 -51.93 -53.36 52.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -174.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 49.4 Cg_exo -56.77 -32.22 90.74 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.13 1.887 . . . . 0.0 112.471 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 48.7 mm -72.46 -41.62 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.184 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 194' ' ' ALA . 43.7 mt -64.22 -39.23 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.626 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.52 -40.5 78.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.59 -47.88 65.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.367 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 97.5 mt -55.91 -43.35 77.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.837 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.22 77.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 206' ' ' ARG . 39.5 tt0 -73.75 -44.19 56.91 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.931 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.65 -28.3 63.66 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.209 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.23 76.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.779 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 203' ' ' GLU . 27.8 ptt180 -71.49 -19.7 62.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.172 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.42 66.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.0 -16.04 27.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.944 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.16 40.83 17.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.245 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HG2' ' HB2' ' A' ' 256' ' ' GLU . 98.8 mtt180 -101.93 136.15 42.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.5 pt -116.34 168.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.687 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -118.76 115.15 23.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.475 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.2 p -108.67 121.21 61.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.366 0.603 . . . . 0.0 110.726 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.77 -179.3 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.929 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 134' ' ' PRO . 8.6 t 71.0 14.67 6.79 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.909 0.756 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.702 HG11 HD21 ' A' ' 240' ' ' LEU . 60.6 t -61.93 122.91 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.429 ' HB3' HD11 ' A' ' 220' ' ' LEU . 6.9 t-80 -60.66 136.08 57.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -63.74 -22.68 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -165.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -48.05 15.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -174.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -82.95 147.82 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.358 0.599 . . . . 0.0 111.786 -174.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 49.9 m -108.25 -175.49 2.79 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.965 -166.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -50.31 -51.77 42.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.181 0.592 . . . . 0.0 112.307 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 226' ' ' LYS . 26.1 t70 -55.8 -29.88 60.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.325 0.583 . . . . 0.0 110.769 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.665 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 58.3 m-20 -76.04 -56.46 4.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.465 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.591 HD11 HD13 ' A' ' 220' ' ' LEU . 36.7 mm -61.12 -22.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.306 -178.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.537 ' HE2' HG21 ' A' ' 235' ' ' ILE . 53.2 tttm -55.62 -31.66 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.399 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.2 m -48.54 -61.82 1.82 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.452 0.644 . . . . 0.0 112.201 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.725 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 5.2 m -67.28 -46.99 82.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.623 -171.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.475 ' HZ ' ' HB ' ' A' ' 213' ' ' VAL . 64.5 m-85 -61.66 -42.42 98.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.692 0.282 . . . . 0.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 50.7 tt0 -77.13 -23.9 51.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.243 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.96 68.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.739 -0.209 . . . . 0.0 111.017 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.77 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.3 m-85 -83.6 -53.85 5.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -141.05 155.94 25.29 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.422 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.491 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 26.9 mmtp -66.37 140.22 58.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.726 0.774 . . . . 0.0 112.169 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.786 HD11 HG23 ' A' ' 255' ' ' ILE . 10.5 tp -84.86 146.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.795 -173.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -107.72 -51.36 2.92 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 16.0 m -143.6 143.01 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.57 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 28.3 p -144.71 133.8 22.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.273 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.0 m -150.81 103.75 3.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.212 0.529 . . . . 0.0 109.951 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.719 HD12 ' HA3' ' A' ' 253' ' ' GLY . 18.8 tp -83.43 129.95 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.85 137.74 51.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 111.461 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.533 ' HA ' ' H ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -143.45 157.75 44.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.757 176.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.527 ' OD1' ' HE3' ' A' ' 250' ' ' LYS . 9.6 m-20 -71.13 108.36 3.7 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.575 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.61 -31.47 21.11 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.39 2.06 . . . . 0.0 112.329 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -96.03 -3.58 44.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.428 . . . . 0.0 110.757 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 243' ' ' ASP . 24.6 m -113.79 -40.84 3.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 0.0 111.406 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.9 53.66 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.157 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 242' ' ' ARG . 95.6 mttt -87.49 -178.0 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -125.21 138.55 54.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.022 0.439 . . . . 0.0 111.685 -171.109 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.533 ' H ' ' HA ' ' A' ' 242' ' ' ARG . 31.8 mmtp -80.41 149.11 30.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.69 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.76 40.92 2.3 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.719 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.56 162.7 19.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.048 0.424 . . . . 0.0 110.331 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.719 ' HA3' HD12 ' A' ' 240' ' ' LEU . . . -167.96 177.37 42.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.225 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.89 134.41 55.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 0.0 110.438 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.786 HG23 HD11 ' A' ' 235' ' ' ILE . 52.0 mt -130.75 140.2 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.498 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 237' ' ' SER . 43.4 tt0 -122.85 131.9 53.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -105.33 153.25 21.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.469 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -85.48 -16.24 40.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.259 0.552 . . . . 0.0 110.293 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -124.38 123.93 41.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.277 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -68.16 -23.62 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.024 0.44 . . . . 0.0 110.574 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -62.22 -37.83 86.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.373 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.442 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 12.2 m -73.62 -36.4 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.056 -176.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 m -59.63 -34.41 72.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.474 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -73.07 -37.12 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 4.7 p-10 -79.11 -26.24 42.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.416 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.11 -52.73 45.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.614 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.72 -25.72 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 p -84.71 -13.52 51.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 p -115.07 -32.24 5.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.839 ' HE2' ' HB2' ' A' ' 273' ' ' PHE . 2.3 mmt -69.14 -4.55 17.83 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.41 -32.78 62.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.99 0.9 . . . . 0.0 108.993 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -77.31 -10.63 59.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.476 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.839 ' HB2' ' HE2' ' A' ' 270' ' ' MET . 2.6 t80 -50.49 105.21 0.09 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.523 0.514 . . . . 0.0 110.403 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.14 125.26 34.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.388 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 220' ' ' LEU . 86.0 mt -130.03 86.83 2.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.681 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.01 14.16 63.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.013 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 102.02 25.02 8.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -140.59 142.17 35.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -81.24 139.45 35.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.125 0.488 . . . . 0.0 110.168 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.1 OUTLIER -79.32 -176.56 5.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.107 176.279 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 281' ' ' ARG . 26.6 mmt180 -142.26 112.7 7.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.687 HG11 ' HB2' ' A' ' 270' ' ' MET . 8.7 p -118.48 131.62 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.581 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -134.96 -161.68 9.51 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.385 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -113.2 168.98 9.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.637 0.255 . . . . 0.0 110.332 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -90.26 113.15 24.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.83 -31.79 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.669 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.51 HG21 ' HG2' ' A' ' 163' ' ' PRO . 9.2 t -133.83 141.03 38.37 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.901 175.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 C--O 1.234 0.315 0 C-N-CA 122.358 2.039 . . . . 0.0 111.937 178.297 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.95 0.405 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.23 -59.73 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.053 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.51 75.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 110.946 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.657 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.6 t80 -70.82 -17.79 62.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 30.2 mmmt -64.29 -50.28 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.74 -37.82 74.25 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.455 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.77 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.16 -58.62 4.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.428 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.758 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.6 OUTLIER -80.78 -17.81 49.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 26.2 mm-40 -56.41 -46.42 80.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.615 ' O ' HG23 ' B' ' 41' ' ' ILE . 30.5 mmm180 -73.65 -36.44 65.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.68 175.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.799 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -59.82 -45.04 93.63 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -80.28 -26.4 38.94 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.556 -1.34 . . . . 0.0 112.462 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -57.19 -45.18 83.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.849 169.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.799 HG12 ' O ' ' B' ' 38' ' ' ALA . 4.9 pt -67.03 -31.37 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.675 ' HA ' HD23 ' A' ' 220' ' ' LEU . . . -67.99 -46.12 72.22 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.192 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.43 68.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.572 ' O ' ' HD2' ' B' ' 44' ' ' LYS . 1.3 tmmm? -70.84 -16.54 62.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.957 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' B' ' 44' ' ' LYS . 75.8 mt . . . . . 0 N--CA 1.465 0.283 0 C-N-CA 123.469 0.708 . . . . 0.0 111.337 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 . . . . . 0 N--CA 1.463 0.183 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.79 -49.45 52.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.562 HD12 ' HG3' ' A' ' 163' ' ' PRO . 4.6 mm? -69.3 -26.01 64.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.552 -176.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.168 0.509 . . . . 0.0 110.74 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.0 mm -82.5 -36.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.095 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.7 mtp -70.72 -28.65 64.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.209 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.2 m -81.72 2.98 27.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.641 ' HB3' ' HG3' ' A' ' 159' ' ' GLU . 38.9 ptt180 -138.32 140.93 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.582 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.5 m -107.92 141.11 23.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.352 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 44.9 t80 -83.7 116.56 22.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.046 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' A' ' 156' ' ' ALA . 42.8 t -101.93 111.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.47 146.04 16.83 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.337 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.7 m 74.37 -53.72 0.68 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.788 0.835 . . . . 0.0 111.776 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 123' ' ' LEU . 63.6 mt 68.93 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.437 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 27.3 t80 177.26 -85.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.483 ' CD2' ' HD3' ' A' ' 153' ' ' LYS . 1.5 t80 177.58 -77.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.308 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.19 43.93 1.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.552 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 35.6 mt -100.86 123.81 45.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.697 ' HA2' ' HH2' ' A' ' 145' ' ' TRP . . . -83.6 171.12 49.13 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.77 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -63.83 -48.16 77.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 129' ' ' ARG . 34.5 t70 -62.44 -30.46 71.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.628 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 m -59.79 -49.8 76.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.029 0.442 . . . . 0.0 110.453 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.69 -34.52 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.308 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.411 ' HB3' ' HA ' ' A' ' 126' ' ' ASP . 26.6 ttm180 -55.58 -45.73 77.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.794 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 32.1 mm-40 -74.83 -30.54 61.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.439 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.75 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.633 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.454 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 93.2 m-85 -100.77 11.13 40.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.046 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.86 -44.04 29.07 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.789 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.633 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 13.2 Cg_exo -72.29 -8.61 23.02 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.774 1.649 . . . . 0.0 111.994 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.567 ' O ' ' HB1' ' A' ' 165' ' ' ALA . 65.7 m-85 -102.64 65.53 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 110.464 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . 84.31 177.16 51.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.621 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -91.3 115.45 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.906 2.404 . . . . 0.0 112.273 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.521 HD13 ' HE1' ' A' ' 160' ' ' TYR . 36.8 mm -56.75 115.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.089 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -96.4 -55.03 3.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.761 0.315 . . . . 0.0 110.604 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.751 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 23.3 t -135.28 137.08 42.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.11 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.18 127.25 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.624 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.7 t70 -133.25 126.11 30.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.397 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.4 mtp -147.37 147.83 30.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.961 0.41 . . . . 0.0 111.616 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.5 m -79.63 131.17 35.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 168.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.697 ' HH2' ' HA2' ' A' ' 124' ' ' GLY . 82.7 m95 -133.53 150.44 51.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.255 0.55 . . . . 0.0 112.264 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -124.35 89.06 3.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.694 168.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.9 m 65.8 -174.37 0.18 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.199 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.44 -20.98 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 110.424 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 p -67.73 9.74 0.25 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.503 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 20.9 ptp 47.45 38.31 7.52 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 171.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.421 ' HE3' ' OH ' ' A' ' 121' ' ' TYR . 56.2 mtpt -92.49 137.86 32.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -170.55 -78.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.483 ' HD3' ' CD2' ' A' ' 121' ' ' TYR . 22.4 mtmm 54.78 35.67 24.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.655 0.382 . . . . 0.0 111.316 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -102.26 -107.78 3.13 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.526 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.96 165.99 23.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.875 0.369 . . . . 0.0 110.581 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.672 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . . . -145.18 135.77 24.35 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.447 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 51.2 m-85 -113.31 107.9 16.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.915 0.388 . . . . 0.0 110.134 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.09 103.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 28.6 tt0 -105.94 126.47 52.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 -172.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.521 ' HE1' HD13 ' A' ' 138' ' ' ILE . 78.0 m-85 -109.25 -177.98 3.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.11 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -109.23 -1.73 18.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.909 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.88 122.53 16.53 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.435 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.562 ' HG3' HD12 ' A' ' 108' ' ' LEU . 34.0 Cg_endo -65.65 -21.62 58.84 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.902 2.401 . . . . 0.0 113.397 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.97 -63.75 1.04 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.164 0.507 . . . . 0.0 110.466 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 135' ' ' PHE . . . -52.56 -43.15 65.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.136 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.88 66.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.445 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.564 ' HB3' HG21 ' A' ' 286' ' ' VAL . 57.8 tp60 -66.88 -35.45 80.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 212' ' ' TYR . 11.0 tp -64.76 -51.77 60.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.197 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.57 -36.58 81.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.308 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.473 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.6 tt -57.19 -62.37 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.485 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.29 -39.0 85.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -67.62 -49.89 60.82 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 57.8 mtt -82.9 -17.78 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -69.49 -35.36 75.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.233 0.54 . . . . 0.0 109.671 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.9 t -88.2 -43.76 11.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.983 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.85 94.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.783 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.437 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 62.3 mtm -65.78 167.99 8.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.439 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.8 tp -80.23 74.41 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.891 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.82 -123.41 9.79 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 12.22 70.17 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.894 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 177' ' ' MET . 30.1 tpt180 -104.14 119.93 40.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.674 0.273 . . . . 0.0 110.76 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.437 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 21.7 p-10 -78.23 116.02 18.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 110.081 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.48 144.97 17.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -102.05 110.39 22.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.1 m -135.39 106.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.53 . . . . 0.0 110.787 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.473 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 125.52 -165.62 18.6 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.796 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 57.86 89.12 0.11 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.312 0.645 . . . . 0.0 110.93 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.25 -14.25 28.4 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.45 2.767 . . . . 0.0 113.82 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 72.95 -61.54 0.5 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.055 0.542 . . . . 0.0 111.209 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -84.05 70.87 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.8 pt -95.75 -172.79 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.323 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.475 ' H ' ' HB2' ' A' ' 195' ' ' GLN . . . 103.28 -50.29 0.9 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.105 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.67 -43.01 39.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.15 0.5 . . . . 0.0 110.183 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.66 6.32 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.779 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.54 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 52.8 tp60 -61.98 -49.33 85.84 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.668 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -55.17 -37.27 94.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.061 1.841 . . . . 0.0 111.722 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.41 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.3 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 194' ' ' ALA . 48.2 mm -56.68 -48.32 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.191 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.02 -50.78 64.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.835 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 98.1 mt-30 -57.04 -44.73 83.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.814 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.15 -56.67 6.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.649 0.261 . . . . 0.0 111.135 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.52 73.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.981 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HG2' ' NH1' ' A' ' 206' ' ' ARG . 3.0 tm-20 -74.35 -46.13 42.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.429 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.93 -30.15 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.358 . . . . 0.0 110.928 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.93 -25.06 67.97 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.26 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.425 ' NH1' ' HG2' ' A' ' 203' ' ' GLU . 93.6 mtt180 -66.7 -26.22 66.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.59 -17.7 62.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.258 0.551 . . . . 0.0 111.257 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.9 -10.05 19.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.755 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 257' ' ' TYR . 3.2 m-80 54.23 29.32 10.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.489 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.9 136.41 33.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 111.26 -174.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 255' ' ' ILE . 8.9 tt -112.94 147.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.588 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.561 ' CD2' HD22 ' A' ' 168' ' ' LEU . 66.1 t80 -107.86 123.0 47.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.5 . . . . 0.0 109.657 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 280' ' ' LEU . 1.6 p -114.53 122.97 69.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.188 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.41 178.22 5.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.633 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 15.6 m 68.55 25.6 6.64 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.776 0.672 . . . . 0.0 110.909 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 225' ' ' ILE . 85.1 t -68.08 138.7 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.683 ' HB2' HD23 ' A' ' 275' ' ' LEU . 21.2 t-80 -66.41 131.15 45.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -50.55 -44.22 56.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -167.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.61 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.62 -46.54 17.03 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 178.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.854 HD22 HD21 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -55.32 114.45 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.262 0.625 . . . . 0.0 110.27 -177.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 6.6 t -95.21 -175.8 3.62 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -166.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.56 -44.0 96.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.838 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.79 -27.91 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 221' ' ' SER . 5.5 m-20 -63.49 -59.64 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.525 HD11 HG13 ' A' ' 216' ' ' VAL . 37.6 mm -55.96 -26.06 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.238 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.493 ' HG3' HD12 ' A' ' 235' ' ' ILE . 88.2 tttt -57.24 -32.29 66.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.653 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.526 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 74.5 m -49.03 -56.64 8.36 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.922 0.868 . . . . 0.0 111.748 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.632 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.2 m -73.85 -49.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.353 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.599 ' HE2' HD13 ' A' ' 211' ' ' ILE . 43.3 m-85 -59.63 -41.82 91.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.629 0.252 . . . . 0.0 111.627 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 30.9 tt0 -74.2 -25.94 59.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.12 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.89 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.693 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.1 OUTLIER -90.18 -58.55 2.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -127.44 154.82 19.72 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 36.7 mmtm -84.11 140.79 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.58 0.705 . . . . 0.0 112.056 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.493 HD12 ' HG3' ' A' ' 226' ' ' LYS . 56.5 mt -103.69 134.38 45.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.094 -171.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 1.092 ' HE2' ' HB3' ' A' ' 258' ' ' GLU . 62.6 mmtt -84.03 -46.08 12.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.986 176.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 21.9 t -147.24 136.63 22.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.614 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.415 ' HB3' HG21 ' A' ' 235' ' ' ILE . 3.5 p -132.64 135.4 45.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.9 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.8 t -157.66 139.77 14.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.336 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.576 HD23 ' HA3' ' A' ' 253' ' ' GLY . 72.7 mt -111.11 129.91 55.78 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.42 134.98 57.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 110.681 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.653 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.0 mtp180 -89.19 157.28 18.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.371 0.605 . . . . 0.0 111.695 -177.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.04 97.99 40.63 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.289 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.86 -23.92 29.8 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.838 2.359 . . . . 0.0 111.624 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 24.3 m -64.43 -47.02 80.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.47 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.469 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 1.7 m -94.69 -33.44 12.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.02 0.438 . . . . 0.0 111.108 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.13 43.3 2.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.529 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.469 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 23.2 pttp -147.51 -166.94 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -175.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.4 p80 -112.98 147.52 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' A' ' 242' ' ' ARG . 88.2 mttt -74.89 152.25 38.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.799 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -76.91 42.77 1.87 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.539 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -161.85 160.31 27.94 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.576 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -172.48 -164.08 27.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.333 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -129.85 137.31 50.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.975 0.417 . . . . 0.0 110.828 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.66 ' HB ' HG23 ' A' ' 211' ' ' ILE . 41.4 mm -119.56 128.98 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.336 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.64 113.26 26.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.153 0.502 . . . . 0.0 111.301 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.511 ' O ' ' HB2' ' A' ' 209' ' ' ASN . 49.6 m-85 -93.33 156.88 16.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.064 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 1.092 ' HB3' ' HE2' ' A' ' 236' ' ' LYS . 8.5 pt-20 -92.01 -17.28 25.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.343 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -127.98 118.54 23.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.473 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.1 66.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.601 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.32 -40.58 93.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.597 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 14.7 m -70.49 -36.03 73.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 267' ' ' VAL . 17.7 m -54.34 -48.63 71.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.209 174.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -64.89 -39.59 93.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -63.04 -46.05 89.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.76 86.49 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.542 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.562 ' HA ' HG23 ' A' ' 282' ' ' VAL . 71.3 t -60.39 -35.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 111.28 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.6 m -89.92 -4.73 57.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.711 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 26.5 p -115.74 -47.01 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.771 ' HB2' HG21 ' A' ' 282' ' ' VAL . 55.3 mmm -65.18 -14.83 61.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 15.0 p-10 -72.76 -26.42 61.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.521 0.677 . . . . 0.0 110.323 176.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.55 -8.72 59.69 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.886 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 69.7 t80 -57.95 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 111.363 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.69 103.48 6.68 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.995 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.854 HD21 HD22 ' A' ' 220' ' ' LEU . 22.1 tp -113.43 86.98 2.5 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.925 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 62.01 41.24 99.66 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.662 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 119.23 -21.48 9.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.749 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.427 ' NE2' ' HD2' ' A' ' 217' ' ' HIS . 0.0 OUTLIER -132.9 137.0 46.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.545 0.672 . . . . 0.0 111.777 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -78.04 128.92 34.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.089 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.886 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 8.0 tp -61.46 169.9 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.177 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.42 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 32.3 mmt180 -142.68 113.34 7.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 121.982 -0.448 . . . . 0.0 110.138 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.771 HG21 ' HB2' ' A' ' 270' ' ' MET . 28.7 m -124.94 168.03 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.991 0.424 . . . . 0.0 112.132 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.544 ' O ' HG13 ' A' ' 211' ' ' ILE . . . 176.94 -164.39 33.81 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.314 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 148.36 43.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.821 0.311 . . . . 0.0 110.343 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -69.37 -16.33 63.5 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 167' ' ' GLN . 49.1 t 72.02 -65.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.673 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 6.2 t -97.33 134.36 22.78 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo . . . . . 0 C--O 1.234 0.282 0 C-N-CA 122.736 2.291 . . . . 0.0 111.636 177.626 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 CA--C 1.523 -0.072 0 CA-C-O 121.368 0.604 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -119.79 -51.33 2.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.006 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.08 -41.0 23.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.875 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.631 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.7 t80 -69.02 -19.86 64.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.6 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' B' ' 32' ' ' LYS . 44.0 mtpt -69.08 -47.0 66.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.719 ' HA ' HE21 ' B' ' 36' ' ' GLN . 0.2 OUTLIER -58.97 -39.5 81.93 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.603 0.716 . . . . 0.0 109.118 175.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.693 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.64 -51.37 49.61 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.648 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.03 -20.85 40.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.719 HE21 ' HA ' ' B' ' 33' ' ' ASP . 37.2 mt-30 -59.53 -44.0 93.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.615 ' O ' HG23 ' B' ' 41' ' ' ILE . 72.7 mtp180 -73.63 -30.3 62.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.685 175.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.843 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -64.5 -49.81 69.86 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -80.1 -24.52 40.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.495 -1.378 . . . . 0.0 112.36 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.18 -50.43 59.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.074 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.843 HG12 ' O ' ' B' ' 38' ' ' ALA . 1.7 pt -66.4 -31.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.63 -22.61 65.32 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.97 -27.31 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.203 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 tmmt? -74.22 -55.26 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.376 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.61 HG23 ' HB2' ' A' ' 219' ' ' ASP . 87.2 mt . . . . . 0 N--CA 1.467 0.378 0 O-C-N 123.573 0.545 . . . . 0.0 112.198 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.7 0.286 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.24 -34.8 61.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 0.0 111.673 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.19 -32.83 69.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.468 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.53 -49.13 62.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.77 0.319 . . . . 0.0 111.65 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.04 -35.93 16.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.79 0.328 . . . . 0.0 111.533 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 91.4 mmm -71.67 -26.58 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.34 -12.34 60.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.19 133.25 50.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.473 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -94.08 138.0 21.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 0.0 110.915 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.567 ' HB2' ' HA ' ' A' ' 188' ' ' PRO . 72.5 t80 -89.66 106.13 18.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.169 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.6 t -103.53 110.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 118' ' ' SER . . . -134.39 100.24 0.37 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.608 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.607 ' OG ' ' HA ' ' A' ' 183' ' ' ILE . 68.5 p 151.59 51.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.306 1.443 . . . . 0.0 107.549 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.81 69.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.483 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.687 ' HE1' ' HA3' ' A' ' 179' ' ' GLY . 35.1 t80 37.86 -92.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.544 1.152 . . . . 0.0 112.387 169.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' HD2' ' HG3' ' A' ' 122' ' ' GLU . 33.0 t80 -179.3 -72.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.485 173.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.522 ' HG3' ' HD2' ' A' ' 121' ' ' TYR . 48.2 mt-10 -90.07 44.27 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 127' ' ' THR . 48.9 mt -102.2 164.63 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.48 175.82 18.1 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.858 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -60.76 -39.59 89.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.3 m-20 -48.43 -50.96 29.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.684 175.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.774 HG21 HD22 ' A' ' 123' ' ' LEU . 6.9 m -57.56 -47.7 81.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.324 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.411 HG23 ' HE2' ' A' ' 132' ' ' PHE . 79.0 mt -69.42 -41.04 80.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.807 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.446 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 14.8 ttm180 -59.57 -44.64 93.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.79 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 92.9 mt-30 -75.52 -21.46 57.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.45 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.96 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.623 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 97.4 m-85 -96.22 13.39 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.012 0.434 . . . . 0.0 111.141 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.584 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.67 -43.6 11.65 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.453 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 38.0 Cg_endo -67.08 -4.47 11.61 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 0.0 112.792 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 169' ' ' ALA . 4.9 m-85 -85.4 -83.06 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.55 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.67 -176.25 14.36 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.898 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.457 ' HD3' ' CZ ' ' A' ' 252' ' ' TYR . 60.9 Cg_endo -74.57 117.32 4.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.513 2.142 . . . . 0.0 111.444 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -57.12 107.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.917 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 159' ' ' GLU . 23.1 tptp -87.55 -54.49 4.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.379 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -166.73 144.05 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.8 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 63.5 mt -127.35 107.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.32 118.68 35.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.065 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 42.2 ttm -126.56 136.65 52.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.972 0.415 . . . . 0.0 111.189 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.628 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 3.7 m -98.73 111.21 23.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.886 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 2.1 p-90 -164.87 159.64 18.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.03 0.443 . . . . 0.0 111.369 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 153' ' ' LYS . 21.5 t70 -89.34 132.89 34.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.64 -176.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.1 t -101.76 4.98 41.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 110.952 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 91.5 t -85.14 -43.24 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.363 0.601 . . . . 0.0 110.058 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.5 p -119.72 5.22 11.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.002 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 58.46 30.0 19.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.611 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -89.27 128.17 35.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.886 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 58.9 m-70 -81.98 75.41 8.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.522 0.677 . . . . 0.0 110.991 -175.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 146' ' ' ASP . 58.9 mttm -78.5 63.79 3.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.506 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 144' ' ' SER . . . 158.89 -157.86 28.86 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -124.66 174.18 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.69 137.22 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 85.7 m-85 -113.42 113.9 25.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.032 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.0 t -101.01 111.68 31.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.816 0.341 . . . . 0.0 110.256 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 37.8 tt0 -101.52 141.22 34.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.93 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -122.96 172.94 8.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.31 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.63 -27.72 31.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.066 0.46 . . . . 0.0 110.203 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.508 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 6.2 m -121.48 136.52 25.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.864 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 8.2 Cg_exo -73.99 -13.82 23.79 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.72 2.947 . . . . 0.0 112.088 -177.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -60.23 -47.97 83.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.217 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.1 -26.1 68.67 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.5 -49.85 44.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.091 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -66.89 -36.05 81.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.721 0.296 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.86 -43.37 96.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.111 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . . . -59.86 -38.61 82.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.766 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.5 tt -60.35 -60.45 3.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -69.35 -47.29 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -71.59 -31.26 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.623 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 24.6 mmt -83.36 -28.79 28.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.76 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -76.97 -16.51 59.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 110.513 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.2 m -78.44 -13.91 59.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.152 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.07 143.18 36.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 110.794 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.1 ttt -99.11 104.25 16.23 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.07 -28.79 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.234 -171.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.687 ' HA3' ' HE1' ' A' ' 120' ' ' TYR . . . -161.08 -150.74 6.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.076 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.03 23.18 1.8 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.931 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.628 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 14.4 ptm180 -157.43 151.66 24.8 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -79.31 141.12 37.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.609 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.607 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 27.3 pt -100.12 131.81 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 0.0 110.388 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 81.2 tttt -103.83 117.74 35.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 48.1 t -125.29 106.58 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 130.82 159.97 9.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.146 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 67.36 83.69 0.18 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.158 0.504 . . . . 0.0 110.817 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 115' ' ' TYR . 17.3 Cg_exo -66.87 -60.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.961 2.441 . . . . 0.0 112.816 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.8 p -151.83 -61.53 0.17 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.918 0.39 . . . . 0.0 110.971 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.53 132.72 33.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.2 tp -142.98 137.34 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.42 . . . . 0.0 110.562 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 195' ' ' GLN . . . 93.42 -42.33 2.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.386 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -59.18 -31.79 69.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.641 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.48 12.11 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 110.849 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.574 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.4 tp60 -63.72 -49.51 76.2 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.563 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.1 -34.2 67.18 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.342 2.028 . . . . 0.0 112.614 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 46.3 mm -67.91 -42.15 85.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.285 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.12 -47.37 93.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.648 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.47 -32.64 74.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.115 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -71.76 -47.1 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.35 -21.49 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.325 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.96 97.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.13 -35.98 76.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.634 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.31 -35.91 82.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.59 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.15 -20.18 62.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.677 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -64.12 -22.27 66.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.948 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.35 58.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.895 0.379 . . . . 0.0 111.138 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -96.48 -17.37 20.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.99 26.25 11.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.776 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 210' ' ' ARG . 8.3 ptm85 -120.23 144.24 47.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.201 0.524 . . . . 0.0 111.654 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.57 170.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.246 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -112.9 133.4 54.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.589 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 33.3 t -118.16 123.45 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.23 169.77 10.57 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.159 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.0 p 53.19 44.53 30.12 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.352 1.061 . . . . 0.0 111.714 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.593 HG13 HD11 ' A' ' 225' ' ' ILE . 48.5 t -79.14 146.13 8.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.218 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.626 ' HB2' HD23 ' A' ' 275' ' ' LEU . 14.1 t-80 -68.95 129.86 41.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -57.0 -36.95 71.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -167.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.978 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -80.11 -47.63 14.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.074 0.464 . . . . 0.0 111.479 174.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -59.67 108.66 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.948 -178.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 225' ' ' ILE . 44.2 m -97.11 -176.96 3.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -168.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.617 ' HB3' HD13 ' A' ' 240' ' ' LEU . 4.5 p-10 -57.88 -38.65 76.15 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.46 -34.92 69.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.483 0.658 . . . . 0.0 109.974 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.649 ' OD2' ' HE3' ' B' ' 44' ' ' LYS . 3.2 m-20 -73.88 -54.34 8.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.298 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.593 HD11 HG13 ' A' ' 216' ' ' VAL . 31.3 mm -54.71 -24.84 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 222' ' ' ASP . 50.4 mtpt -52.01 -33.88 40.4 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.026 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -49.23 -58.73 4.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.529 0.68 . . . . 0.0 111.816 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.661 HG11 ' CD1' ' A' ' 273' ' ' PHE . 13.7 m -74.41 -45.18 46.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.808 -171.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.496 ' CE1' ' HE2' ' A' ' 270' ' ' MET . 76.5 m-85 -68.52 -38.37 80.84 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.096 -0.378 . . . . 0.0 111.799 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.52 -25.64 45.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.384 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.36 83.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.553 0.216 . . . . 0.0 111.368 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.711 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.4 m-30 -75.64 -27.84 58.56 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.47 -109.07 0.45 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.919 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -157.43 139.63 14.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.528 HG21 ' HB2' ' A' ' 238' ' ' CYS . 54.6 mt -94.22 132.16 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.234 0.54 . . . . 0.0 111.085 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -88.32 -42.97 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.17 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.8 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 34.5 t -147.35 143.08 27.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.625 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.528 ' HB2' HG21 ' A' ' 235' ' ' ILE . 41.8 t -146.33 124.03 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 62.8 m -157.18 127.21 6.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 222' ' ' ASP . 7.6 mp -104.49 123.49 47.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.72 136.6 57.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.215 0.531 . . . . 0.0 111.324 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.783 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 49.2 mtp85 -101.01 158.66 15.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.653 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.02 107.95 60.3 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 170.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -62.78 -38.41 49.16 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.035 2.49 . . . . 0.0 111.99 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.7 m -59.87 -42.76 94.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.252 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.4 m -90.74 -22.76 20.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 21.7 62.35 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.899 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -134.81 148.95 50.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.783 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 10.8 p80 -76.12 142.64 41.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.671 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -69.81 153.16 43.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.2 40.39 1.71 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.979 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.457 ' CZ ' ' HD3' ' A' ' 137' ' ' PRO . 28.8 p90 -159.28 160.45 35.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -169.03 -171.82 35.16 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -126.75 136.98 53.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.834 0.349 . . . . 0.0 111.055 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.12 118.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.8 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 57.4 tt0 -105.03 129.88 53.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.006 0.432 . . . . 0.0 110.259 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -107.2 161.57 14.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.84 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -22.14 20.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 262' ' ' SER . 4.8 tppt? -111.8 115.24 28.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.468 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 264' ' ' GLN . . . -60.55 -33.72 73.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.32 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -69.05 -34.51 75.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.978 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 259' ' ' LYS . 9.5 t -62.07 -38.79 90.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.5 m -59.76 -42.99 94.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 260' ' ' ALA . 59.8 mm-40 -68.15 -34.78 76.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 -174.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.4 -40.14 64.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.23 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.83 -51.92 65.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.442 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.04 -26.1 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 97.2 p -65.37 -34.7 78.93 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.672 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.6 t -116.85 0.67 12.56 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.524 ' HB2' HG11 ' A' ' 282' ' ' VAL . 34.9 mmm -79.4 -17.81 53.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.565 HD22 ' HD3' ' A' ' 281' ' ' ARG . 18.9 t-20 -61.37 -31.54 71.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.042 0.925 . . . . 0.0 110.083 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -75.32 -8.37 56.47 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.46 -174.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.713 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 55.9 t80 -57.37 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 110.395 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -77.35 119.81 21.5 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.526 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.79 HD21 HD22 ' A' ' 220' ' ' LEU . 14.5 tp -126.2 85.83 2.44 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.486 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.08 32.33 23.65 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.382 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 87.66 19.56 53.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.754 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.412 HE21 ' HD2' ' A' ' 217' ' ' HIS . 28.3 pt20 -140.9 131.97 26.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.81 0.338 . . . . 0.0 110.382 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -76.35 136.1 39.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.075 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.91 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 14.4 tp -70.71 -174.37 0.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.247 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.91 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 6.4 tpp180 -143.88 118.86 10.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.524 HG11 ' HB2' ' A' ' 270' ' ' MET . 14.7 p -118.31 144.03 27.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 110.544 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.61 -159.9 9.05 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.489 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -118.59 165.13 14.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.828 0.347 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.86 88.86 5.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -51.94 -52.37 23.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 40.8 p -121.85 161.39 42.45 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.409 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.457 -0.672 0 C-N-CA 122.693 2.262 . . . . 0.0 111.409 174.049 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.2 0.524 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -154.51 -63.61 0.13 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.835 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.24 -31.05 33.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.422 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.615 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 15.5 t80 -69.4 -18.48 63.76 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.336 0.588 . . . . 0.0 110.465 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.2 mtpt -70.64 -45.93 64.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.61 -36.15 81.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.905 172.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.711 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.0 -51.01 33.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.483 177.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.593 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -79.86 -23.38 41.97 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -174.036 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 65.6 mt-30 -58.04 -43.31 86.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 170.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 27.1 mmt180 -73.51 -30.68 63.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.456 176.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.731 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -66.51 -43.08 86.26 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -80.86 -26.86 36.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.489 -1.382 . . . . 0.0 112.136 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.15 -44.11 74.85 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.767 HG13 HD11 ' A' ' 220' ' ' LEU . 4.0 pt -69.1 -34.41 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.619 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -64.63 -27.14 68.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.376 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.63 -42.35 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.277 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.649 ' HE3' ' OD2' ' A' ' 224' ' ' ASP . 17.8 pttt -77.45 -35.36 53.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.424 -177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.978 HG23 ' HB2' ' A' ' 219' ' ' ASP . 91.7 mt . . . . . 0 C--O 1.236 0.352 0 CA-C-O 121.388 0.613 . . . . 0.0 111.016 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.754 0.311 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.19 86.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.072 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -66.89 -32.98 74.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.425 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.82 90.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.4 . . . . 0.0 111.001 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.71 -37.22 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 25.4 ttt -60.44 -28.12 68.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.2 m -91.34 6.21 46.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 113' ' ' ARG . 9.7 ptp180 -130.94 126.26 35.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.829 0.347 . . . . 0.0 110.565 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 158' ' ' VAL . 4.3 m -92.3 135.84 26.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.651 0.739 . . . . 0.0 110.834 176.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 81.2 t80 -91.1 111.24 22.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.609 -176.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 119' ' ' ILE . 9.4 t -103.01 110.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.389 . . . . 0.0 110.272 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.509 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -102.25 171.2 21.21 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.1 t 72.57 -65.69 0.34 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.97 0.508 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.512 HD13 HG12 ' A' ' 116' ' ' VAL . 10.0 mm 63.14 12.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.88 0.371 . . . . 0.0 110.545 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.835 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 11.6 t80 60.4 -80.02 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 50.5 t80 169.75 -45.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.701 0.8 . . . . 0.0 109.379 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -104.62 39.15 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.022 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 66.5 mt -114.05 99.92 8.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.98 -175.04 48.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.4 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -50.63 -49.91 55.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.165 0.507 . . . . 0.0 110.823 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -59.43 -33.68 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -80.69 -39.15 27.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.01 -48.06 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 141' ' ' ILE . 4.6 ptm180 -62.13 -35.53 79.01 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.61 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -75.07 -26.55 59.45 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.302 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.33 -34.75 63.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.695 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 84.1 m-85 -96.81 10.5 38.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.957 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 134' ' ' PRO . . . -70.67 -39.07 8.63 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.639 ' O ' ' HB1' ' A' ' 214' ' ' ALA . 52.6 Cg_exo -59.15 -18.33 43.55 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.786 1.657 . . . . 0.0 112.479 170.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.695 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 57.3 m-85 -101.89 66.6 1.05 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.79 0.328 . . . . 0.0 111.033 -175.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.63 44.27 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.38 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.41 123.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.036 2.491 . . . . 0.0 112.128 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.713 HD13 ' HE1' ' A' ' 160' ' ' TYR . 31.6 mm -67.36 108.07 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.979 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.469 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 82.0 tttt -76.6 -53.05 8.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.318 0.58 . . . . 0.0 110.144 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.2 m -155.07 143.79 20.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.466 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 129' ' ' ARG . 66.8 mt -113.11 106.15 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 35.9 t70 -81.71 98.24 8.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.0 tpt -130.3 130.05 44.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.904 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -93.53 106.14 18.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.029 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.593 ' HB3' ' HA ' ' A' ' 150' ' ' MET . 56.3 m95 -91.98 134.78 34.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.1 m-20 -73.75 102.61 4.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.261 174.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.1 t 62.07 -160.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.833 0.708 . . . . 0.0 110.551 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.3 p -74.04 -22.24 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.067 0.46 . . . . 0.0 110.494 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -13.65 61.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -173.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 145' ' ' TRP . 88.2 mtp 60.36 47.11 9.27 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.475 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.834 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 30.4 mmmt -77.79 149.99 34.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.498 . . . . 0.0 111.187 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.86 99.99 11.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.235 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.584 ' NZ ' ' HB3' ' A' ' 153' ' ' LYS . 2.3 ttpm? -149.18 64.44 1.03 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.396 0.617 . . . . 0.0 109.611 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 172.84 -179.04 44.56 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.698 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.509 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 84.1 m-85 -112.36 157.85 20.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.02 130.41 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.041 0.448 . . . . 0.0 110.802 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 67.0 m-85 -111.23 107.77 17.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.872 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.475 ' HB ' HG23 ' A' ' 114' ' ' VAL . 43.0 t -91.77 110.97 23.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.2 138.02 35.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.294 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.713 ' HE1' HD13 ' A' ' 138' ' ' ILE . 50.7 m-85 -118.92 161.01 20.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.37 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 36.0 mt-10 -99.49 9.96 42.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.661 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 10.9 m -132.56 113.51 14.21 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.389 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.46 -24.32 36.62 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 113.326 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.661 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -66.67 -54.46 22.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 110.193 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.515 ' HB3' HG23 ' A' ' 162' ' ' VAL . . . -55.38 -40.13 70.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.212 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.29 91.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.8 -41.57 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.519 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.551 HD21 ' HA3' ' A' ' 283' ' ' GLY . 18.9 mt -62.36 -42.4 99.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.012 0.434 . . . . 0.0 110.648 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.36 83.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.789 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.14 -60.92 2.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.82 -46.87 77.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.473 ' OE1' ' HD3' ' A' ' 281' ' ' ARG . 47.6 mt-30 -79.29 -35.82 40.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.431 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 51.7 tpp -77.27 -27.11 53.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.32 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -70.44 -20.3 62.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.185 0.516 . . . . 0.0 110.17 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.9 m -90.78 -2.87 57.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.728 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.01 171.12 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 111.403 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.8 mtp -117.18 97.11 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.246 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 52.9 tp -77.78 89.85 4.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 110.261 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 119.42 -157.03 15.58 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.526 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.23 18.07 50.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.016 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.835 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 8.9 ptm180 -157.41 155.72 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.19 105.6 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.274 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.63 155.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.174 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -101.69 109.91 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.902 0.382 . . . . 0.0 110.102 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.3 t -101.32 106.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.43 159.89 34.91 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.58 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -164.88 144.76 5.89 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 102.27 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.963 2.442 . . . . 0.0 112.183 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.5 m -113.99 -42.4 3.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.341 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 193' ' ' GLN . 28.5 p30 -150.62 33.82 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.887 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.3 tt -63.29 115.28 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.513 0.673 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 119.02 -38.43 2.85 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 190' ' ' ASN . 14.4 mm100 -82.28 -39.51 22.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.09 0.472 . . . . 0.0 109.863 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.83 -9.27 57.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.071 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 24.4 tp60 -63.43 -52.84 57.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.98 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -54.86 -30.81 70.09 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.519 2.146 . . . . 0.0 112.468 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.0 mm -66.04 -57.69 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.0 mt -64.59 -35.55 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.609 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.5 t70 -57.67 -49.55 76.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.435 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.87 -48.12 80.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.237 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.608 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 80.2 mt -58.97 -42.6 90.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.52 71.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.371 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 45.1 mt-10 -64.79 -42.99 94.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 288' ' ' PRO . 31.0 mt-10 -70.82 -49.36 47.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.569 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 285' ' ' ALA . . . -59.28 -31.82 69.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.995 -176.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -62.88 -27.2 69.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.92 -14.97 60.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.954 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.58 -15.12 17.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.168 0.508 . . . . 0.0 111.094 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.81 40.74 30.67 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.891 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.503 ' HD3' ' HB3' ' A' ' 254' ' ' PHE . 46.1 ttm180 -103.83 136.24 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.721 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.95 165.89 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.776 0.322 . . . . 0.0 110.792 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.526 ' HD2' HD11 ' A' ' 168' ' ' LEU . 49.1 t80 -116.65 122.88 45.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.057 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 255' ' ' ILE . 39.8 t -109.77 121.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.658 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.23 170.49 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.591 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.3 t 67.55 36.28 3.81 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.631 0.582 . . . . 0.0 111.33 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.537 HG13 HD11 ' A' ' 225' ' ' ILE . 59.9 t -79.86 138.58 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -51.81 -43.68 63.19 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -167.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.638 ' HB3' ' HB ' ' B' ' 45' ' ' ILE . 5.2 m-20 -70.17 -45.81 65.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.812 0.339 . . . . 0.0 111.066 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.687 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -66.7 103.94 1.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 225' ' ' ILE . 46.3 m -89.83 -176.85 5.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -166.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.42 -45.46 80.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.849 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.86 -28.94 69.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.277 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.655 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.0 m-20 -67.47 -59.18 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.001 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.701 HG13 HD11 ' A' ' 240' ' ' LEU . 29.5 mm -52.95 -30.58 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.136 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.44 -32.4 39.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.027 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.568 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 70.0 m -49.79 -60.99 2.39 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.654 0.74 . . . . 0.0 112.035 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.589 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.0 m -71.74 -39.82 69.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.624 -171.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.762 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 65.1 m-85 -66.71 -39.71 88.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.726 0.298 . . . . 0.0 111.697 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.9 -24.75 55.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.421 ' O ' ' HB1' ' B' ' 30' ' ' ALA . . . -72.98 -24.28 60.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.256 -174.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.626 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.5 m-30 -87.47 24.71 1.59 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.48 0.657 . . . . 0.0 110.525 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 234' ' ' LYS . . . 149.27 -113.42 0.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 233' ' ' GLY . 28.4 mmmt -136.72 161.67 35.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.567 HG12 ' SG ' ' A' ' 238' ' ' CYS . 6.6 tp -122.17 139.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.528 0.68 . . . . 0.0 110.665 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -88.4 -62.74 1.42 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 15.2 m -140.88 143.79 34.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.366 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.567 ' SG ' HG12 ' A' ' 235' ' ' ILE . 74.7 m -134.52 106.82 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 21.4 m -141.48 104.71 4.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.167 0.508 . . . . 0.0 111.467 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.806 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 79.8 mt -83.57 130.75 35.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.56 101.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.598 0.561 . . . . 0.0 111.205 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 6.5 ppt_? -90.46 144.73 25.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.509 . . . . 0.0 110.846 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.03 122.76 76.02 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.504 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.67 -20.28 40.66 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.911 2.407 . . . . 0.0 113.514 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.87 -39.14 14.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 44.9 p -88.03 -35.5 17.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.864 0.364 . . . . 0.0 111.338 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.15 -2.32 68.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.658 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -108.75 157.46 18.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.887 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 16.8 p80 -86.4 145.57 26.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.254 0.55 . . . . 0.0 110.925 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.75 158.61 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.04 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -74.8 43.79 1.44 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 114.183 0.433 . . . . 0.0 114.183 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -166.18 164.64 17.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.806 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . 178.04 -169.98 42.02 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.559 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.503 ' HB3' ' HD3' ' A' ' 210' ' ' ARG . 90.6 m-85 -119.86 140.01 51.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.847 0.356 . . . . 0.0 110.538 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.433 HD12 HG21 ' A' ' 213' ' ' VAL . 48.8 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.91 176.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.99 146.25 29.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.357 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.415 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 34.2 m-85 -120.19 137.01 54.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.442 170.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -83.6 -29.5 27.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -95.8 113.56 25.21 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.837 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.29 69.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.798 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -69.41 -34.01 73.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.537 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 43.3 m -78.44 -31.51 48.07 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 267' ' ' VAL . 1.5 p -65.6 -42.92 91.1 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.173 -0.329 . . . . 0.0 111.534 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -60.72 -36.58 79.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.588 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.97 -47.38 37.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.745 -176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.43 74.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.076 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 263' ' ' SER . 94.6 t -58.12 -40.25 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.979 0.419 . . . . 0.0 111.254 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.2 t -71.69 -28.9 64.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 t -89.95 -43.51 10.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.768 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.881 ' HB3' HG21 ' A' ' 282' ' ' VAL . 0.0 OUTLIER -74.25 -6.33 47.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.58 -36.6 76.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.416 1.103 . . . . 0.0 109.0 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -79.77 -7.76 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.646 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.715 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 2.4 t80 -58.84 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.278 0.561 . . . . 0.0 110.563 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 8.3 t70 -93.75 116.32 28.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.221 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.687 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.8 mm? -114.73 87.05 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.761 175.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.73 -86.62 0.6 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.582 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -146.37 26.75 1.69 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.106 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 20.2 pt20 -141.02 131.75 25.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.887 0.375 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.454 ' CD2' ' HB2' ' A' ' 274' ' ' ASP . 63.7 m-85 -91.66 130.81 37.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.265 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.693 HD22 ' HD2' ' A' ' 273' ' ' PHE . 7.2 mp -63.54 168.65 4.48 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.528 0.68 . . . . 0.0 111.005 175.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.473 ' HD3' ' OE1' ' A' ' 172' ' ' GLN . 2.6 mmp_? -132.45 112.11 11.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' A' ' 270' ' ' MET . 94.7 t -116.33 133.27 63.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.084 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.551 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -137.83 -156.09 7.07 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.174 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -103.45 172.67 6.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.412 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -59.41 -35.83 74.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.571 0.224 . . . . 0.0 111.502 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 61.5 t 70.42 -64.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.82 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.458 HG22 ' HG3' ' A' ' 164' ' ' GLU . 12.2 t -98.06 143.09 25.64 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 69.5 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 122.722 2.281 . . . . 0.0 112.113 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 . . . . . 0 CA--C 1.526 0.055 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.19 -30.28 18.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.047 0.451 . . . . 0.0 109.919 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 231' ' ' ALA . . . -63.0 -37.02 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.1 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.594 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 19.1 t80 -75.95 -22.75 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 110.271 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -75.8 -43.83 44.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.968 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -61.34 -37.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.626 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.63 -49.44 56.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.611 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.718 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.81 -21.77 37.46 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -171.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -62.55 -38.18 89.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.568 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 61.3 mtp180 -74.09 -35.43 64.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.629 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.718 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -63.13 -44.24 96.13 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 34.3 mtt180 -81.65 -26.99 34.32 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 112.96 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.66 -49.17 65.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 0.0 109.82 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 6.3 pt -68.05 -30.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.496 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.89 -27.9 67.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.377 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.35 -31.02 19.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 7.3 ttpt -82.18 -38.5 24.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.377 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.638 ' HB ' ' HB3' ' A' ' 219' ' ' ASP . 30.6 pt . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 125.288 1.435 . . . . 0.0 114.043 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.36 0.124 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.26 72.3 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.3 mt -64.95 -38.83 92.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.236 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.45 -31.64 60.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.77 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.61 -36.19 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.362 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.0 mtp -69.24 -34.04 74.2 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 28.5 p -73.78 -11.35 60.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.906 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.695 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 91.8 mtt180 -105.71 103.26 12.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -91.51 146.6 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.466 0.651 . . . . 0.0 111.377 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 61.5 t80 -86.33 118.68 25.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.878 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.15 113.47 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 110.192 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.79 174.51 15.25 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.345 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 t 74.73 42.41 0.29 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.541 0.737 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.54 136.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.331 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -108.84 98.51 7.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.451 ' HD1' ' HA ' ' A' ' 151' ' ' LYS . 34.0 t80 37.87 -84.22 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 165.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -71.87 -16.73 62.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.786 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 127' ' ' THR . 88.8 mt -77.96 98.91 5.84 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.79 -167.53 43.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.108 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.95 -29.36 70.29 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.77 -49.58 76.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.482 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.502 HG21 HD22 ' A' ' 123' ' ' LEU . 55.9 m -64.27 -42.2 96.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.052 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.92 -42.3 88.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.425 0.631 . . . . 0.0 110.133 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.481 ' HA ' ' CD1' ' A' ' 138' ' ' ILE . 39.5 ttt180 -56.56 -46.8 80.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.024 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -77.97 -33.34 51.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.187 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.65 77.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.511 . . . . 0.0 111.207 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.496 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 46.2 m-85 -99.59 10.33 41.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.74 -45.25 16.8 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 23.6 Cg_endo -62.06 -10.44 17.9 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.02 1.813 . . . . 0.0 112.795 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -79.25 -67.61 0.74 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 109.803 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.49 165.91 33.09 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.71 112.33 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.31 2.007 . . . . 0.0 111.293 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 129' ' ' ARG . 56.7 mt -68.51 129.16 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 109.981 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -96.83 -50.92 4.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.684 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 t -149.23 161.88 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.5 mt -137.28 109.91 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.635 0.255 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.797 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 47.8 m-20 -84.33 111.17 19.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.271 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.582 ' HG2' ' HB3' ' A' ' 145' ' ' TRP . 24.7 ttp -156.2 101.12 2.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 0.0 110.782 175.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.0 m -77.95 69.24 4.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.91 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 14.3 p-90 -96.32 145.79 25.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.96 111.18 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.424 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 m -90.83 -12.89 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.86 -54.03 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.967 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.5 p -91.7 -19.27 22.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.164 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.652 ' HG3' ' CZ3' ' A' ' 145' ' ' TRP . 15.3 ttp 66.74 25.77 9.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.318 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.451 ' HA ' ' HD1' ' A' ' 121' ' ' TYR . 59.5 pttt -105.32 19.78 20.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.438 . . . . 0.0 110.968 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.91 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 41.1 m-70 60.2 -161.33 0.28 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.626 173.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 145' ' ' TRP . 74.6 mmtt -117.99 -44.14 2.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 157.29 -21.39 0.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.611 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.64 161.61 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.201 0.5 . . . . 0.0 112.173 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.509 ' HB2' ' SD ' ' A' ' 143' ' ' MET . . . -149.36 156.25 41.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.504 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.797 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 80.8 m-85 -114.04 112.39 23.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 57.5 t -99.07 116.86 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.944 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.695 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 42.4 tt0 -94.15 130.51 40.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.91 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 80.4 m-85 -100.18 155.83 17.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.778 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.99 -33.34 75.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 172.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 17.3 m -128.62 133.31 25.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.038 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 37.6 Cg_exo -60.28 -23.15 73.37 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.323 2.682 . . . . 0.0 113.103 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -54.71 -49.91 69.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 111.211 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.32 70.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.056 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.15 86.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.46 -44.85 93.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.142 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 33.7 mt -63.21 -35.4 80.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 0.0 110.577 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -66.6 -30.6 70.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.633 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.46 -59.34 2.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.27 -39.92 14.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 14.6 mm100 -82.45 -34.69 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 55.9 tpp -72.71 -31.74 65.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.462 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.38 -19.8 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.215 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 41.6 t -78.49 -7.73 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.722 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.56 126.52 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 110.799 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 88.5 mtp -83.96 79.77 9.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 55.7 tp -58.51 118.46 5.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.101 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.07 11.89 83.93 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.406 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.67 5.38 89.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.145 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 181' ' ' ARG . 17.6 mtp180 -112.67 155.3 24.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -91.82 103.84 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.852 0.834 . . . . 0.0 109.106 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.47 146.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.116 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -102.08 110.66 22.68 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 16.1 m -118.64 133.85 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.58 145.72 8.61 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.822 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.589 ' HD3' ' HB2' ' A' ' 115' ' ' TYR . 20.8 ptt180 -151.08 123.9 4.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 1.7 Cg_endo -84.36 72.62 4.99 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.258 2.639 . . . . 0.0 111.011 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 m -64.83 -22.36 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.749 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -155.21 151.11 27.75 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.52 125.0 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.839 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.96 -18.7 8.81 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.986 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -72.78 -57.25 4.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.753 0.311 . . . . 0.0 111.239 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.93 5.64 40.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.058 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.517 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 59.8 tp60 -60.96 -51.71 77.4 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.721 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 15.1 Cg_endo -57.78 -25.04 66.83 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.122 1.881 . . . . 0.0 112.169 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.81 -55.93 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.603 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.6 pt -65.84 -32.0 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -45.95 90.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.887 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -58.09 -48.68 79.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.699 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.64 -50.87 70.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.171 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -60.96 -41.61 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.046 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.28 -44.26 95.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.435 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.53 -43.06 95.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.539 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.96 66.88 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.874 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 75.8 mtp180 -65.87 -18.51 65.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.094 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.95 55.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 111.167 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -104.05 -19.43 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.273 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 257' ' ' TYR . 88.6 m-20 59.43 30.45 20.13 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.57 177.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.505 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 97.4 mtt180 -88.54 140.56 29.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.229 0.538 . . . . 0.0 111.666 -175.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.723 HD13 ' HE1' ' A' ' 229' ' ' PHE . 8.3 tt -119.95 151.15 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -108.88 126.99 53.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.119 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.518 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.8 p -118.75 122.72 70.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.147 0.499 . . . . 0.0 110.717 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.05 -177.91 3.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.882 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 41.8 m 67.71 16.68 9.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.634 0.774 . . . . 0.0 111.485 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.675 HG13 HD11 ' A' ' 225' ' ' ILE . 66.9 t -62.52 135.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.485 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.78 139.77 47.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.74 -30.97 69.71 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -167.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -79.59 -24.72 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.366 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.801 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -83.63 104.86 14.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 2.4 p -87.39 -177.28 5.89 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.64 -54.39 14.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.989 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.46 -27.9 69.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.936 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.613 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 3.3 m-20 -63.68 -55.58 22.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.332 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.675 HD11 HG13 ' A' ' 216' ' ' VAL . 33.5 mm -60.5 -24.51 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.25 -31.34 68.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.199 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 69.7 m -48.86 -60.39 2.79 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.985 0.898 . . . . 0.0 111.634 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.676 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.1 m -71.0 -45.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.676 -170.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.723 ' HE1' HD13 ' A' ' 211' ' ' ILE . 41.4 m-85 -60.96 -40.31 92.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -76.68 -34.4 58.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.674 -175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.98 -25.14 66.96 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.724 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 6.9 m-30 -73.59 -42.79 61.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.85 -100.8 0.21 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.672 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.76 157.66 43.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.08 138.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.484 . . . . 0.0 110.831 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 15.0 mmtp -88.02 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.556 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 27.0 t -145.03 145.05 31.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.811 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.31 129.58 45.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.6 p -145.11 112.52 6.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.29 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.623 HD23 ' HA3' ' A' ' 253' ' ' GLY . 78.0 mt -85.91 129.58 34.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.11 143.29 56.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -121.41 157.27 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.62 121.93 73.32 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.12 -18.01 60.39 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.139 2.56 . . . . 0.0 113.96 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 p -82.34 -33.99 28.67 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.559 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 45.2 p -112.25 -34.58 5.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 111.847 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.25 59.12 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.597 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.9 141.53 42.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 5.9 p80 -79.0 143.35 35.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 0.0 110.576 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -81.15 156.09 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.147 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -77.69 46.46 2.6 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.88 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.23 157.27 17.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.966 0.383 . . . . 0.0 110.171 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.623 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -167.97 -175.28 37.59 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.355 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.08 141.17 52.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.763 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.555 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 24.2 mm -124.12 135.75 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.048 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 37.1 mt-10 -104.98 141.6 36.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.675 0.274 . . . . 0.0 111.238 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 209' ' ' ASN . 36.3 m-85 -124.25 149.55 46.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.214 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 258' ' ' GLU . 1.1 pm0 -87.22 -17.89 31.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.822 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.755 ' HA ' ' HE3' ' A' ' 259' ' ' LYS . 1.0 OUTLIER -137.28 132.05 33.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.985 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -62.04 -40.75 96.81 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.187 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 13.3 pt20 -63.76 -32.58 74.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 110.694 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.3 t -65.23 -40.66 94.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.1 m -65.13 -36.27 83.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 91.0 mt-30 -61.88 -33.76 74.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.098 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.91 -48.12 64.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.873 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -56.26 -41.68 76.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.661 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 264' ' ' GLN . 22.9 m -65.47 -27.02 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.3 p -94.02 -29.34 15.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.598 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.6 m -92.72 -38.31 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.724 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.8 mmm -65.83 -23.46 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -171.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.432 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 66.6 t30 -59.06 -35.04 72.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.738 . . . . 0.0 110.54 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.411 ' N ' HD22 ' A' ' 272' ' ' LEU . 3.8 mm? -77.84 -10.51 59.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.879 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -58.64 112.2 1.53 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.388 -175.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.15 120.99 35.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.926 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.801 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.0 mm? -120.19 87.57 2.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.202 172.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.63 35.67 18.85 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.949 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.25 62.45 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.937 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -124.43 131.68 53.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 110.394 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -75.68 149.55 38.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.744 HD21 HD23 ' A' ' 275' ' ' LEU . 11.4 mt -79.35 -172.79 3.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.958 0.409 . . . . 0.0 110.056 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.432 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 56.8 mmt-85 -147.08 113.45 5.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.873 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 270' ' ' MET . 21.0 m -122.65 157.66 27.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.14 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -177.17 -171.24 40.51 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.767 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -82.0 140.06 34.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.059 0.457 . . . . 0.0 109.917 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -67.24 -21.33 65.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.795 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 74.6 t 71.12 -65.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.787 0.435 . . . . 0.0 111.008 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.5 t -111.58 140.76 23.49 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 CA--C 1.531 0.347 0 C-N-CA 122.287 1.992 . . . . 0.0 112.135 176.68 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.604 0.716 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.83 -71.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.091 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.68 -38.59 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.894 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.571 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 6.1 t80 -65.4 -17.24 64.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.675 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.622 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.4 mttt -69.68 -49.49 52.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.751 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 14.4 t70 -57.12 -42.27 80.56 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.676 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -45.47 -54.31 7.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.669 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.865 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.91 -21.49 37.32 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -171.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 79.8 mt-30 -64.94 -39.37 93.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.821 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 17.7 mmt180 -73.79 -32.96 64.02 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.626 172.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.879 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -66.62 -44.66 81.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.253 36.8 mtp85 -82.33 -25.69 33.67 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.209 -1.557 . . . . 0.0 112.773 172.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.815 ' HA ' HE21 ' B' ' 40' ' ' GLN . 0.0 OUTLIER -53.29 -47.0 69.55 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 168.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.749 HD11 ' HZ ' ' A' ' 273' ' ' PHE . 9.2 pt -67.27 -34.27 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.468 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.521 ' O ' HG23 ' B' ' 45' ' ' ILE . . . -66.36 -25.44 66.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.888 0.375 . . . . 0.0 111.287 176.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.55 -15.53 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.748 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.487 ' HE3' ' HB3' ' B' ' 44' ' ' LYS . 1.5 tmmt? -89.84 -33.74 16.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.521 HG23 ' O ' ' B' ' 42' ' ' ALA . 7.3 pt . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.65 157.54 19.66 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.68 -0.119 . . . . 0.0 110.68 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 48.8 ttm 64.94 78.13 0.29 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.594 0.559 . . . . 0.0 110.055 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.96 90.66 4.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.848 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -95.1 -31.26 13.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.575 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 49.79 74.27 0.21 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.223 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 62.83 95.52 0.04 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.305 -173.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -54.21 -31.38 52.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.536 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 111' ' ' MET . . . -56.77 -48.66 77.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.973 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.48 HD11 ' HG3' ' A' ' 163' ' ' PRO . 59.0 tp -71.47 -36.62 71.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.755 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.93 84.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.369 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.2 pt -78.6 -34.55 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.427 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 107' ' ' ALA . 89.9 mtp -61.52 -26.76 68.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -84.35 -2.19 56.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.6 0.238 . . . . 0.0 111.279 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 27.0 ttp180 -128.74 109.48 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.927 0.394 . . . . 0.0 110.714 -175.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.1 m -92.57 141.28 14.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.484 0.659 . . . . 0.0 111.649 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 53.0 t80 -86.09 130.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.982 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 111.71 37.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.07 0.462 . . . . 0.0 110.085 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.07 155.73 15.95 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.928 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.1 m 68.87 49.97 0.64 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 110.462 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.45 127.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.185 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -45.17 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.867 0.729 . . . . 0.0 112.79 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -178.38 -64.54 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.559 0.219 . . . . 0.0 110.98 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.12 18.98 2.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.006 0.431 . . . . 0.0 112.087 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 3.6 pp -130.21 141.3 50.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.954 0.407 . . . . 0.0 110.489 176.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.66 -152.43 5.96 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -59.59 -31.57 69.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.528 0.664 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.22 -43.41 98.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.132 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 2.1 m -84.87 -43.77 13.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.336 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 98.1 mt -60.44 -36.58 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.081 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -55.71 -44.13 77.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.95 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -77.82 -34.75 51.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.312 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -33.27 75.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.395 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.636 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 98.2 m-85 -108.14 12.07 27.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.609 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.55 -44.87 46.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.268 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 17.8 Cg_endo -61.19 -17.28 51.61 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.215 1.943 . . . . 0.0 112.553 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -80.05 -70.16 0.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -150.47 155.06 26.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.544 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 24.5 Cg_exo -64.13 132.5 34.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.621 2.214 . . . . 0.0 111.586 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.68 110.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.164 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.899 ' HD3' ' HG2' ' A' ' 161' ' ' GLU . 39.2 tptt -83.26 -46.96 12.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.063 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -160.15 153.99 22.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.33 123.09 49.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.741 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 21.2 m-20 -90.44 97.34 11.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 171.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 14.0 tpt -105.82 148.67 27.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.002 0.43 . . . . 0.0 111.371 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.0 m -119.09 84.31 2.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.704 176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -80.2 116.38 20.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.141 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 153' ' ' LYS . 14.9 t70 -95.8 117.2 30.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.649 ' HB3' HG22 ' A' ' 149' ' ' THR . 43.9 t 69.13 162.73 0.22 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.059 0.849 . . . . 0.0 111.733 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.45 -22.32 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.649 HG22 ' HB3' ' A' ' 147' ' ' SER . 9.8 t -60.29 -25.12 65.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.102 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.2 mtt 64.32 43.36 4.77 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.827 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.513 ' HG2' HG23 ' A' ' 149' ' ' THR . 31.4 mmmt -93.23 12.79 23.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.052 0.453 . . . . 0.0 110.813 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.0 p80 41.56 44.69 2.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.489 1.116 . . . . 0.0 113.079 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 28.4 tttm -70.75 96.99 1.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.347 0.594 . . . . 0.0 110.033 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 158.18 -129.27 2.27 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.221 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -148.36 170.46 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.238 0.215 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.19 153.13 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 111.047 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HE2' ' HD2' ' A' ' 187' ' ' ARG . 90.6 m-85 -123.14 124.8 43.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.036 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.2 t -106.22 111.04 33.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 31.8 tt0 -99.58 131.04 45.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -105.68 174.15 6.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.085 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.899 ' HG2' ' HD3' ' A' ' 139' ' ' LYS . 32.2 mt-10 -85.4 -16.26 40.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.097 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.81 135.29 21.5 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.4 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.48 ' HG3' HD11 ' A' ' 108' ' ' LEU . 55.4 Cg_endo -69.87 -17.77 36.9 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.987 2.458 . . . . 0.0 112.197 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -62.85 -40.21 96.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.696 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.92 89.16 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.248 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.84 86.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.483 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -62.2 -47.1 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 283' ' ' GLY . 34.4 mt -66.59 -33.49 75.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.15 0.5 . . . . 0.0 110.561 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.614 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -64.77 -34.13 77.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.298 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.17 -55.47 5.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.972 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.93 -47.68 76.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.511 ' HG2' ' HD2' ' A' ' 281' ' ' ARG . 17.1 mp0 -91.0 -49.88 6.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.636 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 12.6 mmt -66.97 -30.81 71.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.76 -21.28 37.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.151 0.5 . . . . 0.0 110.891 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.2 m -90.98 -24.01 20.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.114 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.2 t -116.0 119.51 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.193 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 89.6 mtp -67.19 108.7 2.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 110.882 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 178' ' ' LEU . 2.5 pt? -81.2 7.54 10.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.799 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.53 -167.29 35.53 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.98 25.42 2.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.629 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -158.3 133.69 8.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -91.96 129.47 37.91 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.4 pt -91.61 151.69 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 184' ' ' LYS . 20.6 ptmt -100.95 116.59 33.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.0 t -103.24 122.46 55.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.546 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 105.96 172.99 23.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.419 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.669 ' HD2' ' HE2' ' A' ' 157' ' ' PHE . 75.7 mtp180 -130.0 92.22 37.28 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.624 0.25 . . . . 0.0 110.411 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.06 80.54 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.894 2.396 . . . . 0.0 111.661 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 t -143.9 -54.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.18 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -90.04 5.89 44.68 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.09 0.472 . . . . 0.0 111.212 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 39.9 pt -68.11 153.61 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 88.78 -51.74 3.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.928 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.33 69.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.37 0.605 . . . . 0.0 109.764 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -91.53 1.56 57.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.976 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.554 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.7 tp60 -59.57 -50.04 89.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.103 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 11.2 Cg_endo -55.52 -27.46 59.61 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.353 2.036 . . . . 0.0 112.221 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.9 mm -77.38 -43.66 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.322 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 80.7 mt -59.52 -50.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.89 -29.92 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.206 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -68.01 -50.08 57.67 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.63 -48.56 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.028 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.03 93.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.224 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 206' ' ' ARG . 3.3 tp10 -69.39 -33.51 73.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.511 . . . . 0.0 110.659 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.02 -45.12 62.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.369 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.12 -24.79 64.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 203' ' ' GLU . 68.3 ttt180 -60.45 -25.04 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.908 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.54 -16.45 64.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.481 ' C ' HD22 ' A' ' 209' ' ' ASN . 60.3 m-85 -104.96 -4.94 21.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.155 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.481 HD22 ' C ' ' A' ' 208' ' ' PHE . 0.1 OUTLIER 32.32 43.17 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 114.252 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 256' ' ' GLU . 24.8 mtp180 -90.16 141.8 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.697 HD13 ' HE1' ' A' ' 229' ' ' PHE . 12.8 tt -99.14 152.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.532 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -107.67 124.54 50.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 0.0 110.24 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 255' ' ' ILE . 17.6 t -108.41 116.88 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.002 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.539 ' O ' ' HG ' ' A' ' 280' ' ' LEU . . . -121.07 173.83 7.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.56 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 35.0 m 64.85 28.33 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.744 0.653 . . . . 0.0 110.778 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.548 HG13 HD11 ' A' ' 225' ' ' ILE . 57.7 t -72.69 133.87 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.374 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 13.6 t-80 -69.1 135.04 50.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 109.764 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -55.62 -41.74 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.667 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.604 ' HB2' ' HB ' ' B' ' 45' ' ' ILE . 2.6 p30 -80.35 -46.95 15.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.625 HD13 HD22 ' A' ' 275' ' ' LEU . 0.1 OUTLIER -50.72 122.69 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.403 0.681 . . . . 0.0 109.954 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 225' ' ' ILE . 22.1 m -99.74 -178.46 3.88 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -167.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.13 -55.42 31.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.014 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 226' ' ' LYS . 2.6 m-20 -62.88 -27.35 69.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.411 ' HB3' HD12 ' B' ' 41' ' ' ILE . 71.9 m-20 -66.66 -49.17 67.04 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.749 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.548 HD11 HG13 ' A' ' 216' ' ' VAL . 21.8 mm -61.16 -24.74 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.271 0.558 . . . . 0.0 109.971 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 223' ' ' ASP . 11.0 mmmm -59.43 -31.8 69.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 174.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 71.2 m -47.79 -54.94 10.83 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.506 0.669 . . . . 0.0 111.034 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.611 HG12 ' HB1' ' B' ' 34' ' ' ALA . 12.5 m -75.24 -49.97 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.665 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.697 ' HE1' HD13 ' A' ' 211' ' ' ILE . 50.0 m-85 -61.21 -46.99 88.19 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.55 ' HB2' ' HE2' ' A' ' 226' ' ' LYS . 27.9 tt0 -77.94 -12.53 59.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.368 . . . . 0.0 111.272 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.62 51.36 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.357 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.694 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 0.9 OUTLIER -93.82 -52.66 4.34 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -138.74 -164.5 9.93 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.438 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -108.82 139.1 44.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.549 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.635 ' HB ' ' HE3' ' A' ' 226' ' ' LYS . 3.2 mp -120.27 134.37 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -97.73 -29.06 13.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 111.721 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.6 t -143.34 132.44 23.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.545 ' SG ' ' HD3' ' A' ' 226' ' ' LYS . 9.1 p -144.03 113.56 7.05 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.836 0.35 . . . . 0.0 110.599 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 63.4 m -151.37 122.43 7.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.517 . . . . 0.0 111.353 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.683 HD23 ' HA3' ' A' ' 253' ' ' GLY . 43.4 mt -85.1 130.04 34.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.61 129.63 42.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.691 0.281 . . . . 0.0 110.907 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -78.97 140.47 38.01 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.558 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.3 t70 -111.55 116.82 50.03 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.42 -27.88 46.74 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 123.138 2.559 . . . . 0.0 113.659 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.42 HG22 ' OD1' ' A' ' 243' ' ' ASP . 5.1 t -93.32 -27.76 16.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.991 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.3 m -81.14 -36.67 29.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.061 0.458 . . . . 0.0 110.167 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 96.74 -18.45 57.48 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.738 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -108.04 -84.67 0.53 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 0.0 110.46 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -164.08 154.02 14.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.558 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 56.0 mttm -71.41 155.38 40.7 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.64 31.52 1.03 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 121.293 -0.479 . . . . 0.0 113.661 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 27.1 p90 -152.97 164.02 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.109 0.454 . . . . 0.0 110.281 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.683 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -164.15 168.42 38.58 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.62 114.57 26.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.041 0.448 . . . . 0.0 110.582 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.425 HD12 HG21 ' A' ' 213' ' ' VAL . 43.8 mt -107.1 139.73 27.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.822 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 210' ' ' ARG . 38.1 tt0 -115.67 115.52 26.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.698 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.31 152.93 21.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.554 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.518 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 15.0 pt-20 -88.75 -16.98 30.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.878 0.371 . . . . 0.0 110.494 177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.518 ' HG3' ' HG3' ' A' ' 258' ' ' GLU . 22.5 mtpp -128.57 135.77 49.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.11 -25.17 61.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.618 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -66.03 -50.33 64.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.211 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.9 m -63.61 -33.87 76.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.439 -176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 267' ' ' VAL . 31.7 t -57.3 -46.91 82.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.178 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.55 -34.67 77.53 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.83 -44.43 96.17 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.243 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.22 80.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 263' ' ' SER . 62.0 t -52.73 -36.35 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.853 0.359 . . . . 0.0 111.508 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 42.8 m -69.08 -24.76 64.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 38.9 m -115.33 -27.15 7.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.587 ' HE1' HG21 ' A' ' 228' ' ' VAL . 43.4 mmm -66.94 -13.69 62.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.28 -35.86 80.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.11 0.957 . . . . 0.0 109.121 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.5 mm? -77.39 -9.28 58.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.981 -175.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.922 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 6.2 t80 -51.26 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.137 0.494 . . . . 0.0 111.173 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -82.97 121.49 27.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.242 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.625 HD22 HD13 ' A' ' 220' ' ' LEU . 65.9 mt -125.66 85.87 2.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.041 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.54 27.09 57.93 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.871 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 110.43 -17.42 28.6 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.46 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 18.0 pt20 -102.21 130.45 48.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.816 0.341 . . . . 0.0 110.721 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -80.18 134.61 36.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.654 HD22 ' HD2' ' A' ' 273' ' ' PHE . 2.4 tp -66.78 -178.51 0.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.968 0.792 . . . . 0.0 110.78 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.511 ' HD2' ' HG2' ' A' ' 172' ' ' GLN . 5.6 tpp180 -148.52 112.68 5.21 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.84 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 270' ' ' MET . 18.6 m -111.48 159.48 11.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.558 . . . . 0.0 111.897 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -157.8 -136.03 2.01 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.687 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -142.86 167.75 21.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -87.71 124.92 34.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.03 -29.73 3.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.381 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.7 t -129.94 143.87 50.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -51.04 104.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.34 2.693 . . . . 0.0 112.15 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.04 40.11 0.91 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.974 2.45 . . . . 0.0 112.399 -173.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 82.2 mtp -133.73 136.95 27.6 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.652 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.54 69.28 2.75 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 122.847 2.365 . . . . 0.0 112.196 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 92.8 mt -94.37 40.71 1.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 110.246 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.54 96.89 6.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.259 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.767 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 25.6 m -61.48 -54.69 50.01 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.479 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.767 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 62.8 Cg_endo -91.27 123.11 0.78 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.15 1.9 . . . . 0.0 112.618 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -84.57 67.35 9.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.111 0.481 . . . . 0.0 110.585 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.605 -0.712 . . . . 0.0 110.715 -177.843 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 112.186 -0.366 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.64 132.56 34.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.92 0.391 . . . . 0.0 111.053 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -83.15 166.05 18.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.966 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.97 -53.82 4.4 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -100.65 53.18 0.87 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.558 HG23 ' HB2' ' B' ' 31' ' ' PHE . 25.7 m -62.13 133.08 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.691 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 7.5 t30 -94.52 -46.07 7.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.549 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.91 -46.61 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 -43.53 77.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.694 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 9.8 t80 -78.97 -22.51 45.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.958 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.8 mtpt -79.06 -35.01 43.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.785 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.527 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 58.1 t0 -57.07 -46.48 82.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.689 ' HB2' ' CE1' ' A' ' 232' ' ' PHE . . . -49.09 -52.9 23.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.169 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.803 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.7 -25.28 35.6 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -168.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 32.8 mt-30 -63.24 -38.05 89.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.703 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 67.3 mtt180 -71.57 -39.29 70.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.734 172.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.922 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.98 -46.85 85.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.147 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.262 31.9 mtt-85 -80.51 -24.35 39.45 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.166 -1.413 . . . . 0.0 112.898 174.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 56.1 tt0 -53.63 -49.87 66.95 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.248 0.546 . . . . 0.0 109.976 167.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.809 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -65.69 -30.45 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -21.84 42.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.387 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.91 72.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.732 ' HG3' HG12 ' B' ' 45' ' ' ILE . 48.5 pttt -72.66 -43.91 62.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.448 174.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.732 HG12 ' HG3' ' B' ' 44' ' ' LYS . 5.7 pt -139.37 116.64 10.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.851 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.09 -51.36 0.84 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.855 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.69 104.92 0.23 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.878 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.21 123.48 24.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.834 0.349 . . . . 0.0 110.488 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.57 13.49 28.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.206 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.42 -97.07 1.84 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.163 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 3.5 m -89.41 -67.61 0.83 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.129 0.49 . . . . 0.0 110.098 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 46.9 p . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.895 179.388 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.59 84.59 0.14 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 122.968 0.507 . . . . 0.0 111.625 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.2 ttt -69.52 -31.67 70.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.604 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.23 64.88 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.198 0.523 . . . . 0.0 111.413 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -81.9 67.98 8.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.942 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.567 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.0 ptt180 -74.06 -7.6 53.09 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.421 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.41 -50.76 58.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.361 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -70.32 -29.37 66.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.169 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.07 96.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.412 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 79.9 mt -63.64 -36.98 85.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.56 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.55 -28.08 66.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.824 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.36 -43.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.137 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 81.4 mmm -61.24 -40.55 94.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.094 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.452 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 98.8 m -65.22 -19.57 66.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 9.8 ptm85 -116.27 107.18 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.528 0.68 . . . . 0.0 111.264 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.8 m -97.33 135.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.363 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 19.4 t80 -78.35 126.78 31.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.384 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 185' ' ' VAL . 15.3 m -123.67 111.64 29.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.419 0.628 . . . . 0.0 110.02 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -133.9 102.76 0.47 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.625 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.622 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.6 t 168.12 77.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.3 mt -110.16 134.56 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -60.06 -75.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.17 0.294 . . . . 0.0 111.199 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -169.12 -53.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.198 0.523 . . . . 0.0 110.359 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -19.6 19.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.817 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.6 mt -58.58 108.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 0.0 110.792 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 152' ' ' HIS . . . -83.09 -178.77 52.41 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.614 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.47 -24.42 65.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.749 0.309 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.47 -43.53 93.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.323 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -62.19 -44.58 96.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.71 -46.75 91.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.0 110.57 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.528 ' HG3' HG13 ' A' ' 138' ' ' ILE . 70.6 ttt180 -57.47 -45.75 84.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.006 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -77.25 -19.15 56.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.004 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.43 57.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.986 0.422 . . . . 0.0 110.582 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.762 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 74.0 m-85 -101.86 7.45 41.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.26 0.552 . . . . 0.0 110.797 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -72.14 -42.37 9.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.928 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 133' ' ' ALA . 36.6 Cg_exo -63.59 -4.97 7.74 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.155 1.903 . . . . 0.0 112.716 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -92.7 -75.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.784 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -142.77 168.86 25.8 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 18.6 Cg_exo -66.14 133.71 34.07 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.54 2.16 . . . . 0.0 111.585 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.528 HG13 ' HG3' ' A' ' 129' ' ' ARG . 47.6 mm -72.02 114.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.358 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -94.71 -46.03 7.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 29.9 t -143.88 135.22 25.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.833 0.349 . . . . 0.0 110.946 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.467 HG22 ' HG3' ' A' ' 143' ' ' MET . 65.9 mt -116.65 106.12 19.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.436 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.2 m-20 -111.33 98.28 7.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.467 ' HG3' HG22 ' A' ' 141' ' ' ILE . 79.7 mtp -109.5 163.68 13.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.08 0.466 . . . . 0.0 111.148 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.41 ' O ' ' HA3' ' A' ' 154' ' ' GLY . 66.6 m -145.87 85.67 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.83 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.443 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 13.1 p-90 -144.92 160.13 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.697 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.48 91.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.2 m -85.35 -9.53 57.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.361 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 m -80.15 -52.1 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.623 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -112.9 21.38 15.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.614 0.721 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.443 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 89.7 mmm 61.69 -157.2 0.34 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.16 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm 73.54 105.42 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -172.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.423 ' NE2' ' HA2' ' A' ' 124' ' ' GLY . 14.8 m-70 -77.6 68.87 3.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.35 31.73 1.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.999 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 144' ' ' SER . . . -139.68 175.25 21.88 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.813 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -114.37 173.51 6.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.425 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -139.9 148.51 42.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.461 . . . . 0.0 111.689 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.449 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 86.2 m-85 -116.94 118.67 33.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 p -110.1 120.03 60.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.302 0.572 . . . . 0.0 110.958 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.8 tt0 -107.63 134.76 50.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.906 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.61 167.15 9.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.889 0.376 . . . . 0.0 111.647 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.3 -45.28 88.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.168 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.593 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 23.9 m -115.73 138.2 23.76 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.113 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.452 ' HG3' ' SG ' ' A' ' 112' ' ' CYS . 16.5 Cg_exo -68.09 -20.48 43.98 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.4 2.734 . . . . 0.0 112.29 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.593 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 4.0 mp0 -56.52 -52.24 65.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.469 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.43 62.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.47 53.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -73.13 -32.62 65.03 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.754 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.464 HD22 ' CE2' ' A' ' 212' ' ' TYR . 25.2 tp -57.42 -48.6 78.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.034 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.32 99.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.708 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.531 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 4.9 tt -59.51 -62.48 1.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.039 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.18 -35.21 74.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.383 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.656 ' HG3' ' HD2' ' A' ' 281' ' ' ARG . 14.3 mm100 -83.19 -49.5 9.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.762 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 20.6 mmt -73.7 -31.44 63.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -75.01 -16.92 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.403 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.2 m -91.83 -12.25 34.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 173' ' ' MET . 33.6 m -110.59 140.17 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.345 0.593 . . . . 0.0 111.618 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 27.4 ttt -90.72 105.12 17.61 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.713 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 33.9 tp -69.83 91.57 0.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.46 . . . . 0.0 110.162 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 63.64 -130.21 39.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.829 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.55 5.24 80.19 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.013 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.73 102.64 6.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.311 0.576 . . . . 0.0 110.498 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.77 128.98 38.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.905 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.622 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 21.0 pt -89.39 144.71 8.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.886 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -102.39 110.84 22.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.432 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 116' ' ' VAL . 47.1 t -125.12 136.23 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.454 -174.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.531 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 92.57 46.42 3.48 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.971 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.65 ' HA ' HD11 ' A' ' 191' ' ' ILE . 41.5 ttt85 -139.44 78.69 26.65 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.227 0.514 . . . . 0.0 111.118 175.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 -62.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.587 2.191 . . . . 0.0 111.723 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.4 p -171.63 -52.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.557 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 12.6 m120 -81.51 68.66 7.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.005 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.65 HD11 ' HA ' ' A' ' 187' ' ' ARG . 50.0 mm -74.68 108.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.858 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.89 -8.06 57.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.643 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.557 ' OE1' ' HA ' ' A' ' 190' ' ' ASN . 53.5 mt-30 -77.14 -12.63 59.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 111.259 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.59 16.84 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.622 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.574 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.0 tp60 -58.45 -52.24 76.06 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.441 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 51.5 Cg_exo -55.85 -30.05 75.18 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.768 1.645 . . . . 0.0 112.062 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 47.8 mm -72.61 -56.11 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.769 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 201' ' ' LEU . 35.2 pt -66.7 -30.74 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 -176.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.33 -42.05 96.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.397 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 203' ' ' GLU . 88.9 mt-30 -69.72 -35.81 75.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.709 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.546 HD21 ' HD2' ' A' ' 104' ' ' ARG . 95.6 mt -62.03 -50.66 71.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.21 -29.65 70.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.72 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 206' ' ' ARG . 39.2 tt0 -62.42 -52.42 63.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.055 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.94 -29.24 68.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.5 . . . . 0.0 110.502 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.18 -26.71 68.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.596 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 203' ' ' GLU . 51.1 mtt180 -64.26 -25.54 68.1 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.797 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.43 -18.87 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.587 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.18 -29.3 11.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.073 0.464 . . . . 0.0 110.914 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 58.66 23.98 11.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.688 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 12.3 ptp180 -89.48 150.56 22.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.995 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.98 168.04 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.337 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' A' ' 285' ' ' ALA . 71.7 t80 -112.33 121.66 45.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.382 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.52 123.18 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.286 0.565 . . . . 0.0 110.351 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.37 178.31 5.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.721 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.6 m 68.75 25.94 6.22 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 124.022 0.826 . . . . 0.0 111.481 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.586 HG21 HD13 ' A' ' 240' ' ' LEU . 10.8 m -77.2 164.38 3.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.53 ' HB2' HD23 ' A' ' 275' ' ' LEU . 6.9 t-80 -81.09 147.17 30.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.621 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -57.31 -55.86 29.29 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.718 ' HB2' HG13 ' B' ' 45' ' ' ILE . 0.2 OUTLIER -70.08 -48.36 58.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.689 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 1.011 HD11 HG13 ' B' ' 41' ' ' ILE . 0.4 OUTLIER -61.13 114.99 3.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.024 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.2 t -100.43 -177.06 3.39 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -166.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 240' ' ' LEU . 4.3 p30 -60.31 -37.73 81.5 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.64 -31.31 69.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.617 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 13.4 m-20 -78.2 -53.87 6.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.42 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.643 HG13 HD11 ' A' ' 240' ' ' LEU . 32.4 mm -54.89 -25.59 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.041 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -55.79 -33.34 64.31 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.519 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.47 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 69.2 m -49.46 -56.0 11.26 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.693 0.758 . . . . 0.0 111.716 -174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.663 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.4 m -74.61 -49.68 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.734 -172.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' A' ' 235' ' ' ILE . 58.3 m-85 -60.89 -41.68 96.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.917 0.389 . . . . 0.0 111.626 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.541 ' HB2' HD12 ' A' ' 235' ' ' ILE . 1.1 tm-20 -76.26 -22.4 55.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.34 -23.49 61.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.901 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.808 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 1.0 OUTLIER -93.92 -33.42 13.49 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.226 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -163.67 -179.78 38.22 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.3 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 258' ' ' GLU . 9.1 mmmm -74.66 122.65 23.54 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.676 HG21 ' HB2' ' A' ' 238' ' ' CYS . 55.2 mt -97.57 132.82 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 172.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.71 ' HD2' ' HA ' ' A' ' 258' ' ' GLU . 29.3 mtpp -100.8 -46.01 5.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.198 0.523 . . . . 0.0 110.362 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.5 m -136.28 93.88 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.835 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.676 ' HB2' HG21 ' A' ' 235' ' ' ILE . 48.3 t -96.76 113.17 24.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.0 m -151.12 116.85 5.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.619 0.247 . . . . 0.0 110.99 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.798 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 78.7 mt -85.34 130.02 34.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.81 134.69 54.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.806 0.336 . . . . 0.0 110.35 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.828 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 12.3 ptm180 -117.7 157.42 26.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.035 0.445 . . . . 0.0 110.889 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.452 ' OD1' HG22 ' A' ' 245' ' ' THR . 9.6 t70 -88.01 122.71 69.86 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.089 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.96 -19.0 40.54 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.112 2.542 . . . . 0.0 114.546 -172.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.452 HG22 ' OD1' ' A' ' 243' ' ' ASP . 6.4 t -99.17 -30.12 12.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.513 -174.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 36.3 p -94.23 -26.35 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.986 0.422 . . . . 0.0 110.622 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.85 -18.49 53.07 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.278 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -89.81 150.29 22.31 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.828 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.8 p80 -75.61 152.41 37.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.313 0.578 . . . . 0.0 111.215 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.66 158.71 22.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.188 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.455 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -72.22 43.16 0.83 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.445 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 43.3 p90 -165.63 166.07 18.32 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.798 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.63 -174.4 40.57 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.552 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.577 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 94.3 m-85 -122.58 124.88 44.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.986 0.422 . . . . 0.0 110.267 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 68.2 mt -120.29 126.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 36.0 tt0 -103.67 136.61 43.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.459 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -109.23 151.54 26.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.757 0.789 . . . . 0.0 112.191 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.71 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 3.1 tp10 -80.24 -21.79 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.628 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 50.2 mtpt -143.17 140.14 30.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.807 -171.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.4 -33.64 76.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.86 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -63.61 -41.02 98.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.411 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.504 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 21.7 m -67.8 -39.85 83.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 267' ' ' VAL . 7.8 p -69.61 -32.8 71.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -66.46 -44.07 83.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.423 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.458 ' CG ' HG23 ' B' ' 27' ' ' VAL . 1.7 m-20 -65.39 -39.51 92.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.56 76.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.259 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 263' ' ' SER . 90.8 t -62.5 -29.03 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 111.58 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 p -89.89 -10.12 46.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 27.8 t -115.84 -40.24 3.37 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.808 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 30.5 mmm -70.84 -14.67 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.91 0.862 . . . . 0.0 110.36 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.213 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.653 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 51.6 t80 -56.94 98.82 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.521 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 13.5 t70 -82.77 119.86 24.88 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.926 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.875 HD21 HD22 ' A' ' 220' ' ' LEU . 19.7 tp -126.09 86.88 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.45 22.68 39.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.551 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.4 15.29 30.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.614 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 26.9 pt20 -140.67 132.37 27.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.653 0.263 . . . . 0.0 110.395 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.33 133.61 42.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 216' ' ' VAL . 1.0 OUTLIER -71.95 -169.78 0.51 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.427 0.632 . . . . 0.0 110.972 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.656 ' HD2' ' HG3' ' A' ' 172' ' ' GLN . 21.1 tpp180 -147.79 116.39 6.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.47 139.0 52.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -160.42 -178.81 34.73 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.615 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -72.16 152.2 42.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.43 -20.06 66.21 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.4 t 71.07 -77.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 122.547 0.339 . . . . 0.0 111.764 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 0.1 OUTLIER -110.7 121.9 39.76 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.014 0.435 . . . . 0.0 111.956 -174.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 287' ' ' THR . 74.2 Cg_endo -90.29 110.04 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.924 2.416 . . . . 0.0 112.41 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 288' ' ' PRO . 47.4 Cg_endo -71.18 110.99 2.97 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.481 2.121 . . . . 0.0 111.877 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.458 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 83.7 mtp -88.6 119.74 70.12 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.798 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 3.6 Cg_exo -80.65 88.79 1.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.059 2.506 . . . . 0.0 111.285 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 49.4 tp -131.84 90.81 2.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.024 0.44 . . . . 0.0 110.928 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 52.2 tp -108.22 90.75 3.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.703 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 2.6 p -117.52 102.55 51.84 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.571 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.56 58.92 6.04 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.257 2.638 . . . . 0.0 111.865 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -90.06 75.41 7.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.328 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 29.1 m . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.13 177.166 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.184 -0.367 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.43 71.07 8.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.198 0.523 . . . . 0.0 111.223 -175.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.41 ' O ' ' HD1' ' B' ' 26' ' ' TYR . 70.6 mtm -128.97 146.48 50.96 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.32 126.83 7.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.871 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.41 ' HD1' ' O ' ' B' ' 24' ' ' MET . 41.1 p90 -150.12 23.24 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -176.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.458 HG23 ' CG ' ' A' ' 265' ' ' ASP . 23.8 t -59.85 121.42 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.121 0.486 . . . . 0.0 110.727 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -137.8 -52.41 0.63 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.372 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.27 -33.02 26.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.116 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.42 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -66.35 -31.25 71.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.151 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.58 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.9 t80 -74.29 -19.61 60.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.336 0.589 . . . . 0.0 110.49 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 53.3 mttp -76.37 -43.76 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -39.71 77.99 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.403 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.679 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.24 -52.57 43.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.904 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.683 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.44 -21.95 38.5 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 41.3 mt-30 -63.15 -38.16 90.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.542 ' O ' HG23 ' B' ' 41' ' ' ILE . 76.5 mtp180 -73.71 -35.38 65.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.226 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.802 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -61.47 -45.89 92.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' B' ' 39' ' ' ARG 0.253 16.5 mtp180 -81.38 -25.96 35.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.474 -1.391 . . . . 0.0 113.095 174.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -53.49 -49.72 66.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.155 168.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 1.011 HG13 HD11 ' A' ' 220' ' ' LEU . 3.9 pt -61.45 -37.91 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.076 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.61 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -71.85 -22.37 61.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.095 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.69 -45.57 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 111.08 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 20.6 pttp -74.96 -23.76 58.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.718 HG13 ' HB2' ' A' ' 219' ' ' ASP . 8.3 tp -147.19 102.79 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 122.083 0.944 . . . . 0.0 110.052 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' A' ' 219' ' ' ASP . . . -161.01 -144.86 4.11 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.03 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.01 35.11 4.99 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.453 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -163.37 160.45 23.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.65 -6.34 58.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.373 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.99 41.2 4.12 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.378 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.71 52.79 1.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.344 0.593 . . . . 0.0 111.289 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.83 176.416 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.41 114.07 16.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.763 0.316 . . . . 0.0 110.506 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.465 ' HB3' HD23 ' A' ' 108' ' ' LEU . 10.0 tpt 58.73 43.49 18.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.226 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.47 -17.98 61.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.187 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -82.98 -4.48 58.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.021 0.438 . . . . 0.0 110.864 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -96.39 -55.8 2.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -147.73 116.23 6.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.011 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -58.83 -33.54 70.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.75 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.6 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.313 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 101' ' ' MET . 61.6 tp -73.77 -30.78 62.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.284 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.76 -29.49 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.094 0.473 . . . . 0.0 110.716 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.73 -38.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.483 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.77 -26.8 68.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.349 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 160' ' ' TYR . 15.5 p -92.3 -1.16 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.58 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -118.27 118.95 33.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.4 HG23 HG13 ' A' ' 158' ' ' VAL . 13.2 m -112.62 125.54 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 111.207 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 27.4 t80 -73.74 137.15 43.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.125 175.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.12 110.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 123.415 0.447 . . . . 0.0 109.822 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.2 170.54 13.96 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.111 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 6.4 t 62.68 48.67 4.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.423 0.63 . . . . 0.0 110.376 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -81.85 71.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.069 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.437 ' HB3' ' H ' ' A' ' 121' ' ' TYR . 22.3 t80 36.31 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.554 1.159 . . . . 0.0 112.512 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.437 ' H ' ' HB3' ' A' ' 120' ' ' TYR . 38.3 t80 -178.71 -62.03 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -91.63 45.21 1.21 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.072 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.0 125.84 49.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.983 0.42 . . . . 0.0 110.622 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.49 159.08 23.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.26 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.53 -36.74 74.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 111.268 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.69 -32.52 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.413 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 m -76.53 -41.26 47.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.901 0.381 . . . . 0.0 111.154 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 63.7 mt -72.72 -41.05 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.251 0.548 . . . . 0.0 110.104 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -54.4 -41.21 69.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.151 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -76.92 -22.98 52.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.28 74.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 110.594 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.42 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 71.4 m-85 -96.54 4.65 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.586 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -63.01 -44.07 83.89 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.857 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.624 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.2 Cg_endo -69.1 -4.33 13.37 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.012 1.808 . . . . 0.0 113.37 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.622 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 2.7 m-85 -81.06 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.965 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.87 172.99 39.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.176 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.37 128.73 27.08 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -81.21 117.91 28.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.859 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.591 ' HD3' ' CG ' ' A' ' 161' ' ' GLU . 51.1 tptt -87.34 -53.75 4.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.227 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.8 m -145.79 151.16 37.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.154 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -135.5 107.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 6.4 m-20 -92.3 96.23 10.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.28 0.562 . . . . 0.0 110.172 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.446 ' CE ' ' HB2' ' A' ' 156' ' ' ALA . 41.2 tpp -123.94 94.01 4.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.287 175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 t -83.63 84.1 7.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.379 0.609 . . . . 0.0 109.479 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.774 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 0.1 OUTLIER -134.05 160.77 36.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.098 -178.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.33 102.72 15.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.9 m -66.16 -23.5 66.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.295 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.23 -33.89 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 m -96.69 -13.06 23.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.408 0.623 . . . . 0.0 110.563 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 45.5 ttm 58.32 34.35 23.97 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.316 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -126.03 143.58 51.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.287 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.774 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 22.8 p80 -103.93 112.39 25.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.142 0.496 . . . . 0.0 111.165 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -76.38 -15.3 59.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.135 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -124.89 -152.75 8.37 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.568 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.88 175.2 9.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.446 ' HB2' ' CE ' ' A' ' 143' ' ' MET . . . -99.14 137.32 37.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.066 0.46 . . . . 0.0 111.975 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.643 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 95.4 m-85 -117.73 106.45 13.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 169.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 114' ' ' VAL . 2.7 p -100.46 122.71 52.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.813 0.816 . . . . 0.0 110.377 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -115.1 135.19 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.106 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 41.9 m-85 -115.23 164.98 13.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.591 ' CG ' ' HD3' ' A' ' 139' ' ' LYS . 33.6 mt-10 -95.66 10.02 38.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.338 0.59 . . . . 0.0 109.499 170.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.45 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.0 m -130.25 115.11 17.38 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.213 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 162' ' ' VAL . 20.4 Cg_endo -62.43 -21.73 73.13 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.745 2.296 . . . . 0.0 111.686 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 285' ' ' ALA . 15.9 mp0 -59.47 -63.59 1.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.601 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -57.49 -33.46 68.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.599 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.76 -51.43 62.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.646 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.49 -33.95 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.494 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.441 HD21 ' HG3' ' A' ' 281' ' ' ARG . 8.9 tt -61.29 -48.32 81.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.03 -39.84 91.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.623 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.4 tt -58.83 -55.03 40.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.456 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -75.35 -48.14 24.4 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -91.85 -0.36 57.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -165.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.475 ' HG3' HD11 ' A' ' 183' ' ' ILE . 55.1 tpp -116.42 -32.75 5.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.086 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 6.7 t30 -68.75 -27.04 65.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.365 0.603 . . . . 0.0 110.351 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.4 m -90.83 17.18 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.889 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.12 142.79 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.219 0.533 . . . . 0.0 110.623 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 87.2 mtp -82.54 100.91 10.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.085 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.94 -55.65 32.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.554 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.84 69.09 0.31 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.382 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.86 -38.89 2.37 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.566 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.497 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 5.2 mpt_? -97.52 136.67 37.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.3 118.24 17.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 24.1 pt -84.7 157.03 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.121 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -104.18 110.92 23.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 46.3 t -120.4 128.79 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.765 0.317 . . . . 0.0 110.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.623 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 110.9 -105.47 1.9 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.027 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 14.3 mmt180 66.56 78.06 0.25 Allowed Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.137 0.575 . . . . 0.0 112.456 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.99 97.36 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.831 2.354 . . . . 0.0 110.654 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.3 t -75.48 -28.31 59.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -84.82 80.03 9.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.347 0.594 . . . . 0.0 110.988 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.33 62.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.56 0.695 . . . . 0.0 110.347 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.63 -80.78 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.459 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -82.12 -34.98 28.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.969 0.414 . . . . 0.0 110.535 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -72.85 -33.49 66.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.603 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.49 10.18 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.213 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.628 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 27.2 Cg_endo -62.04 -37.08 67.05 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.795 1.663 . . . . 0.0 112.231 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.45 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 50.5 mm -66.77 -41.45 87.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 194' ' ' ALA . 90.2 mt -59.75 -42.23 88.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.96 -39.82 90.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.551 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 80.8 mm-40 -62.07 -37.84 86.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 99.1 mt -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.529 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -58.85 -47.27 85.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.842 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.79 -33.93 76.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.199 0.524 . . . . 0.0 110.563 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.426 ' O ' ' HD1' ' A' ' 208' ' ' PHE . 7.9 tp10 -66.01 -49.59 67.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.258 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.59 78.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -67.28 -23.35 65.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.635 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.87 -28.88 50.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.121 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.426 ' HD1' ' O ' ' A' ' 204' ' ' GLU . 24.6 m-85 -88.62 -19.57 26.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.37 0.605 . . . . 0.0 110.437 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 65.8 t30 61.1 37.12 17.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.001 168.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.519 ' HD2' ' HG2' ' A' ' 289' ' ' PRO . 98.9 mtt180 -100.58 136.65 40.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.969 0.414 . . . . 0.0 110.176 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.487 ' CG2' ' HB ' ' A' ' 255' ' ' ILE . 9.8 tt -100.45 144.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -108.28 109.51 20.88 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.454 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.3 p -105.64 120.0 55.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 0.0 110.777 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.63 178.16 4.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.447 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.6 m 67.85 14.29 9.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.508 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.655 ' HA ' HD22 ' A' ' 280' ' ' LEU . 10.6 p -71.21 137.49 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.305 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.507 ' HD2' ' O ' ' A' ' 275' ' ' LEU . 2.3 t-80 -67.25 134.81 52.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 -176.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -58.61 -8.8 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.987 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.0 -37.21 47.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.288 0.566 . . . . 0.0 110.319 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.897 HD13 HD13 ' A' ' 275' ' ' LEU . 0.5 OUTLIER -113.32 128.12 56.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.665 -172.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.4 m -100.61 -175.32 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.791 0.437 . . . . 0.0 111.125 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.871 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 6.6 p-10 -53.6 -40.76 65.96 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.86 -35.66 66.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.45 0.643 . . . . 0.0 110.408 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.72 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.8 m-20 -78.89 -58.01 3.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.163 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.508 HG13 HG21 ' A' ' 216' ' ' VAL . 20.6 mm -63.46 -15.52 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.253 0.549 . . . . 0.0 111.067 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.773 ' HG3' HD12 ' A' ' 235' ' ' ILE . 83.1 tttt -54.42 -32.15 56.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.573 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.743 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.7 m -48.78 -61.37 2.08 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.704 0.764 . . . . 0.0 111.477 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.841 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.0 m -73.66 -38.92 52.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.506 -172.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.492 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 19.0 m-85 -62.89 -50.79 69.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.694 0.283 . . . . 0.0 111.661 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.558 ' HG3' ' HA ' ' A' ' 234' ' ' LYS . 27.6 tt0 -77.83 -17.99 56.8 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.47 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.198 -0.314 . . . . 0.0 111.008 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.7 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.4 m-30 -82.88 -42.21 18.02 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -137.85 -107.19 0.79 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.219 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.558 ' HA ' ' HG3' ' A' ' 230' ' ' GLU . 33.6 ttmt -157.51 159.62 37.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.773 HD12 ' HG3' ' A' ' 226' ' ' LYS . 60.3 mt -122.98 128.62 75.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 111.218 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -92.33 -31.03 15.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.333 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 33.2 t -156.93 119.56 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.771 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.621 ' HB3' HG21 ' A' ' 235' ' ' ILE . 6.3 p -117.74 117.12 28.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 36.3 m -153.31 104.99 2.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 112.063 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.871 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 54.7 mt -86.42 119.24 26.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 166.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.95 106.19 0.67 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -92.59 153.48 18.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.66 96.31 27.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.4 -19.53 49.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.584 2.189 . . . . 0.0 112.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -35.98 57.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.248 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.2 m -86.19 -33.0 20.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.337 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.45 35.17 5.3 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.329 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.42 156.83 16.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.774 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 12.0 p80 -84.46 138.33 32.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -67.02 152.57 45.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.69 24.61 1.5 Allowed Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.942 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.34 161.31 42.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.284 0.542 . . . . 0.0 110.583 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.29 -174.95 40.71 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.868 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -120.07 135.89 54.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.035 0.445 . . . . 0.0 111.178 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.487 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 28.8 mm -118.33 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 33.9 tt0 -104.69 126.27 51.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.52 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -101.47 146.83 27.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 1.3 pm0 -78.34 -16.96 57.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.573 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 258' ' ' GLU . 31.3 mtmm -137.09 148.48 46.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.67 64.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.78 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.36 -43.24 88.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.698 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.2 m -68.56 -31.99 71.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.891 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 267' ' ' VAL . 33.2 t -65.77 -52.21 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.382 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.48 -36.29 83.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.379 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.3 -31.32 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.579 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.94 63.7 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.95 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 263' ' ' SER . 42.8 t -54.4 -42.97 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 50.6 m -70.94 -25.89 62.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.4 p -109.65 -37.7 5.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.751 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 0.4 OUTLIER -65.77 -27.65 68.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.496 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.6 t30 -57.53 -34.38 69.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.743 0.783 . . . . 0.0 110.275 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.468 ' O ' ' HD2' ' A' ' 279' ' ' TYR . 18.5 mt -76.43 -6.55 52.18 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.86 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.821 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 3.2 t80 -54.43 102.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 110.252 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.6 t70 -89.07 122.99 32.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.725 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.897 HD13 HD13 ' A' ' 220' ' ' LEU . 88.8 mt -120.55 87.97 2.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.233 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.59 36.75 47.93 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.03 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.84 7.83 46.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.476 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.0 pt20 -136.8 132.76 35.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.99 0.424 . . . . 0.0 110.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.468 ' HD2' ' O ' ' A' ' 272' ' ' LEU . 79.6 m-85 -90.26 135.26 33.78 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.655 HD22 ' HA ' ' A' ' 216' ' ' VAL . 15.7 mt -69.1 -169.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.697 0.761 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -149.87 112.36 4.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.95 -176.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' ' 271' ' ' ASN . 30.7 m -111.41 147.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.256 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.75 -159.72 9.21 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.898 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -92.91 159.41 15.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.595 0.236 . . . . 0.0 110.71 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -67.83 -21.67 65.19 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.612 173.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.461 HG12 HG23 ' A' ' 287' ' ' THR . 92.5 t 72.35 -62.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.472 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.711 ' HB ' ' HD2' ' A' ' 288' ' ' PRO . 63.7 p -114.4 170.27 5.63 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.711 ' HD2' ' HB ' ' A' ' 287' ' ' THR . 30.3 Cg_endo -64.83 108.11 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.329 2.019 . . . . 0.0 111.486 173.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.519 ' HG2' ' HD2' ' A' ' 210' ' ' ARG . 24.3 Cg_exo -64.57 -31.01 60.83 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.033 2.488 . . . . 0.0 112.669 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 27.7 ttt -154.54 80.32 4.66 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.274 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -79.72 -9.57 14.53 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.38 2.054 . . . . 0.0 111.907 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 41.2 tp -84.53 62.04 7.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.429 0.633 . . . . 0.0 110.445 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.79 92.22 4.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.185 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.543 ' OG1' ' HD3' ' A' ' 295' ' ' PRO . 2.5 p -60.77 -39.73 68.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.464 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.543 ' HD3' ' OG1' ' A' ' 294' ' ' THR . 17.1 Cg_exo -69.67 74.5 1.24 Allowed 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.709 1.606 . . . . 0.0 110.961 170.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.97 143.46 56.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.238 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 C--O 1.251 1.155 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.86 178.253 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -159.44 102.09 1.55 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 24.5 mmt 63.82 86.66 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.785 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.82 57.18 3.89 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.318 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -101.9 153.49 19.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.927 0.394 . . . . 0.0 110.444 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.656 HG12 ' HB2' ' B' ' 31' ' ' PHE . 11.5 t -72.48 80.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.947 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -106.32 -7.73 17.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.366 0.603 . . . . 0.0 109.39 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.68 -62.52 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.433 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -65.89 -22.8 66.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.427 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.656 ' HB2' HG12 ' B' ' 27' ' ' VAL . 5.1 t80 -70.38 -18.0 63.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.241 0.543 . . . . 0.0 110.125 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.602 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 50.0 mtmt -69.9 -46.4 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 53.0 t0 -57.44 -44.68 84.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.984 174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.841 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -47.53 -54.11 12.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.125 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.685 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.24 -20.13 38.28 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -168.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 30.1 mt-30 -61.2 -43.6 98.63 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.743 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 45.9 mtt180 -73.67 -28.61 61.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.697 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.821 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.56 -48.56 78.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -80.11 -27.16 39.23 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.075 -1.016 . . . . 0.0 111.941 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.56 -45.83 73.57 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.932 0.396 . . . . 0.0 110.491 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 14.1 pt -68.75 -35.29 69.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.766 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' A' ' 220' ' ' LEU . . . -68.74 -20.04 64.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.134 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.56 -46.72 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.477 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.564 ' O ' HG12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -92.6 -14.52 28.1 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.509 -176.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.564 HG12 ' O ' ' B' ' 44' ' ' LYS . 12.1 pt 52.92 -179.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.282 1.433 . . . . 0.0 113.639 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.09 146.25 13.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.215 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.88 -166.37 11.31 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.943 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -87.04 131.22 34.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.825 0.345 . . . . 0.0 110.587 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.81 31.34 2.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.134 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.4 43.05 2.25 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.229 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 m -68.59 -50.37 52.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.606 0.241 . . . . 0.0 110.441 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.249 1.073 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.839 178.803 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 70.73 -61.98 0.46 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.599 0.759 . . . . 0.0 112.778 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.8 ptp -102.83 35.61 2.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.06 0.457 . . . . 0.0 111.789 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.1 122.12 22.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.222 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 104' ' ' ARG . 45.5 tt0 -155.75 78.12 0.98 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.948 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 103' ' ' GLN . 54.5 ttt180 68.45 147.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.792 0.682 . . . . 0.0 110.538 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.6 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 11.5 tp60 -76.91 46.67 0.48 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.465 0.65 . . . . 0.0 109.832 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -61.31 -37.27 82.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.734 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.431 ' HB2' ' HB1' ' A' ' 194' ' ' ALA . . . -60.03 -46.03 90.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.142 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.6 ' HB3' ' HG3' ' A' ' 105' ' ' GLN . 44.2 tp -71.23 -34.47 70.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.825 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.13 -50.29 74.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.218 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.426 ' HB ' ' HG2' ' A' ' 187' ' ' ARG . 33.9 pt -72.22 -34.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.0 mmm -59.66 -26.62 65.69 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -84.56 -15.61 45.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.612 0.244 . . . . 0.0 111.533 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 23.6 ttm-85 -109.8 108.61 19.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 110.716 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -91.96 134.12 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.73 0.776 . . . . 0.0 111.146 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 21.6 t80 -90.62 122.08 33.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.17 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.559 HG12 HD13 ' A' ' 119' ' ' ILE . 14.3 t -108.81 109.89 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.89 164.34 12.55 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.984 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 m 72.71 -57.22 0.64 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.483 0.713 . . . . 0.0 110.901 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' A' ' 123' ' ' LEU . 17.9 mm 66.59 -79.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 123.235 0.614 . . . . 0.0 111.099 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HA ' ' HG2' ' A' ' 181' ' ' ARG . 89.6 t80 174.48 -72.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.801 0.84 . . . . 0.0 108.743 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 3.6 t80 170.29 -59.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.648 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.09 -24.13 30.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.631 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.849 HD22 HG21 ' A' ' 127' ' ' THR . 39.1 mt -67.52 128.74 37.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.363 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -123.74 -153.57 8.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.921 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -60.24 -54.78 41.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 111.461 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.26 -35.24 78.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.537 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.849 HG21 HD22 ' A' ' 123' ' ' LEU . 1.9 m -66.22 -41.2 90.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.791 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.63 -38.9 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.15 -47.14 72.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.438 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -71.06 -27.47 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.702 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.34 -42.41 18.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.888 0.375 . . . . 0.0 111.435 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.421 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 84.6 m-85 -96.57 12.17 32.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -175.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -67.25 -46.29 50.6 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.785 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.939 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.1 Cg_endo -68.43 -4.62 13.28 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.744 1.63 . . . . 0.0 112.702 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -98.08 64.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.059 0.457 . . . . 0.0 110.432 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.6 175.29 40.6 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.808 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.93 102.62 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.722 2.281 . . . . 0.0 111.555 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.701 HG12 ' HE1' ' A' ' 160' ' ' TYR . 55.5 mt -56.17 119.8 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.206 0.527 . . . . 0.0 110.375 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -89.79 -45.8 9.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.181 -173.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 t -159.55 141.08 12.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 62.0 mt -121.58 115.91 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.429 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.75 106.75 17.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.376 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.424 ' HB3' ' HE2' ' A' ' 143' ' ' MET . 78.9 mtp -106.95 152.88 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.1 p -99.74 97.55 8.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -78.28 113.77 16.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 151' ' ' LYS . 12.7 t70 -80.44 112.49 17.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.203 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 93.8 p 53.8 -159.73 0.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.998 0.919 . . . . 0.0 112.296 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.35 -22.49 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.176 0.512 . . . . 0.0 111.089 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -62.84 -14.2 42.9 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.1 mtm 64.99 22.88 12.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.22 0.533 . . . . 0.0 110.891 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 146' ' ' ASP . 23.6 ttmm -73.15 91.74 1.66 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.552 ' CE1' HG13 ' A' ' 119' ' ' ILE . 11.5 t-160 -76.36 67.49 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.293 0.568 . . . . 0.0 111.715 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -96.57 112.56 24.26 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 152.86 -115.85 0.71 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.388 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -152.28 175.47 12.61 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.88 138.5 18.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.883 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 98.5 m-85 -106.68 123.75 48.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.558 0.218 . . . . 0.0 110.474 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.06 104.69 17.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.837 0.351 . . . . 0.0 110.065 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.3 tt0 -95.35 130.14 42.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.701 ' HE1' HG12 ' A' ' 138' ' ' ILE . 31.0 m-85 -104.01 166.4 10.43 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -100.29 5.79 44.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.847 0.832 . . . . 0.0 109.145 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.74 119.64 12.9 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.034 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.506 ' HG3' HD11 ' A' ' 108' ' ' LEU . 24.8 Cg_endo -64.19 -21.86 67.32 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.095 2.53 . . . . 0.0 112.792 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.447 ' OE2' ' HG2' ' A' ' 163' ' ' PRO . 16.7 mp0 -61.9 -52.53 63.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.92 -35.63 75.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.137 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.52 -38.55 90.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.167 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.449 ' HG2' HG22 ' A' ' 286' ' ' VAL . 56.8 tp60 -65.2 -40.57 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.128 0.489 . . . . 0.0 110.488 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.42 HD11 ' HA3' ' A' ' 283' ' ' GLY . 8.9 mp -66.32 -37.17 84.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.503 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.56 -28.92 69.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.294 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.98 -62.17 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.04 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -71.09 -43.42 67.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -87.31 -21.87 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.583 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 54.2 tpp -98.22 -33.19 11.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.808 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -80.3 -8.95 59.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.275 0.559 . . . . 0.0 110.839 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.1 p -90.31 0.66 57.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.32 168.37 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.696 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 86.3 mtp -129.46 103.02 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.131 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.58 118.69 14.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.79 -73.1 2.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.514 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.3 38.94 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.653 ' HG2' ' HA ' ' A' ' 120' ' ' TYR . 23.8 tpt180 -140.61 138.6 34.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -80.85 102.74 10.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.66 133.06 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.128 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -100.5 110.95 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.938 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 45.9 t -112.27 129.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.276 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 176.75 -144.47 6.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.098 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.426 ' HG2' ' HB ' ' A' ' 110' ' ' ILE . 23.3 tpt180 -162.98 79.02 1.74 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.05 49.07 2.69 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.957 2.438 . . . . 0.0 113.165 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.5 m -90.29 -57.1 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.034 0.445 . . . . 0.0 110.066 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -137.25 -64.18 0.57 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.923 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.1 mt 70.81 138.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.251 0.548 . . . . 0.0 111.676 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.15 -49.97 4.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.385 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -55.48 -56.01 25.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 111.852 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 107' ' ' ALA . . . -105.07 14.0 29.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.053 0.454 . . . . 0.0 110.942 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 0.3 OUTLIER -64.6 -55.18 31.14 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.427 -177.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 76.7 Cg_exo -52.72 -27.53 34.2 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 122.707 2.271 . . . . 0.0 113.738 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 48.2 mm -62.2 -34.89 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.443 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 51.5 mm -70.93 -39.1 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.654 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.25 -37.64 83.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.472 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 29.8 mm-40 -65.09 -36.77 85.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.176 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 89.5 mt -71.21 -37.35 72.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.706 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -63.73 -42.02 97.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -67.66 -34.64 77.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.907 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -63.37 -46.9 84.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.105 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 285' ' ' ALA . . . -62.53 -23.51 67.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.044 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -63.29 -27.57 69.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.774 0.321 . . . . 0.0 110.62 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.94 -13.23 61.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.406 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -93.26 -15.19 26.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.785 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 60.77 17.25 7.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.38 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.74 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 16.1 ptm180 -111.12 144.75 39.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 283' ' ' GLY . 35.5 pt -119.3 169.64 9.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.302 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.429 ' HE1' ' HD2' ' A' ' 252' ' ' TYR . 84.1 t80 -116.82 115.25 25.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.182 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.71 122.59 66.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.256 0.551 . . . . 0.0 110.694 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.25 -174.69 2.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.352 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.939 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 14.2 t 61.42 30.5 18.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 0.0 110.354 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.538 HG12 HD11 ' A' ' 280' ' ' LEU . 5.4 m -81.6 151.25 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.464 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 11.5 t-80 -73.9 137.56 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -166.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.539 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -78.5 -46.46 19.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.898 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.766 HD23 HD13 ' A' ' 225' ' ' ILE . 0.1 OUTLIER -58.56 100.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.606 178.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.7 m -101.05 -174.77 2.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.53 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.611 ' N ' HD12 ' A' ' 240' ' ' LEU . 3.7 p-10 -48.63 -43.28 36.29 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.77 -30.81 71.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.16 0.505 . . . . 0.0 110.819 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.719 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 11.4 m-20 -78.82 -59.65 2.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.772 HG13 HD11 ' A' ' 240' ' ' LEU . 23.5 mm -56.05 -24.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.216 0.532 . . . . 0.0 111.232 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.463 ' HG3' HD12 ' A' ' 235' ' ' ILE . 59.4 tttm -53.73 -32.46 52.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.018 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.923 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 70.8 m -51.89 -62.4 1.65 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.878 0.847 . . . . 0.0 112.204 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.65 HG21 ' HE1' ' A' ' 270' ' ' MET . 1.9 m -63.03 -53.46 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.306 -173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.568 ' HD2' ' HH ' ' A' ' 257' ' ' TYR . 84.2 m-85 -59.0 -34.08 71.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.42 -34.36 47.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -60.53 -26.14 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.751 0.31 . . . . 0.0 111.041 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.623 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 3.9 p90 -129.96 40.22 3.58 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.605 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -177.34 153.8 14.31 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.115 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -94.31 110.47 22.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 0.0 110.167 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.463 HD12 ' HG3' ' A' ' 226' ' ' LYS . 52.5 mt -83.43 130.28 36.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.41 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -89.53 -37.03 15.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.64 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.1 t -168.47 134.04 1.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.37 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.1 t -114.48 113.42 24.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.4 m -136.81 103.77 5.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.996 0.427 . . . . 0.0 111.42 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.772 HD11 HG13 ' A' ' 225' ' ' ILE . 29.7 mt -83.69 129.8 34.96 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.04 138.91 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.707 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.658 ' HG2' ' HA ' ' A' ' 249' ' ' HIS . 69.2 mtp180 -137.58 149.57 46.78 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.76 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.627 ' HB2' HG22 ' A' ' 245' ' ' THR . 3.7 p-10 -80.85 129.34 68.26 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.996 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.13 -16.35 40.13 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.76 2.307 . . . . 0.0 112.027 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 243' ' ' ASP . 12.1 t -74.9 -33.68 62.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.823 -175.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.9 m -134.34 -41.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.007 0.432 . . . . 0.0 111.235 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.12 21.88 5.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.502 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -79.69 153.36 29.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 242' ' ' ARG . 1.9 t-80 -85.72 125.35 33.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.235 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.26 155.41 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.161 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.456 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -73.53 31.77 0.85 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 114.403 0.521 . . . . 0.0 114.403 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 34.9 p90 -160.13 163.78 33.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.915 0.358 . . . . 0.0 110.073 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -178.15 -169.75 39.42 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.309 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.418 ' CB ' HH21 ' A' ' 210' ' ' ARG . 95.5 m-85 -126.94 140.01 52.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.03 129.86 71.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.74 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 38.5 mt-10 -103.61 146.75 28.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.122 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.568 ' HH ' ' HD2' ' A' ' 229' ' ' PHE . 85.2 m-85 -117.29 158.2 24.78 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.306 0.574 . . . . 0.0 110.698 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -82.52 -17.26 45.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.704 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -134.73 140.61 46.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.958 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.05 -19.53 63.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.22 0.533 . . . . 0.0 109.919 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.54 -45.74 78.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.92 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -68.15 -27.15 66.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.404 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 m -61.79 -48.55 80.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.605 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.452 ' O ' HG12 ' A' ' 267' ' ' VAL . 57.5 tp60 -73.8 -34.34 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.866 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.67 -46.52 82.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.38 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.378 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 282' ' ' VAL . 4.0 p -60.76 -26.46 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 120.872 0.367 . . . . 0.0 111.666 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 28.9 m -81.06 -18.38 46.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 9.6 p -116.02 -27.6 6.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.65 ' HE1' HG21 ' A' ' 228' ' ' VAL . 34.5 mmm -69.46 -14.52 62.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -170.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 17.4 p-10 -73.74 -15.3 61.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.008 0.432 . . . . 0.0 111.402 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.53 -9.48 59.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.884 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 4.8 t80 -62.11 87.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.006 0.432 . . . . 0.0 111.406 -170.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.49 124.93 28.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.911 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' A' ' 220' ' ' LEU . 53.4 mt -123.45 107.71 11.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.86 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.7 -78.71 1.74 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.351 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -155.91 23.03 0.54 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.14 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -140.64 138.85 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.743 -0.269 . . . . 0.0 110.418 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 77.0 m-85 -75.05 123.86 25.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.538 HD11 HG12 ' A' ' 216' ' ' VAL . 5.9 tt -67.84 138.78 56.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.478 ' H ' ' HB3' ' A' ' 215' ' ' SER . 34.4 mmt180 -121.08 123.04 41.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.796 0.332 . . . . 0.0 110.773 -167.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' A' ' 270' ' ' MET . 14.9 p -117.25 147.7 20.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.094 0.473 . . . . 0.0 111.455 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 211' ' ' ILE . . . -144.71 -170.71 14.06 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -82.04 179.51 7.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.987 0.393 . . . . 0.0 110.549 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.562 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -67.64 -27.18 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 0.0 110.519 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 167' ' ' GLN . 44.4 t 73.53 -65.47 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.299 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 34.4 p -108.57 158.19 34.62 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.46 105.22 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.208 1.939 . . . . 0.0 111.378 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.656 ' HG2' ' HD3' ' A' ' 210' ' ' ARG . 3.3 Cg_exo -75.37 65.44 6.38 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.384 2.722 . . . . 0.0 113.088 -172.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -141.87 70.69 24.38 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.026 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.65 123.92 9.83 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.777 2.318 . . . . 0.0 112.209 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.12 68.57 4.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.203 0.525 . . . . 0.0 110.242 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 30.3 tp -81.11 67.78 7.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.184 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.5 m 61.79 77.63 0.34 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.844 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.95 31.26 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.196 2.598 . . . . 0.0 112.153 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -147.63 102.43 3.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.265 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.746 -0.645 . . . . 0.0 109.865 179.795 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.8 121.27 31.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 92.8 mmm -98.85 -55.53 2.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.118 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.38 84.5 1.17 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.328 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 69.39 103.59 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.164 0.586 . . . . 0.0 111.231 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.88 72.81 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.958 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -82.46 63.9 6.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.374 0.607 . . . . 0.0 109.841 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -154.32 -65.65 0.14 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 232' ' ' PHE . . . -77.17 -31.28 55.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 110.85 176.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.449 ' HD1' ' CE1' ' A' ' 232' ' ' PHE . 16.9 t80 -65.77 -16.32 63.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.227 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -71.65 -50.81 27.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.262 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.599 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 15.5 t70 -57.88 -42.68 85.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.623 ' CB ' ' HE1' ' A' ' 232' ' ' PHE . . . -49.01 -44.85 41.68 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.54 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.711 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 2.6 mm? -82.19 -21.03 36.67 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -64.4 -40.72 96.35 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.923 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 18.6 mmt180 -73.28 -32.59 64.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.363 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.884 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -62.31 -47.06 85.94 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.099 -175.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 27.5 mtt85 -80.97 -26.27 36.69 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.259 -1.526 . . . . 0.0 112.703 174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -54.38 -41.92 69.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.518 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.815 HG12 ' O ' ' B' ' 38' ' ' ALA . 2.7 pt -69.83 -34.02 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.733 0.301 . . . . 0.0 110.775 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.42 -22.64 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.959 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.08 -27.26 22.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.807 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.793 ' HE2' HG22 ' B' ' 41' ' ' ILE . 45.1 pttt -93.11 -52.71 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.562 ' N ' ' HG3' ' B' ' 44' ' ' LYS . 91.9 mt 65.47 90.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.138 -173.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.86 24.53 23.77 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.695 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.66 -59.68 6.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.038 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -163.52 -63.92 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.55 133.24 33.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.788 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.22 153.31 30.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.213 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.5 m -50.22 112.42 0.68 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 111.842 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.639 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.875 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.73 123.61 32.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.642 0.258 . . . . 0.0 110.345 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 49.3 tpp -82.16 77.37 8.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.542 0.687 . . . . 0.0 110.891 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -124.65 47.88 2.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.148 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.07 -47.02 69.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.082 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -160.85 132.76 5.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.153 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -99.41 127.32 45.44 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.426 ' O ' HG12 ' A' ' 110' ' ' ILE . 73.3 mtt180 -61.53 -30.7 70.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.402 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.47 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.3 -29.23 70.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.843 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.442 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.787 HD12 HG12 ' A' ' 191' ' ' ILE . 29.0 pt -82.57 -36.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.0 mtp -60.25 -26.19 66.25 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.5 m -82.44 -0.98 48.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ttm180 -122.2 118.25 28.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.56 166.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.045 0.45 . . . . 0.0 110.779 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -119.35 114.25 22.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.335 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -104.78 110.83 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 110.856 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.98 170.49 14.99 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 24.7 m 59.91 47.91 9.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.268 0.556 . . . . 0.0 110.428 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -76.49 123.04 32.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.817 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.553 ' HB3' HD13 ' A' ' 123' ' ' LEU . 54.9 t80 -62.91 140.98 58.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.314 0.578 . . . . 0.0 109.895 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -52.73 -31.71 39.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.27 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.38 6.7 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.553 HD13 ' HB3' ' A' ' 120' ' ' TYR . 10.1 mp -100.65 120.46 40.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.68 -165.79 14.59 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.639 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.521 ' OE2' ' HD2' ' A' ' 129' ' ' ARG . 3.9 tm-20 -59.36 -51.76 68.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.458 0.303 . . . . 0.0 110.762 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.86 -29.64 69.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.101 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.49 HG21 ' HG ' ' A' ' 123' ' ' LEU . 5.2 m -64.63 -50.78 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.968 0.413 . . . . 0.0 110.197 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.3 mt -67.48 -40.2 84.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.288 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.521 ' HD2' ' OE2' ' A' ' 125' ' ' GLU . 23.1 ttt180 -51.58 -51.93 51.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.502 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -77.2 -24.12 51.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.927 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.86 -37.57 73.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.27 12.86 36.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -70.88 -41.6 11.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.166 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.79 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 33.7 Cg_exo -63.89 -4.69 7.77 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.222 1.948 . . . . 0.0 112.817 173.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.432 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 23.8 m-85 -93.01 -68.44 0.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.306 . . . . 0.0 110.216 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -155.87 168.68 33.44 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.62 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 13.3 Cg_exo -69.51 121.86 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.513 2.142 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.54 123.87 37.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.95 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -100.35 -36.85 9.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.459 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -145.76 136.93 24.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.942 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 70.0 mt -127.29 116.4 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -103.68 114.55 28.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.319 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' A' ' 156' ' ' ALA . 89.1 mtp -113.64 108.29 16.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.353 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.541 ' O ' ' HA3' ' A' ' 154' ' ' GLY . 12.1 p -94.46 61.09 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.456 0.646 . . . . 0.0 110.796 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -114.13 159.59 19.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.628 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.652 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.7 m-20 -73.73 88.0 1.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.476 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.2 m -65.98 -36.02 82.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.585 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.9 m -63.52 -23.84 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.247 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.799 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 1.6 m -120.64 2.04 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.382 0.61 . . . . 0.0 110.132 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.9 mtp 56.91 35.61 26.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.535 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.799 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 30.7 mmmt -97.27 126.57 42.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.054 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.453 ' HE1' ' O ' ' A' ' 123' ' ' LEU . 27.1 m-70 -84.3 48.16 1.45 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.477 0.656 . . . . 0.0 110.098 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.47 -34.22 74.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.708 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 144' ' ' SER . . . -95.73 -155.53 31.14 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.026 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -140.46 174.57 10.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.258 0.223 . . . . 0.0 110.554 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.432 ' HB2' ' HG2' ' A' ' 143' ' ' MET . . . -124.33 138.42 54.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.805 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 97.1 m-85 -107.27 124.94 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.715 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.1 t -119.45 113.59 41.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 10.3 pt-20 -105.43 137.11 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -105.86 172.36 6.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.132 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 39.0 tt0 -74.53 -29.82 61.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.563 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.3 m -129.44 139.87 36.95 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.583 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.17 -20.54 43.46 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.187 2.592 . . . . 0.0 112.494 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 11.1 mp0 -55.56 -55.32 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.76 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -58.77 -32.24 69.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.514 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.13 -51.61 36.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.35 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.38 -34.82 76.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.19 0.519 . . . . 0.0 110.091 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.612 HD13 ' HA3' ' A' ' 283' ' ' GLY . 25.8 tp -61.01 -44.71 97.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.239 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.22 87.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.532 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.34 -39.27 94.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -81.59 -47.35 13.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.029 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.418 ' CD ' ' HE ' ' A' ' 281' ' ' ARG . 20.3 mm-40 -87.83 -44.84 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -169.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.6 tpp -69.68 -26.74 64.52 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.097 0.475 . . . . 0.0 110.703 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -69.29 -24.2 63.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.204 0.526 . . . . 0.0 109.983 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.1 t -81.52 -27.86 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.83 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.88 110.49 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 111.017 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.589 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 21.3 mmt -61.83 124.13 19.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.913 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.52 105.45 0.44 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.967 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.33 -90.06 0.82 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.9 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.12 42.3 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 120' ' ' TYR . 30.4 tpt180 -134.0 126.09 29.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.703 0.287 . . . . 0.0 110.33 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.589 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 8.6 t30 -72.11 85.08 1.02 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.584 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.4 pt -83.0 156.64 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.272 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -105.94 109.8 21.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.527 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.3 t -115.93 109.59 28.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.159 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 135.6 -115.53 1.37 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.708 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 57.15 68.9 1.84 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 110.265 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.527 ' HB3' ' HB ' ' A' ' 191' ' ' ILE . 5.6 Cg_exo -80.77 61.52 8.25 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.802 3.001 . . . . 0.0 112.353 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 m -50.76 -42.45 57.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.706 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -117.56 13.09 14.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.787 HG12 HD12 ' A' ' 110' ' ' ILE . 53.5 mt -98.46 -25.26 4.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.044 0.45 . . . . 0.0 110.61 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.82 85.45 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.811 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.42 -4.79 52.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 111.204 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.28 7.65 42.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.601 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 61.8 tp60 -53.6 -44.61 98.1 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.79 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.4 Cg_endo -51.79 -32.25 45.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.267 1.978 . . . . 0.0 112.723 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.15 -43.93 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.448 . . . . 0.0 110.121 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.9 mt -59.76 -38.97 78.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.537 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 66.2 m-20 -54.76 -50.96 67.15 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.748 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.38 -32.24 73.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.541 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.4 mt -66.01 -49.75 66.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.047 0.451 . . . . 0.0 110.126 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.62 -40.83 98.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.88 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 31.3 mm-40 -64.14 -30.29 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.287 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.83 -45.68 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.261 0.553 . . . . 0.0 109.54 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.43 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.453 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtp180 -63.03 -21.85 66.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.657 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.99 -29.14 39.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.877 0.37 . . . . 0.0 111.197 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -102.56 -19.24 14.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.66 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 56.98 37.97 29.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.235 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.27 140.5 31.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.314 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 282' ' ' VAL . 19.9 tt -115.86 150.34 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.229 -172.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -109.48 135.38 50.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.265 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 229' ' ' PHE . 5.1 t -113.39 120.76 64.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.17 167.98 13.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.79 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 28.6 m 63.77 27.15 14.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.201 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.523 ' HA ' HD21 ' A' ' 280' ' ' LEU . 29.9 m -74.12 143.31 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.03 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.434 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 12.6 t-80 -69.65 134.39 48.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.84 -24.09 67.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.995 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.87 -46.87 16.04 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.937 -0.477 . . . . 0.0 110.92 173.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.686 HD23 HD13 ' A' ' 225' ' ' ILE . 0.2 OUTLIER -58.11 107.66 0.5 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.96 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.9 p -93.18 -177.95 4.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 4.7 p-10 -53.35 -37.56 62.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.947 0.403 . . . . 0.0 111.1 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.89 -34.35 77.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.379 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 8.8 m-20 -77.47 -55.36 5.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.688 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.789 HG13 HD11 ' A' ' 240' ' ' LEU . 31.4 mm -55.42 -27.58 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 122.792 0.437 . . . . 0.0 111.764 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.704 ' HG3' HD12 ' A' ' 235' ' ' ILE . 83.4 tttt -54.25 -31.67 54.1 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.651 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.655 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 68.7 m -47.86 -61.22 2.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.638 0.732 . . . . 0.0 112.175 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.623 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.7 m -69.42 -51.01 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.167 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.61 ' HB2' HD11 ' A' ' 235' ' ' ILE . 40.2 m-85 -56.44 -43.58 79.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.505 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -79.73 -12.44 59.8 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.36 -35.79 58.51 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.67 -0.644 . . . . 0.0 110.602 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.546 ' HE1' ' CB ' ' B' ' 34' ' ' ALA . 0.2 OUTLIER -107.27 21.15 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.946 173.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.575 ' CA ' ' HB3' ' A' ' 262' ' ' SER . . . -170.64 -153.55 8.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.316 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.09 127.27 12.94 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 238' ' ' CYS . 66.8 mt -101.87 126.57 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.119 -175.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -95.3 -22.91 17.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.706 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 14.2 t -150.38 108.6 3.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.889 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.746 ' HB2' HG21 ' A' ' 235' ' ' ILE . 41.9 t -115.72 111.79 21.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.8 p -143.08 104.57 4.31 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.789 HD11 HG13 ' A' ' 225' ' ' ILE . 40.2 mt -83.93 117.3 23.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -65.35 127.48 31.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.781 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 15.5 ptt180 -110.49 153.88 24.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.964 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.11 130.05 51.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.14 -17.1 40.55 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.725 2.283 . . . . 0.0 112.377 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 48.2 m -74.34 -58.86 3.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.268 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 2.3 m -93.4 -41.22 9.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.928 0.394 . . . . 0.0 111.25 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.92 15.65 19.52 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.837 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.453 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 61.4 pttt -109.08 148.81 30.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.4 p80 -78.39 135.62 37.48 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.213 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.01 156.92 36.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.495 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.6 30.31 0.6 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 114.496 0.558 . . . . 0.0 114.496 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.62 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 39.5 p90 -153.21 173.71 15.19 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.624 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.23 176.24 46.62 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.412 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 94.0 m-85 -121.24 133.38 55.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.69 0.281 . . . . 0.0 110.415 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.657 HG23 HG23 ' A' ' 235' ' ' ILE . 55.0 mt -129.9 136.59 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.128 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -107.53 125.71 51.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.879 0.371 . . . . 0.0 110.952 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.567 ' HE1' ' HA3' ' A' ' 233' ' ' GLY . 17.1 m-85 -98.73 142.79 29.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.212 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.749 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.4 pt-20 -89.01 -23.09 22.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.537 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.749 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 31.6 mmmt -116.95 129.41 56.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.611 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.68 63.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.347 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -56.29 -52.42 64.59 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.48 0.657 . . . . 0.0 110.026 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.575 ' HB3' ' CA ' ' A' ' 233' ' ' GLY . 4.0 m -68.99 -43.72 74.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.172 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 267' ' ' VAL . 10.8 t -61.41 -43.77 98.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.717 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.15 -41.96 97.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.331 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.51 -39.82 57.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.183 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.77 63.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.045 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 263' ' ' SER . 58.3 t -61.31 -26.64 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.186 0.517 . . . . 0.0 111.267 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.6 t -92.84 -36.64 12.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.167 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . 0.552 ' HB3' HG22 ' B' ' 27' ' ' VAL . 3.3 p -87.83 -37.89 16.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 35.6 mmm -60.47 -29.08 68.83 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -172.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 31.8 t30 -58.57 -33.2 69.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.924 0.869 . . . . 0.0 110.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 272' ' ' LEU . 6.3 mp -78.89 -9.55 59.52 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.901 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -56.64 101.09 0.05 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.19 0.519 . . . . 0.0 110.895 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.61 112.4 18.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.189 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.61 HD21 ' CZ ' ' A' ' 273' ' ' PHE . 0.8 OUTLIER -113.3 86.2 2.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.389 171.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.71 34.95 29.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.551 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.89 0.72 74.36 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.802 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 10.9 pt20 -113.75 139.68 48.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.509 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 95.2 m-85 -89.94 126.21 35.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.369 0.604 . . . . 0.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.802 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.3 OUTLIER -55.38 165.04 0.84 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.217 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.678 ' H ' HD13 ' A' ' 280' ' ' LEU . 4.0 tpt180 -132.24 119.7 21.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.367 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.54 ' CG2' HD11 ' A' ' 211' ' ' ILE . 5.6 p -104.82 148.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.513 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.612 ' HA3' HD13 ' A' ' 168' ' ' LEU . . . -150.25 -149.1 4.93 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -139.61 152.99 47.25 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.576 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -95.23 129.46 42.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.46 -31.81 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.706 -171.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.409 HG22 ' OE2' ' A' ' 164' ' ' GLU . 14.9 t -115.11 135.53 22.52 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.228 0.537 . . . . 0.0 110.466 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 37.2 Cg_endo -68.67 119.06 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.293 1.995 . . . . 0.0 110.995 173.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 288' ' ' PRO . 34.3 Cg_exo -58.25 -24.85 69.47 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.983 2.455 . . . . 0.0 112.855 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.08 88.41 51.0 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.09 135.04 24.36 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.1 2.533 . . . . 0.0 112.028 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.74 126.31 32.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.371 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 293' ' ' LEU . 3.9 mm? -78.74 87.38 4.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.968 0.414 . . . . 0.0 110.072 177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.532 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 5.3 m -61.09 -50.3 85.02 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.304 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.532 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 86.3 Cg_endo -79.19 55.54 5.66 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.041 1.828 . . . . 0.0 112.036 174.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -78.83 70.2 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.275 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.784 178.168 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -145.01 -67.32 0.31 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 23.6 ptm -175.24 148.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.397 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.93 131.94 4.02 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.942 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -77.68 -25.35 49.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 0.0 110.389 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 269' ' ' SER . 17.3 t -77.18 73.92 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.396 0.617 . . . . 0.0 110.879 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -138.5 -60.43 0.61 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.28 174.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -103.57 -39.2 6.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.082 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.09 84.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.763 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 8.7 t80 -74.99 -19.01 60.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.54 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.701 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 30.8 mtpp -74.09 -45.81 46.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.4 -45.08 84.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.623 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -45.87 -51.87 12.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.917 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.807 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.9 -23.42 36.27 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -171.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.701 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 61.8 mt-30 -62.71 -40.79 98.25 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.655 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 63.7 mtt180 -70.81 -36.87 73.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.881 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.901 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.25 -43.81 96.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.269 -0.878 . . . . 0.0 113.301 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.29 46.3 mtt-85 -82.45 -25.15 33.85 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.282 -1.511 . . . . 0.0 113.064 172.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -54.08 -43.67 70.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.014 168.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.726 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.5 pt -69.64 -35.21 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.872 0.368 . . . . 0.0 110.429 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.56 -16.34 63.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.45 -36.06 16.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.591 ' HG2' ' HA ' ' B' ' 41' ' ' ILE . 21.6 pttp -84.54 -49.1 8.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.202 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.995 HG23 ' HB2' ' A' ' 219' ' ' ASP . 25.3 mm 65.08 91.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.449 0.643 . . . . 0.0 112.091 173.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.64 -157.62 21.31 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.081 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.09 144.72 15.3 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.77 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -118.16 85.38 2.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.978 0.418 . . . . 0.0 110.225 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.23 -21.34 19.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.07 0.462 . . . . 0.0 110.651 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.54 114.68 3.78 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.34 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.0 m -82.93 -34.91 26.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.375 0.607 . . . . 0.0 109.546 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.466 177.394 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.53 -31.47 69.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.371 . . . . 0.0 111.025 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.2 mmt -119.94 39.08 3.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.055 0.455 . . . . 0.0 110.223 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.62 79.24 9.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.516 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -86.95 91.13 8.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.227 0.537 . . . . 0.0 110.348 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -114.26 108.66 17.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.239 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -95.67 37.48 1.2 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.128 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -56.17 -41.35 75.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.378 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.8 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.16 -35.91 81.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.74 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.049 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.7 pt -82.64 -35.84 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.4 mtp -69.5 -34.29 74.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.0 m -79.61 0.02 31.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -122.97 109.2 13.82 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.3 m -103.41 135.72 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.458 0.647 . . . . 0.0 111.53 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.469 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 80.2 t80 -87.41 132.88 33.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.232 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.44 111.41 36.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.073 0.463 . . . . 0.0 110.328 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -114.84 176.92 17.12 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.793 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 13.9 t 64.99 53.65 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.85 0.833 . . . . 0.0 109.434 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.9 mt -82.54 132.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.828 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 62.3 t80 -86.09 154.46 21.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.683 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -54.95 -51.59 65.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.607 0.241 . . . . 0.0 111.029 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.86 17.32 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.972 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 33.5 tp -107.73 97.56 7.27 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.486 ' HA2' ' HE1' ' A' ' 152' ' ' HIS . . . -113.26 -174.08 18.9 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.5 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.458 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 5.8 pt-20 -63.05 -23.94 67.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.956 0.408 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 7.0 m-20 -78.57 -41.62 31.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.336 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -69.48 -46.87 65.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.131 0.491 . . . . 0.0 110.546 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.5 -41.99 94.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.453 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 19.0 ptp180 -63.21 -36.3 83.19 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.691 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -72.03 -29.93 64.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.794 0.33 . . . . 0.0 111.438 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.11 56.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.431 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 85.8 m-85 -96.31 -0.13 50.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.5 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.532 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -65.64 -46.83 67.87 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.614 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.745 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 25.7 Cg_exo -65.21 -4.66 9.59 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.377 2.051 . . . . 0.0 113.121 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.675 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 3.5 m-85 -84.69 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.849 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.53 38.15 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.879 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.46 103.15 0.64 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.921 2.414 . . . . 0.0 112.231 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.6 mt -79.24 108.68 13.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -90.66 -23.39 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 0.0 110.302 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.866 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 32.1 t -138.81 124.77 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.191 0.519 . . . . 0.0 111.05 -177.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.9 mt -118.98 107.32 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.176 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -116.71 100.82 8.07 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.579 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 125' ' ' GLU . 61.5 mtp -122.77 123.97 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.579 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 26.2 t -108.93 111.52 23.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.771 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.443 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 6.6 p-90 -150.69 158.65 44.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.263 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.82 114.73 4.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.38 0.425 . . . . 0.0 110.169 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.7 m -79.85 -24.85 40.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.713 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.6 t -82.48 -37.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.544 HG21 ' HE3' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -107.69 -7.84 16.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.18 0.514 . . . . 0.0 110.758 -178.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.7 mtp 60.26 35.31 20.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.845 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 149' ' ' THR . 98.7 mttt -84.07 148.23 26.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.486 ' HE1' ' HA2' ' A' ' 124' ' ' GLY . 65.9 m-70 -119.73 73.52 0.97 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.68 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -128.21 11.52 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 110.481 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.64 -116.44 1.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.139 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.469 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 44.8 p90 -154.67 167.0 31.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.818 0.342 . . . . 0.0 111.108 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.439 ' CB ' ' HG2' ' A' ' 143' ' ' MET . . . -146.57 134.92 21.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.52 122.6 35.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.9 t -101.96 111.02 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 37.9 mt-10 -107.05 119.56 39.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.42 0.628 . . . . 0.0 110.996 -175.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 81.2 m-85 -96.2 156.08 16.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.445 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.9 -4.63 57.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 109.325 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.74 130.99 18.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.783 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.18 -11.07 29.63 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.718 2.279 . . . . 0.0 112.808 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.42 ' OE1' HG22 ' A' ' 287' ' ' THR . 4.6 mm-40 -56.7 -64.89 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -65.91 -22.77 66.53 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.389 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.14 -50.94 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.863 0.363 . . . . 0.0 110.749 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HB3' HG21 ' A' ' 286' ' ' VAL . 1.6 tm0? -74.26 -30.87 62.32 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.9 tp -58.72 -51.47 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.075 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.55 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.724 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.78 -50.28 72.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.996 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.01 -47.18 47.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -74.64 -50.8 16.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.415 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 16.5 mmt -77.3 -26.37 52.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -170.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -73.29 -20.31 60.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.37 0.605 . . . . 0.0 110.086 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.3 m -92.73 -12.98 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.536 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 84.3 t -118.5 137.39 52.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.16 0.505 . . . . 0.0 111.517 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 21.5 ptp -103.47 144.73 31.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.887 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.55 32.1 0.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.82 104.71 1.02 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.814 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.44 -59.53 4.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.034 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.821 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -101.84 125.87 48.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.622 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -90.37 110.69 21.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.416 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.793 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 41.8 pt -69.72 157.27 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 0.0 111.102 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -113.92 110.3 19.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 66.1 t -112.18 117.85 56.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.409 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 110.23 176.31 20.85 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.794 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.94 151.07 3.94 Favored Pre-proline 0 C--N 1.328 -0.37 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.09 70.45 7.1 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.825 2.35 . . . . 0.0 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.8 m -69.42 -52.95 22.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.319 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 194' ' ' ALA . 65.9 t30 -142.65 56.04 1.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.339 0.59 . . . . 0.0 110.533 -175.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.5 pt -72.06 151.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.562 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.75 -59.56 4.44 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 190' ' ' ASN . 25.7 mt-30 -67.41 -37.63 83.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 0.0 111.549 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.428 ' HB2' ' ND2' ' A' ' 190' ' ' ASN . . . -95.46 -1.56 50.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.348 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.533 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.0 tp60 -61.36 -50.1 84.77 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 16.6 Cg_endo -57.45 -23.98 58.64 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.126 1.884 . . . . 0.0 112.316 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 49.8 mm -76.8 -45.04 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.87 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.48 -47.88 90.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.846 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.39 -37.57 78.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.764 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.47 -53.71 47.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.435 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 202' ' ' ALA . 2.3 pp -71.23 -32.8 69.21 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.652 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.543 ' N ' HD12 ' A' ' 201' ' ' LEU . . . -72.99 -43.88 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 206' ' ' ARG . 8.9 mm-40 -75.05 -29.25 60.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.619 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.36 -31.95 73.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.08 -17.47 64.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.286 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 203' ' ' GLU . 15.9 mmt180 -63.62 -31.08 72.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.818 0.342 . . . . 0.0 110.427 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.57 63.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.53 . . . . 0.0 110.757 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -96.69 -5.27 39.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.049 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 p30 35.25 40.86 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.011 1.445 . . . . 0.0 113.444 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.86 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 13.7 ptt180 -109.53 139.39 44.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.23 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 20.3 pt -116.37 161.64 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.51 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -109.42 108.74 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.543 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.22 117.13 52.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.514 0.673 . . . . 0.0 110.78 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.1 -173.58 2.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.312 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.745 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 18.7 t 70.62 17.17 6.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.716 0.635 . . . . 0.0 110.239 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.676 HG11 HD21 ' A' ' 240' ' ' LEU . 93.4 t -67.32 136.44 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.59 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.506 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 11.1 t-80 -67.74 138.32 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -21.51 66.75 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -167.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.581 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -82.05 -47.66 12.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.315 0.507 . . . . 0.0 111.602 173.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.803 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.3 OUTLIER -56.43 116.04 2.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.097 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.6 t -101.03 -176.78 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.473 -0.142 . . . . 0.0 111.196 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.11 -36.56 70.78 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.562 0.22 . . . . 0.0 111.365 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.6 -41.0 96.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.187 0.518 . . . . 0.0 110.294 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.452 ' HB3' ' HG ' ' A' ' 220' ' ' LEU . 3.9 m-20 -66.06 -57.53 7.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.113 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.68 HD13 HD23 ' A' ' 220' ' ' LEU . 36.6 mm -57.45 -25.26 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -57.84 -32.26 67.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.495 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 74.4 m -49.87 -59.75 3.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.792 0.806 . . . . 0.0 111.705 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.697 HG12 ' HB1' ' B' ' 34' ' ' ALA . 5.4 m -73.18 -39.58 56.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.735 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -67.51 -41.03 85.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.73 0.3 . . . . 0.0 111.354 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -76.72 -18.81 58.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.126 0.488 . . . . 0.0 111.222 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.27 -31.13 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.654 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.2 m-30 -86.16 -30.57 22.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.87 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.61 179.74 34.99 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.989 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -77.53 113.18 15.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.108 0.48 . . . . 0.0 111.11 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.77 146.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.118 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.507 ' HE2' ' HB3' ' A' ' 256' ' ' GLU . 34.2 ttpt -106.35 -49.56 3.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.1 p -153.26 146.32 24.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 46.5 t -126.71 123.42 37.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.885 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.5 p -136.3 104.01 5.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.676 HD21 HG11 ' A' ' 216' ' ' VAL . 10.8 tp -96.86 114.84 26.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.75 136.47 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -170.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.619 174.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.75 124.38 81.78 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.404 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -68.79 -18.43 41.75 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.0 113.418 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 m -92.65 -52.95 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.752 0.311 . . . . 0.0 110.995 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.4 m -74.22 -27.5 60.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.462 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.61 21.45 64.04 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.593 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.31 146.93 49.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.3 OUTLIER -82.51 139.86 33.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.592 178.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -79.52 151.76 30.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.45 32.79 1.37 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.764 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -153.51 157.62 40.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.052 0.426 . . . . 0.0 109.915 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.635 ' HA3' HD12 ' A' ' 240' ' ' LEU . . . -164.77 178.37 39.95 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.52 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -118.94 131.52 56.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.2 129.2 72.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.86 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 54.6 mt-10 -109.07 141.93 40.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.005 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -106.78 161.08 14.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 0.0 112.005 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -88.58 -17.2 30.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.576 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 45.7 mtpt -133.75 133.33 41.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.759 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.39 -26.15 68.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.629 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -61.67 -46.78 88.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.428 174.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 45.7 m -64.93 -36.99 86.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.525 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -61.67 -41.4 97.5 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -73.97 -34.39 64.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.195 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.57 -35.13 46.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.109 0.481 . . . . 0.0 111.084 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.5 61.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 282' ' ' VAL . 11.0 p -54.59 -39.45 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.7 p -82.13 -25.31 34.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 4.5 m -96.42 -25.81 15.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.984 0.421 . . . . 0.0 111.632 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.693 ' HB3' HG21 ' A' ' 282' ' ' VAL . 26.9 mmm -73.65 -10.46 59.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -173.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 27.8 t-20 -62.05 -32.29 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.029 0.918 . . . . 0.0 110.616 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.4 mm? -76.73 -8.57 57.54 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.364 -172.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.878 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.2 t80 -65.15 105.9 1.18 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.171 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.2 t70 -94.97 121.51 36.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.826 -177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.803 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.8 mm? -116.32 85.91 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.348 173.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.53 29.98 34.46 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.475 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.1 12.35 27.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 13.5 pt20 -138.46 130.71 28.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.887 0.375 . . . . 0.0 110.34 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.638 ' HB2' HH21 ' A' ' 281' ' ' ARG . 63.8 m-85 -89.99 131.62 35.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.342 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 275' ' ' LEU . 17.4 mt -60.97 177.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.909 0.861 . . . . 0.0 111.57 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.638 HH21 ' HB2' ' A' ' 279' ' ' TYR . 4.2 mmt180 -140.41 111.48 7.07 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' A' ' 270' ' ' MET . 48.5 t -120.06 135.02 61.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.965 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.94 -151.2 5.44 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.18 149.9 25.53 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.72 91.99 2.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 167' ' ' GLN . 33.8 t -55.57 -46.76 79.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.704 -171.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.42 HG22 ' OE1' ' A' ' 164' ' ' GLU . 5.9 t -104.98 124.96 34.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.927 0.87 . . . . 0.0 112.371 -174.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.468 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 55.7 Cg_endo -73.9 121.96 7.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.595 2.197 . . . . 0.0 110.778 167.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 288' ' ' PRO . 13.2 Cg_exo -69.97 83.21 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.155 2.57 . . . . 0.0 112.59 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 81.7 mmm -97.63 119.56 62.37 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.614 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 24.1 Cg_exo -64.27 112.62 1.95 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.058 2.505 . . . . 0.0 112.664 -177.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 292' ' ' LEU . 1.0 OUTLIER -154.0 105.89 2.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.405 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.86 171.58 17.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.643 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 11.0 p -107.43 125.1 33.16 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.106 0.479 . . . . 0.0 110.843 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.02 -49.94 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.777 2.318 . . . . 0.0 112.8 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -154.69 72.93 0.87 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.075 0.464 . . . . 0.0 110.589 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.196 -178.78 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.27 145.62 37.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.661 0.267 . . . . 0.0 110.367 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -119.31 6.69 11.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.019 0.437 . . . . 0.0 110.178 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.42 67.14 3.14 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.8 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.411 ' O ' ' HB ' ' B' ' 27' ' ' VAL . 59.4 m-85 -122.63 24.62 9.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 93.5 t 70.35 -55.68 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 123.576 0.548 . . . . 0.0 110.421 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.638 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 62.5 t30 73.76 -52.89 0.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.097 0.959 . . . . 0.0 112.256 174.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -73.93 0.31 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.89 -23.3 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.935 0.398 . . . . 0.0 111.743 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 16.7 t80 -67.12 -20.02 65.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.308 0.575 . . . . 0.0 110.644 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.638 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 92.4 mttt -77.77 -43.37 30.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.57 -39.04 75.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.697 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -51.58 -50.02 60.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.539 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.802 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -81.18 -21.67 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.638 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 50.9 mt-30 -61.83 -42.14 98.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.495 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 73.7 mtp180 -72.06 -31.86 66.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.53 174.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.878 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -68.11 -44.69 75.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.255 6.3 mtm180 -82.94 -26.33 31.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.294 -1.504 . . . . 0.0 113.022 171.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -57.32 -42.55 82.08 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.056 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.695 HD11 ' HZ ' ' A' ' 273' ' ' PHE . 9.8 pt -64.3 -42.72 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.23 -24.67 66.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 111.519 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 -29.38 21.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.832 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -92.13 -33.8 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.581 HG23 ' HB2' ' A' ' 219' ' ' ASP . 79.9 mt 63.88 106.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.25 66.35 1.9 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.641 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.92 45.97 3.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.063 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.56 117.6 7.0 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.552 0.341 . . . . 0.0 110.318 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . 63.98 29.11 14.44 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.668 0.605 . . . . 0.0 110.649 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.44 -58.38 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.607 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 52.4 p 54.06 -174.54 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.892 0.877 . . . . 0.0 112.83 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.247 178.088 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.78 96.9 7.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.409 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.9 mmm -85.93 -22.18 27.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.485 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.75 20.49 0.74 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.161 0.505 . . . . 0.0 110.97 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -85.53 -23.7 27.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.998 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.4 ' HG3' ' HG3' ' A' ' 105' ' ' GLN . 30.0 tpt180 -100.17 127.75 46.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.4 ' HG3' ' HG3' ' A' ' 104' ' ' ARG . 90.0 mt-30 60.2 81.72 0.17 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.485 0.66 . . . . 0.0 111.125 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -56.88 -29.16 62.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.078 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.35 -28.87 70.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.88 -34.78 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.912 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.23 75.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.426 . . . . 0.0 111.22 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.39 -36.32 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.366 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 27.8 ttt -65.6 -26.67 67.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.875 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.9 m -82.17 4.34 23.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.541 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 19.5 ptt180 -135.57 134.61 39.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.975 0.417 . . . . 0.0 110.717 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.1 m -110.8 135.6 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.355 0.598 . . . . 0.0 111.522 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 71.0 t80 -78.83 124.47 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.209 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.53 112.06 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.023 0.439 . . . . 0.0 110.155 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.21 170.28 14.04 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.686 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.675 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 50.6 m 67.63 66.74 0.38 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.615 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.49 -19.84 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.136 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 66.8 t80 65.67 -73.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.286 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 53.4 t80 167.09 -43.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.291 0.636 . . . . 0.0 109.409 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.442 ' H ' ' HD2' ' A' ' 120' ' ' TYR . 28.1 tt0 -83.24 6.08 20.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.212 -173.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.8 mt -110.57 100.06 8.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.31 34.82 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.772 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -60.49 -41.42 94.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.35 -48.38 71.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.238 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -62.18 -53.85 49.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.09 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.75 -46.21 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.298 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -55.5 -48.95 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.494 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -78.27 -29.69 48.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.14 73.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.772 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.541 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 84.9 m-85 -97.71 7.08 47.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.464 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.07 -43.35 35.3 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.607 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 24.2 Cg_exo -65.16 -3.86 8.07 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.249 1.966 . . . . 0.0 112.915 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.705 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 21.8 m-85 -91.06 -63.96 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.683 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.63 175.2 34.28 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 162' ' ' VAL . 21.1 Cg_exo -65.09 123.1 11.07 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.429 2.086 . . . . 0.0 111.724 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.74 123.17 22.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.163 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -87.04 -56.4 3.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.004 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.9 m -162.29 149.35 13.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.53 106.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.83 110.6 23.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 22.9 ptm -137.26 149.44 47.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.043 0.449 . . . . 0.0 111.136 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.3 m -80.25 121.93 26.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.804 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 42.9 m95 -99.95 114.48 27.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.198 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.843 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 2.5 m-20 -69.79 89.82 0.58 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.266 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t 62.5 -163.03 0.27 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 123.864 0.728 . . . . 0.0 111.586 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.73 -18.77 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.482 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.491 ' HB ' ' HE2' ' A' ' 151' ' ' LYS . 21.2 p -66.71 11.45 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.731 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 19.8 mmt 59.09 32.13 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.041 0.537 . . . . 0.0 112.305 172.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.843 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 71.0 mmtt -79.22 -49.7 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.934 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p80 40.91 58.15 2.55 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.889 0.743 . . . . 0.0 112.352 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -104.18 94.28 5.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.288 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.23 -101.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.972 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -147.51 165.95 28.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.742 0.306 . . . . 0.0 110.714 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.47 146.38 33.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.717 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.04 111.71 24.31 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.5 106.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.046 0.45 . . . . 0.0 110.27 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.541 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 45.8 mt-10 -91.62 131.46 37.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.541 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 23.3 m-85 -102.01 147.62 26.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.424 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -75.17 -14.55 60.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.723 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.591 HG22 ' HD2' ' A' ' 137' ' ' PRO . 19.6 m -136.89 130.24 17.55 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.083 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.29 -19.93 68.54 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.169 2.579 . . . . 0.0 113.231 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.73 -65.15 0.64 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.48 -27.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.824 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.55 69.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.688 0.28 . . . . 0.0 111.14 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HB3' HG21 ' A' ' 286' ' ' VAL . 19.5 tt0 -74.54 -36.91 63.13 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.347 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.637 HD22 ' CD2' ' A' ' 212' ' ' TYR . 12.5 tp -55.75 -49.84 72.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.98 96.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.531 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.7 -54.02 45.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.176 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.54 -45.37 81.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.781 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -77.94 -46.04 22.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -175.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 23.1 mmt -73.24 -22.98 60.29 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.591 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -76.01 -23.55 55.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.312 0.577 . . . . 0.0 109.642 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 55.1 m -84.92 -30.66 24.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.458 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.68 130.65 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.1 0.476 . . . . 0.0 111.412 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.55 ' HB2' ' O ' ' A' ' 181' ' ' ARG . 25.7 ptt? -78.8 130.97 36.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.873 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 178' ' ' LEU . 3.5 pp -85.84 139.97 30.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.808 0.337 . . . . 0.0 111.138 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.2 -40.07 1.46 Allowed Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.345 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.38 2.62 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 177' ' ' MET . 30.6 mmt180 -98.13 126.42 43.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -74.85 67.84 1.68 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.665 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.675 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 38.1 pt -66.29 154.67 7.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -116.14 109.05 16.94 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 55.5 t -112.82 109.77 29.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.264 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.0 141.35 8.07 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.414 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 15.8 mtp180 -129.95 137.05 30.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 2.7 Cg_exo -76.4 48.12 2.26 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 111.335 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 p -81.25 -45.63 15.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.901 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -92.79 35.78 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.496 0.665 . . . . 0.0 109.781 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt -65.99 136.4 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.858 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 89.61 -35.22 3.79 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.104 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -83.2 -42.74 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.023 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.37 -18.6 41.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mp0 -57.67 -51.89 78.36 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 14.5 Cg_endo -57.02 -30.41 86.57 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.193 1.929 . . . . 0.0 112.472 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 48.3 mm -75.15 -50.81 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.401 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.28 -43.79 95.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.801 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.68 -42.72 71.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.712 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -60.4 -52.95 63.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 287' ' ' THR . 91.1 mt -64.96 -46.38 81.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.077 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.96 94.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.886 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.16 -35.09 68.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.88 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.24 -38.13 78.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.418 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.32 -27.99 69.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.82 -21.74 66.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.188 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.87 -13.1 51.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.973 0.416 . . . . 0.0 111.321 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.74 -17.78 20.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.402 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 65.82 15.0 9.87 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.618 0.574 . . . . 0.0 111.919 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.495 ' NH1' ' HB2' ' A' ' 289' ' ' PRO . 82.1 mtp180 -105.44 135.67 46.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.048 0.452 . . . . 0.0 110.679 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.462 HD11 ' CE1' ' A' ' 229' ' ' PHE . 30.6 pt -117.67 169.79 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.103 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.637 ' CD2' HD22 ' A' ' 168' ' ' LEU . 44.1 t80 -118.74 118.61 32.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.584 HG23 HG22 ' A' ' 282' ' ' VAL . 2.3 p -116.3 122.45 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.719 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.705 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.06 -179.84 4.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.98 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.607 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 24.7 m 68.07 29.08 6.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.276 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.814 HG13 HD11 ' A' ' 225' ' ' ILE . 73.6 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.319 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -63.25 123.15 17.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.69 -37.37 18.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -167.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.56 -45.75 43.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.616 0.245 . . . . 0.0 111.092 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.834 HD11 HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -58.5 116.43 3.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.6 m -99.88 -178.31 3.82 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -55.73 -44.42 77.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.651 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.44 -32.79 69.04 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.402 0.62 . . . . 0.0 110.185 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.518 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 57.1 m-20 -73.33 -55.91 5.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.645 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.814 HD11 HG13 ' A' ' 216' ' ' VAL . 33.8 mm -54.57 -29.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.103 0.478 . . . . 0.0 111.565 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.489 ' HG3' HD12 ' A' ' 235' ' ' ILE . 62.3 tttm -53.93 -32.53 53.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.94 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.573 ' HB3' ' HG2' ' B' ' 37' ' ' ARG . 68.0 m -48.99 -61.37 2.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.737 0.779 . . . . 0.0 112.826 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.695 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.0 m -70.67 -46.32 69.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.73 -169.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 57.6 m-85 -57.96 -43.93 86.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.687 0.279 . . . . 0.0 111.151 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.7 tt0 -70.9 -24.3 62.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.266 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.08 -21.09 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.372 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.692 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.6 OUTLIER -93.22 -43.75 8.67 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.59 153.69 25.04 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.07 137.94 51.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.487 0.643 . . . . 0.0 111.669 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 229' ' ' PHE . 60.6 mt -95.68 147.51 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.527 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 236' ' ' LYS . 9.7 mmmm -80.02 -64.3 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.429 171.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 35.5 t -150.42 147.67 27.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.495 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 5.3 p -121.95 129.42 52.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.424 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 7.2 t -142.48 125.31 16.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.172 0.51 . . . . 0.0 111.019 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.447 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 8.4 mp -110.19 130.2 55.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.587 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.68 145.92 50.79 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.509 0.671 . . . . 0.0 111.012 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.749 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -122.75 150.19 43.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.553 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -117.04 106.51 47.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.678 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.67 -25.15 34.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.489 2.126 . . . . 0.0 112.094 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.9 m -63.24 -48.29 78.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.355 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -83.65 -30.14 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.677 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.68 6.12 53.01 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.975 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -137.13 177.43 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -82.78 154.04 24.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.842 0.353 . . . . 0.0 110.416 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -84.7 155.71 21.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.36 43.05 2.83 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.833 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -156.26 157.51 35.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.97 0.385 . . . . 0.0 110.083 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -168.42 -172.95 35.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.583 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -119.31 132.81 55.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.732 0.301 . . . . 0.0 110.501 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.2 mm -111.81 126.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 210' ' ' ARG . 35.6 tt0 -103.72 120.89 41.85 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -94.23 142.86 26.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.532 0.682 . . . . 0.0 111.754 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -66.9 -26.25 66.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.179 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.474 ' HB3' ' HE2' ' A' ' 259' ' ' LYS . 34.4 mtpt -124.95 136.31 53.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.77 -18.55 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.532 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -68.8 -44.52 73.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.549 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 65.3 m -67.91 -21.02 65.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.696 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 m -59.03 -39.42 81.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.026 0.441 . . . . 0.0 110.262 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -75.33 -35.17 61.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.497 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 1.004 ' HA ' ' HA2' ' B' ' 25' ' ' GLY . 34.6 t70 -68.17 -34.79 76.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.124 -175.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.53 -47.63 22.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.675 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.551 HG12 HG12 ' A' ' 282' ' ' VAL . 31.1 m -59.44 -35.01 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -169.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.2 p -80.04 -9.47 59.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.2 m -113.81 -35.99 4.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.919 0.39 . . . . 0.0 111.694 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.695 ' HE2' ' HB2' ' A' ' 273' ' ' PHE . 0.6 OUTLIER -72.31 -16.02 61.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -170.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.4 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 8.4 t30 -60.81 -30.14 69.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.749 0.785 . . . . 0.0 110.402 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 272' ' ' LEU . 7.9 mp -76.83 -9.47 58.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.603 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.849 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -54.85 109.17 0.48 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 0.2 OUTLIER -113.82 130.31 56.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 -178.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.676 ' HG ' HD22 ' A' ' 220' ' ' LEU . 3.2 mm? -116.08 87.02 2.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.537 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 89.85 3.47 73.75 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.064 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 134.43 -31.51 2.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.417 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 17.3 pt20 -84.06 129.25 34.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.171 0.486 . . . . 0.0 110.772 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -89.41 139.83 30.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.732 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 273' ' ' PHE . 9.2 mp -76.78 -173.17 2.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.761 0.791 . . . . 0.0 111.568 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 281' ' ' ARG . 39.2 mmt180 -144.66 112.43 6.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.573 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.584 HG22 HG23 ' A' ' 213' ' ' VAL . 46.7 t -125.83 134.32 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.628 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -152.2 -153.61 6.33 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.768 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -85.11 165.82 17.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.088 0.444 . . . . 0.0 110.151 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -76.15 -7.49 54.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.998 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 167' ' ' GLN . 64.3 t 71.22 -64.49 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.119 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 201' ' ' LEU . 8.4 t -111.29 148.97 39.86 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 3.6 Cg_endo -47.42 114.65 1.09 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.835 2.357 . . . . 0.0 111.433 173.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.495 ' HB2' ' NH1' ' A' ' 210' ' ' ARG . 2.9 Cg_exo -74.17 50.95 2.35 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.595 2.863 . . . . 0.0 113.141 -171.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.609 ' N ' ' HD2' ' A' ' 291' ' ' PRO . 70.4 mtm -73.44 -37.44 3.63 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.213 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 290' ' ' MET . 36.4 Cg_endo -66.32 68.97 0.45 Allowed 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 121.937 1.758 . . . . 0.0 112.876 174.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 53.8 tp -80.23 70.13 6.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 74.7 mt -73.56 116.13 13.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.007 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 28.6 m -97.48 106.96 36.27 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.918 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.73 103.09 1.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.928 2.419 . . . . 0.0 111.972 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 63.09 -175.73 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.129 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.916 -179.099 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.57 105.12 17.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.147 0.499 . . . . 0.0 111.226 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 22.8 ptp -134.59 144.42 47.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 1.004 ' HA2' ' HA ' ' A' ' 265' ' ' ASP . . . 89.42 11.2 64.69 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.877 -172.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -132.6 88.2 2.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.086 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.627 HG21 ' HB2' ' B' ' 31' ' ' PHE . 29.1 m -86.69 134.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.112 0.482 . . . . 0.0 110.858 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -125.63 4.64 7.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.472 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.39 -38.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -62.1 -35.6 79.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.625 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.627 ' HB2' HG21 ' B' ' 27' ' ' VAL . 9.1 t80 -74.51 -19.44 60.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.321 0.582 . . . . 0.0 110.032 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.665 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 94.6 mttt -72.84 -45.48 58.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.731 ' HA ' HE21 ' B' ' 36' ' ' GLN . 22.5 t70 -56.28 -44.38 79.75 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.002 0.906 . . . . 0.0 108.744 174.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.695 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -48.23 -54.03 14.97 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.011 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' CB ' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -83.11 -23.42 33.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -168.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.731 HE21 ' HA ' ' B' ' 33' ' ' ASP . 30.3 mt-30 -55.24 -44.27 75.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.573 ' HG2' ' HB3' ' A' ' 227' ' ' SER . 25.2 ttm105 -74.39 -31.62 62.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.662 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.849 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.76 -46.2 83.14 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.251 11.7 mtp180 -81.18 -25.03 37.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.638 -1.289 . . . . 0.0 112.387 174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 19.8 tp60 -51.25 -47.28 62.45 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 165.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.834 HG13 HD11 ' A' ' 220' ' ' LEU . 4.6 pt -72.26 -28.42 29.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.844 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.507 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -65.76 -31.89 73.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.907 0.384 . . . . 0.0 111.076 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.41 -25.22 29.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.269 0.557 . . . . 0.0 110.492 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' B' ' 44' ' ' LYS . 4.8 tmmt? -82.1 -63.77 1.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.089 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 85.0 mt 66.49 102.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.104 0.478 . . . . 0.0 111.788 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.48 -168.12 13.46 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.545 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.6 -112.8 0.52 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.699 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -59.26 99.4 0.05 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.131 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.45 89.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.01 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.67 139.43 6.5 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.628 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 14.0 t -92.47 -175.34 3.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.664 -179.879 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.25 157.24 21.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 24.7 mmt 56.27 53.79 8.46 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.518 0.511 . . . . 0.0 110.839 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.61 91.51 1.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.568 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.93 45.75 2.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.436 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -90.35 67.76 6.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.8 52.88 4.09 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.43 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -61.0 -34.54 74.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.238 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.14 -50.16 73.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.392 . . . . 0.0 110.479 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.11 -39.12 86.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.65 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.13 72.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.909 0.385 . . . . 0.0 111.511 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.6 mt -83.9 -48.31 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.7 -35.29 80.08 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 80.4 m -83.18 2.64 34.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.53 0.205 . . . . 0.0 111.398 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.825 ' HB2' ' HG3' ' A' ' 159' ' ' GLU . 8.5 ttp180 -113.82 112.39 23.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.984 0.421 . . . . 0.0 111.237 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.39 150.89 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.337 0.589 . . . . 0.0 111.067 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.8 t80 -102.84 115.05 29.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.098 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.03 111.82 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.19 167.0 12.37 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.085 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 45.0 m 68.73 47.57 0.83 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.277 0.561 . . . . 0.0 110.991 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 79.1 mt -66.19 115.97 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.119 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -61.87 -78.85 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.339 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -175.61 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.27 -23.99 67.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.688 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.01 98.6 5.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.134 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.55 -175.15 37.09 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.731 ' HB2' ' HE1' ' A' ' 145' ' ' TRP . 40.4 tt0 -62.81 -41.32 99.25 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -66.98 -39.47 87.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.519 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -64.75 -46.08 83.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.96 -48.43 88.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.308 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ppt_? -66.87 -33.93 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.465 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -72.16 -35.7 69.11 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.737 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.84 97.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.878 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.422 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . 81.5 m-85 -97.07 11.29 36.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.266 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.583 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -65.98 -46.02 63.92 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.291 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 1.021 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 27.7 Cg_endo -63.13 -14.88 44.46 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.056 1.837 . . . . 0.0 112.881 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.431 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 5.0 m-85 -76.07 -66.42 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -151.18 156.13 26.51 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 171.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.16 131.46 46.47 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.532 2.155 . . . . 0.0 111.665 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.7 mm -72.32 117.3 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.552 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -90.13 -39.51 12.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.544 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.4 t -160.04 139.3 10.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.756 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.64 121.08 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.75 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.27 96.73 5.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.647 ' HG3' ' HB2' ' A' ' 156' ' ' ALA . 27.9 ttt -107.49 145.13 33.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.515 -175.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -78.12 80.61 4.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 0.0 109.863 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HE1' ' HB2' ' A' ' 125' ' ' GLU . 6.6 m95 -92.49 133.13 36.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.094 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -94.29 111.9 23.66 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.4 m -75.45 3.26 9.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.193 0.521 . . . . 0.0 110.548 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.13 -54.57 8.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.067 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.581 ' HB ' ' HG3' ' A' ' 151' ' ' LYS . 1.5 m -119.55 -15.01 9.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.62 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 82.5 mtp 67.11 32.77 5.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.721 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.581 ' HG3' ' HB ' ' A' ' 149' ' ' THR . 17.8 mtpp -97.16 -14.8 21.24 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.2 p80 44.19 47.04 7.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.74 0.816 . . . . 0.0 112.579 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.69 102.56 15.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.093 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 171.39 -112.83 0.47 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.75 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -142.0 172.93 12.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.858 0.361 . . . . 0.0 111.349 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.647 ' HB2' ' HG3' ' A' ' 143' ' ' MET . . . -151.67 150.58 30.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.707 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.22 131.7 56.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 58.6 t -128.32 115.78 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.854 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.825 ' HG3' ' HB2' ' A' ' 113' ' ' ARG . 1.8 mp0 -92.31 132.62 36.56 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.948 173.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -101.92 169.0 9.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.939 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.94 -48.83 80.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.478 0.656 . . . . 0.0 110.3 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.516 ' HB ' ' HG2' ' A' ' 164' ' ' GLU . 16.0 m -119.75 147.19 43.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.99 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.07 -16.52 44.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.754 2.303 . . . . 0.0 111.129 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.516 ' HG2' ' HB ' ' A' ' 162' ' ' VAL . 1.0 OUTLIER -63.21 -47.12 83.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.879 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.503 ' H ' HG23 ' A' ' 162' ' ' VAL . . . -62.05 -39.23 91.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.063 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.37 86.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.844 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -59.67 -45.33 92.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 13.1 mt -73.0 -35.16 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.983 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.64 85.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.552 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 2.9 tt -77.15 -63.09 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.081 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -63.57 -47.31 82.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -171.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.672 ' HB3' ' HD3' ' A' ' 281' ' ' ARG . 80.7 mm-40 -84.74 -0.72 54.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -171.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.63 ' HB3' HG21 ' A' ' 185' ' ' VAL . 42.6 tpp -119.95 -33.79 3.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.32 -24.82 63.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.233 0.54 . . . . 0.0 110.48 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.2 m -84.37 -0.97 54.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.416 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.54 177.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.362 . . . . 0.0 110.758 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 82.2 mtp -118.01 126.04 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.171 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.52 85.49 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 110.072 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.08 -135.22 12.86 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.908 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.53 77.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.922 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -130.17 154.93 47.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.872 0.368 . . . . 0.0 110.748 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.555 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 24.3 p-10 -100.91 108.76 20.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.506 0.669 . . . . 0.0 110.397 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 45.3 pt -75.57 148.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 184' ' ' LYS . 24.0 tptp -102.24 109.38 21.04 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.135 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 173' ' ' MET . 15.8 m -104.64 127.03 59.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.991 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.552 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 85.75 135.6 3.77 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.285 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -153.34 91.16 3.37 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 81.11 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.201 2.6 . . . . 0.0 112.568 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.6 m -81.7 -17.45 47.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.614 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.48 53.5 2.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.065 0.459 . . . . 0.0 110.802 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.69 124.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.522 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.76 -24.71 4.32 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.558 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 193' ' ' GLN . 13.5 mm-40 -83.68 -47.64 11.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.832 0.349 . . . . 0.0 111.399 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.35 -20.9 27.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.677 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 27.2 mm-40 -57.98 -55.21 47.56 Favored Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 200' ' ' GLN . 19.3 Cg_endo -58.75 -30.97 94.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.109 1.873 . . . . 0.0 112.539 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.0 mm -70.61 -52.43 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.009 0.433 . . . . 0.0 110.178 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.28 -33.54 64.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.963 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.78 -49.46 77.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.597 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 47.1 mt-30 -65.17 -34.85 79.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.118 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.21 -49.81 68.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.477 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -64.67 -29.74 70.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.31 -52.1 66.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.965 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.41 -28.59 59.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.897 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.09 69.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.923 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 14.4 mtm180 -67.23 -20.35 65.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.64 0.257 . . . . 0.0 110.96 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -24.27 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.18 0.514 . . . . 0.0 110.639 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -102.1 -29.13 11.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 52.13 79.14 0.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.839 0.712 . . . . 0.0 111.258 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.682 ' HB2' ' HB3' ' A' ' 285' ' ' ALA . 39.5 mtm180 -125.18 142.35 51.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.047 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.717 HD13 ' HE1' ' A' ' 229' ' ' PHE . 13.5 tt -108.82 142.95 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 282' ' ' VAL . 79.4 t80 -108.44 123.19 48.48 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.799 0.333 . . . . 0.0 110.171 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.527 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.3 p -119.04 122.73 70.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.511 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -123.05 179.6 4.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.191 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 1.021 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 20.0 m 65.29 26.79 12.16 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.799 0.687 . . . . 0.0 110.948 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.43 HG22 ' C ' ' A' ' 251' ' ' GLY . 8.1 m -72.46 145.21 12.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.157 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.442 ' HD1' ' CG ' ' A' ' 219' ' ' ASP . 13.4 t-80 -68.4 130.33 42.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.38 -18.47 64.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -164.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.442 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 0.6 OUTLIER -78.27 -44.08 26.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.169 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.693 HD23 HD13 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -52.8 114.37 1.39 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.818 172.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.2 m -98.79 -177.5 3.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 11.0 p-10 -54.36 -41.29 68.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -70.63 -28.93 65.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.76 0.314 . . . . 0.0 110.684 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.572 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 4.8 m-20 -67.54 -55.79 12.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.693 HD13 HD23 ' A' ' 220' ' ' LEU . 30.8 mm -57.38 -27.28 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.11 0.481 . . . . 0.0 110.816 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.514 ' HG3' HD13 ' A' ' 235' ' ' ILE . 87.7 tttt -56.94 -32.85 66.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.292 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.664 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 57.9 m -48.33 -60.22 2.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.936 0.874 . . . . 0.0 112.092 -176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.721 ' HB ' ' CE ' ' A' ' 270' ' ' MET . 2.8 m -72.14 -36.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.731 -170.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.717 ' HE1' HD13 ' A' ' 211' ' ' ILE . 71.3 m-85 -70.79 -37.13 73.29 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.259 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.472 ' OE1' ' HE2' ' A' ' 226' ' ' LYS . 8.5 tt0 -77.27 -21.09 54.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.737 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.84 -18.7 53.59 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.49 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.676 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 3.8 m-30 -87.77 -38.21 15.95 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.521 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -158.75 -156.97 8.25 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.569 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 234' ' ' LYS . 32.3 mmtp -94.54 128.59 41.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.514 HD13 ' HG3' ' A' ' 226' ' ' LYS . 20.6 tt -104.1 135.68 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.551 0.691 . . . . 0.0 111.286 -171.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 256' ' ' GLU . 23.5 tptp -91.08 -52.42 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.81 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 69.3 m -149.95 124.74 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.846 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 3.8 p -100.54 68.13 1.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.38 0.61 . . . . 0.0 109.739 174.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.5 p -97.8 104.35 16.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.231 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.4 mp -91.72 128.8 37.69 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.29 133.76 49.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.627 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -133.61 151.05 51.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.408 . . . . 0.0 110.738 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.92 118.19 70.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.258 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.75 -17.1 42.41 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.908 2.406 . . . . 0.0 113.412 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 69.7 p -86.8 -47.1 9.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.712 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.1 m -92.23 -25.67 18.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.968 0.413 . . . . 0.0 111.354 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.71 22.61 42.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.986 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.8 122.29 45.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.589 0.233 . . . . 0.0 111.122 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.5 p80 -72.79 138.2 46.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 252' ' ' TYR . 96.4 mttt -70.5 156.62 39.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.45 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.43 ' C ' HG22 ' A' ' 216' ' ' VAL . . . -71.97 33.15 0.63 Allowed Glycine 0 CA--C 1.522 0.505 0 O-C-N 123.476 0.485 . . . . 0.0 113.637 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 250' ' ' LYS . 5.7 p90 -153.24 163.79 39.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.503 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -155.11 162.63 31.04 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.008 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.74 117.14 29.94 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 237' ' ' SER . 2.3 mp -102.79 128.5 55.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 51.6 mt-10 -102.76 145.78 29.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -119.31 132.22 55.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.268 0.556 . . . . 0.0 111.022 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -78.18 -27.21 47.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.344 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 259' ' ' LYS . 20.3 mtpt -112.5 123.05 49.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.157 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -61.85 -34.34 75.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.869 -176.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -61.33 -37.69 84.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.222 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.8 m -73.76 -28.83 61.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.046 0.45 . . . . 0.0 110.446 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.7 t -73.78 -22.4 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.896 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 55.3 mt-30 -74.99 -49.66 19.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.648 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.49 -33.73 41.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -171.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.28 54.01 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 111.177 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 37.4 t -71.9 -34.13 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 111.378 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.2 p -89.89 -17.93 27.1 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.777 0.322 . . . . 0.0 111.661 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 36.0 m -112.1 1.03 16.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -171.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.743 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 6.0 tpp -119.19 2.4 11.39 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -172.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -82.85 -16.86 46.0 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.184 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 9.1 mp -79.6 -9.37 59.62 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.943 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -45.93 106.05 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.341 0.4 . . . . 0.0 111.583 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.404 ' O ' HD13 ' A' ' 275' ' ' LEU . 0.7 OUTLIER -91.38 114.47 27.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.535 -178.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' B' ' 42' ' ' ALA . 2.4 mm? -119.93 86.38 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.312 169.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.23 40.25 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.834 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.84 -2.5 69.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.999 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.89 128.83 49.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 273' ' ' PHE . 86.2 m-85 -98.83 122.46 42.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.742 HD22 ' CD2' ' A' ' 273' ' ' PHE . 9.9 mp -70.55 -179.44 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.028 0.442 . . . . 0.0 110.676 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.672 ' HD3' ' HB3' ' A' ' 172' ' ' GLN . 3.6 mmp_? -136.48 128.04 28.7 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -174.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 3.1 m -122.96 151.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.456 0.646 . . . . 0.0 112.042 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.562 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -160.83 -136.71 2.06 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.352 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.83 152.43 38.4 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.579 -0.365 . . . . 0.0 110.886 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 210' ' ' ARG . . . -96.49 102.9 14.76 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -35.42 8.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.609 -168.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 14.9 t -84.92 136.01 39.19 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.5 123.34 11.3 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.819 2.346 . . . . 0.0 112.013 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.416 ' HG3' ' HD3' ' A' ' 210' ' ' ARG . 66.1 Cg_endo -75.6 81.75 2.26 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.818 2.345 . . . . 0.0 112.918 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.455 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 26.1 ptt? -76.79 127.89 82.98 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.754 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.601 ' HB2' ' HG ' ' A' ' 293' ' ' LEU . 6.0 Cg_exo -74.12 146.46 36.64 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.948 2.432 . . . . 0.0 112.441 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 35.0 tp -81.85 66.92 7.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.399 0.618 . . . . 0.0 109.816 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 291' ' ' PRO . 86.6 mt -83.79 -22.5 31.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.258 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 2.1 p -96.5 146.26 31.0 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.726 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 6.3 Cg_exo -73.7 61.89 4.58 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.153 2.568 . . . . 0.0 112.642 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -83.11 85.44 7.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.296 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 72.1 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.022 -179.451 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.21 69.09 0.78 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.822 0.344 . . . . 0.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.98 129.62 40.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.912 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.41 -26.59 23.99 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -173.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -111.43 34.59 4.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' B' ' 30' ' ' ALA . 47.7 t -77.47 104.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.642 0.734 . . . . 0.0 112.053 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.611 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 15.2 m120 -122.68 -45.78 2.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.184 167.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.92 -52.8 62.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.453 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.586 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -63.99 -31.33 72.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.027 0.441 . . . . 0.0 111.171 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.652 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 11.7 t80 -76.65 -21.48 55.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.224 0.535 . . . . 0.0 110.289 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 71.8 mttt -74.43 -41.0 61.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.8 t70 -58.0 -41.93 84.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.676 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.49 -49.27 55.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.341 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -81.87 -25.15 35.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -169.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 24.9 mt-30 -57.71 -44.93 86.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.664 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 60.6 mtt180 -68.11 -35.99 79.02 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.586 174.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.943 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.06 -49.97 72.44 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 39' ' ' ARG 0.272 13.6 mtp180 -81.44 -25.3 36.25 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.202 -1.561 . . . . 0.0 112.751 174.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -52.47 -46.7 66.65 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 110.073 168.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.847 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.6 pt -67.22 -35.51 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 110.498 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.554 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -65.88 -20.1 66.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.388 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.27 -42.28 12.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.8 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.847 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.1 OUTLIER -92.3 -14.48 28.77 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.436 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.2 pt 42.32 76.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 171.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.16 -143.11 16.39 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.576 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.0 -140.72 11.54 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.119 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.3 128.55 34.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.845 0.355 . . . . 0.0 110.591 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.08 18.06 0.12 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.959 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.72 68.87 0.52 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.457 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 58.1 m -73.16 97.72 2.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.003 0.43 . . . . 0.0 110.324 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.431 -0.795 . . . . 0.0 108.964 -179.195 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.62 82.47 5.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.865 0.365 . . . . 0.0 110.094 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.5 ttt -110.63 -42.4 4.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.632 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.37 78.84 3.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.498 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -89.43 9.74 25.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.626 -175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -81.76 -0.34 42.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.422 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 12.3 pt20 -92.91 29.0 1.92 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.114 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 -58.12 -45.25 87.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 111.099 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.82 -26.74 61.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.987 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 59.4 tp -76.43 -45.76 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.056 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.35 -45.72 76.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.886 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.5 pt -64.99 -34.2 68.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.09 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 75.4 mtp -70.05 -26.39 64.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.483 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.37 -33.1 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 14.6 ptp180 -109.26 127.72 54.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 111.337 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.98 140.89 24.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.495 0.664 . . . . 0.0 110.794 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.446 ' HE1' ' HB2' ' A' ' 155' ' ' PHE . 65.6 t80 -85.12 130.56 34.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.827 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.86 112.23 38.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.547 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.27 169.71 13.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.332 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.444 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 48.2 m 57.86 50.7 10.07 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.323 0.583 . . . . 0.0 110.757 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -90.84 10.26 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.093 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.2 t80 64.05 11.99 6.6 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.618 0.723 . . . . 0.0 109.406 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.995 ' HB2' ' H ' ' A' ' 153' ' ' LYS . 55.0 p90 42.18 33.52 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.852 1.261 . . . . 0.0 113.319 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.46 -58.07 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.162 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.478 ' H ' HD12 ' A' ' 123' ' ' LEU . 7.5 mp -48.94 135.98 14.86 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.56 0.537 . . . . 0.0 112.373 -174.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.63 170.65 48.39 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.447 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.45 -39.17 77.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.603 0.361 . . . . 0.0 111.62 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.32 -27.96 69.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.315 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 48.8 m -66.66 -45.7 78.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 110.307 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.29 -40.03 81.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.984 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -53.35 -48.86 68.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.08 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 78.1 mt-30 -76.96 -30.23 55.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.636 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.37 -32.39 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 110.703 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.512 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 89.5 m-85 -105.62 12.12 31.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.973 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -70.3 -44.03 18.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.843 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.612 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 14.4 Cg_exo -71.46 -4.0 14.14 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.91 1.74 . . . . 0.0 111.73 173.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.454 ' O ' ' HB1' ' A' ' 165' ' ' ALA . 54.6 m-85 -106.41 58.57 0.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.52 164.01 38.34 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.701 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.525 ' HD2' HG22 ' A' ' 162' ' ' VAL . 68.0 Cg_endo -79.49 132.47 10.04 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.81 2.34 . . . . 0.0 112.461 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.87 119.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.36 -56.21 3.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 0.0 110.681 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.6 m -157.53 125.26 5.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.622 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.478 HG22 ' HG3' ' A' ' 143' ' ' MET . 54.9 mt -101.22 107.17 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 173.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.55 120.06 27.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.114 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.478 ' HG3' HG22 ' A' ' 141' ' ' ILE . 82.9 mtp -139.02 131.33 28.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.87 0.366 . . . . 0.0 111.399 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.2 m -106.9 105.76 15.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.934 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 10.6 p-90 -159.49 159.86 33.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -83.74 95.53 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.928 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.404 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 10.4 p -70.64 -23.18 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.528 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.9 m -68.82 -32.71 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.454 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.8 p -109.45 -1.89 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.351 0.596 . . . . 0.0 110.71 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.934 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 74.1 mtp 61.06 36.6 18.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -106.02 137.95 43.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.73 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 11.5 m-70 -95.74 -79.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.995 ' H ' ' HB2' ' A' ' 121' ' ' TYR . 29.5 mtpt 52.22 45.88 27.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.22 -170.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -160.27 -122.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.469 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.446 ' HB2' ' HE1' ' A' ' 115' ' ' TYR . 29.7 p90 -149.53 174.03 12.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.795 -170.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.99 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.119 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -116.69 108.64 16.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.447 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.4 110.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.49 0.662 . . . . 0.0 110.542 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 35.4 tt0 -94.57 134.14 37.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.512 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 84.8 m-85 -102.91 161.01 14.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.426 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.54 -7.96 53.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.687 ' HB ' ' OE2' ' A' ' 164' ' ' GLU . 34.9 m -129.22 128.07 23.25 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.429 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 3.1 Cg_exo -74.83 -22.26 15.41 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.137 2.558 . . . . 0.0 114.083 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.687 ' OE2' ' HB ' ' A' ' 162' ' ' VAL . 1.2 mp0 -63.26 -57.68 9.66 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.617 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 135' ' ' PHE . . . -56.96 -29.63 63.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.627 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.23 64.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.522 ' HB3' HG21 ' A' ' 286' ' ' VAL . 23.6 tm0? -68.49 -39.93 81.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.69 -55.93 26.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.266 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.89 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.317 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.933 ' HG ' ' HA2' ' A' ' 186' ' ' GLY . 7.5 tt -54.87 -63.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.222 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.58 -36.01 15.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -70.51 -27.48 64.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.519 ' HG3' HD11 ' A' ' 183' ' ' ILE . 60.5 tpp -88.87 -27.21 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -73.12 -8.72 57.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.786 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.4 m -90.61 -7.94 51.43 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.188 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.16 163.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.037 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 20.0 ptp -108.93 144.03 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.117 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.41 59.83 1.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.053 0.454 . . . . 0.0 110.431 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.8 77.31 1.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.857 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.97 -51.31 4.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.586 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 181' ' ' ARG . 2.5 mpt_? -88.35 126.79 35.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 0.0 110.818 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.2 109.32 8.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.388 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.519 HD11 ' HG3' ' A' ' 173' ' ' MET . 35.5 pt -76.86 162.04 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -119.64 114.02 21.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.001 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 170' ' ' LEU . 27.6 t -117.45 132.85 66.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.976 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.933 ' HA2' ' HG ' ' A' ' 170' ' ' LEU . . . 156.03 -136.29 4.96 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.285 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -149.03 71.57 10.23 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.375 0.607 . . . . 0.0 110.605 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.63 89.0 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.728 2.285 . . . . 0.0 112.794 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.4 m -143.71 -71.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.686 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.27 117.91 17.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 27.9 pt -102.04 -175.49 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 86.25 -55.97 4.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.191 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -67.96 -51.53 46.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.76 0.314 . . . . 0.0 111.769 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.05 6.44 36.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.677 0.275 . . . . 0.0 111.73 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.503 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.1 OUTLIER -64.9 -55.51 27.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 9.6 Cg_endo -53.13 -32.22 58.37 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.683 2.255 . . . . 0.0 112.725 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -58.01 -46.84 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.397 . . . . 0.0 110.337 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.82 -43.86 98.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.457 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.36 -44.86 93.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.46 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 32.0 mm-40 -67.11 -39.63 86.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.081 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 286' ' ' VAL . 85.7 mt -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.16 -38.2 88.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.88 -40.89 83.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.146 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.15 -40.42 96.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.215 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.13 86.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 82.9 mtp180 -68.51 -30.73 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.51 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.7 72.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -89.8 -6.06 56.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.893 178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.433 HD22 ' N ' ' A' ' 209' ' ' ASN . 0.9 OUTLIER 65.73 26.67 11.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.121 178.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -105.21 136.96 43.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 111.339 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.68 169.68 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.117 174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.474 ' HB2' ' HA ' ' A' ' 285' ' ' ALA . 37.5 t80 -119.79 128.18 53.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.437 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.468 HG23 HD21 ' A' ' 280' ' ' LEU . 1.5 p -119.95 118.63 57.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.14 -178.36 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.169 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.612 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 50.6 m 64.93 26.54 12.79 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.889 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.575 HG13 HD11 ' A' ' 225' ' ' ILE . 58.0 t -72.18 134.89 28.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.519 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -63.22 127.59 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -56.57 -29.64 62.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.856 -171.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.18 -45.96 24.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.516 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.644 HD22 HD11 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -75.08 116.13 15.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.014 -177.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.4 t -106.54 -176.17 3.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -166.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -48.5 -45.1 36.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.33 -34.35 64.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.862 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.44 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.6 m-20 -79.7 -56.79 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.451 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.802 HG13 HD11 ' A' ' 240' ' ' LEU . 27.1 mm -54.39 -26.25 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.835 0.454 . . . . 0.0 112.071 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -50.91 -32.43 20.63 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.77 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 67.2 m -48.93 -62.71 1.38 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.575 0.702 . . . . 0.0 112.698 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.864 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.3 m -74.72 -46.24 42.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.949 -165.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.675 ' HB2' HD11 ' A' ' 235' ' ' ILE . 71.6 m-85 -61.07 -35.89 78.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.967 0.413 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -77.38 -26.52 51.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.192 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.53 81.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.654 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.753 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.5 OUTLIER -82.67 -14.27 54.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.669 -175.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -159.44 -111.3 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.82 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -156.07 131.19 9.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 110.132 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' A' ' 229' ' ' PHE . 58.7 mt -86.39 127.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.472 0.653 . . . . 0.0 110.763 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -79.48 -46.07 18.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.736 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 5.4 p -167.0 129.34 1.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.699 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.445 ' HB3' HG23 ' A' ' 255' ' ' ILE . 20.4 p -131.2 137.76 49.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.901 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 52.8 m -154.88 120.68 5.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.898 0.38 . . . . 0.0 110.915 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.802 HD11 HG13 ' A' ' 225' ' ' ILE . 52.6 mt -83.46 130.83 35.04 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.13 121.04 11.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.254 0.55 . . . . 0.0 110.319 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 44.9 mtt180 -93.59 158.04 15.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.507 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 15.6 t70 -117.89 107.71 43.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.382 -176.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.28 -24.69 57.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.015 2.477 . . . . 0.0 113.187 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.5 p -78.43 -28.36 46.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.688 0.28 . . . . 0.0 111.612 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.4 m -96.55 -33.37 11.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.899 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.3 -10.94 58.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.993 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -108.83 -92.52 0.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.667 -0.314 . . . . 0.0 111.115 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 25.4 p80 -170.0 162.09 9.0 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.507 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 96.0 mttt -84.17 155.82 22.38 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.61 42.03 1.47 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.559 . . . . 0.0 114.05 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.4 p90 -161.09 168.29 24.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 175.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.729 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -174.95 -177.82 44.34 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.189 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.25 137.49 54.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.772 0.32 . . . . 0.0 110.62 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 238' ' ' CYS . 56.4 mt -131.61 126.48 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.03 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.3 136.72 44.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.352 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -104.32 155.81 18.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.851 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -81.74 -19.36 41.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.689 173.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 262' ' ' SER . 28.5 mmmt -127.46 120.98 29.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.407 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -67.29 -22.46 65.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.875 0.369 . . . . 0.0 111.363 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.565 ' HA ' HE21 ' A' ' 264' ' ' GLN . 99.0 mt-30 -65.42 -44.02 88.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 1.9 p -71.58 -29.89 65.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.497 ' O ' HG23 ' A' ' 267' ' ' VAL . 9.1 m -56.06 -41.44 75.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.035 0.445 . . . . 0.0 110.757 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.565 HE21 ' HA ' ' A' ' 261' ' ' GLN . 47.6 mt-30 -67.2 -35.21 79.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.571 -176.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.65 -43.27 63.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -52.17 -44.63 64.72 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.549 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 263' ' ' SER . 67.0 t -61.82 -27.18 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 111.383 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.0 m -91.12 -36.4 14.01 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.193 -0.317 . . . . 0.0 111.463 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 45.3 m -92.24 -35.07 14.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.731 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 40.2 mmm -70.36 -9.23 55.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -59.99 -43.3 95.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.664 0.745 . . . . 0.0 110.649 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 8.8 mp -76.63 -8.61 57.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.709 ' CD2' HD22 ' A' ' 280' ' ' LEU . 49.0 t80 -45.41 102.09 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.523 0.514 . . . . 0.0 110.889 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.4 p-10 -94.68 128.82 41.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.489 0.662 . . . . 0.0 111.016 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.644 HD11 HD22 ' A' ' 220' ' ' LEU . 40.5 mt -124.07 87.24 2.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.759 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.63 -111.08 3.44 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -113.15 34.56 5.01 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.424 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 11.2 pt20 -141.23 159.86 41.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.681 0.24 . . . . 0.0 110.813 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -102.25 162.85 12.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.826 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 13.3 tp -91.09 -170.08 2.55 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.826 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 21.0 tpp180 -148.61 112.41 5.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 175.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 270' ' ' MET . 7.5 p -112.02 146.3 17.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.889 0.376 . . . . 0.0 110.811 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.85 -145.06 4.08 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.546 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 286' ' ' VAL . 92.4 mttt -123.08 150.7 42.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.653 -0.322 . . . . 0.0 110.29 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -65.06 -31.39 72.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.713 -170.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 167' ' ' GLN . 62.3 t 68.58 -65.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.431 HG23 HG12 ' A' ' 286' ' ' VAL . 3.1 p -115.58 83.77 11.51 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.473 ' HG2' ' HD3' ' A' ' 289' ' ' PRO . 19.0 Cg_endo -63.99 -33.82 61.47 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 122.643 2.229 . . . . 0.0 115.828 174.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.473 ' HD3' ' HG2' ' A' ' 288' ' ' PRO . 96.1 Cg_endo -77.43 48.12 2.47 Favored 'Trans proline' 0 C--N 1.367 1.539 0 CA-C-N 121.437 1.549 . . . . 0.0 113.555 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.505 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 50.5 ttp -102.09 124.42 40.03 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 6.2 Cg_exo -74.16 68.56 4.99 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.27 2.647 . . . . 0.0 112.286 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 292' ' ' LEU . 2.0 pp -74.18 142.89 45.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.4 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.8 mt -119.28 72.39 0.9 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.165 0.507 . . . . 0.0 110.532 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' A' ' 295' ' ' PRO . 9.2 m -63.03 -45.58 86.57 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.884 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 294' ' ' THR . 24.1 Cg_endo -64.02 93.28 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.617 1.544 . . . . 0.0 111.647 171.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -79.17 69.61 5.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.597 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.484 -178.82 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.51 ' HB3' HG22 ' B' ' 27' ' ' VAL . . . -122.37 176.1 6.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.603 0.24 . . . . 0.0 110.705 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 66.7 mtt -131.24 46.88 2.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.095 0.474 . . . . 0.0 109.894 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.37 124.49 5.45 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 65.07 70.49 0.47 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.837 0.455 . . . . 0.0 110.378 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 17.8 t -60.08 103.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.195 0.521 . . . . 0.0 111.138 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -87.05 34.17 0.68 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -154.35 -77.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.318 . . . . 0.0 111.026 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.535 ' HB3' HG11 ' B' ' 27' ' ' VAL . . . -64.17 -23.36 67.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.121 -176.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.7 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 12.1 t80 -72.19 -23.88 61.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.08 0.467 . . . . 0.0 110.032 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 51.5 mtpt -71.4 -39.84 70.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.28 -31.52 72.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.864 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -56.93 -55.0 40.22 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.549 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.669 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.7 OUTLIER -82.25 -24.13 34.95 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 4.7 pt20 -60.33 -37.32 80.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.166 169.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.426 ' O ' HG23 ' B' ' 41' ' ' ILE . 32.1 ttm180 -74.01 -31.27 62.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.775 173.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.738 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -71.61 -42.39 67.74 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 121.549 0.69 . . . . 0.0 112.553 -175.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 58.4 mtp180 -79.24 -25.21 42.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.88 -1.137 . . . . 0.0 111.389 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -55.87 -49.8 72.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.35 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.738 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.2 pt -65.41 -34.13 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.847 0.356 . . . . 0.0 110.352 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -68.33 -25.12 64.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.443 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.53 -45.96 34.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.229 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.717 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -86.56 -29.55 22.57 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 59.4 mt 60.22 -87.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 122.868 0.467 . . . . 0.0 111.406 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.65 91.93 0.98 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.54 -119.62 4.44 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.685 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -90.56 31.78 1.01 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.348 0.594 . . . . 0.0 111.093 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.39 56.43 3.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.438 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.65 -122.84 6.94 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.098 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 59.0 m 69.03 -86.95 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.845 0.458 . . . . 0.0 110.573 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.242 -0.885 . . . . 0.0 109.74 176.814 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . . . -66.57 163.03 19.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.3 ttt -47.37 -58.05 4.58 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.517 0.51 . . . . 0.0 111.934 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.62 16.99 16.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.294 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 56.8 tp60 65.38 108.9 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.581 -174.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 104' ' ' ARG . 51.5 mtm180 -71.89 87.55 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.331 0.586 . . . . 0.0 110.315 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 103' ' ' GLN . 66.3 mt-30 -88.53 40.94 0.99 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.315 -172.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -66.17 -29.16 69.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.459 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.9 -26.1 62.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.01 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.5 tp -68.09 -36.18 79.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.28 68.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.4 mt -80.49 -47.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.535 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 52.2 mtm -66.27 -27.02 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.47 -13.41 62.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 21.9 ptt180 -127.23 119.44 26.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.815 0.341 . . . . 0.0 110.566 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.466 HG22 ' HE1' ' A' ' 160' ' ' TYR . 16.8 m -92.47 138.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.69 0.757 . . . . 0.0 111.394 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -86.36 99.49 11.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.642 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.0 t -96.74 115.6 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.155 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.527 ' CA ' ' HD1' ' A' ' 155' ' ' PHE . . . -127.69 -176.91 14.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.8 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 47.2 m 72.43 -72.26 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.582 0.753 . . . . 0.0 111.149 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.42 HD12 HD11 ' A' ' 128' ' ' ILE . 44.1 mm 68.79 158.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 123.23 0.331 . . . . 0.0 110.743 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 69.6 t80 -56.26 -64.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.376 -0.203 . . . . 0.0 110.729 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 42.2 t80 177.86 -49.77 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.104 0 O-C-N 123.456 0.473 . . . . 0.0 110.687 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' LYS . 6.0 pt-20 -136.6 45.19 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.487 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.41 134.36 46.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.925 0.393 . . . . 0.0 111.102 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.56 -177.33 50.43 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.256 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -63.79 -41.65 97.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.478 -0.361 . . . . 0.0 111.866 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -64.37 -41.32 96.77 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.534 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.7 m -57.06 -45.21 83.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 119' ' ' ILE . 65.5 mt -71.08 -45.82 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.689 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 129' ' ' ARG . 20.5 ttp180 -56.59 -47.0 80.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.571 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -77.55 -11.41 59.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.629 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -29.83 38.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.407 . . . . 0.0 110.443 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.796 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 61.7 m-85 -99.29 8.1 45.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.583 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.34 -44.0 12.91 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.583 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.596 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 29.1 Cg_endo -64.84 -4.78 9.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.843 1.695 . . . . 0.0 113.019 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 5.4 m-85 -87.25 -68.35 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.795 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -161.17 167.65 36.18 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.827 ' HG2' ' HB3' ' A' ' 161' ' ' GLU . 19.3 Cg_endo -60.39 126.86 21.11 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.54 2.16 . . . . 0.0 111.833 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.2 mt -87.8 128.89 39.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.367 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -80.26 -56.19 4.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -158.7 152.21 23.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.164 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.402 HG12 HG13 ' A' ' 158' ' ' VAL . 68.4 mt -124.16 107.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.89 112.61 24.61 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 43.1 ttm -134.85 118.27 16.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.204 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.4 t -91.09 115.47 28.04 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' CE3' ' HB2' ' A' ' 152' ' ' HIS . 1.6 p-90 -165.93 151.63 8.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.196 0.522 . . . . 0.0 111.771 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.24 99.8 1.22 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.5 t -94.2 6.53 48.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.6 p -84.75 -31.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.114 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.2 p -108.37 -17.37 14.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 111.202 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.0 mtt 63.21 41.18 8.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.143 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 33.8 mmtp -84.06 -39.93 18.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.588 ' HB2' ' CE3' ' A' ' 145' ' ' TRP . 1.6 t60 60.43 67.04 0.87 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.732 0.777 . . . . 0.0 110.357 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -96.7 64.96 2.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.664 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.25 -155.25 11.36 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.743 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.527 ' HD1' ' CA ' ' A' ' 117' ' ' GLY . 28.7 m-85 -104.99 170.46 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.961 0.41 . . . . 0.0 111.16 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.45 145.4 24.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.76 107.85 18.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.727 0.299 . . . . 0.0 110.277 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.402 HG13 HG12 ' A' ' 141' ' ' ILE . 23.3 t -98.36 111.37 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 30.1 tt0 -100.57 129.32 46.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.963 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.466 ' HE1' HG22 ' A' ' 114' ' ' VAL . 90.3 m-85 -102.01 161.34 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.384 0.611 . . . . 0.0 111.412 -176.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.827 ' HB3' ' HG2' ' A' ' 137' ' ' PRO . 10.8 tp10 -77.62 -27.07 51.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.585 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 16.1 m -126.55 119.76 23.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.665 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 162' ' ' VAL . 19.7 Cg_endo -59.91 -19.4 54.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.299 2.666 . . . . 0.0 113.002 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.43 -56.92 15.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 110.519 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 135' ' ' PHE . . . -64.33 -28.96 70.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.99 -51.2 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.01 -36.62 75.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.422 HD22 ' CE2' ' A' ' 212' ' ' TYR . 22.2 tp -57.47 -45.95 84.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.344 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.05 93.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.185 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.32 -41.48 89.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.701 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -85.13 -32.46 22.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -91.3 -29.42 17.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.796 ' HG3' ' HE1' ' A' ' 132' ' ' PHE . 14.9 mmt -95.25 -34.23 12.28 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.111 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 9.9 t30 -70.18 -15.91 63.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 110.454 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.4 p -92.64 5.49 50.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.25 146.1 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 110.594 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.682 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 36.0 mtm -94.23 132.78 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 38.1 tp -83.52 83.77 7.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.142 0.496 . . . . 0.0 110.22 -176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.71 -36.44 3.26 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.191 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.13 -38.18 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -90.99 128.57 36.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.682 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.0 p-10 -75.48 119.09 19.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.276 0.56 . . . . 0.0 109.995 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.434 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 19.9 pt -74.97 150.95 6.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.003 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -101.48 117.58 35.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.048 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 42.9 t -122.64 106.33 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.06 175.23 18.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.049 174.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 38.9 mtp180 -146.7 128.19 7.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 122.459 0.303 . . . . 0.0 110.424 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.0 Cg_endo -82.19 60.69 7.51 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.059 2.506 . . . . 0.0 111.472 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.5 m -115.76 151.37 35.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.974 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.9 32.48 20.02 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.774 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.479 ' HA ' ' HB2' ' A' ' 195' ' ' GLN . 38.1 mt -79.77 73.12 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.995 0.902 . . . . 0.0 110.222 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 163.08 -36.15 0.32 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.492 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -83.56 -52.64 6.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.836 0.35 . . . . 0.0 110.619 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.87 -21.74 15.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.232 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.58 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 26.7 tp60 -52.74 -47.17 95.48 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.7 Cg_endo -55.15 -30.55 71.5 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.454 2.103 . . . . 0.0 113.072 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.9 mm -69.1 -39.05 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.441 . . . . 0.0 110.067 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.9 -38.86 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.082 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.1 -40.07 92.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.75 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -63.64 -34.38 77.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.076 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.87 -45.96 22.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.657 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.79 -43.41 98.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.064 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' ' 206' ' ' ARG . 5.5 tp10 -62.72 -33.53 75.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.455 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 4.2 tp10 -70.2 -40.79 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.019 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -68.47 -28.08 66.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.466 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 88.7 mtt180 -64.25 -22.99 67.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.23 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.03 -4.01 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 291' ' ' PRO . 94.6 m-85 -111.45 -18.72 12.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.471 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.544 HD21 ' HA ' ' A' ' 260' ' ' ALA . 50.2 t-20 50.58 68.58 0.75 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.348 0.594 . . . . 0.0 110.43 -176.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -130.28 136.66 49.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.505 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.663 HD13 ' HE2' ' A' ' 229' ' ' PHE . 7.6 tt -106.54 147.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.335 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.422 ' CE2' HD22 ' A' ' 168' ' ' LEU . 86.5 t80 -108.01 122.88 47.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.42 ' CG2' HD23 ' A' ' 280' ' ' LEU . 6.5 p -122.87 124.2 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.297 0.57 . . . . 0.0 110.897 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.39 -178.19 3.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.46 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 23.0 m 64.77 33.61 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.768 0.668 . . . . 0.0 111.558 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.758 HG23 HD11 ' A' ' 225' ' ' ILE . 7.1 p -82.78 151.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.281 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 14.7 t-80 -68.89 136.22 52.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -57.48 -35.59 70.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -168.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.42 ' CG ' ' HD1' ' A' ' 217' ' ' HIS . 1.0 OUTLIER -79.01 -45.89 19.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.169 177.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.748 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -52.21 110.25 0.47 Allowed 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.78 0.675 . . . . 0.0 110.156 177.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.2 t -94.8 -178.46 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.674 ' HB3' ' H ' ' A' ' 240' ' ' LEU . 2.3 p30 -62.81 -29.36 70.67 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.7 -41.44 73.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.339 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.518 ' OD1' ' HB ' ' B' ' 41' ' ' ILE . 52.0 m-20 -80.23 -52.35 7.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.771 -175.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.758 HD11 HG23 ' A' ' 216' ' ' VAL . 47.2 mm -56.21 -25.25 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.14 0.495 . . . . 0.0 111.227 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.764 ' HG3' HD11 ' A' ' 235' ' ' ILE . 53.8 tttm -55.57 -31.9 62.58 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.47 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.55 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.0 m -51.02 -61.92 1.93 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.826 0.822 . . . . 0.0 112.019 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.561 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.1 m -68.05 -48.84 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.574 -171.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.663 ' HE2' HD13 ' A' ' 211' ' ' ILE . 52.5 m-85 -59.27 -45.22 91.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.787 0.327 . . . . 0.0 111.22 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 40.9 tt0 -73.43 -23.82 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.726 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.52 71.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.73 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.3 OUTLIER -83.73 -38.08 21.85 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -165.78 148.47 13.85 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.17 139.34 58.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.486 0.66 . . . . 0.0 111.355 -176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.764 HD11 ' HG3' ' A' ' 226' ' ' LYS . 31.0 pt -119.78 137.04 54.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.666 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -85.64 -68.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.407 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' ' 256' ' ' GLU . 11.6 m -94.7 108.99 20.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.336 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 4.3 p -122.12 102.1 7.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.9 m -142.64 116.25 9.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.762 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.674 ' H ' ' HB3' ' A' ' 222' ' ' ASP . 73.6 mt -90.22 117.8 29.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 168.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 123.11 15.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.2 0.524 . . . . 0.0 110.985 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.831 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 53.5 mtt-85 -80.74 157.4 25.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.335 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.637 ' HB2' ' HG3' ' A' ' 250' ' ' LYS . 18.5 t70 -117.34 113.89 38.7 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.161 -175.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.79 -20.35 39.86 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.763 2.309 . . . . 0.0 112.336 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.7 m -64.36 -56.69 12.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.496 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 47.2 p -86.81 -35.39 19.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.509 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 106.58 -10.25 41.86 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.1 -157.93 0.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.831 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 29.6 p80 -108.35 149.42 28.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.637 ' HG3' ' HB2' ' A' ' 243' ' ' ASP . 94.1 mttt -70.7 154.23 42.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.443 ' C ' HG12 ' A' ' 216' ' ' VAL . . . -73.15 34.45 0.77 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 114.669 0.628 . . . . 0.0 114.669 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.478 ' HE2' ' HD3' ' A' ' 137' ' ' PRO . 35.5 p90 -157.07 164.81 37.51 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.555 0.678 . . . . 0.0 110.633 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.25 -175.41 41.01 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.312 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.4 ' C ' HD12 ' A' ' 255' ' ' ILE . 86.5 m-85 -123.41 141.58 51.85 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.4 HD12 ' C ' ' A' ' 254' ' ' PHE . 2.2 mp -124.78 135.47 63.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.973 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.496 ' HB3' ' H ' ' A' ' 237' ' ' SER . 45.6 tt0 -109.04 126.44 53.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.627 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.404 ' OH ' ' HB2' ' A' ' 266' ' ' ALA . 7.9 m-85 -98.15 144.23 27.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.182 0.515 . . . . 0.0 112.181 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.88 ' HG3' ' HG3' ' A' ' 259' ' ' LYS . 5.0 pt-20 -74.84 -31.47 61.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.88 ' HG3' ' HG3' ' A' ' 258' ' ' GLU . 24.0 mtpp -109.47 157.47 18.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.544 ' HA ' HD21 ' A' ' 209' ' ' ASN . . . -81.86 -40.89 21.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 0.0 111.254 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -64.62 -38.63 91.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.588 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 6.3 p -62.74 -34.78 77.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.567 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -39.94 86.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.964 0.411 . . . . 0.0 110.612 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.69 -39.67 70.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.775 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.89 -46.7 86.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.404 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . . . -60.55 -52.62 64.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.469 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.22 -25.95 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.172 0.51 . . . . 0.0 111.693 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.9 m -84.3 -17.89 38.15 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.098 -0.376 . . . . 0.0 111.993 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.6 p -116.09 -34.41 4.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.51 ' HE3' ' HB2' ' A' ' 273' ' ' PHE . 39.9 mmm -65.48 -4.5 5.92 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -171.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -69.99 -35.28 74.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 122.167 0.984 . . . . 0.0 109.477 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.8 mm? -76.92 -8.79 58.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.369 -174.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.825 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.2 t80 -52.78 105.37 0.12 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.877 0.37 . . . . 0.0 110.653 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.3 t70 -97.95 119.2 36.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.637 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.748 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.6 mm? -117.52 86.31 2.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.995 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.5 26.1 61.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.664 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 118.21 -18.68 11.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.228 -0.986 . . . . 0.0 113.646 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.4 pt20 -106.75 131.76 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.136 0.468 . . . . 0.0 111.362 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.462 ' HB2' HH12 ' A' ' 281' ' ' ARG . 50.1 m-85 -94.31 137.95 32.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.275 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.515 HD22 ' HD2' ' A' ' 273' ' ' PHE . 11.1 mp -73.81 -173.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.304 0.573 . . . . 0.0 111.525 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.462 HH12 ' HB2' ' A' ' 279' ' ' TYR . 77.2 mmt-85 -146.89 118.09 7.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.15 146.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' ' 211' ' ' ILE . . . -154.52 -164.37 12.83 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.735 176.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -88.69 169.94 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.499 0.649 . . . . 0.0 110.186 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.91 -32.44 73.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 287' ' ' THR . 54.8 t 70.73 -70.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.954 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.489 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 54.0 p -112.84 138.69 22.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 65.5 Cg_endo -76.39 104.5 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.341 2.028 . . . . 0.0 112.058 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 287' ' ' THR . 5.4 Cg_exo -77.96 -18.12 13.27 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.688 2.259 . . . . 0.0 111.852 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 86.1 mtp -136.65 67.98 59.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.844 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 208' ' ' PHE . 91.9 Cg_endo -83.49 169.14 12.54 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.602 2.202 . . . . 0.0 111.208 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.763 HD13 ' H ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -108.39 130.79 55.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.39 0.614 . . . . 0.0 110.598 178.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.11 87.77 2.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.271 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 12.1 t -120.72 140.57 30.81 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.031 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.05 108.25 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.632 2.222 . . . . 0.0 111.579 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -82.32 69.43 9.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.178 0.513 . . . . 0.0 110.664 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.877 179.351 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.99 124.9 53.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.028 0.442 . . . . 0.0 110.725 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 71.8 mtm -137.92 105.92 5.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.652 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.06 94.15 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.458 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -52.8 -45.54 67.25 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.766 0.427 . . . . 0.0 111.698 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 58.8 t -70.34 -44.52 77.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.006 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.691 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 51.7 t30 66.46 -79.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.498 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.61 -67.76 0.35 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -169.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.88 -24.16 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.053 0.454 . . . . 0.0 111.273 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.576 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 5.2 t80 -75.14 -17.84 60.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.126 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' B' ' 28' ' ' ASN . 89.6 mttt -70.61 -45.5 65.15 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.52 -40.3 86.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.73 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -48.51 -53.43 18.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.326 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.823 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -82.22 -17.51 45.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 57.5 mt-30 -66.07 -43.85 86.23 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.55 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 74.0 mtp180 -69.38 -37.35 77.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.108 173.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -59.55 -50.65 73.06 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.269 31.1 mtp85 -81.55 -25.38 35.91 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.266 -1.521 . . . . 0.0 112.971 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -55.57 -44.89 77.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.018 169.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.821 HG12 ' O ' ' B' ' 38' ' ' ALA . 3.4 pt -66.33 -33.54 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.625 ' HB2' HD12 ' A' ' 275' ' ' LEU . . . -69.28 -24.81 64.01 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.813 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.58 -22.91 24.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.202 0.525 . . . . 0.0 110.637 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 20.1 ttpt -90.91 -41.65 11.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.58 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.419 HG12 ' C ' ' B' ' 44' ' ' LYS . 9.3 pt 41.6 52.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.786 0.835 . . . . 0.0 112.9 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -155.15 122.74 1.25 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.835 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.3 175.19 43.27 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.122 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -123.25 132.43 54.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.035 0.445 . . . . 0.0 110.946 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.75 63.17 4.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.701 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.19 -154.91 25.33 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.935 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -91.3 126.56 36.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.91 0.385 . . . . 0.0 110.978 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.252 1.228 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.313 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.68 47.43 1.19 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.212 0.529 . . . . 0.0 110.97 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 24.0 mmt -80.62 3.46 21.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.041 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.31 -12.98 41.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.982 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -97.67 28.48 3.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.747 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.84 92.05 6.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.436 ' CB ' HD23 ' A' ' 108' ' ' LEU . 32.1 mm-40 -69.65 116.96 10.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.087 -174.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -60.45 -37.95 82.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.773 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.52 -52.79 64.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.758 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.545 HD12 ' HG3' ' A' ' 163' ' ' PRO . 3.8 mm? -66.11 -36.78 84.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.88 74.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.359 . . . . 0.0 111.367 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.9 mt -82.11 -41.29 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.81 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.9 mtp -68.05 -37.01 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.059 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 159' ' ' GLU . 79.8 m -75.91 -17.78 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.832 ' HG2' ' HB3' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.3 99.92 11.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.979 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.78 140.03 17.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.419 0.628 . . . . 0.0 111.226 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.55 ' HE2' ' HE2' ' A' ' 184' ' ' LYS . 42.6 t80 -88.94 121.34 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.406 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.472 HG22 HG13 ' A' ' 185' ' ' VAL . 52.0 t -116.53 110.98 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -130.42 101.98 0.52 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.652 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.544 ' HB3' HG22 ' A' ' 183' ' ' ILE . 8.9 t 168.45 59.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.411 HG21 ' ND1' ' A' ' 152' ' ' HIS . 12.7 mm -82.06 -17.45 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.8 -170.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 t80 66.51 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.1 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 37.2 t80 179.17 -53.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.69 36.05 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.52 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.56 113.45 18.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.583 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -83.18 159.85 37.77 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.236 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.1 OUTLIER -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 109.895 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 25.5 t70 -65.13 -42.12 94.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.085 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 m -58.75 -42.82 89.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.034 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.38 -42.72 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.511 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 129' ' ' ARG . 10.6 ttp180 -61.0 -39.78 91.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 38.3 mt-30 -76.29 -20.42 57.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.05 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.22 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.883 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.43 ' HB2' HD11 ' A' ' 138' ' ' ILE . 78.9 m-85 -94.88 8.12 43.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -66.63 -44.22 53.73 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.991 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 23.9 Cg_exo -65.86 -12.74 36.6 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.852 1.701 . . . . 0.0 112.541 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.584 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 5.9 m-85 -80.39 -68.16 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.654 0.264 . . . . 0.0 110.964 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -149.07 169.55 29.46 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.465 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.55 ' HD2' HG22 ' A' ' 162' ' ' VAL . 15.2 Cg_exo -67.46 100.52 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.682 2.255 . . . . 0.0 111.565 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.43 HD11 ' HB2' ' A' ' 132' ' ' PHE . 64.6 mt -69.34 107.36 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -76.22 -31.83 58.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 p -173.07 128.95 0.47 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.743 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.0 tt -105.92 132.85 51.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 172.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -114.49 115.63 27.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.865 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' A' ' 125' ' ' GLU . 23.0 ttt -140.81 128.54 21.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.093 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.8 t -118.99 124.92 48.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.851 ' HZ3' ' HA ' ' A' ' 150' ' ' MET . 43.6 p-90 -163.64 159.61 21.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.615 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.87 93.25 1.68 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.872 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.454 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 48.3 t -70.86 -22.04 62.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.546 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.5 m -65.82 -26.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.022 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.8 p -121.36 5.73 10.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.851 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 68.5 mtp 60.8 27.35 17.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -91.08 107.57 19.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 0.0 110.608 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.411 ' ND1' HG21 ' A' ' 119' ' ' ILE . 40.8 m-70 -83.25 74.55 10.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -73.92 -51.14 17.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.189 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -76.33 172.7 54.45 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.629 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.09 170.85 7.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -104.7 129.11 52.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 0.0 110.446 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.27 108.03 17.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.27 124.12 67.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.207 0.527 . . . . 0.0 110.554 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.832 ' HB3' ' HG2' ' A' ' 113' ' ' ARG . 10.3 pt-20 -112.82 131.22 55.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.501 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -94.67 162.89 13.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.731 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -78.27 -15.18 59.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.664 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 17.3 m -129.44 128.98 23.19 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.545 ' HG3' HD12 ' A' ' 108' ' ' LEU . 56.2 Cg_endo -72.07 -14.61 29.04 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.009 2.473 . . . . 0.0 113.16 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.664 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 31.0 mp0 -60.74 -52.21 66.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 110.574 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.07 -22.98 67.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.503 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.31 -50.71 36.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.794 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -39.67 94.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.447 ' CD2' ' HB3' ' A' ' 214' ' ' ALA . 15.5 tp -60.36 -49.65 76.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.846 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -61.96 -29.2 70.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.196 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.84 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.9 tt -61.37 -61.15 2.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.092 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.99 -39.49 23.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.704 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 17.3 mm-40 -83.14 0.19 46.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.426 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 58.2 tpp -122.38 -36.54 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.079 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.658 ' OD1' ' HA ' ' A' ' 184' ' ' LYS . 10.4 t30 -67.58 -31.09 70.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.976 0.417 . . . . 0.0 110.959 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.2 m -85.16 -8.91 58.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.81 90.18 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.108 0.48 . . . . 0.0 110.211 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.6 ptm -72.52 118.12 15.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.255 0.55 . . . . 0.0 110.32 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.2 -34.24 68.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.485 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 152.29 133.41 1.94 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.553 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.98 -62.89 3.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.606 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -124.04 155.37 38.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -90.12 127.92 36.21 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.544 HG22 ' HB3' ' A' ' 118' ' ' SER . 23.4 pt -89.97 132.06 35.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.068 176.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.658 ' HA ' ' OD1' ' A' ' 174' ' ' ASN . 21.8 ptmt -102.15 116.94 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.368 0.604 . . . . 0.0 110.176 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 116' ' ' VAL . 62.1 t -123.51 133.5 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.227 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.84 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 106.48 -126.29 8.45 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.841 174.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 54.84 67.93 2.93 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 124.17 0.57 . . . . 0.0 111.013 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.04 -157.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.909 2.406 . . . . 0.0 111.892 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 194' ' ' ALA . 34.1 t 72.55 118.6 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.577 0.703 . . . . 0.0 110.681 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.481 ' OD1' HG13 ' A' ' 191' ' ' ILE . 25.2 t-20 -74.85 -63.51 1.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.278 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.481 HG13 ' OD1' ' A' ' 190' ' ' ASN . 55.5 mt -137.55 67.48 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.268 0.556 . . . . 0.0 110.463 175.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.01 2.07 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -58.63 -10.31 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 189' ' ' SER . . . -84.85 -30.74 24.23 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.044 -0.41 . . . . 0.0 111.269 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.514 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 62.1 tp60 -64.18 -50.16 69.66 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.6 Cg_exo -52.52 -33.57 58.44 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.117 1.878 . . . . 0.0 112.437 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.93 -44.03 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 110.094 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.88 -43.55 97.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.608 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -45.11 93.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 84.2 mm-40 -61.11 -46.22 91.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.704 HD13 HG22 ' A' ' 287' ' ' THR . 96.1 mt -71.21 -28.99 64.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.68 94.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.3 -32.45 71.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.178 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.55 -42.14 87.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.201 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.12 72.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.46 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -68.43 -19.4 64.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.82 -13.49 59.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.512 ' HB3' ' HG3' ' A' ' 210' ' ' ARG . 41.4 m-85 -103.39 -23.07 13.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.144 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 59.09 37.1 24.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.501 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 1.015 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 96.3 mtt180 -97.22 138.25 35.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.503 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.09 158.56 17.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.35 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -109.75 128.54 55.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.833 0.349 . . . . 0.0 110.621 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 4.4 p -120.78 119.23 58.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.129 0.49 . . . . 0.0 110.585 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -123.33 -177.2 3.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.558 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 8.1 t 68.0 22.49 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.055 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.504 HG13 HD11 ' A' ' 225' ' ' ILE . 84.7 t -73.23 129.68 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.018 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -63.18 130.54 45.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.81 -28.82 66.37 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -78.98 -45.87 19.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 111.398 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.662 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -61.34 110.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.638 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 62.4 m -87.14 -178.26 6.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.908 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 19.7 p-10 -66.94 -37.65 84.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.706 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.704 0.764 . . . . 0.0 109.832 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 0.9 OUTLIER -67.78 -54.62 17.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.723 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.726 HG13 HD11 ' A' ' 240' ' ' LEU . 29.4 mm -59.58 -21.28 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 111.032 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.47 ' HG3' HD12 ' A' ' 235' ' ' ILE . 88.4 tttt -59.19 -31.39 68.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.936 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.4 m -48.76 -59.79 3.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.87 0.843 . . . . 0.0 111.43 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.707 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.8 m -68.91 -52.22 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.603 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -58.38 -34.4 70.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.423 ' HA ' HG13 ' A' ' 235' ' ' ILE . 2.2 tm-20 -76.63 -34.67 58.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.026 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.39 -13.75 61.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.709 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 4.2 m-30 -90.06 -10.94 42.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.763 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 173.72 -112.49 0.42 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.583 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -146.45 120.0 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 110.609 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 226' ' ' LYS . 49.8 mt -85.6 134.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.094 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -86.46 -47.99 8.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.093 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 3.8 m -148.55 132.14 16.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.897 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 45.1 t -120.25 111.59 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.9 m -141.02 107.81 5.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.296 0.569 . . . . 0.0 112.288 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 79.4 mt -91.68 130.65 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.9 162.17 22.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.954 0.407 . . . . 0.0 110.967 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 56.3 mtp180 -123.68 158.7 30.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.837 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -107.77 95.72 15.24 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.94 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.32 -23.42 32.82 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.7 2.267 . . . . 0.0 113.136 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -29.35 55.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.634 ' HB ' ' HE2' ' A' ' 248' ' ' LYS . 1.2 m -114.32 -19.33 11.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 111.509 178.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.63 43.18 5.55 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.877 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.634 ' HE2' ' HB ' ' A' ' 246' ' ' THR . 47.1 mtmt -125.8 -178.51 4.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.755 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -113.18 131.61 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 170.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -65.58 136.44 56.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.62 29.83 1.04 Allowed Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.359 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 28.6 p90 -154.15 158.46 40.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.681 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.62 -171.42 38.8 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.114 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.488 ' CZ ' ' HG2' ' A' ' 164' ' ' GLU . 98.4 m-85 -127.65 133.32 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.936 0.398 . . . . 0.0 110.95 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.07 132.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 1.015 ' HG2' ' HG2' ' A' ' 210' ' ' ARG . 39.7 mt-10 -104.31 144.52 31.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.048 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -120.11 141.44 49.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.225 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.451 ' C ' ' HE3' ' A' ' 259' ' ' LYS . 6.8 pt-20 -81.92 -33.03 30.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.706 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.451 ' HE3' ' C ' ' A' ' 258' ' ' GLU . 0.1 OUTLIER -97.95 113.22 25.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.094 173.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.32 68.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.047 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.65 -35.68 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.2 m -68.37 -25.85 65.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 267' ' ' VAL . 6.9 m -62.42 -30.8 71.48 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.84 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.04 -43.66 57.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.896 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -52.94 -45.52 67.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.349 0.405 . . . . 0.0 110.551 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.524 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . . . -60.56 -42.22 96.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.648 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 263' ' ' SER . 98.2 t -64.46 -39.39 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.716 -176.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.1 p -86.45 -1.0 57.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -115.63 -45.4 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.89 ' HA ' ' HE2' ' A' ' 270' ' ' MET . 0.0 OUTLIER -64.45 -20.61 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -60.02 -38.27 82.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.744 0.783 . . . . 0.0 110.4 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -78.06 -9.86 59.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.871 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -46.92 106.96 0.09 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.961 0.41 . . . . 0.0 111.494 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.6 108.89 15.54 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.627 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.662 ' HG ' HD22 ' A' ' 220' ' ' LEU . 1.1 mm? -114.7 86.85 2.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.62 -116.83 4.42 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -110.46 23.59 19.91 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.076 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 9.9 pt20 -125.13 151.55 45.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 0.0 111.222 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -107.27 137.84 44.58 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.79 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 4.5 tp -69.05 -176.39 0.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.282 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.704 ' HD2' ' HB3' ' A' ' 172' ' ' GLN . 73.2 mmt-85 -141.51 113.26 7.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.832 0.348 . . . . 0.0 110.388 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 270' ' ' MET . 12.3 p -115.19 146.55 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.985 0.422 . . . . 0.0 110.997 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.91 -159.44 9.37 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -108.31 171.64 7.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 117.18 0.49 . . . . 0.0 110.249 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 164' ' ' GLU . . . -62.48 -40.59 97.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.609 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.3 t 70.97 -67.05 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.487 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.704 HG22 HD13 ' A' ' 201' ' ' LEU . 0.5 OUTLIER -108.89 160.97 25.38 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.513 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -93.8 95.89 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.152 2.568 . . . . 0.0 111.774 173.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 287' ' ' THR . 54.1 Cg_endo -69.89 137.93 36.23 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.643 2.229 . . . . 0.0 112.316 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 71.3 mtm -110.99 117.82 49.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.427 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.22 64.47 4.34 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.082 2.521 . . . . 0.0 112.432 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 59.3 tp -101.76 118.05 36.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.439 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.39 95.56 9.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.119 0.485 . . . . 0.0 110.649 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.535 ' N ' ' HD2' ' A' ' 295' ' ' PRO . 27.9 m -63.02 -50.26 77.43 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.661 175.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 294' ' ' THR . 30.2 Cg_endo -63.63 148.78 92.09 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.276 1.984 . . . . 0.0 112.854 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 71.65 125.7 0.03 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.931 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.797 179.328 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.665 -0.174 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.15 34.76 2.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.056 0.455 . . . . 0.0 110.52 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 52.9 tpp -166.09 -64.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.73 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -169.16 -85.9 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.336 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.46 ' O ' ' HB ' ' B' ' 27' ' ' VAL . 15.8 m-85 -127.78 171.75 11.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' B' ' 26' ' ' TYR . 90.3 t 73.57 -32.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.476 ' O ' ' HD3' ' B' ' 32' ' ' LYS . 6.4 t30 -46.91 -41.92 16.75 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.673 0.789 . . . . 0.0 112.868 -175.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.02 -51.47 3.84 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.904 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.587 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -58.29 -45.76 87.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.009 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.709 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 23.8 t80 -76.36 -20.47 57.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.125 0.488 . . . . 0.0 110.947 -175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' B' ' 28' ' ' ASN . 0.2 OUTLIER -82.75 -35.45 26.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.101 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 9.7 t70 -57.97 -46.3 85.35 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 168.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.707 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -48.46 -46.74 38.36 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.996 176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.799 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.2 -21.68 39.41 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -64.1 -41.67 97.2 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.693 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 54.5 mtt180 -68.83 -36.86 78.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.898 173.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.871 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -64.0 -42.47 97.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.074 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' B' ' 42' ' ' ALA 0.253 2.7 mtt180 -81.15 -25.99 36.44 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.89 -1.524 . . . . 0.0 112.706 173.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -54.84 -44.34 73.85 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.34 0.59 . . . . 0.0 110.097 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.742 HG12 ' O ' ' B' ' 38' ' ' ALA . 5.5 pt -68.74 -32.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 CA-C-O 121.207 0.527 . . . . 0.0 109.958 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' B' ' 39' ' ' ARG . . . -75.2 -4.59 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.036 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.89 -37.67 15.13 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.259 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' B' ' 41' ' ' ILE . 11.2 ptpt -72.4 -7.8 51.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.056 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 51.1 mt -28.48 116.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.09 -89.01 0.11 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.745 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.0 -142.73 40.27 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.81 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.8 -34.22 19.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.986 0.422 . . . . 0.0 111.255 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.54 91.48 3.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.77 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.14 77.2 0.38 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.442 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 9.9 p -72.85 -68.63 0.47 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.855 0.359 . . . . 0.0 110.061 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.569 177.914 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.547 ' O ' ' HG2' ' A' ' 101' ' ' MET . . . -88.02 78.44 8.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.763 0.281 . . . . 0.0 110.706 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 100' ' ' ALA . 6.6 ptp 64.99 149.57 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.758 1.223 . . . . 0.0 112.477 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -142.61 18.08 2.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.537 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -113.34 123.87 51.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.796 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -161.09 166.51 27.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.586 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 43.05 34.22 0.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.331 1.02 . . . . 0.0 112.863 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -70.08 -29.31 66.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.001 0.429 . . . . 0.0 110.545 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 -27.91 69.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.658 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 29.7 tp -65.72 -33.28 75.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.565 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.6 67.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 0.0 110.651 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.411 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 56.0 mt -82.99 -42.31 17.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.959 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.658 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 26.7 ptm -71.32 -25.47 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.977 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.486 ' SG ' ' HG3' ' A' ' 163' ' ' PRO . 83.9 m -86.43 5.52 34.67 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 12.4 ptp180 -123.87 130.91 53.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 0.0 110.728 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 158' ' ' VAL . 14.7 m -101.7 145.76 11.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.208 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 73.8 t80 -105.43 127.92 53.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.972 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.5 109.88 30.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.7 152.17 17.48 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.373 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.6 m 61.04 64.09 1.17 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.985 0.421 . . . . 0.0 110.959 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.9 mm -54.46 132.09 17.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.376 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 88.5 t80 -44.43 -70.1 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.96 0.787 . . . . 0.0 111.733 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 86.1 t80 171.9 -62.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.752 0.658 . . . . 0.0 109.574 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.81 -25.86 37.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.172 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.52 121.48 13.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -106.41 -175.22 23.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.949 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 32.6 tt0 -65.12 -36.61 84.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.044 0.449 . . . . 0.0 110.07 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.566 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 23.4 m-20 -63.84 -40.9 97.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.319 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.7 m -60.85 -49.74 76.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.571 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 93.1 mt -58.45 -51.74 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.057 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 126' ' ' ASP . 23.0 ptt180 -63.62 -35.68 81.31 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.691 -0.404 . . . . 0.0 112.026 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.78 -22.78 49.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.56 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.08 -36.97 58.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.393 . . . . 0.0 110.723 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.482 ' HE1' ' HG3' ' A' ' 173' ' ' MET . 86.9 m-85 -93.31 14.72 17.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.49 -44.48 18.0 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.273 -178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 34.8 Cg_endo -67.16 -4.67 12.04 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -92.47 -75.7 0.48 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.69 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -145.1 -177.57 20.01 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 2.0 Cg_endo -80.72 135.08 10.03 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.712 2.275 . . . . 0.0 112.069 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.15 109.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.622 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -79.08 -56.42 4.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.81 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.3 m -156.88 136.57 12.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.679 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.7 mt -121.13 114.72 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.76 106.1 13.48 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 156' ' ' ALA . 25.2 ptm -116.65 142.4 46.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.7 t -81.79 104.27 12.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.01 117.18 26.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.452 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' MET . 3.3 t70 -77.25 91.86 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.754 172.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.0 p -94.92 4.49 53.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.988 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.55 -54.35 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 t -120.71 4.83 10.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.364 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 146' ' ' ASP . 26.8 ptm 45.51 37.67 3.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.565 1.146 . . . . 0.0 113.198 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -102.95 7.14 39.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 72.16 44.96 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.642 171.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -76.26 81.1 3.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.329 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.8 -161.08 24.96 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.898 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.91 166.93 23.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.478 -0.361 . . . . 0.0 110.08 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -133.03 138.99 46.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.817 0.342 . . . . 0.0 111.571 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.29 119.09 38.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.78 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.435 ' HB ' HG23 ' A' ' 114' ' ' VAL . 47.4 t -112.57 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.443 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 51.5 mt-10 -96.52 141.65 29.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.89 160.25 20.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.754 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 137' ' ' PRO . 10.6 pt-20 -87.59 -2.4 58.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.123 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.493 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 12.9 m -133.57 126.38 19.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.23 177.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 17.1 Cg_exo -67.88 -18.02 46.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.468 2.779 . . . . 0.0 111.624 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.487 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 14.1 mp0 -62.21 -56.64 16.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.835 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.85 -31.41 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.73 -51.02 66.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.634 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -65.03 -43.64 91.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.216 0.531 . . . . 0.0 110.176 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.49 -48.34 79.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.707 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -58.22 -59.95 4.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.687 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.88 -34.08 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -74.24 -45.03 50.6 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.542 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.677 ' HB3' HD11 ' A' ' 183' ' ' ILE . 26.3 mmt -74.97 -17.85 60.48 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.938 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -76.77 -28.45 55.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.38 0.61 . . . . 0.0 109.644 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.5 m -89.57 -42.92 11.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.042 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 67.4 t -89.52 119.91 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.633 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 88.2 mtp -77.41 112.56 14.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 178' ' ' LEU . 0.6 OUTLIER -79.74 102.98 9.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.234 -176.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.7 -134.41 12.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.856 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -100.21 13.59 60.09 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.97 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -148.79 161.86 40.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.633 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 25.1 p-10 -98.29 119.2 36.55 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 173.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 173' ' ' MET . 28.5 pt -64.4 156.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -100.46 109.73 21.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.6 p -136.52 130.27 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.796 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.69 100.37 1.96 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.952 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 0.1 OUTLIER -151.74 87.78 4.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.221 177.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.46 101.38 1.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.678 2.252 . . . . 0.0 111.594 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.8 p -72.45 -21.07 61.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -99.8 29.67 4.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.008 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.7 tt -64.35 139.88 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.679 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.25 -69.27 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -82.62 -26.18 32.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 110.637 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.432 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.07 -33.95 72.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.532 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.0 tp60 -60.56 -53.93 59.71 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 55.9 Cg_exo -54.32 -28.83 54.9 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.479 2.12 . . . . 0.0 112.689 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.13 -52.61 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 194' ' ' ALA . 35.3 mt -64.33 -42.14 94.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.641 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.3 -37.97 89.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -60.83 -49.29 78.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.623 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.57 -47.5 84.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.449 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -62.1 -35.6 79.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.745 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.65 -39.08 64.74 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.747 0.308 . . . . 0.0 110.894 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.77 -31.59 70.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.09 0.471 . . . . 0.0 109.946 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.94 69.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.719 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.3 mtt180 -66.2 -25.83 67.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.366 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.78 71.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.901 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -95.16 -26.15 16.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.839 0.828 . . . . 0.0 109.861 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.4 HD21 ' HB2' ' A' ' 263' ' ' SER . 6.2 t30 62.26 44.35 7.66 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.799 -1.546 . . . . 0.0 112.124 168.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -95.92 136.88 35.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.695 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 284' ' ' LYS . 12.2 pt -105.47 161.95 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.104 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.47 118.09 35.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.162 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 252' ' ' TYR . 51.5 t -105.84 115.67 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.176 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -121.48 178.19 4.91 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.502 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.53 31.97 12.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.558 0.694 . . . . 0.0 110.142 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.589 HG13 HD11 ' A' ' 225' ' ' ILE . 58.6 t -80.71 132.84 30.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.665 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.484 ' HB2' HD23 ' A' ' 275' ' ' LEU . 4.6 t-80 -65.21 128.65 36.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' A' ' 218' ' ' GLN . 7.8 mt-30 -56.34 -31.98 64.26 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.549 -171.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.66 -26.45 50.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.951 0.405 . . . . 0.0 110.968 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.801 HD11 HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -95.1 117.53 30.36 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -173.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 64.6 m -96.38 -176.53 3.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.6 OUTLIER -61.07 -38.88 87.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -58.24 -37.1 74.23 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.478 0.656 . . . . 0.0 109.83 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.4 m-20 -67.0 -58.57 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.495 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.589 HD11 HG13 ' A' ' 216' ' ' VAL . 43.7 mm -53.48 -28.52 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.574 -177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -53.15 -32.28 46.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.917 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.63 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 63.9 m -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.332 0.587 . . . . 0.0 112.404 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.665 HG12 ' HB1' ' B' ' 34' ' ' ALA . 2.9 m -64.58 -44.69 96.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.779 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.612 ' CE2' ' HG3' ' A' ' 270' ' ' MET . 86.0 m-85 -67.65 -36.48 80.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.507 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 42.4 tt0 -76.32 -28.42 56.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.957 0.408 . . . . 0.0 111.174 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.91 -24.98 67.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.75 ' HE1' ' HA ' ' B' ' 31' ' ' PHE . 0.9 OUTLIER -88.57 -51.22 5.81 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -148.84 160.62 28.46 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.722 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -68.92 131.45 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 111.602 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 229' ' ' PHE . 63.9 mt -96.36 134.39 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.52 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -90.36 -41.68 11.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.1 m -139.15 131.6 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 7.9 p -131.52 91.33 2.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.716 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.9 m -132.15 116.98 17.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.504 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 7.4 mp -90.38 129.89 36.53 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.06 97.43 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.668 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -80.69 149.71 29.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.699 175.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.511 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 0.0 OUTLIER -78.74 140.16 58.73 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 110.219 -176.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 12.2 Cg_exo -70.73 -20.93 29.65 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.709 2.939 . . . . 0.0 114.767 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 t -101.04 -40.29 7.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.484 -169.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.403 ' OG1' ' HE2' ' A' ' 248' ' ' LYS . 0.7 OUTLIER -106.57 -13.06 15.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.806 -0.559 . . . . 0.0 112.175 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.71 10.87 83.68 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.34 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 248' ' ' LYS . 42.6 mtmt -88.14 137.44 32.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.812 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 2.1 p80 -73.8 126.58 30.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.694 ' HD2' ' HE1' ' A' ' 252' ' ' TYR . 23.7 mttp -69.28 157.8 36.27 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.11 35.08 0.64 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 114.146 0.418 . . . . 0.0 114.146 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.694 ' HE1' ' HD2' ' A' ' 250' ' ' LYS . 38.0 p90 -151.64 154.05 35.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -159.28 179.5 34.84 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.86 121.1 36.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.873 0.368 . . . . 0.0 110.935 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.422 ' O ' HG12 ' A' ' 211' ' ' ILE . 41.9 mm -105.89 124.68 61.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -104.16 118.12 35.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -100.86 139.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.97 -28.79 39.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.323 0.583 . . . . 0.0 109.656 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 262' ' ' SER . 41.2 tptt -101.34 117.3 34.68 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.642 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.24 83.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.276 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -68.85 -40.66 79.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.991 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 259' ' ' LYS . 31.6 t -63.37 -30.23 71.4 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 267' ' ' VAL . 44.2 t -59.87 -42.7 94.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.175 173.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.76 -39.94 88.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.438 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -54.93 -50.66 68.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.134 0.492 . . . . 0.0 110.511 175.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.17 -53.07 59.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.754 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 263' ' ' SER . 96.9 t -58.09 -33.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 111.666 -176.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.2 m -70.99 -20.22 62.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.2 m -115.08 -29.76 6.56 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.612 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 58.3 mmm -73.51 -2.07 21.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -167.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.451 ' HB3' HD22 ' A' ' 272' ' ' LEU . 51.6 t-20 -69.56 -39.72 77.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.203 1.001 . . . . 0.0 108.993 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -76.72 -8.99 58.33 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.985 -173.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.879 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 57.0 t80 -52.79 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.27 115.99 19.26 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.688 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.798 HD21 HD22 ' A' ' 220' ' ' LEU . 13.9 tp -122.82 86.1 2.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.53 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.41 33.76 55.73 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.04 1.87 62.77 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.033 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 275' ' ' LEU . 20.3 pt20 -122.89 131.91 53.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.885 0.342 . . . . 0.0 110.701 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -81.32 133.82 35.49 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.863 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.879 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 12.1 tp -67.39 -178.67 0.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.083 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.75 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -147.8 112.29 5.3 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 270' ' ' MET . 7.9 p -115.34 137.66 48.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.184 0.516 . . . . 0.0 111.924 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -143.6 -144.59 4.27 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.919 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 34.3 ttmt -136.41 148.5 47.83 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.487 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -69.67 121.32 16.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.47 -18.22 7.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.136 0.493 . . . . 0.0 110.297 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 2.4 m -108.42 125.2 32.39 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.646 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.37 118.69 5.32 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.674 2.249 . . . . 0.0 111.459 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.09 119.47 6.15 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.58 2.854 . . . . 0.0 113.408 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.714 ' HB2' ' HD3' ' A' ' 291' ' ' PRO . 65.2 mtm -102.47 -54.2 0.13 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.206 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.714 ' HD3' ' HB2' ' A' ' 290' ' ' MET . 1.8 Cg_endo -83.87 151.09 12.73 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.47 2.114 . . . . 0.0 112.385 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.64 140.09 35.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.972 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.07 3.43 38.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.009 0.433 . . . . 0.0 110.733 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.3 p -98.09 152.28 37.95 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.386 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.17 72.37 4.11 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.792 2.328 . . . . 0.0 112.882 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 70.8 -1.37 2.65 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.508 0.723 . . . . 0.0 111.795 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 20.9 m . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.289 178.906 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.56 69.35 10.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.673 0.273 . . . . 0.0 111.679 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 22.4 mmt 62.43 89.52 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.07 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.82 -11.95 53.1 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.646 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' B' ' 28' ' ' ASN . 88.3 t80 -101.92 119.4 38.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.0 110.663 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.767 HG13 ' HB3' ' B' ' 30' ' ' ALA . 58.5 t -119.41 118.45 57.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.095 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.433 ' HB2' ' CE2' ' B' ' 26' ' ' TYR . 23.3 t-20 -107.01 -79.94 0.57 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.788 0.328 . . . . 0.0 110.787 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.29 -18.21 37.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.964 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.767 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -66.22 -37.21 85.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.871 0.367 . . . . 0.0 110.377 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.75 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 17.3 t80 -78.02 -19.38 54.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.679 0.752 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.631 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 73.9 mmtt -73.27 -48.25 36.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.69 175.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 26.3 t70 -58.38 -36.62 73.78 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.73 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -51.52 -54.47 26.95 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.792 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.704 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 2.9 mm? -81.06 -20.36 41.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 44.2 mt-30 -63.74 -42.76 97.8 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.63 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 66.0 mtt180 -68.52 -37.47 80.05 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.939 172.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.762 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -62.37 -42.18 99.21 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -172.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 39' ' ' ARG . 27.5 mtp85 -82.11 -26.25 33.74 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.385 -1.447 . . . . 0.0 112.589 173.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -57.93 -41.21 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 110.183 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.801 HG13 HD11 ' A' ' 220' ' ' LEU . 4.2 pt -68.44 -36.51 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.404 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.04 -15.69 63.88 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.086 0.469 . . . . 0.0 111.092 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.52 -42.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.161 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -82.25 -36.26 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.253 -177.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.405 ' N ' ' HD2' ' B' ' 44' ' ' LYS . 69.3 mt 62.93 -71.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.555 0.742 . . . . 0.0 112.657 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.73 76.86 1.83 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.508 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.41 44.68 3.33 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.428 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.88 -67.84 0.66 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.037 0.446 . . . . 0.0 110.019 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.22 145.16 17.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.075 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.93 -87.75 0.8 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.785 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 39.0 m 71.67 97.21 0.07 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.904 0.414 . . . . 0.0 110.197 -173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.812 -178.165 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 112.719 -0.152 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 56.8 85.42 0.08 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.239 0.616 . . . . 0.0 112.541 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.6 ptm -81.39 -27.17 34.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.229 0.538 . . . . 0.0 109.828 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.63 101.51 8.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.988 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -79.18 -10.19 59.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.595 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 65.39 34.88 7.83 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.325 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 67.05 101.38 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.19 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -58.86 -29.79 67.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.452 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.27 86.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.013 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.81 -33.92 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.243 -177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.98 82.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.526 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.57 -36.87 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.106 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 76.6 mtp -60.3 -26.48 66.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.873 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 75.8 m -73.35 -19.71 60.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.671 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 12.3 ptp180 -118.35 123.35 45.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 0.0 111.321 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -98.13 130.43 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.42 0.629 . . . . 0.0 111.096 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -75.52 119.25 19.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.023 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 42.7 t -108.21 112.24 39.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.57 178.08 28.58 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.841 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t 72.35 -79.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.437 0.695 . . . . 0.0 110.901 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mm 68.45 115.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.219 0.608 . . . . 0.0 111.613 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.657 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 61.9 t80 -72.27 142.65 48.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.471 ' HE1' ' HG2' ' A' ' 151' ' ' LYS . 92.4 t80 -52.85 -58.41 7.01 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -172.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -93.12 34.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.728 . . . . 0.0 110.233 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.657 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 27.8 tp -108.15 95.96 6.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.29 173.36 54.97 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.919 -170.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.22 -35.58 80.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 129' ' ' ARG . 25.4 t70 -77.45 -29.43 52.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.772 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 m -67.33 -47.89 69.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.887 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.3 mt -58.21 -42.55 83.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.76 172.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 126' ' ' ASP . 53.3 ttt180 -51.13 -49.82 60.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.202 176.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 75.5 mt-30 -75.39 -26.83 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.536 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.43 77.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.113 0.482 . . . . 0.0 110.607 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.495 ' CE2' ' HG3' ' A' ' 173' ' ' MET . 52.3 m-85 -100.95 11.14 40.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.462 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 130' ' ' GLN . . . -71.75 -38.34 6.1 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.945 -177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.865 ' HB3' ' HA ' ' A' ' 215' ' ' SER . 45.4 Cg_exo -60.15 -15.2 32.79 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.647 1.565 . . . . 0.0 112.78 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -80.45 -72.52 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.942 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -159.26 -171.9 25.69 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.348 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.87 104.16 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.006 2.47 . . . . 0.0 111.83 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.54 117.87 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.796 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -90.71 -34.89 15.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.789 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t -153.25 142.08 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.917 0.389 . . . . 0.0 110.976 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.8 107.52 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 24.7 t70 -104.6 140.92 37.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.08 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.6 ttm -160.47 143.53 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.582 0.23 . . . . 0.0 110.552 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.2 p -73.95 100.85 3.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.912 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.482 ' CH2' ' HG3' ' A' ' 150' ' ' MET . 2.4 m95 -88.12 158.84 18.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.394 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -129.84 89.86 2.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.511 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 p 46.68 -145.15 0.24 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.496 170.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -81.64 -21.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.911 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 151' ' ' LYS . 9.2 t -66.03 -26.74 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.303 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.482 ' HG3' ' CH2' ' A' ' 145' ' ' TRP . 52.6 ttm 67.21 13.45 9.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.349 0.595 . . . . 0.0 111.561 175.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.535 ' H ' HG23 ' A' ' 149' ' ' THR . 35.7 mtmm -69.28 121.44 16.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.702 -0.623 . . . . 0.0 109.536 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.406 ' HE1' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -141.19 132.2 26.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.114 0.483 . . . . 0.0 111.045 -174.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.445 ' HB3' ' HE2' ' A' ' 153' ' ' LYS . 34.9 ttpt -166.59 122.79 1.23 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.239 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.85 -94.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.122 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -134.92 144.07 47.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.491 0.662 . . . . 0.0 111.918 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -141.26 161.29 38.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.293 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 92.3 m-85 -132.7 113.22 12.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.626 0.25 . . . . 0.0 110.376 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.13 112.18 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 43.5 tt0 -105.42 125.49 51.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.167 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 96.4 m-85 -103.8 162.22 13.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.517 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.36 -19.46 50.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.964 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.59 134.86 25.25 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.592 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.9 -12.69 33.13 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' A' ' 285' ' ' ALA . 7.1 mp0 -63.87 -50.52 68.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.935 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.68 72.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.54 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.55 -39.37 91.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.442 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -59.92 -49.45 77.65 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.426 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.724 HD21 ' HA3' ' A' ' 283' ' ' GLY . 37.4 mt -63.44 -41.44 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.58 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . -62.17 -46.33 89.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.861 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 tt -67.41 -51.58 50.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.152 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -74.56 -47.74 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -79.81 -49.31 12.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.517 ' HB2' ' O ' ' A' ' 169' ' ' ALA . 16.0 mmt -68.32 -35.18 77.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -173.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.72 -17.68 58.95 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.856 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.2 m -91.05 -8.45 48.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.783 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.69 131.0 71.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.393 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.808 ' HG2' ' HB3' ' A' ' 182' ' ' ASN . 73.8 mtp -81.62 89.83 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.2 tp -38.23 -59.5 0.87 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.834 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.6 91.71 0.12 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.994 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.48 -57.56 4.45 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.026 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.406 ' HD3' ' HD2' ' A' ' 120' ' ' TYR . 10.9 ptm180 -104.6 149.9 25.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.808 ' HB3' ' HG2' ' A' ' 177' ' ' MET . 6.3 p30 -97.58 118.11 33.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.415 0.626 . . . . 0.0 110.957 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 183' ' ' ILE . 1.7 pp -77.24 151.53 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.3 OUTLIER -102.34 118.24 36.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.9 115.34 45.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.03 0.443 . . . . 0.0 110.977 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 104.98 -169.05 16.25 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.985 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.471 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 33.4 mtt180 57.45 59.13 7.35 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 122.708 0.403 . . . . 0.0 111.883 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 3.9 Cg_exo -77.62 -39.62 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.433 2.089 . . . . 0.0 112.533 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 p -171.22 151.77 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.878 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 193' ' ' GLN . 94.6 m-20 59.29 56.92 3.61 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.483 0.489 . . . . 0.0 110.794 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.47 -21.36 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.54 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.24 -29.0 8.19 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.911 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 190' ' ' ASN . 12.4 tt0 -75.67 -33.42 60.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.877 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -74.12 -27.81 61.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.87 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.41 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 28.1 tp60 -54.69 -55.62 36.12 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.606 ' O ' ' HG2' ' A' ' 200' ' ' GLN . 13.4 Cg_endo -57.1 -37.17 98.92 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 121.869 1.713 . . . . 0.0 111.938 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.6 mm -63.81 -41.46 92.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.391 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 194' ' ' ALA . 51.0 mm -56.13 -50.64 69.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.826 176.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.45 -44.42 94.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.876 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 25.4 mm-40 -61.87 -41.42 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.59 -44.0 36.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.0 95.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.329 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.609 ' OE2' ' HD3' ' A' ' 206' ' ' ARG . 13.9 tp10 -67.91 -30.27 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.072 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.17 -47.86 47.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.259 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.04 -26.47 67.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.286 0.565 . . . . 0.0 110.552 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.609 ' HD3' ' OE2' ' A' ' 203' ' ' GLU . 75.7 ttt180 -62.68 -23.11 66.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.968 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.65 -23.65 66.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.12 0.486 . . . . 0.0 110.827 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -14.66 36.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.541 0.686 . . . . 0.0 109.994 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.8 t30 57.18 45.4 20.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.679 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.523 ' HD2' ' HG2' ' A' ' 289' ' ' PRO . 94.2 mtt180 -108.58 136.49 48.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.906 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.1 pt -113.21 166.88 6.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.18 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.427 ' HD2' HD11 ' A' ' 168' ' ' LEU . 18.7 t80 -111.35 122.04 46.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.539 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 229' ' ' PHE . 3.9 p -112.97 121.11 64.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 0.0 110.793 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.4 175.94 6.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.576 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.865 ' HA ' ' HB3' ' A' ' 134' ' ' PRO . 8.1 t 68.97 24.61 6.23 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.458 0.703 . . . . 0.0 110.856 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.566 HG21 HD11 ' A' ' 240' ' ' LEU . 61.2 t -75.05 135.46 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.139 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -76.73 141.41 40.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.066 0.46 . . . . 0.0 110.501 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -65.15 -13.42 58.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.39 -47.26 23.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -173.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.898 HD21 HD11 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -101.71 159.33 15.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.181 -174.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 16.0 m -113.06 -177.89 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -167.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 0.0 OUTLIER -53.71 -47.55 70.44 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.334 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -55.14 -30.03 58.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 0.0 110.931 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.935 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 52.4 m-20 -78.79 -53.75 6.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.363 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.483 HD11 HD13 ' A' ' 220' ' ' LEU . 46.0 mm -61.48 -16.95 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.242 0.544 . . . . 0.0 110.89 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -54.34 -31.37 54.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.093 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 69.3 m -52.6 -62.13 1.84 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.934 0.873 . . . . 0.0 111.253 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.609 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.9 m -66.28 -34.05 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.605 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 213' ' ' VAL . 48.3 m-85 -74.68 -35.52 62.78 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.625 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.756 ' HG3' HG22 ' A' ' 235' ' ' ILE . 50.3 tt0 -77.23 -32.29 55.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 111.33 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.05 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.695 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.656 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 4.0 m-30 -85.52 -30.88 23.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 110.209 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -174.02 167.95 40.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.378 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -58.04 106.05 0.33 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 112.254 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.756 HG22 ' HG3' ' A' ' 230' ' ' GLU . 15.9 tt -87.97 142.07 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.047 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.06 -44.35 5.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.732 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 24.8 t -147.58 137.39 22.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.333 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.83 119.42 33.51 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.4 m -138.1 103.17 4.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 13.5 tp -88.36 129.74 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.31 114.21 2.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.193 0.52 . . . . 0.0 110.843 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 24.9 mtt180 -91.38 156.4 17.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 -176.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -128.57 113.31 19.34 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.858 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.445 ' HG3' ' HB1' ' A' ' 296' ' ' ALA . 49.2 Cg_endo -69.43 -19.44 37.72 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.87 2.38 . . . . 0.0 112.613 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -55.52 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 110.429 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.6 p -82.34 -35.47 27.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 104.21 -0.29 44.03 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.33 -175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -112.03 -103.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 111.301 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 32.1 p80 -163.26 164.22 25.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.439 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -90.25 157.58 17.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -76.76 40.86 1.64 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.133 -0.556 . . . . 0.0 113.291 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -157.86 164.62 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.74 -169.59 36.2 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.252 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -125.48 137.99 53.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.36 . . . . 0.0 110.343 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.28 123.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.922 177.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 42.6 tt0 -106.69 131.98 53.2 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.08 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.427 ' CD1' ' HA ' ' A' ' 235' ' ' ILE . 68.5 m-85 -112.47 153.0 28.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.19 0.519 . . . . 0.0 111.498 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -88.98 -22.4 23.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.772 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 261' ' ' GLN . 35.5 ttpt -115.4 117.64 30.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.6 -25.04 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.926 0.393 . . . . 0.0 111.779 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.664 ' HB2' ' HE3' ' A' ' 259' ' ' LYS . 24.2 mp0 -66.65 -33.72 76.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.655 ' OG ' ' HE2' ' A' ' 259' ' ' LYS . 14.8 m -62.93 -38.04 89.43 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 267' ' ' VAL . 14.5 m -59.76 -38.59 82.22 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.55 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.01 -45.56 81.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.68 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.51 -44.33 93.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.582 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -61.42 -53.73 52.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.069 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 263' ' ' SER . 84.2 t -57.6 -27.27 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 0.0 111.336 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.3 m -72.41 -48.14 43.72 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.7 t -116.48 -13.0 10.95 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -168.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.48 ' HA ' ' CE ' ' A' ' 270' ' ' MET . 2.2 tpt -61.78 -32.45 72.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -170.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 279' ' ' TYR . 20.9 p-10 -66.69 -22.63 66.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.81 -10.93 59.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.901 ' CZ ' ' HB1' ' B' ' 38' ' ' ALA . 2.0 t80 -69.28 104.8 2.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.771 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.46 88.55 3.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.54 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.898 HD11 HD21 ' A' ' 220' ' ' LEU . 62.7 tp -93.33 87.14 5.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.449 -174.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.94 37.36 11.6 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.759 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.19 65.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.941 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -141.17 130.92 24.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 271' ' ' ASN . 99.6 m-85 -67.78 132.69 47.89 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.92 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 55.7 mt -61.93 -177.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.595 0.712 . . . . 0.0 110.751 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.31 121.84 9.14 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 7.4 p -121.8 134.59 64.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.224 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.724 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -141.64 -148.36 5.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.454 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -127.93 178.86 5.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.801 0.334 . . . . 0.0 110.56 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -104.54 117.72 34.82 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 66.3 t -94.38 -33.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.304 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 11.1 t -107.29 133.66 20.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 12.0 Cg_endo -56.93 121.78 10.68 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.628 2.219 . . . . 0.0 111.919 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.523 ' HG2' ' HD2' ' A' ' 210' ' ' ARG . 27.9 Cg_exo -62.16 96.29 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.993 2.462 . . . . 0.0 111.941 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 18.2 ptp -82.89 139.6 43.15 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.253 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 4.2 Cg_exo -75.52 47.32 1.84 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.496 2.798 . . . . 0.0 113.134 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 55.7 tp -84.87 93.42 8.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 48.7 tp -99.06 94.56 6.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.759 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 13.9 t -71.28 146.31 91.95 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.671 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.83 86.41 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.662 2.241 . . . . 0.0 111.814 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.445 ' HB1' ' HG3' ' A' ' 244' ' ' PRO . . . -94.27 59.56 2.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.572 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.5 177.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.44 96.99 10.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.863 0.364 . . . . 0.0 110.171 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mmm -78.1 71.95 4.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.12 73.55 0.17 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -166.62 151.66 7.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.764 0.316 . . . . 0.0 110.524 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' B' ' 30' ' ' ALA . 51.9 t -112.34 139.87 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.523 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -110.3 125.12 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.559 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.852 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 5.6 m-20 76.52 -43.12 0.45 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.612 0.765 . . . . 0.0 112.821 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.474 ' HB3' ' CG1' ' B' ' 27' ' ' VAL . . . -68.24 -29.42 68.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.172 0.51 . . . . 0.0 110.043 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 8.5 t80 -79.06 -17.92 54.37 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.624 0.726 . . . . 0.0 109.473 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.852 ' HD3' ' HA ' ' B' ' 29' ' ' ASP . 52.8 mtpt -75.21 -43.62 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.548 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.61 -44.63 85.6 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.656 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -47.59 -52.31 18.2 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.048 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.811 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.1 OUTLIER -82.06 -22.4 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -65.48 -39.01 91.43 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.634 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 22.7 mmt180 -69.28 -41.85 76.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.339 171.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.901 ' HB1' ' CZ ' ' A' ' 273' ' ' PHE . . . -58.5 -45.16 89.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.843 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -79.9 -25.88 40.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.4 -1.437 . . . . 0.0 112.666 174.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.94 -49.06 66.8 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 169.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.935 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 3.2 pt -64.47 -32.42 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.338 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.774 ' HA ' HD23 ' A' ' 220' ' ' LEU . . . -73.12 -25.68 60.94 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.11 -43.06 14.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.175 0.512 . . . . 0.0 110.456 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 2.8 tmmm? -65.98 -41.44 91.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 64.3 mt 70.78 -80.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.05 174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.96 166.49 21.4 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.847 -173.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.96 114.74 2.29 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.722 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.87 139.13 58.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.675 0.274 . . . . 0.0 110.488 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.91 26.35 9.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.949 0.404 . . . . 0.0 111.002 -176.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.01 99.05 2.19 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.085 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.4 p -83.63 126.95 33.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.701 0.286 . . . . 0.0 110.744 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.914 179.85 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 112.024 -0.431 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.38 117.3 22.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.802 0.334 . . . . 0.0 110.85 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -134.29 -175.72 3.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.078 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -86.32 -69.11 0.69 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.868 0.366 . . . . 0.0 110.701 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 178.52 -68.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.484 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.706 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 46.9 ttp180 -166.86 100.8 0.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.45 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -103.6 56.44 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.765 0.317 . . . . 0.0 111.101 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.706 ' HG2' ' HG2' ' A' ' 104' ' ' ARG . 24.1 mmm180 -71.8 -32.5 67.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.047 -177.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -52.7 35.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.654 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 111' ' ' MET . 3.1 mm? -60.61 -37.26 80.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.094 -176.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.54 79.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.45 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 194' ' ' ALA . 35.4 pt -85.27 -40.88 15.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.518 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 25.5 ptm -71.76 -28.24 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -171.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 81.0 m -92.63 6.51 47.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.639 0.257 . . . . 0.0 110.959 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -119.63 101.06 7.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.216 0.532 . . . . 0.0 111.383 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -109.68 125.53 66.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.023 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -91.09 149.1 21.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.524 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 47.1 t -111.52 111.27 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.062 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.5 -178.27 17.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.04 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.879 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 39.3 m 62.13 29.12 17.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.37 0.605 . . . . 0.0 111.027 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 119' ' ' ILE . 8.5 mt -70.02 147.16 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.053 -178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.3 -73.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 151' ' ' LYS . 48.2 t80 -176.42 -67.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -76.93 -26.92 54.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.336 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.847 HD22 HG21 ' A' ' 127' ' ' THR . 90.2 mt -54.61 125.67 20.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.846 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -107.68 -172.02 22.0 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.006 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.505 ' HB2' HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -68.94 -26.6 65.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.896 0.379 . . . . 0.0 110.097 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.7 -40.79 98.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.697 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.847 HG21 HD22 ' A' ' 123' ' ' LEU . 12.2 m -63.58 -46.11 87.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 110.445 177.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -63.14 -39.45 85.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -54.7 -42.49 71.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.028 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -77.69 -34.0 53.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.684 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.49 89.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.563 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 96.5 m-85 -97.17 12.28 33.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.223 0.535 . . . . 0.0 110.99 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.555 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -68.1 -44.99 40.38 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.782 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.97 ' HB2' ' HA ' ' A' ' 215' ' ' SER . 43.9 Cg_endo -68.46 -5.0 14.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.857 1.705 . . . . 0.0 112.991 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.469 ' HA ' ' HB1' ' A' ' 214' ' ' ALA . 4.6 m-85 -84.97 -75.35 0.36 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.843 0.354 . . . . 0.0 110.122 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -147.47 167.19 28.6 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 162' ' ' VAL . 22.8 Cg_exo -64.82 121.62 9.2 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.286 1.991 . . . . 0.0 111.729 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.456 HG21 HG13 ' A' ' 141' ' ' ILE . 2.0 mp -68.16 119.29 13.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.171 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -86.64 -46.1 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.544 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 m -148.38 141.33 24.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.357 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.505 HG21 ' HB2' ' A' ' 125' ' ' GLU . 54.5 mt -124.26 107.03 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.64 108.33 19.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.751 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 125' ' ' GLU . 27.2 ttt -132.0 119.8 21.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.911 0.386 . . . . 0.0 111.034 -176.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.0 t -90.34 83.09 5.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.553 ' CZ3' ' HA ' ' A' ' 150' ' ' MET . 2.9 p-90 -143.26 152.92 42.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.867 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.44 117.4 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.195 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.7 m -75.72 -9.01 58.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.938 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 50.7 t -81.85 -57.44 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.378 . . . . 0.0 110.751 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.419 ' HB ' ' HG2' ' A' ' 151' ' ' LYS . 27.9 p -80.06 -29.84 39.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.553 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 81.4 mtp 71.86 -10.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.799 0.84 . . . . 0.0 112.257 176.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.447 ' HB3' ' HE1' ' A' ' 121' ' ' TYR . 11.7 ptmm? -84.29 114.46 21.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.176 0.512 . . . . 0.0 109.667 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -142.36 145.25 33.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.016 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -119.59 13.06 12.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.624 0.726 . . . . 0.0 109.788 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.57 153.6 22.18 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.479 172.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -106.68 174.26 5.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.868 0.366 . . . . 0.0 110.934 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.19 148.93 36.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.306 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.15 115.25 29.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.068 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.86 108.37 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.043 0.449 . . . . 0.0 110.075 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -102.02 119.67 39.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.439 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.563 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 41.9 m-85 -93.58 149.63 21.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.295 0.569 . . . . 0.0 112.425 -174.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.439 ' OE1' ' HG2' ' A' ' 137' ' ' PRO . 33.8 tt0 -74.29 -27.65 60.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.463 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.507 HG22 ' HD2' ' A' ' 137' ' ' PRO . 26.5 m -121.45 120.9 28.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.942 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.497 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 33.5 Cg_exo -61.22 -25.85 81.3 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.389 2.726 . . . . 0.0 113.403 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.497 ' OE2' ' HD2' ' A' ' 163' ' ' PRO . 1.7 mp0 -58.56 -50.51 73.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.945 0.403 . . . . 0.0 110.122 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.43 -23.09 64.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.77 77.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.488 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -70.6 -39.54 73.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.573 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.4 mp -58.93 -41.46 87.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.666 0.269 . . . . 0.0 110.917 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.49 -43.11 99.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.9 0.381 . . . . 0.0 110.427 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.712 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 6.2 tt -64.57 -42.26 95.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.646 -178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -47.29 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -79.97 -50.13 10.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 56.1 tpp -74.16 -28.15 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.831 0.348 . . . . 0.0 111.378 -172.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 185' ' ' VAL . 10.7 t30 -81.36 -16.82 51.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.201 0.524 . . . . 0.0 110.521 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 t -84.15 -29.21 26.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.32 175.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.462 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 91.4 mtp -111.85 111.63 22.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.022 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 48.9 tp -68.55 104.64 2.0 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.86 -78.56 1.36 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -166.09 35.04 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.407 ' HB2' HG23 ' A' ' 183' ' ' ILE . 18.7 mmm180 -123.34 145.69 48.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.498 0.189 . . . . 0.0 110.81 -176.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -87.65 71.28 9.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.879 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 24.6 pt -69.16 156.31 7.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.399 -171.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 6.5 mmmm -101.94 109.99 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.093 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 174' ' ' ASN . 63.2 t -122.31 121.51 64.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.956 0.408 . . . . 0.0 110.065 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.712 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 73.76 -126.94 10.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.129 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 52.84 77.24 0.46 Allowed Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 110.205 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -55.93 119.68 7.0 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.509 2.806 . . . . 0.0 113.748 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.6 m -71.67 -17.64 62.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.036 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.38 6.38 8.52 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.492 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.6 mm 71.34 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.913 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 173.07 50.68 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.43 -47.84 78.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.009 0.433 . . . . 0.0 111.414 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.555 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -111.61 18.04 19.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.787 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.4 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 21.5 tm0? -64.12 -47.38 79.46 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.583 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 74.1 Cg_exo -49.9 -42.35 44.99 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.794 2.329 . . . . 0.0 114.599 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 198' ' ' ILE . 2.6 pp -75.44 -24.25 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.776 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 194' ' ' ALA . 34.5 mt -65.24 -38.5 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.63 0.252 . . . . 0.0 110.542 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.05 -44.63 87.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.332 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.72 -44.63 81.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.573 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.761 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 91.2 mt -61.67 -45.57 93.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.841 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.2 -37.52 87.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.557 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.34 -34.13 77.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -73.93 -41.18 62.44 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.985 0.421 . . . . 0.0 110.198 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.62 72.42 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.779 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -57.4 -38.31 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.956 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.21 -13.01 61.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.564 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' A' ' 288' ' ' PRO . 17.3 m-85 -93.03 -6.94 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.741 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.29 27.34 16.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.748 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.776 ' HD2' ' HG2' ' A' ' 289' ' ' PRO . 92.2 mtt180 -102.26 137.0 41.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.895 0.379 . . . . 0.0 111.159 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.6 pt -121.21 161.5 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.639 175.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -116.02 135.73 53.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.771 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.45 124.56 60.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.885 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 135' ' ' PHE . . . -122.03 -179.22 4.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.97 ' HA ' ' HB2' ' A' ' 134' ' ' PRO . 51.0 m 69.64 19.16 7.44 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.709 0.804 . . . . 0.0 111.473 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 225' ' ' ILE . 85.1 t -65.61 140.34 19.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.392 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -63.45 132.64 52.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.937 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.614 ' HG3' ' H ' ' A' ' 219' ' ' ASP . 6.2 pt20 -41.42 -55.96 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.614 ' H ' ' HG3' ' A' ' 218' ' ' GLN . 0.5 OUTLIER -79.64 -47.27 15.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.776 HD11 HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -55.89 111.96 1.06 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.042 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 225' ' ' ILE . 56.9 p -97.24 -178.01 4.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -162.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 18.8 p-10 -59.76 -44.04 94.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.434 -178.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.44 -29.29 66.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.546 0.689 . . . . 0.0 109.833 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.674 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 64.5 m-20 -78.73 -54.09 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.513 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.65 HD11 HG13 ' A' ' 216' ' ' VAL . 27.9 mm -53.54 -27.59 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.359 0.599 . . . . 0.0 110.947 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -53.23 -31.6 44.05 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.84 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -48.94 -58.47 4.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.529 0.68 . . . . 0.0 111.932 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.738 HG12 ' HB1' ' B' ' 34' ' ' ALA . 6.0 m -74.35 -42.26 50.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.607 -171.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 270' ' ' MET . 35.6 m-85 -59.76 -52.99 63.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 0.0 110.927 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.1 tt0 -66.79 -24.03 66.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 -176.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.07 -33.26 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.827 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.753 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.6 m-30 -82.95 -42.25 17.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -151.77 148.37 19.3 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 42.0 mmtm -62.02 122.75 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.684 0.754 . . . . 0.0 110.965 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 238' ' ' CYS . 20.1 tt -87.95 141.16 14.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.109 -169.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 256' ' ' GLU . 82.2 tttt -91.96 -42.2 10.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 256' ' ' GLU . 12.8 p -161.59 146.7 13.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.599 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.44 ' HB3' HD11 ' A' ' 235' ' ' ILE . 6.3 p -137.94 129.98 28.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.841 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 48.6 m -150.61 119.73 6.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.047 0.451 . . . . 0.0 110.988 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 8.3 mp -99.38 130.52 45.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.795 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.33 137.22 58.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.077 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 52.3 mtt85 -94.25 157.76 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.188 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.551 ' OD1' HG22 ' A' ' 245' ' ' THR . 8.1 t70 -100.32 108.48 52.92 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 14.8 Cg_exo -70.04 -17.55 36.25 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.364 2.709 . . . . 0.0 114.172 -175.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 243' ' ' ASP . 3.5 t -94.6 -6.51 43.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.42 . . . . 0.0 111.125 -172.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 245' ' ' THR . 24.6 p -133.82 -41.78 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 119.96 -24.64 7.81 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.705 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.46 ' HE3' ' OG1' ' A' ' 246' ' ' THR . 0.0 OUTLIER -82.1 -179.86 7.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.827 0.314 . . . . 0.0 110.776 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.7 p80 -94.0 151.29 19.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.453 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -78.96 154.88 29.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.64 44.62 2.29 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.783 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.432 ' CE2' ' HD3' ' A' ' 137' ' ' PRO . 41.3 p90 -161.8 160.25 28.03 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.149 0.475 . . . . 0.0 110.382 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -170.81 -173.0 37.64 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.354 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.418 ' C ' HD12 ' A' ' 255' ' ' ILE . 87.8 m-85 -123.62 142.6 50.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.681 0.277 . . . . 0.0 110.652 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 254' ' ' PHE . 3.1 mp -124.45 131.32 72.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.618 174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.461 ' HB3' ' OG ' ' A' ' 237' ' ' SER . 30.6 tt0 -112.28 141.07 46.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -119.57 147.74 44.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.176 0.512 . . . . 0.0 111.49 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -79.97 -21.52 43.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.924 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 261' ' ' GLN . 34.9 ttpt -122.08 113.41 19.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.054 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.5 47.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.189 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.444 ' HB3' ' HE3' ' A' ' 259' ' ' LYS . 20.7 tt0 -56.99 -48.19 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.276 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.0 m -62.72 -31.5 72.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.3 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.4 m -59.67 -39.89 85.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.625 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -74.26 -42.97 58.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.858 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -63.78 -31.58 72.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.549 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 232' ' ' PHE . . . -72.43 -54.16 10.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.458 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.58 -26.29 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -85.25 -18.34 34.29 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -115.05 -32.97 5.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.633 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.3 mmm -62.58 -21.33 65.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -172.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -58.07 -36.07 72.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.835 0.826 . . . . 0.0 110.377 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.76 -8.73 57.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.21 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.84 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 1.6 t80 -56.63 102.09 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -175.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.8 t70 -92.26 124.16 36.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.945 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.693 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.2 mm? -122.78 87.08 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.712 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 86.64 22.98 44.53 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.939 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.53 7.25 42.9 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.801 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 18.0 pt20 -125.85 130.66 51.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.789 0.328 . . . . 0.0 110.573 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -87.43 144.54 26.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.698 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 273' ' ' PHE . 11.0 mt -75.92 -173.72 2.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.549 . . . . 0.0 110.409 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.41 113.47 5.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 270' ' ' MET . 7.0 m -114.84 154.04 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.059 0.457 . . . . 0.0 111.866 -177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.31 -150.9 6.67 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.763 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 284' ' ' LYS . 28.3 mmtp -96.31 157.9 15.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.28 62.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 44.6 t 69.17 -71.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.625 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.487 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 12.3 p -89.59 133.86 33.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.412 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.761 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 16.1 Cg_exo -67.29 122.29 9.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.95 2.434 . . . . 0.0 112.613 -175.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.776 ' HG2' ' HD2' ' A' ' 210' ' ' ARG . 12.8 Cg_exo -70.92 75.57 1.68 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.065 2.51 . . . . 0.0 111.581 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.463 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 51.5 ttm -72.91 122.59 88.02 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 6.5 Cg_exo -74.7 59.26 4.91 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.192 2.594 . . . . 0.0 112.024 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 292' ' ' LEU . 0.2 OUTLIER -82.08 66.47 7.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.382 0.611 . . . . 0.0 110.18 -177.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 98.8 mt -101.92 19.25 18.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.349 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.459 ' N ' ' CD ' ' A' ' 295' ' ' PRO . 4.7 p -76.33 -31.3 0.95 Allowed Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 294' ' ' THR . 80.1 Cg_exo -47.23 106.65 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.373 2.049 . . . . 0.0 113.083 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -107.99 84.17 1.91 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.278 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 60.9 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.325 -179.692 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.68 102.22 1.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.001 0.429 . . . . 0.0 111.372 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mmm -102.11 153.02 20.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.658 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.23 -171.33 40.78 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.723 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -112.95 29.92 7.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.044 0.449 . . . . 0.0 110.424 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' B' ' 30' ' ' ALA . 98.2 t -99.07 115.49 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.197 0.522 . . . . 0.0 111.774 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -136.02 143.82 44.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . 0.433 ' HA ' ' CD ' ' B' ' 32' ' ' LYS . 35.2 m-20 72.25 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.786 0.679 . . . . 0.0 112.139 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.454 ' HB3' HG13 ' B' ' 27' ' ' VAL . . . -60.38 -36.74 78.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.966 0.412 . . . . 0.0 111.0 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.646 ' O ' HD22 ' B' ' 35' ' ' LEU . 10.6 t80 -73.99 -19.81 60.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.174 0.512 . . . . 0.0 109.861 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.9 mttt -73.81 -41.49 62.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.95 -38.91 76.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.436 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.753 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.13 -54.13 22.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.339 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.887 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.3 OUTLIER -79.76 -17.46 53.4 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -172.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 43.0 mt-30 -60.08 -47.11 87.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 70.6 mtp180 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.245 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.887 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -68.01 -46.16 72.04 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.559 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 5.4 mtm180 -79.78 -24.66 41.33 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.512 -1.368 . . . . 0.0 112.166 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' B' ' 37' ' ' ARG . 51.9 tt0 -52.74 -50.03 64.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 109.816 167.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.902 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 3.4 pt -68.4 -25.39 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.008 0.432 . . . . 0.0 110.58 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' B' ' 39' ' ' ARG . . . -81.2 -11.92 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.244 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.65 -30.7 20.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.827 0.346 . . . . 0.0 110.298 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.902 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 15.7 ptpt -76.39 -4.33 41.74 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.976 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.72 117.92 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.598 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.94 -9.55 37.07 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.65 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.92 -64.94 4.2 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 t70 56.14 41.8 29.02 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.846 0.458 . . . . 0.0 110.45 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . 73.7 -38.97 0.42 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.785 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.19 -54.48 4.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.339 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -134.23 138.49 45.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.247 0.929 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.37 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.69 146.04 27.96 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -116.69 -177.29 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.453 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 66.16 49.6 1.5 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 123.837 0.711 . . . . 0.0 110.175 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 54.1 mt-30 -63.57 -84.04 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.562 ' HG2' HG21 ' A' ' 297' ' ' THR . 23.4 mtp180 52.45 32.82 11.95 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 173.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 59.69 31.55 20.93 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.016 0.436 . . . . 0.0 110.97 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 103' ' ' GLN . 18.0 ttp180 -65.03 -28.15 69.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.915 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.72 -36.51 64.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.32 -42.68 44.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.186 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . . . -62.06 -35.38 78.46 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.188 -176.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.98 -35.85 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.121 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.4 mmm -68.61 -36.53 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.407 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.573 ' HA ' ' HB2' ' A' ' 166' ' ' ALA . 23.4 p -81.13 6.25 14.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 78.0 ttt180 -111.39 96.24 5.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.4 HG23 HG13 ' A' ' 158' ' ' VAL . 11.6 m -92.76 144.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.554 0.692 . . . . 0.0 111.878 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 187' ' ' ARG . 44.1 t80 -96.9 127.3 42.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.53 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 111.19 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.651 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.57 -179.72 16.18 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.697 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.1 m 56.45 34.53 24.42 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.351 0.596 . . . . 0.0 110.898 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.0 mt -73.86 163.82 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.967 -176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 85.9 t80 -57.29 -72.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 31.1 t80 173.35 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.438 0.461 . . . . 0.0 109.762 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.72 -20.5 58.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.43 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.78 HD22 HG21 ' A' ' 127' ' ' THR . 47.5 mt -58.57 110.16 0.93 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.062 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -109.24 -153.69 15.39 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.144 -172.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.8 -51.18 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.633 0.255 . . . . 0.0 111.136 -175.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.35 -26.81 67.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 -175.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.78 HG21 HD22 ' A' ' 123' ' ' LEU . 3.6 m -67.59 -53.81 25.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.021 0.439 . . . . 0.0 110.053 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.32 -39.38 85.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.274 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -59.52 -38.31 80.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.009 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.29 -44.28 25.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.746 0.308 . . . . 0.0 111.66 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.69 81.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 173' ' ' MET . 84.7 m-85 -106.48 18.98 21.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.839 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.62 ' HA ' HD11 ' A' ' 138' ' ' ILE . . . -65.47 -43.91 64.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.031 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 133' ' ' ALA . 22.6 Cg_exo -68.35 -5.16 14.33 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.03 1.82 . . . . 0.0 112.665 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 165' ' ' ALA . 9.0 m-85 -94.64 60.27 2.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.563 ' HA3' HG21 ' A' ' 162' ' ' VAL . . . 78.12 175.32 44.54 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.75 118.57 3.83 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.861 2.374 . . . . 0.0 111.91 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 133' ' ' ALA . 3.8 mp -60.47 118.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -89.57 -49.56 6.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 109.951 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 p -161.45 147.8 14.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.934 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.98 107.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -98.14 118.42 34.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.7 ptm -143.33 148.29 36.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.53 108.93 11.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.537 0.684 . . . . 0.0 111.633 -177.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 152' ' ' HIS . 78.0 m95 -104.14 155.68 18.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.452 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -101.76 86.72 2.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.663 0.744 . . . . 0.0 110.197 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.0 p 33.58 -108.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.897 -1.501 . . . . 0.0 114.355 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.45 -28.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -170.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -33.51 67.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -170.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.3 mmt 58.93 44.95 15.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.356 0.598 . . . . 0.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 121' ' ' TYR . 10.6 tptm -93.45 -29.1 15.74 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 145' ' ' TRP . 57.0 t60 60.91 75.84 0.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.492 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -102.84 81.21 1.97 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.79 -155.52 11.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.572 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -125.65 175.03 7.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.35 28.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.76 0.314 . . . . 0.0 111.574 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.21 119.91 39.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 114' ' ' VAL . 2.5 p -114.81 119.42 61.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.35 0.595 . . . . 0.0 110.463 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . 33.1 tt0 -104.02 130.4 51.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.164 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.603 ' HE1' HG13 ' A' ' 138' ' ' ILE . 51.6 m-85 -110.71 171.54 7.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.644 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.69 14.95 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.563 HG21 ' HA3' ' A' ' 136' ' ' GLY . 8.7 m -134.42 105.88 11.04 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.609 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.441 ' HD2' ' OE2' ' A' ' 164' ' ' GLU . 38.6 Cg_exo -58.97 -26.9 83.22 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.173 2.582 . . . . 0.0 113.299 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 164' ' ' GLU . 2.1 mp0 -61.8 -57.94 9.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.575 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.27 -26.4 66.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.756 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 112' ' ' CYS . . . -63.02 -51.57 66.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.785 0.326 . . . . 0.0 110.796 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -74.55 -31.82 62.23 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 59.2 tp -56.07 -50.08 71.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.65 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.82 -40.94 97.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.908 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.911 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 5.4 tt -60.68 -42.68 97.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.633 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -79.6 -46.1 17.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 281' ' ' ARG . 75.8 mm-40 -83.95 -50.93 7.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.41 ' HG3' ' CE2' ' A' ' 132' ' ' PHE . 16.0 mmt -74.46 -30.76 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -172.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.37 -24.35 67.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.292 0.567 . . . . 0.0 110.534 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.1 m -92.24 -2.28 56.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.719 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 172' ' ' GLN . 91.6 t -118.28 139.86 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 182' ' ' ASN . 58.7 mtt -99.6 117.28 33.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.83 121.49 27.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 69.98 -88.07 0.3 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -173.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.78 11.75 0.96 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -100.5 132.67 45.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.615 -175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 177' ' ' MET . 6.0 t30 -86.78 89.49 7.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 pt -72.54 142.08 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.83 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -102.73 110.04 21.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.61 110.21 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.189 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.911 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 105.07 110.68 3.53 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.876 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 49.5 ttt180 -109.33 113.82 58.18 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 187' ' ' ARG . 38.1 Cg_endo -66.46 77.06 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.101 2.534 . . . . 0.0 111.549 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.1 m -84.56 -22.7 29.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.525 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -123.31 114.23 19.93 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.8 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.9 mt -129.2 98.41 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 138.48 -47.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -81.27 -57.39 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.034 0.445 . . . . 0.0 110.969 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -92.19 -14.92 28.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.377 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.657 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 24.2 tp60 -56.22 -51.67 78.98 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.057 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 27.6 Cg_exo -63.53 -34.39 64.66 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.028 1.819 . . . . 0.0 111.976 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.07 -42.19 95.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.289 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.4 mt -59.57 -44.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.783 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.36 -42.32 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.493 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -59.86 -51.18 70.81 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.755 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 202' ' ' ALA . 3.3 pp -75.71 -29.02 58.81 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.654 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.444 ' N ' HD12 ' A' ' 201' ' ' LEU . . . -73.36 -40.09 64.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 0.0 110.365 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.44 -44.11 97.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.564 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.73 -30.38 67.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 288' ' ' PRO . . . -64.41 -22.5 66.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -61.14 -32.99 72.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.37 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 111.031 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -87.26 -26.4 23.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.668 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.5 p30 40.53 46.61 2.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.71 0.804 . . . . 0.0 112.944 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -87.41 136.22 33.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 229' ' ' PHE . 15.8 tt -104.78 146.69 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 0.0 110.359 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -111.36 139.25 46.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.578 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.438 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 5.9 p -136.13 125.91 40.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.181 0.515 . . . . 0.0 110.721 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -123.42 179.96 4.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.276 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.476 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.8 t 65.05 25.4 12.59 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.789 0.681 . . . . 0.0 109.674 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 225' ' ' ILE . 46.3 t -70.37 129.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.898 -176.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.62 131.25 50.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.51 -50.56 31.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.898 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -75.53 -46.44 32.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.382 . . . . 0.0 111.451 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.822 HD11 HG13 ' B' ' 41' ' ' ILE . 0.9 OUTLIER -63.53 101.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.015 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.483 ' O ' HG12 ' A' ' 225' ' ' ILE . 50.9 m -91.33 -177.18 4.78 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.043 -169.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.806 ' HB3' ' HB2' ' A' ' 240' ' ' LEU . 21.8 p-10 -61.07 -39.26 89.19 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -56.36 -30.59 62.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 110.467 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.644 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 9.4 m-20 -78.69 -53.05 7.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.048 176.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 216' ' ' VAL . 30.8 mm -52.04 -29.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 123.466 0.706 . . . . 0.0 111.238 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.573 ' HG3' HD12 ' A' ' 235' ' ' ILE . 87.7 tttt -50.32 -31.64 14.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.882 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 63.8 m -48.39 -61.89 1.77 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.543 0.687 . . . . 0.0 111.723 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.807 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 3.7 m -74.04 -35.74 42.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.481 -170.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.63 ' HE2' HD13 ' A' ' 211' ' ' ILE . 38.9 m-85 -68.33 -48.89 63.67 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.091 -0.243 . . . . 0.0 111.311 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 31.4 tt0 -78.24 -11.9 59.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 111.239 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.27 -28.35 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.654 0.264 . . . . 0.0 111.079 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.751 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.8 OUTLIER -94.82 -62.19 1.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.62 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -117.98 175.98 15.94 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.766 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -92.3 118.34 30.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.156 0.503 . . . . 0.0 111.304 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.573 HD12 ' HG3' ' A' ' 226' ' ' LYS . 65.3 mt -75.66 138.39 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.958 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -90.96 -45.4 8.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 4.2 p -156.82 131.7 8.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.33 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 9.6 p -120.5 128.09 52.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.747 0.308 . . . . 0.0 110.223 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.3 p -143.23 111.06 5.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.815 ' HG ' ' HA3' ' A' ' 253' ' ' GLY . 9.4 mp -101.59 116.88 33.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -53.05 112.82 0.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.086 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.942 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -97.21 144.77 26.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.156 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -89.56 118.49 69.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.279 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.91 -21.84 37.01 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.952 2.435 . . . . 0.0 113.522 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 37.9 p -89.08 -17.65 28.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 0.0 111.527 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 31.0 p -102.15 -37.24 8.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.973 0.416 . . . . 0.0 110.52 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 100.21 1.03 55.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.285 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -128.44 158.03 39.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.931 0.396 . . . . 0.0 110.282 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.942 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 15.3 p80 -72.9 148.3 44.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.736 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -79.15 155.4 28.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.86 44.01 1.23 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 20.4 p90 -163.19 160.58 24.27 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.815 ' HA3' ' HG ' ' A' ' 240' ' ' LEU . . . -176.35 -172.59 41.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.635 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.402 ' CE2' ' HG2' ' A' ' 164' ' ' GLU . 91.3 m-85 -126.91 139.99 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 111.323 -176.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 211' ' ' ILE . 2.7 mp -117.94 128.1 75.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -104.93 114.7 29.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.946 0.403 . . . . 0.0 110.115 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -90.97 153.3 20.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.402 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 259' ' ' LYS . 9.7 pt-20 -91.8 -18.86 23.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.493 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' A' ' 258' ' ' GLU . 29.3 mmmt -122.48 125.15 45.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.72 -22.83 64.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.717 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -63.27 -44.24 95.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.62 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 34.8 m -65.93 -34.42 78.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.998 0.428 . . . . 0.0 111.266 -176.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.9 m -60.46 -32.01 70.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -74.17 -43.45 57.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.858 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.52 -27.21 60.44 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.571 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.46 -54.01 28.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.225 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.723 ' HA ' HG21 ' A' ' 282' ' ' VAL . 25.2 m -59.1 -26.19 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.02 0.438 . . . . 0.0 111.52 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.2 m -78.05 -19.81 53.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.741 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -114.96 -33.15 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.807 ' HE1' ' HB ' ' A' ' 228' ' ' VAL . 4.1 mmt -75.97 5.18 6.93 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -166.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.495 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 7.9 t30 -81.92 -38.94 24.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.932 0.873 . . . . 0.0 109.489 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.16 -8.53 57.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.277 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.787 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 4.5 t80 -52.93 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.776 0.431 . . . . 0.0 110.513 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 9.5 t70 -90.89 125.67 35.82 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.502 -176.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.586 HD22 HD13 ' A' ' 220' ' ' LEU . 85.8 mt -128.63 85.53 2.34 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.13 44.81 7.89 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.8 63.98 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.832 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 9.4 pt20 -140.58 130.65 24.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.778 0.323 . . . . 0.0 110.608 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -89.67 133.71 34.52 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.658 HD22 ' CD2' ' A' ' 273' ' ' PHE . 8.5 mp -72.45 -165.75 0.22 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.39 0.614 . . . . 0.0 111.03 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 9.6 tpp180 -147.11 116.65 7.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.042 -172.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.723 HG21 ' HA ' ' A' ' 267' ' ' VAL . 14.4 p -105.68 146.97 11.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.94 0.4 . . . . 0.0 111.271 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.12 -156.71 7.7 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 286' ' ' VAL . 93.9 mttt -126.49 174.52 8.58 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.603 -0.351 . . . . 0.0 110.11 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -59.13 -43.14 91.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.676 0.274 . . . . 0.0 111.429 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 94.4 t 79.8 -52.92 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.676 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 288' ' ' PRO . 4.5 m -139.76 122.85 10.42 Favored Pre-proline 0 N--CA 1.444 -0.752 0 CA-C-O 120.69 0.281 . . . . 0.0 110.846 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 287' ' ' THR . 1.1 Cg_endo -88.27 113.45 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.661 2.907 . . . . 0.0 112.194 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.01 122.9 10.82 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.682 2.255 . . . . 0.0 111.5 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 63.2 mtm -92.78 112.29 55.12 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.016 -177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.62 -22.71 2.41 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.654 2.236 . . . . 0.0 112.473 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.18 95.69 5.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.981 0.419 . . . . 0.0 110.438 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -166.55 170.66 12.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 6.6 t -101.83 109.51 59.78 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 121.172 0.51 . . . . 0.0 109.838 174.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 13.3 Cg_exo -70.26 115.42 4.15 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.022 2.481 . . . . 0.0 112.226 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -100.81 53.83 0.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.523 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.562 HG21 ' HG2' ' A' ' 104' ' ' ARG . 85.3 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.818 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.42 166.08 13.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 22.1 ptp -157.71 178.03 10.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.98 0.419 . . . . 0.0 111.214 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.49 -114.88 4.04 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.827 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -111.38 -4.9 14.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.254 0.55 . . . . 0.0 109.758 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.47 97.93 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.23 0.538 . . . . 0.0 110.708 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.463 ' O ' ' HG3' ' B' ' 32' ' ' LYS . 52.4 t30 -167.73 -66.48 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.109 173.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.25 -60.89 1.85 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.869 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 232' ' ' PHE . . . -58.27 -33.59 69.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.635 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 5.9 t80 -72.34 -27.18 62.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 28.9 mtpp -62.58 -47.85 82.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -57.75 -36.15 71.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.739 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.763 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -53.72 -56.21 19.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.184 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.8 OUTLIER -79.17 -20.72 47.77 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.339 -171.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 81.2 mm-40 -56.84 -45.96 82.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 170.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.703 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 13.2 mmm180 -74.13 -32.93 63.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.429 175.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.787 ' HB1' ' HE1' ' A' ' 273' ' ' PHE . . . -63.86 -44.28 93.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -81.46 -26.64 35.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.813 -1.179 . . . . 0.0 112.599 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -56.44 -45.53 80.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.323 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.956 ' HA ' ' HE3' ' B' ' 44' ' ' LYS . 4.5 pt -65.87 -36.02 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.735 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.52 -10.59 59.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.33 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.9 -49.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.009 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.956 ' HE3' ' HA ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -83.92 -29.57 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.898 HG23 ' HB2' ' A' ' 219' ' ' ASP . 37.6 mm 69.37 106.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.167 0.508 . . . . 0.0 111.978 173.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.6 22.63 19.89 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.559 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.46 ' H ' HG22 ' B' ' 45' ' ' ILE . . . -116.56 -99.74 2.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.845 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -112.71 129.71 56.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.083 0.468 . . . . 0.0 110.228 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -113.93 84.6 2.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.234 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.87 -72.35 0.98 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.577 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.9 m -98.98 98.01 9.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.688 0.28 . . . . 0.0 110.437 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 179.825 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.77 48.72 1.41 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.971 0.415 . . . . 0.0 110.995 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.9 mtt -109.65 2.03 19.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.977 0.417 . . . . 0.0 111.031 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.95 72.37 10.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.683 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -160.16 155.51 25.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -101.0 43.4 1.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.705 0.288 . . . . 0.0 110.716 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 55.22 31.54 16.71 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.346 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -62.3 -29.42 70.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.45 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.69 85.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.85 -30.05 63.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.854 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.56 73.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.99 -41.41 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.731 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.708 ' HB3' ' HB3' ' A' ' 163' ' ' PRO . 84.4 mmm -61.86 -25.84 67.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.2 m -92.62 6.05 48.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -126.85 126.84 44.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 0.0 111.814 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.513 HG13 ' HB1' ' A' ' 166' ' ' ALA . 16.9 m -118.84 142.55 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.292 0.568 . . . . 0.0 111.425 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -87.24 121.37 29.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.915 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.06 111.09 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.144 0.497 . . . . 0.0 110.374 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.07 177.72 20.43 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.825 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 42.1 m 64.99 48.03 2.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.176 0.513 . . . . 0.0 111.061 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.7 mm -71.51 -20.41 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 34.5 t80 66.83 -83.66 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.497 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 151' ' ' LYS . 78.1 t80 -174.03 -56.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 110.966 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.54 8.68 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.66 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.609 HD22 HG21 ' A' ' 127' ' ' THR . 67.9 mt -102.86 124.82 49.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.33 -167.21 11.87 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.842 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.97 -35.17 74.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.907 0.384 . . . . 0.0 109.99 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -58.44 -42.33 87.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.293 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.609 HG21 HD22 ' A' ' 123' ' ' LEU . 3.1 m -72.66 -40.6 66.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.481 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.34 -45.65 92.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.752 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.1 ttm-85 -61.35 -37.43 83.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.222 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -77.25 -36.0 54.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.26 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.448 ' O ' ' HD2' ' A' ' 134' ' ' PRO . . . -78.31 -38.93 41.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.981 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.603 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 96.7 m-85 -95.95 5.46 51.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.478 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.65 -42.1 24.59 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.68 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 71.7 Cg_exo -54.81 -2.54 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.211 2.607 . . . . 0.0 114.362 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.603 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 60.2 m-85 -108.65 -71.1 0.77 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.834 -0.541 . . . . 0.0 111.452 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -146.37 -166.5 12.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.623 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -81.86 114.61 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.668 2.245 . . . . 0.0 111.918 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.65 107.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -100.25 -56.23 2.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -136.53 143.9 43.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.3 mt -133.47 107.02 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.165 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 3.8 m-20 -89.12 96.43 10.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 24.2 ptm -126.82 137.14 53.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.044 0.449 . . . . 0.0 110.758 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.8 t -78.79 115.5 18.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.303 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -110.51 98.12 7.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.279 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.54 89.39 6.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -58.25 -38.92 77.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.381 -171.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.0 m -57.08 -30.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 p -119.2 -10.09 9.83 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.566 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 85.3 mtp 62.23 26.72 16.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 58.2 mttp -109.87 -173.13 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.947 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -126.97 95.91 4.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.128 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -83.53 -19.06 36.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.6 170.54 13.42 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.726 175.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -107.72 175.69 5.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.567 0.222 . . . . 0.0 110.924 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.01 136.72 49.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.831 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 72.8 m-85 -108.84 114.63 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.546 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.83 126.62 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.802 0.334 . . . . 0.0 110.311 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -120.34 130.49 54.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.326 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 78.3 m-85 -109.53 179.0 4.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -94.67 -2.63 50.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.338 172.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.99 125.53 17.22 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.246 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.708 ' HB3' ' HB3' ' A' ' 111' ' ' MET . 28.0 Cg_exo -64.33 -37.06 41.97 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.198 2.599 . . . . 0.0 112.169 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -57.75 -45.98 85.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.202 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 136' ' ' GLY . . . -55.67 -42.94 75.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 111.278 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.513 ' HB1' HG13 ' A' ' 114' ' ' VAL . . . -65.85 -41.29 91.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.885 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -63.12 -47.94 80.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.478 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.581 HD21 ' HA3' ' A' ' 283' ' ' GLY . 45.9 mt -63.14 -40.25 97.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.276 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.65 -43.89 93.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.307 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.849 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.1 tt -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -80.78 -48.01 13.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 168' ' ' LEU . 8.0 mm100 -75.99 -40.53 53.51 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.743 -170.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.4 mmt -80.7 -6.31 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.341 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.1 -21.36 22.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.5 m -90.98 -27.28 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.603 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.1 t -114.67 110.5 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.485 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 23.5 ptm -89.24 138.32 31.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.186 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.47 144.96 39.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.996 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.79 69.88 0.97 Allowed Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.805 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.96 -45.68 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -157.12 137.93 13.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -73.18 92.77 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.825 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 29.2 pt -71.07 158.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.801 -176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -115.63 110.07 18.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.538 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.6 t -114.11 112.37 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.856 0.36 . . . . 0.0 111.023 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.849 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 112.07 134.43 6.31 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.51 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -162.57 94.27 1.21 Allowed Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.12 -39.77 89.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.026 2.484 . . . . 0.0 112.961 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 71.35 -52.14 0.69 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.387 0.675 . . . . 0.0 111.773 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -98.01 64.17 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.153 0.501 . . . . 0.0 110.226 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 mt -90.06 56.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.751 0.786 . . . . 0.0 109.418 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.33 -55.01 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.048 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -82.85 -48.73 10.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.575 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.52 -33.55 62.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.066 -175.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.637 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 57.7 tp60 -51.93 -53.36 52.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -174.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 49.4 Cg_exo -56.77 -32.22 90.74 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.13 1.887 . . . . 0.0 112.471 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 48.7 mm -72.46 -41.62 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.184 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 194' ' ' ALA . 43.7 mt -64.22 -39.23 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.626 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.52 -40.5 78.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.815 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.59 -47.88 65.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.367 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 97.5 mt -55.91 -43.35 77.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.837 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.22 77.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 206' ' ' ARG . 39.5 tt0 -73.75 -44.19 56.91 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.931 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.65 -28.3 63.66 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.209 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.23 76.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.779 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 203' ' ' GLU . 27.8 ptt180 -71.49 -19.7 62.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.172 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.42 66.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.0 -16.04 27.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.944 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.16 40.83 17.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.245 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HG2' ' HB2' ' A' ' 256' ' ' GLU . 98.8 mtt180 -101.93 136.15 42.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.5 pt -116.34 168.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.687 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -118.76 115.15 23.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.475 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 2.2 p -108.67 121.21 61.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.366 0.603 . . . . 0.0 110.726 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.77 -179.3 4.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.929 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 134' ' ' PRO . 8.6 t 71.0 14.67 6.79 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.909 0.756 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.702 HG11 HD21 ' A' ' 240' ' ' LEU . 60.6 t -61.93 122.91 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.319 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.429 ' HB3' HD11 ' A' ' 220' ' ' LEU . 6.9 t-80 -60.66 136.08 57.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -63.74 -22.68 67.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -165.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -48.05 15.11 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -174.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -82.95 147.82 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.358 0.599 . . . . 0.0 111.786 -174.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 49.9 m -108.25 -175.49 2.79 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.965 -166.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -50.31 -51.77 42.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.181 0.592 . . . . 0.0 112.307 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 226' ' ' LYS . 26.1 t70 -55.8 -29.88 60.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.325 0.583 . . . . 0.0 110.769 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.665 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 58.3 m-20 -76.04 -56.46 4.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.465 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.591 HD11 HD13 ' A' ' 220' ' ' LEU . 36.7 mm -61.12 -22.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.306 -178.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.537 ' HE2' HG21 ' A' ' 235' ' ' ILE . 53.2 tttm -55.62 -31.66 62.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.399 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 71.2 m -48.54 -61.82 1.82 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.452 0.644 . . . . 0.0 112.201 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.725 ' HB ' ' HE1' ' A' ' 270' ' ' MET . 5.2 m -67.28 -46.99 82.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.623 -171.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.475 ' HZ ' ' HB ' ' A' ' 213' ' ' VAL . 64.5 m-85 -61.66 -42.42 98.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.692 0.282 . . . . 0.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 50.7 tt0 -77.13 -23.9 51.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.243 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.96 68.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.739 -0.209 . . . . 0.0 111.017 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.77 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.3 m-85 -83.6 -53.85 5.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -141.05 155.94 25.29 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.422 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.491 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 26.9 mmtp -66.37 140.22 58.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.726 0.774 . . . . 0.0 112.169 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.786 HD11 HG23 ' A' ' 255' ' ' ILE . 10.5 tp -84.86 146.36 6.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.795 -173.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -107.72 -51.36 2.92 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 16.0 m -143.6 143.01 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.57 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 28.3 p -144.71 133.8 22.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.273 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.0 m -150.81 103.75 3.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.212 0.529 . . . . 0.0 109.951 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.719 HD12 ' HA3' ' A' ' 253' ' ' GLY . 18.8 tp -83.43 129.95 35.01 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -69.85 137.74 51.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 111.461 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.533 ' HA ' ' H ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -143.45 157.75 44.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.757 176.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.527 ' OD1' ' HE3' ' A' ' 250' ' ' LYS . 9.6 m-20 -71.13 108.36 3.7 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.575 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.61 -31.47 21.11 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.39 2.06 . . . . 0.0 112.329 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -96.03 -3.58 44.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.428 . . . . 0.0 110.757 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 243' ' ' ASP . 24.6 m -113.79 -40.84 3.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 0.0 111.406 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.9 53.66 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.157 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 242' ' ' ARG . 95.6 mttt -87.49 -178.0 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -125.21 138.55 54.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.022 0.439 . . . . 0.0 111.685 -171.109 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.533 ' H ' ' HA ' ' A' ' 242' ' ' ARG . 31.8 mmtp -80.41 149.11 30.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.69 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.76 40.92 2.3 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.719 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.56 162.7 19.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.048 0.424 . . . . 0.0 110.331 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.719 ' HA3' HD12 ' A' ' 240' ' ' LEU . . . -167.96 177.37 42.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.225 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.89 134.41 55.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 0.0 110.438 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.786 HG23 HD11 ' A' ' 235' ' ' ILE . 52.0 mt -130.75 140.2 49.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.498 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 237' ' ' SER . 43.4 tt0 -122.85 131.9 53.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -105.33 153.25 21.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.469 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -85.48 -16.24 40.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.259 0.552 . . . . 0.0 110.293 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -124.38 123.93 41.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.277 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -68.16 -23.62 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.024 0.44 . . . . 0.0 110.574 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -62.22 -37.83 86.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.373 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.442 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 12.2 m -73.62 -36.4 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.056 -176.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 m -59.63 -34.41 72.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.474 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -73.07 -37.12 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 4.7 p-10 -79.11 -26.24 42.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.416 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.11 -52.73 45.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.614 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.72 -25.72 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 p -84.71 -13.52 51.12 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 p -115.07 -32.24 5.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.839 ' HE2' ' HB2' ' A' ' 273' ' ' PHE . 2.3 mmt -69.14 -4.55 17.83 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.41 -32.78 62.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.99 0.9 . . . . 0.0 108.993 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.3 mm? -77.31 -10.63 59.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.476 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.839 ' HB2' ' HE2' ' A' ' 270' ' ' MET . 2.6 t80 -50.49 105.21 0.09 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.523 0.514 . . . . 0.0 110.403 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.14 125.26 34.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.388 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 220' ' ' LEU . 86.0 mt -130.03 86.83 2.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.681 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.01 14.16 63.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.013 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 102.02 25.02 8.16 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -140.59 142.17 35.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -81.24 139.45 35.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.125 0.488 . . . . 0.0 110.168 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 0.1 OUTLIER -79.32 -176.56 5.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.107 176.279 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 281' ' ' ARG . 26.6 mmt180 -142.26 112.7 7.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.687 HG11 ' HB2' ' A' ' 270' ' ' MET . 8.7 p -118.48 131.62 70.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.263 0.554 . . . . 0.0 111.118 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.581 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -134.96 -161.68 9.51 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.385 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -113.2 168.98 9.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.637 0.255 . . . . 0.0 110.332 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -90.26 113.15 24.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 37.9 t -83.83 -31.79 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.669 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.51 HG21 ' HG2' ' A' ' 163' ' ' PRO . 9.2 t -133.83 141.03 38.37 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.901 175.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.59 108.75 0.65 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.358 2.039 . . . . 0.0 111.937 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.85 70.03 6.69 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.596 2.197 . . . . 0.0 112.216 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 46.0 ttm -96.11 109.72 48.43 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.95 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.61 136.14 65.11 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.94 2.426 . . . . 0.0 112.479 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.02 114.8 27.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 43.9 tp -92.85 -12.31 31.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.445 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 18.5 p -105.62 116.75 59.5 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.905 0.384 . . . . 0.0 111.647 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 1.4 Cg_endo -83.23 117.01 2.44 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.193 2.595 . . . . 0.0 111.808 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -83.6 51.17 1.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.059 0.457 . . . . 0.0 111.591 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.57 177.347 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.51 87.16 7.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.043 0.449 . . . . 0.0 111.071 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 67.5 mtt -137.61 173.6 11.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.843 177.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.76 -56.58 4.93 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.56 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -81.71 112.57 19.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.966 0.412 . . . . 0.0 111.707 -176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.467 HG12 ' H ' ' B' ' 31' ' ' PHE . 9.4 t 56.05 46.36 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.377 175.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -85.4 26.67 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.553 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.23 -59.73 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.053 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.51 75.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 110.946 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.657 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.6 t80 -70.82 -17.79 62.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' B' ' 36' ' ' GLN . 30.2 mmmt -64.29 -50.28 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.74 -37.82 74.25 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.455 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.77 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.16 -58.62 4.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.428 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.758 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.6 OUTLIER -80.78 -17.81 49.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -171.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 26.2 mm-40 -56.41 -46.42 80.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 168.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.615 ' O ' HG23 ' B' ' 41' ' ' ILE . 30.5 mmm180 -73.65 -36.44 65.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.68 175.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.799 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -59.82 -45.04 93.63 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -80.28 -26.4 38.94 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.556 -1.34 . . . . 0.0 112.462 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -57.19 -45.18 83.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.849 169.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.799 HG12 ' O ' ' B' ' 38' ' ' ALA . 4.9 pt -67.03 -31.37 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.278 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.675 ' HA ' HD23 ' A' ' 220' ' ' LEU . . . -67.99 -46.12 72.22 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.192 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.43 68.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.679 ' HE3' ' HA2' ' B' ' 46' ' ' GLY . 1.3 tmmm? -70.84 -16.54 62.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.957 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' B' ' 44' ' ' LYS . 75.8 mt 78.88 -63.27 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.469 0.708 . . . . 0.0 111.337 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.679 ' HA2' ' HE3' ' B' ' 44' ' ' LYS . . . 141.21 -106.58 0.48 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.48 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.61 16.73 59.41 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.306 -177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -126.44 87.77 2.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.53 53.1 0.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.96 -174.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.68 83.07 0.07 OUTLIER Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.78 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -74.12 77.53 1.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.217 0.532 . . . . 0.0 110.112 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.179 -0.915 . . . . 0.0 108.649 -179.525 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.92 70.14 0.6 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.1 0.476 . . . . 0.0 111.635 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.5 mmt -98.18 17.52 18.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.985 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.61 92.25 5.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.755 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -61.94 -60.25 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.047 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 13.9 ptm180 -164.06 22.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -89.13 -61.03 1.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.49 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -52.15 -45.24 64.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.83 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.79 -49.45 52.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.562 HD12 ' HG3' ' A' ' 163' ' ' PRO . 4.6 mm? -69.3 -26.01 64.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.552 -176.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.168 0.509 . . . . 0.0 110.74 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.0 mm -82.5 -36.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.095 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 85.7 mtp -70.72 -28.65 64.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.209 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.2 m -81.72 2.98 27.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.641 ' HB3' ' HG3' ' A' ' 159' ' ' GLU . 38.9 ptt180 -138.32 140.93 39.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.582 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.5 m -107.92 141.11 23.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.352 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 44.9 t80 -83.7 116.56 22.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.046 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' A' ' 156' ' ' ALA . 42.8 t -101.93 111.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.47 146.04 16.83 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.337 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.7 m 74.37 -53.72 0.68 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.788 0.835 . . . . 0.0 111.776 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 123' ' ' LEU . 63.6 mt 68.93 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.437 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 27.3 t80 177.26 -85.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -174.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.483 ' CD2' ' HD3' ' A' ' 153' ' ' LYS . 1.5 t80 177.58 -77.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.308 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.19 43.93 1.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.552 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 35.6 mt -100.86 123.81 45.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.697 ' HA2' ' HH2' ' A' ' 145' ' ' TRP . . . -83.6 171.12 49.13 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.77 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -63.83 -48.16 77.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 129' ' ' ARG . 34.5 t70 -62.44 -30.46 71.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.628 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 m -59.79 -49.8 76.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.029 0.442 . . . . 0.0 110.453 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.69 -34.52 41.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.308 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.411 ' HB3' ' HA ' ' A' ' 126' ' ' ASP . 26.6 ttm180 -55.58 -45.73 77.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.794 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 32.1 mm-40 -74.83 -30.54 61.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.439 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.75 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.633 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.454 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 93.2 m-85 -100.77 11.13 40.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.046 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB3' ' HD3' ' A' ' 134' ' ' PRO . . . -68.86 -44.04 29.07 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.789 -177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.633 ' CB ' ' HA ' ' A' ' 215' ' ' SER . 13.2 Cg_exo -72.29 -8.61 23.02 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.774 1.649 . . . . 0.0 111.994 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.567 ' O ' ' HB1' ' A' ' 165' ' ' ALA . 65.7 m-85 -102.64 65.53 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 110.464 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . 84.31 177.16 51.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.621 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -91.3 115.45 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.906 2.404 . . . . 0.0 112.273 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.521 HD13 ' HE1' ' A' ' 160' ' ' TYR . 36.8 mm -56.75 115.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.089 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -96.4 -55.03 3.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.761 0.315 . . . . 0.0 110.604 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.751 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 23.3 t -135.28 137.08 42.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.11 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.18 127.25 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.624 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.7 t70 -133.25 126.11 30.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.397 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 65.4 mtp -147.37 147.83 30.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.961 0.41 . . . . 0.0 111.616 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.5 m -79.63 131.17 35.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 168.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.697 ' HH2' ' HA2' ' A' ' 124' ' ' GLY . 82.7 m95 -133.53 150.44 51.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.255 0.55 . . . . 0.0 112.264 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -124.35 89.06 3.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.694 168.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.9 m 65.8 -174.37 0.18 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.199 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 37.9 t -68.44 -20.98 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 110.424 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 p -67.73 9.74 0.25 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.503 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 20.9 ptp 47.45 38.31 7.52 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 171.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.421 ' HE3' ' OH ' ' A' ' 121' ' ' TYR . 56.2 mtpt -92.49 137.86 32.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -170.55 -78.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.483 ' HD3' ' CD2' ' A' ' 121' ' ' TYR . 22.4 mtmm 54.78 35.67 24.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.655 0.382 . . . . 0.0 111.316 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -102.26 -107.78 3.13 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.526 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.96 165.99 23.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.875 0.369 . . . . 0.0 110.581 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.672 ' HB3' ' HB ' ' A' ' 116' ' ' VAL . . . -145.18 135.77 24.35 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.447 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 51.2 m-85 -113.31 107.9 16.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.915 0.388 . . . . 0.0 110.134 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.09 103.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 28.6 tt0 -105.94 126.47 52.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 -172.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.521 ' HE1' HD13 ' A' ' 138' ' ' ILE . 78.0 m-85 -109.25 -177.98 3.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.11 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -109.23 -1.73 18.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.909 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.88 122.53 16.53 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.435 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.562 ' HG3' HD12 ' A' ' 108' ' ' LEU . 34.0 Cg_endo -65.65 -21.62 58.84 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.902 2.401 . . . . 0.0 113.397 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.97 -63.75 1.04 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.164 0.507 . . . . 0.0 110.466 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 135' ' ' PHE . . . -52.56 -43.15 65.03 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.136 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.02 -51.88 66.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.445 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.564 ' HB3' HG21 ' A' ' 286' ' ' VAL . 57.8 tp60 -66.88 -35.45 80.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 212' ' ' TYR . 11.0 tp -64.76 -51.77 60.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.197 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.57 -36.58 81.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.308 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.473 ' HG ' ' HA3' ' A' ' 186' ' ' GLY . 7.6 tt -57.19 -62.37 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.485 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.29 -39.0 85.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -67.62 -49.89 60.82 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 57.8 mtt -82.9 -17.78 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -69.49 -35.36 75.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.233 0.54 . . . . 0.0 109.671 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.9 t -88.2 -43.76 11.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.983 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.85 94.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.783 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.437 ' SD ' ' HA ' ' A' ' 182' ' ' ASN . 62.3 mtm -65.78 167.99 8.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.439 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.8 tp -80.23 74.41 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.891 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.82 -123.41 9.79 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 12.22 70.17 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.894 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 177' ' ' MET . 30.1 tpt180 -104.14 119.93 40.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.674 0.273 . . . . 0.0 110.76 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.437 ' HA ' ' SD ' ' A' ' 177' ' ' MET . 21.7 p-10 -78.23 116.02 18.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.408 0.623 . . . . 0.0 110.081 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.48 144.97 17.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -102.05 110.39 22.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.1 m -135.39 106.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.53 . . . . 0.0 110.787 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.473 ' HA3' ' HG ' ' A' ' 170' ' ' LEU . . . 125.52 -165.62 18.6 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.796 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 57.86 89.12 0.11 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.312 0.645 . . . . 0.0 110.93 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.25 -14.25 28.4 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.45 2.767 . . . . 0.0 113.82 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t 72.95 -61.54 0.5 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.055 0.542 . . . . 0.0 111.209 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -84.05 70.87 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 30.8 pt -95.75 -172.79 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.323 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.475 ' H ' ' HB2' ' A' ' 195' ' ' GLN . . . 103.28 -50.29 0.9 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.105 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.67 -43.01 39.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.15 0.5 . . . . 0.0 110.183 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.66 6.32 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.779 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.54 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 52.8 tp60 -61.98 -49.33 85.84 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.668 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -55.17 -37.27 94.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.061 1.841 . . . . 0.0 111.722 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.41 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.3 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 194' ' ' ALA . 48.2 mm -56.68 -48.32 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.191 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.02 -50.78 64.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.835 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 196' ' ' PRO . 98.1 mt-30 -57.04 -44.73 83.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.814 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.15 -56.67 6.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.649 0.261 . . . . 0.0 111.135 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -62.24 -32.52 73.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.981 -173.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HG2' ' NH1' ' A' ' 206' ' ' ARG . 3.0 tm-20 -74.35 -46.13 42.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.429 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.93 -30.15 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.358 . . . . 0.0 110.928 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.93 -25.06 67.97 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.26 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.425 ' NH1' ' HG2' ' A' ' 203' ' ' GLU . 93.6 mtt180 -66.7 -26.22 66.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.59 -17.7 62.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.258 0.551 . . . . 0.0 111.257 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.9 -10.05 19.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.755 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 257' ' ' TYR . 3.2 m-80 54.23 29.32 10.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.489 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.9 136.41 33.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 111.26 -174.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.66 HG23 ' HB ' ' A' ' 255' ' ' ILE . 8.9 tt -112.94 147.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.588 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.561 ' CD2' HD22 ' A' ' 168' ' ' LEU . 66.1 t80 -107.86 123.0 47.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.5 . . . . 0.0 109.657 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 280' ' ' LEU . 1.6 p -114.53 122.97 69.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.188 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.41 178.22 5.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.633 ' HA ' ' CB ' ' A' ' 134' ' ' PRO . 15.6 m 68.55 25.6 6.64 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.776 0.672 . . . . 0.0 110.909 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 225' ' ' ILE . 85.1 t -68.08 138.7 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.683 ' HB2' HD23 ' A' ' 275' ' ' LEU . 21.2 t-80 -66.41 131.15 45.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -50.55 -44.22 56.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -167.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.61 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -79.62 -46.54 17.03 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 178.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.854 HD22 HD21 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -55.32 114.45 1.81 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.262 0.625 . . . . 0.0 110.27 -177.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 6.6 t -95.21 -175.8 3.62 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -166.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.56 -44.0 96.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.838 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.79 -27.91 67.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 221' ' ' SER . 5.5 m-20 -63.49 -59.64 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.525 HD11 HG13 ' A' ' 216' ' ' VAL . 37.6 mm -55.96 -26.06 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.238 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.493 ' HG3' HD12 ' A' ' 235' ' ' ILE . 88.2 tttt -57.24 -32.29 66.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.653 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.526 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 74.5 m -49.03 -56.64 8.36 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.922 0.868 . . . . 0.0 111.748 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.632 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.2 m -73.85 -49.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.353 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.599 ' HE2' HD13 ' A' ' 211' ' ' ILE . 43.3 m-85 -59.63 -41.82 91.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.629 0.252 . . . . 0.0 111.627 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 30.9 tt0 -74.2 -25.94 59.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.12 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.89 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.693 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 0.1 OUTLIER -90.18 -58.55 2.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -127.44 154.82 19.72 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 36.7 mmtm -84.11 140.79 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.58 0.705 . . . . 0.0 112.056 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.493 HD12 ' HG3' ' A' ' 226' ' ' LYS . 56.5 mt -103.69 134.38 45.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.094 -171.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 1.092 ' HE2' ' HB3' ' A' ' 258' ' ' GLU . 62.6 mmtt -84.03 -46.08 12.39 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.986 176.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 21.9 t -147.24 136.63 22.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.614 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.415 ' HB3' HG21 ' A' ' 235' ' ' ILE . 3.5 p -132.64 135.4 45.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.9 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.8 t -157.66 139.77 14.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.336 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.576 HD23 ' HA3' ' A' ' 253' ' ' GLY . 72.7 mt -111.11 129.91 55.78 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.42 134.98 57.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 110.681 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.653 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.0 mtp180 -89.19 157.28 18.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.371 0.605 . . . . 0.0 111.695 -177.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.04 97.99 40.63 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.289 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.86 -23.92 29.8 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.838 2.359 . . . . 0.0 111.624 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 24.3 m -64.43 -47.02 80.7 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.47 -176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.469 ' HB ' ' HG2' ' A' ' 248' ' ' LYS . 1.7 m -94.69 -33.44 12.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.02 0.438 . . . . 0.0 111.108 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.13 43.3 2.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.529 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.469 ' HG2' ' HB ' ' A' ' 246' ' ' THR . 23.2 pttp -147.51 -166.94 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -175.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 19.4 p80 -112.98 147.52 36.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' A' ' 242' ' ' ARG . 88.2 mttt -74.89 152.25 38.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.799 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -76.91 42.77 1.87 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.539 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -161.85 160.31 27.94 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.576 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -172.48 -164.08 27.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.333 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -129.85 137.31 50.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.975 0.417 . . . . 0.0 110.828 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.66 ' HB ' HG23 ' A' ' 211' ' ' ILE . 41.4 mm -119.56 128.98 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.336 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.64 113.26 26.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.153 0.502 . . . . 0.0 111.301 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.511 ' O ' ' HB2' ' A' ' 209' ' ' ASN . 49.6 m-85 -93.33 156.88 16.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.064 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 1.092 ' HB3' ' HE2' ' A' ' 236' ' ' LYS . 8.5 pt-20 -92.01 -17.28 25.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.343 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -127.98 118.54 23.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.473 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.1 66.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.601 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.32 -40.58 93.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.597 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 14.7 m -70.49 -36.03 73.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 267' ' ' VAL . 17.7 m -54.34 -48.63 71.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.209 174.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -64.89 -39.59 93.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.388 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -63.04 -46.05 89.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.76 86.49 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.542 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.562 ' HA ' HG23 ' A' ' 282' ' ' VAL . 71.3 t -60.39 -35.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 111.28 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.6 m -89.92 -4.73 57.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.711 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . 0.496 ' HB3' ' CG2' ' B' ' 27' ' ' VAL . 26.5 p -115.74 -47.01 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.771 ' HB2' HG21 ' A' ' 282' ' ' VAL . 55.3 mmm -65.18 -14.83 61.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 15.0 p-10 -72.76 -26.42 61.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.521 0.677 . . . . 0.0 110.323 176.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.55 -8.72 59.69 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.886 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 69.7 t80 -57.95 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 111.363 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.69 103.48 6.68 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.995 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.854 HD21 HD22 ' A' ' 220' ' ' LEU . 22.1 tp -113.43 86.98 2.5 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.925 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 62.01 41.24 99.66 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.662 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 119.23 -21.48 9.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.749 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.427 ' NE2' ' HD2' ' A' ' 217' ' ' HIS . 0.0 OUTLIER -132.9 137.0 46.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.545 0.672 . . . . 0.0 111.777 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -78.04 128.92 34.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.089 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.886 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 8.0 tp -61.46 169.9 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.177 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.42 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 32.3 mmt180 -142.68 113.34 7.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 121.982 -0.448 . . . . 0.0 110.138 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.771 HG21 ' HB2' ' A' ' 270' ' ' MET . 28.7 m -124.94 168.03 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.991 0.424 . . . . 0.0 112.132 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.544 ' O ' HG13 ' A' ' 211' ' ' ILE . . . 176.94 -164.39 33.81 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.314 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 148.36 43.33 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.821 0.311 . . . . 0.0 110.343 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 212' ' ' TYR . . . -69.37 -16.33 63.5 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.178 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 167' ' ' GLN . 49.1 t 72.02 -65.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.673 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 6.2 t -97.33 134.36 22.78 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.416 ' HB2' ' HG3' ' A' ' 291' ' ' PRO . 27.2 Cg_endo -64.27 110.42 1.37 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.736 2.291 . . . . 0.0 111.636 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.14 110.15 1.69 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.809 2.34 . . . . 0.0 112.241 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 290' ' ' MET . 24.8 ptt? 42.21 76.85 0.48 Allowed Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.139 0.976 . . . . 0.0 113.215 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.416 ' HG3' ' HB2' ' A' ' 288' ' ' PRO . 23.4 Cg_exo -65.48 -28.26 53.91 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.165 1.91 . . . . 0.0 110.246 170.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 96.5 mt -123.82 -158.65 0.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.493 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 90.2 mt 62.98 32.96 15.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.991 0.424 . . . . 0.0 111.007 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 27.4 m -96.01 106.17 26.43 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.019 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 4.0 Cg_exo -77.46 60.23 7.0 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.256 2.638 . . . . 0.0 112.163 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -93.49 103.05 15.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.324 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.17 179.937 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.941 -0.463 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.52 40.96 0.92 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 80.9 mtp -59.42 -50.95 71.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.405 0.622 . . . . 0.0 110.437 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.92 123.12 0.68 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.884 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.06 89.82 7.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.73 0.776 . . . . 0.0 109.19 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' A' ' 269' ' ' SER . 8.8 p -66.36 -33.58 64.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.888 -170.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -80.39 15.49 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.368 0.604 . . . . 0.0 110.677 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -119.79 -51.33 2.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.006 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.08 -41.0 23.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.875 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.631 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 10.7 t80 -69.02 -19.86 64.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.6 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' B' ' 32' ' ' LYS . 44.0 mtpt -69.08 -47.0 66.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.719 ' HA ' HE21 ' B' ' 36' ' ' GLN . 0.2 OUTLIER -58.97 -39.5 81.93 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.603 0.716 . . . . 0.0 109.118 175.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.693 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.64 -51.37 49.61 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.648 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.713 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.03 -20.85 40.79 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.719 HE21 ' HA ' ' B' ' 33' ' ' ASP . 37.2 mt-30 -59.53 -44.0 93.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.615 ' O ' HG23 ' B' ' 41' ' ' ILE . 72.7 mtp180 -73.63 -30.3 62.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.685 175.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.843 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -64.5 -49.81 69.86 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -80.1 -24.52 40.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.495 -1.378 . . . . 0.0 112.36 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.18 -50.43 59.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.074 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.843 HG12 ' O ' ' B' ' 38' ' ' ALA . 1.7 pt -66.4 -31.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.63 -22.61 65.32 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.97 -27.31 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.203 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 tmmt? -74.22 -55.26 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.376 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.61 HG23 ' HB2' ' A' ' 219' ' ' ASP . 87.2 mt 66.77 104.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 O-C-N 123.573 0.545 . . . . 0.0 112.198 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.84 165.42 28.05 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.549 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.22 -179.81 50.8 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.193 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.94 96.97 5.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.072 0.463 . . . . 0.0 110.43 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' B' ' 52' ' ' SER . . . -78.45 -21.77 48.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.843 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.22 -116.87 6.94 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.811 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 5.3 p -93.53 47.27 1.23 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.266 0.555 . . . . 0.0 111.007 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.626 ' HB3' ' HB1' ' B' ' 49' ' ' ALA . 5.1 t . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.423 -0.799 . . . . 0.0 109.309 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 112.422 -0.271 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.77 79.03 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.699 0.285 . . . . 0.0 111.225 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 39.4 ttm 62.02 16.76 8.44 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.147 172.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.54 -46.16 60.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.082 0.467 . . . . 0.0 110.51 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -94.6 153.87 17.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.139 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -80.63 50.57 1.34 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.216 0.532 . . . . 0.0 110.49 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.49 20.57 12.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.575 -177.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -53.85 -51.03 64.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.553 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.24 -34.8 61.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 0.0 111.673 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.19 -32.83 69.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.468 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.53 -49.13 62.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.77 0.319 . . . . 0.0 111.65 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.04 -35.93 16.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.79 0.328 . . . . 0.0 111.533 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 91.4 mmm -71.67 -26.58 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 p -78.34 -12.34 60.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.19 133.25 50.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.473 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -94.08 138.0 21.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 0.0 110.915 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.567 ' HB2' ' HA ' ' A' ' 188' ' ' PRO . 72.5 t80 -89.66 106.13 18.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.169 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.6 t -103.53 110.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 118' ' ' SER . . . -134.39 100.24 0.37 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.608 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.607 ' OG ' ' HA ' ' A' ' 183' ' ' ILE . 68.5 p 151.59 51.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.306 1.443 . . . . 0.0 107.549 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.9 mm -74.81 69.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.483 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.687 ' HE1' ' HA3' ' A' ' 179' ' ' GLY . 35.1 t80 37.86 -92.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.544 1.152 . . . . 0.0 112.387 169.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' HD2' ' HG3' ' A' ' 122' ' ' GLU . 33.0 t80 -179.3 -72.76 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.485 173.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.522 ' HG3' ' HD2' ' A' ' 121' ' ' TYR . 48.2 mt-10 -90.07 44.27 1.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.774 HD22 HG21 ' A' ' 127' ' ' THR . 48.9 mt -102.2 164.63 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.48 175.82 18.1 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.858 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -60.76 -39.59 89.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.3 m-20 -48.43 -50.96 29.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.684 175.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.774 HG21 HD22 ' A' ' 123' ' ' LEU . 6.9 m -57.56 -47.7 81.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.324 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.411 HG23 ' HE2' ' A' ' 132' ' ' PHE . 79.0 mt -69.42 -41.04 80.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.807 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.446 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 14.8 ttm180 -59.57 -44.64 93.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.79 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 92.9 mt-30 -75.52 -21.46 57.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.45 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.96 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.623 ' CE1' ' HG3' ' A' ' 173' ' ' MET . 97.4 m-85 -96.22 13.39 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.012 0.434 . . . . 0.0 111.141 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.584 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -71.67 -43.6 11.65 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.453 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 38.0 Cg_endo -67.08 -4.47 11.61 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 0.0 112.792 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 169' ' ' ALA . 4.9 m-85 -85.4 -83.06 0.17 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.55 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -129.67 -176.25 14.36 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.898 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.457 ' HD3' ' CZ ' ' A' ' 252' ' ' TYR . 60.9 Cg_endo -74.57 117.32 4.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.513 2.142 . . . . 0.0 111.444 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -57.12 107.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.917 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 159' ' ' GLU . 23.1 tptp -87.55 -54.49 4.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.379 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -166.73 144.05 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.8 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 63.5 mt -127.35 107.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.32 118.68 35.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.065 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 42.2 ttm -126.56 136.65 52.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.972 0.415 . . . . 0.0 111.189 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.628 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 3.7 m -98.73 111.21 23.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.886 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 2.1 p-90 -164.87 159.64 18.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.03 0.443 . . . . 0.0 111.369 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 153' ' ' LYS . 21.5 t70 -89.34 132.89 34.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.64 -176.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.1 t -101.76 4.98 41.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 110.952 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 91.5 t -85.14 -43.24 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.363 0.601 . . . . 0.0 110.058 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.5 p -119.72 5.22 11.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.002 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 58.46 30.0 19.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.611 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -89.27 128.17 35.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.886 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 58.9 m-70 -81.98 75.41 8.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.522 0.677 . . . . 0.0 110.991 -175.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 146' ' ' ASP . 58.9 mttm -78.5 63.79 3.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.506 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 144' ' ' SER . . . 158.89 -157.86 28.86 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -124.66 174.18 8.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.69 137.22 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 85.7 m-85 -113.42 113.9 25.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.032 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.0 t -101.01 111.68 31.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.816 0.341 . . . . 0.0 110.256 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 37.8 tt0 -101.52 141.22 34.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.93 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -122.96 172.94 8.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.31 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.63 -27.72 31.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.066 0.46 . . . . 0.0 110.203 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.508 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 6.2 m -121.48 136.52 25.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.864 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 8.2 Cg_exo -73.99 -13.82 23.79 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.72 2.947 . . . . 0.0 112.088 -177.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -60.23 -47.97 83.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.217 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.1 -26.1 68.67 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.5 -49.85 44.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.091 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -66.89 -36.05 81.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.721 0.296 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.86 -43.37 96.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.111 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . . . -59.86 -38.61 82.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.766 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.5 tt -60.35 -60.45 3.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -69.35 -47.29 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -71.59 -31.26 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.623 ' HG3' ' CE1' ' A' ' 132' ' ' PHE . 24.6 mmt -83.36 -28.79 28.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.76 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -76.97 -16.51 59.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 110.513 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.2 m -78.44 -13.91 59.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.152 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.07 143.18 36.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.053 0.454 . . . . 0.0 110.794 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 22.1 ttt -99.11 104.25 16.23 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.07 -28.79 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.234 -171.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.687 ' HA3' ' HE1' ' A' ' 120' ' ' TYR . . . -161.08 -150.74 6.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.076 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.03 23.18 1.8 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.931 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.628 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 14.4 ptm180 -157.43 151.66 24.8 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -79.31 141.12 37.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.609 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.607 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 27.3 pt -100.12 131.81 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 0.0 110.388 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 81.2 tttt -103.83 117.74 35.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.248 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 48.1 t -125.29 106.58 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 130.82 159.97 9.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.146 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 67.36 83.69 0.18 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.158 0.504 . . . . 0.0 110.817 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 115' ' ' TYR . 17.3 Cg_exo -66.87 -60.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.961 2.441 . . . . 0.0 112.816 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.8 p -151.83 -61.53 0.17 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.918 0.39 . . . . 0.0 110.971 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.53 132.72 33.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.2 tp -142.98 137.34 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.42 . . . . 0.0 110.562 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 195' ' ' GLN . . . 93.42 -42.33 2.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.386 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -59.18 -31.79 69.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.641 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.48 12.11 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 110.849 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.574 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 62.4 tp60 -63.72 -49.51 76.2 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.563 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.1 -34.2 67.18 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.342 2.028 . . . . 0.0 112.614 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 46.3 mm -67.91 -42.15 85.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.285 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.12 -47.37 93.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.648 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.47 -32.64 74.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.115 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -71.76 -47.1 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.35 -21.49 63.82 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.325 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.96 97.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.13 -35.98 76.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.634 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.31 -35.91 82.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.59 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.15 -20.18 62.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.677 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -64.12 -22.27 66.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.948 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.35 58.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.895 0.379 . . . . 0.0 111.138 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -96.48 -17.37 20.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.99 26.25 11.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.776 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 210' ' ' ARG . 8.3 ptm85 -120.23 144.24 47.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.201 0.524 . . . . 0.0 111.654 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.57 170.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.246 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -112.9 133.4 54.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.589 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 33.3 t -118.16 123.45 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.23 169.77 10.57 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.159 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.0 p 53.19 44.53 30.12 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.352 1.061 . . . . 0.0 111.714 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.593 HG13 HD11 ' A' ' 225' ' ' ILE . 48.5 t -79.14 146.13 8.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.218 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.626 ' HB2' HD23 ' A' ' 275' ' ' LEU . 14.1 t-80 -68.95 129.86 41.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -57.0 -36.95 71.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -167.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.978 ' HB2' HG23 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -80.11 -47.63 14.48 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.074 0.464 . . . . 0.0 111.479 174.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 275' ' ' LEU . 0.3 OUTLIER -59.67 108.66 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.948 -178.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 225' ' ' ILE . 44.2 m -97.11 -176.96 3.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -168.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.617 ' HB3' HD13 ' A' ' 240' ' ' LEU . 4.5 p-10 -57.88 -38.65 76.15 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.46 -34.92 69.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.483 0.658 . . . . 0.0 109.974 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.649 ' OD2' ' HE3' ' B' ' 44' ' ' LYS . 3.2 m-20 -73.88 -54.34 8.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.298 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.593 HD11 HG13 ' A' ' 216' ' ' VAL . 31.3 mm -54.71 -24.84 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 222' ' ' ASP . 50.4 mtpt -52.01 -33.88 40.4 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 112.026 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 72.7 m -49.23 -58.73 4.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.529 0.68 . . . . 0.0 111.816 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.661 HG11 ' CD1' ' A' ' 273' ' ' PHE . 13.7 m -74.41 -45.18 46.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.808 -171.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.496 ' CE1' ' HE2' ' A' ' 270' ' ' MET . 76.5 m-85 -68.52 -38.37 80.84 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.096 -0.378 . . . . 0.0 111.799 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.52 -25.64 45.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.384 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.36 83.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.553 0.216 . . . . 0.0 111.368 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.711 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 1.4 m-30 -75.64 -27.84 58.56 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.47 -109.07 0.45 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.919 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -157.43 139.63 14.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.528 HG21 ' HB2' ' A' ' 238' ' ' CYS . 54.6 mt -94.22 132.16 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.234 0.54 . . . . 0.0 111.085 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -88.32 -42.97 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.17 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.8 ' HB3' ' HB3' ' A' ' 256' ' ' GLU . 34.5 t -147.35 143.08 27.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.625 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.528 ' HB2' HG21 ' A' ' 235' ' ' ILE . 41.8 t -146.33 124.03 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 62.8 m -157.18 127.21 6.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 222' ' ' ASP . 7.6 mp -104.49 123.49 47.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.72 136.6 57.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.215 0.531 . . . . 0.0 111.324 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.783 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 49.2 mtp85 -101.01 158.66 15.84 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.653 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.02 107.95 60.3 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 170.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -62.78 -38.41 49.16 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.035 2.49 . . . . 0.0 111.99 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.7 m -59.87 -42.76 94.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.252 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.4 m -90.74 -22.76 20.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 21.7 62.35 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.899 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -134.81 148.95 50.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.783 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 10.8 p80 -76.12 142.64 41.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.671 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -69.81 153.16 43.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -77.2 40.39 1.71 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.324 -0.465 . . . . 0.0 113.979 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.457 ' CZ ' ' HD3' ' A' ' 137' ' ' PRO . 28.8 p90 -159.28 160.45 35.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -169.03 -171.82 35.16 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -126.75 136.98 53.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.834 0.349 . . . . 0.0 111.055 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.12 118.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.8 ' HB3' ' HB3' ' A' ' 237' ' ' SER . 57.4 tt0 -105.03 129.88 53.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.006 0.432 . . . . 0.0 110.259 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -107.2 161.57 14.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.84 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.22 -22.14 20.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 262' ' ' SER . 4.8 tppt? -111.8 115.24 28.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.468 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 264' ' ' GLN . . . -60.55 -33.72 73.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.32 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -69.05 -34.51 75.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.978 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 259' ' ' LYS . 9.5 t -62.07 -38.79 90.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.5 m -59.76 -42.99 94.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 260' ' ' ALA . 59.8 mm-40 -68.15 -34.78 76.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 -174.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.4 -40.14 64.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.929 0.395 . . . . 0.0 110.23 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.83 -51.92 65.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.442 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.04 -26.1 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 97.2 p -65.37 -34.7 78.93 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.672 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.6 t -116.85 0.67 12.56 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.524 ' HB2' HG11 ' A' ' 282' ' ' VAL . 34.9 mmm -79.4 -17.81 53.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -171.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.565 HD22 ' HD3' ' A' ' 281' ' ' ARG . 18.9 t-20 -61.37 -31.54 71.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.042 0.925 . . . . 0.0 110.083 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' B' ' 24' ' ' MET . 3.3 mm? -75.32 -8.37 56.47 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.46 -174.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.713 ' HD2' ' HB2' ' A' ' 280' ' ' LEU . 55.9 t80 -57.37 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 110.395 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -77.35 119.81 21.5 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.526 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.79 HD21 HD22 ' A' ' 220' ' ' LEU . 14.5 tp -126.2 85.83 2.44 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.486 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.08 32.33 23.65 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.382 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 87.66 19.56 53.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.754 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.412 HE21 ' HD2' ' A' ' 217' ' ' HIS . 28.3 pt20 -140.9 131.97 26.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.81 0.338 . . . . 0.0 110.382 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -76.35 136.1 39.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.075 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.91 ' HG ' ' H ' ' A' ' 281' ' ' ARG . 14.4 tp -70.71 -174.37 0.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.247 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.91 ' H ' ' HG ' ' A' ' 280' ' ' LEU . 6.4 tpp180 -143.88 118.86 10.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.524 HG11 ' HB2' ' A' ' 270' ' ' MET . 14.7 p -118.31 144.03 27.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 110.544 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.61 -159.9 9.05 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.489 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -118.59 165.13 14.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.828 0.347 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.86 88.86 5.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -51.94 -52.37 23.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.634 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 40.8 p -121.85 161.39 42.45 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.409 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -81.71 101.4 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.693 2.262 . . . . 0.0 111.409 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 287' ' ' THR . 85.7 Cg_endo -79.4 -5.85 14.4 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.692 2.261 . . . . 0.0 111.874 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 61.2 mtt -133.66 66.79 74.25 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.952 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -93.35 153.65 2.5 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.829 2.352 . . . . 0.0 112.814 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 92.5 mt -82.16 99.57 9.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.467 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 91.8 mt -67.29 126.42 29.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.033 -176.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 7.2 p -100.8 100.78 13.47 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.506 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 293' ' ' LEU . 5.0 Cg_endo -86.33 41.18 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.561 2.841 . . . . 0.0 112.306 -177.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -78.22 -27.16 47.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.12 0.486 . . . . 0.0 110.532 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 C--O 1.25 1.079 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.285 178.292 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.59 -49.84 3.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.781 0.291 . . . . 0.0 111.032 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.615 ' O ' ' HG ' ' A' ' 272' ' ' LEU . 43.9 ttm 68.74 -60.02 0.45 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.045 0.84 . . . . 0.0 111.229 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.64 169.26 42.19 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -118.91 11.65 12.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.07 0.462 . . . . 0.0 110.847 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' B' ' 31' ' ' PHE . 12.3 t -131.72 50.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -75.38 53.63 0.68 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.2 0.524 . . . . 0.0 111.656 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -154.51 -63.61 0.13 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.835 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.24 -31.05 33.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.422 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.615 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 15.5 t80 -69.4 -18.48 63.76 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.336 0.588 . . . . 0.0 110.465 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 41.2 mtpt -70.64 -45.93 64.27 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.61 -36.15 81.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.905 172.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.711 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -49.0 -51.01 33.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.483 177.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.593 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -79.86 -23.38 41.97 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -174.036 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 65.6 mt-30 -58.04 -43.31 86.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 170.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 27.1 mmt180 -73.51 -30.68 63.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.456 176.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.731 ' O ' HG12 ' B' ' 41' ' ' ILE . . . -66.51 -43.08 86.26 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -80.86 -26.86 36.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.489 -1.382 . . . . 0.0 112.136 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -55.15 -44.11 74.85 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.767 HG13 HD11 ' A' ' 220' ' ' LEU . 4.0 pt -69.1 -34.41 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.619 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -64.63 -27.14 68.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.376 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.63 -42.35 25.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.277 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.649 ' HE3' ' OD2' ' A' ' 224' ' ' ASP . 17.8 pttt -77.45 -35.36 53.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.424 -177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.978 HG23 ' HB2' ' A' ' 219' ' ' ASP . 91.7 mt 63.59 86.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 121.388 0.613 . . . . 0.0 111.016 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.42 -82.48 1.67 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.627 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.85 -82.26 0.85 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.284 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 25.9 t0 52.03 84.27 0.05 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.026 0.531 . . . . 0.0 110.651 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.59 119.37 4.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.328 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.91 29.07 1.07 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.54 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 21.8 m -71.03 127.3 32.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.965 0.412 . . . . 0.0 110.959 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.688 -0.672 . . . . 0.0 109.905 178.025 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.32 -27.73 13.01 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 47.4 ttp 56.51 77.93 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.546 0.529 . . . . 0.0 110.946 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.57 -64.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.676 -0.409 . . . . 0.0 112.051 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -87.5 -40.55 14.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HB3' ' HG2' ' A' ' 106' ' ' ARG . 75.1 mtt85 -69.75 -69.39 0.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -175.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.507 ' HB3' HD12 ' A' ' 108' ' ' LEU . 95.9 mt-30 55.8 49.22 16.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.28 0.562 . . . . 0.0 110.398 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.464 ' HG2' ' HB3' ' A' ' 104' ' ' ARG . 26.2 mmm180 -66.25 -36.21 82.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.377 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.19 86.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.072 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 105' ' ' GLN . 94.4 mt -66.89 -32.98 74.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.425 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.82 90.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.4 . . . . 0.0 111.001 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.71 -37.22 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 25.4 ttt -60.44 -28.12 68.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.2 m -91.34 6.21 46.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 113' ' ' ARG . 9.7 ptp180 -130.94 126.26 35.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.829 0.347 . . . . 0.0 110.565 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 158' ' ' VAL . 4.3 m -92.3 135.84 26.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.651 0.739 . . . . 0.0 110.834 176.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 81.2 t80 -91.1 111.24 22.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.609 -176.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 119' ' ' ILE . 9.4 t -103.01 110.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.389 . . . . 0.0 110.272 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.509 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -102.25 171.2 21.21 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.1 t 72.57 -65.69 0.34 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.97 0.508 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.512 HD13 HG12 ' A' ' 116' ' ' VAL . 10.0 mm 63.14 12.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.88 0.371 . . . . 0.0 110.545 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.835 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 11.6 t80 60.4 -80.02 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.441 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 120' ' ' TYR . 50.5 t80 169.75 -45.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.701 0.8 . . . . 0.0 109.379 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -104.62 39.15 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.022 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 66.5 mt -114.05 99.92 8.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.98 -175.04 48.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.4 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -50.63 -49.91 55.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.165 0.507 . . . . 0.0 110.823 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -59.43 -33.68 71.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 m -80.69 -39.15 27.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.01 -48.06 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 141' ' ' ILE . 4.6 ptm180 -62.13 -35.53 79.01 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.61 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -75.07 -26.55 59.45 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.302 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.33 -34.75 63.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.695 ' HA ' ' HD2' ' A' ' 135' ' ' PHE . 84.1 m-85 -96.81 10.5 38.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.957 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 134' ' ' PRO . . . -70.67 -39.07 8.63 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.495 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.639 ' O ' ' HB1' ' A' ' 214' ' ' ALA . 52.6 Cg_exo -59.15 -18.33 43.55 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.786 1.657 . . . . 0.0 112.479 170.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.695 ' HD2' ' HA ' ' A' ' 132' ' ' PHE . 57.3 m-85 -101.89 66.6 1.05 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.79 0.328 . . . . 0.0 111.033 -175.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.82 -177.63 44.27 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.38 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.41 123.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.036 2.491 . . . . 0.0 112.128 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.713 HD13 ' HE1' ' A' ' 160' ' ' TYR . 31.6 mm -67.36 108.07 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.979 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.469 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 82.0 tttt -76.6 -53.05 8.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.318 0.58 . . . . 0.0 110.144 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.2 m -155.07 143.79 20.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.466 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 129' ' ' ARG . 66.8 mt -113.11 106.15 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 35.9 t70 -81.71 98.24 8.32 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.0 tpt -130.3 130.05 44.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.904 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -93.53 106.14 18.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.029 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.593 ' HB3' ' HA ' ' A' ' 150' ' ' MET . 56.3 m95 -91.98 134.78 34.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.834 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 4.1 m-20 -73.75 102.61 4.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.261 174.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.1 t 62.07 -160.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.833 0.708 . . . . 0.0 110.551 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.3 p -74.04 -22.24 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.067 0.46 . . . . 0.0 110.494 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -13.65 61.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -173.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 145' ' ' TRP . 88.2 mtp 60.36 47.11 9.27 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.475 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.834 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 30.4 mmmt -77.79 149.99 34.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.498 . . . . 0.0 111.187 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -85.86 99.99 11.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.235 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.584 ' NZ ' ' HB3' ' A' ' 153' ' ' LYS . 2.3 ttpm? -149.18 64.44 1.03 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.396 0.617 . . . . 0.0 109.611 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 172.84 -179.04 44.56 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.698 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.509 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 84.1 m-85 -112.36 157.85 20.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.02 130.41 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.041 0.448 . . . . 0.0 110.802 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 67.0 m-85 -111.23 107.77 17.19 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.872 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.475 ' HB ' HG23 ' A' ' 114' ' ' VAL . 43.0 t -91.77 110.97 23.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.867 0.365 . . . . 0.0 110.252 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.2 138.02 35.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.294 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.713 ' HE1' HD13 ' A' ' 138' ' ' ILE . 50.7 m-85 -118.92 161.01 20.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.37 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 36.0 mt-10 -99.49 9.96 42.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.661 ' HB ' ' OE1' ' A' ' 164' ' ' GLU . 10.9 m -132.56 113.51 14.21 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.389 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.46 -24.32 36.62 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.942 2.428 . . . . 0.0 113.326 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.661 ' OE1' ' HB ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -66.67 -54.46 22.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 110.193 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.515 ' HB3' HG23 ' A' ' 162' ' ' VAL . . . -55.38 -40.13 70.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.212 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.29 91.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.8 -41.57 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.519 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.551 HD21 ' HA3' ' A' ' 283' ' ' GLY . 18.9 mt -62.36 -42.4 99.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.012 0.434 . . . . 0.0 110.648 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.36 83.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.789 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.14 -60.92 2.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.82 -46.87 77.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.473 ' OE1' ' HD3' ' A' ' 281' ' ' ARG . 47.6 mt-30 -79.29 -35.82 40.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.431 ' HG2' ' CZ ' ' A' ' 132' ' ' PHE . 51.7 tpp -77.27 -27.11 53.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.32 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -70.44 -20.3 62.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.185 0.516 . . . . 0.0 110.17 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.9 m -90.78 -2.87 57.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.728 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.01 171.12 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 111.403 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.8 mtp -117.18 97.11 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.246 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 52.9 tp -77.78 89.85 4.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.302 0.572 . . . . 0.0 110.261 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 119.42 -157.03 15.58 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.526 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.23 18.07 50.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.016 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.835 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 8.9 ptm180 -157.41 155.72 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.19 105.6 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.274 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.63 155.78 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.174 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -101.69 109.91 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.902 0.382 . . . . 0.0 110.102 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 48.3 t -101.32 106.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.102 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.43 159.89 34.91 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.58 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -164.88 144.76 5.89 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 102.27 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.963 2.442 . . . . 0.0 112.183 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.5 m -113.99 -42.4 3.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.341 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 193' ' ' GLN . 28.5 p30 -150.62 33.82 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.887 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.3 tt -63.29 115.28 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.513 0.673 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 119.02 -38.43 2.85 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 190' ' ' ASN . 14.4 mm100 -82.28 -39.51 22.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.09 0.472 . . . . 0.0 109.863 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.83 -9.27 57.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.071 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 24.4 tp60 -63.43 -52.84 57.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 119.11 -0.472 . . . . 0.0 111.98 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.9 Cg_endo -54.86 -30.81 70.09 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.519 2.146 . . . . 0.0 112.468 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.0 mm -66.04 -57.69 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.09 0.472 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 49.0 mt -64.59 -35.55 74.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.609 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.5 t70 -57.67 -49.55 76.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.435 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.87 -48.12 80.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.237 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.608 ' HB3' ' HD3' ' A' ' 288' ' ' PRO . 80.2 mt -58.97 -42.6 90.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.52 71.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.371 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 45.1 mt-10 -64.79 -42.99 94.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 288' ' ' PRO . 31.0 mt-10 -70.82 -49.36 47.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.569 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 285' ' ' ALA . . . -59.28 -31.82 69.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.995 -176.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -62.88 -27.2 69.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.92 -14.97 60.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.954 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.58 -15.12 17.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.168 0.508 . . . . 0.0 111.094 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.81 40.74 30.67 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.891 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.569 HH11 ' HG2' ' A' ' 289' ' ' PRO . 46.1 ttm180 -103.83 136.24 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.721 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.95 165.89 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.776 0.322 . . . . 0.0 110.792 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.526 ' HD2' HD11 ' A' ' 168' ' ' LEU . 49.1 t80 -116.65 122.88 45.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.057 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 255' ' ' ILE . 39.8 t -109.77 121.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.658 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 134' ' ' PRO . . . -122.23 170.49 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.591 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 10.3 t 67.55 36.28 3.81 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.631 0.582 . . . . 0.0 111.33 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.537 HG13 HD11 ' A' ' 225' ' ' ILE . 59.9 t -79.86 138.58 19.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -51.81 -43.68 63.19 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -167.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.638 ' HB3' ' HB ' ' B' ' 45' ' ' ILE . 5.2 m-20 -70.17 -45.81 65.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.812 0.339 . . . . 0.0 111.066 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.687 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -66.7 103.94 1.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 225' ' ' ILE . 46.3 m -89.83 -176.85 5.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -166.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.42 -45.46 80.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.849 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.86 -28.94 69.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.277 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.655 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 6.0 m-20 -67.47 -59.18 3.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.001 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.701 HG13 HD11 ' A' ' 240' ' ' LEU . 29.5 mm -52.95 -30.58 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.136 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.44 -32.4 39.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.027 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.568 ' HB3' ' CB ' ' B' ' 37' ' ' ARG . 70.0 m -49.79 -60.99 2.39 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.654 0.74 . . . . 0.0 112.035 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.589 HG12 ' HB1' ' B' ' 34' ' ' ALA . 4.0 m -71.74 -39.82 69.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.624 -171.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.762 ' CZ ' ' HG2' ' A' ' 270' ' ' MET . 65.1 m-85 -66.71 -39.71 88.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.726 0.298 . . . . 0.0 111.697 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.9 -24.75 55.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.421 ' O ' ' HB1' ' B' ' 30' ' ' ALA . . . -72.98 -24.28 60.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.256 -174.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.626 ' HE1' ' HB2' ' B' ' 34' ' ' ALA . 2.5 m-30 -87.47 24.71 1.59 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.48 0.657 . . . . 0.0 110.525 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 234' ' ' LYS . . . 149.27 -113.42 0.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 233' ' ' GLY . 28.4 mmmt -136.72 161.67 35.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.567 HG12 ' SG ' ' A' ' 238' ' ' CYS . 6.6 tp -122.17 139.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.528 0.68 . . . . 0.0 110.665 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -88.4 -62.74 1.42 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 15.2 m -140.88 143.79 34.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.366 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.567 ' SG ' HG12 ' A' ' 235' ' ' ILE . 74.7 m -134.52 106.82 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 21.4 m -141.48 104.71 4.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.167 0.508 . . . . 0.0 111.467 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.806 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 79.8 mt -83.57 130.75 35.0 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.56 101.94 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.598 0.561 . . . . 0.0 111.205 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 6.5 ppt_? -90.46 144.73 25.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.509 . . . . 0.0 110.846 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.03 122.76 76.02 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.504 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.67 -20.28 40.66 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.911 2.407 . . . . 0.0 113.514 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.87 -39.14 14.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 44.9 p -88.03 -35.5 17.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.864 0.364 . . . . 0.0 111.338 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.15 -2.32 68.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.658 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -108.75 157.46 18.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.887 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 16.8 p80 -86.4 145.57 26.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.254 0.55 . . . . 0.0 110.925 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.75 158.61 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.04 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -74.8 43.79 1.44 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 114.183 0.433 . . . . 0.0 114.183 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -166.18 164.64 17.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.806 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . 178.04 -169.98 42.02 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.559 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.503 ' HB3' ' HD3' ' A' ' 210' ' ' ARG . 90.6 m-85 -119.86 140.01 51.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.847 0.356 . . . . 0.0 110.538 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.433 HD12 HG21 ' A' ' 213' ' ' VAL . 48.8 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.91 176.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.99 146.25 29.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.357 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.415 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 34.2 m-85 -120.19 137.01 54.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.442 170.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -83.6 -29.5 27.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -95.8 113.56 25.21 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.837 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.29 69.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.798 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -69.41 -34.01 73.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.537 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 43.3 m -78.44 -31.51 48.07 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 267' ' ' VAL . 1.5 p -65.6 -42.92 91.1 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.173 -0.329 . . . . 0.0 111.534 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -60.72 -36.58 79.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.588 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.97 -47.38 37.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.745 -176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.43 74.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.076 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 263' ' ' SER . 94.6 t -58.12 -40.25 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.979 0.419 . . . . 0.0 111.254 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.2 t -71.69 -28.9 64.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.8 t -89.95 -43.51 10.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.768 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.881 ' HB3' HG21 ' A' ' 282' ' ' VAL . 0.0 OUTLIER -74.25 -6.33 47.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.58 -36.6 76.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.416 1.103 . . . . 0.0 109.0 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 272' ' ' LEU . 3.7 mm? -79.77 -7.76 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.646 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.715 ' HE1' ' HB1' ' B' ' 38' ' ' ALA . 2.4 t80 -58.84 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.278 0.561 . . . . 0.0 110.563 -172.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 8.3 t70 -93.75 116.32 28.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.221 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.687 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.8 mm? -114.73 87.05 2.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.761 175.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.73 -86.62 0.6 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.582 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -146.37 26.75 1.69 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.106 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 274' ' ' ASP . 20.2 pt20 -141.02 131.75 25.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.887 0.375 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.454 ' CD2' ' HB2' ' A' ' 274' ' ' ASP . 63.7 m-85 -91.66 130.81 37.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.265 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.693 HD22 ' HD2' ' A' ' 273' ' ' PHE . 7.2 mp -63.54 168.65 4.48 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.528 0.68 . . . . 0.0 111.005 175.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.473 ' HD3' ' OE1' ' A' ' 172' ' ' GLN . 2.6 mmp_? -132.45 112.11 11.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.881 HG21 ' HB3' ' A' ' 270' ' ' MET . 94.7 t -116.33 133.27 63.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.084 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.551 ' HA3' HD21 ' A' ' 168' ' ' LEU . . . -137.83 -156.09 7.07 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.174 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -103.45 172.67 6.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.412 ' HB3' ' HB1' ' A' ' 205' ' ' ALA . . . -59.41 -35.83 74.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.571 0.224 . . . . 0.0 111.502 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 61.5 t 70.42 -64.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.82 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.458 HG22 ' HG3' ' A' ' 164' ' ' GLU . 12.2 t -98.06 143.09 25.64 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' A' ' 201' ' ' LEU . 69.5 Cg_endo -79.69 106.25 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.722 2.281 . . . . 0.0 112.113 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.569 ' HG2' HH11 ' A' ' 210' ' ' ARG . 3.0 Cg_exo -76.62 70.77 6.26 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.133 2.555 . . . . 0.0 111.854 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.55 ' N ' ' HD2' ' A' ' 291' ' ' PRO . 15.2 tpt -65.3 -47.8 69.71 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.288 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 290' ' ' MET . 12.9 Cg_endo -57.34 143.84 92.81 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.988 1.792 . . . . 0.0 111.888 173.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.449 ' HA ' ' HD2' ' A' ' 295' ' ' PRO . 8.9 mp -79.81 53.54 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.097 0.475 . . . . 0.0 111.21 -175.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 76.5 mt -92.29 -17.1 25.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.837 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.667 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 31.4 m -117.16 -52.85 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.924 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 9.0 Cg_exo -73.0 65.73 4.13 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.302 2.002 . . . . 0.0 112.659 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -66.32 107.64 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.147 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.052 -175.286 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.66 -39.11 58.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.878 0.339 . . . . 0.0 111.13 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 55.8 mtm 70.52 -54.21 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.906 0.883 . . . . 0.0 111.291 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -135.46 130.91 5.57 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -84.99 -12.42 53.29 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.71 99.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.067 175.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -155.12 -85.1 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.19 -30.28 18.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.047 0.451 . . . . 0.0 109.919 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 231' ' ' ALA . . . -63.0 -37.02 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.1 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.594 ' HA ' ' HE1' ' A' ' 232' ' ' PHE . 19.1 t80 -75.95 -22.75 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.268 0.556 . . . . 0.0 110.271 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -75.8 -43.83 44.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.968 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -61.34 -37.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.626 ' HB2' ' HE1' ' A' ' 232' ' ' PHE . . . -50.63 -49.44 56.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.611 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.718 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.4 OUTLIER -81.81 -21.77 37.46 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -171.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -62.55 -38.18 89.02 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.568 ' CB ' ' HB3' ' A' ' 227' ' ' SER . 61.3 mtp180 -74.09 -35.43 64.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.629 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.718 ' HB3' ' HA ' ' B' ' 35' ' ' LEU . . . -63.13 -44.24 96.13 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' B' ' 42' ' ' ALA . 34.3 mtt180 -81.65 -26.99 34.32 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 112.96 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.66 -49.17 65.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 0.0 109.82 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 224' ' ' ASP . 6.3 pt -68.05 -30.24 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.496 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' A' ' 220' ' ' LEU . . . -67.89 -27.9 67.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.377 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.35 -31.02 19.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' B' ' 44' ' ' LYS . 7.3 ttpt -82.18 -38.5 24.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.377 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.762 HG13 ' H ' ' B' ' 46' ' ' GLY . 30.6 pt 49.66 -76.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.288 1.435 . . . . 0.0 114.043 -178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.762 ' H ' HG13 ' B' ' 45' ' ' ILE . . . -146.2 124.63 2.08 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.166 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.3 -179.91 17.03 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.012 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -124.74 9.63 8.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.083 0.468 . . . . 0.0 110.822 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.89 110.57 15.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.81 -95.72 0.2 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 176.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -150.96 24.52 0.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.803 0.811 . . . . 0.0 109.527 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.252 1.223 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.646 -178.256 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.67 116.37 15.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.59 0.234 . . . . 0.0 111.017 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 63.9 mtt 63.19 39.94 9.3 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.898 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.25 102.17 4.24 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 67.02 161.88 0.17 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.823 0.702 . . . . 0.0 110.704 -174.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -134.73 148.46 50.29 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.269 -0.269 . . . . 0.0 111.133 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 58.47 64.45 1.47 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.72 0.638 . . . . 0.0 111.255 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -62.0 -29.51 70.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.128 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.26 72.3 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.468 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.3 mt -64.95 -38.83 92.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.236 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.45 -31.64 60.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.77 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.61 -36.19 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.362 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.0 mtp -69.24 -34.04 74.2 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 28.5 p -73.78 -11.35 60.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.906 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.695 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 91.8 mtt180 -105.71 103.26 12.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.1 m -91.51 146.6 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.466 0.651 . . . . 0.0 111.377 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 61.5 t80 -86.33 118.68 25.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.878 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -117.15 113.47 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 110.192 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.79 174.51 15.25 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.345 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 t 74.73 42.41 0.29 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.541 0.737 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.7 mt -80.54 136.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.331 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -108.84 98.51 7.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.451 ' HD1' ' HA ' ' A' ' 151' ' ' LYS . 34.0 t80 37.87 -84.22 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 165.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -71.87 -16.73 62.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.786 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 127' ' ' THR . 88.8 mt -77.96 98.91 5.84 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.79 -167.53 43.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.108 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.95 -29.36 70.29 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.77 -49.58 76.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.482 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.502 HG21 HD22 ' A' ' 123' ' ' LEU . 55.9 m -64.27 -42.2 96.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.052 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.92 -42.3 88.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.425 0.631 . . . . 0.0 110.133 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.481 ' HA ' ' CD1' ' A' ' 138' ' ' ILE . 39.5 ttt180 -56.56 -46.8 80.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.024 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -77.97 -33.34 51.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.187 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.65 77.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.511 . . . . 0.0 111.207 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.496 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 46.2 m-85 -99.59 10.33 41.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.408 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -70.74 -45.25 16.8 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 23.6 Cg_endo -62.06 -10.44 17.9 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.02 1.813 . . . . 0.0 112.795 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -79.25 -67.61 0.74 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 109.803 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -156.49 165.91 33.09 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.71 112.33 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.31 2.007 . . . . 0.0 111.293 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 129' ' ' ARG . 56.7 mt -68.51 129.16 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 109.981 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -96.83 -50.92 4.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.684 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 t -149.23 161.88 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.5 mt -137.28 109.91 7.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.635 0.255 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.797 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 47.8 m-20 -84.33 111.17 19.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.271 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.582 ' HG2' ' HB3' ' A' ' 145' ' ' TRP . 24.7 ttp -156.2 101.12 2.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 0.0 110.782 175.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.0 m -77.95 69.24 4.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.91 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 14.3 p-90 -96.32 145.79 25.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.96 111.18 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.424 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 m -90.83 -12.89 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.86 -54.03 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.967 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.5 p -91.7 -19.27 22.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.164 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.652 ' HG3' ' CZ3' ' A' ' 145' ' ' TRP . 15.3 ttp 66.74 25.77 9.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.318 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.451 ' HA ' ' HD1' ' A' ' 121' ' ' TYR . 59.5 pttt -105.32 19.78 20.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.438 . . . . 0.0 110.968 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.91 ' HA ' ' HB2' ' A' ' 145' ' ' TRP . 41.1 m-70 60.2 -161.33 0.28 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.626 173.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 145' ' ' TRP . 74.6 mmtt -117.99 -44.14 2.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 157.29 -21.39 0.42 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.611 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -140.64 161.61 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.201 0.5 . . . . 0.0 112.173 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.509 ' HB2' ' SD ' ' A' ' 143' ' ' MET . . . -149.36 156.25 41.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.504 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.797 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 80.8 m-85 -114.04 112.39 23.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 57.5 t -99.07 116.86 43.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.944 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.695 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 42.4 tt0 -94.15 130.51 40.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.91 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 80.4 m-85 -100.18 155.83 17.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.778 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.99 -33.34 75.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 172.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 17.3 m -128.62 133.31 25.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.038 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 162' ' ' VAL . 37.6 Cg_exo -60.28 -23.15 73.37 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.323 2.682 . . . . 0.0 113.103 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -54.71 -49.91 69.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 111.211 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.32 70.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.056 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.15 86.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -63.46 -44.85 93.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.142 176.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 33.7 mt -63.21 -35.4 80.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 0.0 110.577 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 173' ' ' MET . . . -66.6 -30.6 70.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.633 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.46 -59.34 2.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.045 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.27 -39.92 14.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 168' ' ' LEU . 14.6 mm100 -82.45 -34.69 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 169' ' ' ALA . 55.9 tpp -72.71 -31.74 65.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.462 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.38 -19.8 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.215 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 41.6 t -78.49 -7.73 57.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.722 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.56 126.52 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 110.799 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 88.5 mtp -83.96 79.77 9.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 55.7 tp -58.51 118.46 5.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.101 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.07 11.89 83.93 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.406 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.67 5.38 89.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.145 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 181' ' ' ARG . 17.6 mtp180 -112.67 155.3 24.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -91.82 103.84 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.852 0.834 . . . . 0.0 109.106 175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.47 146.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.116 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -102.08 110.66 22.68 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 16.1 m -118.64 133.85 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.58 145.72 8.61 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.822 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.589 ' HD3' ' HB2' ' A' ' 115' ' ' TYR . 20.8 ptt180 -151.08 123.9 4.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 1.7 Cg_endo -84.36 72.62 4.99 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.258 2.639 . . . . 0.0 111.011 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 m -64.83 -22.36 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.749 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -155.21 151.11 27.75 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.52 125.0 66.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.839 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.96 -18.7 8.81 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.986 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -72.78 -57.25 4.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.753 0.311 . . . . 0.0 111.239 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -101.93 5.64 40.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.058 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.517 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 59.8 tp60 -60.96 -51.71 77.4 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.721 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 15.1 Cg_endo -57.78 -25.04 66.83 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.122 1.881 . . . . 0.0 112.169 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.6 mm -76.81 -55.93 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.603 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.6 pt -65.84 -32.0 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -45.95 90.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.887 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -58.09 -48.68 79.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.699 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.64 -50.87 70.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.171 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -60.96 -41.61 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.046 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.28 -44.26 95.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.435 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.53 -43.06 95.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.539 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.96 66.88 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.874 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 75.8 mtp180 -65.87 -18.51 65.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.094 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.95 55.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 111.167 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -104.05 -19.43 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.273 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 257' ' ' TYR . 88.6 m-20 59.43 30.45 20.13 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.57 177.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.505 ' HG2' ' HG2' ' A' ' 256' ' ' GLU . 97.4 mtt180 -88.54 140.56 29.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.229 0.538 . . . . 0.0 111.666 -175.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.723 HD13 ' HE1' ' A' ' 229' ' ' PHE . 8.3 tt -119.95 151.15 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -108.88 126.99 53.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.119 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.518 ' HB ' ' HZ ' ' A' ' 229' ' ' PHE . 3.8 p -118.75 122.72 70.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.147 0.499 . . . . 0.0 110.717 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.05 -177.91 3.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.882 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 41.8 m 67.71 16.68 9.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.634 0.774 . . . . 0.0 111.485 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.675 HG13 HD11 ' A' ' 225' ' ' ILE . 66.9 t -62.52 135.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.485 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.78 139.77 47.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.74 -30.97 69.71 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -167.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -79.59 -24.72 41.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.366 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.801 HD22 ' HG ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -83.63 104.86 14.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 2.4 p -87.39 -177.28 5.89 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.64 -54.39 14.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.989 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.46 -27.9 69.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.936 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.613 ' OD2' ' HB ' ' B' ' 41' ' ' ILE . 3.3 m-20 -63.68 -55.58 22.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.332 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.675 HD11 HG13 ' A' ' 216' ' ' VAL . 33.5 mm -60.5 -24.51 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.25 -31.34 68.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.199 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' B' ' 37' ' ' ARG . 69.7 m -48.86 -60.39 2.79 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.985 0.898 . . . . 0.0 111.634 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.676 HG12 ' HB1' ' B' ' 34' ' ' ALA . 3.1 m -71.0 -45.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.676 -170.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.723 ' HE1' HD13 ' A' ' 211' ' ' ILE . 41.4 m-85 -60.96 -40.31 92.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -76.68 -34.4 58.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.674 -175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.98 -25.14 66.96 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.724 ' HE2' ' HG2' ' A' ' 270' ' ' MET . 6.9 m-30 -73.59 -42.79 61.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -150.85 -100.8 0.21 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.672 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.76 157.66 43.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.08 138.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.115 0.484 . . . . 0.0 110.831 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 15.0 mmtp -88.02 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.556 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 27.0 t -145.03 145.05 31.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.811 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.31 129.58 45.04 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.6 p -145.11 112.52 6.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.29 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.623 HD23 ' HA3' ' A' ' 253' ' ' GLY . 78.0 mt -85.91 129.58 34.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.11 143.29 56.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 0.0 OUTLIER -121.41 157.27 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.62 121.93 73.32 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.12 -18.01 60.39 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.139 2.56 . . . . 0.0 113.96 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.5 p -82.34 -33.99 28.67 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.559 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 45.2 p -112.25 -34.58 5.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.817 0.341 . . . . 0.0 111.847 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.78 -7.25 59.12 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.597 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.9 141.53 42.31 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 5.9 p80 -79.0 143.35 35.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 0.0 110.576 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -81.15 156.09 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.147 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' A' ' 216' ' ' VAL . . . -77.69 46.46 2.6 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.88 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -164.23 157.27 17.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.966 0.383 . . . . 0.0 110.171 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.623 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -167.97 -175.28 37.59 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.355 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.08 141.17 52.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.763 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.555 ' HB ' ' CG2' ' A' ' 211' ' ' ILE . 24.2 mm -124.12 135.75 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.048 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 37.1 mt-10 -104.98 141.6 36.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.675 0.274 . . . . 0.0 111.238 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 209' ' ' ASN . 36.3 m-85 -124.25 149.55 46.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.214 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 258' ' ' GLU . 1.1 pm0 -87.22 -17.89 31.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.822 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.755 ' HA ' ' HE3' ' A' ' 259' ' ' LYS . 1.0 OUTLIER -137.28 132.05 33.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.985 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -62.04 -40.75 96.81 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.187 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' A' ' 259' ' ' LYS . 13.3 pt20 -63.76 -32.58 74.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 110.694 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.3 t -65.23 -40.66 94.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.1 m -65.13 -36.27 83.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 91.0 mt-30 -61.88 -33.76 74.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.098 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.91 -48.12 64.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.873 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 270' ' ' MET . . . -56.26 -41.68 76.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.661 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 264' ' ' GLN . 22.9 m -65.47 -27.02 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 23.3 p -94.02 -29.34 15.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.598 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.6 m -92.72 -38.31 11.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.724 ' HG2' ' HE2' ' A' ' 232' ' ' PHE . 28.8 mmm -65.83 -23.46 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -171.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.432 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 66.6 t30 -59.06 -35.04 72.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.738 . . . . 0.0 110.54 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.411 ' N ' HD22 ' A' ' 272' ' ' LEU . 3.8 mm? -77.84 -10.51 59.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.879 ' CE1' ' HB1' ' B' ' 38' ' ' ALA . 1.1 t80 -58.64 112.2 1.53 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.388 -175.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.15 120.99 35.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.926 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.801 ' HG ' HD22 ' A' ' 220' ' ' LEU . 2.0 mm? -120.19 87.57 2.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.202 172.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 82.63 35.67 18.85 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.949 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.25 62.45 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.937 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -124.43 131.68 53.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 110.394 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -75.68 149.55 38.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.744 HD21 HD23 ' A' ' 275' ' ' LEU . 11.4 mt -79.35 -172.79 3.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.958 0.409 . . . . 0.0 110.056 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.432 ' HD3' ' OD1' ' A' ' 271' ' ' ASN . 56.8 mmt-85 -147.08 113.45 5.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.873 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 270' ' ' MET . 21.0 m -122.65 157.66 27.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.14 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -177.17 -171.24 40.51 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.767 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -82.0 140.06 34.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.059 0.457 . . . . 0.0 109.917 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' A' ' 286' ' ' VAL . . . -67.24 -21.33 65.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.795 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 285' ' ' ALA . 74.6 t 71.12 -65.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 122.787 0.435 . . . . 0.0 111.008 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.453 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 7.5 t -111.58 140.76 23.49 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.425 ' HB2' ' HB3' ' A' ' 291' ' ' PRO . 56.0 Cg_endo -72.85 108.68 2.63 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.287 1.992 . . . . 0.0 112.135 176.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 287' ' ' THR . 23.7 Cg_exo -64.88 -32.97 54.29 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.729 2.286 . . . . 0.0 111.85 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.51 83.49 5.38 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.425 ' HB3' ' HB2' ' A' ' 288' ' ' PRO . 83.2 Cg_endo -83.72 10.99 3.45 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.776 2.318 . . . . 0.0 112.839 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 36.0 tp 61.53 61.13 1.53 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.837 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 54.9 tp -55.8 110.39 0.72 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.018 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 24.1 m -106.46 110.0 63.53 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.978 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.09 168.85 21.31 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.753 2.302 . . . . 0.0 111.836 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 59.27 33.06 22.41 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.286 0.565 . . . . 0.0 110.749 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.856 -179.088 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.13 46.71 2.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.132 0.491 . . . . 0.0 110.77 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . . . . . . . . . 67.9 mtt -89.92 85.85 6.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.926 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.27 114.92 2.83 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.659 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -77.35 -47.96 18.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.105 0.479 . . . . 0.0 110.849 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' B' ' 31' ' ' PHE . 1.7 m -126.16 -119.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.667 -170.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 64.4 t30 67.53 19.22 9.97 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.604 0.716 . . . . 0.0 109.785 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.83 -71.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.091 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.68 -38.59 77.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.894 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.571 ' O ' ' HB3' ' B' ' 34' ' ' ALA . 6.1 t80 -65.4 -17.24 64.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.675 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.622 ' O ' ' HG3' ' B' ' 36' ' ' GLN . 83.4 mttt -69.68 -49.49 52.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.751 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 14.4 t70 -57.12 -42.27 80.56 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.676 ' HB1' HG12 ' A' ' 228' ' ' VAL . . . -45.47 -54.31 7.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.669 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.865 ' HA ' ' HB3' ' B' ' 38' ' ' ALA . 0.0 OUTLIER -81.91 -21.49 37.32 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -171.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 79.8 mt-30 -64.94 -39.37 93.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.821 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 17.7 mmt180 -73.79 -32.96 64.02 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.626 172.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.879 ' HB1' ' CE1' ' A' ' 273' ' ' PHE . . . -66.62 -44.66 81.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . 0.253 36.8 mtp85 -82.33 -25.69 33.67 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.209 -1.557 . . . . 0.0 112.773 172.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.815 ' HA ' HE21 ' B' ' 40' ' ' GLN . 0.0 OUTLIER -53.29 -47.0 69.55 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 168.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.749 HD11 ' HZ ' ' A' ' 273' ' ' PHE . 9.2 pt -67.27 -34.27 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.468 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.521 ' O ' HG23 ' B' ' 45' ' ' ILE . . . -66.36 -25.44 66.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.888 0.375 . . . . 0.0 111.287 176.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.55 -15.53 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.748 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.487 ' HE3' ' HB3' ' B' ' 44' ' ' LYS . 1.5 tmmt? -89.84 -33.74 16.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.371 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.521 HG23 ' O ' ' B' ' 42' ' ' ALA . 7.3 pt 36.89 84.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 171.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.96 153.03 8.43 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.463 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.4 110.52 3.29 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.986 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.65 71.59 9.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.256 0.55 . . . . 0.0 110.307 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.97 137.34 44.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.179 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.25 173.37 39.1 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.984 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.9 p -59.55 -43.19 93.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.244 0.777 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.946 175.96 . . . . . . . . 0 0 . 1 stop_ save_